PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pozniak, AL; Arribas, JR				Pozniak, Anton L.; Arribas, Jose R.			FLAMINGO: how much rosier can antiretroviral therapy get?	LANCET			English	Editorial Material							HIV-1 INFECTION; DOUBLE-BLIND; DOLUTEGRAVIR; RALTEGRAVIR		[Pozniak, Anton L.] Chelsea & Westminster Hosp NHS Fdn Trust, HIV Directorate, London SW10 9NH, England; [Pozniak, Anton L.] Univ London Imperial Coll Sci Technol & Med, London, England; [Arribas, Jose R.] Hosp La Paz, IdiPAZ, Madrid, Spain	Imperial College London; Imperial College London; Hospital Universitario La Paz	Pozniak, AL (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, HIV Directorate, London SW10 9NH, England.	anton.pozniak@chelwest.nhs.uk	Arribas, Jose/A-1595-2015	Arribas, Jose/0000-0002-7410-9450				Arribas JR, 2013, CURR OPIN HIV AIDS, V8, P341, DOI 10.1097/COH.0b013e328361fabd; Clotet B, 2014, LANCET; European AIDS Clinical Society, 2013, EACS TREATM GUID VER; Koteff J, 2013, BRIT J CLIN PHARMACO, V75, P990, DOI 10.1111/j.1365-2125.2012.04440.x; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lesko CR, 2013, CLIN INFECT DIS, V57, P1027, DOI 10.1093/cid/cit421; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Mollan K, 2013, IDWEEK 2013 OCT 2 6; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541	11	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2191	2193		10.1016/S0140-6736(14)60447-5	http://dx.doi.org/10.1016/S0140-6736(14)60447-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24698484				2022-12-28	WOS:000338657600006
J	Bonawitz, ND; Kim, JI; Tobimatsu, Y; Ciesielski, PN; Anderson, NA; Ximenes, E; Maeda, J; Ralph, J; Donohoe, BS; Ladisch, M; Chapple, C				Bonawitz, Nicholas D.; Kim, Jeong Im; Tobimatsu, Yuki; Ciesielski, Peter N.; Anderson, Nickolas A.; Ximenes, Eduardo; Maeda, Junko; Ralph, John; Donohoe, Bryon S.; Ladisch, Michael; Chapple, Clint			Disruption of Mediator rescues the stunted growth of a lignin-deficient Arabidopsis mutant	NATURE			English	Article							DOWN-REGULATION; SALICYLIC-ACID; CELL-WALL; BIOSYNTHESIS; DEPOSITION; REGULATOR; 3-HYDROXYLASE; ACCUMULATION; SELAGINELLA; EXPRESSION	Lignin is a phenylpropanoid-derived heteropolymer important for the strength and rigidity of the plant secondary cell wall(1,2). Genetic disruption of lignin biosynthesis has been proposed as a means to improve forage and bioenergy crops, but frequently results in stunted growth and developmental abnormalities, the mechanisms of which are poorly understood(3). Here we show that the phenotype of a lignin-deficient Arabidopsis mutant is dependent on the transcriptional co-regulatory complex, Mediator. Disruption of the Mediator complex subunits MED5a (also known as REF4) and MED5b (also known as RFR1) rescues the stunted growth, lignin deficiency and widespread changes in gene expression seen in the phenylpropanoid pathway mutant ref8, without restoring the synthesis of guaiacyl and syringyl lignin subunits. Cell walls of rescued med5a/5b ref8 plants instead contain a novel lignin consisting almost exclusively of p-hydroxyphenyl lignin subunits, and moreover exhibit substantially facilitated polysaccharide saccharification. These results demonstrate that guaiacyl and syringyl lignin subunits are largely dispensable for normal growth and development, implicate Mediator in an active transcriptional process responsible for dwarfing and inhibition of lignin biosynthesis, and suggest that the transcription machinery and signalling pathways responding to cell wall defects may be important targets to include in efforts to reduce biomass recalcitrance.	[Bonawitz, Nicholas D.; Kim, Jeong Im; Anderson, Nickolas A.; Maeda, Junko; Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tobimatsu, Yuki; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ciesielski, Peter N.; Donohoe, Bryon S.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Ximenes, Eduardo; Ladisch, Michael] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Ximenes, Eduardo; Ladisch, Michael] Purdue Univ, Renewable Resources Engn Lab, W Lafayette, IN 47907 USA; [Ralph, John] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI 53706 USA; [Ralph, John] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA; [Ralph, John] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53726 USA; [Ladisch, Michael] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chapple, C (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	chapple@purdue.edu	Ralph, John/C-3161-2009; Chapple, Clint CS/Q-5456-2017; Tobimatsu, Yuki/S-9248-2019	Ralph, John/0000-0002-6093-4521; Chapple, Clint CS/0000-0002-5195-562X; Tobimatsu, Yuki/0000-0002-7578-7392; Ximenes, Eduardo/0000-0001-9087-0218	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) [DE-FG02-07ER15905]; Life Sciences Research Foundation; US DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64944]; Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - US DOE, Office of Science, Office of Basic Energy Sciences [DE-SC0000997]; US DOE [DE-FG02-06ER64301]; Purdue University Office of Agricultural Research Programs; Bioinformatics Core at Purdue University	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE)(United States Department of Energy (DOE)); Life Sciences Research Foundation; US DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - US DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US DOE(United States Department of Energy (DOE)); Purdue University Office of Agricultural Research Programs; Bioinformatics Core at Purdue University	This work was primarily funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) through grant DE-FG02-07ER15905 to C. C. N.D.B. was supported in part by a fellowship from the Life Sciences Research Foundation. Y.T. and J.R. were funded by the US DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64944). J.I.K., P.N.C. and B. S. D. were supported as part of the Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center funded by the US DOE, Office of Science, Office of Basic Energy Sciences, award number DE-SC0000997. E. X. and M. L. were supported by the US DOE through grant DE-FG02-06ER64301 to M. L. and C. C. and by the Purdue University Office of Agricultural Research Programs. The authors acknowledge the support of the Bioinformatics Core at Purdue University.	Abdulrazzak N, 2006, PLANT PHYSIOL, V140, P30, DOI 10.1104/pp.105.069690; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Bonawitz ND, 2012, J BIOL CHEM, V287, P5434, DOI 10.1074/jbc.M111.312298; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; CHAPPLE CCS, 1992, PLANT CELL, V4, P1413, DOI 10.1105/tpc.4.11.1413; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; CLIFFORD MN, 1974, J CHROMATOGR, V94, P321, DOI 10.1016/S0021-9673(01)92389-1; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Franke R, 2002, PLANT J, V30, P47, DOI 10.1046/j.1365-313X.2002.01267.x; Gallego-Giraldo L, 2011, P NATL ACAD SCI USA, V108, P20814, DOI 10.1073/pnas.1117873108; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Imura Y, 2012, PLANT CELL PHYSIOL, V53, P287, DOI 10.1093/pcp/pcs002; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Knight H, 2009, PLANT J, V58, P97, DOI 10.1111/j.1365-313X.2008.03763.x; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lu FC, 1998, J AGR FOOD CHEM, V46, P547, DOI 10.1021/jf970676m; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; QUIDEAU S, 1992, J AGR FOOD CHEM, V40, P1108, DOI 10.1021/jf00019a003; Ralph J, 2006, J BIOL CHEM, V281, P8843, DOI 10.1074/jbc.M511598200; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Ruegger M, 2001, GENETICS, V159, P1741; Schilmiller AL, 2009, PLANT J, V60, P771, DOI 10.1111/j.1365-313X.2009.03996.x; Stout J, 2008, GENETICS, V178, P2237, DOI 10.1534/genetics.107.083881; Tobimatsu Y, 2012, CHEMSUSCHEM, V5, P676, DOI 10.1002/cssc.201100573; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Wagner A, 2011, PLANT J, V67, P119, DOI 10.1111/j.1365-313X.2011.04580.x; Wathugala DL, 2012, NEW PHYTOL, V195, P217, DOI 10.1111/j.1469-8137.2012.04138.x; Weng JK, 2011, PLANT CELL, V23, P2708, DOI 10.1105/tpc.110.081547; Weng JK, 2010, PLANT CELL, V22, P1033, DOI 10.1105/tpc.109.073528	38	244	252	8	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					376	+		10.1038/nature13084	http://dx.doi.org/10.1038/nature13084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24670657				2022-12-28	WOS:000336121200042
J	Bhatt, DL; Kandzari, DE; O'Neill, WW; D'Agostino, R; Flack, JM; Katzen, BT; Leon, MB; Liu, ML; Mauri, L; Negoita, M; Cohen, SA; Oparil, S; Rocha-Singh, K; Townsend, RR; Bakris, GL				Bhatt, Deepak L.; Kandzari, David E.; O'Neill, William W.; D'Agostino, Ralph; Flack, John M.; Katzen, Barry T.; Leon, Martin B.; Liu, Minglei; Mauri, Laura; Negoita, Manuela; Cohen, Sidney A.; Oparil, Suzanne; Rocha-Singh, Krishna; Townsend, Raymond R.; Bakris, George L.		SYMPLICITY HTN-3 Investigators	A Controlled Trial of Renal Denervation for Resistant Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYMPATHETIC DENERVATION; STATEMENT; EDUCATION; THERAPY; COUNCIL; DESIGN	Background Prior unblinded studies have suggested that catheter-based renal-artery denervation reduces blood pressure in patients with resistant hypertension. Methods We designed a prospective, single-blind, randomized, sham-controlled trial. Patients with severe resistant hypertension were randomly assigned in a 2:1 ratio to undergo renal denervation or a sham procedure. Before randomization, patients were receiving a stable antihypertensive regimen involving maximally tolerated doses of at least three drugs, including a diuretic. The primary efficacy end point was the change in office systolic blood pressure at 6 months; a secondary efficacy end point was the change in mean 24-hour ambulatory systolic blood pressure. The primary safety end point was a composite of death, end-stage renal disease, embolic events resulting in end-organ damage, renovascular complications, or hypertensive crisis at 1 month or new renal-artery stenosis of more than 70% at 6 months. Results A total of 535 patients underwent randomization. The mean (SD) change in systolic blood pressure at 6 months was -14.1323.93 mm Hg in the denervation group as compared with -11.7425.94 mm Hg in the sham-procedure group (P<0.001 for both comparisons of the change from baseline), for a difference of -2.39 mm Hg (95% confidence interval [CI], -6.89 to 2.12; P=0.26 for superiority with a margin of 5 mm Hg). The change in 24-hour ambulatory systolic blood pressure was -6.7515.11 mm Hg in the denervation group and -4.79 +/- 17.25 mm Hg in the sham-procedure group, for a difference of -1.96 mm Hg (95% CI, -4.97 to 1.06; P=0.98 for superiority with a margin of 2 mm Hg). There were no significant differences in safety between the two groups. Conclusions This blinded trial did not show a significant reduction of systolic blood pressure in patients with resistant hypertension 6 months after renal-artery denervation as compared with a sham control. (Funded by Medtronic; SYMPLICITY HTN-3 ClinicalTrials.gov number, NCT01418261.)	[Bhatt, Deepak L.; Mauri, Laura] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.; Mauri, Laura] Harvard Univ, Sch Med, Boston, MA USA; [D'Agostino, Ralph] Boston Univ, Sch Publ Hlth, Boston, MA USA; [D'Agostino, Ralph; Mauri, Laura] Harvard Clin Res Inst, Boston, MA USA; [Kandzari, David E.] Piedmont Heart Inst, Atlanta, GA USA; [O'Neill, William W.] Henry Ford Hosp, Div Cardiol, Detroit, MI 48202 USA; [Flack, John M.] Wayne State Univ, Detroit, MI USA; [Flack, John M.] Detroit Med Ctr, Detroit, MI USA; [Katzen, Barry T.] Baptist Cardiac & Vasc Inst, Miami, FL USA; [Leon, Martin B.] Columbia Univ, New York Presbyterian Hosp, Med Cen ter, New York, NY USA; [Leon, Martin B.] Cardiovasc Res Fdn, New York, NY USA; [Liu, Minglei; Negoita, Manuela; Cohen, Sidney A.] Medtron CardioVasc, Santa Rosa, CA USA; [Oparil, Suzanne] Univ Alabama Birmingham, Birmingham, AL USA; [Rocha-Singh, Krishna] Prairie Heart Inst, Springfield, IL USA; [Cohen, Sidney A.; Townsend, Raymond R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bakris, George L.] Univ Chicago Med, Chicago, IL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Harvard Medical School; Piedmont Heart Institute; Henry Ford Health System; Henry Ford Hospital; Wayne State University; Detroit Medical Center; Baptist Cardiac & Vascular Institute; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine	Bhatt, DL (corresponding author), Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu	mauri, laura/GPS-4868-2022; Byrd, James Brian/H-6674-2019	Byrd, James Brian/0000-0002-0509-3520; Zile, Michael/0000-0001-7076-221X	Medtronic	Medtronic(Medtronic)	Supported by Medtronic.	Bakris G, 2013, J AM COLL CARDIOL; Bakris GL, 2010, HYPERTENSION, V56, P824, DOI 10.1161/HYPERTENSIONAHA.110.156976; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bhatt DL, 2012, CLEV CLIN J MED, V79, P498, DOI 10.3949/ccjm.79a.12051; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Gale Edwin A M, 2007, Diabetes Care, V30, P2989, DOI 10.2337/dc07-0155; GRIMSON KS, 1949, ANN SURG, V129, P850, DOI 10.1097/00000658-194906000-00012; Howard JP, 2013, HEART, V99, P1579, DOI 10.1136/heartjnl-2013-304238; James KE, 1996, STAT MED, V15, P1421; Jung O, 2013, J HYPERTENS, V31, P766, DOI 10.1097/HJH.0b013e32835e2286; Kandzari DE, 2012, CLIN CARDIOL, V35, P528, DOI 10.1002/clc.22008; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Kumbhani DJ, 2013, EUR HEART J, V34, P1204, DOI 10.1093/eurheartj/ehs368; Leon MB, 2005, J AM COLL CARDIOL, V46, P1812, DOI 10.1016/j.jacc.2005.06.079; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Myat A, 2013, CIRC-CARDIOVASC INTE, V6, P184, DOI 10.1161/CIRCINTERVENTIONS.112.000037; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Smith SM, 2014, J HYPERTENS, V32, P635, DOI 10.1097/HJH.0000000000000051; SMITHWICK RH, 1953, JAMA-J AM MED ASSOC, V152, P1501, DOI 10.1001/jama.1953.03690160001001; Staessen JA, 2002, LANCET, V359, P360; Thukkani AK, 2013, CIRCULATION, V128, P2251, DOI 10.1161/CIRCULATIONAHA.113.004660; Vaclavik J, 2011, HYPERTENSION, V57, P1069, DOI 10.1161/HYPERTENSIONAHA.111.169961	25	1445	1535	4	142	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1393	1401		10.1056/NEJMoa1402670	http://dx.doi.org/10.1056/NEJMoa1402670			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24678939				2022-12-28	WOS:000334095200007
J	Eberl, G				Eberl, Gerard			IMMUNOLOGY A is for immunity	NATURE			English	Editorial Material							INNATE LYMPHOID-CELLS; ROR-GAMMA-T; RETINOIC ACID; VITAMIN-A		Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eberl, G (corresponding author), Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Eberl, Gerard/A-1160-2013	Eberl, Gerard/0000-0002-1119-5638				BANG BG, 1972, AM J PATHOL, V68, P147; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JURIN M, 1972, IMMUNOLOGY, V23, P283; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789	13	4	4	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					47	48		10.1038/nature13216	http://dx.doi.org/10.1038/nature13216			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670655				2022-12-28	WOS:000333609900036
J	Fineberg, HV				Fineberg, Harvey V.			Pandemic Preparedness and Response - Lessons from the H1N1 Influenza of 2009	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VIRUS; TRANSMISSION; VACCINES		Inst Med, Washington, DC 20001 USA		Fineberg, HV (corresponding author), Inst Med, 500 Fifth St NW, Washington, DC 20001 USA.	fineberg@nas.edu						Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Dawood FS, 2012, LANCET INFECT DIS, V12, P655, DOI 10.1016/S1473-3099(12)70124-X; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Doshi P, 2011, B WORLD HEALTH ORGAN, V89, P532, DOI 10.2471/BLT.11.086173; Dowdle WR, 1976, INFLUENZA VIRUS VACC, P17; Flynn P., 2010, HANDLING H1N1 PANDEM; Hardiman MC, 2012, EMERG INFECT DIS, V18, P1041, DOI 10.3201/eid1807.120395; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Neustadt Richard E., 1983, EPIDEMIC NEVER WAS P; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Viboud C, 2010, PLOS CURR, V2; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, 2008, INT HLTH REG 2005, V2nd; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O	22	316	326	10	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1335	1342		10.1056/NEJMra1208802	http://dx.doi.org/10.1056/NEJMra1208802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693893	Bronze			2022-12-28	WOS:000333830000012
J	Iacobuzio-Donahue, CA; Herman, JM				Iacobuzio-Donahue, Christine A.; Herman, Joseph M.			Autophagy, p53, and Pancreatic Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, David Rubenstein Ctr Pancreat Canc Res, New York, NY 10021 USA; [Herman, Joseph M.] Johns Hopkins Univ Hosp, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine	Iacobuzio-Donahue, CA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.		Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023				Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215	5	34	36	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1352	1353		10.1056/NEJMcibr1400189	http://dx.doi.org/10.1056/NEJMcibr1400189			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693896				2022-12-28	WOS:000333830000016
J	Lee, SH; Kwan, AC; Dan, Y				Lee, Seung-Hee; Kwan, Alex C.; Dan, Yang			Interneuron subtypes and orientation tuning	NATURE			English	Letter							GABAERGIC INTERNEURONS; CORTICAL-NEURONS; VISUAL-CORTEX; INHIBITION; SELECTIVITY; MECHANISMS		[Lee, Seung-Hee; Kwan, Alex C.; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Helen Wills Neurosci Inst, Div Neurobiol,Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Lee, SH (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	ydan@berkeley.edu		Kwan, Alex/0000-0003-2169-1667; Dan, Yang/0000-0002-3818-877X				Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229	12	50	50	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					E1	E2		10.1038/nature13128	http://dx.doi.org/10.1038/nature13128			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695313	Green Published			2022-12-28	WOS:000333609900001
J	Maynard, MA; Marino-Enriquez, A; Fletcher, JA; Dorfman, DM; Raut, CP; Yassa, L; Guo, CC; Wang, YX; Dorfman, C; Feldman, HA; Frates, MC; Song, HD; Jugo, RH; Taguchi, T; Hershman, JM; Larsen, PR; Huang, SA				Maynard, Michelle A.; Marino-Enriquez, Adrian; Fletcher, Jonathan A.; Dorfman, David M.; Raut, Chandrajit P.; Yassa, Leila; Guo, Cuicui; Wang, Yuexiang; Dorfman, Clara; Feldman, Henry A.; Frates, Mary C.; Song, Huaidong; Jugo, Rebecca H.; Taguchi, Takahiro; Hershman, Jerome M.; Larsen, P. Reed; Huang, Stephen A.			Thyroid Hormone Inactivation in Gastrointestinal Stromal Tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPE-3 IODOTHYRONINE DEIODINASE; CONSUMPTIVE HYPOTHYROIDISM; SUNITINIB; MUTATIONS; SERUM; KIT	Gastrointestinal stromal tumors (GISTs) are resistant to traditional chemotherapy but are responsive to the tyrosine kinase inhibitors imatinib and sunitinib.(1) The use of these agents has improved the outcome for patients but is associated with adverse effects, including hypothyroidism.(2) Multiple mechanisms of this effect have been proposed, including decreased iodine organification(3) and glandular capillary regression.(4) Here we report the finding of consumptive hypothyroidism caused by marked overexpression of the thyroid hormone-inactivating enzyme type 3 iodothyronine deiodinase (D3) within the tumor. Affected patients warrant increased monitoring and may require supernormal thyroid hormone supplementation.	[Maynard, Michelle A.; Guo, Cuicui; Dorfman, Clara; Song, Huaidong; Jugo, Rebecca H.; Huang, Stephen A.] Boston Childrens Hosp, Div Endocrinol, Thyroid Program, Boston, MA 02115 USA; [Feldman, Henry A.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA 02115 USA; [Marino-Enriquez, Adrian; Fletcher, Jonathan A.; Dorfman, David M.; Wang, Yuexiang] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Raut, Chandrajit P.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Frates, Mary C.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Yassa, Leila; Larsen, P. Reed; Huang, Stephen A.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Thyroid Sect, Boston, MA 02115 USA; [Fletcher, Jonathan A.; Raut, Chandrajit P.; Larsen, P. Reed; Huang, Stephen A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Taguchi, Takahiro] Kochi Med Sch, Dept Neurobiol & Anat, Nankoku, Kochi, Japan; [Hershman, Jerome M.] Vet Affairs Greater Los Angeles Healthcare Syst, Endocrinol & Diabet Div, Los Angeles, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Kochi University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Huang, SA (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	stephen.huang@childrens.harvard.edu	Feldman, Henry/M-2302-2013; Wang, Yuexiang/GNH-5248-2022	Marino-Enriquez, Adrian/0000-0002-7680-9901	National Institutes of Health [DK076099, DK044128, 1P50CA12703]; William F. Milton Foundation Award; Harvard Clinical and Translational Science Center [NIH UL1 RR-025758, NIH UL1 TR-001102]; NATIONAL CANCER INSTITUTE [U54CA168512, P50CA127003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044128, R01DK076099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William F. Milton Foundation Award; Harvard Clinical and Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a donation from the Murray Family, grants from the National Institutes of Health (DK076099, DK044128, and 1P50CA12703), the William F. Milton Foundation Award, and a grant from the Harvard Clinical and Translational Science Center (NIH UL1 RR-025758 and NIH UL1 TR-001102, to Dr. Feldman).	Abdulrahman RM, 2010, J CLIN ENDOCR METAB, V95, P3758, DOI 10.1210/jc.2009-2507; Balazs AE, 2007, ANN CLIN LAB SCI, V37, P280; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dang ZC, 2005, MOL CELL BIOCHEM, V268, P159, DOI 10.1007/s11010-005-3857-7; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; Hamnvik OPR, 2011, JNCI-J NATL CANCER I, V103, P1572, DOI 10.1093/jnci/djr373; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Howard D, 2011, J CLIN ENDOCR METAB, V96, P1966, DOI 10.1210/jc.2010-2104; Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305; Huang SA, 2005, MOL ENDOCRINOL, V19, P3126, DOI 10.1210/me.2005-0173; Huang SA, 2005, THYROID, V15, P875, DOI 10.1089/thy.2005.15.875; Huang SA, 2003, J CLIN ENDOCR METAB, V88, P1384, DOI 10.1210/jc.2002-021291; Huang SA, 2002, J CLIN ENDOCR METAB, V87, P4457, DOI 10.1210/jc.2002-020627; Huang SA, 2008, NAT CLIN PRACT ENDOC, V4, P148, DOI 10.1038/ncpendmet0727; Kappers MHW, 2011, J CLIN ENDOCR METAB, V96, P3087, DOI 10.1210/jc.2011-1172; Liegl-Atzwanger B, 2010, VIRCHOWS ARCH, V456, P111, DOI 10.1007/s00428-010-0891-y; Mannavola D, 2007, J CLIN ENDOCR METAB, V92, P3531, DOI 10.1210/jc.2007-0586; REFETOFF S, 1970, ENDOCRINOLOGY, V86, P793, DOI 10.1210/endo-86-4-793; Ruppe MD, 2005, THYROID, V15, P1369, DOI 10.1089/thy.2005.15.1369; Subramanian S, 2004, ONCOGENE, V23, P7780, DOI 10.1038/sj.onc.1208056; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Wong E, 2007, THYROID, V17, P351, DOI 10.1089/thy.2006.0308	25	35	40	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1327	1334		10.1056/NEJMoa1308893	http://dx.doi.org/10.1056/NEJMoa1308893			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693892	Green Accepted, Bronze			2022-12-28	WOS:000333830000011
J	Bennett, WE				Bennett, William E., Jr.			Probiotics and infant colic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-FED INFANTS; CONTROLLED-TRIAL		Indiana Univ Sch Med, Dept Paediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Bennett, WE (corresponding author), Indiana Univ Sch Med, Dept Paediat, Indianapolis, IN 46202 USA.	webjr@iu.edu						Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; Gelfand AA, 2013, J PEDIATR-US, V163, P922, DOI 10.1016/j.jpeds.2013.06.048; GREEN M, 1964, PEDIATRICS, V34, P58; Hill DJ, 2005, PEDIATRICS, V116, pE709, DOI 10.1542/peds.2005-0147; Indrio F, 2014, JAMA PEDIATR, V168, P228, DOI 10.1001/jamapediatrics.2013.4367; Lucassen PLBJ, 2000, PEDIATRICS, V106, P1349, DOI 10.1542/peds.106.6.1349; Orenstein SR, 2009, J PEDIATR-US, V154, P514, DOI 10.1016/j.jpeds.2008.09.054; Rhoads JM, 2009, J PEDIATR-US, V155, P823, DOI 10.1016/j.jpeds.2009.05.012; Savino F, 2010, NEONATOLOGY, V97, P299, DOI 10.1159/000255161; Scherer LD, 2013, PEDIATRICS, V131, P839, DOI 10.1542/peds.2012-3070; Sung V, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2107; Sung V, 2013, JAMA PEDIATR, V167, P1150, DOI 10.1001/jamapediatrics.2013.2572; WEISSBLUTH M, 1984, J PEDIATR-US, V104, P951, DOI 10.1016/S0022-3476(84)80506-5	13	1	1	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g2286	10.1136/bmj.g2286	http://dx.doi.org/10.1136/bmj.g2286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24690628				2022-12-28	WOS:000333976300006
J	Levine, M; Cattoglio, C; Tjian, R				Levine, Michael; Cattoglio, Claudia; Tjian, Robert			Looping Back to Leap Forward: Transcription Enters a New Era	CELL			English	Review							RNA-POLYMERASE-II; BETA-GLOBIN GENE; STRUCTURAL BASIS; SINGLE-MOLECULE; DEFINITIVE ENDODERM; ELONGATION COMPLEX; DROSOPHILA EMBRYOS; ANIMAL DEVELOPMENT; PELVIC REDUCTION; UNEXPECTED ROLES	Comparative genome analyses reveal that organismal complexity scales not with gene number but with gene regulation. Recent efforts indicate that the human genome likely contains hundreds of thousands of enhancers, with a typical gene embedded in a milieu of tens of enhancers. Proliferation of cis-regulatory DNAs is accompanied by increased complexity and functional diversification of transcriptional machineries recognizing distal enhancers and core promoters and by the highorder spatial organization of genetic elements. We review progress in unraveling one of the outstanding mysteries of modern biology: the dynamic communication of remote enhancers with target promoters in the specification of cellular identity.	[Levine, Michael; Cattoglio, Claudia; Tjian, Robert] Univ Calif Berkeley, Li Ka Shing Ctr Biomed & Hlth Sci, CIRM Ctr Excellence, Dept Mol & Cell Biol, Berkeley, CA 94707 USA; [Cattoglio, Claudia; Tjian, Robert] Univ Calif Berkeley, Li Ka Shing Ctr Biomed & Hlth Sci, CIRM Ctr Excellence, Howard Hughes Med Inst, Berkeley, CA 94707 USA	Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Li Ka Shing Ctr Biomed & Hlth Sci, CIRM Ctr Excellence, Dept Mol & Cell Biol, Berkeley, CA 94707 USA.	mlevine@berkeley.edu; jmlim@uclink4.berkeley.edu		Levine, Michael/0000-0001-7629-0081	California Institute for Regenerative Medicine (CIRM) [RB4-06016, TG2-01164]; NIH [GM34431, GM46638]; NATIONAL CANCER INSTITUTE [R37CA025417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046638, R37GM046638, R01GM034431] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.T. and C.C. would like to acknowledge the California Institute for Regenerative Medicine (CIRM) for the Research grant (RB4-06016) to R.T. M.L. is supported by grants from the NIH (GM34431 and GM46638). C.C. has been a postdoctoral fellow of California Institute for Regenerative Medicine (CIRM training program TG2-01164).	Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; ANG SL, 1993, DEVELOPMENT, V119, P1301; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Calhoun VC, 2003, P NATL ACAD SCI USA, V100, P9878, DOI 10.1073/pnas.1233791100; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chen J., 2014, CELL; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cisse II, 2013, SCIENCE, V341, P664, DOI 10.1126/science.1239053; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Dahan N, 2013, BBA-GENE REGUL MECH, V1829, P169, DOI 10.1016/j.bbagrm.2012.08.004; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Dellino GI, 2013, GENOME RES, V23, P1, DOI 10.1101/gr.142331.112; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Deniz AA, 2008, J R SOC INTERFACE, V5, P15, DOI 10.1098/rsif.2007.1021; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gilbert DM, 2010, COLD SH Q B, V75, P143, DOI 10.1101/sqb.2010.75.011; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Groudine M, 1983, Prog Clin Biol Res, V134, P159; Grunberg S, 2013, TRENDS BIOCHEM SCI, V38, P603, DOI 10.1016/j.tibs.2013.09.002; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Guglielmi B, 2013, MOL CELL, V51, P480, DOI 10.1016/j.molcel.2013.08.009; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Karmakar S, 2010, EMBO J, V29, P3260, DOI 10.1038/emboj.2010.204; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lagha M, 2013, CELL, V153, P976, DOI 10.1016/j.cell.2013.04.045; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lewis M, 2013, J MOL BIOL, V425, P2309, DOI 10.1016/j.jmb.2013.03.003; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Liu X, 2013, BBA-GENE REGUL MECH, V1829, P2, DOI 10.1016/j.bbagrm.2012.09.003; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Losick R, 1998, COLD SPRING HARB SYM, V63, P653, DOI 10.1101/sqb.1998.63.653; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Mueller F, 2013, CRIT REV BIOCHEM MOL, V48, P492, DOI 10.3109/10409238.2013.833891; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pavlopoulou A, 2011, INT J MOL MED, V28, P295, DOI 10.3892/ijmm.2011.705; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Roeder RG, 1996, METHOD ENZYMOL, V273, P165; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Saunders A, 2013, GENE DEV, V27, P1146, DOI 10.1101/gad.215459.113; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Smith E, 2013, GENE DEV, V27, P1079, DOI 10.1101/gad.215137.113; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Struhl K, 1998, COLD SPRING HARB SYM, V63, P413, DOI 10.1101/sqb.1998.63.413; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Tadros W, 2007, DEV CELL, V12, P847, DOI 10.1016/j.devcel.2007.05.009; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu Y, 2013, CURR OPIN NEUROBIOL, V23, P1090, DOI 10.1016/j.conb.2013.06.008; Wyatt MD, 2013, ADV CANCER RES, V119, P63, DOI 10.1016/B978-0-12-407190-2.00002-2; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhou HY, 2013, ELIFE, V2, DOI 10.7554/eLife.00170; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	133	317	325	1	91	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					13	25		10.1016/j.cell.2014.02.009	http://dx.doi.org/10.1016/j.cell.2014.02.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679523	Bronze, Green Accepted			2022-12-28	WOS:000333968900004
J	McNulty, EJ; Hung, YY; Almers, LM; Go, AS; Yeh, RW				McNulty, Edward J.; Hung, Yun-Yi; Almers, Lucy M.; Go, Alan S.; Yeh, Robert W.			Population Trends From 2000-2011 in Nuclear Myocardial Perfusion Imaging Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							UNITED-STATES		[McNulty, Edward J.] Kaiser Permanente Med Ctr, Div Cardiol, San Francisco, CA 94115 USA; [Hung, Yun-Yi; Almers, Lucy M.; Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Yeh, Robert W.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Kaiser Permanente; Kaiser Permanente; Harvard University; Massachusetts General Hospital	McNulty, EJ (corresponding author), Kaiser Permanente Med Ctr, 2200 OFarrell Blvd, San Francisco, CA 94115 USA.	edward.j.mcnulty@kp.org	Yeh, Robert/AAJ-3463-2020; Go, Alan S./AAE-7745-2019	Almers, Lucy/0000-0002-8357-9550				Andrus BW, 2012, CIRC-CARDIOVASC QUAL, V5, P31, DOI 10.1161/CIRCOUTCOMES.111.961813; Brindis RG, 2005, J AM COLL CARDIOL, V46, P1587, DOI 10.1016/j.jacc.2005.08.029; Levin DC, 2013, J AM COLL RADIOL, V10, P198, DOI 10.1016/j.jacr.2012.08.009; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	5	34	34	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1248	1249		10.1001/jama.2014.472	http://dx.doi.org/10.1001/jama.2014.472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668108	Bronze			2022-12-28	WOS:000333340500030
J	Holmes, D				Holmes, David			Nulda Beyers: speaking up for children with tuberculosis	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1031	1031		10.1016/S0140-6736(14)60506-7	http://dx.doi.org/10.1016/S0140-6736(14)60506-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24656190				2022-12-28	WOS:000333521200012
J	Rosenberg, JM; Rosenberg, R				Rosenberg, Jacob M.; Rosenberg, Ralph			Bilateral Digital Ischemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenberg, Jacob M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Rosenberg, Ralph] Univ Connecticut, Ctr Hlth, Avon, CT USA	Stanford University; University of Connecticut	Rosenberg, JM (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	jakeros@stanford.edu							0	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1148	1148		10.1056/NEJMicm1309192	http://dx.doi.org/10.1056/NEJMicm1309192			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645947				2022-12-28	WOS:000333054000011
J	Smemo, S; Tena, JJ; Kim, KH; Gamazon, ER; Sakabe, NJ; Gomez-Marin, C; Aneas, I; Credidio, FL; Sobreira, DR; Wasserman, NF; Lee, JH; Puviindran, V; Tam, D; Shen, M; Son, JE; Vakili, NA; Sung, HK; Naranjo, S; Acemel, RD; Manzanares, M; Nagy, A; Cox, NJ; Hui, CC; Gomez-Skarmeta, JL; Nobrega, MA				Smemo, Scott; Tena, Juan J.; Kim, Kyoung-Han; Gamazon, Eric R.; Sakabe, Noboru J.; Gomez-Marin, Carlos; Aneas, Ivy; Credidio, Flavia L.; Sobreira, Debora R.; Wasserman, Nora F.; Lee, Ju Hee; Puviindran, Vijitha; Tam, Davis; Shen, Michael; Son, Joe Eun; Vakili, Niki Alizadeh; Sung, Hoon-Ki; Naranjo, Silvia; Acemel, Rafael D.; Manzanares, Miguel; Nagy, Andras; Cox, Nancy J.; Hui, Chi-Chung; Luis Gomez-Skarmeta, Jose; Nobrega, Marcelo A.			Obesity-associated variants within FTO form long-range functional connections with IRX3	NATURE			English	Article							GENE-EXPRESSION; MASS; DATABASE; TISSUE; VERTEBRATE; CHILDHOOD; ELEMENTS; BROWSER; NEURONS; REVEAL	Genome-wide association studies (GWAS) have reproducibly associated variants within introns of FTO with increased risk for obesity and type 2 diabetes (T2D)(1-3). Although the molecular mechanisms linking these noncoding variants with obesity are not immediately obvious, subsequent studies in mice demonstrated that FTO expression levels influence body mass and composition phenotypes(4-6). However, no direct connection between the obesity-associated variants and FTO expression or function has been made(7-9). Here we show that the obesity-associated noncoding sequences within FTO are functionally connected, at megabase distances, with the homeobox gene IRX3. The obesity-associated FTO region directly interacts with the promoters of IRX3 as well as FTO in the human, mouse and zebrafish genomes. Furthermore, long-range enhancers within this region recapitulate aspects of IRX3 expression, suggesting that the obesity-associated interval belongs to the regulatory landscape of IRX3. Consistent with this, obesity-associated single nucleotide polymorphisms are associated with expression of IRX3, but not FTO, in human brains. A direct link between IRX3 expression and regulation of body mass and composition is demonstrated by a reduction in body weight of 25 to 30% in Irx3-deficient mice, primarily through the loss of fat mass and increase in basal metabolic rate with browning of white adipose tissue. Finally, hypothalamic expression of a dominant negative form of Irx3 reproduces the metabolic phenotypes of Irx3 deficient mice. Our data suggest that IRX3 is a functional long-range target of obesity-associated variants within FTO and represents a novel determinant of body mass and composition.	[Smemo, Scott; Sakabe, Noboru J.; Aneas, Ivy; Credidio, Flavia L.; Sobreira, Debora R.; Wasserman, Nora F.; Shen, Michael; Cox, Nancy J.; Nobrega, Marcelo A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Tena, Juan J.; Gomez-Marin, Carlos; Naranjo, Silvia; Acemel, Rafael D.; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo CABD, Consejo Super Invest Cient, Seville 41013, Spain; [Kim, Kyoung-Han; Lee, Ju Hee; Puviindran, Vijitha; Tam, Davis; Vakili, Niki Alizadeh; Hui, Chi-Chung] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5S 1A8, Canada; [Kim, Kyoung-Han; Lee, Ju Hee; Puviindran, Vijitha; Tam, Davis; Vakili, Niki Alizadeh; Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Med Genet Sect, Dept Med, Chicago, IL 60637 USA; [Son, Joe Eun; Sung, Hoon-Ki; Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5T 3H7, Canada; [Manzanares, Miguel] Ctr Nacl Invest Cardiovasc CNIC, Cardiovasc Dev & Repair Dept, Madrid 28029, Spain	University of Chicago; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Chicago; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Nobrega, MA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	cchui@sickkids.ca; jlgomska@upo.es; nobrega@uchicago.edu	Gamazon, Eric/I-6873-2018; Gómez-Marín, Carlos/AAX-2173-2021; Naranjo, Silvia/P-9845-2016; Gomez-Skarmeta, Jose Luis/B-5268-2014; Kim, Kyoung-Han/AAZ-4908-2021; Son, Joe/AAB-7384-2020; Manzanares, Miguel/E-1702-2015; Manzanares, Miguel/AAZ-8305-2021; Acemel, Rafael Dominguez/AAM-1957-2020; Sung, Hoon-Ki/A-1922-2016; Tena, Juan J./Q-5995-2019; Tena, Juan J/M-2265-2014; Nagy, Andras/G-6465-2013	Gamazon, Eric/0000-0003-4204-8734; Naranjo, Silvia/0000-0002-4529-3332; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Manzanares, Miguel/0000-0003-4849-2836; Manzanares, Miguel/0000-0003-4849-2836; Acemel, Rafael Dominguez/0000-0003-4120-0140; Sung, Hoon-Ki/0000-0001-6677-9385; Tena, Juan J./0000-0001-8165-7984; Tena, Juan J/0000-0001-8165-7984; Nagy, Andras/0000-0003-4311-0413; Gomez-Marin, Carlos/0000-0001-9724-2919; Kim, Kyoung-Han/0000-0002-0433-656X; Son, Joe/0000-0003-3066-2796	National Institutes of Health [DK093972, HL119967, HL114010, DK020595, MH101820, MH090937, DK20595]; Spanish Ministerio de Economia y Competitividad [BFU2010-14839, CSD2007-00008]; Andalusian Government [CVI-3488]; Canadian Institute of Health Research; Heart and Stroke Foundation of Canada; NIH [T32HL007381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114010, T32HL007381, R01HL119967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093972, P60DK020595, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101820, R01MH090937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Economia y Competitividad(Spanish Government); Andalusian Government; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank F. Gage, C. Marchetto, B. Ren and F. Jin for their generosity in sharing reagents and data. This work was funded by grants from the National Institutes of Health (DK093972, HL119967, HL114010 and DK020595) to M.A.N. and (MH101820, MH090937 and DK20595) to N.J.C. J.L.G.-S. was funded by grants from the Spanish Ministerio de Economia y Competitividad (BFU2010-14839, CSD2007-00008) and the Andalusian Government (CVI-3488). C.-C. H. was supported by a grant from the Canadian Institute of Health Research. K.-H. K. is supported by a fellowship from the Heart and Stroke Foundation of Canada. S. S. is supported by an NIH postdoctoral training grant (T32HL007381)	Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li ZJ, 2012, DEVELOPMENT, V139, P4152, DOI 10.1242/dev.081190; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rozen S, 2000, Methods Mol Biol, V132, P365; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Smith RN, 2012, BIOINFORMATICS, V28, P3163, DOI 10.1093/bioinformatics/bts577; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhou X., 2012, CURR PROTOC BIOINFOR, V40, DOI DOI 10.10.1-10.10.14	50	772	791	2	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					371	+		10.1038/nature13138	http://dx.doi.org/10.1038/nature13138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646999	Green Accepted, Green Submitted			2022-12-28	WOS:000333029000037
J	Ukhorskiy, AY; Sitnov, MI; Mitchell, DG; Takahashi, K; Lanzerotti, LJ; Mauk, BH				Ukhorskiy, A. Y.; Sitnov, M. I.; Mitchell, D. G.; Takahashi, K.; Lanzerotti, L. J.; Mauk, B. H.			Rotationally driven 'zebra stripes' in Earth's inner radiation belt	NATURE			English	Article								Structured features on top of nominally smooth distributions of radiation-belt particles at Earth have been previously associated with particle acceleration and transport mechanisms powered exclusively by enhanced solar-wind activity(1-4). Although planetary rotation is considered to be important for particle acceleration at Jupiter and Saturn(5-9), the electric field produced in the inner magnetosphere by Earth's rotation can change the velocity of trapped particles by only about 1-2 kilometres per second, so rotation has been thought inconsequential for radiation-belt electrons with velocities of about 100,000 kilometres per second. Here we report that the distributions of energetic electrons across the entire spatial extent of Earth's inner radiation belt are organized in regular, highly structured and unexpected 'zebra stripes', even when the solar-wind activity is low. Modelling reveals that the patterns are produced by Earth's rotation. Radiation-belt electrons are trapped in Earth's dipole-like magnetic field, where they undergo slow longitudinal drift motion around the planet because of the gradient and curvature of the magnetic field. Earth's rotation induces global diurnal variations of magnetic and electric fields that resonantly interact with electrons whose drift period is close to 24 hours, modifying electron fluxes over a broad energy range into regular patterns composed of multiple stripes extending over the entire span of the inner radiation belt.	[Ukhorskiy, A. Y.; Sitnov, M. I.; Mitchell, D. G.; Takahashi, K.; Mauk, B. H.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Lanzerotti, L. J.] New Jersey Inst Technol, Newark, NJ 07103 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; New Jersey Institute of Technology	Ukhorskiy, AY (corresponding author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	ukhorskiy@jhuapl.edu	Mitchell, Donald G/H-4601-2016; Sitnov, Mikhail I/H-2316-2016; Ukhorskiy, Aleksandr/E-6429-2016; Mauk, Barry H/E-8420-2017; Takahashi, Kazue/H-3060-2016	Mitchell, Donald G/0000-0003-1960-2119; Sitnov, Mikhail I/0000-0002-8990-0456; Ukhorskiy, Aleksandr/0000-0002-3326-4024; Mauk, Barry H/0000-0001-9789-3797; Takahashi, Kazue/0000-0003-1434-4456	NSF [AGS1059736]; NASA [NNX11AO74G, NAS5-01072]; NASA through NJIT [999640-I]; Directorate For Geosciences [1157463] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1059736] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NASA through NJIT; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grant AGS1059736, NASA grant NNX11AO74G and NASA contract NAS5-01072 through a subcontract from NJIT 999640-I. We thank A. Marcotte (JHU/APL) for help with Fig. 2.	Birdsall C. K., 1991, PLASMA PHYS VIA COMP; BOROVSKY JE, 1993, J GEOPHYS RES-SPACE, V98, P3807, DOI 10.1029/92JA02556; BRICE NM, 1970, ICARUS, V13, P173, DOI 10.1016/0019-1035(70)90048-5; Cary JR, 2009, REV MOD PHYS, V81, P693, DOI 10.1103/RevModPhys.81.693; Cowley SWH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016030; HILL TW, 1979, J GEOPHYS RES-SPACE, V84, P6554, DOI 10.1029/JA084iA11p06554; Horne RB, 2007, NAT PHYS, V3, P590, DOI 10.1038/nphys703; Hudson MK, 2008, J ATMOS SOL-TERR PHY, V70, P708, DOI 10.1016/j.jastp.2007.11.003; Kessel RL, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012255; LYONS LR, 1972, J GEOPHYS RES, V77, P3455, DOI 10.1029/JA077i019p03455; MATSUOKA H, 1995, J GEOPHYS RES-SPACE, V100, P12103, DOI 10.1029/94JA03368; Mauk BH, 2013, SPACE SCI REV, V179, P3, DOI 10.1007/s11214-012-9908-y; Mauk BH, 2009, SATURN FROM CASSINI-HUYGENS, P281, DOI 10.1007/978-1-4020-9217-6_11; Meredith NP, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013889; Mitchell DG, 2013, SPACE SCI REV, V179, P263, DOI 10.1007/s11214-013-9965-x; NISHIDA A, 1966, J GEOPHYS RES, V71, P5669, DOI 10.1029/JZ071i023p05669; Northrop T., 1963, ADIABATIC MOTION CHA; NORTHROP TG, 1960, PHYS REV, V117, P215, DOI 10.1103/PhysRev.117.215; Ohtani S, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015745; Petrosyan A, 2010, SPACE SCI REV, V156, P135, DOI 10.1007/s11214-010-9694-3; Sauvaud J.-A., 2013, J GEOPHYS RES, V118, P1; Schulz M., 1974, PHYS CHEM SPACE, V7; SMALE S, 1967, B AM MATH SOC, V73, P747, DOI 10.1090/S0002-9904-1967-11798-1; Thorne RM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044990; Ukhorskiy AY, 2013, SPACE SCI REV, V179, P545, DOI 10.1007/s11214-012-9938-5; Ukhorskiy AY, 2008, J ATMOS SOL-TERR PHY, V70, P1714, DOI 10.1016/j.jastp.2008.07.018; Vasyliunas V.M., 1983, PHYS JOVIAN MAGNETOS, P395, DOI [10.1017/CBO9780511564574.013, DOI 10.1017/CBO9780511564574.013, 10.1017/cbo9780511564574.013]; Wolf RA, 2007, J ATMOS SOL-TERR PHY, V69, P288, DOI 10.1016/j.jastp.2006.07.026	28	33	33	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					338	+		10.1038/nature13046	http://dx.doi.org/10.1038/nature13046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646996				2022-12-28	WOS:000333029000029
J	Rai, J; Malalasekera, A; Terry, T; Deane, A				Rai, Jaskarn; Malalasekera, Ajith; Terry, Timothy; Deane, Anthony			Practice ABC of Major Trauma, 4th Edition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Rai, Jaskarn] Leicester Gen Hosp Leicester, Leicester, Leics, England; William Harvey Hosp Ashford, Ashford, Kent, England; Buckland Hosp Dover, Dover, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital	Rai, J (corresponding author), Leicester Gen Hosp Leicester, Leicester, Leics, England.			Malalasekera, Ajith/0000-0003-1274-8254				Dobrowolski Z, 2002, BJU INT, V89, P748, DOI 10.1046/j.1464-410X.2002.02720.x; LYNCH D, 2003, GUIDELINES UROLOGICA; Martinez-Pineiro TH, 2012, RADIOGRAPHICS, V21, P557; Santucci RA, 2004, BJU INT, V93, P937, DOI 10.1111/j.1464-4096.2004.04820.x	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1141	10.1136/bmj.g1141	http://dx.doi.org/10.1136/bmj.g1141			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24646667				2022-12-28	WOS:000333414500001
J	Lim, LS; Sperling, B				Lim, Lionel S.; Sperling, Brian			Review: Adding alpha(1)-blockers to 5 alpha-reductase inhibitors improves lower urinary tract symptoms in men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lim, Lionel S.; Sperling, Brian] Griffin Hosp, Derby, CT 06418 USA		Lim, LS (corresponding author), Griffin Hosp, Derby, CT 06418 USA.			Lim, Lionel/0000-0002-0730-8767				Kaplan SA, 2008, J UROLOGY, V180, P1030, DOI 10.1016/j.juro.2008.05.004; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC2	10.7326/0003-4819-160-6-201403180-02002	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638180				2022-12-28	WOS:000333521300001
J	Weinshenker, BG				Weinshenker, Brian G.			Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Weinshenker, BG (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		Weinshenker, Brian G/ABH-6146-2020	Weinshenker, Brian G/0000-0001-5806-6203				Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC5	10.7326/0003-4819-160-6-201403180-02005	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638183				2022-12-28	WOS:000333521300004
J	Jacob, Y; Bergamin, E; Donoghue, MTA; Mongeon, V; LeBlanc, C; Voigt, P; Underwood, CJ; Brunzelle, JS; Michaels, SD; Reinberg, D; Couture, JF; Martienssen, RA				Jacob, Yannick; Bergamin, Elisa; Donoghue, Mark T. A.; Mongeon, Vanessa; LeBlanc, Chantal; Voigt, Philipp; Underwood, Charles J.; Brunzelle, Joseph S.; Michaels, Scott D.; Reinberg, Danny; Couture, Jean-Francois; Martienssen, Robert A.			Selective Methylation of Histone H3 Variant H3.1 Regulates Heterochromatin Replication	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; ARABIDOPSIS-THALIANA; DNA-REPLICATION; CAF-1 MUTANTS; CHROMATIN; MAINTENANCE; DEPOSITION; GENE; FASCIATA1	Histone variants have been proposed to act as determinants for posttranslational modifications with widespread regulatory functions. We identify a histone-modifying enzyme that selectively methylates the replication-dependent histone H3 variant H3.1. The crystal structure of the SET domain of the histone H3 lysine-27 (H3K27) methyltransferase ARABIDOPSIS TRITHORAX-RELATED PROTEIN 5 (ATXR5) in complex with a H3.1 peptide shows that ATXR5 contains a bipartite catalytic domain that specifically "reads" alanine-31 of H3.1. Variation at position 31 between H3.1 and replication-independent H3.3 is conserved in plants and animals, and threonine-31 in H3.3 is responsible for inhibiting the activity of ATXR5 and its paralog, ATXR6. Our results suggest a simple model for the mitotic inheritance of the heterochromatic mark H3K27me1 and the protection of H3.3-enriched genes against heterochromatization during DNA replication.	[Jacob, Yannick; Donoghue, Mark T. A.; LeBlanc, Chantal; Underwood, Charles J.; Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Bergamin, Elisa; Mongeon, Vanessa; Couture, Jean-Francois] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Voigt, Philipp; Reinberg, Danny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, Howard Hughes Med Inst, New York, NY 10016 USA; [Brunzelle, Joseph S.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Michaels, Scott D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Martienssen, Robert A.] Ecole Normale Super, Inst Biol, F-75005 Paris, France	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Ottawa; Howard Hughes Medical Institute; New York University; Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Couture, JF (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada.	jean-francois.couture@uottawa.ca; martiens@cshl.edu	Underwood, Charles J/AAM-9246-2020; Michaels, Scott/D-5458-2009	Underwood, Charles J/0000-0001-5730-6279; Reinberg, Danny/0000-0003-4288-2016; Bergamin, Elisa/0000-0001-5277-5156; Voigt, Philipp/0000-0003-4366-0490; Michaels, Scott/0000-0001-5248-3487	Louis-Berlinguet postdoctoral fellowship (Fonds Quebecois de la Recherche en Sante/Genome Quebec); Deutsche Akademie der Naturforscher Leopoldina [LPDS 2009-5]; Empire State Training Program in Stem Cell Research (NYSTEM) [C026880]; NIH [GM064844, R37GM037120, GM075060, GM067014]; Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada [191666]; Howard Hughes Medical Institute-Gordon; Betty Moore Foundation; NSF [DBI-1025830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, R01GM075060, R01GM067014, R37GM037120] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1025830] Funding Source: National Science Foundation	Louis-Berlinguet postdoctoral fellowship (Fonds Quebecois de la Recherche en Sante/Genome Quebec); Deutsche Akademie der Naturforscher Leopoldina; Empire State Training Program in Stem Cell Research (NYSTEM); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Institute-Gordon; Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Calarco for critically reading the manuscript and J. Goodrich, C. Kohler, S. E. Jacobsen, D. J. Patel., and T. Schalch for materials and advice. Y.J. was supported by a Louis-Berlinguet postdoctoral fellowship (Fonds Quebecois de la Recherche en Sante/Genome Quebec). P.V. is supported by fellowships from the Deutsche Akademie der Naturforscher Leopoldina (LPDS 2009-5) and the Empire State Training Program in Stem Cell Research (NYSTEM, contract no. C026880). Work in the Reinberg laboratory is supported by grants from the NIH (GM064844 and R37GM037120) and the Howard Hughes Medical Institute. S.D.M. is supported by a grant from the NIH (GM075060). J.F.C. is supported by grants from the Canadian Institute of Health Research (BMA-355900) and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant 191666) and acknowledges an Ontario Early Research Award and a Canada Research Chair in Structural Biology and Epigenetics. This work was supported by the Howard Hughes Medical Institute-Gordon and Betty Moore Foundation and by grants from the NSF (DBI-1025830) and the NIH (GM067014) to R.A.M. R.A.M. acknowledges a Chaire Blaise Pascal (Region Ile-de-France) at IBENS, Paris. The Protein Data Bank (PDB) accession number for the RcATXR5-H3.1-AdoHcy ternary structure is 4030.pdb.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Exner V, 2006, DEVELOPMENT, V133, P4163, DOI 10.1242/dev.02599; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Jacob Y, 2010, NATURE, V466, P987, DOI 10.1038/nature09290; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ono T, 2006, GENES CELLS, V11, P153, DOI 10.1111/j.1365-2443.2006.00928.x; Ramirez-Parra E, 2007, PLANT PHYSIOL, V144, P105, DOI 10.1104/pp.106.094979; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Rigal M, 2011, BBA-GENE REGUL MECH, V1809, P452, DOI 10.1016/j.bbagrm.2011.04.001; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stroud H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002808; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658	27	111	120	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1249	1253		10.1126/science.1248357	http://dx.doi.org/10.1126/science.1248357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626927	Green Accepted			2022-12-28	WOS:000332728500036
J	Cai, X; Chen, JQ; Xu, H; Liu, SQ; Jiang, QX; Halfmann, R; Chen, ZJJ				Cai, Xin; Chen, Jueqi; Xu, Hui; Liu, Siqi; Jiang, Qiu-Xing; Halfmann, Randal; Chen, Zhijian J.			Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune Defense and Inflammasome Activation	CELL			English	Article							CYCLIC GMP-AMP; RIG-I; CRYSTAL-STRUCTURE; PYRIN DOMAIN; PROTEIN; FORMS; RECEPTORS; MECHANISM; COMPLEX; NLRP3	Pathogens and cellular danger signals activate sensors such as RIG-I and NLRP3 to produce robust immune and inflammatory responses through respective adaptor proteins MAVS and ASC, which harbor essential N-terminal CARD and PYRIN domains, respectively. Here, we show that CARD and PYRIN function as bona fide prions in yeast and that their prion forms are inducible by their respective upstream activators. Likewise, a yeast prion domain can functionally replace CARD and PYRIN in mammalian cell signaling. Mutations in MAVS and ASC that disrupt their prion activities in yeast also abrogate their ability to signal in mammalian cells. Furthermore, fibers of recombinant PYRIN can convert ASC into functional polymers capable of activating caspase-1. Remarkably, a conserved fungal NOD-like receptor and prion pair can functionally reconstitute signaling of NLRP3 and ASC PYRINs in mammalian cells. These results indicate that prion-like polymerization is a conserved signal transduction mechanism in innate immunity and inflammation.	[Cai, Xin; Chen, Jueqi; Xu, Hui; Liu, Siqi; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Xu, Hui; Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Halfmann, Randal] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Halfmann, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	randal.halfmann@utsouthwestern.edu; zhijian.chen@utsouthwestern.edu	Jiang, Qiu-Xing/AAI-8579-2020; Chen, Zhijian/C-6039-2012; Jiang, Qiu-Xing/ABF-1143-2021; Chen, Jueqi/O-2655-2018	Chen, Zhijian/0000-0002-8475-8251; Chen, Jueqi/0000-0001-7164-8988; Halfmann, Randal/0000-0002-6592-1471; Cai, Xin/0000-0001-5238-6193	NIH [AI-093967, GM-63692, DP5-OD009152]; Welch Foundation [I-1389]; International Student Fellowship from Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); International Student Fellowship from Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Daniel Holmes and Sorna Kamara for technical assistance. We thank Hao Wu for FAS plasmid, Susan Lindquist for NM plasmid, and Susan Liebman for kar1 deficient yeast strain used for cytoduction. This work was supported by grants from the NIH (AI-093967 and GM-63692) and the Welch Foundation (I-1389) to Z.J.C., and the NIH Director's Early Independence Award (DP5-OD009152) to R.H. X.C. was supported by an International Student Fellowship from Howard Hughes Medical Institute (HHMI). Z.J.C. is an HHMI investigator.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Daskalov A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034854; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Saupe SJ, 2011, SEMIN CELL DEV BIOL, V22, P460, DOI 10.1016/j.semcdb.2011.02.019; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seuring C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001451; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	37	378	390	2	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1207	1222		10.1016/j.cell.2014.01.063	http://dx.doi.org/10.1016/j.cell.2014.01.063			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630723	Bronze, Green Accepted			2022-12-28	WOS:000332945100011
J	Hadziselimovic, N; Vukojevic, V; Peter, F; Milnik, A; Fastenrath, M; Fenyves, BG; Hieber, P; Demougin, P; Vogler, C; de Quervain, DJF; Papassotiropoulos, A; Stetak, A				Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Fastenrath, Matthias; Fenyves, Bank Gabor; Hieber, Petra; Demougin, Philippe; Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila			Forgetting Is Regulated via Musashi-Mediated Translational Control of the Arp2/3 Complex	CELL			English	Article							RNA-BINDING PROTEIN; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; ACTIN POLYMERIZATION; C. ELEGANS; MEMORY; MECHANISMS; PLASTICITY; DROSOPHILA; DYNAMICS	A plastic nervous system requires the ability not only to acquire and store but also to forget. Here, we report that musashi (msi-1) is necessary for time-dependent memory loss in C. elegans. Tissue-specific rescue demonstrates that MSI-1 function is necessary in the AVA interneuron. Using RNA-binding protein immunoprecipitation (IP), we found that MSI-1 binds to mRNAs of three subunits of the Arp2/3 actin branching regulator complex in vivo and downregulates ARX-1, ARX-2, and ARX-3 translation upon associative learning. The role of msi-1 in forgetting is also reflected by the persistence of learning-induced GLR-1 synaptic size increase in msi-1 mutants. We demonstrate that memory length is regulated cooperatively through the activation of adducin (add-1) and by the inhibitory effect of msi-1. Thus, a GLR-1/MSI-1/Arp2/3 pathway induces forgetting and represents a novel mechanism of memory decay by linking translational control to the structure of the actin cytoskeleton in neurons.	[Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Hieber, Petra; Demougin, Philippe; Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, CH-4055 Basel, Switzerland; [Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Hieber, Petra; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland; [Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Hieber, Petra; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland; [Fastenrath, Matthias; de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland; [Fenyves, Bank Gabor] Semmelweis Univ, Dept Med Chem, H-1094 Budapest, Hungary; [Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Univ Psychiat Clin, CH-4055 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; Semmelweis University; University of Basel	Stetak, A (corresponding author), Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.	a.stetak@unibas.ch	Fenyves, Bank/AAE-8175-2021	Fenyves, Bank/0000-0003-2374-7513; Papassotiropoulos, Andreas/0000-0002-2210-9651; Vogler, Christian/0000-0003-3922-109X; de Quervain, Dominique/0000-0001-7131-2464; Vukojevic, Vanja/0000-0001-5303-9492; Milnik, Annette/0000-0002-3933-3289	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Forschungsfonds of the University of Basel [DPE2112]; Swiss National Science Foundation [CRSIK0_122691, CRSI33_130080]	National Institutes of Health Office of Research Infrastructure Programs; Forschungsfonds of the University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are grateful to Anne Spang and Jean Pieters for generously sharing methods, reagents, and instruments and to Alex Hajnal for his valuable comments on the manuscript and for laser ablation tools. We also like to thank the Caenorhabditis Genetic Center (supported by the National Institutes of Health Office of Research Infrastructure Programs grant P40 OD010440) for providing nematode strains. The Forschungsfonds of the University of Basel (DPE2112 to A.S.) and the Swiss National Science Foundation (Sinergia grants CRSIK0_122691 and CRSI33_130080 to D.J.-F.d.Q. and A.P.) supported this work.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; BRENNER S, 1974, GENETICS, V77, P71; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHALFIE M, 1985, J NEUROSCI, V5, P956; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hirota Y, 1999, MECH DEVELOP, V87, P93, DOI 10.1016/S0925-4773(99)00143-4; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Horisawa K, 2009, FEBS LETT, V583, P2429, DOI 10.1016/j.febslet.2009.06.045; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Inoue A, 2013, CELL REP, V3, P808, DOI 10.1016/j.celrep.2013.02.019; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyanoiri Y, 2003, J BIOL CHEM, V278, P41309, DOI 10.1074/jbc.M306210200; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019; Vukojevic V, 2012, EMBO J, V31, P1453, DOI 10.1038/emboj.2012.14; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yoda A, 2000, GENES CELLS, V5, P885, DOI 10.1046/j.1365-2443.2000.00378.x	40	62	64	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1153	1166		10.1016/j.cell.2014.01.054	http://dx.doi.org/10.1016/j.cell.2014.01.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630719	Bronze			2022-12-28	WOS:000332945100007
J	Wilson, AM; Glickfeld, LL				Wilson, Ashley M.; Glickfeld, Lindsey L.			Visual Circuits Get the VIP Treatment	CELL			English	Editorial Material							CORTEX; MODULATION; MOUSE; STATE; INTERNEURONS; INTEGRATION; MECHANISMS; RESPONSES	Behavioral state, specifically locomotion, has been shown to enhance sensory responses in primary visual cortex. In this issue of Cell, Fu et al. reveal the circuit elements that mediate this plasticity and suggest that these circuits may serve a general modulatory function across primary sensory areas.	[Wilson, Ashley M.; Glickfeld, Lindsey L.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Glickfeld, LL (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	glickfeld@neuro.duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett C, 2013, NEURON, V80, P350, DOI 10.1016/j.neuron.2013.08.007; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567	10	3	3	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1123	1124		10.1016/j.cell.2014.02.043	http://dx.doi.org/10.1016/j.cell.2014.02.043			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630713	Bronze			2022-12-28	WOS:000332945100001
J	Bagley, N				Bagley, Nicholas			The Legality of Delaying Key Elements of the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Bagley, Nicholas] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bagley, N (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							Jarrett Valerie B., 2013, WHITE HOUSE BLO 0702; Price Z, VANDERBILT IN PRESS	2	11	11	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					1967	1969		10.1056/NEJMp1402641	http://dx.doi.org/10.1056/NEJMp1402641			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UZ	24693858				2022-12-28	WOS:000336125500003
J	Grover, T; Sheng, DN; Vishwanath, A				Grover, Tarun; Sheng, D. N.; Vishwanath, Ashvin			Emergent Space-Time Supersymmetry at the Boundary of a Topological Phase	SCIENCE			English	Article							INSULATOR	In contrast to ordinary symmetries, supersymmetry (SUSY) interchanges bosons and fermions. Originally proposed as a symmetry of our universe, it still awaits experimental verification. Here, we theoretically show that SUSY emerges naturally in condensed matter systems known as topological superconductors. We argue that the quantum phase transitions at the boundary of topological superconductors in both two and three dimensions display SUSY when probed at long distances and times. Experimental consequences include exact relations between quantities measured in disparate experiments and, in some cases, exact knowledge of the universal critical exponents. The topological surface states themselves may be interpreted as arising from spontaneously broken SUSY, indicating a deep relation between topological phases and SUSY.	[Grover, Tarun] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Sheng, D. N.] Calif State Univ, Dept Phys & Astron, North Ridge, CA 91330 USA; [Vishwanath, Ashvin] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Vishwanath, Ashvin] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Vishwanath, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	ashvinv@berkeley.edu	Grover, Tarun/AAX-6598-2021; Vishwanath, Ashvin/AAO-6878-2020		Army Research Office Multidisciplinary University Research Initiative grant [W911-NF-12-0461]; NSF Division of Materials Research grant [0645691]; U.S. Department of Energy Office of Basic Energy Sciences [DE-FG02-06ER46305]	Army Research Office Multidisciplinary University Research Initiative grant; NSF Division of Materials Research grant; U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank M. Fisher, T. Mizushima. D. Huse, R. Mong, and S. Trivedi for discussions. This work is supported by Army Research Office Multidisciplinary University Research Initiative grant W911-NF-12-0461 and NSF Division of Materials Research grant 0645691 (A.V.) and by U.S. Department of Energy Office of Basic Energy Sciences under grant DE-FG02-06ER46305 (D.N.S.).	Aharony O, 1997, NUCL PHYS B, V499, P67, DOI 10.1016/S0550-3213(97)00323-4; Balents L, 1998, INT J MOD PHYS B, V12, P1033, DOI 10.1142/S0217979298000570; Bashkirov D., 2013, BOOTSTRAPPING N 1 SC; DAS A, 1978, PHYS REV D, V18, P4540, DOI 10.1103/PhysRevD.18.4540; DIMOPOULOS S, 1981, NUCL PHYS B, V193, P150, DOI 10.1016/0550-3213(81)90522-8; Fendley P, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.120402; FRIEDAN D, 1984, PHYS REV LETT, V52, P1575, DOI 10.1103/PhysRevLett.52.1575; GERVAIS JL, 1971, NUCL PHYS B, VB 34, P632, DOI 10.1016/0550-3213(71)90351-8; Grosfeld E, 2011, P NATL ACAD SCI USA, V108, P11810, DOI 10.1073/pnas.1101469108; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Huijse L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.146406; Kitaev A., 2008, LD LAND MEM C ADV TH; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; LAHIRI A, 1990, INT J MOD PHYS A, V5, P1383, DOI 10.1142/S0217751X90000647; Lee SS, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075103; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; Mizushima T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.165301; Noether E, 1918, NACHR KONIG GESEL MP; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.187001; Roy R., 2008, TOPOLOGICAL SUPERFLU; Sachdev S., 2011, QUANTUM PHASE TRANSI; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Shifman M, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.045016; Teo JCY, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115120; WESS J, 1974, NUCL PHYS B, VB 70, P39, DOI 10.1016/0550-3213(74)90355-1; Wess J., 1992, SUPERSYMMETRY SUPERG; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; WITTEN E, 1978, PHYS LETT B, V78, P97, DOI 10.1016/0370-2693(78)90357-X; Yu Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.150605	33	192	193	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					280	283		10.1126/science.1248253	http://dx.doi.org/10.1126/science.1248253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24700474	Green Submitted			2022-12-28	WOS:000334474500030
J	Huber, KVM; Salah, E; Radic, B; Gridling, M; Elkins, JM; Stukalov, A; Jemth, AS; Gokturk, C; Sanjiv, K; Stromberg, K; Pham, T; Berglund, UW; Colinge, J; Bennett, KL; Loizou, JI; Helleday, T; Knapp, S; Superti-Furga, G				Huber, Kilian V. M.; Salah, Eidarus; Radic, Branka; Gridling, Manuela; Elkins, Jonathan M.; Stukalov, Alexey; Jemth, Ann-Sofie; Gokturk, Camilla; Sanjiv, Kumar; Stromberg, Kia; Pham, Therese; Berglund, Ulrika Warpman; Colinge, Jacques; Bennett, Keiryn L.; Loizou, Joanna I.; Helleday, Thomas; Knapp, Stefan; Superti-Furga, Giulio			Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy	NATURE			English	Article							CELL LUNG-CANCER; SMALL-MOLECULE INHIBITION; HUMAN MUTT HOMOLOG; RAS-TRANSFORMATION; OXIDATIVE STRESS; MESSENGER-RNA; HMTH1; OVEREXPRESSION; TUMORIGENESIS; CRIZOTINIB	Activated RAS GTPase signalling is a critical driver of oncogenic transformation and malignant disease. Cellular models of RAS-dependent cancers have been used to identify experimental small molecules, such as SCH51344, but their molecular mechanism of action remains generally unknown. Here, using a chemical proteomic approach, we identify the target of SCH51344 as the human mutT homologue MTH1 (also known as NUDT1), a nucleotide pool sanitizing enzyme. Loss-of-function of MTH1 impaired growth of KRAS tumour cells, whereas MTH1 overexpression mitigated sensitivity towards SCH51344. Searching for more drug-like inhibitors, we identified the kinase inhibitor crizotinib as a nanomolar suppressor of MTH1 activity. Surprisingly, the clinically used (R)-enantiomer of the drug was inactive, whereas the (S)-enantiomer selectively inhibited MTH1 catalytic activity. Enzymatic assays, chemical proteomic profiling, kinome-wide activity surveys and MTH1 co-crystal structures of both enantiomers provide a rationale for this remarkable stereospecificity. Disruption of nucleotide pool homeostasis via MTH1 inhibition by (S)-crizotinib induced an increase in DNA single-strand breaks, activated DNA repair in human colon carcinoma cells, and effectively suppressed tumour growth in animal models. Our results propose (S)-crizotinib as an attractive chemical entity for further pre-clinical evaluation, and small-molecule inhibitors of MTH1 in general as a promising novel class of anticancer agents.	[Huber, Kilian V. M.; Radic, Branka; Gridling, Manuela; Stukalov, Alexey; Colinge, Jacques; Bennett, Keiryn L.; Loizou, Joanna I.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Salah, Eidarus; Elkins, Jonathan M.; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Jemth, Ann-Sofie; Gokturk, Camilla; Sanjiv, Kumar; Stromberg, Kia; Pham, Therese; Berglund, Ulrika Warpman; Helleday, Thomas] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Oxford; Karolinska Institutet	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Huber, Kilian V. M./L-6921-2015; Colinge, Jacques/D-1578-2017; Superti-Furga, Giulio/F-4755-2015; Stukalov, Alexey/AAS-3208-2021; Colinge, Jacques/Z-2613-2019; Knapp, Stefan/AAG-2347-2019	Huber, Kilian V. M./0000-0002-1103-5300; Colinge, Jacques/0000-0003-2466-4824; Superti-Furga, Giulio/0000-0002-0570-1768; Stukalov, Alexey/0000-0002-4981-8124; Colinge, Jacques/0000-0003-2466-4824; Knapp, Stefan/0000-0001-5995-6494; Jemth, Ann-Sofie/0000-0002-7550-1833; Radic Sarikas, Branka/0000-0002-3597-0483; Warpman Berglund, Ulrika/0000-0002-6372-1396; Pham, Therese M/0000-0002-5577-6039; Elkins, Jon/0000-0003-2858-8929; Loizou, Joanna/0000-0003-1853-0424; Bennett, Keiryn L./0000-0001-9356-7708; Helleday, Thomas/0000-0002-7384-092X	Austrian Academy of Sciences; GEN-AU initiative of the Austrian Federal Ministry for Science and Research; European Union; SGC, a registered charity [1097737]; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Takeda; AbbVie; Novartis Research Foundation; Boehringer Ingelheim; Ontario Ministry of Research and Innovation; Wellcome Trust [092809/Z/10/Z]; European Union [278568]; Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; European Research Council; Swedish Cancer Society; European Union FP7 Career Integration Grant [PCIG11-GA-2012-321602]; FWF Grant [P24766-B20]	Austrian Academy of Sciences; GEN-AU initiative of the Austrian Federal Ministry for Science and Research; European Union(European Commission); SGC, a registered charity; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Novartis Research Foundation; Boehringer Ingelheim(Boehringer Ingelheim); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); European Union FP7 Career Integration Grant; FWF Grant(Austrian Science Fund (FWF))	The team at CeMM was supported by the Austrian Academy of Sciences, the GEN-AU initiative of the Austrian Federal Ministry for Science and Research, and "ASSET", a project funded by the European Union within FP7. S. K., E. S. and J.M.E. are grateful for financial support from the SGC, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, Takeda, AbbVie, the Novartis Research Foundation, Boehringer Ingelheim, the Ontario Ministry of Research and Innovation and the Wellcome Trust (Grant No. 092809/Z/10/Z). E. S. was supported by the European Union FP7 Grant No. 278568 "PRIMES". T. H. was supported by the Torsten and Ragnar Soderberg Foundation, the Knut and Alice Wallenberg Foundation, the Swedish Research Council, the European Research Council and the Swedish Cancer Society. J. I. L. was supported by the European Union FP7 Career Integration Grant (PCIG11-GA-2012-321602) and an FWF Grant (P24766-B20). We are grateful to D. Treiber, J. Hunt, P. Gallant and G. Pallares from DiscoveRx for the KdELECT and scanMAX studies. We thank W. Lindner and N. Maier for chiral HPLC analyses, R. Lichtenecker for NMR measurements, A. C. Muller for the annotation of the MS/MS spectrum, M. Brehme for help with the figures, and H. Pickersgill and G. Vladimer for critically reading the manuscript. We are very grateful to the following colleagues for the respective reagents: S. Lowe for the miR30 vectors and pMLP-p53; R. Weinberg for pLKO.1 shMTH1 and pBABE-puro plasmids; W. Berger for SW480, DLD1 and SW620 cells; R. Oehler for PANC1 cells; W. Hahn and A. Gad for BJ-hTERT, BJ-hTERT-SV40T, BJ-hTERT-SV40T-KRASV12 cells, B. Vogelstein for p53<SUP>-/-</SUP> and p21<SUP>-/-</SUP> HCT116 cells; C. Gasche for LoVo and HCT15 cells; A. Nussenzweig for Atm wild type and Atm<SUP>-/-</SUP> mouse embryonic fibroblasts.	Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Hutt Andrew J., 2007, Drug Metabolism and Drug Interactions, V22, P79; Kennedy CH, 1998, FEBS LETT, V429, P17, DOI 10.1016/S0014-5793(98)00505-5; KUMAR CC, 1995, CANCER RES, V55, P5106; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Okamoto K, 1996, INT J CANCER, V65, P437, DOI 10.1002/(SICI)1097-0215(19960208)65:4<437::AID-IJC7>3.0.CO;2-Y; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Sakumi K, 2003, CANCER RES, V63, P902; Speina E, 2005, JNCI-J NATL CANCER I, V97, P384, DOI 10.1093/jnci/dji058; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Walsh AB, 1997, ONCOGENE, V15, P2553, DOI 10.1038/sj.onc.1201424; Xu J, 2012, BLOOD, V119, P1032, DOI 10.1182/blood-2011-06-358960; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	33	273	291	5	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					222	+		10.1038/nature13194	http://dx.doi.org/10.1038/nature13194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695225	Green Accepted			2022-12-28	WOS:000333979900039
J	Niwa, S; Yu, LJ; Takeda, K; Hirano, Y; Kawakami, T; Wang-Otomo, ZY; Miki, K				Niwa, Satomi; Yu, Long-Jiang; Takeda, Kazuki; Hirano, Yu; Kawakami, Tomoaki; Wang-Otomo, Zheng-Yu; Miki, Kunio			Structure of the LH1-RC complex from Thermochromatium tepidum at 3.0 angstrom	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYNTHETIC REACTION-CENTER; RC-LH1 CORE COMPLEX; RHODOSPIRILLUM-RUBRUM; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURE; RHODOPSEUDOMONAS-VIRIDIS; PROJECTION STRUCTURE; CALCIUM-IONS; PROTEIN	The light-harvesting core antenna (LH1) and the reaction centre (RC) of purple photosynthetic bacteria form a supramolecular complex (LH1-RC) to use sunlight energy in a highly efficient manner. Here we report the first near-atomic structure, to our knowledge, of a LH1-RC complex, namely that of a Ca2+-bound complex from Thermochromatium tepidum, which reveals detailed information on the arrangement and interactions of the protein subunits and the cofactors. The RC is surrounded by 16 heterodimers of the LH1 alpha beta-subunit that form a completely closed structure. The Ca2+ ions are located at the periplasmic side of LH1. Thirty-two bacteriochlorophyll and 16 spirilloxanthin molecules in the LH1 ring form an elliptical assembly. The geometries of the pigment assembly involved in the absorption characteristics of the bacteriochlorophyll in LH1 and excitation energy transfer among the pigments are reported. In addition, possible ubiquinone channels in the closed LH1 complex are proposed based on the atomic structure.	[Niwa, Satomi; Takeda, Kazuki; Hirano, Yu; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Yu, Long-Jiang; Kawakami, Tomoaki; Wang-Otomo, Zheng-Yu] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan	Kyoto University; Ibaraki University	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	wang@ml.ibaraki.ac.jp; miki@kuchem.kyoto-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Takeda, Kazuki/0000-0002-4094-6816; Niwa, Satomi/0000-0002-2648-8257; , Wang-Otomo/0000-0003-1676-2002	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ibaraki University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ibaraki University	We thank S. Takaichi for analysing the pigment compositions in LH1-RC and dry cells; F. Sekine for sequencing the genes encoding RC proteins; T. Nozawa for his support and interest at the initial stage; Y. Kimura, Masayuki Kobayashi and J.-R. Shen for their discussion; H. Suzuki, Dorina, M. Nakamura, F. Oh-hata and Miho Kobayashi for their contributions to the early stage of crystallization and data collection, and the Kao Corporation for kindly providing LDAO. This work was supported by a Grant-in-Aid for Scientific Research on the Priority Area "Structures of Biological Macromolecular Assemblies" and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by funds from the Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation (to Z.-Y.W.-O.), and the Targeted Proteins Research Program and the Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. M.), and by a postdoctoral fellowship from Ibaraki University (to L.-J.Y.). This work was performed using the synchrotron beamline BL44XU at SPring-8 under the Cooperative Research Program of the Institute for Protein Research, Osaka University and the beamlines at the KEK Photon Factory. We are grateful to A. Nakagawa, E. Yamashita, N. Matsugaki and Y. Yamada for their assistance in the data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aird A, 2007, BIOPHYS J, V92, P23, DOI 10.1529/biophysj.106.084715; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Comayras R, 2005, J BIOL CHEM, V280, P11214, DOI 10.1074/jbc.M412089200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DAVIS CM, 1995, J BIOL CHEM, V270, P5793, DOI 10.1074/jbc.270.11.5793; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fathir I, 1997, PHOTOSYNTH RES, V51, P71, DOI 10.1023/A:1005718404736; Fathir I, 1998, PHOTOSYNTH RES, V58, P193, DOI 10.1023/A:1006146713751; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; Kimura Y, 2008, J BIOL CHEM, V283, P13867, DOI 10.1074/jbc.M800256200; Kimura Y, 2012, BBA-BIOENERGETICS, V1817, P1022, DOI 10.1016/j.bbabio.2012.03.016; Kimura Y, 2009, J BIOL CHEM, V284, P93, DOI 10.1074/jbc.M806840200; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MADIGAN MT, 1984, SCIENCE, V225, P313, DOI 10.1126/science.225.4659.313; Mascle-Allemand C, 2008, BBA-BIOENERGETICS, V1777, P1552, DOI 10.1016/j.bbabio.2008.09.010; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Richter MF, 2007, P NATL ACAD SCI USA, V104, P20280, DOI 10.1073/pnas.0704599105; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Rowe JJ., 1973, CHEM ANAL THERMAL WA, DOI [10.3133/b1303, DOI 10.3133/B1303]; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring Simon, 2009, V28, P941; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; Suzuki H, 2007, BBA-BIOENERGETICS, V1767, P1057, DOI 10.1016/j.bbabio.2007.06.002; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walz T, 1997, J MOL BIOL, V265, P107, DOI 10.1006/jmbi.1996.0714; Yu LJ, 2010, PHOTOSYNTH RES, V106, P215, DOI 10.1007/s11120-010-9596-y	46	151	156	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					228	+		10.1038/nature13197	http://dx.doi.org/10.1038/nature13197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24670637				2022-12-28	WOS:000333979900040
J	Muntner, P; Colantonio, LD; Cushman, M; Goff, DC; Howard, G; Howard, VJ; Kissela, B; Levitan, EB; Lloyd-Jones, DM; Safford, MM				Muntner, Paul; Colantonio, Lisandro D.; Cushman, Mary; Goff, David C., Jr.; Howard, George; Howard, Virginia J.; Kissela, Brett; Levitan, Emily B.; Lloyd-Jones, Donald M.; Safford, Monika M.			Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; MYOCARDIAL-INFARCTION; RACIAL-DIFFERENCES; STROKE; TRENDS; STATISTICS; PREVENTION; DIAGNOSIS; REASONS	IMPORTANCE The American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort risk equations were developed to estimate atherosclerotic cardiovascular disease (CVD) risk and guide statin initiation. OBJECTIVE To assess calibration and discrimination of the Pooled Cohort risk equations in a contemporary US population. DESIGN, SETTING, AND PARTICIPANTS Adults aged 45 to 79 years enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study between January 2003 and October 2007 and followed up through December 2010. We studied participants for whom atherosclerotic CVD risk may trigger a discussion of statin initiation (those without clinical atherosclerotic CVD or diabetes, low-density lipoprotein cholesterol level between 70 and 189mg/dL, and not taking statins; n = 10 997). MAIN OUTCOMES AND MEASURES Predicted risk and observed adjudicated atherosclerotic CVD incidence (nonfatal myocardial infarction, coronary heart disease [CHD] death, nonfatal or fatal stroke) at 5 years because REGARDS participants have not been followed up for 10 years. Additional analyses, limited to Medicare beneficiaries (n = 3333), added atherosclerotic CVD events identified in Medicare claims data. RESULTS There were 338 adjudicated events (192 CHD events, 146 strokes). The observed and predicted 5-year atherosclerotic CVD incidence per 1000 person-years for participants with a 10-year predicted atherosclerotic CVD risk of less than 5% was 1.9 (95% CI, 1.3-2.7) and 1.9, respectively, risk of 5% to less than 7.5% was 4.8 (95% CI, 3.4-6.7) and 4.8, risk of 7.5% to less than 10% was 6.1 (95% CI, 4.4-8.6) and 6.9, and risk of 10% or greater was 12.0 (95% CI, 10.6-13.6) and 15.1 (Hosmer-Lemeshow.2 = 19.9, P = .01). The C index was 0.72 (95% CI, 0.70-0.75). There were 234 atherosclerotic CVD events (120 CHD events, 114 strokes) among Medicare-linked participants and the observed and predicted 5-year atherosclerotic CVD incidence per 1000 person-years for participants with a predicted risk of less than 7.5% was 5.3 (95% CI, 2.8-10.1) and 4.0, respectively, risk of 7.5% to less than 10% was 7.9 (95% CI, 4.6-13.5) and 6.4, and risk of 10% or greater was 17.4 (95% CI, 15.3-19.8) and 16.4 (Hosmer-Lemeshow.2 = 5.4, P = .71). The C index was 0.67 (95% CI, 0.64-0.71). CONCLUSIONS AND RELEVANCE In this cohort of US adults for whom statin initiation is considered based on the ACC/AHA Pooled Cohort risk equations, observed and predicted 5-year atherosclerotic CVD risks were similar, indicating that these risk equations were well calibrated in the population for which they were designed to be used, and demonstrated moderate to good discrimination.	[Muntner, Paul; Colantonio, Lisandro D.; Howard, Virginia J.; Levitan, Emily B.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Muntner, Paul; Safford, Monika M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cushman, Mary] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Goff, David C., Jr.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Howard, George] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Kissela, Brett] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Lloyd-Jones, Donald M.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Vermont; Colorado School of Public Health; University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Cincinnati; Northwestern University; Feinberg School of Medicine	Muntner, P (corresponding author), Univ Alabama Birmingham, 1665 Univ Blvd,Ste 230J, Birmingham, AL 35294 USA.	pmuntner@uab.edu	Cushman, Mary/K-1157-2019	Cushman, Mary/0000-0002-7871-6143; Kissela, Brett/0000-0002-9773-4013; Levitan, Emily/0000-0002-5429-3852; Lloyd-Jones, Donald/0000-0003-0847-6110; Howard, George/0000-0002-3068-5720; Colantonio, Lisandro/0000-0001-8742-1788	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; National Heart, Lung, and Blood Institute [R01 HL080477, K24 HL111154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111154, R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041588, U01NS041588] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services. Additional support was provided by grants R01 HL080477 and K24 HL111154 from the National Heart, Lung, and Blood Institute.	[Anonymous], 1989, Stroke, V20, P1407; Colette D., 1994, MODELING SURVIVAL DA; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Fonseca C, 2004, EUR J HEART FAIL, V6, P813, DOI 10.1016/j.ejheart.2004.08.003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goff Jr DC, 2013, J AM COLL CARDIOL, DOI [10.1016/j.jacc.2013.1011.1005, DOI 10.1016/J.JACC.2013.1011.1005]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hlatky MA, 2014, CIRC-CARDIOVASC QUAL, V7, P157, DOI 10.1161/CIRCOUTCOMES.113.000373; HOSMER DW, 2000, WILEY PS TX, P1; Howard VJ, 2011, ANN NEUROL, V69, P619, DOI 10.1002/ana.22385; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Meschia JF, 2000, STROKE, V31, P1076, DOI 10.1161/01.STR.31.5.1076; Muntner P, 2013, AM J CARDIOL, V112, P664, DOI 10.1016/j.amjcard.2013.04.041; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Prineas RJ, 2010, MINNESOTA CODE MANUA; Prineas RJ, 1982, THE MINNESOTA CODE M; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Soliman EZ, 2012, J AM COLL CARDIOL, V59, P1460, DOI 10.1016/j.jacc.2012.01.025; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD	28	369	376	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1406	1415		10.1001/jama.2014.2630	http://dx.doi.org/10.1001/jama.2014.2630			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24682252	Green Accepted, Bronze			2022-12-28	WOS:000333935000016
J	Price, R; MacLennan, G; Glen, J				Price, Richard; MacLennan, Graeme; Glen, John		SuDDICU Collaboration	Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VENTILATOR-ASSOCIATED PNEUMONIA; CRITICALLY-ILL PATIENTS; PLAQUE ANTISEPTIC DECONTAMINATION; RESPIRATORY-TRACT INFECTIONS; DOUBLE-BLIND; ORAL DECONTAMINATION; NOSOCOMIAL INFECTIONS; CONTROLLED-TRIAL; ANTIBIOTIC-PROPHYLAXIS; BACTERIAL-COLONIZATION	Objectives To determine the effect on mortality of selective digestive decontamination, selective oropharyngeal decontamination, and topical oropharyngeal chlorhexidine in adult patients in general intensive care units and to compare these interventions with each other in a network meta-analysis. Design Systematic review, conventional meta-analysis, and network meta-analysis. Medline, Embase, and CENTRAL were searched to December 2012. Previous meta-analyses, conference abstracts, and key journals were also searched. We used pairwise meta-analyses to estimate direct evidence from intervention-control trials and a network meta-analysis within a Bayesian framework to combine direct and indirect evidence. Inclusion criteria Prospective randomised controlled trials that recruited adult patients in general intensive care units and studied selective digestive decontamination, selective oropharyngeal decontamination, or oropharyngeal chlorhexidine compared with standard care or placebo. Results Selective digestive decontamination had a favourable effect on mortality, with a direct evidence odds ratio of 0.73 (95% confidence interval 0.64 to 0.84). The direct evidence odds ratio for selective oropharyngeal decontamination was 0.85 (0.74 to 0.97). Chlorhexidine was associated with increased mortality (odds ratio 1.25, 1.05 to 1.50). When each intervention was compared with the other, both selective digestive decontamination and selective oropharyngeal decontamination were superior to chlorhexidine. The difference between selective digestive decontamination and selective oropharyngeal decontamination was uncertain. Conclusion Selective digestive decontamination has a favourable effect on mortality in adult patients in general intensive care units. In these patients, the effect of selective oropharyngeal decontamination is less certain. Both selective digestive decontamination and selective oropharyngeal decontamination are superior to chlorhexidine, and there is a possibility that chlorhexidine is associated with increased mortality.	[Price, Richard] Royal Alexandra Hosp, Intens Care Unit, Paisley PA2 9PN, Renfrew, Scotland; [MacLennan, Graeme] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Glen, John] Glan Clwyd Gen Hosp, Intens Care Unit, Bodelwyddan LL18 5UJ, Wales	University of Aberdeen	Price, R (corresponding author), Royal Alexandra Hosp, Intens Care Unit, Paisley PA2 9PN, Renfrew, Scotland.	rjp@doctors.org.uk		MacLennan, Graeme/0000-0002-1039-5646	Chief Scientist Office [HSRU1] Funding Source: Medline	Chief Scientist Office		AERDTS SJA, 1991, CHEST, V100, P783, DOI 10.1378/chest.100.3.783; Bastin AJ, 2009, ANAESTHESIA, V64, P46, DOI 10.1111/j.1365-2044.2008.05676.x; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Bellissimo-Rodrigues F, 2009, INFECT CONT HOSP EP, V30, P952, DOI 10.1086/605722; Bergmans DCJJ, 2001, AM J RESP CRIT CARE, V164, P382, DOI 10.1164/ajrccm.164.3.2005003; Berry AM, 2011, INT J NURS STUD, V48, P681, DOI 10.1016/j.ijnurstu.2010.11.004; BLAIR P, 1991, SURGERY, V110, P303; BOLAND JP, 1991, 17 C CHEM; BONTEN MJM, 1994, AM J RESP CRIT CARE, V150, P1332, DOI 10.1164/ajrccm.150.5.7952561; Bonten MJM, 2003, INTENS CARE MED, V29, P672, DOI 10.1007/s00134-003-1714-2; Cabov T, 2010, WIEN KLIN WOCHENSCHR, V122, P397, DOI 10.1007/s00508-010-1397-y; Carvajal C, 2010, MED CLIN-BARCELONA, V135, P491, DOI 10.1016/j.medcli.2010.02.039; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Chlebicki MN, 2007, CRIT CARE MED, V35, P595, DOI 10.1097/01.CCM.0000253395.70708.AC; COCKERILL FR, 1992, ANN INTERN MED, V117, P545, DOI 10.7326/0003-4819-117-7-545; Cuthbertson BH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-117; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Jonge E, 2003, LANCET, V362, P2119, DOI 10.1016/S0140-6736(03)15122-7; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; de Smet AMGA, 2012, CURR OPIN INFECT DIS, V25, P211, DOI 10.1097/QCO.0b013e3283507f8c; Dias S, 2011, 2 NICE DSU; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; Fourrier F, 2005, CRIT CARE MED, V33, P1728, DOI 10.1097/01.CCM.0000171537.03493.B0; Garcia MS, 1998, AM J RESP CRIT CARE, V158, P908, DOI 10.1164/ajrccm.158.3.9712079; GarrousteOrgeas M, 1997, AM J RESP CRIT CARE, V156, P1647, DOI 10.1164/ajrccm.156.5.96-04076; HUMPHREYS H, 1992, INTENS CARE MED, V18, P459, DOI 10.1007/BF01708581; Institute for Healthcare Improvement, 2012, GUID PREV VENTILATOR; Jacobs S., 1992, CLIN INTENSIVE CARE, V3, P52; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; Koeman M, 2006, AM J RESP CRIT CARE, V173, P1348, DOI 10.1164/rccm.200505-820OC; Kola A, 2007, J HOSP INFECT, V66, P207, DOI 10.1016/j.jhin.2007.03.025; Kollef MH, 2003, CHEST, V123, p464S, DOI 10.1378/chest.123.5_suppl.464S; Krueger WA, 2002, AM J RESP CRIT CARE, V166, P1029, DOI 10.1164/rccm.2105141; Labeau SO, 2011, LANCET INFECT DIS, V11, P845, DOI 10.1016/S1473-3099(11)70127-X; Liberati A, 2009, COCHRANE DB SYST REV, V4, P22, DOI 10.1002/14651858.CD000022.pub2; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Macnaughton P., 2004, INTENSIVE CARE MED, V30; Munro CL, 2009, AM J CRIT CARE, V18, P428, DOI 10.4037/ajcc2009792; National Institute for Health and Clinical Excellence, TECHN PAT SAF SOL VE; Oostdijk EAN, 2012, INTENS CARE MED, V38, P533, DOI 10.1007/s00134-012-2488-1; Palomar M., 1997, CLIN INTENSIVE CARE, V8, P228, DOI [10.3109/tcic.8.5.228.235, DOI 10.3109/TCIC.8.5.228.235]; Panchabhai TS, 2009, CHEST, V135, P1150, DOI 10.1378/chest.08-1321; Pileggi C, 2011, CRIT CARE, V15, DOI 10.1186/cc10285; Pineda LA, 2006, CRIT CARE, V10, DOI 10.1186/cc4837; Pugh RJ, 2010, CRIT CARE S1, V14, P85; PUGIN J, 1991, JAMA-J AM MED ASSOC, V265, P2704, DOI 10.1001/jama.265.20.2704; Rello J, 2010, INTENS CARE MED, V36, P773, DOI 10.1007/s00134-010-1841-5; Rios F, 2005, P AM THORACIC SOC, pA820; ROCHA LA, 1992, INTENS CARE MED, V18, P398, DOI 10.1007/BF01694341; Scannapieco FA, 2009, CRIT CARE, V13, DOI 10.1186/cc7967; Schultz MJ, 2011, CRIT CARE, V15, DOI 10.1186/cc9963; Silvestri L, 2008, ANAESTH INTENS CARE, V36, P324, DOI 10.1177/0310057X0803600304; Silvestri L, 2007, J HOSP INFECT, V65, P187, DOI 10.1016/j.jhin.2006.10.014; Silvestri L, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.11.005; Silvestri L, 2010, CRIT CARE MED, V38, P1370, DOI 10.1097/CCM.0b013e3181d9db8c; Stoutenbeek CP, 2007, INTENS CARE MED, V33, P261, DOI 10.1007/s00134-006-0455-4; Tad-Y D, 2007, CHEST, V132, p498a; Tantipong H, 2008, INFECT CONT HOSP EP, V29, P131, DOI 10.1086/526438; ULRICH C, 1989, INTENS CARE MED, V15, P424, DOI 10.1007/BF00255597; van Saene HKF, 2003, INTENS CARE MED, V29, P677, DOI 10.1007/s00134-003-1722-2; van Till JWO, 2007, CRIT CARE, V11, DOI 10.1186/cc6191; VANSAENE HF, 1992, CRIT CARE MED, V20, P691, DOI 10.1097/00003246-199205000-00024; Verbrugh HA, 2003, LANCET, V362, P2117, DOI 10.1016/S0140-6736(03)15117-3; Verwaest C, 1997, CRIT CARE MED, V25, P63, DOI 10.1097/00003246-199701000-00014; Walden AP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6697; WINTER R, 1992, J ANTIMICROB CHEMOTH, V30, P73, DOI 10.1093/jac/30.1.73	66	139	141	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2197	10.1136/bmj.g2197	http://dx.doi.org/10.1136/bmj.g2197			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TK	24687313	hybrid, Green Published			2022-12-28	WOS:000333976100002
J	Darrow, JJ; Avorn, J; Kesselheim, AS				Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.			New FDA Breakthrough- Drug Category Implications for Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							USER FEE ACT; EARLY ACCESS; FOOD; SAFETY; APPROVAL; DEADLINES; INDUSTRY	In July 2012, the FDA Safety and Innovation Act created the breakthrough therapy designation to expedite development of therapies for serious diseases when evidence suggests substantial superiority over existing options. The authors discuss implications of the new designation. U.S. pharmaceutical regulations are based on the principle that patients should not be exposed to new prescription drugs until their efficacy and safety have been shown. Since 1962, the Food and Drug Administration (FDA) and Congress have balanced the efficient review of investigational drugs with the need to withhold judgment until sufficient evidence is available to clarify the benefit-risk relationship. Misjudging these competing interests in either direction causes important problems. On the one hand, the evidentiary hurdles of the FDA are often criticized by pharmaceutical companies and patient advocacy groups for slowing access to promising therapies. On the other hand, ...	[Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Darrow, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017; Darrow, J J/R-8365-2019	Kesselheim, Aaron/0000-0002-8867-2666; Darrow, J J/0000-0002-7351-4243				[Anonymous], 2006, FED REGISTER, V71, P75148; [Anonymous], 1992, DRUG CLASS PRI REV P; [Anonymous], 1992, FED REGISTER, V57, P58958; [Anonymous], 1990, FED REGISTER, V55, P20857; [Anonymous], 1979, FDA CONSUM, P25; [Anonymous], 2013, FED REGISTER, V78, P3005; [Anonymous], 1987, FED REGISTER, V52, P19476; [Anonymous], 1988, FED REGISTER, V53, P41517; [Anonymous], 1991, EXP ACC INV THER HIV; Avorn J, 2007, NEW ENGL J MED, V356, P1697, DOI 10.1056/NEJMp078041; Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Basu S, 2012, NEW ENGL J MED, V367, P485, DOI 10.1056/NEJMp1204170; Bompey N, 2013, FRIENDS CANC RES; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Carpenter D, 2003, HLTH AFF MILLW S, pW3; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Carpenter D, 2012, AM J POLIT SCI, V56, P98, DOI 10.1111/j.1540-5907.2011.00544.x; CRAWFORD SY, 1992, AM J HOSP PHARM, V49, P2383, DOI 10.1093/ajhp/49.10.2383; Department of Health and Human Services Food and Drug Administration, 2011, PROP WITHD APPR BREA; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; ETZIONI A, 1968, ACTIVE SOC THEORY SO; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; Food and Drug Administration, 2004, GUID IND FAST TRACK; Food and Drug Administration, 2013, DUMM NDA APPR REC 19; Food and Drug Administration, 2010, MYL GEMTZ OZ MARK WI; Food and Drug Administration, FREQ ASK QUEST BREAK; Food and Drug Administration, 2006, GUID IND FAST TRACK; Food and Drug Administration, 2012, FY 2012 INN DRUG APP; Food and Drug Administration, 2013, FAST TRACK BREAKTH T; Food and Drug Administration (FDA), 1988, FED REGISTER, V53, P41516; Grabowski H, 2008, J LAW ECON, V51, P377, DOI 10.1086/589934; Grady D, 2013, NY TIMES, pB4; Harris G, 2010, NY TIMES, pA11; Hirschler B., 2010, REUTERS; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Kaitin K I, 1997, Am J Ther, V4, P167, DOI 10.1097/00045391-199705000-00002; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Kessler DA, 1996, FOOD DRUG LAW J, V51, P207; Lexchin J, 2012, ARCH INTERN MED, V172, P1680, DOI 10.1001/archinternmed.2012.4444; Mayer M, 2006, CLIN TRIALS, V3, P149, DOI 10.1191/1740774506cn144oa; McClellan M, 2012, HILL; McCrimmon KK, 2013, HLTH POLICY SOLUTION; Moore TJ, 2014, JAMA INTERN MED, V174, P90, DOI 10.1001/jamainternmed.2013.11813; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007; Olson MK, 2013, J RISK UNCERTAINTY, V47, P1, DOI 10.1007/s11166-013-9169-5; Reaves N, 2009, ANN C PENNS EC ASS; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; Schultz WB, 2007, NEW ENGL J MED, V357, P2217, DOI 10.1056/NEJMp078212; Sherman RE, 2013, NEW ENGL J MED, V369, P1877, DOI 10.1056/NEJMp1311439; Shulman SR, 1996, PHARMACOECONOMICS, V9, P121, DOI 10.2165/00019053-199609020-00004; Shulman SR, 1995, FOOD DRUG LAW J, V50, P503; Steenburg C, 2006, FOOD DRUG LAW J, V61, P295; Zelenay JL, 2005, FOOD DRUG LAW J, V60, P261	54	85	85	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1252	1258		10.1056/NEJMhle1311493	http://dx.doi.org/10.1056/NEJMhle1311493			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD7EW	24670173	Bronze			2022-12-28	WOS:000333426000014
J	Junker, JP; van Oudenaarden, A				Junker, Jan Philipp; van Oudenaarden, Alexander			Every Cell Is Special: Genome-wide Studies Add a New Dimension to Single-Cell Biology	CELL			English	Review							RNA-SEQ; EXPRESSION; AMPLIFICATION; IMMUNE; NOISE	Single-cell analyses have provided invaluable insights into studying heterogenity, signaling, and stochastic gene expression. Recent technological advances now open the door to genome-wide single-cell studies.	[Junker, Jan Philipp; van Oudenaarden, Alexander] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Junker, Jan Philipp; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Junker, JP (corresponding author), KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	j.junker@hubrecht.eu	t, lf/AAJ-4924-2020; Junker, Jan Philipp/A-9754-2010; van Oudenaarden, Alexander/AAA-1705-2019	Junker, Jan Philipp/0000-0002-2826-8290; 				Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Leuchowius KJ, 2013, MOL CELL PROTEOMICS, V12, P1563, DOI 10.1074/mcp.O112.023374; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	23	135	142	4	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					8	11		10.1016/j.cell.2014.02.010	http://dx.doi.org/10.1016/j.cell.2014.02.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679522	Bronze			2022-12-28	WOS:000333968900003
J	Humphreys, RA; Lepper, R; Nicholson, TRJ				Humphreys, Rosemary A.; Lepper, Robert; Nicholson, Timothy R. J.			THE COMPETENT NOVICE When and how to treat patients who refuse treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MENTAL INCAPACITY; PREVALENCE		[Humphreys, Rosemary A.] Barnet Enfield & Haringey NHS Trust, St Anns Hosp, London N15 3TH, England; [Lepper, Robert] South London & Maudsley NHS Fdn Trust, Maudsley Hosp, London, England; [Nicholson, Timothy R. J.] Kings Coll London, Inst Psychiat, Sect Cognit Neuropsychiat, London WC2R 2LS, England	South London & Maudsley NHS Trust; University of London; King's College London	Humphreys, RA (corresponding author), Barnet Enfield & Haringey NHS Trust, St Anns Hosp, London N15 3TH, England.	rosemary.humphreys.13@ucl.ac.uk		Nicholson, Timothy/0000-0002-2350-2332	National Institute for Health Research [CL-2009-17-006] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Cairns R, 2005, BRIT J PSYCHIAT, V187, P379, DOI 10.1192/bjp.187.4.379; Cutter WJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7323; Department of Health, 2008, MENT HLTH ACT 2007; HMSO, 2005, MENTAL CAPACITY ACT; Hotopf M., 2006, J MENT HEALTH, V15, P1; Lepping P, 2011, BRIT J PSYCHIAT, V199, P355, DOI 10.1192/bjp.bp.111.094938; McLean SAM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4112; Nicholson TRJ, 2008, BRIT MED J, V336, P322, DOI 10.1136/bmj.39457.485347.80; Office of Public Guardianship, 2007, MAK DEC IND MENT CAP; Owino AO, 2008, PSYCHIATR BULL, V32, P124, DOI 10.1192/pb.bp.107.016436; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3	11	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2014	348								g2043	10.1136/bmj.g2043	http://dx.doi.org/10.1136/bmj.g2043			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LD	24668621	Green Published			2022-12-28	WOS:000333585700002
J	Halpern, SD; Detsky, AS				Halpern, Scott D.; Detsky, Allan S.			Graded Autonomy in Medical Education - Managing Things That Go Bump in the Night	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTENSIVE-CARE-UNIT; RANDOMIZED-TRIAL		[Halpern, Scott D.] Univ Penn, Dept Med,Ctr Clin Epidemiol & Biostat,Leonard Dav, Fostering Improvement End Of Life Decis Sci Progr, Div Pulm Allergy & Crit Care Med,Ctr Hlth Incent, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Halpern, SD (corresponding author), Univ Penn, Dept Med,Ctr Clin Epidemiol & Biostat,Leonard Dav, Fostering Improvement End Of Life Decis Sci Progr, Div Pulm Allergy & Crit Care Med,Ctr Hlth Incent, Philadelphia, PA 19104 USA.							Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Garland A, 2012, AM J RESP CRIT CARE, V185, P738, DOI 10.1164/rccm.201109-1734OC; Kerlin MP, 2013, NEW ENGL J MED, V368, P2201, DOI 10.1056/NEJMoa1302854; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975	5	42	42	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1086	1089		10.1056/NEJMp1315408	http://dx.doi.org/10.1056/NEJMp1315408			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD2HA	24645941				2022-12-28	WOS:000333054000004
J	Torres, MA; West, AJ; Li, GJ				Torres, Mark A.; West, A. Joshua; Li, Gaojun			Sulphide oxidation and carbonate dissolution as a source of CO2 over geological timescales	NATURE			English	Article							MACKENZIE RIVER-BASIN; ORGANIC-CARBON; ISOTOPE FRACTIONATION; WEATHERING PROCESSES; ATMOSPHERIC OXYGEN; GLOBAL CARBON; MASS-BALANCE; OCEAN; EVOLUTION; SEAWATER	The observed stability of Earth's climate over millions of years is thought to depend on the rate of carbon dioxide (CO2) release from the solid Earth being balanced by the rate of CO2 consumption by silicate weathering(1). During the Cenozoic era, spanning approximately the past 66 million years, the concurrent increases in the marine isotopic ratios of strontium, osmium and lithium(2-4) suggest that extensive uplift of mountain ranges may have stimulated CO2 consumption by silicate weathering(5), but reconstructions of sea-floor spreading(6) do not indicate a corresponding increase in CO2 inputs from volcanic degassing. The resulting imbalance would have depleted the atmosphere of all CO2 within a few million years(7). As a result, reconciling Cenozoic isotopic records with the need for mass balance in the long-term carbon cycle has been a major and unresolved challenge in geochemistry and Earth history. Here we show that enhanced sulphide oxidation coupled to carbonate dissolution can provide a transient source of CO2 to Earth's atmosphere that is relevant over geological timescales. Like drawdown by means of silicate weathering, this source is probably enhanced by tectonic uplift, and so may have contributed to the relative stability of the partial pressure of atmospheric CO2 during the Cenozoic. A variety of other hypotheses(8-10) have been put forward to explain the 'Cenozoic isotope-weathering paradox', and the evolution of the carbon cycle probably depended on multiple processes. However, an important role for sulphide oxidation coupled to carbonate dissolution is consistent with records of radiogenic isotopes2,3, atmospheric CO2 partial pressure(11,12) and the evolution of the Cenozoic sulphur cycle, and could be accounted for by geologically reasonable changes in the global dioxygen cycle, suggesting that this CO2 source should be considered a potentially important but as yet generally unrecognized component of the long-term carbon cycle.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Li, Gaojun] Nanjing Univ, Dept Earth Sci, MOE Key Lab Surficial Geochem, Nanjing 210046, Jiangsu, Peoples R China	University of Southern California; Nanjing University	Li, GJ (corresponding author), Nanjing Univ, Dept Earth Sci, MOE Key Lab Surficial Geochem, Nanjing 210046, Jiangsu, Peoples R China.	marktorr@usc.edu; joshwest@usc.edu; ligaojun@nju.edu.cn	Li, Gaojun/AAD-9870-2022; Li, Gaojun/A-7244-2013	Li, Gaojun/0000-0002-2463-0774; Li, Gaojun/0000-0002-2463-0774; Torres, Mark/0000-0002-9599-2748	USC College Fellowship; C-DEBI Graduate Fellowship; NSF [NSF-EAR/GLD-1053504, EAR/GLTG-1227192]; National Natural Science Foundation of China [41173105, 41102103, 41321062]; Division Of Earth Sciences [1227192] Funding Source: National Science Foundation	USC College Fellowship; C-DEBI Graduate Fellowship; NSF(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support for this work comes from a USC College Fellowship and a C-DEBI Graduate Fellowship to M. A. T., NSF funding (NSF-EAR/GLD-1053504 and EAR/GLTG-1227192) to A.J.W., and National Natural Science Foundation of China funding (grant nos 41173105, 41102103 and 41321062) to G. L. This is C-DEBI contribution #197.	Berner K. E., 2012, GLOBAL ENV WATER AIR, P369; Berner RA, 1997, GEOLOGY, V25, P955, DOI 10.1130/0091-7613(1997)025<0955:TNFMBA>2.3.CO;2; BERNER RA, 1982, AM J SCI, V282, P451, DOI 10.2475/ajs.282.4.451; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; Bickle MJ, 1996, TERRA NOVA, V8, P270, DOI 10.1111/j.1365-3121.1996.tb00756.x; Calmels D, 2007, GEOLOGY, V35, P1003, DOI 10.1130/G24132A.1; Calmels D, 2011, EARTH PLANET SC LETT, V303, P48, DOI 10.1016/j.epsl.2010.12.032; Das A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051549; EDMOND JM, 1992, SCIENCE, V258, P1594, DOI 10.1126/science.258.5088.1594; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FranceLanord C, 1997, NATURE, V390, P65, DOI 10.1038/36324; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Galy A, 1999, CHEM GEOL, V159, P31, DOI 10.1016/S0009-2541(99)00033-9; Galy V, 2008, SCIENCE, V322, P943, DOI 10.1126/science.1161408; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Georg RB, 2013, EARTH PLANET SC LETT, V367, P28, DOI 10.1016/j.epsl.2013.02.018; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; Huh Y, 2004, EARTH PLANET SC LETT, V222, P115, DOI 10.1016/j.epsl.2004.02.026; Ivanov MV, 1983, GLOBAL BIOGEOCHEMICA, P297; Katz ME, 2005, MAR GEOL, V217, P323, DOI 10.1016/j.margeo.2004.08.005; Kerrick DM, 1998, CHEM GEOL, V145, P213, DOI 10.1016/S0009-2541(97)00144-7; Klemm V, 2005, EARTH PLANET SC LETT, V238, P42, DOI 10.1016/j.epsl.2005.07.016; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; LaRowe DE, 2011, GEOCHIM COSMOCHIM AC, V75, P2030, DOI 10.1016/j.gca.2011.01.020; Lerman A, 2007, MAR CHEM, V106, P326, DOI 10.1016/j.marchem.2006.04.004; Levasseur S, 1999, EARTH PLANET SC LETT, V174, P7, DOI 10.1016/S0012-821X(99)00259-9; Li GJ, 2013, GEOCHIM COSMOCHIM AC, V103, P11, DOI 10.1016/j.gca.2012.10.014; Li GJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003220; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Meybeck M, 1996, RIVER DISCHARGES OCE; Millot R, 2003, GEOCHIM COSMOCHIM AC, V67, P1305, DOI 10.1016/S0016-7037(02)01207-3; Misra S, 2012, SCIENCE, V335, P818, DOI 10.1126/science.1214697; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Turchyn AV, 2013, EARTH PLANET SC LETT, V374, P36, DOI 10.1016/j.epsl.2013.04.033; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WATSON A, 1978, BIOSYSTEMS, V10, P293, DOI 10.1016/0303-2647(78)90012-6; Wildman RA, 2004, GEOLOGY, V32, P457, DOI 10.1130/G20255.1; Willenbring JK, 2010, NATURE, V465, P211, DOI 10.1038/nature09044; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	46	159	177	12	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					346	+		10.1038/nature13030	http://dx.doi.org/10.1038/nature13030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646998				2022-12-28	WOS:000333029000031
J	Clarke, M				Clarke, Michael			PERSONAL VIEW NHS sight tests include unevaluated screening examinations that lead to waste	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Clarke, Michael] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Clarke, Michael] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Clarke, M (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	m.p.clarke@ncl.ac.uk						[Anonymous], 2012, WHY AR EYE TESTS IMP; Cameron JR, 2009, EYE, V23, P1134, DOI 10.1038/eye.2008.196; Health and Social Care Information Centre, 2013, HOSP OUTP ACT 2012 1; HOBLEY AJ, 1992, OPHTHAL PHYSL OPT, V12, P395, DOI 10.1111/j.1475-1313.1992.tb00306.x	4	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g2084	10.1136/bmj.g2084	http://dx.doi.org/10.1136/bmj.g2084			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24646722				2022-12-28	WOS:000333414500012
J	Wang, ZV; Deng, YF; Gao, NG; Pedrozo, Z; Li, DL; Morales, CR; Criollo, A; Luo, X; Tan, W; Jiang, N; Lehrman, MA; Rothermel, BA; Lee, AH; Lavandero, S; Mammen, PPA; Ferdous, A; Gillette, TG; Scherer, PE; Hill, JA				Wang, Zhao V.; Deng, Yingfeng; Gao, Ningguo; Pedrozo, Zully; Li, Dan L.; Morales, Cyndi R.; Criollo, Alfredo; Luo, Xiang; Tan, Wei; Jiang, Nan; Lehrman, Mark A.; Rothermel, Beverly A.; Lee, Ann-Hwee; Lavandero, Sergio; Mammen, Pradeep P. A.; Ferdous, Anwarul; Gillette, Thomas G.; Scherer, Philipp E.; Hill, Joseph A.			Spliced X-Box Binding Protein 1 Couples the Unfolded Protein Response to Hexosamine Biosynthetic Pathway	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA-REPERFUSION INJURY; BETA-N-ACETYLGLUCOSAMINE; LINKS ER STRESS; O-GLCNAC; ISCHEMIA/REPERFUSION INJURY; XBP1; PROTECTION; SURVIVAL; HEART	The hexosamine biosynthetic pathway (HBP) generates uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) for glycan synthesis and O-linked GlcNAc (O-GlcNAc) protein modifications. Despite the established role of the HBP in metabolism and multiple diseases, regulation of the HBP remains largely undefined. Here, we show that spliced X-box binding protein 1 (Xbp1s), the most conserved signal transducer of the unfolded protein response (UPR), is a direct transcriptional activator of the HBP. We demonstrate that the UPR triggers HBP activation via Xbp1s-dependent transcription of genes coding for key, rate-limiting enzymes. We further establish that this previously unrecognized UPR-HBP axis is triggered in a variety of stress conditions. Finally, we demonstrate a physiologic role for the UPR-HBP axis by showing that acute stimulation of Xbp1s in heart by ischemia/reperfusion confers robust cardioprotection in part through induction of the HBP. Collectively, these studies reveal that Xbp1s couples the UPR to the HBP to protect cells under stress.	[Wang, Zhao V.; Pedrozo, Zully; Li, Dan L.; Morales, Cyndi R.; Criollo, Alfredo; Luo, Xiang; Tan, Wei; Jiang, Nan; Rothermel, Beverly A.; Lavandero, Sergio; Mammen, Pradeep P. A.; Ferdous, Anwarul; Gillette, Thomas G.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Deng, Yingfeng; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Rothermel, Beverly A.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Pedrozo, Zully; Criollo, Alfredo; Lavandero, Sergio] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Pedrozo, Zully; Criollo, Alfredo; Lavandero, Sergio] Univ Chile, Fac Ciencias Quim & Farmaceut, Ctr Estud Mol Celula, Santiago, Chile; [Pedrozo, Zully; Criollo, Alfredo; Lavandero, Sergio] Univ Chile, Fac Med, Santiago 7, Chile; [Pedrozo, Zully; Lavandero, Sergio] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Santiago 7, Chile; [Criollo, Alfredo] Univ Chile, Fac Odontol, Dental Sci Res Inst, Santiago, Chile; [Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Cornell University	Hill, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA.	joseph.hill@utsouthwestern.edu	Pedrozo, Zully/I-1069-2013; Pedrozo, Zully/AAN-5350-2021; Lavandero, Sergio/B-6001-2013; Deng, Yingfeng/AAB-8962-2019; Scherer, Philipp E/K-7819-2012	Lavandero, Sergio/0000-0003-4258-1483; Deng, Yingfeng/0000-0003-1314-5105; Scherer, Philipp E/0000-0003-0680-3392; Wang, Zhao/0000-0002-9904-9538; Criollo, Alfredo/0000-0002-2737-7751	National Institutes of Health (NIH) [HL-080144, HL-0980842, HL-100401, DK-55758, DK-088761, DK-099110, GM-038545, HL-102478-02, HL-072016, HL-097768]; Cancer Prevention Research Institute of Texas (CPRIT) [RP110486P3]; American Heart Association (AHA) DeHaan Foundation [0970518N]; Fondation Leducq [11CVD04]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile [FONDAP 15130011, Redes 120003]; AHA [10POST4320009]; American Diabetes Association (ADA) [7-08-MN-53]; Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT [3110039]; PEW Latin American Fellows Program in Biomedical Science; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023729] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120732, R01HL080144, R01HL097768, R01HL102478, U01HL100401, R01HL072016, P30HL101254, T32HL007360, R01HL090842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088761, R01DK099110, R01DK055758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM038545, R01GM038545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); American Heart Association (AHA) DeHaan Foundation(American Heart Association); Fondation Leducq(Leducq Foundation); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; AHA(American Heart Association); American Diabetes Association (ADA)(American Diabetes Association); Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PEW Latin American Fellows Program in Biomedical Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Herman May and Yongli Kong for technical assistance. We thank Dr. Gary Wright (Department of Pharmacology, Quillen College of Medicine, East Tennessee State University) for kindly providing equipment for the Langendorff experiments. This work was supported by grants from the National Institutes of Health (NIH) (HL-080144, HL-0980842, and HL-100401 to J.A.H.; DK-55758, DK-088761, and DK-099110 to P. E. S.; GM-038545 to M. A. L.; HL-102478-02 to P. P. A. M.; and HL-072016 and HL-097768 to B. A. R.), the Cancer Prevention Research Institute of Texas (CPRIT) (RP110486P3), the American Heart Association (AHA) DeHaan Foundation (0970518N), and the Fondation Leducq (11CVD04), and the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (FONDAP 15130011 to S. L., Z.P., and A.C.; Redes 120003 to S. L. and J.A.H.). Z. V. W. was supported by a postdoctoral fellowship from the AHA (10POST4320009). Y.D. was supported by a postdoctoral fellowship from the American Diabetes Association (ADA) (7-08-MN-53). Z. P. was supported by a postdoctoral fellowship from the Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT (3110039). A. C. was supported by The PEW Latin American Fellows Program in Biomedical Science.	Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Darley-Usmar VM, 2012, J MOL CELL CARDIOL, V52, P538, DOI 10.1016/j.yjmcc.2011.08.009; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hess DA, 2011, GASTROENTEROLOGY, V141, P1463, DOI 10.1053/j.gastro.2011.06.045; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lazarus BD, 2009, INT J BIOCHEM CELL B, V41, P2134, DOI 10.1016/j.biocel.2009.03.008; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Palorini R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.257; Petrovski G, 2011, ANTIOXID REDOX SIGN, V14, P2191, DOI 10.1089/ars.2010.3486; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Severino A, 2007, J AM COLL CARDIOL, V50, P1029, DOI 10.1016/j.jacc.2007.06.006; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zou LY, 2012, J BIOL CHEM, V287, P34419, DOI 10.1074/jbc.M112.393207	46	253	257	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1179	1192		10.1016/j.cell.2014.01.014	http://dx.doi.org/10.1016/j.cell.2014.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630721	Bronze, Green Accepted			2022-12-28	WOS:000332945100009
J	Gillick, MR				Gillick, Muriel R.			When Frail Elderly Adults Get Sick: Alternatives to Hospitalization	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; PROGRAM		[Gillick, Muriel R.] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Gillick, MR (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	muriel_gillick@hphc.org						Alexcih L, 2010, INDIVIDUALS LIVING C; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; D'Souza S, 2013, BMJ-BRIT MED J, V346; Fox MT, 2012, J AM GERIATR SOC, V60, P2237, DOI 10.1111/jgs.12028; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Fromme EK, 2012, JAMA-J AM MED ASSOC, V307, P34, DOI 10.1001/jama.2011.1956; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Meret-Hanke LA, 2011, GERONTOLOGIST, V51, P774, DOI 10.1093/geront/gnr040	10	5	7	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					201	202		10.7326/M13-1793	http://dx.doi.org/10.7326/M13-1793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA2VE	24658696				2022-12-28	WOS:000330951500008
J	Lee, JH; Lee, EK; Joo, WJ; Jang, Y; Kim, BS; Lim, JY; Choi, SH; Ahn, SJ; Ahn, JR; Park, MH; Yang, CW; Choi, BL; Hwang, SW; Whang, D				Lee, Jae-Hyun; Lee, Eun Kyung; Joo, Won-Jae; Jang, Yamujin; Kim, Byung-Sung; Lim, Jae Young; Choi, Soon-Hyung; Ahn, Sung Joon; Ahn, Joung Real; Park, Min-Ho; Yang, Cheol-Woong; Choi, Byoung Lyong; Hwang, Sung-Woo; Whang, Dongmok			Wafer-Scale Growth of Single-Crystal Monolayer Graphene on Reusable Hydrogen-Terminated Germanium	SCIENCE			English	Article							TRANSPORT; SILICON; SURFACE	The uniform growth of single-crystal graphene over wafer-scale areas remains a challenge in the commercial-level manufacturability of various electronic, photonic, mechanical, and other devices based on graphene. Here, we describe wafer-scale growth of wrinkle-free single-crystal monolayer graphene on silicon wafer using a hydrogen-terminated germanium buffer layer. The anisotropic twofold symmetry of the germanium (110) surface allowed unidirectional alignment of multiple seeds, which were merged to uniform single-crystal graphene with predefined orientation. Furthermore, the weak interaction between graphene and underlying hydrogen-terminated germanium surface enabled the facile etch-free dry transfer of graphene and the recycling of the germanium substrate for continual graphene growth.	[Lee, Jae-Hyun; Kim, Byung-Sung; Lim, Jae Young; Ahn, Joung Real; Whang, Dongmok] Sungkyunkwan Univ SKKU, SKKU Adv Inst Nanotechnol, Suwon 440746, South Korea; [Lee, Jae-Hyun; Jang, Yamujin; Choi, Soon-Hyung; Park, Min-Ho; Yang, Cheol-Woong; Whang, Dongmok] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 440746, South Korea; [Lee, Jae-Hyun; Joo, Won-Jae; Jang, Yamujin; Kim, Byung-Sung; Lim, Jae Young; Choi, Soon-Hyung; Hwang, Sung-Woo; Whang, Dongmok] Samsung Adv Inst Technol, Res Ctr Time Domain Nanofunct Devices, Yongin 449712, South Korea; [Lee, Eun Kyung; Joo, Won-Jae; Choi, Byoung Lyong; Hwang, Sung-Woo] Samsung Adv Inst Technol, Nano Elect Lab, Yongin 449712, South Korea; [Ahn, Sung Joon; Ahn, Joung Real] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung; Samsung; Sungkyunkwan University (SKKU)	Choi, BL (corresponding author), Samsung Adv Inst Technol, Nano Elect Lab, Yongin 449712, South Korea.	choibl@samsung.com; swnano.hwang@samsung.com; dwhang@skku.edu		Choi, Byoung Lyong/0000-0002-8114-588X; Yang, Cheol-Woong/0000-0003-0475-8399	National Research Foundation of Korea (NRF); Korean government (Ministry of Science, ICT, and Future Planning) [2007-0054845]; Basic Science Research Program through the NRF [2009-0083540]; Samsung-SKKU graphene center	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Science, ICT, and Future Planning); Basic Science Research Program through the NRF; Samsung-SKKU graphene center	We are grateful to J.-H. Ahn, B. H. Hong, and Y. J. Song for helpful discussions. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science, ICT, and Future Planning) (no. 2007-0054845). D. W. acknowledges support from the Basic Science Research Program through the NRF (no. 2009-0083540) and Samsung-SKKU graphene center.	Bao WZ, 2009, NAT NANOTECHNOL, V4, P562, DOI [10.1038/nnano.2009.191, 10.1038/NNANO.2009.191]; Bartelt NC, 2012, MRS BULL, V37, P1158, DOI 10.1557/mrs.2012.237; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Gao LB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1702; GIBBONS DF, 1958, PHYS REV, V112, P136, DOI 10.1103/PhysRev.112.136; Hamada I, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153412; Hao YF, 2013, SCIENCE, V342, P720, DOI 10.1126/science.1243879; Kang J, 2012, NANOSCALE, V4, P5527, DOI 10.1039/c2nr31317k; Kim J, 2013, SCIENCE, V342, P833, DOI 10.1126/science.1242988; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Lahiri J, 2010, NAT NANOTECHNOL, V5, P326, DOI [10.1038/NNANO.2010.53, 10.1038/nnano.2010.53]; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lieten RR, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098075; Loscutoff PW, 2006, ANNU REV PHYS CHEM, V57, P467, DOI 10.1146/annurev.physchem.56.092503.141307; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Nie S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155425; Robinson ZR, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235413; SCACE RI, 1959, J CHEM PHYS, V30, P1551, DOI 10.1063/1.1730236; Singh AK, 2009, NANO LETT, V9, P1540, DOI 10.1021/nl803622c; Sutter PW, 2008, NAT MATER, V7, P406, DOI 10.1038/nmat2166; Trung P. Thanh, 2013, APPL PHYS LETT, V102; Tsen AW, 2012, SCIENCE, V336, P1143, DOI 10.1126/science.1218948; Wang G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02465; Wei YJ, 2012, NAT MATER, V11, P759, DOI [10.1038/NMAT3370, 10.1038/nmat3370]; Zhang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.241402; Zhang XY, 2012, J PHYS CHEM LETT, V3, P2822, DOI 10.1021/jz301029g; Zhu WJ, 2012, NANO LETT, V12, P3431, DOI 10.1021/nl300563h	29	709	734	25	821	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					286	289		10.1126/science.1252268	http://dx.doi.org/10.1126/science.1252268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24700471				2022-12-28	WOS:000334474500032
J	Lexis, CPH; van der Horst, ICC; Lipsic, E; Wieringa, WG; de Boer, RA; van den Heuvel, AFM; van der Werf, HW; Schurer, RAJ; Pundziute, G; Tan, ES; Nieuwland, W; Willemsen, HM; Dorhout, B; Molmans, BHW; van der Horst-Schrivers, ANA; Wolffenbuttel, BHR; ter Horst, GJ; van Rossum, AC; Tijssen, JGP; Hillege, HL; de Smet, BJGL; van der Harst, P; van Veldhuisen, DJ				Lexis, Chris P. H.; van der Horst, Iwan C. C.; Lipsic, Erik; Wieringa, Wouter G.; de Boer, Rudolf A.; van den Heuvel, Ad F. M.; van der Werf, Hindrik W.; Schurer, Remco A. J.; Pundziute, Gabija; Tan, Eng S.; Nieuwland, Wybe; Willemsen, Hendrik M.; Dorhout, Bernard; Molmans, Barbara H. W.; van der Horst-Schrivers, Anouk N. A.; Wolffenbuttel, Bruce H. R.; ter Horst, Gert J.; van Rossum, Albert C.; Tijssen, Jan G. P.; Hillege, Hans L.; de Smet, Bart J. G. L.; van der Harst, Pim; van Veldhuisen, Dirk J.		GIPS-III Investigators	Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes The GIPS-III Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; LONG-TERM TRENDS; HEART-FAILURE; NONDIABETIC PATIENTS; ESC GUIDELINES; TASK-FORCE; ASSOCIATION; MANAGEMENT; MORTALITY; REVASCULARIZATION	IMPORTANCE Metformin treatment is associated with improved outcome after myocardial infarction in patients with diabetes. In animal experimental studies metformin preserves left ventricular function. OBJECTIVE To evaluate the effect of metformin treatment on preservation of left ventricular function in patients without diabetes presenting with ST-segment elevation myocardial infarction (STEMI). DESIGN, SETTING, AND PARTICIPANTS Double-blind, placebo-controlled study conducted among 380 patients who underwent primary percutaneous coronary intervention (PCI) for STEMI at the University Medical Center Groningen, the Netherlands, between January 1, 2011, and May 26, 2013. INTERVENTIONS Metformin hydrochloride (500 mg) (n = 191) or placebo (n = 189) twice daily for 4 months. MAIN OUTCOMES AND MEASURES The primary efficacy measure was left ventricular ejection fraction (LVEF) after 4 months, assessed by magnetic resonance imaging. A secondary efficacy measure was the N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration after 4 months. The incidence of major adverse cardiac events (MACE; the combined end point of death, reinfarction, or target-lesion revascularization) was recorded until 4 months as a secondary efficacy measure. RESULTS At 4 months, all patients were alive and none were lost to follow-up. LVEF was 53.1%(95% CI, 51.6%-54.6%) in the metformin group (n = 135), compared with 54.8%(95% CI, 53.5%-56.1%) (P = .10) in the placebo group (n = 136). NT-proBNP concentration was 167 ng/L in the metformin group (interquartile range [IQR], 65-393 ng/L) and 167 ng/L in the placebo group (IQR, 74-383 ng/L) (P = .66). MACE were observed in 6 patients (3.1%) in the metformin group and in 2 patients (1.1%) in the placebo group (P = .16). Creatinine concentration (79 mu mol/L [IQR, 70-87 mu mol/L] vs 79 mu mol/L [IQR, 72-89 mu mol/L], P = .61) and glycated hemoglobin (5.9% [IQR, 5.6%-6.1%] vs 5.9% [IQR, 5.7%-6.1%], P = .15) were not significantly different between both groups. No cases of lactic acidosis were observed. CONCLUSIONS AND RELEVANCE Among patients without diabetes presenting with STEMI and undergoing primary PCI, the use of metformin compared with placebo did not result in improved LVEF after 4 months. The present findings do not support the use of metformin in this setting.	[Lexis, Chris P. H.; Lipsic, Erik; Wieringa, Wouter G.; de Boer, Rudolf A.; van den Heuvel, Ad F. M.; van der Werf, Hindrik W.; Schurer, Remco A. J.; Pundziute, Gabija; Tan, Eng S.; Nieuwland, Wybe; Willemsen, Hendrik M.; Dorhout, Bernard; Hillege, Hans L.; van der Harst, Pim; van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [van der Horst, Iwan C. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, NL-9700 RB Groningen, Netherlands; [Molmans, Barbara H. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 RB Groningen, Netherlands; [van der Horst-Schrivers, Anouk N. A.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [ter Horst, Gert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9700 RB Groningen, Netherlands; [van Rossum, Albert C.] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Tijssen, Jan G. P.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Hillege, Hans L.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [de Smet, Bart J. G. L.] Meander Med Ctr, Dept Cardiol, Amersfoort, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Meander Medisch Centrum	van der Horst, ICC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	i.c.c.van.der.horst@umcg.nl	Nijveldt, Robin/N-8683-2017; van Beek, André P/O-3753-2014; de Boer, Rudolf/ABE-9879-2020	Nijveldt, Robin/0000-0003-1530-6363; van Beek, André P/0000-0002-0335-8177; van Rossum, Albert C./0000-0003-1714-4652; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	ZonMw, the Netherlands Organization for Health Research and Development, The Hague, the Netherlands [95103007]	ZonMw, the Netherlands Organization for Health Research and Development, The Hague, the Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	The GIPS-III trial was supported by grant 95103007 from ZonMw, the Netherlands Organization for Health Research and Development, The Hague, the Netherlands.	Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94; El Aidi H, 2014, J AM COLL CARDIOL, V63, P1031, DOI 10.1016/j.jacc.2013.11.048; El Messaoudi S, 2011, CURR OPIN LIPIDOL, V22, P445, DOI 10.1097/MOL.0b013e32834ae1a7; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kao J, 2004, AM J CARDIOL, V93, P1347, DOI 10.1016/j.amjcard.2004.02.028; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lexis CPH, 2014, CARDIOVASC DRUG THER, V28, P163, DOI 10.1007/s10557-013-6504-7; Lexis CPH, 2012, CARDIOVASC DRUG THER, V26, P417, DOI 10.1007/s10557-012-6413-1; Li J, 2014, CARDIOLOGY, V127, P133, DOI 10.1159/000355574; Luchner A, 2005, J CARD FAIL, V11, pS21, DOI 10.1016/j.cardfail.2005.04.018; Maioli M, 2012, CIRCULATION, V125, P3099, DOI 10.1161/CIRCULATIONAHA.111.085290; McAlister FA, 2008, AM J CARDIOL, V102, P1, DOI 10.1016/j.amjcard.2008.02.089; Mellbin LG, 2011, DIABETOLOGIA, V54, P1308, DOI 10.1007/s00125-011-2084-x; Mellbin LG, 2008, EUR HEART J, V29, P166, DOI 10.1093/eurheartj/ehm518; Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Patel MR, 2009, CIRCULATION, V119, P1330, DOI 10.1161/CIRCULATIONAHA.108.191768; Pinto DS, 2011, CIRCULATION, V124, P2512, DOI 10.1161/CIRCULATIONAHA.111.018549; Pokorney Sean D, 2012, J Cardiovasc Magn Reson, V14, P62, DOI 10.1186/1532-429X-14-62; Preiss D, 2014, LANCET DIABETES ENDO, V2, P116, DOI 10.1016/S2213-8587(13)70152-9; Renda F, 2013, EUR REV MED PHARMACO, V17, P45; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Scirica BM, 2013, CLIN CHEM, V59, P1205, DOI 10.1373/clinchem.2012.198556; SHARPE N, 1991, LANCET, V337, P872, DOI 10.1016/0140-6736(91)90202-Z; Steg PG, 2004, CIRCULATION, V109, P494, DOI 10.1161/01.CIR.0000109691.16944.DA; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Yin MM, 2011, AM J PHYSIOL-HEART C, V301, pH459, DOI 10.1152/ajpheart.00054.2011	38	120	123	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1526	1535		10.1001/jama.2014.3315	http://dx.doi.org/10.1001/jama.2014.3315			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24687169	Bronze			2022-12-28	WOS:000334306000020
J	Navar-Boggan, AM; Pencina, MJ; Williams, K; Sniderman, AD; Peterson, ED				Navar-Boggan, Ann Marie; Pencina, Michael J.; Williams, Ken; Sniderman, Allan D.; Peterson, Eric D.			Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE The new 2014 blood pressure (BP) guideline released by the panel members appointed to the Eighth Joint National Committee (JNC 8; 2014 BP guideline) proposed less restrictive BP targets for adults aged 60 years or older and for those with diabetes and chronic kidney disease. OBJECTIVE To estimate the proportion of US adults potentially affected by recent changes in recommendations for management of hypertension. DESIGN Cross-sectional, nationally representative survey. PARTICIPANTS Using data from the National Health and Nutrition Examination Survey between 2005 and 2010 (n = 16 372), we evaluated hypertension control and treatment recommendations for US adults. MAIN OUTCOMES AND MEASURES Proportion of adults estimated to meet guideline-based BP targets under the 2014 BP guideline and under the previous seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guideline. RESULTS The proportion of younger adults (18-59 years) with treatment-eligible hypertension under the JNC 7 guideline was 20.3%(95% CI, 19.1%-21.4%) and decreased to 19.2%(95% CI, 18.1%-20.4%) under the 2014 BP guideline. Larger declines were observed among older adults (>= 60 years), decreasing from 68.9%(95% CI, 66.9%-70.8%) under JNC 7 to 61.2%(95% CI, 59.3%-63.0%) under the 2014 BP guideline. The proportion of adults with treatment-eligible hypertension who met BP goals increased slightly for younger adults, from 41.2%(95% CI, 38.1%-44.3%) under JNC 7 to 47.5%(95% CI, 44.4%-50.6%) under the 2014 BP guideline, and more substantially for older adults, from 40.0%(95% CI, 37.8%-42.3%) under JNC 7 to 65.8% (95% CI, 63.7%-67.9%) under the 2014 BP guideline. Overall, 1.6%(95% CI, 1.3%-1.9%) of US adults aged 18-59 years and 27.6%(95% CI, 25.9%-29.3%) of adults aged 60 years or older were receiving BP-lowering medication and meeting more stringent JNC 7 targets. These patients may be eligible for less stringent or no BP therapy with the 2014 BP guideline. CONCLUSIONS AND RELEVANCE Compared with the JNC 7 guideline, the 2014 BP guideline from the panel members appointed to the JNC 8 was associated with a reduction in the proportion of US adults recommended for hypertension treatment and a substantial increase in the proportion of adults considered to have achieved goal BP, primarily in older adults.	[Navar-Boggan, Ann Marie] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Pencina, Michael J.] Duke Univ, DCRI, Durham, NC 27710 USA; [Williams, Ken] KenAnCo Biostat, San Antonio, TX USA; [Sniderman, Allan D.] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University; McGill University; Royal Victoria Hospital; Duke University	Navar-Boggan, AM (corresponding author), Duke Univ, Med Ctr, Div Cardiol, 2301 Erwin Rd, Durham, NC 27710 USA.	ann.navar@duke.edu	Peterson, Eric David/ABF-5033-2021		Duke Clinical Research Institute	Duke Clinical Research Institute	This research was supported in part by Duke Clinical Research Institute's research funds and unrestricted grants from M. Jean de Granpre and Louis and Sylvia Vogel.	Centers for Disease Control and Prevention, ABOUT THE NATIONAL H; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Johnson CL, 2013, VITAL HEALTH STAT, V2; Ogihara T, 2004, HYPERTENS RES, V27, P657, DOI 10.1291/hypres.27.657; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981; Yoon Paula W, 2012, MMWR Suppl, V61, P19	8	81	84	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1424	1429		10.1001/jama.2014.2531	http://dx.doi.org/10.1001/jama.2014.2531			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24682242	Bronze, Green Published			2022-12-28	WOS:000333935000018
J	Solis, M				Solis, Michele			PREVENTION Before the break	NATURE			English	Editorial Material							PSYCHOSIS											Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Howes OD, 2011, AM J PSYCHIAT, V168, P1311, DOI 10.1176/appi.ajp.2011.11010160; Koutsouleris N, 2012, SCHIZOPHRENIA BULL, V38, P1200, DOI 10.1093/schbul/sbr037; Walker EF, 2013, BIOL PSYCHIAT, V74, P410, DOI 10.1016/j.biopsych.2013.02.016	4	19	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S12	S13		10.1038/508S12a	http://dx.doi.org/10.1038/508S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695328				2022-12-28	WOS:000333609900010
J	Ekert, A; Renner, R				Ekert, Artur; Renner, Renato			The ultimate physical limits of privacy	NATURE			English	Article							QUANTUM KEY DISTRIBUTION; BELL INEQUALITIES; SIDE INFORMATION; CRYPTOGRAPHY; VIOLATION; SECURITY; AMPLIFICATION; SYSTEMS; THEOREM; RANDOMNESS	Among those who make a living from the science of secrecy, worry and paranoia are just signs of professionalism. Can we protect our secrets against those who wield superior technological powers? Can we trust those who provide us with tools for protection? Can we even trust ourselves, our own freedom of choice? Recent developments in quantum cryptography show that some of these questions can be addressed and discussed in precise and operational terms, suggesting that privacy is indeed possible under surprisingly weak assumptions.	[Ekert, Artur] Univ Oxford, Math Inst, Oxford OX2 9GG, England; [Ekert, Artur] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore; [Renner, Renato] Swiss Fed Inst Technol, Inst Theoret Phys, CH-8093 Zurich, Switzerland	University of Oxford; National University of Singapore; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ekert, A (corresponding author), Univ Oxford, Math Inst, Oxford OX2 9GG, England.	artur.ekert@quibit.org; renner@phys.ethz.ch	Ekert, Artur K/P-1420-2014					Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; Acin A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120405; Arnon-Friedman R, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.062333; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Barrett J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010503; Bell J.S., 2004, SPEAKABLE UNSPEAKABL, P14; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bennett CH, 1995, IEEE T INFORM THEORY, V41, P1915, DOI 10.1109/18.476316; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Biham E, 1997, PHYS REV LETT, V78, P2256, DOI 10.1103/PhysRevLett.78.2256; Brandao F. G. S. L., 2013, PREPRINT; Christensen BG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130406; CIRELSON BS, 1980, LETT MATH PHYS, V4, P93, DOI 10.1007/BF00417500; Colbeck R., 2006, THESIS U CAMBRIDGE; Colbeck R, 2012, NAT PHYS, V8, P450, DOI [10.1038/nphys2300, 10.1038/NPHYS2300]; Colbeck R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1416; De A, 2012, SIAM J COMPUT, V41, P915, DOI 10.1137/100813683; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; EKERT AK, 1992, PHYS REV LETT, V69, P1293, DOI 10.1103/PhysRevLett.69.1293; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Fung CHF, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032314; Gallego R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3654; Gerhardt I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1348; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Hanggi E, 2013, THEOR COMPUT SCI, V486, P27, DOI 10.1016/j.tcs.2012.12.014; Hanggi E, 2010, LECT NOTES COMPUT SC, V6110, P216; Hanggi E., 2010, PREPRINT; Kahn D, 1996, CODEBREAKERS COMPREH; Khalfin L., 1985, S FDN MOD PHYS, P441; Koh DE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.160404; Lim CCW, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031006; Liu Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130502; Lo HK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.130503; Lutkenhaus N, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.052304; Lydersen L, 2010, NAT PHOTONICS, V4, P686, DOI 10.1038/NPHOTON.2010.214; Masanes L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1244; Masanes L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.140501; Mayers D, 2001, J ACM, V48, P351, DOI 10.1145/382780.382781; Mayers D., 1998, FOCS 98 P 39 ANN S F, P503; McKague M., 2010, THESIS U WATERLOO; PEARLE PM, 1970, PHYS REV D, V2, P1418, DOI 10.1103/PhysRevD.2.1418; Pironio S, 2010, NATURE, V464, P1021, DOI 10.1038/nature09008; Poe Edgar Allan, 1841, GRAHAMS MAG, P33; Pomarico E, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.052104; POPESCU S, 1994, FOUND PHYS, V24, P379, DOI 10.1007/BF02058098; Reichardt BW, 2013, NATURE, V496, P456, DOI 10.1038/nature12035; Renner R, 2005, LECT NOTES COMPUT SC, V3378, P407; Renner R, 2005, THESIS ETH ZURICH; Renner R, 2007, NAT PHYS, V3, P645, DOI 10.1038/nphys684; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI [10.1145/359340.359342, 10.1145/357980.358017]; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Rubenok A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130501; Scarani V, 2009, REV MOD PHYS, V81, P1301, DOI 10.1103/RevModPhys.81.1301; Scarani V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.200501; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Stuart TE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020402; Tittel W, 1998, PHYS REV LETT, V81, P3563, DOI 10.1103/PhysRevLett.81.3563; Tomamichel M, 2011, IEEE T INFORM THEORY, V57, P5524, DOI 10.1109/TIT.2011.2158473; Vazirani U., 2012, ITCS 14 P 2014 C INN, P35; Vernam G.S., 1926, J AM I ELECT ENG, V45, P109; Weier H, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073024; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039	68	72	73	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					443	447		10.1038/nature13132	http://dx.doi.org/10.1038/nature13132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670761	Green Published			2022-12-28	WOS:000333402000030
J	Heard, E; Martienssen, RA				Heard, Edith; Martienssen, Robert A.			Transgenerational Epigenetic Inheritance: Myths and Mechanisms	CELL			English	Review							DIRECTED DNA METHYLATION; TRANSPOSABLE ELEMENTS; CAENORHABDITIS-ELEGANS; ARABIDOPSIS-THALIANA; C. ELEGANS; SMALL RNA; RECOMBINATION LANDSCAPE; GERMLINE IMMORTALITY; REPETITIVE ELEMENTS; PRENATAL EXPOSURE	Since the human genome was sequenced, the term ``epigenetics'' is increasingly being associated with the hope that we are more than just the sum of our genes. Might what we eat, the air we breathe, or even the emotions we feel influence not only our genes but those of descendants? The environment can certainly influence gene expression and can lead to disease, but transgenerational consequences are another matter. Although the inheritance of epigenetic characters can certainly occur-particularly in plants-how much is due to the environment and the extent to which it happens in humans remain unclear.	[Heard, Edith] Inst Curie, CNRS UMR3215, INSERM U934, Mammalian Dev Epigenet Grp, F-75248 Paris 05, France; [Heard, Edith] Coll France, F-75005 Paris, France; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA; [Martienssen, Robert A.] Ecole Normale Super, IBENS, Chaire Blaise Pascal, F-75230 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Heard, E (corresponding author), Inst Curie, CNRS UMR3215, INSERM U934, Mammalian Dev Epigenet Grp, 26 Rue Ulm, F-75248 Paris 05, France.	edith.heard@curie.fr; martiens@cshl.edu	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117	National Institutes of Health [GM067014]; National Science Foundation [IOS-1025830]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3033]; EU FP7 MODHEP EU grant [259743]; Labex DEEP [ANR-11-LBX-0044]; IDEX Idex PSL [ANR-10-IDEX-0001-02 PSL]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014, R01GM076396] Funding Source: NIH RePORTER; Direct For Biological Sciences [1025830] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); EU FP7 MODHEP EU grant; Labex DEEP; IDEX Idex PSL; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Adrian Bird, Vincent Colot, Anne Ferguson-Smith, and Bill Kelly for their comments on the manuscript, and we thank Joe Calarco and Filipe Borges for help with the figures. Research in the authors' laboratories is supported by grants from the National Institutes of Health (GM067014 and GM067014), the National Science Foundation (IOS-1025830), the Howard Hughes Medical Institute and Gordon and Betty Moore Foundation (GBMF3033 to R.A.M.), the ``Ligue Nationale contre le cancer,'' the EpiGeneSys FP7 257082 Network of Excellence, ERC Advanced Investigator award 250367 (to E.H.), EU FP7 MODHEP EU grant 259743 (to E.H.), and the Labex DEEP (ANR-11-LBX-0044) part of the IDEX Idex PSL (ANR-10-IDEX-0001-02 PSL). We apologize to the many authors of important original research articles that could not be cited for lack of space.	Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Barbour JE, 2012, PLANT CELL, V24, P1761, DOI 10.1105/tpc.112.097618; Becker C, 2012, CURR OPIN PLANT BIOL, V15, P562, DOI 10.1016/j.pbi.2012.08.004; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Brzeska K, 2010, P NATL ACAD SCI USA, V107, P5516, DOI 10.1073/pnas.1001576107; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burbank L., 1906, CENTURY MAGAZINE MAY, P127; Burkhart KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002249; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Creasey K.M., 2014, NATURE; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Durand S, 2012, CURR BIOL, V22, P326, DOI 10.1016/j.cub.2011.12.054; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Enke RA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002350; Erhard KF, 2013, PLANT CELL, V25, P808, DOI 10.1105/tpc.112.107680; Eun C, 2012, Cold Spring Harb Symp Quant Biol, V77, P195, DOI 10.1101/sqb.2012.77.015099; Ferguson-Smith AC, 2011, CELL METAB, V13, P115, DOI 10.1016/j.cmet.2011.01.011; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gould Stephen J., 1980, PANDAS THUMB; Greaves IK, 2012, P NATL ACAD SCI USA, V109, P3570, DOI 10.1073/pnas.1201043109; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gutierrez-Marcos JF, 2012, PLANT CELL PHYSIOL, V53, P817, DOI 10.1093/pcp/pcs052; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Hackett JA, 2013, CELL, V153, P737, DOI 10.1016/j.cell.2013.04.044; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harvey W, 1651, EXERCITATIONES GENER; Hilbricht T, 2008, NEW PHYTOL, V179, P877, DOI 10.1111/j.1469-8137.2008.02480.x; Hitchins MP, 2011, CANCER CELL, V20, P200, DOI 10.1016/j.ccr.2011.07.003; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Hollick JB, 2012, CURR OPIN PLANT BIOL, V15, P536, DOI 10.1016/j.pbi.2012.09.003; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jacob Y, 2014, SCIENCE, V343, P1249, DOI 10.1126/science.1248357; Jauvion V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029785; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Keller C, 2013, CHROMOSOME RES, V21, P627, DOI 10.1007/s10577-013-9390-8; Kelly WG, 2007, CHROMOSOME RES, V15, P633, DOI 10.1007/s10577-007-1143-0; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li Q, 2014, GENETICS, V196, P667, DOI 10.1534/genetics.113.158980; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lisch D, 2012, CURR OPIN PLANT BIOL, V15, P511, DOI 10.1016/j.pbi.2012.07.001; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Mari-Ordonez A, 2013, NAT GENET, V45, P1029, DOI 10.1038/ng.2703; MARTIENSSEN R, 1990, GENE DEV, V4, P331, DOI 10.1101/gad.4.3.331; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; MCCLINTOCK B, 1961, AM NAT, V95, P265, DOI 10.1086/282188; Messerschmidt DM, 2012, EPIGENETICS-US, V7, P969, DOI 10.4161/epi.21337; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Padmanabhan N, 2013, CELL, V155, P81, DOI 10.1016/j.cell.2013.09.002; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Ream T S, 2012, Cold Spring Harb Symp Quant Biol, V77, P105, DOI 10.1101/sqb.2013.77.014449; Rebollo R, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R89, 10.1186/gb-2012-13-10-r89]; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Reinders J, 2013, EMBO REP, V14, P823, DOI 10.1038/embor.2013.95; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schmitz RJ, 2012, TRENDS PLANT SCI, V17, P149, DOI 10.1016/j.tplants.2012.01.001; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schneider S, 2008, REPROD TOXICOL, V25, P352, DOI 10.1016/j.reprotox.2008.04.001; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Theodorou V, 2013, NEUROGASTROENT MOTIL, V25, P927, DOI 10.1111/nmo.12260; Vu TM, 2013, DEVELOPMENT, V140, P2953, DOI 10.1242/dev.092981; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Veenendaal MVE, 2013, BJOG-INT J OBSTET GY, V120, P548, DOI 10.1111/1471-0528.12136; Walter J, 2006, CYTOGENET GENOME RES, V113, P109, DOI 10.1159/000090821; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Wolff CF, 1759, THEORIA GENERATIONIS; Yu A, 2013, P NATL ACAD SCI USA, V110, P2389, DOI 10.1073/pnas.1211757110; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	133	966	992	17	597	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					95	109		10.1016/j.cell.2014.02.045	http://dx.doi.org/10.1016/j.cell.2014.02.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679529	Green Accepted, Bronze			2022-12-28	WOS:000333968900010
J	Scadden, DT				Scadden, David T.			Nice Neighborhood: Emerging Concepts of the Stem Cell Niche	CELL			English	Review							HEMATOPOIETIC STEM; BONE; REGENERATION; MAINTENANCE; SIGNALS; DEDIFFERENTIATION; RECONSTITUTION; LOCALIZATION; PROGENITORS; ENGRAFTMENT	No metazoan cell survives on its own, absent the signals and support of its milieu. For multicellular life with specialized tissues to persist, organization is everything and so defining the association of position with cell state is critical to understanding how tissues function, maintain, and repair. This review focuses specifically on place for progenitor and stem cells. Especially emphasized are hematopoietic cells that balance free movement and stable position and where concepts of regulatory interrelationships have been shown with some precision. It reviews classical and emerging concepts of the niche, particularly considering how niche functions may participate in neoplastic disease.	[Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	david_scadden@harvard.edu			Gerald and Darlene Jordan Chair;  [HL096372];  [CA148180]; NATIONAL CANCER INSTITUTE [U54CA163191] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL096372, R01HL097794, R01HL044851, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	Gerald and Darlene Jordan Chair; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The contributions of Elizabeth Scadden, Jay Rajagopal, Rushdia Yusuf, Vionnie Yu, Borja Saez, and Jonathon Hoggatt are gratefully acknowledged for their thoughtful input, editing, and help with figures. Members of the Scadden lab have been invaluable in shaping this work and being the best partners in discovery a lab chief could ever imagine. There is much outstanding work in the field that is not included in this piece for reasons of space, and I ask the forbearance of my colleagues for omissions of their contributions. This work was funded by: HL096372, CA148180, and the Gerald and Darlene Jordan Chair.	Adams GB, 2003, BLOOD, V101, P45, DOI 10.1182/blood-2002-02-0486; ASH RC, 1991, BONE MARROW TRANSPL, V7, P443; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; BERNSTEIN SE, 1959, P SOC EXP BIOL MED, V101, P769; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; DARLINGTON PJ, 1972, P NATL ACAD SCI USA, V69, P3151, DOI 10.1073/pnas.69.11.3151; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Ellis SL, 2011, BLOOD, V118, P1516, DOI 10.1182/blood-2010-08-303800; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gilbert PM, 2012, INTEGR BIOL-UK, V4, P360, DOI 10.1039/c2ib00148a; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Guezguez B, 2013, CELL STEM CELL, V13, P175, DOI 10.1016/j.stem.2013.06.015; Heazlewood SY, 2013, STEM CELL RES, V11, P782, DOI 10.1016/j.scr.2013.05.007; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; LORD BI, 1975, BLOOD, V46, P65; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shim J, 2013, CELL, V155, P1141, DOI 10.1016/j.cell.2013.10.032; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Spencer J. A., 2014, NATURE; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yanger K, 2011, DEV DYNAM, V240, P521, DOI 10.1002/dvdy.22561; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zong Y, 2012, P NATL ACAD SCI USA, V109, pE3395, DOI 10.1073/pnas.1217982109	70	227	235	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					41	50		10.1016/j.cell.2014.02.013	http://dx.doi.org/10.1016/j.cell.2014.02.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679525	Bronze, Green Accepted			2022-12-28	WOS:000333968900006
J	Pell, J; Valentine, J; Inskip, H				Pell, Jill; Valentine, Janet; Inskip, Hazel			One in 30 people in the UK take part in cohort studies	LANCET			English	Editorial Material							MORTALITY; CHILDHOOD		[Pell, Jill] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Valentine, Janet] MRC, Head Off, London WC2B 4AN, England; [Inskip, Hazel] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Glasgow; University of Southampton	Valentine, J (corresponding author), MRC, Head Off, London WC2B 4AN, England.	jill.pell@glasgow.ac.uk	Inskip, Hazel/L-5467-2018	Inskip, Hazel/0000-0001-8897-1749; Pell, Jill/0000-0002-8898-7035	MRC [MC_UP_A620_1017, MC_UU_12011/4] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2014, CLOSER COHORT LONGIT; BARKER DJP, 1989, LANCET, V2, P577; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076; Kuh D, 2014, LIFE COURSE APPROACH; Medical Research Council, 2014, MRC STRAT REV LARG U; Pearson H, 2011, NATURE, V471, P20, DOI 10.1038/471020a; University of Oxford, MILL WOM STUD PUBL	11	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1015	1016		10.1016/S0140-6736(14)60412-8	http://dx.doi.org/10.1016/S0140-6736(14)60412-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24656186	Green Accepted			2022-12-28	WOS:000333521200004
J	Neubauer, S; Redwood, C				Neubauer, Stefan; Redwood, Charles			New Mechanisms and Concepts for Cardiac-Resynchronization Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEART		[Neubauer, Stefan; Redwood, Charles] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England	University of Oxford	Neubauer, S (corresponding author), Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England.			Neubauer, Stefan/0000-0001-9017-5645				Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Holzmeister J, 2011, LANCET, V378, P722, DOI 10.1016/S0140-6736(11)61228-2; Kirk JA, 2013, J CLIN INVEST; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659	5	11	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1164	1166		10.1056/NEJMcibr1315508	http://dx.doi.org/10.1056/NEJMcibr1315508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645952				2022-12-28	WOS:000333054000016
J	Turner, DL				Turner, Drew L.			SPACE SCIENCE Near-Earth space shows its stripes	NATURE			English	Editorial Material							RADIATION; ACCELERATION		Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Turner, DL (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA.	dturner@igpp.ucla.edu	Turner, Drew L/G-3224-2012	Turner, Drew L/0000-0002-2425-7818				Baker DN, 2002, SCIENCE, V297, P1486, DOI 10.1126/science.1074956; Horne RB, 2007, NAT PHYS, V3, P590, DOI 10.1038/nphys703; Mauk BH, 2013, SPACE SCI REV, V179, P3, DOI 10.1007/s11214-012-9908-y; Mauk BH, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015660; Mitchell DG, 2013, SPACE SCI REV, V179, P263, DOI 10.1007/s11214-013-9965-x; Sauvaud JA, 2013, J GEOPHYS RES-SPACE, V118, P1723, DOI 10.1002/jgra.50125; Ukhorskiy AY, 2014, NATURE, V507, P338, DOI 10.1038/nature13046; VANALLEN JA, 1959, NATURE, V183, P430, DOI 10.1038/183430a0; Vernov S., 1960, P MOSC COSM RAY C, V3, P19	9	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					308	309		10.1038/507308a	http://dx.doi.org/10.1038/507308a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646988				2022-12-28	WOS:000333029000020
J	Slot, KMHB; Berge, E				Slot, Karsten M. H. Bruins; Berge, Eivind			Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Is treatment with factor Xa inhibitors associated with better efficacy and safety compared with the vitamin K antagonist warfarin for preventing strokes or other systemic embolic events in patients with atrial fibrillation? BOTTOM LINE Compared with warfarin, factor Xa inhibitors are associated with a lower risk of stroke and other systemic embolic events in patients with atrial fibrillation. Factor Xa inhibitors were associated with lower rates of intracranial hemorrhage and mortality compared with warfarin. Factor Xa inhibitors were associated with a reduction in major bleeding events, but there was heterogeneity between the included studies, and the reduction was not statistically significant in a prespecified sensitivity analysis.	[Slot, Karsten M. H. Bruins; Berge, Eivind] Oslo Univ Hosp, Dept Internal Med, NO-0424 Oslo, Norway	University of Oslo	Slot, KMHB (corresponding author), Oslo Univ Hosp, Dept Internal Med, POB 4956 Nydalen, NO-0424 Oslo, Norway.	kbruinsslot@yahoo.no						Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Slot KMHB, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008980.pub2	3	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1150	1151		10.1001/jama.2014.1403	http://dx.doi.org/10.1001/jama.2014.1403			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643605				2022-12-28	WOS:000333010100020
J	Carpenter, CR				Carpenter, Christopher R.			In suspected ACS, a diagnostic protocol using hs-TnI identified patients at low cardiac risk at 30 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Carpenter, CR (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.		Carpenter, Christopher R./E-3720-2013; Cullen, Louise/D-2274-2013	Carpenter, Christopher R./0000-0002-2603-7157; Cullen, Louise/0000-0001-6611-8229				Hess EP, 2008, CAN J EMERG MED, V10, P373; Hoffman JR, 2012, ARCH INTERN MED, V172, P1123, DOI 10.1001/archinternmed.2012.3319; Panju AA, 2009, RATIONAL CLIN EXAMIN, P461; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pearl WS, 1999, ANN EMERG MED, V33, P77, DOI 10.1016/S0196-0644(99)70421-X	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC13	10.7326/0003-4819-160-6-201403180-02013	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638179				2022-12-28	WOS:000333521300012
J	O'Donoghue, C; Eklund, M; Ozanne, EM; Esserman, LJ				O'Donoghue, Cristina; Eklund, Martin; Ozanne, Elissa M.; Esserman, Laura J.			Aggregate Cost of Mammography Screening in the United States: Comparison of Current Practice and Advocated Guidelines	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER; RISK-FACTORS; SERVICES; BENEFITS; OUTCOMES; DENSITY; ANXIETY; RECALL; RATES	Background: Controversy exists over how often and at what age mammography screening should be implemented. Given that evidence supports less frequent screening, the cost differences among advocated screening policies should be better understood. Objective: To estimate the aggregate cost of mammography screening in the United States in 2010 and compare the costs of policy recommendations by professional organizations. Design: A model was developed to estimate the cost of mammography screening in 2010 and 3 screening strategies: annual (ages 40 to 84 years), biennial (ages 50 to 69 years), and U. S. Preventive Services Task Force (USPSTF) guidelines (biennial for those aged 50 to 74 years and personalized based on risk for those younger than 50 years and based on comorbid conditions for those 75 years and older). Setting: United States. Patients: Women aged 40 to 85 years. Intervention: Mammography annually, biennially, or following USPSTF guidelines. Measurements: Cost of screening per year, using Medicare reimbursements. Results: The estimated cost of mammography screening in the United States in 2010 was $ 7.8 billion, with approximately 70% of women screened. The simulated cost of screening 85% of women was $ 10.1 billion, $ 2.6 billion, and $ 3.5 billion for annual, biennial, and USPSTF guidelines, respectively. The largest drivers of cost (in order) were screening frequency, percentage of women screened, cost of mammography, percentage of women screened with digital mammography, and percentage of mammography recalls. Limitation: Cost estimates and assumptions used in the model were conservative. Conclusion: The cost of mammography varies by at least $ 8 billion per year on the basis of screening strategy. The USPSTF guidelines are based on the scientific evidence to date to maximize patient benefit and minimize harm but also result in far more effective use of resources.	[O'Donoghue, Cristina] Univ Illinois, Dept Surg, Chicago, IL 60612 USA; [Eklund, Martin; Esserman, Laura J.] Univ Calif San Francisco, San Francisco Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Ozanne, Elissa M.] Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Dartmouth College	Esserman, LJ (corresponding author), Univ Calif San Francisco, San Francisco Comprehens Canc Ctr, 1600 Divisadero St,2nd Floor,Box 1710, San Francisco, CA 94115 USA.	cristina.odonoghue@gmail.com; martin.eklund@ucsfmedctr.org; Laura.esserman@ucsfmedctr.org			University of California and Safeway Foundation; National Cancer Institute-funded Program Project [P01CA154292]; Breast Cancer Surveillance Consortium [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C]; University of Illinois at Chicago Eleanor B. Pillsbury Fellowship; Swedish Council for Working Life and Social Research (FAS) [2012-0073]; NATIONAL CANCER INSTITUTE [U01CA069976, U01CA063731, U01CA086076, U01CA086082, U01CA070040, U01CA063736, U01CA063740, P01CA154292, U01CA070013] Funding Source: NIH RePORTER	University of California and Safeway Foundation; National Cancer Institute-funded Program Project; Breast Cancer Surveillance Consortium; University of Illinois at Chicago Eleanor B. Pillsbury Fellowship; Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This effort is part of the analysis proposed for breast cancer screening and prevention as part of the Athena Breast Health Network, a collaboration of the 5 University of California medical centers. Athena is supported by the University of California and Safeway Foundation. Data collection for this work was supported by a National Cancer Institute-funded Program Project (P01CA154292) and the Breast Cancer Surveillance Consortium (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, and HHSN261201100031C). Dr. O'Donoghue is funded in part by the University of Illinois at Chicago Eleanor B. Pillsbury Fellowship. Dr. Eklund is funded by the Swedish Council for Working Life and Social Research (FAS), project number 2012-0073. The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please visit www. breastscreening. cancer. gov/ work/ acknowledgment. html.	Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; American Cancer Society, 2013, AMERICAN CANCER SOCI; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Burnside E, 2001, Clin Breast Cancer, V2, P145, DOI 10.3816/CBC.2001.n.019; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Centers for Disease Control and Prevention, 2010, BRFSS ANNUAL SURVEY; Centers for Medicare & Medicaid Services, MEDICARE PHYSICIAN F; Centers for Medicare & Medicaid Services, 2003, MEDICARE CURRENT BEN; Centers for Medicare & Medicaid Services, 2010, DETAILS FOR SECTION, P57; D'Orsi C, 2003, BREAST IMAGING REPOR; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; Esserman L, 2002, JNCI-J NATL CANCER I, V94, P369; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Fenton JJ, 2011, J NATL CANCER I, V103, P1152, DOI 10.1093/jnci/djr206; Flowers CI, 2013, BREAST CANCER RES TR, V139, P769, DOI 10.1007/s10549-013-2576-0; Frieden Thomas R, 2012, MMWR Suppl, V61, P1; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Gross CP, 2013, JAMA INTERN MED, V173, P220, DOI 10.1001/jamainternmed.2013.1397; Hafslund B, 2012, CANCER NURS, V35, pE26, DOI 10.1097/NCC.0b013e3182341ddb; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Howden LM, 2011, AGE SEX COMPOSITION, P1; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Joy JE, 2005, SAVING WOMENS LIVES, P63; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Keyzer-Dekker CMG, 2012, BREAST, V21, P83, DOI 10.1016/j.breast.2011.08.137; Levy AR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120069; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; National Center for Health Statistics, 2014, HEDIS 2014 PUBLIC CO, P1; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Onega T, 2012, J AM COLL RADIOL, V9, P788, DOI 10.1016/j.jacr.2012.05.020; Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105; Rauscher GH, 2012, J WOMENS HEALTH, V21, P154, DOI 10.1089/jwh.2010.2415; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Saltelli A, 2006, RELIAB ENG SYST SAFE, V91, P1109, DOI 10.1016/j.ress.2005.11.014; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Smith M, 2012, BEST CARE AT LOWER C; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; U.S. Bureau of Labor Statistics, 2011, CONSUMER PRICE INDEX; U.S. Food and Drug Administration, 2010, MAMMOGRAPHY QUALITY; U.S. Government Accountability Office, 2006, MAMMOGRAPHY CURRENT; U.S. Preventive Services Task Force, SCREENING FOR BREAST; US Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2013, HEALTHY PEOPLE 2020; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002	53	69	71	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					145	+		10.7326/M13-1217	http://dx.doi.org/10.7326/M13-1217			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2VE	24658691	Green Accepted			2022-12-28	WOS:000330951500001
J	Madhi, SA; Parashar, UD				Madhi, Shabir A.; Parashar, Umesh D.			116E rotavirus vaccine development: a successful alliance	LANCET			English	Editorial Material									[Madhi, Shabir A.] Natl Inst Communicable Dis, Natl Hlth Lab Serv, ZA-2131 Johannesburg, Gauteng, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; Centers for Disease Control & Prevention - USA	Madhi, SA (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, ZA-2131 Johannesburg, Gauteng, South Africa.	shabirm@nicd.ac.za			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Bhandari N, 2014, LANCET; GAVI Alliance, 2013, VACC COF FREQ ASK QU; Levine OS, 2010, HUM VACCINES, V6, P1021, DOI 10.4161/hv.6.12.13076; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Parashar UD, 2013, CLIN INFECT DIS, V57, P1435, DOI 10.1093/cid/cit532; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Unite for Children, 2013, UNICEF PROC PRIC ROT; Velazquez FR, 1996, N ENGL J MED; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	13	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2106	+		10.1016/S0140-6736(13)62701-4	http://dx.doi.org/10.1016/S0140-6736(13)62701-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24629992	Green Accepted			2022-12-28	WOS:000337906600007
J	Zheng, SY; Redberg, RF				Zheng, Sarah Y.; Redberg, Rita F.			Premarket Approval Supplement Pathway: Do We Know What We Are Getting?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVERTER-DEFIBRILLATOR LEAD; FIDELIS; MULTICENTER		[Zheng, Sarah Y.; Redberg, Rita F.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 USA.							Abdelhadi RH, 2013, HEART RHYTHM, V10, P361, DOI 10.1016/j.hrthm.2012.10.045; Hauser RG, 2009, HEART RHYTHM, V6, P605, DOI 10.1016/j.hrthm.2009.02.024; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; MarketsandMarkets, 2011, 1620 MD MARKETSANDMA; Maytin M, 2010, J AM COLL CARDIOL, V56, P646, DOI 10.1016/j.jacc.2010.03.058; U.S. Food and Drug Administration, 2012, PREM APPR PMA	6	13	13	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					798	+		10.7326/M13-2931	http://dx.doi.org/10.7326/M13-2931			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MT	24664113				2022-12-28	WOS:000337348700006
J	Cao, YN; He, MH; Gao, ZB; Peng, Y; Li, YL; Li, L; Zhou, WW; Li, XC; Zhong, X; Lei, YM; Su, TW; Wang, H; Jiang, YR; Yang, L; Wei, W; Yang, X; Jiang, XL; Liu, L; He, J; Ye, JN; Wei, Q; Li, YR; Wang, WQ; Wang, J; Ning, G				Cao, Yanan; He, Minghui; Gao, Zhibo; Peng, Ying; Li, Yanli; Li, Lin; Zhou, Weiwei; Li, Xiangchun; Zhong, Xu; Lei, Yiming; Su, Tingwei; Wang, Hang; Jiang, Yiran; Yang, Lin; Wei, Wei; Yang, Xu; Jiang, Xiuli; Liu, Li; He, Juan; Ye, Junna; Wei, Qing; Li, Yingrui; Wang, Weiqing; Wang, Jun; Ning, Guang			Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome	SCIENCE			English	Article							ACUTE REGULATORY PROTEIN; CRYSTAL-STRUCTURE; GENE; HYPERPLASIA; SUBUNIT; NETWORK; TUMORS	Adrenal Cushing's syndromeis caused by excess production of glucocorticoid from adrenocortical tumors and hyperplasias, which leads to metabolic disorders. We performed whole-exome sequencing of 49 blood-tumor pairs and RNA sequencing of 44 tumors from cortisol-producing adrenocortical adenomas (ACAs), adrenocorticotropic hormone-independent macronodular adrenocortical hyperplasias (AIMAHs), and adrenocortical oncocytomas (ADOs). We identified a hotspot in the PRKACA gene with a L205R mutation in 69.2%(27 out of 39) of ACAs and validated in 65.5% of a total of 87 ACAs. Our data revealed that the activating L205R mutation, which locates in the P+1 loop of the protein kinase A (PKA) catalytic subunit, promoted PKA substrate phosphorylation and target gene expression. Moreover, we discovered the recurrently mutated gene DOT1L in AIMAHs and CLASP2 in ADOs. Collectively, these data highlight potentially functional mutated genes in adrenal Cushing's syndrome.	[Cao, Yanan; Peng, Ying; Li, Yanli; Zhou, Weiwei; Zhong, Xu; Su, Tingwei; Jiang, Yiran; Wei, Wei; Jiang, Xiuli; He, Juan; Ye, Junna; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Key Lab Endocrine Tumors,Rui Jin Hosp, Shanghai 200030, Peoples R China; [He, Minghui; Gao, Zhibo; Li, Lin; Li, Xiangchun; Lei, Yiming; Wang, Hang; Yang, Lin; Yang, Xu; Liu, Li; Li, Yingrui; Wang, Jun] BGI Shenzhen, BGI Shanghai, Shenzhen, Peoples R China; [Wei, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ning, Guang] Chinese Acad Sci, Shanghai Inst Biol Sci SIBS, Inst Hlth Sci, Lab Endocrinol & Metab, Shanghai, Peoples R China; [Ning, Guang] Shanghai Jiao Tong Univ, Sch Med SJTUSM, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Beijing Genomics Institute (BGI); Shanghai Jiao Tong University; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Wang, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Key Lab Endocrine Tumors,Rui Jin Hosp, Shanghai 200030, Peoples R China.	wqingw@hotmail.com; wangj@genomics.org.cn; guangning@medmail.com.cn	Ye, Junna/ABF-6141-2020; Wei, Weijun/AAZ-3551-2021; Li, Yingrui/K-1064-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Cao, Yanan/0000-0002-3848-7040; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Natural Science Foundation of China grants [30900702, 81130016, 81270859]; Guangdong Innovative Research Team Program grant [2009010016]	Natural Science Foundation of China grants(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program grant	Supported by Natural Science Foundation of China grants 30900702, 81130016, and 81270859, and by Guangdong Innovative Research Team Program grant 2009010016. The sequencing data have been deposited in the European Genome-phenome Archive (accession no. EGAS00001000712).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603; Berthon A, 2012, MOL CELL ENDOCRINOL, V351, P87, DOI 10.1016/j.mce.2011.09.009; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gaujoux S, 2010, CLIN CANCER RES, V16, P5133, DOI 10.1158/1078-0432.CCR-10-1497; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Meimaridou E, 2013, ENDOCR DEV, V24, P57, DOI 10.1159/000342504; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Sarkar D, 2001, J CLIN ENDOCR METAB, V86, P1653, DOI 10.1210/jc.86.4.1653; Stratakis CA, 2007, NAT CLIN PRACT ENDOC, V3, P748, DOI 10.1038/ncpendmet0648; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030	25	151	158	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					913	917		10.1126/science.1249480	http://dx.doi.org/10.1126/science.1249480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24700472				2022-12-28	WOS:000336233800051
J	Atallah, BV; Scanziani, M; Carandini, M				Atallah, Bassam V.; Scanziani, Massimo; Carandini, Matteo			Interneuron subtypes and orientation tuning Reply	NATURE			English	Letter									[Atallah, Bassam V.] Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Atallah, Bassam V.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Atallah, Bassam V.; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Atallah, Bassam V.; Scanziani, Massimo] Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; [Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England	Fundacao Champalimaud; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of London; University College London	Atallah, BV (corresponding author), Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal.	matteo@cortexlab.net	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682; Atallah, Bassam/0000-0003-2315-7126				Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Lee SH, 2014, NATURE, V508, pE1, DOI 10.1038/nature13128; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312	3	18	18	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					E3	E3		10.1038/nature13129	http://dx.doi.org/10.1038/nature13129			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695314	Bronze			2022-12-28	WOS:000333609900002
J	Gawande, A; Landon, B; Colla, C; Halpern, S				Gawande, Atul; Landon, Bruce; Colla, Carrie; Halpern, Scott			Avoiding Low-Value Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The enormous cost of health care in the United States has inspired new efforts to assess the true value of commonly provided services. Carrie Colla, Scott Halpern, and Bruce Landon discuss decision making regarding low-value care in a video roundtable moderated by Atul Gawande. The enormous cost of health care in the United States, driven in part by the fee-for-service payment system, has inspired new efforts to assess the true value of commonly provided services. When a service is widely recognized as providing little or no benefit, what should be done to reduce its use? How can physicians work with patients to make appropriate choices when the value of a given intervention is dubious? Carrie Colla, Scott Halpern, and Bruce Landon discuss decision making regarding low-value care in a video roundtable moderated by Atul Gawande. View the video of this roundtable discussion and contribute . . .	[Gawande, Atul] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gawande, Atul] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Gawande, Atul] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Gawande, A (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.								0	17	17	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14							e21	10.1056/NEJMp1401245	http://dx.doi.org/10.1056/NEJMp1401245			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE2VA	24693918				2022-12-28	WOS:000333830000002
J	Hansen, AK; Versolato, OO; Klosowski, L; Kristensen, SB; Gingell, A; Schwarz, M; Windberger, A; Ullrich, J; Lopez-Urrutia, JRC; Drewsen, M				Hansen, A. K.; Versolato, O. O.; Klosowski, L.; Kristensen, S. B.; Gingell, A.; Schwarz, M.; Windberger, A.; Ullrich, J.; Lopez-Urrutia, J. R. Crespo; Drewsen, M.			Efficient rotational cooling of Coulomb-crystallized molecular ions by a helium buffer gas	NATURE			English	Article							COOLED IONS; SINGLE-ION; LASER; COLD; SPECTROSCOPY; TRAP	The preparation of cold molecules is of great importance in many contexts, such as fundamental physics investigations(1,2), high-resolution spectroscopy of complex molecules(3-5), cold chemistry(6,7) and astrochemistry(8). One versatile and widely applied method to cool molecules is helium buffer-gas cooling in either a supersonic beam expansion(9,10) or a cryogenic trap environment(11,12). Another more recent method applicable to trapped molecular ions relies on sympathetic translational cooling, through collisional interactions with co-trapped, laser-cooled atomic ions, into spatially ordered structures called Coulomb crystals, combined with laser-controlled internal-state preparation(6,7,13-23). Here we present experimental results on helium buffer-gas cooling of the rotational degrees of freedom of MgH+ molecular ions, which have been trapped and sympathetically cooled(13) in a cryogenic linear radio-frequency quadrupole trap. With helium collision rates of only about ten per second-that is, four to five orders of magnitude lower than in typical buffer-gas cooling settings-we have cooled a single molecular ion to a rotational temperature of 7.5(-0.7)(+0.9) kelvin, the lowest such temperature so far measured. In addition, by varying the shape of, or the number of atomic and molecular ions in, larger Coulomb crystals, or both, we have tuned the effective rotational temperature from about 7 kelvin to about 60 kelvin by changing the translational micromotion energy of the ions(24). The extremely low helium collision rate may allow for sympathetic sideband cooling of single molecular ions, and eventually make quantum-logic spectroscopy(25) of buffer-gas-cooled molecular ions feasible. Furthermore, application of the present cooling scheme to complex molecular ions should enable single- or few-state manipulations of individual molecules of biological interest(4,5).	[Hansen, A. K.; Kristensen, S. B.; Gingell, A.; Drewsen, M.] Aarhus Univ, Dept Phys & Astron, Danish Natl Res Fdn Ctr Quantum Opt QUANTOP, DK-8000 Aarhus C, Denmark; [Versolato, O. O.; Schwarz, M.; Windberger, A.; Ullrich, J.; Lopez-Urrutia, J. R. Crespo] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Klosowski, L.] Nicolaus Copernicus Univ, Inst Phys, Fac Phys Astron & Informat, PL-87100 Torun, Poland; [Ullrich, J.] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany	Aarhus University; Danmarks Grundforskningsfond; Max Planck Society; Nicolaus Copernicus University; Physikalisch-Technische Bundesanstalt (PTB)	Drewsen, M (corresponding author), Aarhus Univ, Dept Phys & Astron, Danish Natl Res Fdn Ctr Quantum Opt QUANTOP, DK-8000 Aarhus C, Denmark.	drewsen@phys.au.dk	Hansen, Anders Kragh/AAF-4979-2020; Klosowski, Lukasz/G-3878-2014; Versolato, Oscar/Q-9640-2017; López-Urrutia, José R. Crespo/F-7069-2011	Hansen, Anders Kragh/0000-0002-4632-6538; Versolato, Oscar/0000-0003-3852-5227; López-Urrutia, José R. Crespo/0000-0002-2937-8037; Klosowski, Lukasz/0000-0002-5463-5381; Drewsen, Michael/0000-0002-0420-9923	Danish National Research Foundation Center for Quantum Optics - QUANTOP; Danish Agency for Science, Technology and Innovation; Carlsberg Foundation; Lundbeck Foundation; European Commission [FP7 GA 607491 COMIQ]; STSM; COST-Action IOTA	Danish National Research Foundation Center for Quantum Optics - QUANTOP; Danish Agency for Science, Technology and Innovation; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); STSM; COST-Action IOTA	M. D. appreciates generous support through the Danish National Research Foundation Center for Quantum Optics - QUANTOP; The Danish Agency for Science, Technology and Innovation; the Carlsberg Foundation; the Lundbeck Foundation; and the European Commission under the Seventh Framework Programme FP7 GA 607491 COMIQ. O. O. V., M. S., L. K. and A. W. acknowledge funding from STSM travel grants from COST-Action IOTA. Finally, the MPIK mechanical workshops have been of crucial importance for the construction of the cryogenic trap.	BLUMEL R, 1989, PHYS REV A, V40, P808, DOI 10.1103/PhysRevA.40.808; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; GERLICH D, 1995, PHYS SCRIPTA, VT59, P256, DOI 10.1088/0031-8949/1995/T59/035; Hansen AK, 2012, ANGEW CHEM INT EDIT, V51, P7960, DOI 10.1002/anie.201203550; Hlavenka P, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3080809; Hojbjerre K, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.030702; Hudson ER, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.143004; Hutzler NR, 2011, PHYS CHEM CHEM PHYS, V13, P18976, DOI 10.1039/c1cp20901a; Kamrath MZ, 2011, INT J MASS SPECTROM, V300, P91, DOI 10.1016/j.ijms.2010.10.021; Molhave K, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.011401; Ostendorf A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243005; Rellergert WG, 2013, NATURE, V495, P490, DOI 10.1038/nature11937; RIZZO TR, 1986, J CHEM PHYS, V84, P2534, DOI 10.1063/1.450323; Schlemmer S, 1999, INT J MASS SPECTROM, V185, P589, DOI 10.1016/S1387-3806(98)14141-6; Schmid S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.133202; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schneider T, 2010, NAT PHYS, V6, P275, DOI 10.1038/NPHYS1605; Schwarz M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4742770; Scoles G., 1988, ATOMIC MOL BEAM METH, V1; Smith I. W., 2008, LOW TEMPERATURES COL; Staanum PF, 2010, NAT PHYS, V6, P271, DOI 10.1038/NPHYS1604; Staanum PF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.243003; Stearns JA, 2007, J AM CHEM SOC, V129, P11814, DOI 10.1021/ja0736010; Tong X, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143001; Versolato OO, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053002; Vogelius IS, 2006, J PHYS B-AT MOL OPT, V39, pS1259, DOI 10.1088/0953-4075/39/19/S31; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949; Willitsch S, 2008, PHYS CHEM CHEM PHYS, V10, P7200, DOI 10.1039/b813408c; Zipkes C, 2010, NATURE, V464, P388, DOI 10.1038/nature08865	31	75	75	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					76	79		10.1038/nature12996	http://dx.doi.org/10.1038/nature12996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670662				2022-12-28	WOS:000333609900045
J	Sun, C; Wang, LQ; Huang, SD; Heynen, GJJE; Prahallad, A; Robert, C; Haanen, J; Blank, C; Wesseling, J; Willems, SM; Zecchin, D; Hobor, S; Bajpe, PK; Lieftink, C; Mateus, C; Vagner, S; Grernrum, W; Hofland, I; Schlicker, A; Wessels, LFA; Beijersbergen, RL; Bardelli, A; Di Nicolantonio, F; Eggermont, AMM; Bernards, R				Sun, Chong; Wang, Liqin; Huang, Sidong; Heynen, Guus J. J. E.; Prahallad, Anirudh; Robert, Caroline; Haanen, John; Blank, Christian; Wesseling, Jelle; Willems, Stefan M.; Zecchin, Davide; Hobor, Sebastijan; Bajpe, Prashanth K.; Lieftink, Cor; Mateus, Christina; Vagner, Stephan; Grernrum, Wipawadee; Hofland, Ingrid; Schlicker, Andreas; Wessels, Lodewyk F. A.; Beijersbergen, Roderick L.; Bardelli, Alberto; Di Nicolantonio, Federica; Eggermont, Alexander M. M.; Bernards, Rene			Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; IMPROVED SURVIVAL; BRAF INHIBITOR; RAF INHIBITION; C-JUN; CANCER; EXPRESSION; CELLS; EGFR; DIFFERENTIATION	Treatment of BRAF(V600E) mutant melanoma by small molecule drugs that target the BRAF or MEK kinases can be effective, but resistance develops invariably(1,2). In contrast, colon cancers that harbour the same BRAF(V600E) mutation are intrinsically resistant to BRAF inhibitors, due to feedback activation of the epidermal growth factor receptor (EGFR)(3,4). Here we show that 6 out of 16 melanoma tumours analysed acquired EGFR expression after the development of resistance to BRAF or MEK inhibitors. Using a chromatin-regulator-focused short hairpin RNA (shRNA) library, we find that suppression of sex determining region Y-box 10(SOX10) in melanoma causes activation of TGF-beta signalling, thus leading to upregulation of EGFR and platelet-derived growth factor receptor-beta (PDGFRB), which confer resistance to BRAF and MEK inhibitors. Expression of EGFR in melanoma or treatment with TGF-beta results in a slow-growth phenotype with cells displaying hallmarks of oncogene-induced senescence. However, EGFR expression or exposure to TGF-beta becomes beneficial for proliferation in the presence of BRAF or MEK inhibitors. In a heterogeneous population of melanoma cells having varying levels of SOX10 suppression, cells with low SOX10 and consequently high EGFR expression are rapidly enriched in the presence of drug, but this is reversed when the drug treatment is discontinued. We find evidence for SOX10 loss and/or activation of TGF-beta signalling in 4 of the 6 EGFR-positive drug-resistant melanoma patient samples. Our findings provide a rationale for why some BRAF or MEK inhibitor-resistant melanoma patients may regain sensitivity to these drugs after a 'drug holiday' and identify patients with EGFR-positive melanoma as a group that may benefit from re-treatment after a drug holiday.	[Sun, Chong; Wang, Liqin; Huang, Sidong; Heynen, Guus J. J. E.; Prahallad, Anirudh; Willems, Stefan M.; Bajpe, Prashanth K.; Lieftink, Cor; Grernrum, Wipawadee; Schlicker, Andreas; Wessels, Lodewyk F. A.; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Canc Syst Biol Ctr, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Sun, Chong; Wang, Liqin; Huang, Sidong; Heynen, Guus J. J. E.; Prahallad, Anirudh; Haanen, John; Blank, Christian; Wesseling, Jelle; Willems, Stefan M.; Bajpe, Prashanth K.; Lieftink, Cor; Grernrum, Wipawadee; Hofland, Ingrid; Schlicker, Andreas; Wessels, Lodewyk F. A.; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr Netherlands, NL-1066 CX Amsterdam, Netherlands; [Huang, Sidong] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada; [Robert, Caroline; Mateus, Christina; Vagner, Stephan; Eggermont, Alexander M. M.] Inst Gustave Roussy, F-94800 Villejuif, France; [Haanen, John; Blank, Christian] Netherlands Canc Inst, Div Med Oncol, Canc Syst Biol Ctr, NL-1066 CX Amsterdam, Netherlands; [Wesseling, Jelle; Hofland, Ingrid] Netherlands Canc Inst, Div Pathol, Canc Syst Biol Ctr, NL-1066 CX Amsterdam, Netherlands; [Willems, Stefan M.] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Zecchin, Davide; Bardelli, Alberto; Di Nicolantonio, Federica] Univ Turin, Dept Oncol, I-10060 Turin, Italy; [Zecchin, Davide; Hobor, Sebastijan; Bardelli, Alberto; Di Nicolantonio, Federica] IRCCS, Candiolo Canc Inst FPO, I-10060 Turin, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol IFOM, I-20139 Milan, Italy	Netherlands Cancer Institute; Netherlands Cancer Institute; McGill University; UNICANCER; Gustave Roussy; Netherlands Cancer Institute; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IFOM - FIRC Institute of Molecular Oncology	Bernards, R (corresponding author), Netherlands Canc Inst, Canc Syst Biol Ctr, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Sun, Chong/AAB-4859-2021; Di Nicolantonio, Federica/A-2503-2011; Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022; Vagner, Stephan/G-3664-2013; Robert, Caroline/G-6157-2018; BARDELLI, Alberto/J-9721-2018	Sun, Chong/0000-0001-9008-2158; Di Nicolantonio, Federica/0000-0001-9618-2010; Haanen, John/0000-0001-5884-7704; Robert, Caroline/0000-0002-9493-0238; Huang, Sidong/0000-0002-2838-4726; Schlicker, Andreas/0000-0002-6588-7883; vagner, stephan/0000-0003-1452-7164; Beijersbergen, Roderick/0000-0003-0116-4130; BARDELLI, Alberto/0000-0003-1647-5070; Wesseling, Jelle/0000-0002-8940-2676; Bernards, Rene/0000-0001-8677-3423; Wang, Liqin/0000-0002-9881-6432	European Research Council (ERC); Dutch Cancer Society (KWF); EU COLTHERES project; Netherlands Organization for Scientific Research (NWO) to Cancer Genomics Netherlands (CGC.NL); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS grant 'Farmacogenomica-5 per mille 2009 MIUR'; AIRC MFAG [11349]; AIRC IG grant [12812]; Canadian Institutes of Health Research (CIHR) [MOP-130540]	European Research Council (ERC)(European Research Council (ERC)European Commission); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); EU COLTHERES project; Netherlands Organization for Scientific Research (NWO) to Cancer Genomics Netherlands (CGC.NL)(Netherlands Organization for Scientific Research (NWO)); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS grant 'Farmacogenomica-5 per mille 2009 MIUR'; AIRC MFAG(Fondazione AIRC per la ricerca sul cancro); AIRC IG grant(Fondazione AIRC per la ricerca sul cancro); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank the NKI Core Facilities for Genomics and Molecular Pathology & Biobanking for tumour tissue and support in DNA sequencing. We thank S. Roy for collecting clinical data and N. Kamsu Kom for tissue preparation. This work was supported by grants from the European Research Council (ERC), the Dutch Cancer Society (KWF), the EU COLTHERES project and grants by the Netherlands Organization for Scientific Research (NWO) to Cancer Genomics Netherlands (CGC.NL). Additional support was provided by Fondazione Piemontese per la Ricerca sul Cancro-ONLUS grant 'Farmacogenomica-5 per mille 2009 MIUR' (F. D. N.); AIRC MFAG 11349 (F. D. N.); AIRC IG grant n. 12812 (A. B.); and Canadian Institutes of Health Research (CIHR) grant MOP-130540 (S.Hu).	Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Brummelkamp TR, 2003, NAT REV CANCER, V3, P781, DOI 10.1038/nrc1191; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cronin JC, 2009, PIGM CELL MELANOMA R, V22, P435, DOI 10.1111/j.1755-148X.2009.00578.x; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Mialon A, 2005, MOL CELL BIOL, V25, P5040, DOI 10.1128/MCB.25.12.5040-5051.2005; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; REAL FX, 1986, CANCER RES, V46, P4726; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	29	544	556	5	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					118	+		10.1038/nature13121	http://dx.doi.org/10.1038/nature13121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670642	Green Submitted			2022-12-28	WOS:000333609900054
J	van de Pavert, SA; Ferreira, M; Domingues, RG; Ribeiro, H; Molenaar, R; Moreira-Santos, L; Almeida, FF; Ibiza, S; Barbosa, I; Goverse, G; Labao-Almeida, C; Godinho-Silva, C; Konijn, T; Schooneman, D; O'Toole, T; Mizee, MR; Habani, Y; Haak, E; Santori, FR; Littman, DR; Schulte-Merker, S; Dzierzak, E; Simas, JP; Mebius, RE; Veiga-Fernandes, H				van de Pavert, Serge A.; Ferreira, Manuela; Domingues, Rita G.; Ribeiro, Helder; Molenaar, Rosalie; Moreira-Santos, Lara; Almeida, Francisca F.; Ibiza, Sales; Barbosa, Ines; Goverse, Gera; Labao-Almeida, Carlos; Godinho-Silva, Cristina; Konijn, Tanja; Schooneman, Dennis; O'Toole, Tom; Mizee, Mark R.; Habani, Yasmin; Haak, Esther; Santori, Fabio R.; Littman, Dan R.; Schulte-Merker, Stefan; Dzierzak, Elaine; Simas, J. Pedro; Mebius, Reina E.; Veiga-Fernandes, Henrique			Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity	NATURE			English	Article							ROR-GAMMA-T; ACID; FETAL; MICE; RESPONSES; SURVIVAL; ORGANS; NOTCH; RET	The impact of nutritional status during fetal life on the overall health of adults has been recognized(1); however, dietary effects on the developing immune system are largely unknown. Development of secondary lymphoid organs occurs during embryogenesis and is considered to be developmentally programmed(2,3). Secondary lymphoid organ formation depends on a subset of type 3 innate lymphoid cells (ILC3) named lymphoid tissue inducer(LTi) cells(2-5). Here we show that mouse fetal ILC3s are controlled by cell-autonomous retinoic acid (RA) signalling in utero, which pre-sets the immune fitness in adulthood. We found that embryonic lymphoid organs contain ILC progenitors that differentiate locally into mature LTi cells. Local LTi cell differentiation was controlled by maternal retinoid intake and fetal RA signalling acting in a haematopoietic cell-autonomous manner. RA controlled LTi cell maturation upstream of the transcription factor ROR gamma t. Accordingly, enforced expression of Rorgt restored maturation of LTi cells with impaired RA signalling, whereas RA receptors directly regulated the Rorgt locus. Finally, we established that maternal levels of dietary retinoids control the size of secondary lymphoid organs and the efficiency of immune responses in the adult offspring. Our results reveal a molecular link between maternal nutrients and the formation of immune structures required for resistance to infection in the offspring.	[van de Pavert, Serge A.; Molenaar, Rosalie; Goverse, Gera; Konijn, Tanja; Schooneman, Dennis; O'Toole, Tom; Mizee, Mark R.; Habani, Yasmin; Mebius, Reina E.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [Ferreira, Manuela; Domingues, Rita G.; Ribeiro, Helder; Moreira-Santos, Lara; Almeida, Francisca F.; Ibiza, Sales; Barbosa, Ines; Labao-Almeida, Carlos; Godinho-Silva, Cristina; Simas, J. Pedro; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Med Mol, P-1649028 Lisbon, Portugal; [Haak, Esther; Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Santori, Fabio R.; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, Mol Pathogenesis Program,Skirball Inst Biomol Med, New York, NY 10016 USA; [Schulte-Merker, Stefan] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Schulte-Merker, Stefan] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Vrije Universiteit Amsterdam; Universidade de Lisboa; Erasmus University Rotterdam; Erasmus MC; Howard Hughes Medical Institute; New York University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Med Mol, Av Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal.	jhfernandes@medicina.ulisboa.pt	Ferreira, Manuela/I-7904-2018; Simas, J Pedro/M-5157-2013; van de Pavert, Serge A./A-7307-2008; Ferreira, Manuela/AAF-5299-2020; Santori, Fabio/GRF-1002-2022	Ferreira, Manuela/0000-0001-9498-8061; Simas, J Pedro/0000-0001-6982-9253; van de Pavert, Serge A./0000-0002-7147-4380; Ferreira, Manuela/0000-0001-9498-8061; Labao-Almeida, Carlos/0000-0002-7797-3797; F. de Almeida, Francisca/0000-0001-6632-7610; Barbosa, Ines/0000-0001-8977-0930; Ibiza, Sales/0000-0002-5748-382X; Ribeiro, Helder/0000-0002-7090-9274; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Ferreira, Manuela/0000-0002-0075-2400; Mebius, Reina/0000-0003-0451-7464; Godinho-Silva, Cristina/0000-0002-0300-8839; Santori, Fabio/0000-0002-0220-8935	FCT, Portugal; EMBO [1648]; ERC [207057]; NIH [RO1AI080885]; HHMI; Dutch MS research foundation [MS 12-797]; NGI Breakthrough Horizon [40-41009-98-9077]; VICI [918.56.612]; ALW-TOP [09.048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080885] Funding Source: NIH RePORTER	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Dutch MS research foundation; NGI Breakthrough Horizon; VICI(Netherlands Organization for Scientific Research (NWO)); ALW-TOP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the imaging, animal and flow cytometry facilities at IMM and UPC for technical assistance; C. Mendelsohn for providing ROSA26-RAR alpha 403 mice; N. Schmolka, J. G. van Rietschoten, R. E. van Kesteren, T. H. B. Geijtenbeek, S. Gringhuis, E. Keuning, J. Peterson-Maduro, M. G. Roukens, D. D'Astolfo, M. Vermunt, A. Rijerkerk, J. Koning, J. van der Meulen and B. Oliver for technical help; and G. Vilhais-Neto, M. C. Coles and G. Eberl for discussion. M. F., L.M.-S. and R. G. D. were supported by FCT, Portugal; H.V.-F. by EMBO (1648) and ERC (207057); D. R. L. by NIH (RO1AI080885) and HHMI; M. R. M. by Dutch MS research foundation (MS 12-797); S.A.vd.P. by NGI Breakthrough Horizon (40-41009-98-9077); and R. E. M. by a VICI (918.56.612) and ALW-TOP grant (09.048).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2010, METHODS MOL BIOL, V616, P161, DOI 10.1007/978-1-60761-461-6_11; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	42	257	262	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					123	+		10.1038/nature13158	http://dx.doi.org/10.1038/nature13158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670648	Green Accepted			2022-12-28	WOS:000333609900055
J	Chivian, E				Chivian, Eric			Why doctors and their organisations must help tackle climate change: an essay by Eric Chivian	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Chivian, E (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	eric_chivian@hms.harvard.edu							0	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g2407	10.1136/bmj.g2407	http://dx.doi.org/10.1136/bmj.g2407			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696173				2022-12-28	WOS:000333977000005
J	Putnis, A				Putnis, Andrew			Why Mineral Interfaces Matter	SCIENCE			English	Editorial Material							DISSOLUTION-REPRECIPITATION; REPLACEMENT REACTIONS; WATER		Univ Munster, Inst Mineral, D-48149 Munster, Germany	University of Munster	Putnis, A (corresponding author), Univ Munster, Inst Mineral, D-48149 Munster, Germany.	putnis@uni-muenster.de	Putnis, Andrew/R-6388-2019	Putnis, Andrew/0000-0003-2232-9942				Ague J.J., 2003, TREATISE GEOCHEMISTR, V3, P195, DOI DOI 10.1016/B0-08-043751-6/03023-1; Daval D, 2011, CHEM GEOL, V284, P193, DOI 10.1016/j.chemgeo.2011.02.021; Dohmen L, 2013, INT J APPL GLASS SCI, V4, P357, DOI 10.1111/ijag.12046; Harlov D.E., 2012, METASOMATISM CHEM TR; Hellmann R, 2012, CHEM GEOL, V294, P203, DOI 10.1016/j.chemgeo.2011.12.002; Hovelmann J, 2012, ENVIRON SCI TECHNOL, V46, P5253, DOI 10.1021/es300403n; Milke R, 2013, GEOLOGY, V41, P247, DOI 10.1130/G33674.1; Putnis A, 2009, REV MINERAL GEOCHEM, V70, P87, DOI 10.2138/rmg.2009.70.3; Putnis CV, 2013, ELEMENTS, V9, P177, DOI 10.2113/gselements.9.3.177; Reboul J, 2012, NAT MATER, V11, P717, DOI [10.1038/NMAT3359, 10.1038/nmat3359]; Xia F, 2008, CHEM MATER, V20, P2809, DOI 10.1021/cm7033883; Xia F, 2009, CRYST GROWTH DES, V9, P4902, DOI 10.1021/cg900691a	12	127	129	7	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1441	1442		10.1126/science.1250884	http://dx.doi.org/10.1126/science.1250884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675943				2022-12-28	WOS:000333471000023
J	Chiappa, V; Chang, CY; Sellas, MI; Pierce, VM; Kradin, RL				Chiappa, Victor; Chang, Connie Y.; Sellas, Monique I.; Pierce, Virginia M.; Kradin, Richard L.			Case 10-2014: A 45-Year- Old Man with a Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								A 45-year-old man was admitted to the hospital because of diffuse, purple, blanching livedo and signs of severe sepsis. Three days earlier, he had been bitten by a dog. A diagnostic test result was received. Presentation of CaseDr. Douglas S. Micalizzi (Medicine): A 45-year-old man was admitted to this hospital because of a new rash. The patient had been well until 2 p.m. on the day before admission, when nausea, epigastric pain, and vomiting developed. The next morning, he was seen at another hospital, where he reported increasing asthma and right-sided back pain, which he rated at 10 on a scale of 0 to 10 (with 10 indicating the most severe pain). On examination, he was in moderate distress. The temperature was 36.5 degrees C, the blood pressure 112/69 mm Hg, the pulse 125 beats per ...	[Chiappa, Victor] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chang, Connie Y.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sellas, Monique I.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Pierce, Virginia M.; Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Chiappa, Victor] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Chang, Connie Y.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sellas, Monique I.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Pierce, Virginia M.; Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chiappa, V (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Pierce, Virginia/0000-0002-3723-1326				Dellinger RP, 2008, CRIT CARE MED, V36, P1394; Mitsuma SF, 2013, CLIN INFECT DIS, V56, P996, DOI 10.1093/cid/cis1014; Oehler RL, 2009, LANCET INFECT DIS, V9, P439, DOI 10.1016/S1473-3099(09)70110-0; Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71	4	9	9	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1238	1248		10.1056/NEJMcpc1304162	http://dx.doi.org/10.1056/NEJMcpc1304162			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670171				2022-12-28	WOS:000333426000012
J	Jung, H; Gkogkas, CG; Sonenberg, N; Holt, CE				Jung, Hosung; Gkogkas, Christos G.; Sonenberg, Nahum; Holt, Christine E.			Remote Control of Gene Function by Local Translation	CELL			English	Review							MESSENGER-RNA LOCALIZATION; TERM SYNAPTIC PLASTICITY; AXONAL PROTEIN-SYNTHESIS; CELL-FREE FORMATION; BINDING-PROTEIN; GROWTH CONES; CYTOPLASMIC POLYADENYLATION; INTRAAXONAL TRANSLATION; ACTIN-POLYMERIZATION; MAMMALIAN TARGET	The subcellular position of a protein is a key determinant of its function. Mounting evidence indicates that RNA localization, where specific mRNAs are transported subcellularly and subsequently translated in response to localized signals, is an evolutionarily conserved mechanism to control protein localization. On-site synthesis confers novel signaling properties to a protein and helps to maintain local proteome homeostasis. Local translation plays particularly important roles in distal neuronal compartments, and dysregulated RNA localization and translation cause defects in neuronal wiring and survival. Here, we discuss key findings in this area and possible implications of this adaptable and swift mechanism for spatial control of gene function.	[Jung, Hosung] Yonsei Univ, Coll Med, Brain Res Inst, Dept Anat, Seoul 120752, South Korea; [Jung, Hosung] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Gkogkas, Christos G.] Univ Edinburgh, Ctr Integrat Physiol, Patrick Wild Ctr, Edinburgh EH8 9XD, Midlothian, Scotland; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Edinburgh; McGill University; McGill University; University of Cambridge	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca; ceh33@cam.ac.uk	Jung, Hosung/A-4401-2012; Gkogkas, Christos/GQH-2659-2022; Gkogkas, Christos/GLR-5348-2022	Jung, Hosung/0000-0002-5059-8050; Gkogkas, Christos/0000-0001-6281-3419; Holt, Christine Elizabeth/0000-0003-2829-121X	Basic Science Research Program [2013R1A1A1009625]; Bio and Medical Technology Development Program through NRF [2010-0020232]; Korean government (MSIP); Autism Speaks [7109]; Canadian Institutes of Health Research [MOP114994]; Wellcome Trust Programme [085314/Z/08/Z]; ERC [322817]	Basic Science Research Program; Bio and Medical Technology Development Program through NRF(National Research Foundation of Korea); Korean government (MSIP); Autism Speaks; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust Programme(Wellcome Trust); ERC(European Research Council (ERC)European Commission)	We thank A. Bellon for comments on the manuscript. This work was supported by Basic Science Research Program (2013R1A1A1009625) and Bio and Medical Technology Development Program (2010-0020232) funded through NRF by the Korean government (MSIP) (H.J.), Autism Speaks (C.G.G.; 7109), Canadian Institutes of Health Research (N.S.;MOP114994), Wellcome Trust Programme Grant (C.E.H.; 085314/Z/08/Z) and ERC Advanced Grant (C.E.H.; 322817).	Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Alvarez J, 2001, BIOL RES, V34, P103; Amrute-Nayak M, 2012, NAT CELL BIOL, V14, P416, DOI 10.1038/ncb2446; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Troca-Marin JA, 2012, PROG NEUROBIOL, V96, P268, DOI 10.1016/j.pneurobio.2012.01.005; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Aschrafi A, 2010, MOL CELL NEUROSCI, V43, P422, DOI 10.1016/j.mcn.2010.01.009; Bassell GJ, 1998, J NEUROSCI, V18, P251; Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Baulcombe D, 2013, SCIENCE, V342, P45, DOI 10.1126/science.1245010; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buckley PT, 2014, WIRES RNA, V5, P223, DOI 10.1002/wrna.1203; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Byrgazov K, 2013, CURR OPIN MICROBIOL, V16, P133, DOI 10.1016/j.mib.2013.01.009; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campenot RB, 2000, J NEUROCYTOL, V29, P793, DOI 10.1023/A:1010939307434; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Colak D, 2013, CELL, V153, P1252, DOI 10.1016/j.cell.2013.04.056; Condeelis J, 2005, BIOL CELL, V97, P97; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Court FA, 2008, J NEUROSCI, V28, P11024, DOI 10.1523/JNEUROSCI.2429-08.2008; Court FA, 2011, GLIA, V59, P1529, DOI 10.1002/glia.21196; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deglincerti A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120079; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; EDERY I, 1983, J BIOL CHEM, V258, P1398; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Eom T, 2003, J NEUROSCI, V23, P10433; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friend K, 2008, RNA, V14, P1459, DOI 10.1261/rna.1119708; Fritzsche R, 2013, CELL REP, V5, P1749, DOI 10.1016/j.celrep.2013.11.023; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Gonsalvez GB, 2005, BIOL CELL, V97, P75; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Han L, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-40; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; Hsiao K, 2014, DEV NEUROBIOL, V74, P351, DOI 10.1002/dneu.22154; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kaplan BB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00126; Kaplan BB, 2009, RESULTS PROBL CELL D, V48, P225, DOI 10.1007/400_2009_1; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Keller KC, 2011, CURR OPIN MICROBIOL, V14, P155, DOI 10.1016/j.mib.2011.01.009; Kilchert C, 2011, EMBO J, V30, P3567, DOI 10.1038/emboj.2011.247; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lasko P., 2012, COLD SPRING HARB PER, V4, P4; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee J.H., 2014, SCIENCE; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; McEvoy M, 2007, J NEUROSCI, V27, P6400, DOI 10.1523/JNEUROSCI.5211-06.2007; Mikl M, 2011, EMBO REP, V12, P1077, DOI 10.1038/embor.2011.149; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Minis A, 2014, DEV NEUROBIOL, V74, P365, DOI 10.1002/dneu.22140; Mohammad-Qureshi SS, 2008, BIOCHEM SOC T, V36, P658, DOI 10.1042/BST0360658; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nukazuka A, 2008, GENE DEV, V22, P1025, DOI 10.1101/gad.1644008; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Sotelo JR, 2014, DEV NEUROBIOL, V74, P292, DOI 10.1002/dneu.22125; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Sarkies P, 2013, SCIENCE, V341, P467, DOI 10.1126/science.1243175; Sasaki Y, 2014, DEV NEUROBIOL, V74, P397, DOI 10.1002/dneu.22113; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Taylor AM, 2013, J NEUROSCI, V33, P5584, DOI 10.1523/JNEUROSCI.2944-12.2013; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Thelen K, 2012, J CELL SCI, V125, P1003, DOI 10.1242/jcs.096149; Thompson SR, 2012, TRENDS MICROBIOL, V20, P558, DOI 10.1016/j.tim.2012.08.002; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Tsai NP, 2007, EMBO J, V26, P1522, DOI 10.1038/sj.emboj.7601598; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yang Y, 2013, TRENDS NEUROSCI, V36, P418, DOI 10.1016/j.tins.2013.04.001; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	168	207	209	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					26	40		10.1016/j.cell.2014.03.005	http://dx.doi.org/10.1016/j.cell.2014.03.005			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679524	hybrid, Green Published			2022-12-28	WOS:000333968900005
J	Schwamb, ME				Schwamb, Megan E.			Stranded in no-man's-land	NATURE			English	Editorial Material							INNER OORT CLOUD; KUIPER-BELT; SCATTERED DISK; PERIHELION; DISCOVERY; OBJECTS; ORIGIN; SEDNA		Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan	Academia Sinica - Taiwan	Schwamb, ME (corresponding author), Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan.	mschwamb@asiaa.sinica.edu.tw		Schwamb, Megan/0000-0003-4365-1455				Brasser R, 2006, ICARUS, V184, P59, DOI 10.1016/j.icarus.2006.04.010; Brasser R, 2012, ICARUS, V217, P1, DOI 10.1016/j.icarus.2011.10.012; Brown ME, 2004, ASTROPHYS J, V617, P645, DOI 10.1086/422095; Chen YT, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L8; Gladman B, 2002, ICARUS, V157, P269, DOI 10.1006/icar.2002.6860; Gomes RS, 2005, CELEST MECH DYN ASTR, V91, P109, DOI 10.1007/s10569-004-4623-y; Millis RL, 2002, ASTRON J, V123, P2083, DOI 10.1086/339481; Schwamb ME, 2010, ASTROPHYS J, V720, P1691, DOI 10.1088/0004-637X/720/2/1691; Stern SA, 2003, NATURE, V424, P639, DOI 10.1038/nature01725; Trujillo CA, 2014, NATURE, V507, P471, DOI 10.1038/nature13156	12	3	3	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					435	436		10.1038/507435a	http://dx.doi.org/10.1038/507435a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670755				2022-12-28	WOS:000333402000024
J	Moore, CL; Bomann, S; Daniels, B; Luty, S; Molinaro, A; Singh, D; Gross, CP				Moore, Christopher L.; Bomann, Scott; Daniels, Brock; Luty, Seth; Molinaro, Annette; Singh, Dinesh; Gross, Cary P.			Derivation and validation of a clinical prediction rule for uncomplicated ureteral stone-the STONE score: retrospective and prospective observational cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE FLANK PAIN; UNENHANCED HELICAL CT; LOW-DOSE CT; COMPUTED-TOMOGRAPHY; REGIONAL-VARIATIONS; PULMONARY-EMBOLISM; EMERGENCY-MEDICINE; UNITED-STATES; CALCULI; UROLITHIASIS	Objective To derive and validate an objective clinical prediction rule for the presence of uncomplicated ureteral stones in patients eligible for computed tomography (CT). We hypothesized that patients with a high probability of ureteral stones would have a low probability of acutely important alternative findings. Design Retrospective observational derivation cohort; prospective observational validation cohort. Setting Urban tertiary care emergency department and suburban freestanding community emergency department. Participants Adults undergoing non-contrast CT for suspected uncomplicated kidney stone. The derivation cohort comprised a random selection of patients undergoing CT between April 2005 and November 2010 (1040 patients); the validation cohort included consecutive prospectively enrolled patients from May 2011 to January 2013 (491 patients). Main outcome measures In the derivation phase a priori factors potentially related to symptomatic ureteral stone were derived from the medical record blinded to the dictated CT report, which was separately categorized by diagnosis. Multivariate logistic regression was used to determine the top five factors associated with ureteral stone and these were assigned integer points to create a scoring system that was stratified into low, moderate, and high probability of ureteral stone. In the prospective phase this score was observationally derived blinded to CT results and compared with the prevalence of ureteral stone and important alternative causes of symptoms. Results The derivation sample included 1040 records, with five factors found to be most predictive of ureteral stone: male sex, short duration of pain, non-black race, presence of nausea or vomiting, and microscopic hematuria, yielding a score of 0-13 (the STONE score). Prospective validation was performed on 491 participants. In the derivation and validation cohorts ureteral stone was present in, respectively, 8.3% and 9.2% of the low probability (score 0-5) group, 51.6% and 51.3% of the moderate probability (score 6-9) group, and 89.6% and 88.6% of the high probability (score 10-13) group. In the high score group, acutely important alternative findings were present in 0.3% of the derivation cohort and 1.6% of the validation cohort. Conclusions The STONE score reliably predicts the presence of uncomplicated ureteral stone and lower likelihood of acutely important alternative findings. Incorporation in future investigations may help to limit exposure to radiation and over-utilization of imaging.	[Moore, Christopher L.; Bomann, Scott; Molinaro, Annette] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA; [Daniels, Brock] Wellington Hosp, Wellington, New Zealand; [Luty, Seth] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Singh, Dinesh] Univ Calif San Francisco, Sch Med, Dept Neurosurg, San Francisco, CA USA; [Singh, Dinesh] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Gross, Cary P.] Yale Univ, Sch Med, Dept Urol, New Haven, CT USA; [Gross, Cary P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Yale University	Moore, CL (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA.	chris.moore@yale.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018322] Funding Source: NIH RePORTER; AHRQ HHS [5R01HS018322-03] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Abramson S, 2000, AM J ROENTGENOL, V175, P1689, DOI 10.2214/ajr.175.6.1751689; [Anonymous], 2011, AM COLL RAD APPR CRI; [Anonymous], 2009, NY TIMES; Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; Brenner D. J., 2012, Annals of the ICRP, V41, P161, DOI 10.1016/j.icrp.2012.06.004; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; ELTON TJ, 1993, J GEN INTERN MED, V8, P57, DOI 10.1007/BF02599984; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Frei R, 2012, REN UROL NEWS 2012; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Gottlieb RH, 2002, RADIOLOGY, V225, P441, DOI 10.1148/radiol.2252020101; Hoppe H, 2006, J UROLOGY, V175, P1725, DOI 10.1016/S0022-5347(05)00987-0; Hyams ES, 2011, J UROLOGY, V186, P2270, DOI 10.1016/j.juro.2011.07.079; Katz SI, 2006, AM J ROENTGENOL, V186, P1120, DOI 10.2214/AJR.04.1838; Kim BS, 2005, ACTA RADIOL, V46, P756, DOI 10.1080/02841850500216004; Kline JA, 2010, ANN EMERG MED, V55, P327, DOI 10.1016/j.annemergmed.2010.01.005; Kluner C, 2006, J COMPUT ASSIST TOMO, V30, P44, DOI 10.1097/01.rct.0000191685.58838.ef; Lukasiewicz A, 2013, ACAD EMERG MED S, V20, pS54; Lukasiewicz A, 2014, RADIOLOGY, V271, P445, DOI 10.1148/radiol.14131601; Moore CL, 2013, ACAD EMERG MED, V20, P470, DOI 10.1111/acem.12127; Moore CL, 2012, J ULTRAS MED, V31, P1703; National Academies of Science, 2006, HLTH RISKS EXP LOW L; Niemann T, 2008, AM J ROENTGENOL, V191, P396, DOI 10.2214/AJR.07.3414; Papa Linda, 2005, CJEM, V7, P78; Park SJ, 2008, J ULTRAS MED, V27, P1441, DOI 10.7863/jum.2008.27.10.1441; Patlas M, 2001, BRIT J RADIOL, V74, P901, DOI 10.1259/bjr.74.886.740901; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; Poletti PA, 2007, AM J ROENTGENOL, V188, P927, DOI 10.2214/AJR.06.0793; Ripolles T, 2004, EUR RADIOL, V14, P129, DOI 10.1007/s00330-003-1924-6; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Smith RC, 1996, AM J ROENTGENOL, V166, P97, DOI 10.2214/ajr.166.1.8571915; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Studer UE, 2006, J UROLOGY, DOI [DOI 10.1016/S0022-5347(05)00987-0, 10.1016/S0022-5347(05)00987-0]; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Swensen SJ, 2012, AM J MED, V125, P115, DOI 10.1016/j.amjmed.2011.06.002; Teichman JMH, 2004, NEW ENGL J MED, V350, P684, DOI 10.1056/NEJMcp030813; Tiselius HG, 2001, EUR UROL, V40, P362, DOI 10.1159/000049803; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Westphalen AC, 2011, ACAD EMERG MED, V18, P700, DOI 10.1111/j.1553-2712.2011.01103.x	41	87	90	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2014	348								g2191	10.1136/bmj.g2191	http://dx.doi.org/10.1136/bmj.g2191			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LN	24671981	Green Published, hybrid			2022-12-28	WOS:000333586700002
J	Onnela, JPJP				Onnela, Jukka-Pekka JP			Flow of Control in Networks	SCIENCE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Onnela, JPJP (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	onnela@hsph.harvard.edu						Cowan NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038398; Fang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3655; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063	7	11	12	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1325	1326		10.1126/science.1251746	http://dx.doi.org/10.1126/science.1251746			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653028				2022-12-28	WOS:000333108500026
J	Kim, JS; Zee, DS				Kim, Ji-Soo; Zee, David S.			Benign Paroxysmal Positional Vertigo	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CLINICAL-TRIAL; SEMONT MANEUVER; SELF-TREATMENT; NYSTAGMUS; VARIANT; CANALOLITHIASIS; EFFICACY	A 58-year-old woman seeks care from her primary physician after the occurrence of sudden vertigo and imbalance with nausea and vomiting, which began that morning when she got out of bed. The vertigo lasted less than a minute but recurred when she lay back down in bed, rolled over in bed, or got up again. She reports no tinnitus or hearing loss. How should this patient be evaluated and treated?	[Kim, Ji-Soo] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Coll Med, Songnam, South Korea; [Zee, David S.] Johns Hopkins Univ Hosp, Dept Neurol, Sch Med, Baltimore, MD 21287 USA; [Zee, David S.] Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Sch Med, Baltimore, MD 21287 USA; [Zee, David S.] Johns Hopkins Univ Hosp, Dept Neurosci, Sch Med, Baltimore, MD 21287 USA; [Zee, David S.] Johns Hopkins Univ Hosp, Dept Ophthalmol, Sch Med, Baltimore, MD 21287 USA	Seoul National University (SNU); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zee, DS (corresponding author), Johns Hopkins Univ Hosp, Dept Neurol, 600 N Wolfe St, Baltimore, MD 21287 USA.	dzee@jhu.edu	Kim, Ji-Soo/D-8744-2012	Kim, Ji-Soo/0000-0002-1508-2024				Appiani GC, 2005, OTOL NEUROTOL, V26, P257, DOI 10.1097/00129492-200503000-00022; Asprella Libonati G, 2005, Acta Otorhinolaryngol Ital, V25, P277; Balatsouras DG, 2012, OTOLARYNG HEAD NECK, V146, P98, DOI 10.1177/0194599811425158; BALOH RW, 1993, NEUROLOGY, V43, P2542, DOI 10.1212/WNL.43.12.2542; BALOH RW, 1995, NEUROLOGY, V45, P1297, DOI 10.1212/WNL.45.7.1297; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Bertholon P, 2002, J NEUROL NEUROSUR PS, V72, P366, DOI 10.1136/jnnp.72.3.366; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Cambi J, 2013, J NEUROL, V260, P1489, DOI 10.1007/s00415-012-6815-9; Casani AP, 2002, LARYNGOSCOPE, V112, P172, DOI 10.1097/00005537-200201000-00030; Choung YH, 2006, LARYNGOSCOPE, V116, P1776, DOI 10.1097/01.mlg.0000231291.44818.be; Devaiah AK, 2010, OTOLARYNG HEAD NECK, V142, P155, DOI 10.1016/j.otohns.2009.09.013; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; Faldon ME, 2008, AUDIOL NEURO-OTOL, V13, P345, DOI 10.1159/000136153; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; Gordon CR, 2004, ACTA NEUROL SCAND, V110, P166, DOI 10.1111/j.1600-0404.2004.00296.x; Gufoni M, 1998, Acta Otorhinolaryngol Ital, V18, P363; Han BI, 2006, NEUROLOGY, V66, P706, DOI 10.1212/01.wnl.0000201184.69134.23; Helminski JO, 2010, PHYS THER, V90, P663, DOI 10.2522/ptj.20090071; Herdman SJ, 1996, ARCH OTOLARYNGOL, V122, P281; Hilton M, 2004, COCHRANE DB SYST REV, V2; Hunt WT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008675.pub2; Imai T, 2005, NEUROLOGY, V64, P920, DOI 10.1212/01.WNL.0000152890.00170.DA; Jeong SH, 2009, NEUROLOGY, V72, P1069, DOI 10.1212/01.wnl.0000345016.33983.e0; Jeong SH, 2013, J NEUROL, V260, P832, DOI 10.1007/s00415-012-6712-2; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Kerber KA, 2013, OTOLARYNG HEAD NECK, V148, P425, DOI 10.1177/0194599812471633; Kim JS, 2012, NEUROLOGY, V78, P159, DOI 10.1212/WNL.0b013e31823fcd26; Kim JS, 2012, NEUROLOGY, V79, P700, DOI 10.1212/WNL.0b013e3182648b8b; Korres S, 2011, OTOL NEUROTOL, V32, P1302, DOI 10.1097/MAO.0b013e31822f0bc5; Lee SH, 2007, J NEUROL SCI, V256, P75, DOI 10.1016/j.jns.2007.02.026; LEMPERT T, 1994, NEUROLOGY, V44, P2213, DOI 10.1212/WNL.44.11.2213-a; Lopez-Escamez JA, 2005, EUR ARCH OTO-RHINO-L, V262, P507, DOI 10.1007/s00405-004-0841-x; Mandala M, 2012, J NEUROL, V259, P882, DOI 10.1007/s00415-011-6272-x; MCCLURE JA, 1985, J OTOLARYNGOL, V14, P30; Nunez RA, 2000, OTOLARYNG HEAD NECK, V122, P647, DOI 10.1067/mhn.2000.105185; Nuti D, 1996, J VESTIBUL RES-EQUIL, V6, P173, DOI 10.1016/0957-4271(95)02040-3; Nuti D., 2013, OXFORD TXB VERTIGO I, P217; Nuti D, 2009, ANN NY ACAD SCI, V1164, P316, DOI 10.1111/j.1749-6632.2008.03720.x; Oh HJ, 2007, NEUROLOGY, V68, P1219, DOI 10.1212/01.wnl.0000259037.76469.e4; Oh SY, 2009, J NEUROL, V256, P1330, DOI 10.1007/s00415-009-5122-6; Radtke A, 2004, NEUROLOGY, V63, P150, DOI 10.1212/01.WNL.0000130250.62842.C9; Semont A, 1988, Adv Otorhinolaryngol, V42, P290; Soto-Varela A, 2011, OTOL NEUROTOL, V32, P1008, DOI 10.1097/MAO.0b013e3182267f02; Steddin S, 1996, ANN NEUROL, V40, P918; Tanimoto H, 2005, NEUROLOGY, V65, P1299, DOI 10.1212/01.wnl.0000180518.34672.3d; Vannucchi P, 1997, J VESTIBUL RES-EQUIL, V7, P1; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420	50	214	242	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1138	1147		10.1056/NEJMcp1309481	http://dx.doi.org/10.1056/NEJMcp1309481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645946				2022-12-28	WOS:000333054000010
J	Ramasamy, SK; Kusumbe, AP; Wang, L; Adams, RH				Ramasamy, Saravana K.; Kusumbe, Anjali P.; Wang, Lin; Adams, Ralf H.			Endothelial Notch activity promotes angiogenesis and osteogenesis in bone	NATURE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION; NOGGIN; VEGF; PROTOCOL; LIGANDS; CULTURE; JAGGED1; MARROW	Blood vessel growth in the skeletal system and osteogenesis seem to be coupled, suggesting the existence of molecular crosstalk between endothelial and osteoblastic cells(1,2). Understanding the nature of the mechanisms linking angiogenesis and bone formation should be of great relevance for improved fracture healing or prevention of bone mass loss. Here we show that vascular growth in bone involves a specialized, tissue-specific form of angiogenesis. Notch signalling promotes endothelial cell proliferation and vessel growth in postnatal long bone, which is the opposite of the well-established function of Notch and its ligand Dll4 in the endothelium of other organs and tumours(3,4). Endothelial-cell-specific and inducible genetic disruption of Notch signalling in mice not only impaired bone vessel morphology and growth, but also led to reduced osteogenesis, shortening of long bones, chondrocyte defects, loss of trabeculae and decreased bone mass. On the basis of a series of genetic experiments, we conclude that skeletal defects in these mutants involved defective angiocrine release of Noggin from endothelial cells, which is positively regulated by Notch. Administration of recombinant Noggin, a secreted antagonist of bone morphogenetic proteins, restored bone growth and mineralization, chondrocyte maturation, the formation of trabeculae and osteoprogenitor numbers in endothelial-cell-specific Notch pathway mutants. These findings establish a molecular framework coupling angiogenesis, angiocrine signals and osteogenesis, which may prove significant for the development of future therapeutic applications.	[Ramasamy, Saravana K.; Kusumbe, Anjali P.; Wang, Lin; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; University of Munster	Adams, RH (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	ralf.adams@mpi-muenster.mpg.de	Adams, Ralf H/AAE-9274-2019	Ramasamy, Saravana/0000-0003-2658-2945	Max Planck Society; University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council [AdG 339409 AngioBone]	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council(European Research Council (ERC)European Commission)	We thank A. Duarte, F. Radtke and T. Honjo for floxed Dll4 and Rbpj mutant mice, A. Borgscheiper for technical assistance, M. Stehling for endothelial cell sorting, D. Zeuschner for electron microscopy. Funding was provided by the Max Planck Society, the University of Munster, the DFG cluster of excellence 'Cells in Motion', and the European Research Council (AdG 339409 AngioBone).	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Canalis E, 2012, ENDOCRINOLOGY, V153, P1616, DOI 10.1210/en.2011-1604; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Izumi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041116; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kuhn A, 2002, J INVEST DERMATOL, V119, P1388, DOI 10.1046/j.1523-1747.2002.19647.x; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; SKAWINA A, 1994, J ANAT, V185, P369; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Suzuki H, 2005, ARCH HISTOL CYTOL, V68, P371, DOI 10.1679/aohc.68.371; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P97, DOI 10.1302/0301-620X.42B1.97; Tylzanowski P, 2006, DEV DYNAM, V235, P1599, DOI 10.1002/dvdy.20782; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	28	504	561	20	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					376	+		10.1038/nature13146	http://dx.doi.org/10.1038/nature13146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24647000	Green Accepted			2022-12-28	WOS:000333029000038
J	Righini, M; Van Es, J; Den Exter, PL; Roy, PM; Verschuren, F; Ghuysen, A; Rutschmann, OT; Sanchez, O; Jaffrelot, M; Trinh-Duc, A; Le Gall, C; Moustafa, F; Principe, A; Van Houten, AA; Ten Wolde, M; Douma, RA; Hazelaar, G; Erkens, PMG; Van Kralingen, KW; Grootenboers, MJJH; Durian, MF; Cheung, YW; Meyer, G; Bounameaux, H; Huisman, MV; Kamphuisen, PW; Le Gal, G				Righini, Marc; Van Es, Josien; Den Exter, Paul L.; Roy, Pierre-Marie; Verschuren, Franck; Ghuysen, Alexandre; Rutschmann, Olivier T.; Sanchez, Olivier; Jaffrelot, Morgan; Trinh-Duc, Albert; Le Gall, Catherine; Moustafa, Fares; Principe, Alessandra; Van Houten, Anja A.; Ten Wolde, Marije; Douma, Renee A.; Hazelaar, Germa; Erkens, Petra M. G.; Van Kralingen, Klaas W.; Grootenboers, Marco J. J. H.; Durian, Marc F.; Cheung, Y. Whitney; Meyer, Guy; Bounameaux, Henri; Huisman, Menno V.; Kamphuisen, Pieter W.; Le Gal, Gregoire			Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism The ADJUST-PE Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REVISED GENEVA SCORE; VENOUS THROMBOEMBOLISM; ELDERLY-PATIENTS; DIAGNOSTIC STRATEGIES; CLINICAL PROBABILITY; COMPUTED-TOMOGRAPHY; EXCLUSION; MANAGEMENT; THROMBOSIS; EMERGENCY	IMPORTANCE D-dimer measurement is an important step in the diagnostic strategy of clinically suspected acute pulmonary embolism (PE), but its clinical usefulness is limited in elderly patients. OBJECTIVE To prospectively validate whether an age-adjusted D-dimer cutoff, defined as age x 10 in patients 50 years or older, is associated with an increased diagnostic yield of D-dimer in elderly patients with suspected PE. DESIGN, SETTINGS, AND PATIENTS A multicenter, multinational, prospective management outcome study in 19 centers in Belgium, France, the Netherlands, and Switzerland between January 1, 2010, and February 28, 2013. INTERVENTIONS All consecutive outpatients who presented to the emergency department with clinically suspected PE were assessed by a sequential diagnostic strategy based on the clinical probability assessed using either the simplified, revised Geneva score or the 2-level Wells score for PE; highly sensitive D-dimer measurement; and computed tomography pulmonary angiography (CTPA). Patients with a D-dimer value between the conventional cutoff of 500 mu g/L and their age-adjusted cutoff did not undergo CTPA and were left untreated and formally followed-up for a 3-month period. MAIN OUTCOMES AND MEASURES The primary outcome was the failure rate of the diagnostic strategy, defined as adjudicated thromboembolic events during the 3-month follow-up period among patients not treated with anticoagulants on the basis of a negative age-adjusted D-dimer cutoff result. RESULTS Of the 3346 patients with suspected PE included, the prevalence of PE was 19%. Among the 2898 patients with a nonhigh or an unlikely clinical probability, 817 patients (28.2%) had a D-dimer level lower than 500 mu g/L (95% CI, 26.6%-29.9%) and 337 patients (11.6%) had a D-dimer between 500 mu g/L and their age-adjusted cutoff (95% CI, 10.5%-12.9%). The 3-month failure rate in patients with a D-dimer level higher than 500 mu g/L but below the age-adjusted cut-off was 1 of 331 patients (0.3% [95% CI, 0.1%-1.7%]). Among the 766 patients 75 years or older, of whom 673 had a nonhigh clinical probability, using the age-adjusted cutoff instead of the 500 mu g/L cutoff increased the proportion of patients in whom PE could be excluded on the basis of D-dimer from 43 of 673 patients (6.4% [95% CI, 4.8%-8.5%) to 200 of 673 patients (29.7% [95% CI, 26.4%-33.3%), without any additional false-negative findings. CONCLUSIONS AND RELEVANCE Compared with a fixed D-dimer cutoff of 500 mu g/L, the combination of pretest clinical probability assessment with age-adjusted D-dimer cutoff was associated with a larger number of patients in whom PE could be considered ruled out with a low likelihood of subsequent clinical venous thromboembolism.	[Righini, Marc; Bounameaux, Henri] Univ Hosp Geneva, Div Angiol & Hemostasis, CH-1211 Geneva, Switzerland; [Van Es, Josien; Douma, Renee A.] Amsterdam Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Den Exter, Paul L.; Huisman, Menno V.; Le Gal, Gregoire] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Roy, Pierre-Marie] Univ Nantes Angers Le Mans, CHU Angers, Emergency Dept, Angers, France; [Verschuren, Franck] Clin Univ St Luc, B-1200 Brussels, Belgium; [Ghuysen, Alexandre] Liege Univ Hosp, Liege, Belgium; [Rutschmann, Olivier T.] Univ Hosp Geneva, Emergency Dept, Geneva, Switzerland; [Sanchez, Olivier; Meyer, Guy] Hop Europeen Georges Pompidou, Paris, France; [Jaffrelot, Morgan] Brest Univ Hosp, Emergency Dept, Brest, France; [Trinh-Duc, Albert] Ctr Hosp Agen, Agen, France; [Le Gall, Catherine] Ctr Hosp Argenteuil, Argenteuil, France; [Moustafa, Fares] Ctr Hosp Univ Clermont Ferrand, Clermont Ferrand, France; [Principe, Alessandra] Ctr Hosp Morlaix, Morlaix, France; [Van Houten, Anja A.] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands; [Ten Wolde, Marije; Cheung, Y. Whitney] Flevoziekenhuis Hosp, Dept Internal Med, Almere, Netherlands; [Hazelaar, Germa] Rijnstate Hosp, Arnhem, Netherlands; [Erkens, Petra M. G.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Van Kralingen, Klaas W.] Van Weel Bethesda Hosp, Dirksland, Netherlands; [Grootenboers, Marco J. J. H.] Amphia Hosp, Breda, Netherlands; [Durian, Marc F.] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Kamphuisen, Pieter W.] Univ Groningen, Univ Med Ctr Groningen, Dept Vasc Med, NL-9713 AV Groningen, Netherlands; [Le Gal, Gregoire] Ottawa Hlth Res Inst, Ottawa, ON, Canada; Univ Brest, Ctr Invest Clin, Brest, France	University of Geneva; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Liege; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; CHU Clermont Ferrand; Maasstad Hospital; Rijnstate Hospital; Maastricht University; Amphia Hospital; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Ottawa; Ottawa Hospital Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale	Righini, M (corresponding author), Univ Hosp Geneva, Dept Med Specialties, Div Angiol & Hemostasis, Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	marc.righini@hcuge.ch	Roy, Pierre-Marie/AAA-7737-2022; Moustafa, Fares/Z-2829-2019; Righini, Marc/AAX-8731-2020	Kamphuisen, Pieter/0000-0002-6263-0177; SANCHEZ, Olivier/0000-0003-1633-8391; den Exter, Paul/0000-0002-1543-5731	Swiss National Research Foundation [32003B-130863]; International Society on Thrombosis and Haemostasis; Dutch Thrombosis Foundation [2010-5]; Projets Hospitaliers de Recherche Clinique, French Ministry of Health [PHRC 2011 08-01]; Direction de la Recherche Clinique et de l'Innovation, Brest University Hospital; Center of Clinical Research, Geneva University Hospital	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); International Society on Thrombosis and Haemostasis; Dutch Thrombosis Foundation; Projets Hospitaliers de Recherche Clinique, French Ministry of Health; Direction de la Recherche Clinique et de l'Innovation, Brest University Hospital; Center of Clinical Research, Geneva University Hospital	The study was supported by grant 32003B-130863 from the Swiss National Research Foundation, the 2007 presidential fund from the International Society on Thrombosis and Haemostasis, grant 2010-5 from the Dutch Thrombosis Foundation, and grant PHRC 2011 08-01 from the Projets Hospitaliers de Recherche Clinique, French Ministry of Health. In France, the study was sponsored by Direction de la Recherche Clinique et de l'Innovation, Brest University Hospital. Participating centers are members of the Groupe d'Investigation et de Recherche Clinique (GIRC) Thrombose. The study was also supported by the Center of Clinical Research, Geneva University Hospital.	Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; Dunn KL, 2002, J AM COLL CARDIOL, V40, P1475, DOI 10.1016/S0735-1097(02)02172-1; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Kriegel Irene, 2008, Ann Fr Anesth Reanim, V27, P521; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Moores LK, 2006, ARCH INTERN MED, V166, P147, DOI 10.1001/archinte.166.2.147; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Pernod G, 2009, J MAL VASCUL, V34, P156, DOI 10.1016/j.jmv.2009.02.005; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Righini M, 2000, AM J MED, V109, P357, DOI 10.1016/S0002-9343(00)00493-9; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Righini M, 2007, J THROMB HAEMOST, V5, P1869, DOI 10.1111/j.1538-7836.2007.02667.x; Righini M, 2005, J AM GERIATR SOC, V53, P1039, DOI 10.1111/j.1532-5415.2005.53309.x; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Salaun PY, 2005, INT J QUAL HEALTH C, V17, P433, DOI 10.1093/intqhc/mzi050; Schouten HJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2985; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Tardy B, 1998, THROMB HAEMOSTASIS, V79, P38, DOI 10.1055/s-0037-1614215; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	27	497	521	3	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1117	1124		10.1001/jama.2014.2135	http://dx.doi.org/10.1001/jama.2014.2135			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643601	Green Published, Bronze			2022-12-28	WOS:000333010100016
J	Kalkhoran, S; Glantz, SA				Kalkhoran, Sara; Glantz, Stanton A.			Smoke-free policies: cleaning the air with money to spare	LANCET			English	Editorial Material							ASTHMA; ASSOCIATION		[Glantz, Stanton A.] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Kalkhoran, Sara; Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu						Been JV, 2014, LANCET; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Centers for Disease Control and Prevention, 2011, VIT SIGNS ASTH US AT; Cheng KW, 2011, AM J PREV MED, V41, P566, DOI 10.1016/j.amepre.2011.08.014; Gilpin EA, 2006, NICOTINE TOB RES, V8, P661, DOI 10.1080/14622200600910801; Howrylak JA, 2014, PEDIATRICS, V133, pE355, DOI 10.1542/peds.2013-2422; Jin Y, 2013, PREV MED, V57, P125, DOI 10.1016/j.ypmed.2013.05.003; Lightwood J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047145; Nazar GP, 2014, PREV MED, V59, P47, DOI 10.1016/j.ypmed.2013.11.017; Nurmagambetov TA, 2011, AM J PREV MED, V41, pS33, DOI 10.1016/j.amepre.2011.05.011; Sargent JD, 2012, CLIN RES CARDIOL, V101, P227, DOI 10.1007/s00392-011-0385-1; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Zablocki RW, 2014, PREV MED, V59, P73, DOI 10.1016/j.ypmed.2013.11.018	13	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1526	1528		10.1016/S0140-6736(14)60224-5	http://dx.doi.org/10.1016/S0140-6736(14)60224-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG5YO	24680632				2022-12-28	WOS:000335495400006
J	Yealy, DM; Kellum, JA; Huang, DT; Barnato, AE; Weissfeld, LA; Pike, F; Terndrup, T; Wang, HE; Hou, PC; LoVecchio, F; Filbin, MR; Shapiro, NI; Angus, DC				Yealy, Donald M.; Kellum, John A.; Huang, David T.; Barnato, Amber E.; Weissfeld, Lisa A.; Pike, Francis; Terndrup, Thomas; Wang, Henry E.; Hou, Peter C.; LoVecchio, Frank; Filbin, Michael R.; Shapiro, Nathan I.; Angus, Derek C.		ProCESS Investigators	A Randomized Trial of Protocol-Based Care for Early Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GOAL-DIRECTED THERAPY; SEVERE SEPSIS	BackgroundIn a single-center study published more than a decade ago involving patients presenting to the emergency department with severe sepsis and septic shock, mortality was markedly lower among those who were treated according to a 6-hour protocol of early goal-directed therapy (EGDT), in which intravenous fluids, vasopressors, inotropes, and blood transfusions were adjusted to reach central hemodynamic targets, than among those receiving usual care. We conducted a trial to determine whether these findings were generalizable and whether all aspects of the protocol were necessary. MethodsIn 31 emergency departments in the United States, we randomly assigned patients with septic shock to one of three groups for 6 hours of resuscitation: protocol-based EGDT; protocol-based standard therapy that did not require the placement of a central venous catheter, administration of inotropes, or blood transfusions; or usual care. The primary end point was 60-day in-hospital mortality. We tested sequentially whether protocol-based care (EGDT and standard-therapy groups combined) was superior to usual care and whether protocol-based EGDT was superior to protocol-based standard therapy. Secondary outcomes included longer-term mortality and the need for organ support. ResultsWe enrolled 1341 patients, of whom 439 were randomly assigned to protocol-based EGDT, 446 to protocol-based standard therapy, and 456 to usual care. Resuscitation strategies differed significantly with respect to the monitoring of central venous pressure and oxygen and the use of intravenous fluids, vasopressors, inotropes, and blood transfusions. By 60 days, there were 92 deaths in the protocol-based EGDT group (21.0%), 81 in the protocol-based standard-therapy group (18.2%), and 86 in the usual-care group (18.9%) (relative risk with protocol-based therapy vs. usual care, 1.04; 95% confidence interval [CI], 0.82 to 1.31; P=0.83; relative risk with protocol-based EGDT vs. protocol-based standard therapy, 1.15; 95% CI, 0.88 to 1.51; P=0.31). There were no significant differences in 90-day mortality, 1-year mortality, or the need for organ support. ConclusionsIn a multicenter trial conducted in the tertiary care setting, protocol-based resuscitation of patients in whom septic shock was diagnosed in the emergency department did not improve outcomes. (Funded by the National Institute of General Medical Sciences; ProCESS ClinicalTrials.gov number, NCT00510835.)	[Yealy, Donald M.; Kellum, John A.; Huang, David T.; Barnato, Amber E.; Weissfeld, Lisa A.; Pike, Francis; Angus, Derek C.] Univ Pittsburgh, Pittsburgh, PA 15261 USA; [Terndrup, Thomas] Ohio State Univ, Columbus, OH 43210 USA; [Wang, Henry E.] Univ Alabama Birmingham, Birmingham, AL USA; [Hou, Peter C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [LoVecchio, Frank] Maricopa Cty Gen Hosp, Phoenix, AZ USA; [Filbin, Michael R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Maricopa County General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Angus, DC (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 3550 Terrace St,614 Scaife Hall, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Angus, Derek C/E-9671-2012; Kellum, John/AAP-3072-2020; McCurdy, Michael/T-5518-2019; Shapiro, Nathan/F-1718-2016; Kellum, John A/HCH-2944-2022; Conrad, Steven/F-3257-2015; Limkakeng, Alexander T./AAH-7733-2020; Wilson, Jason/C-8939-2017	Kellum, John/0000-0003-1995-2653; McCurdy, Michael/0000-0001-5319-0475; Kellum, John A/0000-0003-1995-2653; Conrad, Steven/0000-0002-4014-969X; Limkakeng, Alexander T./0000-0002-9822-5595; terndrup, thomas/0000-0003-4376-2593; Huang, David/0000-0001-7649-1633; Kulstad, Erik/0000-0002-9331-8266; Self, Wesley/0000-0002-9300-3045; NOIRI, Eisei/0000-0002-9515-7582; Chawla, Lakhmir/0000-0001-5987-8318; Bajwa, Ednan/0000-0001-9026-1009; Wilson, Jason/0000-0002-4291-5802	National Institute of General Medical Sciences, National Institutes of Health [P50 GM076659]; Thermo Fisher Scientific; Cumberland Pharmaceuticals; Rapid Pathogen Screening; Cheetah Medical; Astute Medical; MedImmune; Ferring Pharmaceuticals; Roche Diagnostics; Pfizer; Eli Lilly; Eisai; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076659] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Thermo Fisher Scientific; Cumberland Pharmaceuticals; Rapid Pathogen Screening; Cheetah Medical; Astute Medical; MedImmune(AstraZenecaMedimmune); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Roche Diagnostics; Pfizer(Pfizer); Eli Lilly(Eli Lilly); Eisai(Eisai Co Ltd); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a grant (P50 GM076659) from the National Institute of General Medical Sciences, National Institutes of Health.; Dr. Shapiro reports receiving consulting fees from Thermo Fisher Scientific, fees for serving on a data and safety monitoring board from Cumberland Pharmaceuticals, and grant support from Thermo Fisher Scientific, Rapid Pathogen Screening, Cheetah Medical, and Astute Medical. Dr. Angus reports receiving consulting fees from MedImmune, Ferring Pharmaceuticals, and Roche Diagnostics, lecture fees from Pfizer, fees for serving on a data and safety monitoring board from Eli Lilly, and grant support through his institution from Eisai. No other potential conflict of interest relevant to this article was reported.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2013, HDB CLIN INV COND TH; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carlbom DJ, 2007, CRIT CARE MED, V35, P2525, DOI 10.1097/01.ccm.0000298122.49245.d7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellinger RP, 2008, CRIT CARE MED, V36, P1394; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Huang DT, 2013, INTENS CARE MED, V39, P1760, DOI 10.1007/s00134-013-3024-7; Jones AE, 2007, ACAD EMERG MED, V14, P1072, DOI 10.1197/j.aem.2007.04.014; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Minneci PC, 2008, INTENS CARE MED, V34, P942, DOI 10.1007/s00134-008-0999-6; Pike F, 2013, CRIT CARE RESUSC, V15, P301; Reade MC, 2010, EMERG MED J, V27, P110, DOI 10.1136/emj.2008.070912; Reade MC, 2010, INTENS CARE MED, V36, P11, DOI 10.1007/s00134-009-1650-x; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2012, MINERVA ANESTESIOL, V78, P712; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1	20	1280	1405	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1683	1693		10.1056/NEJMoa1401602	http://dx.doi.org/10.1056/NEJMoa1401602			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24635773	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000335405200006
J	Miller, JA; Ding, SL; Sunkin, SM; Smith, KA; Ng, L; Szafer, A; Ebbert, A; Riley, ZL; Royall, JJ; Aiona, K; Arnold, JM; Bennet, C; Bertagnolli, D; Brouner, K; Butler, S; Caldejon, S; Carey, A; Cuhaciyan, C; Dalley, RA; Dee, N; Dolbeare, TA; Facer, BAC; Feng, D; Fliss, TP; Gee, G; Goldy, J; Gourley, L; Gregor, BW; Gu, GY; Howard, RE; Jochim, JM; Kuan, CL; Lau, C; Lee, CK; Lee, F; Lemon, TA; Lesnar, P; McMurray, B; Mastan, N; Mosqueda, N; Naluai-Cecchini, T; Ngo, NK; Nyhus, J; Oldre, A; Olson, E; Parente, J; Parker, PD; Parry, SE; Stevens, A; Pletikos, M; Reding, M; Roll, K; Sandman, D; Sarreal, M; Shapouri, S; Shapovalova, NV; Shen, EH; Sjoquist, N; Slaughterbeck, CR; Smith, M; Sodt, AJ; Williams, D; Zollei, L; Fischl, B; Gerstein, MB; Geschwind, DH; Glass, IA; Hawrylycz, MJ; Hevner, RF; Huang, H; Jones, AR; Knowles, JA; Levitt, P; Phillips, JW; Sestan, N; Wohnoutka, P; Dang, C; Bernard, A; Hohmann, JG; Lein, ES				Miller, Jeremy A.; Ding, Song-Lin; Sunkin, Susan M.; Smith, Kimberly A.; Ng, Lydia; Szafer, Aaron; Ebbert, Amanda; Riley, Zackery L.; Royall, Joshua J.; Aiona, Kaylynn; Arnold, James M.; Bennet, Crissa; Bertagnolli, Darren; Brouner, Krissy; Butler, Stephanie; Caldejon, Shiella; Carey, Anita; Cuhaciyan, Christine; Dalley, Rachel A.; Dee, Nick; Dolbeare, Tim A.; Facer, Benjamin A. C.; Feng, David; Fliss, Tim P.; Gee, Garrett; Goldy, Jeff; Gourley, Lindsey; Gregor, Benjamin W.; Gu, Guangyu; Howard, Robert E.; Jochim, Jayson M.; Kuan, Chihchau L.; Lau, Christopher; Lee, Chang-Kyu; Lee, Felix; Lemon, Tracy A.; Lesnar, Phil; McMurray, Bergen; Mastan, Naveed; Mosqueda, Nerick; Naluai-Cecchini, Theresa; Ngo, Nhan-Kiet; Nyhus, Julie; Oldre, Aaron; Olson, Eric; Parente, Jody; Parker, Patrick D.; Parry, Sheana E.; Stevens, Allison; Pletikos, Mihovil; Reding, Melissa; Roll, Kate; Sandman, David; Sarreal, Melaine; Shapouri, Sheila; Shapovalova, Nadiya V.; Shen, Elaine H.; Sjoquist, Nathan; Slaughterbeck, Clifford R.; Smith, Michael; Sodt, Andy J.; Williams, Derric; Zoellei, Lilla; Fischl, Bruce; Gerstein, Mark B.; Geschwind, Daniel H.; Glass, Ian A.; Hawrylycz, Michael J.; Hevner, Robert F.; Huang, Hao; Jones, Allan R.; Knowles, James A.; Levitt, Pat; Phillips, John W.; Sestan, Nenad; Wohnoutka, Paul; Dang, Chinh; Bernard, Amy; Hohmann, John G.; Lein, Ed S.			Transcriptional landscape of the prenatal human brain	NATURE			English	Article							OUTER SUBVENTRICULAR ZONE; RADIAL GLIAL-CELLS; CEREBRAL-CORTEX; GENE-EXPRESSION; MESSENGER-RNA; NEURONS; NETWORKS; SUBPLATE; CONNECTIONS; ASTROCYTES	The anatomical and functional architecture of the human brain is mainly determined by prenatal transcriptional processes. We describe an anatomically comprehensive atlas of the mid-gestational human brain, including de novo reference atlases, in situ hybridization, ultra-high-resolution magnetic resonance imaging(MRI) and microarray analysis on highly discrete laser-microdissected brain regions. In developing cerebral cortex, transcriptional differences are found between different proliferative and post-mitotic layers, wherein laminar signatures reflect cellular composition and developmental processes. Cytoarchitectural differences between human and mouse have molecular correlates, including species differences in gene expression in subplate, although surprisingly we find minimal differences between the inner and outer subventricular zones even though the outer zone is expanded in humans. Both germinal and post-mitotic cortical layers exhibit fronto-temporal gradients, with particular enrichment in the frontal lobe. Finally, many neurodevelopmental disorder and human-evolution-related genes show patterned expression, potentially underlying unique features of human cortical formation. These data provide a rich, freely-accessible resource for understanding human brain development.	[Miller, Jeremy A.; Ding, Song-Lin; Sunkin, Susan M.; Smith, Kimberly A.; Ng, Lydia; Szafer, Aaron; Ebbert, Amanda; Riley, Zackery L.; Royall, Joshua J.; Aiona, Kaylynn; Arnold, James M.; Bennet, Crissa; Bertagnolli, Darren; Brouner, Krissy; Butler, Stephanie; Caldejon, Shiella; Carey, Anita; Cuhaciyan, Christine; Dalley, Rachel A.; Dee, Nick; Dolbeare, Tim A.; Facer, Benjamin A. C.; Feng, David; Fliss, Tim P.; Gee, Garrett; Goldy, Jeff; Gourley, Lindsey; Gregor, Benjamin W.; Gu, Guangyu; Howard, Robert E.; Jochim, Jayson M.; Kuan, Chihchau L.; Lau, Christopher; Lee, Chang-Kyu; Lee, Felix; Lemon, Tracy A.; Lesnar, Phil; McMurray, Bergen; Mastan, Naveed; Mosqueda, Nerick; Ngo, Nhan-Kiet; Nyhus, Julie; Oldre, Aaron; Olson, Eric; Parente, Jody; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Roll, Kate; Sandman, David; Sarreal, Melaine; Shapouri, Sheila; Shapovalova, Nadiya V.; Shen, Elaine H.; Sjoquist, Nathan; Slaughterbeck, Clifford R.; Smith, Michael; Sodt, Andy J.; Williams, Derric; Hawrylycz, Michael J.; Jones, Allan R.; Phillips, John W.; Wohnoutka, Paul; Dang, Chinh; Bernard, Amy; Hohmann, John G.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Naluai-Cecchini, Theresa; Glass, Ian A.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Stevens, Allison; Zoellei, Lilla; Fischl, Bruce] Harvard Univ, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol,Med Sch, Charlestown, MA 02129 USA; [Stevens, Allison; Fischl, Bruce] MIT, Comp Sci & AI Lab, Cambridge, MA 02139 USA; [Pletikos, Mihovil; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Pletikos, Mihovil; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hevner, Robert F.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Hevner, Robert F.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98105 USA; [Huang, Hao] UT Southwestern Med Ctr, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Knowles, James A.] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Knowles, James A.] Univ So Calif, Dept Psychiat, Los Angeles, CA 90033 USA; [Levitt, Pat] Childrens Hosp, Dept Pediat, Los Angeles, CA 90027 USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	Allen Institute for Brain Science; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Yale University; Yale University; Yale University; Yale University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Lein, ES (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	edl@alleninstitute.org	Ding, Song-Lin/F-7963-2013	Zollei, Lilla/0000-0002-6447-9626; Lesnar, Phil/0000-0002-2152-604X; Parker, Patrick/0000-0001-5217-107X; Dee, Nick/0000-0002-2831-9254; Ding, Song-Lin/0000-0002-7072-5272; Arnold, James/0000-0001-7011-591X; Bernard, Amy/0000-0003-2540-1153; Feng, David/0000-0002-4920-8123; Sjoquist, Nathan/0000-0002-2037-6828	National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836]; National Institute of Mental Health [RC2MH089921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836, R00HD061485] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089921, R37MH060233, R01MH092535] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement and support. We express our gratitude to past and present Allen Institute staff members R. Adams, A. Alpisa, A. Boe, E. Byrnes, M. Chapin, J. Chen, C. Copeland, N. Dotson, K. Fotheringham, E. Fulfs, M. Gasparrini, T. Gilbert, Z. Haradon, N. Hejazinia, N. Ivanov, J. Kinnunen, A. Kriedberg, J. Laoenkue, S. Levine, V. Menon, E. Mott, N. Motz, J. Pendergraft, L. Potekhina, J. Redmayne-Titley, D. Rosen, C. Simpson, S. Shi, L. Velasquez, U. Wagley, N. Wong and B. Youngstrom for their technical assistance. We would also like to thank J. Augustinack, T. Benner, A. Mayaram, M. Roy, A. van der Kouwe and L. Wald from the Fischl laboratory. Also, we wish to acknowledge Covance Genomics Laboratory (Seattle, Washington) for microarray probe generation, hybridization and scanning. In addition, we express our gratitude to Advanced Bioscience Resources, for providing tissue used for expression profiling and reference atlas generation as well as to the Laboratory of Developmental Biology, University of Washington, for providing tissue used for expression profiling and reference atlas generation. The Laboratory of Developmental Biology work was supported by the National Institutes of Health (NIH) Award Number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The BrainSpan project was supported by Award Number RC2MH089921 (PIs: E. Lein and M. Hawrylycz, Allen Institute for Brain Science) from the National Institute of Mental Health. The content is solely the responsibility of the respective authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health.	ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Brun A., 1965, ACTA PATHOL MICROB S, V179, P3; Butler DM, 1998, J NEUROBIOL, V34, P135; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Dong H.W., 2008, ALLEN REFERENCE ATLA; Dubourg C, 2004, HUM MUTAT, V24, P43, DOI 10.1002/humu.20056; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Gaspard Nicolas, 2011, F1000 Biol Rep, V3, P6, DOI 10.3410/B3-6; Gerashchenko D, 2001, J NEUROSCI, V21, P7273, DOI 10.1523/JNEUROSCI.21-18-07273.2001; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hevner RF, 2005, ACTA NEUROPATHOL, V110, P208, DOI 10.1007/s00401-005-1059-8; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Mallamaci A, 2006, EUR J NEUROSCI, V23, P847, DOI 10.1111/j.1460-9568.2006.04634.x; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Montiel JF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00025; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Paxinos G, 2012, PAXINOS FRANKLINS MO; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2002, PROG BRAIN RES, V138, P3, DOI 10.1016/S0079-6123(02)38067-1; Saleem KS, 2012, COMBINED MRI HISTOLO; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Sorensen S. A., 2013, CEREB CORTEX; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Vogt Weisenhorn D. M., 1994, BRAIN RES DEV BRAIN, V82, P293; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang WZ, 2011, CEREB CORTEX, V21, P2187, DOI 10.1093/cercor/bhq278; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	64	720	729	8	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					199	+		10.1038/nature13185	http://dx.doi.org/10.1038/nature13185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695229	Green Submitted, Green Accepted			2022-12-28	WOS:000333979900036
J	Moresi, L; Betts, PG; Miller, MS; Cayley, RA				Moresi, L.; Betts, P. G.; Miller, M. S.; Cayley, R. A.			Dynamics of continental accretion	NATURE			English	Article							LACHLAN FOLD BELT; SOUTHEASTERN AUSTRALIA; CENOZOIC TECTONICS; EASTERN AUSTRALIA; NUMERICAL-MODELS; SUBDUCTION ZONES; EVOLUTION; MANTLE; ASIA; CONVERGENCE	Subduction zones become congested when they try to consume buoyant, exotic crust. The accretionary mountain belts (orogens) that format these convergent plate margins have been the principal sites of lateral continental growth through Earth's history. Modern examples of accretionary margins are the North American Cordilleras and southwest Pacific subduction zones. The geologic record contains abundant accretionary orogens, such as the Tasmanides(1), along the eastern margin of the supercontinent Gondwana, and the Altaides, which formed on the southern margin of Laurasia(2). In modern and ancient examples of long-lived accretionary orogens, the overriding plate is subjected to episodes of crustal extension and back-arc basin development, often related to subduction rollback(3) and transient episodes of orogenesis and crustal shortening(4-7), coincident with accretion of exotic crust. Here we present three-dimensional dynamic models that show how accretionary margins evolve from the initial collision, through a period of plate margin instability, to re-establishment of a stable convergent margin. The models illustrate how significant curvature of the orogenic system develops, as well as the mechanism for tectonic escape of the back-arc region. The complexity of the morphology and the evolution of the system are caused by lateral rollback of a tightly arcuate trench migrating parallel to the plate boundary and orthogonally to the convergence direction. We find geological and geophysical evidence for this process in the Tasmanides of eastern Australia, and infer that this is a recurrent and global phenomenon.	[Moresi, L.; Betts, P. G.] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; [Moresi, L.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Moresi, L.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Miller, M. S.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Cayley, R. A.] Geol Survey Victoria, Melbourne, Vic 3001, Australia	Monash University; Monash University; University of Melbourne; University of Southern California	Moresi, L (corresponding author), Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia.	louis.moresi@unimelb.edu.au	Moresi, Louis/H-1390-2011; Miller, Meghan S/A-2688-2011	Moresi, Louis/0000-0003-3685-174X; Miller, Meghan S/0000-0001-5494-2296; Betts, Peter/0000-0002-2088-7433	Australian Research Council [DP130101946, DP110101697]; Australian Commonwealth Government; Monash Research Accelerator Program; National Science Foundation [EAR-1054638]	Australian Research Council(Australian Research Council); Australian Commonwealth Government(Australian Government); Monash Research Accelerator Program; National Science Foundation(National Science Foundation (NSF))	L.M. acknowledges support from the Australian Research Council's Discovery Projects funding scheme (projects DP130101946 and DP110101697) and use of the NCI National Facility in Canberra, Australia, which is supported by the Australian Commonwealth Government. P. G. B. acknowledges the support of the Monash Research Accelerator Program. M. S. M. acknowledges the support of the National Science Foundation under grant no. EAR-1054638. R. C. publishes with the permission of the Director of the Geological Survey of Victoria. Underworld development was supported by AuScope, under the National Collaborative Research Infrastructure Strategy.	Baes M, 2011, GEOPHYS J INT, V184, P991, DOI 10.1111/j.1365-246X.2010.04896.x; Betts PG, 2012, GEOLOGY, V40, P739, DOI 10.1130/G32909.1; Capitanio FA, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002348; Cawood PA, 2005, EARTH-SCI REV, V69, P249, DOI 10.1016/j.earscirev.2004.09.001; Cawood PA, 2009, GEOL SOC SPEC PUBL, V318, P1, DOI 10.1144/SP318.1; Cayley RA, 2011, GONDWANA RES, V19, P628, DOI 10.1016/j.gr.2010.11.013; Cayley R. A., 2012, GREAT E AUSTR ARM WA, P34; Collins WJ, 2002, GEOLOGY, V30, P535, DOI 10.1130/0091-7613(2002)030<0535:HOTSAC>2.0.CO;2; CONEY PJ, 1980, NATURE, V288, P329, DOI 10.1038/288329a0; Dewey JF, 1986, GEOL SOC LOND SPEC P, V19, P1, DOI DOI 10.1144/GSL.SP.1986.019.01.01; ENGLAND P, 1989, J GEOPHYS RES-SOLID, V94, P17561, DOI 10.1029/JB094iB12p17561; Fergusson CL, 2010, AUST J EARTH SCI, V57, P627, DOI 10.1080/08120099.2010.494767; Giles D, 2002, GEOLOGY, V30, P823, DOI 10.1130/0091-7613(2002)030<0823:FFCBSF>2.0.CO;2; Glen RA, 2005, GEOL SOC SPEC PUBL, V246, P23, DOI 10.1144/GSL.SP.2005.246.01.02; Glen RA, 2013, AUST J EARTH SCI, V60, P371, DOI [10.1080/08120099.2013.782899, 10.1080/08120099.2013.772537]; Glen RA, 2009, TECTONOPHYSICS, V479, P130, DOI 10.1016/j.tecto.2009.03.023; Govers R, 2005, EARTH PLANET SC LETT, V236, P505, DOI 10.1016/j.epsl.2005.03.022; Gray DR, 1997, AM J SCI, V297, P859, DOI 10.2475/ajs.297.9.859; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Johnston ST, 2001, EARTH PLANET SC LETT, V193, P259, DOI 10.1016/S0012-821X(01)00516-7; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Kennett BLN, 2011, GEOPHYS J INT, V187, P946, DOI 10.1111/j.1365-246X.2011.05194.x; Lenardic A, 2003, PHYS FLUIDS, V15, P455, DOI 10.1063/1.1533755; Lister GS, 2001, GEOL SOC SPEC PUBL, V184, P89, DOI 10.1144/GSL.SP.2001.184.01.06; Mason WG, 2010, TECTONOPHYSICS, V483, P71, DOI 10.1016/j.tecto.2009.08.021; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; Moore DH, 2013, GONDWANA RES, V23, P1581, DOI 10.1016/j.gr.2012.08.006; Moresi L, 2007, PHYS EARTH PLANET IN, V163, P69, DOI 10.1016/j.pepi.2007.06.009; ROYDEN LH, 1993, TECTONICS, V12, P629, DOI 10.1029/92TC02641; Schellart WP, 2010, SCIENCE, V329, P316, DOI 10.1126/science.1190366; SENGOR AMC, 1993, NATURE, V364, P299, DOI 10.1038/364299a0; Stegman DR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001056; Velic M., 2008, J MATH MODEL ALGORIT, V8, P343; Wallace LM, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002220; Wilhem C, 2012, EARTH-SCI REV, V113, P303, DOI 10.1016/j.earscirev.2012.04.001	35	185	186	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					245	+		10.1038/nature13033	http://dx.doi.org/10.1038/nature13033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24670638				2022-12-28	WOS:000333979900044
J	Fauci, AS; Marovich, MA; Dieffenbach, CW; Hunter, E; Buchbinder, SP				Fauci, Anthony S.; Marovich, Mary A.; Dieffenbach, Carl W.; Hunter, Eric; Buchbinder, Susan P.			Immune Activation with HIV Vaccines	SCIENCE			English	Editorial Material							T-CELLS; EFFICACY TRIAL; DOUBLE-BLIND; STEP; ACQUISITION; AIDSVAX; ALVAC; RISK; TIME		[Fauci, Anthony S.; Marovich, Mary A.; Dieffenbach, Carl W.] NIAID, Bethesda, MD 20892 USA; [Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Med, San Francisco Dept Publ Hlth, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; San Francisco Department of Public Health; University of California System; University of California San Francisco	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov			NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096187, Z01AI000677, UM1AI068614, ZIAAI000390] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000390-25, Z01 AI000677-15] Funding Source: Medline; NCRR NIH HHS [P51 RR000165] Funding Source: Medline; NIAID NIH HHS [U19 AI096187, UM1 AI068614] Funding Source: Medline; NIH HHS [P51 OD011132] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer S, 2013, AIDS RES HUM RETROV, V29, pA172; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Heemskerk B, 2003, J VIROL, V77, P6562, DOI 10.1128/JVI.77.11.6562-6566.2003; Hoke CH, 2013, VACCINE, V31, P1623, DOI 10.1016/j.vaccine.2012.12.029; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; McElrath J., 2013, COLL AIDS VACC DISC; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; National Institute of Allergy and Infectious Diseases, 2013, MIN AD PLATF HIV VAC; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Williams WB, 2013, AIDS RES HUM RETROV, V29, pA9	19	58	60	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					49	51		10.1126/science.1250672	http://dx.doi.org/10.1126/science.1250672			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700849	Green Accepted			2022-12-28	WOS:000333746100046
J	Burns, JA				Burns, Joseph A.			SOLAR SYSTEM Ring in the new	NATURE			English	Editorial Material							URANUS		[Burns, Joseph A.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Burns, Joseph A.] Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Burns, JA (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	joseph.burns@cornell.edu						Belskaya IN, 2010, ICARUS, V210, P472, DOI 10.1016/j.icarus.2010.06.005; Braga-Ribas F, 2014, NATURE, V508, P72, DOI 10.1038/nature13155; Burns JA, 1999, SCIENCE, V284, P1146, DOI 10.1126/science.284.5417.1146; CANUP RM, 2000, ORIGIN EARTH MOON; Colwell JE, 2009, SATURN FROM CASSINI-HUYGENS, P375, DOI 10.1007/978-1-4020-9217-6_13; ELLIOT JL, 1977, NATURE, V267, P328, DOI 10.1038/267328a0; GOLDREICH P, 1979, NATURE, V277, P97, DOI 10.1038/277097a0; Guilbert A, 2009, ASTRON ASTROPHYS, V501, P777, DOI 10.1051/0004-6361/200911660; HUBBARD WB, 1986, NATURE, V319, P636, DOI 10.1038/319636a0; MILLIS RL, 1977, NATURE, V267, P330, DOI 10.1038/267330a0; Noll K. S., 2008, SOLAR SYSTEM NEPTUNE, P345; POLLACK JB, 1975, SPACE SCI REV, V18, P3, DOI 10.1007/BF00350197; Roques F., 1984, BAAS, V16, P1027; SMITH BA, 1989, SCIENCE, V246, P1422, DOI 10.1126/science.246.4936.1422; Tiscareno M., 2013, PLANETS STARS STELLA, V3, P309	15	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					48	49		10.1038/nature13218	http://dx.doi.org/10.1038/nature13218			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670646				2022-12-28	WOS:000333609900037
J	Ellison, AM				Ellison, Aaron M.			Political borders should not hamper wildlife	NATURE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Ellison, AM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	aellison@fas.harvard.edu		Ellison, Aaron/0000-0003-4151-6081					0	10	10	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					9	9		10.1038/508009a	http://dx.doi.org/10.1038/508009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695280	Bronze			2022-12-28	WOS:000333609900018
J	Erler, JT				Erler, Janine T.			CANCER Disabling defences in the brain	NATURE			English	Editorial Material							METASTASIS		Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, DK-2200 Copenhagen, Denmark	University of Copenhagen	Erler, JT (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, DK-2200 Copenhagen, Denmark.	janine.erler@bric.ku.dk		Erler, Janine/0000-0001-8675-6527				Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Erler JT, 2010, J PATHOL, V220, P290, DOI 10.1002/path.2646; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040	10	1	1	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					46	47		10.1038/508046a	http://dx.doi.org/10.1038/508046a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695307				2022-12-28	WOS:000333609900035
J	Fujiwara, T				Fujiwara, Takashi			I parodied a drug company's direct-to-consumer advertising on YouTube	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OSELTAMIVIR		Ehime Univ, Dept Otolaryngol Head & Neck Surg, Toon City, Ehime 7910295, Japan	Ehime University	Fujiwara, T (corresponding author), Ehime Univ, Dept Otolaryngol Head & Neck Surg, Toon City, Ehime 7910295, Japan.	t.fujiwarabi@gmail.com		Fujiwara, Takashi/0000-0002-6790-8713				[Anonymous], PER ADV; [Anonymous], COCHRANE DATABASE SY; [Anonymous], ANTIINFLUENZA SURROU; [Anonymous], UNFAITHFUL DRUG CO C; [Anonymous], PARODY SHIONOGIS INF; [Anonymous], LETS KNOW INFL VIR I; Ebell MH, 2013, FAM PRACT, V30, P125, DOI 10.1093/fampra/cms059; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Haynes RB, 2002, BMJ-BRIT MED J, V324, P1350, DOI 10.1136/bmj.324.7350.1350; Lavelle TA, 2012, J PEDIATR-US, V160, P67, DOI 10.1016/j.jpeds.2011.07.001	10	0	0	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g2484	10.1136/bmj.g2484	http://dx.doi.org/10.1136/bmj.g2484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696309				2022-12-28	WOS:000333977000010
J	McCartney, M				McCartney, Margaret			Fed up with forms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g2519	10.1136/bmj.g2519	http://dx.doi.org/10.1136/bmj.g2519			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696177				2022-12-28	WOS:000333977000013
J	Richardson, R				Richardson, Ruth			Preserving the name of Middlesex Hospital Chapel	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Richardson, R (corresponding author), The Lancet, London NW1 7BY, England.							English Heritage, RISK REG; Fitzrovia News, 2014, FITZROVIA NEWS  0304; George Saunders H. St., 1949, MIDDLESEX HOSP 1745	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1120	1121		10.1016/S0140-6736(14)60554-7	http://dx.doi.org/10.1016/S0140-6736(14)60554-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4MH	24693549				2022-12-28	WOS:000333956000016
J	Touraine, M				Touraine, Marisol			Health inequalities and France's national health strategy	LANCET			English	Editorial Material									Minist Social Affairs & Hlth, F-75007 Paris, France		Touraine, M (corresponding author), Minist Social Affairs & Hlth, F-75007 Paris, France.	marisol.touraine@sante.gouv.fr						CORDIER A., 2013, PROJET GLOBAL STRATE; COUR DES COMPTES, 2013, FIN PUBL RECH ENJ NA; Deloitte, 2012, ET SANT FRANC SANT; European Commission, 2013, HLTH IN EU FIN REP C; Lang T, 2010, INEGALITES SOCIALES; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Organisation for Economic Cooperation and Development, COUNTR STAT PROF KEY; WHO, 2000, WORLD HLTH REP HLTH	8	22	22	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1101	1102		10.1016/S0140-6736(14)60423-2	http://dx.doi.org/10.1016/S0140-6736(14)60423-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4MH	24679616				2022-12-28	WOS:000333956000005
J	Amunts, A; Brown, A; Bai, XC; Llacer, JL; Hussain, T; Emsley, P; Long, F; Murshudov, G; Scheres, SHW; Ramakrishnan, V				Amunts, Alexey; Brown, Alan; Bai, Xiao-chen; Llacer, Jose L.; Hussain, Tanweer; Emsley, Paul; Long, Fei; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.			Structure of the Yeast Mitochondrial Large Ribosomal Subunit	SCIENCE			English	Article							EM STRUCTURE DETERMINATION; CRYO-EM; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; EUKARYOTIC RIBOSOME; TRANSFER-RNA; TUNNEL EXIT; PROTEINS; EVOLUTION; PROTEOME	Mitochondria have specialized ribosomes that have diverged from their bacterial and cytoplasmic counterparts. We have solved the structure of the yeast mitoribosomal large subunit using single-particle cryo-electron microscopy. The resolution of 3.2 angstroms enabled a nearly complete atomic model to be built de novo and refined, including 39 proteins, 13 of which are unique to mitochondria, as well as expansion segments of mitoribosomal RNA. The structure reveals a new exit tunnel path and architecture, unique elements of the E site, and a putative membrane docking site.	[Amunts, Alexey; Brown, Alan; Bai, Xiao-chen; Llacer, Jose L.; Hussain, Tanweer; Emsley, Paul; Long, Fei; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Scheres, SHW (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	scheres@mrc-lmb.cam.ac.uk; ramak@mrc-lmb.cam.ac.uk	Llácer, José Luis/AAB-8711-2022; Brown, Alan/I-1473-2019; Bai, Xiao-chen/HGV-1244-2022; Llacer, José Luis/K-4299-2017; Amunts, A./AAZ-2279-2020; Scheres, Sjors H.W./AAY-2265-2021	Llácer, José Luis/0000-0001-5304-1795; Brown, Alan/0000-0002-0021-0476; Bai, Xiao-chen/0000-0002-4234-5686; Llacer, José Luis/0000-0001-5304-1795; Amunts, A./0000-0002-5302-1740; Scheres, Sjors H.W./0000-0002-0462-6540; Ramakrishnan, V/0000-0002-4699-2194; Hussain, Tanweer/0000-0003-4735-2380	UK Medical Research Council [MC_U105184332, MC_UP_A025_1013, MC_UP_A025_1012]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; Human Frontiers Science Program; EU; FEBS; EMBO; Medical Research Council [MC_UP_A025_1012, MC_UP_A025_1013, MC_U105184332] Funding Source: researchfish; MRC [MC_UP_A025_1013, MC_U105184332, MC_UP_A025_1012] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; Human Frontiers Science Program(Human Frontier Science Program); EU(European Commission); FEBS; EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Walker for co-initiating this project and his support in the early phase of the work; G. McMullan, X. Chen, and C. Savva for help with data collection; I. S. Fernandez and D. Tourigny for help with preliminary modeling; S. Peak-Chew and M. Skehel for mass spectrometry; J. Grimmett and T. Darling for help with computing; and R. Nicholls for help with ProSMART. Supported by UK Medical Research Council grants MC_U105184332 (V. R.), MC_UP_A025_1013 (S. H. W. S.), and MC_UP_A025_1012 (G. M.); a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V. R.); and fellowships from Human Frontiers Science Program (A. A.), EU FP7 Marie Curie (X.-C. B.), FEBS (J. L. L.), and EMBO (T. H.). Cryo-EM density maps have been deposited with the EMDB (accession no. EMD-2566) and coordinates have been deposited with the Protein Data Bank (entry code 3J6B).	Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; DENSLOW ND, 1978, EUR J BIOCHEM, V91, P441, DOI 10.1111/j.1432-1033.1978.tb12696.x; Dontsova Olga A, 2005, Int J Biomed Sci, V1, P1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; Jones CN, 2009, MITOCHONDRION, V9, P429, DOI 10.1016/j.mito.2009.08.001; Keil M, 2012, J BIOL CHEM, V287, P34484, DOI 10.1074/jbc.M112.382630; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; MALY P, 1983, NUCLEIC ACIDS RES, V11, P7263, DOI 10.1093/nar/11.21.7263; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Prestele M, 2009, MOL BIOL CELL, V20, P2615, DOI 10.1091/mbc.E08-12-1162; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	38	400	446	1	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1485	1489		10.1126/science.1249410	http://dx.doi.org/10.1126/science.1249410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675956	Green Accepted, Green Submitted			2022-12-28	WOS:000333471000040
J	King, MC				King, Mary-Claire			"The Race" to Clone BRCA1	SCIENCE			English	Editorial Material							POLYMERASE CHAIN-REACTION; HUMAN-BREAST-CANCER; OVARIAN-CANCER; GENE BRCA1; INHERITED MUTATIONS; HUMAN DNA; CHROMOSOME-17Q21; FAMILIES; LINKAGE; POLYMORPHISMS	The existence of BRCA1 was proven in 1990 by mapping predisposition to young-onset breast cancer in families to chromosome 17q21. Knowing that such a gene existed and approximately where it lay triggered efforts by public and private groups to clone and sequence it. The press baptized the competition "the race" and reported on it in detail for the next 4 years. BRCA1 was positionally cloned in September 1994. Twenty years later, I reflect on "the race" and its consequences for breast cancer prevention and treatment.	[King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	mcking@uw.edu		King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [R01CA157744, R35CA197458] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA157744, R35 CA197458] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON DE, 1972, J NATL CANCER I, V48, P1029; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; Broca P., 1866, TRAITE TUMERURS; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; COUCH FJ, 1995, GENOMICS, V25, P264, DOI 10.1016/0888-7543(95)80134-8; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Finch AP, 2014, J CLIN ONCOL; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; FRIEDMAN LS, 1995, GENOMICS, V25, P256, DOI 10.1016/0888-7543(95)80133-7; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Giblett ER., 1969, GENETIC MARKERS HUMA; GOLDGAR DE, 1993, AM J HUM GENET, V52, P743; Gorrini C., 2014, P NATL ACAD SCI US; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lane-Claypon J, 2016, REPORTS PUBLIC HLTH, V32; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OCONNOR M, 1989, SCIENCE, V244, P1307, DOI 10.1126/science.2660262; OTT J, 1985, ANAL HUMAN GENETIC L; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	36	54	57	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1462	1465		10.1126/science.1251900	http://dx.doi.org/10.1126/science.1251900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675952				2022-12-28	WOS:000333471000035
J	Martinez-Garcia, A; Sigman, DM; Ren, HJ; Anderson, RF; Straub, M; Hodell, DA; Jaccard, SL; Eglinton, TI; Haug, GH				Martinez-Garcia, Alfredo; Sigman, Daniel M.; Ren, Haojia; Anderson, Robert F.; Straub, Marietta; Hodell, David A.; Jaccard, Samuel L.; Eglinton, Timothy I.; Haug, Gerald H.			Iron Fertilization of the Subantarctic Ocean During the Last Ice Age	SCIENCE			English	Article							SOUTHERN-OCEAN; ATMOSPHERIC CO2; INTERGLACIAL CHANGES; NITRATE UTILIZATION; NITROGEN-FIXATION; SURFACE NITRATE; GLACIAL PERIOD; INDIAN SECTOR; CLIMATE; PRODUCTIVITY	John H. Martin, who discovered widespread iron limitation of ocean productivity, proposed that dust-borne iron fertilization of Southern Ocean phytoplankton caused the ice age reduction in atmospheric carbon dioxide (CO2). In a sediment core from the Subantarctic Atlantic, we measured foraminifera-bound nitrogen isotopes to reconstruct ice age nitrate consumption, burial fluxes of iron, and proxies for productivity. Peak glacial times and millennial cold events are characterized by increases in dust flux, productivity, and the degree of nitrate consumption; this combination is uniquely consistent with Subantarctic iron fertilization. The associated strengthening of the Southern Ocean's biological pump can explain the lowering of CO2 at the transition from mid-climate states to full ice age conditions as well as the millennial-scale CO2 oscillations.	[Martinez-Garcia, Alfredo; Straub, Marietta; Eglinton, Timothy I.; Haug, Gerald H.] ETH, Inst Geol, CH-8092 Zurich, Switzerland; [Sigman, Daniel M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ren, Haojia] Acad Sinica, Res Ctr Environm Changes, Taipei 11529, Taiwan; [Anderson, Robert F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Hodell, David A.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Jaccard, Samuel L.] Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland; [Jaccard, Samuel L.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; Academia Sinica - Taiwan; Columbia University; University of Cambridge; University of Bern; University of Bern	Martinez-Garcia, A (corresponding author), ETH, Inst Geol, CH-8092 Zurich, Switzerland.	alfredo.martinez-garcia@erdw.ethz.ch	Sigman, Daniel M/A-2649-2008; Martínez-García, Alfredo/A-6244-2010; Jaccard, Samuel/G-3447-2014	Sigman, Daniel M/0000-0002-7923-1973; Martínez-García, Alfredo/0000-0002-7206-5079; Jaccard, Samuel/0000-0002-5793-0896; Anderson, Robert/0000-0002-8472-2494; REN, HAO-JIA/0000-0002-1769-4243; Straub, Marietta/0000-0002-1156-4085; Hodell, David/0000-0001-8537-1588; Eglinton, Timothy/0000-0001-5060-2155	Swiss National Science Foundation [PZ00P2_142424, PP00P2_144811]; UK Natural Environment Research Council; NSF [OCE-1060947, OCE-0823507]; Princeton University; MacArthur Foundation; NERC [NE/H009930/1] Funding Source: UKRI; Natural Environment Research Council [NE/H009930/1] Funding Source: researchfish; Directorate For Geosciences [1060947] Funding Source: National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Princeton University(Princeton University); MacArthur Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by Swiss National Science Foundation Ambizione grant PZ00P2_142424 (A.M.-G.), Swiss National Science Foundation grant PP00P2_144811 (S.L.J.), the UK Natural Environment Research Council (D.A.H.), NSF grants OCE-1060947 (D.M.S.) and OCE-0823507 (R.F.A.), the Grand Challenges Program of Princeton University (D.M.S.), and the MacArthur Foundation (D.M.S.). This research used samples provided by the Integrated Ocean Drilling Program (IODP).	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Altabet MA, 1989, GLOBAL BIOGEOCHEM CY, V3, P107, DOI 10.1029/GB003i002p00107; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Bereiter B, 2012, P NATL ACAD SCI USA, V109, P9755, DOI 10.1073/pnas.1204069109; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; DEANGELIS M, 1987, NATURE, V325, P318, DOI 10.1038/325318a0; DESCOMBES HJ, 2008, PALEOCEANOGRAPHY, V0023; DiFiore PJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003216; DiFiore PJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044090; FRANCOIS R, 1993, PALEOCEANOGRAPHY, V8, P611, DOI 10.1029/93PA00784; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Francois R, 1992, PALEOCEANOGRAPHY, V7, P589, DOI 10.1029/92PA01573; Garcia H. E, 2010, WORLD OCEAN ATLAS 20; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; KNOX F, 1984, J GEOPHYS RES-ATMOS, V89, P4629, DOI 10.1029/JD089iD03p04629; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lambert F, 2012, CLIM PAST, V8, P609, DOI 10.5194/cp-8-609-2012; Lamy F, 2014, SCIENCE, V343, P403, DOI 10.1126/science.1245424; Lourey MJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001973; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; McCartney M. S., 1977, DEEP SEA RES S, P103; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Ren H, 2009, SCIENCE, V323, P244, DOI 10.1126/science.1165787; Ren HJ, 2012, LIMNOL OCEANOGR, V57, P1011, DOI 10.4319/lo.2012.57.4.1011; Robinson RS, 2008, QUATERNARY SCI REV, V27, P1076, DOI 10.1016/j.quascirev.2008.02.005; Robinson RS, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001114; Sachs JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000862; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; SIEGENTHALER U, 1984, NATURE, V308, P624, DOI 10.1038/308624a0; Straub M, 2013, NATURE, V501, P200, DOI 10.1038/nature12397; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561	44	274	282	7	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1347	1350		10.1126/science.1246848	http://dx.doi.org/10.1126/science.1246848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653031				2022-12-28	WOS:000333108500035
J	Vivante, A; Twig, G; Tirosh, A; Skorecki, K; Calderon-Margalit, R				Vivante, Asaf; Twig, Gilad; Tirosh, Amir; Skorecki, Karl; Calderon-Margalit, Ronit			Childhood History of Resolved Glomerular Disease and Risk of Hypertension During Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							NEPHROTIC SYNDROME; FOLLOW-UP; GLOMERULONEPHRITIS; ADOLESCENTS		[Vivante, Asaf; Twig, Gilad] IDF Med Corps, Talpiot Med Leadership Program, Tel Hashomer, Israel; [Tirosh, Amir] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, IL-32000 Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Res Inst, IL-32000 Haifa, Israel; [Calderon-Margalit, Ronit] Hadassah Hebrew Univ, Braun Sch Publ Hlth, Jerusalem, Israel	Harvard University; Brigham & Women's Hospital; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hadassah University Medical Center	Vivante, A (corresponding author), Chaim Sheba Med Ctr, IDF Med Corps, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel.	asafvivante@gmail.com	Twig, Gilad/C-4373-2018	Twig, Gilad/0000-0003-2829-3645; Tirosh, Amir/0000-0003-2210-5906				KOSKIMIES O, 1982, ARCH DIS CHILD, V57, P544, DOI 10.1136/adc.57.7.544; PERLMAN LV, 1965, J AMER MED ASSOC, V194, P63, DOI 10.1001/jama.194.1.63; POTTER EV, 1982, NEW ENGL J MED, V307, P725, DOI 10.1056/NEJM198209163071205; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; TROMPETER RS, 1985, LANCET, V1, P368; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85	6	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1155	1157		10.1001/jama.2013.284310	http://dx.doi.org/10.1001/jama.2013.284310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643607	Bronze			2022-12-28	WOS:000333010100022
J	Hawkes, N				Hawkes, Nigel			BRIEFING Rise of the federation: how GPs are meeting the challenge of competition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Darzi A., 2007, HEALTHCARE LONDON FR; NHS England, 121304 NHSE; NHS England, 2013, IMPR GEN PRACT CALL; RCGP King's Fund Nuffield Trust Hempsons, PRIM CAR FED TOOLK; Royal College of General Practitioners, 2007, FUT DIR GEN PRACT RO	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2014	348								g2155	10.1136/bmj.g2155	http://dx.doi.org/10.1136/bmj.g2155			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6YD	24637540				2022-12-28	WOS:000333406500003
J	Watts, G				Watts, Geoff			Nicholas Wald: epidemiologist with a radical prospectus	LANCET			English	Biographical-Item																		WALD N, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					945	945		10.1016/S0140-6736(14)60470-0	http://dx.doi.org/10.1016/S0140-6736(14)60470-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24629287				2022-12-28	WOS:000333520700013
J	Vincenz, L; Hart, FU				Vincenz, Lisa; Hart, F. Ulrich			Sugarcoating ER Stress	CELL			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; PATHWAY	The hexosamine biosynthetic pathway (HBP) generates metabolites for protein N-and O-glycosylation. Wang et al. and Denzel et al. report a hitherto unknown link between the HBP and stress in the endoplasmic reticulum. These studies establish the HBP as a critical component of the cellular machinery of protein homeostasis.	[Vincenz, Lisa; Hart, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hart, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019	Vincenz-Donnelly, Lisa/0000-0001-8825-7166				Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Llorente IL, 2013, J NEUROCHEM, V127, P701, DOI 10.1111/jnc.12337; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Palorini R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.257; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014	8	17	17	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1125	1127		10.1016/j.cell.2014.02.035	http://dx.doi.org/10.1016/j.cell.2014.02.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630714	Bronze			2022-12-28	WOS:000332945100002
J	Graham, SM; Sismanidis, C; Menzies, HJ; Marais, BJ; Detjen, AK; Black, RE				Graham, Stephen M.; Sismanidis, Charalambos; Menzies, Heather J.; Marais, Ben J.; Detjen, Anne K.; Black, Robert E.			Importance of tuberculosis control to address child survival	LANCET			English	Editorial Material							SEVERE PNEUMONIA; MORTALITY; MENINGITIS; AFRICA		[Graham, Stephen M.] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Graham, Stephen M.; Detjen, Anne K.] Int Union TB & Lung Dis, Paris, France; [Sismanidis, Charalambos] WHO, Global TB Programme, CH-1211 Geneva, Switzerland; [Menzies, Heather J.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Marais, Ben J.] Univ Sydney, Sydney Emerging Infect Dis & Biosecur Inst SEIB, Sydney Med Sch, Sydney, NSW 2006, Australia; [Marais, Ben J.] Univ Sydney, Childrens Hosp Westmead, Sydney Med Sch, Sydney, NSW 2006, Australia; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; World Health Organization; Centers for Disease Control & Prevention - USA; University of Sydney; University of Sydney; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Graham, SM (corresponding author), Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Flemington Rd, Parkville, Vic 3052, Australia.	steve.graham@rch.org.au	Marais, Ben/AAX-2626-2021	Graham, Stephen/0000-0003-3525-2294	World Health Organization [001] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline	World Health Organization(World Health Organization); Intramural CDC HHS		Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Chisti MJ, PLOS ONE IN PRESS; De Maayer T, 2011, ARCH DIS CHILD; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; Drobac PC, 2012, PEDIATRICS, V130, pE373, DOI 10.1542/peds.2011-3048; Gomes VF, 2011, THORAX, V66, P163, DOI 10.1136/thx.2010.141309; Li N, 2013, AIDS; LINCOLN EM, 1961, ARCH ENVIRON HEALTH, V3, P444, DOI 10.1080/00039896.1961.10663049; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marais BJ, 2013, LANCET INFECT DIS, V13, P287, DOI 10.1016/S1473-3099(13)70031-8; Mathad JS, 2012, CLIN INFECT DIS, V55, P1532, DOI 10.1093/cid/cis732; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Nantongo JM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-16; Schoeman JF, 2013, HAND CLINIC, V112, P1135, DOI 10.1016/B978-0-444-52910-7.00033-7; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2013, GLOB UPD HIV TREATM; Wolzak NK, 2012, J TROP PEDIATRICS, V58, P491, DOI 10.1093/tropej/fms031; World Health Organization, 2013, ROADM CHILDH TUB ZER, P39; World Health Organization, 2013, XPERT MTBRIF ASSAY D; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742	22	83	84	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1605	1607		10.1016/S0140-6736(14)60420-7	http://dx.doi.org/10.1016/S0140-6736(14)60420-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24671079	Green Accepted			2022-12-28	WOS:000335495400032
J	Tonelli, M; Riella, M				Tonelli, Marcello; Riella, Miguel			Chronic kidney disease and the ageing population	LANCET			English	Editorial Material							UNITED-STATES; DIALYSIS; OUTCOMES; TRANSPLANTATION; MANAGEMENT		[Tonelli, Marcello] Univ Alberta, Fac Med, Edmonton, AB T6G 2C3, Canada; [Riella, Miguel] Catholic Univ Parana, Fac Med, Curitiba, Parana, Brazil	University of Alberta; Pontificia Universidade Catolica do Parana	Tonelli, M (corresponding author), Univ Alberta, Fac Med, Edmonton, AB T6G 2C3, Canada.	sophie@worldkidneyday.org	Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187				Chandna SM, 2011, NEPHROL DIAL TRANSPL, V26, P1608, DOI 10.1093/ndt/gfq630; Gill J, 2008, AM J KIDNEY DIS, V52, P541, DOI 10.1053/j.ajkd.2008.05.017; Knoll GA, 2013, AM J KIDNEY DIS, V61, P790, DOI 10.1053/j.ajkd.2012.08.049; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Wiener JM, 2002, INT J EPIDEMIOL, V31, P776, DOI 10.1093/ije/31.4.776	9	20	20	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1278	1279		10.1016/S0140-6736(14)60155-0	http://dx.doi.org/10.1016/S0140-6736(14)60155-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LQ	24630776				2022-12-28	WOS:000334104900008
J	Kelley, KA				Kelley, Katherine A.			Inside Earth Runs Hot and Cold	SCIENCE			English	Editorial Material									Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Kelley, KA (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	kelley@gso.uri.edu	Kelley, Katherine A/J-3728-2013	Kelley, Katherine A/0000-0002-7516-2683				Asimow PD, 2003, NATURE, V421, P815, DOI 10.1038/nature01429; Dalton CA, 2014, SCIENCE, V344, P80, DOI 10.1126/science.1249466; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Karato S.-i, 2003, GEOPHYS MONOGR AM GE, V138, P135; Langmuir C.H., 1992, MANTLE FLOW MELT GEN, V71, P183, DOI DOI 10.1029/GM071P0183; Lehnert K, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000026; Niu YL, 2008, J PETROL, V49, P633, DOI 10.1093/petrology/egm051; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Stixrude L, 2012, ANNU REV EARTH PL SC, V40, P569, DOI 10.1146/annurev.earth.36.031207.124244	10	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					51	52		10.1126/science.1252089	http://dx.doi.org/10.1126/science.1252089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700850				2022-12-28	WOS:000333746100047
J	Krystal, JH; State, MW				Krystal, John H.; State, Matthew W.			Psychiatric Disorders: Diagnosis to Therapy	CELL			English	Review							DE-NOVO MUTATIONS; TRANSCRANIAL MAGNETIC STIMULATION; OBSESSIVE-COMPULSIVE DISORDER; RECEPTOR ANTAGONIST; BRAIN-STIMULATION; RESONANCE-SPECTROSCOPY; D-CYCLOSERINE; LARGE-SCALE; FOLLOW-UP; ANTIDEPRESSANT	Recent findings in a range of scientific disciplines are challenging the conventional wisdom regarding the etiology, classification, and treatment of psychiatric disorders. This Review focuses on the current state of the psychiatric diagnostic nosology and recent progress in three areas: genomics, neuroimaging, and therapeutics development. The accelerating pace of novel and unexpected findings is transforming the understanding of mental illness and represents a hopeful sign that the approaches and models that have sustained the field for the past 40 years are yielding to a flood of new data and presaging the emergence of a new and more powerful scientific paradigm.	[Krystal, John H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Krystal, John H.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Krystal, John H.] VA Connecticut Healthcare Syst, VA Natl Ctr PTSD, West Haven, CT 06516 USA; [State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [State, Matthew W.] Univ Calif San Francisco, Langley Porter Psychiat Inst, San Francisco, CA 94143 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krystal, JH (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA.	john.krystal@yale.edu; matthew.state@ucsf.edu	State, Matthew/W-2256-2019	State, Matthew/0000-0003-1624-8302	Department of Veterans Affairs; VA National Center for PTSD; Coalition to Alleviate PTSD; National Institute on Alcohol Abuse and Alcoholism [3P50AA012870]; National Institute of Mental Health (FAST-PS) [R01 MH092289-01A1, R01 MH081754, U01 MH100239]; National Center for Advancing Translational Science [UH2TR000960-01]; Clinical and Translational Science Award; UL1 RR024139; State of Connecticut Department of Mental Health and Addiction Services; Abraham Ribicoff Research Facilities of the Connecticut Mental Health Center; Simons Foundation Autism Research Initiative and the Overlook International Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000960] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH100239, R01MH092289, R01MH081754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA012870] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); VA National Center for PTSD; Coalition to Alleviate PTSD; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health (FAST-PS); National Center for Advancing Translational Science; Clinical and Translational Science Award; UL1 RR024139; State of Connecticut Department of Mental Health and Addiction Services; Abraham Ribicoff Research Facilities of the Connecticut Mental Health Center; Simons Foundation Autism Research Initiative and the Overlook International Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We gratefully acknowledge the Department of Veterans Affairs, the VA National Center for PTSD and its joint funding (with the Department of Defense) of the Coalition to Alleviate PTSD (to J.H.K.), the National Institute on Alcohol Abuse and Alcoholism (3P50AA012870 to J.H.K.), the National Institute of Mental Health (FAST-PS to J.H.K. and R01 MH092289-01A1, R01 MH081754, and U01 MH100239 to M. W. S.), the National Center for Advancing Translational Science (UH2TR000960-01; Clinical and Translational Science Award Grant No. UL1 RR024139 to J.H.K.), the State of Connecticut Department of Mental Health and Addiction Services for its support of the Abraham Ribicoff Research Facilities of the Connecticut Mental Health Center (to J.H.K.), and the Simons Foundation Autism Research Initiative and the Overlook International Fund (to M.W.S.). J.H.K. has served as a scientific consultant to the following companies with compensation in the past year of more than $5,000: Novartis Pharma AG, Janssen Research and Development LLC, AbbVie, Inc., Eli Lilly Corporation, and Naurex, Inc. He holds stock in Biohaven Medical Sciences. He also has the following patents and inventions: (1) dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia, patent no. 5447948, 5 September 1995; (2) a pending patent for glutamatergic treatments for neuropsychiatric disorders (PCTWO06108055A1); and (3) a pending patent for some applications of ketamine to the treatment of depression.	Aan Het Rot M, 2012, BIOL PSYCHIAT, V72, P537, DOI 10.1016/j.biopsych.2012.05.003; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; [Anonymous], 2003, 16 STATE STUDY MENTA; Anticevic A, 2013, CEREB CORTEX; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; BAER L, 1995, ARCH GEN PSYCHIAT, V52, P384; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Barsaglini A, 2014, PROG NEUROBIOL, V114, P1, DOI 10.1016/j.pneurobio.2013.10.006; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Brennand K.J., 2013, BIOL PSYCHIAT; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Cavus I, 1996, J NEUROPHYSIOL, V76, P3038, DOI 10.1152/jn.1996.76.5.3038; Cerletti U., 1940, RIV SPERIMENTALE FRE, V1, P209; Chowdhury GMI, 2012, BIOL PSYCHIAT, V71, P1022, DOI 10.1016/j.biopsych.2011.11.006; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; D'Astous M, 2013, J NEUROL NEUROSUR PS, V84, P1208, DOI 10.1136/jnnp-2012-303826; Drevets WC, 2013, BIOL PSYCHIAT, V73, P1156, DOI 10.1016/j.biopsych.2012.09.031; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fryer SL, 2013, BIOL PSYCHOL, V92, P282, DOI 10.1016/j.biopsycho.2012.10.004; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Goodman WK, 2010, BIOL PSYCHIAT, V67, P535, DOI 10.1016/j.biopsych.2009.11.028; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; HARVEY PD, 1993, SCHIZOPHRENIA BULL, V19, P723, DOI 10.1093/schbul/19.4.723; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; Hoffman RE, 2007, CEREB CORTEX, V17, P2733, DOI 10.1093/cercor/bhl183; Hoffman RE, 2005, BIOL PSYCHIAT, V58, P97, DOI 10.1016/j.biopsych.2005.03.041; Hoffman RE, 2002, AM J PSYCHIAT, V159, P1093, DOI 10.1176/appi.ajp.159.7.1093; Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456; Hyman Steven E, 2013, Cerebrum, V2013, P5; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Koike H, 2013, BEHAV BRAIN RES, V238, P48, DOI 10.1016/j.bbr.2012.10.023; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Krystal JH, 2013, BIOL PSYCHIAT, V73, P1133, DOI 10.1016/j.biopsych.2013.03.026; Krystal JH, 2009, DRUG DISCOV TODAY, V14, P690, DOI 10.1016/j.drudis.2009.05.002; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Laruelle M, 2005, CLIN THER, V27, pS16, DOI 10.1016/j.clinthera.2005.07.017; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindholm JSO, 2012, NEUROPHARMACOLOGY, V62, P391, DOI 10.1016/j.neuropharm.2011.08.015; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Logothetis NK, 2012, NEUROIMAGE, V62, P962, DOI 10.1016/j.neuroimage.2012.01.033; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Lujan JL, 2013, BRAIN STIMUL, V6, P737, DOI 10.1016/j.brs.2013.03.008; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malone Donald A Jr, 2010, Cleve Clin J Med, V77 Suppl 3, pS77, DOI 10.3949/ccjm.77.s3.14; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Moniz E, 1937, AM J PSYCHIAT, V93, P1379, DOI 10.1176/ajp.93.6.1379; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Potenza MN, 2012, AM J PSYCHIAT, V169, P406, DOI 10.1176/appi.ajp.2011.11020289; Prisciandaro JJ, 2013, DRUG ALCOHOL DEPEN, V132, P195, DOI 10.1016/j.drugalcdep.2013.02.009; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; ROBINS E, 1970, AM J PSYCHIAT, V126, P983, DOI 10.1176/ajp.126.7.983; Rowland LM, 2005, AM J PSYCHIAT, V162, P394, DOI 10.1176/appi.ajp.162.2.394; Sanacora G, 2000, CRIT REV NEUROBIOL, V14, P23, DOI 10.1615/CritRevNeurobiol.v14.i1.20; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Schnack HG, 2014, NEUROIMAGE, V84, P299, DOI 10.1016/j.neuroimage.2013.08.053; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Sjoerds Z, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.107; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; SNYDER SH, 1972, ARCH GEN PSYCHIAT, V27, P169; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stone JM, 2012, MOL PSYCHIATR, V17, P664, DOI 10.1038/mp.2011.171; SZASZ TS, 1960, AM PSYCHOL, V15, P113, DOI 10.1037/h0046535; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Uhlhaas PJ, 2013, CURR OPIN NEUROBIOL, V23, P283, DOI 10.1016/j.conb.2012.11.004; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Voleti B, 2013, BIOL PSYCHIAT, V74, P742, DOI 10.1016/j.biopsych.2013.04.025; Williams SCP, 2013, P NATL ACAD SCI USA, V110, P16287, DOI 10.1073/pnas.1317033110; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yoshimizu T, 2006, PSYCHOPHARMACOLOGY, V186, P587, DOI 10.1007/s00213-006-0390-7; Yu QB, 2012, CURR TOP MED CHEM, V12, P2415, DOI 10.2174/156802612805289890; Yuksel C, 2010, BIOL PSYCHIAT, V68, P785, DOI 10.1016/j.biopsych.2010.06.016	101	87	91	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					201	214		10.1016/j.cell.2014.02.042	http://dx.doi.org/10.1016/j.cell.2014.02.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679536	Green Accepted, Bronze			2022-12-28	WOS:000333968900017
J	Vourexakis, Z				Vourexakis, Zacharias			Tonsillar Asymmetry from a Parotid Tumor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 28-year-old woman presented with tonsillar asymmetry and a small, painless lump behind the left cheek that had been slowly enlarging over several months. Physical examination revealed displacement of the left tonsil and a firm, immobile mass in the retromandibular region. An otherwise healthy 28-year-old woman presented with tonsillar asymmetry, which she had just recently discovered, and a small painless lump behind the left cheek that had been slowly enlarging over several months. Physical examination revealed medial displacement of the left tonsil (Panel A, arrow) and confirmed the presence of a firm, immobile mass in the left retromandibular region. There was no cervical lymphadenopathy or facial-nerve abnormality. T-2-weighted magnetic resonance imaging (MRI) revealed a hyperintense tumor of the left parotid gland (Panel B, coronal view, arrows) measuring 6 cm by 4 cm by 5 cm, principally occupying the deep ...	Univ Hosp Geneva, Geneva, Switzerland	University of Geneva	Vourexakis, Z (corresponding author), Univ Hosp Geneva, Geneva, Switzerland.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					E20	E20		10.1056/NEJMicm1310638	http://dx.doi.org/10.1056/NEJMicm1310638			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670188				2022-12-28	WOS:000333426000001
J	Qi, QB; Chu, AY; Kang, JH; Huang, JY; Rose, LM; Jensen, MK; Liang, LM; Curhan, GC; Pasquale, LR; Wiggs, JL; De Vivo, I; Chan, AT; Choi, HK; Tamimi, RM; Ridker, PM; Hunter, DJ; Willett, WC; Rimm, EB; Chasman, DI; Hu, FB; Qi, L				Qi, Qibin; Chu, Audrey Y.; Kang, Jae H.; Huang, Jinyan; Rose, Lynda M.; Jensen, Majken K.; Liang, Liming; Curhan, Gary C.; Pasquale, Louis R.; Wiggs, Janey L.; De Vivo, Immaculata; Chan, Andrew T.; Choi, Hyon K.; Tamimi, Rulla M.; Ridker, Paul M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Chasman, Daniel I.; Hu, Frank B.; Qi, Lu			Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; REPRODUCIBILITY; VALIDITY; OBESITY; DISEASE; WOMEN; VARIANTS; QUALITY	Objective To examine the interactions between genetic predisposition and consumption of fried food in relation to body mass index (BMI) and obesity. Design Prospective cohort study. Setting Health professionals in the United States. Participants 9623 women from the Nurses' Health Study, 6379 men from the Health Professionals Follow-up Study, and a replication cohort of 21 421 women from the Women's Genome Health Study. Main outcome measure Repeated measurement of BMI over follow-up. Results There was an interaction between fried food consumption and a genetic risk score based on 32 BMI-associated variants on BMI in both the Nurses' Health Study and Health Professionals Follow-up Study (P <= 0.001 for interaction). Among participants in the highest third of the genetic risk score, the differences in BMI between individuals who consumed fried foods four or more times a week and those who consumed fried foods less than once a week amounted to 1.0 (SE 0.2) in women and 0.7 (SE 0.2) in men, whereas the corresponding differences were 0.5 (SE 0.2) and 0.4 (SE 0.2) in the lowest third of the genetic risk score. The gene-diet interaction was replicated in the Women's Genome Health Study (P<0.001 for interaction). Viewed differently, the genetic association with adiposity was strengthened with higher consumption of fried foods. In the combined three cohorts, the differences in BMI per 10 risk alleles were 1.1 (SE 0.2), 1.6 (SE 0.3), and 2.2 (SE 0.6) for fried food consumption less than once, one to three times, and four or more times a week (P<0.001 for interaction); and the odds ratios (95% confidence intervals) for obesity per 10 risk alleles were 1.61 (1.40 to 1.87), 2.12 (1.73 to 2.59), and 2.72 (2.12 to 3.48) across the three categories of consumption (P=0.002 for interaction). In addition, the variants in or near genes highly expressed or known to act in the central nervous system showed significant interactions with fried food consumption, with the FTO (fat mass and obesity associated) variant showing the strongest result (P<0.001 for interaction). Conclusion Our findings suggest that consumption of fried food could interact with genetic background in relation to obesity, highlighting the particular importance of reducing fried food consumption in individuals genetically predisposed to obesity.	[Qi, Qibin; Jensen, Majken K.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Harvard Univ, Dept Nutr, Sch Publ Hlth, Boston, MA 02115 USA; [Qi, Qibin] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Chu, Audrey Y.; Rose, Lynda M.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Chu, Audrey Y.; Kang, Jae H.; Rose, Lynda M.; Curhan, Gary C.; Pasquale, Louis R.; De Vivo, Immaculata; Chan, Andrew T.; Choi, Hyon K.; Tamimi, Rulla M.; Ridker, Paul M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Chasman, Daniel I.; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kang, Jae H.; Curhan, Gary C.; Pasquale, Louis R.; De Vivo, Immaculata; Chan, Andrew T.; Choi, Hyon K.; Tamimi, Rulla M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Huang, Jinyan; Liang, Liming; Curhan, Gary C.; De Vivo, Immaculata; Tamimi, Rulla M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02115 USA; [Pasquale, Louis R.; Wiggs, Janey L.] Harvard Univ, Dept Ophthalmol, Sch Med, Mass Eye & Ear Infirm, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Sect Rheumatol, Boston, MA 02118 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Dis, Boston, MA 02115 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Qi, L (corresponding author), Harvard Univ, Dept Nutr, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	nhlqi@channing.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; De Vivo, Immaculata/0000-0002-7185-7402; Jensen, Majken Karoline/0000-0003-4729-7545; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health [DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, P30DK46200, U01CA137088, U54CA155626, DK58845, DK098311, U01HG004728, EY015473, CA134958, DK70756, DK46200, HL043851, HL080467, CA047988]; Merck Research Laboratories, North Wales, PA; Amgen; American Heart Association Scientist Development Award [0730094N]; Arthur Ashley Williams Foundation; Harvard Ophthalmology Scholar Award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence; NATIONAL CANCER INSTITUTE [R01CA047988, U54CA155626, U01CA049449, R01CA134958, U01CA137088, R01CA049449, P01CA087969] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981, R01HL080467, R01HL043851, R01HL088521, R01HL034594, R01HL073168] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399, U01HG004728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, P01DK070756, K24DK098311, K24DK080140, R01DK091718, R01DK058845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories, North Wales, PA(Merck & Company); Amgen(Amgen); American Heart Association Scientist Development Award(American Heart Association); Arthur Ashley Williams Foundation; Harvard Ophthalmology Scholar Award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, P30DK46200, U01CA137088, U54CA155626, DK58845, DK098311, U01HG004728, EY015473, CA134958, DK70756 and DK46200 from the National Institutes of Health, with additional support for genotyping from Merck Research Laboratories, North Wales, PA. The Women's Genome Health Study is supported by HL043851, HL080467 and CA047988 from the National Institutes of Health, with collaborative scientific support and funding for genotyping provided by Amgen. LQ is a recipient of the American Heart Association Scientist Development Award (0730094N). LRP is supported by the Arthur Ashley Williams Foundation and a Harvard Ophthalmology Scholar Award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence. ATC is a Damon Runyon Cancer Foundation Clinical Investigator. The funding sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; [Anonymous], AGR INFORM B; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Corella D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052344; Corella D, 2011, J NUTR, V141, P2219, DOI 10.3945/jn.111.143826; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Dai Q, 2002, CANCER EPIDEM BIOMAR, V11, P801; Donfrancesco C, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-53; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fillion L, 1998, INT J FOOD SCI NUTR, V49, P157, DOI 10.3109/09637489809089395; Galeone C, 2005, BRIT J CANCER, V92, P2065, DOI 10.1038/sj.bjc.6602542; Greenfield JR, 2003, J CLIN ENDOCR METAB, V88, P5381, DOI 10.1210/jc.2003-030851; Guallar-Castillon P, 2007, AM J CLIN NUTR, V86, P198, DOI 10.1093/ajcn/86.1.198; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Pokorn Jan, 2003, Forum Nutr, V56, P348; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Sayon-Orea C, 2013, NUTR METAB CARDIOVAS, V23, P144, DOI 10.1016/j.numecd.2011.03.014; Silventoinen K, 2009, AM J CLIN NUTR, V90, P1096, DOI 10.3945/ajcn.2009.27689; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Soriguer F, 2003, AM J CLIN NUTR, V78, P1092, DOI 10.1093/ajcn/78.6.1092; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van Vliet-Ostaptchouk Jana V, 2012, Curr Nutr Rep, V1, P184; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Williams MJA, 1999, J AM COLL CARDIOL, V33, P1050, DOI 10.1016/S0735-1097(98)00681-0; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wosje KS, 2010, AM J CLIN NUTR, V92, P294, DOI 10.3945/ajcn.2009.28925; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	56	172	175	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1610	10.1136/bmj.g1610	http://dx.doi.org/10.1136/bmj.g1610			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24646652	Green Published, hybrid			2022-12-28	WOS:000333414500002
J	Weich, S; Pearce, HL; Croft, P; Singh, S; Crome, I; Bashford, J; Frisher, M				Weich, Scott; Pearce, Hannah Louise; Croft, Peter; Singh, Swaran; Crome, Ilana; Bashford, James; Frisher, Martin			Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TERM BENZODIAZEPINE USE; OLDER-PEOPLE; NONADHERENCE; METAANALYSIS; INSOMNIA; IMPACT; RISKS; BIAS	Objective To test the hypothesis that people taking anxiolytic and hypnotic drugs are at increased risk of premature mortality, using primary care prescription records and after adjusting for a wide range of potential confounders. Design Retrospective cohort study. Setting 273 UK primary care practices contributing data to the General Practice Research Database. Participants 34 727 patients aged 16 years and older first prescribed anxiolytic or hypnotic drugs, or both, between 1998 and 2001, and 69 418 patients with no prescriptions for such drugs (controls) matched by age, sex, and practice. Patients were followed-up for a mean of 7.6 years (range 0.1-13.4 years). Main outcome All cause mortality ascertained from practice records. Results Physical and psychiatric comorbidities and prescribing of non-study drugs were significantly more prevalent among those prescribed study drugs than among controls. The age adjusted hazard ratio for mortality during the whole follow-up period for use of any study drug in the first year after recruitment was 3.46 (95% confidence interval 3.34 to 3.59) and 3.32 (3.19 to 3.45) after adjusting for other potential confounders. Dose-response associations were found for all three classes of study drugs (benzodiazepines, Z drugs (zaleplon, zolpidem, and zopiclone), and other drugs). After excluding deaths in the first year, there were approximately four excess deaths linked to drug use per 100 people followed for an average of 7.6 years after their first prescription. Conclusions In this large cohort of patients attending UK primary care, anxiolytic and hypnotic drugs were associated with significantly increased risk of mortality over a seven year period, after adjusting for a range of potential confounders. As with all observational findings, however, these results are prone to bias arising from unmeasured and residual confounding.	[Weich, Scott; Singh, Swaran] Univ Warwick, Div Mental Hlth & Wellbeing, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Pearce, Hannah Louise; Bashford, James; Frisher, Martin] Keele Univ, Sch Pharm, Keele ST5 5BG, Staffs, England; [Croft, Peter] Keele Univ, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Crome, Ilana] South Staffordshire & Shropshire Healthcare NHS F, Acad Psychiat Unit, St Georges Hosp, Stafford, Staffs, England	University of Warwick; Keele University; Keele University; St Georges University London	Weich, S (corresponding author), Univ Warwick, Div Mental Hlth & Wellbeing, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	s.weich@warwick.ac.uk		Weich, Scott/0000-0002-7552-7697; Singh, Swaran/0000-0003-3454-2089	Medical Research Council Funding Source: Medline; National Institute for Health Research [NF-SI-0509-10183] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Belleville G, 2010, CAN J PSYCHIAT, V55, P558, DOI 10.1177/070674371005500904; Berry S. D., 2013, JAMA INTERN MED, V4, P1; Billioti de Gage S., 2012, BMJ-BRIT MED J, V27, P345; BMA and Royal Pharmaceutical Society of Great Britain, 2012, BRIT NATL FORMULARY; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Gisev N, 2011, CAN J PSYCHIAT, V56, P377, DOI 10.1177/070674371105600609; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Hartz A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001413; Hausken AM, 2007, PHARMACOEPIDEM DR S, V16, P913, DOI 10.1002/pds.1417; Huedo-Medina TB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8343; Kao CH, 2012, J CLIN PSYCHIAT, V73, P1264, DOI [10.4088/JCP.11m07333, 10.4088/JCP.12lr07984a]; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kripke DF, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-42; Kripke DF, 2008, J SLEEP RES, V17, P245, DOI 10.1111/j.1365-2869.2008.00685.x; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kripke DF, 1998, BIOL PSYCHIAT, V43, P687, DOI 10.1016/S0006-3223(97)00292-8; Kripke DF, 2000, SLEEP MED REV, V4, P5, DOI 10.1053/smrv.1999.0076; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Mallon L, 2009, SLEEP MED, V10, P279, DOI 10.1016/j.sleep.2008.12.004; Neutel C. Ineke, 1995, Annals of Epidemiology, V5, P239; NHS Prescription Services, 2012, CENTR NERV SYST NAT; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; Royal College of General Practitioners and Royal College of Psychiatrists, 2013, ADD MED CONS STAT 20; SAVITZ DA, 1989, AM J EPIDEMIOL, V129, P1062, DOI 10.1093/oxfordjournals.aje.a115210; Solomon MD, 2010, J GEN INTERN MED, V25, P280, DOI 10.1007/s11606-010-1286-0; Tiihonen J, 2012, ARCH GEN PSYCHIAT, V69, P476, DOI 10.1001/archgenpsychiatry.2011.1532; Tsimtsiou Z, 2009, BRIT J GEN PRACT, V59, P409, DOI 10.3399/bjgp09X420923; Vinkers DJ, 2003, JAMA-J AM MED ASSOC, V290, P2942, DOI 10.1001/jama.290.22.2942; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca	37	123	124	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1996	10.1136/bmj.g1996	http://dx.doi.org/10.1136/bmj.g1996			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647164	Green Published, hybrid			2022-12-28	WOS:000333414500008
J	Dunn, A				Dunn, Andrew			In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic range	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Hlth Syst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Mt Sinai Hlth Syst, New York, NY 10029 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC10	10.7326/0003-4819-160-6-201403180-02010	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638176				2022-12-28	WOS:000333521300009
J	Muller, D; Cherukuri, P; Henningfeld, K; Poh, CH; Wittler, L; Grote, P; Schluter, O; Schmidt, J; Laborda, J; Bauer, SR; Brownstone, RM; Marquardt, T				Mueller, Daniel; Cherukuri, Pitchaiah; Henningfeld, Kristine; Poh, Chor Hoon; Wittler, Lars; Grote, Phillip; Schlueter, Oliver; Schmidt, Jennifer; Laborda, Jorge; Bauer, Steven R.; Brownstone, Robert M.; Marquardt, Till			Dlk1 Promotes a Fast Motor Neuron Biophysical Signature Required for Peak Force Execution	SCIENCE			English	Article							MUSCLE; UNITS; INNERVATION; CHANNEL; PROTEIN; CELLS; SIZE	Motor neurons, which relay neural commands to drive skeletal muscle movements, encompass types ranging from "slow" to "fast," whose biophysical properties govern the timing, gradation, and amplitude of muscle force. Here we identify the noncanonical Notch ligand Delta-like homolog 1 (Dlk1) as a determinant of motor neuron functional diversification. Dlk1, expressed by similar to 30% of motor neurons, is necessary and sufficient to promote a fast biophysical signature in the mouse and chick. Dlk1 suppresses Notch signaling and activates expression of the K+ channel subunit Kcng4 to modulate delayed-rectifier currents. Dlk1 inactivation comprehensively shifts motor neurons toward slow biophysical and transcriptome signatures, while abolishing peak force outputs. Our findings provide insights into the development of motor neuron functional diversity and its contribution to the execution of movements.	[Mueller, Daniel; Cherukuri, Pitchaiah; Poh, Chor Hoon; Marquardt, Till] European Neurosci Inst ENI G, Dev Neurobiol Lab, D-37077 Gottingen, Germany; [Henningfeld, Kristine] Univ Med Ctr Gottingen, Inst Dev Biochem, D-37077 Gottingen, Germany; [Henningfeld, Kristine; Marquardt, Till] Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany; [Wittler, Lars; Grote, Phillip] Max Planck Inst Mol Genet, Dept Dev Genet, D-14195 Berlin, Germany; [Schlueter, Oliver] ENI G, Mol Neurobiol Lab, D-37077 Gottingen, Germany; [Schmidt, Jennifer] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Laborda, Jorge] Univ Castilla La Mancha, Sch Med, Dept Inorgan & Organ Chem & Biochem, Albacete 02006, Spain; [Bauer, Steven R.] USDA, Cellular & Tissue Therapies Branch, Div Cellular & Gene Therapies, Ctr Biol & Res, Bethesda, MD 20892 USA; [Brownstone, Robert M.] Dalhousie Univ, QEII Hlth Sci Ctr, Dept Surg, Halifax, NS B3H 4R2, Canada; [Brownstone, Robert M.] Dalhousie Univ, QEII Hlth Sci Ctr, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada	University of Gottingen; Max Planck Society; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidad de Castilla-La Mancha; United States Department of Agriculture (USDA); Dalhousie University; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Marquardt, T (corresponding author), European Neurosci Inst ENI G, Dev Neurobiol Lab, Grisebachstr 5, D-37077 Gottingen, Germany.	t.marquardt@eni-g.de	Laborda, Jorge/L-5726-2014; Grote, Phillip/AAG-9188-2020	Laborda, Jorge/0000-0002-9210-838X; Grote, Phillip/0000-0002-9254-1458; Brownstone, Robert/0000-0001-5135-2725	European Research Council under the European Union [311710 MU TUNING]; Emmy-Noether Program of the Deutsche Forschungsgemeinschaft [MA4278/1-1]; Center for Biologics Evaluation and Research, Food and Drug Administration; Emmy-Noether Program [SCHL592-4]; Canadian Institutes of Health Research; Canada Research Chairs Program; Canada Foundation for Innovation; Nova Scotia Research and Innovation Trust; Ministerio de Educacion y Ciencia, Spain; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042013] Funding Source: NIH RePORTER	European Research Council under the European Union(European Research Council (ERC)); Emmy-Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biologics Evaluation and Research, Food and Drug Administration; Emmy-Noether Program(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Nova Scotia Research and Innovation Trust; Ministerio de Educacion y Ciencia, Spain(Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Klusowski, B. Veith, T. V. Bui, and T. G. Hampton for technical support; S. Schiaffino and K. Kawakami for reagents; P. D'Adamo for phenotyping service; and O. Shomroni and S. Bonn for bioinformatics advice. This research received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement 311710 MU TUNING and the Emmy-Noether Program of the Deutsche Forschungsgemeinschaft (MA4278/1-1). S.R.B. was supported by the Center for Biologics Evaluation and Research, Food and Drug Administration, operating funds; O.S. by the Emmy-Noether Program (SCHL592-4); R.M.B. by the Canadian Institutes of Health Research, Canada Research Chairs Program, Canada Foundation for Innovation, and Nova Scotia Research and Innovation Trust; and J.L. by the Ministerio de Educacion y Ciencia, Spain, from whom Dlk1<SUP>ko</SUP> mice are available through a materials transfer agreement. Dlk1<SUP>fx</SUP> mice are deposited at jaxmice.jax.org (no. 019074). Notch1:Gal4 is available Iron R. Kopan (Cincinnati Children's Hospital Medical Center). ENI-G is a cooperation of University Medical Center Gottingen and the Max-Planck Society.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; BAKELS R, 1993, J PHYSIOL-LONDON, V463, P307, DOI 10.1113/jphysiol.1993.sp019596; BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; ECCLES JC, 1957, NATURE, V179, P866, DOI 10.1038/179866b0; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; FLADBY T, 1990, DEVELOPMENT, V109, P723; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; GUSTAFSSON B, 1985, TRENDS NEUROSCI, V8, P431, DOI 10.1016/0166-2236(85)90152-3; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; KERNELL D, 1966, SCIENCE, V152, P1637, DOI 10.1126/science.152.3729.1637; Kernell D, 2006, MOTONEURON ITS MUSCL; Manuel M, 2011, J NEUROSCI, V31, P15188, DOI 10.1523/JNEUROSCI.2893-11.2011; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Rafuse VF, 1996, J NEUROSCI, V16, P6864; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; THOMPSON WJ, 1984, NATURE, V309, P709, DOI 10.1038/309709a0; Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089; ZENGEL JE, 1985, J NEUROPHYSIOL, V53, P1323, DOI 10.1152/jn.1985.53.5.1323	25	44	45	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1264	1266		10.1126/science.1246448	http://dx.doi.org/10.1126/science.1246448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626931	Green Submitted, Green Published			2022-12-28	WOS:000332728500040
J	Cacoub, PP				Cacoub, Patrice P.			Colchicine for treatment of acute or recurrent pericarditis	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; THERAPY; DISEASE		[Cacoub, Patrice P.] Univ Paris 06, Dept Hosp Univ I2B, UMR 7211, F-75005 Paris, France; [Cacoub, Patrice P.] INSERM, UMR S 959, Paris, France; [Cacoub, Patrice P.] CNRS, UMR 7211, Paris, France; [Cacoub, Patrice P.] Grp Hosp Pitie Salpetriere, AP HP, Dept Internal Med, F-75634 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Cacoub, PP (corresponding author), Univ Paris 06, Dept Hosp Univ I2B, UMR 7211, F-75005 Paris, France.	patrice.cacoub@psl.aphp.fr		Cacoub, Patrice/0000-0002-6727-4992				Brucato A, 2006, AM J CARDIOL, V98, P267, DOI 10.1016/j.amjcard.2006.01.086; Cacoub P, 2000, ARCH MAL COEUR VAISS, V93, P1511; Geri G, 2012, MEDICINE, V91, P25, DOI 10.1097/MD.0b013e3182428f49; Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738; Imazio M, 2005, ARCH INTERN MED, V165, P1987, DOI 10.1001/archinte.165.17.1987; Imazio M, 2014, LANCET; Imazio M, 2007, CIRCULATION, V115, P2739, DOI 10.1161/CIRCULATIONAHA.106.662114; Imazio M, 2013, NEW ENGL J MED, V369, P1522, DOI 10.1056/NEJMoa1208536; Imazio M, 2011, ANN INTERN MED, V155, P409, DOI 10.7326/0003-4819-155-7-201110040-00359; Imazio M, 2011, CIRCULATION, V124, P1270, DOI 10.1161/CIRCULATIONAHA.111.018580; Maestroni S, 2012, AUTOIMMUN REV, V12, P60, DOI 10.1016/j.autrev.2012.07.023; Picco P, 2009, ARTHRITIS RHEUM-US, V60, P264, DOI 10.1002/art.24174	12	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2193	2194		10.1016/S0140-6736(14)60113-6	http://dx.doi.org/10.1016/S0140-6736(14)60113-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24694984				2022-12-28	WOS:000338657600007
J	Palace, J; Robertson, N				Palace, Jacqueline; Robertson, Neil			Modifying disability in progressive multiple sclerosis	LANCET			English	Editorial Material							BRAIN ATROPHY; RELAPSES		[Palace, Jacqueline] John Radcliffe Hosp, Dept Neurol, Oxford OX3 9DU, England; [Robertson, Neil] Cardiff Univ, Univ Wales Hosp, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales	University of Oxford; Cardiff University	Palace, J (corresponding author), John Radcliffe Hosp, Dept Neurol, Oxford OX3 9DU, England.	jacqueline.palace@ndcn.ox.ac.uk			Medical Research Council [MR/L010305/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Chataway J, 2014, LANCET; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Hirst C, 2008, J NEUROL NEUROSUR PS, V79, P1137, DOI 10.1136/jnnp.2007.133785; Mackenzie IS, 2013, J NEUROL NEUROSUR PS, V84, DOI 10.1136/jnnp-2013-306573.27; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Pickin M, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-1; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Sormani MP, 2014, ANN NEUROL, V75, P43, DOI 10.1002/ana.24018; Sormani MP, 2013, 29 EUR COMM TREATM R, P1080; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; Vukusic S, 2003, J NEUROL SCI, V206, P135, DOI 10.1016/S0022-510X(02)00426-4; Zajicek J, 2013, LANCET NEUROL, V12, P857, DOI 10.1016/S1474-4422(13)70159-5; Zivadinov R, 2001, NEUROLOGY, V57, P1239, DOI 10.1212/WNL.57.7.1239	15	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2189	2191		10.1016/S0140-6736(13)62641-0	http://dx.doi.org/10.1016/S0140-6736(13)62641-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24655728	hybrid			2022-12-28	WOS:000338657600005
J	Bhandari, N; Rongsen-Chandola, T; Bavdekar, A; John, J; Antony, K; Taneja, S; Goyal, N; Kawade, A; Kang, G; Rathore, SS; Juvekar, S; Muliyil, J; Arya, A; Shaikh, H; Abraham, V; Vrati, S; Proschan, M; Kohberger, R; Thiry, G; Glass, R; Greenberg, HB; Curlin, G; Mohan, K; Harshavardhan, GVJA; Prasad, S; Rao, TS; Boslego, J; Bhan, MK				Bhandari, Nita; Rongsen-Chandola, Temsunaro; Bavdekar, Ashish; John, Jacob; Antony, Kalpana; Taneja, Sunita; Goyal, Nidhi; Kawade, Anand; Kang, Gagandeep; Rathore, Sudeep Singh; Juvekar, Sanjay; Muliyil, Jayaprakash; Arya, Alok; Shaikh, Hanif; Abraham, Vinod; Vrati, Sudhanshu; Proschan, Michael; Kohberger, Robert; Thiry, Georges; Glass, Roger; Greenberg, Harry B.; Curlin, George; Mohan, Krishna; Harshavardhan, G. V. J. A.; Prasad, Sai; Rao, T. S.; Boslego, John; Bhan, Maharaj Kishan		India Rotavirus Vaccine Grp	Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							1ST 2 YEARS; RRV-TV; SAFETY; IMMUNOGENICITY; CHILDREN; POLIO; GASTROENTERITIS; CONFIDENCE; PROTECTION; INFECTION	Background Rotavirus is the most common cause of severe dehydrating gastroenteritis in developing countries. Safe, effective, and affordable rotavirus vaccines are needed in these countries. We aimed to assess the efficacy and tolerability of a monovalent human-bovine rotavirus vaccine for severe rotavirus gastroenteritis in low-resource urban and rural settings in India. Methods We did a randomised double-blind, placebo-controlled, multicentre trial at three sites in Delhi (urban), Pune (rural), and Vellore (urban and rural) between March 11, 2011, and Nov 5, 2012. Infants aged 6-7 weeks were randomly assigned (2: 1), via a central interactive voice or web response system with a block size of 12, to receive either three doses of oral human-bovine natural reassortant vaccine (116E) or placebo at ages 6-7 weeks, 10 weeks, and 14 weeks. Infants' families, study investigators, paediatricians in referral hospitals, laboratory staff, and committee members were all masked to treatment allocation. The primary outcome was incidence of severe rotavirus gastroenteritis (>= 11 on the Vesikari scale). Efficacy outcomes and adverse events were ascertained through active surveillance. Analysis was by intention to treat and per protocol. The trial is registered with Clinical Trial Registry-India (CTRI/2010/091/000102) and ClinicalTrials. gov (NCT01305109). Findings 4532 infants were assigned to receive the 116E vaccine and 2267 to receive placebo, of whom 4354 (96%) and 2187 (96%) infants, respectively, were included in the primary per-protocol efficacy analysis. 71 events of severe rotavirus gastroenteritis were reported in 4752 person-years in infants in the vaccine group compared with 76 events in 2360 person-years in those in the placebo group; vaccine efficacy against severe rotavirus gastroenteritis was 53 . 6% (95% CI 35 . 0-66 . 9; p= 0.0013) and 56 . 4% (36 . 6-70.1; p< 0.0001) in the first year of life. The number of infants needed to be immunised to prevent one severe rotavirus gastroenteritis episode was 55 (95% CI 37-97). The incidence of severe rotavirus gastroenteritis per 100 person-years was 1 . 5 in the vaccine group and 3 . 2 in the placebo group, with an incidence rate ratio of 0.46 (95% CI 0.33-0.65). Prevalence of immediate, solicited, and serious adverse events was similar in both groups. One case of urticaria in the vaccine group and one each of acute gastroenteritis and suspected sepsis in the placebo group were regarded as related to the study product. We recorded six cases of intussusception in the vaccine group and two in the placebo group, all of which happened after the third dose. 25 (< 1%) infants in the vaccine group and 17 (< 1%) in the placebo group died; no death was regarded as related to the study product. Interpretation Monovalent human-bovine (116E) rotavirus vaccine is effective and well tolerated in Indian infants.	[Bhandari, Nita; Rongsen-Chandola, Temsunaro; Taneja, Sunita; Goyal, Nidhi; Rathore, Sudeep Singh; Arya, Alok] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India; [Bavdekar, Ashish; Kawade, Anand; Juvekar, Sanjay; Shaikh, Hanif] KEM Hosp, Res Ctr, Pune, Maharashtra, India; [John, Jacob; Kang, Gagandeep; Muliyil, Jayaprakash; Abraham, Vinod] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Antony, Kalpana] PATH, New Delhi, India; [Vrati, Sudhanshu] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India; [Proschan, Michael; Glass, Roger; Curlin, George] NIH, Bethesda, MD 20892 USA; [Kohberger, Robert] Blair & Co, Greenwich, CT USA; [Thiry, Georges] PATH, Adv Rotavirus Vaccines Dev Project, Ferney Voltaire, France; [Greenberg, Harry B.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Mohan, Krishna; Harshavardhan, G. V. J. A.; Prasad, Sai] Bharat Biotech Int, Genome Valley, Andhra Pradesh, India; [Rao, T. S.] Govt India, Dept Biotechnol, New Delhi 110017, India; [Bhan, Maharaj Kishan] Govt India, Minist Sci & Technol, New Delhi 110017, India; [Boslego, John] PATH, Vaccine Dev Global Program, Seattle, WA USA	Christian Medical College & Hospital (CMCH) Vellore; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); National Institutes of Health (NIH) - USA; Stanford University; Department of Biotechnology (DBT) India	Bhan, MK (corresponding author), Govt India, Minist Sci & Technol, New Delhi 110017, India.	rajkbhan@gmail.com	John, Jacob/K-7093-2012; Strand, Tor/D-9836-2016; John, Jacob/M-3563-2019; KAWADE, ANAND/AAY-1006-2021	John, Jacob/0000-0003-3654-5099; Strand, Tor/0000-0002-4038-151X; John, Jacob/0000-0003-3654-5099; KAWADE, ANAND/0000-0001-6806-077X; Kang, Gagandeep/0000-0002-3656-564X; sapru, anil/0000-0003-1528-8249; greenberg, harry/0000-0002-2128-9080	Department of Biotechnology; Bill & Melinda Gates Foundation; Research Council of Norway; UK Department for International Development; National Institutes of Health, Bethesda, USA; Bharat Biotech International, Hyderabad, India; Biotechnology Industry Research Assistance Council, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI053719] Funding Source: NIH RePORTER	Department of Biotechnology; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Research Council of Norway(Research Council of Norway); UK Department for International Development; National Institutes of Health, Bethesda, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bharat Biotech International, Hyderabad, India; Biotechnology Industry Research Assistance Council, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Department of Biotechnology and the Biotechnology Industry Research Assistance Council, Government of India; Bill & Melinda Gates Foundation to PATH, USA; Research Council of Norway; UK Department for International Development; National Institutes of Health, Bethesda, USA; and Bharat Biotech International, Hyderabad, India.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; [Anonymous], 2006, ETH GUID BIOM RES HU; Armah GE, 2013, J INFECT DIS, V208, P423, DOI 10.1093/infdis/jit174; Armah GE, 2012, VACCINE, V30, pA86, DOI 10.1016/j.vaccine.2011.10.006; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Banerjee I, 2007, J MED VIROL, V79, P1413, DOI 10.1002/jmv.20872; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; Bhandari N, 2006, VACCINE, V24, P5817, DOI 10.1016/j.vaccine.2006.05.001; Bhandari N, 2009, J INFECT DIS, V200, P421, DOI 10.1086/600104; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Breiman RF, 2012, VACCINE, V30, pA24, DOI 10.1016/j.vaccine.2011.08.124; Chandola TR, 2013, EPIDEMIOL INFECT, V141, P2094, DOI 10.1017/S0950268812002762; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Government of India, 2003, DRUGS COSM ACT RUL; Government of India: Ministry of Health and Family Welfare, 2009, INT MAN NEON CHILDH; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; IIPS, 2007, IND NAT FAM HLTH SUR, V1; Iturriza-Gomara M, J CLIN VIROL; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; MIGASENA S, 1995, VACCINE, V13, P168, DOI 10.1016/0264-410X(95)93131-R; Mukhopadhya I, 2013, J MED VIROL, V85, P1661, DOI 10.1002/jmv.23641; National Institutes of Health, 2012, IND US VACC ACT PROG; Patel M, 2012, VACCINE, V30, pA30, DOI 10.1016/j.vaccine.2011.11.093; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Soares-Weiser K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008521.pub3; Sow SO, 2012, VACCINE, V30, pA71, DOI 10.1016/j.vaccine.2011.11.094; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; VODOPIJA I, 1986, VACCINE, V4, P233, DOI 10.1016/0264-410X(86)90135-0; WARD RL, 1989, J INFECT DIS, V159, P79, DOI 10.1093/infdis/159.1.79; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	37	198	207	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2136	2143		10.1016/S0140-6736(13)62630-6	http://dx.doi.org/10.1016/S0140-6736(13)62630-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24629994	Green Accepted			2022-12-28	WOS:000337906600028
J	Maeng, M; Tilsted, HH; Jensen, LO; Krusell, LR; Kaltoft, A; Kelbaek, H; Villadsen, AB; Ravkilde, J; Hansen, KN; Christiansen, EH; Aaroe, J; Jensen, JS; Kristensen, SD; Botker, HE; Thuesen, L; Madsen, M; Thayssen, P; Sorensen, HT; Lassen, JF				Maeng, Michael; Tilsted, Hans Henrik; Jensen, Lisette Okkels; Krusell, Lars Romer; Kaltoft, Anne; Kelbaek, Henning; Villadsen, Anton B.; Ravkilde, Jan; Hansen, Knud Norregaard; Christiansen, Evald Hoj; Aaroe, Jens; Jensen, Jan Skov; Kristensen, Steen Dalby; Botker, Hans Erik; Thuesen, Leif; Madsen, Morten; Thayssen, Per; Sorensen, Henrik Toft; Lassen, Jens Flensted			Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial	LANCET			English	Article							BARE-METAL STENTS; ARTERY-DISEASE; FOLLOW-UP; SCANDINAVIAN ORGANIZATION; ANGIOGRAPHIC OUTCOMES; SAFETY; ENDEAVOR; REVASCULARIZATION; INTERVENTION; THROMBOSIS	Background In head-to-head comparisons of coronary drug-eluting stents, the primary endpoint is traditionally assessed after 9-12 months. However, the optimum timepoint for this assessment remains unclear. In this study, we assessed clinical outcomes at up to 5 years' follow-up in patients who received two different types of drug-eluting stents. Methods We undertook this multicentre, open-label, randomised superiority trial at five percutaneous coronary intervention centres in Denmark. We randomly allocated 2332 eligible adult patients (>= 18 years of age) with an indication for drug-eluting stent implantation to the zotarolimus-eluting Endeavor Sprint stent (Medtronic, Santa Rosa, CA, USA) or the sirolimus-eluting Cypher Select Plus stent (Cordis, Johnson & Johnson, Warren, NJ, USA). Randomisation of participants was achieved by computer-generated block randomisation and a telephone allocation service. The primary endpoint of the SORT OUT III study was a composite of major adverse cardiac events-cardiac death, myocardial infarction, and target vessel revascularisation-at 9 months' follow-up. In this study, endpoints included the occurrence of major adverse cardiac events and definite stent thrombosis at follow-up times of up to 5 years. Analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00660478. Findings We randomly allocated 1162 patients to receive the zotarolimus-eluting stent and 1170 to the sirolimus-eluting stent. At 5-year follow-up, rates of major adverse cardiac events were similar in patients treated with both types of stents (zotarolimus-eluting stents 197/1162 [17.0%] vs sirolimus-eluting stents 182/1170 [15.6%]; odds ratio [OR] 1.10, 95% CI 0.88-1.37; p=0.40). This finding was indicative of the directly contrasting results for rates of major adverse cardiac events at 1-year follow up (zotarolimus 93/1162 [8.0%] vs sirolimus 46/1170 [3.9%]; OR 2.13, 95% CI 1.48-3.07; p<0.0001) compared with those at follow-up between 1 and 5 years (104 [9.0%] vs 136 [11.6%]; OR 0.78, 95% CI 0.59-1.02; p=0.071). At 1-year follow-up, definite stent thrombosis was more frequent after implantation of the zotarolimus-eluting stent (13/1162 [1.1%]) than the sirolimus-eluting stent (4/1170 [0.3%]; OR 3.34, 95% CI 1.08-10.3; p=0.036), whereas the opposite finding was recorded for between 1 and 5 years' follow-up (zotarolimus-eluting stent 1/1162 [0.1%] vs sirolimus-eluting stent 21/1170 [1.8%], OR 0.05, 95% CI 0.01-0.36; p=0.003). 26 of 88 (30%) target lesion revascularisations in the zotarolimus-eluting stent group occurred between 1 and 5 years' follow-up, whereas 54 of 70 (77%) of those in the sirolimus-eluting stent group occurred during this follow-up period. Interpretation The superiority of sirolimus-eluting stents compared with zotarolimus-eluting stents at 1-year follow-up was lost after 5 years. The traditional 1-year primary endpoint assessment therefore might be insufficient to predict 5-year clinical outcomes in patients treated with coronary drug-eluting stent implantation.	[Maeng, Michael; Krusell, Lars Romer; Kaltoft, Anne; Christiansen, Evald Hoj; Kristensen, Steen Dalby; Botker, Hans Erik; Thuesen, Leif; Lassen, Jens Flensted] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Tilsted, Hans Henrik; Villadsen, Anton B.; Ravkilde, Jan; Aaroe, Jens] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Jensen, Lisette Okkels; Hansen, Knud Norregaard; Thayssen, Per] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Kelbaek, Henning] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Jensen, Jan Skov] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Madsen, Morten; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Maeng, M (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.	michael.maeng@ki.au.dk	Maeng, Michael/AAY-2135-2021; Sorensen, Henrik Toft/Z-6181-2019; Lassen, Jens Flensted/AAY-2127-2021	Maeng, Michael/0000-0002-4310-6433; Sorensen, Henrik Toft/0000-0003-4299-7040; Lassen, Jens Flensted/0000-0001-7972-9192; Madsen, Morten/0000-0002-6036-8240; Jensen, Lisette Okkels/0000-0002-4838-2429; Christiansen, Evald/0000-0002-8740-4862; Botker, Hans Erik/0000-0001-6358-8962	Cordis; Medtronic; Novo Nordisk Fonden [NNF13OC0007447] Funding Source: researchfish	Cordis; Medtronic(Medtronic); Novo Nordisk Fonden(Novo Nordisk Foundation)	Cordis and Medtronic.	Briguori C, 2011, CIRC-CARDIOVASC INTE, V4, P121, DOI 10.1161/CIRCINTERVENTIONS.110.959924; Byrne RA, 2010, J AM COLL CARDIOL, V55, P2536, DOI 10.1016/j.jacc.2010.03.020; Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cutlip DE, 2011, CIRCULATION, V123, P2779, DOI 10.1161/CIRCULATIONAHA.111.033654; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Jensen LO, 2012, J AM COLL CARDIOL, V60, P1140, DOI 10.1016/j.jacc.2012.07.004; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kaltoft A, 2009, J AM COLL CARDIOL, V53, P658, DOI 10.1016/j.jacc.2008.09.058; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014; Kelbaek H, 2006, J AM COLL CARDIOL, V47, P449, DOI 10.1016/j.jacc.2005.10.045; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Lee CW, 2009, AM J CARDIOL, V104, P1370, DOI 10.1016/j.amjcard.2009.06.059; Leon MB, 2010, JACC-CARDIOVASC INTE, V3, P1043, DOI 10.1016/j.jcin.2010.07.008; Maeng M, 2012, JACC-CARDIOVASC INTE, V5, P812, DOI 10.1016/j.jcin.2012.04.008; Mauri L, 2010, JACC-CARDIOVASC INTE, V3, P1240, DOI 10.1016/j.jcin.2010.08.021; Miyazawa A, 2008, AM HEART J, V155, P108, DOI 10.1016/j.ahj.2007.08.008; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakazawa G, 2007, AM J CARDIOL, V100, p36M, DOI 10.1016/j.amjcard.2007.08.020; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park HJ, 2012, CIRC J, V76, P868, DOI 10.1253/circj.CJ-11-1021; Radu MD, 2013, EUR HEART J, DOI [10.1093/eurheartj/, DOI 10.1093/EURHEARTJ/]; Raber L, 2011, CIRCULATION, V123, P2819, DOI 10.1161/CIRCULATIONAHA.110.004762; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Thuesen Leif, 2013, Clin Epidemiol, V5, P357, DOI 10.2147/CLEP.S44651; Webster MWI, 2010, LANCET, V375, P375, DOI 10.1016/S0140-6736(10)60163-8	39	78	78	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2047	2056		10.1016/S0140-6736(14)60405-0	http://dx.doi.org/10.1016/S0140-6736(14)60405-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24631162				2022-12-28	WOS:000337292400024
J	D'Arena, G; Cammarota, A; Musto, P				D'Arena, Giovanni; Cammarota, Aldo; Musto, Pellegrino			Fournier's gangrene complicating thrombocytopenia treated with steroids	LANCET			English	Editorial Material									[D'Arena, Giovanni; Musto, Pellegrino] IRCCS Ctr Riferimento Oncol Basilicata, Oncohematol Dept, I-85028 Rionero In Vulture, Pz, Italy; [Cammarota, Aldo] IRCCS Ctr Riferimento Oncol Basilicata, Radiol Unit, I-85028 Rionero In Vulture, Pz, Italy	IRCCS CROB; IRCCS CROB	D'Arena, G (corresponding author), IRCCS Ctr Riferimento Oncol Basilicata, Oncohematol Dept, Via Padre Pio 1, I-85028 Rionero In Vulture, Pz, Italy.	giovannidarena@libero.it		Musto, Pellegrino/0000-0003-3277-6594					0	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1580	1580		10.1016/S0140-6736(13)61098-3	http://dx.doi.org/10.1016/S0140-6736(13)61098-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24631163				2022-12-28	WOS:000335495400029
J	Devereaux, PJ; Sessler, DI; Leslie, K; Kurz, A; Mrkobrada, M; Alonso-Coello, P; Villar, JC; Sigamani, A; Biccard, BM; Meyhoff, CS; Parlow, JL; Guyatt, G; Robinson, A; Garg, AX; Rodseth, RN; Botto, F; Buse, GL; Xavier, D; Chan, MTV; Tiboni, M; Cook, D; Kumar, PA; Forget, P; Malaga, G; Fleischmann, E; Amir, M; Eikelboom, J; Mizera, R; Torres, D; Wang, CY; VanHelder, T; Paniagua, P; Berwanger, O; Srinathan, S; Graham, M; Pasin, L; Le Manach, Y; Gao, P; Pogue, J; Whitlock, R; Lamy, A; Kearon, C; Chow, C; Pettit, S; Chrolavicius, S; Yusuf, S				Devereaux, P. J.; Sessler, D. I.; Leslie, K.; Kurz, A.; Mrkobrada, M.; Alonso-Coello, P.; Villar, J. C.; Sigamani, A.; Biccard, B. M.; Meyhoff, C. S.; Parlow, J. L.; Guyatt, G.; Robinson, A.; Garg, A. X.; Rodseth, R. N.; Botto, F.; Buse, G. Lurati; Xavier, D.; Chan, M. T. V.; Tiboni, M.; Cook, D.; Kumar, P. A.; Forget, P.; Malaga, G.; Fleischmann, E.; Amir, M.; Eikelboom, J.; Mizera, R.; Torres, D.; Wang, C. Y.; VanHelder, T.; Paniagua, P.; Berwanger, O.; Srinathan, S.; Graham, M.; Pasin, L.; Le Manach, Y.; Gao, P.; Pogue, J.; Whitlock, R.; Lamy, A.; Kearon, C.; Chow, C.; Pettit, S.; Chrolavicius, S.; Yusuf, S.		POISE-2 Investigators	Clonidine in Patients Undergoing Noncardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIOPERATIVE MYOCARDIAL-INFARCTION; TRANSDERMAL CLONIDINE; VASCULAR-SURGERY; CARDIAC RISK; EFFICACY; STRESS; METAANALYSIS; RESPONSES; ISCHEMIA; TRIALS	Background: Marked activation of the sympathetic nervous system occurs during and after noncardiac surgery. Low-dose clonidine, which blunts central sympathetic outflow, may prevent perioperative myocardial infarction and death without inducing hemodynamic instability. Methods: We performed a blinded, randomized trial with a 2-by-2 factorial design to allow separate evaluation of low-dose clonidine versus placebo and low-dose aspirin versus placebo in patients with, or at risk for, atherosclerotic disease who were undergoing noncardiac surgery. A total of 10,010 patients at 135 centers in 23 countries were enrolled. For the comparison of clonidine with placebo, patients were randomly assigned to receive clonidine (0.2 mg per day) or placebo just before surgery, with the study drug continued until 72 hours after surgery. The primary outcome was a composite of death or nonfatal myocardial infarction at 30 days. Results: Clonidine, as compared with placebo, did not reduce the number of primary-outcome events (367 and 339, respectively; hazard ratio with clonidine, 1.08; 95% confidence interval [CI], 0.93 to 1.26; P=0.29). Myocardial infarction occurred in 329 patients (6.6%) assigned to clonidine and in 295 patients (5.9%) assigned to placebo (hazard ratio, 1.11; 95% CI, 0.95 to 1.30; P=0.18). Significantly more patients in the clonidine group than in the placebo group had clinically important hypotension (2385 patients [47.6%] vs. 1854 patients [37.1%]; hazard ratio 1.32; 95% CI, 1.24 to 1.40; P<0.001). Clonidine, as compared with placebo, was associated with an increased rate of nonfatal cardiac arrest (0.3% [16 patients] vs. 0.1% [5 patients]; hazard ratio, 3.20; 95% CI, 1.17 to 8.73; P=0.02). Conclusions: Administration of low-dose clonidine in patients undergoing noncardiac surgery did not reduce the rate of the composite outcome of death or nonfatal myocardial infarction; it did, however, increase the risk of clinically important hypotension and nonfatal cardiac arrest. (Funded by the Canadian Institutes of Health Research and others; POISE-2 ClinicalTrials.gov number, NCT01082874.)	[Devereaux, P. J.; Mrkobrada, M.; Robinson, A.; Botto, F.; Buse, G. Lurati; Eikelboom, J.; Le Manach, Y.; Gao, P.; Pogue, J.; Whitlock, R.; Lamy, A.; Pettit, S.; Chrolavicius, S.; Yusuf, S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Devereaux, P. J.; Guyatt, G.; Cook, D.; Eikelboom, J.; Le Manach, Y.; Pogue, J.; Kearon, C.; Yusuf, S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Devereaux, P. J.; Guyatt, G.; Tiboni, M.; Cook, D.; Eikelboom, J.; Mizera, R.; Kearon, C.; Yusuf, S.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [VanHelder, T.; Le Manach, Y.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Whitlock, R.; Lamy, A.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Whitlock, R.] McMaster Univ, Dept Crit Care, Hamilton, ON L8S 4L8, Canada; [Mrkobrada, M.] London Hlth Sci Ctr, Dept Med, London, ON, Canada; [Parlow, J. L.] Kingston Gen Hosp, Dept Anesthesiol & Perioperat Med, Kingston, ON K7L 2V7, Canada; [Parlow, J. L.] Queens Univ, Kingston, ON, Canada; [Garg, A. X.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Srinathan, S.] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada; [Graham, M.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Sessler, D. I.; Kurz, A.] Cleveland Clin, Dept Outcomes Res, Inst Anesthesiol, Cleveland, OH USA; [Leslie, K.] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia; [Alonso-Coello, P.] Biomed Res Inst IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Paniagua, P.] Biomed Res Inst IIB St Pau, Dept Anesthesiol, Barcelona, Spain; [Villar, J. C.] Univ Autonoma Bucaramanga, Bogota, Colombia; [Villar, J. C.] Fdn Cardioinfantil, Bogota, Colombia; [Sigamani, A.; Xavier, D.] St Johns Natl Acad Hlth Sci, Dept Pharmacol, Div Clin Res & Training, Bangalore, Karnataka, India; [Biccard, B. M.; Rodseth, R. N.] Univ KwaZulu Natal, Dept Anaesthet, Perioperat Res Grp, Nelson R Mandela Sch Med, Durban, South Africa; [Meyhoff, C. S.] Univ Copenhagen, Herlev Hosp, Dept Anesthesiol, DK-2730 Herlev, Denmark; [Botto, F.] Inst Cardiovasc Buenos Aires ICBA, Estudios Clin Latino Amer ECLA, Buenos Aires, DF, Argentina; [Buse, G. Lurati] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland; [Chan, M. T. V.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Kumar, P. A.] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA; [Forget, P.] Clin Univ St Luc, Brussels, Belgium; [Malaga, G.] Univ Peruana Cayetano Heredia, Lima, Peru; [Fleischmann, E.] Med Univ Vienna, Dept Anesthesia & Intens Care, Vienna, Austria; [Amir, M.] Shifa Int Hosp, Dept Surg, Islamabad, Pakistan; [Torres, D.] Clin Santa Maria, Dept Anesthesiol, Santiago, Chile; [Wang, C. Y.] Univ Malaya, Dept Anesthesiol, Kuala Lumpur, Malaysia; [Berwanger, O.] Hosp Coracao, Res Inst HCor, Sao Paulo, Brazil; [Pasin, L.] Ist Sci San Raffaele, I-20132 Milan, Italy; [Chow, C.] George Inst Global Hlth, Sydney, NSW, Australia; [Chow, C.] Univ Sydney, Sydney, NSW 2006, Australia	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; London Health Sciences Centre; Queens University - Canada; Queens University - Canada; Western University (University of Western Ontario); University of Manitoba; University of Alberta; Cleveland Clinic Foundation; Royal Melbourne Hospital; Fundacion Cardioinfantil - Instituto de Cardiologia; St. John's National Academy of Health Sciences; University of Kwazulu Natal; University of Copenhagen; Herlev & Gentofte Hospital; Instituto Cardiovascular de Buenos Aires (ICBA); University of Basel; Chinese University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universidad Peruana Cayetano Heredia; Medical University of Vienna; Universiti Malaya; Hospital do Coracao - HCor; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; George Institute for Global Health; University of Sydney; University of Sydney	Devereaux, PJ (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, Perioperat Med & Surg Res Unit, Rm C1-116,237 Barton St East, Hamilton, ON L8L 2X2, Canada.	philipj@mcmaster.ca	Painter, Thomas/K-3899-2019; Garg, Amit X/G-3295-2011; Amir, Mohammed/AAI-8792-2020; Forget, Patrice/AAO-6918-2020; Sigamani, Alben/GQH-0406-2022; Eikelboom, John/AAG-6117-2019; de Nadal, Miriam/J-8127-2017; Ong, Gracie/B-8554-2010; Álvarez-García, Jesús/N-9426-2016; Painter, Thomas/K-6311-2017; Wang, Chew Yin/F-7573-2010; Le Manach, Yannick/AAE-5700-2019; Devereaux, PJ/AAY-1757-2021; Villar Centeno, Juan Carlos/AAX-5401-2021; Salmasi, Vafi/O-9908-2019; Wijeysundera, Duminda/L-3350-2018; Rodseth, Reitze/B-2471-2010; Sessler, Daniel/D-3504-2011; WANG, CHEW YIN/B-7534-2010; GIN, Tony/J-2521-2013; Buse, Giovanna Lurati/ABE-6008-2020; Wetterslev, Jørn/ABF-1251-2020; Pasin, Laura/AAA-8188-2020; Meyhoff, Christian S./B-4777-2009; Mrkobrada, Marko/G-3336-2011; Wittmann, Maria/AAN-5276-2021; Chan, Matthew/J-2884-2013; Whitlock, Richard/AAQ-1593-2021; Devereaux, PJ/AAF-2862-2019; Gluud, Christian/AAY-1027-2021; Wittmann, Maria/I-2125-2018; Vizcaychipi, Marcela/H-5487-2011	Painter, Thomas/0000-0003-2216-2046; Forget, Patrice/0000-0001-5772-8439; Eikelboom, John/0000-0003-4126-1285; de Nadal, Miriam/0000-0002-4559-2463; Álvarez-García, Jesús/0000-0002-2015-6446; Painter, Thomas/0000-0003-2216-2046; Le Manach, Yannick/0000-0003-0474-8545; Wijeysundera, Duminda/0000-0002-5897-8605; Rodseth, Reitze/0000-0002-3779-7805; Sessler, Daniel/0000-0001-9932-3077; GIN, Tony/0000-0001-7283-6761; Buse, Giovanna Lurati/0000-0002-8076-5737; Wetterslev, Jørn/0000-0001-7778-1771; Meyhoff, Christian S./0000-0002-4885-4609; Wittmann, Maria/0000-0003-4786-7712; Chan, Matthew/0000-0002-3574-7855; Whitlock, Richard/0000-0002-6863-5884; Gluud, Christian/0000-0002-8861-0799; Wittmann, Maria/0000-0003-4786-7712; Torres, David/0000-0003-2908-6365; Devereaux, PJ/0000-0003-2935-637X; Kurz, Andrea/0000-0001-5887-3099; Pasin, Laura/0000-0001-5757-4791; Alonso-Coello, Pablo/0000-0002-8001-8504; Tena, Beatriz/0000-0001-9325-0858; Seeberger, Manfred/0000-0002-2358-7233; Yusuf, Salim/0000-0003-4776-5601; Leslie, Kate/0000-0001-8512-3517; Botto, Fernando/0000-0002-0572-8493; piriou, vincent/0000-0001-6900-1480; Popova, Ekaterine/0000-0002-8781-9873; Villar, Juan Carlos/0000-0002-7047-7299; Vested, Matias/0000-0002-5165-2725; SIGAMANI, ALBEN/0000-0002-6927-1947; Myles, Paul/0000-0002-3324-5456; Amir, Mohammed/0000-0003-4726-5674; Malaga, German/0000-0002-7828-300X; Caballero-Alvarado, Jose/0000-0001-8297-6901; Vizcaychipi, Marcela/0000-0001-7894-873X; Salmasi, Vafi/0000-0002-1288-4531	Canadian Institutes of Health Research; Commonwealth Government of Australia's National Health and Medical Research Council; Spanish Ministry of Health and Social Policy; Boehringer Ingelheim; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Commonwealth Government of Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Health and Social Policy(Spanish Government); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Canadian Institutes of Health Research, the Commonwealth Government of Australia's National Health and Medical Research Council, the Spanish Ministry of Health and Social Policy, and Boehringer Ingelheim. Bayer Pharma provided the aspirin study drug, and Boehringer Ingelheim the clonidine study drug.	[Anonymous], 2010, EVIDENCE BASED CARDI; Beattie WS, 2008, ANESTH ANALG, V106, P1039, DOI 10.1213/ane.0b013e318163f6a9; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; Darvish-Kazem S, 2009, CAN J CARDIOL B, V25B, P158; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Devereaux PJ, 2014, AM HEART J; ELLIS JE, 1994, ANESTH ANALG, V79, P1133; Kranke P, 2002, ANESTH ANALG, V94, P453, DOI 10.1097/00000539-200202000-00043; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; LANGLEY MS, 1988, DRUGS, V35, P123, DOI 10.2165/00003495-198835020-00003; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Nishina K, 2002, ANESTHESIOLOGY, V96, P323, DOI 10.1097/00000542-200202000-00016; Quintin L, 1996, ANESTH ANALG, V83, P687, DOI 10.1097/00000539-199610000-00005; Sametz W, 1999, EUR J CLIN INVEST, V29, P582; Schneemilch CE, 2006, ANESTH ANALG, V103, P297, DOI 10.1213/01.ane.0000223673.68072.42; Stuhmeier KD, 1996, ANESTHESIOLOGY, V85, P706, DOI 10.1097/00000542-199610000-00004; UDELSMAN R, 1987, J CLIN ENDOCR METAB, V64, P986, DOI 10.1210/jcem-64-5-986; Wallace AW, 2004, ANESTHESIOLOGY, V101, P284, DOI 10.1097/00000542-200408000-00007; Wijeysundera DN, 2003, AM J MED, V114, P742, DOI 10.1016/S0002-9343(03)00165-7; Wu CT, 2004, ANESTH ANALG, V99, P502, DOI 10.1213/01.ANE.0000117146.46373.51	22	200	208	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1504	1513		10.1056/NEJMoa1401106	http://dx.doi.org/10.1056/NEJMoa1401106			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24679061				2022-12-28	WOS:000334601600007
J	Lea, DW				Lea, David W.			Not So Permanent El Nino	SCIENCE			English	Editorial Material							EQUATORIAL PACIFIC; CLIMATE		Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93109 USA	University of California System; University of California Santa Barbara	Lea, DW (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93109 USA.	lea@geol.ucsb.edu			Division Of Ocean Sciences [1260696] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Ballantyne AP, 2010, GEOLOGY, V38, P603, DOI 10.1130/G30815.1; DiNezio PN, 2009, J CLIMATE, V22, P4873, DOI 10.1175/2009JCLI2982.1; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Hill DJ, 2014, CLIM PAST, V10, P79, DOI 10.5194/cp-10-79-2014; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Medina-Elizalde M, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001780; Tachikawa K, 2014, QUATERNARY SCI REV, V86, P24, DOI 10.1016/j.quascirev.2013.12.018; Tierney JE, 2014, GEOCHIM COSMOCHIM AC, V127, P83, DOI 10.1016/j.gca.2013.11.026; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Williams IN, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039849; Zhang YG, 2014, SCIENCE, V344, P84, DOI 10.1126/science.1246172	12	5	6	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					52	53		10.1126/science.1252246	http://dx.doi.org/10.1126/science.1252246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700851				2022-12-28	WOS:000333746100048
J	Theodoratou, E; Tzoulaki, I; Zgaga, L; Ioannidis, JPA				Theodoratou, Evropi; Tzoulaki, Ioanna; Zgaga, Lina; Ioannidis, John P. A.			Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CIRCULATING 25-HYDROXYVITAMIN D; HIP FRACTURE RISK; D SUPPLEMENTATION; D DEFICIENCY; COLORECTAL-CANCER; CALCIUM SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; OLDER-ADULTS; MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS	Objective To evaluate the breadth, validity, and presence of biases of the associations of vitamin D with diverse outcomes. Design Umbrella review of the evidence across systematic reviews and meta-analyses of observational studies of plasma 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D concentrations and randomised controlled trials of vitamin D supplementation. Data sources Medline, Embase, and screening of citations and references. Eligibility criteria Three types of studies were eligible for the umbrella review: systematic reviews and meta-analyses that examined observational associations between circulating vitamin D concentrations and any clinical outcome; and meta-analyses of randomised controlled trials assessing supplementation with vitamin D or active compounds (both established and newer compounds of vitamin D). Results 107 systematic literature reviews and 74 meta-analyses of observational studies of plasma vitamin D concentrations and 87 meta-analyses of randomised controlled trials of vitamin D supplementation were identified. The relation between vitamin D and 137 outcomes has been explored, covering a wide range of skeletal, malignant, cardiovascular, autoimmune, infectious, metabolic, and other diseases. Ten outcomes were examined by both meta-analyses of observational studies and meta-analyses of randomised controlled trials, but the direction of the effect and level of statistical significance was concordant only for birth weight (maternal vitamin D status or supplementation). On the basis of the available evidence, an association between vitamin D concentrations and birth weight, dental caries in children, maternal vitamin D concentrations at term, and parathyroid hormone concentrations in patients with chronic kidney disease requiring dialysis is probable, but further studies and better designed trials are needed to draw firmer conclusions. In contrast to previous reports, evidence does not support the argument that vitamin D only supplementation increases bone mineral density or reduces the risk of fractures or falls in older people. Conclusions Despite a few hundred systematic reviews and meta-analyses, highly convincing evidence of a clear role of vitamin D does not exist for any outcome, but associations with a selection of outcomes are probable.	[Theodoratou, Evropi] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Tzoulaki, Ioanna] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Tzoulaki, Ioanna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Zgaga, Lina] Univ Dublin Trinity Coll, Dept Publ Hlth & Primary Care, Dublin 24, Ireland; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	University of Edinburgh; Imperial College London; University of Ioannina; Trinity College Dublin; Stanford University; Stanford University; Stanford University	Theodoratou, E (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	e.theodoratou@ed.ac.uk	Zgaga, Lina/Q-9415-2018; Theodoratou, Evropi/C-3430-2014; Tzoulaki, Ioanna/ABE-6269-2020; Ioannidis, John P. A./G-9836-2011	Zgaga, Lina/0000-0003-4089-9703; Theodoratou, Evropi/0000-0001-5887-9132; Tzoulaki, Ioanna/0000-0002-4275-9328; 				Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Aghajafari F., 2013, BMJ-BRIT MED J, V346, DOI [DOI 10.1136/BMJ.F1169, 10.1136/bmj.f1169]; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2304; Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Barnard K, 2010, AM J GERIATR PHARMAC, V8, P4, DOI 10.1016/j.amjopharm.2010.02.004; Bauer SR, 2013, MEDICINE, V92, P123, DOI 10.1097/MD.0b013e3182943bc2; Bergman GJD, 2010, CURR MED RES OPIN, V26, P1193, DOI 10.1185/03007991003659814; Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Brondum-Jacobsen P, 2013, ANN NEUROL, V73, P38, DOI 10.1002/ana.23738; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Burgaz A, 2011, J HYPERTENS, V29, P636, DOI 10.1097/HJH.0b013e32834320f9; Buttigliero C, 2011, ONCOLOGIST, V16, P1215, DOI 10.1634/theoncologist.2011-0098; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Cao YL, 2013, RHEUMATOLOGY, V52, P1323, DOI 10.1093/rheumatology/ket132; Chen P. K., 2013, PLOS ONE, V8; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Chowdhury R, 2012, EUR J EPIDEMIOL, V27, P581, DOI 10.1007/s10654-012-9729-z; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Cook LS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.062; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Cutolo M, 2007, AUTOIMMUN REV, V7, P59, DOI 10.1016/j.autrev.2007.07.001; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Dolinsky DH, 2013, CLIN PEDIATR, V52, P210, DOI 10.1177/0009922812470742; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Etgen T, 2012, DEMENT GERIATR COGN, V33, P297, DOI 10.1159/000339702; Fedirko V, 2010, AM J EPIDEMIOL, V172, P489, DOI 10.1093/aje/kwq157; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P47, DOI 10.1093/aje/kwq115; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Gilbert R, 2011, CANCER CAUSE CONTROL, V22, P319, DOI 10.1007/s10552-010-9706-3; Gillespie LD, 2012, COCHRANE DATABASE SY; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hui S, 2010, SOUTH MED J, V103, P729, DOI 10.1097/SMJ.0b013e3181e6d389; Hujoel PP, 2013, NUTR REV, V71, P88, DOI 10.1111/j.1753-4887.2012.00544.x; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2013, J MATH PSYCHOL, V57, P184, DOI 10.1016/j.jmp.2013.03.002; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Jolliffe DA, 2013, J STEROID BIOCHEM, V136, P321, DOI 10.1016/j.jsbmb.2012.11.017; Kalyani RR, 2010, J AM GERIATR SOC, V58, P1299, DOI 10.1111/j.1532-5415.2010.02949.x; Kandula P, 2011, CLIN J AM SOC NEPHRO, V6, P50, DOI 10.2215/CJN.03940510; Kavvoura FK, 2008, AM J EPIDEMIOL, V168, P855, DOI 10.1093/aje/kwn206; Kelly JL, 2009, CANCER INVEST, V27, P942, DOI 10.3109/07357900902849632; Kriegel MA, 2011, SEMIN ARTHRITIS RHEU, V40, P512, DOI 10.1016/j.semarthrit.2010.07.009; Kunutsor SK, 2013, EUR J EPIDEMIOL, V28, P205, DOI 10.1007/s10654-013-9790-2; Lai JKC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-331; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Maxmen A, 2011, NATURE, V475, P23, DOI 10.1038/475023a; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Mohr SB, 2011, ANTICANCER RES, V31, P2939; Muir SW, 2011, J AM GERIATR SOC, V59, P2291, DOI 10.1111/j.1532-5415.2011.03733.x; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; Myhr KM, 2009, J NEUROL SCI, V286, P104, DOI 10.1016/j.jns.2009.05.002; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Nassar N, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.058; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Palmer SC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008175; Palmer SC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005633.pub2; Parker J, 2010, MATURITAS, V65, P225, DOI 10.1016/j.maturitas.2009.12.013; Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Poel YHM, 2012, EUR J INTERN MED, V23, P465, DOI 10.1016/j.ejim.2012.01.007; Purdue MP, 2010, AM J EPIDEMIOL, V172, P58, DOI 10.1093/aje/kwq117; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Renzaho AMN, 2011, NUTRITION, V27, P868, DOI 10.1016/j.nut.2010.12.014; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sakthiswary R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055275; Saneei P, 2013, OBES REV, V14, P393, DOI 10.1111/obr.12016; Sokol SI, 2011, CARDIOL REV, V19, P192, DOI 10.1097/CRD.0b013e31821da9a5; Song GG, 2012, CLIN RHEUMATOL, V31, P1733, DOI 10.1007/s10067-012-2080-7; Spedding S, 2013, NUTRIENTS, V5, P5127, DOI 10.3390/nu5125127; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Tsilidis KK, 2012, JNCI-J NATL CANCER I, V104, P1867, DOI 10.1093/jnci/djs437; Tzoulaki I, 2013, JAMA INTERN MED, V173, P664, DOI 10.1001/jamainternmed.2013.3018; van der Rhee H, 2009, EUR J CANCER PREV, V18, P458, DOI 10.1097/CEJ.0b013e32832f9bb1; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Wang H, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-42; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Weatherall M, 2000, NEW ZEAL MED J, V113, P137; Wei MY, 2008, CANCER EPIDEM BIOMAR, V17, P2958, DOI 10.1158/1055-9965.EPI-08-0402; Winzenberg T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7254; Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b; Yaghjyan L, 2012, CANCER CAUSE CONTROL, V23, P1, DOI 10.1007/s10552-011-9851-3; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; Yin L, 2009, ALIMENT PHARM THER, V30, P113, DOI 10.1111/j.1365-2036.2009.04022.x; Yin L, 2011, PREV MED, V53, P10, DOI 10.1016/j.ypmed.2011.05.013; Yin L, 2011, GYNECOL ONCOL, V121, P369, DOI 10.1016/j.ygyno.2011.01.023; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037; Yin L, 2009, CANCER EPIDEMIOL, V33, P435, DOI 10.1016/j.canep.2009.10.014; Zgaga L, 2011, J NUTR, V141, P1535, DOI 10.3945/jn.111.140012	140	609	621	11	57	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g2035	10.1136/bmj.g2035	http://dx.doi.org/10.1136/bmj.g2035			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24690624	hybrid, Green Published			2022-12-28	WOS:000333976300002
J	Carlsson, S; Assel, M; Sjoberg, D; Ulmert, D; Hugosson, J; Lilja, H; Vickers, A				Carlsson, Sigrid; Assel, Melissa; Sjoberg, Daniel; Ulmert, David; Hugosson, Jonas; Lilja, Hans; Vickers, Andrew			Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTION; DIAGNOSIS; MORTALITY; SERUM; RISK; MEN	Objective To determine the relative risks of prostate cancer incidence, metastasis, and mortality associated with screening by serum prostate specific antigen (PSA) levels at age 60. Design Population based cohort study. Setting General male population of Sweden taking part in a screening trial in Gothenburg or participating in a cardiovascular study, the Malmo Preventive Project. Participants The screened group consisted of 1756 men aged 57.5-62.5 participating in the screening arm of the Gothenburg randomized prostate cancer screening trial since 1995. The unscreened group consisted of 1162 men, born in 1921, participating in the Malmo Preventive Project, with PSA levels measured retrospectively in stored blood samples from 1981. Intervention PSA screening versus no screening. Main outcome measures Incidence rate ratios for the effect of screening on prostate cancer diagnosis, metastasis, and death by PSA levels at age 60. Results The distribution of PSA levels was similar between the two cohorts. Differences in benefits by baseline PSA levels were large. Among men with baseline levels measured, 71.7% (1646/2295) had a PSA level <2 ng/mL. For men aged 60 with PSA level <2 ng/mL, there was an increase in incidence of 767 cases per 10 000 without a decrease in prostate cancer mortality. For men with PSA levels >= 2 ng/mL, the reduction in cancer mortality was large, with only 23 men needing to be screened and six diagnosed to avoid one prostate cancer death by 15 years. Conclusions The ratio of benefits to harms of PSA screening varies noticeably with blood PSA levels at age 60. For men with a PSA level <1 ng/mL at age 60, no further screening is recommended. Continuing to screen men with PSA levels >2 ng/mL at age 60 is beneficial, with the number needed to screen and treat being extremely favourable. Screening men with a PSA level of 1-2 ng/mL is an individual decision to be based on a discussion between patient and doctor.	[Carlsson, Sigrid; Hugosson, Jonas] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Urol, Gothenburg, Sweden; [Carlsson, Sigrid; Ulmert, David; Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Assel, Melissa; Sjoberg, Daniel; Vickers, Andrew] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10065 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med GU Oncol, New York, NY 10065 USA; [Lilja, Hans] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Lilja, Hans] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Lilja, Hans] Lund Univ, Dept Lab Med Malmo, Malmo, Sweden	University of Gothenburg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Oxford; Tampere University; Lund University	Lilja, H (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA.	liljah@mskcc.org	Lilja, Hans/S-9703-2019	Lilja, Hans/0000-0001-5871-7846; Carlsson, Sigrid/0000-0003-3553-5710; Vickers, Andrew/0000-0003-1525-6503; Sjoberg, Daniel/0000-0003-0862-2018	Swedish Cancer Society; Sweden America Foundation; Swedish Council for Working Life and Social Research; Swedish Society for Medical Research; Swedish Prostate Cancer Foundation; David H Koch Prostate Cancer Foundation Young Investigator Award; Tegger Foundation; Bertha Kamprad Foundation; National Cancer Institute [R01CA160816, R01 CA175491, P50-CA92629]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research Oxford Biomedical Research Centre programme; Swedish Cancer Society [11-0624]; TEKES in Finland; Fundacion Federico; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA160816, R01CA175491, P50CA092629] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Sweden America Foundation; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Society for Medical Research; Swedish Prostate Cancer Foundation; David H Koch Prostate Cancer Foundation Young Investigator Award; Tegger Foundation; Bertha Kamprad Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research Oxford Biomedical Research Centre programme(National Institute for Health Research (NIHR)); Swedish Cancer Society(Swedish Cancer Society); TEKES in Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Fundacion Federico; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SC was supported by grants from the Swedish Cancer Society, the Sweden America Foundation, the Swedish Council for Working Life and Social Research, the Swedish Society for Medical Research, and the Swedish Prostate Cancer Foundation. DU was supported by the David H Koch Prostate Cancer Foundation Young Investigator Award, The Tegger Foundation, and The Bertha Kamprad Foundation. This work was further supported by the National Cancer Institute (R01CA160816, R01 CA175491, and P50-CA92629), the Sidney Kimmel Center for Prostate and Urologic Cancers, and David H Koch through the Prostate Cancer Foundation, the National Institute for Health Research Oxford Biomedical Research Centre programme, Swedish Cancer Society (project No 11-0624), a FiDiPro-programme award from TEKES in Finland, and Fundacion Federico. Role of the funding source: none.	Bratt O, 2010, SCAND J UROL NEPHROL, V44, P384, DOI 10.3109/00365599.2010.498793; Bul M, 2011, EUR UROL, V59, P498, DOI 10.1016/j.eururo.2011.01.001; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jonsson H, 2011, INT J CANCER, V129, P1881, DOI 10.1002/ijc.25846; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Lilja H, 2011, CANCER-AM CANCER SOC, V117, P1210, DOI 10.1002/cncr.25568; Loeb S, 2012, EUR UROL, V61, P1, DOI 10.1016/j.eururo.2011.07.067; MITRUNEN K, 1995, CLIN CHEM, V41, P1115; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schwartz KL, 2003, CANCER CAUSE CONTROL, V14, P761, DOI 10.1023/A:1026321923883; Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641; van Leeuwen PJ, 2010, CANCER-AM CANCER SOC, V116, P4857, DOI 10.1002/cncr.25474; Vickers AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4521; Whittemore AS, 2005, J UROLOGY, V174, P872, DOI 10.1097/01.ju.0000169262.18000.8a; WHITTEMORE AS, 1995, J NATL CANCER I, V87, P354, DOI 10.1093/jnci/87.5.354; Zhu XY, 2012, EUR UROL, V61, P652, DOI 10.1016/j.eururo.2011.11.029	17	52	53	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2014	348								g2296	10.1136/bmj.g2296	http://dx.doi.org/10.1136/bmj.g2296			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9MF	24682399	Green Published, hybrid			2022-12-28	WOS:000333588500002
J	Giering, SLC; Sanders, R; Lampitt, RS; Anderson, TR; Tamburini, C; Boutrif, M; Zubkov, MV; Marsay, CM; Henson, SA; Saw, K; Cook, K; Mayor, DJ				Giering, Sarah L. C.; Sanders, Richard; Lampitt, Richard S.; Anderson, Thomas R.; Tamburini, Christian; Boutrif, Mehdi; Zubkov, Mikhail V.; Marsay, Chris M.; Henson, Stephanie A.; Saw, Kevin; Cook, Kathryn; Mayor, Daniel J.			Reconciliation of the carbon budget in the ocean's twilight zone	NATURE			English	Article							PARTICULATE ORGANIC-MATTER; GROWTH EFFICIENCY; MESOPELAGIC ZONE; METABOLIC RATES; PARTICLE EXPORT; MICROBIAL LOOP; WATER-COLUMN; SPRING BLOOM; BODY-MASS; ZOOPLANKTON	Photosynthesis in the surface ocean produces approximately 100 gigatonnes of organic carbon per year, of which 5 to 15 per cent is exported to the deep ocean(1,2). The rate at which the sinking carbon is converted into carbon dioxide by heterotrophic organisms at depth is important in controlling oceanic carbon storage(3). It remains uncertain, however, to what extent surface ocean carbon supply meets the demand of water-column biota; the discrepancy between known carbon sources and sinks is as much as two orders of magnitude(4-8). Here we present field measurements, respiration rate estimates and a steady-state model that allow us to balance carbon sources and sinks to within observational uncertainties at the Porcupine Abyssal Plain site in the eastern North Atlantic Ocean. We find that prokaryotes are responsible for 70 to 92 per cent of the estimated remineralization in the twilight zone (depths of 50 to 1,000 metres) despite the fact that much of the organic carbon is exported in the form of large, fast-sinking particles accessible to larger zooplankton. We suggest that this occurs because zooplankton fragment and ingest half of the fast-sinking particles, of which more than 30 per cent may be released as suspended and slowly sinking matter, stimulating the deep-ocean microbial loop. The synergy between microbes and zooplankton in the twilight zone is important to our understanding of the processes controlling the oceanic carbon sink.	[Giering, Sarah L. C.; Sanders, Richard; Lampitt, Richard S.; Anderson, Thomas R.; Zubkov, Mikhail V.; Henson, Stephanie A.; Saw, Kevin] Univ Southampton, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton SO14 3ZH, Hants, England; [Giering, Sarah L. C.; Marsay, Chris M.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Giering, Sarah L. C.; Mayor, Daniel J.] Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Newburgh AB41 6AA, Scotland; [Tamburini, Christian; Boutrif, Mehdi] Aix Marseille Univ, Univ Toulon, CNRS INSU, IRD,MIO,UM110, F-13288 Marseille 09, France; [Marsay, Chris M.] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [Cook, Kathryn] Scottish Govt, Marine Lab, Marine Scotland Sci, Aberdeen AB11 9DB, Scotland	NERC National Oceanography Centre; University of Southampton; University of Southampton; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Marine Scotland Science (MSS)	Anderson, TR (corresponding author), Univ Southampton, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton SO14 3ZH, Hants, England.	s.giering@abdn.ac.uk; tra@noc.ac.uk	Henson, Stephanie/AAC-9709-2019; Zubkov, Mikhail/AAW-9674-2020; Sanders, Richard J/B-8717-2012; Mayor, Daniel/HDN-8520-2022; Tamburini, Christian/AAO-8577-2020; Tamburini, Christian/I-7821-2012; Anderson, Thomas/K-5487-2012	Zubkov, Mikhail/0000-0001-7723-6810; Sanders, Richard J/0000-0002-6884-7131; Mayor, Daniel/0000-0002-1295-0041; Tamburini, Christian/0000-0003-3752-7423; Tamburini, Christian/0000-0003-3752-7423; Anderson, Thomas/0000-0002-7408-1566; Cook, Kathryn/0000-0001-8590-3011; Giering, Sarah Lou Carolin/0000-0002-3090-1876; Marsay, Christopher/0000-0003-1244-0444; BOUTRIF, Mehdi/0000-0002-1355-4876	Oceans 2025; EU [264933]; ANR-POTES program [ANR-05-BLAN-0161-01]; Agence Nationale de la Recherche (ANR, France); NERC [NE/G014744/1]; Natural Environment Research Council [NE/J004383/1, NE/K001833/1, NE/H005196/1, NE/G014744/1, noc010009, noc010003, noc010013] Funding Source: researchfish; NERC [NE/J004383/1, noc010009, NE/H005196/1, noc010003, noc010013, NE/K001833/1] Funding Source: UKRI	Oceans 2025; EU(European Commission); ANR-POTES program(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the captain and crew of the RRS Discovery and scientists during D341, especially J. Hunter for executing the ARIES deployments and S. Ward for the PELAGRA deployments. We thank the OSCAR Project Office and BODC for providing data. Finally, we thank T. Cornulier for statistical help. This work was funded by Oceans 2025 and EU FP7-ENV-2010 Collaborative Project 264933 BASIN Basin-Scale Analysis, Synthesis and Integration. C. T. and M. B. were funded by the ANR-POTES program (no. ANR-05-BLAN-0161-01, awarded to C. T.) supported by the Agence Nationale de la Recherche (ANR, France). D.J.M. was funded by NERC (NE/G014744/1).	Al-Mutairi H, 2001, DEEP-SEA RES PT II, V48, P2083, DOI 10.1016/S0967-0645(00)00174-0; Alonso-Saez L, 2007, LIMNOL OCEANOGR, V52, P533, DOI 10.4319/lo.2007.52.2.0533; Anderson TR, 2010, DEEP-SEA RES PT II, V57, P1581, DOI 10.1016/j.dsr2.2010.02.024; Anderson TR, 2001, AQUAT MICROB ECOL, V26, P37, DOI 10.3354/ame026037; Aristegui J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021863; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baltar F, 2010, AQUAT MICROB ECOL, V60, P227, DOI 10.3354/ame01422; Baltar F, 2009, LIMNOL OCEANOGR, V54, P182, DOI 10.4319/lo.2009.54.1.0182; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Boyd PW, 1999, DEEP-SEA RES PT II, V46, P2761, DOI 10.1016/S0967-0645(99)00083-1; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Buesseler KO, 2009, LIMNOL OCEANOGR, V54, P1210, DOI 10.4319/lo.2009.54.4.1210; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; del Giorgio PA, 2011, LIMNOL OCEANOGR, V56, P1, DOI 10.4319/lo.2011.56.1.0001; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doval MD, 2000, MAR CHEM, V68, P249, DOI 10.1016/S0304-4203(99)00081-X; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Fileman E, 2007, J EXP MAR BIOL ECOL, V348, P70, DOI 10.1016/j.jembe.2007.04.003; Gasol JM, 2009, PROG OCEANOGR, V83, P189, DOI 10.1016/j.pocean.2009.07.014; Hansell DA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004069; Henson SA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046735; Henson SA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005139; Ikeda T, 2001, MAR BIOL, V139, P587, DOI 10.1007/s002270100608; IKEDA T, 1985, MAR BIOL, V85, P1, DOI 10.1007/BF00396409; Ikeda T, 2006, MAR ECOL PROG SER, V322, P199, DOI 10.3354/meps322199; Iversen MH, 2010, DEEP-SEA RES PT I, V57, P771, DOI 10.1016/j.dsr.2010.03.007; JUMARS PA, 1989, DEEP-SEA RES, V36, P483, DOI 10.1016/0198-0149(89)90001-0; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Kwon EY, 2009, NAT GEOSCI, V2, P630, DOI 10.1038/NGEO612; Lampitt RS, 2008, DEEP-SEA RES PT I, V55, P1484, DOI 10.1016/j.dsr.2008.07.002; LAMPITT RS, 1990, MAR BIOL, V104, P15, DOI 10.1007/BF01313152; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Legendre L, 2008, MAR ECOL PROG SER, V365, P289, DOI 10.3354/meps07467; Martin AP, 2010, DEEP-SEA RES PT II, V57, P1293, DOI 10.1016/j.dsr2.2010.01.006; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Mayor DJ, 2006, J PLANKTON RES, V28, P1167, DOI 10.1093/plankt/fbl047; Mayor DJ, 2011, FUNCT ECOL, V25, P509, DOI 10.1111/j.1365-2435.2010.01791.x; Mayor DJ, 2009, J MARINE SYST, V78, P505, DOI 10.1016/j.jmarsys.2008.12.019; MCCLATCHIE S, 1986, LIMNOL OCEANOGR, V31, P469, DOI 10.4319/lo.1986.31.3.0469; OHMAN MD, 1984, MAR ECOL PROG SER, V19, P125, DOI 10.3354/meps019125; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; Reinthaler T, 2010, DEEP-SEA RES PT II, V57, P1572, DOI 10.1016/j.dsr2.2010.02.023; Riley JS, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004085; SASAKI H, 1988, DEEP-SEA RES, V35, P505, DOI 10.1016/0198-0149(88)90128-8; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Steinberg DK, 2000, DEEP-SEA RES PT I, V47, P137, DOI 10.1016/S0967-0637(99)00052-7; STRAYER D, 1988, LIMNOL OCEANOGR, V33, P1217, DOI 10.4319/lo.1988.33.5.1217; Tamburini C, 2002, DEEP-SEA RES PT II, V49, P2109, DOI 10.1016/S0967-0645(02)00030-9; WRIGHT RT, 1966, ECOLOGY, V47, P447, DOI 10.2307/1932984; Yamaguchi A, 2002, DEEP-SEA RES PT I, V49, P1007, DOI 10.1016/S0967-0637(02)00008-0; Zubkov MV, 2008, J PLANKTON RES, V30, P211, DOI 10.1093/plankt/fbm091	53	218	224	19	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					480	+		10.1038/nature13123	http://dx.doi.org/10.1038/nature13123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670767	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000333402000036
J	Magill, SS; Edwards, JR; Bamberg, W; Beldavs, ZG; Dumyati, G; Kainer, MA; Lynfield, R; Maloney, M; McAllister-Hollod, L; Nadle, J; Ray, SM; Thompson, DL; Wilson, LE; Fridkin, SK				Magill, Shelley S.; Edwards, Jonathan R.; Bamberg, Wendy; Beldavs, Zintars G.; Dumyati, Ghinwa; Kainer, Marion A.; Lynfield, Ruth; Maloney, Meghan; McAllister-Hollod, Laura; Nadle, Joelle; Ray, Susan M.; Thompson, Deborah L.; Wilson, Lucy E.; Fridkin, Scott K.		Emerging Infect Program Healthcare	Multistate Point- Prevalence Survey of Health Care- Associated Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL-ACQUIRED INFECTIONS; NOSOCOMIAL INFECTIONS; CLOSTRIDIUM-DIFFICILE; RISK-FACTORS; SURVEILLANCE; MULTICENTER; PREVENTION; BURDEN	BackgroundCurrently, no single U.S. surveillance system can provide estimates of the burden of all types of health care-associated infections across acute care patient populations. We conducted a prevalence survey in 10 geographically diverse states to determine the prevalence of health care-associated infections in acute care hospitals and generate updated estimates of the national burden of such infections. MethodsWe defined health care-associated infections with the use of National Healthcare Safety Network criteria. One-day surveys of randomly selected inpatients were performed in participating hospitals. Hospital personnel collected demographic and limited clinical data. Trained data collectors reviewed medical records retrospectively to identify health care-associated infections active at the time of the survey. Survey data and 2010 Nationwide Inpatient Sample data, stratified according to patient age and length of hospital stay, were used to estimate the total numbers of health care-associated infections and of inpatients with such infections in U.S. acute care hospitals in 2011. ResultsSurveys were conducted in 183 hospitals. Of 11,282 patients, 452 had 1 or more health care-associated infections (4.0%; 95% confidence interval, 3.7 to 4.4). Of 504 such infections, the most common types were pneumonia (21.8%), surgical-site infections (21.8%), and gastrointestinal infections (17.1%). Clostridium difficile was the most commonly reported pathogen (causing 12.1% of health care-associated infections). Device-associated infections (i.e., central-catheter-associated bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneumonia), which have traditionally been the focus of programs to prevent health care-associated infections, accounted for 25.6% of such infections. We estimated that there were 648,000 patients with 721,800 health care-associated infections in U.S. acute care hospitals in 2011. ConclusionsResults of this multistate prevalence survey of health care-associated infections indicate that public health surveillance and prevention activities should continue to address C. difficile infections. As device- and procedure-associated infections decrease, consideration should be given to expanding surveillance and prevention activities to include other health care-associated infections. Hospital-acquired infections cause substantial morbidity in inpatient settings. On the basis of a 1-day point-prevalence survey, CDC investigators report the burden and types of health care-associated infection in 183 hospitals across 10 geographically diverse states. Elimination of health care-associated infections is a priority of the Department of Health and Human Services.(1) Considerable success in prevention has been reported for some infections, particularly central-catheter-associated bloodstream infections.(2)-(5) Continued improvements in patient safety depend on maintaining a comprehensive understanding of the epidemiology of health care-associated infections. Currently, no single U.S. surveillance system can provide estimates of the burden of all types of such infections across acute care patient populations. The most recent estimate produced by the Centers for Disease Control and Prevention (CDC) and published in 2007 1.7 million health care-associated infections per year relied ...	[Magill, Shelley S.; Edwards, Jonathan R.; McAllister-Hollod, Laura; Fridkin, Scott K.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Ray, Susan M.] Emory Univ, Sch Med, Atlanta, GA USA; [Bamberg, Wendy] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Beldavs, Zintars G.] Oregon Publ Hlth Author, Portland, OR USA; [Dumyati, Ghinwa] New York Rochester Emerging Infect Program, Rochester, NY USA; [Dumyati, Ghinwa] Univ Rochester, Rochester, NY 14627 USA; [Kainer, Marion A.] Tennessee Dept Hlth, Nashville, TN USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Maloney, Meghan] Connecticut Dept Publ Hlth, Hartford, CT USA; [Nadle, Joelle] Calif Emerging Infect Program, Oakland, CA USA; [Ray, Susan M.] Georgia Emerging Infect Program, Decatur, GA USA; [Ray, Susan M.] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Thompson, Deborah L.] New Mexico Dept Hlth, Santa Fe, NM USA; [Wilson, Lucy E.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Emory University; Colorado Department of Public Health & Environment; University of Rochester; Tennessee Department Health; Minnesota Department of Health (MHD); California Emerging Infections Program; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; New Mexico Department of Health; Maryland Department of Health & Mental Hygiene	Magill, SS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS A-24, Atlanta, GA 30333 USA.	smagill@cdc.gov		Ray, Susan/0000-0002-6327-088X	Infectious Disease Consulting Corporation	Infectious Disease Consulting Corporation	Dr. Kainer reports receiving consulting, lecture, and board membership fees from and owning stock in the Infectious Disease Consulting Corporation. Dr. Lynfield reports receiving travel support from Parexel. No other potential conflict of interest relevant to this article was reported.	American Hospital Association, FAST FACTS US HOSP; Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940; [Anonymous], 2012, 2011 NAT STAT HEALTH; Astagneau P, 2000, J HOSP INFECT, V46, P186, DOI 10.1053/jhin.2000.0833; Azzam R, 2001, J HOSP INFECT, V49, P74, DOI 10.1053/jhin.2001.1043; Centers for Disease Control and Prevention, 2011, ACT BACT COR SURV AB; Cohen J, 2012, IDWEEK 2012 SAN DIEG; Danchaivijitr Somwang, 2007, Journal of the Medical Association of Thailand, V90, P1524; Department of Health & Human Services, NAT ACT PLAN PREV HE; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Dubberke ER, 2011, CLIN INFECT DIS, V53, P20, DOI 10.1093/cid/cir246; Dubberke ER, 2010, INFECT CONT HOSP EP, V31, P1030, DOI 10.1086/656245; Duerink DO, 2006, J HOSP INFECT, V62, P219, DOI 10.1016/j.jhin.2005.08.004; Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9; Faria S, 2007, J HOSP INFECT, V65, P244, DOI 10.1016/j.jhin.2006.11.007; Gastmeier P, 1998, J HOSP INFECT, V38, P37, DOI 10.1016/S0195-6701(98)90173-6; Gikas A, 2002, J HOSP INFECT, V50, P269, DOI 10.1053/jhin.2002.1181; Gravel D, 2007, J HOSP INFECT, V66, P243, DOI 10.1016/j.jhin.2007.04.008; Gravel D, 2007, AM J INFECT CONTROL, V35, P157, DOI 10.1016/j.ajic.2006.06.006; Hajdu A, 2007, J HOSP INFECT, V66, P378, DOI 10.1016/j.jhin.2007.04.018; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; Healthcare Cost and Utilization Project (HCUP), 2010, NAT INP SAMPL NIS; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kallel H, 2005, J HOSP INFECT, V59, P343, DOI 10.1016/j.jhin.2004.09.015; Klavs I, 2003, J HOSP INFECT, V54, P149, DOI 10.1016/S0195-6701(03)00112-9; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Lee MK, 2007, J HOSP INFECT, V65, P341, DOI 10.1016/j.jhin.2006.12.013; Lyytikainen O, 2008, J HOSP INFECT, V69, P288, DOI 10.1016/j.jhin.2008.03.005; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Marsteller JA, 2012, CRIT CARE MED, V40, P2933, DOI 10.1097/CCM.0b013e31825fd4d8; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Metintas S, 2004, AM J INFECT CONTROL, V32, P409, DOI 10.1016/j.ajic.2004.05.001; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268; RHAME FS, 1981, AM J EPIDEMIOL, V113, P1; Scheel O, 1999, J HOSP INFECT, V41, P331, DOI 10.1053/jhin.1998.0520; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; Struwe J, 2006, Euro Surveill, V11, P167; Vaque J, 1999, J HOSP INFECT, V43, pS105, DOI 10.1016/S0195-6701(99)90073-7; Zarb P, 2012, EUROSURVEILLANCE, V17, P4; Zerey Marc, 2007, Surg Infect (Larchmt), V8, P557, DOI 10.1089/sur.2006.062; Zotti CM, 2004, J HOSP INFECT, V56, P142, DOI 10.1016/j.jhin.2003.10.001	44	2282	2388	11	288	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1198	1208		10.1056/NEJMoa1306801	http://dx.doi.org/10.1056/NEJMoa1306801			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670166	Green Accepted			2022-12-28	WOS:000333426000007
J	Mojtabai, R				Mojtabai, Ramin			Diagnosing Depression in Older Adults in Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Depression is less prevalent among older adults than in other age groups, but the number of antidepressant prescriptions does not match this trend. Many patients are treated in primary care settings, where diagnosis and treatment of depression need improvement. The prevalence of diagnosed depression in U.S. adults 65 years of age or older doubled from 3% to 6% between 1992 and 2005.(1) A majority of patients with diagnosed depression were treated with antidepressant medications by primary care and other general medical clinicians.(1) Several factors probably contributed to this trend, including publicity regarding the extent of underdiagnosis and undertreatment of depression in older adults, aggressive pharmaceutical marketing efforts targeting providers and consumers, and the introduction of new antidepressants. A majority of the people diagnosed with depression in primary care settings, however, do not meet the diagnostic criteria for major depressive ...	[Mojtabai, Ramin] Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Mojtabai, Ramin] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Mojtabai, R (corresponding author), Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.		Mojtabai, Ramin/AAL-5023-2020; Mojtabai, Ramin/D-7907-2012	Mojtabai, Ramin/0000-0002-2134-4043; 				Akincigil A, 2011, J AM GERIATR SOC, V59, P1042, DOI 10.1111/j.1532-5415.2011.03447.x; Batstra L, 2012, PSYCHOTHER PSYCHOSOM, V81, P5, DOI 10.1159/000331565; Mitchell AJ, 2010, PSYCHOTHER PSYCHOSOM, V79, P285, DOI 10.1159/000318295; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160	5	34	34	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1180	1182		10.1056/NEJMp1311047	http://dx.doi.org/10.1056/NEJMp1311047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD7EW	24670164				2022-12-28	WOS:000333426000003
J	Paabo, S				Paeaebo, Svante			The Human Condition-A Molecular Approach	CELL			English	Review							BIASED GENE CONVERSION; POSITIVE SELECTION; GREAT APE; DNA-SEQUENCES; NONCODING SEQUENCES; GENOME SEQUENCE; HUMAN-EVOLUTION; SPECIES MODEL; ANCIENT DNA; NEANDERTHAL	Research into when and where modern humans originated and how they differ from, and interacted with, other now-extinct forms of human has so far been the realm of archaeologists and paleoanthropologists. However, over the past decade, molecular geneticists have begun to study genomes of extinct humans. Here, I discuss where we stand today with respect to understanding how modern humans came to differ from Neandertals and other human forms that existed until about 30,000 years ago.	Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	paabo@eva.mpg.de			Presidential Innovation Fund of the Max Planck Society; Paul Allen Family Foundation	Presidential Innovation Fund of the Max Planck Society; Paul Allen Family Foundation	I am grateful to many members of our laboratory for making this work possible, to the Presidential Innovation Fund of the Max Planck Society and the Paul Allen Family Foundation for financial support, and to Aida Andres, Adrian Briggs, Sergi Castellano, Janet Kelso, Fernando Racimo, David Reich, Monty Slatkin, Bence Viola, and especially Kay Prufer for input and help.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Buchlis G, 2013, J IMMUNOL, V191, P228, DOI 10.4049/jimmunol.1202905; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Handt O, 1996, AM J HUM GENET, V59, P368; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Maricic T, 2013, MOL BIOL EVOL, V30, P844, DOI 10.1093/molbev/mss271; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars Paul A., 1996, NEANDERTHAL LEGACY A; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; PAABO S, 1989, J BIOL CHEM, V264, P9709; Paabo S., 1984, ALTERTUM, V30, P213; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Przeworski M, 2002, GENETICS, V160, P1179; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sankararaman S, 2014, NATURE; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Su B., 2010, BMC EVOLUTIONARY BIO, V10, P15; Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	99	91	91	5	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					216	226		10.1016/j.cell.2013.12.036	http://dx.doi.org/10.1016/j.cell.2013.12.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679537	Bronze			2022-12-28	WOS:000333968900018
J	Zhang, JK; Chan, FKM				Zhang, Jianke; Chan, Francis Ka-Ming			RIPK3 Takes Another Deadly Turn	SCIENCE			English	Editorial Material							NF-KAPPA-B; PROGRAMMED NECROSIS; KINASE; APOPTOSIS; PHOSPHORYLATION; IDENTIFICATION; PROTEIN; CELL		[Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Zhang, JK (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	jianke.zhang@jefferson.edu; francis.chan@umassmed.edu	Chan, Francis/ABB-1895-2021; Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis K.L./F-4851-2010	Chan, Francis Ka-Ming/0000-0002-4803-8353; Chan, Francis K.L./0000-0001-7388-2436	NCI NIH HHS [P30 CA056036] Funding Source: Medline; NIAID NIH HHS [R01 AI083497] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083497] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; McQuade T, 2013, BIOCHEM J, V456, P409, DOI 10.1042/BJ20130860; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Taylor SS, 2013, BIOCHEM SOC T, V41, P981, DOI 10.1042/BST20130120; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5	12	6	6	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1322	1323		10.1126/science.1252526	http://dx.doi.org/10.1126/science.1252526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653026	Green Accepted			2022-12-28	WOS:000333108500024
J	Gorkin, DU; Ren, B				Gorkin, David U.; Ren, Bing			GENETICS Closing the distance on obesity culprits	NATURE			English	Editorial Material							FTO GENE; REGULATORY DNA; ADULT OBESITY; CHILDHOOD; ENHANCER		[Gorkin, David U.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Gorkin, David U.; Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Gorkin, DU (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dgorkin@gmail.com; biren@ucsd.edu		Gorkin, David/0000-0003-4944-4107	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NIEHS NIH HHS [U01 ES017166] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111	13	9	9	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					309	310		10.1038/nature13212	http://dx.doi.org/10.1038/nature13212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646989				2022-12-28	WOS:000333029000021
J	Zivanovic, S; Peacock, J; Alcazar-Paris, M; Lo, JW; Lunt, A; Marlow, N; Calvert, S; Greenough, A				Zivanovic, Sanja; Peacock, Janet; Alcazar-Paris, Mireia; Lo, Jessica W.; Lunt, Alan; Marlow, Neil; Calvert, Sandy; Greenough, Anne		United Kingdom Oscillation	Late Outcomes of a Randomized Trial of High-Frequency Oscillation in Neonates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LUNG-DISEASE; CHILDREN AGED 4; REFERENCE VALUES; PRETERM INFANTS; VENTILATION; STANDARDIZATION; PULMONARY	Background Results from an observational study involving neonates suggested that high-frequency oscillatory ventilation (HFOV), as compared with conventional ventilation, was associated with superior small-airway function at follow-up. Data from randomized trials are needed to confirm this finding. Methods We studied 319 adolescents who had been born before 29 weeks of gestation and had been enrolled in a multicenter, randomized trial that compared HFOV with conventional ventilation immediately after birth. The trial involved 797 neonates, of whom 592 survived to hospital discharge. We compared follow-up data from adolescents who had been randomly assigned to HFOV with follow-up data from those who had been randomly assigned to conventional ventilation, with respect to lung function and respiratory health, health-related quality of life, and functional status, as assessed with the use of questionnaires completed when the participants were 11 to 14 years of age. The primary outcome was forced expiratory flow at 75% of the expired vital capacity (FEF75). Results The HFOV group had superior results on a test of small-airway function (z score for FEF75, -0.97 with HFOV vs. -1.19 with conventional therapy; adjusted difference, 0.23 [95% confidence interval, 0.02 to 0.45]). There were significant differences in favor of HFOV in several other measures of respiratory function, including forced expiratory volume in 1 second, forced vital capacity, peak expiratory flow, diffusing capacity, and impulse-oscillometric findings. As compared with the conventional-therapy group, the HFOV group had significantly higher ratings from teachers in three of eight school subjects assessed, but there were no other significant differences in functional outcomes. Conclusions In a randomized trial involving children who had been born extremely prematurely, those who had undergone HFOV, as compared with those who had received conventional ventilation, had superior lung function at 11 to 14 years of age, with no evidence of poorer functional outcomes.	[Zivanovic, Sanja; Alcazar-Paris, Mireia; Lunt, Alan; Greenough, Anne] Kings Coll London, Div Asthma Allergy & Lung Biol, Med Res Council, Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Peacock, Janet; Lo, Jessica W.] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Zivanovic, Sanja; Peacock, Janet; Lo, Jessica W.; Lunt, Alan; Greenough, Anne] Guys & St Thomas Natl Hlth Serv Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Zivanovic, Sanja; Peacock, Janet; Lo, Jessica W.; Lunt, Alan; Greenough, Anne] Kings Coll London, London WC2R 2LS, England; [Marlow, Neil] UCL, Inst Womens Hlth, London WC1E 6BT, England; [Calvert, Sandy] Univ London, Dept Child Hlth, London WC1E 7HU, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of London	Greenough, A (corresponding author), Kings Coll Hosp London, Neonatal Intens Care Unit, 4th Fl Golden Jubilee Wing,Denmark Hill, London SE5 9RS, England.	anne.greenough@kcl.ac.uk	Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953; Cunningham, Steve/0000-0001-7342-251X; Lo, Jessica/0000-0003-4778-8360; Alcazar, Mireia/0000-0002-9691-7942; Halliday, Henry/0000-0001-7978-4992; Greenough, Anne/0000-0002-8672-5349; Lunt, Alan/0000-0002-4585-9180; Peacock, Janet/0000-0002-0310-2518	National Institute for Health Research Health Technology Assessment Programme [08/116/10]; the South London Comprehensive Local Research Network; the Department of Health NIHR Biomedical Research Centre at University College London Hospitals and University College London; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; National Institute for Health Research [NF-SI-0512-10034, 08/116/10] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); the South London Comprehensive Local Research Network; the Department of Health NIHR Biomedical Research Centre at University College London Hospitals and University College London; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute for Health Research Health Technology Assessment Programme and others.; Supported by a grant (08/116/10) from the NIHR Health Technology Assessment Programme, the South London Comprehensive Local Research Network, the Department of Health NIHR Biomedical Research Centre funding scheme at University College London Hospitals and University College London, and the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London.	[Anonymous], 1990, J Pediatr, V116, P933; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Clausen JL, CONSENSUS STATEMENT; Coates AL, 1997, EUR RESPIR J, V10, P1415, DOI 10.1183/09031936.97.10061415; Cools F, 2011, LANCET, V377, P1572; Cools F, 2009, COCHRANE DB SYST REV, V3; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Gerstmann DR, 1996, PEDIATRICS, V98, P1044; Gerstmann DR, 2001, PEDIATRICS, V108, P617, DOI 10.1542/peds.108.3.617; Greenough A, 2012, COCHRANE DB SYST REV, V1; Hofhuis W, 2002, AM J RESP CRIT CARE, V166, P1539, DOI 10.1164/rccm.2202046; Hoo AF, 2002, J PEDIATR-US, V141, P652, DOI 10.1067/mpd.2002.128114; Horsley A, 2009, RESP MED, V103, P793, DOI 10.1016/j.rmed.2009.01.025; Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; Latzin P, 2008, THORAX, V63, P98, DOI 10.1136/thx.2007.085332; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Moriette G, 2001, PEDIATRICS, V107, P363, DOI 10.1542/peds.107.2.363; Nowowiejska B, 2008, PEDIATR PULM, V43, P1193, DOI 10.1002/ppul.20926; Peacock JL, 2012, STAT MED, V31, P3089, DOI 10.1002/sim.5354; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; ROSENTHAL M, 1993, THORAX, V48, P803, DOI 10.1136/thx.48.8.803; ROSENTHAL M, 1993, THORAX, V48, P794, DOI 10.1136/thx.48.8.794; Sauzet O, 2013, STAT MED, V32, P1429, DOI 10.1002/sim.5638; SINNETT E, 1989, NEW ENGL J MED, V320, P88; Smith HJ, 2005, EUROPEAN RESP MONOGR, V31, P72, DOI [DOI 10.1183/1025448X.00031005, 10.1183/1025448x.00031005]; Stark AR, 2002, NEW ENGL J MED, V347, P682, DOI 10.1056/NEJMe020080; Thomas MR, 2004, AM J RESP CRIT CARE, V169, P868, DOI 10.1164/rccm.200310-1425OC; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wheeler K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003666.pub3	29	79	80	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1121	1130		10.1056/NEJMoa1309220	http://dx.doi.org/10.1056/NEJMoa1309220			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645944	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000333054000008
J	Vohra, P				Vohra, Pankaj			PERSONAL VIEW India should worry about underdiagnosis and overdiagnosis of coeliac disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Max Super Special Hosp, Delhi 110021, India		Vohra, P (corresponding author), Max Super Special Hosp, Press Enclave Marg, Delhi 110021, India.	pankajvohramd@yahoo.com						Makharia GK, 2011, J GASTROEN HEPATOL, V26, P894, DOI 10.1111/j.1440-1746.2010.06606.x; Mooney PD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1561	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g2046	10.1136/bmj.g2046	http://dx.doi.org/10.1136/bmj.g2046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647342				2022-12-28	WOS:000333414500009
J	Karthikesalingam, A; Holt, PJ; Vidal-Diez, A; Ozdemir, BA; Poloniecki, JD; Hinchliffe, RJ; Thompson, MM				Karthikesalingam, Alan; Holt, Peter J.; Vidal-Diez, Alberto; Ozdemir, Baris A.; Poloniecki, Jan D.; Hinchliffe, Robert J.; Thompson, Matthew M.			Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA	LANCET			English	Article							ENDOVASCULAR REPAIR; ADMINISTRATIVE DATA; NATIONWIDE BENEFITS; IMPROVE TRIALISTS; RANDOMIZED-TRIAL; CO-MORBIDITY; OPEN SURGERY; VOLUME; MANAGEMENT; SCORE	Background The outcome of patients with ruptured abdominal aortic aneurysm (rAAA) varies by country. Study of practice differences might allow the formulation of pathways to improve care. Methods We compared data from the Hospital Episode Statistics for England and the Nationwide Inpatient Sample for the USA for patients admitted to hospital with rAAA from 2005 to 2010. Primary outcomes were in-hospital mortality, mortality after intervention, and decision to follow non-corrective treatment. In-hospital mortality and the rate of non-corrective treatment were analysed by binary logistic regression for each health-care system, after adjustment for age, sex, year, and Charlson comorbidity index. Findings The study included 11 799 patients with rAAA in England and 23 838 patients with rAAA in the USA. Inhospital mortality was lower in the USA than in England (53.05% [95% CI 51.26-54.85] vs 65.90%; p<0.0001). Intervention (open or endovascular repair) was offered to a greater proportion of cases in the USA than in England (19 174 [80.43%] vs 6897 [58.45%]; p<0.0001) and endovascular repair was more common in the USA than in England (4003 [20.88%] vs 589 [8.54%]; p<0.0001). Postintervention mortality was similar in both countries (41.77% for England and 41.65% for USA). These observations persisted in age-matched and sex-matched comparisons. In both countries, reduced mortality was associated with increased use of endovascular repair, increased hospital case-load (volume) for rAAA, high hospital bed capacity, hospitals with teaching status, and admission on a weekday. Interpretation In-hospital survival from rAAA, intervention rates, and uptake of endovascular repair are lower in England than in the USA. In England and the USA, the lowest mortality for rAAA was seen in teaching hospitals with larger bed capacities and doing a greater proportion of cases with endovascular repair. These common factors suggest strategies for improving outcomes for patients with rAAA.	[Karthikesalingam, Alan; Holt, Peter J.; Vidal-Diez, Alberto; Ozdemir, Baris A.; Poloniecki, Jan D.; Hinchliffe, Robert J.; Thompson, Matthew M.] Univ London, St Georges Vasc Inst, London SW17 0RE, England	St Georges University London; University of London	Holt, PJ (corresponding author), Univ London, St Georges Vasc Inst, Room 0-232,Cranmer Terrace, London SW17 0RE, England.	pholt@sgul.ac.uk	Holt, Peter/B-2003-2013	Holt, Peter/0000-0002-5739-2813; Vidal-Diez, Alberto/0000-0001-6380-3925; Ozdemir, Baris Ata/0000-0002-0982-4482	Circulation Foundation Surgeon Scientist Award; National Institute for Health Research [NIHR-CS-011-008]; Medtronic; Cook Endovascular; Endologix	Circulation Foundation Surgeon Scientist Award; National Institute for Health Research(National Institute for Health Research (NIHR)); Medtronic(Medtronic); Cook Endovascular; Endologix	AK is a Clinical Lecturer supported by the Circulation Foundation Surgeon Scientist Award. PH is a Clinician Scientist financially supported by the National Institute for Health Research (NIHR-CS-011-008). MMT has received research grants from Medtronic, Cook Endovascular, and Endologix. The NIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, NHS, or Department of Health.	Anjum A, 2012, BRIT J SURG, V99, P637, DOI 10.1002/bjs.8698; Antoniou GA, 2013, J VASC SURG, V58, P1091, DOI 10.1016/j.jvs.2013.07.109; Armitage JN, 2010, BRIT J SURG, V97, P772, DOI 10.1002/bjs.6930; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Basnyat PS, 1999, BRIT J SURG, V86, P765, DOI 10.1046/j.1365-2168.1999.01170.x; Bown MJ, 2002, BRIT J SURG, V89, P714, DOI 10.1046/j.1365-2168.2002.02122.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CK, 2013, WORLD J SURG, V37, P2360, DOI 10.1007/s00268-013-2136-0; Dillavou ED, 2006, J VASC SURG, V43, P230, DOI 10.1016/j.jvs.2005.09.043; Dillavou ED, 2006, J VASC SURG, V43, P446, DOI 10.1016/j.jvs.2005.11.017; Edwards ST, 2014, J VASC SURG, V59, P575, DOI 10.1016/j.jvs.2013.08.093; Egorova N, 2008, J VASC SURG, V48, P1092, DOI 10.1016/j.jvs.2008.06.036; Egorova NN, 2011, J VASC SURG, V54, P1, DOI 10.1016/j.jvs.2010.12.049; Filipovic M, 2007, BRIT J SURG, V94, P1096, DOI 10.1002/bjs.5784; Gibbons C, 2008, 2 VASCULAR SURG DAT; Hardman DTA, 1996, J VASC SURG, V23, P123, DOI 10.1016/S0741-5214(05)80042-4; Hinchliffe RJ, 2006, EUR J VASC ENDOVASC, V32, P506, DOI 10.1016/j.ejvs.2006.05.016; Holt PJE, 2007, BRIT J SURG, V94, P441, DOI 10.1002/bjs.5725; Holt PJE, 2012, BRIT J SURG, V99, P666, DOI 10.1002/bjs.8696; Holt PJE, 2012, BRIT J SURG, V99, P58, DOI 10.1002/bjs.7680; Holt PJE, 2010, BRIT J SURG, V97, P496, DOI 10.1002/bjs.6911; Holt PJE, 2009, CIRC-CARDIOVASC QUAL, V2, P624, DOI 10.1161/CIRCOUTCOMES.109.848465; Hoornweg LL, 2007, EUR J VASC ENDOVASC, V33, P679, DOI 10.1016/j.ejvs.2006.12.011; Houchens R, 2005, 20032 US AG HEALTHC; Karkos CD, 2011, EUR J VASC ENDOVASC, V42, P775, DOI 10.1016/j.ejvs.2011.07.028; Karthikesalingam A, 2010, J ENDOVASC THER, V17, P356, DOI 10.1583/10-3035.1; Kent KC, 2006, J VASC SURG, V43, P451; Landon BE, 2010, CIRCULATION, V122, P1290, DOI 10.1161/CIRCULATIONAHA.110.949172; Lemaire A, 2008, J VASC SURG, V47, P1172, DOI 10.1016/j.jvs.2008.01.033; Lesperance K, 2008, J VASC SURG, V47, P1165, DOI 10.1016/j.jvs.2008.01.055; Mani K, 2013, BRIT J SURG, V100, P638, DOI 10.1002/bjs.9046; Mani K, 2011, EUR J VASC ENDOVASC, V42, P598, DOI 10.1016/j.ejvs.2011.06.043; Mani K, 2009, CIRCULATION, V120, P201, DOI 10.1161/CIRCULATIONAHA.108.832774; Mathieson SA, 2011, GUARDIAN        0629; Mayer D, 2012, ANN SURG, V256, P688, DOI 10.1097/SLA.0b013e318271cebd; Mell MW, 2014, J VASC SURG, V59, P583, DOI 10.1016/j.jvs.2013.09.032; Mureebe L, 2008, J VASC SURG, V48, P1101, DOI 10.1016/j.jvs.2008.06.031; Mureebe L, 2010, J VASC SURG, V51, p9S, DOI 10.1016/j.jvs.2009.10.129; Park BD, 2013, J AM COLL SURGEONS, V216, P745, DOI 10.1016/j.jamcollsurg.2012.12.028; Powell JT, 2009, ACTA CHIR BELG, V109, P678; Powell JT, 2009, EUR J VASC ENDOVASC, V38, P237, DOI 10.1016/j.ejvs.2009.04.002; Powell JT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7661; Reimerink JJ, 2013, ANN SURG, V258, P248, DOI 10.1097/SLA.0b013e31828d4b76; Samy AK, 1996, J ROY COLL SURG EDIN, V41, P105; Schermerhorn ML, 2012, ANN SURG, V256, P651, DOI 10.1097/SLA.0b013e31826b4f91; Tambyraja A, 2007, WORLD J SURG, V31, P2243, DOI 10.1007/s00268-007-9181-5; Tambyraja AL, 2008, J VASC SURG, V47, P222, DOI 10.1016/j.jvs.2007.07.035; Veith FJ, 2009, ANN SURG, V250, P818, DOI 10.1097/SLA.0b013e3181bdd7f5; Visser JJ, 2009, J VASC SURG, V49, P1093, DOI 10.1016/j.jvs.2008.12.027; Wanhainen A, 2008, BRIT J SURG, V95, P564, DOI 10.1002/bjs.6109; West Dave, 2011, Health Serv J, V121, P10; Wyatt MG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1854	52	190	193	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					963	969		10.1016/S0140-6736(14)60109-4	http://dx.doi.org/10.1016/S0140-6736(14)60109-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24629298	Green Submitted			2022-12-28	WOS:000333520700027
J	Kleine, C; Schoefer, H; Amendt, J; Bexten, T; Just-Nuebling, G				Kleine, Christian; Schoefer, Helmut; Amendt, Jens; Bexten, Tobias; Just-Nuebling, Gudrun			Cutaneous myiasis in a patient with seborrhoeic eczema	LANCET			English	Editorial Material									[Kleine, Christian; Just-Nuebling, Gudrun] JW Goethe Univ Hosp, Dept Infect Dis & Trop Med, Frankfurt, Germany; [Schoefer, Helmut] JW Goethe Univ Hosp, Dept Dermatol Venereol & Allergol, Frankfurt, Germany; [Amendt, Jens] JW Goethe Univ Hosp, Inst Forens Med, Frankfurt, Germany; [Bexten, Tobias] JW Goethe Univ Hosp, Dept Gen & Visceral Surg, Frankfurt, Germany; [Kleine, Christian] Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Kleine, Christian] Univ Tubingen, Inst Tropenmed, Tubingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Eberhard Karls University of Tubingen	Kleine, C (corresponding author), JW Goethe Univ Hosp Frankfurt, Ctr Internal Med 2, Dept Infect Dis & Trop Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	christian.kleine@kgu.de	schoefer, helmut/ABI-3942-2020	Amendt, Jens/0000-0001-8050-3211				Francesconi F, 2012, CLIN MICROBIOL REV, V25, P79, DOI 10.1128/CMR.00010-11; Mariwalla K, 2007, J AM ACAD DERMATOL, V57, pS51, DOI 10.1016/j.jaad.2006.10.022; McGraw TA, 2008, J AM ACAD DERMATOL, V58, P907, DOI 10.1016/j.jaad.2008.03.014	3	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					1012	1012		10.1016/S0140-6736(14)60199-9	http://dx.doi.org/10.1016/S0140-6736(14)60199-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24629299				2022-12-28	WOS:000333520700032
J	Imazio, M; Belli, R; Brucato, A; Cemin, R; Ferrua, S; Beqaraj, F; Demarie, D; Ferro, S; Forno, D; Maestroni, S; Cumetti, D; Varbella, F; Trinchero, R; Spodick, DH; Adler, Y				Imazio, Massimo; Belli, Riccardo; Brucato, Antonio; Cemin, Roberto; Ferrua, Stefania; Beqaraj, Federico; Demarie, Daniela; Ferro, Silvia; Forno, Davide; Maestroni, Silvia; Cumetti, Davide; Varbella, Ferdinando; Trinchero, Rita; Spodick, David H.; Adler, Yehuda			Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial	LANCET			English	Article							RELAPSING PERICARDITIS; MANAGEMENT; DISEASES; DIAGNOSIS; THERAPY	Background Colchicine is effective for the treatment of acute pericarditis and first recurrences. However, conclusive data are lacking for the efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis. Methods We did this multicentre, double-blind trial at four general hospitals in northern Italy. Adult patients with multiple recurrences of pericarditis (>= two) were randomly assigned (1:1) to placebo or colchicine (0.5 mg twice daily for 6 months for patients weighing more than 70 kg or 0.5 mg once daily for patients weighing 70 kg or less) in addition to conventional anti-inflammatory treatment with aspirin, ibuprofen, or indometacin. Permuted block randomisation (size four) was done with a central computer-based automated sequence. Patients and all investigators were masked to treatment allocation. The primary outcome was recurrent pericarditis in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT00235079. Findings 240 patients were enrolled and 120 were assigned to each group. The proportion of patients who had recurrent pericarditis was 26 (21.6%) of 120 in the colchicine group and 51 (42.5%) of 120 in the placebo group (relative risk 0.49; 95% CI 0.24-0.65; p=0.0009; number needed to treat 5). Adverse effects and discontinuation of study drug occurred in much the same proportions in each group. The most common adverse events were gastrointestinal intolerance (nine patients in the colchicine group vs nine in the placebo group) and hepatotoxicity (three vs one). No serious adverse events were reported. Interpretation Colchicine added to conventional anti-inflammatory treatment significantly reduced the rate of subsequent recurrences of pericarditis in patients with multiple recurrences. Taken together with results from other randomised controlled trials, these findings suggest that colchicine should be probably regarded as a first-line treatment for either acute or recurrent pericarditis in the absence of contraindications or specific indications. Funding Azienda Sanitaria 3 of Torino (now ASLTO2).	[Imazio, Massimo; Belli, Riccardo; Beqaraj, Federico; Demarie, Daniela; Ferro, Silvia; Forno, Davide; Trinchero, Rita] Maria Vittoria Hosp, Dept Cardiol, I-10141 Turin, Italy; [Brucato, Antonio; Maestroni, Silvia; Cumetti, Davide] Ex Osped Riuniti, Papa Giovanni XXIII Hosp, Dept Internal Med, Bergamo, Italy; [Cemin, Roberto] San Maurizio Reg Hosp, Dept Cardiol, Bolzano, Italy; [Ferrua, Stefania; Varbella, Ferdinando] Osped Infermi, Dept Cardiol, Rivoli, Italy; [Spodick, David H.] St Vincent Hosp, Dept Internal Med, Worcester, MA 01604 USA; [Adler, Yehuda] Tel Hashomer & Sacker Fac Med, Chaim Sheba Med Ctr, Tel Aviv, Israel	Maria Vittoria Hospital; ASST Papa Giovanni XXIII; Krankenhaus Bozen; Hospital of Rimini; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Imazio, M (corresponding author), Maria Vittoria Hosp, Dept Cardiol, Via Luigi Cibrario 72, I-10141 Turin, Italy.	massimo_imazio@yahoo.it	brucato, antonio/U-6879-2019; VARBELLA, FERDINANDO/AAA-9428-2019	brucato, antonio/0000-0002-7566-5600; VARBELLA, FERDINANDO/0000-0002-8213-359X; Imazio, Massimo/0000-0002-5722-0245	ASLTO2 within the Italian National Health Service	ASLTO2 within the Italian National Health Service	The CORP-2 trial was supported by the former Azienda Sanitaria 3 of Torino (now ASLTO2) within the Italian National Health Service. Acarpia (Madeira, Portugal) provided the study drug and placebo as an unrestricted grant.	Brucato A, 2008, AUTOIMMUN REV, V8, P44, DOI 10.1016/j.autrev.2008.07.024; Cacoub P, 2000, ARCH MAL COEUR VAISS, V93, P1511; Geri G, 2012, MEDICINE, V91, P25, DOI 10.1097/MD.0b013e3182428f49; Imazio M, 2005, ARCH INTERN MED, V165, P1987, DOI 10.1001/archinte.165.17.1987; Imazio M, 2008, CIRCULATION, V118, P667, DOI 10.1161/CIRCULATIONAHA.107.761064; Imazio M, 2007, J CARDIOVASC MED, V8, P830, DOI 10.2459/JCM.0b013e3280110616; Imazio M, 2013, NEW ENGL J MED, V369, P1522, DOI 10.1056/NEJMoa1208536; Imazio M, 2013, CIRCULATION, V128, P42, DOI 10.1161/CIRCULATIONAHA.113.001531; Imazio M, 2013, EXPERT REV CARDIOVAS, V11, P193, DOI [10.1586/erc.12.184, 10.1586/ERC.12.184]; Imazio M, 2012, EXPERT REV CARDIOVAS, V10, P1165, DOI [10.1586/ERC.12.101, 10.1586/erc.12.101]; Imazio M, 2012, HEART, V98, P1078, DOI 10.1136/heartjnl-2011-301306; Imazio M, 2012, CURR OPIN CARDIOL, V27, P308, DOI 10.1097/HCO.0b013e3283524fbe; Imazio M, 2011, ANN INTERN MED, V155, P409, DOI 10.7326/0003-4819-155-7-201110040-00359; Imazio M, 2010, CIRCULATION, V121, P916, DOI 10.1161/CIRCULATIONAHA.108.844753; Imazio M, 2009, J CARDIOVASC MED, V10, P217, DOI 10.2459/JCM.0b013e328322f9b1; Imazio M, 2009, EUR HEART J, V30, P532, DOI 10.1093/eurheartj/ehn608; Kabbani Samer S., 2002, Curr Treat Options Cardiovasc Med, V4, P487, DOI 10.1007/s11936-002-0042-0; Khandaker MH, 2012, MAYO CLIN PROC, V87, P1062, DOI 10.1016/j.mayocp.2012.05.024; Little WC, 2006, CIRCULATION, V113, P1622, DOI 10.1161/CIRCULATIONAHA.105.561514; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Moretti M, 2013, AM J CARDIOL, V112, P1493, DOI 10.1016/j.amjcard.2013.06.036; Soler-Soler J, 2004, HEART, V90, P1364, DOI 10.1136/hrt.2003.026120; Vassilopoulos D, 2012, INT J CARDIOL, V160, P66, DOI 10.1016/j.ijcard.2012.05.086; Vianello F, 2011, INT J CARDIOL, V147, P477, DOI 10.1016/j.ijcard.2011.01.027	24	218	228	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2232	2237		10.1016/S0140-6736(13)62709-9	http://dx.doi.org/10.1016/S0140-6736(13)62709-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK8DO	24694983				2022-12-28	WOS:000338657600027
J	Poortmans, P				Poortmans, Philip			Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate	LANCET			English	Editorial Material							HEART-DISEASE; WOMEN; RADIOTHERAPY; MORTALITY		Inst Verbeeten, Dept Radiat Oncol, NL-5000 LA Tilburg, Netherlands	Instituut Verbeeten	Poortmans, P (corresponding author), Inst Verbeeten, Dept Radiat Oncol, NL-5000 LA Tilburg, Netherlands.	poortmans.ph@bvi.nl	Poortmans, P.M.P./L-4581-2015					Abe O, 2005, LANCET, V366, P2087; Bartlett FR, 2013, RADIOTHER ONCOL, V108, P242, DOI 10.1016/j.radonc.2013.04.021; Constantinidou A, 2011, ANN ONCOL, V22, P307, DOI 10.1093/annonc/mdq343; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; EBCTCG, 2014, LANCET; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Janssen-Heijnen MLG, 2014, ANN ONCOL, V25, P64, DOI 10.1093/annonc/mdt424; Poortmans P, 2012, SEMIN RADIAT ONCOL, V22, P29, DOI 10.1016/j.semradonc.2011.09.007; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284	12	52	54	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2104	2106		10.1016/S0140-6736(14)60192-6	http://dx.doi.org/10.1016/S0140-6736(14)60192-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24656686	hybrid			2022-12-28	WOS:000337906600006
J	Dick, KJ; Nelson, CP; Tsaprouni, L; Sandling, JK; Aissi, D; Wahl, S; Meduri, E; Morange, PE; Gagnon, F; Grallert, H; Waldenberger, M; Peters, A; Erdmann, J; Hengstenberg, C; Cambien, F; Goodall, AH; Ouwehand, WH; Schunkert, H; Thompson, JR; Spector, TD; Gieger, C; Tregouet, DA; Deloukas, P; Samani, NJ				Dick, Katherine J.; Nelson, Christopher P.; Tsaprouni, Loukia; Sandling, Johanna K.; Aissi, Dylan; Wahl, Simone; Meduri, Eshwar; Morange, Pierre-Emmanuel; Gagnon, France; Grallert, Harald; Waldenberger, Melanie; Peters, Annette; Erdmann, Jeanette; Hengstenberg, Christian; Cambien, Francois; Goodall, Alison H.; Ouwehand, Willem H.; Schunkert, Heribert; Thompson, John R.; Spector, Tim D.; Gieger, Christian; Tregout, David-Alexandre; Deloukas, Panos; Samani, Nilesh J.			DNA methylation and body-mass index: a genome-wide analysis	LANCET			English	Article							PAS DOMAIN PROTEIN; ADIPOSE-TISSUE; OBESITY; EXPRESSION; DISCOVERY; PATTERNS; OLIGONUCLEOTIDE; NORMALIZATION; ASSOCIATION; DRIVERS	Background Obesity is a major health problem that is determined by interactions between lifestyle and environmental and genetic factors. Although associations between several genetic variants and body-mass index (BMI) have been identified, little is known about epigenetic changes related to BMI. We undertook a genome-wide analysis of methylation at CpG sites in relation to BMI. Methods 479 individuals of European origin recruited by the Cardiogenics Consortium formed our discovery cohort. We typed their whole-blood DNA with the Infinium HumanMethylation450 array. After quality control, methylation levels were tested for association with BMI. Methylation sites showing an association with BMI at a false discovery rate q value of 0.05 or less were taken forward for replication in a cohort of 339 unrelated white patients of northern European origin from the MARTHA cohort. Sites that remained significant in this primary replication cohort were tested in a second replication cohort of 1789 white patients of European origin from the KORA cohort. We examined whether methylation levels at identified sites also showed an association with BMI in DNA from adipose tissue (n=635) and skin (n=395) obtained from white female individuals participating in the MuTHER study. Finally, we examined the association of methylation at BMI-associated sites with genetic variants and with gene expression. Findings 20 individuals from the discovery cohort were excluded from analyses after quality-control checks, leaving 459 participants. After adjustment for covariates, we identified an association (q value <= 0.05) between methylation at five probes across three different genes and BMI. The associations with three of these probes-cg22891070, cg27146050, and cg16672562, all of which are in intron 1 of HIF3A-were confirmed in both the primary and second replication cohorts. For every 0.1 increase in methylation beta value at cg22891070, BMI was 3.6% (95% CI 2.4-4.9) higher in the discovery cohort, 2.7% (1.2-4.2) higher in the primary replication cohort, and 0.8% (0.2-1.4) higher in the second replication cohort. For the MuTHER cohort, methylation at cg22891070 was associated with BMI in adipose tissue (p=1.72 x 10(-5)) but not in skin (p=0.882). We observed a significant inverse correlation (p=0.005) between methylation at cg22891070 and expression of one HIF3A gene-expression probe in adipose tissue. Two single nucleotide polymorphisms-rs8102595 and rs3826795-had independent associations with methylation at cg22891070 in all cohorts. However, these single nucleotide polymorphisms were not significantly associated with BMI. Interpretation Increased BMI in adults of European origin is associated with increased methylation at the HIF3A locus in blood cells and in adipose tissue. Our findings suggest that perturbation of hypoxia inducible transcription factor pathways could have an important role in the response to increased weight in people.	[Dick, Katherine J.; Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester LE3 9QP, Leics, England; [Dick, Katherine J.; Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.] Glenfield Gen Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Tsaprouni, Loukia; Sandling, Johanna K.; Meduri, Eshwar; Ouwehand, Willem H.; Deloukas, Panos] Wellcome Trust Res Labs, Sanger Inst, Hinxton, England; [Tsaprouni, Loukia] Univ Bedforshire, ISPAR Inst, Bedford, England; [Sandling, Johanna K.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sandling, Johanna K.] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Aissi, Dylan; Cambien, Francois; Tregout, David-Alexandre] Univ Paris 06, Univ Sorbonne, UPMC, UMR S1166, F-75013 Paris, France; [Aissi, Dylan; Cambien, Francois; Tregout, David-Alexandre] INSERM, UMR S1166, F-75013 Paris, France; [Aissi, Dylan; Cambien, Francois; Tregout, David-Alexandre] ICAN Inst Cardiometab & Nutr, F-75013 Paris, France; [Wahl, Simone; Grallert, Harald] German Ctr Diabet Res, Neuherberg, Germany; [Wahl, Simone; Grallert, Harald; Waldenberger, Melanie; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Wahl, Simone; Grallert, Harald; Waldenberger, Melanie; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Morange, Pierre-Emmanuel] Aix Marseille Univ, INSERM, UMR S1062, Marseille, France; [Gagnon, France] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Peters, Annette; Hengstenberg, Christian; Schunkert, Heribert] Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany; [Erdmann, Jeanette] Univ Lubeck, Inst Integrat & Expt Genom, Lubeck, Germany; [Erdmann, Jeanette] German Ctr Cardiovasc Res, Hamburg, Germany; [Hengstenberg, Christian; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts London Sch Med & Dent, London, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia	University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Wellcome Trust Sanger Institute; University of Bedfordshire; Uppsala University; Uppsala University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Toronto; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Lubeck; German Centre for Cardiovascular Research; German Heart Centre Munich; Technical University of Munich; University of Cambridge; NHS Blood & Transplant (NHSBT); University of London; King's College London; University of London; Queen Mary University London; King Abdulaziz University	Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Groby Rd, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Trégouët, David-Alexandre/P-9210-2019; Morange, Pierre/T-9070-2019; Aïssi, Dylan/AAH-1499-2019; Cambien, Francois/AAP-9751-2020; Hengstenberg, Christian/U-5485-2019; Waldenberger, Melanie/B-5355-2014; Erdmann, Jeanette/P-7513-2014; Sandling, Johanna/AAG-6376-2019; Deloukas, Panos/B-2922-2013; Sandling, Johanna K/B-2973-2016; Grallert, Harald/B-3424-2013; Erdmann, Jeanette/A-4417-2009; Peters, Annette/A-6117-2011; Tregouet, David-Alexandre/E-3961-2016	Trégouët, David-Alexandre/0000-0001-9084-7800; Morange, Pierre/0000-0002-9065-722X; Aïssi, Dylan/0000-0002-5858-6468; Waldenberger, Melanie/0000-0003-0583-5093; Erdmann, Jeanette/0000-0002-4486-6231; Sandling, Johanna/0000-0003-1382-2321; Deloukas, Panos/0000-0001-9251-070X; Sandling, Johanna K/0000-0003-1382-2321; Peters, Annette/0000-0001-6645-0985; Meduri, Eshwar/0000-0002-3821-312X; Nelson, Christopher/0000-0001-8025-2897; Gieger, Christian/0000-0001-6986-9554; Goodall, Alison/0000-0002-7883-9645; Ouwehand, Willem/0000-0002-7744-1790	European Commission; National Institute for Health Research; British Heart Foundation; Wellcome Trust [081917/Z/07/Z, 098051]; European Union [LSHM-CT 2006-037593]; Program Hospitalier de Recherche Clinique; Canadian Institutes of Health Research [MOP 86466]; Heart and Stroke Foundation of Canada [T6484]; Fondation pour la Recherche Medicale; Region Ile de France; Helmholtz Zentrum Munchen German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; National Institute for Health Research BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit; Region Ile de France (CORDDIM); Fondation Leducq Grant [12CVD02]; ERC; National Institute for Health Research Senior Investigator; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10170, NF-SI-0510-10214, NF-SI-0513-10151, RP-PG-0310-1002] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Program Hospitalier de Recherche Clinique; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Ile de France(Region Ile-de-France); Helmholtz Zentrum Munchen German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; National Institute for Health Research BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit; Region Ile de France (CORDDIM)(Region Ile-de-France); Fondation Leducq Grant(Leducq Foundation); ERC(European Research Council (ERC)European Commission); National Institute for Health Research Senior Investigator; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The European Commission, National Institute for Health Research, British Heart Foundation, and Wellcome Trust.; This work was done as part of the Cardiogenics Project, which is funded by the European Union (LSHM-CT 2006-037593). The MARTHA project was supported by a grant from the Program Hospitalier de Recherche Clinique, and the methylation array typing was funded by the Canadian Institutes of Health Research (grant MOP 86466) and the Heart and Stroke Foundation of Canada (grant T6484). Statistical analyses of the MARTHA datasets were done in the C2BIG computing centre (UPMC, Paris, France), which is funded by the Fondation pour la Recherche Medicale and Region Ile de France. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The MuTHER study was funded by a programme grant from the Wellcome Trust (081917/Z/07/Z), and receives support from the National Institute for Health Research BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. CPN is funded by the National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit, and this work comes under the portfolio of translational research supported by this unit. DA was supported by a PhD grant from the Region Ile de France (CORDDIM). FG holds a Canada Research Chair. JE, FC, HS, D-AT, and NJS collaborate under a Fondation Leducq Grant (12CVD02). TDS is a European Research Council Senior Investigator and is holder of an ERC Advanced Principal Investigator award. PD is supported by the Wellcome Trust core grant to the Wellcome Trust Sanger Institute (098051), which funded DNA methylation analysis for MuTHER. NJS holds a chair funded by the British Heart Foundation and is a National Institute for Health Research Senior Investigator. We thank the staff from the genotyping facilities at the Wellcome Trust Sanger Institute for sample preparation, quality control, and typing for the Cardiogenics and MuTHER cohorts.	Almen MS, 2012, GENOMICS, V99, P132, DOI 10.1016/j.ygeno.2011.12.007; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonsignore MR, 2012, EUR RESPIR J, V39, P746, DOI 10.1183/09031936.00047010; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cockerill PN, 2011, FEBS J, V278, P2182, DOI 10.1111/j.1742-4658.2011.08128.x; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hatanaka M, 2009, BIOL PHARM BULL, V32, P1166, DOI 10.1248/bpb.32.1166; Heidbreder M, 2007, BIOCHEM BIOPH RES CO, V352, P437, DOI 10.1016/j.bbrc.2006.11.027; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Moleres A, 2013, FASEB J, V27, P2504, DOI 10.1096/fj.12-215566; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Park YS, 2012, J CONTROL RELEASE, V161, P1, DOI 10.1016/j.jconrel.2012.04.026; Relton CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031821; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shin MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046562; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112	45	526	542	1	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1990	1998		10.1016/S0140-6736(13)62674-4	http://dx.doi.org/10.1016/S0140-6736(13)62674-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24630777	Green Accepted			2022-12-28	WOS:000336848200027
J	Jain, SH; Rosenblatt, M; Duke, J				Jain, Sachin H.; Rosenblatt, Michael; Duke, Jon			Is Big Data the New Frontier for Academic-Industry Collaboration?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jain, Sachin H.; Rosenblatt, Michael] Merck & Co Inc, Boston, MA USA; [Jain, Sachin H.] Harvard Univ, Sch Med, Boston, MA USA; [Jain, Sachin H.] Boston Vet Affairs Med Ctr, Boston, MA USA; [Duke, Jon] Indiana Univ Sch Med, Regenstrief Inst, Indianapolis, IN 46202 USA	Merck & Company; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Jain, SH (corresponding author), 65 E India Row,33B, Boston, MA 02110 USA.	shjain@post.harvard.edu						Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Dooley L, 2007, EUR J INNOV MANAG, V10, P316, DOI 10.1108/14601060710776734; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500	4	18	18	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2171	2172		10.1001/jama.2014.1845	http://dx.doi.org/10.1001/jama.2014.1845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24699902				2022-12-28	WOS:000336668400014
J	Marais, B				Marais, Ben J.			Quantifying the tuberculosis disease burden in children	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS; TIME		[Marais, Ben J.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Marais, Ben J.] Univ Sydney, Sch Clin, Childrens Hosp Westmead, Sydney Med Sch, Sydney, NSW 2145, Australia	University of Sydney; University of Sydney	Marais, B (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.	ben.marais@health.nsw.gov.au	Marais, Ben/AAX-2626-2021					Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6; Graham SM, 2014, LANCET, V383, P1605, DOI 10.1016/S0140-6736(14)60420-7; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marais BJ, 2013, LANCET INFECT DIS, V13, P287, DOI 10.1016/S1473-3099(13)70031-8; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Schaaf HS, 2011, PAEDIATR RESPIR REV, V12, P31, DOI 10.1016/j.prrv.2010.09.010; Seddon JA, 2013, CLIN INFECT DIS, V57, P1676, DOI 10.1093/cid/cit655; Shah NS, 2014, CLIN INFECT DIS, V58, P381, DOI 10.1093/cid/cit643; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zignol M, 2013, EUR RESPIR J, V42, P701, DOI 10.1183/09031936.00175812	14	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1530	1531		10.1016/S0140-6736(14)60489-X	http://dx.doi.org/10.1016/S0140-6736(14)60489-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24671078				2022-12-28	WOS:000335495400008
J	Geisler, JH; Colbert, MW; Carew, JL				Geisler, Jonathan H.; Colbert, Matthew W.; Carew, James L.			A new fossil species supports an early origin for toothed whale echolocation	NATURE			English	Article							FUNCTIONAL-MORPHOLOGY; NORTH-CAROLINA; NASAL COMPLEX; OLIGOCENE; CETACEAN; ASYMMETRY; EVOLUTION; EOCENE	Odontocetes (toothed whales, dolphins and porpoises) hunt and navigate through dark and turbid aquatic environments using echolocation; a key adaptation that relies on the same principles as sonar(1). Among echolocating vertebrates, odontocetes are unique in producing high-frequency vocalizations at the phonic lips, a constriction in the nasal passages just beneath the blowhole, and then using air sinuses and the melon to modulate their transmission(2,3). Allextant odontocetes seem to echolocate(2,4); however, exactly when and how this complex behaviour-and its underlying anatomy-evolved is largely unknown. Here we report an odontocete fossil, Oligocene in age (approximately 28 Myr ago), from South Carolina (Cotylocara macei, gen. et sp. nov.) that has several features suggestive of echolocation: a dense, thick and downturned rostrum; air sac fossae; cranial asymmetry; and exceptionally broad maxillae. Our phylogenetic analysis places Cotylocara in a basal clade of odontocetes, leading us to infer that a rudimentary form of echolocation evolved in the early Oligocene, shortly after odontocetes diverged from the ancestors of filter-feedingwhales (mysticetes). This was followed by enlargement of the facial muscles that modulate echolocation calls, which in turn led to marked, convergent changes in skull shape in the ancestors of Cotylocara, and in the lineage leading to extant odontocetes.	[Geisler, Jonathan H.] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Colbert, Matthew W.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Carew, James L.] Coll Charleston, Nat Hist Museum, Dept Geol & Environm Geosci, Charleston, SC 29424 USA	New York Institute Technology; University of Texas System; University of Texas Austin; College of Charleston	Geisler, JH (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Anat, Northern Blvd, Old Westbury, NY 11568 USA.	jgeisler@nyit.edu		Geisler, Jonathan/0000-0002-4880-1152	New York Institute of Technology, College of Charleston; NSF [IIS-987-4781]	New York Institute of Technology, College of Charleston; NSF(National Science Foundation (NSF))	This research was supported by funds from the New York Institute of Technology, College of Charleston, and M. Brown. During this project we benefitted from discussions with B. Beatty, P. Gingerich, W. Hillenius, M. Mihlbachler, A. Sanders and N. Solounias. We thank A. Sanders and The Charleston Museum for access to specimens under their care. B. Dulguun drew the skulls in Fig. 3. We acknowledge the Deptartment of Radiology, Medical University of South Carolina, and T. Holden in particular, for conducting CT scans of Cotylocara. We thank T. Rowe for access to the Tursiops scan data, which were scanned using his NSF digital libraries initiative grant (IIS-987-4781).	Au W. W., 1993, SONAR DOLPHINS; BARNES LG, 2001, W ASS VERTEBRATE PAL, V8, P91; Carter A., 1868, Philosophical Transactions, Vvol. clviii., P201; Cranford TW, 2011, J EXP MAR BIOL ECOL, V407, P81, DOI 10.1016/j.jembe.2011.07.010; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Cranford TW, 1996, J MORPHOL, V228, P223; Dubrovo IA, 2000, J VERTEBR PALEONTOL, V20, P577, DOI 10.1671/0272-4634(2000)020[0577:ANSOPM]2.0.CO;2; Fahlke JM, 2011, P NATL ACAD SCI USA, V108, P14545, DOI 10.1073/pnas.1108927108; Fordyce R. Ewan, 1994, Proceedings of the San Diego Society of Natural History, V29, P147; Fordyce RE, 2002, SM C PALEOB, P185; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Geisler JH, 2012, J VERTEBR PALEONTOL, V32, P198, DOI 10.1080/02724634.2012.629016; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Goloboff P, 2008, CLADISTICS, V24, P91; HEYNING J E, 1989, Contributions in Science (Los Angeles), P1; Huggenberger S, 2009, ANAT REC, V292, P902, DOI 10.1002/ar.20854; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P53; MacLeod CD, 2007, ANAT REC, V290, P539, DOI 10.1002/ar.20539; Madsen PT, 2010, J EXP BIOL, V213, P3105, DOI 10.1242/jeb.044420; Martinez-Caceres M, 2011, CR PALEVOL, V10, P517, DOI 10.1016/j.crpv.2011.03.006; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; McKenna MF, 2012, MAR MAMMAL SCI, V28, P690, DOI 10.1111/j.1748-7692.2011.00526.x; Mead J.G., 1975, Smithsonian Contributions to Zoology, VNo. 207, P1; Norberg RA., 2002, ECOLOGY CONSERVATION, P329; Reidenberg JS, 2008, ANAT REC, V291, P1389, DOI 10.1002/ar.20792; SANDERS AE, 1982, US GEOLOGICAL SURV H, V1529, P105; Uhen MD, 2008, J SYST PALAEONTOL, V6, P433, DOI 10.1017/S1477201908002472	30	72	74	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					383	+		10.1038/nature13086	http://dx.doi.org/10.1038/nature13086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24670659				2022-12-28	WOS:000334403000049
J	Mann, RS				Mann, Richard S.			The Michael Jackson Fly	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; BACKWARD WALKING; LOCOMOTION; CIRCUITS; DIRECTION		Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	rsm10@columbia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070644] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS070644, R01NS070644] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akay T, 2007, J NEUROSCI, V27, P3285, DOI 10.1523/JNEUROSCI.5202-06.2007; Bidaye SS, 2014, SCIENCE, V344, P97, DOI 10.1126/science.1249964; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; CHALFIE M, 1985, J NEUROSCI, V5, P956; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Lee M, 2013, GAIT POSTURE, V38, P674, DOI 10.1016/j.gaitpost.2013.02.014; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; Neporent L., 1998, NY TIMES; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Rosenbaum P, 2010, J NEUROPHYSIOL, V104, P1681, DOI 10.1152/jn.00362.2010; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Zill S, 2004, ARTHROPOD STRUCT DEV, V33, P273, DOI 10.1016/j.asd.2004.05.005	14	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					48	49		10.1126/science.1252431	http://dx.doi.org/10.1126/science.1252431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700848	Green Accepted			2022-12-28	WOS:000333746100045
J	Post, WS; Budoff, M; Kingsley, L; Palella, FJ; Witt, MD; Li, XH; George, RT; Brown, TT; Jacobson, LP				Post, Wendy S.; Budoff, Matthew; Kingsley, Lawrence; Palella, Frank J., Jr.; Witt, Mallory D.; Li, Xiuhong; George, Richard T.; Brown, Todd T.; Jacobson, Lisa P.			Associations Between HIV Infection and Subclinical Coronary Atherosclerosis	ANNALS OF INTERNAL MEDICINE			English	Article							MULTICENTER AIDS COHORT; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ACTIVE ANTIRETROVIRAL THERAPY; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; RISK-FACTORS; DISEASE; MEN; PROGRESSION; MORTALITY	Background: Coronary artery disease (CAD) has been associated with HIV infection, but data are not consistent. Objective: To determine whether HIV-infected men have more coronary atherosclerosis than uninfected men. Design: Cross-sectional study. Setting: Multicenter AIDS Cohort Study. Participants: HIV-infected (n = 618) and uninfected (n = 383) men who have sex with men who were aged 40 to 70 years, weighed less than 136 kg (200 lb), and had no history of coronary revascularization. Measurements: Presence and extent of coronary artery calcium (CAC) on noncontrast cardiac computed tomography (CT) and of any plaque; noncalcified, mixed, or calcified plaque; or stenosis on coronary CT angiography. Results: 1001 men had noncontrast CT, of whom 759 had coronary CT angiography. After adjustment for age, race, CT scanning center, and cohort, HIV-infected men had a greater prevalence of CAC (prevalence ratio [PR], 1.21 [95% CI, 1.08 to 1.35]; P = 0.001) and any plaque (PR, 1.14 [CI, 1.05 to 1.24]; P = 0.001), including noncalcified (PR, 1.28 [CI, 1.13 to 1.45]; P < 0.001) and mixed (PR, 1.35 [CI, 1.10 to 1.65]; P = 0.004) plaque, than uninfected men. Associations between HIV infection and any plaque or noncalcified plaque remained significant (P < 0.005) after CAD risk factor adjustment. HIV-infected men had a greater extent of noncalcified plaque after CAD risk factor adjustment (P = 0.026). They also had a greater prevalence of coronary artery stenosis greater than 50% (PR, 1.48 [CI, 1.06 to 2.07]; P = 0.020), but not after CAD risk factor adjustment. Longer duration of highly active antiretroviral therapy (PR, 1.09 [CI, 1.02 to 1.17]; P = 0.007) and lower nadir CD4(+) T-cell count (PR, 0.80 [CI, 0.69 to 0.94]; P = 0.005) were associated with coronary stenosis greater than 50%. Limitation: Cross-sectional observational study design and inclusion of only men. Conclusion: Coronary artery plaque, especially noncalcified plaque, is more prevalent and extensive in HIV-infected men, independent of CAD risk factors.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; Univ Pittsburgh, Pittsburgh, PA USA; Northwestern Univ, Chicago, IL 60611 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University	Post, WS (corresponding author), Johns Hopkins Univ, Sch Med, Ciccarone Ctr Prevent Heart Dis, Div Cardiol, Carnegie 568,600 North Wolfe St, Baltimore, MD 21287 USA.	wpost@jhmi.edu	Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946; Jacobson, Lisa P./0000-0003-1722-6826; Kingsley, Lawrence/0000-0002-7000-8556	National Heart, Lung, and Blood Institute [RO1 HL095129]; National Center for Advancing Translational Sciences, a component of the National Institutes of Health and National Institutes of Health Roadmap for Medical Research [UL1 RR 025005]; National Institute of Allergy and Infectious Diseases; National Cancer Institute [UO1-AI-35042, UL1-RR025005, UM1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR000424] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035043, UM1AI035043, U01AI035041, U01AI035042, U01AI035040, U01AI035039] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences, a component of the National Institutes of Health and National Institutes of Health Roadmap for Medical Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is funded by the National Heart, Lung, and Blood Institute (grant RO1 HL095129 to Dr. Post), with additional support from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health and National Institutes of Health Roadmap for Medical Research (grant UL1 RR 025005). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute (grants UO1-AI-35042, UL1-RR025005, UM1-AI-35043, UO1-AI-35039, UO1-AI-35040, and UO1-AI-35041).	Ahmadi N, 2011, AM J CARDIOL, V107, P10, DOI 10.1016/j.amjcard.2010.08.034; Austen W G, 1975, Circulation, V51, P5; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; Delaney JAC, 2010, AIDS, V24, P2201, DOI 10.1097/QAD.0b013e32833d2132; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Hacioglu Y, 2013, ANATOL J CARDIOL, V13, P207, DOI 10.5152/akd.2013.065; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kingsley LA, 2008, AIDS, V22, P1589, DOI 10.1097/QAD.0b013e328306a6c5; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Pagali SR, 2010, J CARDIOVASC COMPUT, V4, P312, DOI 10.1016/j.jcct.2010.05.018; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Voros S, 2011, JACC-CARDIOVASC IMAG, V4, P537, DOI 10.1016/j.jcmg.2011.03.006; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	26	235	240	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					458	+		10.7326/M13-1754	http://dx.doi.org/10.7326/M13-1754			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24687069	Green Accepted			2022-12-28	WOS:000334093800003
J	Howard, SJ; Davies, SC				Howard, Simon J.; Davies, Sally C.			Chief medical officer urges action to tackle overweight and obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howard, Simon J.; Davies, Sally C.] Off Chief Med Officer, Dept Hlth, London, England		Howard, SJ (corresponding author), Off Chief Med Officer, Dept Hlth, London, England.	sjhoward@doctors.org.uk	Howard, Simon/I-4976-2015	Howard, Simon/0000-0002-6317-0942				Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Cetateanu A, 2014, HEALTH PLACE, V27, P68, DOI 10.1016/j.healthplace.2014.01.007; Davies SC, 2014, ANN REPORT CHIEF MED; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Jeffery AN, 2005, BRIT MED J, V330, P23, DOI 10.1136/bmj.38315.451539.F7; Matthews D, 2010, BBC HIST MAGAZIN FEB; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Myska S., 2013, BBC NEWS; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; The Economist, 2012, ECONOMIST; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	11	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2014	348								g2375	10.1136/bmj.g2375	http://dx.doi.org/10.1136/bmj.g2375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LW	24677657				2022-12-28	WOS:000333587600004
J	Collins, S; Ramsay, M; Slack, MPE; Campbell, H; Flynn, S; Litt, D; Ladhani, SN				Collins, Sarah; Ramsay, Mary; Slack, Mary P. E.; Campbell, Helen; Flynn, Sally; Litt, David; Ladhani, Shamez N.			Risk of Invasive Haemophilus influenzae Infection During Pregnancy and Association With Adverse Fetal Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STREPTOCOCCUS-PNEUMONIAE; B DISEASE; ENGLAND; VACCINE; SEPSIS; BURDEN; IMPACT	IMPORTANCE Unencapsulated Haemophilus influenzae frequently causes noninvasive upper respiratory tract infections in children but can also cause invasive disease, especially in older adults. A number of studies have reported an increased incidence in neonates and suggested that pregnant women may have an increased susceptibility to invasive unencapsulated H influenzae disease. OBJECTIVE To describe the epidemiology, clinical characteristics, and outcomes of invasive H influenzae disease in women of reproductive age during a 4-year period. DESIGN, SETTING, AND PARTICIPANTS Public Health England conducts enhanced national surveillance of invasive H influenzae disease in England and Wales. Clinical questionnaires were sent prospectively to general practitioners caring for all women aged 15 to 44 years with laboratory-confirmed invasive H influenzae disease during 2009-2012, encompassing 45 215 800 woman-years of follow-up. The final outcome was assessed in June 2013. EXPOSURES Invasive H influenzae disease confirmed by positive culture from a normally sterile site. MAIN OUTCOMES AND MEASURES The primary outcome was H influenzae infection and the secondary outcomes were pregnancy-related outcomes. RESULTS In total, 171 women had laboratory-confirmed invasive H influenzae infection, which included 144 (84.2%; 95% CI, 77.9%-89.3%) with unencapsulated, 11 (6.4%; 95% CI, 3.3%-11.2%) with serotype b, and 16 (9.4%; 95% CI, 5.4%-14.7%) with other encapsulated serotypes. Questionnaire response rate was 100%. Overall, 75 of 171 women (43.9%; 95% CI, 36.3%-51.6%) were pregnant at the time of infection, most of whom were previously healthy and presented with unencapsulated H influenzae bacteremia. The incidence rate of invasive unencapsulated H influenzae disease was 17.2 (95% CI, 12.2-24.1; P < .001) times greater among pregnant women (2.98/100 000 woman-years) compared with nonpregnant women (0.17/100 000 woman-years). Unencapsulated H influenzae infection during the first 24 weeks of pregnancy was associated with fetal loss (44/47; 93.6% [95% CI, 82.5%-98.7%]) and extremely premature birth (3/47; 6.4% [95% CI, 1.3%-17.5%]). Unencapsulated H influenzae infection during the second half of pregnancy was associated with premature birth in 8 of 28 cases (28.6%; 95% CI, 13.2%-48.7%) and stillbirth in 2 of 28 cases (7.1%; 95% CI, 0.9%-23.5%). The incidence rate ratio for pregnancy loss was 2.91 (95% CI, 2.13-3.88) for all serotypes of H influenzae and 2.90 (95% CI, 2.11-3.89) for unencapsulated H influenzae compared with the background rate for pregnant women. CONCLUSIONS AND RELEVANCE Among women in England and Wales, pregnancy was associated with a greater risk of invasive H influenzae infection. These infections were associated with poor pregnancy outcomes.	[Collins, Sarah; Ramsay, Mary; Campbell, Helen; Ladhani, Shamez N.] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England; [Slack, Mary P. E.; Flynn, Sally; Litt, David] Publ Hlth England, Resp & Vaccine Preventable Bacterial Reference Un, London NW9 5EQ, England; [Ladhani, Shamez N.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England	Public Health England; Public Health England; St Georges University London	Ladhani, SN (corresponding author), Publ Hlth England, Hlth Protect Serv, Immunisat Hepatitis & Blood Safety Dept, 61 Colindale Ave, London NW9 5EQ, England.	shamez.ladhani@phe.gov.uk	; Ramsay, Mary Elizabeth/S-8281-2016	Collins, Sarah/0000-0001-9989-8794; Ladhani, Shamez/0000-0002-0856-2476; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014; Berndsen MR, 2012, CLIN MICROBIOL INFEC, V18, P918, DOI 10.1111/j.1469-0691.2011.03700.x; Calner PA, 2012, WEST J EMERG MED, V13, P133, DOI 10.5811/westjem.2011.7.6783; Cherpes Thomas L, 2002, Infect Dis Obstet Gynecol, V10, P161, DOI 10.1155/S1064744902000170; Collins S, 2013, CLIN INFECT DIS, V57, P1715, DOI 10.1093/cid/cit579; Department of Health, 2011, AB STAT; Deutscher M, 2011, CLIN INFECT DIS, V53, P114, DOI 10.1093/cid/cir325; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; Gkentzi D, 2013, J PUBLIC HEALTH-HEID, V21, P491, DOI 10.1007/s10389-013-0576-5; Gkentzi D, 2012, CURR OPIN INFECT DIS, V25, P266, DOI 10.1097/QCO.0b013e32835310a4; Heath PT, 2001, PEDIATR INFECT DIS J, V20, P300, DOI 10.1097/00006454-200103000-00016; Hoffman JA, 2003, PEDIATRICS, V112, P1095, DOI 10.1542/peds.112.5.1095; Jackson KA, 2010, EPIDEMIOL INFECT, V138, P1503, DOI 10.1017/S0950268810000294; Ladhani S, 2007, EPIDEMIOL INFECT, V135, P861, DOI 10.1017/S0950268806007382; Ladhani S, 2010, EMERG INFECT DIS, V16, P455, DOI 10.3201/eid1603.090290; Ladhani S, 2009, J INFECTION, V58, P3, DOI 10.1016/j.jinf.2008.10.007; Ladhani SN, 2013, CLIN INFECT DIS, V56, P633, DOI 10.1093/cid/cis934; Ladhani SN, 2012, EMERG INFECT DIS, V18, P725, DOI 10.3201/eid1805.111738; Martinez MA, 1999, EUR J CLIN MICROBIOL, V18, P890, DOI 10.1007/s100960050425; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Office for National Statistics, 2009, ANN TABL 5 CONC NUMB; Office for National Statistics, 2011, ANN TABL 5 CONC NUMB; Office for National Statistics, 2010, ANN TABL 5 CONC NUMB; Office for National Statistics, 1938, TABL 1 SUMM KEY LIV; Office for National Statistics, TABL B MID 1971 MID; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089; PRIMHAK RA, 1993, ARCH DIS CHILD-FETAL, V69, P317, DOI 10.1136/adc.69.3_Spec_No.317; Public Health England, HAEM INFL ENH SURV; QUENTIN R, 1993, J CLIN MICROBIOL, V31, P1111, DOI 10.1128/JCM.31.5.1111-1116.1993; Royal College of Obstetricians and Gynaecologists, BACT SEPS PREGN; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Singh J, 2000, PEDIATR INFECT DIS J, V19, P260, DOI 10.1097/00006454-200003000-00021; Smith B, 2009, SCAND J INFECT DIS, V41, P21, DOI 10.1080/00365540802468094; TAKALA AK, 1991, ARCH DIS CHILD-FETAL, V66, P437, DOI 10.1136/adc.66.4_Spec_No.437; Trotter C L, 2003, Commun Dis Public Health, V6, P55; WALLACE RJ, 1983, REV INFECT DIS, V5, P123; Warren S, 2010, J MED MICROBIOL, V59, P370, DOI 10.1099/jmm.0.016543-0	38	31	31	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1125	1132		10.1001/jama.2014.1878	http://dx.doi.org/10.1001/jama.2014.1878			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643602	Bronze			2022-12-28	WOS:000333010100017
J	Gros, J; Tabin, CJ				Gros, Jerome; Tabin, Clifford J.			Vertebrate Limb Bud Formation Is Initiated by Localized Epithelial-to-Mesenchymal Transition	SCIENCE			English	Article							ADDITIONAL LIMB; CHICK-EMBRYOS; OUTGROWTH; FLANK; FGF10; TBX5	Vertebrate limbs first emerge as small buds at specific locations along the trunk. Although a fair amount is known about the molecular regulation of limb initiation and outgrowth, the cellular events underlying these processes have remained less clear. We show that the mesenchymal limb progenitors arise through localized epithelial-to-mesenchymal transition (EMT) of the coelomic epithelium specifically within the presumptive limb fields. This EMT is regulated at least in part by Tbx5 and Fgf10, two genes known to control limb initiation. This work shows that limb buds initiate earlier than previously thought, as a result of localized EMT rather than differential proliferation rates.	[Gros, Jerome; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Gros, Jerome/0000-0002-2264-2851	NIH [R01-HD045499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank F. Constantini for help rederiving the Fgf10 mutant mouse line, B. Bruneau for kindly providing Tbx5 mutant embryos, and J. deMelo and P. Tschopp for help with mouse work. J.G. was a fellow of the Human Frontier Science Program. This work was supported by NIH grant R01-HD045499 to C.J.T.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; MAUGER A, 1972, J EMBRYOL EXP MORPH, V28, P313; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; OHUCHI H, 1995, BIOCHEM BIOPH RES CO, V209, P809, DOI 10.1006/bbrc.1995.1572; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; SEARLS RL, 1971, DEV BIOL, V24, P198, DOI 10.1016/0012-1606(71)90095-9; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vogel A, 1996, DEVELOPMENT, V122, P1737	12	95	97	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1253	1256		10.1126/science.1248228	http://dx.doi.org/10.1126/science.1248228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626928	Green Accepted			2022-12-28	WOS:000332728500037
J	McFadden, DG; Papagiannakopoulos, T; Taylor-Weiner, A; Stewart, C; Carter, SL; Cibulskis, K; Bhutkar, A; McKenna, A; Dooley, A; Vernon, A; Sougnez, C; Malstrom, S; Heimann, M; Park, J; Chen, F; Farago, AF; Dayton, T; Shefler, E; Gabriel, S; Getz, G; Jacks, T				McFadden, David G.; Papagiannakopoulos, Thales; Taylor-Weiner, Amaro; Stewart, Chip; Carter, Scott L.; Cibulskis, Kristian; Bhutkar, Arjun; McKenna, Aaron; Dooley, Alison; Vernon, Amanda; Sougnez, Carrie; Malstrom, Scott; Heimann, Megan; Park, Jennifer; Chen, Frances; Farago, Anna F.; Dayton, Talya; Shefler, Erica; Gabriel, Stacey; Getz, Gad; Jacks, Tyler			Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing	CELL			English	Article							COPY-NUMBER ALTERATION; PTEN TUMOR-SUPPRESSOR; SOMATIC MUTATIONS; MOUSE MODEL; CANCER; EVOLUTION; HETEROGENEITY; INACTIVATION; INSTABILITY; ABERRATIONS	Small cell lung carcinoma (SCLC) is a highly lethal, smoking-associated cancer with few known targetable genetic alterations. Using genome sequencing, we characterized the somatic evolution of a genetically engineered mouse model (GEMM) of SCLC initiated by loss of Trp53 and Rb1. We identified alterations in DNA copy number and complex genomic rearrangements and demonstrated a low somatic point mutation frequency in the absence of tobacco mutagens. Alterations targeting the tumor suppressor Pten occurred in the majority of murine SCLC studied, and engineered Pten deletion accelerated murine SCLC and abrogated loss of Chr19 in Trp53; Rb1; Pten compound mutant tumors. Finally, we found evidence for polyclonal and sequential metastatic spread of murine SCLC by comparative sequencing of families of related primary tumors and metastases. We propose a temporal model of SCLC tumorigenesis with implications for human SCLC therapeutics and the nature of cancer-genome evolution in GEMMs.	[McFadden, David G.; Papagiannakopoulos, Thales; Bhutkar, Arjun; Dooley, Alison; Vernon, Amanda; Malstrom, Scott; Heimann, Megan; Park, Jennifer; Chen, Frances; Farago, Anna F.; Dayton, Talya; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [McFadden, David G.; Papagiannakopoulos, Thales; Bhutkar, Arjun; Dooley, Alison; Vernon, Amanda; Malstrom, Scott; Heimann, Megan; Park, Jennifer; Chen, Frances; Farago, Anna F.; Dayton, Talya; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Taylor-Weiner, Amaro; Stewart, Chip; Carter, Scott L.; Cibulskis, Kristian; McKenna, Aaron; Sougnez, Carrie; Shefler, Erica; Gabriel, Stacey; Getz, Gad] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org; tjacks@mit.edu	Cibulskis, Kristian/AAC-7380-2019	Dayton, Talya/0000-0002-7994-7963; Cibulskis, Kristian/0000-0003-1343-1582	Ludwig Center for Molecular Oncology at MIT; Howard Hughes Medical Institute; National Human Genome Research Institute; NIH-NCI Career Development award [K08CA160658]; Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA014051, K08CA160658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER	Ludwig Center for Molecular Oncology at MIT; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-NCI Career Development award; Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Denise Crowley and the Swanson Biotechnology Core Facility for histology preparation and IHC; Harold Varmus, Nadya Dimitrova, and Eric L. Snyder for critical review of the manuscript; and Peter Campbell for a fruitful discussion. This work was supported by the Ludwig Center for Molecular Oncology at MIT (to T.J.), the Howard Hughes Medical Institute (to T.J.), the National Human Genome Research Institute (to S. G. and G. G.), NIH-NCI Career Development award K08CA160658 (to D. G. M.), and a Hope Funds for Cancer Research Fellowship (to T. P.). G. G. is the Paul C. Zamecnik, MD, Chair in Oncology at Massachusetts General Hospital. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar at MIT. The authors wish to dedicate this paper to the memory of Officer Sean Collier, for his caring service to the MIT community and for his sacrifice.	Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Calbo J, 2005, COLD SH Q B, V70, P225, DOI 10.1101/sqb.2005.70.026; Califano R, 2012, DRUGS, V72, P471, DOI 10.2165/11597640-000000000-00000; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen SL, 2006, CA-CANCER J CLIN, V56, P292, DOI 10.3322/canjclin.56.5.292; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dacic S, 2002, HUM PATHOL, V33, P927, DOI 10.1053/hupa.2002.126875; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pilarski R, 2011, J MED GENET, V48, P505, DOI 10.1136/jmg.2011.088807; Podsypanina K, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-24; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Shepherd C, 2013, LEUKEMIA, V27, P650, DOI 10.1038/leu.2012.285; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Sweet-Cordero A, 2006, GENE CHROMOSOME CANC, V45, P338, DOI 10.1002/gcc.20296; To MD, 2011, MOL CANCER RES, V9, P1339, DOI 10.1158/1541-7786.MCR-11-0219; Tsou HC, 1998, HUM GENET, V102, P467, DOI 10.1007/s004390050723; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Wegmann F, 2004, EXP CELL RES, V300, P121, DOI 10.1016/j.yexcr.2004.07.010; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; Yuan W, 2013, ONCOGENE, V32, P318, DOI 10.1038/onc.2012.53; Zmajkovicova K, 2013, MOL CELL, V50, P43, DOI 10.1016/j.molcel.2013.01.037	55	191	204	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1298	1311		10.1016/j.cell.2014.02.031	http://dx.doi.org/10.1016/j.cell.2014.02.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630729	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000332945100018
J	Hurley, LP; Bridges, CB; Harpaz, R; Allison, MA; O'Leary, ST; Crane, LA; Brtnikova, M; Stokley, S; Beaty, BL; Jimenez-Zambrano, A; Ahmed, F; Hales, C; Kempe, A				Hurley, Laura P.; Bridges, Carolyn B.; Harpaz, Rafael; Allison, Mandy A.; O'Leary, Sean T.; Crane, Lori A.; Brtnikova, Michaela; Stokley, Shannon; Beaty, Brenda L.; Jimenez-Zambrano, Andrea; Ahmed, Faruque; Hales, Craig; Kempe, Allison			US Physicians' Perspective of Adult Vaccine Delivery	ANNALS OF INTERNAL MEDICINE			English	Article							PNEUMOCOCCAL VACCINATION; MISSED OPPORTUNITIES; IMMUNIZATION RATES; INFLUENZA; PHARMACISTS; PERCEPTIONS; ATTITUDES; BARRIERS; OLDER; MAIL	Background: Adults are at substantial risk for vaccine-preventable disease, but their vaccination rates remain low. Objective: To assess practices for assessing vaccination status and stocking recommended vaccines, barriers to vaccination, characteristics associated with reporting financial barriers to delivering vaccines, and practices regarding vaccination by alternate vaccinators. Design: Mail and Internet-based survey. Setting: Survey conducted from March to June 2012. Participants: General internists and family physicians throughout the United States. Measurements: A financial barriers scale was created. Multivariable linear modeling for each specialty was performed to assess associations between a financial barrier score and physician and practice characteristics. Results: Response rates were 79% (352 of 443) for general internists and 62% (255 of 409) for family physicians. Twenty-nine percent of general internists and 32% of family physicians reported assessing vaccination status at every visit. A minority used immunization information systems (8% and 36%, respectively). Almost all respondents reported assessing need for and stocking seasonal influenza; pneumococcal; tetanus and diphtheria; and tetanus, diphtheria, and acellular pertussis vaccines. However, fewer as-sessed and stocked other recommended vaccines. The most commonly reported barriers were financial. Characteristics significantly associated with reporting greater financial barriers included private practice setting, fewer than 5 providers in the practice, and, for general internists only, having more patients with Medicare Part D. The most commonly reported reasons for referring patients elsewhere included lack of insurance coverage for the vaccine (55% for general internists and 62% for family physicians) or inadequate reimbursement (36% and 41%, respectively). Patients were most often referred to pharmacies/retail stores and public health departments. Limitations: Surveyed physicians may not be representative of all physicians. Conclusion: Improving adult vaccination delivery will require increased use of evidence-based methods for vaccination delivery and concerted efforts to resolve financial barriers, especially for smaller practices and for general internists who see more patients with Medicare Part D.	[Hurley, Laura P.] Wellington Webb Ctr Primary Care, Denver, CO 80204 USA; [Bridges, Carolyn B.; Harpaz, Rafael; Stokley, Shannon; Ahmed, Faruque; Hales, Craig] Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Allison, Mandy A.; O'Leary, Sean T.; Brtnikova, Michaela; Beaty, Brenda L.; Jimenez-Zambrano, Andrea; Kempe, Allison] Childrens Outcomes Res Program, Aurora, CO 80045 USA	Centers for Disease Control & Prevention - USA	Brtnikova, M (corresponding author), Childrens Outcomes Res Program, 13199 East Montview Blvd, Aurora, CO 80045 USA.	michael.brtnikova@ucdenver.edu		O'Leary, Sean/0000-0003-2365-582X; Hales, Craig/0000-0002-2355-1177	Centers for Disease Control and Prevention [SIP-5U48DP001938]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001938] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Grant Support: By the Centers for Disease Control and Prevention (SIP-5U48DP001938).	Advisory Committee on Immunization Practices, 2012, Ann Intern Med, V156, P211, DOI 10.7326/0003-4819-156-3-201202070-00388; American College of Physicians, 2012, ACP IMM ADV APP; [Anonymous], UN REC VACC IMM INF; Atkeson LR, 2011, POLIT BEHAV, V33, P161, DOI 10.1007/s11109-010-9121-1; Blake EW, 2003, PHARMACOTHERAPY, V23, P248, DOI 10.1592/phco.23.2.248.32083; Brand W., 2011, Morbidity and Mortality Weekly Report, V60, P10; Bridges CB, 2013, MMWR-MORBID MORTAL W, V62, P9; Centers for Disease Control and Prevention, 2012, FLUVAX VIEW; Centers for Disease Control and Prevention, 2012, AD IMM SCHED; Crane LA, 2008, EVAL HEALTH PROF, V31, P43, DOI 10.1177/0163278707311872; Daley MF, 2009, AM J PREV MED, V36, P491, DOI 10.1016/j.amepre.2009.01.037; Dillman D.A., 2007, MAIL INTERNET SURVEY, V2nd; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Fairbrother G, 2001, AMBUL PEDIATR, V1, P206, DOI 10.1367/1539-4409(2001)001<0206:IOFIOD>2.0.CO;2; Freed GL, 2011, VACCINE, V29, P1850, DOI 10.1016/j.vaccine.2010.12.097; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hogue MD, 2006, J AM PHARM ASSOC, V46, P168, DOI 10.1331/154434506776180621; Hurley LP, 2011, VACCINE, V29, P8649, DOI 10.1016/j.vaccine.2011.08.126; Hurley LP, 2010, ANN INTERN MED, V152, P555, DOI 10.7326/0003-4819-152-9-201005040-00005; Hurley LP, 2008, J INFECT DIS S2, V197, pS216; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Kempe A, 2008, J GEN INTERN MED, V23, P2010, DOI 10.1007/s11606-008-0800-0; Kennedy Erin D., 2011, Morbidity and Mortality Weekly Report, V60, P781; Kouides RW, 1998, AM J PREV MED, V14, P89, DOI 10.1016/S0749-3797(97)00028-7; Ledwich LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1505, DOI 10.1002/art.24873; McMahon SR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e299; Medicare Payment Advisory Commission, 2007, REP C PROM GREAT FIC REP C PROM GREAT FIC, P157; National Vaccine Advisory Committee, 2012, PUBLIC HLTH REP S1, V127, P1; Nowalk MP, 2004, VACCINE, V22, P3457, DOI 10.1016/j.vaccine.2004.02.022; Nowalk MP, 2005, J AM BOARD FAM PRACT, V18, P20, DOI 10.3122/jabfm.18.1.20; Robert Wood Johnson Foundation, 2010, AD IMM SHOTS SAV LIV; Rothholz MC, 2013, ROLE COMMUNITY PHARM; Schuman H., 1996, QUESTIONS ANSWERS AT, V2nd; Smalley HK, 2011, INTERFACES, V41, P436, DOI 10.1287/inte.1110.0583; Swenson CJ, 2012, JT COMM J QUAL PATIE, V38, P15, DOI 10.1016/S1553-7250(12)38003-3; Szilagyi PG, 2005, PREV MED, V40, P152, DOI 10.1016/j.ypmed.2004.05.010; Tan L, IMPACT AFFORDABLE CA; U.S. Department of Health and Human Services, 2012, HLTH PEOPL 2020 IMM; U.S. Government Accountability Office, 2011, MED MAN FACT INCL AD; University of Colorado Children's Outcomes Research, 2013, VACC POL COLL IN; Urquhart G., 2008, Morbidity and Mortality Weekly Report, V57, P289; Welch AC, 2005, J AM PHARM ASSOC, V45, P486, DOI 10.1331/1544345054475414; Williams WW, 2013, MMWR-MORBID MORTAL W, V62, P66; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66	44	99	99	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					161	+		10.7326/M13-2332	http://dx.doi.org/10.7326/M13-2332			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2VE	24658693	Green Accepted			2022-12-28	WOS:000330951500003
J	Pohl, H; Robertson, D; Welch, HG				Pohl, Heiko; Robertson, Douglas; Welch, H. Gilbert			Repeated Upper Endoscopy in the Medicare Population	ANNALS OF INTERNAL MEDICINE			English	Article							OPEN-ACCESS ENDOSCOPY; BARRETTS-ESOPHAGUS; UNITED-STATES; SURVEILLANCE; APPROPRIATENESS; VALIDATION; GUIDELINES; NEOPLASIA	Background: Esophagogastroduodenoscopy (EGD) is done often for various indications. Little is known about the frequency of repeated EGD and the diagnoses that drive it. Objective: To describe the frequency of repeated EGD in the Medicare population and determine diagnoses most often associated with it. Design: Retrospective analysis. Setting: Medicare database. Patients: Among a 5% random sample of Medicare beneficiaries, Current Procedural Terminology (CPT) codes were used to identify patients who had an index EGD between 2004 and 2006. Diagnoses from the International Classification of Diseases, Ninth Revision, Clinical Modification, reported for the index endoscopy were divided into 3 diagnostic groups on the basis of whether the index diagnosis suggested that repeated EGD was expected, uncertain, or not expected. Measurements: Proportion of patients with repeated EGD within 3 years of an index EGD. Results: Approximately 12% of Medicare beneficiaries had an EGD between 2004 and 2006 (n = 108 785). Of these, 33% (n = 36 331) had at least 1 repeated EGD within 3 years. Of all patients with initial EGDs, 10% (n = 11 370) had an associated diagnosis suggesting a need for follow-up examination, whereas 61% (n = 66 307) did not. Of all patients with repeated examinations, 54% (n = 19 687) came from the group in which repeated EGD was not expected. When new clinical events were excluded, 43% of all patients with repeated EGDs (n = 15 706) did not have a diagnosis at index or repeated EGD that justified a repeated examination. Limitation: Whether individual procedures were clinically indicated cannot be verified. Conclusion: One in 3 Medicare beneficiaries who received an EGD had a repeated EGD within 3 years. Nearly one half of repeated examinations were done in patients with diagnoses at index or repeated EGD that did not suggest the need for a repeated examination.	[Pohl, Heiko; Robertson, Douglas; Welch, H. Gilbert] Vet Affairs Med Ctr, Dept Gastroenterol, White River Jct, VT 05009 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pohl, H (corresponding author), Vet Affairs Med Ctr, Dept Gastroenterol, 215 North Main St, White River Jct, VT 05009 USA.	heiko.pohl@dartmouth.edu			Medicare Payment Advisory Commission	Medicare Payment Advisory Commission	The research underlying this article was completed with support from the Medicare Payment Advisory Commission.	ABIM Foundation, CHOOS WIS; American Gastroenterological Association, 2011, 5 THINGS PHYS PAT SH; [Anonymous], 2000, GASTROINTEST ENDOSC, V52, P831; BARON JA, 1994, EPIDEMIOLOGY, V5, P541; Charles RJ, 2003, GASTROINTEST ENDOSC, V57, P183, DOI 10.1067/mge.2003.55; Cohen J, 2006, AM J GASTROENTEROL, V101, P886, DOI 10.1111/j.1572-0241.2006.00676.x; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Crockett SD, 2012, GASTROINTEST ENDOSC, V75, P23, DOI 10.1016/j.gie.2011.08.042; Dunbar KB, 2009, GASTROINTEST ENDOSC, V70, P645, DOI 10.1016/j.gie.2009.02.009; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Fenton JJ, 2012, CANCER EPIDEM BIOMAR, V21, P1344, DOI 10.1158/1055-9965.EPI-12-0406; Gonvers JJ, 1996, ENDOSCOPY, V28, P661, DOI 10.1055/s-2007-1005573; Hassan C, 2007, GASTROINTEST ENDOSC, V65, P767, DOI 10.1016/j.gie.2006.12.058; KEEFFE EB, 1990, GASTROINTEST ENDOSC, V36, P541, DOI 10.1016/S0016-5107(90)71146-7; Keren D, 2011, CAN J GASTROENTEROL, V25, P83, DOI 10.1155/2011/379014; Ko CW, 2011, GASTROINTEST ENDOSC, V73, P447, DOI 10.1016/j.gie.2010.07.044; Kravetz RE, 2003, AM J GASTROENTEROL, V98, P2794, DOI 10.1016/j.amjgastroenterol.2003.09.047; Pohl H, 2008, GUT, V57, P1648, DOI 10.1136/gut.2008.157461; Pouw RE, 2010, GUT, V59, P1169, DOI 10.1136/gut.2010.210229; Rossi A, 2002, GASTROINTEST ENDOSC, V56, P714, DOI 10.1067/mge.2002.129222; Saini SD, 2008, AM J GASTROENTEROL, V103, P1920, DOI 10.1111/j.1572-0241.2008.01945.x; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Schwartz LM, 1996, ARCH INTERN MED, V156, P873, DOI 10.1001/archinte.156.8.873; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Shaheen NJ, 2012, ANN INTERN MED, V157, P808, DOI 10.7326/0003-4819-157-11-201212040-00008; Shaheen NJ, 2011, GASTROENTEROLOGY, V141, P460, DOI 10.1053/j.gastro.2011.04.061; Sirovich BE, 2011, ARCH INTERN MED, V171, P1582, DOI 10.1001/archinternmed.2011.437; Sonnenberg A, 2008, GASTROINTEST ENDOSC, V67, P489, DOI 10.1016/j.gie.2007.08.041; U.S. Department of Health and Human Services; Centers for Medicare and Medicaid Services, 2001, PROGR MEM INT CARR I; Welch HG, 2012, ARCH INTERN MED, V172, P1745, DOI 10.1001/2013.jamainternmed.727; Wolfsen HC, 2008, GASTROENTEROLOGY, V135, P24, DOI 10.1053/j.gastro.2008.03.019	31	21	21	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					154	+		10.7326/M13-0046	http://dx.doi.org/10.7326/M13-0046			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2VE	24658692				2022-12-28	WOS:000330951500002
J	Ryan, KK; Tremaroli, V; Clemmensen, C; Kovatcheva-Datchary, P; Myronovych, A; Karns, R; Wilson-Perez, HE; Sandoval, DA; Kohli, R; Backhed, F; Seeley, RJ				Ryan, Karen K.; Tremaroli, Valentina; Clemmensen, Christoffer; Kovatcheva-Datchary, Petia; Myronovych, Andriy; Karns, Rebekah; Wilson-Perez, Hilary E.; Sandoval, Darleen A.; Kohli, Rohit; Backhed, Fredrik; Seeley, Randy J.			FXR is a molecular target for the effects of vertical sleeve gastrectomy	NATURE			English	Article							FARNESOID-X-RECEPTOR; Y GASTRIC BYPASS; BILE-ACID METABOLISM; HUMAN GUT MICROBIOTA; INSULIN-SENSITIVITY; WEIGHT-LOSS; BARIATRIC SURGERY; HIGH-FAT; GLUCOSE-HOMEOSTASIS; IMPROVES GLUCOSE	Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms contributing to these benefits remain largely undetermined, despite offering the potential to reveal new targets for therapeutic intervention. Substantial changes in circulating total bile acids are known to occur after VSG. Moreover, bile acids are known to regulate metabolism by binding to the nuclear receptor FXR (farsenoid-X receptor, also known as NR1H4). We therefore examined the results of VSG surgery applied to mice with diet-induced obesity and targeted genetic disruption of FXR. Here we demonstrate that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach. Rather, VSG is associated with increased circulating bile acids, and associated changes to gut microbial communities. Moreover, in the absence of FXR, the ability of VSG to reduce body weight and improve glucose tolerance is substantially reduced. These results point to bile acids and FXR signalling as an important molecular underpinning for the beneficial effects of this weight-loss surgery.	[Ryan, Karen K.; Clemmensen, Christoffer; Wilson-Perez, Hilary E.; Sandoval, Darleen A.; Seeley, Randy J.] Univ Cincinnati, Div Endocrinol Diabet & Metab, Dept Internal Med, Cincinnati, OH 45237 USA; [Tremaroli, Valentina; Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-41345 Gothenburg, Sweden; [Tremaroli, Valentina; Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, S-41345 Gothenburg, Sweden; [Clemmensen, Christoffer] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Myronovych, Andriy; Kohli, Rohit] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Cincinnati, OH 45229 USA; [Karns, Rebekah] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Backhed, Fredrik] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	University System of Ohio; University of Cincinnati; University of Gothenburg; University of Gothenburg; University of Copenhagen; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Novo Nordisk Foundation; University of Copenhagen	Seeley, RJ (corresponding author), Univ Cincinnati, Div Endocrinol Diabet & Metab, Dept Internal Med, Cincinnati, OH 45237 USA.	randy.seeley@uc.edu	Tremaroli, Valentina/AAE-8001-2019; Clemmensen, Christoffer/AAM-3347-2020; kohli, Rohit/H-3020-2013; Clemmensen, Christoffer/N-4680-2017; Backhed, Fredrik/ABE-6613-2020	Tremaroli, Valentina/0000-0002-9150-4233; Clemmensen, Christoffer/0000-0003-2456-9667; kohli, Rohit/0000-0002-0198-7703; Clemmensen, Christoffer/0000-0003-2456-9667; Backhed, Fredrik/0000-0002-4871-8818; Seeley, Randy/0000-0002-3721-5625; Ryan, Karen/0000-0003-4563-3744	UNIK Food Fitness and Pharma for Health and Disease research programme; Torsten Soderberg foundation; NovoNordisk foundation; Ethicon Endo-Surgery; NIH [DK082173, HL111319, DK093848]; NIH (Bioinformatics Core of the Digestive Disease Research Core Center in Cincinnati) [DK078392]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL111319, R00HL111319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK082173, K08DK084310, P30DK078392, R01DK093848] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0008163] Funding Source: researchfish	UNIK Food Fitness and Pharma for Health and Disease research programme; Torsten Soderberg foundation; NovoNordisk foundation(Novo Nordisk Foundation); Ethicon Endo-Surgery; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Bioinformatics Core of the Digestive Disease Research Core Center in Cincinnati); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank J. Berger, A. Haller, B. Li, E. Orr and M. Toure for technical assistance. This work was supported by grants from the UNIK Food Fitness and Pharma for Health and Disease research programme (C. C.), the Torsten Soderberg and NovoNordisk foundations (F. B.), Ethicon Endo-Surgery (R. K., D. A. S., R. J. S.) and the NIH (DK082173, HL111319 to K. K. R., DK093848 to R. J. S. and the Bioinformatics Core of the Digestive Disease Research Core Center in Cincinnati DK078392).	Bradley D, 2012, J CLIN INVEST, V122, P4667, DOI 10.1172/JCI64895; Brodziak F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072317; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chambers AP, 2013, GASTROENTEROLOGY, V144, P50, DOI 10.1053/j.gastro.2012.09.009; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jackness C, 2013, DIABETES, V62, P3027, DOI 10.2337/db12-1762; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lhoste EF, 2003, FOOD CHEM TOXICOL, V41, P695, DOI 10.1016/S0278-6915(03)00010-3; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Myronovych A, 2014, OBESITY, V22, P390, DOI 10.1002/oby.20548; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Pories WJ, 2008, J CLIN ENDOCR METAB, V93, pS89, DOI 10.1210/jc.2008-1641; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	54	648	693	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					183	+		10.1038/nature13135	http://dx.doi.org/10.1038/nature13135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24670636	Green Accepted			2022-12-28	WOS:000335454300030
J	Kavousi, M; Leening, MJG; Nanchen, D; Greenland, P; Graham, IM; Steyerberg, EW; Ikram, MA; Stricker, BH; Hofman, A; Franco, OH				Kavousi, Maryam; Leening, Maarten J. G.; Nanchen, David; Greenland, Philip; Graham, Ian M.; Steyerberg, Ewout W.; Ikram, M. Arfan; Stricker, Bruno H.; Hofman, Albert; Franco, Oscar H.			Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CHOLESTEROL; ROTTERDAM; STATINS; PEOPLE; MONICA	IMPORTANCE The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines introduced a prediction model and lowered the threshold for treatment with statins to a 7.5% 10-year hard atherosclerotic cardiovascular disease (ASCVD) risk. Implications of the new guideline's threshold and model have not been addressed in non-US populations or compared with previous guidelines. OBJECTIVE To determine population-wide implications of the ACC/AHA, the Adult Treatment Panel III (ATP-III), and the European Society of Cardiology (ESC) guidelines using a cohort of Dutch individuals aged 55 years or older. DESIGN, SETTING, AND PARTICIPANTS We included 4854 Rotterdam Study participants recruited in 1997-2001. We calculated 10-year risks for "hard" ASCVD events (including fatal and nonfatal coronary heart disease [CHD] and stroke) (ACC/AHA), hard CHD events (fatal and nonfatal myocardial infarction, CHD mortality) (ATP-III), and atherosclerotic CVD mortality (ESC). MAIN OUTCOMES AND MEASURES Events were assessed until January 1, 2012. Per guideline, we calculated proportions of individuals for whom statins would be recommended and determined calibration and discrimination of risk models. RESULTS The mean age was 65.5 (SD, 5.2) years. Statins would be recommended for 96.4% (95% CI, 95.4%-97.1%; n = 1825) of men and 65.8% (95% CI, 63.8%-67.7%; n = 1523) of women by the ACC/AHA, 52.0%(95% CI, 49.8%-54.3%; n = 985) of men and 35.5%(95% CI, 33.5%-37.5%; n = 821) of women by the ATP-III, and 66.1%(95% CI, 64.0%-68.3%; n = 1253) of men and 39.1%(95% CI, 37.1%-41.2%; n = 906) of women by ESC guidelines. With the ACC/AHA model, average predicted risk vs observed cumulative incidence of hard ASCVD events was 21.5%(95% CI, 20.9%-22.1%) vs 12.7%(95% CI, 11.1%-14.5%) for men (192 events) and 11.6% (95% CI, 11.2%-12.0%) vs 7.9%(95% CI, 6.7%-9.2%) for women (151 events). Similar overestimation occurred with the ATP-III model (98 events in men and 62 events in women) and ESC model (50 events in men and 37 events in women). The C statistic was 0.67 (95% CI, 0.63-0.71) in men and 0.68 (95% CI, 0.64-0.73) in women for hard ASCVD (ACC/AHA), 0.67 (95% CI, 0.62-0.72) in men and 0.69 (95% CI, 0.63-0.75) in women for hard CHD (ATP-III), and 0.76 (95% CI, 0.70-0.82) in men and 0.77 (95% CI, 0.71-0.83) in women for CVD mortality (ESC). CONCLUSIONS AND RELEVANCE In this European population aged 55 years or older, proportions of individuals eligible for statins differed substantially among the guidelines. The ACC/AHA guideline would recommend statins for nearly all men and two-thirds of women, proportions exceeding those with the ATP-III or ESC guidelines. All 3 risk models provided poor calibration and moderate to good discrimination. Improving risk predictions and setting appropriate population-wide thresholds are necessary to facilitate better clinical decision making.	[Kavousi, Maryam; Leening, Maarten J. G.; Ikram, M. Arfan; Stricker, Bruno H.; Hofman, Albert; Franco, Oscar H.] Erasmus MC Univ Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Leening, Maarten J. G.] Erasmus MC Univ Med Ctr Rotterdam, Dept Cardiol, Rotterdam, Netherlands; [Nanchen, David] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Greenland, Philip] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Greenland, Philip] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Graham, Ian M.] Univ Dublin Trinity Coll, Dublin 2, Ireland; [Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [Stricker, Bruno H.] Erasmus MC Univ Med Ctr Rotterdam, Dept Internal Med, Rotterdam, Netherlands; [Stricker, Bruno H.] Inspectorate Hlth Care, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Lausanne; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Trinity College Dublin; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Kavousi, M (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.kavousi@erasmusmc.nl	Greenland, Philip/ABD-5528-2021; Ikram, M. Arfan/AAM-5225-2021; Kavousi, Maryam/F-1174-2018; Nanchen, David/AAQ-1118-2021; Franco, Óscar H/ABE-2305-2020	Kavousi, Maryam/0000-0001-5976-6519; Nanchen, David/0000-0002-2493-3505; Franco, Óscar H/0000-0002-4606-4929; Ikram, Mohammad Arfan/0000-0003-0372-8585	Erasmus MC; Erasmus University, Rotterdam, the Netherlands; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; AXA Research Fund; ZonMw (HTA) [80.82500.98.10208]; Nestle Nutrition (Nestec Ltd); Metagenics Inc; AXA	Erasmus MC; Erasmus University, Rotterdam, the Netherlands(Netherlands Government); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; AXA Research Fund(AXA Research Fund); ZonMw (HTA); Nestle Nutrition (Nestec Ltd)(Nestle SA); Metagenics Inc; AXA	The Rotterdam Study is funded by Erasmus MC and Erasmus University, Rotterdam, the Netherlands; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. Dr Kavousi is supported by the AXA Research Fund. Drs Leening and Stricker are supported by a grant from the ZonMw (HTA grant 80.82500.98.10208). Dr Franco works in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd), Metagenics Inc, and AXA.	Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Framingham Heart Study, HARD COR HEART DIS 1; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Graham IM, 2014, EUR HEART J, V35, P537, DOI 10.1093/eurheartj/eht286; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; McCarthy M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6858; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nichols M., 2012, EUROPEAN CARDIOVASCU; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Psaty BM, 2014, JAMA-J AM MED ASSOC, V311, P461, DOI 10.1001/jama.2013.284203; Pyorala K, 2000, EUR HEART J, V21, P348, DOI 10.1053/euhj.1999.1927; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Vikhireva O, 2014, EUR HEART J, V35, P571, DOI 10.1093/eurheartj/eht189; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	26	243	251	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1416	1423		10.1001/jama.2014.2632	http://dx.doi.org/10.1001/jama.2014.2632			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24681960	Green Published, Bronze			2022-12-28	WOS:000333935000017
J	Dolgin, E				Dolgin, Elie			THERAPEUTICS Negative feedback	NATURE			English	Editorial Material							SYMPTOMS; AGONIST; TRIAL											Demirtas-Tatlidede A, 2010, SCHIZOPHR RES, V124, P91, DOI 10.1016/j.schres.2010.08.015; Elis O, 2013, CLIN PSYCHOL REV, V33, P914, DOI 10.1016/j.cpr.2013.07.001; Freedman R, 2008, AM J PSYCHIAT, V165, P1040, DOI 10.1176/appi.ajp.2008.07071135; Lieberman JA, 2013, NEUROPSYCHOPHARMACOL, V38, P968, DOI 10.1038/npp.2012.259; Prikryl R, 2013, J ECT, V29, P67, DOI 10.1097/YCT.0b013e318270295f; Umbricht D., 2010, NEUROPSYCHOPHARMACOL, V35, pS320	6	1	1	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S10	S11		10.1038/508S10a	http://dx.doi.org/10.1038/508S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695327	Bronze			2022-12-28	WOS:000333609900009
J	Greif, DM; Eichmann, A				Greif, Daniel M.; Eichmann, Anne			VASCULAR BIOLOGY Brain vessels squeezed to death	NATURE			English	Editorial Material							PERICYTES; INTEGRITY; BARRIER		[Greif, Daniel M.; Eichmann, Anne] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Eichmann, Anne] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Eichmann, Anne] Coll France, Ctr Interdisciplinary Res Biol, Paris, France	Yale University; Yale University; UDICE-French Research Universities; PSL Research University Paris; College de France	Greif, DM (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06510 USA.	daniel.greif@yale.edu; anne.eichmann@yale.edu						Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Rouget C., 1873, ARCH PHYSIOL NORM P, V5, P603; Vates GE, 2010, NAT MED, V16, P959, DOI 10.1038/nm0910-959; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	12	13	13	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					50	51		10.1038/nature13217	http://dx.doi.org/10.1038/nature13217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670635				2022-12-28	WOS:000333609900038
J	Kamerow, D				Kamerow, Douglas			The poisonous "juice" in e-cigarettes Yet another reason to oppose their unregulated use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Robert Graham Ctr Policy Studies Primary Care, Washington, DC USA		Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Grana RA, 2014, JAMA INTERN MED, V174, P812, DOI 10.1001/jamainternmed.2014.187; Kamerow D, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3418; Richtel M., 2014, NY TIMES; Welch W. W., 2014, US TODAY	4	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g2504	10.1136/bmj.g2504	http://dx.doi.org/10.1136/bmj.g2504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24691068				2022-12-28	WOS:000333976300012
J	Pollard, AJ; Riordan, A; Ramsay, M				Pollard, Andrew J.; Riordan, Andrew; Ramsay, Mary			Group B meningococcal vaccine: recommendations for UK use	LANCET			English	Editorial Material							4CMENB VACCINE; ROUTINE INFANT; IMMUNOGENICITY; MULTICOMPONENT; VACCINATIONS; TOLERABILITY; IMMUNIZATION; ADOLESCENTS; RECOMBINANT; DISEASE		[Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford OX3 9DU, England; [Riordan, Andrew] Alder Hey Childrens NHS Fdn, Liverpool, Merseyside, England; [Ramsay, Mary] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England	University of Oxford; Alder Hey Children's NHS Foundation Trust; Public Health England	Pollard, AJ (corresponding author), Univ Oxford, Dept Paediat, Oxford OX3 9DU, England.	andrew.pollard@paediatrics.ox.ac.uk	Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640				Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Health Protection Agency, 2012, INV MEN INF LAB REP; Joint Committee on Vaccination and Immunisation, 2013, JCVI INT POS STAT US; Mekalanos JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007588; Moxon R, 2013, LANCET, V382, P369, DOI 10.1016/S0140-6736(13)61572-X; Vesikari T, 2013, LANCET, V381, P825, DOI 10.1016/S0140-6736(12)61961-8; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1	10	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1103	1104		10.1016/S0140-6736(14)60226-9	http://dx.doi.org/10.1016/S0140-6736(14)60226-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4MH	24661533				2022-12-28	WOS:000333956000006
J	Alvarado, AS; Yamanaka, S				Alvarado, Alejandro Sanchez; Yamanaka, Shinya			Rethinking Differentiation: Stem Cells, Regeneration, and Plasticity	CELL			English	Review							SEE VOL. 511; SOMATIC-CELLS; REVERSE DEVELOPMENT; SMALL-INTESTINE; PG. 112; FIBROBLASTS; PLURIPOTENCY; ARABIDOPSIS; EXPRESSION; HOMEOSTASIS	Cell differentiation is an essential process for the development, growth, reproduction, and longevity of all multicellular organisms, and its regulation has been the focus of intense investigation for the past four decades. The study of natural and induced stem cells has ushered an age of re-examination of what it means to be a stem or a differentiated cell. Past and recent discoveries in plants and animals, as well as novel experimental manipulations, are beginning to erode many of these established concepts and are forcing a re-evaluation of the experimental systems and paradigms presently being used to explore these and other biological process.	[Alvarado, Alejandro Sanchez] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Alvarado, Alejandro Sanchez] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 606, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Stowers Institute for Medical Research; Howard Hughes Medical Institute; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Alvarado, AS (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	asa@stowers.org; yamanaka@cira.kyoto-u.ac.jp		Sanchez Alvarado, Alejandro/0000-0002-1966-6959	NIH [R37GM057260]; Core Research for Evolutional Science and Technology (CREST); Yamanaka iPS Cell Special Project from the Japan Science and Technology Agency; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057260] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Yamanaka iPS Cell Special Project from the Japan Science and Technology Agency; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.S.A. would like to acknowledge Ms. Rose Owens, the head librarian at the Stowers Institute for Medical Research, for her help in procuring historical material for this article. NIH R37GM057260 to A.S.A. and Core Research for Evolutional Science and Technology (CREST) and Yamanaka iPS Cell Special Project from the Japan Science and Technology Agency (J.S.T.) and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) to S.Y. funded some of the work reviewed in this article. A.S.A. is a Howard Hughes Medical Institute and Stowers Institute for Medical Research Investigator. S.Y. is a member without salary of the scientific advisory boards of iPierian, iPS Academia Japan, Megakaryon Corporation, and HEALIOS K.K. Japan.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Browne EN, 1909, J EXP ZOOL, V7, P1, DOI 10.1002/jez.1400070102; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Carla' EC, 2003, TISSUE CELL, V35, P213, DOI 10.1016/S0040-8166(03)00028-4; Chen CCG, 2013, DEVELOPMENT, V140, P719, DOI 10.1242/dev.083741; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Colucci VL, 1891, MEM R ACAD SCI I BOL, V1, P593; Dejosez M, 2013, SCIENCE, V341, P1511, DOI 10.1126/science.1241628; Dutrochet H, 1824, RECHERCHES ANATOMIQU; EGUCHI G, 1971, DEV GROWTH DIFFER, V13, P337; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gilbert S.F, 2013, DEV BIOL, VTenth; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Haeckel E., 1869, ENTWICKLUNGSGESCHICH; Haeckel E., 1904, KUNSTFORMEN NATUR; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hartsoeker N., 1694, ESSAY DIOPTRIQUE; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; HOLTFRETER J, 1947, J EXP ZOOL, V106, P197, DOI 10.1002/jez.1401060205; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inoue H., 2014, EMBO J IN PRESS; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Kleier C, 2004, AUSTRAL ECOL, V29, P461, DOI 10.1111/j.1442-9993.2004.01386.x; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Laird DJ, 2004, DEV BIOL, V273, P185, DOI 10.1016/j.ydbio.2004.05.029; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; LAUZON RJ, 1992, DEV DYNAM, V194, P71, DOI 10.1002/aja.1001940109; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; Lewis WH, 1904, AM J ANAT, V3, P505, DOI 10.1002/aja.1000030405; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Medine CN, 2013, STEM CELL TRANSL MED, V2, P505, DOI 10.5966/sctm.2012-0138; Moldenhawer JJP, 1812, BEYTRAGE ANATOMIE PF; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Obokata H, 2014, NATURE, V505, P676, DOI 10.1038/nature12969; Obokata H, 2014, NATURE, V505, P641, DOI 10.1038/nature12968; Obokata H, 2011, TISSUE ENG PT A, V17, P607, DOI [10.1089/ten.tea.2010.0385, 10.1089/ten.TEA.2010.0385]; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Pinto D, 2005, BIOL CELL, V97, P185; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Piraino S, 1996, BIOL BULL-US, V190, P302, DOI 10.2307/1543022; Piraino S, 2004, CAN J ZOOL, V82, P1748, DOI 10.1139/Z04-174; Plutarch, 1859, PLUTR LIV TRANSL CAL, VV; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Reddien PW, 2013, DEVELOPMENT, V140, P951, DOI 10.1242/dev.080499; Reddien PW, 2011, TRENDS GENET, V27, P277, DOI 10.1016/j.tig.2011.04.004; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; REYER RW, 1977, EXP EYE RES, V24, P511, DOI 10.1016/0014-4835(77)90272-X; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Richards Robert J., 2008, TRAGIC SENSE LIFE E; RINKEVICH B, 1992, P NATL ACAD SCI USA, V89, P3546, DOI 10.1073/pnas.89.8.3546; Rinkevich Y, 2013, DEV CELL, V24, P76, DOI 10.1016/j.devcel.2012.11.010; Roy S, 2013, P NATL ACAD SCI USA, V110, P4598, DOI 10.1073/pnas.1218682110; Schmich J, 2007, INT J DEV BIOL, V51, P45, DOI 10.1387/ijdb.062152js; Scimone ML, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003999; Scimone ML, 2011, DEVELOPMENT, V138, P4387, DOI 10.1242/dev.068098; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Spemann H., 1938, EMBYONIC DEV IND; Spemann H, 1901, VERH ANAT GESELLSCH, V15, P61; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Treviranus LC, 1811, BEYTRAGE PFLANZENPHY; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Voskoboynik A, 2008, CELL STEM CELL, V3, P456, DOI 10.1016/j.stem.2008.07.023; Voskoboynik A, 2007, FASEB J, V21, P1335, DOI 10.1096/fj.06-7337com; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Weismann A, 1893, GERM PLASM THEORY HE; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wolff G., 1895, REGEN URODELENLINSE, V1, P380; World Health Organization, 2012, GLOB DAT VIS IMP 201; Yamada T, 1977, Monogr Dev Biol, V13, P1; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	105	169	171	4	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					110	119		10.1016/j.cell.2014.02.041	http://dx.doi.org/10.1016/j.cell.2014.02.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679530	Green Accepted, Bronze			2022-12-28	WOS:000333968900011
J	Eisman, S; Sinclair, R				Eisman, Samantha; Sinclair, Rodney			Fungal nail infection: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TOENAIL ONYCHOMYCOSIS; DOUBLE-BLIND; CONTINUOUS TERBINAFINE; EFFICACY; THERAPY; EPIDEMIOLOGY; FLUCONAZOLE; LACQUER; SAFETY; ITRACONAZOLE		[Eisman, Samantha; Sinclair, Rodney] Sinclair Dermatol, East Melbourne, Vic 3002, Australia		Sinclair, R (corresponding author), Sinclair Dermatol, East Melbourne, Vic 3002, Australia.	rodney.sinclair@epworthdermatology.com.au	Sinclair, Rodney/AAI-8355-2020	Sinclair, Rodney/0000-0001-6751-1428				Barak O, 2010, J CUTAN PATHOL, V37, P1038, DOI 10.1111/j.1600-0560.2010.01545.x; Baran R, 2005, J DERMATOL TREAT, V16, P52, DOI 10.1080/09546630510025950; Brown SJ, 2009, ANN PHARMACOTHER, V43, P1684, DOI 10.1345/aph.1M165; Crawford F, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001434.PUB2; Dai T, 2008, BRIT J DERMATOL, V158, P1239, DOI 10.1111/j.1365-2133.2008.08549.x; de Berker D, 2009, NEW ENGL J MED, V360, P2108, DOI 10.1056/NEJMcp0804878; Electronic Medicines Compendium, LAM TABL 250MG; Elewski BE, 2013, J AM ACAD DERMATOL, V68, P600, DOI 10.1016/j.jaad.2012.10.013; Evans EGV, 1999, BMJ-BRIT MED J, V318, P1031, DOI 10.1136/bmj.318.7190.1031; Faergemann J, 2005, J EUR ACAD DERMATOL, V19, P17, DOI 10.1111/j.1468-3083.2005.01283.x; Ghannoum M, 2014, BRIT J DERMATOL, V170, P182, DOI 10.1111/bjd.12594; Gupta A, 2012, Skin Therapy Lett, V17, P4; Gupta AK, 2013, CLIN DERMATOL, V31, P544, DOI 10.1016/j.clindermatol.2013.06.011; Gupta AK, 2013, CLIN DERMATOL, V31, P555, DOI 10.1016/j.clindermatol.2013.06.010; Gupta AK, 2013, CLIN DERMATOL, V31, P540, DOI 10.1016/j.clindermatol.2013.06.009; Gupta AK, 2013, PEDIATR DERMATOL, V30, P294, DOI 10.1111/pde.12048; Gupta AK, 2013, J DERMATOL TREAT, V24, P75, DOI 10.3109/09546634.2012.703308; Gupta AK, 2012, J AM ACAD DERMATOL, V66, P494, DOI 10.1016/j.jaad.2011.02.038; Gupta AK, 1998, BRIT J DERMATOL, V139, P665, DOI 10.1046/j.1365-2133.1998.02464.x; Gupta AK, 2000, INT J DERMATOL, V39, P746, DOI 10.1046/j.1365-4362.2000.00012.x; Gupta AK, 1997, BRIT J DERMATOL, V136, P786, DOI 10.1111/j.1365-2133.1997.tb03673.x; Gupta AK, 2004, BRIT J DERMATOL, V150, P537, DOI 10.1046/j.1365-2133.2003.05728.x; Gupta AK, 1998, BRIT J DERMATOL, V138, P529, DOI 10.1046/j.1365-2133.1998.02140.x; Gupta AK, 2002, J CUTAN MED SURG, V6, P210, DOI 10.1007/s10227-001-0048-3; Gupta AK, 2000, J EUR ACAD DERMATOL, V14, P466, DOI 10.1046/j.1468-3083.2000.00124.x; Gupta AK, 2000, J AM ACAD DERMATOL, V43, pS96, DOI 10.1067/mjd.2000.109068; Havu V, 1997, BRIT J DERMATOL, V136, P230, DOI 10.1111/j.1365-2133.1997.tb14902.x; Havu V, 2000, BRIT J DERMATOL, V142, P97, DOI 10.1046/j.1365-2133.2000.03247.x; Hay R, 2005, J EUR ACAD DERMATOL, V19, P1, DOI 10.1111/j.1468-3083.2005.01288.x; Hay RJ, 2001, BRIT J DERMATOL, V145, P3, DOI 10.1046/j.1365-2133.2001.145s60003.x; HAY RJ, 1985, CLIN EXP DERMATOL, V10, P111, DOI 10.1111/j.1365-2230.1985.tb00537.x; Hay RJ, 2011, J AM ACAD DERMATOL, V65, P1219, DOI 10.1016/j.jaad.2010.09.730; Jesudanam T Madhuri, 2002, Indian J Dermatol Venereol Leprol, V68, P326; Katz HI, 1997, DERMATOL CLIN, V15, P535, DOI 10.1016/S0733-8635(05)70460-5; Lahfa M, 2013, DERMATOLOGY, V226, P5, DOI 10.1159/000345105; Lecha M, 2005, J EUR ACAD DERMATOL, V19, P25, DOI 10.1111/j.1468-3083.2005.01284.x; Lecha M, 2001, BRIT J DERMATOL, V145, P21, DOI 10.1046/j.1365-2133.2001.145s60021.x; Malay DS, 2009, J FOOT ANKLE SURG, V48, P294, DOI 10.1053/j.jfas.2008.12.012; Millard LG, 2010, ROOKS TXB DERMATOLOG, P1; Mohd Mustapa MF, 2013, BRIT ASS DE IN PRESS; National Institute for Health and Care Excellence, 2013, FUNG NAIL INF SUMM; Pandhi D, 2012, INDIAN J DERMATOL VE, V78, P299, DOI 10.4103/0378-6323.95444; Paul C, 2013, DERMATOLOGY, V227, P157, DOI 10.1159/000353667; PHILPOT CM, 1989, CLIN EXP DERMATOL, V14, P203, DOI 10.1111/j.1365-2230.1989.tb00932.x; Rodgers P, 2001, AM FAM PHYSICIAN, V63, P663; Scher RK, 2003, BRIT J DERMATOL, V149, P5, DOI 10.1046/j.1365-2133.149.s65.5.x; Sigurgeirsson B, 2010, J EUR ACAD DERMATOL, V24, P679, DOI 10.1111/j.1468-3083.2009.03487.x; Sigurgeirsson B, 2013, J EUR ACAD DERMATOL; Singal A, 2011, INDIAN J DERMATOL VE, V77, P358; Sotiriou E, 2010, ACTA DERM-VENEREOL, V90, P216, DOI 10.2340/00015555-0811; SUMMERBELL RC, 1989, MYCOSES, V32, P609, DOI 10.1111/j.1439-0507.1989.tb02192.x; Tsunemi Y, 2014, BRIT J DERMATOL, V170, P328, DOI 10.1111/bjd.12660; Warshaw EM, 2005, J AM ACAD DERMATOL, V53, P578, DOI 10.1016/j.jaad.2005.04.055; Weinberg JM, 2003, J AM ACAD DERMATOL, V49, P193, DOI 10.1067/S0190-9622(03)01480-4; Yin ZQ, 2012, J DERMATOL TREAT, V23, P449, DOI 10.3109/09546634.2011.579082	55	20	21	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2014	348								g1800	10.1136/bmj.g1800	http://dx.doi.org/10.1136/bmj.g1800			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9KZ	24661991				2022-12-28	WOS:000333585300003
J	Gregory, CD				Gregory, Christopher D.			CELL BIOLOGY The disassembly of death	NATURE			English	Editorial Material							FIND-ME SIGNAL		Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, MRC, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Gregory, CD (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, MRC, Edinburgh EH16 4TJ, Midlothian, Scotland.	chris.gregory@ed.ac.uk	Gregory, Chris/C-6927-2019	Gregory, Chris/0000-0002-7553-0132				Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Liu HH, 2010, DRUG SAFETY, V33, P353, DOI 10.2165/11536360-000000000-00000; Lucena MI, 2000, CLIN INFECT DIS, V30, P400, DOI 10.1086/313680; Poon IKH, 2014, NATURE, V507, P329, DOI 10.1038/nature13147; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25	9	6	6	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					312	313		10.1038/nature13213	http://dx.doi.org/10.1038/nature13213			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646991				2022-12-28	WOS:000333029000023
J	Bloem, BR; Munneke, M				Bloem, Bastiaan R.; Munneke, Marten			Revolutionising management of chronic disease: the ParkinsonNet approach	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; HEALTH-CARE; MULTIDISCIPLINARY CARE; EPDA CHARTER; ROTTERDAM; PEOPLE; IMPACT; PHYSIOTHERAPY; SATISFACTION; EXPERIENCE		[Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Bloem, Bastiaan R.; Munneke, Marten] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Munneke, Marten] Nijmegen Ctr Evidence Based Practice, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Bloem, BR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	bas.bloem@radboudumc.nl	Munneke, Marten/N-3583-2014; Bloem, Bastiaan/H-8013-2014	Bloem, Bastiaan/0000-0002-6371-3337				Bloem BR, 2012, EUR J NEUROL, V19, P402, DOI 10.1111/j.1468-1331.2011.03532.x; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Findley LJ, 2002, BRIT MED J, V324, P1466, DOI 10.1136/bmj.324.7352.1466; Gage H, 2003, J NEUROL NEUROSUR PS, V74, P163, DOI 10.1136/jnnp.74.2.163; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; Hass CJ, 2010, LANCET NEUROL, V9, P20, DOI 10.1016/S1474-4422(09)70331-X; Hoeksema N, 2011, ONDERZOEK NAAR MEERW, P1; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Keus SHJ, 2004, J NEUROL, V251, P680, DOI 10.1007/s00415-004-0402-7; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Munneke M, 2010, LANCET NEUROL, V9, P46, DOI 10.1016/S1474-4422(09)70327-8; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Nijkrake MJ, 2010, MOVEMENT DISORD, V25, P823, DOI 10.1002/mds.22813; Nijkrake MJ, 2009, MOVEMENT DISORD, V24, P282, DOI 10.1002/mds.22377; Parashos SA, 2013, LANCET NEUROL, V12, P932, DOI 10.1016/S1474-4422(13)70145-5; Post B, 2011, Pract Neurol, V11, P58, DOI 10.1136/jnnp.2011.241604; Stocchi F, 2013, EUR J NEUROL, V20, P461, DOI 10.1111/j.1468-1331.2012.03876.x; Tomlinson CL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5004; van der Eijk M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2476; van der Eijk M, 2012, PARKINSONISM RELAT D, V18, P1011, DOI 10.1016/j.parkreldis.2012.05.017; van der Eijk M, 2011, PARKINSONISM RELAT D, V17, P360, DOI 10.1016/j.parkreldis.2011.02.012; van der Marck MA, 2013, LANCET NEUROL, V12, P947, DOI 10.1016/S1474-4422(13)70196-0; Weerkamp NJ, 2012, J AM GERIATR SOC, V60, P2277, DOI 10.1111/jgs.12027; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-67	26	80	80	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1838	10.1136/bmj.g1838	http://dx.doi.org/10.1136/bmj.g1838			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647365				2022-12-28	WOS:000333414500004
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE; DEMENTIA; PREVALENCE; DIAGNOSIS; DONEPEZIL; DISPARITY; DISEASE	Description: Update of the 2003 U. S. Preventive Services Task Force (USPSTF) recommendation on screening for dementia. Methods: The USPSTF reviewed the evidence on the benefits, harms, and sensitivity and specificity of screening instruments for cognitive impairment in older adults and the benefits and harms of commonly used treatment and management options for older adults with mild cognitive impairment or early dementia and their caregivers. Population: This recommendation applies to universal screening with formal screening instruments in community-dwelling adults in the general primary care population who are older than 65 years and have no signs or symptoms of cognitive impairment. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment. (I statement)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2006, INT J GERIATR PSYCH, V21, P556, DOI 10.1002/gps.1524; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Chodosh J, 2004, J AM GERIATR SOC, V52, P1051, DOI 10.1111/j.1532-5415.2004.52301.x; Cordell CB, 2013, ALZHEIMERS DEMENT, V9, P141, DOI 10.1016/j.jalz.2012.09.011; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.3.CO;2-X; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Koontz Jennifer, 2005, Am J Alzheimers Dis Other Demen, V20, P295, DOI 10.1177/153331750502000502; Lin J. S, 2013, AHRQ PUBLICATION; Lin JS, 2013, ANN INTERN MED, V159, P601, DOI 10.7326/0003-4819-159-9-201311050-00730; Olafsdottir M, 2000, DEMENT GERIATR COGN, V11, P223, DOI 10.1159/000017241; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Potter GG, 2009, ALZHEIMERS DEMENT, V5, P445, DOI 10.1016/j.jalz.2009.04.1234; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Salloway S, 2004, NEUROLOGY, V63, P651, DOI 10.1212/01.WNL.0000134664.80320.92; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002	24	127	133	4	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					791	+		10.7326/M14-0496	http://dx.doi.org/10.7326/M14-0496			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0MT	24663815				2022-12-28	WOS:000337348700005
J	Natsuaki, M; Kozuma, K; Morimoto, T; Shiomi, H; Kimura, T				Natsuaki, Masahiro; Kozuma, Ken; Morimoto, Takeshi; Shiomi, Hiroki; Kimura, Takeshi			Two-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Biodegradable or Durable Polymer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							METAANALYSIS		[Natsuaki, Masahiro] Saiseikai Fukuoka Gen Hosp, Div Cardiol, Fukuoka, Japan; [Kozuma, Ken] Teikyo Univ Hosp, Div Cardiol, Tokyo, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Div Gen Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Shiomi, Hiroki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan	Teikyo University; Hyogo College of Medicine; Kyoto University	Kimura, T (corresponding author), Kyoto Univ, Grad Sch Med, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	taketaka@kuhp.kyoto-u.ac.jp	Kozuma, Ken/W-9547-2019; Shiomi, Hiroki/ADJ-9510-2022	Shiomi, Hiroki/0000-0001-7234-023X				Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625; Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530	4	26	28	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2125	2127		10.1001/jama.2014.3584	http://dx.doi.org/10.1001/jama.2014.3584			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24687156	Bronze			2022-12-28	WOS:000336392400030
J	Marder, SR				Marder, Stephen R.			PERSPECTIVE Retreat from the radical	NATURE			English	Editorial Material							SCHIZOPHRENIA; METAANALYSIS; THERAPY		[Marder, Stephen R.] Univ Calif Los Angeles, Semel Inst Neurosci, Los Angeles, CA 90095 USA; [Marder, Stephen R.] VA Desert Pacific Mental Illness Res Educ & Clin, Los Angeles, CA USA	University of California System; University of California Los Angeles	Marder, SR (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci, Los Angeles, CA 90095 USA.	smarder@mednet.ucla.edu						Bespalov Anton, 2012, Handb Exp Pharmacol, P419, DOI 10.1007/978-3-642-25758-2_14; Eack SM, 2010, ARCH GEN PSYCHIAT, V67, P674, DOI 10.1001/archgenpsychiatry.2010.63; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Morris SE, 2011, SCHIZOPHR RES, V127, P1, DOI 10.1016/j.schres.2011.01.027; Penades R, 2013, BIOL PSYCHIAT, V73, P1015, DOI 10.1016/j.biopsych.2013.01.017; Stafford MR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f185	6	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S18	S18		10.1038/508S18a	http://dx.doi.org/10.1038/508S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695331	Bronze			2022-12-28	WOS:000333609900013
J	Kheifets, S; Simha, A; Melin, K; Li, TC; Raizen, MG				Kheifets, Simon; Simha, Akarsh; Melin, Kevin; Li, Tongcang; Raizen, Mark G.			Observation of Brownian Motion in Liquids at Short Times: Instantaneous Velocity and Memory Loss	SCIENCE			English	Article							HYDRODYNAMIC THEORY; LANGEVIN EQUATION; AUTOCORRELATION; DYNAMICS; FLUID; TAIL	Measurement of the instantaneous velocity of Brownian motion of suspended particles in liquid probes the microscopic foundations of statistical mechanics in soft condensed matter. However, instantaneous velocity has eluded experimental observation for more than a century since Einstein's prediction of the small length and time scales involved. We report shot-noise-limited, high-bandwidth measurements of Brownian motion of micrometer-sized beads suspended in water and acetone by an optical tweezer. We observe the hydrodynamic instantaneous velocity of Brownian motion in a liquid, which follows a modified energy equipartition theorem that accounts for the kinetic energy of the fluid displaced by the moving bead. We also observe an anticorrelated thermal force, which is conventionally assumed to be uncorrelated.	[Raizen, Mark G.] Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA; Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Raizen, MG (corresponding author), Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA.	raizen@physics.utexas.edu	Kheifets, Simon/M-9776-2016	Kheifets, Simon/0000-0001-8196-9208; Li, Tongcang/0000-0003-3308-8718	Sid W. Richardson Foundation; R. A. Welch Foundation [F-1258]	Sid W. Richardson Foundation; R. A. Welch Foundation(The Welch Foundation)	M.G.R. acknowledges support from the Sid W. Richardson Foundation and the R. A. Welch Foundation (grant F-1258). All raw data and analysis code used to generate results presented in this work are available upon request to M.G.R.	BALAKRISHNAN V, 1979, PRAMANA, V12, P301, DOI 10.1007/BF02894699; BASSET A. B, 1888, PHILOS T ROY SOC LON, V179, P43, DOI DOI 10.1098/RSTA.1888.0003; Beard DA, 2000, J CHEM PHYS, V112, P7323, DOI 10.1063/1.481371; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Boussinesq J., 1885, CR HEBD ACAD SCI, V100, P935; CLERCX HJH, 1992, PHYS REV A, V46, P1942, DOI 10.1103/PhysRevA.46.1942; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; Duplat J, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.020105; Einstein A, 1907, Z ELKTROCHEM ANGEW P, V13, P41, DOI 10.1002/bbpc.19070130602; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Felderhof BU, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2084948; FOX RF, 1977, J MATH PHYS, V18, P2331, DOI 10.1063/1.523242; Franosch T, 2011, NATURE, V478, P85, DOI 10.1038/nature10498; Grimm M, 2011, SOFT MATTER, V7, P2076, DOI 10.1039/c0sm00636j; HINCH EJ, 1975, J FLUID MECH, V72, P499, DOI 10.1017/S0022112075003102; Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/NPHYS1953, 10.1038/nphys1953]; KERKER M, 1974, J CHEM EDUC, V51, P764, DOI 10.1021/ed051p764; KIM YW, 1973, PHYS REV LETT, V31, P208, DOI 10.1103/PhysRevLett.31.208; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; LANDAU LD, 1987, FLUID MECHANICS, V6; Li TC, 2011, NAT PHYS, V7, P527, DOI [10.1038/nphys1952, 10.1038/NPHYS1952]; Li TC, 2010, SCIENCE, V328, P1673, DOI 10.1126/science.1189403; LONDON RE, 1977, J CHEM PHYS, V66, P471, DOI 10.1063/1.433965; Nagele G, 1997, PHYSICA A, V245, P297, DOI 10.1016/S0378-4371(97)00307-5; PAUL GL, 1981, J PHYS A-MATH GEN, V14, P3301, DOI 10.1088/0305-4470/14/12/025; Perrin J, 1909, ANN CHIM PHYS, V18, P5; Rings D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.090604; Svitelskiy O, 2011, OPT LETT, V36, P2862, DOI 10.1364/OL.36.002862; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Vladimirsky V., 1945, FIZ, V15, P258; Wang GM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050601; ZWANZIG R, 1975, J FLUID MECH, V69, P21, DOI 10.1017/S0022112075001280; ZWANZIG R, 1970, PHYS REV A, V2, P2005, DOI 10.1103/PhysRevA.2.2005	33	150	153	3	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1493	1496		10.1126/science.1248091	http://dx.doi.org/10.1126/science.1248091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675957				2022-12-28	WOS:000333471000042
J	Evans, RM; Mangelsdorf, DJ				Evans, Ronald M.; Mangelsdorf, David J.			Nuclear Receptors, RXR, and the Big Bang	CELL			English	Article							RETINOID-X-RECEPTOR; HUMAN GLUCOCORTICOID-RECEPTOR; THYROID-HORMONE RECEPTORS; BREAST-CANCER CELLS; REV-ERB-ALPHA; TRANSCRIPTIONAL CONTROL; HETERODIMER FORMATION; SIGNALING PATHWAYS; ENERGY-METABOLISM; RESPONSE ELEMENTS	Isolation of genes encoding the receptors for steroids, retinoids, vitamin D, and thyroid hormone and their structural and functional analysis revealed an evolutionarily conserved template for nuclear hormone receptors. This discovery sparked identification of numerous genes encoding related proteins, termed orphan receptors. Characterization of these orphan receptors and, in particular, of the retinoid X receptor (RXR) positioned nuclear receptors at the epicenter of the "Big Bang'' of molecular endocrinology. This Review provides a personal perspective on nuclear receptors and explores their integrated and coordinated signaling networks that are essential for multicellular life, highlighting the RXR heterodimer and its associated ligands and transcriptional mechanism.	[Evans, Ronald M.; Mangelsdorf, David J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu; davo.mango@utsouthwestern.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Mangelsdorf, David/0000-0002-4355-0796	National Institutes of Health (NIH) [DK057978, HL105278, DK090962, HL088093, ES010337, CA014195, R01DK067158]; Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure; Robert A. Welch Foundation [I-1275]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090962, R37DK057978, R01DK067158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank R. Yu, M. Downes, A. Atkins, S. Kliewer, and N. McKenna for discussions and critical input, J. Simon for artwork, and C. Brondos and E. Ong for administrative assistance. R.M.E. holds the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute and is supported by grants from the National Institutes of Health (NIH) (DK057978, HL105278, DK090962, HL088093, ES010337 and CA014195), as well as the Helmsley Charitable Trust, Samuel Waxman Cancer Research Foundation, and Ipsen/Biomeasure. D.J.M. is supported by the NIH (R01DK067158) and the Robert A. Welch Foundation (grant I-1275). R.M.E. and D.J.M. are investigators of the Howard Hughes Medical Institute.	Baker ME, 2011, MOL CELL ENDOCRINOL, V334, P14, DOI 10.1016/j.mce.2010.07.013; BEATO M, 1991, FASEB J, V5, P2044, DOI 10.1096/fasebj.5.7.2010057; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Contreras AV, 2013, ADV NUTR, V4, P439, DOI 10.3945/an.113.003798; DALLMAN MF, 1994, ANN NY ACAD SCI, V746, P22; de Lange P, 2008, PPAR RES, V2008, DOI 10.1155/2008/172676; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Desvergne B, 2007, VITAM HORM, V75, P1, DOI 10.1016/S0083-6729(06)75001-4; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fahrbach SE, 2012, ANNU REV ENTOMOL, V57, P83, DOI 10.1146/annurev-ento-120710-100607; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; HANUKOGLU I, 1992, J STEROID BIOCHEM, V43, P779, DOI 10.1016/0960-0760(92)90307-5; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kendall EC, 1917, ENDOCRINOLOGY, V1, P153, DOI 10.1210/endo-1-2-153; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; LEBLANC BP, 1995, GENE DEV, V9, P1811, DOI 10.1101/gad.9.15.1811; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Lou XH, 2014, NAT STRUCT MOL BIOL, V21, P277, DOI 10.1038/nsmb.2778; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Markov GV, 2011, MOL CELL ENDOCRINOL, V334, P21, DOI 10.1016/j.mce.2010.10.017; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; McSorley LC, 2000, BIOCHEM PHARMACOL, V60, P517, DOI 10.1016/S0006-2952(00)00356-7; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Miranda TB, 2013, MOL CELL ENDOCRINOL, V380, P16, DOI 10.1016/j.mce.2013.03.002; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; O'Malley BW, 2012, MOL ENDOCRINOL, V26, P1646, DOI 10.1210/me.2012-1114; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; OMALLEY BW, 1971, NEW ENGL J MED, V284, P370; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; PARDRIDGE WM, 1981, ENDOCR REV, V2, P103, DOI 10.1210/edrv-2-1-103; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Robinson-Rechavi M, 2004, MOL BIOL EVOL, V21, P580, DOI 10.1093/molbev/msh046; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Seminara SB, 2001, ENDOCRINOLOGY, V142, P2173, DOI 10.1210/en.142.6.2173; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vacca M, 2011, WIRES SYST BIOL MED, V3, P562, DOI 10.1002/wsbm.137; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WATANABE S, 1991, BIOCHIM BIOPHYS ACTA, V1073, P275, DOI 10.1016/0304-4165(91)90132-Z; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	101	690	709	13	223	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					255	266		10.1016/j.cell.2014.03.012	http://dx.doi.org/10.1016/j.cell.2014.03.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679540	Green Accepted, Bronze			2022-12-28	WOS:000333968900021
J	Forrest, ARR; Kawaji, H; Rehli, M; Baillie, JK; de Hoon, MJL; Haberle, V; Lassmann, T; Kulakovskiy, IV; Lizio, M; Itoh, M; Andersson, R; Mungall, CJ; Meehan, TF; Schmeier, S; Bertin, N; Jorgensen, M; Dimont, E; Arner, E; Schmidl, C; Schaefer, U; Medvedeva, YA; Plessy, C; Vitezic, M; Severin, J; Semple, CA; Ishizu, Y; Young, RS; Francescatto, M; Alam, I; Albanese, D; Altschuler, GM; Arakawa, T; Archer, JAC; Arner, P; Babina, M; Rennie, S; Balwierz, PJ; Beckhouse, AG; Pradhan-Bhatt, S; Blake, JA; Blumenthal, A; Bodega, B; Bonetti, A; Briggs, J; Brombacher, F; Burroughs, AM; Califano, A; Cannistraci, CV; Carbajo, D; Chen, Y; Chierici, M; Ciani, Y; Clevers, HC; Dalla, E; Davis, CA; Detmar, M; Diehl, AD; Dohi, T; Drablos, F; Edge, ASB; Edinger, M; Ekwall, K; Endoh, M; Enomoto, H; Fagiolini, M; Fairbairn, L; Fang, H; Farach-Carson, MC; Faulkner, GJ; Favorov, AV; Fisher, ME; Frith, MC; Fujita, R; Fukuda, S; Furlanello, C; Furuno, M; Furusawa, J; Geijtenbeek, TB; Gibson, AP; Gingeras, T; Goldowitz, D; Gough, J; Guhl, S; Guler, R; Gustincich, S; Ha, TJ; Hamaguchi, M; Hara, M; Harbers, M; Harshbarger, J; Hasegawa, A; Hasegawa, Y; Hashimoto, T; Herlyn, M; Hitchens, KJ; Sui, SJH; Hofmann, OM; Hoof, I; Hori, F; Huminiecki, L; Iida, K; Ikawa, T; Jankovic, BR; Jia, H; Joshi, A; Jurman, G; Kaczkowski, B; Kai, C; Kaida, K; Kaiho, A; Kajiyama, K; Kanamori-Katayama, M; Kasianov, A; Kasukawa, T; Katayama, S; Kato, S; Kawaguchi, S; Kawamoto, H; Kawamura, YI; Kawashima, T; Kempfle, JS; Kenna, TJ; Kere, J; Khachigian, LM; Kitamura, T; Klinken, SP; Knox, AJ; Kojima, M; Kojima, S; Kondo, N; Koseki, H; Koyasu, S; Krampitz, S; Kubosaki, A; Kwon, AT; Laros, JFJ; Lee, W; Lennartsson, A; Li, K; Lilje, B; Lipovich, L; Mackay-sim, A; Manabe, R; Mar, JC; Marchand, B; Mathelier, A; Mejhert, N; Meynert, A; Mizuno, Y; Morais, DAD; Morikawa, H; Morimoto, M; Moro, K; Motakis, E; Motohashi, H; Mummery, CL; Murata, M; Nagao-Sato, S; Nakachi, Y; Nakahara, F; Nakamura, T; Nakamura, Y; Nakazato, K; Van Nimwegen, E; Ninomiya, N; Nishiyori, H; Noma, S; Nozaki, T; Ogishima, S; Ohkura, N; Ohmiya, H; Ohno, H; Ohshima, M; Okada-Hatakeyama, M; Okazaki, Y; Orlando, V; Ovchinnikov, DA; Pain, A; Passier, R; Patrikakis, M; Persson, H; Piazza, S; Prendergast, JGD; Rackham, OJL; Ramilowski, JA; Rashid, M; Ravasi, T; Rizzu, P; Roncador, M; Roy, S; Rye, MB; Saijyo, E; Sajantila, A; Saka, A; Sakaguchi, S; Sakai, M; Sato, H; Satoh, H; Savvi, S; Saxena, A; Schneider, C; Schultes, EA; Schulze-Tanzil, GG; Schwegmann, A; Sengstag, T; Sheng, GJ; Shimoji, H; Shimoni, Y; Shin, JW; Simon, C; Sugiyama, D; Sugiyama, T; Suzuki, M; Suzuki, N; Swoboda, RK; 't Hoen, PAC; Tagami, M; Takahashi, N; Takai, J; Tanaka, H; Tatsukawa, H; Tatum, Z; Thompson, M; Toyoda, H; Toyoda, T; Valen, E; van de Wetering, M; van den Berg, LM; Verardo, R; Vijayan, D; Vorontsov, IE; Wasserman, WW; Watanabe, S; Wells, CA; Winteringham, LN; Wolvetang, E; Wood, EJ; Yamaguchi, Y; Yamamoto, M; Yoneda, M; Yonekura, Y; Yoshida, S; Zabierowski, SE; Zhang, PG; Zhao, XB; Zucchelli, S; Summers, KM; Suzuki, H; Daub, CO; Kawai, J; Heutink, P; Hide, W; Freeman, TC; Lenhard, B; Bajic, VB; Taylor, MS; Makeev, VJ; Sandelin, A; Hume, DA; Carninci, P; Hayashizaki, Y				Forrest, Alistair R. R.; Kawaji, Hideya; Rehli, Michael; Baillie, J. Kenneth; de Hoon, Michiel J. L.; Haberle, Vanja; Lassmann, Timo; Kulakovskiy, Ivan V.; Lizio, Marina; Itoh, Masayoshi; Andersson, Robin; Mungall, Christopher J.; Meehan, Terrence F.; Schmeier, Sebastian; Bertin, Nicolas; Jorgensen, Mette; Dimont, Emmanuel; Arner, Erik; Schmidl, Christian; Schaefer, Ulf; Medvedeva, Yulia A.; Plessy, Charles; Vitezic, Morana; Severin, Jessica; Semple, Colin A.; Ishizu, Yuri; Young, Robert S.; Francescatto, Margherita; Alam, Intikhab; Albanese, Davide; Altschuler, Gabriel M.; Arakawa, Takahiro; Archer, John A. C.; Arner, Peter; Babina, Magda; Rennie, Sarah; Balwierz, Piotr J.; Beckhouse, Anthony G.; Pradhan-Bhatt, Swati; Blake, Judith A.; Blumenthal, Antje; Bodega, Beatrice; Bonetti, Alessandro; Briggs, James; Brombacher, Frank; Burroughs, A. Maxwell; Califano, Andrea; Cannistraci, Carlo V.; Carbajo, Daniel; Chen, Yun; Chierici, Marco; Ciani, Yari; Clevers, Hans C.; Dalla, Emiliano; Davis, Carrie A.; Detmar, Michael; Diehl, Alexander D.; Dohi, Taeko; Drablos, Finn; Edge, Albert S. B.; Edinger, Matthias; Ekwall, Karl; Endoh, Mitsuhiro; Enomoto, Hideki; Fagiolini, Michela; Fairbairn, Lynsey; Fang, Hai; Farach-Carson, Mary C.; Faulkner, Geoffrey J.; Favorov, Alexander V.; Fisher, Malcolm E.; Frith, Martin C.; Fujita, Rie; Fukuda, Shiro; Furlanello, Cesare; Furuno, Masaaki; Furusawa, Jun-ichi; Geijtenbeek, Teunis B.; Gibson, Andrew P.; Gingeras, Thomas; Goldowitz, Daniel; Gough, Julian; Guhl, Sven; Guler, Reto; Gustincich, Stefano; Ha, Thomas J.; Hamaguchi, Masahide; Hara, Mitsuko; Harbers, Matthias; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hashimoto, Takehiro; Herlyn, Meenhard; Hitchens, Kelly J.; Sui, Shannan J. Ho; Hofmann, Oliver M.; Hoof, Ilka; Hori, Fumi; Huminiecki, Lukasz; Iida, Kei; Ikawa, Tomokatsu; Jankovic, Boris R.; Jia, Hui; Joshi, Anagha; Jurman, Giuseppe; Kaczkowski, Bogumil; Kai, Chieko; Kaida, Kaoru; Kaiho, Ai; Kajiyama, Kazuhiro; Kanamori-Katayama, Mutsumi; Kasianov, ArtemS.; Kasukawa, Takeya; Katayama, Shintaro; Kato, Sachi; Kawaguchi, Shuji; Kawamoto, Hiroshi; Kawamura, Yuki I.; Kawashima, Tsugumi; Kempfle, Judith S.; Kenna, Tony J.; Kere, Juha; Khachigian, Levon M.; Kitamura, Toshio; Klinken, S. Peter; Knox, Alan J.; Kojima, Miki; Kojima, Soichi; Kondo, Naoto; Koseki, Haruhiko; Koyasu, Shigeo; Krampitz, Sarah; Kubosaki, Atsutaka; Kwon, Andrew T.; Laros, Jeroen F. J.; Lee, Weonju; Lennartsson, Andreas; Li, Kang; Lilje, Berit; Lipovich, Leonard; Mackay-sim, Alan; Manabe, Ri-ichiroh; Mar, Jessica C.; Marchand, Benoit; Mathelier, Anthony; Mejhert, Niklas; Meynert, Alison; Mizuno, Yosuke; Morais, David A. de Lima; Morikawa, Hiromasa; Morimoto, Mitsuru; Moro, Kazuyo; Motakis, Efthymios; Motohashi, Hozumi; Mummery, Christine L.; Murata, Mitsuyoshi; Nagao-Sato, Sayaka; Nakachi, Yutaka; Nakahara, Fumio; Nakamura, Toshiyuki; Nakamura, Yukio; Nakazato, Kenichi; Van Nimwegen, Erik; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Nozaki, Tadasuke; Ogishima, Soichi; Ohkura, Naganari; Ohmiya, Hiroko; Ohno, Hiroshi; Ohshima, Mitsuhiro; Okada-Hatakeyama, Mariko; Okazaki, Yasushi; Orlando, Valerio; Ovchinnikov, Dmitry A.; Pain, Arnab; Passier, Robert; Patrikakis, Margaret; Persson, Helena; Piazza, Silvano; Prendergast, James G. D.; Rackham, Owen J. L.; Ramilowski, Jordan A.; Rashid, Mamoon; Ravasi, Timothy; Rizzu, Patrizia; Roncador, Marco; Roy, Sugata; Rye, Morten B.; Saijyo, Eri; Sajantila, Antti; Saka, Akiko; Sakaguchi, Shimon; Sakai, Mizuho; Sato, Hiroki; Satoh, Hironori; Savvi, Suzana; Saxena, Alka; Schneider, Claudio; Schultes, Erik A.; Schulze-Tanzil, Gundula G.; Schwegmann, Anita; Sengstag, Thierry; Sheng, Guojun; Shimoji, Hisashi; Shimoni, Yishai; Shin, Jay W.; Simon, Christophe; Sugiyama, Daisuke; Sugiyama, Takaaki; Suzuki, Masanori; Suzuki, Naoko; Swoboda, Rolf K.; 't Hoen, Peter A. C.; Tagami, Michihira; Takahashi, Naoko; Takai, Jun; Tanaka, Hiroshi; Tatsukawa, Hideki; Tatum, Zuotian; Thompson, Mark; Toyoda, Hiroo; Toyoda, Tetsuro; Valen, Eivind; van de Wetering, Marc; van den Berg, Linda M.; Verardo, Roberto; Vijayan, Dipti; Vorontsov, Ilya E.; Wasserman, Wyeth W.; Watanabe, Shoko; Wells, Christine A.; Winteringham, Louise N.; Wolvetang, Ernst; Wood, Emily J.; Yamaguchi, Yoko; Yamamoto, Masayuki; Yoneda, Misako; Yonekura, Yohei; Yoshida, Shigehiro; Zabierowski, Susan E.; Zhang, Peter G.; Zhao, Xiaobei; Zucchelli, Silvia; Summers, Kim M.; Suzuki, Harukazu; Daub, Carsten O.; Kawai, Jun; Heutink, Peter; Hide, Winston; Freeman, Tom C.; Lenhard, Boris; Bajic, Vladimir B.; Taylor, Martin S.; Makeev, Vsevolod J.; Sandelin, Albin; Hume, David A.; Carninci, Piero; Hayashizaki, Yoshihide		FANTOM Consortium; RIKEN PMI CLST DGT	A promoter-level mammalian expression atlas	NATURE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; HOMEOBOX GENE; MICE LACKING; DIFFERENTIATION; MOUSE; CLASSIFICATION; SIGNATURES; MUTATIONS; DEAFNESS	Regulated transcription controls the diversity, developmental pathways and spatial organization of the hundreds of cell types that make up a mammal. Using single-molecule cDNA sequencing, we mapped transcription start sites (TSSs) and their usage in human and mouse primary cells, cell lines and tissues to produce a comprehensive overview of mammalian gene expression across the human body. We find that few genes are truly 'housekeeping', whereas many mammalian promoters are composite entities composed of several closely separated TSSs, with independent cell-type-specific expression profiles. TSSs specific to different cell types evolve at different rates, whereas promoters of broadly expressed genes are the most conserved. Promoter-based expression analysis revealskey transcription factors defining cell states and links them to binding-site motifs. The functions of identified novel transcripts can be predicted by coexpression and sample ontology enrichment analyses. The functional annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles and functional annotation of mammalian cell-type-specific transcriptomes with wide applications in biomedical research.	[Forrest, Alistair R. R.; Kawaji, Hideya; de Hoon, Michiel J. L.; Lassmann, Timo; Lizio, Marina; Itoh, Masayoshi; Bertin, Nicolas; Arner, Erik; Plessy, Charles; Vitezic, Morana; Severin, Jessica; Ishizu, Yuri; Arakawa, Takahiro; Bonetti, Alessandro; Burroughs, A. Maxwell; Fukuda, Shiro; Furuno, Masaaki; Harbers, Matthias; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hashimoto, Takehiro; Hori, Fumi; Kaczkowski, Bogumil; Kaida, Kaoru; Kaiho, Ai; Kajiyama, Kazuhiro; Kanamori-Katayama, Mutsumi; Katayama, Shintaro; Kato, Sachi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Kubosaki, Atsutaka; Kwon, Andrew T.; Manabe, Ri-ichiroh; Motakis, Efthymios; Murata, Mitsuyoshi; Nagao-Sato, Sayaka; Nakazato, Kenichi; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Ohmiya, Hiroko; Ramilowski, Jordan A.; Roy, Sugata; Saijyo, Eri; Saka, Akiko; Sakai, Mizuho; Saxena, Alka; Sengstag, Thierry; Shimoji, Hisashi; Shin, Jay W.; Simon, Christophe; Suzuki, Masanori; Suzuki, Naoko; Tagami, Michihira; Takahashi, Naoko; Watanabe, Shoko; Yoshida, Shigehiro; Suzuki, Harukazu; Daub, Carsten O.; Kawai, Jun; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN, OSC, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Forrest, Alistair R. R.; Kawaji, Hideya; de Hoon, Michiel J. L.; Lassmann, Timo; Lizio, Marina; Itoh, Masayoshi; Bertin, Nicolas; Arner, Erik; Plessy, Charles; Severin, Jessica; Ishizu, Yuri; Arakawa, Takahiro; Bonetti, Alessandro; Furuno, Masaaki; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hori, Fumi; Kaczkowski, Bogumil; Kaida, Kaoru; Kajiyama, Kazuhiro; Kasukawa, Takeya; Kato, Sachi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Kwon, Andrew T.; Manabe, Ri-ichiroh; Motakis, Efthymios; Murata, Mitsuyoshi; Nishiyori, Hiromi; Noma, Shohei; Ohmiya, Hiroko; Ramilowski, Jordan A.; Roy, Sugata; Sakai, Mizuho; Shin, Jay W.; Simon, Christophe; Suzuki, Naoko; Tagami, Michihira; Takahashi, Naoko; Yoshida, Shigehiro; Suzuki, Harukazu; Carninci, Piero] RIKEN, CLST, DGT, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kawaji, Hideya; Itoh, Masayoshi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN, Prevent Med & Diag Innovat Program PMI, Wako, Saitama 3510198, Japan; [Rehli, Michael; Schmidl, Christian; Edinger, Matthias] Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany; [Rehli, Michael; Edinger, Matthias] Regensburg Ctr Intervent Immunol RCI, D-93042 Regensburg, Germany; [Baillie, J. Kenneth; Fairbairn, Lynsey; Fisher, Malcolm E.; Joshi, Anagha; Summers, Kim M.; Freeman, Tom C.; Hume, David A.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Baillie, J. Kenneth; Fairbairn, Lynsey; Fisher, Malcolm E.; Joshi, Anagha; Summers, Kim M.; Freeman, Tom C.; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland; [Haberle, Vanja] Univ Bergen, Dept Biol, NO-5006 Bergen, Norway; [Haberle, Vanja; Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, MRC Clin Sci Ctr, London W12 0NN, England; [Kulakovskiy, Ivan V.; Makeev, Vsevolod J.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; [Kulakovskiy, Ivan V.; Medvedeva, Yulia A.; Favorov, Alexander V.; Kasianov, ArtemS.; Vorontsov, Ilya E.; Makeev, Vsevolod J.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Andersson, Robin; Jorgensen, Mette; Chen, Yun; Hoof, Ilka; Li, Kang; Lilje, Berit; Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, Bioinformat Ctr, Dept Biol, DK-2200 Copenhagen, Denmark; [Andersson, Robin; Jorgensen, Mette; Chen, Yun; Hoof, Ilka; Li, Kang; Lilje, Berit; Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Meehan, Terrence F.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Schmeier, Sebastian; Schaefer, Ulf; Medvedeva, Yulia A.; Alam, Intikhab; Archer, John A. C.; Jankovic, Boris R.; Marchand, Benoit; Pain, Arnab; Rashid, Mamoon; Bajic, Vladimir B.] KAUST, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia; [Schmeier, Sebastian] Massey Univ, North Shore Mail Ctr, Inst Nat & Math Sci, Auckland 0745, New Zealand; [Dimont, Emmanuel; Altschuler, Gabriel M.; Sui, Shannan J. Ho; Hofmann, Oliver M.; Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vitezic, Morana; Huminiecki, Lukasz] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Semple, Colin A.; Young, Robert S.; Rennie, Sarah; Meynert, Alison; Prendergast, James G. D.; Taylor, Martin S.] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, MRC IGMM, Edinburgh EH4 2XU, Midlothian, Scotland; [Francescatto, Margherita; Rizzu, Patrizia; Heutink, Peter] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr Amsterdam, NL-1081 BT Amsterdam, Netherlands; [Francescatto, Margherita] Univ Porto, Grad Program Areas Basic & Appl Biol, Abel Salazar Biomed Sci Inst, P-4050313 Oporto, Portugal; [Albanese, Davide; Chierici, Marco; Furlanello, Cesare; Jurman, Giuseppe; Roncador, Marco] Fdn Bruno Kessler, I-38123 Trento, Italy; [Arner, Peter; Mejhert, Niklas] Karolinska Inst, Dept Med, Karolinska Univ Hosp, SE-14186 Huddinge, Sweden; [Babina, Magda; Guhl, Sven] Univ Med Berlin, Dept Dermatol & Allergy, D-10117 Berlin, Germany; [Balwierz, Piotr J.; Van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Beckhouse, Anthony G.; Briggs, James; Hitchens, Kelly J.; Ovchinnikov, Dmitry A.; Vijayan, Dipti; Wells, Christine A.; Wolvetang, Ernst] Univ Queensland, AIBN, St Lucia, Qld 4072, Australia; [Beckhouse, Anthony G.; Blumenthal, Antje; Hitchens, Kelly J.; Vijayan, Dipti; Wells, Christine A.] Univ Queensland, Australian Infect Dis Res Ctr AID, St Lucia, Qld 4072, Australia; [Pradhan-Bhatt, Swati] Univ Delaware, Dept Biol Sci, Newark, DE 19713 USA; [Blake, Judith A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Blumenthal, Antje; Kenna, Tony J.] Univ Queensland, Diamantina Inst, St Lucia, Qld 4072, Australia; [Bodega, Beatrice; Orlando, Valerio] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy; [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Int Ctr Genet Engn & Biotechnol ICGEB Cape Town C, ZA-7925 Cape Town, South Africa; [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Califano, Andrea; Shimoni, Yishai] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Inst Canc Genet, New York, NY 10032 USA; [Cannistraci, Carlo V.; Orlando, Valerio; Pain, Arnab; Rashid, Mamoon; Ravasi, Timothy] KAUST, Biol & Environm Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Cannistraci, Carlo V.; Ravasi, Timothy] KAUST, Appl Math & Computat Sci Program, Thuwal 239556900, Saudi Arabia; [Carbajo, Daniel; Mar, Jessica C.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Ciani, Yari; Dalla, Emiliano; Piazza, Silvano; Schneider, Claudio; Verardo, Roberto] LNCIB, I-34149 Trieste, Italy; [Clevers, Hans C.; van de Wetering, Marc] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans C.] Royal Netherlands Acad Arts & Sci, NL-1000 GC Amsterdam, Netherlands; [Clevers, Hans C.] Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands; [Davis, Carrie A.; Gingeras, Thomas] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11797 USA; [Detmar, Michael; Krampitz, Sarah] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Diehl, Alexander D.] SUNY Buffalo, Dept Neurol, Sch Med & Biomed Sci, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA; [Dohi, Taeko; Kawamura, Yuki I.] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol Res Inst, Ichikawa, Chiba 2728516, Japan; [Drablos, Finn; Rye, Morten B.] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway; [Edge, Albert S. B.; Kempfle, Judith S.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol, Boston, MA 02114 USA; [Ekwall, Karl; Kere, Juha; Lennartsson, Andreas; Persson, Helena] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, SE-14183 Huddinge, Sweden; [Endoh, Mitsuhiro; Furusawa, Jun-ichi; Ikawa, Tomokatsu; Kawamoto, Hiroshi; Koseki, Haruhiko; Koyasu, Shigeo; Moro, Kazuyo; Ohno, Hiroshi; Okada-Hatakeyama, Mariko] RIKEN, RCAI, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Endoh, Mitsuhiro; Furusawa, Jun-ichi; Ikawa, Tomokatsu; Koseki, Haruhiko; Koyasu, Shigeo; Moro, Kazuyo; Ohno, Hiroshi; Okada-Hatakeyama, Mariko] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Enomoto, Hideki; Morimoto, Mitsuru; Sheng, Guojun; Yonekura, Yohei] RIKEN, CDB, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Fagiolini, Michela] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp Boston, Boston, MA 02115 USA; [Fang, Hai; Gough, Julian; Rackham, Owen J. L.] Univ Bristol, Dept Comp Sci, Bristol BS8 1UB, Avon, England; [Farach-Carson, Mary C.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Faulkner, Geoffrey J.] Mater Med Res Inst, Cancer Biol Program, South Brisbane, Qld 4101, Australia; [Favorov, Alexander V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Oncol Biostat & Bioinformat, Baltimore, MD 21205 USA; [Favorov, Alexander V.] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia; [Frith, Martin C.] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Fujita, Rie; Satoh, Hironori; Takai, Jun; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Furusawa, Jun-ichi; Koyasu, Shigeo; Moro, Kazuyo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Geijtenbeek, Teunis B.; van den Berg, Linda M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Gibson, Andrew P.; Laros, Jeroen F. J.; Schultes, Erik A.; 't Hoen, Peter A. C.; Tatum, Zuotian; Thompson, Mark] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [Goldowitz, Daniel; Ha, Thomas J.; Mathelier, Anthony; Wasserman, Wyeth W.; Zhang, Peter G.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Gustincich, Stefano; Zucchelli, Silvia] SISSA, I-34136 Trieste, Italy; [Hamaguchi, Masahide; Morikawa, Hiromasa; Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Hara, Mitsuko; Kojima, Soichi] RIKEN, ASI, Wako, Saitama 3510198, Japan; [Herlyn, Meenhard; Swoboda, Rolf K.; Zabierowski, Susan E.] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Iida, Kei; Kawaguchi, Shuji; Toyoda, Tetsuro] RIKEN, Bioinformat & Syst Engn Div BASE, Yokohama, Kanagawa 2300045, Japan; [Jia, Hui; Lipovich, Leonard; Wood, Emily J.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Kai, Chieko; Nakamura, Toshiyuki; Sato, Hiroki; Sugiyama, Takaaki; Yoneda, Misako] Univ Tokyo, Lab Anim Res Ctr, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Kere, Juha] Sci Life Lab, SE-17121 Solna, Sweden; [Khachigian, Levon M.; Patrikakis, Margaret] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Kitamura, Toshio; Nakahara, Fumio] Univ Tokyo, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan; [Kitamura, Toshio; Nakahara, Fumio] Univ Tokyo, Div Stem Cell Signaling, Inst Med Sci, Tokyo 1088639, Japan; [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Perth, WA 6009, Australia; [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Med Res Ctr, QEII Med Ctr, Perth, WA 6009, Australia; [Knox, Alan J.] Univ Nottingham, City Hosp, Nottingham NG5 1PB, England; [Lee, Weonju] Kyungpook Natl Univ, Sch Med, Dept Dermatol, Taegu 700721, South Korea; [Mackay-sim, Alan] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Mizuno, Yosuke; Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Morais, David A. de Lima] Univ Bristol, Fac Engn, Clifton BS81UB, England; [Moro, Kazuyo] Japanese Sci & Technol Agcy JST, PRESTO, Tokyo 1020076, Japan; [Motohashi, Hozumi] Tohoku Univ, Ctr Radioisotope Sci, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Mummery, Christine L.; Passier, Robert] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Nakamura, Yukio] RIKEN, BioResource Ctr BRC, Tsukuba, Ibaraki 3050074, Japan; [Nozaki, Tadasuke; Toyoda, Hiroo] Tokyo Univ Pharm & Life Sci, Dept Clin Mol Genet, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Ogishima, Soichi; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Ohshima, Mitsuhiro] Ohu Univ, Dept Biochem, Sch Pharmaceut Sci, Koriyama, Fukushima 9638611, Japan; [Sajantila, Antti] Univ Helsinki, Dept Forens Med, Hjelt Inst, Helsinki 003000, Finland; [Schneider, Claudio] Univ Udine, DSMB, I-33100 Udine, Italy; [Schulze-Tanzil, Gundula G.] Charite, Dept Orthoped Trauma & Reconstruct Surg, D-14195 Berlin, Germany; [Sugiyama, Daisuke] Kyushu Univ Hosp, Ctr Clin & Translat Reseach, Higashi Ku, Fukuoka 8128582, Japan; [Tatsukawa, Hideki] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Valen, Eivind] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Yamaguchi, Yoko] Nihon Univ, Dept Biochem, Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Lenhard, Boris] Univ Bergen, Dept Informat, NO-5008 Bergen, Norway; [Makeev, Vsevolod J.] MIPT, Dept Biol & Med Phys, Dolgoprudnyi 141700, Moscow Region, Russia	RIKEN; RIKEN; RIKEN; University of Regensburg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Bergen; Imperial College London; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Vavilov Institute of General Genetics; University of Copenhagen; University of Copenhagen; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); King Abdullah University of Science & Technology; Massey University; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; University of Edinburgh; Vrije Universiteit Amsterdam; Universidade do Porto; Fondazione Bruno Kessler; Karolinska Institutet; Karolinska University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; University of Queensland; University of Queensland; University of Delaware; Jackson Laboratory; University of Queensland; IRCCS Santa Lucia; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Columbia University; Columbia University; Columbia University; Columbia University; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Yeshiva University; Albert Einstein College of Medicine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cold Spring Harbor Laboratory; Swiss Federal Institutes of Technology Domain; ETH Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Center for Global Health & Medicine - Japan; Norwegian University of Science & Technology (NTNU); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Karolinska Institutet; RIKEN; RIKEN; RIKEN; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Bristol; Rice University; Mater Research; Johns Hopkins University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; Keio University; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Child & Family Research Institute; University of British Columbia; International School for Advanced Studies (SISSA); Osaka University; RIKEN; The Wistar Institute; RIKEN; Wayne State University; University of Tokyo; University of New South Wales Sydney; University of Tokyo; University of Tokyo; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Kyungpook National University; Griffith University; Saitama Medical University; University of Bristol; Japan Science & Technology Agency (JST); Tohoku University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Saitama Medical University; RIKEN; Tokyo University of Pharmacy & Life Sciences; Tokyo Medical & Dental University (TMDU); University of Helsinki; University of Udine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Nagoya University; Harvard University; Nihon University; University of Bergen; Moscow Institute of Physics & Technology	Forrest, ARR (corresponding author), RIKEN, OSC, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	alistair.forrest@gmail.com; carninci@riken.jp; yosihide@gsc.riken.jp	Medvedva, Yulia A/H-5947-2016; Makeev, Vsevolod/E-8015-2013; Suzuki, Harukazu/N-9553-2015; Dalla, Emiliano/AAH-3039-2020; Hayashizaki, Yoshihide/N-6590-2015; de Hoon, Michiel/A-6443-2013; Andersson, Robin/B-5311-2009; Kitamura, Toshio/AAA-2071-2021; Plessy, Charles/N-5054-2015; Koyasu, Shigeo/J-5583-2015; Semple, Colin A M/A-5613-2009; van Nimwegen, Erik/ABF-1085-2021; Daub, Carsten O/A-7436-2010; Mungall, Chris/I-6006-2019; Carninci, Piero/K-1568-2014; Cannistraci, Carlo Vittorio/G-1710-2014; Kawai, Jun/A-6451-2016; Rackham, Owen/AAM-3108-2021; Kasianov, Artem S/R-3495-2016; Sajantila, Antti/AAY-9084-2021; Valen, Eivind/A-8617-2011; Lipovich, Leonard/B-2355-2019; Kaczkowski, Bogumil/D-5336-2017; Mathelier, Anthony/Y-4693-2019; Archer, John/D-5200-2012; Kawaji, Hideya/N-5116-2015; Lassmann, Timo/A-8271-2008; Kenna, Tony/A-6035-2011; Yamamoto, Masayuki/A-4873-2010; Tomic, Nevena/AAA-2135-2021; Kwon, Andrew/D-4625-2017; Ravasi, Timothy/B-8777-2008; Schmidl, Christian/HDO-6299-2022; Arner, Erik/A-1895-2010; Archer, John/AAW-1990-2021; Sheng, Guojun/G-4116-2014; Lassmann, Timo/HCH-4313-2022; Mackay-Sim, Alan/C-3431-2008; KONDO, NAOTO/A-5829-2016; Favorov, Alexander V/K-2699-2018; Hitchens, Kelly/D-4320-2009; Taylor, Martin S/C-3825-2009; Hide, Winston Hide/C-7217-2009; Wasserman, Wyeth/I-4866-2015; Itoh, Masayoshi/N-5363-2015; Beckhouse, Anthony G/A-2601-2010; Kojima, Soichi/N-7104-2015; Drablos, Finn/L-4970-2019; Hoen, Peter A 't/D-3950-2018; Jurman, Giuseppe/GRS-8221-2022; Severin, Jessica/AAQ-2723-2020; Ramilowski, Jordan A./Z-3103-2019; Sakaguchi, Shimon/C-9535-2009; Vorontsov, Ilya E/C-6333-2014; Edge, Albert/Q-5448-2019; Wolvetang, Ernst jurgen/D-6644-2017; Summers, Kim M/M-4086-2015; Tatsukawa, Hideki/AAE-8377-2020; Sandelin, Albin/G-2881-2011; Baillie, John Kenneth/F-3124-2011; Zhao, Xiaobei/G-3567-2014; Katayama, Shintaro/F-2958-2010; Persson, Helena/ABE-5003-2020; Nakachi, Yutaka/M-2446-2013; Moro, Kazuyo/A-5987-2016; Bertin, Nicolas/O-9602-2019; Fisher, Malcolm Edgar/GQH-8954-2022; Ovchinnikov, Dmitry/J-7963-2014; Motakis, Efthymios/AAL-6863-2020; Pain, Arnab/L-5766-2015; Sheng, Guojun/I-4900-2015; Nakamura, Yukio/A-5263-2016; Kasukawa, Takeya/N-5070-2015; Faulkner, Geoffrey J/M-3168-2014; Koseki, Haruhiko/I-3825-2014; Kulakovskiy, Ivan/A-1462-2014; Morikawa, Hiromasa/H-5958-2013; Khachigian, Levon/AAZ-7458-2020; Baillie, Kenneth/AEK-6650-2022; Ohno, Hiroshi/L-7899-2014; Hide, Winston A/V-2727-2017; Diehl, Alexander/G-9883-2016; Vitezic, Morana/A-6165-2013; Motohashi, Hozumi/AAZ-2628-2020; Rehli, Michael/E-9093-2011; Albanese, Davide/AAA-7295-2021; Morikawa, Hiromasa/AAU-9261-2020; Kere, Juha/A-9179-2008; Schmeier, Sebastian/D-4731-2011; Hide, Winston/R-3815-2019; Chierici, Marco/P-9949-2019; Bodega, Beatrice/I-4644-2018; Blumenthal, Antje/A-3608-2011; Kere, Juha/AAX-9117-2021; Hofmann, Oliver/F-1800-2013; Schultes, Erik/B-6035-2012; Bertin, Nicolas/C-3025-2008; Wells, Christine/A-5071-2010; Bajic, Vladimir/D-2810-2009	Medvedva, Yulia A/0000-0002-7587-1666; Makeev, Vsevolod/0000-0001-9405-9748; Suzuki, Harukazu/0000-0002-8087-0836; Dalla, Emiliano/0000-0002-4687-6011; Andersson, Robin/0000-0003-1516-879X; Plessy, Charles/0000-0001-7410-6295; Koyasu, Shigeo/0000-0001-9585-3038; Semple, Colin A M/0000-0003-1765-4118; van Nimwegen, Erik/0000-0001-6338-1312; Daub, Carsten O/0000-0002-3295-8729; Mungall, Chris/0000-0002-6601-2165; Carninci, Piero/0000-0001-7202-7243; Cannistraci, Carlo Vittorio/0000-0003-0100-8410; Rackham, Owen/0000-0002-4390-0872; Kasianov, Artem S/0000-0001-8086-392X; Lipovich, Leonard/0000-0002-0531-3570; Kaczkowski, Bogumil/0000-0001-6554-5608; Mathelier, Anthony/0000-0001-5127-5459; Kawaji, Hideya/0000-0002-0575-0308; Lassmann, Timo/0000-0002-0138-2691; Yamamoto, Masayuki/0000-0002-9073-9436; Kwon, Andrew/0000-0001-5019-8156; Schmidl, Christian/0000-0002-0522-202X; Arner, Erik/0000-0003-1225-4908; Archer, John/0000-0002-3302-3933; Lassmann, Timo/0000-0002-0138-2691; Mackay-Sim, Alan/0000-0003-4446-5371; KONDO, NAOTO/0000-0001-9576-7615; Favorov, Alexander V/0000-0003-2595-1091; Hitchens, Kelly/0000-0002-8777-6332; Taylor, Martin S/0000-0001-7656-330X; Hide, Winston Hide/0000-0002-8621-3271; Itoh, Masayoshi/0000-0002-1772-318X; Beckhouse, Anthony G/0000-0002-5141-8250; Kojima, Soichi/0000-0002-5252-1612; Drablos, Finn/0000-0001-5794-828X; Hoen, Peter A 't/0000-0003-4450-3112; Severin, Jessica/0000-0003-1274-208X; Ramilowski, Jordan A./0000-0002-3156-6416; Vorontsov, Ilya E/0000-0001-8888-0804; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Summers, Kim M/0000-0002-7084-4386; Sandelin, Albin/0000-0002-7109-7378; Baillie, John Kenneth/0000-0001-5258-793X; Zhao, Xiaobei/0000-0002-5277-0846; Katayama, Shintaro/0000-0001-7581-5157; Nakachi, Yutaka/0000-0003-1964-2495; Fisher, Malcolm Edgar/0000-0003-1074-8103; Ovchinnikov, Dmitry/0000-0001-9603-8385; Pain, Arnab/0000-0002-1755-2819; Nakamura, Yukio/0000-0001-8056-4946; Kasukawa, Takeya/0000-0001-5085-0802; Faulkner, Geoffrey J/0000-0001-5769-4494; Koseki, Haruhiko/0000-0001-8424-5854; Kulakovskiy, Ivan/0000-0002-6554-8128; Morikawa, Hiromasa/0000-0002-6793-5885; Baillie, Kenneth/0000-0001-5258-793X; Ohno, Hiroshi/0000-0001-8776-9661; Hide, Winston A/0000-0002-8621-3271; Diehl, Alexander/0000-0001-9990-8331; Vitezic, Morana/0000-0002-7994-9600; Rehli, Michael/0000-0003-3992-932X; Albanese, Davide/0000-0002-9493-3850; Morikawa, Hiromasa/0000-0002-6793-5885; Kere, Juha/0000-0003-1974-0271; Schmeier, Sebastian/0000-0002-3947-8226; Hide, Winston/0000-0002-8621-3271; Chierici, Marco/0000-0001-9791-9301; Bodega, Beatrice/0000-0003-0527-9234; Blumenthal, Antje/0000-0003-3673-7015; Kere, Juha/0000-0003-1974-0271; Joshi, Anagha/0000-0003-1184-3305; /0000-0002-6191-4709; Moro, Kazuyo/0000-0002-7377-1303; Sajantila, Antti/0000-0003-4117-5248; Califano, Andrea/0000-0003-4742-3679; Khachigian, Levon/0000-0003-3446-0323; Heutink, Peter/0000-0001-5218-1737; Gingeras, Thomas/0000-0001-9106-3573; Francescatto, Margherita/0000-0003-1232-7302; Freeman, Thomas/0000-0001-5235-8483; Hofmann, Oliver/0000-0002-7738-1513; Arner, Peter/0000-0002-6208-6220; Haberle, Vanja/0000-0003-4191-3714; Schultes, Erik/0000-0001-8888-635X; Ekwall, Karl/0000-0002-3029-4041; Mejhert, Niklas/0000-0003-1785-833X; Mar, Jessica/0000-0002-5147-9299; Gustincich, Stefano/0000-0002-2749-2514; Babina, Magda/0000-0002-4500-7615; Goldowitz, Daniel/0000-0003-4756-4017; IIDA, Kei/0000-0001-7130-8705; Lenhard, Boris/0000-0002-1114-1509; Lennartsson, Andreas/0000-0002-3272-2505; Winteringham, Louise/0000-0002-8117-5069; Knox, Alan/0000-0002-5906-4143; Piazza, Silvano/0000-0002-7156-5434; Mummery, Christine/0000-0002-4549-6535; Jurman, Giuseppe/0000-0002-2705-5728; Nakahara, Fumio/0000-0003-1515-8284; Prendergast, James/0000-0001-8916-018X; Roy, Sugata/0000-0001-7183-7957; Huminiecki, Lukasz/0000-0003-1943-4450; Valen, Eivind/0000-0003-1840-6108; Burroughs, A. Max/0000-0002-2229-8771; Laros, Jeroen F.J./0000-0002-8715-7371; Hamaguchi, Masahide/0000-0002-8651-4445; Frith, Martin/0000-0003-0998-2859; Ciani, Yari/0000-0002-9635-2830; Endoh, Mitsuhiro/0000-0003-0715-1701; Rashid, Mamoon/0000-0003-1457-477X; Ravasi, Timothy/0000-0002-9950-465X; Rashid, Mamoon/0000-0003-4851-4994; Bertin, Nicolas/0000-0002-9835-9606; Wells, Christine/0000-0003-3133-3628; Forrest, Alistair/0000-0003-4543-1675; Jorgensen, Mette/0000-0002-2804-0560; Jankovic, Boris/0000-0003-1868-6007; Alam, Intikhab/0000-0001-5306-847X; Persson, Helena/0000-0002-5187-6446; fagiolini, michela/0000-0003-2807-803X; Kenna, Tony/0000-0001-6844-3463; Hume, David/0000-0002-2615-1478; Bajic, Vladimir/0000-0001-5435-4750; Sengstag, Thierry/0000-0002-7516-6246; Wasserman, Wyeth/0000-0001-6098-6412; Edinger, Matthias/0000-0003-2889-2533; Okazaki, Yasushi/0000-0003-3241-5502; Furlanello, Cesare/0000-0002-5384-3605; Zucchelli, Silvia/0000-0003-4556-2990; Farach-Carson, Mary/0000-0002-4526-3088; Meehan, Terrence/0000-0003-1980-3228; de Hoon, Michiel/0000-0003-0489-2352; Harbers, Matthias/0000-0002-5613-7220	MEXT; MEXT, Japan; Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program(RIKEN PMI); RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT, Japan; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084875] Funding Source: NIH RePORTER; BBSRC [BB/I024801/1, BB/I001107/1, BBS/E/D/20251969, BB/G022771/1, BBS/E/D/20211552, BBS/E/D/20231759, BB/F003722/1, BB/I025018/1, BBS/E/D/20211551, BBS/E/D/20211550] Funding Source: UKRI; MRC [MC_UP_1102/1, MC_PC_U127597124] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I024801/1, BBS/E/D/20211552, BBS/E/D/20211550, BBS/E/D/20251969, BBS/E/D/20231759, BB/I001107/1, BBS/E/D/20211551, BB/G022771/1, BB/F003722/1, BB/I025018/1] Funding Source: researchfish; Lundbeck Foundation [R82-2010-6779] Funding Source: researchfish; Medical Research Council [MC_UP_1102/1, MC_PC_U127597124] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016371] Funding Source: researchfish; Wellcome Trust [103258/Z/13/Z] Funding Source: researchfish	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program(RIKEN PMI); RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT, Japan; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to Y. Hayashizaki and a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to Y. Hayashizaki. It was also supported by Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program(RIKEN PMI) to Y. Hayashizaki and RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT, Japan. Extended acknowledgements are provided in the Supplementary Information.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chabchoub E, 2012, CLIN GENET, V81, P584, DOI 10.1111/j.1399-0004.2011.01684.x; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; He GY, 2010, DEV BIOL, V344, P720, DOI 10.1016/j.ydbio.2010.05.509; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Ioshikhes I, 2011, GENOME RES, V21, P1863, DOI 10.1101/gr.116228.110; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Kapoor S, 2011, INDIAN PEDIATR, V48, P727, DOI 10.1007/s13312-011-0108-8; Kawaji H., 2014, GENOME RES; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lee MS, 1999, J CELL BIOCHEM, V75, P566, DOI 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Lu MF, 1999, DEVELOPMENT, V126, P495; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Oja E., 2001, INDEPENDENT COMPONEN; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pringle IA, 2012, J MOL MED, V90, P1487, DOI 10.1007/s00109-012-0928-6; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Severin J., 2014, NATURE BIOTECHNOL; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shulha HP, 2012, ARCH GEN PSYCHIAT, V69, P314, DOI 10.1001/archgenpsychiatry.2011.151; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	54	1219	1231	4	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					462	+		10.1038/nature13182	http://dx.doi.org/10.1038/nature13182			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670764	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000333402000033
J	Moss, H; O'Neill, D				Moss, Hilary; O'Neill, Desmond			Aesthetic deprivation in clinical settings	LANCET			English	Editorial Material									[O'Neill, Desmond] Tallaght Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland; [Moss, Hilary] Tallaght Hosp, Natl Ctr Arts & Hlth, Dublin 24, Ireland	Trinity College Dublin; Trinity College Dublin	O'Neill, D (corresponding author), Tallaght Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland.	doneill@tcd.ie	MOSS, HILARY/I-2921-2016; MOSS, HILARY/S-7810-2017; O'Neill, Desmond/D-1486-2013	MOSS, HILARY/0000-0003-4813-2910; MOSS, HILARY/0000-0003-4813-2910; O'Neill, Desmond/0000-0002-5542-9897				Cuypers K, 2012, J EPIDEMIOL COMMUN H, V66, P698, DOI 10.1136/jech.2010.113571; Eco U., 2011, IRAN MED J; Moss H, 2014, J ADV NURS, V70, P121, DOI 10.1111/jan.12175; Saito Yuriko, 2007, EVERYDAY AESTHETICS; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Wikstrom Britt-Maj, 2002, Clin Nurs Res, V11, P22, DOI 10.1177/1054773802011001003	6	25	25	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1032	1033		10.1016/S0140-6736(14)60507-9	http://dx.doi.org/10.1016/S0140-6736(14)60507-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24665475				2022-12-28	WOS:000333521200013
J	Cappellini, E; Collins, MJ; Gilbert, MTP				Cappellini, Enrico; Collins, Matthew J.; Gilbert, M. Thomas P.			Unlocking Ancient Protein Palimpsests	SCIENCE			English	Editorial Material							KINETICS		[Cappellini, Enrico; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Collins, Matthew J.] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6845, Australia	University of Copenhagen; University of York - UK; Curtin University	Cappellini, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark.	ecappellini@googlemail.com	Collins, Matthew J/A-7534-2008; Gilbert, Marcus TP/A-8936-2013; Collins, Matthew James/O-1095-2019; Cappellini, Enrico/F-9346-2013	Collins, Matthew J/0000-0003-4226-5501; Gilbert, Marcus TP/0000-0002-5805-7195; Collins, Matthew James/0000-0003-4226-5501; Cappellini, Enrico/0000-0001-7885-7811				Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Buckley M, 2011, ARCHAEOL ANTHROP SCI, V3, P271, DOI 10.1007/s12520-011-0066-z; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Corthals A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041244; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Ostrom PH, 2000, GEOCHIM COSMOCHIM AC, V64, P1043, DOI 10.1016/S0016-7037(99)00381-6; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Renard BY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014167; Tomiak PJ, 2013, QUAT GEOCHRONOL, V16, P87, DOI 10.1016/j.quageo.2012.07.001; van Doorn NL, 2012, RAPID COMMUN MASS SP, V26, P2319, DOI 10.1002/rcm.6351; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	13	47	48	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1320	1322		10.1126/science.1249274	http://dx.doi.org/10.1126/science.1249274			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653025				2022-12-28	WOS:000333108500023
J	Newell, RG; Pizer, WA; Raimi, D				Newell, Richard G.; Pizer, William A.; Raimi, Daniel			Carbon Market Lessons and Global Policy Outlook	SCIENCE			English	Editorial Material									[Newell, Richard G.; Pizer, William A.; Raimi, Daniel] Duke Univ, Durham, NC 27708 USA; [Newell, Richard G.; Pizer, William A.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Newell, Richard G.; Pizer, William A.] Resources Future Inc, Washington, DC 20036 USA; [Pizer, William A.] Ctr Global Dev, Washington, DC 20036 USA	Duke University; National Bureau of Economic Research; Resources for the Future	Newell, RG (corresponding author), Duke Univ, Durham, NC 27708 USA.	richard.newell@duke.edu	Newell, Richard G/I-3838-2015	Newell, Richard G/0000-0002-3205-5562; Raimi, Daniel/0000-0002-9154-3371				Aldy J. E., 2013, HANDBOOK ON ENERGY A; Aldy JE, 2010, J ECON LIT, V48, P903, DOI 10.1257/jel.48.4.903; Bauer N, 2016, CLIMATIC CHANGE, V136, P69, DOI 10.1007/s10584-013-0901-6; Ellerman A.D., 2010, PRICING CARBON; Fawcett AA, 2009, ENERG ECON, V31, pS198, DOI 10.1016/j.eneco.2009.10.015; Fischer C., 2013, ENVIRONMENTAL AND TE; Interagency Working Group on Social Cost of Carbon, 2013, TECHNICAL UPDATE OF; Jaffe J, 2009, ECOL LAW QUART, V36, P789; Metcalf G. E., 2010, U S ENERGY TAX POLIC; Murray BC, 2009, REV ENV ECON POLICY, V3, P84, DOI 10.1093/reep/ren016; Newell RG, 2013, J ECON PERSPECT, V27, P123, DOI 10.1257/jep.27.1.123; Newell RG, 2010, OXFORD REV ECON POL, V26, P253, DOI 10.1093/oxrep/grq009; Pizer W. A., 2014, DISCUSSION PAPER 201; RGGI, 2013, RGGI STATES PROPOSE; Sijm J. P. M., 2008, THE IMPACT OF THE EU; Stavins R., 2014, WORKING PAPER 19824; van Benthem A, 2013, J PUBLIC ECON, V107, P31, DOI 10.1016/j.jpubeco.2013.08.004	17	45	46	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1316	1317		10.1126/science.1246907	http://dx.doi.org/10.1126/science.1246907			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD3AI	24653022				2022-12-28	WOS:000333108500020
J	Poon, IKH; Chiu, YH; Armstrong, AJ; Kinchen, JM; Juncadella, IJ; Bayliss, DA; Ravichandran, KS				Poon, Ivan K. H.; Chiu, Yu-Hsin; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Bayliss, Douglas A.; Ravichandran, Kodi S.			Unexpected link between an antibiotic, pannexin channels and apoptosis	NATURE			English	Article							FIND-ME SIGNAL; ATP RELEASE; CELL-DEATH; IN-VIVO; ROCK-I; SAFETY; ACTIVATION; PHARMACOKINETICS; FLUOROQUINOLONES; TROVAFLOXACIN	Plasma membrane pannexin 1 channels (PANX1) release nucleotide find-me signals from apoptotic cells to attract phagocytes. Here we show that the quinolone antibiotic trovafloxacin is a novel PANX1 inhibitor, by using a small-molecule screen. Although quinolones are widely used to treat bacterial infections, some quinolones have unexplained side effects, including deaths among children. PANX1 is a direct target of trovafloxacin at drug concentrations seen in human plasma, and its inhibition led to dysregulated fragmentation of apoptotic cells. Genetic loss of PANX1 phenocopied trovafloxacin effects, revealing a non-redundant role for pannexin channels in regulating cellulardisassemblyduring apoptosis. Increase in drug-resistant bacteria worldwide and the dearth of new antibiotics is a major human health challenge. Comparing different quinolone antibiotics suggests that certain structural features may contribute to PANX1 blockade. These data identify a novel linkage between an antibiotic, pannexin channels and cellular integrity, and suggest that re-engineering certain quinolones might help develop newer antibacterials.	[Poon, Ivan K. H.; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Poon, Ivan K. H.; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Poon, Ivan K. H.; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Poon, Ivan K. H.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic, Australia; [Chiu, Yu-Hsin; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; La Trobe University; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021; Chiu, Yu-Hsin/AAT-8759-2021	Chiu, Yu-Hsin/0000-0002-4730-8104; Kinchen, Jason/0000-0001-8430-2265; Poon, Ivan/0000-0002-9119-7173; Ravichandran, Kodi/0000-0001-9049-1410	US National Institutes of Health [NIGMS 107848]; National Health & Medical Research Council of Australia; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107848, R01GM064709] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Isakson, M. Billaud, J. Lannigan and other colleagues for discussions. Grants from the US National Institutes of Health (NIGMS 107848 to K. S. R. and D. B.) and the National Health & Medical Research Council of Australia (I. K. H. P.), a training fellowship to I. K. H. P., and the American Heart Association (J. M. K.) supported this work.	Ahmed K, 2001, LANCET, V358, P815, DOI 10.1016/S0140-6736(01)06011-1; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Billaud M, 2012, TRENDS CARDIOVAS MED, V22, P68, DOI 10.1016/j.tcm.2012.06.014; Bortner CD, 1999, J BIOL CHEM, V274, P21953, DOI 10.1074/jbc.274.31.21953; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; CDC, 2013, ANTIBIOTIC RESISTANC; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Dubyak GR, 2004, ADV PHYSIOL EDUC, V28, P143, DOI 10.1152/advan.00046.2004; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Henry CM, 2013, METHODS, V61, P90, DOI 10.1016/j.ymeth.2013.01.008; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu HH, 2010, DRUG SAFETY, V33, P353, DOI 10.2165/11536360-000000000-00000; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Moss DK, 2006, J CELL SCI, V119, P2362, DOI 10.1242/jcs.02959; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Stahlmann R, 2010, DRUG AGING, V27, P193, DOI 10.2165/11531490-000000000-00000; Teng RL, 1996, J ANTIMICROB CHEMOTH, V37, P955, DOI 10.1093/jac/37.5.955; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Vincent J, 1997, J ANTIMICROB CHEMOTH, V39, P75, DOI 10.1093/jac/39.suppl_2.75; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25	40	161	165	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					329	+		10.1038/nature13147	http://dx.doi.org/10.1038/nature13147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646995	Green Accepted			2022-12-28	WOS:000333029000027
J	Slaughter, SR; Hearns-Stokes, R; van der Vlugt, T; Joffe, HV				Slaughter, Shelley R.; Hearns-Stokes, Rhonda; van der Vlugt, Theresa; Joffe, Hylton V.			FDA Approval of Doxylamine-Pyridoxine Therapy for Use in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BIRTH-DEFECTS; BENDECTIN		[Slaughter, Shelley R.; Hearns-Stokes, Rhonda; van der Vlugt, Theresa; Joffe, Hylton V.] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Slaughter, SR (corresponding author), US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							BRENT RL, 1995, REPROD TOXICOL, V9, P337, DOI 10.1016/0890-6238(95)00020-B; EINARSON TR, 1988, DRUG INTEL CLIN PHAR, V22, P813, DOI 10.1177/106002808802201021; HOLMES LB, 1983, TERATOLOGY, V27, P277, DOI 10.1002/tera.1420270216; Kutcher JS, 2003, BIRTH DEFECTS RES A, V67, P88, DOI 10.1002/bdra.10034; MCKEIGUE PM, 1994, TERATOLOGY, V50, P27, DOI 10.1002/tera.1420500105	5	34	34	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1081	1083		10.1056/NEJMp1316042	http://dx.doi.org/10.1056/NEJMp1316042			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645939	Bronze			2022-12-28	WOS:000333054000002
J	Dunn, A				Dunn, Andrew			Warfarin dosing by genotype did not improve time in therapeutic range	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHARMACOGENETICS; POLYMORPHISMS; INITIATION; CYP2C9; TRIAL		Mt Sinai Hlth Syst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Mt Sinai Hlth Syst, New York, NY 10029 USA.							Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Burmester JK, 2011, GENET MED, V13, P509, DOI 10.1097/GIM.0b013e31820ad77d; Gong IY, 2011, BLOOD, V118, P3163, DOI 10.1182/blood-2011-03-345173; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Kirchheiner J, 2004, PHARMACOGENETICS, V14, P19, DOI 10.1097/00008571-200401000-00002; Patrick AR, 2009, CIRC-CARDIOVASC QUAL, V2, P429, DOI 10.1161/CIRCOUTCOMES.108.808592; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Voora D, 2005, PHARMACOGENOMICS, V6, P503, DOI 10.2217/14622416.6.5.503	8	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC8	10.7326/0003-4819-160-6-201403180-02008	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638186				2022-12-28	WOS:000333521300007
J	Chen, JJ; Zhang, ZJ; Li, L; Chen, BC; Revyakin, A; Hajj, B; Legant, W; Dahan, M; Lionnet, T; Betzig, E; Tjian, R; Liu, Z				Chen, Jiji; Zhang, Zhengjian; Li, Li; Chen, Bi-Chang; Revyakin, Andrey; Hajj, Bassam; Legant, Wesley; Dahan, Maxime; Lionnet, Timothee; Betzig, Eric; Tjian, Robert; Liu, Zhe			Single-Molecule Dynamics of Enhanceosome Assembly in Embryonic Stem Cells	CELL			English	Article							GENE-EXPRESSION; DNA; DIFFUSION; NETWORK; KINETICS; REGIONS; BINDING	Enhancer-binding pluripotency regulators (Sox2 and Oct4) play a seminal role in embryonic stem (ES) cell-specific gene regulation. Here, we combine in vivo and in vitro single-molecule imaging, transcription factor (TF) mutagenesis, and ChIP-exo mapping to determine how TFs dynamically search for and assemble on their cognate DNA target sites. We find that enhanceosome assembly is hierarchically ordered with kinetically favored Sox2 engaging the target DNA first, followed by assisted binding of Oct4. Sox2/Oct4 follow a trial-and-error sampling mechanism involving 84-97 events of 3D diffusion (3.3-3.7 s) interspersed with brief nonspecific collisions (0.75-0.9 s) before acquiring and dwelling at specific target DNA (12.0-14.6 s). Sox2 employs a 3D diffusion-dominated search mode facilitated by 1D sliding along open DNA to efficiently locate targets. Our findings also reveal fundamental aspects of gene and developmental regulation by fine-tuning TF dynamics and influence of the epigenome on target search parameters.	[Chen, Jiji; Revyakin, Andrey; Hajj, Bassam; Dahan, Maxime; Lionnet, Timothee; Tjian, Robert; Liu, Zhe] Howard Hughes Med Inst, Janelia Farm Res Campus, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Liu, Zhe] Howard Hughes Med Inst, Janelia Farm Res Campus, Junior Fellow Program, Ashburn, VA 20147 USA; [Zhang, Zhengjian; Li, Li; Chen, Bi-Chang; Legant, Wesley; Betzig, Eric; Tjian, Robert] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Tjian, Robert] Univ Calif Berkeley, CIRM Ctr Excellence, LKS Biomed & Hlth Sci Ctr, Berkeley, CA 94720 USA; [Hajj, Bassam; Dahan, Maxime] Inst Curie, CNRS, Lab Physo Chim Curie, Unite Mixte Rech 168, F-75794 Paris, France	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California Berkeley; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Liu, Z (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Transcript Imaging Consortium, 19700 Helix Dr, Ashburn, VA 20147 USA.	liuz11@janelia.hhmi.org	Dahan, Maxime/F-1740-2010; Chen, Bi-Chang/F-3480-2014	Chen, Bi-Chang/0000-0002-1876-7432; Dahan, Maxime/0000-0002-4943-2491; Lionnet, Timothee/0000-0003-1508-0202; HAJJ, Bassam/0000-0002-5097-6832	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; De-Leon SBT, 2007, ANNU REV BIOPH BIOM, V36, P191, DOI 10.1146/annurev.biophys.35.040405.102002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Lam CS, 2012, BIOCHEM J, V448, P21, DOI 10.1042/BJ20120725; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Mueller F, 2013, CRIT REV BIOCHEM MOL, V48, P492, DOI 10.3109/10409238.2013.833891; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zakrzewska K, 2012, CURR OPIN STRUC BIOL, V22, P160, DOI 10.1016/j.sbi.2012.01.004	31	363	369	0	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1274	1285		10.1016/j.cell.2014.01.062	http://dx.doi.org/10.1016/j.cell.2014.01.062			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630727	Green Accepted, Bronze			2022-12-28	WOS:000332945100016
J	Clotet, B; Feinberg, J; van Lunzen, J; Khuong-Josses, MA; Antinori, A; Dumitru, I; Pokrovskiy, V; Fehr, J; Ortiz, R; Saag, M; Harris, J; Brennan, C; Fujiwara, T; Min, S				Clotet, Bonaventura; Feinberg, Judith; van Lunzen, Jan; Khuong-Josses, Marie-Aude; Antinori, Andrea; Dumitru, Irina; Pokrovskiy, Vadim; Fehr, Jan; Ortiz, Roberto; Saag, Michael; Harris, Julia; Brennan, Clare; Fujiwara, Tamio; Min, Sherene		ING114915 Study Team	Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study	LANCET			English	Article							CO-FORMULATED ELVITEGRAVIR; NON-INFERIORITY TRIAL; DOUBLE-BLIND; INITIAL TREATMENT; INTEGRASE INHIBITOR; VALIDATION; THERAPY; EMTRICITABINE; RALTEGRAVIR; COBICISTAT	Background Dolutegravir has been shown to be non-inferior to an integrase inhibitor and superior to a non-nucleoside reverse transcriptase inhibitor (NNRTI). In FLAMINGO, we compared dolutegravir with darunavir plus ritonavir in individuals naive for antiretroviral therapy. Methods In this multicentre, open-label, phase 3b, non-inferiority study, HIV-1-infected antiretroviral therapy-naive adults with HIV-1 RNA concentration of 1000 copies per mL or more and no resistance at screening were randomly assigned (1:1) to receive either dolutegravir 50 mg once daily or darunavir 800 mg plus ritonavir 100 mg once daily, with investigator-selected tenofovir-emtricitabine or abacavir-lamivudine. Randomisation was stratified by screening HIV-1 RNA (<= 100 000 or >100 000 copies per mL) and nucleoside reverse transcriptase inhibitor (NRTI) selection. The primary endpoint was the proportion of patients with HIV-1 RNA concentration lower than 50 copies per mL (Food and Drug Administration [FDA] snapshot algorithm) at week 48 with a 12% non-inferiority margin. This trial is registered with ClinicalTrials.gov, NCT01449929. Findings Recruitment began on Oct 31, 2011, and was completed on May 24, 2012, in 64 research centres in nine countries worldwide. Of 595 patients screened, 484 patients were included in the analysis (242 in each group). At week 48, 217 (90%) patients receiving dolutegravir and 200 (83%) patients receiving darunavir plus ritonavir had HIV-1 RNA of less than 50 copies per mL (adjusted difference 7 1%, 95% CI 0.9-13.2), non-inferiority and on pre-specified secondary analysis dolutegravir was superior (p=0.025). Confirmed virological failure occurred in two (<1%) patients in each group; we recorded no treatment-emergent resistance in either group. Discontinuation due to adverse events or stopping criteria was less frequent for dolutegravir (four [2%] patients) than for darunavir plus ritonavir (ten [4%] patients) and contributed to the difference in response rates. The most commonly reported (>= 10%) adverse events were diarrhoea (dolutegravir 41 [17%] patients vs darunavir plus ritonavir 70 [29%] patients), nausea (39 [16%] vs 43 [18%]), and headache (37 [15%] vs 24 [10%]). Patients receiving dolutegravir had significantly fewer low-density lipoprotein values of grade 2 or higher (11 [2%] vs 36 [7%]; p=0.0001). Interpretation Once-daily dolutegravir was superior to once-daily darunavir plus ritonavir. Once-daily dolutegravir in combination with fixed-dose NRTIs represents an effective new treatment option for HIV-1-infected, treatment-naive patients. Funding ViiV Healthcare and Shionogi & Co.	[Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, IrsiCaixa, Badalona, Spain; [Clotet, Bonaventura] Univ Vic, UAB, Catalonia, Spain; [Feinberg, Judith] Univ Cincinnati, Cincinnati, OH USA; [van Lunzen, Jan] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Khuong-Josses, Marie-Aude] Hop Delafontaine, St Denis, France; [Antinori, Andrea] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Rome, Italy; [Dumitru, Irina] Clin Infect Dis Hosp, Constanta, Romania; [Pokrovskiy, Vadim] Minist Publ Hlth Russia, Cent Res Inst Epidemiol, Moscow, Russia; [Fehr, Jan] Univ Zurich, Div Infect Dis, Zurich, Switzerland; [Fehr, Jan] Univ Zurich, Hosp Epidemiol, Zurich, Switzerland; [Ortiz, Roberto] Orlando Immunol Ctr, Orlando, FL USA; [Saag, Michael] Univ Alabama Birmingham, Dept Med, Ctr AIDS Res, Birmingham, AL 35294 USA; [Harris, Julia] GlaxoSmithKline, Uxbridge, Middx, England; [Brennan, Clare; Min, Sherene] GlaxoSmithKline, Res Triangle Pk, NC USA; [Fujiwara, Tamio] Shionogi & Co Ltd, Osaka, Japan	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University System of Ohio; University of Cincinnati; University of Hamburg; University Medical Center Hamburg-Eppendorf; IRCCS Lazzaro Spallanzani; University of Zurich; University of Zurich; Orlando Immunology Center; University of Alabama System; University of Alabama Birmingham; GlaxoSmithKline; GlaxoSmithKline; Shionogi & Company Limited	Clotet, B (corresponding author), Hosp Badalona Germans Trias & Pujol, IrsiCaixa, Badalona, Spain.	bclotet@irsicaixa.es	Shuldyakov, Andrey/U-5598-2017; Fehr, Jan S/V-7499-2017; Antinori, Andrea/K-7125-2016; Dumitru, Irina/U-5493-2019; Rugina, Sorin/U-5168-2019; Stephan, Christoph/D-1305-2014	Shuldyakov, Andrey/0000-0002-3009-9262; Fehr, Jan S/0000-0003-1113-9895; Antinori, Andrea/0000-0003-2121-4684; Dumitru, Irina/0000-0003-0395-6713; Stephan, Christoph/0000-0003-3777-9006; feinberg, judith/0000-0003-4206-7214	ViiV Healthcare LLC and Shionogi Co	ViiV Healthcare LLC and Shionogi Co	Funding for this work was provided by ViiV Healthcare LLC and Shionogi & Co. We thank the FLAMINGO study patients and their families and caregivers for participation in the study. We thank the following FLAMINGO investigators and their staff. France: M-A Khuong-Josses, J-M Molina, G Pialoux, F Raffi, J Reynes, P Yeni. Germany: W Kern, C Stephan, J Van Lunzen. Italy: A Antinori, A D'Arminio Monforte, G Di Perri, G Guaraldi, A Lazzarin. Puerto Rico: I Melendez-Rivera, J Morales Ramirez, J Santana-Bagur. Romania: D Duiculescu, L Preotescu, S Rugina. Russia: O Kozyrev, V Kulagin, V Pokrovskiy, A Shuldyakov, E Voronin. Spain: B Clotet, J Gatell, D Podzamczer, R Rubio, P Viciana. Switzerland: M Cavassini, J Fehr, H Furrer. USA: N Bellos, G Blick, I Brar, C Dietz, R Dretler, R Elion, J Eron, J Feinberg, G Georgescu/A Scribner, D Hagins, W Henry, C Martorell, C Mayer, L McCurdy, A Mills, M Murphy, C Newman, R Ortiz, G Pierone, A Rana, M Saag, P Shalit, G Simon, L Sloan, J Stephens, P Tebas, W Towner, M Tribble, D Warner, A Wilkin, B Young. The authors also wish to acknowledge the following individuals for editorial assistance during the development of this report: Susan Porter-Atkinson, J Louise Martin-Carpenter, and Gina Uhlenbrauck.	[Anonymous], 2011, IS PACK INS; [Anonymous], 2013, NORV; [Anonymous], 2013, PREZ; BURGESS E, 1982, RENAL PHYSIOL BIOCH, V5, P27; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Dmitrienko A, 2008, BIOMETRICAL J, V50, P667, DOI 10.1002/bimj.200710464; EuroQol Group, 2013, EQ 5D; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hill A, 2008, AIDS, V22, P913, DOI 10.1097/QAD.0b013e3282f5556d; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; KASTRUP J, 1985, BRIT J UROL, V57, P265, DOI 10.1111/j.1464-410X.1985.tb06340.x; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Koteff J, 2013, BRIT J CLIN PHARMACO, V75, P990, DOI 10.1111/j.1365-2125.2012.04440.x; Lepist E, 2011, 51 INT C ANT AG CHEM; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Schrijvers R, 2012, LANCET, V379, P2403, DOI 10.1016/S0140-6736(12)61029-0; Song I, 2012, ANTIMICROB AGENTS CH, V56, P1627, DOI 10.1128/AAC.05739-11; Stellbrink HJ, 2013, AIDS, V27, P1771, DOI 10.1097/QAD.0b013e3283612419; US Food and Drug Administration, 2013, FDA APPR NEW COMB PI; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Viiv Healthcare, 2013, TIV PACK INS; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Wiens BL, 2005, J BIOPHARM STAT, V15, P929, DOI 10.1080/10543400500265660; Woodcock A, 2001, QUAL LIFE RES, V10, P517, DOI 10.1023/A:1013050904635; Woodcock A, 2006, VALUE HEALTH, V9, P320, DOI 10.1111/j.1524-4733.2006.00121.x; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	32	350	374	0	46	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2222	2231		10.1016/S0140-6736(14)60084-2	http://dx.doi.org/10.1016/S0140-6736(14)60084-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK8DO	24698485				2022-12-28	WOS:000338657600026
J	Farrar, J; Savill, J				Farrar, Jeremy; Savill, John			UK funders' framework for health-related findings in research	LANCET			English	Editorial Material							INCIDENTAL FINDINGS		[Farrar, Jeremy] Wellcome Trust Res Labs, London NW1 2BE, England; [Savill, John] MRC, London, England		Farrar, J (corresponding author), Wellcome Trust Res Labs, London NW1 2BE, England.	J.Farrar@wellcome.ac.uk	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Booth TC, 2012, BRIT J RADIOL, V85, P11, DOI 10.1259/bjr/73283917; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2010, TRIC POL STAT ETH CO; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Leader Opinion, 2012, ASS PUBL ATT HLTH RE; The Royal College of Radiologists, 2011, MAN INC FIND DET RES; Wellcome Trust & Medical Research Council, 2014, FRAM FEEDB HLTH REL; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x	7	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1954	1955		10.1016/S0140-6736(14)60545-6	http://dx.doi.org/10.1016/S0140-6736(14)60545-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24698482				2022-12-28	WOS:000336848200008
J	Iyer, SM; Delp, SL				Iyer, Shrivats M.; Delp, Scott L.			Optogenetic Regeneration	SCIENCE			English	Editorial Material							SPINAL-CORD-INJURY; RECRUITMENT; STIMULATION; PAIN; MICE		[Iyer, Shrivats M.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Iyer, SM (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	delp@stanford.edu		Delp, Scott/0000-0002-9643-7551; Iyer, Shrivats/0000-0003-4648-3637	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080954] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01-NS080954, R01 NS080954] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arlow RL, 2013, NEUROSCIENCE, V248, P541, DOI 10.1016/j.neuroscience.2013.06.031; Bickel CS, 2011, EUR J APPL PHYSIOL, V111, P2399, DOI 10.1007/s00421-011-2128-4; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Busskamp V, 2011, CURR OPIN NEUROBIOL, V21, P942, DOI 10.1016/j.conb.2011.06.001; Daou I, 2013, J NEUROSCI, V33, P18631, DOI 10.1523/JNEUROSCI.2424-13.2013; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514; Williams JC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003100	14	4	7	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					44	45		10.1126/science.1253088	http://dx.doi.org/10.1126/science.1253088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700845	Green Accepted			2022-12-28	WOS:000333746100042
J	Hyman, SE				Hyman, Steven E.			PERSPECTIVE Revealing molecular secrets	NATURE			English	Editorial Material							MUTATIONS		[Hyman, Steven E.] Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Hyman, Steven E.] US Natl Inst Mental Hlth, Bethesda, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hyman, SE (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA.	seh@harvard.edu						Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Kirov G, 2014, BIOL PSYCHIAT, V75, P378, DOI 10.1016/j.biopsych.2013.07.022; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; McCarroll SA, 2013, NEURON, V80, P578, DOI 10.1016/j.neuron.2013.10.046; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742	7	7	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S20	S20		10.1038/508S20a	http://dx.doi.org/10.1038/508S20a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695333	Bronze			2022-12-28	WOS:000333609900014
J	Katsnelson, A				Katsnelson, Alla			DRUG DEVELOPMENT The modelling challenge	NATURE			English	Editorial Material																		Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Moore H, 2013, NEUROSCI BIOBEHAV R, V37, P2087, DOI 10.1016/j.neubiorev.2013.09.011	2	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S8	S9		10.1038/508S8a	http://dx.doi.org/10.1038/508S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695336				2022-12-28	WOS:000333609900008
J	Wolpaw, DR; Shapiro, D				Wolpaw, Daniel R.; Shapiro, Dan			The Virtues of Irrelevance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								"Interesting belt - where did you get that?" "I see you are from Youngstown. The key question is, are you a Steelers fan or a Browns fan?" These are not the usual opening questions we teach for the medical interview. The answers are not included in the chief complaint, history of present illness, past history, social history, family history, review of systems, medications, or allergies. There is no hat or belt section in the physical exam. Differential diagnoses on sports, clothing, or food preferences are not a highly valued component of clinical reasoning. But often these opening comments and questions . . . Through irrelevant, friendly comments or questions, physicians can establish key connections with patients. Such small talk conveys physicians' recognition of patients' individuality and their own shared experiences, observance of details, and openness to conversation.	[Wolpaw, Daniel R.; Shapiro, Dan] Penn State Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wolpaw, DR (corresponding author), Penn State Coll Med, Hershey, PA 17033 USA.							AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Jauhar S, 2004, NEW ENGL J MED, V351, P2149, DOI 10.1056/NEJMp048109; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	3	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1283	1285		10.1056/NEJMp1315661	http://dx.doi.org/10.1056/NEJMp1315661			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE2VA	24693889				2022-12-28	WOS:000333830000006
J	Shapiro, J				Shapiro, Jonathan			English clinical commissioning groups: how to ensure their first birthday isn't their last	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jsx@me.com						Baker S.D., 2007, J LEADERSH ORG STUD, V14, P50, DOI [10.1177/0002831207304343, DOI 10.1177/0002831207304343]; Covey S.R., 1989, 7 HABITS HIGHLY EFFE; NHS England, 2013, CONS SPEC SERV SPEC; NHS England, 2013, EV COUNTS PLANN PAT	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g2306	10.1136/bmj.g2306	http://dx.doi.org/10.1136/bmj.g2306			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696172				2022-12-28	WOS:000333977000003
J	Bisschop, PH; van Trotsenburg, ASP				Bisschop, Peter H.; van Trotsenburg, A. S. Paul			Neonatal Thyrotoxicosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 22-year-old woman was referred at 31 weeks of gestation for assessment of oligohydramnios. The fetal heart rate was 158 beats per minute. Ultrasonography was repeated every 2 weeks. At 35 weeks of gestation, intrauterine growth retardation was evident. An infant born after 36 weeks of gestation was admitted to the intensive care unit and treated empirically for sepsis. His mother, who was 22 years of age, had been referred at 31 weeks of gestation for assessment of oligohydramnios. The fetal heart rate was 158 beats per minute. Ultrasonography was repeated every 2 weeks. At 35 weeks of gestation, intrauterine growth retardation was evident. No goiter was noted, and the fetal heart rate was 150 beats per minute. At birth, the boy weighed 1800 g. Apgar scores were normal, but the pulse was 200 beats per minute; no palpable ...	[Bisschop, Peter H.; van Trotsenburg, A. S. Paul] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Bisschop, PH (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		van Trotsenburg, Paul/ABC-2379-2020	van Trotsenburg, Paul/0000-0002-9677-7441					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1237	1237		10.1056/NEJMicm1308956	http://dx.doi.org/10.1056/NEJMicm1308956			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670170				2022-12-28	WOS:000333426000011
J	Canestrari, D; Bolopo, D; Turlings, TCJ; Roder, G; Marcos, JM; Baglione, V				Canestrari, Daniela; Bolopo, Diana; Turlings, Ted C. J.; Roeder, Gregory; Marcos, Jose M.; Baglione, Vittorio			From Parasitism to Mutualism: Unexpected Interactions Between a Cuckoo and Its Host	SCIENCE			English	Article							GREAT-SPOTTED-CUCKOOS; BROOD PARASITISM; CARRION CROWS; OUTCOMES; AGENTS; BIRDS	Avian brood parasites lay eggs in the nests of other birds, which raise the unrelated chicks and typically suffer partial or complete loss of their own brood. However, carrion crows Corvus corone corone can benefit from parasitism by the great spotted cuckoo Clamator glandarius. Parasitized nests have lower rates of predation-induced failure due to production of a repellent secretion by cuckoo chicks, but among nests that are successful, those with cuckoo chicks fledge fewer crows. The outcome of these counterbalancing effects fluctuates between parasitism and mutualism each season, depending on the intensity of predation pressure.	[Canestrari, Daniela] Univ Oviedo, Dept Biol Organisms & Syst, Oviedo, Spain; [Canestrari, Daniela] Univ Oviedo, Consejo Super Invest Cient, Unidad Mixta Invest Biodivesidad, Res Unit Biodivers, Oviedo, Spain; [Bolopo, Diana; Marcos, Jose M.; Baglione, Vittorio] Univ Valladolid, Dept Agroforestry, Valladolid, Spain; [Turlings, Ted C. J.; Roeder, Gregory] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Baglione, Vittorio] Sustainable Forest Management Res Inst, Palencia, Spain	University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Universidad de Valladolid; University of Neuchatel	Canestrari, D (corresponding author), Univ Oviedo, Dept Biol Organisms & Syst, Oviedo, Spain.	canestraridaniela@uniovi.es	Baglione, Vittorio/D-6456-2014; Bolopo, Diana/K-3413-2017; Canestrari, Daniela/F-9696-2016; Turlings, Ted CJ/E-8671-2012; Bolopo, Diana/AAU-2798-2020	Bolopo, Diana/0000-0002-7989-534X; Canestrari, Daniela/0000-0001-9112-0208; Turlings, Ted CJ/0000-0002-8315-785X; Bolopo, Diana/0000-0002-7989-534X; Baglione, Vittorio/0000-0001-8464-7861; Roder, Gregory/0000-0002-7110-294X	Spanish Plan Nacional I+D [CGL2008-01829BOS, SEJ2007-29836-E, CGL2011-27260]; Junta of Castilla y Leon [VA059A11-2]	Spanish Plan Nacional I+D; Junta of Castilla y Leon	We thank three anonymous referees for helpful comments; M. Soler for discussions; H. Robles and J. C. Seoane for statistical advice; and G. Robles, C. Nunez, and B. Gonzalez for help in the field. Funding was provided by Spanish Plan Nacional I+D (grants CGL2008-01829BOS, SEJ2007-29836-E, and CGL2011-27260) and Junta of Castilla y Leon (grant VA059A11-2) to V.B. Data are available from DRYAD (DOI:10.5061/dryad.j81r0).	Baglione V, 2005, J ANIM ECOL, V74, P842, DOI 10.1111/j.1365-2656.2005.00983.x; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Canestrari D, 2008, ANIM BEHAV, V75, P403, DOI 10.1016/j.anbehav.2007.05.005; Canestrari D, 2009, ANIM BEHAV, V77, P1337, DOI 10.1016/j.anbehav.2009.02.009; Cheney KL, 2005, BIOL LETTERS, V1, P162, DOI 10.1098/rsbl.2004.0288; Cramp S, 1994, BIRDS W PALEARTIC, VVIII; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DEREYNA LA, 1998, PARASITIC BIRDS THEI, P129; Hatchwell BJ, 1999, AM NAT, V154, P205, DOI 10.1086/303227; Kilner RM, 2011, BIOL REV, V86, P836, DOI 10.1111/j.1469-185X.2010.00173.x; Kruger O, 2011, P ROY SOC B-BIOL SCI, V278, P2777, DOI 10.1098/rspb.2010.2629; Landa A, 1997, J WILDLIFE MANAGE, V61, P510, DOI 10.2307/3802609; LEHNER PN, 1976, J WILDLIFE MANAGE, V40, P145, DOI 10.2307/3800169; SCHAFER EW, 1983, ARCH ENVIRON CON TOX, V12, P355, DOI 10.1007/BF01059413; Siepielski AM, 2007, P ROY SOC B-BIOL SCI, V274, P1799, DOI 10.1098/rspb.2007.0449; SMITH NG, 1968, NATURE, V219, P690, DOI 10.1038/219690a0; SOLER M, 1991, CONDOR, V93, P49, DOI 10.2307/1368605; SOLER M, 1994, CONDOR, V96, P802, DOI 10.2307/1369485; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler M., 2001, AVIAN SCI, V1, P1; Spottiswoode CN, 2012, EVOLUTION OF PARENTAL CARE, P226; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M	22	62	63	4	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1350	1352		10.1126/science.1249008	http://dx.doi.org/10.1126/science.1249008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653032				2022-12-28	WOS:000333108500036
J	Ghelfi, P; Laghezza, F; Scotti, F; Serafino, G; Capria, A; Pinna, S; Onori, D; Porzi, C; Scaffardi, M; Malacarne, A; Vercesi, V; Lazzeri, E; Berizzi, F; Bogoni, A				Ghelfi, Paolo; Laghezza, Francesco; Scotti, Filippo; Serafino, Giovanni; Capria, Amerigo; Pinna, Sergio; Onori, Daniel; Porzi, Claudio; Scaffardi, Mirco; Malacarne, Antonio; Vercesi, Valeria; Lazzeri, Emma; Berizzi, Fabrizio; Bogoni, Antonella			A fully photonics-based coherent radar system	NATURE			English	Article							WAVE-FORM GENERATION; SIGNALS	The next generation of radar (radio detection and ranging) systems needs to be based on software-defined radio to adapt to variable environments, with higher carrier frequencies for smaller antennas and broadened bandwidth for increased resolution(1-4). Today's digital microwave components (synthesizers and analogue-to-digital converters) suffer from limited bandwidth with high noise at increasing frequencies(5-7), so that fully digital radar systems can work up to only a few gigahertz, and noisy analogue up-and downconversions are necessary for higher frequencies. In contrast, photonics provide high precision and ultrawide bandwidth(8,9), allowing both the flexible generation of extremely stable radio-frequency signals with arbitrary waveforms up to millimetre waves(10-22), and the detection of such signals and their precise direct digitization without downconversion(23-26). Until now, the photonics-based generation and detection of radio-frequency signals have been studied separately and have not been tested in a radar system. Here we present the development and the field trial results of a fully photonics-based coherent radar demonstrator carried out within the project PHODIR27. The proposed architecture exploits a single pulsed laser for generating tunable radar signals and receiving their echoes, avoiding radio-frequency up-and downconversion and guaranteeing both the software-defined approach and high resolution. Its performance exceeds state-of-the-art electronics at carrier frequencies above two gigahertz, and the detection of non-cooperating aeroplanes confirms the effectiveness and expected precision of the system.	[Ghelfi, Paolo; Laghezza, Francesco; Scotti, Filippo; Scaffardi, Mirco; Malacarne, Antonio; Lazzeri, Emma; Bogoni, Antonella] Interuniv Natl Consortium Telecommun CNIT, Natl Lab Photon Networks, I-56124 Pisa, Italy; [Serafino, Giovanni; Pinna, Sergio; Onori, Daniel; Porzi, Claudio; Vercesi, Valeria] Scuola Super Sant Anna, TeCIP Inst, I-56124 Pisa, Italy; [Capria, Amerigo; Berizzi, Fabrizio] Interuniv Natl Consortium Telecommun CNIT, Natl Lab Radars & Surveillance Syst, I-56126 Pisa, Italy; [Berizzi, Fabrizio] Univ Pisa, Dept Informat Engn, I-56122 Pisa, Italy	Scuola Superiore Sant'Anna; University of Pisa	Bogoni, A (corresponding author), Interuniv Natl Consortium Telecommun CNIT, Natl Lab Photon Networks, Via Moruzzi 1, I-56124 Pisa, Italy.	antonella.bogoni@cnit.it	PINNA, Sergio/AAC-5026-2019; Lazzeri, Emma/M-1642-2014; Laghezza, Francesco/K-8906-2016	Lazzeri, Emma/0000-0003-0506-046X; Laghezza, Francesco/0000-0003-3301-3142; Capria, Amerigo/0000-0003-4855-5323; Vercesi, Valeria/0000-0001-5368-3974; SERAFINO, Giovanni/0000-0003-1544-9399	ERC [239640, 324629]; EU NEXPRESSO programme through the project INSIDE; Selex ES S.p.A.	ERC(European Research Council (ERC)European Commission); EU NEXPRESSO programme through the project INSIDE; Selex ES S.p.A.	This work was supported by the ERC projects PHODIR (contract number 239640) and PREPARE (contract number 324629), and by the EU NEXPRESSO programme through the project INSIDE with Selex Sistemi Integrati S.p.A. (now Selex ES S.p.A.).	Capmany J, 2007, NAT PHOTONICS, V1, P319, DOI 10.1038/nphoton.2007.89; Chi H, 2007, IEEE PHOTONIC TECH L, V19, P768, DOI 10.1109/LPT.2007.895898; Chou J, 2003, IEEE PHOTONIC TECH L, V15, P581, DOI 10.1109/LPT.2003.809309; Chou J, 2009, J LIGHTWAVE TECHNOL, V27, P5073, DOI 10.1109/JLT.2009.2030519; Ghelfi P, 2013, OPT EXPRESS, V21, P22905, DOI 10.1364/OE.21.022905; Ghelfi P, 2012, IEEE J QUANTUM ELECT, V48, P1151, DOI 10.1109/JQE.2012.2205371; Ghelfi P, 2011, IEEE PHOTONIC TECH L, V23, P639, DOI 10.1109/LPT.2011.2120605; Ghelfi P, 2012, J LIGHTWAVE TECHNOL, V30, P1638, DOI 10.1109/JLT.2012.2187879; GOLDBERG L, 1992, IEE PROC-J, V139, P288, DOI 10.1049/ip-j.1992.0049; Haykin I, 2006, IEEE SIGNAL PROC MAG, V23, P30, DOI 10.1109/MSP.2006.1593335; Khan MH, 2010, NAT PHOTONICS, V4, P117, DOI 10.1038/NPHOTON.2009.266; Khilo A, 2012, OPT EXPRESS, V20, P4454, DOI 10.1364/OE.20.004454; Laghezza F, 2013, IEEE RAD CONF; Li Z, 2011, IEEE PHOTONIC TECH L, V23, P712, DOI 10.1109/LPT.2011.2132121; Lin IS, 2005, IEEE MICROW WIREL CO, V15, P226, DOI 10.1109/LMWC.2005.845698; Maleki L, 2010, P IEEE INT FREQ CONT, P558, DOI 10.1109/FREQ.2010.5556265; Maleki L, 2011, NAT PHOTONICS, V5, P728, DOI 10.1038/nphoton.2011.293; McKinney JD, 2002, OPT LETT, V27, P1345, DOI 10.1364/OL.27.001345; Pierno L., 2013, P EUR MICR INT CIRC; Ravenni V, 2007, 2007 EUROPEAN MICROWAVE CONFERENCE, VOLS 1-4, P1715, DOI 10.1109/EUMC.2007.4405545; Richards M. A., 2010, PRINCIPLE MODERN RAD; SCHEER JA, 1993, COHERENT RADAR PERFO; Serafino G, 2010, 2010 23RD ANNUAL MEETING OF THE IEEE PHOTONICS SOCIETY, P193, DOI 10.1109/PHOTONICS.2010.5698824; Skolnik M. I., 1980, INTRO RADAR SYSTEMS; TSUI J. B., 2004, DIGITAL TECHNIQUES W, V2a; Valley GC, 2007, OPT EXPRESS, V15, P1955, DOI 10.1364/OE.15.001955; Walden R., 2008, WILEY ENCY COMPUTER; Yao JP, 2009, J LIGHTWAVE TECHNOL, V27, P314, DOI 10.1109/JLT.2008.2009551; Yilmaz T, 2002, IEEE PHOTONIC TECH L, V14, P1608, DOI 10.1109/LPT.2002.803326	29	646	683	46	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					341	345		10.1038/nature13078	http://dx.doi.org/10.1038/nature13078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646997				2022-12-28	WOS:000333029000030
J	Hayes, JH; Barry, MJ				Hayes, Julia H.; Barry, Michael J.			Screening for Prostate Cancer With the Prostate-Specific Antigen Test A Review of Current Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED PROSTATE; RADICAL PROSTATECTOMY; FOLLOW-UP; MORTALITY; TRIAL; OUTCOMES; RISK; OVERDIAGNOSIS; OVERDETECTION; CONSEQUENCES	IMPORTANCE Prostate cancer screening with the prostate-specific antigen (PSA) test remains controversial. OBJECTIVE To review evidence from randomized trials and related modeling studies examining the effect of PSA screening vs no screening on prostate cancer-specific mortality and to suggest an approach balancing potential benefits and harms. EVIDENCE ACQUISITION MEDLINE, EMBASE, and the Cochrane Register of Controlled Trials were searched from January 1, 2010, to April 3, 2013, for PSA screening trials to update a previous systematic review. Another search was performed in EMBASE and MEDLINE to identify modeling studies extending the results of the 2 large randomized trials identified. The American Heart Association Evidence-Based Scoring System was used to rate level of evidence. RESULTS Two trials-the Prostate, Lung, Colorectal and Ovarian (PLCO) screening trial and the European Randomized Study of Screening for Prostate Cancer (ERSPC)-dominate the evidence regarding PSA screening. The former trial demonstrated an increase in cancer incidence in the screening group (relative risk [RR], 1.12; 95% CI, 1.07-1.17) but no cancer-specific mortality benefit to PSA screening after 13-year follow-up (RR, 1.09; 95% CI, 0.87-1.36). The ERSPC demonstrated an increase in cancer incidence with screening (RR, 1.63; 95% CI, 1.57-1.69) and an improvement in the risk of prostate cancer-specific death after 11 years (RR, 0.79; 95% CI, 0.68-0.91). The ERSPC documented that 37 additional men needed to receive a diagnosis through screening for every 1 fewer prostate cancer death after 11 years of follow-up among men aged 55 to 69 years (level B evidence for prostate cancer mortality reduction). Harms associated with screening include false-positive results and complications of biopsy and treatment. Modeling studies suggest that this high ratio of additional men receiving diagnoses to prostate cancer deaths prevented will decrease during a longer follow-up (level B evidence). CONCLUSIONS AND RELEVANCE Available evidence favors clinician discussion of the pros and cons of PSA screening with average-risk men aged 55 to 69 years. Only men who express a definite preference for screening should have PSA testing. Other strategies to mitigate the potential harms of screening include considering biennial screening, a higher PSA threshold for biopsy, and conservative therapy for men receiving a new diagnosis of prostate cancer.	[Hayes, Julia H.] Harvard Univ, Sch Med, Inst Canc, Boston, MA USA; [Hayes, Julia H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Inst Technol Assessment, Boston, MA USA; [Barry, Michael J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Internal Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hayes, JH (corresponding author), 450 Brookline Ave,Dana 1230, Boston, MA 02115 USA.	julia_hayes@dfci.harvard.edu						Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Barry MJ, 2012, J CLIN ONCOL, V30, P513, DOI 10.1200/JCO.2011.36.8621; Barry MJ, 2009, NEW ENGL J MED, V360, P1351, DOI 10.1056/NEJMe0901166; Basch E, 2012, J CLIN ONCOL, V30, P3020, DOI 10.1200/JCO.2012.43.3441; Brawley OW, 2012, WORLD J UROL, V30, P195, DOI 10.1007/s00345-012-0824-2; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Carter HB, EARLY DETECTION PROS; CATALONA WJ, 1994, J UROLOGY, V152, P2031, DOI 10.1016/S0022-5347(17)32299-1; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Evans R, 2005, PATIENT EDUC COUNS, V58, P13, DOI 10.1016/j.pec.2004.06.009; Grubb RL, 2008, BJU INT, V102, P1524, DOI 10.1111/j.1464-410X.2008.08214.x; Gulati R, 2012, CANCER CAUSE CONTROL, V23, P827, DOI 10.1007/s10552-012-9951-8; Gulati R, 2011, J CLIN EPIDEMIOL, V64, P1412, DOI 10.1016/j.jclinepi.2011.06.011; Heidenreich A, 2013, EUR UROL, V64, P347, DOI 10.1016/j.eururo.2013.06.051; Heijnsdijk EAM, 2009, BRIT J CANCER, V101, P1833, DOI 10.1038/sj.bjc.6605422; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ilic D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub2; Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x; Izawa JI, 2011, CUAJ-CAN UROL ASSOC, V5, P235, DOI 10.5489/cuaj.11134; Kiellman A, 2009, J UROLOGY, V181, P1615, DOI 10.1016/j.juro.2008.11.115; Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017; Loeb S, 2011, J UROLOGY, V186, P1830, DOI 10.1016/j.juro.2011.06.057; Loeb S, 2011, J CLIN ONCOL, V29, P464, DOI 10.1200/JCO.2010.30.6373; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; National Cancer Institute, 1975, SEER CANC STAT REV; National Research Council, 2001, CROSS QUAL CHASM NEW; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Roobol MJ, 2007, JNCI-J NATL CANCER I, V99, P1296, DOI 10.1093/jnci/djm101; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Sandblom G, 2004, EUR UROL, V46, P717, DOI 10.1016/j.eururo.2004.08.011; Sandblom G, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1539; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shteynshlyuger A, 2011, J UROLOGY, V185, P828, DOI 10.1016/j.juro.2010.10.079; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Walter LC, 2013, JAMA INTERN MED, V173, P866, DOI 10.1001/jamainternmed.2013.323; Wever EM, 2012, BRIT J CANCER, V107, P778, DOI 10.1038/bjc.2012.317; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wolters T, 2010, INT J CANCER, V126, P2387, DOI 10.1002/ijc.24870; Wu GHM, 2012, INT J CANCER, V131, P1367, DOI 10.1002/ijc.27340; Wu GHM, 2012, EUR UROL, V61, P1011, DOI 10.1016/j.eururo.2012.01.008; Wu GHM, 2012, BIOMETRICAL J, V54, P20, DOI 10.1002/bimj.201000107	53	234	244	2	67	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1143	1149		10.1001/jama.2014.2085	http://dx.doi.org/10.1001/jama.2014.2085			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643604				2022-12-28	WOS:000333010100019
J	Noronha, AM; Brozak, S				Noronha, Anne Marie; Brozak, Steve			FEATURE A 21st century nosocomial issue with endoscopes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PSEUDOMONAS-AERUGINOSA INFECTIONS; DISPOSABLE-SHEATH SYSTEM; OUTBREAKS		[Noronha, Anne Marie; Brozak, Steve] WBB Secur, Clark, NJ 07066 USA		Noronha, AM (corresponding author), WBB Secur, 67 Walnut Ave, Clark, NJ 07066 USA.	sbrozak@wbbsec.com						Aumeran C, 2011, ENDOSKOPIE HEUTE, V24, P124, DOI 10.1055/s-0030-1255647; Baker EH, 1999, LARYNGOSCOPE, V109, P636, DOI 10.1097/00005537-199904000-00022; Banerjee S, 2008, GASTROINTEST ENDOSC, V67, P781, DOI 10.1016/j.gie.2008.01.027; Bommarito M., 2013, APIC 2013 ANN C 9 JU; Carter K. C., 2005, CHILDBED FEVER SCI B; Centers for Disease Control and Prevention (CDC), 2014, NOT FIELD NEW DELH M; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P675; Cetre JC, 2005, J HOSP INFECT, V61, P39, DOI 10.1016/j.jhin.2004.12.020; Corne P, 2005, J HOSP INFECT, V61, P20, DOI 10.1016/j.jhin.2005.01.024; Department of Veterans Affairs Office of Inspector General, 2009, HEALTHC INSP FOLL CO; Emergency Care Research Institute (ECRI), 2013, 2014 TOP 10 HLTH TEC; French GL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8330; Gonzalez-Candelas F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-217; Gupta D, 2012, J BIOMED RES, V26, P241, DOI 10.7555/JBR.26.20120050; Herve R, 2013, J HOSP INFECT, V83, P22, DOI 10.1016/j.jhin.2012.08.008; Krebs A, 2007, UROLOGY, V70, P883, DOI 10.1016/j.urology.2007.06.1112; Larson JL, 2003, INFECT CONT HOSP EP, V24, P825, DOI 10.1086/502144; Lawrentschuk N, 2005, UROLOGY, V66, P1310, DOI 10.1016/j.urology.2005.06.118; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Routh CH, 1848, LANCET, V2, P642; Ryan K, 2013, WICHITA EAGLE   0716; Sabnis RB, 2014, CURR OPIN UROL, V24, P195, DOI 10.1097/MOU.0000000000000034; Seoane-Vazquez E, 2006, CURR MED RES OPIN, V22, P2007, DOI 10.1185/030079906X121048; Smiley D, 2012, MIAMI HERALD    1121; Society of Gastroenterology Nurses and Associates Inc., 2012, STAND INF CONTR REPR; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; Tosh PK, 2011, INFECT CONT HOSP EP, V32, P1179, DOI 10.1086/662712; U.K. Department of Health, 2013, CHOIC FRAM LOC POL P; Winter SCA, 2002, CLIN OTOLARYNGOL, V27, P81, DOI 10.1046/j.1365-2273.2002.00534.x	30	7	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g2047	10.1136/bmj.g2047	http://dx.doi.org/10.1136/bmj.g2047			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647343				2022-12-28	WOS:000333414500010
J	Hankey, GJ				Hankey, Graeme J.			In intracranial artery stenosis, adding angioplasty and stenting to medical therapy increased stroke or death	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328; Derdeyn, Colin/0000-0002-5932-2683					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC4	10.7326/0003-4819-160-6-201403180-02004	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638182				2022-12-28	WOS:000333521300003
J	Johnson, SA; Rondina, MT				Johnson, Stacy A.; Rondina, Matthew T.			Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Johnson, Stacy A.; Rondina, Matthew T.] Univ Utah, Univ Healthcare Thrombosis Serv, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Johnson, SA (corresponding author), Univ Utah, Univ Healthcare Thrombosis Serv, Salt Lake City, UT 84112 USA.		Giugliano, Robert/N-7233-2017	Giugliano, Robert/0000-0003-4110-7675	NIA NIH HHS [R03 AG040631] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG040631] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Mahaffey KW, 2013, CIRC-CARDIOVASC QUAL, V6, P470, DOI 10.1161/CIRCOUTCOMES.113.000132	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC7	10.7326/0003-4819-160-6-201403180-02007	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638185				2022-12-28	WOS:000333521300006
J	Gluckman, P				Gluckman, Peter			The art of science advice to government	NATURE			English	Editorial Material									Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Auckland	Gluckman, P (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	csa@pmcsa.org.nz						[Anonymous], 2013, COD COND SCI REV VER; Doubleday R, 2012, NATURE, V485, P301, DOI 10.1038/485301a; Douglas HE, 2009, SCI POLICY VALUE FRE, DOI [DOI 10.2307/J.CTT6WRC78, 10.2307/j.ctt6wrc78]; FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; Gluckman P., 2013, ROLE EVIDENCE POLICY; Gluckman Peter., 2011, BETT US EV POL FORM; Hickey GM, 2013, SCI PUBL POLICY, V40, P529, DOI 10.1093/scipol/sct004; Jasanoff S., 2012, SCI PUBLIC REASON; Pielke R.A.J., 2007, HONEST BROKER MAKING; Sutherland WJ, 2013, NATURE, V503, P335, DOI 10.1038/503335a	10	94	97	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					163	165		10.1038/507163a	http://dx.doi.org/10.1038/507163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC6RJ	24627919	Bronze			2022-12-28	WOS:000332651800015
J	Zheng, SY; Kim, H; Verhaak, RGW				Zheng, Siyuan; Kim, Hoon; Verhaak, Roel G. W.			Silent Mutations Make Some Noise	CELL			English	Editorial Material							CANCER	Synonymous mutations do not alter amino acids and are generally considered nonfunctional in cancer. Supek et al. now present a compelling analysis suggesting that such silent mutations can be oncogenic by altering transcript splicing and thereby affecting protein function.	[Zheng, Siyuan; Kim, Hoon; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	rverhaak@mdanderson.org	Zheng, sy/GRS-3136-2022; Kim, Hoon/AAL-9283-2020; Verhaak, Roel/ABE-7058-2020	Kim, Hoon/0000-0003-4244-6126; Zheng, Siyuan/0000-0002-1031-9424	NATIONAL CANCER INSTITUTE [P30CA016672, U24CA143883] Funding Source: NIH RePORTER; NCI NIH HHS [U24 CA143883, P30 CA016672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Stark M, 2011, J BIOL CHEM, V286, P3741, DOI 10.1074/jbc.M110.163444; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429	10	30	31	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1129	1131		10.1016/j.cell.2014.02.037	http://dx.doi.org/10.1016/j.cell.2014.02.037			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630716	Bronze			2022-12-28	WOS:000332945100004
J	Been, JV; Nurmatov, UB; Cox, B; Nawrot, TS; van Schayck, CP; Sheikh, A				Been, Jasper V.; Nurmatov, Ulugbek B.; Cox, Bianca; Nawrot, Tim S.; van Schayck, Constant P.; Sheikh, Aziz			Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis	LANCET			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PRETERM BIRTHS ANALYSIS; FREE AIR LAWS; SECONDHAND SMOKE; PUBLIC PLACES; EXPOSURE; ASSOCIATION; ASTHMA; IMPLEMENTATION; DISEASES	Background Smoke-free legislation has the potential to reduce the substantive disease burden associated with second-hand smoke exposure, particularly in children. We investigated the effect of smoke-free legislation on perinatal and child health. Methods We searched 14 online databases from January, 1975 to May, 2013, with no language restrictions, for published studies, and the WHO International Clinical Trials Registry Platform for unpublished studies. Citations and reference lists of articles of interest were screened and an international expert panel was contacted to identify additional studies. We included studies undertaken with designs approved by the Cochrane Effective Practice and Organisation of Care that reported associations between smoking bans in workplaces, public places, or both, and one or more predefined early-life health indicator. The primary outcomes were preterm birth, low birthweight, and hospital attendances for asthma. Effect estimates were pooled with random-effects meta-analysis. This study is registered with PROSPERO, number CRD42013003522. Findings We identified 11 eligible studies (published 2008-13), involving more than 2.5 million births and 247 168 asthma exacerbations. All studies used interrupted time-series designs. Five North American studies described local bans and six European studies described national bans. Risk of bias was high for one study, moderate for six studies, and low for four studies. Smoke-free legislation was associated with reductions in preterm birth (four studies, 1 366 862 individuals; -10.4% [95% CI -18.8 to -2.0]; p=0.016) and hospital attendances for asthma (three studies, 225 753 events: -10.1% [95% CI -15.2 to -5.0]; p=0.0001). No significant effect on low birthweight was identified (six studies, >1.9 million individuals: -1.7% [95% CI -5.1 to 1.6]; p=0.31). Interpretation Smoke-free legislation is associated with substantial reductions in preterm births and hospital attendance for asthma. Together with the health benefits in adults, this study provides strong support for WHO recommendations to create smoke-free environments.	[Been, Jasper V.; van Schayck, Constant P.; Sheikh, Aziz] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, NL-6202 AZ Maastricht, Netherlands; [Been, Jasper V.; Nurmatov, Ulugbek B.; van Schayck, Constant P.; Sheikh, Aziz] Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Been, Jasper V.] Maastricht Univ, Med Ctr, Dept Paediat, NL-6202 AZ Maastricht, Netherlands; [Cox, Bianca; Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Hasselt, Belgium; [Nawrot, Tim S.] Univ Louvain, Dept Publ Hlth, Louvain, Belgium; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	Maastricht University; University of Edinburgh; Maastricht University; Hasselt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Been, JV (corresponding author), Maastricht Univ, Med Ctr, Dept Paediat, POB 5800, NL-6202 AZ Maastricht, Netherlands.	jasper.been@mumc.nl	Sheikh, Aziz/D-2818-2009; Nawrot, Tim/AAA-4531-2019; Cox, Bianca/A-9480-2015	Sheikh, Aziz/0000-0001-7022-3056; Cox, Bianca/0000-0001-9824-6276; Nawrot, Tim/0000-0002-3583-3593	Thrasher Fund; Lung Foundation Netherlands; International Paediatric Research Foundation; Maastricht University; Commonwealth Fund; Medical Research Council [MR/K007017/1] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01] Funding Source: researchfish; MRC [MR/K007017/1] Funding Source: UKRI	Thrasher Fund; Lung Foundation Netherlands; International Paediatric Research Foundation; Maastricht University; Commonwealth Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Thrasher Fund, Lung Foundation Netherlands, International Paediatric Research Foundation, Maastricht University, Commonwealth Fund.	Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Amaral M., 2009, EFFECT LOCAL SMOKING; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Barnoya J, 2013, NICOTINE TOB RES, V15, P789, DOI 10.1093/ntr/nts200; Bartholomew KS, 2011, NEW ENGL J MED; Been JV, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002261; Best D, 2009, PEDIATRICS, V124, pE1017, DOI 10.1542/peds.2009-2120; Bharadwaj P, 2012, 7006 IZA; Biglan A, 2000, Prev Sci, V1, P31, DOI 10.1023/A:1010024016308; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Cheng KW, 2011, AM J PREV MED, V41, P566, DOI 10.1016/j.amepre.2011.08.014; Cochrane Effective Practice and Organisation of Care, SUGG RISK BIAS CRIT; Cochrane Effective Practice and Organization of Care Review Group (EPOC), DAT COLL CHECKL; Cox B, 2013, BMJ-BRIT MED J, V346, pf441, DOI DOI 10.1136/bmj.f441; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Dove MS, 2011, PEDIATRICS, V127, P102, DOI 10.1542/peds.2010-1532; Dove MS, 2010, PEDIATRICS, V126, P80, DOI 10.1542/peds.2009-3462; El-Mohandes AAE, 2010, PEDIATRICS, V125, P721, DOI 10.1542/peds.2009-1809; Gaudreau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056102; Glantz S, 2012, LANCET, V379, P1269, DOI 10.1016/S0140-6736(11)60615-6; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grad R, 2012, J ALLERGY CLIN IMMUN, V130, P299, DOI 10.1016/j.jaci.2012.05.022; Hade E, 2011, ANAL IMPACT ASS BIRT; HARLAP S, 1974, LANCET, V1, P529; Higgins JPT, 2001, COCHRANE HDB SYSTEMA; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Holliday JC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-430; Jarvis MJ, 2012, TOB CONTROL, V21, P18, DOI 10.1136/tc.2010.041608; Kabir Z, 2009, BJOG-INT J OBSTET GY, V116, P1782, DOI 10.1111/j.1471-0528.2009.02374.x; Kabir Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057441; Kabir Z, 2012, J WOMENS HEALTH, V21, P616, DOI 10.1089/jwh.2012.3695; Lechner Michael, 2011, Foundations and Trends in Econometrics, V4, P165, DOI 10.1561/0800000014; Lee J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016806, 10.1371/journal.pone.0020933]; Lee JT, 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2012-050817, DOI 10.1136/TOBCOCONTROL-2012-050817]; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Levy D, 2013, NICOTINE TOB RES, V15, P1797, DOI 10.1093/ntr/ntt073; Levy DT, 2013, B WORLD HEALTH ORGAN, V91, P509, DOI 10.2471/BLT.12.113878; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lovasi GS, 2010, AM J EPIDEMIOL, V171, P54, DOI 10.1093/aje/kwp358; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mackay DF, 2010, HEART, V96, P1525, DOI 10.1136/hrt.2010.199026; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Mackay DF, 2012, PLOS MED, V9, DOI DOI 10.1371/journal.pmed.1001175; Markowitz S, 2011, 17160 NBER; Markowitz S, 2008, J HEALTH ECON, V27, P106, DOI 10.1016/j.jhealeco.2007.03.006; McCowan LM, 2009, BMJ-BRIT MED J, V338, pb1081; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Millett C, 2013, PEDIATRICS, V131, pE495, DOI 10.1542/peds.2012-2592; Moore GF, 2012, J PUBLIC HEALTH-UK, V34, P599, DOI 10.1093/pubmed/fds025; Moore GF, 2011, NICOTINE TOB RES, V13, P903, DOI 10.1093/ntr/ntr093; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Olivo-Marston SE, 2009, CANCER EPIDEM BIOMAR, V18, P3375, DOI 10.1158/1055-9965.EPI-09-0986; Page RL, 2012, J WOMENS HEALTH, V21, P621, DOI 10.1089/jwh.2011.3305; Peelen MJ, 2013, REIMPACT STEPWISE IN; Rayens MK, 2008, J ALLERGY CLIN IMMUN, V122, P537, DOI 10.1016/j.jaci.2008.06.029; Royal College of Physicians, 2010, PASS SMOK CHILDR; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13; Shetty KD, 2011, J POLICY ANAL MANAG, V30, P6, DOI 10.1002/pam.20548; Sims M, 2012, ADDICTION, V107, P2009, DOI 10.1111/j.1360-0443.2012.03924.x; State of California Air Resources Board, 2005, PROP ID ENV TOB SMOK; Sterne JA, 2007, SYSTEMATIC REV HLTH, P189; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Tinuoye O, 2013, NICOTINE TOB RES, V15, P1475, DOI 10.1093/ntr/ntt033; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; WHO, 2011, SCAL ACT NONC DIS MU; World Health Organization, 2012, GLOB PROGR REP IMPL; World Health Organization, 2005, WHO FRAM CONV TOB CO; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	76	188	191	0	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1549	1560		10.1016/S0140-6736(14)60082-9	http://dx.doi.org/10.1016/S0140-6736(14)60082-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG5YO	24680633				2022-12-28	WOS:000335495400026
J	Liu, PD; Begley, M; Michowski, W; Inuzuka, H; Ginzberg, M; Gao, DM; Tsou, PL; Gan, WJ; Papa, A; Kim, BM; Wan, LX; Singh, A; Zhai, B; Yuan, M; Wang, ZW; Gygi, SP; Lee, TH; Lu, KP; Toker, A; Pandolfi, PP; Asara, JM; Kirschner, MW; Sicinski, P; Cantley, L; Wei, WY				Liu, Pengda; Begley, Michael; Michowski, Wojciech; Inuzuka, Hiroyuki; Ginzberg, Miriam; Gao, Daming; Tsou, Peiling; Gan, Wenjian; Papa, Antonella; Kim, Byeong Mo; Wan, Lixin; Singh, Amrik; Zhai, Bo; Yuan, Min; Wang, Zhiwei; Gygi, Steven P.; Lee, Tae Ho; Lu, Kun-Ping; Toker, Alex; Pandolfi, Pier Paolo; Asara, John M.; Kirschner, Marc W.; Sicinski, Piotr; Cantley, Lewis; Wei, Wenyi			Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus	NATURE			English	Article							PROMOTES; SKP2; IDENTIFICATION; MECHANISMS; INHIBITOR; PROTEINS; INSIGHTS; AKT/PKB; PATHWAY; COMPLEX	Akt, also known as protein kinase B, plays key roles in cell proliferation, survival and metabolism. Akt hyperactivation contributes to many pathophysiological conditions, including human cancers(1-3), and is closely associated with poor prognosis and chemo-or radio-therapeutic resistance(4). Phosphorylation of Akt at S473 (ref. 5) and T308 (ref. 6) activates Akt. However, it remains unclear whether further mechanisms account for full Akt activation, and whether Akt hyperactivation is linked to misregulated cell cycle progression, another cancer hallmark(7). Here we report that Akt activity fluctuates across the cell cycle, mirroring cyclin A expression. Mechanistically, phosphorylation of S477 and T479 at the Akt extreme carboxy terminus by cyclin-dependent kinase 2 (Cdk2)/cyclin A or mTORC2, under distinct physiological conditions, promotes Akt activation through facilitating, or functionally compensating for, S473 phosphorylation. Furthermore, deletion of the cyclin A2 allele in the mouse olfactory bulb leads to reduced S477/T479 phosphorylation and elevated cellular apoptosis. Notably, cyclin A2-deletion-induced cellular apoptosis in mouse embryonic stem cells is partly rescued by S477D/T479E-Akt1, supporting a physiological role for cyclin A2 in governing Akt activation. Together, the results of our study show Akt S477/T479 phosphorylation to be an essential layer of the Akt activation mechanism to regulate its physiological functions, thereby providing a new mechanistic link between aberrant cell cycle progression and Akt hyperactivation in cancer.	[Liu, Pengda; Inuzuka, Hiroyuki; Gao, Daming; Gan, Wenjian; Papa, Antonella; Wan, Lixin; Wang, Zhiwei; Toker, Alex; Pandolfi, Pier Paolo; Wei, Wenyi] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Begley, Michael; Tsou, Peiling; Papa, Antonella; Yuan, Min; Lu, Kun-Ping; Pandolfi, Pier Paolo; Asara, John M.; Cantley, Lewis] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Begley, Michael; Tsou, Peiling; Kirschner, Marc W.; Cantley, Lewis] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Michowski, Wojciech; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Michowski, Wojciech; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ginzberg, Miriam; Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Papa, Antonella; Pandolfi, Pier Paolo] Beth Israel Deaconess Med Ctr, Canc Genet Program, Dept Med, Boston, MA 02115 USA; [Papa, Antonella; Pandolfi, Pier Paolo] Beth Israel Deaconess Med Ctr, Div Genet, Dept Med, Boston, MA 02115 USA; [Singh, Amrik] Cell Signaling Technol, Danvers, MA 01923 USA; [Kim, Byeong Mo; Lee, Tae Ho] Beth Israel Deaconess Med Ctr, Div Gerontol, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Wei, WY (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014; Lee, Tae Ho/AAT-1721-2020	Cantley, Lewis C/0000-0002-1298-7653; Ginzberg, Miriam/0000-0001-8431-3714; Papa, Antonella/0000-0001-8653-7121; Gan, Wenjian/0000-0001-7599-5020; Kim, Byeong Mo/0000-0002-0582-3132; Gao, Daming/0000-0003-4374-1055; Wang, Zhiwei/0000-0002-6465-7779; Pandolfi, Pier Paolo/0000-0002-5352-5295	National Institutes of Health [GM089763, GM094777, CA177910, 2P01CA120964, R01CA132740];  [5T32HL007893]; NATIONAL CANCER INSTITUTE [R01CA132740, R01CA167677, P01CA120964, R01CA177910] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111430, T32HL007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094777, R01GM089763, R01GM041890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Guo, J. J. Liu, A. W. Lau, S. Shaik, A. Tron, X. Dai and K. Xu for reading the manuscript, S. B. Breitkopf for help with mass spectrometry experiments, Y. Geng, L. Liu, K. Ran, R. Chin and S. Elloul for providing reagents, and members of the Wei, Toker, Sicinski, Pandolfi and Cantley laboratories for discussions. W. W. is an American Cancer Society and a Leukemia & Lymphoma Society research scholar. P. L. is supported by 5T32HL007893. This work was supported in part by National Institutes of Health grants to W. W. (GM089763, GM094777 and CA177910), J. M. A. (2P01CA120964) and P. S. (R01CA132740).	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Burgess DJ, 2011, NAT REV CANCER, V11, P389, DOI 10.1038/nrc3070; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Liu PD, 2010, MOL BIOL EVOL, V27, P2628, DOI 10.1093/molbev/msq151; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Otero JJ, 2014, DEV BIOL, V385, P328, DOI 10.1016/j.ydbio.2013.10.019; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Toker A, 2008, TRENDS BIOCHEM SCI, V33, P356, DOI 10.1016/j.tibs.2008.05.003; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wei WY, 2003, MOL CELL BIOL, V23, P2859, DOI 10.1128/MCB.23.8.2859-2870.2003; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	223	232	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					541	+		10.1038/nature13079	http://dx.doi.org/10.1038/nature13079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670654	Green Accepted			2022-12-28	WOS:000334741600040
J	Haas, F; Volz, J; Gehr, R; Reichel, J; Esteve, J				Haas, Florian; Volz, Juergen; Gehr, Roger; Reichel, Jakob; Esteve, Jerome			Entangled States of More Than 40 Atoms in an Optical Fiber Cavity	SCIENCE			English	Article							STANDARD QUANTUM LIMIT; PHOTONS; FIELD; CHIP	Multiparticle entanglement enables quantum simulations, quantum computing, and quantum-enhanced metrology. Yet, there are few methods to produce and measure such entanglement while maintaining single-qubit resolution as the number of qubits is scaled up. Using atom chips and fiber-optical cavities, we have developed a method based on nondestructive collective measurement and conditional evolution to create symmetric entangled states and perform their tomography. We demonstrate creation and analysis of entangled states with mean atom numbers up to 41 and experimentally prove multiparticle entanglement. Our method is independent of atom number and should allow generalization to other entangled states and other physical implementations, including circuit quantum electrodynamics.	[Haas, Florian; Volz, Juergen; Gehr, Roger; Reichel, Jakob; Esteve, Jerome] Univ Paris 06, Ecole Normale Super, Lab Kastler Brossel, CNRS, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Reichel, J (corresponding author), Univ Paris 06, Ecole Normale Super, Lab Kastler Brossel, CNRS, 24 Rue Lhomond, F-75005 Paris, France.	jakob.reichel@ens.fr; esteve@lkb.ens.fr	Volz, Jürgen/N-6457-2016; Esteve, Jerome/G-1084-2014; Reichel, Jakob/AAW-1107-2021	Volz, Jürgen/0000-0002-3174-2141; Esteve, Jerome/0000-0002-1556-8120; Reichel, Jakob/0000-0003-3420-4178	European Union Information and Communication Technologies project QIBEC (Quantum Interferometry with Bose-Einstein Condensates) [GA 284584]; Integrating Project AQUTE (Atomic Quantum Technologies) [GA 247687]; Institut Francilien de Recherche sur les Atomes Froids	European Union Information and Communication Technologies project QIBEC (Quantum Interferometry with Bose-Einstein Condensates); Integrating Project AQUTE (Atomic Quantum Technologies); Institut Francilien de Recherche sur les Atomes Froids	We thank G. Semerjian for help with the calculations on the entanglement criterion and B. Huard for discussions. This work was supported by the European Union Information and Communication Technologies project QIBEC (Quantum Interferometry with Bose-Einstein Condensates) (GA 284584) and the Integrating Project AQUTE (Atomic Quantum Technologies) (GA 247687). F.H. acknowledges a scholarship by Institut Francilien de Recherche sur les Atomes Froids. Author contributions: F.H. and J.V. performed the experiment; R. G. made contributions in its early stages; and F.H., J.V., J.R., and J.E. contributed to data analysis and interpretation, as well as to the manuscript.	Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; ARECCHI FT, 1972, PHYS REV A, V6, P2211, DOI 10.1103/PhysRevA.6.2211; Bohnet J. G., 2013, REDUCED BACK ACTION; Boozer AD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083602; Brakhane S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.173601; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Casabone B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.100505; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Christensen S. L., 2013, QUANTUM INTERFERENCE; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Gehr R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203602; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Guhne O, 2009, PHYS REP, V474, P1, DOI 10.1016/j.physrep.2009.02.004; Kimble HJ, 1998, PHYS SCRIPTA, VT76, P127, DOI 10.1238/Physica.Topical.076a00127; Koschorreck M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.093602; Kuzmich A, 1998, EUROPHYS LETT, V42, P481, DOI 10.1209/epl/i1998-00277-9; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Massar S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.060401; Mlynek JA, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.053838; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Purdy TP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.133602; Raimond JM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.213601; Raimond JM, 2005, J PHYS B-AT MOL OPT, V38, pS535, DOI 10.1088/0953-4075/38/9/006; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Vedral V, 2008, NATURE, V453, P1004, DOI 10.1038/nature07124; Volz J, 2011, NATURE, V475, P210, DOI 10.1038/nature10225	32	116	116	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					180	183		10.1126/science.1248905	http://dx.doi.org/10.1126/science.1248905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24674870				2022-12-28	WOS:000334096300030
J	Xu, S; Zhang, YH; Jia, L; Mathewson, KE; Jang, KI; Kim, J; Fu, HR; Huang, X; Chava, P; Wang, RH; Bhole, S; Wang, LZ; Na, YJ; Guan, Y; Flavin, M; Han, ZS; Huang, YG; Rogers, JA				Xu, Sheng; Zhang, Yihui; Jia, Lin; Mathewson, Kyle E.; Jang, Kyung-In; Kim, Jeonghyun; Fu, Haoran; Huang, Xian; Chava, Pranav; Wang, Renhan; Bhole, Sanat; Wang, Lizhe; Na, Yoon Joo; Guan, Yue; Flavin, Matthew; Han, Zheshen; Huang, Yonggang; Rogers, John A.			Soft Microfluidic Assemblies of Sensors, Circuits, and Radios for the Skin	SCIENCE			English	Article							ELECTRONIC SKIN; EPIDERMAL ELECTRONICS; PRESSURE; TRANSPARENT; DESIGN; FILMS	When mounted on the skin, modern sensors, circuits, radios, and power supply systems have the potential to provide clinical-quality health monitoring capabilities for continuous use, beyond the confines of traditional hospital or laboratory facilities. The most well-developed component technologies are, however, broadly available only in hard, planar formats. As a result, existing options in system design are unable to effectively accommodate integration with the soft, textured, curvilinear, and time-dynamic surfaces of the skin. Here, we describe experimental and theoretical approaches for using ideas in soft microfluidics, structured adhesive surfaces, and controlled mechanical buckling to achieve ultralow modulus, highly stretchable systems that incorporate assemblies of high-modulus, rigid, state-of-the-art functional elements. The outcome is a thin, conformable device technology that can softly laminate onto the surface of the skin to enable advanced, multifunctional operation for physiological monitoring in a wireless mode.	[Xu, Sheng; Jia, Lin; Jang, Kyung-In; Kim, Jeonghyun; Huang, Xian; Chava, Pranav; Wang, Renhan; Bhole, Sanat; Wang, Lizhe; Na, Yoon Joo; Guan, Yue; Flavin, Matthew; Han, Zheshen; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Xu, Sheng; Jia, Lin; Jang, Kyung-In; Kim, Jeonghyun; Huang, Xian; Chava, Pranav; Wang, Renhan; Bhole, Sanat; Wang, Lizhe; Na, Yoon Joo; Guan, Yue; Flavin, Matthew; Han, Zheshen; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Zhang, Yihui; Fu, Haoran; Huang, Yonggang] Northwestern Univ, Ctr Engn & Hlth, Dept Mech Engn, Evanston, IL 60208 USA; [Zhang, Yihui; Fu, Haoran; Huang, Yonggang] Northwestern Univ, Ctr Engn & Hlth, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Zhang, Yihui; Fu, Haoran; Huang, Yonggang] Northwestern Univ, Skin Dis Res Ctr, Evanston, IL 60208 USA; [Zhang, Yihui] Tsinghua Univ, Ctr Mech & Mat, Beijing 100084, Peoples R China; [Mathewson, Kyle E.; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Fu, Haoran] Zhejiang Univ, Dept Civil Engn & Architecture, Hangzhou 310058, Peoples R China; [Kim, Jeonghyun] Hanyang Univ, Dept Energy Engn, Dept Mat Sci & Engn, Seoul 133791, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Northwestern University; Tsinghua University; University of Illinois System; University of Illinois Urbana-Champaign; Zhejiang University; Hanyang University	Huang, YG (corresponding author), Northwestern Univ, Ctr Engn & Hlth, Dept Mech Engn, Evanston, IL 60208 USA.	y-huang@northwestern.edu; jrogers@illinois.edu	Zhang, Yihui/G-9876-2011; Xu, Sheng/D-7717-2011; Fu, Haoran/ABA-6690-2021; Flavin, Matthew/B-7196-2015; Huang, Yonggang/B-6998-2009; Rogers, John/L-2798-2016; huang, yonggang/O-6236-2019	Zhang, Yihui/0000-0003-0885-2067; Xu, Sheng/0000-0002-3120-4992; Fu, Haoran/0000-0002-5400-3042; Flavin, Matthew/0000-0001-6636-0445; Huang, Xian/0000-0002-8788-9185	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471]; Korean Foundation for International Cooperation of Science and Technology (KICOS) [Global Research Laboratory (GRL) Program], Korean ministry of Science and Technology (MOST) [K2070400000307A050000310]; Beckman Institute	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign; Korean Foundation for International Cooperation of Science and Technology (KICOS) [Global Research Laboratory (GRL) Program], Korean ministry of Science and Technology (MOST); Beckman Institute	This work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award DE-FG02-07ER46471 through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign, and the Korean Foundation for International Cooperation of Science and Technology (KICOS) through a grant [K2070400000307A050000310, Global Research Laboratory (GRL) Program] provided by the Korean ministry of Science and Technology (MOST). K. E. M was supported by a postdoctoral fellowship from the Beckman Institute. The authors thank V. Malyarchuk, S. H. Ali, Y. Song, T. Banks, and S. Xiang for technical support and stimulating discussions.	Axisa F., 2007, C P IEEE ENG MED BIO, V2011, P5687; Chow EY, 2013, IEEE MICROW MAG, V14, P64, DOI 10.1109/MMM.2013.2248586; Gonzalez M, 2011, MICROELECTRON RELIAB, V51, P1069, DOI 10.1016/j.microrel.2011.03.012; Jeong JW, 2013, ADV MATER, V25, P6839, DOI 10.1002/adma.201301921; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Keplinger C, 2013, SCIENCE, V341, P984, DOI 10.1126/science.1240228; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203905; Kubo M, 2010, ADV MATER, V22, P2749, DOI 10.1002/adma.200904201; Lacour SP, 2006, J APPL PHYS, V100, DOI 10.1063/1.2210170; Lee Y, 2013, IEEE J SOLID-ST CIRC, V48, P2511, DOI 10.1109/JSSC.2013.2275660; Lee Y, 2013, IEEE J SOLID-ST CIRC, V48, P229, DOI 10.1109/JSSC.2012.2221233; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; Mannoor MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1767; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Palleau E, 2013, ADV MATER, V25, P1589, DOI 10.1002/adma.201203921; Pan CF, 2013, NAT PHOTONICS, V7, P752, DOI [10.1038/nphoton.2013.191, 10.1038/NPHOTON.2013.191]; Rogers JA, 2011, NATURE, V477, P45, DOI 10.1038/nature10381; Romeo A, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799653; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Sekitani T, 2012, MRS BULL, V37, P236, DOI 10.1557/mrs.2012.42; Sterken T, 2011, IEEE ENG MED BIO, P6886, DOI 10.1109/IEMBS.2011.6091734; Sun Y, 2012, IEEE T DEPEND SECURE, V9, P785, DOI 10.1109/TDSC.2012.68; Thomas SJ, 2012, IEEE T BIOMED CIRC S, V6, P424, DOI 10.1109/TBCAS.2012.2222881; Vandeparre H, 2013, ADV MATER, V25, P3117, DOI 10.1002/adma.201300587; Vogt DM, 2013, IEEE SENS J, V13, P4056, DOI 10.1109/JSEN.2013.2272320; Wagner S, 2012, MRS BULL, V37, P207, DOI 10.1557/mrs.2012.37; Wang C, 2013, NAT MATER, V12, P899, DOI [10.1038/NMAT3711, 10.1038/nmat3711]; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/NPHOTON.2013.188, 10.1038/nphoton.2013.188]	29	826	884	64	1281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					70	74		10.1126/science.1250169	http://dx.doi.org/10.1126/science.1250169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700852	Green Submitted			2022-12-28	WOS:000333746100053
J	Chambers, J				Chambers, John			PLANETARY SCIENCE A chronometer for Earth's age	NATURE			English	Editorial Material							GIANT IMPACT; MOON		Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Chambers, J (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	jchambers@carnegiescience.edu		Chambers, John/0000-0001-9046-2265				Allegre CJ, 2008, EARTH PLANET SC LETT, V267, P386, DOI 10.1016/j.epsl.2007.11.056; Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Dong SB, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/53; Halliday AN, 2008, PHILOS T R SOC A, V366, P4163, DOI 10.1098/rsta.2008.0209; Jacobson SA, 2014, NATURE, V508, P84, DOI 10.1038/nature13172; Valley JW, 2014, NAT GEOSCI, V7, P219, DOI [10.1038/ngeo2075, 10.1038/NGEO2075]; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	11	0	0	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					51	52		10.1038/508051a	http://dx.doi.org/10.1038/508051a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695308				2022-12-28	WOS:000333609900039
J	Anderson, TS; Dave, S; Good, CB; Gellad, WF				Anderson, Timothy S.; Dave, Shravan; Good, Chester B.; Gellad, Walid F.			Academic Medical Center Leadership on Pharmaceutical Company Boards of Directors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Anderson, Timothy S.] Univ Pittsburgh, Med Ctr, Dept Internal Med, Pittsburgh, PA USA; [Dave, Shravan] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Good, Chester B.; Gellad, Walid F.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Gellad, WF (corresponding author), VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, 151C Univ Dr, Pittsburgh, PA 15240 USA.	wfg3@pitt.edu	Good, Chester B/K-2818-2019	Good, Chester B/0000-0003-4388-4558				Association of American Medical Colleges, 2010, INT PAT REC PHYS FIN; Campbell EG, 2007, JAMA-J AM MED ASSOC, V298, P1779, DOI 10.1001/jama.298.15.1779; Freshwater DM, 2011, ARCH INTERN MED, V171, P586, DOI 10.1001/archinternmed.2011.71; Lo B, 2010, NEW ENGL J MED, V362, P669, DOI 10.1056/NEJMp1000213; Noor W, 2013 PHARM EXEC TOP; US Securities and Exchange Commission (SEC), EL DAT GATH AN RETR	6	14	14	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1353	1355		10.1001/jama.2013.284925	http://dx.doi.org/10.1001/jama.2013.284925			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691612				2022-12-28	WOS:000333645400020
J	Fox, GN				Fox, Gary N.			Chronic Nail Pigmentation in a 50-Year-Old Woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LONGITUDINAL MELANONYCHIA; MANAGEMENT; MELANOMA; FEATURES; BIOPSY		[Fox, Gary N.] Mercy Defiance Clin Skin Care, Defiance, OH USA		Fox, GN (corresponding author), Mercy Defiance Clin Skin Care, 2458 Willesden Green Rd, Toledo, OH 43617 USA.	foxgary@yahoo.com						Adigun CG, 2012, DERMATOL THER, V25, P491, DOI 10.1111/j.1529-8019.2012.01554.x; Cohen T, 2008, AM J SURG, V195, P244, DOI 10.1016/j.amjsurg.2007.03.010; Jellinek N, 2007, J AM ACAD DERMATOL, V56, P803, DOI 10.1016/j.jaad.2006.12.001; Johr RH, 2010, DERMOSCOPY AN ILLUST; Mannava KA, 2013, J HAND SURG-ASIAN-PA, V18, P133, DOI 10.1142/S0218810413300015; Phan A, 2010, BRIT J DERMATOL, V162, P765, DOI 10.1111/j.1365-2133.2009.09594.x; Ronger S, 2002, ARCH DERMATOL, V138, P1327, DOI 10.1001/archderm.138.10.1327; Ruben BS, 2010, SEMIN CUTAN MED SURG, V29, P148, DOI 10.1016/j.sder.2010.06.008; Ruben BS, 2010, J CUTAN PATHOL, V37, P1027, DOI 10.1111/j.1600-0560.2010.01593_1.x; Tosti A, 2002, ARCH DERMATOL, V138, P1369, DOI 10.1001/archderm.138.10.1369	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1350	1351		10.1001/jama.2013.286235	http://dx.doi.org/10.1001/jama.2013.286235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691611				2022-12-28	WOS:000333645400019
J	Kaukonen, KM; Bailey, M; Suzuki, S; Pilcher, D; Bellomo, R				Kaukonen, Kirsi-Maija; Bailey, Michael; Suzuki, Satoshi; Pilcher, David; Bellomo, Rinaldo			Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE INSULIN THERAPY; HYDROXYETHYL STARCH; HOSPITAL MORTALITY; SURVIVING SEPSIS; UNITED-STATES; RESUSCITATION; ADULTS; RISK; HYDROCORTISONE; IMPLEMENTATION	IMPORTANCE Severe sepsis and septic shock are major causes of mortality in intensive care unit (ICU) patients. It is unknown whether progress has been made in decreasing their mortality rate. OBJECTIVE To describe changes in mortality for severe sepsis with and without shock in ICU patients. DESIGN, SETTING, AND PARTICIPANTS Retrospective, observational study from 2000 to 2012 including 101 064 patients with severe sepsis from 171 ICUs with various patient case mix in Australia and New Zealand. MAIN OUTCOMES AND MEASURES Hospital outcome (mortality and discharge to home, to other hospital, or to rehabilitation). RESULTS Absolute mortality in severe sepsis decreased from 35.0% (95% CI, 33.2%-36.8%; 949/2708) to 18.4% (95% CI, 17.8%-19.0%; 2300/12 512; P<.001), representing an overall decrease of 16.7% (95% CI, 14.8%-18.6%), an annual rate of absolute decrease of 1.3%, and a relative risk reduction of 47.5% (95% CI, 44.1%-50.8%). After adjusted analysis, mortality decreased throughout the study period with an odds ratio (OR) of 0.49 (95% CI, 0.46-0.52) in 2012, using the year 2000 as the reference (P<.001). The annual decline in mortality did not differ significantly between patients with severe sepsis and those with all other diagnoses (OR, 0.94 [95% CI, 0.94-0.95] vs 0.94 [95% CI, 0.94-0.94]; P = .37). The annual increase in rates of discharge to home was significantly greater in patients with severe sepsis compared with all other diagnoses (OR, 1.03 [95% CI, 1.02-1.03] vs 1.01 [95% CI, 1.01-1.01]; P<.001). Conversely, the annual increase in the rate of patients discharged to rehabilitation facilities was significantly less in severe sepsis compared with all other diagnoses (OR, 1.08 [95% CI, 1.07-1.09] vs 1.09 [95% CI, 1.09-1.10]; P<.001). In the absence of comorbidities and older age, mortality was less than 5%. CONCLUSIONS AND RELEVANCE In critically ill patients in Australia and New Zealand with severe sepsis with and without shock, there was a decrease in mortality from 2000 to 2012. These findings were accompanied by changes in the patterns of discharge to home, rehabilitation, and other hospitals.	[Kaukonen, Kirsi-Maija; Bailey, Michael; Pilcher, David; Bellomo, Rinaldo] Monash Univ, ANZIC RC, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Kaukonen, Kirsi-Maija] Univ Helsinki, Cent Hosp, Intens Care Unit, Crit Care Res Grp, Helsinki, Finland; [Suzuki, Satoshi; Bellomo, Rinaldo] Austin Hlth, Intens Care Unit, Heidelberg, Vic 3084, Australia; [Pilcher, David] ANZICS Ctr Outcome & Resource Evaluat CORE, Melbourne, Vic, Australia; [Pilcher, David] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia	Monash University; University of Helsinki; Helsinki University Central Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health	Bellomo, R (corresponding author), Austin Hlth, Dept Intens Care, Heidelberg, Vic 3084, Australia.	rinaldo.bellomo@austin.org.au	SUZUKI, Satoshi/AAM-4902-2021; Bailey, Michael J/A-4499-2012	Bailey, Michael J/0000-0002-5551-1401; Bellomo, Rinaldo/0000-0002-1650-8939; Pilcher, David/0000-0002-8939-7985	Academy of Finland; Gambro; Baxter; Philips; Braun	Academy of Finland(Academy of Finland); Gambro; Baxter; Philips; Braun	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kaukonen reported having received a grant for clinical research career from the Academy of Finland. Dr Bellomo reported having received personal fees and nonfinancial support from Gambro, grants and personal fees from Baxter and personal fees from Philips and Braun. No other disclosures were reported.	Aberegg Scott K, 2010, Crit Care, V14, pR77, DOI 10.1186/cc8990; Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; [Anonymous], QUICKSTATS ABOUT NEW; [Anonymous], 2012, 3101 0 AUSTRALIAN DE; Banta JE, 2012, CRIT CARE MED, V40, P2960, DOI 10.1097/CCM.0b013e31825bc92f; Bellomo R, 2011, CRIT CARE RESUSC, V13, P211; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Graham PL, 2004, CHEST, V125, P1458, DOI 10.1378/chest.125.4.1458; Gronlykke L, 2012, DAN MED J, V59; Ho BCH, 2006, CRIT CARE, V10, DOI 10.1186/cc4918; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Miller RR, 2013, AM J RESP CRIT CARE, V188, P77, DOI 10.1164/rccm.201212-2199OC; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Poukkanen M, 2013, ACTA ANAESTH SCAND, V57, P863, DOI 10.1111/aas.12133; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Webb SAR, 2013, CRIT CARE RESUSC, V15, P143; Zhao HF, 2012, CRIT CARE MED, V40, P1700, DOI 10.1097/CCM.0b013e318246b83a; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	45	1082	1158	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1308	1316		10.1001/jama.2014.2637	http://dx.doi.org/10.1001/jama.2014.2637			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24638143				2022-12-28	WOS:000333645400014
J	Wood, J; Freemantle, N; King, M; Nazareth, I				Wood, John; Freemantle, Nick; King, Michael; Nazareth, Irwin			Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Wood, John; Freemantle, Nick; Nazareth, Irwin] UCL, Res Dept Primary Care, London NW3 2PF, England; [Wood, John; Freemantle, Nick; Nazareth, Irwin] UCL, Populat Hlth & PRIMENT Clin Trials Unit, London NW3 2PF, England; [King, Michael] UCL, Div Psychiat, London W1W 7EJ, England; [King, Michael] UCL, PRIMENT Clin Trials Unit, London W1W 7EJ, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Wood, J (corresponding author), UCL, Res Dept Primary Care, London NW3 2PF, England.	john.x.wood@ucl.ac.uk		Nazareth, Irwin/0000-0003-2146-9628; Freemantle, Nick/0000-0001-5807-5740	National Institute for Health Research [NF-SI-0611-10210] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Dorrance AM, 2009, HYPERTENSION, V54, P451, DOI 10.1161/HYPERTENSIONAHA.109.135855; Fisher RA, 1966, DESIGN EXPT, P21; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Sedgewick P., 2010, BMJ-BRIT MED J, V340, pc2458; Tukey J, 1991, STAT SCI, V6, P100, DOI DOI 10.1214/SS/1177011945; Xie MG, 2013, INT STAT REV, V81, P3, DOI 10.1111/insr.12000	7	47	47	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2215	10.1136/bmj.g2215	http://dx.doi.org/10.1136/bmj.g2215			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TK	24687314	Green Published, Bronze			2022-12-28	WOS:000333976100003
J	McAlinden, C; Ioannidis, P; Roberts, S; Skiadaresi, E				McAlinden, Colm; Ioannidis, Pantelis; Roberts, Shaun; Skiadaresi, Eirini			Giant cell arteritis	LANCET			English	Editorial Material									[McAlinden, Colm] Swansea Opt House, Swansea SA5 8NU, W Glam, Wales; [McAlinden, Colm] Flinders Med Ctr, Sch Med, Adelaide, SA, Australia; [McAlinden, Colm] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [McAlinden, Colm] Wenzhou Med Coll, Wenzhou, Zhejiang, Peoples R China; [Ioannidis, Pantelis; Skiadaresi, Eirini] Abertawe Bro Morgannwg, Hlth Board, Singleton Hosp, Dept Ophthalmol, Swansea, W Glam, Wales; [Roberts, Shaun] Abertawe Bro Morgannwg, Hlth Board, Singleton Hosp, Dept Cellular Pathol, Swansea, W Glam, Wales	Flinders Medical Centre; Flinders University South Australia; Wenzhou Medical University; Singleton Hospital; Singleton Hospital	McAlinden, C (corresponding author), Swansea Opt House, Caebricks Rd, Swansea SA5 8NU, W Glam, Wales.	colm.mcalinden@gmail.com						Hayreh SS, 1998, AM J OPHTHALMOL, V125, P509, DOI 10.1016/S0002-9394(99)80192-5; Hegg R, 2011, J NEURO-OPHTHALMOL, V31, P135, DOI 10.1097/WNO.0b013e31820c4421; Kanski JJ, 2011, CLIN OPHTHALMOLOGY S; Kermani TA, 2012, SEMIN ARTHRITIS RHEU, V41, P866, DOI 10.1016/j.semarthrit.2011.10.005; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6	5	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1182	1182		10.1016/S0140-6736(14)60459-1	http://dx.doi.org/10.1016/S0140-6736(14)60459-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24679632				2022-12-28	WOS:000333956000038
J	Brandeker, A				Brandeker, Alexis			A Different Class of Planets	SCIENCE			English	Editorial Material							BETA-PICTORIS; DISK; COMPANION; STAR		Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, S-10691 Stockholm, Sweden	Stockholm University	Brandeker, A (corresponding author), Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, S-10691 Stockholm, Sweden.	alexis@astro.su.se		Brandeker, Alexis/0000-0002-7201-7536				Baruteau C, 2014, PROTOSTARS PLANETS, DOI 10.2458/azu_uapress_9780816531240-ch029; Dent WRF, 2014, SCIENCE, V343, P1490, DOI 10.1126/science.1248726; Kratter KM, 2006, MON NOT R ASTRON SOC, V373, P1563, DOI 10.1111/j.1365-2966.2006.11103.x; Lafreniere D, 2008, ASTROPHYS J LETT, V689, pL153, DOI 10.1086/595870; Mouillet D, 1997, MON NOT R ASTRON SOC, V292, P896, DOI 10.1093/mnras/292.4.896; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Wyatt MC, 2003, ASTROPHYS J, V598, P1321, DOI 10.1086/379064; Youdin AN, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/38	10	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1440	1441		10.1126/science.1251123	http://dx.doi.org/10.1126/science.1251123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675942				2022-12-28	WOS:000333471000022
J	Kraus, VB				Kraus, Virginia Byers			OSTEOARTHRITIS The zinc link	NATURE			English	Editorial Material									Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC 27701 USA	Duke University	Kraus, VB (corresponding author), Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC 27701 USA.	vbk@duke.edu						de Isla NG, 2006, BIORHEOLOGY, V43, P595; Findlay D, 2012, PRINCIPLES OSTEOARTH, P139; Gao J, 2008, J BIOL CHEM, V283, P21462, DOI 10.1074/jbc.M803150200; Gege C, 2012, J MED CHEM, V55, P709, DOI 10.1021/jm201152u; Joosten L. A. B., 1999, CLIN EXP RHEUMAT S18, V17, P0105; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kraus V. B., 1979, RHEUMATOLOG IN PRESS; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Lewis JS, 2013, ARTHRITIS RHEUM-US, V65, P660, DOI 10.1002/art.37796; Liu-Bryan R, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0323-5; Rai MF, 2012, ARTHRITIS RHEUM-US, V64, P2300, DOI 10.1002/art.34396; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Song J, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-31; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Xue ML, 2006, EXPERT OPIN THER TAR, V10, P143, DOI 10.1517/14728222.10.1.143	16	16	18	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					441	442		10.1038/507441a	http://dx.doi.org/10.1038/507441a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670760				2022-12-28	WOS:000333402000029
J	Dalton, J; Shaw, R; Democratis, J				Dalton, Julian; Shaw, Robert; Democratis, Jane			Kikuchi-Fujimoto disease	LANCET			English	Editorial Material									[Dalton, Julian] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England; [Shaw, Robert] John Radcliffe Hosp, Oxford OX3 9DU, England; [Democratis, Jane] Wexham Pk Hosp, Slough SL2 4HL, Berks, England	Royal Berkshire Hospital; University of Oxford	Dalton, J (corresponding author), Royal Berkshire Hosp, London Rd, Reading RG1 5AN, Berks, England.	j.dalton@doctors.org.uk		Shaw, Robert/0000-0003-3449-5876				FUJIMOTO Y, 1972, NAIKA, V30, P920; KIKUCHI M, 1972, Acta Haematologica Japonica, V35, P379; Rosado FGN, 2013, HUM PATHOL, V44, P255, DOI 10.1016/j.humpath.2012.05.016; Sopena B, 2012, SEMIN ARTHRITIS RHEU, V41, P900, DOI 10.1016/j.semarthrit.2011.11.001; Tong TRSW, 2001, ACTA CYTOL, V45, P953	5	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1098	1098		10.1016/S0140-6736(14)60262-2	http://dx.doi.org/10.1016/S0140-6736(14)60262-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24656202				2022-12-28	WOS:000333521200036
J	Vandermolen, S; Ewins, K; Perera, S; Wright, J; Huwez, F				Vandermolen, S.; Ewins, K.; Perera, S.; Wright, J.; Huwez, F.			PICTURE QUIZ A complicated case of diarrhoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; DIVERTICULAR-DISEASE; MANAGEMENT; DIAGNOSIS; ABSCESSES; CANCER		[Vandermolen, S.; Ewins, K.; Huwez, F.] Southend Univ Hosp, Dept Med Elderly, Southend On Sea SS0 0RY, England; [Perera, S.] Southend Univ Hosp, Dept Radiol, Southend On Sea SS0 0RY, England; [Wright, J.] Southend Univ Hosp, Dept Surg, Southend On Sea SS0 0RY, England		Vandermolen, S (corresponding author), Southend Univ Hosp, Dept Med Elderly, Southend On Sea SS0 0RY, England.	s.vandermolen@southend.nhs.uk						Albrecht S., MEDSCAPE; Ayuk P, 1996, ANN ROY COLL SURG, V78, P5; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Hinchey E J, 1978, Adv Surg, V12, P85; Janes SEJ, 2006, BMJ-BRIT MED J, V332, P271, DOI 10.1136/bmj.332.7536.271; Kang JY, 2004, DRUG AGING, V21, P211, DOI 10.2165/00002512-200421040-00001; Lau KC, 2011, DIS COLON RECTUM, V54, P1265, DOI 10.1097/DCR.0b013e31822899a2; Murphy T, 2007, DIVERTICULAR DIS WOR; National Institute for Health and Care Excellence, 2013, CLIN KNOWL SUMM DIV; Oberkofler CE, 2012, ANN SURG, V256, P819, DOI 10.1097/SLA.0b013e31827324ba; Okita A, 2007, ACTA MED OKAYAMA, V61, P107; Regenbogen SE, 2014, JAMA SURG; Salzman H, 2005, AM FAM PHYSICIAN, V72, P1229; Simon H., 2010, HARVARD MENS HLTH WA	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2014	348								g2172	10.1136/bmj.g2172	http://dx.doi.org/10.1136/bmj.g2172			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7BC	24653004				2022-12-28	WOS:000333414800011
J	Pisano, ED; Golden, RN; Schweitzer, L				Pisano, Etta D.; Golden, Robert N.; Schweitzer, Laura			Conflict of Interest Policies for Academic Health System Leaders Who Work With Outside Corporations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pisano, Etta D.] Med Univ S Carolina, Coll Med, Charleston, SC 29425 USA; [Golden, Robert N.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Madison, WI USA; [Schweitzer, Laura] Union Grad Coll, Schenectady, NY USA	Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; Union College	Pisano, ED (corresponding author), Med Univ S Carolina, Coll Med, 96 Jonathan Lucas St,MSC617, Charleston, SC 29425 USA.	pisanoe@musc.edu						Campbell EG, 2007, JAMA-J AM MED ASSOC, V298, P1779, DOI 10.1001/jama.298.15.1779; Chimonas S, 2011, ACAD MED, V86, P293, DOI 10.1097/ACM.0b013e3182087156; Institute of Medicine (IOM), 2009, CONFLICT INTEREST ME; Swick HM, 2000, ACAD MED, V75, P612, DOI 10.1097/00001888-200006000-00010; *TASK FORC FIN CON, 2002, PROT SUBJ PRES TRUST; University of North Carolina at Chapel Hill, GUID POL US U RS SUP	6	9	9	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1111	1112		10.1001/jama.2014.788	http://dx.doi.org/10.1001/jama.2014.788			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643598				2022-12-28	WOS:000333010100013
J	MacGregor, GA; Hashem, KM				MacGregor, Graham A.; Hashem, Kawther M.			Action on sugar-lessons from UK salt reduction programme	LANCET			English	Editorial Material							BODY-WEIGHT; OBESITY; FOOD; HEALTH		[MacGregor, Graham A.; Hashem, Kawther M.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England	University of London; Queen Mary University London	MacGregor, GA (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	g.macgregor@qmul.ac.uk						[Anonymous], 2013, LANCET, V381, P963, DOI 10.1016/S0140-6736(13)60695-9; [Anonymous], 2011, NAT DIET NUTR SURV H; Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food Standards Agency, 2007, LOW INC DIET NUTR SU; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2012; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Sutherland J, 2013, BRIT J NUTR, V110, P552, DOI 10.1017/S0007114512005430; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; UK Government's Foresight Programme, 2007, FORESIGHT TACKLING O; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organization, 2014, WHO OP PUBL CONS DRA; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	24	53	54	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					929	931		10.1016/S0140-6736(14)60200-2	http://dx.doi.org/10.1016/S0140-6736(14)60200-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24629282				2022-12-28	WOS:000333520700004
J	Hick, JL; Hanfling, D; Courtney, B; Lurie, N				Hick, John L.; Hanfling, Dan; Courtney, Brooke; Lurie, Nicole			Rationing Salt Water - Disaster Planning and Daily Care Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hick, John L.] Univ Minnesota, Dept Emergency Med, Minneapolis, MN 55455 USA; [Hick, John L.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Hanfling, Dan] George Washington Univ, Dept Emergency Med, Washington, DC USA; [Lurie, Nicole] Dept Hlth & Human Serv, Off Assistant Secretary Preparedness & Response, Washington, DC USA; [Hanfling, Dan] Inova Hlth Syst, Falls Church, VA USA; [Courtney, Brooke] US FDA, Off Counterterrorism & Emerging Threats, Silver Spring, MD USA	University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; George Washington University; Inova Health System; US Food & Drug Administration (FDA)	Hick, JL (corresponding author), Univ Minnesota, Dept Emergency Med, Minneapolis, MN 55455 USA.							[Anonymous], 2014, DRUG SHORT PUBL HLTH; [Anonymous], 2012, COP MIT EFF SHORT EM, DOI [10.1056/NEJMp1401833, DOI 10.1056/NEJMP1401833]; Hanfling D., 2012, CRISIS STANDARDS CAR; Lee J., MODERN HEALTHCARE	4	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1573	1576		10.1056/NEJMp1401833	http://dx.doi.org/10.1056/NEJMp1401833			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TG	24645847				2022-12-28	WOS:000336120500002
J	Orthwein, A; Fradet-Turcotte, A; Noordermeer, SM; Canny, MD; Brun, CM; Strecker, J; Escribano-Diaz, C; Durocher, D				Orthwein, Alexandre; Fradet-Turcotte, Amelie; Noordermeer, Sylvie M.; Canny, Marella D.; Brun, Catherine M.; Strecker, Jonathan; Escribano-Diaz, Cristina; Durocher, Daniel			Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions	SCIENCE			English	Article							DAMAGE RESPONSE; UBIQUITIN; CHECKPOINT; 53BP1; RIF1; RESECTION	Mitotic cells inactivate DNA double-strand break (DSB) repair, but the rationale behind this suppression remains unknown. Here, we unravel how mitosis blocks DSB repair and determine the consequences of repair reactivation. Mitotic kinases phosphorylate the E3 ubiquitin ligase RNF8 and the nonhomologous end joining factor 53BP1 to inhibit their recruitment to DSB-flanking chromatin. Restoration of RNF8 and 53BP1 accumulation at mitotic DSB sites activates DNA repair but is, paradoxically, deleterious. Aberrantly controlled mitotic DSB repair leads to Aurora B kinase-dependent sister telomere fusions that produce dicentric chromosomes and aneuploidy, especially in the presence of exogenous genotoxic stress. We conclude that the capacity of mitotic DSB repair to destabilize the genome explains the necessity for its suppression during mitosis, principally due to the fusogenic potential of mitotic telomeres.	[Orthwein, Alexandre; Fradet-Turcotte, Amelie; Noordermeer, Sylvie M.; Canny, Marella D.; Brun, Catherine M.; Strecker, Jonathan; Escribano-Diaz, Cristina; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Strecker, Jonathan; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Durocher, D (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	durocher@lunenfeld.ca	Durocher, Daniel/A-7733-2010; Noordermeer, Sylvie M/T-8095-2017; Noordermeer, Sylvie M/F-3517-2012; Fradet-Turcotte, Amelie/G-5790-2017	Durocher, Daniel/0000-0003-3863-8635; Noordermeer, Sylvie M/0000-0003-2737-9690; Noordermeer, Sylvie M/0000-0003-2737-9690; Fradet-Turcotte, Amelie/0000-0002-5431-8650; Orthwein, Alexandre/0000-0002-7350-3413	Canadian Institutes of Health Research (CIHR); Swiss National Science Foundation; CIHR [MOP89754]; Krembil Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CIHR(Canadian Institutes of Health Research (CIHR)); Krembil Foundation	All primary data are archived at the Lunenfeld-Tanenbaum Research Institute. We thank R. Szilard and Durocher lab members for critically reading the manuscript; A. Nussenzweig, J. Karlseder, D. Xu, J. Lukas, A.-C. Gingras, W. Dunham, M. Cook, A. Rosebrock, L. Harrington, F. Rossiello, F. d'Adda di Fagagna, S. Lawo, and L. Pelletier for reagents or technical advice; and D. Chowdhury for the pT1609/pS1618 antibody and for sharing unpublished data. A.O. and A.F.-T. received postdoctoral fellowships from the Canadian Institutes of Health Research (CIHR); S.M.N. is a scholar of the EIRR21st training program; C.M.B. received a fellowship from the Swiss National Science Foundation; J.S. received a doctoral award from the CIHR; and D.D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 1). The work was supported by CIHR grant MOP89754 and by the Krembil Foundation.	Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Heijink AM, 2013, MUTAT RES-FUND MOL M, V750, P45, DOI 10.1016/j.mrfmmm.2013.07.003; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; ZIRKLE RE, 1953, SCIENCE, V117, P487, DOI 10.1126/science.117.3045.487	25	217	224	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					189	193		10.1126/science.1248024	http://dx.doi.org/10.1126/science.1248024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24652939				2022-12-28	WOS:000334096300033
J	Pencina, MJ; Navar-Boggan, AM; D'Agostino, RB; Williams, K; Neely, B; Sniderman, AD; Peterson, ED				Pencina, Michael J.; Navar-Boggan, Ann Marie; D'Agostino, Ralph B.; Williams, Ken; Neely, Benjamin; Sniderman, Allan D.; Peterson, Eric D.			Application of New Cholesterol Guidelines to a Population-Based Sample	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; RISK	BackgroundThe 2013 guidelines of the American College of Cardiology and the American Heart Association (ACC-AHA) for the treatment of cholesterol expand the indications for statin therapy for the prevention of cardiovascular disease. MethodsUsing data from the National Health and Nutrition Examination Surveys of 2005 to 2010, we estimated the number, and summarized the risk-factor profile, of persons for whom statin therapy would be recommended (i.e., eligible persons) under the new ACC-AHA guidelines, as compared with the guidelines of the Third Adult Treatment Panel (ATP III) of the National Cholesterol Education Program, and extrapolated the results to a population of 115.4 million U.S. adults between the ages of 40 and 75 years. ResultsAs compared with the ATP-III guidelines, the new guidelines would increase the number of U.S. adults receiving or eligible for statin therapy from 43.2 million (37.5%) to 56.0 million (48.6%). Most of this increase in numbers (10.4 million of 12.8 million) would occur among adults without cardiovascular disease. Among adults between the ages of 60 and 75 years without cardiovascular disease who are not receiving statin therapy, the percentage who would be eligible for such therapy would increase from 30.4% to 87.4% among men and from 21.2% to 53.6% among women. This effect would be driven largely by an increased number of adults who would be classified solely on the basis of their 10-year risk of a cardiovascular event. Those who would be newly eligible for statin therapy include more men than women and persons with a higher blood pressure but a markedly lower level of low-density lipoprotein cholesterol. As compared with the ATP-III guidelines, the new guidelines would recommend statin therapy for more adults who would be expected to have future cardiovascular events (higher sensitivity) but would also include many adults who would not have future events (lower specificity). ConclusionsThe new ACC-AHA guidelines for the management of cholesterol would increase the number of adults who would be eligible for statin therapy by 12.8 million, with the increase seen mostly among older adults without cardiovascular disease. (Funded by the Duke Clinical Research Institute and others.) The investigators used NHANES data for 2005 to 2010 to extrapolate the effects of the new 2013 cholesterol treatment guidelines across the United States. They estimate that the new guidelines would increase the number of adults eligible for statin therapy by 12.8 million. Until recently, the guidelines of the Third Adult Treatment Panel (ATP III) of the National Cholesterol Education Program were the recommended guidelines to aid in the treatment of hyperlipidemia in the United States.(1),(2) The ATP-III guidelines identified patients with established cardiovascular disease or diabetes and low-density lipoprotein (LDL) cholesterol levels of 100 mg per deciliter (2.59 mmol per liter) or higher as candidates for statin therapy. In addition, the ATP-III guidelines recommended the use of statin therapy for primary prevention in patients on the basis of a combined assessment of LDL cholesterol level and the 10-year risk of coronary ...	[Pencina, Michael J.; Neely, Benjamin; Peterson, Eric D.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Pencina, Michael J.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27705 USA; [Navar-Boggan, Ann Marie] Duke Univ, Div Cardiol, Durham, NC 27705 USA; [D'Agostino, Ralph B.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [D'Agostino, Ralph B.] Harvard Clin Res Inst, Boston, MA USA; [Williams, Ken] KenAnCo Biostat, San Antonio, TX USA; [Sniderman, Allan D.] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada	Duke University; Duke University; Duke University; Boston University; Harvard University; Harvard Medical School; McGill University; Royal Victoria Hospital	Pencina, MJ (corresponding author), Duke Univ, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	michael.pencina@duke.edu	Peterson, Eric David/ABF-5033-2021		Duke Clinical Research Institute; M. Jean de Granpre; Louis and Sylvia Vogel	Duke Clinical Research Institute; M. Jean de Granpre; Louis and Sylvia Vogel	Supported in part by Duke Clinical Research Institute's research funds and unrestricted grants from M. Jean de Granpre and Louis and Sylvia Vogel.	Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Johnson CL, 2013, VITAL HLTH STAT, V161, P1; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5	14	468	484	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1422	1431		10.1056/NEJMoa1315665	http://dx.doi.org/10.1056/NEJMoa1315665			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24645848	Bronze			2022-12-28	WOS:000334095200010
J	Xu, PF; Houssin, N; Ferri-Lagneau, KF; Thisse, B; Thisse, C				Xu, Peng-Fei; Houssin, Nathalie; Ferri-Lagneau, Karine F.; Thisse, Bernard; Thisse, Christine			Construction of a Vertebrate Embryo from Two Opposing Morphogen Gradients	SCIENCE			English	Article							ZEBRAFISH ORGANIZER; MOLECULAR NATURE; BMP ACTIVITY; XENOPUS; AXIS; INDUCTION; ACTIVIN; PATTERN; SQUINT; RANGE	Development of vertebrate embryos involves tightly regulated molecular and cellular processes that progressively instruct proliferating embryonic cells about their identity and behavior. Whereas numerous gene activities have been found to be essential during early embryogenesis, little is known about the minimal conditions and factors that would be sufficient to instruct pluripotent cells to organize the embryo. Here, we show that opposing gradients of bone morphogenetic protein (BMP) and Nodal, two transforming growth factor family members that act as morphogens, are sufficient to induce molecular and cellular mechanisms required to organize, in vivo or in vitro, uncommitted cells of the zebrafish blastula animal pole into a well-developed embryo.	[Xu, Peng-Fei; Houssin, Nathalie; Ferri-Lagneau, Karine F.; Thisse, Bernard; Thisse, Christine] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia	Thisse, C (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA.	christhisse@virginia.edu	Houssin, Nathalie/AAU-7200-2020	THISSE, Christine/0000-0002-8684-1681; Xu, Pengf-Fei/0000-0002-7318-8548	European Molecular Biology Organization; University of Virginia	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); University of Virginia	We thank L. Solnica-Krezel for fruitful discussion; R. Bloodgood, R. Keller, and A. Sutherland for careful reading of the manuscript; S. Snyder for technical assistance; and S. Vecchio for taking care of the fish. K.F.F.-L. was supported by the European Molecular Biology Organization. This work was supported by funds from the University of Virginia.	Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Cox WG, 1995, DEVELOPMENT, V121, P4349; DALE L, 1992, DEVELOPMENT, V115, P573; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Fauny JD, 2009, DEVELOPMENT, V136, P3811, DOI 10.1242/dev.039693; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; HO RK, 1993, SCIENCE, V261, P109, DOI 10.1126/science.8316841; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Schier AF, 2001, INT J DEV BIOL, V45, P289; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; SOKOL S, 1991, NATURE, V351, P409, DOI 10.1038/351409a0; Spemann H, 2001, INT J DEV BIOL, V45, P13; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	27	64	66	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					87	89		10.1126/science.1248252	http://dx.doi.org/10.1126/science.1248252			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700857				2022-12-28	WOS:000333746100058
J	Laurance, J				Laurance, Jeremy			Philip Cotton: building a medical college in Rwanda	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1119	1119		10.1016/S0140-6736(14)60553-5	http://dx.doi.org/10.1016/S0140-6736(14)60553-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24679619	Bronze			2022-12-28	WOS:000333956000015
J	Aychek, T; Jung, S				Aychek, Tegest; Jung, Steffen			The Axis of Tolerance	SCIENCE			English	Editorial Material							CYTOKINE GM-CSF; DENDRITIC CELLS; MACROPHAGES; HOMEOSTASIS; MONOCYTES		[Aychek, Tegest; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Aychek, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716				Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	11	12	13	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1439	1440		10.1126/science.1252785	http://dx.doi.org/10.1126/science.1252785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675941				2022-12-28	WOS:000333471000021
J	Antman, EM; Jessup, M				Antman, Elliott M.; Jessup, Mariell			Clinical Practice Guidelines for Chronic Cardiovascular Disorders: A Roadmap for the Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Antman, Elliott M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Jessup, Mariell] Univ Penn, Sch Med, Penn Heart & Vasc Ctr, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania	Antman, EM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu		Jessup, Mariell/0000-0002-3010-0112				Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Food and Drug Administration Center for Drug Evaluation and Research, 2013, GUIDANCE FOR INDUSTR; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; World Health Organization, THE TOP 10 CAUSES OF	6	8	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1195	1196		10.1001/jama.2014.1742	http://dx.doi.org/10.1001/jama.2014.1742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668097				2022-12-28	WOS:000333340500017
J	Perler, BA				Perler, Bruce A.			Outcomes of Carotid Endarterectomy and Stenting in Elderly Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ARTERY STENOSIS; AGE		[Perler, Bruce A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; [Perler, Bruce A.] Johns Hopkins Univ Hosp, Dept Surg, Div Vasc Surg & Endovasc Therapy, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Perler, BA (corresponding author), Johns Hopkins Univ, Johns Hopkins Hosp, Sch Med, Div Vasc Surg & Endovasc Therapy,Dept Surg, 600 N Wolfe St,Halsted 668, Baltimore, MD 21287 USA.	bperler@jhmi.edu	Perler, Bruce/AAG-9873-2021					[Anonymous], 1995, JAMA-J AM MED ASSOC, V273, P1421; Antoniou GA, 2013, JAMA SURG, V148, P1140, DOI 10.1001/jamasurg.2013.4135; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Halliday A, 2004, LANCET, V363, P1491; Jim J, 2012, J VASC SURG, V55, P1313, DOI 10.1016/j.jvs.2011.11.128; Perler BA, 1998, J VASC SURG, V27, P25, DOI 10.1016/S0741-5214(98)70288-5; Perler BA, 1996, J AM COLL SURGEONS, V183, P559; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445	8	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1244	1245		10.1001/jama.2014.908	http://dx.doi.org/10.1001/jama.2014.908			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668106				2022-12-28	WOS:000333340500028
J	Wright, BD; Drivas, K; Lei, Z; Merrill, SA				Wright, Brian D.; Drivas, Kyriakos; Lei, Zhen; Merrill, Stephen A.			Industry-funded academic inventions boost innovation	NATURE			English	Editorial Material									[Wright, Brian D.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Drivas, Kyriakos] Agr Univ Athens, GR-11855 Athens, Greece; [Drivas, Kyriakos] Univ Piraeus, Piraeus, Greece; [Lei, Zhen] Penn State Univ, University Pk, PA 16802 USA; [Merrill, Stephen A.] US Natl Acad Sci, Program Sci Technol & Econ Policy, Washington, DC USA	University of California System; University of California Berkeley; Agricultural University of Athens; University of Piraeus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Academies of Sciences, Engineering & Medicine	Wright, BD (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	bwright@berkeley.edu	Drivas, Kyriakos/AAP-5221-2021	Drivas, Kyriakos/0000-0002-9567-6083; Wright, Brian/0000-0002-6440-8596				BUSCH L, 2004, EXTERNAL REV COLLABO; Evans JA, 2010, AM J SOCIOL, V116, P389, DOI 10.1086/653834; Foley HC, 2012, RES TECHNOL MANAGE, V55, P12, DOI 10.5437/08956308X5505008; Kramer D, 2008, PHYS TODAY, V61, P20; Litan RE, 2007, INNOV POLICY ECON, V8, P31, DOI 10.1086/ipe.8.25056198; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; The National Human Rights Commission Nigeria, 2014, NAT PRIS AUD 2012, P5; Washburn J, 2005, U INC CORPORATE CORR; White J, 2010, STANFORD LAW POL REV, V21, P105	9	32	32	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					297	299		10.1038/507297a	http://dx.doi.org/10.1038/507297a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD1YG	24654278	Bronze			2022-12-28	WOS:000333029000012
J	Pirmohamed, M; Burnside, G; Eriksson, N				Pirmohamed, M.; Burnside, G.; Eriksson, N.			In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Pirmohamed, M (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	munirp@liverpool.ac.uk	Pirmohamed, Munir/H-6004-2011; Burnside, Girvan/AAO-4490-2020	Pirmohamed, Munir/0000-0002-7534-7266; 					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC9	10.7326/0003-4819-160-6-201403180-02009	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638187				2022-12-28	WOS:000333521300008
J	Lu, A; Magupalli, VG; Ruan, J; Yin, Q; Atianand, MK; Vos, MR; Schroder, GF; Fitzgerald, KA; Wu, H; Egelman, EH				Lu, Alvin; Magupalli, Venkat Giri; Ruan, Jianbin; Yin, Qian; Atianand, Maninjay K.; Vos, Matthijn R.; Schroeder, Gunnar F.; Fitzgerald, Katherine A.; Wu, Hao; Egelman, Edward H.			Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes	CELL			English	Article							CRYSTAL-STRUCTURE; PYRIN DOMAIN; ELECTRON-MICROSCOPY; AIM2 INFLAMMASOME; PROTEIN; DEATH; OLIGOMERIZATION; AUTOINHIBITION; ACTIVATION; MUTATIONS	Inflammasomes elicit host defense inside cells by activating caspase-1 for cytokine maturation and cell death. AIM2 and NLRP3 are representative sensor proteins in two major families of inflammasomes. The adaptor protein ASC bridges the sensor proteins and caspase-1 to form ternary inflammasome complexes, achieved through pyrin domain ( PYD) interactions between sensors and ASC and through caspase activation and recruitment domain ( CARD) interactions between ASC and caspase-1. We found that PYD and CARD both form filaments. Activated AIM2 and NLRP3 nucleate PYD filaments of ASC, which, in turn, cluster the CARD of ASC. ASC thus nucleates CARD filaments of caspase-1, leading to proximity-induced activation. Endogenous NLRP3 inflammasome is also filamentous. The cryoelectron microscopy structure of ASC(PYD) filament at near-atomic resolution provides a template for homo-and hetero-PYD/PYD associations, as confirmed by structure-guided mutagenesis. We propose that ASC-dependent inflammasomes in both families share a unified assembly mechanism that involves two successive steps of nucleation-induced polymerization.	[Lu, Alvin; Magupalli, Venkat Giri; Ruan, Jianbin; Yin, Qian; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lu, Alvin; Magupalli, Venkat Giri; Ruan, Jianbin; Yin, Qian; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Atianand, Maninjay K.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Vos, Matthijn R.] FEI Co, Nanoport Europe, NL-5651 GG Eindhoven, Netherlands; [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; [Schroeder, Gunnar F.] Univ Dusseldorf, Dept Phys, D-40225 Dusseldorf, Germany; [Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Massachusetts System; University of Massachusetts Worcester; Thermo Fisher Scientific; FEI Company; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; University of Virginia	Wu, H (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu	Schröder, Gunnar F/H-5261-2013; Atianand, Maninjay/AAF-7823-2019; Fitzgerald, Katherine/ABE-6317-2020	Schröder, Gunnar F/0000-0003-1803-5431; Atianand, Maninjay/0000-0003-4135-2515; Lu, Alvin/0000-0003-2353-848X; Fitzgerald, Kate/0000-0003-3175-609X; Egelman, Edward/0000-0003-4844-5212; Ruan, Jianbin/0000-0001-5843-8273; Magupalli, Venkat/0000-0003-4638-3062	National Institutes of Health [AI050872, EB001567, AI083713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050872, R01AI083713, R01AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Natacha Opalka, Seth Darst, Leona Cohen-Gould, Maria Ericsson, William Rice, and Mariena Silvestry Ramos for help with EM imaging, Harry Leung for help with confocal microscopy, Gabriel Nunez for providing cDNAs, and the National Institutes of Health for funding support (AI050872 to H.W., EB001567 to E.H.E., and AI083713 to K.A.F.).	Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bammes BE, 2012, J STRUCT BIOL, V177, P589, DOI 10.1016/j.jsb.2012.01.008; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; EGELMAN EH, 1982, ACTA CRYSTALLOGR A, V38, P796, DOI 10.1107/S0567739482001624; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Zhou ZH, 2011, ADV PROTEIN CHEM STR, V82, P1, DOI 10.1016/B978-0-12-386507-6.00001-4	42	759	787	6	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1193	1206		10.1016/j.cell.2014.02.008	http://dx.doi.org/10.1016/j.cell.2014.02.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630722	Bronze, Green Accepted			2022-12-28	WOS:000332945100010
J	Ozkul-Wermester, O; Lefaucheur, R; Bourre, B				Ozkul-Wermester, Ozlem; Lefaucheur, Romain; Bourre, Bertrand			Cervical osteophyte causing cerebellar infarction	LANCET			English	Editorial Material									[Ozkul-Wermester, Ozlem; Lefaucheur, Romain; Bourre, Bertrand] Rouen Univ Hosp, Dept Neurol, F-76031 Rouen, France; [Ozkul-Wermester, Ozlem; Lefaucheur, Romain; Bourre, Bertrand] Univ Rouen, Rouen, France	CHU de Rouen; Universite de Rouen Normandie	Lefaucheur, R (corresponding author), Rouen Univ Hosp, Dept Neurol, F-76031 Rouen, France.	romain.lefaucheur@chu-rouen.fr		Lefaucheur, Romain/0000-0002-9592-5940					0	3	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1748	1748		10.1016/S0140-6736(13)61786-9	http://dx.doi.org/10.1016/S0140-6736(13)61786-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24680631				2022-12-28	WOS:000336267300028
J	Wahlquist, C; Jeong, D; Rojas-Munoz, A; Kho, C; Lee, A; Mitsuyama, S; van Mil, A; Park, WJ; Sluijter, JPG; Doevendans, PAF; Hajjar, RJ; Mercola, M				Wahlquist, Christine; Jeong, Dongtak; Rojas-Munoz, Agustin; Kho, Changwon; Lee, Ahyoung; Mitsuyama, Shinichi; van Mil, Alain; Park, Woo Jin; Sluijter, Joost P. G.; Doevendans, Pieter A. F.; Hajjar, Roger J.; Mercola, Mark			Inhibition of miR-25 improves cardiac contractility in the failing heart	NATURE			English	Article							MICRORNA EXPRESSION; FAILURE; DYSFUNCTION; SIGNATURE; REVERSAL; MYOCYTES; REVEALS; TARGETS; SERCA2A; NOX4	Heart failure is characterized by a debilitating decline in cardiac function(1), and recent clinical trial results indicate that improving the contractility of heart muscle cells by boosting intracellular calcium handling might be an effective therapy(2,3). MicroRNAs (miRNAs) are dysregulated in heart failure(4,5) but whether they control contractility or constitute therapeutic targets remains speculative. Using high-throughput functional screening of the human microRNAome, here we identify miRNAs that suppress intracellular calcium handling in heart muscle by interacting with messenger RNA encoding the sarcoplasmic reticulum calcium uptake pump SERCA2a (also known as ATP2A2). Of 875 miRNAs tested, miR-25 potently delayed calcium uptake kinetics in cardiomyocytes in vitro and was upregulated in heart failure, both in mice and humans. Whereas adeno-associated virus 9 (AAV9)-mediated overexpression of miR-25 in vivo resulted in a significant loss of contractile function, injection of an antisense oligonucleotide (antagomiR) against miR-25 markedly halted established heart failure in a mouse model, improving cardiac function and survival relative to a control antagomiR oligonucleotide. These data reveal that increased expression of endogenous miR-25 contributes to declining cardiac function during heart failure and suggest that it might be targeted therapeutically to restore function.	[Wahlquist, Christine; Rojas-Munoz, Agustin; van Mil, Alain; Mercola, Mark] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA; [Wahlquist, Christine; Rojas-Munoz, Agustin; van Mil, Alain; Mercola, Mark] Sanford Burnham Med Res Inst, Muscle Dev & Regenerat Program, La Jolla, CA 92037 USA; [Jeong, Dongtak; Kho, Changwon; Lee, Ahyoung; Mitsuyama, Shinichi; Hajjar, Roger J.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [van Mil, Alain; Sluijter, Joost P. G.; Doevendans, Pieter A. F.] Univ Med Ctr Utrecht, Dept Cardiol, NL-3584 CX Utrecht, Netherlands; [van Mil, Alain; Sluijter, Joost P. G.; Doevendans, Pieter A. F.] ICIN Netherlands Heart Inst, NL-3584 CX Utrecht, Netherlands; [Park, Woo Jin] Gwangju Inst Sci & Technol, Global Res Lab, Kwangju 500712, South Korea	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Icahn School of Medicine at Mount Sinai; Utrecht University; Utrecht University Medical Center; Gwangju Institute of Science & Technology (GIST)	Mercola, M (corresponding author), Univ Calif San Diego, Dept Bioengn, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mmercola@sanfordburnham.org	Jeong, Dongtak/AAK-4194-2020; Dongtak, Jeong/AGZ-5435-2022; Jeong, Dongtak/ABA-7745-2020	Jeong, Dongtak/0000-0003-4153-3498; Sluijter, Joost/0000-0003-2088-9102; van Mil, Alain/0000-0001-9906-5047	California Institute for Regenerative Medicine [RC1-000132]; National Institutes of Health (NIH) [R01HL113601, P01HL098053, R01HL108176]; Fondation Leducq; NIH [NIH R01HL093183, R01HL088434, P20HL100396, HHSN26820100045C, P50HL112324]; Global Research Laboratory Program of the South Korean Government [M6-0605-00-0001]; Netherlands Heart foundation; BioMedical Materials institute [P1.05 LUST]; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Spanish National Research Council;  [P30CA030199];  [P30AR061303]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021084] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, P20HL100396, R01HL093183, P50HL112324, R01HL108176, R01HL113601, R01HL088434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Research Laboratory Program of the South Korean Government; Netherlands Heart foundation(Netherlands Heart Foundation); BioMedical Materials institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Spanish National Research Council; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Aza-Blanc and F. Cerignoli; O. Kim, L. Liang and E. Kohlbrenner for their technical support; G. Christensen for providing the SERCA2a knockout mice; and H. el Azzouzi for TAC operations and histological sections. This work was supported by California Institute for Regenerative Medicine (RC1-000132), the National Institutes of Health (NIH) (R01HL113601, P01HL098053 and R01HL108176) and the Fondation Leducq to M. M.; by the NIH (NIH R01HL093183, R01HL088434, P20HL100396 and a Program of Excellence in Nanotechnology Contract no. HHSN26820100045C and P50HL112324) to R.J.H.; P30CA030199 and P30AR061303 for Sanford-Burnham Medical Research Institute functional genomics and cytometry. W.J.P. was supported by the Global Research Laboratory Program of the South Korean Government (M6-0605-00-0001). J.P. G. S. and P. A. F. D. were supported by the Netherlands Heart foundation and Project P1.05 LUST of the BioMedical Materials institute co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. C. W. was supported by a fellowship from the Spanish National Research Council. A. v. M. was a Netherlands Heart Institute ICIN fellow.	Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bonow RO, 2011, BRAUNWALDS HEART DIS; Bootman MD, 2008, AM J PHYSIOL-HEART C, V294, pH579, DOI 10.1152/ajpheart.01378.2007; Cerignoli F, 2012, J PHARMACOL TOX MET, V66, P246, DOI 10.1016/j.vascn.2012.08.167; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Colas AR, 2012, GENE DEV, V26, P2567, DOI 10.1101/gad.200758.112; Dirkx E, 2013, NAT CELL BIOL, V15, P1282, DOI 10.1038/ncb2866; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Greenstein JL, 2011, CIRC RES, V108, P70, DOI 10.1161/CIRCRESAHA.110.223578; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lemons D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00223; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; McKeithan W. L., 2012, CURR PROTOC STEM CEL, V13; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmidt HHHW, 2012, CIRC RES, V111, pE15, DOI 10.1161/CIRCRESAHA.112.271957; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Swift F, 2012, P NATL ACAD SCI USA, V109, P3997, DOI 10.1073/pnas.1120172109; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	44	298	320	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					531	+		10.1038/nature13073	http://dx.doi.org/10.1038/nature13073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670661	Green Accepted			2022-12-28	WOS:000334741600038
J	Jo, KN; Woo, KS; Yi, S; Yang, DY; Lim, HS; Wang, YJ; Cheng, H; Edwards, RL				Jo, Kyoung-nam; Woo, Kyung Sik; Yi, Sangheon; Yang, Dong Yoon; Lim, Hyoun Soo; Wang, Yongjin; Cheng, Hai; Edwards, R. Lawrence			Mid-latitude interhemispheric hydrologic seesaw over the past 550,000 years	NATURE			English	Article							MILLENNIAL-SCALE; KOREAN PENINSULA; ASIAN MONSOON; SPELEOTHEM GROWTH; CLIMATE; RECORD; VEGETATION; REGION; CAVE; PRECIPITATION	An interhemispheric hydrologic seesaw-in which latitudinal migrations of the Intertropical Convergence Zone (ITCZ) produce simultaneous wetting (increased precipitation) in one hemisphere and drying in the other-has been discovered in some tropical and subtropical regions(1-3). For instance, Chinese and Brazilian subtropical speleothem (cave formations such as stalactites and stalagmites) records show opposite trends in time series of oxygen isotopes (a proxy for precipitation variability) at millennial to orbital timescales(2,3), suggesting that hydrologic cycles were antiphased in the northerly versus southerly subtropics. This tropical to subtropical hydrologic phenomenon is likely to be an initial and important climatic response to orbital forcing(3). The impacts of such an interhemispheric hydrologic seesaw on higher-latitude regions and the global climate system, however, are unknown. Here we show that the antiphasing seen in the tropical records is also present in both hemispheres of the mid-latitude western Pacific Ocean. Our results are based on a new 550,000-year record of the growth frequency of speleothems from the Korean peninsula, which we compare to Southern Hemisphere equivalents(4). The Korean data are discontinuous and derived from 24 separate speleothems, but still allow the identification of periods of peak speleothem growth and, thus, precipitation. The clear hemispheric antiphasing indicates that the sphere of influence of the interhemispheric hydrologic seesaw over the past 550,000 years extended at least to the mid-latitudes, such as northeast Asia, and that orbital-timescale ITCZshifts can have serious effects on temperate climate systems. Furthermore, our result implies that insolationdriven ITCZ dynamics may provoke water vapour and vegetation feedbacks in northern mid-latitude regions and could have regulated global climate conditions throughout the late Quaternary ice age cycles.	[Jo, Kyoung-nam; Yi, Sangheon; Yang, Dong Yoon] Korea Inst Geosci & Mineral Resources, Taejon 305350, South Korea; [Woo, Kyung Sik] Kangwon Natl Univ, Dept Geol, Gangwondo 200701, South Korea; [Lim, Hyoun Soo] Pusan Natl Univ, Dept Geol Sci, Pusan 609735, South Korea; [Wang, Yongjin] Nanjing Normal Univ, Coll Geog Sci, Nanjing 210097, Peoples R China; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, Hai; Edwards, R. Lawrence] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	Korea Institute of Geoscience & Mineral Resources (KIGAM); Kangwon National University; Pusan National University; Nanjing Normal University; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities	Woo, KS (corresponding author), Korea Inst Geosci & Mineral Resources, Taejon 305350, South Korea.	wooks@kangwon.ac.kr	Edwards, R. Lawrence/I-3124-2014; CHENG, HAI/H-3413-2017; Lim, Hyoun Soo/AAC-5499-2022; Yi, Sangheon/AAE-2086-2022; Yi, Sangheon/D-4780-2011	Edwards, R. Lawrence/0000-0002-7027-5881; CHENG, HAI/0000-0002-5305-9458; Lim, Hyoun Soo/0000-0002-2489-4470; Yi, Sangheon/0000-0002-2938-0380; Yi, Sangheon/0000-0002-2938-0380	Ministry of Oceans and Fisheries, Korea; Basic Research Project of KIGAM [GP2009-005, NSFC 41230524, NBRP 2013CB955902]; US NSF [1103403, 1337693]; Directorate For Geosciences [1103403] Funding Source: National Science Foundation	Ministry of Oceans and Fisheries, Korea; Basic Research Project of KIGAM; US NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the Kangwon National University Cave Investigation Club (KNUCIC) for collecting some of the speleothem samples, S. S. Lee for the supplementary statistical test and K. R. Ludwig for providing the analytical software package. This research was a part of the project titled K-IODP(KIGAM; Korea Institute of Geoscience and Mineral Resources) funded by the Ministry of Oceans and Fisheries, Korea. This project was also partially supported by Basic Research Project (GP2009-005) of KIGAM, grants NSFC 41230524 and NBRP 2013CB955902 (to H.C.) and US NSF grants 1103403 and 1337693 (to R.L.E. and H.C.).	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Asmerom Y, 2010, NAT GEOSCI, V3, P114, DOI 10.1038/NGEO754; Ayliffe LK, 1998, GEOLOGY, V26, P147, DOI 10.1130/0091-7613(1998)026<0147:KPRFSA>2.3.CO;2; BAKER A, 1993, PALAEOGEOGR PALAEOCL, V100, P291, DOI 10.1016/0031-0182(93)90059-R; Bar-Matthews M, 2000, CHEM GEOL, V169, P145, DOI 10.1016/S0009-2541(99)00232-6; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Burns SJ, 2001, GEOLOGY, V29, P623, DOI 10.1130/0091-7613(2001)029<0623:SEFOFC>2.0.CO;2; Cai YJ, 2010, GEOLOGY, V38, P243, DOI 10.1130/G30306.1; Chae N, 2011, J PLANT BIOL, V54, P101, DOI 10.1007/s12374-011-9148-9; Cheddadi R, 2009, CLIM DYNAM, V32, P371, DOI 10.1007/s00382-008-0405-7; Cheng H, 2008, GEOCHIM COSMOCHIM AC, V72, pA157; Cheng H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050202; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Chough SK, 2000, EARTH-SCI REV, V52, P175, DOI 10.1016/S0012-8252(00)00029-5; Cruz FW, 2005, NATURE, V434, P63, DOI 10.1038/nature03365; Dobinski W, 2011, EARTH-SCI REV, V108, P158, DOI 10.1016/j.earscirev.2011.06.007; Dorale JA, 2009, J CAVE KARST STUD, V71, P73; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Ersek V, 2009, EARTH PLANET SC LETT, V279, P316, DOI 10.1016/j.epsl.2009.01.008; Fleitmann D, 2011, QUATERNARY SCI REV, V30, P783, DOI 10.1016/j.quascirev.2011.01.004; GORDON D, 1989, QUATERNARY RES, V31, P14, DOI 10.1016/0033-5894(89)90082-3; Griffiths ML, 2009, NAT GEOSCI, V2, P636, DOI 10.1038/NGEO605; He X., 2006, KARST WATERS I SPEC, V10, P31; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; HENNIG GJ, 1983, QUATERNARY RES, V20, P1, DOI 10.1016/0033-5894(83)90063-7; Jo KN, 2011, QUATERNARY SCI REV, V30, P1218, DOI 10.1016/j.quascirev.2011.02.012; Jo KN, 2010, QUATERNARY RES, V74, P100, DOI 10.1016/j.yqres.2010.04.005; Jo KN, 2010, EARTH PLANET SC LETT, V295, P441, DOI 10.1016/j.epsl.2010.04.024; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kim JM, 2000, QUATERNARY SCI REV, V19, P1067, DOI 10.1016/S0277-3791(99)00086-4; Kim SJ, 2008, CLIM DYNAM, V31, P1, DOI 10.1007/s00382-007-0332-z; Kutzbach J, 1996, NATURE, V384, P623, DOI 10.1038/384623a0; Levavasseur G., 2011, CLIMATE DISCUSSIONS, V7, P1647, DOI [10.5194/cpd-7-1647-2011, DOI 10.5194/CPD-7-1647-2011]; Lim HS, 2007, QUATERNARY RES, V68, P213, DOI 10.1016/j.yqres.2007.05.001; Linge H, 2001, QUATERNARY RES, V56, P155, DOI 10.1006/qres.2001.2254; Lisiecki L. E., 2005, PALEOCEANOGRAPHY, V20; Ludwig K.R, 2003, BERKELEY GEOCHRONOLO; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; McCarthy MP, 2012, EARTH SYST DYNAM, V3, P87, DOI 10.5194/esd-3-87-2012; Nakagawa T, 2008, GEOLOGY, V36, P491, DOI 10.1130/G24586A.1; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Severinghaus JP, 2009, SCIENCE, V326, P240, DOI 10.1126/science.1179941; Soden BJ, 2002, SCIENCE, V296, P727, DOI 10.1126/science.296.5568.727; Spotl C, 2002, GEOLOGY, V30, P815, DOI 10.1130/0091-7613(2002)030<0815:SOTLIP>2.0.CO;2; Stager JC, 2011, SCIENCE, V331, P1299, DOI 10.1126/science.1198322; Tan M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017352; Vaks A, 2006, EARTH PLANET SC LETT, V249, P384, DOI 10.1016/j.epsl.2006.07.009; Vaks A, 2013, SCIENCE, V340, P183, DOI 10.1126/science.1228729; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Weber ME, 2011, SCIENCE, V334, P1265, DOI 10.1126/science.1209299; Whittaker TE, 2011, GEOLOGY, V39, P455, DOI 10.1130/G31827.1; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; Yi S, 2010, GEOSCI J, V14, P1, DOI 10.1007/s12303-010-0001-9; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Ziegler M, 2010, QUATERNARY SCI REV, V29, P1481, DOI 10.1016/j.quascirev.2010.03.011	58	47	53	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					378	+		10.1038/nature13076	http://dx.doi.org/10.1038/nature13076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24695222				2022-12-28	WOS:000334403000048
J	Abdel-Wahab, M; Mehilli, J; Frerker, C; Neumann, FJ; Kurz, T; Tolg, R; Zachow, D; Guerra, E; Massberg, S; Schafer, U; El-Mawardy, M; Richardt, G				Abdel-Wahab, Mohamed; Mehilli, Julinda; Frerker, Christian; Neumann, Franz-Josef; Kurz, Thomas; Toelg, Ralph; Zachow, Dirk; Guerra, Elena; Massberg, Steffen; Schaefer, Ulrich; El-Mawardy, Mohamed; Richardt, Gert		CHOICE Investigators	Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement The CHOICE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EDWARDS-SAPIEN; IMPLANTATION INCIDENCE; MEDTRONIC-COREVALVE; REGURGITATION; STENOSIS; OUTCOMES; PREDICTORS; ROOT	IMPORTANCE Transcatheter aortic valve replacement (TAVR) is an effective treatment option for high-risk patients with severe aortic stenosis. Different from surgery, transcatheter deployment of valves requires either a balloon-expandable or self-expandable system. A randomized comparison of these 2 systems has not been performed. OBJECTIVE To determine whether the balloon-expandable device is associated with a better success rate than the self-expandable device. DESIGN, SETTING, AND PATIENTS The CHOICE study was an investigator-initiated trial in high-risk patients with severe aortic stenosis and an anatomy suitable for the transfemoral TAVR procedure. One hundred twenty-one patients were randomly assigned to receive a balloon-expandable valve (Edwards Sapien XT) and 120 were assigned to receive a self-expandable valve (Medtronic CoreValve). Patients were enrolled between March 2012 and December 2013 at 5 centers in Germany. INTERVENTIONS Transfemoral TAVR with a balloon-expandable or self-expandable device. MAIN OUTCOMES AND MEASURES The primary end point was device success, which is a composite end point including successful vascular access and deployment of the device and retrieval of the delivery system, correct position of the device, intended performance of the heart valve without moderate or severe regurgitation, and only 1 valve implanted in the proper anatomical location. Secondary end points included cardiovascular mortality, bleeding and vascular complications, postprocedural pacemaker placement, and a combined safety end point at 30 days, including all-cause mortality, major stroke, and other serious complications. RESULTS Device success occurred in 116 of 121 patients (95.9%) in the balloon-expandable valve group and 93 of 120 patients (77.5%) in the self-expandable valve group (relative risk [RR], 1.24, 95% CI, 1.12-1.37, P <.001). This was attributed to a significantly lower frequency of residual more-than-mild aortic regurgitation (4.1% vs 18.3%; RR, 0.23; 95% CI, 0.09-0.58; P <.001) and the less frequent need for implanting more than 1 valve (0.8% vs 5.8%, P = .03) in the balloon-expandable valve group. Cardiovascular mortality at 30 days was 4.1% in the balloon-expandable valve group and 4.3% in the self-expandable valve group (RR, 0.97; 95% CI, 0.29-3.25; P = .99). Bleeding and vascular complications were not significantly different, and the combined safety end point occurred in 18.2% of those in the balloon-expandable valve group and 23.1% of the self-expandable valve group (RR, 0.79; 95% CI, 0.48-1.30; P = .42). Placement of a new permanent pacemaker was less frequent in the balloon-expandable valve group (17.3% vs 37.6%, P = .001). CONCLUSIONS AND RELEVANCE Among patients with high-risk aortic stenosis undergoing TAVR, the use of a balloon-expandable valve resulted in a greater rate of device success than use of a self-expandable valve.	[Abdel-Wahab, Mohamed; Toelg, Ralph; El-Mawardy, Mohamed; Richardt, Gert] Segeberger Kliniken, Ctr Heart, Bad Segeberg, Germany; [Mehilli, Julinda; Massberg, Steffen] Munich Univ Clin, Munich, Germany; [Frerker, Christian; Schaefer, Ulrich] Asklepios Clin St Georg, Dept Cardiol, Hamburg, Germany; [Neumann, Franz-Josef] Univ Heart Ctr Freiburg Bad Krozingen, Bad Krozingen, Germany; [Kurz, Thomas] Lubeck Univ Hosp, Dept Cardiol, Lubeck, Germany; [Zachow, Dirk] Segeberger Kliniken, Dept Radiol, Bad Segeberg, Germany; [Guerra, Elena] Intracoronary Stenting & Antithrombosis Res Ctr, Munich, Germany; [Schaefer, Ulrich] Univ Hosp Hamburg Eppendorf, Dept Cardiol, Hamburg, Germany	Segeberger Kliniken Group; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Asklepios Klinik St. Georg; Universitats Herzzentrum Freiburg; University of Lubeck; Segeberger Kliniken Group; University of Hamburg; University Medical Center Hamburg-Eppendorf	Abdel-Wahab, M (corresponding author), Univ Kiel, Ctr Heart, Acad Teaching Hosp, Segeberger Kliniken GmbH, Kurpk 1, D-23795 Bad Segeberg, Germany.	mohamed.abdel-wahab@segebergerkliniken.de	Doğan, Ali/AAN-5331-2020; Mehilli, Julinda/F-2629-2016; Massberg, Steffen/AAN-6054-2021		Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany	Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany	This trial was sponsored by the Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany.	Abdel-Wahab M, 2014, JACC-CARDIOVASC INTE, V7, P284, DOI 10.1016/j.jcin.2013.11.011; Abdel-Wahab M, 2011, HEART, V97, P899, DOI 10.1136/hrt.2010.217158; Athappan G, 2013, J AM COLL CARDIOL, V61, P1585, DOI 10.1016/j.jacc.2013.01.047; Barbanti M, 2013, CIRCULATION, V128, P244, DOI 10.1161/CIRCULATIONAHA.113.002947; Chieffo A, 2013, J AM COLL CARDIOL, V61, P830, DOI 10.1016/j.jacc.2012.11.050; Genereux P, 2013, J AM COLL CARDIOL, V61, P1125, DOI 10.1016/j.jacc.2012.08.1039; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; Kasel AM, 2013, JACC-CARDIOVASC IMAG, V6, P249, DOI 10.1016/j.jcmg.2012.12.005; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2013, J AM COLL CARDIOL, V62, P418, DOI 10.1016/j.jacc.2013.04.037; Merten C, 2013, CIRC-CARDIOVASC INTE, V6, P476, DOI 10.1161/CIRCINTERVENTIONS.112.000115; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Nombela-Franco L, 2013, AM J CARDIOL, V111, P1026, DOI 10.1016/j.amjcard.2012.11.063; Piazza N, 2014, EUROINTERVENTION, V9, P1260, DOI 10.4244/EIJV9I11A215; Popma JJ., 2013, TRANSC CARD THER OCT; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; SELLERS RD, 1964, AM J CARDIOL, V14, P437, DOI 10.1016/0002-9149(64)90027-X; Sherif MA, 2011, EUROINTERVENTION, V7, P57, DOI 10.4244/EIJV7I8A12; Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Tchetche D, 2012, EUROINTERVENTION, V8, P556, DOI 10.4244/EIJV8I5A86; Tops LF, 2008, JACC-CARDIOVASC IMAG, V1, P321, DOI 10.1016/j.jcmg.2007.12.006; Tzamtzis S, 2013, MED ENG PHYS, V35, P125, DOI 10.1016/j.medengphy.2012.04.009; Unbehaun A, 2012, J AM COLL CARDIOL, V59, P211, DOI 10.1016/j.jacc.2011.10.857; Vahanian A, 2008, EUR HEART J, V29, P1463, DOI 10.1093/eurheartj/ehn183; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807; Willson AB, 2012, J CARDIOVASC COMPUT, V6, P406, DOI 10.1016/j.jcct.2012.10.002; Willson AB, 2012, J AM COLL CARDIOL, V59, P1287, DOI 10.1016/j.jacc.2011.12.015; Zegdi R, 2010, ANN THORAC SURG, V89, P768, DOI 10.1016/j.athoracsur.2009.12.022; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	35	476	484	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1503	1514		10.1001/jama.2014.3316	http://dx.doi.org/10.1001/jama.2014.3316			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24682026	Bronze			2022-12-28	WOS:000334306000018
J	Delbo, M; Libourel, G; Wilkerson, J; Murdoch, N; Michel, P; Ramesh, KT; Ganino, C; Verati, C; Marchi, S				Delbo, Marco; Libourel, Guy; Wilkerson, Justin; Murdoch, Naomi; Michel, Patrick; Ramesh, K. T.; Ganino, Clement; Verati, Chrystele; Marchi, Simone			Thermal fatigue as the origin of regolith on small asteroids	NATURE			English	Article							NEAR-EARTH OBJECTS; TEMPERATURE; SPACECRAFT	Space missions(1,2) and thermal infrared observations(3) have shown that small asteroids (kilometre-sized or smaller) are covered by a layer of centimetre-sized or smaller particles, which constitute the regolith. Regolith generation has traditionally been attributed to the fall back of impact ejecta and by the break-up of boulders by micrometeoroid impact(4,5). Laboratory experiments(6) and impact models(4), however, show that crater ejecta velocities are typically greater than several tens of centimetres per second, which corresponds to the gravitational escape velocity of kilometre-sized asteroids. Therefore, impact debris cannot be the main source of regolith on small asteroids(4). Here we report that thermal fatigue(7-9), a mechanism of rock weathering and fragmentation with no subsequent ejection, is the dominant process governing regolith generation on small asteroids. We find that thermal fragmentation induced by the diurnal temperature variations breaks up rocks larger than a few centimetres more quickly than do micrometeoroid impacts. Because thermal fragmentation is independent of asteroid size, this process can also contribute to regolith production on larger asteroids. Production of fresh regolith originating in thermal fatigue fragmentation may be an important process for the rejuvenation of the surfaces of near-Earth asteroids, and may explain the observed lack of low-perihelion, carbonaceous, near-Earth asteroids(10).	[Delbo, Marco; Murdoch, Naomi; Michel, Patrick] UNS, CNRS, Lab Lagrange, Observ Cote Azur, F-06304 Nice 4, France; [Libourel, Guy] Univ Lorraine, CRPG, CNRS, F-54501 Vandoeuvre Les Nancy, France; [Libourel, Guy; Ganino, Clement; Verati, Chrystele] UNS, CNRS, Observ Cote Azur, Lab Geoazur, F-06560 Valbonne, France; [Wilkerson, Justin; Ramesh, K. T.] Johns Hopkins Univ, Hopkins Extreme Mat Inst, Baltimore, MD 21218 USA; [Murdoch, Naomi] Inst Super Aeronaut & Espace, F-31055 Toulouse 4, France; [Marchi, Simone] SW Res Inst, Inst Sci Explorat Targets, Solar Syst Explorat Res Virtual Inst, Boulder, CO 80302 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Johns Hopkins University; Universite de Toulouse; Institut Superieur de l'Aeronautique et de l'Espace (ISAE-SUPAERO)	Delbo, M (corresponding author), UNS, CNRS, Lab Lagrange, Observ Cote Azur, Blvd Observ CS 34229, F-06304 Nice 4, France.	delbo@oca.eu; libou@oca.eu	Ramesh, KT/D-5451-2009; Michel, Patrick/AGX-0167-2022; Murdoch, Naomi/AAD-7502-2021	Ramesh, KT/0000-0003-2659-4698; Michel, Patrick/0000-0002-0884-1993; Murdoch, Naomi/0000-0002-9701-4075	French Agence National de la Recherche (ANR) SHOCKS; BQR of the Observatoire de la Cote d'Azur (OCA); University of Nice-Sophia Antipolis; Laboratory GeoAzur; French National Program of Planetology (PNP); NASA SSERVI	French Agence National de la Recherche (ANR) SHOCKS(French National Research Agency (ANR)); BQR of the Observatoire de la Cote d'Azur (OCA); University of Nice-Sophia Antipolis; Laboratory GeoAzur; French National Program of Planetology (PNP); NASA SSERVI	This work was supported by the French Agence National de la Recherche (ANR) SHOCKS, the BQR of the Observatoire de la Cote d'Azur (OCA), the University of Nice-Sophia Antipolis, the Laboratory GeoAzur and the French National Program of Planetology (PNP). We benefited from discussions with K. J. Walsh and W. F. Bottke. A. Morbidelli helped with the dynamical model. M. Moumni, J.-M. Hiver and G. Thomas helped with the experiments, X-ray tomography and early data analysis. G. L. conducted part of his work as an INSU-CNRS delegate. S. M. acknowledges support from NASA SSERVI. The comments of S. Byrne improved this work fundamentally. Computations and data analysis were done on the CRIMSON cluster at OCA.	ANDERSON OL, 1991, J GEOPHYS RES-SOL EA, V96, P18037, DOI 10.1029/91JB01579; Briani G, 2011, METEORIT PLANET SCI, V46, P1863, DOI 10.1111/j.1945-5100.2011.01302.x; Capek D, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201014281; Christensen R.M., 1979, MECH COMPOSITE MAT, P31; Flynn GJ, 2005, EARTH MOON PLANETS, V95, P361, DOI 10.1007/s11038-005-9025-y; GLINKA G, 1991, ENG FRACT MECH, V40, P1135, DOI 10.1016/0013-7944(91)90177-3; Gundlach B, 2013, ICARUS, V223, P479, DOI 10.1016/j.icarus.2012.11.039; HAZEN RM, 1977, PHYS CHEM MINER, V1, P83, DOI 10.1007/BF00307981; HORZ F, 1975, MOON PLANETS, V13, P235, DOI 10.1007/BF00567517; Horz F, 1997, METEORIT PLANET SCI, V32, P179; Housen KR, 2011, ICARUS, V211, P856, DOI 10.1016/j.icarus.2010.09.017; HOUSEN KR, 1979, ICARUS, V39, P317, DOI 10.1016/0019-1035(79)90145-3; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Luque A, 2011, ENVIRON EARTH SCI, V62, P1375, DOI 10.1007/s12665-010-0624-1; Mainzer A, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/110; Marchi S, 2006, MON NOT R ASTRON SOC, V368, pL39, DOI 10.1111/j.1745-3933.2006.00152.x; Marchi S, 2009, MON NOT R ASTRON SOC, V400, P147, DOI 10.1111/j.1365-2966.2009.15459.x; McFadden LD, 2005, GEOL SOC AM BULL, V117, P161, DOI 10.1130/B25508.1; Michel P, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321657; Migliazza M, 2011, INT J ROCK MECH MIN, V48, P1038, DOI 10.1016/j.ijrmms.2011.06.016; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Opeil CP, 2010, ICARUS, V208, P449, DOI 10.1016/j.icarus.2010.01.021; SMYTH JR, 1975, AM MINERAL, V60, P1092; SPENCER JR, 1989, ICARUS, V78, P337, DOI 10.1016/0019-1035(89)90182-6; Suresh S., 1998, FATIGUE MAT, P505; Veverka J, 2001, NATURE, V413, P390, DOI 10.1038/35096507; Wanhill R., 2004, FRACTURE MECH, P207; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164; Zotkin I.T., 1985, METEORITIKA, V44, P105	30	224	226	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					233	+		10.1038/nature13153	http://dx.doi.org/10.1038/nature13153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695219				2022-12-28	WOS:000333979900041
J	Alabugin, I; Mohamed, RK				Alabugin, Igor; Mohamed, Rana K.			A CO2 Cloak for the Cyanide Dagger	SCIENCE			English	Editorial Material							PI-BONDS; ETHYLENE; HYDROGENATION; BIOSYNTHESIS; CATALYST; ACID		[Alabugin, Igor; Mohamed, Rana K.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Alabugin, I (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	alabugin@chem.fsu.edu	Alabugin, Igor/C-3659-2015	Alabugin, Igor/0000-0001-9289-3819				ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; Alabugin IV, 2013, J ORG CHEM, V78, P7777, DOI 10.1021/jo401091w; Alabugin IV, 2010, SCIENCE, V330, DOI 10.1126/science.1196188; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Jeletic MS, 2013, J AM CHEM SOC, V135, P11533, DOI 10.1021/ja406601v; Murphy LJ, 2014, SCIENCE, V344, P75, DOI 10.1126/science.1250808; NICOLAIDES A, 1991, J AM CHEM SOC, V113, P6750, DOI 10.1021/ja00018a005; Pirrung MC, 1999, ACCOUNTS CHEM RES, V32, P711, DOI 10.1021/ar960003+; RADZINSKY E, 2000, RASPUTIN FILE; Rochelle GT, 2009, SCIENCE, V325, P1652, DOI 10.1126/science.1176731; Schuchmann K, 2013, SCIENCE, V342, P1382, DOI 10.1126/science.1244758; Seigler D.S., 1999, PLANT SECONDARY META; Strecker, 1850, CHEM, V75, P27; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237	14	8	8	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					45	46		10.1126/science.1252466	http://dx.doi.org/10.1126/science.1252466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700846				2022-12-28	WOS:000333746100043
J	Zhang, YG; Pagani, M; Liu, ZH				Zhang, Yi Ge; Pagani, Mark; Liu, Zhonghui			A 12-Million-Year Temperature History of the Tropical Pacific Ocean	SCIENCE			English	Article							PERMANENT EL-NINO; PLIOCENE WARM PERIOD; EQUATORIAL PACIFIC; SEA; CLIMATE; CALIBRATION; MECHANISMS; EVOLUTION; POOL; ENSO	The appearance of permanent El Nino-like conditions prior to 3 million years ago is founded on sea-surface temperature (SST) reconstructions that show invariant Pacific warm pool temperatures and negligible equatorial zonal temperature gradients. However, only a few SST records are available, and these are potentially compromised by changes in seawater chemistry, diagenesis, and calibration limitations. For this study, we establish new biomarker-SST records and show that the Pacific warm pool was similar to 4 degrees C warmer 12 million years ago. Both the warm pool and cold tongue slowly cooled toward modern conditions while maintaining a zonal temperature gradient of similar to 3 degrees C in the late Miocene, which increased during the Plio-Pleistocene. Our results contrast with previous temperature reconstructions that support the supposition of a permanent El Nino-like state.	[Zhang, Yi Ge; Pagani, Mark] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Liu, Zhonghui] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China	Yale University; University of Hong Kong	Zhang, YG (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.	yige.zhang@yale.edu	Liu, Zhonghui/D-3163-2009; Zhang, Yige/R-6330-2018; Zhang, Yi Ge/B-6712-2008	Liu, Zhonghui/0000-0002-2168-8305; Zhang, Yi Ge/0000-0001-7331-1246	NSF [AGS 1203163]; Schlanger Ocean Drilling Fellowship; NSF	NSF(National Science Foundation (NSF)); Schlanger Ocean Drilling Fellowship; NSF(National Science Foundation (NSF))	We thank M. Huber, H. Dijkstra, G. Foster, A. von der Heydt, M. Leckie, P. Hull, H. Spero, J. Zachos, A. Ravelo, A. Fedorov, and S. Hu for helpful discussions and four anonymous reviewers for their thoughtful reviews. This research used samples and data provided by the Integrated Ocean Drilling Program (IODP). Funding for this research was provided by NSF AGS 1203163 (to M.P.) and a Schlanger Ocean Drilling Fellowship (to Y.G.Z.), which is part of the NSF-sponsored U.S. Science Support Program for IODP that is administered by the Consortium for Ocean Leadership, Inc.	Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Coggon RM, 2010, SCIENCE, V327, P1114, DOI 10.1126/science.1182252; Conte MH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001054; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; Farrell J.W., 1995, P OCEAN DRILLING PRO, V138; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Galeotti S, 2010, GEOLOGY, V38, P419, DOI 10.1130/G30629.1; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Haywood AM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001323; Karnauskas KB, 2009, J CLIMATE, V22, P4316, DOI 10.1175/2009JCLI2936.1; Kim JH, 2010, GEOCHIM COSMOCHIM AC, V74, P4639, DOI 10.1016/j.gca.2010.05.027; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; Li L, 2011, EARTH PLANET SC LETT, V309, P10, DOI 10.1016/j.epsl.2011.04.016; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Pagani M., 2013, TREATISE GEOCHEMISTR, V6, P281, DOI [10.1016/B978-0-08-095975-7.01314-0, DOI 10.1016/B978-0-08-095975-7.01314-0]; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; Rousselle G, 2013, EARTH PLANET SC LETT, V361, P412, DOI 10.1016/j.epsl.2012.11.003; Schouten S, 2007, ORG GEOCHEM, V38, P1537, DOI 10.1016/j.orggeochem.2007.05.014; Scroxton N, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002097; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Tierney JE, 2014, GEOCHIM COSMOCHIM AC, V127, P83, DOI 10.1016/j.gca.2013.11.026; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; von der Heydt AS, 2011, CLIM PAST, V7, P903, DOI 10.5194/cp-7-903-2011; Wakeham SG, 2003, GEOCHIM COSMOCHIM AC, V67, P1359, DOI 10.1016/S0016-7037(02)01220-6; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Watanabe T, 2011, NATURE, V471, P209, DOI 10.1038/nature09777; Williams IN, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039849	34	174	187	6	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					84	87		10.1126/science.1246172	http://dx.doi.org/10.1126/science.1246172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700856				2022-12-28	WOS:000333746100057
J	Corley, DA; Jensen, CD; Marks, AR; Zhao, WK; Lee, JK; Doubeni, CA; Zauber, AG; de Boer, J; Fireman, BH; Schottinger, JE; Quinn, VP; Ghai, NR; Levin, TR; Quesenberry, CP				Corley, Douglas A.; Jensen, Christopher D.; Marks, Amy R.; Zhao, Wei K.; Lee, Jeffrey K.; Doubeni, Chyke A.; Zauber, Ann G.; de Boer, Jolanda; Fireman, Bruce H.; Schottinger, Joanne E.; Quinn, Virginia P.; Ghai, Nirupa R.; Levin, Theodore R.; Quesenberry, Charles P.			Adenoma Detection Rate and Risk of Colorectal Cancer and Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONOSCOPIC MISS RATES; FLEXIBLE SIGMOIDOSCOPY; QUALITY INDICATORS; INTERVAL; SURVEILLANCE; ENDOSCOPIST; POLYPECTOMY; PREVALENCE; PREDICTORS; PREVENTION	Background The proportion of screening colonoscopic examinations performed by a physician that detect one or more adenomas (the adenoma detection rate) is a recommended quality measure. However, little is known about the association between this rate and patients' risks of a subsequent colorectal cancer (interval cancer) and death. Methods Using data from an integrated health care delivery organization, we evaluated the associations between the adenoma detection rate and the risks of colorectal cancer diagnosed 6 months to 10 years after colonoscopy and of cancer-related death. With the use of Cox regression, our estimates of attributable risk were adjusted for the demographic characteristics of the patients, indications for colonoscopy, and coexisting conditions. Results We evaluated 314,872 colonoscopies performed by 136 gastroenterologists; the adenoma detection rates ranged from 7.4 to 52.5%. During the follow-up period, we identified 712 interval colorectal adenocarcinomas, including 255 advanced-stage cancers, and 147 deaths from interval colorectal cancer. The unadjusted risks of interval cancer according to quintiles of adenoma detection rates, from lowest to highest, were 9.8, 8.6, 8.0, 7.0, and 4.8 cases per 10,000 person-years of follow-up, respectively. Among patients of physicians with adenoma detection rates in the highest quintile, as compared with patients of physicians with detection rates in the lowest quintile, the adjusted hazard ratio for any interval cancer was 0.52 (95% confidence interval [CI], 0.39 to 0.69), for advanced-stage interval cancer, 0.43 (95% CI, 0.29 to 0.64), and for fatal interval cancer, 0.38 (95% CI, 0.22 to 0.65). Each 1.0% increase in the adenoma detection rate was associated with a 3.0% decrease in the risk of cancer (hazard ratio, 0.97; 95% CI, 0.96 to 0.98). Conclusions The adenoma detection rate was inversely associated with the risks of interval colorectal cancer, advanced-stage interval cancer, and fatal interval cancer. (Funded by the Kaiser Permanente Community Benefit program and the National Cancer Institute.)	[Corley, Douglas A.; Jensen, Christopher D.; Marks, Amy R.; Zhao, Wei K.; Lee, Jeffrey K.; de Boer, Jolanda; Fireman, Bruce H.; Levin, Theodore R.; Quesenberry, Charles P.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Schottinger, Joanne E.; Quinn, Virginia P.; Ghai, Nirupa R.] Kaiser Permanente So Calif, Res & Evaluat, Pasadena, CA 91101 USA; [Doubeni, Chyke A.] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Publ Hlth, New York, NY 10021 USA	Kaiser Permanente; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	Corley, DA (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	douglas.corley@kp.org	Doubeni, Chyke A/W-6749-2019	Doubeni, Chyke A/0000-0001-7495-0285; Barret, Maximilien/0000-0002-0566-7870; Marks, Amy/0000-0002-3047-5379	Kaiser Permanente Community Benefit program; National Cancer Institute [U54 CA163262, U24 CA171524]; NATIONAL CANCER INSTITUTE [U54CA163262, U24CA171524, P30CA008748, U01CA151736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007007] Funding Source: NIH RePORTER	Kaiser Permanente Community Benefit program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the Kaiser Permanente Community Benefit program and the National Cancer Institute (U54 CA163262 [PROSPR] and U24 CA171524).	ADAMO MB, 2013, 2013 SEER PROGRAM CO; Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Bretthauer M, 2003, SCAND J GASTROENTERO, V38, P1268, DOI 10.1080/00365520310006513; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Cooper GS, 2012, CANCER-AM CANCER SOC, V118, P3044, DOI 10.1002/cncr.26602; Corley DA, 2013, CLIN GASTROENTEROL H, V11, P172, DOI 10.1016/j.cgh.2012.09.010; Corley DA, 2011, GASTROINTEST ENDOSC, V74, P656, DOI 10.1016/j.gie.2011.04.017; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Gordon N, 2006, KAISER PERMANENTE ME; Hewett David G, 2010, Gastrointest Endosc Clin N Am, V20, P673, DOI 10.1016/j.giec.2010.07.011; HIXSON LJ, 1990, JNCI-J NATL CANCER I, V82, P1769, DOI 10.1093/jnci/82.22.1769; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Imperiale TF, 2009, NEW ENGL J MED, V361, P2004; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Leaper M, 2004, ENDOSCOPY, V36, P499, DOI 10.1055/s-2004-814399; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Meester RG, 2013, GASTROENTEROLOGY, V144, pS190; Nakao SK, 2013, SURG ENDOSC, V27, P768, DOI 10.1007/s00464-012-2543-6; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Rogal SS, 2013, CLIN GASTROENTEROL H, V11, P73, DOI 10.1016/j.cgh.2012.08.002; Sanchez W, 2004, AM J GASTROENTEROL, V99, P1941, DOI 10.1111/j.1572-0241.2004.40569.x; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Schoen RE, 2003, JAMA-J AM MED ASSOC, V290, P41, DOI 10.1001/jama.290.1.41; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh H, 2010, AM J GASTROENTEROL, V105, P2588, DOI 10.1038/ajg.2010.390; Wang YZR, 2013, AM J GASTROENTEROL, V108, P444, DOI 10.1038/ajg.2012.429; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; 2010, CPT CURR PROC TERM 2	44	1154	1200	4	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1298	1306		10.1056/NEJMoa1309086	http://dx.doi.org/10.1056/NEJMoa1309086			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693890	Green Accepted			2022-12-28	WOS:000333830000008
J	Coulter, A; Locock, L; Ziebland, S; Calabrese, J				Coulter, Angela; Locock, Louise; Ziebland, Sue; Calabrese, Joe			Collecting data on patient experience is not enough: they must be used to improve care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE; CENTERED CARE; FEEDBACK; SATISFACTION; PHYSICIANS; MORTALITY; QUALITY; SKILLS		[Coulter, Angela] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Locock, Louise; Ziebland, Sue] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Calabrese, Joe] UCL, Dept Anthropol, London, England	University of Oxford; University of Oxford; University of London; University College London	Coulter, A (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.	angela.coulter@dph.ox.ac.uk	Calabrese, Joseph/AFU-2467-2022; Coulter, Angela/N-6998-2019	Calabrese, Joseph/0000-0002-7966-3493; Coulter, Angela/0000-0002-6308-8375				Asprey A, 2013, BRIT J GEN PRACT, V63, pE200, DOI 10.3399/bjgp13X664252; Bardach NS, 2013, BMJ QUAL SAF, V22, P194, DOI 10.1136/bmjqs-2012-001360; Bate P, 2008, BRINGING USER EXPERI; Cheraghi-Sohi S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-179; Coulter A., 2012, LEADERSHIP PATIENT E; Coulter A, 2009, MEASURES PATIENTS EX; DeCourcy A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-71; Department of Health, 2013, MAND MAND GOV NHS EN; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Garratt A., 2008, 072008 NORW I PUBL H; General Medical Council, 2012, SUPP INF APPR REV SE; Glickman SW, 2010, CIRC-CARDIOVASC QUAL, V3, P188, DOI 10.1161/CIRCOUTCOMES.109.900597; Graham C., 2013, DEV MEASURES PEOPLES; Greaves F, 2014, BMJ QUAL SAF, V23, DOI 10.1136/bmjqs-2014-002893.5; Greaves F, 2013, BMJ QUAL SAF, V22, P251, DOI 10.1136/bmjqs-2012-001527; Hewitson P, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-33; King's Fund, CAS STUD 1 OXL MENT; Luxford K, 2011, INT J QUAL HEALTH C, V23, P510, DOI 10.1093/intqhc/mzr024; Meterko M, 2010, HEALTH SERV RES, V45, P1188, DOI 10.1111/j.1475-6773.2010.01138.x; National Institute for Health and Care Excellence, 2012, PAT EXP AD NHS SERV; Office for National Statistics, 2012, OFF NAT STAT STAT B; Reinders ME, 2011, ACAD MED, V86, P1426, DOI 10.1097/ACM.0b013e3182312162; Robert G, 2011, WHAT MATTERS PATIENT; Rozenblum R, 2013, BMJ QUAL SAF, V22, P242, DOI 10.1136/bmjqs-2012-001045; Shaller D., 2011, TALE 3 PRACTICES MED; Ziebland S, 2014, HLTH SERV DELIVERY R, V2; Ziebland S, 2013, UNDERSTANDING USING	27	174	174	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2014	348								g2225	10.1136/bmj.g2225	http://dx.doi.org/10.1136/bmj.g2225			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LW	24671966	Green Submitted			2022-12-28	WOS:000333587600002
J	Hawkes, N				Hawkes, Nigel			Education team of the year: innovative approaches to support better care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2014	348								g1990	10.1136/bmj.g1990	http://dx.doi.org/10.1136/bmj.g1990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LW	24674759	Green Published			2022-12-28	WOS:000333587600001
J	Lienhardt, C				Lienhardt, Christian			Fundamental research is the key to eliminating TB	NATURE			English	Editorial Material									WHO, Global TB Programme, CH-1211 Geneva, Switzerland	World Health Organization	Lienhardt, C (corresponding author), WHO, Global TB Programme, CH-1211 Geneva, Switzerland.	lienhardtc@who.int	Lienhardt, Christian/AAU-4969-2021	Lienhardt, Christian/0000-0003-0233-893X	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)			0	9	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					401	401		10.1038/507401a	http://dx.doi.org/10.1038/507401a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6WN	24670725	Bronze			2022-12-28	WOS:000333402000004
J	O'Shea, JJ; Kanno, Y; Chan, AC				O'Shea, John J.; Kanno, Yuka; Chan, Andrew C.			In Search of Magic Bullets: The Golden Age of Immunotherapeutics	CELL			English	Review							B-CELL DEPLETION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY THERAPY; JANUS KINASE INHIBITOR; TUMOR-NECROSIS-FACTOR; TARGETING BTK; AUTOIMMUNE; TNF; EFFICACY; SAFETY	Once upon a time, immunology was a black box, inflammatory and autoimmune diseases were a mystery, and relatively blunt tools were used to treat these diseases. In the last 40 years, advances in molecular biology, DNA recombination technology, and genome sequencing allowed immunologists to open the box. As the complexity and diversity of the immune response are unveiled, targeted cellular and molecular therapies now offer rational approaches to treat immune-mediated diseases. Here, we discuss how the tried and true bench-to-bedside strategies resulted in some spectacular successes, along with some puzzling failures. Conversely, the advent of targeted therapies in the clinic has led to a wealth of information that changes how we think about the pathogenesis of immune-mediated diseases and how we categorize disease. In turn, these insights can inform next-generation drug discovery and refine targeted therapies for the appropriate patient subsets.	[O'Shea, John J.; Kanno, Yuka] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Chan, Andrew C.] Genentech Inc, San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Roche Holding; Genentech	O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov; acc@gene.com	Kanno, Yuka/B-5802-2013	Kanno, Yuka/0000-0001-5668-9319	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041106] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AR041106-19] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; [Anonymous], 1999, Neurology, V53, P457; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Arron JR, 2013, ADV PHARMACOL, V66, P1, DOI 10.1016/B978-0-12-404717-4.00001-9; Bandala-Sanchez E, 2013, NAT IMMUNOL, V14, P741, DOI 10.1038/ni.2610; Banham-Hall Edward, 2012, Open Rheumatol J, V6, P245, DOI 10.2174/1874312901206010245; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Bielekova B, 2013, NEUROTHERAPEUTICS, V10, P55, DOI 10.1007/s13311-012-0147-4; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Dennis G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4555; Derer S, 2013, GUT, V62, P376, DOI 10.1136/gutjnl-2011-300384; Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Federici S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00351; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Gran B, 2004, J NEUROIMMUNOL, V156, P123, DOI 10.1016/j.jneuroim.2004.07.019; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Isaacs JD, 1997, CLIN EXP IMMUNOL, V110, P158; Jacobi AM, 2010, CURR OPIN PHARMACOL, V10, P316, DOI 10.1016/j.coph.2010.02.002; Keating GM, 2013, DRUGS, V73, P1095, DOI 10.1007/s40265-013-0080-9; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lichtman EI, 2012, CLIN IMMUNOL, V143, P210, DOI 10.1016/j.clim.2012.03.005; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Mele DA, 2013, J EXP MED, V210, P2181, DOI 10.1084/jem.20130376; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nielsen OH, 2013, NEW ENGL J MED, V369, P754, DOI 10.1056/NEJMct1209614; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; O'Shea JJ, 2013, NAT REV RHEUMATOL, V9, P173, DOI 10.1038/nrrheum.2013.7; OPPENHEIM JJ, 1993, IMMUNOL TODAY, V14, P232, DOI 10.1016/0167-5699(93)90169-L; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Pillai S, 2011, CURR OPIN IMMUNOL, V23, P721, DOI 10.1016/j.coi.2011.10.007; Roll P, 2006, ARTHRITIS RHEUM-US, V54, P2377, DOI 10.1002/art.22019; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Schmidt J, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.14; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Strober B, 2013, BRIT J DERMATOL, V169, P992, DOI 10.1111/bjd.12517; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Uno JK, 2010, GASTROENTEROLOGY, V139, P1642, DOI 10.1053/j.gastro.2010.07.008; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030; Waldmann H, 2005, PHILOS T ROY SOC B, V360, P1707, DOI 10.1098/rstb.2005.1702; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Winkler DG, 2013, CHEM BIOL, V20, P1364, DOI 10.1016/j.chembiol.2013.09.017	74	29	31	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					227	240		10.1016/j.cell.2014.03.010	http://dx.doi.org/10.1016/j.cell.2014.03.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679538	Green Accepted, Bronze			2022-12-28	WOS:000333968900019
J	Hayward, LE; Hawthorn, DG; Melko, RG; Sachdev, S				Hayward, Lauren E.; Hawthorn, David G.; Melko, Roger G.; Sachdev, Subir			Angular Fluctuations of a Multicomponent Order Describe the Pseudogap of YBa2Cu3O6+x	SCIENCE			English	Article							SUPERFLUID DENSITY; MOTT INSULATOR; SUPERCONDUCTIVITY; STATE; EXCITATIONS; SYMMETRY; LA2CUO4; PHASES; PURE	The hole-doped cuprate high-temperature superconductors enter the pseudogap regime as their superconducting critical temperature, T-c, falls with decreasing hole density. Recent x-ray scattering experiments in YBa2Cu3O6+x observe incommensurate charge-density wave fluctuations whose strength rises gradually over a wide temperature range above T-c, but then decreases as the temperature is lowered below T-c. We propose a theory in which the superconducting and charge-density wave orders exhibit angular fluctuations in a six-dimensional space. The theory provides a natural quantitative fit to the x-ray data and can be a basis for understanding other characteristics of the pseudogap.	[Hayward, Lauren E.; Hawthorn, David G.; Melko, Roger G.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Melko, Roger G.] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Sachdev, Subir] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	University of Waterloo; Perimeter Institute for Theoretical Physics; Harvard University	Sachdev, S (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	sachdev@g.harvard.edu	Sachdev, Subir/Y-3037-2019; Hawthorn, David G/I-6491-2012; Sachdev, Subir/A-8781-2013	Sachdev, Subir/0000-0002-2432-7070; Hawthorn, David G/0000-0002-7002-0416; Sachdev, Subir/0000-0002-2432-7070; Hayward, Lauren/0000-0002-5227-8552	NSF [DMR-1103860]; Natural Sciences and Engineering Research Council of Canada; Perimeter Institute for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation; John Templeton Foundation	NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Perimeter Institute for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); John Templeton Foundation	We thank A. Chubukov, A. Georges, M.-H. Julien, B. Keimer, S. Kivelson, J. Orenstein, and A. Yacoby for useful discussions. This research was supported by the NSF under grant DMR-1103860 and the Natural Sciences and Engineering Research Council of Canada. This research was also supported in part by Perimeter Institute for Theoretical Physics; research at Perimeter Institute is supported by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Research and Innovation. R.G.M. and S.S. acknowledge the John Templeton Foundation for support.	Achkar AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167001; AFFLECK I, 1988, PHYS REV B, V38, P745, DOI 10.1103/PhysRevB.38.745; Banerjee S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2667; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; Carlson EW, 2004, PHYSICS OF SUPERCONDUCTORS, VOL II, P275; CHAKRAVARTY S, 1988, PHYS REV LETT, V60, P1057, DOI 10.1103/PhysRevLett.60.1057; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; DAGOTTO E, 1988, PHYS REV B, V38, P2926, DOI 10.1103/PhysRevB.38.2926; Efetov KB, 2013, NAT PHYS, V9, P442, DOI [10.1038/nphys2641, 10.1038/NPHYS2641]; ENDOH Y, 1988, PHYS REV B, V37, P7443, DOI 10.1103/PhysRevB.37.7443; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; KEIMER B, 1992, PHYS REV B, V46, P14034, DOI 10.1103/PhysRevB.46.14034; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kokanovic I, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.060505; Larkin A., 2005, THEORY FLUCTUATIONS; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054510; Meier H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020506; Metlitski MA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075128; NELSON DR, 1977, PHYS REV LETT, V39, P1201, DOI 10.1103/PhysRevLett.39.1201; Oganesyan V, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094503; Podolsky D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.117004; POLYAKOV AM, 1975, PHYS LETT B, V59, P79, DOI 10.1016/0370-2693(75)90161-6; Sachdev S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144504; Sachdev S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027202; Wu T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014511; Wu T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3113; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016; Zhang SC, 1997, SCIENCE, V275, P1089, DOI 10.1126/science.275.5303.1089	34	91	91	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1336	1339		10.1126/science.1246310	http://dx.doi.org/10.1126/science.1246310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653030	Green Submitted			2022-12-28	WOS:000333108500032
J	Chataway, J; Schuerer, N; Alsanousi, A; Chan, D; MacManus, D; Hunter, K; Anderson, V; Bangham, CRM; Clegg, S; Nielsen, C; Fox, NC; Wilkie, D; Nicholas, JM; Calder, VL; Greenwood, J; Frost, C; Nicholas, R				Chataway, Jeremy; Schuerer, Nadine; Alsanousi, Ali; Chan, Dennis; MacManus, David; Hunter, Kelvin; Anderson, Val; Bangham, Charles R. M.; Clegg, Shona; Nielsen, Casper; Fox, Nick C.; Wilkie, David; Nicholas, Jennifer M.; Calder, Virginia L.; Greenwood, John; Frost, Chris; Nicholas, Richard			Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial	LANCET			English	Article							CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; CLINICAL-TRIALS; REDUCTASE INHIBITORS; AUTOIMMUNE-DISEASE; OUTCOME MEASURE; VOLUME CHANGES; DOUBLE-BLIND; INTERFERON; THERAPY	Background Secondary progressive multiple sclerosis, for which no satisfactory treatment presently exists, accounts for most of the disability in patients with multiple sclerosis. Simvastatin, which is widely used for treatment of vascular disease, with its excellent safety profile, has immunomodulatory and neuroprotective properties that could make it an appealing candidate drug for patients with secondary progressive multiple sclerosis. Methods We undertook a double-blind, controlled trial between Jan 28, 2008, and Nov 4, 2011, at three neuroscience centres in the UK. Patients aged 18-65 years with secondary progressive multiple sclerosis were randomly assigned (1:1), by a centralised web-based service with a block size of eight, to receive either 80 mg of simvastatin or placebo. Patients, treating physicians, and outcome assessors were masked to treatment allocation. The primary outcome was the annualised rate of whole-brain atrophy measured from serial volumetric MRI. Analyses were by intention to treat and per protocol. This trial is registered with ClinicalTrials. gov, number NCT00647348. Findings 140 participants were randomly assigned to receive either simvastatin (n=70) or placebo (n=70). The mean annualised atrophy rate was significantly lower in patients in the simvastatin group (0.288% per year [SD 0.521]) than in those in the placebo group (0.584% per year [0.498]). The adjusted difference in atrophy rate between groups was -0.254% per year (95% CI -0.422 to -0.087; p=0.003); a 43% reduction in annualised rate. Simvastatin was well tolerated, with no differences between the placebo and simvastatin groups in proportions of participants who had serious adverse events (14 [20%] vs nine [13%]). Interpretation High-dose simvastatin reduced the annualised rate of whole-brain atrophy compared with placebo, and was well tolerated and safe. These results support the advancement of this treatment to phase 3 testing.	[Chataway, Jeremy; Fox, Nick C.] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, London, England; [Chataway, Jeremy; MacManus, David; Hunter, Kelvin; Anderson, Val] UCL, Queen Sq Multiple Sclerosis Ctr, Dept Neuroinflammat, London, England; [Chataway, Jeremy; MacManus, David; Hunter, Kelvin; Anderson, Val; Clegg, Shona; Nielsen, Casper; Fox, Nick C.] UCL, UCL Inst Neurol, London, England; [Schuerer, Nadine; Calder, Virginia L.; Greenwood, John] UCL, UCL Inst Ophthalmol, London, England; [Chataway, Jeremy; Alsanousi, Ali; Nicholas, Richard] Imperial Coll Healthcare NHS Trust, London, England; [Chataway, Jeremy; Bangham, Charles R. M.; Wilkie, David; Nicholas, Richard] Univ London Imperial Coll Sci Technol & Med, London, England; [Chan, Dennis] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Nicholas, Jennifer M.; Frost, Chris] London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London; Imperial College London; University of Brighton; University of Sussex; University of London; London School of Hygiene & Tropical Medicine	Chataway, J (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	jeremy.chataway@uclh.nhs.uk	Fox, Nick C/B-1319-2009; Calder, Virginia/AAG-8278-2020; Macedo, Ana/L-9912-2018	Fox, Nick C/0000-0002-6660-657X; Calder, Virginia/0000-0003-1422-2926; Macedo, Ana/0000-0002-6978-8989; Bangham, Charles/0000-0003-2624-3599; Schuerer, Nadine/0000-0002-5894-2784; MacManus, David/0000-0002-0902-977X; Frost, Chris/0000-0003-0098-9915; Greenwood, John/0000-0003-4496-2984; Anderson, Valerie/0000-0002-8018-0974	Moulton Foundation [1109891]; Berkeley Foundation [268369]; Multiple Sclerosis Trials Collaboration [1113598]; Rosetrees Trust [298582]; UK National Institute of Health Research (NIHR) University College London Hospitals/UCL Biomedical Research Centres funding scheme; National Institute for Health Research [NF-SI-0513-10134, NF-SI-0508-10123] Funding Source: researchfish; Rosetrees Trust [M122-F1] Funding Source: researchfish	Moulton Foundation; Berkeley Foundation; Multiple Sclerosis Trials Collaboration; Rosetrees Trust(Rosetrees Trust); UK National Institute of Health Research (NIHR) University College London Hospitals/UCL Biomedical Research Centres funding scheme; National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	The Moulton Foundation [charity number 1109891], Berkeley Foundation [268369], the Multiple Sclerosis Trials Collaboration [1113598], the Rosetrees Trust [298582] and a personal contribution from A Pidgley, UK National Institute of Health Research (NIHR) University College London Hospitals/UCL Biomedical Research Centres funding scheme.	Anderson VM, 2007, J NEUROIMAGING, V17, P61, DOI 10.1111/j.1552-6569.2006.00081.x; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bhardwaj S, 2012, AM J HEALTH-SYST PH, V69, P1494, DOI 10.2146/ajhp110675; Birnbaum G, 2008, NEUROLOGY, V71, P1390, DOI 10.1212/01.wnl.0000319698.40024.1c; BRESLOW NE, 1984, J R STAT SOC C-APPL, V33, P38; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Davison AC, 1997, BOOTSTRAP METHODS TH; De Stefano N, 2010, NEUROLOGY, V74, P1868, DOI 10.1212/WNL.0b013e3181e24136; Durand-Dubief F, 2012, AM J NEURORADIOL, V33, P1918, DOI 10.3174/ajnr.A3107; Efron B., 1994, MONOGRAPHS STAT APPL; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Freeborough PA, 1997, IEEE T MED IMAGING, V16, P623, DOI 10.1109/42.640753; Freedman MS, 2011, NEUROLOGY, V77, P1551, DOI 10.1212/WNL.0b013e318233b240; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Frost C, 2004, STAT MED, V23, P3275, DOI 10.1002/sim.1909; Frost C, 2008, STAT MED, V27, P3717, DOI 10.1002/sim.3280; Giannopoulos S, 2012, J CEREBR BLOOD F MET, V32, P1973, DOI 10.1038/jcbfm.2012.122; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Greenwood J, 2003, FASEB J, V17, P905, DOI 10.1096/fj.02-1014fje; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Hill T, 2005, CLIN EXP IMMUNOL, V139, P132, DOI 10.1111/j.1365-2249.2005.02669.x; Hobart J, 2000, BRAIN, V123, P1027, DOI 10.1093/brain/123.5.1027; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Humphries C, 2012, NATURE, V484, pS10, DOI 10.1038/nature11108; ICH Expert Working Group, 1996, E6R1 ICH EXP WORK GR; Kamm CP, 2012, J NEUROL, V259, P2401, DOI 10.1007/s00415-012-6513-7; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Little R.J.A., 2002, STAT ANAL MISSING DA; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mantis LL, 2013, J NEUROL NEUROSUR PS, V84, P420, DOI [10.1136/jnnp-2012-303291, DOI 10.1136/JNNP-2012-303291]; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; NOSEWORTHY JH, 1991, LANCET, V337, P441; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Schmeer C, 2006, RESTOR NEUROL NEUROS, V24, P79; Smith SM, 2007, NEUROIMAGE, V36, P1200, DOI 10.1016/j.neuroimage.2007.04.035; Sorensen PS, 2011, LANCET NEUROL, V10, P691, DOI 10.1016/S1474-4422(11)70144-2; Togha M, 2010, MULT SCLER J, V16, P848, DOI 10.1177/1352458510369147; Tsakiri A, 2012, MULT SCLER J, V18, P72, DOI 10.1177/1352458511415452; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wang J, 2011, COCHRANE DB SYST REV, V12; Waubant E, 2012, NEUROLOGY, V78, P1171, DOI 10.1212/WNL.0b013e31824f7fdd; Weber MS, 2006, J NEUROIMMUNOL, V178, P140, DOI 10.1016/j.jneuroim.2006.06.006; World Medical Association, DECL HELS ETH PRINC; Zajicek J, 2013, LANCET NEUROL, V12, P857, DOI 10.1016/S1474-4422(13)70159-5; Zamvil SS, 2002, NEUROLOGY, V59, P970, DOI 10.1212/WNL.59.7.970; Zivadinov R, 2008, NEUROLOGY, V71, P136, DOI 10.1212/01.wnl.0000316810.01120.05	57	255	260	1	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2213	2221		10.1016/S0140-6736(13)62242-4	http://dx.doi.org/10.1016/S0140-6736(13)62242-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK8DO	24655729	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000338657600025
J	Liu, Y; Samuel, BS; Breen, PC; Ruvkun, G				Liu, Ying; Samuel, Buck S.; Breen, Peter C.; Ruvkun, Gary			Caenorhabditis elegans pathways that surveil and defend mitochondria	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; C-ELEGANS; CERAMIDE SYNTHASE; APOPTOSIS; ACTIVATION; LONGEVITY; STRESS; UPR	Mitochondrial function is challenged by toxic by-products of metabolism as well as by pathogen attack(1,2). Caenorhabditis elegans normally responds to mitochondrial dysfunction with activation of mitochondrial-repair, drug-detoxification and pathogen-response pathways(1-7). Here, from a genome-wide RNA interference (RNAi) screen, we identified 45 C. elegans genes that are required to upregulate detoxification, pathogen-response and mitochondrial-repair pathways after inhibition of mitochondrial function by drug-induced or genetic disruption. Animals defective in ceramide biosynthesis are deficient in mitochondrial surveillance, and addition of particular ceramides can rescue the surveillance defects. Ceramide can also rescue the mitochondrial surveillance defects of other gene inactivations, mapping these gene activities upstream of ceramide. Inhibition of the mevalonate pathway, either by RNAi or statin drugs, also disrupts mitochondrial surveillance. Growth of C. elegans with a significant fraction of bacterial species from their natural habitat causes mitochondrial dysfunction. Other bacterial species inhibit C. elegans defence responses to a mitochondrial toxin, revealing bacterial countermeasures to animal defence.	[Liu, Ying; Samuel, Buck S.; Breen, Peter C.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Liu, Ying; Samuel, Buck S.; Breen, Peter C.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Samuel, Buck/I-3837-2019	Samuel, Buck/0000-0002-4347-3997	Helen Hay Whitney research fellowship; Charles King Trust postdoctoral fellowship; National Institutes of Health [NIH AG043184-16]; NATIONAL INSTITUTE ON AGING [R01AG043184] Funding Source: NIH RePORTER	Helen Hay Whitney research fellowship; Charles King Trust postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Haynes (Memorial Sloan Kettering Cancer Center), F. Ausubel (Massachusetts General Hospital) and the Caenorhabditis Genetics Center for providing strains; and the V. Mootha laboratory (Massachusetts General Hospital) for providing C2C12 cells. We thank J. Larkins-Ford, C. Phillips, S. Garcia and M. Pellegrino for technical support, as well as M. A. Felix for bacterial strains and for guidance in the collection of microbial strains from C. elegans natural habitats. Y.L. is supported by the Helen Hay Whitney research fellowship; B.S.S. is supported by the Charles King Trust postdoctoral fellowship. The work is supported by a grant from the National Institutes of Health, awarded to G.R. (NIH AG043184-16).	Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hage-Sleiman R, 2013, INT J MOL SCI, V14, P4982, DOI 10.3390/ijms14034982; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Moyer MW, 2010, NAT MED, V16, P150, DOI 10.1038/nm0210-150; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Phillips CM, 2009, METHODS MOL BIOL, V558, P171, DOI 10.1007/978-1-60761-103-5_11; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Wagner BK, 2011, ACS CHEM BIOL, V6, P900, DOI 10.1021/cb200206w	24	196	198	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					406	+		10.1038/nature13204	http://dx.doi.org/10.1038/nature13204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24695221	Green Submitted, Green Accepted			2022-12-28	WOS:000334403000054
J	Oh, SW; Harris, JA; Ng, L; Winslow, B; Cain, N; Mihalas, S; Wang, QX; Lau, C; Kuan, L; Henry, AM; Mortrud, MT; Ouellette, B; Nguyen, TN; Sorensen, SA; Slaughterbeck, CR; Wakeman, W; Li, Y; Feng, D; Ho, A; Nicholas, E; Hirokawa, KE; Bohn, P; Joines, KM; Peng, HC; Hawrylycz, MJ; Phillips, JW; Hohmann, JG; Wohnoutka, P; Koch, C; Bernard, A; Dang, C; Jones, AR; Zeng, HK; Gerfen, CR				Oh, Seung Wook; Harris, Julie A.; Ng, Lydia; Winslow, Brent; Cain, Nicholas; Mihalas, Stefan; Wang, Quanxin; Lau, Chris; Kuan, Leonard; Henry, Alex M.; Mortrud, Marty T.; Ouellette, Benjamin; Nguyen, Thuc Nghi; Sorensen, Staci A.; Slaughterbeck, Clifford R.; Wakeman, Wayne; Li, Yang; Feng, David; Ho, Anh; Nicholas, Eric; Hirokawa, Karla E.; Bohn, Phillip; Joines, Kevin M.; Peng, Hanchuan; Hawrylycz, Michael J.; Phillips, John W.; Hohmann, John G.; Wohnoutka, Paul; Koch, Christof; Bernard, Amy; Dang, Chinh; Jones, Allan R.; Zeng, Hongkui; Gerfen, Charles R.			A mesoscale connectome of the mouse brain	NATURE			English	Article							MEDIAL PREFRONTAL CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; PARAFASCICULAR THALAMIC NUCLEUS; EFFERENT PROJECTIONS; THALAMOCORTICAL PROJECTIONS; BARREL CORTEX; AFFERENT CONNECTIONS; PERIRHINAL CORTEX; LIMBIC CORTEX; CORTICOTHALAMIC PROJECTIONS	Comprehensive knowledge of the brain's wiring diagram is fundamental for understanding how the nervous system processes information at both local and global scales. However, with the singular exception of the C. elegans microscale connectome, there are no complete connectivity data sets in other species. Here we report a brain-wide, cellular-level, mesoscale connectome for the mouse. The Allen Mouse Brain Connectivity Atlas uses enhanced green fluorescent protein (EGFP)-expressing adeno-associated viral vectors to trace axonal projections from defined regions and cell types, and high-throughput serial two-photon tomography to image the EGFP-labelled axons throughout the brain. This systematic and standardized approach allows spatial registration of individual experiments into a common three dimensional (3D) reference space, resulting in a whole-brain connectivity matrix. A computational model yields insights into connectional strength distribution, symmetry and other network properties. Virtual tractography illustrates 3D topography among interconnected regions. Cortico-thalamic pathway analysis demonstrates segregation and integration of parallel pathways. The Allen Mouse Brain Connectivity Atlas is a freely available, foundational resource for structural and functional investigations into the neural circuits that support behavioural and cognitive processes in health and disease.	[Oh, Seung Wook; Harris, Julie A.; Ng, Lydia; Winslow, Brent; Cain, Nicholas; Mihalas, Stefan; Wang, Quanxin; Lau, Chris; Kuan, Leonard; Henry, Alex M.; Mortrud, Marty T.; Ouellette, Benjamin; Nguyen, Thuc Nghi; Sorensen, Staci A.; Slaughterbeck, Clifford R.; Wakeman, Wayne; Li, Yang; Feng, David; Ho, Anh; Nicholas, Eric; Hirokawa, Karla E.; Bohn, Phillip; Joines, Kevin M.; Peng, Hanchuan; Hawrylycz, Michael J.; Phillips, John W.; Hohmann, John G.; Wohnoutka, Paul; Koch, Christof; Bernard, Amy; Dang, Chinh; Jones, Allan R.; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Gerfen, Charles R.] NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA	Allen Institute for Brain Science; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.			Bernard, Amy/0000-0003-2540-1153; OH, SEUNG WOOK/0000-0001-7632-6822; Feng, David/0000-0002-4920-8123; Hirokawa, Karla/0000-0002-9954-5515; Koch, Christof/0000-0001-6482-8067; Winslow, Brent/0000-0001-7098-6336; Nguyen, Thuc Nghi/0000-0002-6466-5883	Allen Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002497] Funding Source: NIH RePORTER	Allen Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank the Allen Mouse Brain Connectivity Atlas Advisory Council members, D. Anderson, E. M. Callaway, K. Svoboda, J. L. R. Rubenstein, C. B. Saper and M. P. Stryker for their insightful advice. We thank T. Ragan for providing invaluable support and advice in the development and customization of the TissueCyte 1000 systems. We are grateful for the technical support of the many staff members in the Allen Institute who are not part of the authorship of this paper. This work was funded by the Allen Institute for Brain Science. The authors wish to thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement and support.	Alloway KD, 2008, J COMP NEUROL, V510, P100, DOI 10.1002/cne.21782; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Azuma Michio, 1996, Acta Anatomica Nipponica, V71, P523; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barbas H, 1997, CEREB CORTEX, V7, P635, DOI 10.1093/cercor/7.7.635; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; BECKSTEAD RM, 1979, J COMP NEUROL, V184, P43, DOI 10.1002/cne.901840104; BENZINGER H, 1983, EXP BRAIN RES, V50, P1; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bokor H, 2008, J NEUROSCI, V28, P5169, DOI 10.1523/JNEUROSCI.0490-08.2008; Bollobas B., 2001, RANDOM GRAPHS; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Conte WL, 2008, BRAIN RES, V1240, P87, DOI 10.1016/j.brainres.2008.09.013; CORNWALL J, 1988, BRAIN RES BULL, V20, P139, DOI 10.1016/0361-9230(88)90171-2; Dang C, 2007, LECT N BIOINFORMAT, V4544, P17; DEACON TW, 1983, J COMP NEUROL, V220, P168, DOI 10.1002/cne.902200205; Desbois C, 2001, NEUROSCIENCE, V102, P885, DOI 10.1016/S0306-4522(00)00537-6; DONALDSON L, 1975, EXP NEUROL, V47, P448, DOI 10.1016/0014-4886(75)90077-1; Dong H.W., 2008, ALLEN REFERENCE ATLA; Ercsey-Ravasz M, 2013, NEURON, V80, P184, DOI 10.1016/j.neuron.2013.07.036; ERDOS P, 1960, B INT STATIST INST, V38, P343; FEGER J, 1994, NEUROSCIENCE, V60, P125, DOI 10.1016/0306-4522(94)90208-9; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Graziano A, 2008, J COMP NEUROL, V507, P1258, DOI 10.1002/cne.21592; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; GULDIN WO, 1983, J COMP NEUROL, V215, P135, DOI 10.1002/cne.902150203; Haque T, 2010, BRAIN RES, V1346, P69, DOI 10.1016/j.brainres.2010.05.034; Harris Julie A, 2012, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0120s59; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hoover WB, 2011, J COMP NEUROL, V519, P3766, DOI 10.1002/cne.22733; Hsu DT, 2007, J COMP NEUROL, V504, P89, DOI 10.1002/cne.21440; Hsu DT, 2009, J COMP NEUROL, V512, P825, DOI 10.1002/cne.21934; Huang ZJ, 2013, ANNU REV NEUROSCI, V36, P183, DOI 10.1146/annurev-neuro-062012-170307; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; KAITZ SS, 1981, J COMP NEUROL, V195, P527, DOI 10.1002/cne.901950309; Kamishina H, 2009, BRAIN RES, V1264, P39, DOI 10.1016/j.brainres.2009.01.024; Kealy J, 2011, PROG NEUROBIOL, V93, P522, DOI 10.1016/j.pneurobio.2011.03.002; Killackey HP, 2003, J NEUROSCI, V23, P7381; Kolmac CI, 2000, J NEUROCYTOL, V29, P31, DOI 10.1023/A:1007160029506; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Li S, 2008, J COMP NEUROL, V506, P263, DOI 10.1002/cne.21502; Li S, 2012, BRAIN STRUCT FUNCT, V217, P257, DOI 10.1007/s00429-011-0360-7; Liao CC, 2010, J COMP NEUROL, V518, P2592, DOI 10.1002/cne.22354; Linke R, 2000, CEREB CORTEX, V10, P753, DOI 10.1093/cercor/10.8.753; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MASON R, 1981, NEUROSCI LETT, V25, P107, DOI 10.1016/0304-3940(81)90316-5; McIntyre DC, 1996, J COMP NEUROL, V369, P302, DOI 10.1002/(SICI)1096-9861(19960527)369:2<302::AID-CNE10>3.0.CO;2-J; McKenna JT, 2004, J COMP NEUROL, V480, P115, DOI 10.1002/cne.20342; MILLER MW, 1984, J COMP NEUROL, V226, P184, DOI 10.1002/cne.902260204; Mitchell BD, 2001, BRAIN RES, V921, P68, DOI 10.1016/S0006-8993(01)03084-0; Monconduit L, 1999, J NEUROSCI, V19, P9063, DOI 10.1523/JNEUROSCI.19-20-09063.1999; Nakashima M, 2000, NEUROSCI RES, V36, P297, DOI 10.1016/S0168-0102(99)00129-7; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; REEP RL, 1994, EXP BRAIN RES, V100, P67; Reep RL, 1996, EXP BRAIN RES, V111, P215; Reep RL, 1999, BRAIN RES, V841, P43, DOI 10.1016/S0006-8993(99)01779-5; REEP RL, 1982, NEUROSCIENCE, V7, P2609, DOI 10.1016/0306-4522(82)90087-2; ROBERTSON RT, 1981, J COMP NEUROL, V195, P501, DOI 10.1002/cne.901950308; ROGER M, 1989, J COMP NEUROL, V287, P339, DOI 10.1002/cne.902870306; Samuelsen CL, 2013, J NEUROSCI, V33, P1815, DOI 10.1523/JNEUROSCI.4026-12.2013; SANDERSON KJ, 1991, EXP BRAIN RES, V85, P324; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schmitt O, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00081; SCHOBER W, 1981, Z MIKROSK ANAT FORSC, V95, P827; Seung S., 2012, CONNECTOME BRAINS WI, V359; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Shi CJ, 1997, J COMP NEUROL, V382, P153; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Shibata H, 2005, BRAIN RES, V1059, P93, DOI 10.1016/j.brainres.2005.08.025; SHIBATA H, 1993, J COMP NEUROL, V330, P533, DOI 10.1002/cne.903300409; Shibata H, 2012, J COMP NEUROL, V520, P2647, DOI 10.1002/cne.23057; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P221, DOI 10.1016/0361-9230(84)90049-2; SIMMONS PA, 1982, J COMP NEUROL, V211, P295, DOI 10.1002/cne.902110308; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; SPORNS O, 2011, NETWORKS BRAIN, P412; Swanson L. W., 2012, BRAIN ARCHITECTURE U, V331; TAKAGISHI M, 1991, BRAIN RES, V566, P26, DOI 10.1016/0006-8993(91)91677-S; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; van Groen T, 1999, BRAIN RES REV, V30, P1, DOI 10.1016/S0165-0173(99)00006-5; VANGROEN T, 1990, J COMP NEUROL, V300, P593, DOI 10.1002/cne.903000412; VANGROEN T, 1995, J COMP NEUROL, V358, P584, DOI 10.1002/cne.903580411; VAUDANO E, 1991, EUR J NEUROSCI, V3, P317, DOI 10.1111/j.1460-9568.1991.tb00818.x; Vertes RP, 2012, NEUROSCIENCE, V219, P120, DOI 10.1016/j.neuroscience.2012.04.067; Vertes RP, 2006, J COMP NEUROL, V499, P768, DOI 10.1002/cne.21135; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang Q., 2014, J COMP NEUROL; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Wright NF, 2013, J COMP NEUROL, V521, P2966, DOI 10.1002/cne.23325; YASUI Y, 1987, J COMP NEUROL, V257, P253, DOI 10.1002/cne.902570210; Zhang ZW, 1998, CEREB CORTEX, V8, P428, DOI 10.1093/cercor/8.5.428	127	1285	1300	9	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					207	+		10.1038/nature13186	http://dx.doi.org/10.1038/nature13186			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695228	Green Accepted			2022-12-28	WOS:000333979900037
J	DeJong, C; Santa, J; Dudley, RA				DeJong, Colette; Santa, John; Dudley, R. Adams			Websites That Offer Care Over the Internet Is There an Access Quality Tradeoff?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VISITS		[DeJong, Colette] Univ Calif San Francisco, Sch Med, San Francisco, CA 94118 USA; [Santa, John] Consumers Union, Consumer Reports Hlth Ratings Ctr, Yonkers, NY USA; [Dudley, R. Adams] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, Ctr Healthcare Value, Dept Med, San Francisco, CA 94118 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dudley, RA (corresponding author), Univ Calif San Francisco, Dept Med, 3333 Calif,POB 0936,Ste 265, San Francisco, CA 94118 USA.	adams.dudley@ucsf.edu						Courneya PT, 2013, HEALTH AFFAIR, V32, P385, DOI 10.1377/hlthaff.2012.1157; How SK, 2008, PUBLIC VIEWS ON US H; Leblanc VR, 2002, ACAD MED, V77, pS67, DOI 10.1097/00001888-200210001-00022; Mehrotra A, 2013, JAMA-J AM MED ASSOC, V310, P35, DOI 10.1001/jama.2013.6825; Mehrotra A, 2013, JAMA INTERN MED, V173, P72, DOI 10.1001/2013.jamainternmed.305; MORRELL DC, 1986, BMJ-BRIT MED J, V292, P870, DOI 10.1136/bmj.292.6524.870; Reid RO, 2013, J GEN INTERN MED, V28, P504, DOI 10.1007/s11606-012-2243-x	7	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1287	1288		10.1001/jama.2014.1026	http://dx.doi.org/10.1001/jama.2014.1026			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691602				2022-12-28	WOS:000333645400007
J	Walter, LC; Schonberg, MA				Walter, Louise C.; Schonberg, Mara A.			Screening Mammography in Older Women A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BREAST-CANCER RISK; CARCINOMA IN-SITU; ESTROGEN PLUS PROGESTIN; HORMONE-RECEPTOR STATUS; REPLACEMENT THERAPY USE; AGE 80 YEARS; ADJUVANT CHEMOTHERAPY; TUMOR CHARACTERISTICS; POSTMENOPAUSAL WOMEN; DECISION-MAKING	IMPORTANCE Guidelines recommend individualizing screening mammography decisions for women aged 75 years and older. However, little pragmatic guidance is available to help counsel patients. OBJECTIVE To provide an evidence-based approach for individualizing decision-making about screening mammography in older women. E EVIDENCE ACQUISITION We searched PubMed for English-language studies in peer-reviewed journals published from January 1,1990, to February 1, 2014, to identify risk factors for late-life breast cancer in women aged 65 years and older and to quantify the benefits and harms of screening mammography for women aged 75 years and older. FINDINGS Age is the major risk factor for developing and dying from breast cancer. Breast cancer risk factors that reflect hormonal exposures in the distant past, such as age at first birth or age at menarche, are less predictive of late-life breast cancer than factors indicating recent hormonal exposures such as high bone mass or obesity. Randomized trials of the benefits of screening mammography did not include women older than 74 years. Thus it is not known if screening mammography benefits older women. Observational studies favor extending screening mammography to older women who have a life expectancy of more than 10 years. Modeling studies estimate 2 fewer breast cancer deaths/1000 women who in their 70s continue biennial screening for 10 years instead of stopping screening at age 69. Potential harms of continued screening over 10 years include false-positive mammograms in approximately 200/1000 women screened and overdiagnosis (ie, finding breast cancer that would not have clinically surfaced otherwise) in approximately 13/1000 women screened. Providing information about life expectancy along with potential benefits and harms of screening may help older women's decision-making about screening mammography. CONCLUSIONS AND RELEVANCE For women with less than a 10-year life expectancy, recommendations to stop screening mammography should emphasize increased potential harms from screening and highlight health promotion measures likely to be beneficial over the short term. For women with a life expectancy of more than 10 years, deciding whether potential benefits of screening outweigh harms becomes a value judgment for patients, requiring a realistic understanding of screening outcomes.	[Walter, Louise C.] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Walter, Louise C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Schonberg, Mara A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Dept Med,Med Sch, Boston, MA 02215 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Walter, LC (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco VA Med Ctr 181G, 4150 Clement St, San Francisco, CA 94121 USA.	Louise.Walter@ucsf.edu	wang, edwin/G-5372-2010		National Cancer Institute [RO1 CA134425]; National Institute on Aging [K24AG041180]; Paul B. Beeson Career Development Award in Aging [K23AG028584]; John A. Hartford Foundation; Atlantic Philanthropies; Starr Foundation; American Federation for Aging Research; NATIONAL CANCER INSTITUTE [R01CA134425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028584, K24AG041180] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Paul B. Beeson Career Development Award in Aging; John A. Hartford Foundation; Atlantic Philanthropies; Starr Foundation; American Federation for Aging Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Cancer Institute (grant RO1 CA134425) and the National Institute on Aging (grant K24AG041180) (Dr Walter); the Paul B. Beeson Career Development Award in Aging (grant K23AG028584) (Dr Schonberg); as well as support from the John A. Hartford Foundation, the Atlantic Philanthropies, the Starr Foundation, and the American Federation for Aging Research.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Allegra CJ, 2010, J NATL CANCER I, V102, P161, DOI 10.1093/jnci/djp485; American College of Obstetricians and Gynecologists Practice Bulletin, 2011, OBSTET GYNECOL, V118, P372, DOI DOI 10.1097/AOG.0B013E31822C98E5; American College of Radiology, ACR PRACT GUID PERF; Badgwell BD, 2008, J CLIN ONCOL, V26, P2482, DOI 10.1200/JCO.2007.12.8058; Barratt A, 2005, BMJ-BRIT MED J, V330, P936, DOI 10.1136/bmj.38398.469479.8F; Barrett AL, 2012, MED J AUSTRALIA, V196, P681, DOI 10.5694/mja12.10236; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bond M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17130; Bond M, 2013, HEALTH TECHNOL ASSES, V17, pv, DOI DOI 10.3310/HTA17130; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Bruening W, 2010, ANN INTERN MED, V152, P238, DOI 10.7326/0003-4819-152-1-201001050-00190; Buchholz TA, 2009, NEW ENGL J MED, V360, P63, DOI 10.1056/NEJMct0803525; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Cerhan JR, 1998, J GERONTOL A-BIOL, V53, pM251, DOI 10.1093/gerona/53A.4.M251; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cummings SR, 2005, CANCER EPIDEM BIOMAR, V14, P1047, DOI 10.1158/1055-9965.EPI-04-0375; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; de Glas NA, 2013, BREAST CANCER RES TR, V138, P561, DOI 10.1007/s10549-013-2462-9; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; Dijkstra JB, 1999, BRIT J ANAESTH, V82, P867, DOI 10.1093/bja/82.6.867; ePrognosis, EST PROGN ELD; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Fagerlin A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S8; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Galit W, 2007, MATURITAS, V57, P109, DOI 10.1016/j.maturitas.2007.01.010; Ganry O, 2004, EUR J EPIDEMIOL, V19, P785, DOI 10.1023/B:EJEP.0000036567.60387.39; Garcia-Retamero R, 2012, SCI WORLD J, DOI 10.1100/2012/562637; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Grabler P, 2012, BREAST CANCER RES TR, V135, P549, DOI 10.1007/s10549-012-2193-3; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Hoffman RM, 2010, MED DECIS MAKING, V30, p53S, DOI 10.1177/0272989X10378701; Horn J, 2013, BREAST CANCER RES TR, V139, P237, DOI 10.1007/s10549-013-2531-0; Hughes KS, 2013, J CLIN ONCOL, V31, P2382, DOI 10.1200/JCO.2012.45.2615; Hurria A, 2012, J NATL COMPR CANC NE, V10, P162, DOI 10.6004/jnccn.2012.0019; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Kerlikowske K, 2010, J CLIN ONCOL, V28, P3830, DOI 10.1200/JCO.2009.26.4770; Krebs EE, 2006, J AM GERIATR SOC, V54, P63, DOI 10.1111/j.1532-5415.2005.00541.x; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Li CI, 2005, CANCER CAUSE CONTROL, V16, P975, DOI 10.1007/s10552-005-2906-6; Li CI, 2003, CANCER EPIDEM BIOMAR, V12, P1061; Li CI, 2003, INT J CANCER, V107, P647, DOI 10.1002/ijc.11465; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 1992, ANN INTERN MED, V116, P722, DOI 10.7326/0003-4819-116-9-722; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McCarthy EP, 2000, J AM GERIATR SOC, V48, P1226, DOI 10.1111/j.1532-5415.2000.tb02595.x; McPherson CP, 2002, J AM GERIATR SOC, V50, P1061, DOI 10.1046/j.1532-5415.2002.50261.x; Montgomery M, 2010, J ADV NURS, V66, P2372, DOI 10.1111/j.1365-2648.2010.05439.x; Morimoto LM, 2002, CANCER CAUSE CONTROL, V13, P741, DOI 10.1023/A:1020239211145; Morrow DG, 1998, EXP AGING RES, V24, P231; Muss HB, 2005, JAMA-J AM MED ASSOC, V293, P1073, DOI 10.1001/jama.293.9.1073; Muss HB, 2009, NEW ENGL J MED, V360, P2055, DOI 10.1056/NEJMoa0810266; National Center for Health Statistics, 2008, LIF TABL US 2008; National Comprehensive Cancer Network, 2013, BREAST CANC SCREEN D; National Health System, NHS BREAST SCREEN PR; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Peters E, 2008, CANCER-AM CANCER SOC, V113, P3556, DOI 10.1002/cncr.23944; Petri AL, 2004, ALCOHOL CLIN EXP RES, V28, P1084, DOI 10.1097/01.ALC.0000130812.85638.E1; Poynter JN, 2013, CANCER EPIDEM BIOMAR, V22, P681, DOI 10.1158/1055-9965.EPI-12-0966; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Raik BL, 2004, J AM GERIATR SOC, V52, P440, DOI 10.1111/j.1532-5415.2004.52119.x; Ritte R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3186; Schonberg MA, 2006, J GEN INTERN MED, V21, P979, DOI 10.1007/BF02743148; Schonberg MA, 2010, J CLIN ONCOL, V28, P2038, DOI 10.1200/JCO.2009.25.9796; Schonberg MA, 2009, J CLIN ONCOL, V27, P1774, DOI 10.1200/JCO.2008.19.9877; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Shantakumar S, 2007, BREAST CANCER RES TR, V102, P365, DOI 10.1007/s10549-006-9343-4; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Sox HC, 1998, J GEN INTERN MED, V13, P424, DOI 10.1046/j.1525-1497.1998.00126.x; Stefanek ME, 2011, JNCI-J NATL CANCER I, V103, P1821, DOI 10.1093/jnci/djr474; Sweeney C, 2004, AM J EPIDEMIOL, V160, P868, DOI 10.1093/aje/kwh276; Torke AM, 2013, JAMA INTERN MED, V173, P526, DOI 10.1001/jamainternmed.2013.2903; TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011, DOI 10.1093/oxfordjournals.aje.a009057; Vacek PM, 2011, BREAST CANCER RES TR, V130, P291, DOI 10.1007/s10549-011-1576-1; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; VanDijck JAAM, 1996, INT J CANCER, V66, P727, DOI 10.1002/(SICI)1097-0215(19960611)66:6<727::AID-IJC3>3.0.CO;2-1; Walter LC, 2001, J GEN INTERN MED, V16, P779, DOI 10.1046/j.1525-1497.2001.10113.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warner E, 2012, CAN MED ASSOC J, V184, P1803, DOI 10.1503/cmaj.120392; Wegwarth O, 2013, JAMA INTERN MED, V173, P2086, DOI 10.1001/jamainternmed.2013.10363; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 1998, J NATL CANCER I, V90, P1389, DOI 10.1093/jnci/90.18.1389; Wildiers H, 2007, LANCET ONCOL, V8, P1101, DOI 10.1016/S1470-2045(07)70378-9; Yong LC, 1996, AM J EPIDEMIOL, V143, P985, DOI 10.1093/oxfordjournals.aje.a008681; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zmuda JM, 2001, J NATL CANCER I, V93, P930, DOI 10.1093/jnci/93.12.930	98	137	138	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1336	1347		10.1001/jama.2014.2834	http://dx.doi.org/10.1001/jama.2014.2834			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691609	Green Accepted			2022-12-28	WOS:000333645400017
J	Bhandari, N				Bhandari, Neena			INFECTIOUS DISEASE After eradication: India's post-polio problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												neena@india-voice.com						[Anonymous], 2010, TIMES INDIA; Chan M, 2014, WHO DIRECTOR GEN CEL; HALSTEAD LS, 1985, ORTHOPEDICS, V8, P845; March of Dimes, 2000, MARCH DIMES, P9; March of Dimes Steering Committee on Post-Polio Syndrome, 2002, MARCH DIM INT C POST; Ministry of Health and Family Welfare Government of India, 2011, POL ER IND PROGR CUR; National Institute of Neurological Disorders and Stroke, 2012, NIH PUBLICATION; Raymond M, 1875, COMPTES RENDUS SOC B, V127, P158; UNICEF, 2012, 200 000 ZER JOURN PO	9	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2275	10.1136/bmj.g2275	http://dx.doi.org/10.1136/bmj.g2275			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TK	24687315				2022-12-28	WOS:000333976100004
J	Assad, JA				Assad, John A.			Updating views of visual updating	NATURE			English	Editorial Material							SPATIAL ATTENTION; EYE-MOVEMENTS		[Assad, John A.] Ctr Neurosci & Cognit Syst, Ist Italiano Tecnol, I-38068 Rovereto, Italy; [Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Istituto Italiano di Tecnologia - IIT; Harvard University; Harvard Medical School	Assad, JA (corresponding author), Ctr Neurosci & Cognit Syst, Ist Italiano Tecnol, I-38068 Rovereto, Italy.	jassad@hms.harvard.edu						Conner CE, 1997, J NEUROSCI, V17, P3201; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Von Helmholtz H, 1866, TREATISE PHYSL OPTIC; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Zirnsak M, 2014, NATURE, V507, P504, DOI 10.1038/nature13149	7	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					434	435		10.1038/507434a	http://dx.doi.org/10.1038/507434a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670754				2022-12-28	WOS:000333402000023
J	Iacobucci, G				Iacobucci, Gareth			Raiding the public health budget	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Department of Health, PUBL HLT GRANTS LOC; Department of Health, PUBL HLTH RINGF GRAN; Dunton J., 2010, LOCAL GOVT CHRO 1005; Iacobucci G., 2014, BMJ CAREERS; Limb M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7311; Mansfield C., HLTH DIALOGUES EMBED	6	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2014	348								g2274	10.1136/bmj.g2274	http://dx.doi.org/10.1136/bmj.g2274			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LW	24671967				2022-12-28	WOS:000333587600003
J	Trujillo, CA; Sheppard, SS				Trujillo, Chadwick A.; Sheppard, Scott S.			A Sedna-like body with a perihelion of 80 astronomical units	NATURE			English	Article							KUIPER-BELT OBJECTS; OUTER SOLAR-SYSTEM; EXTENDED SCATTERED DISK; TRANS-NEPTUNIAN BELT; INNER OORT CLOUD; STELLAR ENCOUNTERS; BIRTH CLUSTER; GIANT PLANETS; ORIGIN; PERTURBATIONS	The observable Solar System can be divided into three distinct regions: the rocky terrestrial planets including the asteroids at 0.39 to 4.2 astronomical units (AU) from the Sun (where 1 AU is the mean distance between Earth and the Sun), the gas giant planets at 5 to 30 AU from the Sun, and the icy Kuiper belt objects at 30 to 50 AU from the Sun. The 1,000-kilometre-diameter dwarf planet Sedna was discovered ten years ago and was unique in that its closest approach to the Sun (perihelion) is 76 AU, far greater than that of any other Solar System body(1). Formation models indicate that Sedna could be a link between the Kuiper belt objects and the hypothesized outer Oort cloud at around 10,000 AU from the Sun(2-6). Here we report the presence of a second Sedna-like object, 2012 VP113, whose perihelion is 80 AU. The detection of 2012 VP113 confirms that Sedna is not an isolated object; instead, both bodies may be members of the inner Oort cloud, whose objects could outnumber all other dynamically stable populations in the Solar System.	[Trujillo, Chadwick A.] Gemini Observ, Hilo, HI 96720 USA; [Sheppard, Scott S.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Trujillo, CA (corresponding author), Gemini Observ, 670 North Aohoku Pl, Hilo, HI 96720 USA.	trujillo@gemini.edu		Sheppard, Scott/0000-0003-3145-8682; Trujillo, Chadwick/0000-0001-9859-0894	National Science Foundation; NASA [NNX12AG26G]; Gemini Observatory	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Gemini Observatory	We thank the Dark Energy Camera (DECam) team for obtaining observations during DECam commissioning, D. Norman for scheduling the November 2012 DECam observations, and D. Norman, A. Kunder and K. Holhjem for queue observing in November. T. Abbott and F. Valdes were very helpful during our December 2012 DECam observations. This project used data obtained with DECam, which was constructed by the Dark Energy Survey collaborating institutions. Observations were in part obtained at the Cerro Tololo Inter-American Observatory, National Optical Astronomy Observatory, which is operated by the Association of Universities for Research in Astronomy, under contract with the National Science Foundation. This paper includes data gathered with the 6.5-m Magellan telescopes located at Las Campanas Observatory, Chile. This research was funded by NASA Planetary Astronomy grant NNX12AG26G and has also been supported by the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, Inc., on behalf of the international Gemini partnership of Argentina, Australia, Brazil, Canada, Chile and the USA.	Becker AC, 2008, ASTROPHYS J LETT, V682, pL53, DOI 10.1086/590429; Bernstein G, 2000, ASTRON J, V120, P3323, DOI 10.1086/316868; Brasser R, 2006, ICARUS, V184, P59, DOI 10.1016/j.icarus.2006.04.010; Brasser R, 2012, ICARUS, V217, P1, DOI 10.1016/j.icarus.2011.10.012; Brasser R, 2008, ASTRON ASTROPHYS, V492, P251, DOI 10.1051/0004-6361:200810452; Brown ME, 2004, ASTROPHYS J, V617, P645, DOI 10.1086/422095; Chambers J. E., 2012, MERCURY SOFTWARE PAC; Chen YT, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L8; Diehl T., 2012, PHYS PROCEDIA, V37, P1332; Doressoundiram A., 2008, SOLAR SYSTEM NEPTUNE, P91; Dukes D, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/56; Gladman B, 2006, ASTROPHYS J, V643, pL135, DOI 10.1086/505214; Gladman B, 2002, ICARUS, V157, P269, DOI 10.1006/icar.2002.6860; Goldreich P, 2004, ASTROPHYS J, V614, P497, DOI 10.1086/423612; Gomes RS, 2006, ICARUS, V184, P589, DOI 10.1016/j.icarus.2006.05.026; Gomes RS, 2005, CELEST MECH DYN ASTR, V91, P109, DOI 10.1007/s10569-004-4623-y; Gomes RS, 2008, SOLAR SYSTEM NEPTUNE, P259; Gulbis AAS, 2010, ASTRON J, V140, P350, DOI 10.1088/0004-6256/140/2/350; Ida S, 2000, ASTROPHYS J, V528, P351, DOI 10.1086/308179; Kaib NA, 2011, ICARUS, V215, P491, DOI 10.1016/j.icarus.2011.07.037; Kenyon SJ, 2004, NATURE, V432, P598, DOI 10.1038/nature03136; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Levison HF, 2007, ICARUS, V189, P196, DOI 10.1016/j.icarus.2007.01.004; Levison HF, 2010, SCIENCE, V329, P187, DOI 10.1126/science.1187535; Lykawka PS, 2008, ASTRON J, V135, P1161, DOI 10.1088/0004-6256/135/4/1161; Lykawka PS, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/65; Melita MD, 2005, ICARUS, V173, P559, DOI 10.1016/j.icarus.2004.08.020; Nesvorny D, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/117; Petit J. M., 2008, SOLAR SYSTEM NEPTUNE, P71; Petit JM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/131; Pfalzner S, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201218792; Schwamb ME, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/2; Schwamb ME, 2010, ASTROPHYS J, V720, P1691, DOI 10.1088/0004-637X/720/2/1691; Sheppard SS, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/98; Sheppard SS, 2010, ASTROPHYS J LETT, V723, pL233, DOI 10.1088/2041-8205/723/2/L233; Sheppard SS, 2010, ASTRON J, V139, P1394, DOI 10.1088/0004-6256/139/4/1394; Soares JS, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201219840; Stansberry J., 2008, SOLAR SYSTEM NEPTUNE, V161; Trujillo CA, 2001, ASTRON J, V122, P457, DOI 10.1086/321117	42	192	192	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					471	+		10.1038/nature13156	http://dx.doi.org/10.1038/nature13156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670765				2022-12-28	WOS:000333402000034
J	Woodford, M				Woodford, Maralyn			Practice ABC of Major Trauma, 4th Edition Scoring Systems for Trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INJURY SEVERITY SCORE; CARE		Univ Manchester, Manchester, Lancs, England	University of Manchester	Woodford, M (corresponding author), Univ Manchester, Manchester, Lancs, England.							[Anonymous], 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; HOLLIS S, 1995, J TRAUMA, V38, P763, DOI 10.1097/00005373-199505000-00015; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9	8	6	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2014	348								g1142					10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7BF	24657602				2022-12-28	WOS:000333415200009
J	Kamar, N; Izopet, J; Tripon, S; Bismuth, M; Hillaire, S; Dumortier, J; Radenne, S; Coilly, A; Garrigue, V; D'Alteroche, L; Buchler, M; Couzi, L; Lebray, P; Dharancy, S; Minello, A; Hourmant, M; Roque-Afonso, AM; Abravanel, F; Pol, S; Rostaing, L; Mallet, V				Kamar, Nassim; Izopet, Jacques; Tripon, Simona; Bismuth, Michael; Hillaire, Sophie; Dumortier, Jerome; Radenne, Sylvie; Coilly, Audrey; Garrigue, Valerie; D'Alteroche, Louis; Buchler, Matthias; Couzi, Lionel; Lebray, Pascal; Dharancy, Sebastien; Minello, Anne; Hourmant, Maryvonne; Roque-Afonso, Anne-Marie; Abravanel, Florence; Pol, Stanislas; Rostaing, Lionel; Mallet, Vincent			Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEGYLATED INTERFERON-ALPHA; ORGAN-TRANSPLANTATION; VIROLOGICAL RESPONSE; HIV-INFECTION; CELL RESPONSE; THERAPY; PATIENT; KIDNEY	Background There is no established therapy for hepatitis E virus (HEV) infection. The aim of this retrospective, multicenter case series was to assess the effects of ribavirin as monotherapy for solid-organ transplant recipients with prolonged HEV viremia. Methods We examined the records of 59 patients who had received a solid-organ transplant (37 kidney-transplant recipients, 10 liver-transplant recipients, 5 heart-transplant recipients, 5 kidney and pancreas-transplant recipients, and 2 lung-transplant recipients). Ribavirin therapy was initiated a median of 9 months (range, 1 to 82) after the diagnosis of HEV infection at a median dose of 600 mg per day (range, 29 to 1200), which was equivalent to 8.1 mg per kilogram of body weight per day (range, 0.6 to 16.3). Patients received ribavirin for a median of 3 months (range, 1 to 18); 66% of the patients received ribavirin for 3 months or less. Results All the patients had HEV viremia when ribavirin was initiated (all 54 in whom genotyping was performed had HEV genotype 3). At the end of therapy, HEV clearance was observed in 95% of the patients. A recurrence of HEV replication occurred in 10 patients after ribavirin was stopped. A sustained virologic response, defined as an undetectable serum HEV RNA level at least 6 months after cessation of ribavirin therapy, occurred in 46 of the 59 patients (78%). A sustained virologic response was also observed in 4 patients who had a recurrence and were re-treated for a longer period. A higher lymphocyte count when ribavirin therapy was initiated was associated with a greater likelihood of a sustained virologic response. Anemia was the main identified side effect and required a reduction in ribavirin dose in 29% of the patients, the use of erythropoietin in 54%, and blood transfusions in 12%. Conclusions This retrospective, multicenter study showed that ribavirin as monotherapy may be effective in the treatment of chronic HEV infection; a 3-month course seemed to be an appropriate duration of therapy for most patients.	[Kamar, Nassim; Rostaing, Lionel] Ctr Hosp Univ CHU Rangueil, Dept Nephrol Dialysis & Organ Transplantat, Toulouse, France; [Kamar, Nassim; Izopet, Jacques; Abravanel, Florence; Rostaing, Lionel] CHU Purpan, Inst Federatif Rech Biomed Toulouse, INSERM U1043, Toulouse, France; [Kamar, Nassim; Izopet, Jacques; Abravanel, Florence; Rostaing, Lionel] Univ Toulouse 3, F-31062 Toulouse, France; [Izopet, Jacques; Abravanel, Florence] CHU Purpan, Dept Virol, Toulouse, France; [Izopet, Jacques; Abravanel, Florence] Natl Reference Ctr Hepatitis Virus E, Toulouse, France; [Tripon, Simona; Pol, Stanislas; Mallet, Vincent] Univ Paris 05, Inst Cochin, Sorbonne Paris Cite, CNRS,Unite Mixte Rech Sci 1016,Unite Mixte Rech 8, Paris, France; [Tripon, Simona; Pol, Stanislas; Mallet, Vincent] Grp Hosp Cochin St Vincent de Paul, AP HP, Unite Hepatol, Paris, France; [Lebray, Pascal] Hop La Pitie Salpetriere, Dept Hepatol, Paris, France; [Pol, Stanislas; Mallet, Vincent] INSERM U1016, Paris, France; [Bismuth, Michael] St Eloi Hosp, Dept Hepatol, Montpellier, France; [Garrigue, Valerie] Lapeyronie Hosp, Dept Nephrol & Transplantat, Montpellier, France; [Hillaire, Sophie] Hop Foch, Dept Hepatol, Suresnes, France; [Dumortier, Jerome] CHU Lyon, Hop Edouard Herriot, Dept Hepatol, Lyon, France; [Radenne, Sylvie] Univ Lyon 1, Dept Hepatol & Liver Transplantat, CHU Croix Rousse, F-69365 Lyon, France; [Radenne, Sylvie] INSERM U1052, Lyon, France; [Coilly, Audrey; Roque-Afonso, Anne-Marie] Univ Paris 11, Hop Paul Brousse, AP HP, Ctr Hepatobiliaire,Unite Mixte Rech Sci 785, Villejuif, France; [Coilly, Audrey; Roque-Afonso, Anne-Marie] INSERM U785, Villejuif, France; [D'Alteroche, Louis] Univ Hosp, Trousseau Hosp, Dept Hepatol, Tours, France; [Buchler, Matthias] Univ Hosp, Bretonneau Hosp, Dept Nephrol & Clin Immunol, Tours, France; [Couzi, Lionel] CHU Bordeaux, Dept Nephrol & Transplantat, Bordeaux, France; [Dharancy, Sebastien] CHU Lille, Hop Claude Huriez, Serv Malad Appareil Digestif, INSERM U995, F-59037 Lille, France; [Dharancy, Sebastien] Univ Nord France, Lille, France; [Minello, Anne] CHU Bocage, Serv Hepatogastroenterol, Dijon, France; [Hourmant, Maryvonne] CHU Nantes, Dept Nephrol & Clin Immunol, F-44035 Nantes 01, France	CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Hospital Foch; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Tours; CHU Tours; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; CHU Dijon Bourgogne; Nantes Universite; CHU de Nantes	Kamar, N (corresponding author), CHU Rangueil, Dept Nephrol & Organ Transplantat, TSA 50032, F-31059 Toulouse 9, France.	kamar.n@chu-toulouse.fr	Abrvaanel, florence/K-3776-2014; ABRAVANEL, Florence/AAC-2993-2021; Dharancy, Sebastien/M-4357-2018; IZOPET, Jacques/L-5756-2014; Roque-Afonso, Anne-Marie/AAF-9706-2021; Kamar, Nassim/L-6462-2014; Mallet, Vincent/G-4623-2011	ABRAVANEL, Florence/0000-0002-1753-1065; Dharancy, Sebastien/0000-0002-8262-5607; Kamar, Nassim/0000-0003-1930-8964; Mallet, Vincent/0000-0003-2219-9201; IZOPET, JACQUES/0000-0002-8462-3234				Abravanel F, 2012, J CLIN MICROBIOL, V50, P897, DOI 10.1128/JCM.05942-11; Alric L, 2011, AM J GASTROENTEROL, V106, P1562, DOI 10.1038/ajg.2011.158; Alric L, 2010, ANN INTERN MED, V153, P135, DOI 10.7326/0003-4819-153-2-201007200-00256; Chaillon A, 2011, J HEART LUNG TRANSPL, V30, P841, DOI 10.1016/j.healun.2011.03.013; Cheung MCM, 2012, ANN HEPATOL, V11, P618, DOI 10.1016/S1665-2681(19)31434-6; Dalton HR, 2011, ANN INTERN MED, V155, P479, DOI 10.7326/0003-4819-155-7-201110040-00017; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; de Niet A, 2012, NETH J MED, V70, P261; Del Bello A, 2012, J HEPATOL, V57, P1152, DOI 10.1016/j.jhep.2012.05.010; Fang SH, 2000, J HEPATOL, V33, P791, DOI 10.1016/S0168-8278(00)80312-8; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Haagsma EB, 2010, LIVER TRANSPLANT, V16, P474, DOI 10.1002/lt.22014; HEAGY W, 1991, J CLIN INVEST, V87, P1916, DOI 10.1172/JCI115217; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Hultgren C, 1998, J GEN VIROL, V79, P2381, DOI 10.1099/0022-1317-79-10-2381; Kamar N, 2013, AM J TRANSPLANT, V13, P1935, DOI 10.1111/ajt.12253; Kamar N, 2004, AM J KIDNEY DIS, V43, P140, DOI 10.1053/j.ajkd.2003.09.019; Kamar N, 2012, AM J TRANSPLANT, V12, P507, DOI 10.1111/j.1600-6143.2011.03838.x; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2012, HEPATOLOGY, V55, P1643, DOI 10.1002/hep.25578; Kamar N, 2012, TRANSPLANTATION, V93, P617, DOI 10.1097/TP.0b013e318245f14c; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; Kamar N, 2010, GASTROENTEROLOGY, V139, P1612, DOI 10.1053/j.gastro.2010.08.002; Kamar N, 2010, NEPHROL DIAL TRANSPL, V25, P2792, DOI 10.1093/ndt/gfq282; Kamar N, 2010, TRANSPLANTATION, V89, P353, DOI 10.1097/TP.0b013e3181c4096c; Kamar N, 2010, CLIN INFECT DIS, V50, pE30, DOI 10.1086/650488; Koning L, 2013, J HEART LUNG TRANSPL, V32, P78, DOI 10.1016/j.healun.2012.10.008; Mallet V, 2010, ANN INTERN MED, V153, P85, DOI 10.7326/0003-4819-153-2-201007200-00257; Ning Q, 1998, J IMMUNOL, V160, P3487; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; PATTERSON JL, 1990, REV INFECT DIS, V12, P1139; Pischke S, 2012, AM J TRANSPLANT, V12, P3128, DOI 10.1111/j.1600-6143.2012.04200.x; Pischke S, 2013, LIVER INT, V33, P722, DOI 10.1111/liv.12114; Riezebos-Brilman A, 2013, J HEART LUNG TRANSPL, V32, P341, DOI 10.1016/j.healun.2012.11.027; ROSTAING L, 1995, TRANSPLANTATION, V59, P1426, DOI 10.1097/00007890-199505270-00012; Singh GKJ, 2013, J INFECTION, V66, P103, DOI 10.1016/j.jinf.2011.11.027; Suneetha PV, 2012, HEPATOLOGY, V55, P695, DOI 10.1002/hep.24738	39	314	322	3	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1111	1120		10.1056/NEJMoa1215246	http://dx.doi.org/10.1056/NEJMoa1215246			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645943				2022-12-28	WOS:000333054000007
J	le Noble, F; le Noble, J				le Noble, Ferdinand; le Noble, Jos			BONE BIOLOGY Vessels of rejuvenation	NATURE			English	Editorial Material							REGENERATION; ANGIOGENESIS; HYPOXIA		[le Noble, Ferdinand] Max Delbruck Ctr Mol Med, Dept Angiogenesis & Cardiovasc Pathol, D-13125 Berlin, Germany; [le Noble, Jos] VieCuri Med Ctr, Dept Intens Care, NL-5912 BL Venlo, Netherlands	Helmholtz Association; Max Delbruck Center for Molecular Medicine; VieCuri Medical Center	le Noble, F (corresponding author), Max Delbruck Ctr Mol Med, Dept Angiogenesis & Cardiovasc Pathol, D-13125 Berlin, Germany.	lenoble@mdc-berlin.de	le Noble, Ferdinand/L-7867-2017					Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Thomas JL, 2013, CELL MOL LIFE SCI, V70, P1779, DOI 10.1007/s00018-013-1312-6; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Wong BW, 2013, TRENDS BIOCHEM SCI, V38, P3, DOI 10.1016/j.tibs.2012.10.004	10	19	20	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					313	314		10.1038/nature13210	http://dx.doi.org/10.1038/nature13210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646993	Green Submitted			2022-12-28	WOS:000333029000024
J	McKinney, JD				McKinney, Jason D.			TECHNOLOGY Photonics illuminates the future of radar	NATURE			English	Editorial Material									US Naval Res Lab, Microwave Photon Sect, Opt Sci Div, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	McKinney, JD (corresponding author), US Naval Res Lab, Microwave Photon Sect, Opt Sci Div, Washington, DC 20375 USA.	jason.mckinney@nrl.navy.mil						Fortier TM, 2011, NAT PHOTONICS, V5, P425, DOI [10.1038/NPHOTON.2011.121, 10.1038/nphoton.2011.121]; Ghelfi P, 2014, NATURE, V507, P341, DOI 10.1038/nature13078; Kim J, 2008, OPT EXPRESS, V16, P16509, DOI 10.1364/OE.16.016509; Skolnik M. I, 1990, RADAR HDB, Vsecond; VONDERLINDE D, 1986, APPL PHYS B-PHOTO, V39, P201, DOI 10.1007/BF00697487	5	62	66	8	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					310	312		10.1038/507310a	http://dx.doi.org/10.1038/507310a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646990				2022-12-28	WOS:000333029000022
J	Ibrahim, MA				Ibrahim, Michel A.			A PATIENT'S JOURNEY The joy of cochlear implants	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ibrahim, MA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.								0	3	3	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2014	348								g2019	10.1136/bmj.g2019	http://dx.doi.org/10.1136/bmj.g2019			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AW	24643003				2022-12-28	WOS:000333414100002
J	Margo, K				Margo, Katherine			Review: Some clinical tests performed by specialists identify rotator cuff disease or tears	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Margo, K (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Alqunaee M, 2012, ARCH PHYS MED REHAB, V93, P229, DOI 10.1016/j.apmr.2011.08.035; Bot SDM, 2005, ANN RHEUM DIS, V64, P118, DOI 10.1136/ard.2003.019349	2	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC12	10.7326/0003-4819-160-6-201403180-02012	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638178				2022-12-28	WOS:000333521300011
J	Li, ZP; Heber, D				Li, Zhaoping; Heber, David			Managing Weight Loss Expectations The Challenge and the Opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTRIC BYPASS; SURGERY; MORTALITY; OUTCOMES; RISK	IMPORTANCE: Weight loss surgery (WLS) has been shown to produce long-term weight loss but is not risk free or universally effective. The weight loss expectations and willingness to undergo perioperative risk among patients seeking WLS remain unknown. OBJECTIVES: To examine the expectations and motivations of WLS patients and the mortality risks they are willing to undertake and to explore the demographic characteristics, clinical factors, and patient perceptions associated with high weight loss expectations and willingness to assume high surgical risk. DESIGN: We interviewed patients seeking WLS and conducted multivariable analyses to examine the characteristics associated with high weight loss expectations and the acceptance of mortality risks of 10% or higher. SETTING: Two WLS centers in Boston. PARTICIPANTS: Six hundred fifty-four patients. MAIN OUTCOME MEASURES: Disappointment with a sustained weight loss of 20% and willingness to accept a mortality risk of 10% or higher with WLS. RESULTS: On average, patients expected to lose as much as 38% of their weight after WLS and expressed disappointment if they did not lose at least 26%. Most patients (84.8%) accepted some risk of dying to undergo WLS, but only 57.5% were willing to undergo a hypothetical treatment that produced a 20% weight loss. The mean acceptable mortality risk to undergo WLS was 6.7%, but the median risk was only 0.1%; 19.5% of all patients were willing to accept a risk of at least 10%. Women were more likely than men to be disappointed with a 20% weight loss but were less likely to accept high mortality risk. After initial adjustment, white patients appeared more likely than African American patients to have high weight loss expectations and to be willing to accept high risk. Patients with lower quality-of-life scores and those who perceived needing to lose more than 10% and 20% of weight to achieve "any" health benefits were more likely to have unrealistic weight loss expectations. Low quality-of-life scores were also associated with willingness to accept high risk. CONCLUSIONS AND RELEVANCE: Most patients seeking WLS have high weight loss expectations and believe they need to lose substantial weight to derive any health benefits. Educational efforts may be necessary to align expectations with clinical reality.	[Li, Zhaoping; Heber, David] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA; [Li, Zhaoping] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Heber, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, 900 Vet Ave, Los Angeles, CA 90095 USA.	dheber@mednet.ucla.edu						Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Foster GD, 2001, ARCH INTERN MED, V161, P2133, DOI 10.1001/archinte.161.17.2133; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Ostlund MP, 2011, BRIT J SURG, V98, P811, DOI 10.1002/bjs.7416; Price HI, 2013, OBES SURG, V23, P1987, DOI 10.1007/s11695-013-1007-y; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; van Hout GCM, 2009, OBES SURG, V19, P701, DOI 10.1007/s11695-008-9446-6; Wee CC, 2013, JAMA SURG, V148, P264, DOI 10.1001/jamasurg.2013.1048	10	0	0	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1348	1349		10.1001/jama.2014.1154	http://dx.doi.org/10.1001/jama.2014.1154			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691610				2022-12-28	WOS:000333645400018
J	Shen, YC; Ye, DX; Celanovic, I; Johnson, SG; Joannopoulos, JD; Soljacic, M				Shen, Yichen; Ye, Dexin; Celanovic, Ivan; Johnson, Steven G.; Joannopoulos, John D.; Soljacic, Marin			Optical Broadband Angular Selectivity	SCIENCE			English	Article							PHOTONIC CRYSTALS; FREQUENCY-RANGE; HETEROSTRUCTURES; ENLARGEMENT; REFLECTION; EMISSION; GAP	Light selection based purely on the angle of propagation is a long-standing scientific challenge. In angularly selective systems, however, the transmission of light usually also depends on the light frequency. We tailored the overlap of the band gaps of multiple one-dimensional photonic crystals, each with a different periodicity, in such a way as to preserve the characteristic Brewster modes across a broadband spectrum. We provide theory as well as an experimental realization with an all-visible spectrum, p-polarized angularly selective material system. Our method enables transparency throughout the visible spectrum at one angle-the generalized Brewster angle-and reflection at every other viewing angle.	[Shen, Yichen; Celanovic, Ivan; Johnson, Steven G.; Joannopoulos, John D.; Soljacic, Marin] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Ye, Dexin] Zhejiang Univ, Lab Appl Res Electromagnet, Hangzhou 310027, Peoples R China; [Johnson, Steven G.] MIT, Dept Math, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Zhejiang University; Massachusetts Institute of Technology (MIT)	Shen, YC (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	ycshen@mit.edu	Soljacic, Marin/AAA-4868-2019; Shen, Yi/GRS-3602-2022; Joannopoulos, John D/E-6401-2013	Johnson, Steven/0000-0001-7327-4967	Army Research Office through the Institute for Soldier Nanotechnologies [W911NF-13-D0001]; MIT S3TEC Energy Research Frontier Center of the U.S. Department of Energy [DE-SC0001299]	Army Research Office through the Institute for Soldier Nanotechnologies; MIT S3TEC Energy Research Frontier Center of the U.S. Department of Energy	We thank P. Rebusco for critical reading and editing of the manuscript, J. J. Senkevich for advice on fabricating the sample, and C.-W. Hsu for valuable discussion. Supported in part by the Army Research Office through the Institute for Soldier Nanotechnologies under contract W911NF-13-D0001. The fabrication part of the effort, as well as M. S. (in part), were supported by the MIT S3TEC Energy Research Frontier Center of the U.S. Department of Energy under grant DE-SC0001299.	Akozbek N, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205430; Alu A, 2011, PHYS REV LETT, V106, DOI [10.1109/CLEOE.2011.5943650, 10.1103/PhysRevLett.106.123902]; ARCHARD JF, 1948, J SCI INSTR PHYS IND, V25, P407, DOI 10.1088/0950-7671/25/12/304; Bermel P, 2010, OPT EXPRESS, V18, pA314, DOI 10.1364/OE.18.00A314; Fink Y, 1998, SCIENCE, V282, P1679, DOI 10.1126/science.282.5394.1679; Hamam RE, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.035806; Hecht E., 2002, OPTICS; Hohn O, 2012, PROC SPIE, V8438, DOI 10.1117/12.921773; Joannopoulos J. D., 2011, PHOTONIC CRYSTALS MO; Johnson SG, 2000, APPL PHYS LETT, V77, P3490, DOI 10.1063/1.1328369; Kosten ED, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.1; Liu V, 2012, COMPUT PHYS COMMUN, V183, P2233, DOI 10.1016/j.cpc.2012.04.026; MacMaster S. W., 2006, U.S. Patent, Patent No. 7052746; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Perilloux B. E., 2002, THIN FILM DESIGN MOD; SCHAEFER DW, 1986, PHYS REV LETT, V56, P2199, DOI 10.1103/PhysRevLett.56.2199; Shin J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.093903; Sriram S., 1985, US Patent, Patent No. [4512638A, 4512638]; Wang X, 2002, APPL PHYS LETT, V80, P4291, DOI 10.1063/1.1484547; Winn JN, 1998, OPT LETT, V23, P1573, DOI 10.1364/OL.23.001573; Xu J, 2010, J LIGHTWAVE TECHNOL, V28, P2660, DOI 10.1109/JLT.2010.2060471; YABLONOVITCH E, 1993, J OPT SOC AM B, V10, P283, DOI 10.1364/JOSAB.10.000283; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Zhang C, 2000, J APPL PHYS, V87, P3174, DOI 10.1063/1.372318; Zhurin VV, 2000, J VAC SCI TECHNOL A, V18, P37, DOI 10.1116/1.582155	26	140	148	3	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1499	1501		10.1126/science.1249799	http://dx.doi.org/10.1126/science.1249799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675959	Green Submitted			2022-12-28	WOS:000333471000044
J	Way, JC; Collins, JJ; Keasling, JD; Silver, PA				Way, Jeffrey C.; Collins, James J.; Keasling, Jay D.; Silver, Pamela A.			Integrating Biological Redesign: Where Synthetic Biology Came From and Where It Needs to Go	CELL			English	Review							MICROBIAL-PRODUCTION; GENE-EXPRESSION; TRANSFECTED DNA; MEMORY; CELLS; TRANSCRIPTION; CIRCUITS; PATHWAY; LAMBDA; SWITCH	Synthetic biology seeks to extend approaches from engineering and computation to redesign of biology, with goals such as generating new chemicals, improving human health, and addressing environmental issues. Early on, several guiding principles of synthetic biology were articulated, including design according to specification, separation of design from fabrication, use of standardized biological parts and organisms, and abstraction. We review the utility of these principles over the past decade in light of the field's accomplishments in building complex systems based on microbial transcription and metabolism and describe the progress in mammalian cell engineering.	[Way, Jeffrey C.; Collins, James J.; Silver, Pamela A.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Keasling, Jay D.; Silver, Pamela A.] Univ Calif Berkeley, Synthet Biol Engn Res Ctr SynBERC, Berkeley, CA 94720 USA	Harvard University; Harvard University; Harvard Medical School; Boston University; Howard Hughes Medical Institute; Boston University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley	Silver, PA (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	Wyss Institute; DARPA; ONR; HHMI; DOE; NIH; NSF	Wyss Institute; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ONR(Office of Naval Research); HHMI(Howard Hughes Medical Institute); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	We acknowledge the Wyss Institute for continued support, the original Synthetic Biology Working Group at MIT, the many participants in iGEM since its inception, past and present members of our laboratories, a few visionary government scientists and program managers from DARPA and ONR who appreciated the potential of the field before it existed, and Devin Burrill for comments on the manuscript. The authors acknowledge support over the years from DARPA, ONR, HHMI, DOE, NIH, NSF, and their respective institutions.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Agapakis Christina M, 2010, J Biol Eng, V4, P3, DOI 10.1186/1754-1611-4-3; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Albert R, 2013, CHAOS, V23, DOI 10.1063/1.4810923; Arkin A, 1998, GENETICS, V149, P1633; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bagshawe KD, 2009, CURR DRUG TARGETS, V10, P152, DOI 10.2174/138945009787354520; Bergmann JH, 2012, CHROMOSOME RES, V20, P505, DOI 10.1007/s10577-012-9293-0; Bomford P., 2009, CROP YIELD PROJECTIO; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Bork P, 1997, TRENDS BIOCHEM SCI, V22, P296, DOI 10.1016/S0968-0004(97)01084-0; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Burrill DR, 2011, GENE DEV, V25, P434, DOI 10.1101/gad.1994911; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Carlson R, 2009, NAT BIOTECHNOL, V27, P1091, DOI 10.1038/nbt1209-1091; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Chester J, 2002, NAT BIOTECHNOL, V20, P256, DOI 10.1038/nbt0302-256; Cironi P, 2008, J BIOL CHEM, V283, P8469, DOI 10.1074/jbc.M708502200; de Almeida CR, 2012, BLOOD, V119, P6209, DOI 10.1182/blood-2012-03-402586; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dharmadi Y., 2013, NUCL ACIDS RES; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; Endy D., 2003, SYNTHETIC BIOL STUDY; Evans A. N., 2008, METHODS PSYCHOL RES; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feld B., 2011, START CUSTOMER EXPER; Fischer R.A., 2009, CAN TECHNOLOGY DELIV; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gardner TS, 2013, CURR OPIN CHEM BIOL, V17, P871, DOI 10.1016/j.cbpa.2013.09.013; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Guye P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt605; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kahl LJ, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-13; Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Knight T., 2003, STRUCTURE, V1, P11, DOI 10.21236/ADA457791; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Kung Y, 2012, ACS SYNTH BIOL, V1, P498, DOI 10.1021/sb300074k; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lienert F, 2013, NUCLEIC ACIDS RES, V41, P9967, DOI 10.1093/nar/gkt758; MATHEWS CK, 1993, J BACTERIOL, V175, P6377, DOI 10.1128/jb.175.20.6377-6381.1993; Meister GE, 2013, CHEMBIOCHEM, V14, P1460, DOI 10.1002/cbic.201300168; Merrihew RV, 1996, MOL CELL BIOL, V16, P10; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Moon TS, 2009, APPL ENVIRON MICROB, V75, P589, DOI 10.1128/AEM.00973-08; MURNANE JP, 1990, NUCLEIC ACIDS RES, V18, P2733, DOI 10.1093/nar/18.9.2733; Mutalik VK, 2013, NAT METHODS, V10, P347, DOI [10.1038/nmeth.2403, 10.1038/NMETH.2403]; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rader R. A., 2012, FDA BIOPHARMACEUTICA; Ren XY, 2006, STEM CELL REV, V2, P43, DOI 10.1385/SCR:2:1:43; Robinson-Mosher A, 2013, CHAOS, V23, DOI 10.1063/1.4810915; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Sharma SS, 2007, METAB ENG, V9, P133, DOI 10.1016/j.ymben.2006.10.002; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; SILHAVY TJ, 1976, P NATL ACAD SCI USA, V73, P3423, DOI 10.1073/pnas.73.10.3423; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wei KY, 2013, BIOTECHNOL BIOENG, V110, P1201, DOI 10.1002/bit.24792; Whitaker WR, 2011, METHOD ENZYMOL, V497, P447, DOI 10.1016/B978-0-12-385075-1.00019-6; Wieland M, 2012, ANNU REV CHEM BIOMOL, V3, P209, DOI 10.1146/annurev-chembioeng-061010-114145; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185	89	168	184	7	207	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					151	161		10.1016/j.cell.2014.02.039	http://dx.doi.org/10.1016/j.cell.2014.02.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679533	Bronze			2022-12-28	WOS:000333968900014
J	Wolff, S; Weissman, JS; Dillin, A				Wolff, Suzanne; Weissman, Jonathan S.; Dillin, Andrew			Differential Scales of Protein Quality Control	CELL			English	Review							EMBRYONIC STEM-CELLS; UBIQUITIN-PROTEASOME SYSTEM; HEAT-SHOCK GENES; ENDOPLASMIC-RETICULUM; MISFOLDED PROTEINS; TRANSCRIPTION FACTOR; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; COTRANSLATIONAL UBIQUITINATION; RIBOSOMAL-PROTEINS	Proteins are notorious for their unpleasant behavior-continually at risk of misfolding, collecting damage, aggregating, and causing toxicity and disease. To counter these challenges, cells have evolved elaborate chaperone and quality control networks that can resolve damage at the level of the protein, organelle, cell, or tissue. On the smallest scale, the integrity of individual proteins is monitored during their synthesis. On a larger scale, cells use compartmentalized defenses and networks of communication, capable sometimes of signaling between cells, to respond to changes in the proteome's health. Together, these layered defenses help protect cells from damaged proteins.	[Wolff, Suzanne; Dillin, Andrew] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Ctr RNA Syst Biol, Calif Inst Quantitat Biol,Dept Cellular & Mol Pha, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Ctr RNA Syst Biol, Calif Inst Quantitat Biol,Dept Cellular & Mol Pha, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu; dillin@berkeley.edu		Weissman, Jonathan/0000-0003-2445-670X	Glenn Foundation for Medical Research; Howard Hughes Medical Institute; National Institutes of Health (NIH) [GM098254, AG024365, AG042679, ES021667]; Thomas and Stacey Siebel Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024365, R01AG024365, R01AG042679] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas and Stacey Siebel Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Lindsay Daniele for the preparation of the figures used in this review. S.W. is supported by the Glenn Foundation for Medical Research. J.S.W. is supported by the Howard Hughes Medical Institute and by National Institutes of Health (NIH) grant GM098254. A.D. is supported by the , Thomas and Stacey Siebel Foundation, the Howard Hughes Medical Institute, and by NIH grants AG024365, AG042679 and ES021667. A.D. is a founder of Proteostasis Therapeutics and of Mitokyne.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Barna M, 2013, P NATL ACAD SCI USA, V110, P9, DOI 10.1073/pnas.1218764110; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gloge F, 2014, CURR OPIN STRUC BIOL, V24, P24, DOI 10.1016/j.sbi.2013.11.004; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Hashimoto Y, 2008, DEV GROWTH DIFFER, V50, pS269, DOI 10.1111/j.1440-169X.2008.00994.x; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; HIROMI Y, 1985, EMBO J, V4, P1681, DOI 10.1002/j.1460-2075.1985.tb03837.x; HIROMI Y, 1986, CELL, V44, P293, DOI 10.1016/0092-8674(86)90763-4; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ishiwata-Kimata Y, 2013, GENES CELLS, V18, P288, DOI 10.1111/gtc.12035; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Karbstein K, 2013, TRENDS CELL BIOL, V23, P242, DOI 10.1016/j.tcb.2013.01.004; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Madian AG, 2010, J PROTEOME RES, V9, P3766, DOI 10.1021/pr1002609; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Noller HF, 2012, CSH PERSPECT BIOL, V4, P1, DOI 10.1101/cshperspect.a003681; O'Brien EP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3988; Oikawa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051290; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; PARKER CS, 1984, CELL, V37, P273, DOI 10.1016/0092-8674(84)90323-4; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rock K. L., 2014, TRENDS IMMUNOL; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Salminen A, 2010, AGEING RES REV, V9, P211, DOI 10.1016/j.arr.2010.04.003; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; SINCLAIR JF, 1994, NAT STRUCT BIOL, V1, P320, DOI 10.1038/nsb0594-320; Siwiak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073943; Snapp E, 2005, MOL B INT U, P63; Soltys BJ, 1996, J CELL SCI, V109, P1909; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Takalo Mari, 2013, Am J Neurodegener Dis, V2, P1; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; WU C, 1984, NATURE, V311, P81, DOI 10.1038/311081a0; Xu D, 1998, FOLD DES, V3, P11, DOI 10.1016/S1359-0278(98)00004-2; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	134	169	170	1	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					52	64		10.1016/j.cell.2014.03.007	http://dx.doi.org/10.1016/j.cell.2014.03.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679526	Bronze			2022-12-28	WOS:000333968900007
J	Herbert, N; George, A; Masham Ilton; Sharma, V; Oliver, M; Oxley, A; Raviglione, M; Zumla, AI				Herbert, Nick; George, Andrew; Baroness Masham of Ilton; Sharma, Virendra; Oliver, Matt; Oxley, Aaron; Raviglione, Mario; Zumla, Alimuddin I.			World TB Day 2014: finding the missing 3 million	LANCET			English	Editorial Material							MTB/RIF ASSAY; TUBERCULOSIS		[Herbert, Nick; George, Andrew; Sharma, Virendra] Houses Parliament, All Party Parliamentary Grp Global TB, London, England; [Oliver, Matt; Oxley, Aaron] RESULTS UK, London, England; [Raviglione, Mario] WHO, Global TB Dept, CH-1211 Geneva, Switzerland; [Zumla, Alimuddin I.] UCL, Div Infect & Immun, UCL Royal Free Campus, London NW3 2PF, England; [Zumla, Alimuddin I.] UCL Hosp NHS Fdn Trust, London NW3 2PF, England	World Health Organization; University of London; University College London; University of London; University College London	Zumla, AI (corresponding author), UCL, Div Infect & Immun, UCL Royal Free Campus, London NW3 2PF, England.		ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; RAVIGLIONE, Mario/0000-0002-9331-2067				Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Bates M, 2013, TROP MED INT HEALTH, V18, P1134, DOI 10.1111/tmi.12145; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; O'Grady J, 2012, CLIN INFECT DIS, V55, P1171, DOI 10.1093/cid/cis631; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Raviglione M, 2013, 3 STOP TB PARTN COOR; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	12	42	43	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1016	1018		10.1016/S0140-6736(14)60422-0	http://dx.doi.org/10.1016/S0140-6736(14)60422-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24656187				2022-12-28	WOS:000333521200005
J	Deschene, ER; Myung, P; Rompolas, P; Zito, G; Sun, TY; Taketo, MM; Saotome, I; Greco, V				Deschene, Elizabeth R.; Myung, Peggy; Rompolas, Panteleimon; Zito, Giovanni; Sun, Thomas Yang; Taketo, Makoto M.; Saotome, Ichiko; Greco, Valentina			beta-Catenin Activation Regulates Tissue Growth Non-Cell Autonomously in the Hair Stem Cell Niche	SCIENCE			English	Article							FOLLICLE MORPHOGENESIS; TRANSIENT ACTIVATION; EMBRYONIC EPIDERMIS; MAINTENANCE; INITIATION; RENEWAL; PHASE; CYCLE	Wnt/beta-catenin signaling is critical for tissue regeneration. However, it is unclear how beta-catenin controls stem cell behaviors to coordinate organized growth. Using live imaging, we show that activation of beta-catenin specifically within mouse hair follicle stem cells generates new hair growth through oriented cell divisions and cellular displacement. beta-Catenin activation is sufficient to induce hair growth independently of mesenchymal dermal papilla niche signals normally required for hair regeneration. Wild-type cells are co-opted into new hair growths by beta-catenin mutant cells, which non-cell autonomously activate Wnt signaling within the neighboring wild-type cells via Wnt ligands. This study demonstrates a mechanism by which Wnt/beta-catenin signaling controls stem cell-dependent tissue growth non-cell autonomously and advances our understanding of the mechanisms that drive coordinated regeneration.	[Deschene, Elizabeth R.; Rompolas, Panteleimon; Zito, Giovanni; Sun, Thomas Yang; Saotome, Ichiko; Greco, Valentina] Yale Univ, Dept Genet, Yale Stem Cell Ctr, Yale Canc Ctr,Sch Med, New Haven, CT 06510 USA; [Myung, Peggy; Greco, Valentina] Yale Univ, Dept Dermatol, Sch Med, New Haven, CT 06510 USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Yale University; Yale University; Kyoto University	Greco, V (corresponding author), Yale Univ, Dept Genet, Yale Stem Cell Ctr, Yale Canc Ctr,Sch Med, New Haven, CT 06510 USA.	valentina.greco@yale.edu	Sun, Thomas/AAG-4824-2020; Zito, Giovanni/AAC-3639-2022; , Zito/O-3836-2019	, Zito/0000-0002-0482-6729; Sun, Thomas Yang/0000-0001-7436-0138; Rompolas, Panteleimon/0000-0001-9135-7651	American Cancer Society [RSG-12-059-02]; Yale Spore Grant National Cancer Institute, NIH [2P50CA121974]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [1R01AR063663-01]; Yale Stem Cell Center Lo Fellowship; NIH Predoctoral Program in Cellular and Molecular Biology [TG32 GM007223]; CT Innovations [13-SCA-YALE-20]; Rheumatic Diseases Research Core Centers [5 P30 AR053495-07]; NATIONAL CANCER INSTITUTE [P50CA121974, P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495, K08AR066790, R01AR063663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Yale Spore Grant National Cancer Institute, NIH; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Yale Stem Cell Center Lo Fellowship; NIH Predoctoral Program in Cellular and Molecular Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CT Innovations; Rheumatic Diseases Research Core Centers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ito, J. Lim, K. Politi, A. Habermann, and D. Gonzalez for insights and equipment; E. Fuchs for the K14 Delta N beta-catenin construct and K14-H2B-GFP;Lef1-RFP mice; and G. Gu for K19Cre<SUP>ER</SUP> and M. Taketo for beta-catn<SUP>flox(Ex3)/+</SUP> mice. This work is supported by grants to V.G. by the American Cancer Society, grant no. RSG-12-059-02; Yale Spore Grant National Cancer Institute, NIH, grant no. 2P50CA121974; and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, grant no. 1R01AR063663-01. E.D. was supported by the Yale Stem Cell Center Lo Fellowship and the NIH Predoctoral Program in Cellular and Molecular Biology, grant no. TG32 GM007223. P.R. and G.Z. are New York Stem Cell Foundation-Druckenmiller Fellows. P.R. is supported by the CT Innovations, grant no. 13-SCA-YALE-20. Intravital microscopy was done in the In Vivo Imaging Facility at Yale School of Medicine supported by the Rheumatic Diseases Research Core Centers, grant no. 5 P30 AR053495-07. K14-H2B-GFP;Lef1-RFP mice and the K14 Delta N beta-catenin construct are available from E. Fuchs under a material transfer agreement with Rockefeller University. beta-catn<SUP>flox(Ex3)/+</SUP> mice are available from M. Taketo under a material transfer agreement with Banyu-Merck. We declare no conflict of interest.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Baker CM, 2010, DEV BIOL, V343, P40, DOI 10.1016/j.ydbio.2010.04.005; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chi WY, 2010, J INVEST DERMATOL, V130, P2664, DOI 10.1038/jid.2010.176; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DasGupta R, 2002, J CELL BIOL, V158, P331, DOI 10.1083/jcb.200204134; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Myung PS, 2013, J INVEST DERMATOL, V133, P31, DOI 10.1038/jid.2012.230; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rompolas P., 2013, SEMIN CELL DEV BIOL, V2013; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Tortelote GG, 2013, DEV BIOL, V374, P164, DOI 10.1016/j.ydbio.2012.10.013; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459	30	82	83	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1353	1356		10.1126/science.1248373	http://dx.doi.org/10.1126/science.1248373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653033	Green Published, Green Accepted			2022-12-28	WOS:000333108500037
J	Paul, BD; Sbodio, JI; Xu, RS; Vandiver, MS; Cha, JY; Snowman, AM; Snyder, SH				Paul, Bindu D.; Sbodio, Juan I.; Xu, Risheng; Vandiver, M. Scott; Cha, Jiyoung Y.; Snowman, Adele M.; Snyder, Solomon H.			Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease	NATURE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HYDROGEN-SULFIDE; OXIDATIVE STRESS; H2S; SULFHYDRATION; CYSTEINE; MICE; DYSFUNCTION; MODEL	Huntington's disease is an autosomal dominant disease associated with a mutation in the gene encoding huntingtin (Htt) leading to expanded polyglutamine repeats of mutant Htt (mHtt) that elicit oxidative stress, neurotoxicity, and motor and behavioural changes(1). Huntington's disease is characterized by highly selective and profound damage to the corpus striatum, which regulates motor function. Striatal selectivity of Huntington's disease may reflect the striatally selective small G protein Rhes binding to mHtt and enhancing its neurotoxicity(2). Specific molecular mechanisms by which mHtt elicits neurodegeneration have been hard to determine. Here we show a major depletion of cystathionine gamma-lyase (CSE), the biosynthetic enzyme for cysteine, in Huntington's disease tissues, which may mediate Huntington's disease pathophysiology. The defect occurs at the transcriptional level and seems to reflect influences of mHtt on specificity protein 1, a transcriptional activator for CSE. Consistent with the notion of loss of CSE as a pathogenic mechanism, supplementation with cysteine reverses abnormalities in cultures of Huntington's disease tissues and in intact mouse models of Huntington's disease, suggesting therapeutic potential.	[Paul, Bindu D.; Sbodio, Juan I.; Xu, Risheng; Vandiver, M. Scott; Cha, Jiyoung Y.; Snowman, Adele M.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; [Xu, Risheng; Vandiver, M. Scott; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			United States Public Health Service [MH18501]; CHDI; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); CHDI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. C. Troncoso and O. Pletnikova for providing the human post-mortemtissue samples; D. Krainc for the constructsCMV-SP1 and TAF4; M. MacDonald for the striatal Q7 and Q111 cell lines; and the Cure Huntington's Disease Initiative (CHDI) for the Q175 mice tissues. This work was supported by United States Public Health Service Grant MH18501 to S. H. S. and by the CHDI. M. S. V. and R. X. are supported by the National Institutes of Health Medical Scientist Training Program Award.	ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Cyr M, 2005, NEUROIMAGE, V26, P83, DOI 10.1016/j.neuroimage.2005.01.039; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Droge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fox JH, 2004, J NEUROCHEM, V91, P413, DOI 10.1111/j.1471-4159.2004.02726.x; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Subramaniam S, 2011, NEUROPHARMACOLOGY, V60, P1187, DOI 10.1016/j.neuropharm.2010.10.025; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030	30	256	263	4	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					96	+		10.1038/nature13136	http://dx.doi.org/10.1038/nature13136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670645	Green Accepted			2022-12-28	WOS:000335199100046
J	Signer, RAJ; Magee, JA; Salic, A; Morrison, SJ				Signer, Robert A. J.; Magee, Jeffrey A.; Salic, Adrian; Morrison, Sean J.			Haematopoietic stem cells require a highly regulated protein synthesis rate	NATURE			English	Article							DIAMOND-BLACKFAN ANEMIA; TRANSLATIONAL CONTROL; PROTEASOME ACTIVITY; PROGENITOR CELLS; S19 DEFICIENCY; MTOR PATHWAY; SELF-RENEWAL; BONE-MARROW; IN-VIVO; PTEN	Many aspects of cellular physiology remain unstudied in somatic stem cells, for example, there are almost no data on protein synthesis in any somatic stem cell. Here we set out to compare protein synthesis in haematopoietic stem cells (HSCs) and restricted haematopoietic progenitors. We found that the amount of protein synthesized per hour in HSCs in vivo was lower than in most other haematopoietic cells, even if we controlled for differences in cell cycle status or forced HSCs to undergo self-renewing divisions. Reduced ribosome function in Rpl24(Bst/+) mice further reduced protein synthesis in HSCs and impaired HSC function. Pten deletion increased protein synthesis in HSCs but also reduced HSC function. Rpl24(Bst/+) cell-autonomously rescued the effects of Pten deletion in HSCs; blocking the increase in protein synthesis, restoring HSC function, and delaying leukaemogenesis. Pten deficiency thus depletes HSCs and promotes leukaemia partly by increasing protein synthesis. Either increased or decreased protein synthesis impairs HSC function.	[Signer, Robert A. J.; Magee, Jeffrey A.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA; [Salic, Adrian] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021; Salic, Adrian/GXG-1611-2022	Morrison, Sean/0000-0003-1587-8329; Signer, Robert/0000-0003-3286-1334	Cancer Prevention and Research Institute of Texas; National Institute on Aging [R37 AG024945]; Leukemia & Lymphoma Society [5541-11]; Canadian Institutes of Health Research [MFE-106993]; UT Southwestern K12 Pediatrics Training Grant [K12-HD068369]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024945] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UT Southwestern K12 Pediatrics Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	S.J.M. is a Howard Hughes Medical Institute Investigator, the Mary McDermott Cook Chair in Pediatric Genetics, and the director of the Hamon Laboratory for Stem Cells and Cancer. This work was supported by the Cancer Prevention and Research Institute of Texas and the National Institute on Aging (R37 AG024945). R.A.J.S. was supported by fellowships from the Leukemia & Lymphoma Society (5541-11) and the Canadian Institutes of Health Research (MFE-106993). J.A.M. was supported by the UT Southwestern K12 Pediatrics Training Grant (K12-HD068369). We thank A. Pineda, K. Cowan, E. Daniel, M. Acar, H. Oguro, J. Peyer, K. Rajagopalan, M. Agathocleous and E. Piskounova for technical support and advice; N. Loof and the Moody Foundation Flow Cytometry Facility, L. Hynan and J. Reisch for advice regarding statistics; J. Shelton for histology; and R. Coolon, S. Manning, M. Gross and K. Correll for mouse colony management.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Fumagalli S, 2011, SEMIN HEMATOL, V48, P97, DOI 10.1053/j.seminhematol.2011.02.004; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Payne EM, 2012, BLOOD, V120, P2214, DOI 10.1182/blood-2011-10-382986; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Sakamoto KM, 2010, BIOL BLOOD MARROW TR, V16, pS12, DOI 10.1016/j.bbmt.2009.09.012; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sen S, 2011, BLOOD, V118, P6407, DOI 10.1182/blood-2011-02-335190; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Starck SR, 2004, CHEM BIOL, V11, P999, DOI 10.1016/j.chembiol.2004.05.011; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	47	356	362	4	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					49	+		10.1038/nature13035	http://dx.doi.org/10.1038/nature13035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670665	Green Accepted, Green Submitted			2022-12-28	WOS:000335199100037
J	Boyce, JW; Tomlinson, SM; McCubbin, FM; Greenwood, JP; Treiman, AH				Boyce, J. W.; Tomlinson, S. M.; McCubbin, F. M.; Greenwood, J. P.; Treiman, A. H.			The Lunar Apatite Paradox	SCIENCE			English	Article							WATER; CHLORINE; HYDROXYL; DELIVERY; FLUORINE; HYDROGEN; OLIVINE; LIQUID; SYSTEM; MANTLE	Recent discoveries of water-rich lunar apatite are more consistent with the hydrous magmas of Earth than the otherwise volatile-depleted rocks of the Moon. Paradoxically, this requires H-rich minerals to form in rocks that are otherwise nearly anhydrous. We modeled existing data from the literature, finding that nominally anhydrous minerals do not sufficiently fractionate H from F and Cl to generate H-rich apatite. Hydrous apatites are explained as the products of apatite-induced low magmatic fluorine, which increases the H/F ratio in melt and apatite. Mare basalts may contain hydrogen-rich apatite, but lunar magmas were most likely poor in hydrogen, in agreement with the volatile depletion that is both observed in lunar rocks and required for canonical giant-impact models of the formation of the Moon.	[Boyce, J. W.; Tomlinson, S. M.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [McCubbin, F. M.] Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Greenwood, J. P.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA	University of California System; University of California Los Angeles; University of New Mexico; Wesleyan University	Boyce, JW (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA.	jwboyce@alum.mit.edu	Boyce, Jeremy W/A-7514-2008; McCubbin, Francis/AAG-1095-2020		NASA Cosmochemistry grant [NNX13AG40G, NNX12AH64G]; NASA Lunar Advanced Science for Exploration Research grant [NNX13AK32G]; NASA Lunar Advanced Science for Exploration Research [NNX11AB29G]	NASA Cosmochemistry grant; NASA Lunar Advanced Science for Exploration Research grant; NASA Lunar Advanced Science for Exploration Research	J.W.B. acknowledges support from NASA Cosmochemistry grant NNX13AG40G; A. H. T. and J.W.B. acknowledge support from NASA Cosmochemistry grant NNX12AH64G to A. H. T. F. M. M. acknowledges support from NASA Lunar Advanced Science for Exploration Research grant NNX13AK32G. J.P.G. acknowledges support from NASA Lunar Advanced Science for Exploration Research NNX11AB29G and J. Eckert (Yale) for assistance with the electron-probe microanalysis. All data used in the modeling and testing of the model for this paper are available in the supplementary materials or in the published, refereed journal articles that are cited in the references section. J. W. B., F. M. M., and A. H. T. conceived of the solution to the lunar apatite paradox. S. M. T. and J. W. B. wrote the numerical model. J. P. G. provided essential tests of the model. All authors contributed to the writing of the paper.	Anand M, 2006, GEOCHIM COSMOCHIM AC, V70, P246, DOI 10.1016/j.gca.2005.08.018; Anand M., 2013, MINERAL MAG, V77, P589; Barnes JJ, 2013, CHEM GEOL, V337, P48, DOI 10.1016/j.chemgeo.2012.11.015; Beaty D., 1978, P LUNAR PLANET SCI C, V9, P58; Beyer C, 2012, EARTH PLANET SC LETT, V337, P1, DOI 10.1016/j.epsl.2012.05.003; Boyce JW, 2012, AM MINERAL, V97, P1116, DOI 10.2138/am.2012.3965; Boyce JW, 2010, NATURE, V466, P466, DOI 10.1038/nature09274; Elardo SM, 2014, METEORIT PLANET SCI, V49, P261, DOI 10.1111/maps.12239; Fabbrizio A, 2013, GEOCHIM COSMOCHIM AC, V121, P684, DOI 10.1016/j.gca.2013.05.026; Greenwood JP, 2011, NAT GEOSCI, V4, P79, DOI 10.1038/NGEO1050; Hauri EH, 2006, EARTH PLANET SC LETT, V248, P715, DOI 10.1016/j.epsl.2006.06.014; Hauri EH, 2011, SCIENCE, V333, P213, DOI 10.1126/science.1204626; Huh M., 2011, AM GEOPH UN FALL M A, V1, P2534; Hui HJ, 2013, NAT GEOSCI, V6, P177, DOI 10.1038/ngeo1735; Mathez EA, 2005, GEOCHIM COSMOCHIM AC, V69, P1275, DOI 10.1016/j.gca.2004.08.035; McCubbin FM, 2011, GEOCHIM COSMOCHIM AC, V75, P5073, DOI 10.1016/j.gca.2011.06.017; Mccubbin FM, 2010, AM MINERAL, V95, P1141, DOI 10.2138/am.2010.3448; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; O'Leary JA, 2010, EARTH PLANET SC LETT, V297, P111, DOI 10.1016/j.epsl.2010.06.011; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; Tartese R, 2013, EARTH PLANET SC LETT, V361, P480, DOI 10.1016/j.epsl.2012.11.015; Taylor SR, 2006, REV MINERAL GEOCHEM, V60, P657, DOI 10.2138/rmg.2006.60.7; Toplis MJ, 2005, CONTRIB MINERAL PETR, V149, P22, DOI 10.1007/s00410-004-0629-4; Vander Kaaden K., 2012, P LUNAR PLANET SCI C, V43; Webster JD, 2009, GEOCHIM COSMOCHIM AC, V73, P559, DOI 10.1016/j.gca.2008.10.034	29	125	128	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					400	402		10.1126/science.1250398	http://dx.doi.org/10.1126/science.1250398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24652938				2022-12-28	WOS:000334867800037
J	Asfar, P; Meziani, F; Hamel, JF; Grelon, F; Megarbane, B; Anguel, N; Mira, JP; Dequin, PF; Gergaud, S; Weiss, N; Legay, F; Le Tulzo, Y; Conrad, M; Robert, R; Gonzalez, F; Guitton, C; Tamion, F; Tonnelier, JM; Guezennec, P; Van der Linden, T; Vieillard-Baron, A; Mariotte, E; Pradel, G; Lesieur, O; Ricard, JD; Herve, F; du Cheyron, D; Guerin, C; Mercat, A; Teboul, JL; Radermacher, P				Asfar, Pierre; Meziani, Ferhat; Hamel, Jean-Francois; Grelon, Fabien; Megarbane, Bruno; Anguel, Nadia; Mira, Jean-Paul; Dequin, Pierre-Francois; Gergaud, Soizic; Weiss, Nicolas; Legay, Francois; Le Tulzo, Yves; Conrad, Marie; Robert, Rene; Gonzalez, Frederic; Guitton, Christophe; Tamion, Fabienne; Tonnelier, Jean-Marie; Guezennec, Pierre; Van der Linden, Thierry; Vieillard-Baron, Antoine; Mariotte, Eric; Pradel, Gael; Lesieur, Olivier; Ricard, Jean-Damien; Herve, Fabien; du Cheyron, Damien; Guerin, Claude; Mercat, Alain; Teboul, Jean-Louis; Radermacher, Peter		SEPSISPAM Investigators	High versus Low Blood-Pressure Target in Patients with Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE SEPSIS; NOREPINEPHRINE; MANAGEMENT; GUIDELINES; VARIABLES; THERAPY	Background The Surviving Sepsis Campaign recommends targeting a mean arterial pressure of at least 65 mm Hg during initial resuscitation of patients with septic shock. However, whether this blood-pressure target is more or less effective than a higher target is unknown. Methods In a multicenter, open-label trial, we randomly assigned 776 patients with septic shock to undergo resuscitation with a mean arterial pressure target of either 80 to 85 mm Hg (high-target group) or 65 to 70 mm Hg (low-target group). The primary end point was mortality at day 28. Results At 28 days, there was no significant between-group difference in mortality, with deaths reported in 142 of 388 patients in the high-target group (36.6%) and 132 of 388 patients in the low-target group (34.0%) (hazard ratio in the high-target group, 1.07; 95% confidence interval [CI], 0.84 to 1.38; P = 0.57). There was also no significant difference in mortality at 90 days, with 170 deaths (43.8%) and 164 deaths (42.3%), respectively (hazard ratio, 1.04; 95% CI, 0.83 to 1.30; P = 0.74). The occurrence of serious adverse events did not differ significantly between the two groups (74 events [19.1%] and 69 events [17.8%], respectively; P = 0.64). However, the incidence of newly diagnosed atrial fibrillation was higher in the high-target group than in the low-target group. Among patients with chronic hypertension, those in the high-target group required less renal-replacement therapy than did those in the low-target group, but such therapy was not associated with a difference in mortality. Conclusions Targeting a mean arterial pressure of 80 to 85 mm Hg, as compared with 65 to 70 mm Hg, in patients with septic shock undergoing resuscitation did not result in significant differences in mortality at either 28 or 90 days. (Funded by the French Ministry of Health; SEPSISPAM ClinicalTrials.gov number, NCT01149278.)	[Asfar, Pierre; Mercat, Alain] Univ Hosp Angers, Dept Med Intens Care, F-49933 Angers 9, France; [Gergaud, Soizic] Univ Hosp Angers, Dept Surg Intens Care, F-49933 Angers 9, France; [Hamel, Jean-Francois] Univ Hosp Angers, Clin Res Ctr, F-49933 Angers 9, France; [Asfar, Pierre] Univ Hosp Angers, F-49933 Angers 9, France; [Meziani, Ferhat] Strasbourg Univ, Nouvel Hop Civil, Dept Med Intens Care, Strasbourg, France; [Grelon, Fabien] Le Mans Hosp, Med & Surg Intens Care Unit, Le Mans, France; [Megarbane, Bruno] Lariboisiere Univ Hosp, Dept Med & Toxicol Intens Care, Paris, France; [Mira, Jean-Paul] Cochin Univ Hosp, Dept Med Intens Care, Paris, France; [Weiss, Nicolas] Georges Pompidou European Hosp, Dept Med Intens Care, Paris, France; [Mariotte, Eric] St Louis Hosp, Dept Intens Care, Paris, France; [Anguel, Nadia; Teboul, Jean-Louis] Le Kremlin Bicetre Univ Hosp, Dept Med Intens Care, Le Kremlin Bicetre, France; [Dequin, Pierre-Francois] Tours Univ Hosp, Dept Med Intens Care, Tours, France; [Legay, Francois] St Brieuc Hosp, Dept Med Intens Care, St Brieuc, France; [Le Tulzo, Yves] Rennes Univ Hosp, Dept Infect Dis & Med Intens Care, Rennes, France; [Conrad, Marie] Nancy Univ Hosp, Dept Med Intens Care, Nancy, France; [Robert, Rene] Univ Poitiers Hosp, Dept Med Intens Care, Poitiers, France; [Gonzalez, Frederic] Avicenne Teaching Hosp, Dept Med & Surg Intens Care, Bobigny, France; [Guitton, Christophe] Nantes Univ Hosp, Dept Med Intens Care, Nantes, France; [Tamion, Fabienne] Rouen Univ Hosp, Dept Med Intens Care, Rouen, France; [Tonnelier, Jean-Marie] Brest Univ Hosp, Dept Med Intens Care, Brest, France; [Guezennec, Pierre] Versailles Univ Hosp, Dept Med Intens Care, Versailles, France; [Van der Linden, Thierry] Lille Univ Hosp, Dept Intens Care, Lille, France; [Vieillard-Baron, Antoine] Boulogne Billancourt Univ Hosp, Dept Med & Surg Intens Care, Boulogne Billancourt, France; [Pradel, Gael] Avignon Hosp, Dept Intens Care, Avignon, France; [Lesieur, Olivier] La Rochelle St Louis Hosp, Dept Med & Surg Intens Care, La Rochelle, France; [Ricard, Jean-Damien] Univ Paris Diderot, Dept Medicosurg Intens Care, Colombes, France; [Herve, Fabien] Quimper Hosp, Dept Med & Surg Intens Care, Quimper, France; [du Cheyron, Damien] Caen Univ Hosp, Dept Med Intens Care, Caen, France; [Guerin, Claude] Lyon Univ Hosp, Dept Med Intens Care, Lyon, France; [Radermacher, Peter] Ulm Univ Hosp, Dept Anesthesiol, Ulm, Germany	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre Hospitalier Le Mans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CHU Tours; CHU Rennes; Universite de Rennes; CHU de Nancy; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Nantes Universite; CHU de Nantes; CHU de Rouen; CHU Brest; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Lyon; Ulm University	Asfar, P (corresponding author), Univ Hosp Angers, Dept Med Intens Care & Hyperbar Med, 4 Rue Larrey, F-49933 Angers 9, France.	piasfar@chu-angers.fr	Legriel, Stephane/J-1307-2017; Asfar, Pierre/K-1402-2015; guerin, claude/H-5692-2014; lesieur, olivier/X-7745-2019; DUFOUR, Nicolas N/U-4634-2018; Pradel, Gaël/AAZ-7723-2020; Mercat, Alain/AFU-4426-2022; Weiss, Nicolas/E-7345-2011	Legriel, Stephane/0000-0003-4782-6734; guerin, claude/0000-0003-4700-6672; lesieur, olivier/0000-0001-9135-2041; DUFOUR, Nicolas N/0000-0002-1359-6689; Weiss, Nicolas/0000-0001-5155-196X; Teboul, Jean-Louis/0000-0002-5748-7820; NOIRI, Eisei/0000-0002-9515-7582; Coudroy, Remi/0000-0002-0036-1899; Chemouni, Frank/0000-0001-6834-1803; Mariotte, Eric/0000-0002-3614-0457; Grelon, Fabien/0000-0002-2606-9933; Megarbane, Bruno/0000-0002-2522-2764; Charron, Cyril/0000-0002-7328-525X	French Ministry of Health; LFB; Gore; Covidien; Maquet; General Electric; Air Liquide Medical Systems; Faron Pharmaceuticals	French Ministry of Health; LFB; Gore; Covidien; Maquet; General Electric(General Electric); Air Liquide Medical Systems; Faron Pharmaceuticals	Supported by the French Ministry of Health.; Dr. Asfar reports receiving lecture fees from LFB; Dr. Meziani, receiving grant support from LFB; Dr. Mira, receiving honoraria and travel support from LFB and Eisai and honoraria from AstraZeneca; Dr. Weiss, receiving lecture fees from Gore; Dr. Gonzalez, receiving travel support from Merck Sharp and Dohme and Novartis; and Dr. Mercat, receiving grant support from Covidien, Maquet, and General Electric, consulting fees from Air Liquide Medical Systems, and fees for serving on a steering committee from Faron Pharmaceuticals and being named as an inventor on a patent related to methods of evaluating a patient for positive end-expiratory pressure therapy (US 12/834,354), which is to be licensed to General Electric. No other potential conflict of interest relevant to this article was reported.	Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Badin J, 2011, CRIT CARE, V15, DOI 10.1186/cc10253; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bourgoin A, 2005, CRIT CARE MED, V33, P780, DOI 10.1097/01.CCM.0000157788.20591.23; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Dunser MW, 2009, INTENS CARE MED, V35, P1225, DOI 10.1007/s00134-009-1427-2; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10110; LeDoux D, 2000, CRIT CARE MED, V28, P2729, DOI 10.1097/00003246-200008000-00007; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Pottecher T, 2006, CRIT CARE, V10, DOI 10.1186/cc4965; Poukkanen M, 2013, CRIT CARE, V17, DOI 10.1186/cc13161; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615	19	639	682	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1583	1593		10.1056/NEJMoa1312173	http://dx.doi.org/10.1056/NEJMoa1312173			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4TG	24635770	Bronze			2022-12-28	WOS:000336120500005
J	Low, HH; Gubellini, F; Rivera-Calzada, A; Braun, N; Connery, S; Dujeancourt, A; Lu, F; Redzej, A; Fronzes, R; Orlova, EV; Waksman, G				Low, Harry H.; Gubellini, Francesca; Rivera-Calzada, Angel; Braun, Nathalie; Connery, Sarah; Dujeancourt, Annick; Lu, Fang; Redzej, Adam; Fronzes, Remi; Orlova, Elena V.; Waksman, Gabriel			Structure of a type IV secretion system	NATURE			English	Article							ELECTRON-MICROSCOPY; CORE COMPLEX; SUBNANOMETER RESOLUTION; NEEDLE COMPLEX; IMAGE; VIRB4; DNA; INSIGHTS; ATPASE; VISUALIZATION	Bacterial type IV secretion systems translocate virulence factors into eukaryotic cells(1,2), distribute genetic material between bacteria and have shown potential as a tool for the genetic modification of human cells(3). Given the complex choreography of the substrate through the secretion apparatus(4), the molecular mechanism of the type IV secretion system has proved difficult to dissect in the absence of structural data for the entire machinery. Here we use electron microscopy to reconstruct the type IV secretion system encoded by the Escherichia coli R388 conjugative plasmid. We show that eight proteins assemble in an intricate stoichiometric relationship to form an approximately 3 megadalton nanomachine that spans the entire cell envelope. The structure comprises an outer membrane-associated core complex(1) connected by a central stalk to a substantial inner membrane complex that is dominated by a battery of 12 VirB4 ATPase subunits organized as side-by-side hexameric barrels. Our results show a secretion system with markedly different architecture, and consequently mechanism, to other known bacterial secretion systems(1,4-6).	[Low, Harry H.; Rivera-Calzada, Angel; Braun, Nathalie; Connery, Sarah; Lu, Fang; Redzej, Adam; Orlova, Elena V.; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Low, Harry H.; Rivera-Calzada, Angel; Braun, Nathalie; Connery, Sarah; Lu, Fang; Redzej, Adam; Orlova, Elena V.; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Gubellini, Francesca; Dujeancourt, Annick; Fronzes, Remi] Inst Pasteur, F-75015 Paris, France; [Gubellini, Francesca; Dujeancourt, Annick; Fronzes, Remi] CNRS, UMR 3528, F-75015 Paris, France	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, London WC1E 7HX, England.	remi.fronzes@pasteur.fr; e.orlova@mail.cryst.bbk.ac.uk; g.waksman@mail.cryst.bbk.ac.uk	Low, Harry/T-4482-2019; Fronzes, Rémi/GLS-0406-2022; Orlova, Elena/CAF-8290-2022; Rivera-Calzada, Angel/K-3617-2014; Fronzes, Remi/T-2578-2019	Rivera-Calzada, Angel/0000-0003-2472-5535; Gubellini, Francesca/0000-0002-2155-9765; Redzej, Adam/0000-0003-2471-289X; Fronzes, Remi/0000-0003-3031-9824; Orlova, Elena/0000-0003-3371-415X	Wellcome Trust [098302, 079605]; Institut Pasteur; CNRS; MRC [MR/K012401/1] Funding Source: UKRI; Medical Research Council [MR/K012401/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was financed by grant 098302 from the Wellcome Trust to G. W. and by equipment grant 079605 from the Wellcome Trust. R. F. and A. D. were financed by Institut Pasteur and the CNRS. F. G. was the recipient of 'Bourse Roux' from Institut Pasteur. We thank G. Pehau-Arnaudet for support with the electron microscopes at Institut Pasteur.	Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; De Carlo S, 2008, MICRON, V39, P934, DOI 10.1016/j.micron.2007.11.003; Durand E, 2010, J BACTERIOL, V192, P2315, DOI 10.1128/JB.01384-09; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Orlov S. S., 1976, Soviet Physics - Crystallography, V20, P312; Pantoja M, 2002, MOL MICROBIOL, V45, P1325, DOI 10.1046/j.1365-2958.2002.03098.x; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Pena A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413849; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ripoll-Rozada J, 2013, J BACTERIOL, V195, P4195, DOI 10.1128/JB.00437-13; Rivera-Calzada A, 2013, EMBO J, V32, P1195, DOI 10.1038/emboj.2013.58; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wallden K, 2012, P NATL ACAD SCI USA, V109, P11348, DOI 10.1073/pnas.1201428109	30	204	210	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					550	+		10.1038/nature13081	http://dx.doi.org/10.1038/nature13081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670658	Green Accepted			2022-12-28	WOS:000334741600042
J	Elert, E				Elert, Emily			SEARCHING FOR SCHIZ OPHRENIA'S ROOTS	NATURE			English	Editorial Material																			0	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S2	S3		10.1038/508S2a	http://dx.doi.org/10.1038/508S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695332	Bronze			2022-12-28	WOS:000333609900005
J	Hartung, DM; Zarin, DA; Guise, JM; McDonagh, M; Paynter, R; Helfand, M				Hartung, Daniel M.; Zarin, Deborah A.; Guise, Jeanne-Marie; McDonagh, Marian; Paynter, Robin; Helfand, Mark			Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications	ANNALS OF INTERNAL MEDICINE			English	Article							BONE MORPHOGENETIC PROTEIN-2; RANDOMIZED-TRIALS; OUTCOMES; DISSEMINATION	Background: ClinicalTrials.gov requires reporting of result summaries for many drug and device trials. Purpose: To evaluate the consistency of reporting of trials that are registered in the ClinicalTrials.gov results database and published in the literature. Data Sources: ClinicalTrials.gov results database and matched publications identified through ClinicalTrials.gov and a manual search of 2 electronic databases. Study Selection: 10% random sample of phase 3 or 4 trials with results in the ClinicalTrials.gov results database, completed before 1 January 2009, with 2 or more groups. Data Extraction: One reviewer extracted data about trial design and results from the results database and matching publications. A subsample was independently verified. Data Synthesis: Of 110 trials with results, most were industry-sponsored, parallel-design drug studies. The most common inconsistency was the number of secondary outcome measures reported (80%). Sixteen trials (15%) reported the primary outcome description inconsistently, and 22 (20%) reported the primary outcome value inconsistently. Thirty-eight trials inconsistently reported the number of individuals with a serious adverse event (SAE); of these, 33 (87%) reported more SAEs in ClinicalTrials.gov. Among the 84 trials that reported SAEs in ClinicalTrials.gov, 11 publications did not mention SAEs, 5 reported them as zero or not occurring, and 21 reported a different number of SAEs. Among 29 trials that reported deaths in ClinicalTrials.gov, 28% differed from the matched publication. Limitation: Small sample that included earliest results posted to the database. Conclusion: Reporting discrepancies between the ClinicalTrials.gov results database and matching publications are common. Which source contains the more accurate account of results is unclear, although ClinicalTrials.gov may provide a more comprehensive description of adverse events than the publication.	Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Portland VA Med Ctr, Portland, OR USA; Natl Lib Med, Bethesda, MD USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Hartung, DM (corresponding author), Oregon Hlth & Sci Univ, Coll Pharm, Oregon State Univ, 3303 SW Bond Ave,CH12C, Portland, OR 97239 USA.	hartungd@ohsu.edu		Paynter, Robin/0000-0002-6969-4261; Guise, Jeanne-Marie/0000-0002-8961-488X	National Library of Medicine [HHSN 276-2009-00128P]; Agency for Healthcare Research and Quality [K12HS019456]; Agency for Healthcare Research and Quality career development award [K12 HS019456]; intramural research program of the National Library of Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019456] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [KM1CA031878] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM008926] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality career development award(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); intramural research program of the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	By contract HHSN 276-2009-00128P from the National Library of Medicine and grant K12HS019456 from the Agency for Healthcare Research and Quality. Dr. Hartung received support from an Agency for Healthcare Research and Quality career development award (K12 HS019456). Dr. Zarin was funded by the intramural research program of the National Library of Medicine.	Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Earley A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001963; Ewart R, 2009, ANN FAM MED, V7, P542, DOI 10.1370/afm.1017; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; U.S. National Library of Medicine, 2011, CLIN TRIAL REG NUMB; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	18	139	140	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					477	+		10.7326/M13-0480	http://dx.doi.org/10.7326/M13-0480			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24687070	Green Accepted			2022-12-28	WOS:000334093800005
J	Kuhlbrandt, W				Kuehlbrandt, Werner			The Resolution Revolution	SCIENCE			English	Editorial Material							LARGE RIBOSOMAL-SUBUNIT; ANGSTROM RESOLUTION; CRYO-EM		Max Planck Inst Biophys, Dept Biol Struct, D-60538 Frankfurt, Germany	Max Planck Society	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, D-60538 Frankfurt, Germany.	werner.kuehlbrandt@biophys.mpg.de		Kuhlbrandt, Werner/0000-0002-2013-4810				Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; [Anonymous], 2014, SCIENCE         0307; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110; Faruqi AR, 2007, CURR OPIN STRUC BIOL, V17, P549, DOI 10.1016/j.sbi.2007.08.014; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schur FKM, 2013, J STRUCT BIOL, V184, P394, DOI 10.1016/j.jsb.2013.10.015; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	11	655	661	8	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1443	1444		10.1126/science.1251652	http://dx.doi.org/10.1126/science.1251652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675944				2022-12-28	WOS:000333471000024
J	Page, L				Page, Leigh			FEATURE The end of life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-LIFE				Page, L (corresponding author), 2525 North Talman Ave, Chicago, IL USA.	leighpage@comcast.net						American Association of Neurological Surgeons (AANS), INF CONS; American Medical Association (AMA) Council on Ethical and Judicial Affairs, 2008, 5A08 CEJA AMA; Astrow AB, 2011, NEW ENGL J MED, V364, P1885, DOI 10.1056/NEJMp1102392; Bergman J, 2013, JAMA SURG, V148, P215, DOI 10.1001/jamasurg.2013.1568; Davison SN, 2010, CLIN J AM SOC NEPHRO, V5, P195, DOI 10.2215/CJN.05960809; Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055; National Hospice and Palliative Care Organization (NHPCO), 2006, TALK TREATM OPT PALL	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2014	348								g2261	10.1136/bmj.g2261	http://dx.doi.org/10.1136/bmj.g2261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LN	24671982				2022-12-28	WOS:000333586700003
J	King, A				King, Andrew			Testing the Limits of Accretion	SCIENCE			English	Editorial Material							X-RAY SOURCES		Univ Leicester, Theoret Astrophys Grp, Leicester LE1 7RH, Leics, England	University of Leicester	King, A (corresponding author), Univ Leicester, Theoret Astrophys Grp, Leicester LE1 7RH, Leics, England.	ark@leicester.ac.uk			Science and Technology Facilities Council [PP/E00119X/1, ST/K001000/1, ST/H00856X/1] Funding Source: researchfish; STFC [ST/K001000/1, PP/E00119X/1, ST/H00856X/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Begelman MC, 2006, MON NOT R ASTRON SOC, V370, P399, DOI 10.1111/j.1365-2966.2006.10469.x; King AR, 2001, ASTROPHYS J, V552, pL109, DOI 10.1086/320343; King AR, 2000, ASTROPHYS J, V530, pL25, DOI 10.1086/312475; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Soria R, 2014, SCIENCE, V343, P1330, DOI 10.1126/science.1248759	5	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1318	1319		10.1126/science.1251944	http://dx.doi.org/10.1126/science.1251944			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653023				2022-12-28	WOS:000333108500021
J	Ruths, J; Ruths, D				Ruths, Justin; Ruths, Derek			Control Profiles of Complex Networks	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; EMERGENCE	Studying the control properties of complex networks provides insight into how designers and engineers can influence these systems to achieve a desired behavior. Topology of a network has been shown to strongly correlate with certain control properties; here we uncover the fundamental structures that explain the basis of this correlation. We develop the control profile, a statistic that quantifies the different proportions of control-inducing structures present in a network. We find that standard random network models do not reproduce the kinds of control profiles that are observed in real-world networks. The profiles of real networks form three well-defined clusters that provide insight into the high-level organization and function of complex systems.	[Ruths, Justin] Singapore Univ Technol & Design, Singapore, Singapore; [Ruths, Derek] McGill Univ, Dept Comp Sci, Montreal, PQ, Canada	Singapore University of Technology & Design; McGill University	Ruths, J (corresponding author), Singapore Univ Technol & Design, Singapore, Singapore.	justinruths@sutd.edu.sg			Singapore University of Technology and Design-Massachusetts Institute of Technology International Design Center [IDG31300103]; Natural Sciences and Engineering Research Council [125517855]	Singapore University of Technology and Design-Massachusetts Institute of Technology International Design Center(Singapore University of Technology & Design); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank the anonymous reviewers for their thoughtful and insightful critiques, which substantively improved this manuscript. Supported by the Singapore University of Technology and Design-Massachusetts Institute of Technology International Design Center (IDG31300103) and by Natural Sciences and Engineering Research Council (Discovery Grant 125517855).	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bhardwaj N, 2010, P NATL ACAD SCI USA, V107, P6841, DOI 10.1073/pnas.0910867107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Commault C, 2002, KYBERNETIKA, V38, P503; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gutkind J S, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.40.re1; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Jackson MO, 2007, AM ECON REV, V97, P890, DOI 10.1257/aer.97.3.890; Jia T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3002; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Muller FJ, 2011, NATURE, V478, pE4, DOI 10.1038/nature10543; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	20	291	296	1	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1373	1376		10.1126/science.1242063	http://dx.doi.org/10.1126/science.1242063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653036				2022-12-28	WOS:000333108500043
J	Stefanini, GG; Windecker, S				Stefanini, Giulio G.; Windecker, Stephan			Stent performance: never too late to sort it out	LANCET			English	Editorial Material							PACLITAXEL-ELUTING STENTS; NON-INFERIORITY TRIAL; CORONARY; OUTCOMES; THROMBOSIS		[Stefanini, Giulio G.; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Stefanini, GG (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	giulio.stefanini@insel.ch	Stefanini, Giulio/GZG-4754-2022; Stefanini, Giulio G/K-7406-2016	Stefanini, Giulio/0000-0002-3558-6967; Stefanini, Giulio G/0000-0002-3558-6967				Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Jensen LO, 2012, J AM COLL CARDIOL, V60, P1140, DOI 10.1016/j.jacc.2012.07.004; Maeng M, 2014, LANCET; Raber L, 2012, JACC-CARDIOVASC INTE, V5, P946, DOI 10.1016/j.jcin.2012.05.012; Raber L, 2011, CIRCULATION, V123, P2819, DOI 10.1161/CIRCULATIONAHA.110.004762; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2024	2026		10.1016/S0140-6736(14)60461-X	http://dx.doi.org/10.1016/S0140-6736(14)60461-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24631164				2022-12-28	WOS:000337292400007
J	Zhang, KH; Zhang, J; Gao, ZG; Zhang, DD; Zhu, L; Han, GW; Moss, SM; Paoletta, S; Kiselev, E; Lu, WZ; Fenalti, G; Zhang, WR; Muller, CE; Yang, HY; Jiang, HL; Cherezov, V; Katritch, V; Jacobson, KA; Stevens, RC; Wu, BL; Zhao, Q				Zhang, Kaihua; Zhang, Jin; Gao, Zhan-Guo; Zhang, Dandan; Zhu, Lan; Han, Gye Won; Moss, Steven M.; Paoletta, Silvia; Kiselev, Evgeny; Lu, Weizhen; Fenalti, Gustavo; Zhang, Wenru; Mueller, Christa E.; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Katritch, Vsevolod; Jacobson, Kenneth A.; Stevens, Raymond C.; Wu, Beili; Zhao, Qiang			Structure of the human P2Y(12) receptor in complex with an antithrombotic drug	NATURE			English	Article							ACTIVE METABOLITE; NUCLEOTIDE RECEPTORS; CRYSTAL-STRUCTURE; AMINO-ACIDS; PROTEIN; IDENTIFICATION; CLOPIDOGREL; ANTAGONISTS; INHIBITION; PRASUGREL	P2Y receptors (P2YRs), a family of purinergic G-protein-coupled receptors (GPCRs), are activated by extracellular nucleotides. There are a total of eight distinct functional P2YRs expressed in human, which are subdivided into P2Y1-like receptors and P2Y(12)-like receptors(1). Their ligands are generally charged molecules with relatively low bioavailability and stability in vivo(2), which limits our understanding of this receptor family. P2Y(12)R regulates platelet activation and thrombus formation(3,4), and several antithrombotic drugs targeting P2Y(12)R-including the prodrugs clopidogrel (Plavix) and prasugrel (Effient) that are metabolized and bind covalently, and the nucleoside analogue ticagrelor (Brilinta) that acts directly on the receptor-have been approved for the prevention of stroke and myocardial infarction. However, limitations of these drugs (for example, a very long half-life of clopidogrel action and a characteristic adverse effect profile of ticagrelor) 5,6 suggest that there is an unfulfilled medical need for developing a new generation of P2Y(12)R inhibitors(7,8). Here we report the 2.6 angstrom resolution crystal structure of human P2Y(12)R in complex with a non-nucleotide reversible antagonist, AZD1283. The structure reveals a distinct straight conformation of helix V, which sets P2Y(12)R apart from all other known class A GPCR structures. With AZD1283 bound, the highly conserved disulphide bridge in GPCRs between helix III and extracellular loop 2 is not observed and appears to be dynamic. Along with the details of the AZD1283-binding site, analysis of the extracellular interface reveals an adjacent ligand-binding region and suggests that both pockets could be required for dinucleotide binding. The structure provides essential insights for the development of improved P2Y(12)R ligands and allosteric modulators as drug candidates.	[Zhang, Kaihua; Zhang, Jin; Zhang, Dandan; Zhu, Lan; Lu, Weizhen; Zhang, Wenru; Wu, Beili; Zhao, Qiang] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Gao, Zhan-Guo; Moss, Steven M.; Paoletta, Silvia; Kiselev, Evgeny; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Han, Gye Won; Fenalti, Gustavo; Cherezov, Vadim; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Mueller, Christa E.] PharmaCtr Bonn, Inst Pharmaceut, D-53121 Bonn, Germany; [Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University	Zhao, Q (corresponding author), Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	zhaoq@simm.ac.cn	Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8673-2022; Katritch, Vsevolod/Q-8357-2016; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8724-2022; Müller, Christa Elisabeth/C-7748-2014; Katritch, Vsevolod/Y-2721-2019; Zhang, Kaihua/AAD-7882-2022; Jacobson, Kenneth Alan/A-1530-2009; Han, Gye Won/GLT-1531-2022	Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Müller, Christa Elisabeth/0000-0002-0013-6624; Zhang, Kaihua/0000-0003-3734-3624; Jacobson, Kenneth Alan/0000-0001-8104-1493; Zhang, Dandan/0000-0002-8863-5806	National Basic Research Program of China [2012CB910400, 2012CB518000]; National Institutes of Health (NIH) [R01 AI100604, U54 GM094618]; National Science Foundation of China [31370729, 31170683]; National Institute of General Medical Sciences Postdoctoral Research Associate program; NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031126, ZIADK031116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of General Medical Sciences Postdoctoral Research Associate program; NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China grants 2012CB910400 and 2012CB518000 (B. W., Q.Z.), National Institutes of Health (NIH) grants R01 AI100604 (B. W., Q.Z.) and U54 GM094618 (V. C., V. K., R. C. S.; Target GPCR-87), National Science Foundation of China grants 31370729 and 31170683 (B. W., Q.Z.), the National Institute of General Medical Sciences Postdoctoral Research Associate program (E. K.) and the NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program (K.A.J.). The authors thank AstraZeneca for their gift of AZD1283, and thank S. Nylander, F. Giordanetto and H. van Giezen for careful review and scientific feedback on the manuscript, A. Walker for assistance with manuscript preparation, and C. Wang and D. Wacker for help on collection of X-ray diffraction data.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Algaier I, 2008, J THROMB HAEMOST, V6, P1908, DOI 10.1111/j.1538-7836.2008.03136.x; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Bach P, 2013, J MED CHEM, V56, P7015, DOI 10.1021/jm400820m; Bach P, 2013, EUR J MED CHEM, V65, P360, DOI 10.1016/j.ejmech.2013.04.007; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cattaneo M, 2005, SEMIN THROMB HEMOST, V31, P168, DOI 10.1055/s-2005-869522; Cattaneo M, 2003, P NATL ACAD SCI USA, V100, P1978, DOI 10.1073/pnas.0437879100; Cattaneo M, 2011, BLOOD, V117, P2102, DOI 10.1182/blood-2010-08-263111; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Ding Z, 2009, J THROMB HAEMOST, V7, P232, DOI 10.1111/j.1538-7836.2008.03202.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hasegawa M, 2005, THROMB HAEMOSTASIS, V94, P593, DOI 10.1160/TH05-03-0208; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; Ignatovica V, 2012, FEBS J, V279, P180, DOI 10.1111/j.1742-4658.2011.08410.x; Jacobson KA, 2010, DRUG DISCOV TODAY, V15, P570, DOI 10.1016/j.drudis.2010.05.011; Jagroop IA, 2003, PLATELETS, V14, P15, DOI 10.1080/0953710021000062914; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Mao YY, 2010, EUR J PHARMACOL, V644, P10, DOI 10.1016/j.ejphar.2010.06.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nylander S, 2004, BRIT J PHARMACOL, V142, P1325, DOI 10.1038/sj.bjp.0705885; Ohlmann P, 2013, PURINERG SIGNAL, V9, P59, DOI 10.1007/s11302-012-9329-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	36	276	288	6	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					115	118		10.1038/nature13083	http://dx.doi.org/10.1038/nature13083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670650	Green Accepted			2022-12-28	WOS:000335199100050
J	Gad, H; Koolmeister, T; Jemth, AS; Eshtad, S; Jacques, SA; Strom, CE; Svensson, LM; Schultz, N; Lundback, T; Einarsdottir, BO; Saleh, A; Gokturk, C; Baranczewski, P; Svensson, R; Berntsson, RPA; Gustafsson, R; Stromberg, K; Sanjiv, K; Jacques-Cordonnier, MC; Desroses, M; Gustavsson, AL; Olofsson, R; Johansson, F; Homan, EJ; Loseva, O; Brautigam, L; Johansson, L; Hoglund, A; Hagenkort, A; Pham, T; Altun, M; Gaugaz, FZ; Vikingsson, S; Evers, B; Henriksson, M; Vallin, KSA; Wallner, OA; Hammarstrom, LGJ; Wiita, E; Almlof, I; Kalderen, C; Axelsson, H; Djureinovic, T; Puigvert, JC; Haggblad, M; Jeppsson, F; Martens, U; Lundin, C; Lundgren, B; Granelli, I; Jensen, AJ; Artursson, P; Nilsson, JA; Stenmark, P; Scobie, M; Berglund, UW; Helleday, T				Gad, Helge; Koolmeister, Tobias; Jemth, Ann-Sofie; Eshtad, Saeed; Jacques, Sylvain A.; Strom, Cecilia E.; Svensson, Linda M.; Schultz, Niklas; Lundback, Thomas; Einarsdottir, Berglind Osk; Saleh, Aljona; Gokturk, Camilla; Baranczewski, Pawel; Svensson, Richard; Berntsson, Ronnie P. -A.; Gustafsson, Robert; Stromberg, Kia; Sanjiv, Kumar; Jacques-Cordonnier, Marie-Caroline; Desroses, Matthieu; Gustavsson, Anna-Lena; Olofsson, Roger; Johansson, Fredrik; Homan, Evert J.; Loseva, Olga; Brautigam, Lars; Johansson, Lars; Hoglund, Andreas; Hagenkort, Anna; Pham, Therese; Altun, Mikael; Gaugaz, Fabienne Z.; Vikingsson, Svante; Evers, Bastiaan; Henriksson, Martin; Vallin, Karl S. A.; Wallner, Olov A.; Hammarstrom, Lars G. J.; Wiita, Elisee; Almlof, Ingrid; Kalderen, Christina; Axelsson, Hanna; Djureinovic, Tatjana; Puigvert, Jordi Carreras; Haggblad, Maria; Jeppsson, Fredrik; Martens, Ulf; Lundin, Cecilia; Lundgren, Bo; Granelli, Ingrid; Jensen, Annika Jenmalm; Artursson, Per; Nilsson, Jonas A.; Stenmark, Pal; Scobie, Martin; Berglund, Ulrika Warpman; Helleday, Thomas			MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool	NATURE			English	Article							MUTAGENIC SUBSTRATE; DNA; REPAIR; 8-OXOGUANINE; TARGET; CELLS; ACTIVATION; HYDROLYZES; ENZYME; HMTH1	Cancers have dysfunctional redox regulation resulting in reactive oxygen species production, damaging both DNA and free dNTPs. The MTH1 protein sanitizes oxidized dNTP pools to prevent incorporation of damaged bases during DNA replication. Although MTH1 is non-essential in normal cells, we show that cancer cells require MTH1 activity to avoid incorporation of oxidized dNTPs, resulting in DNA damage and cell death. We validate MTH1 as an anticancer target in vivo and describe small molecules TH287 and TH588 as first-in-class nudix hydrolase family inhibitors that potently and selectively engage and inhibit the MTH1 protein in cells. Protein co-crystal structures demonstrate that the inhibitors bindin the active site of MTH1. The inhibitors cause incorporation of oxidized dNTPs in cancer cells, leading to DNA damage, cytotoxicity and therapeutic responses in patient-derived mouse xenografts. This study exemplifies the non-oncogene addiction concept for anticancer treatment and validates MTH1 as being cancer phenotypic lethal.	[Gad, Helge; Koolmeister, Tobias; Jemth, Ann-Sofie; Eshtad, Saeed; Jacques, Sylvain A.; Strom, Cecilia E.; Schultz, Niklas; Lundback, Thomas; Gokturk, Camilla; Baranczewski, Pawel; Stromberg, Kia; Sanjiv, Kumar; Jacques-Cordonnier, Marie-Caroline; Desroses, Matthieu; Gustavsson, Anna-Lena; Homan, Evert J.; Loseva, Olga; Brautigam, Lars; Johansson, Lars; Hoglund, Andreas; Hagenkort, Anna; Pham, Therese; Altun, Mikael; Gaugaz, Fabienne Z.; Vikingsson, Svante; Evers, Bastiaan; Henriksson, Martin; Vallin, Karl S. A.; Wallner, Olov A.; Hammarstrom, Lars G. J.; Wiita, Elisee; Almlof, Ingrid; Kalderen, Christina; Axelsson, Hanna; Puigvert, Jordi Carreras; Jeppsson, Fredrik; Lundin, Cecilia; Jensen, Annika Jenmalm; Scobie, Martin; Berglund, Ulrika Warpman; Helleday, Thomas] Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden; [Svensson, Linda M.; Berntsson, Ronnie P. -A.; Gustafsson, Robert; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Lundback, Thomas; Svensson, Richard; Gustavsson, Anna-Lena; Johansson, Lars; Hammarstrom, Lars G. J.; Axelsson, Hanna; Jensen, Annika Jenmalm; Artursson, Per] Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys,Chem Biol Consortium S, S-17121 Stockholm, Sweden; [Einarsdottir, Berglind Osk; Olofsson, Roger; Nilsson, Jonas A.] Univ Gothenburg, Sahlgrenska Translat Melanoma Grp, Sahlgrenska Canc Ctr, Dept Surg, S-40530 Gothenburg, Sweden; [Einarsdottir, Berglind Osk; Olofsson, Roger; Nilsson, Jonas A.] Sahlgrens Univ Hosp, S-40530 Gothenburg, Sweden; [Saleh, Aljona; Granelli, Ingrid] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden; [Baranczewski, Pawel; Svensson, Richard; Gaugaz, Fabienne Z.; Artursson, Per] Uppsala Univ, Dept Pharm, Uppsala Univ Drug Optimizat & Pharmaceut Profilin, S-75123 Uppsala, Sweden; [Johansson, Fredrik; Djureinovic, Tatjana] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Vikingsson, Svante] Linkoping Univ, Dept Med & Hlth Sci, S-58185 Linkoping, Sweden; [Haggblad, Maria; Martens, Ulf; Lundgren, Bo] Stockholm Univ, Sci Life Lab, RNAi Cell Screening Facil, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; University of Gothenburg; Sahlgrenska University Hospital; Stockholm University; Uppsala University; Stockholm University; Linkoping University; Stockholm University	Helleday, T (corresponding author), Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden.	thomas.helleday@scilifelab.se	Altun, Mikael/AAI-9527-2020; Schultz, Niklas/AFQ-8244-2022; Axelsson, Hanna/AGG-7882-2022; Gad, Helge/J-2238-2014; Ström, Cecilia/M-9134-2019; Bagge, Roger Olofsson/H-3481-2019; Höglund, Andreas/AAP-3372-2021; Lundbäck, Thomas/G-8076-2018; Berntsson, Ronnie/J-3535-2019; Altun, Mikael/AAF-5496-2020	Altun, Mikael/0000-0002-6937-6124; Axelsson, Hanna/0000-0003-2365-1749; Bagge, Roger Olofsson/0000-0001-5795-0355; Lundbäck, Thomas/0000-0002-8145-7808; Berntsson, Ronnie/0000-0001-6848-322X; Scobie, Martin/0000-0002-7073-8495; Pham, Therese M/0000-0002-5577-6039; Desroses, Matthieu/0000-0003-4152-3855; Nilsson, Jonas/0000-0003-0346-6837; Gad, Helge/0000-0001-6530-1443; Helleday, Thomas/0000-0002-7384-092X; Gustafsson, Robert/0000-0002-4854-5531; Warpman Berglund, Ulrika/0000-0002-6372-1396; Einarsdottir, Berglind Osk/0000-0002-5227-8149; Jemth, Ann-Sofie/0000-0002-7550-1833; Homan, Evert/0000-0002-9057-1848; Gustavsson, Anna-Lena/0000-0003-4332-2336; Hammarstrom, Lars/0000-0002-3903-7746; Stenmark, Pal/0000-0003-4777-3417; Wallner, Olov/0000-0002-6481-237X; Gaugaz, Fabienne/0000-0001-9171-8891; Kalderen, Christina/0000-0001-7004-7048	Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; European Research Council; Swedish Cancer Society; Swedish Children's Cancer Foundation; AFA insurance; Swedish Pain Relief Foundation; Cancer Society in Stockholm; Wenner-Gren Foundations; Swedish Foundation for Strategic Research; Dutch Cancer Society; EMBO LTF; Region Vastra Gotaland; BioCARE; Swiss National Science Foundation; Nicholson Exchange Program	Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation; AFA insurance; Swedish Pain Relief Foundation; Cancer Society in Stockholm; Wenner-Gren Foundations; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Dutch Cancer Society(KWF Kankerbestrijding); EMBO LTF(European Molecular Biology Organization (EMBO)); Region Vastra Gotaland; BioCARE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Nicholson Exchange Program	We thank scientists at BESSY, ESRF, Max-Lab and the Swiss Light Source for structural biology data collection support, PSF for protein purification, GE Healthcare for instrument access, HTSRC (Rockefeller University) for iTC<INF>200</INF> calorimeter access, S. Nordstrand for animal support, and L. Ny, U. Stierner and J. Mattsson for discussions. The Helleday Laboratory is primarily funded by the Torsten and Ragnar Soderberg Foundation (T. H.). This project is primarily supported by The Knut and Alice Wallenberg Foundation. Further support was received from the Swedish Research Council (T. H., A. J. J., P. A., P. S., J.A.N.), the European Research Council (T. H.), Swedish Cancer Society (T. H., J.A.N.), the Swedish Children's Cancer Foundation (T. H.), AFA insurance (T. H.), the Swedish Pain Relief Foundation (T. H.), The Cancer Society in Stockholm (T. H.), the Wenner-Gren Foundations (P. S.), the Swedish Foundation for Strategic Research (P. S.), the Dutch Cancer Society (B. E.), EMBO LTF (R. B.), Region Vastra Gotaland (J.A.N.), BioCARE (J.A.N.), the Swiss National Science Foundation (F.Z.G.) and the Nicholson Exchange Program (T. L.). Chemical Biology Consortium Sweden (CBCS) is primarily funded by the Swedish Research Council. CBCS acknowledge Swedish Orphan Biovitrum for their donation of a small-molecule infrastructure including a compound collection.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baranczewski P, 2006, PHARMACOL REP, V58, P453; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Britsun V.M., 2008, UKR KHIM ZH, V74, P126; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Collins A, 2003, FREE RADICAL BIO MED, V34, P1089, DOI 10.1016/s0891-5849(03)00041-8; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; De Luca G, 2013, AGING CELL, V12, P695, DOI 10.1111/acel.12094; De Luca G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000266; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Ichikawa J, 2008, DNA REPAIR, V7, P418, DOI 10.1016/j.dnarep.2007.11.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Sakumi K, 2003, CANCER RES, V63, P902; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Speina E, 2005, JNCI-J NATL CANCER I, V97, P384, DOI 10.1093/jnci/dji058; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; Tsuzuki T, 2001, MUTAT RES-FUND MOL M, V477, P71, DOI 10.1016/S0027-5107(01)00108-7; Ushijima Y, 2005, NUCLEIC ACIDS RES, V33, P672, DOI 10.1093/nar/gki214; Waters NJ, 2008, J PHARM SCI-US, V97, P4586, DOI 10.1002/jps.21317; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685	45	348	372	5	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					215	+		10.1038/nature13181	http://dx.doi.org/10.1038/nature13181			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695224				2022-12-28	WOS:000333979900038
J	Kitambi, SS; Toledo, EM; Usoskin, D; Wee, SM; Harisankar, A; Svensson, R; Sigmundsson, K; Kalderen, C; Niklasson, M; Kundu, S; Aranda, S; Westermark, B; Uhrbom, L; Andang, M; Damberg, P; Nelander, S; Arenas, E; Artursson, P; Walfridsson, J; Nilsson, KF; Hammarstrom, LGJ; Ernfors, P				Kitambi, Satish Srinivas; Toledo, Enrique M.; Usoskin, Dmitry; Wee, Shimei; Harisankar, Aditya; Svensson, Richard; Sigmundsson, Kristmundur; Kalderen, Christina; Niklasson, Mia; Kundu, Soumi; Aranda, Sergi; Westermark, Bengt; Uhrbom, Lene; Andang, Michael; Damberg, Peter; Nelander, Sven; Arenas, Ernest; Artursson, Per; Walfridsson, Julian; Nilsson, Karin Forsberg; Hammarstrom, Lars G. J.; Ernfors, Patrik			RETRACTED: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule (Retracted article. See vol. 170, pg. 407, 2017)	CELL			English	Article; Retracted Publication							INTEGRATED GENOMIC ANALYSIS; MULTIDRUG-RESISTANCE; GLIOMA-CELLS; STEM-CELL; BRAIN; TEMOZOLOMIDE; MACROPINOCYTOSIS; IDENTIFICATION; CHLOROQUINE; NSC23925	Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer with marginal life expectancy. Based on the assumption that GBM cells gain functions not necessarily involved in the cancerous process, patient-derived glioblastoma cells (GCs) were screened to identify cellular processes amenable for development of targeted treatments. The quinine-derivative NSC13316 reliably and selectively compromised viability. Synthetic chemical expansion reveals delicate structure-activity relationship and analogs with increased potency, termed Vacquinols. Vacquinols stimulate death by membrane ruffling, cell rounding, massive macropinocytic vacuole accumulation, ATP depletion, and cytoplasmic membrane rupture of GCs. The MAP kinase MKK4, identified by a shRNA screen, represents a critical signaling node. Vacquinol-1 displays excellent in vivo pharmacokinetics and brain exposure, attenuates disease progression, and prolongs survival in a GBM animal model. These results identify a vulnerability to massive vacuolization that can be targeted by small molecules and point to the possible exploitation of this process in the design of anticancer therapies.	[Kitambi, Satish Srinivas; Toledo, Enrique M.; Usoskin, Dmitry; Wee, Shimei; Aranda, Sergi; Andang, Michael; Arenas, Ernest; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden; [Sigmundsson, Kristmundur; Kalderen, Christina; Hammarstrom, Lars G. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab,Chem Biol Consortium Sweden, S-17177 Stockholm, Sweden; [Svensson, Richard; Artursson, Per] Uppsala Univ, Chem Biol Consortium Sweden, UDOPP, Dept Pharm, S-75105 Uppsala, Sweden; [Wee, Shimei; Andang, Michael] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Harisankar, Aditya] Karolinska Inst, HERM, Dept Med, S-14186 Stockholm, Sweden; [Niklasson, Mia; Kundu, Soumi; Westermark, Bengt; Uhrbom, Lene; Nelander, Sven; Nilsson, Karin Forsberg] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, S-75185 Uppsala, Sweden; [Damberg, Peter] Karolinska Inst, Dept Clin Sci Intervent & Technol, S-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska Institutet; Uppsala University; Karolinska Institutet	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	patrik.ernfors@ki.se	Kitambi, Satish S/J-4521-2013; Arenas, Ernest/AAO-5231-2020; Aranda, Sergi/K-1211-2015; Andäng, Michael/GRE-9898-2022	Arenas, Ernest/0000-0003-0197-6577; Aranda, Sergi/0000-0003-3853-430X; Westermark, Bengt/0000-0001-7153-5545; Hammarstrom, Lars/0000-0002-3903-7746; Andang, Michael/0000-0002-2886-7891; Nelander, Sven/0000-0003-1758-1262	Swedish Research Council for Medicine and Health; Swedish Cancer Society; Swedish strategic funds (DBRM, StratNeuro); Swedish Brain Foundation; Hallsten Foundation; Torsten Soderberg Professorship; Wallenberg Foundation (Wallenberg Scholar grant); ERC advanced grant [232675]; Chemical Biology Consortium Sweden (CBCS); Swedish Research Council	Swedish Research Council for Medicine and Health; Swedish Cancer Society(Swedish Cancer Society); Swedish strategic funds (DBRM, StratNeuro); Swedish Brain Foundation; Hallsten Foundation; Torsten Soderberg Professorship; Wallenberg Foundation (Wallenberg Scholar grant); ERC advanced grant(European Research Council (ERC)); Chemical Biology Consortium Sweden (CBCS); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors thank Helena Samuelsson for technical help and Robert Harmel for help with the synthesis of compounds. We also thank Susan Warner and the team at Mice and Zebrafish Core facility for wonderful support during the course of experiments, the CLICK Imaging Facility supported by the Wallenberg Foundation, Erik Nilsson for setting up the spectral analysis, and the Core Facility AKM/Karolinska Experimental Research and Imaging Centre at Karolinska University Hospital for MRI. This work was supported by the Swedish Research Council for Medicine and Health, the Swedish Cancer Society, the Swedish strategic funds (DBRM, StratNeuro), the Swedish Brain Foundation, Hallsten Foundation, Torsten Soderberg Professorship, Wallenberg Foundation (Wallenberg Scholar grant), and ERC advanced grant (232675) to P.E. (who is a Wallenberg Scholar). The contributions of K.S., C.K., R.S., P.A., and L.G.J.H. to the project were supported by Chemical Biology Consortium Sweden (CBCS) and funded by the Swedish Research Council. K.F.N., L.U., and B.W. were supported by grants from the Swedish Research Council for Medicine and Health and the Swedish Cancer Society. S.S.K., L.G.J.H., and P.E. have applied for protection of intellectual property related to the results in the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barami K, 2009, J CLIN NEUROSCI, V16, P195, DOI 10.1016/j.jocn.2008.03.006; Bhanot H, 2010, MOL CANCER RES, V8, P1358, DOI 10.1158/1541-7786.MCR-10-0090; Bleau AM, 2009, M S-MED SCI, V25, P775, DOI 10.1051/medsci/20092510775; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dent P, 2008, CANCER BIOL THER, V7, P1335, DOI 10.4161/cbt.7.9.6408; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Duan ZF, 2012, J MED CHEM, V55, P3113, DOI 10.1021/jm300117u; Duan ZF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007415; Fuhler GM, 2012, MOL MED, V18, P65, DOI 10.2119/molmed.2011.00178; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gallo M, 2013, CANCER RES, V73, P417, DOI 10.1158/0008-5472.CAN-12-1881; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Grimmer S, 2002, J CELL SCI, V115, P2953; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; HYAFIL F, 1993, CANCER RES, V53, P4595; Kaul A, 2007, CELL SIGNAL, V19, P1034, DOI 10.1016/j.cellsig.2006.11.010; Kitambi Satish Srinivas, 2012, BMC Physiology, V12, P3, DOI 10.1186/1472-6793-12-3; Leon B, 2013, ORG LETT, V15, P1234, DOI 10.1021/ol400150z; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mercer J, 2012, CURR OPIN MICROBIOL, V15, P490, DOI 10.1016/j.mib.2012.05.016; Morrison Deborah K, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a011254; Overmeyer JH, 2008, MOL CANCER RES, V6, P965, DOI 10.1158/1541-7786.MCR-07-2036; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PINDER RM, 1968, J MED CHEM, V11, P267, DOI 10.1021/jm00308a017; Polivka J, 2012, ANTICANCER RES, V32, P2935; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; RAPPORT MM, 1946, J AM CHEM SOC, V68, P2697, DOI 10.1021/ja01216a085; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Zhang JH, 2010, ONCOLOGY-BASEL, V78, P103, DOI 10.1159/000306139	47	82	88	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2								10.1016/j.cell.2014.02.021	http://dx.doi.org/10.1016/j.cell.2014.02.021			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24656405	Bronze			2022-12-28	WOS:000334304500007
J	Dalton, CA; Langmuir, CH; Gale, A				Dalton, Colleen A.; Langmuir, Charles H.; Gale, Allison			Geophysical and Geochemical Evidence for Deep Temperature Variations Beneath Mid-Ocean Ridges	SCIENCE			English	Article							BASALT CHEMISTRY; GLOBAL CORRELATIONS; WAVE VELOCITY; AXIAL DEPTH; MANTLE; ORIGIN; ATTENUATION; TIME; FLOW	The temperature and composition of Earth's mantle control fundamental planetary properties, including the vigor of mantle convection and the depths of the ocean basins. Seismic wave velocities, ocean ridge depths, and the composition of mid-ocean ridge basalts can all be used to determine variations in mantle temperature and composition, yet are typically considered in isolation. We show that correlations among these three data sets are consistent with 250 degrees C variation extending to depths >400 kilometers and are inconsistent with variations in mantle composition at constant temperature. Anomalously hot ridge segments are located near hot spots, confirming a deep mantle-plume origin for hot spot volcanism. Chemical heterogeneity may contribute to scatter about the global trend. The coherent temperature signal provides a thermal calibration scale for interpreting seismic velocities located distant from ridges.	[Dalton, Colleen A.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Langmuir, Charles H.; Gale, Allison] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Gale, Allison] Univ Wisconsin, Dept Plant & Earth Sci, River Falls, WI 54022 USA	Boston University; Harvard University; University of Wisconsin System	Dalton, CA (corresponding author), Brown Univ, Dept Geol Sci, 324 Brook St,Box 1846, Providence, RI 02912 USA.	colleen_dalton@brown.edu			NSF [OCE-0752166, OCE-0752281]	NSF(National Science Foundation (NSF))	We acknowledge NSF grants OCE-0752166 to C. A. D. and OCE-0752281 to C. H. L. We thank P. Hall, M. Jackson, S. Parman, and M. Ishii for helpful discussions. The major-element MORB data and the catalog of ridge segments are available in the supporting information of (19).	Asimow PD, 1998, AM MINERAL, V83, P1127; Collier ML, 2010, J PETROL, V51, P1913, DOI 10.1093/petrology/egq043; Connolly JAD, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002540; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Faul UH, 2005, EARTH PLANET SC LETT, V234, P119, DOI 10.1016/j.epsl.2005.02.008; FORSYTH DW, 1987, EARTH PLANET SC LETT, V84, P471, DOI 10.1016/0012-821X(87)90011-2; French S, 2013, SCIENCE, V342, P227, DOI 10.1126/science.1241514; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Gale A, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003446; Gurnis M, 1998, SCIENCE, V279, P1499, DOI 10.1126/science.279.5356.1499; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; HUMLER E, 1993, NATURE, V364, P225, DOI 10.1038/364225a0; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; Kimura JI, 2012, J PETROL, V53, P1637, DOI 10.1093/petrology/egs028; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; Lee CTA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002413; MACDONALD KC, 1988, NATURE, V335, P217, DOI 10.1038/335217a0; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Niu YL, 2008, J PETROL, V49, P633, DOI 10.1093/petrology/egm051; Priestley K, 2006, EARTH PLANET SC LETT, V244, P285, DOI 10.1016/j.epsl.2006.01.008; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Ritzwoller MH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002522; SHEN Y, 1995, J GEOPHYS RES-SOL EA, V100, P2211, DOI 10.1029/94JB02768; Wiens DA, 2006, EARTH PLANET SC LETT, V248, P30, DOI 10.1016/j.epsl.2006.04.011; Xu WB, 2008, EARTH PLANET SC LETT, V275, P70, DOI 10.1016/j.epsl.2008.08.012; Yang YJ, 2007, EARTH PLANET SC LETT, V258, P260, DOI 10.1016/j.epsl.2007.03.040; ZHANG YS, 1994, PHYS EARTH PLANET IN, V84, P79, DOI 10.1016/0031-9201(94)90035-3; Zhou HY, 2013, NATURE, V494, P195, DOI 10.1038/nature11842	30	135	140	5	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					80	83		10.1126/science.1249466	http://dx.doi.org/10.1126/science.1249466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700855				2022-12-28	WOS:000333746100056
J	Noonan, D				Noonan, David			LANGUAGE Lost in translation	NATURE			English	Editorial Material																			0	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S4	S5		10.1038/508S4a	http://dx.doi.org/10.1038/508S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695334	Bronze			2022-12-28	WOS:000333609900006
J	Kahn, MW; Bell, SK; Walker, J; Delbanco, T				Kahn, Michael W.; Bell, Sigall K.; Walker, Jan; Delbanco, Tom			Let's Show Patients Their Mental Health Records	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOCTORS NOTES		[Kahn, Michael W.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Bell, Sigall K.; Walker, Jan; Delbanco, Tom] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kahn, MW (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA.	mkahn@bidmc.harvard.edu						Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Guest JA, 2013, JAMA-J AM MED ASSOC, V310, P1939, DOI 10.1001/jama.2013.282000; Vodicka E, 2013, J MED INTERNET RES, V15, P186, DOI 10.2196/jmir.2670; Walker J, 2014, NEW ENGL J MED, V370, P6, DOI 10.1056/NEJMp1310132	4	47	47	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1291	1292		10.1001/jama.2014.1824	http://dx.doi.org/10.1001/jama.2014.1824			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691603				2022-12-28	WOS:000333645400009
J	Bonney, R; Shirk, JL; Phillips, TB; Wiggins, A; Ballard, HL; Miller-Rushing, AJ; Parrish, JK				Bonney, Rick; Shirk, Jennifer L.; Phillips, Tina B.; Wiggins, Andrea; Ballard, Heidi L.; Miller-Rushing, Abraham J.; Parrish, Julia K.			Next Steps for Citizen Science	SCIENCE			English	Editorial Material									[Bonney, Rick; Shirk, Jennifer L.; Phillips, Tina B.; Wiggins, Andrea] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Wiggins, Andrea] Univ New Mexico, DataONE, Albuquerque, NM 87106 USA; [Ballard, Heidi L.] Univ Calif Davis, Sch Educ, Davis, CA 95616 USA; [Miller-Rushing, Abraham J.] Natl Pk Serv, Schood Educ & Res Ctr, Winter Harbor, ME 04693 USA; [Miller-Rushing, Abraham J.] Acadia Natl Pk, Winter Harbor, ME 04693 USA; [Parrish, Julia K.] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA	Cornell University; University of New Mexico; University of California System; University of California Davis; United States Department of the Interior; University of Washington; University of Washington Seattle	Bonney, R (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA.	reb5@cornell.edu	Bonney, Rick/HHS-0679-2022; Wiggins, Andrea/A-8946-2009; Miller-Rushing, Abraham/D-5102-2009	Wiggins, Andrea/0000-0003-4082-4138; Miller-Rushing, Abraham/0000-0003-3203-0143; Newman, Gregory/0000-0003-0503-5782	Direct For Education and Human Resources [1020909] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))		Air Quality, 2013, AIR QUAL; Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Danielsen F, 2014, BIOSCIENCE, V64, P236, DOI 10.1093/biosci/biu001; Delgado S, 2005, MARITAIN STUD, V4, P89; Ellul C., 2013, PROGR LOCATION BASED, P71; International Federation of Red Cross and Red Crescent Societies, 2009, WORLD DIS REP; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Munson MA, 2010, METHODS ECOL EVOL, V1, P263, DOI 10.1111/j.2041-210X.2010.00035.x; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Smith A., 2013, CR1301 ASS ADV ART I; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003	12	621	639	2	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1436	1437		10.1126/science.1251554	http://dx.doi.org/10.1126/science.1251554			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675940				2022-12-28	WOS:000333471000020
J	Nordlander, P				Nordlander, Peter			Molecular Tuning of Quantum Plasmon Resonances	SCIENCE			English	Editorial Material									Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Rice University	Nordlander, P (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.	nordland@rice.edu	Nordlander, Peter J. A./A-2560-2008	Nordlander, Peter J. A./0000-0002-1633-2937				Dieringer JA, 2007, J AM CHEM SOC, V129, P16249, DOI 10.1021/ja077243c; Lal S, 2008, CHEM SOC REV, V37, P898, DOI 10.1039/b705969h; Le F, 2008, ACS NANO, V2, P707, DOI 10.1021/nn800047e; Perez-Gonzalez O, 2010, NANO LETT, V10, P3090, DOI 10.1021/nl1017173; Savage KJ, 2012, NATURE, V491, P574, DOI 10.1038/nature11653; Scholl JA, 2013, NANO LETT, V13, P564, DOI 10.1021/nl304078v; Song P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554420; Tan SF, 2014, SCIENCE, V343, P1496, DOI 10.1126/science.1248797; Zuloaga J, 2009, NANO LETT, V9, P887, DOI 10.1021/nl803811g	9	15	16	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1444	1445		10.1126/science.1252245	http://dx.doi.org/10.1126/science.1252245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675945				2022-12-28	WOS:000333471000025
J	Xu, B; Ohtani, M; Yamaguchi, M; Toyooka, K; Wakazaki, M; Sato, M; Kubo, M; Nakano, Y; Sano, R; Hiwatashi, Y; Murata, T; Kurata, T; Yoneda, A; Kato, K; Hasebe, M; Demura, T				Xu, Bo; Ohtani, Misato; Yamaguchi, Masatoshi; Toyooka, Kiminori; Wakazaki, Mayumi; Sato, Mayuko; Kubo, Minoru; Nakano, Yoshimi; Sano, Ryosuke; Hiwatashi, Yuji; Murata, Takashi; Kurata, Tetsuya; Yoneda, Arata; Kato, Ko; Hasebe, Mitsuyasu; Demura, Taku			Contribution of NAC Transcription Factors to Plant Adaptation to Land	SCIENCE			English	Article							VASCULAR-RELATED NAC-DOMAIN6; SECONDARY WALL BIOSYNTHESIS; CONDUCTING TISSUES; WOOD FORMATION; XYLEM; ARABIDOPSIS; GENE; EXPRESSION; EVOLUTION; TRANSPORT	The development of cells specialized for water conduction or support is a striking innovation of plants that has enabled them to colonize land. The NAC transcription factors regulate the differentiation of these cells in vascular plants. However, the path by which plants with these cells have evolved from their nonvascular ancestors is unclear. We investigated genes of the moss Physcomitrella patens that encode NAC proteins. Loss-of-function mutants formed abnormal water-conducting and supporting cells, as well as malformed sporophyte cells, and overexpression induced ectopic differentiation of water-conducting-like cells. Our results show conservation of transcriptional regulation and cellular function between moss and Arabidopsis thaliana water-conducting cells. The conserved genetic basis suggests roles for NAC proteins in the adaptation of plants to land.	[Xu, Bo; Yamaguchi, Masatoshi; Nakano, Yoshimi; Sano, Ryosuke; Kurata, Tetsuya; Yoneda, Arata; Kato, Ko; Demura, Taku] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Ohtani, Misato; Toyooka, Kiminori; Wakazaki, Mayumi; Sato, Mayuko; Demura, Taku] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Kubo, Minoru; Hiwatashi, Yuji; Murata, Takashi; Hasebe, Mitsuyasu] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan	Nara Institute of Science & Technology; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Ohtani, M (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	misato@psc.riken.jp; demura@bs.naist.jp	Toyooka, Kiminori/B-5027-2011; Demura, Taku/ABE-7871-2021; Kubo, Minoru/AAH-1689-2019; Sato, Mayuko/D-4601-2017; Yamaguchi, Masatoshi/F-2183-2011; Nakano, Yoshimi/AAC-8626-2020; Wakazaki, Mayumi/D-4581-2017	Kubo, Minoru/0000-0001-8691-6252; Sato, Mayuko/0000-0002-9876-5612; Yamaguchi, Masatoshi/0000-0002-1396-5376; Nakano, Yoshimi/0000-0002-4515-1633; HIWATASHI, YUJI/0000-0002-3996-0549; Murata, Takashi/0000-0002-1543-0439; Hasebe, Mitsuyasu/0000-0001-7425-8758; Xu, Bo/0000-0001-7264-7127	RIKEN Biomass Engineering Program, Japan Society for the Promotion of Science KAKENHI [22370020, 24114002, 25291062, 22128002]; MEXT NC-CARP project; Grants-in-Aid for Scientific Research [24114001] Funding Source: KAKEN	RIKEN Biomass Engineering Program, Japan Society for the Promotion of Science KAKENHI; MEXT NC-CARP project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. L. Bowman (Monash University), K. Sakakibara (University of Tokyo), J. C. Mortimer (RIKEN), and I. Smith (NAIST) for critically reading the manuscript; N.-H. Chua (Rockefeller University) for providing the pER8 vector; T. Nomura (RIKEN) for valuable discussion; H. Endo (NAIST), A. Ihara, and K. Hashimoto (RIKEN) for technical assistance; T. Kuriyama and M. Matsui (RIKEN) for their contribution to A. thaliana transformation; and E. Nakamoto and T. Sakamoto (NAIST) for the RNA-seq experiment. Nucleotide sequences for PpVNS genes were deposited in the National Center for Biotechnology Information (accession nos. AB898081 to AB898088), and raw RNA-seq data were deposited in the DNA Data Bank of Japan Sequence Read Archive (DRA) database (accession no. DRA001341). This work was supported in part by the RIKEN Biomass Engineering Program, Japan Society for the Promotion of Science KAKENHI, grant numbers 22370020, 24114002, and 25291062 to T. D. and 22128002 to M. H., and by Grants-in-Aid from the MEXT NC-CARP project to T. D. The pER8 vector is available for noncommercial purposes from N. H. Chua under a materials transfer agreement with Rockefeller University.	Avci U, 2008, PLANT J, V56, P303, DOI 10.1111/j.1365-313X.2008.03592.x; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HEBANT C, 1977, CONDUCT TISSUES BRYO; Hornblad E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kenrick P, 2000, PHILOS T R SOC B, V355, P847, DOI 10.1098/rstb.2000.0619; KENRICK P, 1997, ORIGIN EARLY DIVERS; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kubo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077356; LAL M, 1981, PROTOPLASMA, V107, P79, DOI 10.1007/BF01275609; Lesniewicz K, 2013, PLANT CELL PHYSIOL, V54, P1064, DOI 10.1093/pcp/pct061; Ligrone R, 2000, PHILOS T ROY SOC B, V355, P795, DOI 10.1098/rstb.2000.0616; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Roberts AW, 2007, PLANT MOL BIOL, V63, P207, DOI 10.1007/s11103-006-9083-1; ROCKLAND LB, 1960, ANAL CHEM, V32, P1375, DOI 10.1021/ac60166a055; Sakakibara K, 2003, DEVELOPMENT, V130, P4835, DOI 10.1242/dev.00644; SCHEIRER DC, 1980, B TORREY BOT CLUB, V107, P298, DOI 10.2307/2484153; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tansley AG, 1901, ANN BOT-LONDON, V15, P1; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vidali L, 2010, PLANT CELL, V22, P1868, DOI 10.1105/tpc.109.073288; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; WIENCKE C, 1983, Z PFLANZENPHYSIOL, V112, P337, DOI 10.1016/S0044-328X(83)80051-8; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013; Zhao CS, 2000, PLANT PHYSIOL, V123, P1185, DOI 10.1104/pp.123.3.1185; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhu TT, 2012, EVOLUTION, V66, P1833, DOI 10.1111/j.1558-5646.2011.01553.x; Zimmer AD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-498; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	44	153	161	12	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1505	1508		10.1126/science.1248417	http://dx.doi.org/10.1126/science.1248417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24652936				2022-12-28	WOS:000333471000046
J	Andersson, R; Gebhard, C; Miguel-Escalada, I; Hoof, I; Bornholdt, J; Boyd, M; Chen, Y; Zhao, X; Schmidl, C; Suzuki, T; Ntini, E; Arner, E; Valen, E; Li, K; Schwarzfischer, L; Glatz, D; Raithel, J; Lilje, B; Rapin, N; Bagger, FO; Jorgensen, M; Andersen, PR; Bertin, N; Rackham, O; Burroughs, AM; Baillie, JK; Ishizu, Y; Shimizu, Y; Furuhata, E; Maeda, S; Negishi, Y; Mungall, CJ; Meehan, TF; Lassmann, T; Itoh, M; Kawaji, H; Kondo, N; Kawai, J; Lennartsson, A; Daub, CO; Heutink, P; Hume, DA; Jensen, TH; Suzuki, H; Hayashizaki, Y; Muller, F; Forrest, ARR; Carninci, P; Rehli, M; Sandelin, A				Andersson, Robin; Gebhard, Claudia; Miguel-Escalada, Irene; Hoof, Ilka; Bornholdt, Jette; Boyd, Mette; Chen, Yun; Zhao, Xiaobei; Schmidl, Christian; Suzuki, Takahiro; Ntini, Evgenia; Arner, Erik; Valen, Eivind; Li, Kang; Schwarzfischer, Lucia; Glatz, Dagmar; Raithel, Johanna; Lilje, Berit; Rapin, Nicolas; Bagger, Frederik Otzen; Jorgensen, Mette; Andersen, Peter Refsing; Bertin, Nicolas; Rackham, Owen; Burroughs, A. Maxwell; Baillie, J. Kenneth; Ishizu, Yuri; Shimizu, Yuri; Furuhata, Erina; Maeda, Shiori; Negishi, Yutaka; Mungall, Christopher J.; Meehan, Terrence F.; Lassmann, Timo; Itoh, Masayoshi; Kawaji, Hideya; Kondo, Naoto; Kawai, Jun; Lennartsson, Andreas; Daub, Carsten O.; Heutink, Peter; Hume, David A.; Jensen, Torben Heick; Suzuki, Harukazu; Hayashizaki, Yoshihide; Mueller, Ferenc; Forrest, Alistair R. R.; Carninci, Piero; Rehli, Michael; Sandelin, Albin		FANTOM Consortium	An atlas of active enhancers across human cell types and tissues	NATURE			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; CAP-ANALYSIS; REGULATORY SEQUENCES; DNA METHYLATION; DISCOVERY; INFORMATION; LANDSCAPE; UPSTREAM; PATTERN	Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation.	[Andersson, Robin; Hoof, Ilka; Bornholdt, Jette; Boyd, Mette; Chen, Yun; Zhao, Xiaobei; Valen, Eivind; Li, Kang; Lilje, Berit; Rapin, Nicolas; Bagger, Frederik Otzen; Jorgensen, Mette; Sandelin, Albin] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Andersson, Robin; Hoof, Ilka; Bornholdt, Jette; Boyd, Mette; Chen, Yun; Zhao, Xiaobei; Valen, Eivind; Li, Kang; Lilje, Berit; Rapin, Nicolas; Bagger, Frederik Otzen; Jorgensen, Mette; Sandelin, Albin] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Gebhard, Claudia; Schmidl, Christian; Schwarzfischer, Lucia; Glatz, Dagmar; Raithel, Johanna; Rehli, Michael] Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany; [Gebhard, Claudia; Rehli, Michael] Regensburg Ctr Intervent Immunol RCI, D-93042 Regensburg, Germany; [Miguel-Escalada, Irene; Mueller, Ferenc] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Zhao, Xiaobei] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Suzuki, Takahiro; Arner, Erik; Bertin, Nicolas; Rackham, Owen; Burroughs, A. Maxwell; Ishizu, Yuri; Shimizu, Yuri; Furuhata, Erina; Maeda, Shiori; Negishi, Yutaka; Lassmann, Timo; Itoh, Masayoshi; Kawaji, Hideya; Kondo, Naoto; Kawai, Jun; Daub, Carsten O.; Hume, David A.; Suzuki, Harukazu; Hayashizaki, Yoshihide; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Yokohama Inst, RIKEN OMICS Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Suzuki, Takahiro; Arner, Erik; Bertin, Nicolas; Rackham, Owen; Burroughs, A. Maxwell; Ishizu, Yuri; Shimizu, Yuri; Furuhata, Erina; Maeda, Shiori; Negishi, Yutaka; Lassmann, Timo; Itoh, Masayoshi; Daub, Carsten O.; Suzuki, Harukazu; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Yokohama Inst, RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ntini, Evgenia; Andersen, Peter Refsing; Jensen, Torben Heick] Ctr mRNP Biogenesis & Metab, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Valen, Eivind] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Rapin, Nicolas; Bagger, Frederik Otzen] Univ Copenhagen, Finsen Lab, Rigshosp, DK-2200 Copenhagen, Denmark; [Rapin, Nicolas; Bagger, Frederik Otzen] Univ Copenhagen, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen, Denmark; [Baillie, J. Kenneth; Hume, David A.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Meehan, Terrence F.] EMBL Outstn Hinxton, European Bioinformat Inst, Cambridge CB10 1SD, England; [Itoh, Masayoshi; Kawaji, Hideya; Kondo, Naoto; Kawai, Jun] RIKEN Yokohama Inst, RIKEN Prevent Med & Diag Innovat Program, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Lennartsson, Andreas; Daub, Carsten O.] Karolinska Inst, Dept Biosci & Nutr, SE-4183 Stockholm, Sweden; [Hayashizaki, Yoshihide] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands	University of Copenhagen; University of Copenhagen; University of Regensburg; University of Birmingham; University of North Carolina; University of North Carolina Chapel Hill; RIKEN; RIKEN; Harvard University; Rigshospitalet; University of Copenhagen; University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); RIKEN; Karolinska Institutet; Vrije Universiteit Amsterdam	Forrest, ARR (corresponding author), RIKEN Yokohama Inst, RIKEN OMICS Sci Ctr, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	alistair.forrest@gmail.com; carninci@riken.jp; michael.rehli@ukr.de; albin@binf.ku.dk	Katayama, Shintaro/F-2958-2010; Zhao, Xiaobei/G-3567-2014; Daub, Carsten O/A-7436-2010; Baillie, Kenneth/AEK-6650-2022; Hide, Winston A/V-2727-2017; Faulkner, Geoffrey J/M-3168-2014; Miguel-Escalada, Irene/J-6535-2014; Carninci, Piero/K-1568-2014; Mackay-Sim, Alan/C-3431-2008; Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Lassmann, Timo/HCH-4313-2022; Muller, Ferenc/C-6426-2009; Jensen, Torben H/G-2954-2017; Baillie, John Kenneth/F-3124-2011; Kenna, Tony/A-6035-2011; Suzuki, Harukazu/N-9553-2015; Wolvetang, Ernst jurgen/D-6644-2017; Rackham, Owen/AAM-3108-2021; Lassmann, Timo/A-8271-2008; Kawaji, Hideya/N-5116-2015; Itoh, Masayoshi/N-5363-2015; Mungall, Chris/I-6006-2019; Ovchinnikov, Dmitry/J-7963-2014; Bodega, Beatrice/I-4644-2018; Kawai, Jun/A-6451-2016; Arner, Erik/A-1895-2010; Dalla, Emiliano/AAH-3039-2020; Hayashizaki, Yoshihide/N-6590-2015; Taylor, Martin S/C-3825-2009; Andersson, Robin/B-5311-2009; Rehli, Michael/E-9093-2011; Kere, Juha/A-9179-2008; Ohno, Hiroshi/L-7899-2014; Sandelin, Albin/G-2881-2011; Ravasi, Timothy/B-8777-2008; KONDO, NAOTO/A-5829-2016; Suzuki, Takahiro/AAW-8509-2020; Bertin, Nicolas/O-9602-2019; Schmidl, Christian/HDO-6299-2022; Valen, Eivind/A-8617-2011; Wells, Christine/A-5071-2010; Bertin, Nicolas/C-3025-2008	Katayama, Shintaro/0000-0001-7581-5157; Zhao, Xiaobei/0000-0002-5277-0846; Daub, Carsten O/0000-0002-3295-8729; Baillie, Kenneth/0000-0001-5258-793X; Hide, Winston A/0000-0002-8621-3271; Faulkner, Geoffrey J/0000-0001-5769-4494; Miguel-Escalada, Irene/0000-0003-3461-6404; Carninci, Piero/0000-0001-7202-7243; Mackay-Sim, Alan/0000-0003-4446-5371; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Lassmann, Timo/0000-0002-0138-2691; Baillie, John Kenneth/0000-0001-5258-793X; Suzuki, Harukazu/0000-0002-8087-0836; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Rackham, Owen/0000-0002-4390-0872; Lassmann, Timo/0000-0002-0138-2691; Kawaji, Hideya/0000-0002-0575-0308; Itoh, Masayoshi/0000-0002-1772-318X; Mungall, Chris/0000-0002-6601-2165; Ovchinnikov, Dmitry/0000-0001-9603-8385; Bodega, Beatrice/0000-0003-0527-9234; Arner, Erik/0000-0003-1225-4908; Dalla, Emiliano/0000-0002-4687-6011; Taylor, Martin S/0000-0001-7656-330X; Andersson, Robin/0000-0003-1516-879X; Rehli, Michael/0000-0003-3992-932X; Kere, Juha/0000-0003-1974-0271; Ohno, Hiroshi/0000-0001-8776-9661; Sandelin, Albin/0000-0002-7109-7378; KONDO, NAOTO/0000-0001-9576-7615; Suzuki, Takahiro/0000-0002-0972-6911; Schmidl, Christian/0000-0002-0522-202X; Huminiecki, Lukasz/0000-0003-1943-4450; Moro, Kazuyo/0000-0002-7377-1303; Sajantila, Antti/0000-0003-4117-5248; Laros, Jeroen F.J./0000-0002-8715-7371; Wells, Christine/0000-0003-3133-3628; Sengstag, Thierry/0000-0002-7516-6246; Jensen, Torben Heick/0000-0001-5127-1239; Rapin, Nicolas/0000-0001-5208-8874; Bertin, Nicolas/0000-0002-9835-9606; Jorgensen, Mette/0000-0002-2804-0560; Nakahara, Fumio/0000-0003-1515-8284; Fisher, Malcolm/0000-0003-1074-8103; Heutink, Peter/0000-0001-5218-1737; Forrest, Alistair/0000-0003-4543-1675; mueller, ferenc/0000-0002-0996-774X; Lenhard, Boris/0000-0002-1114-1509; Lennartsson, Andreas/0000-0002-3272-2505; Knox, Alan/0000-0002-5906-4143; Prendergast, James/0000-0001-8916-018X; Blake, Judith/0000-0001-8522-334X; Andersen, Peter Ebert/0000-0001-5815-4860; Rashid, Mamoon/0000-0003-4851-4994; Ekwall, Karl/0000-0002-3029-4041; Arner, Peter/0000-0002-6208-6220; Burroughs, A. Max/0000-0002-2229-8771; Winteringham, Louise/0000-0002-8117-5069; Hoof, Ilka/0000-0003-3827-7227; Hume, David/0000-0002-2615-1478; Otzen Bagger, Frederik/0000-0003-0636-8845; Ntini, Evgenia/0000-0002-4649-6051; Freeman, Thomas/0000-0001-5235-8483; Wasserman, Wyeth/0000-0001-6098-6412; Meehan, Terrence/0000-0003-1980-3228; Valen, Eivind/0000-0003-1840-6108	MEXT; MEXT, Japan; European Research Council/ERC [204135]; Novo Nordisk foundation; Lundbeck foundation; Deutsche Forschungsgemeinschaft [RE1310/7, RE1310/11, RE1310/13]; Rudolf Bartling Stiftung; "BOLD" MarieCurie ITN; "ZF-Health" Integrated project of the European Commission; BBSRC [BB/I024801/1, BBS/E/D/20251969] Funding Source: UKRI; MRC [MC_UP_1102/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I024801/1, BBS/E/D/20251969] Funding Source: researchfish; Lundbeck Foundation [R167-2013-15058] Funding Source: researchfish; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0001211] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022969] Funding Source: NIH RePORTER	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Research Council/ERC(European Research Council (ERC)European Commission); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck foundation(Lundbeckfonden); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Bartling Stiftung; "BOLD" MarieCurie ITN; "ZF-Health" Integrated project of the European Commission; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to Y.H. and a Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan, to Y.H. The A. S. group was supported by funds from the European Research Council FP7/2007-2013/ERC no. 204135, the Novo Nordisk and Lundbeck foundations. Work in the M. R. group was funded by grants from the Deutsche Forschungsgemeinschaft (RE1310/7,11,13) and Rudolf Bartling Stiftung. F. M. and I. M. E. were supported by "BOLD" MarieCurie ITN and "ZF-Health" Integrated project of the European Commission. We thank S. Noma, M. Sakai and H. Tarui for RNA-seq and sRNA-seq preparation, RIKEN GeNAS for generation and sequencing of the Heliscope CAGE libraries, Illumina RNA-seq and sRNA-seq, the Copenhagen National High-throughput DNA Sequencing Center for Illumina CAGE-seq, M. Edinger, P. Hoffmann and R. Eder for cell sorting, A. Albrechtsen, I. Moltke, W. Wasserman for advice, and the Netherlands Brain Bank for post-mortem human brain material.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Buckner J, 2010, BIOINFORMATICS, V26, P134, DOI 10.1093/bioinformatics/btp608; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fort A., NATURE GENE IN PRESS; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Groemping U., 2006, J STAT SOFTW, V17, DOI [http://dx.doi.org/10.18637/jss.v017.i01, DOI 10.1867/JSS.V017.I01]; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronnerblad M., BLOOD IN PRESS; SCHAFFNER G, 1988, J MOL BIOL, V201, P81, DOI 10.1016/0022-2836(88)90440-8; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuber V, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1730	73	1495	1519	13	302	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					455	+		10.1038/nature12787	http://dx.doi.org/10.1038/nature12787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670763	Green Accepted, Green Published			2022-12-28	WOS:000333402000032
J	Julienne, PS				Julienne, Paul S.			LOW-TEMPERATURE PHYSICS Chaos in the cold	NATURE			English	Editorial Material							GASES		Univ Maryland, Joint Quantum Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Julienne, PS (corresponding author), Univ Maryland, Joint Quantum Inst, College Pk, MD 20742 USA.	psj@umd.edu	Julienne, Paul S/E-9378-2012	Julienne, Paul S/0000-0002-5494-1442				Baranov MA, 2008, PHYS REP, V464, P71, DOI 10.1016/j.physrep.2008.04.007; Baranov MA, 2012, CHEM REV, V112, P5012, DOI 10.1021/cr2003568; Baumann K, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.020701; Bowman JM, 2011, PHYS TODAY, V64, P33, DOI 10.1063/PT.3.1330; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Frisch A, 2014, NATURE, V507, P475, DOI 10.1038/nature13137; Jacobson MP, 2000, J PHYS CHEM A, V104, P3073, DOI 10.1021/jp992428u; Mayle M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062712	8	3	3	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					440	441		10.1038/nature13211	http://dx.doi.org/10.1038/nature13211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670759				2022-12-28	WOS:000333402000028
J	Mermin, ND				Mermin, N. David			QBism puts the scientist back into science	NATURE			English	Editorial Material									[Mermin, N. David] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Mermin, N. David] Stellenbosch Inst Adv Study, Stellenbosch, South Africa	Cornell University; Stellenbosch University	Mermin, ND (corresponding author), Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	david.mermin@cornell.edu						Bohr N., 1934, ATOMIC THEORY DESCRI, P18; Carnap Rudolf, 1963, PHILOS R CARNAP, P37; Caves CM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.022305; Freud Sigmund, 2004, MASS PSYCHOL OTHER W; Fuchs C.A., 2010, PREPRINT; Fuchs C. A., 2013, PREPRINT; Fuchs CA, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1693; Price H, 2013, SCIENCE, V341, P960, DOI 10.1126/science.1239717; Schrodinger E., 1996, NATURE GREEKS SCI HU; Schrodinger E., 2011, ENTDECKUNG GANZ AUSS, P490	10	48	48	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					421	423		10.1038/507421a	http://dx.doi.org/10.1038/507421a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6WN	24678539	Bronze			2022-12-28	WOS:000333402000013
J	Cole, TB				Cole, Thomas B.			Cobalt Yvonne McKague Housser	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1184	1185		10.1001/jama.2013.279404	http://dx.doi.org/10.1001/jama.2013.279404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668082				2022-12-28	WOS:000333340500003
J	Di Angelantonio, E; Gao, P; Khan, H; Butterworth, AS; Wormser, D; Kaptoge, S; Seshasai, SRK; Thompson, A; Sarwar, N; Willeit, P; Ridker, PM; Barr, ELM; Khaw, KT; Psaty, BM; Brenner, H; Balkau, B; Dekker, JM; Lawlor, DA; Daimon, M; Willeit, J; Njolstad, I; Nissinen, A; Brunner, EJ; Kuller, LH; Price, JF; Sundstrom, J; Knuiman, MW; Feskens, EJM; Verschuren, WMM; Wald, N; Bakker, SJL; Whincup, PH; Ford, I; Goldbourt, U; Gomez-de-la-Camara, A; Gallacher, J; Simons, LA; Rosengren, A; Sutherland, SE; Bjorkelund, C; Blazer, DG; Wassertheil-Smoller, S; Onat, A; Ibanez, AM; Casiglia, E; Jukema, JW; Simpson, LM; Giampaoli, S; Nordestgaard, BG; Selmer, R; Wennberg, P; Kauhanen, J; Salonen, JT; Dankner, R; Barrett-Connor, E; Kavousi, M; Gudnason, V; Evans, D; Wallace, RB; Cushman, M; D'Agostino, RB; Umans, JG; Kiyohara, Y; Nakagawa, H; Sato, S; Gillum, RF; Folsom, AR; van der Schouw, YT; Moons, KG; Griffin, SJ; Sattar, N; Wareham, NJ; Selvin, E; Thompson, SG; Danesh, J				Di Angelantonio, Emanuele; Gao, Pei; Khan, Hassan; Butterworth, Adam S.; Wormser, David; Kaptoge, Stephen; Seshasai, Sreenivasa Rao Kondapally; Thompson, Alex; Sarwar, Nadeem; Willeit, Peter; Ridker, Paul M.; Barr, Elizabeth L. M.; Khaw, Kay-Tee; Psaty, Bruce M.; Brenner, Hermann; Balkau, Beverley; Dekker, Jacqueline M.; Lawlor, Debbie A.; Daimon, Makoto; Willeit, Johann; Njolstad, Inger; Nissinen, Aulikki; Brunner, Eric J.; Kuller, Lewis H.; Price, Jackie F.; Sundstrom, Johan; Knuiman, Matthew W.; Feskens, Edith J. M.; Verschuren, W. M. M.; Wald, Nicholas; Bakker, Stephan J. L.; Whincup, Peter H.; Ford, Ian; Goldbourt, Uri; Gomez-de-la-Camara, Agustin; Gallacher, John; Simons, Leon A.; Rosengren, Annika; Sutherland, Susan E.; Bjorkelund, Cecilia; Blazer, Dan G.; Wassertheil-Smoller, Sylvia; Onat, Altan; Ibanez, Alejandro Marin; Casiglia, Edoardo; Jukema, J. Wouter; Simpson, Lara M.; Giampaoli, Simona; Nordestgaard, Borge G.; Selmer, Randi; Wennberg, Patrik; Kauhanen, Jussi; Salonen, Jukka T.; Dankner, Rachel; Barrett-Connor, Elizabeth; Kavousi, Maryam; Gudnason, Vilmundur; Evans, Denis; Wallace, Robert B.; Cushman, Mary; D'Agostino, Ralph B., Sr.; Umans, Jason G.; Kiyohara, Yutaka; Nakagawa, Hidaeki; Sato, Shinichi; Gillum, Richard F.; Folsom, Aaron R.; van der Schouw, Yvonne T.; Moons, Karel G.; Griffin, Simon J.; Sattar, Naveed; Wareham, Nicholas J.; Selvin, Elizabeth; Thompson, Simon G.; Danesh, John		Emerging Risk Factors	Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STATISTICAL-METHODS; RISK; GLUCOSE; GUIDELINES	IMPORTANCE The value of measuring levels of glycated hemoglobin (HbA(1c)) for the prediction of first cardiovascular events is uncertain. OBJECTIVE To determine whether adding information on HbA(1c) values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS Analysis of individual-participant data available from 73 prospective studies involving 294 998 participants without a known history of diabetes mellitus or CVD at the baseline assessment. MAIN OUTCOMES AND MEASURES Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (<5%), intermediate (5% to <7.5%), and high (>= 7.5%) risk. RESULTS During a median follow-up of 9.9 (interquartile range, 7.6-13.2) years, 20 840 incident fatal and nonfatal CVD outcomes (13 237 coronary heart disease and 7603 stroke outcomes) were recorded. In analyses adjusted for several conventional cardiovascular risk factors, there was an approximately J-shaped association between HbA(1c) values and CVD risk. The association between HbA(1c) values and CVD risk changed only slightly after adjustment for total cholesterol and triglyceride concentrations or estimated glomerular filtration rate, but this association attenuated somewhat after adjustment for concentrations of high-density lipoprotein cholesterol and C-reactive protein. The C-index for a CVD risk prediction model containing conventional cardiovascular risk factors alone was 0.7434 (95% CI, 0.7350 to 0.7517). The addition of information on HbA(1c) was associated with a C-index change of 0.0018 (0.0003 to 0.0033) and a net reclassification improvement of 0.42 (-0.63 to 1.48) for the categories of predicted 10-year CVD risk. The improvement provided by HbA(1c) assessment in prediction of CVD risk was equal to or better than estimated improvements for measurement of fasting, random, or postload plasma glucose levels. CONCLUSIONS AND RELEVANCE In a study of individuals without known CVD or diabetes, additional assessment of HbA(1c) values in the context of CVD risk assessment provided little incremental benefit for prediction of CVD risk.	[Di Angelantonio, Emanuele; Gao, Pei; Khan, Hassan; Butterworth, Adam S.; Wormser, David; Kaptoge, Stephen; Thompson, Alex; Sarwar, Nadeem; Willeit, Peter; Khaw, Kay-Tee; Griffin, Simon J.; Wareham, Nicholas J.; Thompson, Simon G.; Danesh, John] Univ Cambridge, Cambridge, England; [Seshasai, Sreenivasa Rao Kondapally; Whincup, Peter H.] St Georges Univ London, London, England; [Ridker, Paul M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Barr, Elizabeth L. M.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA USA; [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Balkau, Beverley] INSERM, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Villejuif, France; [Dekker, Jacqueline M.] Vrije Univ Med Ctr, Amsterdam, Netherlands; [Lawlor, Debbie A.] Univ Bristol, Bristol, Avon, England; [Daimon, Makoto] Yamagata Univ, Yamagata 990, Japan; [Willeit, Johann] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Njolstad, Inger] Univ Tromso, Tromso, Norway; [Nissinen, Aulikki] Natl Inst Hlth & Welf, Helsinki, Finland; [Brunner, Eric J.] UCL, London, England; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Price, Jackie F.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Sundstrom, Johan] Uppsala Univ, Uppsala, Sweden; [Knuiman, Matthew W.] Univ Western Australia, Perth, WA 6009, Australia; [Feskens, Edith J. M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Verschuren, W. M. M.] Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands; [Wald, Nicholas] Wolfson Inst Prevent Med, London, England; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Ford, Ian; Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Goldbourt, Uri] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Gomez-de-la-Camara, Agustin] Hosp 12 Octubre, E-28041 Madrid, Spain; [Gallacher, John] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Simons, Leon A.] Univ New S Wales, Kensington, NSW 2033, Australia; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Sutherland, Susan E.] Med Univ S Carolina, Charleston, SC USA; [Bjorkelund, Cecilia] Univ Gothenburg, Gothenburg, Sweden; [Blazer, Dan G.] Duke Univ, Med Ctr, Durham, NC USA; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, New York, NY USA; [Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Ibanez, Alejandro Marin] San Jose Norte Hlth Ctr, Zaragoza, Spain; [Casiglia, Edoardo] Univ Padua, Padua, Italy; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Leiden, Netherlands; [Simpson, Lara M.] Univ Texas Sch Publ Hlth, Houston, TX USA; [Giampaoli, Simona] Ist Super Sanita, I-00161 Rome, Italy; [Nordestgaard, Borge G.] Univ Copenhagen, Herlev Hosp, Copenhagen Univ Hosp, Copenhagen, Denmark; [Selmer, Randi] Norwegian Inst Publ Hlth, Oslo, Norway; [Wennberg, Patrik] Umea Univ, Umea, Sweden; [Kauhanen, Jussi] Univ Eastern Finland, Kuopio, Finland; [Salonen, Jukka T.] Univ Helsinki, Helsinki, Finland; [Dankner, Rachel] Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; [Dankner, Rachel] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Dankner, Rachel] Feinstein Inst Med Res, New York, NY USA; [Barrett-Connor, Elizabeth] Univ Calif San Diego, San Diego, CA 92103 USA; [Kavousi, Maryam] Erasmus MC, Rotterdam, Netherlands; [Gudnason, Vilmundur] Icelandic Heart Assoc, Reyjavik, Iceland; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Evans, Denis] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Cushman, Mary] Univ Vermont, Burlington, VT 05405 USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Boston, MA 02215 USA; [Umans, Jason G.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Kiyohara, Yutaka] Kyushu Univ, Kyushu, Japan; [Nakagawa, Hidaeki] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan; [Sato, Shinichi] Osaka Med Ctr Hlth Sci & Promot, Chiba Prefectural Inst Publ Hlth, Osaka, Japan; [Gillum, Richard F.] Howard Univ, Washington, DC 20059 USA; [Folsom, Aaron R.] Univ Minnesota, Minneapolis, MN USA; [van der Schouw, Yvonne T.; Moons, Karel G.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Selvin, Elizabeth] Johns Hopkins Univ, Baltimore, MD USA	University of Cambridge; St Georges University London; Harvard University; Brigham & Women's Hospital; Baker Heart and Diabetes Institute; University of Washington; University of Washington Seattle; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Bristol; Yamagata University; Medical University of Innsbruck; UiT The Arctic University of Tromso; Finland National Institute for Health & Welfare; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Uppsala University; University of Western Australia; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; University of London; Queen Mary University London; University of Groningen; University of Glasgow; Chaim Sheba Medical Center; Hospital Universitario 12 de Octubre; Cardiff University; University of New South Wales Sydney; University of Gothenburg; Medical University of South Carolina; University of Gothenburg; Duke University; Yeshiva University; Istanbul University; University of Padua; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Istituto Superiore di Sanita (ISS); University of Copenhagen; Herlev & Gentofte Hospital; Norwegian Institute of Public Health (NIPH); Umea University; University of Eastern Finland; University of Helsinki; Tel Aviv University; Northwell Health; University of California System; University of California San Diego; Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; University of Iceland; Rush University; University of Iowa; University of Vermont; Boston University; Georgetown University; Kyushu University; Kanazawa Medical University; Howard University; University of Minnesota System; University of Minnesota Twin Cities; Utrecht University; Utrecht University Medical Center; Johns Hopkins University	Danesh, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Daimon, Makoto/AAY-1289-2020; Khan, Hassan/D-6267-2013; Sundstrom, Johan/R-2139-2019; Brunner, Eric/H-2114-2011; Rubio, Miguel Angel/GRJ-0134-2022; de la Camara, Agustin Gomez/S-7123-2018; Schöttker, Ben/F-8183-2014; Gudnason, Vilmundur/K-6885-2015; Gao, Pei/AAF-3065-2019; Knuiman, Matthew W/I-5549-2013; Dankner, Rachel/Q-5245-2019; Gao, Pei/R-4794-2018; Brenner, Hermann/B-4627-2017; Kavousi, Maryam/F-1174-2018; Harshfield, Eric L/AAG-8081-2020; Benn, Marianne/O-4164-2019; Gudnason, Vilmundur/AAE-7126-2019; Kauhanen, Jussi/ABC-4064-2021; Wald, Nicholas/AAY-8924-2021; Nordestgaard, Borge Gronne/ABF-1310-2020; Wald, Nicholas/AAY-2814-2021; Sundström, Johan/A-6286-2009; Bakker, Stephan J. L./J-4023-2015; van der Schouw, Yvonne T./F-8327-2014; Sakurai, Masaru/AAC-6551-2021; Ford, Ian/ABE-6145-2020; Cushman, Mary/K-1157-2019; Brenner, Hermann/ABE-6383-2020; Khaw, Kay-Tee/AAZ-3209-2021; Willeit, Peter/HCI-7091-2022; DiAngelantonio, Emanuele/ABE-6852-2020; Lennon, Lucy/ABB-9433-2020; Jukema, J. Wouter/ABD-6503-2021; Ademoglu, Evin/AAD-8990-2020; Feskens, Edith/ABI-1446-2020; Njolstad, Inger/X-3784-2019; Griffin, Simon/K-3106-2013	Daimon, Makoto/0000-0002-3775-1719; Khan, Hassan/0000-0003-1468-8654; Sundstrom, Johan/0000-0003-2247-8454; Brunner, Eric/0000-0002-0595-4474; Rubio, Miguel Angel/0000-0002-0495-6240; Schöttker, Ben/0000-0002-1217-4521; Gudnason, Vilmundur/0000-0001-5696-0084; Gao, Pei/0000-0001-8649-1290; Dankner, Rachel/0000-0001-6454-6000; Gao, Pei/0000-0001-8649-1290; Brenner, Hermann/0000-0002-6129-1572; Kavousi, Maryam/0000-0001-5976-6519; Harshfield, Eric L/0000-0001-8767-0928; Benn, Marianne/0000-0002-1701-595X; Gudnason, Vilmundur/0000-0001-5696-0084; Sundström, Johan/0000-0003-2247-8454; Bakker, Stephan J. L./0000-0003-3356-6791; van der Schouw, Yvonne T./0000-0002-4605-435X; Sakurai, Masaru/0000-0002-4929-3225; Cushman, Mary/0000-0002-7871-6143; Brenner, Hermann/0000-0002-6129-1572; Willeit, Peter/0000-0002-1866-7159; Lennon, Lucy/0000-0002-1738-1351; Jukema, J. Wouter/0000-0002-3246-8359; Ademoglu, Evin/0000-0003-2933-3119; Feskens, Edith/0000-0001-5819-2488; Burgess, Stephen/0000-0001-5365-8760; Franco, Oscar/0000-0002-4606-4929; Butterworth, Adam/0000-0002-6915-9015; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Whincup, Peter/0000-0002-5589-4107; Lawlor, Debbie A/0000-0002-6793-2262; Stehouwer, Coen/0000-0001-8752-3223; Nordestgaard, Borge/0000-0002-1954-7220; Rosengren, Annika/0000-0002-5409-6605; Price, Jackie/0000-0003-3251-3970; Griffin, Simon/0000-0002-2157-4797; Gomez de la Camara, Agustin/0000-0001-6827-6319; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Rothenbacher, Dietrich/0000-0002-3563-2791; Pennells, Lisa Anne/0000-0002-8594-3061; Woodward, Mark/0000-0001-9800-5296; Di Angelantonio, Emanuele/0000-0001-8776-6719; Knuiman, Matthew/0000-0001-8874-2305	British Heart Foundation; UK Medical Research Council; UK National Institute of Health Research; Cambridge Biomedical Research Centre; MRC [MC_U106179474, MC_UU_12015/4, MR/L003120/1, MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/16/30528, RG/13/2/30098, PG/13/66/30442, RG/08/014/24067, RG/08/013/25942] Funding Source: researchfish; Medical Research Council [MC_U106179474, MC_UU_12013/5, MR/K013351/1, G0401527, G1000143, MR/L003120/1, MC_UU_12015/4] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10165] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health Research(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was funded by the British Heart Foundation, the UK Medical Research Council, UK National Institute of Health Research, and the Cambridge Biomedical Research Centre. The collaboration's website (http://www.phpc.cam.ac.uk/ceu/research/erfc/studies/) has compiled a list provided by investigators of some of the funders of the component studies in this analysis.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Barr ELM, 2009, DIABETOLOGIA, V52, P415, DOI 10.1007/s00125-008-1246-y; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Christman AL, 2012, DIABETOLOGIA, V55, P2307; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Goff D. C., 2014, J AM COLL CARDIOL, V63, P25, DOI DOI 10.1161/01.CIR.0000437741.48606.98; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kissel CK, 2012, CAN J CARDIOL, V28, P251, DOI 10.1016/j.cjca.2011.12.008; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pennells L, 2014, AM J EPIDEMIOL, V179, P621, DOI 10.1093/aje/kwt298; Pfister R, 2011, DIABETOLOGIA, V54, P2025, DOI 10.1007/s00125-011-2162-0; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, LANCET, V376, P957, DOI 10.1016/S0140-6736(10)61450-X; Schottker B, 2013, DIABETOLOGIA, V56, P92, DOI 10.1007/s00125-012-2707-x; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Simmons RK, 2008, ARCH INTERN MED, V168, P1209, DOI 10.1001/archinte.168.11.1209; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063	27	146	148	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1225	1233		10.1001/jama.2014.1873	http://dx.doi.org/10.1001/jama.2014.1873			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668104	Green Accepted, Bronze			2022-12-28	WOS:000333340500026
J	Spence, D				Spence, Des			FROM THE FRONTLINE So long for now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2014	348								g2343	10.1136/bmj.g2343	http://dx.doi.org/10.1136/bmj.g2343			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LN	24671984				2022-12-28	WOS:000333586700005
J	[Anonymous]				[Anonymous]			Cardiac Disturbances as the Result of Exhaustion (Reprinted from vol 28, 559, 1897)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1897, JAMA, V28, P559	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1255	1255		10.1001/jama.2013.279411	http://dx.doi.org/10.1001/jama.2013.279411			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668116				2022-12-28	WOS:000333340500037
J	McKenna, P; Kingdon, D				McKenna, Peter; Kingdon, David			Has cognitive behavioural therapy for psychosis been oversold?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PERSISTENT SYMPTOMS; SCHIZOPHRENIA; RESISTANT; PEOPLE		[McKenna, Peter] FIDMAG Germanes Hosp Res Fdn, Barcelona, Spain; [Kingdon, David] Univ Southampton, Southampton, Hants, England	University of Southampton	McKenna, P (corresponding author), FIDMAG Germanes Hosp Res Fdn, Barcelona, Spain.	mckennapeter1@googlemail.com; D.Kingdon@soton.ac.uk	Kingdon, David/B-8200-2009	Kingdon, David/0000-0002-8913-0906; McKenna, Peter/0000-0001-5474-1144	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2012, PROG NEUROL PSYCHIAT, V16, P35, DOI 10.1002/14651858.CD008712.pub2; Balter M, 2014, SCIENCE, V343, P1190, DOI 10.1126/science.343.6176.1190; Barrowclough C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6325; Benjamini Y, 2001, ANN STAT, V29, P1165; Bentall RP, 2009, ARCH GEN PSYCHIAT, V66, P236, DOI 10.1001/archgenpsychiatry.2009.1; Gaebel W, 2011, INT REV PSYCHIATR, V23, P379, DOI 10.3109/09540261.2011.606801; Jauhar S, 2014, BRIT J PSYCHIAT, V204, P20, DOI 10.1192/bjp.bp.112.116285; Kingdon D, 2013, BRIT J PSYCHIAT, V202, P394, DOI 10.1192/bjp.bp.112.125039; Kingdon D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f402; Kuipers E, 1997, BRIT J PSYCHIAT, V171, P319, DOI 10.1192/bjp.171.4.319; Moncrieff J, 2003, BRIT J PSYCHIAT, V183, P161, DOI 10.1192/bjp.183.2.161; Morrison AP, 2014, LANCET, V383, P1395, DOI 10.1016/S0140-6736(13)62246-1; NICE, 2009, SCHIZ COR INT TREATM; Reininghaus U, 2010, SCHIZOPHR RES, V124, P43, DOI 10.1016/j.schres.2010.08.038; Sensky T, 2000, ARCH GEN PSYCHIAT, V57, P165, DOI 10.1001/archpsyc.57.2.165; Tarrier N, 2004, BRIT J PSYCHIAT, V184, P231, DOI 10.1192/bjp.184.3.231; Turkington D, 2002, BRIT J PSYCHIAT, V180, P523, DOI 10.1192/bjp.180.6.523; Turkington D, 2008, SCHIZOPHR RES, V98, P1, DOI 10.1016/j.schres.2007.09.026; Turner D.T, 2014, AM J PSYCHIAT; van der Gaag M, 2011, BRIT J PSYCHIAT, V198, P59, DOI 10.1192/bjp.bp.109.071522	20	19	19	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2014	348								g2295	10.1136/bmj.g2295	http://dx.doi.org/10.1136/bmj.g2295			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LD	24668904	Green Accepted, Green Published			2022-12-28	WOS:000333585700008
J	Bushdid, C; Magnasco, MO; Vosshall, LB; Keller, A				Bushdid, C.; Magnasco, M. O.; Vosshall, L. B.; Keller, A.			Humans Can Discriminate More than 1 Trillion Olfactory Stimuli	SCIENCE			English	Article								Humans can discriminate several million different colors and almost half a million different tones, but the number of discriminable olfactory stimuli remains unknown. The lay and scientific literature typically claims that humans can discriminate 10,000 odors, but this number has never been empirically validated. We determined the resolution of the human sense of smell by testing the capacity of humans to discriminate odor mixtures with varying numbers of shared components. On the basis of the results of psychophysical testing, we calculated that humans can discriminate at least 1 trillion olfactory stimuli. This is far more than previous estimates of distinguishable olfactory stimuli. It demonstrates that the human olfactory system, with its hundreds of different olfactory receptors, far outperforms the other senses in the number of physically different stimuli it can discriminate.	[Bushdid, C.; Vosshall, L. B.; Keller, A.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Magnasco, M. O.] Rockefeller Univ, Phys Math Lab, New York, NY 10065 USA; [Vosshall, L. B.] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute	Keller, A (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	andreas.keller@rockefeller.edu		Keller, Andreas/0000-0001-5491-2214	Branco Weiss Science in Society Fellowship; NARSAD; National Center for Advancing Translational Sciences [NCATS, National Institutes of Health (NIH)] [UL1 TR000043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	Branco Weiss Science in Society Fellowship; NARSAD(NARSAD); National Center for Advancing Translational Sciences [NCATS, National Institutes of Health (NIH)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank A. N. Gilbert, J. D. Mainland, and members of the Vosshall Lab for discussion and comments on the manuscript. We also thank M. Hempstead for support with data collection. A.K. was supported by a Branco Weiss Science in Society Fellowship and a NARSAD Young Investigator Award. L.B.V. is an investigator of the Howard Hughes Medical Institute. This study was supported in part by grant UL1 TR000043 from the National Center for Advancing Translational Sciences [NCATS, National Institutes of Health (NIH)] Clinical and Translational Science Award (CTSA) program.	Conway J., 1999, GRUNDLEHREN MATH WIS; Crocker EC, 1927, AM PERFUMERY ESSENT, V22, P325; Gilbert A. N., 2008, WHAT NOSE KNOWS, P1; Gottfried J. A., 2006, TASTE SMELL UPDATE, P46; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; HILZ RL, 1974, J OPT SOC AM, V64, P763, DOI 10.1364/JOSA.64.000763; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Le Berre E, 2008, CHEM SENSES, V33, P389, DOI 10.1093/chemse/bjn006; Nickerson D, 1943, J OPT SOC AM, V33, P419, DOI 10.1364/JOSA.33.000419; Ohloff G., 1994, SCENT FRAGRANCES FAS; Pointer MR, 1998, COLOR RES APPL, V23, P52, DOI 10.1002/(SICI)1520-6378(199802)23:1<52::AID-COL8>3.0.CO;2-2; Snitz K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003184; Stevens SS, 1938, HEARING, P152; Weiss T, 2012, P NATL ACAD SCI USA, V109, P19959, DOI 10.1073/pnas.1208110109	15	404	417	12	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1370	1372		10.1126/science.1249168	http://dx.doi.org/10.1126/science.1249168			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653035	Green Accepted			2022-12-28	WOS:000333108500042
J	Fraser, C; Lythgoe, K; Leventhal, GE; Shirreff, G; Hollingsworth, TD; Alizon, S; Bonhoeffer, S				Fraser, Christophe; Lythgoe, Katrina; Leventhal, Gabriel E.; Shirreff, George; Hollingsworth, T. Deirdre; Alizon, Samuel; Bonhoeffer, Sebastian			Virulence and Pathogenesis of HIV-1 Infection: An Evolutionary Perspective	SCIENCE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL-ACTIVATION; VIRAL-LOAD; SET-POINT; DISEASE PROGRESSION; IMMUNE ACTIVATION; ESCAPE MUTATIONS; WITHIN-HOST; TRANSMISSION; REPLICATION	Why some individuals develop AIDS rapidly whereas others remain healthy without treatment for many years remains a central question of HIV research. An evolutionary perspective reveals an apparent conflict between two levels of selection on the virus. On the one hand, there is rapid evolution of the virus in the host, and on the other, new observations indicate the existence of virus factors that affect the virulence of infection whose influence persists over years in infected individuals and across transmission events. Here, we review recent evidence that shows that viral genetic factors play a larger role in modulating disease severity than anticipated. We propose conceptual models that reconcile adaptive evolution at both levels of selection. Evolutionary analysis provides new insight into HIV pathogenesis.	[Fraser, Christophe; Lythgoe, Katrina] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling,Sch Publ Hlth, London SW7 2AZ, England; [Leventhal, Gabriel E.; Shirreff, George; Bonhoeffer, Sebastian] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Hollingsworth, T. Deirdre] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; [Hollingsworth, T. Deirdre] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Hollingsworth, T. Deirdre] Liverpool Sch Trop Med LSTM, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Alizon, Samuel] CNRS, Lab Malad Infect & Vecteurs Ecol Genet Evolut & c, UMR 5290, IRD,UM1,UM2, F-34394 Montpellier, France	Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Warwick; University of Warwick; Liverpool School of Tropical Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Fraser, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling,Sch Publ Hlth, London SW7 2AZ, England.	c.fraser@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Bonhoeffer, Sebastian/A-2735-2008; Hollingsworth, Deirdre/D-2421-2009; Shirreff, George/GWR-4778-2022; Leventhal, Gabriel/E-1364-2011	Fraser, Christophe/0000-0003-2399-9657; Bonhoeffer, Sebastian/0000-0001-8052-3925; Hollingsworth, Deirdre/0000-0001-5962-4238; Alizon, Samuel/0000-0002-0779-9543; Lythgoe, Katrina/0000-0002-7089-7680; Leventhal, Gabriel/0000-0002-4463-166X	Royal Society; UK Medical Research Council; European Research Council [PBDR-339251, PBDR-268540]; Wellcome Trust; ATIP-Avenir; Swiss National Science Foundation [133129]; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish	Royal Society(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); ATIP-Avenir; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	C.F. thanks the Royal Society, the UK Medical Research Council, and the European Research Council (PBDR-339251) for funding. K.L. is funded by the Wellcome Trust. T.D.H. is a member of the Centre for Applied Health Research and Delivery (http://lstmliverpool.ac.uk/research/cross-cutting-themes/cahrd), and her position is partly funded by a Wellcome Trust Institutional Strategic Support Award to LSTM. S.A. thanks the Centre National de la Recherche Scientifique and the IRD and is funded by an ATIP-Avenir. S.B. thanks the Swiss National Science Foundation (133129) and the European Research Council (PBDR-268540). We thank O. Laeyendecker and the Rakai Health Sciences Program and H. Gunthard and the Swiss HIV Cohort studies for use of data from their previously published studies. We thank F. de Wolf, P. Reiss, and the HIV Monitoring Foundation of the Netherlands for use of data on the distribution of SPVLs among Dutch seroconverters.	Abu-Raddad LJ, 2013, AIDS, V27, P981, DOI 10.1097/QAD.0b013e32835cb927; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Alizon S, 2012, VIRUSES-BASEL, V4, P1984, DOI 10.3390/v4101984; Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Bartha I, 2008, TRENDS IMMUNOL, V29, P322, DOI 10.1016/j.it.2008.04.005; Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123; Bonhoeffer S, 2003, TRENDS MICROBIOL, V11, P499, DOI 10.1016/j.tim.2003.09.002; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bushman F. D., 2011, HIV BIOL PREVENTION; CHIRMULE N, 1995, J IMMUNOL, V155, P917; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Falconer DS, 1996, INTRO QUANTITATIVE G; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gras L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007365; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08; Kouyos RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002551; Kouyos RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002321; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Lindback S, 2000, AIDS, V14, P2283, DOI 10.1097/00002030-200010200-00009; Lingappa JR, 2013, AIDS RES HUM RETROV, V29, P164, DOI 10.1089/aid.2012.0206; Lythgoe KA, 2013, EVOLUTION, V67, P2769, DOI 10.1111/evo.12166; Lythgoe KA, 2012, P ROY SOC B-BIOL SCI, V279, P3367, DOI 10.1098/rspb.2012.0595; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Meyer L, 1997, AIDS, V11, pF73, DOI 10.1097/00002030-199711000-00001; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Redd AD, 2012, J INFECT DIS, V206, P1433, DOI 10.1093/infdis/jis503; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Shirreff George, 2013, Evolution Medicine and Public Health, P209, DOI 10.1093/emph/eot019; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; Trkola A, 2003, J VIROL, V77, P13146, DOI 10.1128/JVI.77.24.13146-13155.2003; van der Kuyl AC, 2010, AIDS, V24, P1607, DOI 10.1097/QAD.0b013e32833b318f; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Yue L, 2013, J VIROL, V87, P708, DOI 10.1128/JVI.02118-12; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	70	154	157	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1328	+	1243727	10.1126/science.1243727	http://dx.doi.org/10.1126/science.1243727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653038	Green Accepted			2022-12-28	WOS:000333108500028
J	Perricone, G; Mazzarelli, C				Perricone, Giovanni; Mazzarelli, Chiara			Reexpansion Pulmonary Edema after Thoracentesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Perricone, Giovanni; Mazzarelli, Chiara] AO Osped Niguarda Ca Granda, Milan, Italy	Ospedale Niguarda Ca' Granda	Perricone, G (corresponding author), AO Osped Niguarda Ca Granda, Milan, Italy.	giovanniperricone@gmail.com	Perricone, Giovanni/AAC-1205-2022	Perricone, Giovanni/0000-0003-3890-5393					0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12							e19	10.1056/NEJMicm1309844	http://dx.doi.org/10.1056/NEJMicm1309844			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645962				2022-12-28	WOS:000333054000001
J	Saukkonen, K; Tan, TC; Sharma, A; Channick, RN; Murali, MR; Zukerberg, LR				Saukkonen, Kai; Tan, Timothy C.; Sharma, Amita; Channick, Richard N.; Murali, Mandakolathur R.; Zukerberg, Lawrence R.			Case 9-2014: A 34-Year-Old Woman with Increasing Dyspnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONNECTIVE-TISSUE DISEASE; PULMONARY-HYPERTENSION; CRITERIA		[Saukkonen, Kai; Tan, Timothy C.; Channick, Richard N.; Murali, Mandakolathur R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Saukkonen, Kai; Tan, Timothy C.; Channick, Richard N.; Murali, Mandakolathur R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sharma, Amita] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saukkonen, K (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Tan, Timothy/0000-0003-4449-1457	Actelion Pharmaceuticals; Bayer; United Therapeutics	Actelion Pharmaceuticals; Bayer(Bayer AG); United Therapeutics	Dr. Channick reports receiving consulting fees and grant support from Actelion Pharmaceuticals, Bayer, and United Therapeutics. No other potential conflict of interest relevant to this article was reported.	ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P328; AVINAZUBIETA JA, 1995, LUPUS, V4, P370, DOI 10.1177/096120339500400507; Bang WD, 2010, YONSEI MED J, V51, P971, DOI [10.3349/ymj.2010.51.6.971, 10.3349/ymj.2010.51.6.]; Cappelli S, 2012, SEMIN ARTHRITIS RHEU, V41, P589, DOI 10.1016/j.semarthrit.2011.07.010; FRAYHA RA, 1985, BRIT J RHEUMATOL, V24, P70; GORDONSON J, 1978, AM J ROENTGENOL, V131, P325, DOI 10.2214/ajr.131.2.325; Kahn MF, 1991, MALADIES SYSTEMIQUES, V3, P545; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; SHIOKAWA S, 1993, J RHEUMATOL, V20, P147; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Venables PJW, 2006, LUPUS, V15, P132, DOI 10.1191/0961203306lu2283rr; Xia YK, 2013, RHEUMATOL INT, V33, P1211, DOI 10.1007/s00296-012-2525-y	14	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1149	1157		10.1056/NEJMcpc1305992	http://dx.doi.org/10.1056/NEJMcpc1305992			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645948				2022-12-28	WOS:000333054000012
J	Taylor, D; Sparshatt, A; Varma, S; Olofinjana, O				Taylor, David; Sparshatt, Anna; Varma, Seema; Olofinjana, Olubanke			Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAJOR DEPRESSIVE DISORDER; SEROTONIN REUPTAKE INHIBITORS; DOUBLE-BLIND; SUBJECTIVE SLEEP; POOLED ANALYSIS; ESCITALOPRAM; SYMPTOMS; TRIALS; TOLERABILITY; MEDICATION	Objective To systematically review published and unpublished efficacy studies of agomelatine in people with depression. Design Systematic review and meta-analysis. Data sources Literature search (Pubmed, Embase, Medline), Cochrane Central Register of Controlled Trials, European Medicines Agency (EMA) regulatory file for agomelatine, manufacturers of agomelatine (Servier). Eligibility criteria Double blind randomised placebo and comparator controlled trials of agomelatine in depression with standard depression rating scales. Data synthesis Studies were pooled by using a random effects model with DerSimonian and Laird weights for comparisons with placebo and comparator antidepressant. The primary efficacy measure (change in rating scale score) was summarised with standardised mean difference (SMD; a measure of effect size) and secondary outcome measures with relative risks. All results were presented with 95% confidence intervals. Statistical heterogeneity was explored by visual inspection of funnel plots and by the I-2 statistic. Moderators of effect were explored by meta-regression. Results We identified 20 trials with 7460 participants meeting inclusion criteria (11 in the published literature, four from the European Medicines Agency file, and five from the manufacturer). Almost all studies used the 17 item Hamilton depression rating scale (score 0-50). Agomelatine was significantly more effective than placebo with an effect size (SMD) of 0.24 (95% confidence interval 0.12 to 0.35) and relative risk of response 1.25 (1.11 to 1.4). Compared with other antidepressants, agomelatine showed equal efficacy (SMD 0.00, -0.09 to 0.10). Significant heterogeneity was uncovered in most analyses, though risk of bias was low. Published studies were more likely than unpublished studies to have results that suggested advantages for agomelatine. Conclusions Agomelatine is an effective antidepressant with similar efficacy to standard antidepressants. Published trials generally had more favourable results than unpublished studies.	[Taylor, David] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Taylor, David; Sparshatt, Anna; Varma, Seema; Olofinjana, Olubanke] South London & Maudsley NHS Fdn Trust, Dept Pharm, London SE5 8AZ, England	University of London; King's College London; South London & Maudsley NHS Trust	Taylor, D (corresponding author), South London & Maudsley NHS Fdn Trust, Dept Pharm, London SE5 8AZ, England.	david.taylor@slam.nhs.uk		Dzahini, Olubanke/0000-0003-3878-2143; Taylor, David/0000-0002-2557-1710	Servier	Servier(Servier)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare that DT has received personal fees and grants from Servier outside the submitted work.	Borenstein M., 2009, INTRO META ANAL, P239, DOI 10.1002/9780470743386.ch25; Corruble E, 2013, INT J NEUROPSYCHOPH, V16, P2219, DOI 10.1017/S1461145713000679; Demyttenaere K, 2013, CNS SPECTRUMS, V18, P163, DOI 10.1017/S1092852913000060; Doshi P, 2013, BMJ-BRIT MED J, V346, pf2865; European Medicines Agency, 2012, VALD AG; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gahr M, 2013, PHARMACOPSYCHIATRY, V46, P214, DOI 10.1055/s-0033-1353156; Goodwin GM, 2009, J CLIN PSYCHIAT, V70, P1128, DOI 10.4088/JCP.08m04548; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Hale A, 2010, INT CLIN PSYCHOPHARM, V25, P305, DOI 10.1097/YIC.0b013e32833a86aa; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heun R, 2013, J CLIN PSYCHIAT, V74, P587, DOI 10.4088/JCP.12m08250; Higgins J.P.T, 2011, BMJ, V343; Howland RH, 2011, DRUG SAFETY, V34, P709, DOI 10.2165/11593960-000000000-00000; Hung CC, 2013, AM J GERIAT PSYCHIAT, V21, P811, DOI 10.1016/j.jagp.2013.01.018; KASPER S, 2010, INT J PSYCHIAT CL S1, V14, P26; Kasper S, 2013, INT CLIN PSYCHOPHARM, V28, P12, DOI 10.1097/YIC.0b013e328359768e; Kasper S, 2010, J CLIN PSYCHIAT, V71, P109, DOI 10.4088/JCP.09m05347blu; Kennedy SH, 2006, EUR NEUROPSYCHOPHARM, V16, P93, DOI 10.1016/j.euroneuro.2005.09.002; Kennedy SH, 2013, 21 EUR C PSYCH NIC F; Kennedy SH, 2008, J CLIN PSYCHOPHARM, V28, P329, DOI 10.1097/JCP.0b013e318172b48c; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Koesters M, 2013, BRIT J PSYCHIAT, V203, P179, DOI 10.1192/bjp.bp.112.120196; Lemoine P, 2007, J CLIN PSYCHIAT, V68, P1723, DOI 10.4088/JCP.v68n1112; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Loo H, 2002, INT CLIN PSYCHOPHARM, V17, P239; Medawar C, 2004, LANCET, V363, P2087, DOI 10.1016/S0140-6736(04)16463-5; Medicines and Healthcare Products Regulatory Agency, 2013, YELL CARD DRUG AN PR; Montejo A, 2011, HUM PSYCHOPHARM CLIN, V26, P537, DOI 10.1002/hup.1243; Montgomery SA, 2004, INT CLIN PSYCHOPHARM, V19, P271, DOI 10.1097/01.yic.0000137184.64610.c8; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; National Institute for Clinical Excellence, 2009, CG90 NICE; National Institute for Health and Clinical Excellence, 2009, DEPR CHRON PHYS HLTH; Novartis Pharmaceuticals Corporation, 2008, 8 WEEK MULT RAND DOU; Olie JP, 2007, INT J NEUROPSYCHOPH, V10, P661, DOI 10.1017/S1461145707007766; Posternak MA, 2007, BRIT J PSYCHIAT, V190, P287, DOI 10.1192/bjp.bp.106.028555; Quera-Salva MA, 2011, INT CLIN PSYCHOPHARM, V26, P252, DOI 10.1097/YIC.0b013e328349b117; Racagni G, 2011, WORLD J BIOL PSYCHIA, V12, P574, DOI 10.3109/15622975.2011.595823; Rief W, 2009, J AFFECT DISORDERS, V118, P1, DOI 10.1016/j.jad.2009.01.029; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Serretti A, 2009, J CLIN PSYCHOPHARM, V29, P259, DOI 10.1097/JCP.0b013e3181a5233f; Servier, 2004, CL320098024 EUR MED; Servier, 2004, CL320098026 EUR MED; Servier, 2007, CL320098022 EUR MED, V1/36; Servier, 2004, CL320098023 EUR MED, V1/34; Servier Laboratories, 2009, STUD CL3 070 A UNPUB; Servier Laboratories, 2009, STUD CL3 063 A UNPUB; Servier Laboratories, 2008, STUD CL3 048 A UNPUB; Servier Laboratories, 2013, STUD CL3 052 A UNPUB; Sevier Laboratories, 2013, SUMM PROD CHAR; Singh SP, 2011, INT J NEUROPSYCHOPH, V23, P1; Sparshatt A, 2013, ACTA PSYCHIAT SCAND, V128, P203, DOI 10.1111/acps.12044; Stahl SM, 2010, J CLIN PSYCHIAT, V71, P616, DOI 10.4088/JCP.09m05471blu; StataCorp, 2021, STATA STAT SOFTWARE; Stein DJ, 2012, J CLIN PSYCHIAT, V73, P1002, DOI 10.4088/JCP.11m07493; Taylor D.M., 2018, MAUDSLEY PRESCRIBING, V13th ed.); Taylor D, 2006, J AFFECT DISORDERS, V95, P129, DOI 10.1016/j.jad.2006.04.026; The Cochrane Collaboration, 2008, REV MAN REVMAN COMP; Trowman R, 2007, J CLIN EPIDEMIOL, V60, P1229, DOI 10.1016/j.jclinepi.2007.03.014; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vahia V, 2011, CL320098074 EUR MED; Watanabe N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006528.pub2; Zajecka J, 2010, J CLIN PSYCHOPHARM, V30, P135, DOI 10.1097/JCP.0b013e3181d420a7	64	110	114	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1888	10.1136/bmj.g1888	http://dx.doi.org/10.1136/bmj.g1888			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647162	Green Published, hybrid			2022-12-28	WOS:000333414500005
J	Wunsch, H; Christiansen, CF; Johansen, MB; Olsen, M; Ali, N; Angus, DC; Sorensen, HT				Wunsch, Hannah; Christiansen, Christian F.; Johansen, Martin B.; Olsen, Morten; Ali, Naeem; Angus, Derek C.; Sorensen, Henrik Toft			Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical Ventilation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NATIONAL-COMORBIDITY-SURVEY; CARE-UNIT SURVIVORS; LONG-TERM OUTCOMES; CRITICAL ILLNESS; INTENSIVE-CARE; SEVERE SEPSIS; PROSPECTIVE COHORT; OLDER AMERICANS; DEPRESSION	IMPORTANCE The relationship between critical illness and psychiatric illness is unclear. OBJECTIVE To assess psychiatric diagnoses and medication prescriptions before and after critical illness. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study in Denmark of critically ill patients in 2006-2008 with follow-up through 2009, and 2 matched comparison cohorts from hospitalized patients and from the general population. EXPOSURES Critical illness defined as intensive care unit admission with mechanical ventilation. MAIN OUTCOMES AND MEASURES Adjusted prevalence ratios (PRs) of psychiatrist-diagnosed psychiatric illnesses and prescriptions for psychoactive medications in the 5 years before critical illness. For patients with no psychiatric history, quarterly cumulative incidence (risk) and adjusted hazard ratios (HRs) for diagnoses and medications in the following year, using Cox regression. RESULTS Among 24 179 critically ill patients, 6.2% had 1 or more psychiatric diagnoses in the prior 5 years vs 5.4% for hospitalized patients (adjusted PR, 1.31; 95% CI, 1.22-1.42; P<.001) and 2.4% for the general population (adjusted PR, 2.57; 95% CI, 2.41-2.73; P<.001). Five-year preadmission psychoactive prescription rates were similar to hospitalized patients: 48.7% vs 48.8% (adjusted PR, 0.97; 95% CI, 0.95-0.99; P<.001) but were higher than the general population (33.2%; adjusted PR, 1.40; 95% CI, 1.38-1.42; P<.001). Among the 9912 critical illness survivors with no psychiatric history, the absolute risk of new psychiatric diagnoses was low but higher than hospitalized patients: 0.5% vs 0.2% over the first 3 months (adjusted HR, 3.42; 95% CI, 1.96-5.99; P<.001), and the general population cohort (0.02%; adjusted HR, 21.77; 95% CI, 9.23-51.36; P<.001). Risk of new psychoactive medication prescriptions was also increased in the first 3 months: 12.7% vs 5.0% for the hospital cohort (adjusted HR, 2.45; 95% CI, 2.19-2.74; P<.001) and 0.7% for the general population (adjusted HR, 21.09; 95% CI, 17.92-24.82; P<.001). These differences had largely resolved by 9 to 12 months after discharge. CONCLUSIONS AND RELEVANCE Prior psychiatric diagnoses are more common in critically ill patients than in hospital and general population cohorts. Among survivors of critical illness, new psychiatric diagnoses and psychoactive medication use is increased in the months after discharge. Our data suggest both a possible role of psychiatric disease in predisposing patients to critical illness and an increased but transient risk of new psychiatric diagnoses and treatment after critical illness.	[Wunsch, Hannah] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Wunsch, Hannah] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Christiansen, Christian F.; Johansen, Martin B.; Olsen, Morten; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Christiansen, Christian F.] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care, DK-8200 Aarhus N, Denmark; [Ali, Naeem] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA	Columbia University; Columbia University; Aarhus University; Aarhus University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Christiansen, CF (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus N, Denmark.	cc@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Christiansen, Christian Fynbo/B-5870-2014; Johansen, Martin Nygård/L-6845-2014; Angus, Derek C/E-9671-2012; Christiansen, Christian/ABE-9423-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Christiansen, Christian Fynbo/0000-0002-0727-953X; Johansen, Martin Nygård/0000-0001-9790-0985; Christiansen, Christian/0000-0002-0727-953X; ALI, NORA'AINI/0000-0003-1391-2757				Abrams TE, 2010, ARCH SURG-CHICAGO, V145, P947, DOI 10.1001/archsurg.2010.190; Blichert-Hansen Linea, 2013, Clin Epidemiol, V5, P9, DOI 10.2147/CLEP.S37763; Christensen Steffen, 2011, Clin Epidemiol, V3, P203, DOI 10.2147/CLEP.S20247; Christiansen CF, 2011, ACTA ANAESTH SCAND, V55, P962, DOI 10.1111/j.1399-6576.2011.02480.x; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Davydow DS, 2013, AM J GERIAT PSYCHIAT, V21, P887, DOI 10.1016/j.jagp.2013.01.017; Davydow DS, 2009, INTENS CARE MED, V35, P796, DOI 10.1007/s00134-009-1396-5; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Friese RS, 2008, CRIT CARE MED, V36, P697, DOI 10.1097/CCM.0B013E3181643F29; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2012, AM J RESP CRIT CARE, V185, P835, DOI 10.1164/rccm.201109-1660OC; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Martin JL, 2012, AM J GERIAT PSYCHIAT, V20, P477, DOI 10.1097/JGP.0b013e31824877c1; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Munk-Olsen T, 2011, NEW ENGL J MED, V364, P332, DOI 10.1056/NEJMoa0905882; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nelson JE, 2004, CRIT CARE MED, V32, P1527, DOI 10.1097/01.CCM.0000129485.08835.5A; Olsen M, 2011, CARDIOL YOUNG, V21, P197, DOI 10.1017/S1047951110001769; Parikh SV, 1997, CAN J PSYCHIAT, V42, P929, DOI 10.1177/070674379704200903; Pedersen CB, 2006, DAN MED BULL, V53, P441; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rosted E, 2013, GERIATR NURS, V34, P477, DOI 10.1016/j.gerinurse.2013.08.001; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Stuart M, 2001, GERONTOLOGIST, V41, P474, DOI 10.1093/geront/41.4.474; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; VERHAAK PFM, 1993, BRIT J GEN PRACT, V43, P203; Weinert CR, 2001, CHEST, V119, P547, DOI 10.1378/chest.119.2.547; Weinert C, 2006, PSYCHOSOMATICS, V47, P399, DOI 10.1176/appi.psy.47.5.399; Wunsch H, 2010, CRIT CARE, V14, DOI 10.1186/cc8863; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Zisberg A, 2012, DRUG AGING, V29, P565, DOI 10.2165/11632350-000000000-00000	39	85	87	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1133	1142		10.1001/jama.2014.2137	http://dx.doi.org/10.1001/jama.2014.2137			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD1RC	24643603				2022-12-28	WOS:000333010100018
J	King, H				King, Helen			Narratives of healing: a new approach to the past?	LANCET			English	Editorial Material									Open Univ, Dept Class Studies, Fac Arts, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	King, H (corresponding author), Open Univ, Dept Class Studies, Fac Arts, Milton Keynes MK7 6AA, Bucks, England.	helen.king@open.ac.uk						Aronson JK, 2000, BRIT MED J, V321, P1599, DOI 10.1136/bmj.321.7276.1599; Behr CA., 1968, AELIUS ARISTIDES SAC; Charon R, 2005, NARRATIVE, V13, P261, DOI 10.1353/nar.2005.0017; Downie J., 2013, LIMITS ART LIT STUDY; Harris W. V., 2008, AELIUS ARISTIDES GRE; Israelowitch I, 2012, SOC MED RELIG SACRED; Petsalis-Diomidis A., 2010, TRULY WONDERS AELIUS	7	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					946	947		10.1016/S0140-6736(14)60471-2	http://dx.doi.org/10.1016/S0140-6736(14)60471-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MR	24639993	Bronze			2022-12-28	WOS:000333520700014
J	Diebolder, CA; Beurskens, FJ; de Jong, RN; Koning, RI; Strumane, K; Lindorfer, MA; Voorhorst, M; Ugurlar, D; Rosati, S; Heck, AJR; van de Winkel, JGJ; Wilson, IA; Koster, AJ; Taylor, RP; Saphire, EO; Burton, DR; Schuurman, J; Gros, P; Parren, PWHI				Diebolder, Christoph A.; Beurskens, Frank J.; de Jong, Rob N.; Koning, Roman I.; Strumane, Kristin; Lindorfer, Margaret A.; Voorhorst, Marleen; Ugurlar, Deniz; Rosati, Sara; Heck, Albert J. R.; van de Winkel, Jan G. J.; Wilson, Ian A.; Koster, Abraham J.; Taylor, Ronald P.; Saphire, Erica Ollmann; Burton, Dennis R.; Schuurman, Janine; Gros, Piet; Parren, Paul W. H. I.			Complement Is Activated by IgG Hexamers Assembled at the Cell Surface	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; MEDIATED LYSIS; IMMUNOGLOBULIN-G; HUMAN CD20; ANTIGEN; BINDING; HIV-1; SPECIFICITY; COMPLEXES; COMPONENT	Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feature of natural immune defense, a number of disease processes, and immunotherapies. How antibodies activate the complement cascade, however, is poorly understood. We found that specific noncovalent interactions between Fc segments of immunoglobulin G (IgG) antibodies resulted in the formation of ordered antibody hexamers after antigen binding on cells. These hexamers recruited and activated C1, the first component of complement, thereby triggering the complement cascade. The interactions between neighboring Fc segments could be manipulated to block, reconstitute, and enhance complement activation and killing of target cells, using all four human IgG subclasses. We offer a general model for understanding antibody-mediated complement activation and the design of antibody therapeutics with enhanced efficacy.	[Diebolder, Christoph A.; Ugurlar, Deniz; Gros, Piet] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Diebolder, Christoph A.; Koning, Roman I.; Koster, Abraham J.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Electron Microscopy Sect, NL-2300 RC Leiden, Netherlands; [Beurskens, Frank J.; de Jong, Rob N.; Strumane, Kristin; Voorhorst, Marleen; van de Winkel, Jan G. J.; Schuurman, Janine; Parren, Paul W. H. I.] Genmab, NL-3584 CM Utrecht, Netherlands; [Lindorfer, Margaret A.; Taylor, Ronald P.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Rosati, Sara; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Rosati, Sara; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [van de Winkel, Jan G. J.] Univ Med Ctr, Dept Immunol, NL-3584 CX Utrecht, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Wilson, Ian A.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Genmab; University of Virginia; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Gros, P (corresponding author), Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	p.gros@uu.nl; p.parren@genmab.com	Gros, Piet/AAD-6452-2019; Heck, Albert/D-7098-2011; Gros, Piet/I-5569-2016; Koster, Abraham/I-7665-2017	Gros, Piet/0000-0002-7782-2585; Heck, Albert/0000-0002-2405-4404; Gros, Piet/0000-0002-7782-2585; Parren, Paul/0000-0002-4365-3859; Diebolder, Christoph/0000-0001-7694-7362; Koster, Abraham/0000-0003-1717-2549; Saphire, Erica Ollmann/0000-0002-1206-7451; Koning, Roman/0000-0001-6736-7147; de Jong, Rob N./0000-0002-9300-6633	European Research Council [233229, FES0908]; Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden; Netherlands Organization for Scientific Research [NWO 175.010.2009.001]; European Regional Development Fund of the European Commission [21Z.014]; National Institute of Allergy and Infectious Diseases (NIAID) [AI055332]; NIAID [AI084817]; Genmab; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084817, R01AI055332, R37AI055332, R01AI084817] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund of the European Commission; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Genmab(Genmab); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Daha for purified C1, and F. G. A. Faas and W. Vossenaar-Horstman for technical support. Supported in part by European Research Council advanced grant 233229; Cyttron II (Life Sciences Health framework FES0908); the Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden; the Netherlands Organization for Scientific Research (NWO 175.010.2009.001); and the European Regional Development Fund of the European Commission (21Z.014). D.R.B. is supported by National Institute of Allergy and Infectious Diseases (NIAID) grant AI055332. I.A.W. is supported by NIAID grant AI084817. The data presented are tabulated in the main paper and in the supplementary materials. The ET data presented are archived at EMDataBank, entries EMD-2506, EMD-2507, and EMD-2554. F.J.B., R.N.d.J., K.S., M.V., J.G.J.v.d.W., J.S., and P.W.H.I.P. are Genmab employees and own Genmab warrants and/or stock. M.A.L., R.P.T., S.R., and A.J.R.H. received Genmab funding. F.J.B., R.N.d.J., J.S., and P.W.H.I.P. are inventors on Genmab patent applications related to technology to enhance complement activation.	BINDON CI, 1988, EUR J IMMUNOL, V18, P1507, DOI 10.1002/eji.1830181006; BORSOS T, 1965, SCIENCE, V150, P505, DOI 10.1126/science.150.3695.505; BURTON DR, 1990, TRENDS BIOCHEM SCI, V15, P64, DOI 10.1016/0968-0004(90)90178-E; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; BURTON DR, 1986, IMMUNOL TODAY, V7, P165, DOI 10.1016/0167-5699(86)90166-0; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Czajkowsky DM, 2009, P NATL ACAD SCI USA, V106, P14960, DOI 10.1073/pnas.0903805106; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dechant M, 2008, CANCER RES, V68, P4998, DOI 10.1158/0008-5472.CAN-07-6226; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; HUGHESJONES NC, 1985, EUR J IMMUNOL, V15, P976, DOI 10.1002/eji.1830151003; HUGHESJONES NC, 1979, MOL IMMUNOL, V16, P697, DOI 10.1016/0161-5890(79)90010-5; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kushihata F, 2004, TRANSPLANTATION, V78, P995, DOI 10.1097/01.TP.0000136966.63957.E2; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; PARCE JW, 1983, BIOCHIM BIOPHYS ACTA, V736, P92; Pawluczkowycz AW, 2009, J IMMUNOL, V183, P749, DOI 10.4049/jimmunol.0900632; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROSSE WF, 1967, J IMMUNOL, V98, P1190; ROSSE WF, 1971, J CLIN INVEST, V50, P727, DOI 10.1172/JCI106543; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Saphire EO, 2001, ACTA CRYSTALLOGR D, V57, P168, DOI 10.1107/S0907444900017376; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; THOMPSON JJ, 1974, IMMUNOCHEMISTRY, V11, P537, DOI 10.1016/0019-2791(74)90244-4; WATTS HF, 1985, MOL IMMUNOL, V22, P803, DOI 10.1016/0161-5890(85)90146-4; Wu YJ, 2013, CELL REP, V5, P1443, DOI 10.1016/j.celrep.2013.11.015; XIA MQ, 1993, MOL IMMUNOL, V30, P1089	31	448	478	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1260	1263		10.1126/science.1248943	http://dx.doi.org/10.1126/science.1248943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626930	Green Accepted			2022-12-28	WOS:000332728500039
J	Supek, F; Minana, B; Valcarcel, J; Gabaldon, T; Lehner, B				Supek, Fran; Minana, Belen; Valcarcel, Juan; Gabaldon, Toni; Lehner, Ben			Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers	CELL			English	Article							SOMATIC MUTATIONS; TRANSLATION EFFICIENCY; SPLICING MUTATION; SILENT MUTATIONS; PROTEIN; GENE; GENOME; VARIANT; IDENTIFICATION; POLYMORPHISMS	Synonymous mutations change the sequence of a gene without directly altering the sequence of the encoded protein. Here, we present evidence that these "silent'' mutations frequently contribute to human cancer. Selection on synonymous mutations in oncogenes is cancer-type specific, and although the functional consequences of cancer-associated synonymous mutations may be diverse, they recurrently alter exonic motifs that regulate splicing and are associated with changes in oncogene splicing in tumors. The p53 tumor suppressor (TP53) also has recurrent synonymous mutations, but, in contrast to those in oncogenes, these are adjacent to splice sites and inactivate them. We estimate that between one in two and one in five silent mutations in oncogenes have been selected, equating to similar to 6%-8% of all selected single-nucleotide changes in these genes. In addition, our analyses suggest that dosage-sensitive oncogenes have selected mutations in their 3' UTRs.	[Supek, Fran; Lehner, Ben] Ctr Genom Regulat, EMBL CRG, Syst Biol Res Unit, Barcelona 08003, Spain; [Minana, Belen; Valcarcel, Juan] Ctr Genom Regulat, Gene Regulat Stem Cells & Canc Program, Barcelona 08003, Spain; [Gabaldon, Toni] Ctr Genom Regulat, Bioinformat & Genom Program, Barcelona 08003, Spain; [Supek, Fran; Minana, Belen; Valcarcel, Juan; Gabaldon, Toni; Lehner, Ben] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Valcarcel, Juan; Gabaldon, Toni; Lehner, Ben] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), Ctr Genom Regulat, EMBL CRG, Syst Biol Res Unit, Dr Aiguader 88, Barcelona 08003, Spain.	ben.lehner@crg.eu	Lehner, Ben/L-3413-2014; Supek, Fran/B-2359-2012; Lehner, Ben/ABH-6562-2020; Valcarcel, Juan/O-9814-2014; minana, belen/K-5530-2015; Gabaldón, Toni/A-7336-2008	Lehner, Ben/0000-0002-8817-1124; Supek, Fran/0000-0002-7811-6711; Lehner, Ben/0000-0002-8817-1124; Valcarcel, Juan/0000-0001-5398-3571; minana, belen/0000-0001-7676-5788; Gabaldón, Toni/0000-0003-0019-1735	Marie Curie Actions (INTERPOD); ERC Starting Grant; ERASysBio+ ERANET; MICINN [BFU2011-26206, BIO2012-37161]; AGAUR; EMBO Young Investigator Program; EU Framework 7 project [277899 4DCellFate]; EMBL-CRG Systems Biology Program; ERC; Fundacion Botin; Fundacion Alicia Koplowicz; Consolider RNAREG; MINECO; ICREA Funding Source: Custom	Marie Curie Actions (INTERPOD); ERC Starting Grant(European Research Council (ERC)); ERASysBio+ ERANET; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); EU Framework 7 project; EMBL-CRG Systems Biology Program; ERC(European Research Council (ERC)European Commission); Fundacion Botin; Fundacion Alicia Koplowicz; Consolider RNAREG(Spanish Government); MINECO(Spanish Government); ICREA(ICREA)	F.S. was cofunded by Marie Curie Actions (INTERPOD). Work in the lab of B. L. is supported by an ERC Starting Grant, ERASysBio+ ERANET, MICINN BFU2011-26206, AGAUR, the EMBO Young Investigator Program, EU Framework 7 project 277899 4DCellFate, and the EMBL-CRG Systems Biology Program. Work in the lab of T. G. is supported by an ERC Starting Grant and MICINN BIO2012-37161. Work in the lab of J.V. is supported by Fundacion Botin, Fundacion Alicia Koplowicz, Consolider RNAREG, and MINECO.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druillennec S, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/639062; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Griseri P, 2011, HUM MOL GENET, V20, P4556, DOI 10.1093/hmg/ddr390; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kaida D, 2012, CANCER SCI, V103, P1611, DOI 10.1111/j.1349-7006.2012.02356.x; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lamolle G, 2006, MUTAT RES-FUND MOL M, V600, P102, DOI 10.1016/j.mrfmmm.2006.03.004; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Ma F, 2009, LUNG CANCER, V66, P114, DOI 10.1016/j.lungcan.2008.12.025; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Schutz FAB, 2013, LANCET ONCOL, V14, P81, DOI 10.1016/S1470-2045(12)70517-X; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stark M, 2011, J BIOL CHEM, V286, P3741, DOI 10.1074/jbc.M110.163444; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Strauss BS, 2000, MUTAT RES-FUND MOL M, V457, P93, DOI 10.1016/S0027-5107(00)00135-4; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Varley JM, 1998, ONCOGENE, V16, P3291, DOI 10.1038/sj.onc.1201878; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang J, 2011, DATABASE OXFORD, V2011; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	55	353	367	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1324	1335		10.1016/j.cell.2014.01.051	http://dx.doi.org/10.1016/j.cell.2014.01.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630730	Bronze			2022-12-28	WOS:000332945100020
J	Nakamura, N; Lill, JR; Phung, Q; Jiang, ZS; Bakalarski, C; de Maziere, A; Klumperman, J; Schlatter, M; Delamarre, L; Mellman, I				Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; de Maziere, Ann; Klumperman, Judith; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira			Endosomes are specialized platforms for bacterial sensing and NOD2 signalling	NATURE			English	Article							MHC CLASS-II; DENDRITIC CELLS; HOST RECOGNITION; PLASMA-MEMBRANE; CROHNS-DISEASE; KAPPA-B; PROTEIN; SUSCEPTIBILITY; PEPTIDOGLYCAN; SALMONELLA	The detection of microbial pathogens involves the recognition of conserved microbial components by host cell sensors such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs). TLRs are membrane receptors that survey the extracellular environment for microbial infections, whereas NLRs are cytosolic complexes that detect microbial products that reach the cytosol. Upon detection, both sensor classes trigger innate inflammatory responses and allow the engagement of adaptive immunity(1,2). Endo-lysosomes are the entry sites for a variety of pathogens, and therefore the sites at which the immune system first senses their presence. Pathogens internalized by endocytosis are well known to activate TLRs 3 and 7-9 that are localized to endocytic compartments and detect ligands present in the endosomal lumen(3). Internalized pathogens also activate sensors in the cytosol such as NOD1 and NOD2 (ref. 2), indicating that endosomes also provide for the translocation of bacterial components across the endosomal membrane. Despite the fact that NOD2 is well understood to have a key role in regulating innate immune responses and that mutations at the NOD2 locus are a common risk factor in inflammatory bowel disease and possibly other chronic inflammatory states(4,5), little is known about how its ligands escape from endosomes. Here we show that two endo-lysosomal peptide transporters, SLC15A3 and SLC15A4, are preferentially expressed by dendritic cells, especially after TLR stimulation. The transporters mediate the egress of bacterially derived components, such as the NOD2 cognate ligand muramyl dipeptide (MDP)(6,7), and are selectively required for NOD2 responses to endosomally derived MDP. Enhanced expression of the transporters also generates endosomal membrane tubules characteristic of dendritic cells, which further enhanced the NOD2-dependent response to MDP. Finally, sensing required the recruitment of NOD2 and its effector kinase RIPK2 (refs 8, 9) to the endosomal membrane, possibly by forming a complex with SLC15A3 or SLC15A4. Thus, dendritic cell endosomes are specialized platforms for both the lumenal and cytosolic sensing of pathogens.	[Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [de Maziere, Ann; Klumperman, Judith] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Roche Holding; Genentech; Utrecht University; Utrecht University Medical Center	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020	Bakalarski, Corey/0000-0003-1085-7828	Genentech	Genentech(Roche HoldingGenentech)	The authors thank Mellman laboratory members for discussions, C. Chalouni for excellent advice and assistance with fluorescence microscopy, S. van Dijk and R. Scriwanek for immuno-electron microscopy, and R. Gentleman, V. Dixit and N. Kayagaki for advice. N. N., J.R.L., Q. P., Z.J., C. B., M. S., L. D. and I. M. are full-time employees of Genentech, which funded the research in its entirety.	Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Chow AY, 2005, TRENDS IMMUNOL, V26, P72, DOI 10.1016/j.it.2004.11.008; Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keestra AM, 2011, MBIO, V2, DOI 10.1128/mBio.00266-11; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Ma JK, 2012, P NATL ACAD SCI USA, V109, P8820, DOI 10.1073/pnas.1202977109; MARSH M, 1986, P NATL ACAD SCI USA, V83, P2899, DOI 10.1073/pnas.83.9.2899; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pham VC, 2012, J PROTEOME RES, V11, P2947, DOI 10.1021/pr300035k; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	40	183	190	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					240	+		10.1038/nature13133	http://dx.doi.org/10.1038/nature13133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24695226				2022-12-28	WOS:000335454300042
J	Lincoff, AM; Tardif, JC; Schwartz, GG; Nicholls, SJ; Ryden, L; Neal, B; Malmberg, K; Wedel, H; Buse, JB; Henry, RR; Weichert, A; Cannata, R; Svensson, A; Volz, D; Grobbee, DE				Lincoff, A. Michael; Tardif, Jean-Claude; Schwartz, Gregory G.; Nicholls, Stephen J.; Ryden, Lars; Neal, Bruce; Malmberg, Klas; Wedel, Hans; Buse, John B.; Henry, Robert R.; Weichert, Arlette; Cannata, Ruth; Svensson, Anders; Volz, Dietmar; Grobbee, Diederick E.		AleCardio Investigators	Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus The AleCardio Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; SECONDARY PREVENTION; FENOFIBRATE THERAPY; GLUCOSE CONTROL; EVENTS; PIOGLITAZONE; RISK; MEN; THIAZOLIDINEDIONES	IMPORTANCE No therapy directed against diabetes has been shown to unequivocally reduce the excess risk of cardiovascular complications. Aleglitazar is a dual agonist of peroxisome proliferator-activated receptors with insulin-sensitizing and glucose-lowering actions and favorable effects on lipid profiles. OBJECTIVE To determine whether the addition of aleglitazar to standard medical therapy reduces cardiovascular morbidity and mortality among patients with type 2 diabetes mellitus and a recent acute coronary syndrome (ACS). DESIGN, SETTING, AND PARTICIPANTS AleCardio was a phase 3, multicenter, randomized, double-blind, placebo-controlled trial conducted in 720 hospitals in 26 countries throughout North America, Latin America, Europe, and Asia-Pacific regions. The enrollment of 7226 patients hospitalized for ACS (myocardial infarction or unstable angina) with type 2 diabetes occurred between February 2010 and May 2012; treatment was planned to continue until patients were followed-up for at least 2.5 years and 950 primary end point events were positively adjudicated. INTERVENTIONS Randomized in a 1:1 ratio to receive aleglitazar 150 mu g or placebo daily. MAIN OUTCOMES AND MEASURES The primary efficacy end point was time to cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. Principal safety end points were hospitalization due to heart failure and changes in renal function. RESULTS The trial was terminated on July 2, 2013, after a median follow-up of 104 weeks, upon recommendation of the data and safety monitoring board due to futility for efficacy at an unplanned interim analysis and increased rates of safety end points. A total of 3.1% of patients were lost to follow-up and 3.2% of patients withdrew consent. The primary end point occurred in 344 patients (9.5%) in the aleglitazar group and 360 patients (10.0%) in the placebo group (hazard ratio, 0.96 [95% CI, 0.83-1.11]; P = .57). Rates of serious adverse events, including heart failure (3.4% for aleglitazar vs 2.8% for placebo, P = .14), gastrointestinal hemorrhages (2.4% for aleglitazar vs 1.7% for placebo, P = .03), and renal dysfunction (7.4% for aleglitazar vs 2.7% for placebo, P < .001) were increased. CONCLUSIONS AND RELEVANCE Among patients with type 2 diabetes and recent ACS, use of aleglitazar did not reduce the risk of cardiovascular outcomes. These findings do not support the use of aleglitazar in this setting with a goal of reducing cardiovascular risk.	[Lincoff, A. Michael; Cannata, Ruth] Cleveland Clin, Dept Cardiovasc Med, Coordinating Ctr Clin Res, Cleveland, OH 44195 USA; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Coordinating Ctr, Montreal, PQ, Canada; [Schwartz, Gregory G.] Vet Affairs Med Ctr, Denver, CO USA; [Schwartz, Gregory G.] Univ Colorado, Sch Med, Denver, CO USA; [Nicholls, Stephen J.] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Ryden, Lars; Malmberg, Klas] Karolinska Inst, Dept Med, Stockholm, Sweden; [Neal, Bruce] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Malmberg, Klas; Weichert, Arlette; Svensson, Anders; Volz, Dietmar] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Wedel, Hans] Nord Sch Publ Hlth, Frolunda, Sweden; [Buse, John B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Henry, Robert R.] Univ Calif San Diego, San Diego, CA 92103 USA; [Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care & Julius Clin, Utrecht, Netherlands	Cleveland Clinic Foundation; Universite de Montreal; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; Karolinska Institutet; George Institute for Global Health; University of Sydney; Roche Holding; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Diego; Utrecht University; Utrecht University Medical Center	Lincoff, AM (corresponding author), Cleveland Clin, Dept Cardiovasc Med, C5Research, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lincofa@ccf.org	Ponikowski, Piotr/O-6454-2015; Colquhoun, David M/F-9078-2013; Benedek, Theodora/F-6353-2016; GUERRERO, DIEGO BELLIDO/C-9446-2017; Carmen, Team3/Y-7384-2019; Petrella, Robert J/G-6557-2018; Lavi, Shahar/G-3317-2011; Wainstein, Marco Vugman/AAQ-1248-2020; Sahay, Rakesh Kumar/I-1336-2013; Benedek, Imre/E-7052-2017; De+Servi, Stefano/AAT-2631-2021; sharma, kamal/AAG-7271-2019; Buse, John Bernard/J-9742-2019	Ponikowski, Piotr/0000-0002-3391-7064; Benedek, Theodora/0000-0001-8326-1537; GUERRERO, DIEGO BELLIDO/0000-0003-0631-2710; Carmen, Team3/0000-0002-3614-0924; Lavi, Shahar/0000-0002-6105-8084; Wainstein, Marco Vugman/0000-0002-7284-1453; Sahay, Rakesh Kumar/0000-0002-5471-0695; Benedek, Imre/0000-0003-0051-4047; sharma, kamal/0000-0001-5866-2566; Buse, John Bernard/0000-0002-9723-3876; Alpizar, Melchor/0000-0003-2033-481X; Koranyi, Laszlo/0000-0002-5733-9350; Welsh, Robert/0000-0003-2613-9142; Nicholls, Stephen/0000-0002-9668-4368; Garcia-Moll, Xavier/0000-0001-7837-8378; Lab, Carmen/0000-0002-5935-3236; Sanz-Girgas, Esther/0000-0001-7058-6711; Feitosa, Audes/0000-0002-9983-4720; Kim, Sang-Hyun/0000-0001-8026-1582; Boman, Kurt/0000-0002-0350-2132; GALINIER, Michel/0000-0003-1735-3390; Neal, Bruce/0000-0002-0490-7465; Maher, Vincent/0000-0002-3592-4508; Cosentino, Francesco/0000-0002-6967-5685; Pijanowski, Zbigniew/0000-0002-6624-7642	F. Hoffmann-La Roche (Basel, Switzerland)	F. Hoffmann-La Roche (Basel, Switzerland)(Hoffmann-La Roche)	The trial was sponsored by F. Hoffmann-La Roche (Basel, Switzerland).	Ahmed S, 2006, EUR HEART J, V27, P2323, DOI 10.1093/eurheartj/ehl220; Armitage J, 2013, AM COLL CARD SCI SES; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; AstraZeneca, ASTRAZENECA DISC DEV; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Schwartz GG, 2012, NEW ENGL J MED, V367, p[2089, 2255]; Dietz M, 2012, CHEMMEDCHEM, V7, P1101, DOI 10.1002/cmdc.201100598; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormuth CR, 2009, ARCH INTERN MED, V169, P1395, DOI 10.1001/archinternmed.2009.214; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Frier BM, 2011, DIABETES CARE, V34, pS132, DOI 10.2337/dc11-s220; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Henry RR, 2009, LANCET, V374, P126, DOI 10.1016/S0140-6736(09)60870-9; Herz M, 2011, INT J CARDIOL, V151, P136, DOI 10.1016/j.ijcard.2010.08.037; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lalic NM, 2013, DIABETES CARE, V36, pS264, DOI 10.2337/dcS13-2016; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lincoff AM, 2013, AM HEART J, V166, P429, DOI 10.1016/j.ahj.2013.05.013; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Mychaleckyj JC, 2012, DIABETES CARE, V35, P1008, DOI 10.2337/dc11-1811; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Ruilope L, 2012, J AM SOC NEPHROL, V23; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Wang CH, 2003, CIRCULATION, V107, P1350, DOI 10.1161/01.CIR.0000054675.30348.9A; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	44	168	173	0	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1515	1525		10.1001/jama.2014.3321	http://dx.doi.org/10.1001/jama.2014.3321			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24682069	Green Published, Bronze			2022-12-28	WOS:000334306000019
J	Wilkerson, CG; Mansfield, SD; Lu, F; Withers, S; Park, JY; Karlen, SD; Gonzales-Vigil, E; Padmakshan, D; Unda, F; Rencoret, J; Ralph, J				Wilkerson, C. G.; Mansfield, S. D.; Lu, F.; Withers, S.; Park, J. -Y.; Karlen, S. D.; Gonzales-Vigil, E.; Padmakshan, D.; Unda, F.; Rencoret, J.; Ralph, J.			Monolignol Ferulate Transferase Introduces Chemically Labile Linkages into the Lignin Backbone	SCIENCE			English	Article							BIOSYNTHETIC-PATHWAY; CONIFERYL FERULATE; ARABIDOPSIS; ALCOHOL; BIOMASS; ENZYME; LEADS; COMT	Redesigning lignin, the aromatic polymer fortifying plant cell walls, to be more amenable to chemical depolymerization can lower the energy required for industrial processing. We have engineered poplar trees to introduce ester linkages into the lignin polymer backbone by augmenting the monomer pool with monolignol ferulate conjugates. Herein, we describe the isolation of a transferase gene capable of forming these conjugates and its xylem-specific introduction into poplar. Enzyme kinetics, in planta expression, lignin structural analysis, and improved cell wall digestibility after mild alkaline pretreatment demonstrate that these trees produce the monolignol ferulate conjugates, export them to the wall, and use them during lignification. Tailoring plants to use such conjugates during cell wall biosynthesis is a promising way to produce plants that are designed for deconstruction.	[Wilkerson, C. G.; Withers, S.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Wilkerson, C. G.; Withers, S.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Wilkerson, C. G.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Mansfield, S. D.; Park, J. -Y.; Gonzales-Vigil, E.; Unda, F.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V6T 1Z4, Canada; [Rencoret, J.; Ralph, J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Karlen, S. D.; Padmakshan, D.; Rencoret, J.; Ralph, J.] Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Wisconsin Energy Inst, Madison, WI 53726 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University; University of British Columbia; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Ralph, J (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	jralph@wisc.edu	RENCORET, JORGE/ABE-4139-2020; Ralph, John/C-3161-2009; Lu, Fachuang/K-6487-2019; RENCORET, JORGE/E-1747-2013	RENCORET, JORGE/0000-0003-2728-7331; Ralph, John/0000-0002-6093-4521; RENCORET, JORGE/0000-0003-2728-7331; Mansfield, Shawn/0000-0002-0175-554X; Gonzales-Vigil, Eliana/0000-0002-8267-9285	DOE Great Lakes Bioenergy Research Center (DOE Basic Energy Research Office of Science) [DE-FC02-07ER64494]	DOE Great Lakes Bioenergy Research Center (DOE Basic Energy Research Office of Science)	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE Basic Energy Research Office of Science DE-FC02-07ER64494). We also thank Y. Zhu, M. Regner, and H. Kim for making some of the required conjugates as described (24); S. Liu for sample preparation; N. Santoro for the digestibility data determinations; and the original team, including J. Grabber and R. Hatfield, who embarked with us on the idea and demonstrated its potential in models systems as described (18). The redesigned polymer presented herein has become known as Zip-lignin; the method for plant modification and the use of the gene for altering plants have been patented (25-27). Angelica sinensis plants were obtained with the help of Joe Hollis at Mountain Garden Herbs in Burnsville, North Carolina. The DNA sequence for the AsFMT gene (see supplementary materials) has been deposited in GenBank under the accession number JA758320.1 (www.ncbi.nlm.nih.gov/nuccore/JA758320.1). Materials and methods, other figures, and further data are reported in the supplementary materials. Future use of materials involved with these projects is governed by material transfer agreements, available from Lauren Meyers, (Wisconsin Energy Institute, lmeyers@energy.wisc.edu) or from the University of Wisconsin's Office of Industrial Partnerships (oip@gran.wisc.edu).	Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Li EY, 2012, NEW PHYTOL, V194, P102, DOI 10.1111/j.1469-8137.2011.04016.x; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Lu FC, 1999, J AGR FOOD CHEM, V47, P1988, DOI 10.1021/jf981140j; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; Petrik DL, 2014, PLANT J, V77, P713, DOI 10.1111/tpj.12420; Ralph J., 2013, Patent, Patent No. [8,569,465 B2, 8569465, US8569465B2]; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ralph J, 2008, REC ADV POLYPHEN RES, V1, P36; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Santoro N, 2010, BIOENERG RES, V3, P93, DOI 10.1007/s12155-009-9074-6; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2010, PLANT J, V64, P885, DOI 10.1111/j.1365-313X.2010.04353.x; Weng JK, 2010, PLANT J, V64, P898, DOI 10.1111/j.1365-313X.2010.04391.x; Wilkerson C, 2013, Patent No. [US 2013-0219547 A12013, 20130219547]; Wilkerson C, 2013, Patent No. [US 2013-0203973 A1, 20130203973]; Withers S, 2012, J BIOL CHEM, V287, P8347, DOI 10.1074/jbc.M111.284497; Xie JJ, 2009, MOLECULES, V14, P555, DOI 10.3390/molecules14010555; Zhao Q, 2013, P NATL ACAD SCI USA, V110, P13660, DOI 10.1073/pnas.1312234110; Zhu YM, 2013, RSC ADV, V3, P21964, DOI 10.1039/c3ra42818d	27	255	264	12	331	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					90	93		10.1126/science.1250161	http://dx.doi.org/10.1126/science.1250161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700858	Green Submitted			2022-12-28	WOS:000333746100059
J	D'Silva, J				D'Silva, Jeetha			Expert views: what the next Indian government should do for health and healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2014	348								g2479	10.1136/bmj.g2479	http://dx.doi.org/10.1136/bmj.g2479			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TX	24699174				2022-12-28	WOS:000333978000015
J	Imperiale, TF; Ransohoff, DF; Itzkowitz, SH; Levin, TR; Lavin, P; Lidgard, GP; Ahlquist, DA; Berger, BM				Imperiale, Thomas F.; Ransohoff, David F.; Itzkowitz, Steven H.; Levin, Theodore R.; Lavin, Philip; Lidgard, Graham P.; Ahlquist, David A.; Berger, Barry M.			Multitarget Stool DNA Testing for Colorectal-Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FECAL OCCULT BLOOD; AMERICAN-COLLEGE; COLONOSCOPY; POLYPS; COLON; PREVALENCE; EXCISION	BackgroundAn accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening. MethodsWe compared a noninvasive, multitarget stool DNA test with a fecal immunochemical test (FIT) in persons at average risk for colorectal cancer. The DNA test includes quantitative molecular assays for KRAS mutations, aberrant NDRG4 and BMP3 methylation, and -actin, plus a hemoglobin immunoassay. Results were generated with the use of a logistic-regression algorithm, with values of 183 or more considered to be positive. FIT values of more than 100 ng of hemoglobin per milliliter of buffer were considered to be positive. Tests were processed independently of colonoscopic findings. ResultsOf the 9989 participants who could be evaluated, 65 (0.7%) had colorectal cancer and 757 (7.6%) had advanced precancerous lesions (advanced adenomas or sessile serrated polyps measuring 1 cm in the greatest dimension) on colonoscopy. The sensitivity for detecting colorectal cancer was 92.3% with DNA testing and 73.8% with FIT (P=0.002). The sensitivity for detecting advanced precancerous lesions was 42.4% with DNA testing and 23.8% with FIT (P<0.001). The rate of detection of polyps with high-grade dysplasia was 69.2% with DNA testing and 46.2% with FIT (P=0.004); the rates of detection of serrated sessile polyps measuring 1 cm or more were 42.4% and 5.1%, respectively (P<0.001). Specificities with DNA testing and FIT were 86.6% and 94.9%, respectively, among participants with nonadvanced or negative findings (P<0.001) and 89.8% and 96.4%, respectively, among those with negative results on colonoscopy (P<0.001). The numbers of persons who would need to be screened to detect one cancer were 154 with colonoscopy, 166 with DNA testing, and 208 with FIT. ConclusionsIn asymptomatic persons at average risk for colorectal cancer, multitarget stool DNA testing detected significantly more cancers than did FIT but had more false positive results. (Funded by Exact Sciences; ClinicalTrials.gov number, NCT01397747.) A stool test that measures mutant KRAS, abnormal gene methylation, and hemoglobin detected significantly more colorectal cancers than a commercial fecal immunochemical test (FIT) but had more false positive results. Colorectal cancer is a major cause of death and disease among men and women in the United States.(1) The underlying neoplastic processes of colorectal carcinogenesis lend themselves to screening.(2) Evidence supports and guidelines endorse several tests and strategies,(3)-(5) and screening for colorectal cancer has been found to be cost-effective.(5)-(7) Despite the supporting evidence, recommendations, and availability of several screening tests, a substantial proportion of the U.S. population is not up to date with screening.(8) A simple, noninvasive test with high sensitivity for both colorectal cancer and advanced precancerous lesions might increase uptake and adherence rates, which could improve ...	[Imperiale, Thomas F.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Imperiale, Thomas F.] Regenstrief Inst Hlth Care, Indianapolis, IN USA; [Imperiale, Thomas F.] Simon Canc Ctr, Indianapolis, IN USA; [Imperiale, Thomas F.] Richard L Roudebush Vet Affairs Med Ctr, Ctr Innovat, Indianapolis, IN 46202 USA; [Ransohoff, David F.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Ransohoff, David F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Ransohoff, David F.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Itzkowitz, Steven H.] Icahn Sch Med Mt Sinai, Dept Med, Dr Henry D Janowitz Div Gastroenterol, New York, NY USA; [Levin, Theodore R.] Kaiser Permanente Med Ctr, Walnut Creek, CA USA; [Lavin, Philip] Boston Biostat Res Fdn, Framingham, MA USA; [Lidgard, Graham P.; Berger, Barry M.] Exact Sci, Madison, WI USA; [Ahlquist, David A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Kaiser Permanente; Mayo Clinic	Imperiale, TF (corresponding author), Indiana Univ, Med Ctr, Regenstrief Inst, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.		Manager, Exact Sciences Content/AAU-6068-2021	Senore, Carlo/0000-0003-1023-7477; Chen, Hongda/0000-0001-6171-1162; Segnan, Nereo/0000-0002-4730-5384; Imperiale, Thomas/0000-0001-7586-1073	Exact Sciences	Exact Sciences	Supported by Exact Sciences.	Ahlquist DA, 2012, J MOL BIOMARK DIAGN, V3; Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; American Joint Committee on Cancer, 2009, AJCC CANC STAGING MA; [Anonymous], OC AUTOMICRO 80 FOB; Aronchick CA, 2000, GASTROINTEST ENDOSC, V52, P346, DOI 10.1067/mge.2000.108480; Bardan E, 1997, ISRAEL J MED SCI, V33, P777; Berger BM, 2012, PATHOLOGY, V44, P80, DOI 10.1097/PAT.0b013e3283502fdf; Boynton KA, 2003, CLIN CHEM, V49, P1058, DOI 10.1373/49.7.1058; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CHRISTIE JP, 1977, AM J GASTROENTEROL, V67, P430; Corley DA, 2013, CLIN GASTROENTEROL H, V11, P172, DOI 10.1016/j.cgh.2012.09.010; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Heitman SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000370; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Itzkowitz S, 2008, AM J GASTROENTEROL, V103, P2862, DOI 10.1111/j.1572-0241.2008.02088.x; Kahi CJ, 2012, GASTROINTEST ENDOSC, V75, P515, DOI 10.1016/j.gie.2011.08.021; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Lidgard GP, 2013, CLIN GASTROENTEROL H, V11, P1313, DOI 10.1016/j.cgh.2013.04.023; Lieberman D, 2008, GASTROENTEROLOGY, V135, P1100, DOI 10.1053/j.gastro.2008.06.083; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; NIVATVONGS S, 1984, GASTROINTEST ENDOSC, V30, P18, DOI 10.1016/S0016-5107(84)72287-5; Parekh M, 2008, ALIMENT PHARM THER, V27, P697, DOI 10.1111/j.1365-2036.2008.03632.x; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Raginel T, 2013, GASTROENTEROLOGY, V144, P918, DOI 10.1053/j.gastro.2013.01.042; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rex DK, 2009, AM J GASTROENTEROL, V104, P1612, DOI 10.1038/ajg.2009.265; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Zauber AG, 2009, AHRQ PUBLICATION; Zou HZ, 2006, CANCER EPIDEM BIOMAR, V15, P1115, DOI 10.1158/1055-9965.EPI-05-0992	37	982	1052	7	150	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1287	1297		10.1056/NEJMoa1311194	http://dx.doi.org/10.1056/NEJMoa1311194			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24645800	Green Published			2022-12-28	WOS:000333830000007
J	Todres, J; Clayton, EW				Todres, Jonathan; Clayton, Ellen Wright			Responding to the Sexual Exploitation of Minors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								If they think about it at all, most people in the United States probably imagine that commercial sexual exploitation and sex trafficking of children and adolescents are problems primarily affecting other parts of the world; in reality, these crimes occur in this country every day. These abuses have physical and mental health consequences that are both immediate - such as physical trauma and exposure to HIV and other sexually transmitted infections - and long-term - such as substance abuse, post-traumatic stress disorder, depression, and anxiety. Health care professionals in a variety of settings may encounter children and adolescents who are . . . Commercial sexual exploitation and sex trafficking of children and adolescents have both immediate and long-term physical and mental health consequences. A new IOM-NRC report argues that clinicians can help prevent these crimes and identify and respond to the victims.	[Todres, Jonathan] Georgia State Univ, Coll Law, Atlanta, GA 30303 USA; [Clayton, Ellen Wright] Vanderbilt Law Sch, Nashville, TN USA; [Clayton, Ellen Wright] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	University System of Georgia; Georgia State University; Vanderbilt University; Vanderbilt University	Todres, J (corresponding author), Georgia State Univ, Coll Law, Atlanta, GA 30303 USA.			Clayton, Ellen/0000-0002-0308-4110; Todres, Jonathan/0000-0002-6617-878X				Estes R., 2002, COMMERCIAL SEXUAL EX; Institute of Medicine and the National Research Council Committee on the Commercial Sexual Exploitation and Sex Trafficking of Minors, 2013, CONFR COMM SEX EXPL; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004	3	6	6	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1282	1283		10.1056/NEJMp1314927	http://dx.doi.org/10.1056/NEJMp1314927			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE2VA	24693888				2022-12-28	WOS:000333830000005
J	Strickland, S				Strickland, Sarah			Does it work to pay people to live healthier lives?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FINANCIAL INCENTIVES					Sarahbstrick@yahoo.com						Aon Hewitt, 2013, NEW CHOICES BETTER R; Bjorkman-Nyqvist M, 2013, SEX TRANSM INFECT, V89, pA325, DOI 10.1136/sextrans-2013-051184.1017; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; Jochelson K., 2007, PAYING PATIENT IMPRO; Local government association, 2013, CHANG BEH PUBL HLTH; Loewenstein G, 2013, HEALTH AFFAIR, V32, P1244, DOI 10.1377/hlthaff.2012.1163; Mazumdar S, 2011, FINANCIAL INCENTIVES; Paes-Sousa R, 2011, B WORLD HEALTH ORGAN, V89, P496, DOI 10.2471/BLT.10.084202; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Puska P., 2002, Public Health Medicine, V4, P5; Puska P., PROFILE SUMMARY; Sheather J., 2010, BMJ; Tan M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4929; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819	14	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g2458	10.1136/bmj.g2458	http://dx.doi.org/10.1136/bmj.g2458			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696175				2022-12-28	WOS:000333977000008
J	Basu, B				Basu, Biswanath			Ofatumumab for Rituximab- Resistant Nephrotic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter								Cases of the steroid-resistant nephrotic syndrome that are resistant to rituximab can be difficult to treat. In this report, ofatumumab, an anti-CD20 monoclonal antibody, showed some benefit in five young patients.To the Editor: Treatment of children with the steroid-resistant nephrotic syndrome (SRNS) is challenging. During the past decade, rituximab was found to be a promising agent in managing SRNS that was resistant to alkylating agents and calcineurin inhibitors. But increasing evidence of rituximab resistance in patients with SRNS has spurred a search for additional therapies.(1),(2) Patient 1, a 19-year-old girl with a 6-year history of SRNS (in whom focal segmental glomerulosclerosis had been diagnosed), had resistance to all available standard drugs, including two courses of rituximab. After the withdrawal of glucocorticoids, she continued to have nephrotic-range proteinuria (Table 1). ...	Nil Ratan Sircar Med Coll & Hosp, Kolkata, India		Basu, B (corresponding author), Nil Ratan Sircar Med Coll & Hosp, Kolkata, India.	basuv3000@gmail.com	BASU, BISWANATH/H-5910-2019					Cheson BD, 2010, J CLIN ONCOL, V28, P3525, DOI 10.1200/JCO.2010.27.9836; Magnasco A, 2012, J AM SOC NEPHROL, V23, P1117, DOI 10.1681/ASN.2011080775; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Sinha A, 2013, NAT REV NEPHROL, V9, P154, DOI 10.1038/nrneph.2012.289	4	74	84	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1268	1270		10.1056/NEJMc1308488	http://dx.doi.org/10.1056/NEJMc1308488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670185				2022-12-28	WOS:000333426000026
J	Belkaid, Y; Hand, TW				Belkaid, Yasmine; Hand, Timothy W.			Role of the Microbiota in Immunity and Inflammation	CELL			English	Review							SEGMENTED FILAMENTOUS BACTERIA; REGULATORY T-CELLS; CHAIN FATTY-ACIDS; INTESTINAL DENDRITIC CELLS; GUT COMMENSAL BACTERIA; LECTIN REGIII-GAMMA; TOLL-LIKE RECEPTORS; GERM-FREE MICE; ORAL TOLERANCE; CROHNS-DISEASE	The microbiota plays a fundamental role on the induction, training, and function of the host immune system. In return, the immune system has largely evolved as a means to maintain the symbiotic relationship of the host with these highly diverse and evolving microbes. When operating optimally, this immune system-microbiota alliance allows the induction of protective responses to pathogens and the maintenance of regulatory pathways involved in the maintenance of tolerance to innocuous antigens. However, in high-income countries, overuse of antibiotics, changes in diet, and elimination of constitutive partners, such as nematodes, may have selected for a microbiota that lack the resilience and diversity required to establish balanced immune responses. This phenomenon is proposed to account for some of the dramatic rise in autoimmune and inflammatory disorders in parts of the world where our symbiotic relationship with the microbiota has been the most affected.	[Belkaid, Yasmine; Hand, Timothy W.] NIAID, Immun Barrier Sites Initiat, NIH, Bethesda, MD 20892 USA; [Hand, Timothy W.] NIAID, Parasit Dis Lab, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Immun Barrier Sites Initiat, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Hand, Timothy W/AAH-1216-2021	Hand, Timothy W/0000-0002-2684-9462; Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. We would like to thank the members of the Belkaid laboratory for helpful discussions and, more particularly, John Grainger, Sean Spencer, and Nicolas Bouladoux for critical reading of the manuscript. We would like to also apologize to our colleagues for not having cited all papers relevant to this expanding field because of space constraints.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; BAUER H, 1963, AM J PATHOL, V42, P471; Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Caruso R, 2020, NAT REV IMMUNOL, V20, P411, DOI [10.4161/gmic.20228, 10.1038/s41577-019-0268-7]; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dixon DR, 2004, J PERIODONTOL, V75, P1486, DOI 10.1902/jop.2004.75.11.1486; Doderlein A., 1892, SCHEIDENSEKRET SEINE; Dubinsky MC, 2006, AM J GASTROENTEROL, V101, P360, DOI 10.1111/j.1572-0241.2006.00456.x; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ergin A, 2011, J CLIN IMMUNOL, V31, P998, DOI 10.1007/s10875-011-9575-x; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Garcia-Crespo KE, 2013, ANTIVIR RES, V97, P270, DOI 10.1016/j.antiviral.2012.12.022; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hammami R, 2013, CELL MOL LIFE SCI, V70, P2947, DOI 10.1007/s00018-012-1202-3; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; HORNQUIST E, 1995, ADV EXP MED BIOL, V371, P1507; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Issa M, 2008, INFLAMM BOWEL DIS, V14, P1432, DOI 10.1002/ibd.20500; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Johnston CJ, 2014, TRANSPLANTATION, V97, P127, DOI 10.1097/TP.0b013e3182a53f59; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Jung C, 2012, J CLIN INVEST, V122, P2239, DOI 10.1172/JCI58147; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; KIYONO H, 1982, J EXP MED, V155, P605, DOI 10.1084/jem.155.2.605; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lamps LW, 2003, AM J SURG PATHOL, V27, P220, DOI 10.1097/00000478-200302000-00011; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2001, MICROBES INFECT, V3, P1021, DOI 10.1016/S1286-4579(01)01460-5; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marcobal A, 2012, CLIN MICROBIOL INFEC, V18, P12, DOI 10.1111/j.1469-0691.2012.03863.x; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; MARSHALL BJ, 1984, LANCET, V1, P1311; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Molloy MJ, 2012, SEMIN IMMUNOL, V24, P58, DOI 10.1016/j.smim.2011.11.008; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Packey CD, 2008, J INTERN MED, V263, P597, DOI 10.1111/j.1365-2796.2008.01962.x; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; PCHOAREPARAZ J, 2009, J IMMUNOL, V183, P6041; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312; Schamberger GP, 2002, J FOOD PROTECT, V65, P1381, DOI 10.4315/0362-028X-65.9.1381; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Sudo N, 1997, J IMMUNOL, V159, P1739; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Turovskiy Y, 2011, J APPL MICROBIOL, V110, P1105, DOI 10.1111/j.1365-2672.2011.04977.x; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wade TK, 2008, MICROBIOL IMMUNOL, V52, P611, DOI 10.1111/j.1348-0421.2008.00078.x; WANNEMUEHLER MJ, 1982, J IMMUNOL, V129, P959; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Weinstock JV, 2004, GUT, V53, P7, DOI 10.1136/gut.53.1.7; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zoumpopoulou G., 2008, International Journal of Food Microbiology, V121, P18, DOI 10.1016/j.ijfoodmicro.2007.10.013	244	2305	2407	79	782	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					121	141		10.1016/j.cell.2014.03.011	http://dx.doi.org/10.1016/j.cell.2014.03.011			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679531	Green Accepted, Bronze			2022-12-28	WOS:000333968900012
J	Frisch, A; Mark, M; Aikawa, K; Ferlaino, F; Bohn, JL; Makrides, C; Petrov, A; Kotochigova, S				Frisch, Albert; Mark, Michael; Aikawa, Kiyotaka; Ferlaino, Francesca; Bohn, John L.; Makrides, Constantinos; Petrov, Alexander; Kotochigova, Svetlana			Quantum chaos in ultracold collisions of gas-phase erbium atoms	NATURE			English	Article							FESHBACH RESONANCES; RANDOM MATRICES; PHYSICS	Atomic and molecular samples reduced to temperatures below one microkelvin, yet still in the gas phase, afford unprecedented energy resolution in probing and manipulating the interactions between their constituent particles. As a result of this resolution, atoms can be made to scatter resonantly on demand, through the precise control of a magnetic field(1). For simple atoms, such as alkalis, scattering resonances are extremely well characterized(2). However, ultracold physics is now poised to enter a new regime, where much more complex species can be cooled and studied, including magnetic lanthanide atoms and even molecules. For molecules, it has been speculated(3,4) that a dense set of resonances in ultracold collision cross-sections will probably exhibit essentially random fluctuations, much as the observed energy spectra of nuclear scattering do(5). According to the Bohigas-Giannoni-Schmit conjecture, such fluctuations would imply chaotic dynamics of the underlying classical motion driving the collision(6-8). This would necessitate new ways of looking at the fundamental interactions in ultracold atomic and molecular systems, as well as perhaps new chaos-driven states of ultracold matter. Here we describe the experimental demonstration that random spectra are indeed found at ultralow temperatures. In the experiment, an ultracold gas of erbium atoms is shown to exhibit many Fano-Feshbach resonances, of the order of three per gauss for bosons. Analysis of their statistics verifies that their distribution of nearest-neighbour spacings is what one would expect from random matrix theory(9). The density and statistics of these resonances are explained by fully quantum mechanical scattering calculations that locate their origin in the anisotropy of the atoms' potential energy surface. Our results therefore reveal chaotic behaviour in the native interaction between ultracold atoms.	[Frisch, Albert; Mark, Michael; Aikawa, Kiyotaka; Ferlaino, Francesca] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Bohn, John L.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Bohn, John L.] NIST, Boulder, CO 80309 USA; [Makrides, Constantinos; Petrov, Alexander; Kotochigova, Svetlana] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA; [Petrov, Alexander] St Petersburg Nucl Phys Inst, Gatchina 188300, Russia; [Petrov, Alexander] St Petersburg State Univ, Div Quantum Mech, St Petersburg 198904, Russia	University of Innsbruck; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Saint Petersburg State University	Ferlaino, F (corresponding author), Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria.	francesca.ferlaino@uibk.ac.at	Aikawa, Kiyotaka/D-4896-2016; Petrov, Alexander N/I-7865-2013; Ferlaino, Francesca/E-6726-2012	Petrov, Alexander N/0000-0003-1342-3160; Ferlaino, Francesca/0000-0002-3020-6291	ARO MURI; Austrian Science Fund (FWF) through a START grant [Y479-N20]; European Research Council [259435]; Lise-Meitner program of the FWF; AFOSR; NSF [PHY-1308573]; Austrian Science Fund (FWF) [Y 479] Funding Source: researchfish; Division Of Physics [1308573] Funding Source: National Science Foundation	ARO MURI(MURI); Austrian Science Fund (FWF) through a START grant(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Lise-Meitner program of the FWF(Austrian Science Fund (FWF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The Innsbruck group thanks R. Grimm for discussions and S. Baier, C. Ravensbergen and M. Brownnutt for reading the manuscript. S. K. and A. P. thank E. Tiesinga for discussions. J.L.B. is supported by an ARO MURI. The Innsbruck team is supported by the Austrian Science Fund (FWF) through a START grant under project no. Y479-N20 and by the European Research Council under project no. 259435. K.A. is supported within the Lise-Meitner program of the FWF. Research at Temple University is supported by AFOSR and NSF PHY-1308573.	Aikawa K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.010404; Aikawa K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210401; ALT H, 1995, PHYS REV LETT, V74, P62, DOI 10.1103/PhysRevLett.74.62; Berninger M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032517; BRODY TA, 1973, LETT NUOVO CIMENTO, V7, P482, DOI 10.1007/BF02727859; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Connolly CB, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.010702; DYSON FJ, 1963, J MATH PHYS, V4, P701, DOI 10.1063/1.1704008; Frisch A, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.051401; Gao B, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.050702; Guhr T, 1998, PHYS REP, V299, P190; Hancox CI, 2004, NATURE, V431, P281, DOI 10.1038/nature02938; HASEGAWA H, 1989, PROG THEOR PHYS SUPP, P198, DOI 10.1143/PTPS.98.198; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Kokoouline V, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.133201; Kollath C, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/08/P08011; Kotochigova S, 1997, INT J QUANTUM CHEM, V65, P575, DOI 10.1002/(SICI)1097-461X(1997)65:5<575::AID-QUA22>3.0.CO;2-0; Kramida A., 2013, NIST ATOMIC SPECTRA; Krems RV, 2004, J PHYS CHEM A, V108, P8941, DOI 10.1021/jp0488416; Lawler JE, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/23/235001; Lu MW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215301; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; Mayle M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.012709; Mayle M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062712; Mitchell GE, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.2845; Oganesyan V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155111; Petrov A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.103002; Takekoshi T, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032506; Taylor J., 1997, INTRO ERROR ANAL STU, P272; WATTS JD, 1993, J CHEM PHYS, V98, P8718, DOI 10.1063/1.464480; Weidenmuller HA, 2009, REV MOD PHYS, V81, P539, DOI 10.1103/RevModPhys.81.539; WIGNER EP, 1951, ANN MATH, V53, P36, DOI 10.2307/1969342	34	159	159	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					475	+		10.1038/nature13137	http://dx.doi.org/10.1038/nature13137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670766	Green Submitted			2022-12-28	WOS:000333402000035
J	Hoehler, TM; Alperin, MJ				Hoehler, Tori M.; Alperin, Marc J.			Methane minimalism	NATURE			English	Editorial Material							TEMPERATURE		[Hoehler, Tori M.] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; [Alperin, Marc J.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of North Carolina; University of North Carolina Chapel Hill	Hoehler, TM (corresponding author), NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA.	tori.m.hoehler@nasa.gov; alperin@email.unc.edu						Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Prather M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1395; Riley WJ, 2011, BIOGEOSCIENCES, V8, P1925, DOI 10.5194/bg-8-1925-2011; TIJHUIS L, 1993, BIOTECHNOL BIOENG, V42, P509, DOI 10.1002/bit.260420415; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164	7	16	16	6	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					436	437		10.1038/nature13215	http://dx.doi.org/10.1038/nature13215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670756				2022-12-28	WOS:000333402000025
J	Stoner, R; Chow, ML; Boyle, MP; Sunkin, SM; Mouton, PR; Roy, S; Wynshaw-Boris, A; Colamarino, SA; Lein, ES; Courchesne, E				Stoner, Rich; Chow, Maggie L.; Boyle, Maureen P.; Sunkin, Susan M.; Mouton, Peter R.; Roy, Subhojit; Wynshaw-Boris, Anthony; Colamarino, Sophia A.; Lein, Ed S.; Courchesne, Eric			Patches of Disorganization in the Neocortex of Children with Autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRAIN OVERGROWTH; CORTEX; CONNECTIVITY; PATTERNS; NUMBER; SIZE; LIFE	BackgroundAutism involves early brain overgrowth and dysfunction, which is most strongly evident in the prefrontal cortex. As assessed on pathological analysis, an excess of neurons in the prefrontal cortex among children with autism signals a disturbance in prenatal development and may be concomitant with abnormal cell type and laminar development. MethodsTo systematically examine neocortical architecture during the early years after the onset of autism, we used RNA in situ hybridization with a panel of layer- and cell-type-specific molecular markers to phenotype cortical microstructure. We assayed markers for neurons and glia, along with genes that have been implicated in the risk of autism, in prefrontal, temporal, and occipital neocortical tissue from postmortem samples obtained from children with autism and unaffected children between the ages of 2 and 15 years. ResultsWe observed focal patches of abnormal laminar cytoarchitecture and cortical disorganization of neurons, but not glia, in prefrontal and temporal cortical tissue from 10 of 11 children with autism and from 1 of 11 unaffected children. We observed heterogeneity between cases with respect to cell types that were most abnormal in the patches and the layers that were most affected by the pathological features. No cortical layer was uniformly spared, with the clearest signs of abnormal expression in layers 4 and 5. Three-dimensional reconstruction of layer markers confirmed the focal geometry and size of patches. ConclusionsIn this small, explorative study, we found focal disruption of cortical laminar architecture in the cortexes of a majority of young children with autism. Our data support a probable dysregulation of layer formation and layer-specific neuronal differentiation at prenatal developmental stages. (Funded by the Simons Foundation and others.) Molecular analysis of postmortem samples of brain tissue obtained from 11 children with autism showed that the prefrontal and temporal cortexes in 10 of these children had patches of neuronal disorganization. Autism is, in part, a heritable developmental disorder involving macroscopic early brain overgrowth in the majority of cases(1)-(7) and dysfunction(8) that affects several cortical and subcortical regions mediating autistic symptoms, including prefrontal and temporal cortexes.(4),(9)-(11) The underlying cortical defects remain uncertain. Despite the early diagnosable onset, in more than 40 studies, the average age of patients with autism in postmortem analyses was 22 years.(4) Three previous case studies that evaluated Nissl-stained sections of brains obtained from patients with autism ranging in age from 4 to 60 years described individual instances of heterotopias, slight focal laminar disorganization,(12), ...	[Stoner, Rich; Chow, Maggie L.; Boyle, Maureen P.; Courchesne, Eric] Univ Calif San Diego, Autism Ctr Excellence, La Jolla, CA 92037 USA; [Stoner, Rich; Chow, Maggie L.; Boyle, Maureen P.; Roy, Subhojit; Courchesne, Eric] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92037 USA; [Roy, Subhojit] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92037 USA; [Boyle, Maureen P.; Sunkin, Susan M.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA USA; [Mouton, Peter R.] Univ S Florida, Sch Med, Dept Pathol & Cell Biol, Tampa, FL 33620 USA; [Mouton, Peter R.] Alzheimers Inst, Tampa, FL USA; [Mouton, Peter R.] Res Ctr, Tampa, FL USA; [Wynshaw-Boris, Anthony] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Colamarino, Sophia A.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Allen Institute for Brain Science; State University System of Florida; University of South Florida; Case Western Reserve University; Stanford University	Courchesne, E (corresponding author), Univ Calif San Diego, Sch Med, Autism Ctr Excellence, Dept Neurosci, 8110 La Jolla Shores Dr, La Jolla, CA 92037 USA.	ecourchesne@ucsd.edu			Simons Foundation; Peter Emch Family Foundation; Cure Autism Now/Autism Speaks; Thursday Club Juniors; Allen Institute for Brain Science; University of California, San Diego, Autism Center of Excellence [P50-MH081755]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755] Funding Source: NIH RePORTER	Simons Foundation; Peter Emch Family Foundation; Cure Autism Now/Autism Speaks; Thursday Club Juniors; Allen Institute for Brain Science; University of California, San Diego, Autism Center of Excellence; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the Simons Foundation (to Drs. Courchesne and Wynshaw-Boris), the Peter Emch Family Foundation (to Dr. Cour-chesne), Cure Autism Now/Autism Speaks (to Dr. Courchesne), the Thursday Club Juniors (to Dr. Courchesne), the Allen Institute for Brain Science (to Drs. Lein, Sunkin, and Boyle), and the University of California, San Diego, Autism Center of Excellence (P50-MH081755, to Dr. Courchesne). Tissue for this study was provided by the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders (Baltimore) (N01-HD-4-3368 and N01-HD-4-3383), the Brain and Tissue Bank for Developmental Disorders (Miami), Autism Tissue Program (Princeton, NJ), and Harvard Brain Tissue Resource Center (Belmont, MA).	Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gohlke JM, 2007, CEREB CORTEX, V17, P2433, DOI 10.1093/cercor/bhl151; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; Hutsler JJ, 2007, BIOL PSYCHIAT, V61, P449, DOI 10.1016/j.biopsych.2006.01.015; Larsen CC, 2006, NEUROSCIENCE, V139, P999, DOI 10.1016/j.neuroscience.2006.01.005; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabinowicz T, 1996, J NEUROPATH EXP NEUR, V55, P320, DOI 10.1097/00005072-199603000-00007; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Santos M, 2011, BRAIN RES, V1380, P206, DOI 10.1016/j.brainres.2010.08.067; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	28	443	450	1	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1209	1219		10.1056/NEJMoa1307491	http://dx.doi.org/10.1056/NEJMoa1307491			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670167	Green Accepted			2022-12-28	WOS:000333426000008
J	[Anonymous]				[Anonymous]			Surgery and Fatal Pulmonary Embolism (Reprinted from vol 89, pg 1153, 1927)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Allen EV, 1927, ARCH SURG-CHICAGO, V15, P254, DOI 10.1001/archsurg.1927.01130200102008; Brown GE, 1927, ARCH SURG-CHICAGO, V15, P245, DOI 10.1001/archsurg.1927.01130200093007; Henderson EF, 1927, ARCH SURG-CHICAGO, V15, P231, DOI 10.1001/archsurg.1927.01130200079005; Snell AM, 1927, ARCH SURG-CHICAGO, V15, P237, DOI 10.1001/archsurg.1927.01130200085006; 1927, JAMA, V89, P1153	5	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1163	1163		10.1001/jama.2013.279397	http://dx.doi.org/10.1001/jama.2013.279397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643617				2022-12-28	WOS:000333010100032
J	Denzel, MS; Storm, NJ; Gutschmidt, A; Baddi, R; Hinze, Y; Jarosch, E; Sommer, T; Hoppe, T; Antebi, A				Denzel, Martin S.; Storm, Nadia J.; Gutschmidt, Aljona; Baddi, Ruth; Hinze, Yvonne; Jarosch, Ernst; Sommer, Thomas; Hoppe, Thorsten; Antebi, Adam			Hexosamine Pathway Metabolites Enhance Protein Quality Control and Prolong Life	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSGENIC CAENORHABDITIS-ELEGANS; HEAT-SHOCK FACTOR; C. ELEGANS; AUTOPHAGY GENES; LONGEVITY; ER; DEGRADATION; DISEASE; SPAN	Aging entails a progressive decline in protein homeostasis, which often leads to age-related diseases. The endoplasmic reticulum (ER) is the site of protein synthesis and maturation for secreted and membrane proteins. Correct folding of ER proteins requires covalent attachment of N-linked glycan oligosaccharides. Here, we report that increased synthesis of N-glycan precursors in the hexosamine pathway improves ER protein homeostasis and extends lifespan in C. elegans. Addition of the N-glycan precursor N-acetylglucosamine to the growth medium slows aging in wild-type animals and alleviates pathology of distinct neurotoxic disease models. Our data suggest that reduced aggregation of metastable proteins and lifespan extension depend on enhanced ER-associated protein degradation, proteasomal activity, and autophagy. Evidently, hexosamine pathway activation or N-acetylglucosamine supplementation induces distinct protein quality control mechanisms, which may allow therapeutic intervention against age-related and proteotoxic diseases.	[Denzel, Martin S.; Storm, Nadia J.; Baddi, Ruth; Hinze, Yvonne; Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Antebi, Adam] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gutschmidt, Aljona; Hoppe, Thorsten; Antebi, Adam] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respo, D-50674 Cologne, Germany; [Gutschmidt, Aljona; Hoppe, Thorsten] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Jarosch, Ernst; Sommer, Thomas] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Sommer, Thomas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Max Planck Society; Baylor College of Medicine; University of Cologne; University of Cologne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin	Antebi, A (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany.	antebi@age.mpg.de	Denzel, Martin/C-9047-2014; Hoppe, Thorsten/AAC-7880-2020	Denzel, Martin/0000-0002-5691-3349; Hoppe, Thorsten/0000-0002-4734-9352; Jarosch, Ernst/0000-0002-5897-3492	EMBO fellowship; Marie-Curie Career Integration Grant; Max Planck Society; BMBF/Sybacol; Deutsche Forschungsgemeinschaft (DFG)/CECAD; DFG; DIP8 grant [2014376]; CECAD [FOR885, KFO286, SFB635]; German-Israel Project Cooperation DIP;  [JA 1830/1-2];  [SFB 740];  [1365]	EMBO fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Career Integration Grant; Max Planck Society(Max Planck SocietyFoundation CELLEX); BMBF/Sybacol; Deutsche Forschungsgemeinschaft (DFG)/CECAD(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DIP8 grant; CECAD; German-Israel Project Cooperation DIP; ; ; 	We thank the Caenorhabditis Genetics Center for strains. We also thank Dr. Claudia Knief and Dr. Richard Reinhardt from the Max Planck Genome Centre Cologne for whole-genome sequencing and Dr. Assa Yeroslaviz for support with bioinformatic analyses. This work was supported by an EMBO fellowship and a Marie-Curie Career Integration Grant (M.S.D.); by the Max Planck Society, BMBF/Sybacol, and Deutsche Forschungsgemeinschaft (DFG)/CECAD (A.A.); by grants from the DFG, the DIP8 grant 2014376, CECAD FOR885, KFO286, and SFB635 (T.H.); and by grants JA 1830/1-2 and SFB 740, Priority Program 1365, and the German-Israel Project Cooperation DIP (T.S. and E.J.).	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernasconi R, 2012, MOL CELL, V46, P809, DOI 10.1016/j.molcel.2012.04.017; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BRENNER S, 1974, GENETICS, V77, P71; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fredriksson A, 2012, AGING CELL, V11, P634, DOI 10.1111/j.1474-9726.2012.00823.x; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson WG, 2000, J ANAT, V196, P609, DOI 10.1046/j.1469-7580.2000.19640609.x; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Plemper RK, 1999, J CELL SCI, V112, P4123; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Saito Y, 1999, J BIOCHEM-TOKYO, V125, P130, DOI 10.1093/oxfordjournals.jbchem.a022249; Schipanski A, 2013, GENETICS, V193, P865, DOI 10.1534/genetics.112.149088; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shintani T, 2010, BIOCHEM BIOPH RES CO, V391, P1775, DOI 10.1016/j.bbrc.2009.12.154; Shore DE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002792; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Zhao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064228; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	46	149	157	0	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1167	1178		10.1016/j.cell.2014.01.061	http://dx.doi.org/10.1016/j.cell.2014.01.061			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630720	Bronze, Green Published			2022-12-28	WOS:000332945100008
J	Murphy, TM; Mill, J				Murphy, Therese M.; Mill, Jonathan			Epigenetics in health and disease: heralding the EWAS era	LANCET			English	Editorial Material									[Murphy, Therese M.; Mill, Jonathan] Univ Exeter, Royal Devon & Exeter Hosp, Sch Med, Exeter EX2 5DW, Devon, England; [Mill, Jonathan] Kings Coll London, Inst Psychiat, London, England	University of Exeter; University of London; King's College London	Murphy, TM (corresponding author), Univ Exeter, Royal Devon & Exeter Hosp, Sch Med, Exeter EX2 5DW, Devon, England.	j.mill@exeter.ac.uk	Erdmann, Jeanette/P-7513-2014; Mill, Jonathan/B-5678-2014; Mill, Jonathan S/B-3276-2010; Murphy, Therese/C-7481-2014	Erdmann, Jeanette/0000-0002-4486-6231; Mill, Jonathan/0000-0003-1115-3224; Mill, Jonathan S/0000-0003-1115-3224; Murphy, Therese/0000-0002-7647-2798	MRC [MR/K013807/1] Funding Source: UKRI; Medical Research Council [MR/K013807/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], [No title captured]; Bell JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3978; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Huynh JL, 2014, NAT NEUROSCI, V17, P121, DOI 10.1038/nn.3588; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Mill J, 2013, NAT REV GENET, V14, P585, DOI 10.1038/nrg3405; Petersen AK, 2014, HUM MOL GENET, V23, P534, DOI 10.1093/hmg/ddt430; Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233; Shin MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046562; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686	13	49	50	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1952	1954		10.1016/S0140-6736(14)60269-5	http://dx.doi.org/10.1016/S0140-6736(14)60269-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24630775				2022-12-28	WOS:000336848200007
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			The Perpetual Challenge of Antimicrobial Resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fauci, Anthony S.; Marston, Hilary D.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov	Hassali, Mohamed Azmi/A-6895-2011	Hassali, Mohamed Azmi/0000-0001-9575-403X				Broad Institute, ACT GROUP DAT; Centers for Disease Control and Prevention, THREAT REP 2013; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Jerse AE, 2014, VACCINE, V32, P1579, DOI 10.1016/j.vaccine.2013.08.067; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; National Institutes of Health, 2014, NIAIDS ANT RES PROGR; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280	9	68	73	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1853	1854		10.1001/jama.2014.2465	http://dx.doi.org/10.1001/jama.2014.2465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24652442				2022-12-28	WOS:000335798100013
J	Devereaux, PJ; Mrkobrada, M; Sessler, DI; Leslie, K; Alonso-Coello, P; Kurz, A; Villar, JC; Sigamani, A; Biccard, BM; Meyhoff, CS; Parlow, JL; Guyatt, G; Robinson, A; Garg, AX; Rodseth, RN; Botto, F; Buse, GL; Xavier, D; Chan, MTV; Tiboni, M; Cook, D; Kumar, PA; Forget, P; Malaga, G; Fleischmann, E; Amir, M; Eikelboom, J; Mizera, R; Torres, D; Wang, CY; VanHelder, T; Paniagua, P; Berwanger, O; Srinathan, S; Graham, M; Pasin, L; Le Manach, Y; Gao, P; Pogue, J; Whitlock, R; Lamy, A; Kearon, C; Baigent, C; Chow, C; Pettit, S; Chrolavicius, S; Yusuf, S				Devereaux, P. J.; Mrkobrada, M.; Sessler, D. I.; Leslie, K.; Alonso-Coello, P.; Kurz, A.; Villar, J. C.; Sigamani, A.; Biccard, B. M.; Meyhoff, C. S.; Parlow, J. L.; Guyatt, G.; Robinson, A.; Garg, A. X.; Rodseth, R. N.; Botto, F.; Buse, G. Lurati; Xavier, D.; Chan, M. T. V.; Tiboni, M.; Cook, D.; Kumar, P. A.; Forget, P.; Malaga, G.; Fleischmann, E.; Amir, M.; Eikelboom, J.; Mizera, R.; Torres, D.; Wang, C. Y.; VanHelder, T.; Paniagua, P.; Berwanger, O.; Srinathan, S.; Graham, M.; Pasin, L.; Le Manach, Y.; Gao, P.; Pogue, J.; Whitlock, R.; Lamy, A.; Kearon, C.; Baigent, C.; Chow, C.; Pettit, S.; Chrolavicius, S.; Yusuf, S.		POISE-2 Investigators	Aspirin in Patients Undergoing Noncardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE ASPIRIN; MYOCARDIAL-INFARCTION; ACETYLSALICYLIC-ACID; PLATELET-FUNCTION; VASCULAR-DISEASE; THERAPY; PREVENTION; METAANALYSIS; ASSOCIATION	Background: There is substantial variability in the perioperative administration of aspirin in patients undergoing noncardiac surgery, both among patients who are already on an aspirin regimen and among those who are not. Methods: Using a 2-by-2 factorial trial design, we randomly assigned 10,010 patients who were preparing to undergo noncardiac surgery and were at risk for vascular complications to receive aspirin or placebo and clonidine or placebo. The results of the aspirin trial are reported here. The patients were stratified according to whether they had not been taking aspirin before the study (initiation stratum, with 5628 patients) or they were already on an aspirin regimen (continuation stratum, with 4382 patients). Patients started taking aspirin (at a dose of 200 mg) or placebo just before surgery and continued it daily (at a dose of 100 mg) for 30 days in the initiation stratum and for 7 days in the continuation stratum, after which patients resumed their regular aspirin regimen. The primary outcome was a composite of death or nonfatal myocardial infarction at 30 days. Results: The primary outcome occurred in 351 of 4998 patients (7.0%) in the aspirin group and in 355 of 5012 patients (7.1%) in the placebo group (hazard ratio in the aspirin group, 0.99; 95% confidence interval [CI], 0.86 to 1.15; P=0.92). Major bleeding was more common in the aspirin group than in the placebo group (230 patients [4.6%] vs. 188 patients [3.8%]; hazard ratio, 1.23; 95% CI, 1.01, to 1.49; P=0.04). The primary and secondary outcome results were similar in the two aspirin strata. Conclusions: Administration of aspirin before surgery and throughout the early postsurgical period had no significant effect on the rate of a composite of death or nonfatal myocardial infarction but increased the risk of major bleeding. (Funded by the Canadian Institutes of Health Research and others; POISE-2 ClinicalTrials.gov number, NCT01082874.)	[Devereaux, P. J.; Mrkobrada, M.; Robinson, A.; Botto, F.; Buse, G. Lurati; Eikelboom, J.; Le Manach, Y.; Gao, P.; Pogue, J.; Whitlock, R.; Lamy, A.; Pettit, S.; Chrolavicius, S.; Yusuf, S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8S 4L8, Canada; [Devereaux, P. J.; Guyatt, G.; Cook, D.; Eikelboom, J.; Le Manach, Y.; Pogue, J.; Kearon, C.; Yusuf, S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Devereaux, P. J.; Guyatt, G.; Tiboni, M.; Cook, D.; Eikelboom, J.; Mizera, R.; Kearon, C.; Yusuf, S.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [VanHelder, T.; Le Manach, Y.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Whitlock, R.; Lamy, A.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Whitlock, R.] McMaster Univ, Dept Crit Care, Hamilton, ON L8S 4L8, Canada; [Mrkobrada, M.] London Hlth Sci Ctr, Dept Med, London, ON, Canada; [Parlow, J. L.] Kingston Gen Hosp, Dept Anesthesiol & Perioperat Med, Kingston, ON K7L 2V7, Canada; [Parlow, J. L.] Queens Univ, Kingston, ON, Canada; [Garg, A. X.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Srinathan, S.] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada; [Graham, M.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Sessler, D. I.; Kurz, A.] Cleveland Clin, Dept Outcomes Res, Inst Anesthesiol, Cleveland, Qld, Australia; [Leslie, K.] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia; [Alonso-Coello, P.] Biomed Res Inst, Iberoamer Cochrane Ctr, Barcelona, Spain; [Paniagua, P.] Biomed Res Inst, Dept Anesthesiol, Barcelona, Spain; [Villar, J. C.] Univ Autonoma Bucaramanga, Bogota, Colombia; [Villar, J. C.] Fdn Cardioinfantil, Bogota, Colombia; [Sigamani, A.; Xavier, D.] St Johns Natl Acad Hlth Sci, Dept Pharmacol, Div Clin Res & Training, Bangalore, Karnataka, India; [Biccard, B. M.; Rodseth, R. N.] Univ KwaZulu Natal, Dept Anaesthet, Perioperat Res Grp, Nelson R Mandela Sch Med, Durban, South Africa; [Meyhoff, C. S.] Univ Copenhagen, Herlev Hosp, Dept Anesthesiol, DK-2730 Herlev, Denmark; [Botto, F.] Inst Cardiovasc Buenos Aires, Estudios Clin Latino Amer, Buenos Aires, DF, Argentina; [Buse, G. Lurati] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland; [Chan, M. T. V.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Kumar, P. A.] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA; [Forget, P.] Clin Univ St Luc, Brussels, Belgium; [Malaga, G.] Univ Peruana Cayetano Heredia, Lima, Peru; [Fleischmann, E.] Med Univ Vienna, Dept Anesthesia & Intens Care, Vienna, Austria; [Amir, M.] Shifa Int Hosp, Dept Surg, Islamabad, Pakistan; [Torres, D.] Clin Santa Maria, Dept Anesthesiol, Santiago, Chile; [Wang, C. Y.] Univ Malaya, Dept Anesthesiol, Kuala Lumpur, Malaysia; [Berwanger, O.] Hosp Coracao, Res Inst HCor, Sao Paulo, Brazil; [Pasin, L.] Ist Sci San Raffaele, I-20132 Milan, Italy; [Baigent, C.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Baigent, C.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Chow, C.] George Inst Global Hlth, Sydney, NSW, Australia; [Chow, C.] Univ Sydney, Sydney, NSW 2006, Australia	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; London Health Sciences Centre; Queens University - Canada; Queens University - Canada; Western University (University of Western Ontario); University of Manitoba; University of Alberta; Cleveland Clinic Foundation; Royal Melbourne Hospital; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Fundacion Cardioinfantil - Instituto de Cardiologia; St. John's National Academy of Health Sciences; University of Kwazulu Natal; University of Copenhagen; Herlev & Gentofte Hospital; Instituto Cardiovascular de Buenos Aires (ICBA); University of Basel; Chinese University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universidad Peruana Cayetano Heredia; Medical University of Vienna; Universiti Malaya; Hospital do Coracao - HCor; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oxford; University of Oxford; George Institute for Global Health; University of Sydney; University of Sydney	Devereaux, PJ (corresponding author), Hamilton Gen Hosp, David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, Perioperat Med & Surg Res Unit, Rm C1-116,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	philipj@mcmaster.ca	Devereaux, PJ/AAY-1757-2021; Garg, Amit X/G-3295-2011; Giovanni, Landoni/AAH-1881-2019; Chan, Matthew/J-2884-2013; Meyhoff, Christian S./B-4777-2009; Ong, Gracie/B-8554-2010; Whitlock, Richard/AAQ-1593-2021; Álvarez-García, Jesús/N-9426-2016; GIN, Tony/J-2521-2013; Eikelboom, John/AAG-6117-2019; Wittmann, Maria/I-2125-2018; Villar Centeno, Juan Carlos/AAX-5401-2021; Mrkobrada, Marko/G-3336-2011; Amir, Mohammed/AAI-8792-2020; Gluud, Christian/AAY-1027-2021; Rodseth, Reitze/B-2471-2010; Le Manach, Yannick/AAE-5700-2019; Forget, Patrice/AAO-6918-2020; Sigamani, Alben/GQH-0406-2022; de Nadal, Miriam/J-8127-2017; Wijeysundera, Duminda/L-3350-2018; Wang, Chew Yin/F-7573-2010; Pasin, Laura/AAA-8188-2020; Buse, Giovanna Lurati/ABE-6008-2020; Painter, Thomas/K-6311-2017; Wetterslev, Jørn/ABF-1251-2020; Painter, Thomas/K-3899-2019; Salmasi, Vafi/O-9908-2019; Sessler, Daniel/D-3504-2011; Wittmann, Maria/AAN-5276-2021; WANG, CHEW YIN/B-7534-2010; Devereaux, PJ/AAF-2862-2019; Vizcaychipi, Marcela/H-5487-2011	Giovanni, Landoni/0000-0002-8594-5980; Chan, Matthew/0000-0002-3574-7855; Meyhoff, Christian S./0000-0002-4885-4609; Whitlock, Richard/0000-0002-6863-5884; Álvarez-García, Jesús/0000-0002-2015-6446; GIN, Tony/0000-0001-7283-6761; Eikelboom, John/0000-0003-4126-1285; Wittmann, Maria/0000-0003-4786-7712; Gluud, Christian/0000-0002-8861-0799; Rodseth, Reitze/0000-0002-3779-7805; Le Manach, Yannick/0000-0003-0474-8545; Forget, Patrice/0000-0001-5772-8439; de Nadal, Miriam/0000-0002-4559-2463; Wijeysundera, Duminda/0000-0002-5897-8605; Buse, Giovanna Lurati/0000-0002-8076-5737; Painter, Thomas/0000-0003-2216-2046; Wetterslev, Jørn/0000-0001-7778-1771; Painter, Thomas/0000-0003-2216-2046; Sessler, Daniel/0000-0001-9932-3077; Wittmann, Maria/0000-0003-4786-7712; Devereaux, PJ/0000-0003-2935-637X; Malaga, German/0000-0002-7828-300X; piriou, vincent/0000-0001-6900-1480; Vested, Matias/0000-0002-5165-2725; Amir, Mohammed/0000-0003-4726-5674; SIGAMANI, ALBEN/0000-0002-6927-1947; Alonso-Coello, Pablo/0000-0002-8001-8504; Yusuf, Salim/0000-0003-4776-5601; Botto, Fernando/0000-0002-0572-8493; Tena, Beatriz/0000-0001-9325-0858; Myles, Paul/0000-0002-3324-5456; Bergese, Sergio/0000-0001-5641-5908; Pasin, Laura/0000-0001-5757-4791; Popova, Ekaterine/0000-0002-8781-9873; Seeberger, Manfred/0000-0002-2358-7233; Kurz, Andrea/0000-0001-5887-3099; Salmasi, Vafi/0000-0002-1288-4531; Torres, David/0000-0003-2908-6365; Vizcaychipi, Marcela/0000-0001-7894-873X; Leslie, Kate/0000-0001-8512-3517; Caballero-Alvarado, Jose/0000-0001-8297-6901; Villar, Juan Carlos/0000-0002-7047-7299	Canadian Institutes of Health Research; National Health and Medical Research Council of Australia; Spanish Ministry of Health and Social Policy; Boehringer Ingelheim	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Health and Social Policy(Spanish Government); Boehringer Ingelheim(Boehringer Ingelheim)	Supported by grants from the Canadian Institutes of Health Research, the National Health and Medical Research Council of Australia, and the Spanish Ministry of Health and Social Policy. Bayer Pharma provided the aspirin used in the study, and Boehringer Ingelheim provided the clonidine and some funding.	Albaladejo P, 2011, HEART, V97, P1566, DOI 10.1136/hrt.2011.224519; Anderson DR, 2013, ANN INTERN MED, V158, P800, DOI 10.7326/0003-4819-158-11-201306040-00004; [Anonymous], 2010, EVIDENCE BASED CARDI; [Anonymous], 2000, LANCET, V355, P1295; Antiplatelet trialists' collaboration, 1994, BMJ, V308, P235; Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P141; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; BRADLOW BA, 1982, THROMB RES, V27, P99, DOI 10.1016/0049-3848(82)90283-3; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; CERSKUS AL, 1980, THROMB RES, V18, P389, DOI 10.1016/0049-3848(80)90334-5; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1504, DOI 10.1056/NEJMoa1401106; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Devereaux PJ, 2014, AM HEART J; Gerstein NS, 2012, ANN SURG, V255, P811, DOI 10.1097/SLA.0b013e318250504e; Gualandro DM, 2012, ATHEROSCLEROSIS, V222, P191, DOI 10.1016/j.atherosclerosis.2012.02.021; Hiralal R, 2010, CLIN INVEST MED, V33, pE375; Kamel H, 2012, CIRCULATION, V126, P207, DOI 10.1161/CIRCULATIONAHA.112.094326; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; NAESH O, 1985, THROMB HAEMOSTASIS, V54, P849; Neilipovitz DT, 2001, ANESTH ANALG, V93, P573, DOI 10.1097/00000539-200109000-00009; OBRIEN JR, 1968, LANCET, V1, P779; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; REILLY IAG, 1987, BLOOD, V69, P180; Robless P, 2001, BRIT J SURG, V88, P787, DOI 10.1046/j.0007-1323.2001.01774.x; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; The CURRENT-OASIS 7 Investigators, 2010, N ENGL J MED, V363, P1585; The CURRENT-OASIS 7 Investigators, 2010, N ENGL J MED, V363, P930; 2002, BMJ, V324, P71	33	510	529	2	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1494	1503		10.1056/NEJMoa1401105	http://dx.doi.org/10.1056/NEJMoa1401105			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24679062				2022-12-28	WOS:000334601600006
J	Birsoy, K; Possemato, R; Lorbeer, FK; Bayraktar, EC; Thiru, P; Yucel, B; Wang, T; Chen, WW; Clish, CB; Sabatini, DM				Birsoy, Kivanc; Possemato, Richard; Lorbeer, Franziska K.; Bayraktar, Erol C.; Thiru, Prathapan; Yucel, Burcu; Wang, Tim; Chen, Walter W.; Clish, Clary B.; Sabatini, David M.			Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides	NATURE			English	Article							OXIDATIVE-PHOSPHORYLATION; COMPLEX I; RESPIRATORY-CHAIN; PANCREATIC-CANCER; DIABETIC-PATIENTS; BREAST-CANCER; METFORMIN; MUTATIONS; DEFICIENCY; TUMORS	As the concentrations of highly consumed nutrients, particularly glucose, are generally lower in tumours than in normal tissues(1,2), cancer cells must adapt their metabolism to the tumour microenvironment. Abetter understanding of these adaptations might reveal cancer cell liabilities that can be exploited for therapeutic benefit. Here we developed a continuous-flow culture apparatus (Nutrostat) for maintaining proliferating cells in low-nutrient media for long periods of time, and used it to undertake competitive proliferation assays on a pooled collection of barcoded cancer cell lines cultured in low-glucose conditions. Sensitivity to low glucose varies amongst cell lines, and an RNA interference (RNAi) screen pinpointed mitochondrial oxidative phosphorylation (OXPHOS) as the major pathway required for optimal proliferation in low glucose. We found that cell lines most sensitive to low glucose are defective in the OXPHOS upregulation that is normally caused by glucose limitation as a result of either mitochondrial DNA (mtDNA) mutations in complex I genes or impaired glucose utilization. These defects predict sensitivity to biguanides, antidiabetic drugs that inhibit OXPHOS3,4, when cancer cells are grown in low glucose or as tumour xenografts. Notably, the biguanide sensitivity of cancer cells with mtDNA mutations was reversed by ectopic expression of yeast NDI1, a ubiquinone oxidoreductase that allows bypass of complex I function(5). Thus, we conclude that mtDNA mutations and impaired glucose utilization are potential biomarkers for identifying tumours with increased sensitivity to OXPHOS inhibitors.	[Birsoy, Kivanc; Possemato, Richard; Lorbeer, Franziska K.; Bayraktar, Erol C.; Thiru, Prathapan; Yucel, Burcu; Wang, Tim; Chen, Walter W.; Clish, Clary B.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Clish, Clary B.; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	BAYRAKTAR, EROL CAN/AAD-4986-2019; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Possemato, Richard/0000-0002-2401-0030; Wang, Timothy/0000-0001-5730-3019; BAYRAKTAR, EROL/0000-0002-2950-0215; Chen, Walter/0000-0002-7752-9581; Lorbeer, Franziska/0000-0002-3152-6852; /0000-0002-1446-7256	Leukemia and Lymphoma Society; Jane Coffin Childs Fund; Council of Higher Education Turkey; Karadeniz T. University Scholarships; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH [K99 CA168940, CA103866, CA129105, AI07389]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [K99CA168940, R01CA103866, R01CA129105, R00CA168940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Jane Coffin Childs Fund; Council of Higher Education Turkey(Ministry of National Education - Turkey); Karadeniz T. University Scholarships; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Stephanopoulos for assistance with Nutrostat design, M. Holland for mtDNA sequencing consultation, L. Garraway for assistance identifying mtDNA mutant cell lines, T. Yagi for the NDI1 antibody, T. DiCesare for diagrams, and members of the Sabatini Laboratory for assistance (particularly A. Saucedo, C. Koch, O. Yilmaz, Y. Gultekin and A. Hutchins for technical assistance, and D. Lamming and W. Comb for critical reading of the manuscript). This research is supported by fellowships from The Leukemia and Lymphoma Society and The Jane Coffin Childs Fund to K. B., the Council of Higher Education Turkey and Karadeniz T. University Scholarships to B. Y. and grants from the David H. Koch Institute for Integrative Cancer Research at MIT, The Alexander and Margaret Stewart Trust Fund, the NIH (K99 CA168940 to R. P. and CA103866, CA129105, and AI07389 to D. M. S.) and the Starr Cancer Consortium. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; GULLINO PM, 1967, CANCER RES, V27, P1031; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Javeshghani S, 2012, CANCER RES, V72, P6257, DOI 10.1158/0008-5472.CAN-12-2907; Jones JB, 2001, CANCER RES, V61, P1299; Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pollak M, 2012, CLIN CANCER RES, V18, P2723, DOI 10.1158/1078-0432.CCR-12-0694; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Urasaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036775	27	474	490	4	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					108	+		10.1038/nature13110	http://dx.doi.org/10.1038/nature13110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670634	Green Accepted, Green Submitted			2022-12-28	WOS:000333609900052
J	Revello, MG; Lazzarotto, T; Guerra, B; Spinillo, A; Ferrazzi, E; Kustermann, A; Guaschino, S; Vergani, P; Todros, T; Frusca, T; Arossa, A; Furione, M; Rognoni, V; Rizzo, N; Gabrielli, L; Klersy, C; Gerna, G; Zavattoni, M; Lilleri, D; Stronati, M; Cervi, F; Contoli, M; Murano, P; Puccetti, C; Simonazzi, G; Piccirilli, G; Chiereghin, A; Petrisli, E; Lanari, M; Capretti, MG; Tassis, B; Mosca, F; Pugni, L; Quarenghi, A; Ornaghi, S; Tibaldi, C; Masuelli, G; Scata, M; Mombro, M; Tomasoni, L; De Seta, F; De Santo, D; D'Ottavio, G; Demarini, S; Dal Molin, G; Merati, R; Cristina, E; Strobelt, N				Revello, Maria Grazia; Lazzarotto, Tiziana; Guerra, Brunella; Spinillo, Arsenio; Ferrazzi, Enrico; Kustermann, Alessandra; Guaschino, Secondo; Vergani, Patrizia; Todros, Tullia; Frusca, Tiziana; Arossa, Alessia; Furione, Milena; Rognoni, Vanina; Rizzo, Nicola; Gabrielli, Liliana; Klersy, Catherine; Gerna, Giuseppe; Zavattoni, M.; Lilleri, D.; Stronati, M.; Cervi, F.; Contoli, M.; Murano, P.; Puccetti, C.; Simonazzi, G.; Piccirilli, G.; Chiereghin, A.; Petrisli, E.; Lanari, M.; Capretti, M. G.; Tassis, B.; Mosca, F.; Pugni, L.; Quarenghi, A.; Ornaghi, S.; Tibaldi, C.; Masuelli, G.; Scata, M.; Mombro, M.; Tomasoni, L.; De Seta, F.; De Santo, D.; D'Ottavio, G.; Demarini, S.; Dal Molin, G.; Merati, R.; Cristina, E.; Strobelt, N.		CHIP Study Grp	A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL/EPITHELIAL CELLS; MONOCLONAL-ANTIBODIES; PRENATAL-DIAGNOSIS; PREGNANT-WOMEN; HCMV INFECTION; QUANTIFICATION; THERAPY; COMPLEX; MOTHER	Background Congenital infection with human cytomegalovirus (CMV) is a major cause of morbidity and mortality. In an uncontrolled study published in 2005, administration of CMV-specific hyperimmune globulin to pregnant women with primary CMV infection significantly reduced the rate of intrauterine transmission, from 40% to 16%. Methods We evaluated the efficacy of hyperimmune globulin in a phase 2, randomized, placebo-controlled, double-blind study. A total of 124 pregnant women with primary CMV infection at 5 to 26 weeks of gestation were randomly assigned within 6 weeks after the presumed onset of infection to receive hyperimmune globulin or placebo every 4 weeks until 36 weeks of gestation or until detection of CMV in amniotic fluid. The primary end point was congenital infection diagnosed at birth or by means of amniocentesis. Results A total of 123 women could be evaluated in the efficacy analysis (1 woman in the placebo group withdrew). The rate of congenital infection was 30% (18 fetuses or infants of 61 women) in the hyperimmune globulin group and 44% (27 fetuses or infants of 62 women) in the placebo group (a difference of 14 percentage points; 95% confidence interval, -3 to 31; P=0.13). There was no significant difference between the two groups or, within each group, between the women who transmitted the virus and those who did not, with respect to levels of virus-specific antibodies, T-cell-mediated immune response, or viral DNA in the blood. The clinical outcome of congenital infection at birth was similar in the two groups. The number of obstetrical adverse events was higher in the hyperimmune globulin group than in the placebo group (13% vs. 2%). Conclusions In this study involving 123 women who could be evaluated, treatment with hyperimmune globulin did not significantly modify the course of primary CMV infection during pregnancy. (Funded by Agenzia Italiana del Farmaco; CHIP ClinicalTrials.gov number, NCT00881517; EudraCT no. 2008-006560-11.)	[Zavattoni, M.; Lilleri, D.; Stronati, M.] Fdn IRCCS Policlin San Matteo, Ple Golgi 19, I-27100 Pavia, Italy; [Revello, Maria Grazia; Spinillo, Arsenio; Arossa, Alessia] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Dept Obstet & Gynecol, Pavia, Italy; [Furione, Milena] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Virol Unit, Pavia, Italy; [Klersy, Catherine] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Dept Stat & Biometr, Pavia, Italy; [Gerna, Giuseppe] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Expt Res Labs, Pavia, Italy; [Rognoni, Vanina] Univ Pavia, Clin Microbiol Unit, I-27100 Pavia, Italy; [Lazzarotto, Tiziana] Univ Bologna, St Orsola Malpighi Gen Hosp, Dept Specialized Expt & Diagnost Med, Operat Unit Microbiol, Bologna, Italy; [Guerra, Brunella; Rizzo, Nicola] Univ Bologna, St Orsola Malpighi Gen Hosp, Dept Med Surg Sci, Operat Unit Obstet & Prenatal Med, Bologna, Italy; [Gabrielli, Liliana] Univ Bologna, St Orsola Malpighi Gen Hosp, Operat Unit Microbiol, Bologna, Italy; [Ferrazzi, Enrico] Univ Milan, Buzzi Childrens Hosp, Dept Woman Mother & Neonate, Milan, Italy; [Kustermann, Alessandra] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Emergency Dept Obstet & Gynecol, Milan, Italy; [Guaschino, Secondo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Vergani, Patrizia] Univ Milano Bicocca, San Gerardo Hosp, Dept Interdisciplinary Surg & Med Sci, Monza, Italy; [Todros, Tullia] Univ Turin, Dept Surg Sci, Turin, Italy; [Frusca, Tiziana] Univ Brescia, Dept Obstet, Brescia, Italy; [Frusca, Tiziana] Univ Brescia, Dept Gynecol, Brescia, Italy; [Cervi, F.; Contoli, M.; Murano, P.; Puccetti, C.; Simonazzi, G.; Piccirilli, G.; Chiereghin, A.; Petrisli, E.; Lanari, M.; Capretti, M. G.] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Tassis, B.; Mosca, F.; Pugni, L.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Quarenghi, A.] Osped Buzzi, Milan, Italy; [Ornaghi, S.] Univ Milano Bicocca, Osped San Gerardo, Monza, Italy; [Tibaldi, C.; Masuelli, G.; Scata, M.; Mombro, M.] Univ Torino, Citta Salute & Sci, Turin, Italy; [Tomasoni, L.] Spedali Civil Brescia, Brescia, Italy; [De Seta, F.; De Santo, D.; D'Ottavio, G.; Demarini, S.; Dal Molin, G.] IRCCS Burlo Garofolo, Trieste, Italy; [Merati, R.] Azienda Osped Niguarda, Milan, Italy; [Cristina, E.] IRCCS Giannina Gaslini, Genoa, Italy; [Strobelt, N.] Osped Papa Giovanni XXXIII, Bergamo, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Trieste; San Gerardo Hospital; University of Milano-Bicocca; University of Turin; University of Brescia; University of Brescia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico; San Gerardo Hospital; University of Milano-Bicocca; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Hospital Spedali Civili Brescia; IRCCS Burlo Garofolo; Ospedale Niguarda Ca' Granda; University of Genoa; IRCCS Istituto Giannina Gaslini	Revello, MG (corresponding author), Fdn IRCCS Policlin San Matteo, Ple Golgi 19, I-27100 Pavia, Italy.	mg.revello@smatteo.pv.it	De Seta, Francesco/AAC-1857-2022; Ornaghi, Sara/K-4261-2018; klersy, catherine/AAA-3003-2019; CAPRETTI, MARIA GRAZIA/K-4152-2016; Furione, Milena/AAC-1945-2022; Tassis, Beatrice/AAC-5129-2022; Lilleri, Daniele/K-7776-2016; Chiereghin, Angela/K-5443-2018; Ferrazzi, Enrico Mario/AAB-9416-2019; Kustermann, Alessandra/J-2865-2015; PICCIRILLI, GIULIA/K-3963-2016; Mosca, Fabio/C-5826-2017; Spinillo, Arsenio/AAB-9315-2022; Lanari, Marcello/AAE-8932-2020	De Seta, Francesco/0000-0003-1611-0813; Ornaghi, Sara/0000-0001-6898-7217; klersy, catherine/0000-0003-0314-8548; CAPRETTI, MARIA GRAZIA/0000-0002-0124-0829; Tassis, Beatrice/0000-0001-8663-9611; Lilleri, Daniele/0000-0001-7747-7622; Ferrazzi, Enrico Mario/0000-0001-5243-0537; Kustermann, Alessandra/0000-0002-1445-6717; PICCIRILLI, GIULIA/0000-0002-2596-2367; Mosca, Fabio/0000-0001-6477-0299; Spinillo, Arsenio/0000-0002-7755-1084; Stronati, Mauro/0000-0002-8367-3264; Zavattoni, Maurizio/0000-0002-5199-0038; Milena, Furione/0000-0001-7328-1454; VERGANI, PATRIZIA/0000-0001-5028-0045; Todros, Tullia/0000-0003-3016-1510; Gerna, Giuseppe/0000-0001-5956-2786; Gabrielli, Liliana/0000-0002-5994-4749; Chiereghin, Angela/0000-0002-7509-297X	Agenzia Italiana del Farmaco [FARM7J4HCH]	Agenzia Italiana del Farmaco	Supported by a grant (FARM7J4HCH) from Agenzia Italiana del Farmaco.	Adler SP, 2009, J CLIN VIROL, V46, pS54, DOI 10.1016/j.jcv.2009.08.017; Buxmann H, 2012, J PERINAT MED, V40, P439, DOI 10.1515/jpm-2011-0257; Cahill AG, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.056; Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70; Clinicaltrials.gov, EFF STUD HUM CYT HCM; de Vries JJC, 2011, REV MED VIROL, V21, P54, DOI 10.1002/rmv.679; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Eggers M, 2000, J MED VIROL, V60, P324, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;324::AID-JMV11&gt;3.0.CO;2-D; Enders G, 2001, PRENATAL DIAG, V21, P362, DOI 10.1002/pd.59; Fouts AE, 2012, J VIROL, V86, P7444, DOI 10.1128/JVI.00467-12; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x; GERNA G, 1990, J CLIN MICROBIOL, V28, P2681, DOI 10.1128/JCM.28.12.2681-2688.1990; GERNA G, 1992, J CLIN MICROBIOL, V30, P1232, DOI 10.1128/JCM.30.5.1232-1237.1992; Gerna G, 2008, J GEN VIROL, V89, P853, DOI 10.1099/vir.0.83523-0; Gindes L, 2008, BJOG-INT J OBSTET GY, V115, P830, DOI 10.1111/j.1471-0528.2007.01651.x; Guerra B, 2007, AM J OBSTET GYNECOL, V196, P221, DOI 10.1016/j.ajog.2006.08.039; Liberati A, 2010, EUR J CLIN INVEST, V40, P69, DOI 10.1111/j.1365-2362.2009.02226.x; Lilleri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059863; Lilleri D, 2012, J CLIN IMMUNOL, V32, P1324, DOI 10.1007/s10875-012-9739-3; Lozza L, 2005, EUR J IMMUNOL, V35, P1795, DOI 10.1002/eji.200526023; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Nigro G, 2003, BJOG-INT J OBSTET GY, V110, P572, DOI 10.1046/j.1471-0528.2003.01302.x; Nigro G, 2012, J INFECT DIS, V205, P215, DOI 10.1093/infdis/jir718; Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118; Pierce LR, 2003, TRANSFUS MED REV, V17, P241, DOI 10.1016/S0887-7963(03)00038-5; Polilli E, 2012, CLIN VACCINE IMMUNOL, V19, P1991, DOI 10.1128/CVI.00509-12; Revello MG, 2010, REV MED VIROL, V20, P136, DOI 10.1002/rmv.645; Revello MG, 2008, J INFECT DIS, V197, P593, DOI 10.1086/526499; Revello MG, 2011, J CLIN VIROL, V50, P303, DOI 10.1016/j.jcv.2010.12.012; Revello MG, 1998, J INFECT DIS, V177, P1170, DOI 10.1086/515277; Revello MG, 2006, J INFECT DIS, V193, P269, DOI 10.1086/498872; Revello MG, 2004, J CLIN VIROL, V29, P71, DOI 10.1016/j.jcv.2003.09.012; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Visentin S, 2012, CLIN INFECT DIS, V55, P497, DOI 10.1093/cid/cis423; Yamada H, 2012, J REPROD IMMUNOL, V95, P73, DOI 10.1016/j.jri.2012.05.002	37	274	284	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1316	1326		10.1056/NEJMoa1310214	http://dx.doi.org/10.1056/NEJMoa1310214			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693891	Green Published			2022-12-28	WOS:000333830000010
J	Ubel, PA; Jagsi, R				Ubel, Peter A.; Jagsi, Reshma			Promoting Population Health through Financial Stewardship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Health care costs are straining budgets throughout the developed world, threatening the fiscal solvency of governments, employers, and individuals. Many countries are trying to restrain health care spending through top-down approaches, such as price regulation and even refusal to reimburse for interventions that are not cost-effective. Still controversial is the role that physicians should play in controlling health care costs. For instance, the Choosing Wisely campaign of the American Board of Internal Medicine Foundation encourages physicians to avoid interventions that "may be unnecessary, and in some instances can cause harm," but it does not ask physicians to contemplate trading off . . . Financial stewardship of health care resources promotes population health by increasing access to affordable care, reducing pressure on health care institutions to cut back on important services, and freeing up resources for other activities that improve health.	[Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Ubel, Peter A.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Ubel, Peter A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Jagsi, Reshma] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA	Duke University; Duke University; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ubel, PA (corresponding author), Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA.			Jagsi, Reshma/0000-0001-6562-1228				Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Muennig P, 2011, AM J PUBLIC HEALTH, V101, P512, DOI 10.2105/AJPH.2010.200063; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025	5	24	23	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1280	1281		10.1056/NEJMp1401335	http://dx.doi.org/10.1056/NEJMp1401335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE2VA	24693887				2022-12-28	WOS:000333830000004
J	Rohde, JM; Dimcheff, DE; Blumberg, N; Saint, S; Langa, KM; Kuhn, L; Hickner, A; Rogers, MAM				Rohde, Jeffrey M.; Dimcheff, Derek E.; Blumberg, Neil; Saint, Sanjay; Langa, Kenneth M.; Kuhn, Latoya; Hickner, Andrew; Rogers, Mary A. M.			Health Care-Associated Infection After Red Blood Cell Transfusion A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RESTRICTIVE TRANSFUSION; CARDIAC-SURGERY; CONTROLLED-TRIAL; STRATEGIES; RISK; REQUIREMENTS; MULTICENTER; THRESHOLDS	IMPORTANCE The association between red blood cell (RBC) transfusion strategies and health care-associated infection is not fully understood. OBJECTIVE To evaluate whether RBC transfusion thresholds are associated with the risk of infection and whether risk is independent of leukocyte reduction. DATA SOURCES MEDLINE, EMBASE, Web of Science Core Collection, Cochrane Central Register of Controlled Trials, Cochrane Database of Sytematic Reviews, ClinicalTrials.gov, International Clinical Trials Registry, and the International Standard Randomized Controlled Trial Number register were searched through January 22, 2014. STUDY SELECTION Randomized clinical trials with restrictive vs liberal RBC transfusion strategies. DATA EXTRACTION AND SYNTHESIS Twenty-one randomized trials with 8735 patients met eligibility criteria, of which 18 trials (n = 7593 patients) contained sufficient information for meta-analyses. DerSimonian and Laird random-effects models were used to report pooled risk ratios. Absolute risks of infection were calculated using the profile likelihood random-effects method. MAIN OUTCOMES AND MEASURES Incidence of health care-associated infection such as pneumonia, mediastinitis, wound infection, and sepsis. RESULTS The pooled risk of all serious infections was 11.8% (95% CI, 7.0%-16.7%) in the restrictive group and 16.9% (95% CI, 8.9%-25.4%) in the liberal group. The risk ratio (RR) for the association between transfusion strategies and serious infection was 0.82 (95% CI, 0.72-0.95) with little heterogeneity (I-2 = 0%; t(2) <. 0001). The number needed to treat (NNT) with restrictive strategies to prevent serious infection was 38 (95% CI, 24-122). The risk of infection remained reduced with a restrictive strategy, even with leukocyte reduction (RR, 0.80 [95% CI, 0.67-0.95]). For trials with a restrictive hemoglobin threshold of < 7.0 g/dL, the RR was 0.82 (95% CI, 0.70-0.97) with NNT of 20 (95% CI, 12-133). With stratification by patient type, the RR was 0.70 (95% CI, 0.54-0.91) in patients undergoing orthopedic surgery and 0.51 (95% CI, 0.28-0.95) in patients presenting with sepsis. There were no significant differences in the incidence of infection by RBC threshold for patients with cardiac disease, the critically ill, those with acute upper gastrointestinal bleeding, or for infants with low birth weight. CONCLUSIONS AND RELEVANCE Among hospitalized patients, a restrictive RBC transfusion strategy was associated with a reduced risk of health care-associated infection compared with a liberal transfusion strategy. Implementing restrictive strategies may have the potential to lower the incidence of health care-associated infection.	[Rohde, Jeffrey M.; Dimcheff, Derek E.; Saint, Sanjay; Langa, Kenneth M.; Hickner, Andrew; Rogers, Mary A. M.] Univ Michigan, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Blumberg, Neil] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Saint, Sanjay; Langa, Kenneth M.; Kuhn, Latoya; Hickner, Andrew; Rogers, Mary A. M.] Univ Michigan, Patient Safety Enhancement Program, VA Ann Arbor Med Ctr, Ann Arbor, MI 48109 USA; [Saint, Sanjay; Langa, Kenneth M.; Kuhn, Latoya] VA Ann Arbor Hlth Serv, Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Saint, Sanjay; Langa, Kenneth M.; Rogers, Mary A. M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Rochester; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Rogers, MAM (corresponding author), Univ Michigan, Patient Safety Enhancement Program, Dept Internal Med, 016-422W NCRC, Ann Arbor, MI 48109 USA.	maryroge@umich.edu	Girelli, Domenico/B-1183-2008; Saint, Sanjay/AAF-5126-2019; Callahan, Charles D/L-1641-2013	Girelli, Domenico/0000-0001-9684-1899; Langa, Kenneth/0000-0002-2798-1836; Rogers, Mary/0000-0001-5519-3223; Hickner, Andy/0000-0003-1922-3813	National Heart, Lung, and Blood Institute [5R21HL093129-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093129] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grant 5R21HL093129-02 from National Heart, Lung, and Blood Institute.	Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; Buddeberg F, 2008, BEST PRACT RES-CLIN, V22, P503, DOI 10.1016/j.bpa.2008.05.003; Carson Jeffrey L, 2012, Cochrane Database Syst Rev, pCD002042, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1998, TRANSFUSION, V38, P522, DOI 10.1046/j.1537-2995.1998.38698326331.x; Centers for Disease Control and Prevention, CDC NHSN SURVEILLANC; Cholette JM, 2011, PEDIATR CRIT CARE ME, V12, P39, DOI 10.1097/PCC.0b013e3181e329db; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; de Gast-Bakker DH, 2013, INTENS CARE MED, V39, P2011, DOI 10.1007/s00134-013-3085-7; Department of Health and Human Services, NATIONAL ACTION PLAN; Fergusson D, 2004, CAN J ANAESTH, V51, P417, DOI 10.1007/BF03018302; Foss NB, 2009, TRANSFUSION, V49, P227, DOI 10.1111/j.1537-2995.2008.01967.x; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Gregersen M, 2012, EUR GERIATR MED SUPP, V3, pS74, DOI [10.1016/j.eurger.2012.07.139, DOI 10.1016/J.EURGER.2012.07.139]; Grover M, 2006, VOX SANG, V90, P105, DOI 10.1111/j.1423-0410.2006.00730.x; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Horvath KA, 2013, ANN THORAC SURG, V95, P2194, DOI 10.1016/j.athoracsur.2012.11.078; Howard J, 2013, LANCET, V381, P930, DOI 10.1016/S0140-6736(12)61726-7; Karam O, 2011, PEDIATR CRIT CARE ME, V12, P512, DOI 10.1097/PCC.0b013e3181fe344b; Kirpalani H, 2006, J PEDIATR-US, V149, P301, DOI 10.1016/j.jpeds.2006.05.011; Kuhnert R, 2007, STAT MED, V26, P2277, DOI 10.1002/sim.2710; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Lannan KL, 2013, BLOOD CELL MOL DIS, V50, P61, DOI 10.1016/j.bcmd.2012.08.009; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Prick BW, 2014, BJOG-INT J OBSTET GY, V121, P1005, DOI 10.1111/1471-0528.12531; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rogers MAM, 2006, AM HEART J, V152, P1028, DOI 10.1016/j.ahj.2006.07.009; Rogers MAM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-37; Saint S, 2013, JAMA INTERN MED, V173, P874, DOI 10.1001/jamainternmed.2013.101; Scott RD, THE DIRECT MEDICAL C; Shehata N, 2012, TRANSFUSION, V52, P91, DOI 10.1111/j.1537-2995.2011.03236.x; So-Osman C, 2010, VOX SANG, V98, P56, DOI 10.1111/j.1423-0410.2009.01225.x; So-Osman C, 2013, BLOOD TRANSFUS-ITALY, V11, P289, DOI 10.2450/2013.0172-12; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Whitaker BI, THE 2011 NATIONAL BL	42	402	422	3	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1317	1326		10.1001/jama.2014.2726	http://dx.doi.org/10.1001/jama.2014.2726			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691607	Green Accepted			2022-12-28	WOS:000333645400015
J	Kleinjan, A; Di Nisio, M; Beyer-Westendorf, J; Camporese, G; Cosmi, B; Ghirarduzzi, A; Kamphuisen, PW; Otten, HM; Porreca, E; Aggarwal, A; Brodmann, M; Guglielmi, MD; Iotti, M; Kaasjager, K; Kamvissi, V; Lerede, T; Marschang, P; Meijer, K; Palareti, G; Rickles, FR; Righini, M; Rutjes, AWS; Tonello, C; Verhamme, P; Werth, S; van Wissen, S; Buller, HR				Kleinjan, Ankie; Di Nisio, Marcello; Beyer-Westendorf, Jan; Camporese, Giuseppe; Cosmi, Benilde; Ghirarduzzi, Angelo; Kamphuisen, Pieter W.; Otten, Hans-Martin; Porreca, Ettore; Aggarwal, Anita; Brodmann, Marianne; Guglielmi, Maria Domenica; Iotti, Matteo; Kaasjager, Karin; Kamvissi, Virginia; Lerede, Teresa; Marschang, Peter; Meijer, Karina; Palareti, Gualtiero; Rickles, Frederick R.; Righini, Marc; Rutjes, Anne W. S.; Tonello, Chiara; Verhamme, Peter; Werth, Sebastian; van Wissen, Sanne; Bueller, Harry R.			Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, D-Dimer Testing, and Ultrasonography for Suspected Upper Extremity Deep Venous Thrombosis A Prospective Management Study	ANNALS OF INTERNAL MEDICINE			English	Article							VEIN THROMBOSIS; PULMONARY-EMBOLISM; THROMBOEMBOLISM; PERSPECTIVE; STRATEGIES; ACCURACY; SCORE; DVT	Background: Although well-established for suspected lower limb deep venous thrombosis, an algorithm combining a clinical decision score, D-dimer testing, and ultrasonography has not been evaluated for suspected upper extremity deep venous thrombosis (UEDVT). Objective: To assess the safety and feasibility of a new diagnostic algorithm in patients with clinically suspected UEDVT. Design: Diagnostic management study. (ClinicalTrials.gov: NCT01324037) Setting: 16 hospitals in Europe and the United States. Patients: 406 inpatients and outpatients with suspected UEDVT. Measurements: The algorithm consisted of the sequential application of a clinical decision score, D-dimer testing, and ultrasonography. Patients were first categorized as likely or unlikely to have UEDVT; in those with an unlikely score and normal D-dimer levels, UEDVT was excluded. All other patients had (repeated) compression ultrasonography. The primary outcome was the 3-month incidence of symptomatic UEDVT and pulmonary embolism in patients with a normal diagnostic work-up. Results: The algorithm was feasible and completed in 390 of the 406 patients (96%). In 87 patients (21%), an unlikely score combined with normal D-dimer levels excluded UEDVT. Superficial venous thrombosis and UEDVT were diagnosed in 54 (13%) and 103 (25%) patients, respectively. All 249 patients with a normal diagnostic work-up, including those with protocol violations (n = 16), were followed for 3 months. One patient developed UEDVT during follow-up, for an overall failure rate of 0.4% (95% CI, 0.0% to 2.2%). Limitations: This study was not powered to show the safety of the substrategies. D-Dimer testing was done locally. Conclusion: The combination of a clinical decision score, D-dimer testing, and ultrasonography can safely and effectively exclude UEDVT. If confirmed by other studies, this algorithm has potential as a standard approach to suspected UEDVT.	Slotervaart Hosp, Acad Med Ctr, Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; Gabriele dAnnunzio Univ, Chieti, Italy; Gabriele dAnnunzio Univ Fdn, Ctr Excellence Aging, Chieti, Italy; Dresden Univ Hosp Carl Gustav Carus, Ctr Vasc Dis, Dresden, Germany; Dresden Univ Hosp Carl Gustav Carus, Med Clin 3, Dresden, Germany; Univ Hosp Padova, Padua, Italy; Univ Hosp Bologna, Bologna, Italy; Azienda Arcispedale Santa Maria Nova, Inst Ricovero & Cura Carattere Sci, Reggio Emilia, Italy; Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; Vet Affairs Med Ctr, Washington, DC 20422 USA; Med Univ, Abt Angiol, Graz, Austria; Univ Med Utrecht, Utrecht, Netherlands; Hosp Papa Giovanni XXIII, Bergamo, Italy; Med Univ Innsbruck, A-6020 Innsbruck, Austria; Univ Hosp Geneva, Geneva, Switzerland; Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; Katholieke Univ Leuven Hosp, Ctr Mol & Vasc Biol, Louvain, Belgium	Slotervaart Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Padua; Azienda Ospedaliera - Universita di Padova; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Arcispedale S. Maria Nuova; University of Groningen; US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical University of Graz; Utrecht University; ASST Papa Giovanni XXIII; Medical University of Innsbruck; University of Geneva; University of Bern; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Kleinjan, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, F4,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	ankiekleinjan@gmail.com	Cosmi, Benilde/K-9459-2016; Rutjes, Anne/L-8750-2017; Camporese, Giuseppe/J-8751-2016; Righini, Marc/AAX-8731-2020; Beyer-Westendorf, Jan/K-7569-2019	Cosmi, Benilde/0000-0003-0606-6038; Rutjes, Anne/0000-0001-9782-779X; Beyer-Westendorf, Jan/0000-0002-6983-9993; Meijer, Karina/0000-0001-9447-0465; Iotti, Matteo/0000-0002-7265-9109; Kamphuisen, Pieter/0000-0002-6263-0177; Marschang, Peter/0000-0002-8239-3447				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bernardi E, 2006, SEMIN THROMB HEMOST, V32, P729, DOI 10.1055/s-2006-951458; Constans J, 2008, THROMB HAEMOSTASIS, V99, P202, DOI 10.1160/TH07-08-0485; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Di Nisio M, 2010, J THROMB HAEMOST, V8, P684, DOI 10.1111/j.1538-7836.2010.03771.x; Flinterman LE, 2008, J THROMB HAEMOST, V6, P1262, DOI 10.1111/j.1538-7836.2008.03017.x; Gardner MJ, 1989, STAT CONFIDENCE, P28; Gibson NS, 2009, J THROMB HAEMOST, V7, P2035, DOI 10.1111/j.1538-7836.2009.03635.x; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Merminod T, 2006, BLOOD COAGUL FIBRIN, V17, P225, DOI 10.1097/01.mbc.0000220248.04789.79; Monreal M., 2006, Experimental Oncology, V28, P245; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Prandoni P, 2004, BMJ-BRIT MED J, V329, P484, DOI 10.1136/bmj.38167.684444.3A; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Tick LW, 2002, AM J MED, V113, P630, DOI 10.1016/S0002-9343(02)01347-5; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153	18	48	53	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					451	+		10.7326/M13-2056	http://dx.doi.org/10.7326/M13-2056			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24687068				2022-12-28	WOS:000334093800002
J	Silvente-Poirot, S; Poirot, M				Silvente-Poirot, Sandrine; Poirot, Marc			Cholesterol and Cancer, in the Balance	SCIENCE			English	Editorial Material							BREAST-CANCER; METABOLISM; TAMOXIFEN; PATHWAY; GROWTH; CELLS		[Silvente-Poirot, Sandrine] Univ Toulouse 3, INSERM, UMR 1037, Canc Res Ctr Toulouse, F-31052 Toulouse, France; Inst Claudius Regaud, F-31052 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Institut Claudius Regaud	Silvente-Poirot, S (corresponding author), Univ Toulouse 3, INSERM, UMR 1037, Canc Res Ctr Toulouse, F-31052 Toulouse, France.	sandrine.poirot@inserm.fr; marc.poirot@inserm.fr	Poirot, Sandrine/D-5448-2017; Poirot, Marc/C-7613-2009; Poirot, Marc/K-3551-2012	Poirot, Marc/0000-0002-5711-6624; Poirot, Marc/0000-0002-5711-6624; Silvente-Poirot, Sandrine/0000-0003-2245-9069				Alikhani N, 2013, ONCOGENE, V32, P961, DOI 10.1038/onc.2012.113; de Medina P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2835; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gabitova L, 2014, CLIN CANCER RES, V20, P28, DOI 10.1158/1078-0432.CCR-13-0122; Lasuncion MA, 2012, CURR OPIN PHARMACOL, V12, P717, DOI 10.1016/j.coph.2012.07.001; Liu J, 2013, ONCOTARGET, V4, P1804, DOI 10.18632/oncotarget.1364; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; McDougall JA, 2013, CANCER EPIDEM BIOMAR, V22, P1529, DOI 10.1158/1055-9965.EPI-13-0414; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Pitroda SP, 2009, P NATL ACAD SCI USA, V106, P5837, DOI 10.1073/pnas.0812029106; Poirot M, 2012, CURR OPIN PHARMACOL, V12, P683, DOI 10.1016/j.coph.2012.09.007; Segala G, 2013, BIOCHEM PHARMACOL, V86, P175, DOI 10.1016/j.bcp.2013.02.031; Silvente-Poirot S, 2012, CURR OPIN PHARMACOL, V12, P673, DOI 10.1016/j.coph.2012.10.004; Sukhanova A, 2013, CANCER DISCOV, V3, P96, DOI 10.1158/2159-8290.CD-12-0031; Wu Q, 2013, CELL REP, V5, P637, DOI 10.1016/j.celrep.2013.10.006	15	142	143	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1445	1446		10.1126/science.1252787	http://dx.doi.org/10.1126/science.1252787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675946				2022-12-28	WOS:000333471000026
J	Eisenberg, MS; Bobrow, BJ; Rea, T				Eisenberg, Mickey S.; Bobrow, Bentley J.; Rea, Tom			Fulfilling the Promise of "Anyone, Anywhere" to Perform CPR	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSISTED CARDIOPULMONARY-RESUSCITATION; HOSPITAL CARDIAC-ARREST; SURVIVAL; INSTRUCTIONS		[Eisenberg, Mickey S.; Rea, Tom] Univ Washington, Dept Med, Seattle, WA USA; [Eisenberg, Mickey S.; Rea, Tom] King Cty Emergency Med Serv, Seattle, WA USA; [Bobrow, Bentley J.] Univ Arizona, Coll Med, Dept Emergency Med, Maricopa Med Ctr, Phoenix, AZ USA; [Bobrow, Bentley J.] Arizona Dept Hlth Serv, Bur Emergency Med Serv & Trauma Syst, Phoenix, AZ 85007 USA	University of Washington; University of Washington Seattle; University of Arizona; Arizona Department of Health Services	Bobrow, BJ (corresponding author), Arizona Dept Hlth Serv, Bur Emergency Med Serv & Trauma Syst, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA.	bentley.bobrow@azdhs.gov						Bobrow BJ, 2008, CIRCULATION, V118, P2550, DOI 10.1161/CIRCULATIONAHA.108.799940; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Lerner EB, 2012, CIRCULATION, V125, P648, DOI 10.1161/CIR.0b013e31823ee5fc; Lewis M, 2013, CIRCULATION, V128, P1522, DOI 10.1161/CIRCULATIONAHA.113.002627; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Resuscitation Academy, RESOURCES; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Song KJ, 2014, RESUSCITATION, V85, P34, DOI 10.1016/j.resuscitation.2013.06.004; Valenzuela TD, 1997, CIRCULATION, V96, P3308	10	2	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1197	1198		10.1001/jama.2014.1485	http://dx.doi.org/10.1001/jama.2014.1485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668098				2022-12-28	WOS:000333340500018
J	Lieberman, PM				Lieberman, Paul M.			Epstein-Barr Virus Turns 50	SCIENCE			English	Editorial Material									Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Lieberman, PM (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	lieberman@wistar.org			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017336] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE017336] Funding Source: Medline; Wellcome Trust [096496] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bollard CM, 2012, NAT REV CLIN ONCOL, V9, P510, DOI 10.1038/nrclinonc.2012.111; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; Dreyfus DH, 2011, AUTOIMMUN REV, V11, P88, DOI 10.1016/j.autrev.2011.08.005; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PATTENGALE PK, 1973, LANCET, V2, P93; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Schiller JT, 2004, NAT REV MICROBIOL, V2, P343, DOI 10.1038/nrmicro867; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Tsai MH, 2013, CELL REP, V5, P458, DOI 10.1016/j.celrep.2013.09.012; Varmus H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005899; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	15	61	64	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1323	1325		10.1126/science.1252786	http://dx.doi.org/10.1126/science.1252786			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD3AI	24653027	Green Accepted			2022-12-28	WOS:000333108500025
J	Eroglu, E; Burkard, TR; Jiang, YR; Saini, N; Homem, CCF; Reichert, H; Knoblich, JA				Eroglu, Elif; Burkard, Thomas R.; Jiang, Yanrui; Saini, Nidhi; Homem, Catarina C. F.; Reichert, Heinrich; Knoblich, Juergen A.			SWI/SNF Complex Prevents Lineage Reversion and Induces Temporal Patterning in Neural Stem Cells	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; DROSOPHILA-BRAIN-TUMOR; REGULATES SELF-RENEWAL; TRANSCRIPTION FACTORS; PROGENITOR CELLS; NEUROBLAST LINEAGES; FACS PURIFICATION; MOSAIC ANALYSIS; DOMAIN PROTEIN; NERVOUS-SYSTEM	Members of the SWI/SNF chromatin-remodeling complex are among the most frequently mutated genes in human cancer, but how they suppress tumorigenesis is currently unclear. Here, we use Drosophila neuroblasts to demonstrate that the SWI/SNF component Osa (ARID1) prevents tumorigenesis by ensuring correct lineage progression in stem cell lineages. We show that Osa induces a transcriptional program in the transit-amplifying population that initiates temporal patterning, limits self-renewal, and prevents dedifferentiation. We identify the Prdm protein Hamlet as a key component of this program. Hamlet is directly induced by Osa and regulates the progression of progenitors through distinct transcriptional states to limit the number of transit-amplifying divisions. Our data provide a mechanistic explanation for the widespread tumor suppressor activity of SWI/SNF. Because the Hamlet homologs Evi1 and Prdm16 are frequently mutated in cancer, this mechanism could well be conserved in human stem cell lineages.	[Eroglu, Elif; Burkard, Thomas R.; Homem, Catarina C. F.; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Jiang, Yanrui; Saini, Nidhi; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Basel	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Burkard, Thomas/0000-0002-0884-2929; Eroglu, Elif/0000-0003-3952-3178; Homem, Catarina/0000-0003-4243-0298	Austrian Academy of Sciences; Austrian Science Fund (FWF) [I_552-B19, I_1281_B19, Z_153_B09]; European Research Council; Austrian Science Fund (FWF) [I 1281, Z 153] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank I. Reichardt, M. Lancaster, and H. Harzer for critical comments on the manuscript; A. W. Moore, C.Y. Lee, Y.N. Jan, S. Thor, S.X. Hou, U. Walldorf, the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center, the Developmental Studies Hybridoma Bank, and TriP at Harvard Medical School (NIH/NIGMS R01-GM084947) for fly stocks and reagents; F. Mauri for the help with generating Dpn antibody; H. Harzer for generating the rabbit Pros antibody; J. Steinmann for the help with the shmiR design; M. Madalinski for peptide synthesis and affinity purification; G. Schmauss and T. Lendl for FACS support; P. Pasierbek for bio-optics support; and CSF NGS unit for next-generation sequencing. Work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF, grants I_552-B19, I_1281_B19, and Z_153_B09), and an advanced grant of the European Research Council.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Bayraktar OA, 2013, NATURE, V498, P449, DOI 10.1038/nature12266; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Endo K, 2012, NAT NEUROSCI, V15, P224, DOI 10.1038/nn.2998; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Harzer H, 2013, NAT PROTOC, V8, P1088, DOI 10.1038/nprot.2013.062; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Homem CCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079588; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Klein T, 1997, DEVELOPMENT, V124, P3123; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Liu C, 2012, CURR OPIN NEUROBIOL, V22, P844, DOI 10.1016/j.conb.2012.04.012; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma Y, 1998, MECH DEVELOP, V73, P169, DOI 10.1016/S0925-4773(98)00050-1; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Moore AW, 2004, GENE DEV, V18, P623, DOI 10.1101/gad.1170904; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Song Y, 2011, GENE DEV, V25, P2644, DOI 10.1101/gad.171959.111; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Vazquez M, 1999, DEVELOPMENT, V126, P733; Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xiao Q, 2012, DEVELOPMENT, V139, P2670, DOI 10.1242/dev.081687; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779; Zeng XK, 2013, DEVELOPMENT, V140, P3532, DOI 10.1242/dev.096891; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2011, P NATL ACAD SCI USA, V108, P20615, DOI 10.1073/pnas.1118595109	94	96	98	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1259	1273		10.1016/j.cell.2014.01.053	http://dx.doi.org/10.1016/j.cell.2014.01.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630726	Green Accepted, hybrid			2022-12-28	WOS:000332945100015
J	Bhan, MK; Glass, RI; Ella, KM; Bhandari, N; Boslego, J; Greenberg, HB; Mohan, K; Curlin, G; Rao, TS				Bhan, Maharaj K.; Glass, Roger I.; Ella, Krishna M.; Bhandari, Nita; Boslego, John; Greenberg, Harry B.; Mohan, Krishna; Curlin, George; Rao, T. S.			Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development	LANCET			English	Editorial Material									[Bhan, Maharaj K.] Govt India, Minist Sci & Technol, New Delhi 110017, India; [Rao, T. S.] Govt India, Dept Biotechnol, New Delhi 110017, India; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Curlin, George] NIAID, NIH, Bethesda, MD 20892 USA; [Ella, Krishna M.; Mohan, Krishna] Bharat Biotech Int, Hyderabad, Andhra Pradesh, India; [Bhandari, Nita] Soc Appl Studies, New Delhi, India; [Boslego, John] PATH, Vaccine Dev Global Program, Seattle, WA USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Stanford, CA USA	Department of Biotechnology (DBT) India; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University	Bhan, MK (corresponding author), Govt India, Minist Sci & Technol, New Delhi 110017, India.	rajkbhan@gmail.com		greenberg, harry/0000-0002-2128-9080				Bhandari N, 2014, LANCET; BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203; Glass RI, 2005, J INFECT DIS, V192, pS30, DOI 10.1086/431498; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Tate JE, 2009, VACCINE, V27, pF18, DOI 10.1016/j.vaccine.2009.08.098; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	6	14	15	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2180	2183		10.1016/S0140-6736(14)60191-4	http://dx.doi.org/10.1016/S0140-6736(14)60191-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24629993				2022-12-28	WOS:000337906600032
J	Migliori, GB; Sotgiu, G				Migliori, Giovanni Battista; Sotgiu, Giovanni			Measuring the effect of tuberculosis control: a step forward	LANCET			English	Editorial Material							DELAMANID		[Migliori, Giovanni Battista] Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy; [Sotgiu, Giovanni] Univ Sassari Res, Med Educ & Profess Dev Unit, AOU Sassari, Epidemiol & Med Stat Unit,Dept Biomed Sci, Sassari, Italy	Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization	Migliori, GB (corresponding author), Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy.	giovannibattista.migliori@fsm.it	Sotgiu, Giovanni/N-1032-2017; Migliori, Giovanni Battista/AAB-8589-2020	Sotgiu, Giovanni/0000-0002-1600-4474; Migliori, Giovanni Battista/0000-0002-2597-574X				Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Diel R, 2013, EUR RESPIR J, V42, P785, DOI 10.1183/09031936.00205512; Dye C, 2013, LANCET, V381, P972, DOI 10.1016/S0140-6736(13)60137-3; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Skripconoka V, 2013, EUR RESPIR J, V41, P1393, DOI 10.1183/09031936.00125812; Sotgiu G, 2013, NEW ENGL J MED, V368, P88, DOI 10.1056/NEJMc1212308; STYBLO K, 1969, Bulletin of the International Union Against Tuberculosis, V42, P5; Tiberi S, 2014, EUR RESPIR J, V43, P289, DOI 10.1183/09031936.00122313; Van der Werf MJ, 2014, EUR RESPIR J, V44; Wang L, 2014, LANCET; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, 2 WHO	14	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2026	2028		10.1016/S0140-6736(14)60032-5	http://dx.doi.org/10.1016/S0140-6736(14)60032-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI9VZ	24650956				2022-12-28	WOS:000337292400008
J	Powell, AC; Landman, AB; Bates, DW				Powell, Adam C.; Landman, Adam B.; Bates, David W.			In Search of a Few Good Apps	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Powell, Adam C.] Payer Provider Syndicate, Boston, MA 02116 USA; [Landman, Adam B.; Bates, David W.] Harvard Univ, Sch Med, Boston, MA USA; [Landman, Adam B.; Bates, David W.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Landman, Adam B.; Bates, David W.] Partners Informat Syst, Wellesley, MA USA; [Bates, David W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Powell, AC (corresponding author), Payer Provider Syndicate, 8 Garrison St,Ste 101, Boston, MA 02116 USA.	powell@payerprovider.com	Bates, David/AAE-7283-2019	Landman, Adam/0000-0002-2166-0521; Powell, Adam/0000-0001-6519-3120				Happtique, REGISTRY STATEMENT; Health On the Net Foundation (HON), THE CERTIFICATION PR; Health Resources and Services Administration, MHEALTH; IMS Institute for Healthcare Informatics, 2013, PATIENT APPS FOR IMP; Ricbardson CR, 2008, ANN FAM MED, V6, P69, DOI 10.1370/afm.761; US Department of Health and Human Services Food and Drug Administration, 2013, MOBILE MEDICAL APPLI	6	157	162	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1851	1852		10.1001/jama.2014.2564	http://dx.doi.org/10.1001/jama.2014.2564			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24664278				2022-12-28	WOS:000335798100012
J	Stevenson, DG; Huskamp, HA				Stevenson, David G.; Huskamp, Haiden A.			Integrating Care at the End of Life Should Medicare Advantage Include Hospice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PALLIATIVE CARE		[Stevenson, David G.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37215 USA; [Huskamp, Haiden A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Vanderbilt University; Harvard University; Harvard Medical School	Stevenson, DG (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 W End Ave,Ste 1200, Nashville, TN 37215 USA.	david.stevenson@vanderbilt.edu			NIA NIH HHS [K01 AG038481] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG038481] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Dahlin CM, 2010, INT J PALLIAT NURS, V16, P420, DOI 10.12968/ijpn.2010.16.9.78633; Harrison S, 2013, PRESENTED AT MEDICAR; Spettell CM, 2009, J PALLIAT MED, V12, P827, DOI 10.1089/jpm.2009.0089; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624	5	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1493	1494		10.1001/jama.2014.1018	http://dx.doi.org/10.1001/jama.2014.1018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24633593	Green Accepted			2022-12-28	WOS:000334306000013
J	Chen, X; Iliopoulos, D; Zhang, Q; Tang, QZ; Greenblatt, MB; Hatziapostolou, M; Lim, E; Tam, WL; Ni, M; Chen, YW; Mai, JH; Shen, HF; Hu, DZ; Adoro, S; Hu, B; Song, MY; Tan, C; Landis, MD; Ferrari, M; Shin, SJ; Brown, M; Chang, JC; Liu, XS; Glimcher, LH				Chen, Xi; Iliopoulos, Dimitrios; Zhang, Qing; Tang, Qianzi; Greenblatt, Matthew B.; Hatziapostolou, Maria; Lim, Elgene; Tam, Wai Leong; Ni, Min; Chen, Yiwen; Mai, Junhua; Shen, Haifa; Hu, Dorothy Z.; Adoro, Stanley; Hu, Bella; Song, Minkyung; Tan, Chen; Landis, Melissa D.; Ferrari, Mauro; Shin, Sandra J.; Brown, Myles; Chang, Jenny C.; Liu, X. Shirley; Glimcher, Laurie H.			XBP1 promotes triple-negative breast cancer by controlling the HIF1 alpha pathway	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; STRESS-RESPONSE; STEM-CELLS; ER STRESS; METASTASIS; PHENOTYPE; THERAPY; GROWTH	Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization(1). One such adaptive pathway is the unfolded protein(UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE1 (ref. 2) and its substrate XBP1 (ref. 3). Previous studies report UPR activation in various human tumours(4-6), but the role of XBP1 in cancer progression in mammary epithelial cells is largely unknown. Triple-negative breast cancer (TNBC)-a form of breast cancer in which tumour cells do not express the genes for oestrogen receptor, progesterone receptor and HER2 (also called ERBB2 or NEU)-is a highly aggressive malignancy with limited treatment options(7,8). Here we report that XBP1 is activated in TNBC and has a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and reduced the CD44(high)CD24(low) population. Hypoxia-inducing factor 1 alpha (HIF1 alpha) is known to be hyperactivated in TNBCs9,10. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1 alpha that regulates the expression of HIF1 alpha targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1 alpha and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.	[Chen, Xi; Adoro, Stanley; Song, Minkyung; Tan, Chen; Glimcher, Laurie H.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Chen, Xi; Adoro, Stanley; Song, Minkyung; Tan, Chen; Ferrari, Mauro; Chang, Jenny C.; Glimcher, Laurie H.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Iliopoulos, Dimitrios; Hatziapostolou, Maria] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Syst Biomed, Los Angeles, CA 90095 USA; [Iliopoulos, Dimitrios; Hatziapostolou, Maria] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Zhang, Qing] Univ N Carolina, Dept Pathol & Lab Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tang, Qianzi] Tongji Univ, Dept Bioinformat, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Tang, Qianzi] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan 625014, Sichuan, Peoples R China; [Greenblatt, Matthew B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lim, Elgene; Ni, Min; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Lim, Elgene; Ni, Min; Brown, Myles] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Tam, Wai Leong] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chen, Yiwen; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chen, Yiwen; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Mai, Junhua; Shen, Haifa; Ferrari, Mauro] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Hu, Dorothy Z.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Hu, Bella] Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; [Landis, Melissa D.; Chang, Jenny C.] Houston Methodist Canc Ctr, Houston, TX 77030 USA; [Shin, Sandra J.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	Cornell University; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; Tongji University; Sichuan Agricultural University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University	Glimcher, LH (corresponding author), Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, 1300 York Ave, New York, NY 10065 USA.	lglimche@med.cornell.edu	Brown, Myles/AAX-5332-2021; Lim, Elgene/AAS-7280-2020; Brown, Myles/B-6906-2008; Hatziapostolou, Maria/N-1820-2015; ZHANG, QING/AGY-7972-2022; Iliopoulos, Dimitrios/AAE-9106-2019; Tam, Wai Leong/P-1497-2019; Tang, Qianzi/AAA-8021-2019; chang, jenny/G-7614-2015	Brown, Myles/0000-0002-8213-1658; Lim, Elgene/0000-0001-8065-8838; Hatziapostolou, Maria/0000-0003-2493-7028; ZHANG, QING/0000-0002-6595-8995; Tam, Wai Leong/0000-0003-2365-5264; chang, jenny/0000-0002-0890-9302; Chen, Xi/0000-0002-7995-6202; Mai, Junhua/0000-0001-8374-4352; Song, Minkyung/0000-0003-2668-7528	National Institutes of Health [CA112663, AI32412, R01HG004069, K99CA175290]; Leukemia and Lymphoma Society; National Natural Science Foundation of China [NSFC31329003]; NATIONAL CANCER INSTITUTE [P30CA016086, K99CA175290, R00CA160351, R01CA112663, P50CA058223] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. G. Kaelin, A.-H. Lee, F. Martinon, M. N. Wein and X. Li for critical review of the manuscript. We are grateful to A. L. Richardson, H. Xu and J. Wang for advice and discussions. We thank L. A. Paskett, X. Liu, R. Kim and Y. Liu for technical support. This work was supported by the National Institutes of Health (CA112663 and AI32412 to L. H. G.; R01HG004069 to X. S. L.; K99CA175290 to Y. C.), the Leukemia and Lymphoma Society (to X. C.) and the National Natural Science Foundation of China (NSFC31329003 to X.S.L.).	BARNARD GA, 1945, NATURE, V156, P177, DOI 10.1038/156177a0; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lin Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-59; Mahoney DJ, 2011, CANCER CELL, V20, P443, DOI 10.1016/j.ccr.2011.09.005; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Spiotto MT, 2010, CANCER RES, V70, P78, DOI 10.1158/0008-5472.CAN-09-2747; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	30	531	556	5	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					103	+		10.1038/nature13119	http://dx.doi.org/10.1038/nature13119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670641	Green Accepted, Green Submitted			2022-12-28	WOS:000333609900051
J	Yao, Z; Shafer, OT				Yao, Z.; Shafer, O. T.			The Drosophila Circadian Clock Is a Variably Coupled Network of Multiple Peptidergic Units	SCIENCE			English	Article							NEURONS; OSCILLATORS; PACEMAKERS; RHYTHMS; SIGNAL; PDF	Daily rhythms in behavior emerge from networks of neurons that express molecular clocks. Drosophila's clock neuron network consists of a diversity of cell types, yet is modeled as two hierarchically organized groups, one of which serves as a master pacemaker. Here, we establish that the fly's clock neuron network consists of multiple units of independent neuronal oscillators, each unified by its neuropeptide transmitter and mode of coupling to other units. Our work reveals that the circadian clock neuron network is not orchestrated by a small group of master pacemakers but rather consists of multiple independent oscillators, each of which drives rhythms in activity.	[Yao, Z.; Shafer, O. T.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Shafer, OT (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	oshafer@umich.edu		Yao, Zepeng/0000-0002-0186-5503	NIH (National Institute of Neurological Disorders and Stroke) [R00NS062953, R01NS077933]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077933, R00NS062953] Funding Source: NIH RePORTER	NIH (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. L. Price, P. H. Taghert, M. Rosbash, F. Rouyer, N. R. Glossop, and the Bloomington Drosophila Stock Center for fly stocks; M. Rosbash for PER antisera; D. R. Nassel for sNPF antibody; the Developmental Studies Hybridoma Bank for PDF antibody; P. H. Taghert, M. Rosbash, E. D. Herzog, S. J. Aton, and J. Y. Kuwada for helpful comments on the manuscript; and M. Rosbash for communicating results before publication. This work was supported by NIH (National Institute of Neurological Disorders and Stroke) grants R00NS062953 and R01NS077933 to O.T.S. We declare no conflicting interests.	DESOUZA NJ, 1983, MED RES REV, V3, P201, DOI 10.1002/med.2610030205; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Im SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018974; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Muskus MJ, 2007, MOL CELL BIOL, V27, P8049, DOI 10.1128/MCB.00680-07; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Vansteensel MJ, 2008, BRAIN RES REV, V58, P18, DOI 10.1016/j.brainresrev.2007.10.009; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	19	135	137	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1516	1520		10.1126/science.1251285	http://dx.doi.org/10.1126/science.1251285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675961	Green Accepted			2022-12-28	WOS:000333471000049
J	Anderson, DJ; Adolphs, R				Anderson, David J.; Adolphs, Ralph			A Framework for Studying Emotions across Species	CELL			English	Review							NEURAL CIRCUITS; DROSOPHILA; AMYGDALA; FEAR; AROUSAL; MODEL; BEHAVIOR; MODULATION; EXPERIENCE; NEUROPSYCHOLOGY	Since the 19th century, there has been disagreement over the fundamental question of whether "emotions'' are cause or consequence of their associated behaviors. This question of causation is most directly addressable in genetically tractable model organisms, including invertebrates such as Drosophila. Yet there is ongoing debate about whether such species even have "emotions,'' as emotions are typically defined with reference to human behavior and neuroanatomy. Here, we argue that emotional behaviors are a class of behaviors that express internal emotion states. These emotion states exhibit certain general functional and adaptive properties that apply across any specific human emotions like fear or anger, as well as across phylogeny. These general properties, which can be thought of as "emotion primitives,'' can be modeled and studied in evolutionarily distant model organisms, allowing functional dissection of their mechanistic bases and tests of their causal relationships to behavior. More generally, our approach not only aims at better integration of such studies in model organisms with studies of emotion in humans, but also suggests a revision of how emotion should be operationalized within psychology and psychiatry.	[Anderson, David J.; Adolphs, Ralph] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Adolphs, Ralph] CALTECH, Div Human & Social Sci, Pasadena, CA 91125 USA; [Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	wuwei@caltech.edu; radolphs@caltech.edu			Conte Center grant from NIMH [P50MH094258]; Allen Distinguished Investigator award; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258, R01MH085082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499] Funding Source: NIH RePORTER	Conte Center grant from NIMH; Allen Distinguished Investigator award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	R.A. was supported by a Conte Center grant from NIMH (P50MH094258). D.J.A. is an Investigator of the Howard Hughes Medical Institute. This work was supported, in part, by an Allen Distinguished Investigator award. We thank Richard Axel, Cori Bargman, Christopher Hitchcock, and Frederick Eberhardt for helpful comments.	Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Cannon WB, 1927, AM J PSYCHOL, V39, P106, DOI 10.2307/1415404; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Clark JJ, 2012, CURR OPIN NEUROBIOL, V22, P1054, DOI 10.1016/j.conb.2012.06.004; Craig A. D., 2008, HDB EMOTIONS, P272; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Damasio A.R., 2003, LOOKING SPINOZA JOY; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Devidze N, 2006, PHYSIOL BEHAV, V88, P283, DOI 10.1016/j.physbeh.2006.05.030; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Giuggioli L, 2013, P NATL ACAD SCI USA, V110, P16904, DOI 10.1073/pnas.1307071110; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Harris RJ, 2012, P NATL ACAD SCI USA, V109, P21164, DOI 10.1073/pnas.1212207110; Iliadi KG, 2009, J NEUROGENET, V23, P136, DOI 10.1080/01677060802471650; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/NMETH.2765, 10.1038/nmeth.2765]; James W., 1884, MIND Q REV PSYCHOL P, V9, P188, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188, https://doi.org/10.1093/mind/os-IX.34.188]; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Keltner D, 2003, COGNITION EMOTION, V17, P297, DOI 10.1080/02699930302297; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lazarus R.S., 1991, EMOTION ADAPTATION; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Lee H, 2014, NATURE; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Mendl M, 2011, CURR BIOL, V21, pR463, DOI 10.1016/j.cub.2011.05.028; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Moors A, 2009, COGNITION EMOTION, V23, P625, DOI 10.1080/02699930802645739; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pfaff D, 2005, J COMP NEUROL, V493, P86, DOI 10.1002/cne.20720; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; ROLLS ET, 1999, BRAIN EMOTION; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Scherer KR, 2009, PHILOS T R SOC B, V364, P3459, DOI 10.1098/rstb.2009.0141; Sengupta P, 2007, PFLUG ARCH EUR J PHY, V454, P721, DOI 10.1007/s00424-006-0196-9; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Shohat-Ophir G, 2012, SCIENCE, V335, P1351, DOI 10.1126/science.1215932; Simpson JH, 2009, ADV GENET, V65, P79, DOI 10.1016/S0065-2660(09)65003-3; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; TINBERGEN N, 1950, SYM SOC EXP BIOL, V4, P305; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; Vazdarjanova A, 2001, EUR J NEUROSCI, V14, P709, DOI 10.1046/j.0953-816x.2001.01696.x; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Winkielman P, 2004, CURR DIR PSYCHOL SCI, V13, P120, DOI 10.1111/j.0963-7214.2004.00288.x	92	265	266	7	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					187	200		10.1016/j.cell.2014.03.003	http://dx.doi.org/10.1016/j.cell.2014.03.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679535	Green Accepted, Bronze			2022-12-28	WOS:000333968900016
J	Cech, TR; Steitz, JA				Cech, Thomas R.; Steitz, Joan A.			The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones	CELL			English	Review							SMALL NUCLEOLAR RNAS; DOUBLE-STRANDED-RNA; SELF-SPLICING RNA; TRANSCRIPTION TERMINATION CONTROL; 23S RIBOSOMAL-RNA; MESSENGER-RNA; CRYSTAL-STRUCTURE; GENE-EXPRESSION; PEPTIDYL TRANSFERASE; ANTISENSE RNA	Noncoding RNAs (ncRNAs) accomplish a remarkable variety of biological functions. They regulate gene expression at the levels of transcription, RNA processing, and translation. They protect genomes from foreign nucleic acids. They can guide DNA synthesis or genome rearrangement. For ribozymes and riboswitches, the RNA structure itself provides the biological function, but most ncRNAs operate as RNA-protein complexes, including ribosomes, snRNPs, snoRNPs, telomerase, microRNAs, and long ncRNAs. Many, though not all, ncRNAs exploit the power of base pairing to selectively bind and act on other nucleic acids. Here, we describe the pathway of ncRNA research, where every established "rule'' seems destined to be overturned.	[Cech, Thomas R.; Steitz, Joan A.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Cech, Thomas R.] Univ Colorado, BioFrontiers Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Steitz, Joan A.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Mol Biophys & Biochem, New Haven, CT 06536 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Yale University	Cech, TR (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	thomas.cech@colorado.edu			NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA016038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BASS BL, 1984, NATURE, V308, P820, DOI 10.1038/308820a0; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blaha GM, 2012, CURR OPIN STRUC BIOL, V22, P750, DOI 10.1016/j.sbi.2012.07.016; Braun JE, 2013, ADV EXP MED BIOL, V768, P147, DOI 10.1007/978-1-4614-5107-5_9; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Burdon R H, 1971, Prog Nucleic Acid Res Mol Biol, V11, P33, DOI 10.1016/S0079-6603(08)60325-6; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Darnell F E, 1976, Prog Nucleic Acid Res Mol Biol, V19, P493; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Deng XX, 2006, TRENDS BIOCHEM SCI, V31, P526, DOI 10.1016/j.tibs.2006.07.007; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Egan ED, 2010, MOL CELL BIOL, V30, P2775, DOI 10.1128/MCB.00151-10; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ENGELMAN DM, 1975, ANNU REV BIOPHYS BIO, V4, P219, DOI 10.1146/annurev.bb.04.060175.001251; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gardner EJ, 2012, GENE DEV, V26, P2550, DOI 10.1101/gad.202184.112; GARRIGA G, 1984, CELL, V39, P631, DOI 10.1016/0092-8674(84)90470-7; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; GOTT JM, 1986, CELL, V47, P81, DOI 10.1016/0092-8674(86)90368-5; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Grigg JC, 2013, STRUCTURE, V21, P2025, DOI 10.1016/j.str.2013.09.001; Grundy FJ, 2003, FRONT BIOSCI-LANDMRK, V8, pD20, DOI 10.2741/908; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hajduk S, 2010, RNA BIOL, V7, P229, DOI 10.4161/rna.7.2.11393; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; ILLANGASEKARE M, 1995, SCIENCE, V267, P643, DOI 10.1126/science.7530860; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; KRINKE L, 1987, GENE DEV, V1, P1005, DOI 10.1101/gad.1.9.1005; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kulesza CA, 2006, P NATL ACAD SCI USA, V103, P18302, DOI 10.1073/pnas.0608718103; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LAKE JA, 1976, J MOL BIOL, V105, P131, DOI 10.1016/0022-2836(76)90200-X; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; LIU J, 1990, NUCLEIC ACIDS RES, V18, P6565, DOI 10.1093/nar/18.22.6565; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Mellin JR, 2013, P NATL ACAD SCI USA, V110, P13132, DOI 10.1073/pnas.1304795110; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Moore PB, 2012, ANNU REV BIOPHYS, V41, P1, DOI 10.1146/annurev-biophys-050511-102314; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Nilsen T.W., 1998, RNA RNA INTERACTIONS; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pessa HKJ, 2011, SCIENCE, V332, P184, DOI 10.1126/science.1205503; PESTKA S, 1968, J BIOL CHEM, V243, P2810; Pomeranz Krummel Daniel A, 2009, Nature, V458, P475, DOI 10.1038/nature07851; Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Roth A, 2014, NAT CHEM BIOL, V10, P56, DOI [10.1038/nchembio.1386, 10.1038/NCHEMBIO.1386]; Sabin LR, 2013, MOL CELL, V49, P783, DOI 10.1016/j.molcel.2013.02.010; SALDITTGEORGIEFF M, 1982, MOL CELL BIOL, V2, P701, DOI 10.1128/MCB.2.6.701; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Schellenberg MJ, 2013, NAT STRUCT MOL BIOL, V20, P728, DOI 10.1038/nsmb.2556; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schumperli D, 2004, CELL MOL LIFE SCI, V61, P2560, DOI 10.1007/s00018-004-4190-0; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; STEITZ JA, 1975, P NATL ACAD SCI USA, V72, P4734, DOI 10.1073/pnas.72.12.4734; STEITZ JA, 1995, SCIENCE, V270, P1626, DOI 10.1126/science.270.5242.1626; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; Terns MP, 2002, GENE EXPRESSION, V10, P17; TOMIZAWA J, 1981, P NATL ACAD SCI-BIOL, V78, P1421, DOI 10.1073/pnas.78.3.1421; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Valadkhan S, 2009, P NATL ACAD SCI USA, V106, P11901, DOI 10.1073/pnas.0902020106; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Voigts-Hoffmann F, 2012, CURR OPIN STRUC BIOL, V22, P768, DOI 10.1016/j.sbi.2012.07.010; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WALLER JP, 1961, P NATL ACAD SCI USA, V47, P18, DOI 10.1073/pnas.47.1.18; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; WITTMANNLIEBOLD B, 1984, MOL GEN GENET, V196, P439, DOI 10.1007/BF00436191; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; YONATH A, 1982, J CELL BIOCHEM, V19, P145, DOI 10.1002/jcb.240190205; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105; Zhang JW, 2013, NATURE, V500, P363, DOI 10.1038/nature12440; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	206	1433	1494	26	386	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					77	94		10.1016/j.cell.2014.03.008	http://dx.doi.org/10.1016/j.cell.2014.03.008			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679528	Bronze			2022-12-28	WOS:000333968900009
J	Forties, RA; Wang, MD				Forties, Robert A.; Wang, Michelle D.			Discovering the Power of Single Molecules	CELL			English	Review							TORQUE MEASUREMENTS; SUPERCOILED DNA; REVEALS; TRANSCRIPTION; TRANSITIONS; ELASTICITY; DYNAMICS	Mechanical manipulations of single biological molecules have revealed highly dynamic and mechanical processes at the molecular level. Recent developments have permitted examination of the impact of torque on these processes and visualization of detailed molecular motions, enabling studies of increasingly complex systems. Here we highlight some recent important discoveries.	[Forties, Robert A.; Wang, Michelle D.] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Forties, Robert A.; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA	Cornell University; Cornell University; Howard Hughes Medical Institute	Wang, MD (corresponding author), Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	mwang@physics.cornell.edu			American Cancer Society [125126-PF-13-205-01-DMC]; National Science Foundation [MCB-0820293]	American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF))	We thank Dr. M.Y. Sheinin and members of the Wang lab for critical reading of the manuscript. We wish to acknowledge postdoctoral support to R.A.F. from the American Cancer Society (125126-PF-13-205-01-DMC) and support to M. D. W. from the National Science Foundation grant (MCB-0820293).	Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Fazio T, 2008, LANGMUIR, V24, P10524, DOI 10.1021/la801762h; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Heller I, 2013, NAT METHODS, V10, P910, DOI [10.1038/NMETH.2599, 10.1038/nmeth.2599]; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Lipfert J, 2010, NAT METHODS, V7, P977, DOI 10.1038/NMETH.1520; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Oberstrass FC, 2012, P NATL ACAD SCI USA, V109, P6106, DOI 10.1073/pnas.1113532109; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Sheinin MY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108102; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; van Loenhout MTJ, 2012, SCIENCE, V338, P94, DOI 10.1126/science.1225810; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	20	10	11	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					4	7		10.1016/j.cell.2014.02.011	http://dx.doi.org/10.1016/j.cell.2014.02.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679521	Bronze			2022-12-28	WOS:000333968900002
J	Wollman, R				Wollman, Roy			Counting the Ways to Decode Dynamic Signals	SCIENCE			English	Editorial Material							CELL FATE		[Wollman, Roy] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Wollman, Roy] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wollman, Roy] San Diego Ctr Syst Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Wollman, R (corresponding author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.	rwollman@ucsd.edu						Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Cai HQ, 2014, SCIENCE, V343, P1329, DOI 10.1126/science.1249531; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Loomis WF, 2008, ADV EXP MED BIOL, V641, P39; Matthews MR., 2005, PENDULUM; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543	11	2	2	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1326	1327		10.1126/science.1252247	http://dx.doi.org/10.1126/science.1252247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653029	Green Published			2022-12-28	WOS:000333108500027
J	Senniappan, S; Alexandrescu, S; Tatevian, N; Shah, P; Arya, V; Flanagan, S; Ellard, S; Rampling, D; Ashworth, M; Brown, RE; Hussain, K				Senniappan, Senthil; Alexandrescu, Sanda; Tatevian, Nina; Shah, Pratik; Arya, Ved; Flanagan, Sarah; Ellard, Sian; Rampling, Dyanne; Ashworth, Michael; Brown, Robert E.; Hussain, Khalid			Sirolimus Therapy in Infants with Severe Hyperinsulinemic Hypoglycemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STIMULATED INSULIN-SECRETION; CONGENITAL HYPERINSULINISM; RECEPTOR SUBSTRATE-1; BETA-CELLS; RAPAMYCIN; MTOR; ACTIVATION; EVEROLIMUS; MUTATIONS; INHIBITION	Hyperinsulinemic hypoglycemia is the most common cause of severe, persistent neonatal hypoglycemia. The treatment of hyperinsulinemic hypoglycemia that is unresponsive to diazoxide is subtotal pancreatectomy. We examined the effectiveness of the mammalian target of rapamycin (mTOR) inhibitor sirolimus in four infants with severe hyperinsulinemic hypoglycemia that had been unresponsive to maximal doses of diazoxide (20 mg per kilogram of body weight per day) and octreotide (35 mu g per kilogram per day). All the patients had a clear glycemic response to sirolimus, although one patient required a small dose of octreotide to maintain normoglycemia. There were no major adverse events during 1 year of follow-up.	[Senniappan, Senthil; Shah, Pratik; Arya, Ved; Hussain, Khalid] UCL, Dev Endocrinol Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London WC1N 1EH, England; [Senniappan, Senthil; Shah, Pratik; Arya, Ved; Hussain, Khalid] Great Ormond St Hosp Sick Children, Dept Paediat Endocrinol, London WC1N 3JH, England; [Ashworth, Michael] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England; [Flanagan, Sarah; Ellard, Sian] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Alexandrescu, Sanda] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Tatevian, Nina; Brown, Robert E.] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX USA	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Exeter; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston	Hussain, K (corresponding author), UCL, Dev Endocrinol Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	khalid.hussain@ucl.ac.uk	SHAH, PRATIK/AAI-6068-2020	SHAH, PRATIK/0000-0002-4402-8297; Ellard, Sian/0000-0002-7620-5526	Medical Research Council [G1001821] Funding Source: Medline; MRC [G1001821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandrescu S, 2010, INT J CLIN EXP PATHO, V3, P691; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Beltrand J, 2012, DIABETES CARE, V35, P198, DOI 10.2337/dc11-1296; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bourcier ME, 2009, J CLIN ENDOCR METAB, V94, P3157, DOI 10.1210/jc.2009-0788; Bussiere CT, 2006, DIABETOLOGIA, V49, P2341, DOI 10.1007/s00125-006-0374-5; Di Paolo S, 2006, J AM SOC NEPHROL, V17, P2236, DOI 10.1681/ASN.2006030196; Fiebrich HB, 2011, ONCOLOGIST, V16, P783, DOI 10.1634/theoncologist.2010-0222; Flanagan SE, 2012, PEDIATR DIABETES, V13, P285, DOI 10.1111/j.1399-5448.2011.00821.x; Flanagan SE, 2013, AM J HUM GENET, V92, P131, DOI 10.1016/j.ajhg.2012.11.017; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kulke MH, 2009, NEW ENGL J MED, V360, P195, DOI 10.1056/NEJMc0806740; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Rahier J, 2000, ARCH DIS CHILD-FETAL, V82, pF108, DOI 10.1136/fn.82.2.F108; Sankhala K, 2009, TARGET ONCOL, V4, P135, DOI 10.1007/s11523-009-0107-z; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Senniappan S, 2012, J INHERIT METAB DIS, V35, P589, DOI 10.1007/s10545-011-9441-2; Stanescu DE, 2012, J CLIN ENDOCR METAB, V97, pE2026, DOI 10.1210/jc.2012-1356; Suchi M, 2006, MODERN PATHOL, V19, P122, DOI 10.1038/modpathol.3800497; Thomas NJ, 2013, CLIN ENDOCRINOL, V78, P799, DOI 10.1111/cen.12059; van Veen MR, 2011, PEDIATRICS, V127, pE1021, DOI 10.1542/peds.2010-1706; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669	25	81	86	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1131	1137		10.1056/NEJMoa1310967	http://dx.doi.org/10.1056/NEJMoa1310967			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645945				2022-12-28	WOS:000333054000009
J	Corn, BW				Corn, Benjamin W.			Breaking Good	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BAD-NEWS; SKILLS		Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	Tel Aviv University	Corn, BW (corresponding author), Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel.	bencorn@tasmc.health.gov.il						Farrell L, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7355; Han J, 2012, AM J CLIN ONCOL-CANC, V35, P309, DOI 10.1097/COC.0b013e31825eb235; Kissane DW, 2012, J CLIN ONCOL, V30, P1242, DOI 10.1200/JCO.2011.39.6184; Lienard A, 2010, BRIT J CANCER, V103, P171, DOI 10.1038/sj.bjc.6605749	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1113	1114		10.1001/jama.2014.1605	http://dx.doi.org/10.1001/jama.2014.1605			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643599				2022-12-28	WOS:000333010100014
J	Brown, JB; Boley, N; Eisman, R; May, GE; Stoiber, MH; Duff, MO; Booth, BW; Wen, JY; Park, S; Suzuki, AM; Wan, KH; Yu, C; Zhang, DY; Carlson, JW; Cherbas, L; Eads, BD; Miller, D; Mockaitis, K; Roberts, J; Davis, CA; Frise, E; Hammonds, AS; Olson, S; Shenker, S; Sturgill, D; Samsonova, AA; Weiszmann, R; Robinson, G; Hernandez, J; Andrews, J; Bickel, PJ; Carninci, P; Cherbas, P; Gingeras, TR; Hoskins, RA; Kaufman, TC; Lai, EC; Oliver, B; Perrimon, N; Graveley, BR; Celniker, SE				Brown, James B.; Boley, Nathan; Eisman, Robert; May, Gemma E.; Stoiber, Marcus H.; Duff, Michael O.; Booth, Ben W.; Wen, Jiayu; Park, Soo; Suzuki, Ana Maria; Wan, Kenneth H.; Yu, Charles; Zhang, Dayu; Carlson, Joseph W.; Cherbas, Lucy; Eads, Brian D.; Miller, David; Mockaitis, Keithanne; Roberts, Johnny; Davis, Carrie A.; Frise, Erwin; Hammonds, Ann S.; Olson, Sara; Shenker, Sol; Sturgill, David; Samsonova, Anastasia A.; Weiszmann, Richard; Robinson, Garret; Hernandez, Juan; Andrews, Justen; Bickel, Peter J.; Carninci, Piero; Cherbas, Peter; Gingeras, Thomas R.; Hoskins, Roger A.; Kaufman, Thomas C.; Lai, Eric C.; Oliver, Brian; Perrimon, Norbert; Graveley, Brenton R.; Celniker, Susan E.			Diversity and dynamics of the Drosophila transcriptome	NATURE			English	Article							GENOME-WIDE ANALYSIS; LONG NONCODING RNAS; EXPRESSION ANALYSIS; ENDOGENOUS SIRNAS; GENE-EXPRESSION; CAP-ANALYSIS; IDENTIFICATION; LANDSCAPE; REVEALS; GENCODE	Animal transcriptomes are dynamic with each cell type, tissue and organ system expressing an ensemble of transcript forms that give rise to substantial diversity. Here we have identified new genes, transcripts and proteins using poly(A)(+) RNA sequencing from Drosophila melanogaster in cultured cell lines, dissected organ systems and under environmental perturbations. We found that a small set of mostly neural-specific genes has the potential to encode thousands of transcripts each through extensive alternative promoter usage and RNA splicing. The magnitudes of splicing changes are larger between tissues than between developmental stages, and most sex-specific splicing is gonad-specific. Gonads express hundreds of previously unknown coding and long non-coding RNAs (lncRNAs), some of which are antisense to protein-coding genes and produce short regulatory RNAs. Furthermore, previously identified pervasive intergenic transcription occurs primarily within newly identified introns. The fly transcriptome is substantially more complex than previously recognized, with this complexity arising from combinatorial usage of promoters splice sites and polyaclenylation sites.	[Brown, James B.; Boley, Nathan; Stoiber, Marcus H.; Robinson, Garret; Hernandez, Juan; Bickel, Peter J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Brown, James B.; Booth, Ben W.; Park, Soo; Wan, Kenneth H.; Yu, Charles; Carlson, Joseph W.; Frise, Erwin; Hammonds, Ann S.; Weiszmann, Richard; Hoskins, Roger A.; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Eisman, Robert; Cherbas, Lucy; Eads, Brian D.; Miller, David; Mockaitis, Keithanne; Andrews, Justen; Cherbas, Peter; Kaufman, Thomas C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [May, Gemma E.; Duff, Michael O.; Olson, Sara; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Wen, Jiayu; Shenker, Sol; Lai, Eric C.] Sloan Kettering Inst, Rockefeller Res Labs 1017C, New York, NY 10065 USA; [Suzuki, Ana Maria; Carninci, Piero] RIKEN Omics Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Suzuki, Ana Maria; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan; [Zhang, Dayu; Roberts, Johnny; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Davis, Carrie A.; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sturgill, David; Oliver, Brian] NIDDK, Sect Dev Genom, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Samsonova, Anastasia A.; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Samsonova, Anastasia A.; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; University of Connecticut; Memorial Sloan Kettering Cancer Center; RIKEN; RIKEN; Indiana University System; Indiana University Bloomington; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Brown, JB (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	benbrownofberkeley@gmail.com; graveley@neuron.uchc.edu; celniker@fruitfly.org	Graveley, Brenton R/C-3108-2013; Carninci, Piero/K-1568-2014; Samsonova, Anastasia/Q-7591-2016; Wen, Jiayu/R-1673-2017; Brown, James/H-2971-2015; Samsonova, Anastasia/AAU-7269-2021; Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Carninci, Piero/0000-0001-7202-7243; Samsonova, Anastasia/0000-0002-9353-9173; Wen, Jiayu/0000-0003-1249-6456; Samsonova, Anastasia/0000-0002-9353-9173; Lai, Eric/0000-0002-8432-5851; Perrimon, Norbert/0000-0001-7542-472X; Sturgill, David/0000-0002-7902-3605; Graveley, Brenton/0000-0001-5777-5892; Gingeras, Thomas/0000-0001-9106-3573	National Human Genome Research Institute; Department of Energy [U01 HG004271, U54 HG006944, R01 GM076655, DE-AC02-05CH11231]; NHGRI [K99 HG006698]; modENCODE DAC sub-award [5710003102, 1U01HG007031-01]; ENCODE DAC [5U01HG004695-04]; Indiana METACyt Initiative of Indiana University - Lilly Endowment;  [U01-HG004261];  [RC2-HG005639]; Direct For Biological Sciences [1062432] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004261, U01HG004271, U01HG004695, K99HG006698, U01HG007031, RC2HG005639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076655, R01GM083300, R01GM097231] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy(United States Department of Energy (DOE)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); modENCODE DAC sub-award; ENCODE DAC; Indiana METACyt Initiative of Indiana University - Lilly Endowment; ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the modENCODE transcription consortium, especially J. Landolin and J. Sandler for their early contributions to these studies. We also thank A. Kundaje and H. Huang for helpful discussions. This work was funded by a contract from the National Human Genome Research Institute modENCODE Project, contract U01 HG004271 and U54 HG006944, to S.E.C. (principal investigator) and P.C., T.R.G., R.A.H. and B.R.G. (co-principal investigators) with additional support from R01 GM076655 (S.E.C.) both under Department of Energy contract no. DE-AC02-05CH11231. J.B.B.'s work was supported by NHGRI K99 HG006698. Work in P.J.B.'s group was supported by the modENCODE DAC sub-award 5710003102, 1U01HG007031-01 and the ENCODE DAC 5U01HG004695-04. Work in Bloomington was supported in part by the Indiana METACyt Initiative of Indiana University, funded by an award from the Lilly Endowment. Work in E.C.L.'s group was supported by U01-HG004261 and RC2-HG005639.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bickel PJ, 2010, ANN APPL STAT, V4, P1660, DOI 10.1214/10-AOAS363; Boley N, 2014, NAT BIOTECHNOL, V32, P341, DOI 10.1038/nbt.2850; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Celniker SE, 2003, ANNU REV GENOM HUM G, V4, P89, DOI 10.1146/annurev.genom.4.070802.110323; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Spradling AC, 1999, GENETICS, V153, P135; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Takahashi H, 2012, METHODS MOL BIOL, V786, P181, DOI 10.1007/978-1-61779-292-2_11; Telonis-Scott M, 2009, GENETICS, V181, P421, DOI 10.1534/genetics.108.096743; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	50	391	400	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					393	399		10.1038/nature12962	http://dx.doi.org/10.1038/nature12962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	24670639	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000340840600025
J	Mancias, JD; Wang, XX; Gygi, SP; Harper, JW; Kimmelman, AC				Mancias, Joseph D.; Wang, Xiaoxu; Gygi, Steven P.; Harper, J. Wade; Kimmelman, Alec C.			Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy	NATURE			English	Article							ANDROGEN RECEPTOR; RAT-LIVER; IRON; AUTOPHAGY; COACTIVATOR; MECHANISMS	Autophagy, the process by which proteins and organelles are sequestered in double-membrane structures called autophagosomes and delivered to lysosomes for degradation, is critical in diseases such as cancer and neurodegeneration(1,2). Much of our understanding of this process has emerged from analysis of bulk cytoplasmic autophagy, but our understanding of how specific cargo, including organelles, proteins or intracellular pathogens, are targeted for selective autophagy is limited(3). Here we use quantitative proteomics to identify a cohort of novel and known autophagosome-enriched proteins in human cells, including cargo receptors. Like known cargo receptors, nuclear receptor coactivator 4 (NCOA4) was highly enriched in autophagosomes, and associated with ATG8 proteins that recruit cargo-receptor complexes into autophagosomes. Unbiased identification of NCOA4-associated proteins revealed ferritin heavy and light chains, components of an iron-filled cage structure that protects cells from reactive iron species(4) but is degraded via autophagy to release iron(5,6) through an unknown mechanism. We found that delivery of ferritin to lysosomes required NCOA4, and an inability of NCOA4-deficient cells to degrade ferritin led to decreased bioavailable intracellular iron. This work identifies NCOA4 as a selective cargo receptor for autophagic turnover of ferritin (ferritinophagy), which is critical for iron homeostasis, and provides a resource for further dissection of autophagosomal cargo-receptor connectivity.	[Mancias, Joseph D.; Wang, Xiaoxu; Kimmelman, Alec C.] Dana Farber Canc Inst, Div Genom Stabil & DNA Repair, Dept Radiat Oncol, Boston, MA 02215 USA; [Mancias, Joseph D.; Gygi, Steven P.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Mancias, Joseph D.] Harvard Radiat Oncol Program, Boston, MA 02115 USA; [Mancias, Joseph D.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kimmelman, AC (corresponding author), Dana Farber Canc Inst, Div Genom Stabil & DNA Repair, Dept Radiat Oncol, Boston, MA 02215 USA.	wade_harper@hms.harvard.edu; alec_kimmelman@dfci.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [GM070565, GM095567]; National Cancer Institute [R01CA157490]; American Cancer Society [RSG-13-298-01-TBG]; Lustgarten Foundation; American Board of Radiology Holman Research Pathway Post-doctoral Fellowship; American Society of Radiation Oncology Junior Faculty Career Research Training Award [JF2013-2]; NATIONAL CANCER INSTITUTE [P50CA127003, R01CA157490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565, R01GM095567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Lustgarten Foundation; American Board of Radiology Holman Research Pathway Post-doctoral Fellowship; American Society of Radiation Oncology Junior Faculty Career Research Training Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Everley and E. Huttlin for assistance with LC-MS/MS, A. Cuervo for assistance with autophagosome purification protocol development, Y. Liu for technical support with cell culture, A. White, J. Lydeard and S. Hayes for interaction proteomics support, M. Haigis for access to nitrogen cavitation equipment, and the Nikon Imaging and Electron Microscopy Centers (Harvard Medical School) for imaging support. We thank Millennium Pharmaceuticals for the GABARAPL2 antibody. We acknowledge support from National Institutes of Health grants GM070565 and GM095567 to J. W. H., and National Cancer Institute grant R01CA157490, American Cancer Society Research Scholar grant RSG-13-298-01-TBG and the Lustgarten Foundation to A. C. K. J. D. M. was supported by an American Board of Radiology Holman Research Pathway Post-doctoral Fellowship and an American Society of Radiation Oncology Junior Faculty Career Research Training Award (JF2013-2). J. W. H. is a consultant for Millennium: The Takeda Oncology Company and Biogen Idec. A. C. K. is a consultant for Forma Therapeutics.	Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; Dengjel J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014035; Gao TS, 1999, MOL ENDOCRINOL, V13, P1645, DOI 10.1210/me.13.10.1645; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Griffiths RE, 2012, AUTOPHAGY, V8, P1150, DOI 10.4161/auto.20648; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Overbye A, 2007, AUTOPHAGY, V3, P300, DOI 10.4161/auto.3910; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Sandilands E, 2012, NAT CELL BIOL, V14, P51, DOI 10.1038/ncb2386; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; TRUMP BF, 1973, AM J PATHOL, V72, P295; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517	30	751	772	16	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					105	+		10.1038/nature13148	http://dx.doi.org/10.1038/nature13148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24695223	Green Accepted, Green Submitted			2022-12-28	WOS:000335199100048
J	Borer, ET; Seabloom, EW; Gruner, DS; Harpole, WS; Hillebrand, H; Lind, EM; Adler, PB; Alberti, J; Anderson, TM; Bakker, JD; Biederman, L; Blumenthal, D; Brown, CS; Brudvig, LA; Buckley, YM; Cadotte, M; Chu, CJ; Cleland, EE; Crawley, MJ; Daleo, P; Damschen, EI; Davies, KF; DeCrappeo, NM; Du, GZ; Firn, J; Hautier, Y; Heckman, RW; Hector, A; HilleRisLambers, J; Iribarne, O; Klein, JA; Knops, JMH; La Pierre, KJ; Leakey, ADB; Li, W; MacDougall, AS; McCulley, RL; Melbourne, BA; Mitchell, CE; Moore, JL; Mortensen, B; O'Halloran, LR; Orrock, JL; Pascual, J; Prober, SM; Pyke, DA; Risch, AC; Schuetz, M; Smith, MD; Stevens, CJ; Sullivan, LL; Williams, RJ; Wragg, PD; Wright, JP; Yang, LH				Borer, Elizabeth T.; Seabloom, Eric W.; Gruner, Daniel S.; Harpole, W. Stanley; Hillebrand, Helmut; Lind, Eric M.; Adler, Peter B.; Alberti, Juan; Anderson, T. Michael; Bakker, Jonathan D.; Biederman, Lori; Blumenthal, Dana; Brown, Cynthia S.; Brudvig, Lars A.; Buckley, Yvonne M.; Cadotte, Marc; Chu, Chengjin; Cleland, Elsa E.; Crawley, Michael J.; Daleo, Pedro; Damschen, Ellen I.; Davies, Kendi F.; DeCrappeo, Nicole M.; Du, Guozhen; Firn, Jennifer; Hautier, Yann; Heckman, Robert W.; Hector, Andy; HilleRisLambers, Janneke; Iribarne, Oscar; Klein, Julia A.; Knops, Johannes M. H.; La Pierre, Kimberly J.; Leakey, Andrew D. B.; Li, Wei; MacDougall, Andrew S.; McCulley, Rebecca L.; Melbourne, Brett A.; Mitchell, Charles E.; Moore, Joslin L.; Mortensen, Brent; O'Halloran, Lydia R.; Orrock, John L.; Pascual, Jesus; Prober, Suzanne M.; Pyke, David A.; Risch, Anita C.; Schuetz, Martin; Smith, Melinda D.; Stevens, Carly J.; Sullivan, Lauren L.; Williams, Ryan J.; Wragg, Peter D.; Wright, Justin P.; Yang, Louie H.			Herbivores and nutrients control grassland plant diversity via light limitation	NATURE			English	Article							RESOURCE CONTROL; COMPETITION; GROWTH; CONSUMER; DEPENDS; IMPACT	Human alterations to nutrient cycles(1,2) and herbivore communities(3-7) are affecting global biodiversity dramatically(2). Ecological theory predicts these changes should be strongly counteractive: nutrient addition drives plant species loss through intensified competition for light, whereas herbivores prevent competitive exclusion by increasing ground-level light, particularly in productive systems(8,9). Here we use experimental data spanning a globally relevant range of conditions to test the hypothesis that herbaceous plant species losses caused by eutrophication may be offset by increased light availability due to herbivory. This experiment, replicated in 40 grasslands on 6 continents, demonstrates that nutrients and herbivores can serve as counteracting forces to control local plant diversity through light limitation, independent of site productivity, soil nitrogen, herbivore type and climate. Nutrient addition consistently reduced local diversity through light limitation, and herbivory rescued diversity at sites where it alleviated light limitation. Thus, species loss from anthropogenic eutrophication can be ameliorated in grasslands where herbivory increases ground-level light.	[Borer, Elizabeth T.; Seabloom, Eric W.; Lind, Eric M.; Hautier, Yann; Wragg, Peter D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Harpole, W. Stanley; Biederman, Lori; Li, Wei; Mortensen, Brent; Sullivan, Lauren L.; Williams, Ryan J.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26382 Oldenburg, Germany; [Adler, Peter B.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Adler, Peter B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Alberti, Juan; Daleo, Pedro; Iribarne, Oscar; Pascual, Jesus] Consejo Nacl Invest Cient & Tecn, IIMyC, RA-7600 Mar Del Plata, Argentina; [Anderson, T. Michael] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Bakker, Jonathan D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Blumenthal, Dana] ARS, USDA, Ft Collins, CO 80526 USA; [Brown, Cynthia S.; Klein, Julia A.; Smith, Melinda D.] Colorado State Univ, Dept Forest Rangeland & Watershed Stewardship, Ft Collins, CO 80523 USA; [Brudvig, Lars A.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Buckley, Yvonne M.] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Buckley, Yvonne M.] Trinity Coll Dublin, Sch Nat Sci, Dublin 2, Ireland; [Cadotte, Marc] Univ Toronto, Dept Ecol & Evolutionary Biol, Scarborough, ON M1C 1A4, Canada; [Chu, Chengjin; Du, Guozhen] Lanzhou Univ, Sch Life Sci, Res Stn Alpine Meadow & Wetland Ecosyst, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Gansu, Peoples R China; [Cleland, Elsa E.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA; [Crawley, Michael J.] Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; [Damschen, Ellen I.; Orrock, John L.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Davies, Kendi F.; Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [DeCrappeo, Nicole M.; Pyke, David A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97331 USA; [Firn, Jennifer] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Heckman, Robert W.; Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Hector, Andy] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [HilleRisLambers, Janneke] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [La Pierre, Kimberly J.] Univ Calif Berkeley, Berkeley Initiat Global Change Biol, Berkeley, CA 94704 USA; [Leakey, Andrew D. B.] Univ Illinois, Dept Plant Biol, Champaign, IL 61820 USA; [MacDougall, Andrew S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Moore, Joslin L.] Univ Melbourne, Sch Bot, Australian Res Ctr Urban Ecol, Melbourne, Vic 3010, Australia; [Moore, Joslin L.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [O'Halloran, Lydia R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Prober, Suzanne M.] CSIRO Ecosyst Sci, Wembley, WA 6913, Australia; [Risch, Anita C.; Schuetz, Martin] Swiss Fed Inst Forest Snow & Landscape Res, CH-8903 Birmensdorf, Switzerland; [Stevens, Carly J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Wright, Justin P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Yang, Louie H.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland College Park; Iowa State University; Carl von Ossietzky Universitat Oldenburg; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Wake Forest University; University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); Colorado State University; Michigan State University; University of Queensland; Trinity College Dublin; University of Toronto; University Toronto Scarborough; Lanzhou University; University of California System; University of California San Diego; Imperial College London; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; Queensland University of Technology (QUT); University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; University of Washington; University of Washington Seattle; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign; University of Guelph; University of Kentucky; University of Melbourne; Monash University; Oregon State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Lancaster University; Duke University; University of California System; University of California Davis	Borer, ET (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	borer@umn.edu	Smith, Melinda D/J-8987-2014; Bakker, Jonathan/I-6960-2013; Mortensen, Brent/AAD-2092-2021; Wright, Justin/AAG-6461-2019; MacDougall, Andrew S/F-2037-2011; Prober, Suzanne/G-6465-2010; Hautier, Yann/D-5426-2015; Mitchell, Charles E/I-3709-2014; Adler, Peter B./D-3781-2009; Heckman, Robert W/J-2640-2015; Hillebrand, Helmut/I-1717-2014; Cadotte, Marc/AAG-8147-2020; Harpole, William S/C-2814-2013; Heckman, Robert W./L-4824-2019; Heckman, Robert/AAC-1302-2020; Hautier, Yann/I-2526-2019; Buckley, Yvonne/B-1281-2008; Wragg, Peter D/C-8385-2009; Hector, Andrew/H-4199-2011; Moore, Joslin/AAE-3819-2020; Daleo, Pedro/A-4694-2008; Pyke, David A./AAW-8291-2020; Leakey, Andrew DB/Q-9889-2016; Moore, Joslin L/C-5270-2009; Risch, Anita C./A-9836-2012; Gruner, Daniel Stephen/A-5166-2010; Chu, Chu/T-6038-2019; Knops, Johannes/AAA-8546-2020	Bakker, Jonathan/0000-0002-8973-2771; Mortensen, Brent/0000-0002-4873-6127; Wright, Justin/0000-0002-9102-5347; Prober, Suzanne/0000-0002-6518-239X; Hautier, Yann/0000-0003-4347-7741; Mitchell, Charles E/0000-0002-1633-1993; Heckman, Robert W/0000-0002-2281-3091; Hillebrand, Helmut/0000-0001-7449-1613; Cadotte, Marc/0000-0002-5816-7693; Harpole, William S/0000-0002-3404-9174; Heckman, Robert/0000-0002-2281-3091; Hautier, Yann/0000-0003-4347-7741; Buckley, Yvonne/0000-0001-7599-3201; Wragg, Peter D/0000-0003-2361-4286; Hector, Andrew/0000-0002-1309-7716; Moore, Joslin/0000-0001-9809-5092; Pyke, David A./0000-0002-4578-8335; Leakey, Andrew DB/0000-0001-6251-024X; Moore, Joslin L/0000-0001-9809-5092; Risch, Anita C./0000-0003-0531-8336; Gruner, Daniel Stephen/0000-0002-3153-4297; Firn, Jennifer/0000-0001-6026-8912; Alberti, Juan/0000-0003-1600-0921; Borer, Elizabeth/0000-0003-2259-5853; Biederman, Lori/0000-0003-2171-7898; Brown, Cynthia/0000-0001-8486-7119; Daleo, Pedro/0000-0001-9759-1203; Lind, Eric/0000-0003-3051-7724; Yang, Louie/0000-0002-9237-5357; MELBOURNE, BRETT/0000-0002-8843-4131; Chu, Chengjin/0000-0002-0606-449X; Stevens, Carly/0000-0002-2390-1763; Komatsu, Kimberly/0000-0001-7056-4547; Seabloom, Eric/0000-0001-6780-9259	NSF Research Coordination Network [NSF-DEB-1042132]; NSF Long Term Ecological Research program [NSF-DEB-1234162]; UMN Institute on the Environment [DG-0001-13]; Natural Environment Research Council [ceh010010] Funding Source: researchfish; Direct For Biological Sciences [1440484] Funding Source: National Science Foundation	NSF Research Coordination Network(National Science Foundation (NSF)); NSF Long Term Ecological Research program(National Science Foundation (NSF)); UMN Institute on the Environment; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work uses data from the Nutrient Network (http://nutnet.org) experiment, funded at the site scale by individual researchers. Coordination and data management are supported by funding to E. Borer and E. Seabloom from the NSF Research Coordination Network (NSF-DEB-1042132) and Long Term Ecological Research (NSF-DEB-1234162 to Cedar Creek LTER) programs and the UMN Institute on the Environment (DG-0001-13). The Minnesota Supercomputer Institute hosts project data. We are grateful to F. Isbell for suggestions that improved the manuscript. Any use of trade names is for descriptive purposes only and does not imply endorsement by the US Government.	Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Crawley MJ, 1997, PLANT ECOL; De Schrijver A, 2011, GLOBAL ECOL BIOGEOGR, V20, P803, DOI 10.1111/j.1466-8238.2011.00652.x; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dybzinski R, 2007, AM NAT, V170, P305, DOI 10.1086/519857; Foley JA, 2007, P NATL ACAD SCI USA, V104, P12585, DOI 10.1073/pnas.0705190104; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gibson D. J., 2009, GRASSES GRASSLAND EC; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Lind EM, 2013, ECOL LETT, V16, P513, DOI 10.1111/ele.12078; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Millennium Ecosystem Assessment Panel,, 2005, EC HUM WELL BEING SY; Neely C., 2009, REV EVIDENCE DRYLAND; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; P Grime J., 2012, EVOLUTIONARY STRATEG, DOI [DOI 10.1002/9781118223246, 10.1002/9781118223246]; Proulx M, 1998, ECOLOGY, V79, P2581, DOI 10.1890/0012-9658(1998)079[2581:ROGIOP]2.0.CO;2; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; WEISSING FJ, 1994, J THEOR BIOL, V168, P323, DOI 10.1006/jtbi.1994.1113; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	31	526	551	64	1011	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					517	+		10.1038/nature13144	http://dx.doi.org/10.1038/nature13144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670649	Green Published			2022-12-28	WOS:000334741600035
J	Wolff, S; Dillin, A				Wolff, Suzanne; Dillin, Andrew			The stressful influence of microbes	NATURE			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; C. ELEGANS; MITOCHONDRIA; ACTIVATION; CELLS		[Wolff, Suzanne] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Wolff, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	dillin@berkeley.edu						DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Mosbech MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070087; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Pang SS, 2014, CELL METAB, V19, P221, DOI 10.1016/j.cmet.2013.12.005; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Virk B, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-67; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	15	3	4	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					328	329		10.1038/nature13220	http://dx.doi.org/10.1038/nature13220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24695220				2022-12-28	WOS:000334403000038
J	Anthes, E				Anthes, Emily			AGEING Live faster, die younger	NATURE			English	Editorial Material							NONAFFECTIVE PSYCHOSIS; TELOMERE LENGTH; NAIVE PATIENTS; SCHIZOPHRENIA; HYPOTHESIS											Fernandez-Egea E, 2011, PSYCHOSOM MED, V73, P643, DOI 10.1097/PSY.0b013e318230343f; Fernandez-Egea E, 2009, SCHIZOPHRENIA BULL, V35, P437, DOI 10.1093/schbul/sbn169; Kirkpatrick B, 2008, SCHIZOPHRENIA BULL, V34, P1024, DOI 10.1093/schbul/sbm140; Kochunov P, 2013, BIOL PSYCHIAT, V73, P482, DOI 10.1016/j.biopsych.2012.10.002; Nieratschker V, 2013, SCHIZOPHR RES, V149, P116, DOI 10.1016/j.schres.2013.06.043; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x	6	15	15	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S16	S17		10.1038/508S16a	http://dx.doi.org/10.1038/508S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695330				2022-12-28	WOS:000333609900012
J	El-Boustani, S; Wilson, NR; Runyan, CA; Sur, M				El-Boustani, Sami; Wilson, Nathan R.; Runyan, Caroline A.; Sur, Mriganka			Interneuron subtypes and orientation tuning Reply	NATURE			English	Letter							NEURONS; NETWORKS		[El-Boustani, Sami; Wilson, Nathan R.; Runyan, Caroline A.; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	El-Boustani, S (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msur@mit.edu		El-Boustani, Sami/0000-0003-1733-4341				Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Lee SH, 2014, NATURE, V508, pE1, DOI 10.1038/nature13128; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347	9	15	15	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					E3	E4		10.1038/nature13130	http://dx.doi.org/10.1038/nature13130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695315				2022-12-28	WOS:000333609900003
J	Handley, AJ				Handley, Anthony J.			Basic Life Support	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Colchester Hosp Univ, NHS Fdn Trust, Colchester, Essex, England	Oxford University Hospitals NHS Foundation Trust	Handley, AJ (corresponding author), Colchester Hosp Univ, NHS Fdn Trust, Colchester, Essex, England.	digitalrightsuk@wiley.com						[Anonymous], 2011, CARD RES AUT EXT DEF; Handley AJ, 2010, ADULT BLS GUIDELINES; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g1730	10.1136/bmj.g1730	http://dx.doi.org/10.1136/bmj.g1730			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696230				2022-12-28	WOS:000333977000018
J	Brunet, M				Brunet, Martin			Targets for dementia diagnoses will lead to overdiagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; ENGLAND		Binscombe Med Ctr, Godalming GU7 3PR, Surrey, England		Brunet, M (corresponding author), Binscombe Med Ctr, Godalming GU7 3PR, Surrey, England.	martin@binscombe.net						Brunet M, EARLY DIAGNOSIS DEME; Brunet MD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8588; Department of Health, 2014, PUTT DEM MAP; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Herefordshire Clinical Commissioning Group, 2013, GP NEWS         0924; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; NHS England, 2014, DEM PREV CALC; UK National Screening Committee, 2010, ALZH DIS UK NSC POL	9	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g2224	10.1136/bmj.g2224	http://dx.doi.org/10.1136/bmj.g2224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24690626				2022-12-28	WOS:000333976300004
J	McCartney, M				McCartney, Margaret			Why the Sun's breast check campaign may actually harm women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-EXAMINATION					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Breakthrough Cancer, SIGN SYMPT; CoppaFeel, BOOK CHECK; Kosters JP, 2008, COCHRANE DB SYST REV, V3; NHS Choices, SHOULD I CHECK MY BR; Parsons R., 2014, MARKETING WEEK; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Thornton H, 2008, EUR J CANCER, V44, P2118, DOI 10.1016/j.ejca.2008.08.015	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g2447	10.1136/bmj.g2447	http://dx.doi.org/10.1136/bmj.g2447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24690629				2022-12-28	WOS:000333976300008
J	Blom, L; Black, JJM				Blom, Lizle; Black, John J. M.			ABC of Major Trauma, 4th Edition - Major incident	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Advanced Life Support Group, 2011, MAJOR INCIDENT MEDIC; Department of Health, 2006, NHS EMERGENCY PLANNI; Department of Health, 2007, NHS EMERGENCY PLANNI; HODGETTS TJ, 2002, MAJOR INCIDENT MANAG; Hodgetts TJ, 2002, EU TRIAGE POSITION S	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2014	348								g1144	10.1136/bmj.g1144	http://dx.doi.org/10.1136/bmj.g1144			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9MF	24682424				2022-12-28	WOS:000333588500001
J	Eun, SH; Shi, Z; Cui, KR; Zhao, KJ; Chen, X				Eun, Suk Ho; Shi, Zhen; Cui, Kairong; Zhao, Keji; Chen, Xin			A Non-Cell Autonomous Role of E(z) to Prevent Germ Cells from Turning on a Somatic Cell Marker	SCIENCE			English	Article							DROSOPHILA TESTIS; SELF-RENEWAL; DIRECT CONVERSION; GENE-EXPRESSION; STEM-CELLS; NICHE; LESSONS; POLYCOMB; FATE; LINE	In many metazoans, germ cells are separated from somatic lineages early in development and maintain their identity throughout life. Here, we show that a Polycomb group (PcG) component, Enhancer of Zeste [E(z)], a histone transferase that generates trimethylation at lysine 27 of histone H3, maintains germline identity in Drosophila adult testes. We find excessive early-stage somatic gonadal cells in E(z) mutant testes, which originate from both overproliferative cyst stem cells and germ cells turning on an early-stage somatic cell marker. Using complementary lineage-tracing experiments in E(z) mutant testes, a portion of excessive early-stage somatic gonadal cells are found to originate from early-stage germ cells, including germline stem cells. Moreover, knocking down E(z) specifically in somatic cells caused this change, which suggests a non-cell autonomous role of E(z) to antagonize somatic identity in germ cells.	[Eun, Suk Ho; Shi, Zhen; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chen, X (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	xchen32@jhu.edu			National Institute of Child Health and Human Development (NIH) [R00HD055052, R01HD065816]; David and Lucile Packard Foundation; March of Dimes [05-FY09-88]; Johns Hopkins University; Division of Intramural Research, NHLBI, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); March of Dimes(March of Dimes); Johns Hopkins University(Johns Hopkins University); Division of Intramural Research, NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. Choi for technical assistance and D. Drummond-Barbosa, M. Van Doren, H. Zhao, Y. Yamashita, and the Chen laboratory members for suggestions. ChIP-Seq libraries were sequenced at National Heart, Lung, and Blood Institute (NHLBI) Sequencing and Computation Core facility (NIH); the GEO accession number is GSE53238. Supported by National Institute of Child Health and Human Development (NIH) grants R00HD055052 and R01HD065816, the David and Lucile Packard Foundation, March of Dimes #05-FY09-88, Johns Hopkins University start-up (X. C.), and Division of Intramural Research, NHLBI, NIH (K.Z.).	Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Iovino N, 2013, DEV CELL, V26, P431, DOI 10.1016/j.devcel.2013.06.021; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; JONES RS, 1990, GENETICS, V126, P185; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Leatherman JL, 2003, BIOESSAYS, V25, P326, DOI 10.1002/bies.10247; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lehmann R, 2012, CELL STEM CELL, V10, P729, DOI 10.1016/j.stem.2012.05.016; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Patel T, 2012, CELL REP, V2, P1178, DOI 10.1016/j.celrep.2012.09.020; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Tarayrah L, 2013, DEVELOPMENT, V140, P1014, DOI 10.1242/dev.089433; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Van Doren M, 1998, CURR BIOL, V8, P243	30	33	34	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1513	1516		10.1126/science.1246514	http://dx.doi.org/10.1126/science.1246514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675960	Green Accepted			2022-12-28	WOS:000333471000048
J	Green, DR; Levine, B				Green, Douglas R.; Levine, Beth			To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate	CELL			English	Review							PHOSPHATIDYLSERINE EXPOSURE; NONCANONICAL AUTOPHAGY; PATERNAL MITOCHONDRIA; MITOPHAGY; PARKIN; APOPTOSIS; MEMBRANE; ULK1; DEGRADATION; CLEARANCE	The health of metazoan organisms requires an effective response to organellar and cellular damage either by repair of such damage and/or by elimination of the damaged parts of the cells or the damaged cell in its entirety. Here, we consider the progress that has been made in the last few decades in determining the fates of damaged organelles and damaged cells through discrete, but genetically overlapping, pathways involving the selective autophagy and cell death machinery. We further discuss the ways in which the autophagy machinery may impact the clearance and consequences of dying cells for host physiology. Failure in the proper removal of damaged organelles and/or damaged cells by selective autophagy and cell death processes is likely to contribute to developmental abnormalities, cancer, aging, inflammation, and other diseases.	[Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38205 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dept Internal Med, Dept Microbiol, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	St Jude Children's Research Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38205 USA.	douglas.green@stjude.org; beth.levine@utsouthwestern.edu	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417	NIH [R01 CA109618, R01 AI40646, AI47891, AI44828, CA169291, GM 096208]; CPRIT grant [RP120718-P1]; NATIONAL CANCER INSTITUTE [R01CA109618, R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828, R01AI040646, R01AI047891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Haley Harrington for assistance with manuscript preparation and Angela Diehl for expert scientific illustration. B.L. is supported by NIH R01 CA109618 and CPRIT grant RP120718-P1. D.R.G. is supported by NIH R01 AI40646, AI47891, AI44828, CA169291, and GM 096208.	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Cebollero Eduardo, 2012, Int J Cell Biol, V2012, P182834, DOI 10.1155/2012/182834; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Florey O, 2010, CURR BIOL, V20, pR88, DOI 10.1016/j.cub.2009.11.020; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Green DR, 2012, TRENDS CELL BIOL, V22, P555, DOI 10.1016/j.tcb.2012.08.008; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Green DR, 2011, MEANS END APOPTOSIS; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Hamasaki M, 2013, CURR OPIN CELL BIOL, V25, P455, DOI 10.1016/j.ceb.2013.03.004; Han CZ, 2011, CELL, V147, P1442, DOI 10.1016/j.cell.2011.12.006; Hara-Kuge S, 2008, EXP CELL RES, V314, P3531, DOI 10.1016/j.yexcr.2008.09.015; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Levine B, 2011, SCIENCE, V334, P1069, DOI 10.1126/science.1215480; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lu HQ, 2013, AUTOPHAGY, V9, P1720, DOI 10.4161/auto.26550; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Meijer AJ, 2011, AUTOPHAGY, V7, P563, DOI 10.4161/auto.7.6.14873; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perot BP, 2013, IMMUNOL REV, V255, P40, DOI 10.1111/imr.12096; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Sarosiek KA, 2013, TRENDS CELL BIOL, V23, P612, DOI 10.1016/j.tcb.2013.08.003; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Till Andreas, 2012, Int J Cell Biol, V2012, P512721, DOI 10.1155/2012/512721; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wirth M, 2013, SEMIN CANCER BIOL, V23, P301, DOI 10.1016/j.semcancer.2013.05.007; Yin XC, 2011, EMBO REP, V12, P727, DOI 10.1038/embor.2011.79; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182	79	492	535	5	235	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					65	75		10.1016/j.cell.2014.02.049	http://dx.doi.org/10.1016/j.cell.2014.02.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679527	Bronze, Green Accepted			2022-12-28	WOS:000333968900008
J	Kusumbe, AP; Ramasamy, SK; Adams, RH				Kusumbe, Anjali P.; Ramasamy, Saravana K.; Adams, Ralf H.			Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; LINDAU TUMOR-SUPPRESSOR; ENDOTHELIAL-CELLS; FRACTURE REPAIR; VASCULAR CONTRIBUTION; ANGIOCRINE FACTORS; PLASMA-MEMBRANE; TRABECULAR BONE; MARROW; HYPOXIA	The mammalian skeletal system harbours a hierarchical system of mesenchymal stem cells, osteoprogenitors and osteoblasts sustaining lifelong bone formation. Osteogenesis is indispensable for the homeostatic renewal of bone as well as regenerative fracture healing, but these processes frequently decline in ageing organisms, leading to loss of bone mass and increased fracture incidence. Evidence indicates that the growth of blood vessels in bone and osteogenesis are coupled, but relatively little is known about the underlying cellular and molecular mechanisms. Here we identify a new capillary subtype in the murine skeletal system with distinct morphological, molecular and functional properties. These vessels are found in specific locations, mediate growth of the bone vasculature, generate distinct metabolic and molecular microenvironments, maintain perivascular osteoprogenitors and couple angiogenesis to osteogenesis. The abundance of these vessels and associated osteoprogenitors was strongly reduced in bone from aged animals, and pharmacological reversal of this decline allowed the restoration of bone mass.	[Kusumbe, Anjali P.; Ramasamy, Saravana K.; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; University of Munster	Adams, RH (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	ralf.adams@mpi-muenster.mpg.de	Adams, Ralf H/AAE-9274-2019	Ramasamy, Saravana/0000-0003-2658-2945	Max Planck Society; University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council [AdG 339409 AngioBone]	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council(European Research Council (ERC)European Commission)	We thank A. Medvinsky for kindly providing Flk1-GFP mice, M. Stehling for endothelial cell sorting and A. Borgscheiper for technical assistance. Funding was provided by the Max Planck Society, the University of Munster, the DFG cluster of excellence 'Cells in Motion' and the European Research Council (AdG 339409 AngioBone).	Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Boado RJ, 2002, J NEUROCHEM, V80, P552, DOI 10.1046/j.0022-3042.2001.00756.x; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; CROCK HV, 1965, J ANAT, V99, P77; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ellis SL, 2011, BLOOD, V118, P1516, DOI 10.1182/blood-2010-08-303800; Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Heaney RP, 1998, ENDOCRIN METAB CLIN, V27, P255, DOI 10.1016/S0889-8529(05)70004-9; Helisch A, 2003, MICROCIRCULATION, V10, P83, DOI 10.1038/sj.mn.7800173; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Jones DT, 2006, MOL CANCER THER, V5, P2193, DOI 10.1158/1535-7163.MCT-05-0443; KATAOKA M, 1985, BLOOD, V65, P1163; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227; Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Ribatti D, 2002, J HEMATOTH STEM CELL, V11, P81, DOI 10.1089/152581602753448559; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Sale S, 2013, NAT CELL BIOL, V15, P451, DOI 10.1038/ncb2725; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; SKAWINA A, 1994, J ANAT, V185, P369; SMITH DM, 1975, J CLIN INVEST, V56, P311, DOI 10.1172/JCI108095; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tashiro Y, 2012, BLOOD, V119, P6382, DOI 10.1182/blood-2011-12-399659; TRUETA J, 1953, J BONE JOINT SURG BR, V35, P442, DOI 10.1302/0301-620X.35B3.442; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P97, DOI 10.1302/0301-620X.42B1.97; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	50	972	1034	36	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					323	+		10.1038/nature13145	http://dx.doi.org/10.1038/nature13145			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646994	Green Accepted			2022-12-28	WOS:000333029000026
J	Macilwain, C				Macilwain, Colin			Wanted: Fraud-buster with political antennae	NATURE			English	Editorial Material												cfmworldview@gmail.com						Fanelli D, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001563	1	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					275	275		10.1038/507275a	http://dx.doi.org/10.1038/507275a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD1YG	24646961	Bronze			2022-12-28	WOS:000333029000004
J	Ladizinski, B; Lee, KC				Ladizinski, Barry; Lee, Kachiu C.			Oral Ulcers and Targetoid Lesions on the Palms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ERYTHEMA MULTIFORME		[Ladizinski, Barry] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lee, Kachiu C.] Brown Univ, Dept Dermatol, Providence, RI 02912 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Brown University	Ladizinski, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	barryladizinski@gmail.com						HUFF JC, 1985, DERMATOL CLIN, V3, P141, DOI 10.1016/S0733-8635(18)30925-2; LEMAK MA, 1986, J AM ACAD DERMATOL, V15, P50, DOI 10.1016/S0190-9622(86)70141-2; STAMPIEN TM, 1992, AM FAM PHYSICIAN, V46, P1171; Wetter DA, 2010, J AM ACAD DERMATOL, V62, P45, DOI 10.1016/j.jaad.2009.06.046	4	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1152	1153		10.1001/jama.2013.286218	http://dx.doi.org/10.1001/jama.2013.286218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643606				2022-12-28	WOS:000333010100021
J	Smith, JM				Smith, Jeanette M.			Thistle Blossoms E. Martin Hennings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1094	1094		10.1001/jama.2013.279390	http://dx.doi.org/10.1001/jama.2013.279390			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643587				2022-12-28	WOS:000333010100001
J	Blazeby, JM; Byrne, J; Welbourn, R				Blazeby, Jane M.; Byrne, James; Welbourn, Richard			UNCERTAINTIES PAGE What is the most effective operation for adults with severe and complex obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							Y GASTRIC BYPASS; QUALITY-OF-LIFE; BARIATRIC SURGERY; SLEEVE		[Blazeby, Jane M.] Univ Bristol, Ctr Surg Res, Sch Social & Community Med, Bristol BS8 2PR, Avon, England; [Blazeby, Jane M.] Univ Hosp Bristol NHS Fdn Trust, Div Surg Head & Neck, Bristol, Avon, England; [Byrne, James] Univ Hosp Southampton NHS Trust, Dept Upper Gastrointestinal Surg, Southampton, Hants, England; [Welbourn, Richard] Musgrove Pk Hosp, Dept Upper Gastrointestinal & Bariatr Surg, Taunton, Somerset, England	University of Bristol; University of Bristol; Musgrove Park Hospital	Blazeby, JM (corresponding author), Univ Bristol, Ctr Surg Res, Sch Social & Community Med, Bristol BS8 2PR, Avon, England.	j.m.blazeby@bris.ac.uk		Byrne, james/0000-0003-3517-5110	National Institute for Health Research [09/127/53] Funding Source: researchfish; Department of Health [09/127/53] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Angrisani L, 2007, SURG OBES RELAT DIS, V3, P127, DOI 10.1016/j.soard.2006.12.005; Bal BS, 2012, NAT REV ENDOCRINOL, V8, P544, DOI 10.1038/nrendo.2012.48; Birkmeyer NJO, 2010, JAMA-J AM MED ASSOC, V304, P435, DOI 10.1001/jama.2010.1034; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Coulman KD, 2013, OBES REV, V14, P707, DOI 10.1111/obr.12041; DeMaria EJ, 2010, SURG OBES RELAT DIS, V6, P347, DOI 10.1016/j.soard.2009.11.015; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Helmio M, 2012, SURG ENDOSC, V26, P2521, DOI 10.1007/s00464-012-2225-4; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Kehagias I, 2011, OBES SURG, V21, P1650, DOI 10.1007/s11695-011-0479-x; Nguyen NT, 2009, ANN SURG, V250, P631, DOI 10.1097/SLA.0b013e3181b92480; NHS Commissioning Board, 2013, CLIN COMM POL COMPL; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Raj PP, 2012, OBES SURG, V22, P422, DOI 10.1007/s11695-011-0507-x; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Soreide K, 2013, LANCET, V382, P1140, DOI 10.1016/S0140-6736(13)61455-5; Welbourn R, 2011, NATL BARIATRIC SURG	18	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2014	348								g1763	10.1136/bmj.g1763	http://dx.doi.org/10.1136/bmj.g1763			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZW	24633209				2022-12-28	WOS:000333033200001
J	McLeish, TCB; Bower, RG; Tanner, BK; Smithson, HE; Panti, C; Lewis, N; Gasper, GEM				McLeish, Tom C. B.; Bower, Richard G.; Tanner, Brian K.; Smithson, Hannah E.; Panti, Cecilia; Lewis, Neil; Gasper, Giles E. M.			A medieval multiverse	NATURE			English	Editorial Material							13TH-CENTURY		[McLeish, Tom C. B.; Bower, Richard G.; Tanner, Brian K.] Univ Durham, Dept Phys, Durham DH1 3HP, England; [Smithson, Hannah E.] Univ Oxford, Dept Expt Psychol, Oxford OX1 2JD, England; [Panti, Cecilia] Univ Roma Tor Vergata, Dept Corp Governance Philosophy, Rome, Italy; [Lewis, Neil] Georgetown Univ, Dept Philosophy, Washington, DC USA; [Gasper, Giles E. M.] Univ Durham, Inst Medieval & Early Modern Studies, Durham DH1 3HP, England; [Gasper, Giles E. M.] Univ Durham, Dept Hist, Durham DH1 3HP, England	Durham University; University of Oxford; University of Rome Tor Vergata; Georgetown University; Durham University; Durham University	McLeish, TCB (corresponding author), Univ Durham, Dept Phys, Durham DH1 3HP, England.	t.c.b.mcleish@durham.ac.uk	Smithson, Hannah E/C-3218-2008; Gasper, Giles/AAF-9231-2021	Smithson, Hannah E/0000-0001-8904-8315; Gasper, Giles/0000-0001-5121-3389; Tanner, Brian/0000-0002-1474-177X	AHRC [AH/K003658/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/K003658/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Bower R. G., 2014, PREPRINT; Smithson HE, 2014, J OPT SOC AM A, V31, pA341, DOI 10.1364/JOSAA.31.00A341; Smithson HE, 2012, J OPT SOC AM A, V29, pA346, DOI 10.1364/JOSAA.29.00A346	3	2	2	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					161	163		10.1038/507161a	http://dx.doi.org/10.1038/507161a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AC6RJ	24627918	Green Accepted, Bronze			2022-12-28	WOS:000332651800014
J	Caironi, P; Tognoni, G; Masson, S; Fumagalli, R; Pesenti, A; Romero, M; Fanizza, C; Caspani, L; Faenza, S; Grasselli, G; Iapichino, G; Antonelli, M; Parrini, V; Fiore, G; Latini, R; Gattinoni, L				Caironi, Pietro; Tognoni, Gianni; Masson, Serge; Fumagalli, Roberto; Pesenti, Antonio; Romero, Marilena; Fanizza, Caterina; Caspani, Luisa; Faenza, Stefano; Grasselli, Giacomo; Iapichino, Gaetano; Antonelli, Massimo; Parrini, Vieri; Fiore, Gilberto; Latini, Roberto; Gattinoni, Luciano		ALBIOS Study Investigators	Albumin Replacement in Patients with Severe Sepsis or Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-SERUM-ALBUMIN; ORGAN DYSFUNCTION/FAILURE; INTENSIVE-CARE; NITRIC-OXIDE; CONTROLLED-TRIALS; SOFA SCORE; METAANALYSIS; MULTICENTER; FLUID; RESUSCITATION	BackgroundAlthough previous studies have suggested the potential advantages of albumin administration in patients with severe sepsis, its efficacy has not been fully established. MethodsIn this multicenter, open-label trial, we randomly assigned 1818 patients with severe sepsis, in 100 intensive care units (ICUs), to receive either 20% albumin and crystalloid solution or crystalloid solution alone. In the albumin group, the target serum albumin concentration was 30 g per liter or more until discharge from the ICU or 28 days after randomization. The primary outcome was death from any cause at 28 days. Secondary outcomes were death from any cause at 90 days, the number of patients with organ dysfunction and the degree of dysfunction, and length of stay in the ICU and the hospital. ResultsDuring the first 7 days, patients in the albumin group, as compared with those in the crystalloid group, had a higher mean arterial pressure (P=0.03) and lower net fluid balance (P<0.001). The total daily amount of administered fluid did not differ significantly between the two groups (P=0.10). At 28 days, 285 of 895 patients (31.8%) in the albumin group and 288 of 900 (32.0%) in the crystalloid group had died (relative risk in the albumin group, 1.00; 95% confidence interval [CI], 0.87 to 1.14; P=0.94). At 90 days, 365 of 888 patients (41.1%) in the albumin group and 389 of 893 (43.6%) in the crystalloid group had died (relative risk, 0.94; 95% CI, 0.85 to 1.05; P=0.29). No significant differences in other secondary outcomes were observed between the two groups. ConclusionsIn patients with severe sepsis, albumin replacement in addition to crystalloids, as compared with crystalloids alone, did not improve the rate of survival at 28 and 90 days. (Funded by the Italian Medicines Agency; ALBIOS ClinicalTrials.gov number, NCT00707122.) In patients with severe sepsis, albumin replacement in addition to crystalloid administration conferred no benefit, as compared with crystalloids alone, with respect to mortality at 28 or 90 days. Post hoc analysis suggested a possible benefit in patients with septic shock. For decades, human albumin has been administered to patients to provide adequate oncotic pressure and intravascular volume.(1) In 1998, however, a report from the Cochrane Injuries Group Albumin Reviewers indicated that the administration of albumin may be potentially harmful in critically ill patients, as compared with the administration of crystalloid solutions.(2) Subsequent meta-analyses reported contradictory findings.(3),(4) To clarify this issue, a large, double-blind, randomized trial (the Saline versus Albumin Fluid Evaluation [SAFE] study)(5) was conducted, in which 4% albumin solution was compared with normal saline as fluid replacement in critically ill patients, with results indicating that albumin administration was ...	[Caironi, Pietro; Tognoni, Gianni; Gattinoni, Luciano] Univ Milan, Dipartimento Fisiopatol Medico Chirurg & Trapiant, Fdn IRCCS Granda, Osped Maggiore Policlinico, I-20122 Milan, Italy; [Caironi, Pietro; Caspani, Luisa; Gattinoni, Luciano] Univ Milan, Dipartimento Anestesia, Rianimazione Terapia Dolore, Fdn IRCCS Granda,Osped Maggiore Policlin, Milan, Italy; [Masson, Serge; Latini, Roberto] IRCCS, Ist Ric Farmacolo Mario Negri, Milan, Italy; [Fumagalli, Roberto; Pesenti, Antonio] Univ Milano Bicocca, Dipartimento Sci Salute, Milan, Italy; [Iapichino, Gaetano] Polo Univ, Dipartimento Emergenza Urgenza, Azienda Osped S Paolo, Milan, Italy; [Faenza, Stefano] Policlinico Univ S Orsola Malpighi, Anestesiol Rianimazione, Dipartimento Emergenza Urgenza, Bologna, Italy; [Grasselli, Giacomo] Azienda Ospedaliera S Gerardo, Dipartimento Emergenza Urgenza, Monza, Italy; [Antonelli, Massimo] Univ Cattol, Policlinico Univ Gemelli, Rome, Italy; [Parrini, Vieri] Osped Mugello Azienda Sanitaria Firenze, Florence, Italy; [Fiore, Gilberto] Osped S Croce, Moncalieri, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milano-Bicocca; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Catholic University of the Sacred Heart; Azienda Sanitaria di Firenze	Gattinoni, L (corresponding author), Univ Milan, Dipartimento Fisiopatol Medico Chirurg & Trapiant, Fdn IRCCS Granda, Osped Maggiore Policlinico, Via F Sforza 35, I-20122 Milan, Italy.	gattinon@policlinico.mi.it	Iacobone, Emanuele/AAJ-8335-2020; Volta, Carlo A/G-5981-2012; Cortegiani, Andrea/H-4902-2016; Rocco, Monica/B-8407-2013; Fumagalli, Roberto/AAB-9746-2019; Antonelli, Massimo/K-9915-2016; Pesenti, Antonio/H-7483-2012; Colombo, Riccardo/AAK-9081-2020; Casadio, Rita/K-3747-2017; Latini, Roberto/AAB-1410-2020; Panigada, Mauro/K-4650-2014; Chelazzi, Cosimo/E-5611-2017	Volta, Carlo A/0000-0003-3533-6121; Cortegiani, Andrea/0000-0003-1416-9993; Rocco, Monica/0000-0001-8380-3607; Fumagalli, Roberto/0000-0003-0398-1329; Antonelli, Massimo/0000-0003-3007-1670; Pesenti, Antonio/0000-0003-2593-729X; Colombo, Riccardo/0000-0002-9616-803X; Latini, Roberto/0000-0002-3729-4650; Grasselli, Giacomo/0000-0002-1735-1400; martini, alvise/0000-0002-7280-5356; Panigada, Mauro/0000-0003-4841-9794; Bottazzi, Andrea/0000-0002-5531-298X; GIARRATANO, Antonino/0000-0001-9344-8311; Chelazzi, Cosimo/0000-0002-5156-8638; Gattinoni, Luciano/0000-0001-5380-2494; Raineri, Santi Maurizio/0000-0002-0675-2399; Caironi, Pietro/0000-0003-0490-0818; Vincent, Jean-Louis/0000-0001-6011-6951	Italian Medicines Agency	Italian Medicines Agency	Supported by the Italian Medicines Agency.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; ERSTAD BL, 1991, ARCH INTERN MED, V151, P901, DOI 10.1001/archinte.151.5.901; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Hollenberg SM, 1997, AM J PHYSIOL-REG I, V272, pR969, DOI 10.1152/ajpregu.1997.272.3.R969; Kellum JA, 2007, CONTRIB NEPHROL, V156, P10; KING TP, 1961, J BIOL CHEM, V236, pPC5; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; McCann KB, 2009, BIOLOGICALS, V37, P32, DOI 10.1016/j.biologicals.2008.08.004; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Quinlan GJ, 1998, CLIN SCI, V95, P459, DOI 10.1042/CS19980191; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; REEVES RB, 1976, J APPL PHYSIOL, V40, P762, DOI 10.1152/jappl.1976.40.5.762; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Vincent JL, 2011, MINERVA ANESTESIOL, V77, P1190; Vincent JL, 2009, BEST PRACT RES-CLIN, V23, P183, DOI 10.1016/j.bpa.2008.11.004; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; WEIL MH, 1979, CRIT CARE MED, V7, P113, DOI 10.1097/00003246-197903000-00006; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007	28	615	657	2	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1412	1421		10.1056/NEJMoa1305727	http://dx.doi.org/10.1056/NEJMoa1305727			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IW	24635772	Green Published			2022-12-28	WOS:000334095200009
J	Weinberg, BA; Owen-Smith, J; Rosen, RF; Schwarz, L; Allen, BM; Weiss, RE; Lane, J				Weinberg, Bruce A.; Owen-Smith, Jason; Rosen, Rebecca F.; Schwarz, Lou; Allen, Barbara McFadden; Weiss, Roy E.; Lane, Julia			Science Funding and Short-Term Economic Activity	SCIENCE			English	Editorial Material									[Weinberg, Bruce A.] Ohio State Univ, Columbus, OH 43210 USA; [Weinberg, Bruce A.] Inst Study Labor IZA, D-53113 Bonn, Germany; [Weinberg, Bruce A.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Owen-Smith, Jason] Univ Michigan, Ann Arbor, MI 48109 USA; [Rosen, Rebecca F.; Lane, Julia] Amer Inst Res, Washington, DC 20007 USA; [Schwarz, Lou] Factor 21, Arlington, VA 22201 USA; [Allen, Barbara McFadden] Comm Inst Cooperat, Champaign, IL 61820 USA; [Weiss, Roy E.] Univ Chicago, Chicago, IL 60637 USA; [Lane, Julia] Observ Sci & Tech, F-75015 Paris, France; [Lane, Julia] Univ Strasbourg, CNRS, BETA, F-6700 Strasbourg, France; [Lane, Julia] Univ Melbourne, Melbourne, Vic 3010, Australia	University System of Ohio; Ohio State University; IZA Institute Labor Economics; National Bureau of Economic Research; University of Michigan System; University of Michigan; American Institutes for Research; University of Chicago; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lorraine; University of Melbourne	Lane, J (corresponding author), Amer Inst Res, Washington, DC 20007 USA.	jlane@air.org	Owen-Smith, Jason/B-3665-2012	Lane, Julia/0000-0002-8139-2960; Owen-Smith, Jason/0000-0001-8007-1121; Weinberg, Bruce/0000-0001-8856-1803	NATIONAL INSTITUTE ON AGING [P01AG039347] Funding Source: NIH RePORTER; Direct For Education and Human Resources [1348701] Funding Source: National Science Foundation; Direct For Social, Behav & Economic Scie [1064220] Funding Source: National Science Foundation; Division Of Graduate Education [1348691] Funding Source: National Science Foundation; NIA NIH HHS [P01AG039347, P01 AG039347] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Graduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEGLEY S, 1991, NEWSWEEK        0114, P44; Center for the Science of Science and Innovation Policy, 2013, EMP FDN SCI INN POL; Furman JL, 2010, NATURE, V468, P757, DOI 10.1038/468757a; Lane J, 2011, SCIENCE, V331, P678, DOI 10.1126/science.1201865; Lerner J., 2012, RATE DIRECTION INVEN; National Collaborating Centre for Mental Health, 2010, CLIN GUIDELINE, P1; National Institutes of Health, 2012, BIOM RES WORKF WORK; NSF, 2013, HIGH ED RES DEV SURV; Owen-Smith J., 2012, J POLICY ANAL MANAG, V31, P741; Stephan P., 2012, EC SHAPES SCI	10	38	38	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					41	43		10.1126/science.1250055	http://dx.doi.org/10.1126/science.1250055			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE1RD	24700844	Green Accepted			2022-12-28	WOS:000333746100041
J	Woodroffe, R; Hedges, S; Durant, SM				Woodroffe, Rosie; Hedges, Simon; Durant, Sarah M.			To Fence or Not to Fence	SCIENCE			English	Editorial Material							POPULATIONS		[Woodroffe, Rosie; Durant, Sarah M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hedges, Simon; Durant, Sarah M.] Wildlife Conservat Soc, Bronx, NY 10460 USA	Zoological Society of London; Wildlife Conservation Society	Woodroffe, R (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	rosie.woodroffe@ioz.ac.uk	Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878				BENSHAHAR R, 1993, J TROP ECOL, V9, P249, DOI 10.1017/S0266467400007252; Cassidy L, 2013, AFR J ECOL, V51, P513, DOI 10.1111/aje.12061; Creel S, 2013, ECOL LETT, V16, P1413, DOI 10.1111/ele.12145; Davies-Mostert HT, 2013, J APPL ECOL, V50, P1358, DOI 10.1111/1365-2664.12129; Ewen John G., 2011, Conservation Evidence, V8, P58; Hoole A, 2010, GEOFORUM, V41, P304, DOI 10.1016/j.geoforum.2009.10.009; Jackson CR, 2012, WILDLIFE RES, V39, P31, DOI 10.1071/WR11070; Naess MW, 2013, INT J SUST DEV WORLD, V20, P123, DOI 10.1080/13504509.2013.779615; Nath C.D., 1998, ELEPHANT HUMAN CONFL; Packer C, 2013, Ecol Lett, V16, pe4, DOI 10.1111/ele.12171; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Shrader AM, 2010, BIODIVERS CONSERV, V19, P2235, DOI 10.1007/s10531-010-9836-7; Southern African Development Community, 2012, PHAK DECL AD NONG AP; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Woodroffe R., 2005, CONSERV BIOL	15	83	84	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					46	48		10.1126/science.1246251	http://dx.doi.org/10.1126/science.1246251			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700847	Green Published			2022-12-28	WOS:000333746100044
J	Ronan, N; Barrett, G				Ronan, Natalie; Barrett, George			Hearing impairment in a 5 year old child	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OTITIS-MEDIA		[Ronan, Natalie; Barrett, George] Royal Cornwall Hosp, Ear Nose & Throat Dept, Truro TR1 3LJ, England	Royal Cornwall Hospital	Ronan, N (corresponding author), Royal Cornwall Hosp, Ear Nose & Throat Dept, Truro TR1 3LJ, England.	natalieronan@doctors.net.uk						Browning GG, 2010, COCHRANE DB SYST REV, V10; Casselbrant ML, 2008, INT J AUDIOL, V47, P584, DOI 10.1080/14992020802331230; Griffin G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003423.pub3; Jardine AH, 1999, J LARYNGOL OTOL, V113, P314, DOI 10.1017/S0022215100143865; Keles E, 2004, INT J PEDIATR OTORHI, V68, P1069, DOI 10.1016/j.ijporl.2004.04.006; National Collaborating Centre for Women's and Children's Health, 2008, SURG MAN OT MED EFF; PERERA R, 2013, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD006285.PUB2; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, P8, DOI 10.1177/0194599813490141; Simpson SA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004163.pub2; van den Aardweg MTA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007810.pub2; van Zon A, 2012, COCHRANE DB SYST REV, V9, pCD009163, DOI DOI 10.1002/14651858.CD009163.PUB3	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2014	348								g2468	10.1136/bmj.g2468	http://dx.doi.org/10.1136/bmj.g2468			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TX	24699128				2022-12-28	WOS:000333978000014
J	Tamblyn, R; Eguale, T; Huang, A; Winslade, N; Doran, P				Tamblyn, Robyn; Eguale, Tewodros; Huang, Allen; Winslade, Nancy; Doran, Pamela			The Incidence and Determinants of Primary Nonadherence With Prescribed Medication in Primary Care A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ALTERNATING LOGISTIC REGRESSIONS; UNITED-STATES; HEALTH-INSURANCE; PRESCRIPTION NONADHERENCE; 1ST-FILL ADHERENCE; CHRONIC DISEASE; DRUG; CANADA; COST; MANAGEMENT	Background: Primary nonadherence is probably an important contributor to suboptimal disease management, but methodological challenges have limited investigation of it. Objective: To estimate the incidence of primary nonadherence in primary care and the drug, patient, and physician characteristics that are associated with nonadherence. Design: A prospective cohort of patients and all their incident prescriptions from primary care electronic health records between 2006 and 2009 linked to provincial drug insurer data on all drugs dispensed from community-based pharmacies were assembled. Setting: Quebec, Canada. Patients: 15 961 patients in a primary care network of 131 physicians. Measurements: Primary nonadherence was defined as not filling an incident prescription within 9 months. Multivariate alternating logistic regression was used to estimate predictors of nonadherence and account for patient and physician clustering. Results: Overall, 31.3% of the 37 506 incident prescriptions written for the 15 961 patients were not filled. Drugs in the upper quartile of cost were least likely to be filled (odds ratio [OR], 1.11 [95% CI, 1.07 to 1.17]), as were skin agents, gastrointestinal drugs, and autonomic drugs, compared with anti-infectives. Reduced odds of nonadherence were associated with increasing patient age (OR per 10 years, 0.89 [CI, 0.85 to 0.92]), elimination of prescription copayments for low-income groups (OR, 0.37 [CI, 0.32 to 0.41]), and a greater proportion of all physician visits with the prescribing physician (OR per 0.5 increase, 0.77 [CI, 0.70 to 0.85]). Limitation: Patients' rationale for choosing not to fill their prescriptions could not be measured. Conclusion: Primary nonadherence is common and may be reduced by lower drug costs and copayments, as well as increased follow-up care with prescribing physicians for patients with chronic conditions.	McGill Univ, Clin & Hlth Informat Res Grp, Montreal, PQ H3A 1A3, Canada; Univ Ottawa, Ottawa, ON, Canada; Ottawa Hosp, Ottawa, ON, Canada	McGill University; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Tamblyn, R (corresponding author), McGill Univ, Morrice House,1140 Pine Ave West, Montreal, PQ H3A 1A3, Canada.	robyn.tamblyn@mcgill.ca	Tamblyn, Robyn/L-6010-2016		Canadian Institutes of Health Research Fellowship	Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR))	Dr. Eguale was supported by the Canadian Institutes of Health Research Fellowship.	Alter David A, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P691, DOI 10.1586/14737167.3.6.691; American Society of Hospital Pharmacists, 2012, AHFS DRUG INF 2012; Ananth CV, 2004, J DENT RES, V83, P776, DOI 10.1177/154405910408301008; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Boothe K, 2012, J HEALTH POLIT POLIC, V37, P779, DOI 10.1215/03616878-1672718; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Briesacher B, 2009, SOC WORK PUBLIC HLTH, V24, P600, DOI 10.1080/19371910802672346; Calman NS, 2012, MT SINAI J MED, V79, P527, DOI 10.1002/msj.21335; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheetham TC, 2013, J MANAGE CARE PHARM, V19, P367, DOI 10.18553/jmcp.2013.19.5.367; Cope SF, 2008, PEDIATR PULM, V43, P745, DOI 10.1002/ppul.20847; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Daw JR, 2012, HEALTH POLICY, V104, P19, DOI 10.1016/j.healthpol.2011.08.015; Derose SF, 2013, JAMA INTERN MED, V173, P38, DOI 10.1001/2013.jamainternmed.717; Eguale T, 2008, DRUG SAFETY, V31, P1005, DOI 10.2165/00002018-200831110-00005; Eguale T, 2010, DRUG SAFETY, V33, P559, DOI 10.2165/11534580-000000000-00000; Ekedahl A, 2004, PHARM WORLD SCI, V26, P26, DOI 10.1023/B:PHAR.0000013464.09197.41; Fang R, 2009, PREV CHRONIC DIS, V6; Fischer MA, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.028; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hakim A, 2010, PROF CASE MANAG, V15, P62, DOI 10.1097/NCM.0b013e3181bcc823; Halm EA, 2006, CHEST, V129, P573, DOI 10.1378/chest.129.3.573; Halpin HA, 2010, PUBLIC HEALTH REV, V32, P120, DOI 10.1007/BF03391595; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hynd A, 2009, AUST NZ J PUBL HEAL, V33, P246, DOI 10.1111/j.1753-6405.2009.00383.x; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Kennedy J, 2006, CLIN THER, V28, P1217, DOI 10.1016/j.clinthera.2006.07.009; Kennedy J, 2009, CLIN THER, V31, P213, DOI 10.1016/j.clinthera.2009.01.006; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Ko DT, 2009, AM HEART J, V158, P592, DOI 10.1016/j.ahj.2009.06.030; Kraut A, 2001, DIABETES CARE, V24, P64, DOI 10.2337/diacare.24.1.64; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; Law MR, 2012, CAN MED ASSOC J, V184, P297, DOI 10.1503/cmaj.111270; Lexchin J, 2004, INT J HEALTH SERV, V34, P101, DOI 10.2190/4M3E-L0YF-W1TD-EKG0; Lexchin J., 2001, NATL PHARMACARE PLAN; McKee M, 2013, VALUE HEALTH, V16, pS39, DOI 10.1016/j.jval.2012.10.001; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Newhouse JP, 1993, FREE ALL LESSONS RAN, P8; Preisser JS, 2003, AM J EPIDEMIOL, V158, P495, DOI 10.1093/aje/kwg169; Raebel MA, 2012, J GEN INTERN MED, V27, P57, DOI 10.1007/s11606-011-1829-z; Reynolds K, 2013, OSTEOPOROSIS INT, V24, P2509, DOI 10.1007/s00198-013-2326-5; Rosenthal TC, 2008, J AM BOARD FAM MED, V21, P427, DOI 10.3122/jabfm.2008.05.070287; Samuelson Marianne, 2012, Qual Prim Care, V20, P303; Schoen C, 2000, HEALTH POLICY, V51, P67, DOI 10.1016/S0168-8510(99)00084-6; Schuetz B, 2010, HEALTH AFFAIR, V29, P1476, DOI 10.1377/hlthaff.2010.0052; Shah NR, 2009, AM J HYPERTENS, V22, P392, DOI 10.1038/ajh.2008.367; Shah NR, 2009, J GEN INTERN MED, V24, P233, DOI 10.1007/s11606-008-0870-z; Shin J, 2012, AM J MANAG CARE, V18, P426; Solomon MD, 2010, J GEN INTERN MED, V25, P280, DOI 10.1007/s11606-010-1286-0; Storm A, 2008, J AM ACAD DERMATOL, V59, P27, DOI 10.1016/j.jaad.2008.03.045; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Tamblyn R, 2006, J AM MED INFORM ASSN, V13, P148, DOI 10.1197/jamia.M1887; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Tamblyn R, 2010, ARCH INTERN MED, V170, P1064, DOI 10.1001/archinternmed.2010.167; Tamblyn R, 2010, MED DECIS MAKING, V30, P176, DOI 10.1177/0272989X09342752; Todd J, 2006, PEDIATRICS, V118, P577, DOI 10.1542/peds.2006-0162; Tunstall-Pedoe H, 2005, PREVENTING CHRONIC D; Ungar WJ, 2011, ANN ALLERG ASTHMA IM, V106, P17, DOI 10.1016/j.anai.2010.10.006; van der Linden CMJ, 2010, ARCH INTERN MED, V170, P1085, DOI 10.1001/archinternmed.2010.159; WHO, 2010, INT STAT CLASS DIS R; Wilchesky M, 2001, CAN J CLIN PHARM, V8, P39; Wilkins R, 1993, Health Rep, V5, P157; Yang Y, 2009, DRUG BENEFIT TRENDS, V21, P330; Zeber JE, 2013, VALUE HEALTH, V16, P891, DOI 10.1016/j.jval.2013.04.014	71	139	140	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					441	+		10.7326/M13-1705	http://dx.doi.org/10.7326/M13-1705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24687067				2022-12-28	WOS:000334093800001
J	Perrin, S				Perrin, Steve			Make mouse studies work	NATURE			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; LITHIUM; ALS; TRIAL; MICE; PROGRESSION; TDP-43; MODEL		ALS Therapy Dev Inst, Cambridge, MA USA		Perrin, S (corresponding author), ALS Therapy Dev Inst, Cambridge, MA USA.	sperrin@als.net						Aggarwal SP, 2010, LANCET NEUROL, V9, P481, DOI 10.1016/S1474-4422(10)70068-5; Allen C, 2013, LANCET NEUROL, V12, P339, DOI [10.1016/S1474-4422(13)70037-1, 10.1016/S1474-4422(13)700374]; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Hatzipetros T., 2013, BRAIN RES; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P557, DOI 10.1136/jnnp-2011-302021; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106	13	390	405	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					423	425		10.1038/507423a	http://dx.doi.org/10.1038/507423a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24678540	Bronze			2022-12-28	WOS:000333402000014
J	Virgin, HW				Virgin, Herbert W.			The Virome in Mammalian Physiology and Disease	CELL			English	Review							ENDOGENOUS RETROVIRUS HERV-K18; LATENT HERPESVIRUS-INFECTION; VIRAL-INFECTION; MURINE GAMMAHERPESVIRUS-68; VIRUS-INFECTION; HUMAN GUT; T-CELL; MICROBIOTA; IMMUNITY; COMMUNITIES	The virome contains the most abundant and fastest mutating genetic elements on Earth. The mammalian virome is constituted of viruses that infect host cells, virus-derived elements in our chromosomes, and viruses that infect the broad array of other types of organisms that inhabit us. Virome interactions with the host cannot be encompassed by a monotheistic view of viruses as pathogens. Instead, the genetic and transcriptional identity of mammals is defined in part by our coevolved virome, a concept with profound implications for understanding health and disease.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 South Euclid Ave, St Louis, MO 63110 USA.	virgin@wustl.edu		Virgin, Herbert/0000-0001-8580-7628	NIH [AI054483, U54 AI057160, AI084887, OD011170]; Crohn's and Colitis Foundation [3132, 274415]; Broad Medical Foundation [IBD-0357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054483, R01AI084887, U54AI057160] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; Broad Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H.W.V. is supported by NIH grants AI054483, U54 AI057160, AI084887, and OD011170, Crohn's and Colitis Foundation grants 3132 and 274415, and grant IBD-0357 from the Broad Medical Foundation.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ACTOR JK, 1993, P NATL ACAD SCI USA, V90, P948, DOI 10.1073/pnas.90.3.948; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Bao XD, 2013, CURR OPIN MICROBIOL, V16, P514, DOI 10.1016/j.mib.2013.05.007; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Canny SP, 2014, J VIROL, V88, P730, DOI 10.1128/JVI.02708-13; Colson P, 2013, J CLIN VIROL, V57, P191, DOI 10.1016/j.jcv.2013.03.018; Contreras-Galindo R, 2013, GENOME RES, V23, P1505, DOI 10.1101/gr.144303.112; Cuesta AM, 2006, IMMUNOLOGY, V117, P502, DOI 10.1111/j.1365-2567.2006.02325.x; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; DELATORRE JC, 1992, P NATL ACAD SCI USA, V89, P9939, DOI 10.1073/pnas.89.20.9939; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Eriksson F, 2009, J IMMUNOL, V182, P3105, DOI 10.4049/jimmunol.0800224; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Fulop T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00271; Gill EE, 2011, BIOESSAYS, V33, P248, DOI 10.1002/bies.201000091; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Haque A, 2004, CLIN EXP IMMUNOL, V138, P396, DOI 10.1111/j.1365-2249.2004.02652.x; Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Kamal SM, 2001, GASTROENTEROLOGY, V121, P646, DOI 10.1053/gast.2001.27024; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Mori K, 1996, ANTIVIR RES, V31, P79, DOI 10.1016/0166-3542(96)00951-5; Morsy MR, 2010, BIOCHEM BIOPH RES CO, V401, P225, DOI 10.1016/j.bbrc.2010.09.034; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Norman J.M., 2014, GASTROENTEROLOGY; Patel MR, 2011, CURR OPIN VIROL, V1, P304, DOI 10.1016/j.coviro.2011.06.007; Peacock JW, 2003, EUR J IMMUNOL, V33, P1849, DOI 10.1002/eji.200323148; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Popgeorgiev N, 2013, INTERVIROLOGY, V56, P395, DOI 10.1159/000354561; Prangishvili D, 2013, ANNU REV MICROBIOL, V67, P565, DOI 10.1146/annurev-micro-092412-155633; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Rosenberg R, 2013, P NATL ACAD SCI USA, V110, P13961, DOI 10.1073/pnas.1307243110; Sancho-Shimizu V, 2011, CURR OPIN VIROL, V1, P487, DOI 10.1016/j.coviro.2011.10.016; Sen A, 2012, P NATL ACAD SCI USA, V109, P20667, DOI 10.1073/pnas.1212188109; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Smith KA, 2007, J IMMUNOL, V179, P7325, DOI 10.4049/jimmunol.179.11.7325; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Sutkowski N, 2004, J VIROL, V78, P7852, DOI 10.1128/JVI.78.14.7852-7860.2004; UHR JW, 1962, J CLIN INVEST, V41, P1509, DOI 10.1172/JCI104606; VALSAMAKIS A, 1987, VIROLOGY, V156, P214, DOI 10.1016/0042-6822(87)90400-4; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; White DW, 2012, IMMUNOL REV, V245, P189, DOI 10.1111/j.1600-065X.2011.01074.x; White DW, 2010, BLOOD, V115, P4377, DOI 10.1182/blood-2009-09-245464; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Woolhouse MEJ, 2008, P ROY SOC B-BIOL SCI, V275, P2111, DOI 10.1098/rspb.2008.0294; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018	74	368	384	1	107	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					142	150		10.1016/j.cell.2014.02.032	http://dx.doi.org/10.1016/j.cell.2014.02.032			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679532	Green Accepted, Bronze			2022-12-28	WOS:000333968900013
J	Yvon-Durocher, G; Allen, AP; Bastviken, D; Conrad, R; Gudasz, C; St-Pierre, A; Thanh-Duc, N; del Giorgio, PA				Yvon-Durocher, Gabriel; Allen, Andrew P.; Bastviken, David; Conrad, Ralf; Gudasz, Cristian; St-Pierre, Annick; Nguyen Thanh-Duc; del Giorgio, Paul A.			Methane fluxes show consistent temperature dependence across microbial to ecosystem scales	NATURE			English	Article							EMISSIONS; CARBON; MODEL; WETLANDS; METHANOGENESIS; RESPIRATION	Methane (CH4) is an important greenhouse gas because it has 25 times the global warming potential of carbon dioxide (CO2) by mass over a century(1). Recent calculations suggest that atmospheric CH4 emissions have been responsible for approximately 20% of Earth's warming since pre-industrial times(2). Understanding how CH4 emissions from ecosystems will respond to expected increases in global temperature is therefore fundamental to predicting whether the carbon cycle will mitigate or accelerate climate change. Methanogenesis is the terminal step in the remineralization of organic matter and is carried out by strictly anaerobic Archaea(3). Like most other forms of metabolism, methanogenesis is temperature-dependent(4,5). However, it is not yet known how this physiological response combines with other biotic processes (for example, methanotrophy(6), substrate supply(3,7), microbial community composition(8)) and abiotic processes (for example, water-table depth(9,10)) to determine the temperature dependence of ecosystem-level CH4 emissions. It is also not known whether CH4 emissions at the ecosystem level have a fundamentally different temperature dependence than other key fluxes in the carbon cycle, such as photosynthesis and respiration. Here we use meta-analyses to show that seasonal variations in CH4 emissions from a wide range of ecosystems exhibit an average temperature dependence similar to that of CH4 production derived from pure cultures of methanogens and anaerobic microbial communities. This average temperature dependence (0.96 electron volts (eV)), which corresponds to a 57-fold increase between 0 and 30 degrees C, is considerably higher than previously observed for respiration (approximately 0.65 eV)(11) and photosynthesis (approximately 0.3 eV)(12). As a result, we show that both the emission of CH4 and the ratio of CH4 to CO2 emissions increase markedly with seasonal increases in temperature. Our findings suggest that global warming may have a large impact on the relative contributions of CO2 and CH4 to total greenhouse gas emissions from aquatic ecosystems, terrestrial wetlands and rice paddies.	[Yvon-Durocher, Gabriel] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England; [Allen, Andrew P.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58183 Linkoping, Sweden; [Conrad, Ralf] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Gudasz, Cristian] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Gudasz, Cristian] Uppsala Univ, Dept Ecol & Genet, SE-75236 Uppsala, Sweden; [St-Pierre, Annick; del Giorgio, Paul A.] Univ Quebec, Dept Sci Biol, Montreal, PQ H2X 3X8, Canada; [Nguyen Thanh-Duc] Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA	University of Exeter; Macquarie University; Linkoping University; Max Planck Society; Umea University; Uppsala University; University of Quebec; University of Quebec Montreal; University System Of New Hampshire; University of New Hampshire	Yvon-Durocher, G (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England.	g.yvon-durocher@exeter.ac.uk	del Giorgio, Paul/AAD-1315-2019; Yvon-Durocher, Gabriel/M-4600-2014; Toledo-Morales, Purificacion/K-8999-2014	del Giorgio, Paul/0000-0003-1866-8159; Yvon-Durocher, Gabriel/0000-0002-1749-3417; Toledo-Morales, Purificacion/0000-0002-2160-0000; Bastviken, David/0000-0003-0038-2152; Allen, Andrew/0000-0003-0304-7544				Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Bastviken D, 2010, ENVIRON SCI TECHNOL, V44, P5450, DOI 10.1021/es1005048; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; Christensen TR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016848; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Eyring H, 1935, CHEM REV, V17, P65, DOI 10.1021/cr60056a006; Fey A, 2000, APPL ENVIRON MICROB, V66, P4790, DOI 10.1128/AEM.66.11.4790-4797.2000; Forster P., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1103/PHYSREVB.77.220407; Gedney N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020919; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Lapierre JF, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001945; Lofton DD, 2014, HYDROBIOLOGIA, V721, P209, DOI 10.1007/s10750-013-1663-x; Megonigal JP, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001594; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; Moore TR, 1998, CLIMATIC CHANGE, V40, P229, DOI 10.1023/A:1005408719297; MOORE TR, 1993, GEOPHYS RES LETT, V20, P587, DOI 10.1029/93GL00208; Nguyen TD, 2010, BIOGEOCHEMISTRY, V100, P185, DOI 10.1007/s10533-010-9415-8; Pinheiro JC, 2000, MIXED EFFECTS MODELS; R Development Core Team, 2009, R LANG ENV STAT COMP; Riley WJ, 2011, BIOGEOSCIENCES, V8, P1925, DOI 10.5194/bg-8-1925-2011; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; Spahni R, 2011, BIOGEOSCIENCES, V8, P1643, DOI 10.5194/bg-8-1643-2011; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Vachon D, 2010, LIMNOL OCEANOGR, V55, P1723, DOI 10.4319/lo.2010.55.4.1723; van Bodegom PM, 1999, CHEMOSPHERE, V39, P167, DOI 10.1016/S0045-6535(99)00101-0; VANDENBERG L, 1976, CAN J MICROBIOL, V22, P1312, DOI 10.1139/m76-194; Walter BP, 2000, GLOBAL BIOGEOCHEM CY, V14, P745, DOI 10.1029/1999GB001204; Wania R, 2010, GEOSCI MODEL DEV, V3, P565, DOI 10.5194/gmd-3-565-2010; WESTERMANN P, 1989, APPL ENVIRON MICROB, V55, P1262, DOI 10.1128/AEM.55.5.1262-1266.1989; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Yao H, 2000, BIOL FERT SOILS, V32, P135, DOI 10.1007/s003740000227; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1225, DOI 10.1111/j.1365-2486.2010.02289.x; ZINDER SH, 1984, APPL ENVIRON MICROB, V47, P808, DOI 10.1128/AEM.47.4.808-813.1984; Zuur A.F., 2009, MIXED EFFECTS MODELS, P574	38	493	519	47	830	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					488	491		10.1038/nature13164	http://dx.doi.org/10.1038/nature13164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670769	Green Submitted			2022-12-28	WOS:000333402000038
J	Goldberg, DS; French, B; Forde, KA; Groeneveld, PW; Bittermann, T; Backus, L; Halpern, SD; Kaplan, DE				Goldberg, David S.; French, Benjamin; Forde, Kimberly A.; Groeneveld, Peter W.; Bittermann, Therese; Backus, Lisa; Halpern, Scott D.; Kaplan, David E.			Association of Distance From a Transplant Center With Access to Waitlist Placement, Receipt of Liver Transplantation, and Survival Among US Veterans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATITIS-C VIRUS; BARIATRIC SURGERY; UNITED-STATES; PRIMARY-CARE; SERVICES; POLICY; MODEL; IMPLEMENTATION; EXCELLENCE; GUIDELINES	IMPORTANCE Centralization of specialized health care services such as organ transplantation and bariatric surgery is advocated to improve quality, increase efficiency, and reduce cost. The effect of increased travel on access and outcomes from these services is not fully understood. OBJECTIVE To evaluate the association between distance from a Veterans Affairs (VA) transplant center (VATC) and access to being waitlisted for liver transplantation, actually having a liver transplant, and mortality. DESIGN, SETTING, AND PARTICIPANTS Retrospective study of veterans meeting liver transplantation eligibility criteria from January 1, 2003, until December 31, 2010, using data from the Veterans Health Administration's integrated, national, electronic medical record linked to Organ Procurement and Transplantation Network data. MAIN OUTCOMES AND MEASURES The primary outcome was being waitlisted for transplantation at a VATC. Secondary outcomes included being waitlisted at any transplant center, undergoing a transplantation, and survival. RESULTS From 2003-2010, 50 637 veterans were classified as potentially eligible for transplant; 2895 (6%) were waitlisted and 1418 of those were waitlisted (49%) at 1 of the 5 VATCs. Of 3417 veterans receiving care at a VA hospital located within 100 miles from a VATC, 244 (7.1%) were waitlisted at a VATC and 372 (10.9%) at any transplant center (VATC and non-VATCs). Of 47 219 veterans receiving care at a VA hospital located more than 100 miles from a VATC, 1174 (2.5%) were waitlisted at a VATC and 2523 (5.3%) at any transplant center (VATC and non-VATCs). In multivariable models, increasing distance to closest VATC was associated with significantly lower odds of being waitlisted at a VATC (odds ratio [OR], 0.91 [95% CI, 0.89-0.93] for each doubling in distance) or any transplant center (OR, 0.94 [95% CI, 0.92-0.96] for each doubling in distance). For example, a veteran living 25 miles from a VATC would have a 7.4%(95% CI, 6.6%-8.1%) adjusted probability of being waitlisted, whereas a veteran 100 miles from a VATC would have a 6.2%(95% CI, 5.7%-6.6%) adjusted probability. In adjusted models, increasing distance from a VATC was associated with significantly lower transplantation rates (subhazard ratio, 0.97; 95% CI, 0.95-0.98 for each doubling in distance). There was significantly increased mortality among waitlisted veterans from the time of first hepatic decompensation event in multivariable survival models (hazard ratio, 1.03; 95% CI, 1.01-1.04 for each doubling in distance). For example, a waitlisted veteran living 25 miles from a VATC would have a 62.9% (95% CI, 59.1%-66.1%) 5-year adjusted probability of survival from first hepatic decompensation event compared with a 59.8%(95% CI, 56.3%-63.1%) 5-year adjusted probability of survival for a veteran living 100 miles from a VATC. CONCLUSIONS AND RELEVANCE Among VA patients meeting eligibility criteria for liver transplantation, greater distance from a VATC or any transplant center was associated with lower likelihood of being waitlisted, receiving a liver transplant, and greater likelihood of death. The relationship between these findings and centralizing specialized care deserves further investigation.	[Goldberg, David S.; Forde, Kimberly A.; Kaplan, David E.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Goldberg, David S.; French, Benjamin; Forde, Kimberly A.; Halpern, Scott D.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Goldberg, David S.; French, Benjamin; Groeneveld, Peter W.; Halpern, Scott D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Groeneveld, Peter W.] Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Groeneveld, Peter W.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Bittermann, Therese] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Backus, Lisa] Dept Vet Affairs, Off Publ Hlth, Philadelphia, PA USA; [Halpern, Scott D.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Kaplan, David E.] Philadelphia VA Med Ctr, Gastroenterol Sect, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Goldberg, DS (corresponding author), Hosp Univ Penn, 3400 Civ Ctr Blvd,9 Penn Tower, Philadelphia, PA 19104 USA.	david.goldberg@uphs.upenn.edu	Bittermann, Therese/AAG-1406-2019	Bittermann, Therese/0000-0002-8576-0193; Groeneveld, Peter/0000-0002-7374-4292; Kaplan, David/0000-0002-3839-336X	Health Resources and Services Administration [234-2005-37011C]	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This work was supported in part by Health Resources and Services Administration contract 234-2005-37011C.	[Anonymous], US HOSPITALS WITH LI; Axelrod DA, 2008, JAMA-J AM MED ASSOC, V299, P202, DOI 10.1001/jama.2007.50; Backus LI, 2007, HEPATOLOGY, V46, P37, DOI 10.1002/hep.21662; Backus LI, 2013, JAMA INTERN MED, V173, P1549, DOI 10.1001/jamainternmed.2013.8133; Backus LI, 2009, J AM MED INFORM ASSN, V16, P775, DOI 10.1197/jamia.M3203; Ballman KV, 2008, CIRCULATION, V118, P1593, DOI 10.1161/CIRCULATIONAHA.107.714600; Beehler GP, 2013, PAIN MED, V14, P1021, DOI 10.1111/pme.12126; Bittermann T, 2012, LIVER TRANSPLANT, V18, P1302, DOI 10.1002/lt.23537; Blue Cross and Blue Shield, BLUE DISTINCTION SEL; Bryce CL, 2009, AM J TRANSPLANT, V9, P2092, DOI 10.1111/j.1600-6143.2009.02737.x; Carr Brendan G, 2009, LDI Issue Brief, V14, P1; Carr BG, 2009, ANN EMERG MED, V54, P261, DOI 10.1016/j.annemergmed.2008.11.016; Centers for Medicare & Medicaid Services, MEDICARE NATIONAL CO; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Evans R W, 1997, Clin Liver Dis, V1, P287, DOI 10.1016/S1089-3261(05)70272-5; Evans RW, 1997, CLIN LIVER DIS, V1, pviii; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; French B, 2008, STAT MED, V27, P5005, DOI 10.1002/sim.3340; Gillespie BW, 2010, AM J TRANSPLANT, V10, P1621, DOI 10.1111/j.1600-6143.2010.03039.x; Goldberg DS, 2011, TRANSPLANTATION, V91, P1148, DOI 10.1097/TP.0b013e31821694b3; Gregory PM, 2000, MED CARE, V38, P45, DOI 10.1097/00005650-200001000-00006; Julapalli VR, 2005, LIVER TRANSPLANT, V11, P1370, DOI 10.1002/lt.20434; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Katz IR, 2012, AM J PUBLIC HEALTH, V102, pS105, DOI 10.2105/AJPH.2011.300503; Kim WR, 2006, HEPATOLOGY, V43, P345, DOI 10.1002/hep.21025; Livingston EH, 2010, ARCH SURG-CHICAGO, V145, P993, DOI 10.1001/archsurg.2010.218; Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148; Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; O'Leary JG, 2008, GASTROENTEROLOGY, V134, P1764, DOI 10.1053/j.gastro.2008.02.028; Organ Procurement and Transplantation Network, POLICIES AND BYLAWS; Stitzenberg KB, 2010, ANN SURG ONCOL, V17, P2824, DOI 10.1245/s10434-010-1159-0; Stitzenberg KB, 2009, J CLIN ONCOL, V27, P4671, DOI 10.1200/JCO.2008.20.1715; Thabut G, 2012, AM J TRANSPLANT, V12, P3085, DOI 10.1111/j.1600-6143.2012.04202.x; Tonelli M, 2009, JAMA-J AM MED ASSOC, V301, P1681, DOI 10.1001/jama.2009.545; US Department of Veteran Affairs, VA CMS DATA REPOSITO; Wang L, 2013, MED CARE, V51, P368, DOI 10.1097/MLR.0b013e31827da95a; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Yeh HD, 2011, TRANSPLANTATION, V91, P479, DOI 10.1097/TP.0b013e3182066275; Zorzi D, 2012, AM J TRANSPLANT, V12, P2188, DOI 10.1111/j.1600-6143.2012.04083.x	40	100	100	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1234	1243		10.1001/jama.2014.2520	http://dx.doi.org/10.1001/jama.2014.2520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668105	Green Accepted			2022-12-28	WOS:000333340500027
J	Russell, R; Clasper, J; Jenner, B; Hodgetts, TJ; Mahoney, PF				Russell, Rob; Clasper, Jon; Jenner, Bruce; Hodgetts, Timothy J.; Mahoney, Peter F.			ABC of Major Trauma, 4th Edition Ballistic Injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												digitalrightsuk@wiley.com						*BORD I, 2004, EM WAR SURG; Brooks AJ, 2011, RYAN'S BALLISTIC TRAUMA: A PRACTICAL GUIDE, THIRD EDITION, P1, DOI 10.1007/978-1-84882-124-8; COUPLAND RM, 2001, CARE FIELD VICTIMS W; Coupland RM, 2000, WAR WOUNDS LIMBS SUR; DUFOUR D, 1998, SURG VICTIMS WAR; Giannou C, 2009, WAR SURG; HODGETTS TJ, 2002, MAJOR INCIDENT MANAG; Hodgetts TJ, 2006, J RAMC S, V152; HUSUM H, 2000, SAVE LIVES SAVE LIMB; HUSUM H, 1995, WAR SURG FIELD MANUA; International Committee of the Red Cross, 2006, 1 AID ARM CONFL OTH; Roberts P, 2004, BRIT MILITARY SURG P; Ross AH, GUNSHOT WOUNDS SUMMA; RYAN JM, 1997, BALLISTIC TRAUMA CLI	14	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2014	348								g1143	10.1136/bmj.g1143	http://dx.doi.org/10.1136/bmj.g1143			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9KZ	24665141				2022-12-28	WOS:000333585300001
J	Cai, HQ; Katoh-Kurasawa, M; Muramoto, T; Santhanam, B; Long, Y; Li, L; Ueda, M; Iglesias, PA; Shaulsky, G; Devreotes, PN				Cai, Huaqing; Katoh-Kurasawa, Mariko; Muramoto, Tetsuya; Santhanam, Balaji; Long, Yu; Li, Lei; Ueda, Masahiro; Iglesias, Pablo A.; Shaulsky, Gad; Devreotes, Peter N.			Nucleocytoplasmic Shuttling of a GATA Transcription Factor Functions as a Development Timer	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM; CYCLIC-AMP; ADENYLYL-CYCLASE; OSCILLATIONS; DYNAMICS; AGGREGATION; ACTIVATION; EXPRESSION; INDUCTION; CELLS	Biological oscillations are observed at many levels of cellular organization. In the social amoeba Dictyostelium discoideum, starvation-triggered multicellular development is organized by periodic cyclic adenosine 3',5'-monophosphate (cAMP) waves, which provide both chemoattractant gradients and developmental signals. We report that GtaC, a GATA transcription factor, exhibits rapid nucleocytoplasmic shuttling in response to cAMP waves. This behavior requires coordinated action of a nuclear localization signal and reversible G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor-mediated phosphorylation. Although both are required for developmental gene expression, receptor occupancy promotes nuclear exit of GtaC, which leads to a transient burst of transcription at each cAMP cycle. We demonstrate that this biological circuit filters out high-frequency signals and counts those admitted, thereby enabling cells to modulate gene expression according to the dynamic pattern of the external stimuli.	[Cai, Huaqing; Long, Yu; Iglesias, Pablo A.; Devreotes, Peter N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Katoh-Kurasawa, Mariko; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Muramoto, Tetsuya; Ueda, Masahiro] RIKEN Quantitat Biol Ctr, Lab Cell Signaling Dynam, Osaka 5650874, Japan; [Santhanam, Balaji; Shaulsky, Gad] Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Li, Lei] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Ueda, Masahiro] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5650043, Japan; [Iglesias, Pablo A.] Johns Hopkins Univ, Whiting Sch Engn, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Baylor College of Medicine; RIKEN; Baylor College of Medicine; University of Virginia; Osaka University; Johns Hopkins University	Devreotes, PN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	pnd@jhmi.edu	Iglesias, Pablo A/A-5202-2008; Muramoto, Tetsuya/C-9127-2011	Iglesias, Pablo A/0000-0002-0840-155X; Muramoto, Tetsuya/0000-0001-9624-8577; Cai, Huaqing/0000-0001-8434-6639; Ueda, Masahiro/0000-0002-9354-3404; Shaulsky, Gad/0000-0002-0532-0551	NIH [GM 28007, GM 34933, HD 039691]; Helen Hay Whitney postdoctoral fellowship; JSPS KAKENHI [25840095]; RIKEN Incentive Research Projects; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM034933, R01GM028007] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney postdoctoral fellowship; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Incentive Research Projects; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. R. Kay for providing the library used for the genetic screen and S. Willard and J. Borleis from the Devreotes laboratory for the initial characterization of the library. We thank J. A. Hadwiger and the Dictyostelium stock center (www.dictybase.org) for providing the erkA<SUP>-</SUP>, erkB<SUP>-</SUP>, erkA<SUP>-</SUP>B<SUP>-</SUP>, and gskA<SUP>-</SUP> cell lines; the proteomics core facility in Johns Hopkins University, School of Medicine, for phosphoproteomic analysis; the microscope facility in Johns Hopkins University, School of Medicine, Institute for Basic Biomedical Sciences, for assistance with imaging; and B. Zupan and G. Rot (University of Ljubljana) for assistance with RNA-Seq analyses. Antibody to CsaA (33-294-17-s) was a gift from the Developmental Studies Hybridoma Bank. We also thank P. J. Espenshade and D. J. Andrew for critical reading of the manuscript. This work was supported by NIH grants GM 28007 and GM 34933 (to P.N.D.), HD 039691 (to G.S.), Helen Hay Whitney postdoctoral fellowship (to H.C.), and JSPS KAKENHI 25840095 and RIKEN Incentive Research Projects (to T.M.). RNA-Seq data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GSE54866).	ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321, DOI 10.1099/00221287-85-2-321; Artemenko Y, 2011, METHODS MOL BIOL, V769, P287, DOI 10.1007/978-1-61779-207-6_20; Bader S, 2007, BIOCHEM J, V402, P153, DOI 10.1042/BJ20061153; BARKLEY DS, 1969, SCIENCE, V165, P1133, DOI 10.1126/science.165.3898.1133; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Cai HQ, 2011, METHODS MOL BIOL, V757, P451, DOI 10.1007/978-1-61779-166-6_26; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dormann D, 2002, CURR BIOL, V12, P1178, DOI 10.1016/S0960-9822(02)00950-8; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang EY, 2011, DEV BIOL, V358, P137, DOI 10.1016/j.ydbio.2011.07.017; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; KONIJN TM, 1969, NATURE, V224, P1211, DOI 10.1038/2241211a0; Kuspa Adam, 2006, V346, P201; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lim CJ, 2001, EMBO J, V20, P4490, DOI 10.1093/emboj/20.16.4490; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Otsuka H, 1998, GENE DEV, V12, P1738, DOI 10.1101/gad.12.11.1738; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; ROSSIER C, 1979, J CELL SCI, V35, P321; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Teo R, 2010, MOL BIOL CELL, V21, P2788, DOI 10.1091/mbc.E09-10-0891; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Veltman DM, 2009, PLASMID, V61, P119, DOI 10.1016/j.plasmid.2008.11.002; WURSTER B, 1983, J CELL BIOL, V96, P1566, DOI 10.1083/jcb.96.6.1566; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440	40	48	48	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1329	+	1249531	10.1126/science.1249531	http://dx.doi.org/10.1126/science.1249531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653039	Green Accepted			2022-12-28	WOS:000333108500029
J	Bridges, CB; Coyne-Beasley, T				Bridges, Carolyn B.; Coyne-Beasley, Tamera		Advisory Comm Immunization Practic	Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2014	ANNALS OF INTERNAL MEDICINE			English	Article							BARRIERS		[Bridges, Carolyn B.; Coyne-Beasley, Tamera] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Bridges, CB (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, 1600 Clifton Rd,MS A-19, Atlanta, GA 30329 USA.	cbridges@cdc.gov						[Anonymous], COMM GUID VACC PREV; [Anonymous], MMWR MORB M IN PRESS; [Anonymous], MMWR RECOMM IN PRESS; [Anonymous], UPD NAT VACC ADV COM; Ball S, 2013, MMWR-MORBID MORTAL W, V62, P787; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Miller BL, 2011, VACCINE, V29, P3850, DOI 10.1016/j.vaccine.2011.03.058; Tan TQ, 2011, J REPROD MED, V56, P301; Zimmerman RK, 2011, AM J PREV MED, V40, P144, DOI 10.1016/j.amepre.2010.10.027	10	26	29	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					190	+		10.7326/M13-2826	http://dx.doi.org/10.7326/M13-2826			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2VE	24658695				2022-12-28	WOS:000330951500006
J	Lee, JK; Liles, EG; Bent, S; Levin, TR; Corley, DA				Lee, Jeffrey K.; Liles, Elizabeth G.; Bent, Stephen; Levin, Theodore R.; Corley, Douglas A.			Accuracy of Fecal Immunochemical Tests for Colorectal Cancer Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							OCCULT BLOOD-TEST; DIAGNOSTIC-TEST; AVERAGE-RISK; LONGITUDINAL ADHERENCE; COLONOSCOPY; POPULATION; PERFORMANCE; SENSITIVITY; NEOPLASMS; LANGUAGE	Background: Performance characteristics of fecal immunochemical tests (FITs) to screen for colorectal cancer (CRC) have been inconsistent. Purpose: To synthesize data about the diagnostic accuracy of FITs for CRC and identify factors affecting its performance characteristics. Data Sources: Online databases, including MEDLINE and EMBASE, and bibliographies of included studies from 1996 to 2013. Study Selection: All studies evaluating the diagnostic accuracy of FITs for CRC in asymptomatic, average-risk adults. Data Extraction: Two reviewers independently extracted data and critiqued study quality. Data Synthesis: Nineteen eligible studies were included and metaanalyzed. The pooled sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of FITs for CRC were 0.79 (95% CI, 0.69 to 0.86), 0.94 (CI, 0.92 to 0.95), 13.10 (CI, 10.49 to 16.35), 0.23 (CI, 0.15 to 0.33), respectively, with an overall diagnostic accuracy of 95% (CI, 93% to 97%). There was substantial hetero-geneity between studies in both the pooled sensitivity and specificity estimates. Stratifying by cutoff value for a positive test result or removal of discontinued FIT brands resulted in homogeneous sensitivity estimates. Sensitivity for CRC improved with lower assay cutoff values for a positive test result (for example, 0.89 [CI, 0.80 to 0.95] at a cutoff value less than 20 mu g/g vs. 0.70 [CI, 0.55 to 0.81] at cutoff values of 20 to 50 mu g/g) but with a corresponding decrease in specificity. A single-sample FIT had similar sensitivity and specificity as several samples, independent of FIT brand. Limitations: Only English-language articles were included. Lack of data prevented complete subgroup analyses by FIT brand. Conclusion: Fecal immunochemical tests are moderately sensitive, are highly specific, and have high overall diagnostic accuracy for detecting CRC. Diagnostic performance of FITs depends on the cutoff value for a positive test result.	[Lee, Jeffrey K.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Liles, Elizabeth G.] Kaiser Permanente, Ctr Hlth Res, Portland, OR 97227 USA; [Bent, Stephen] Univ Calif San Francisco, Vet Affairs Med Ctr, Osher Ctr Integrat Med, Dept Med, San Francisco, CA 94121 USA; [Levin, Theodore R.; Corley, Douglas A.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA	University of California System; University of California San Francisco; Kaiser Permanente; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Kaiser Permanente	Corley, DA (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	Douglas.Corley@kp.org			National Institutes of Health [T32DK007007]; National Cancer Institute [U54 CA163262]; National Institute of Diabetes and Digestive and Kidney Diseases [T32DK007007]; National Cancer Institute Cancer Research Network [U24 CA171524]; Population-Based Research Optimizing Screening through Personalized Regimens [U54 CA163262]; NATIONAL CANCER INSTITUTE [U24CA171524, U54CA163262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute Cancer Research Network; Population-Based Research Optimizing Screening through Personalized Regimens; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institutes of Health (T32DK007007), National Cancer Institute (U54 CA163262), National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007007), National Cancer Institute Cancer Research Network (U24 CA171524), and Population-Based Research Optimizing Screening through Personalized Regimens (U54 CA163262).	Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Chen LS, 2011, LANCET ONCOL, V12, P551, DOI 10.1016/S1470-2045(11)70101-2; Cheng TI, 2002, J FORMOS MED ASSOC, V101, P685; Chiang TH, 2011, CAN MED ASSOC J, V183, P1474, DOI 10.1503/cmaj.101248; Chiu HM, 2013, CLIN GASTROENTEROL H, V11, P832, DOI 10.1016/j.cgh.2013.01.013; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; Dwamena Ben A, 2007, MIDAS STATA MODULE M; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Fenton JJ, 2010, ANN FAM MED, V8, P397, DOI 10.1370/afm.1133; Fraser CG, 2012, JNCI-J NATL CANCER I, V104, P810, DOI 10.1093/jnci/djs190; Gellad ZF, 2011, AM J GASTROENTEROL, V106, P1125, DOI 10.1038/ajg.2011.11; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Itoh M, 1996, J Med Screen, V3, P66; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Launoy GD, 2005, INT J CANCER, V115, P493, DOI 10.1002/ijc.20921; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Levi Z, 2007, ANN INTERN MED, V146, P244, DOI 10.7326/0003-4819-146-4-200702200-00003; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Nakama H, 1996, J Med Screen, V3, P63; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; Nakazato M., 2006, JMAJ - Japan Medical Association Journal, V49, P203; Pai MMM, 2004, EVID BASED MED, V141, pA11, DOI DOI 10.1136/EBM.9.4.101; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Parra-Blanco A, 2010, J GASTROENTEROL, V45, P703, DOI 10.1007/s00535-010-0214-8; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Rabeneck L, 2012, CAN J GASTROENTEROL, V26, P131, DOI 10.1155/2012/486328; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sohn Dae Kyung, 2005, Cancer Res Treat, V37, P20, DOI 10.4143/crt.2005.37.1.20; Stegeman I, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-73; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992	55	418	435	2	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					171	+		10.7326/M13-1484	http://dx.doi.org/10.7326/M13-1484			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2VE	24658694	Green Accepted			2022-12-28	WOS:000330951500004
J	Master, CL; Balcer, L; Collins, M				Master, Christina L.; Balcer, Laura; Collins, Michael			Concussion	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; UNITED-STATES; RISK-FACTORS; SPORTS; EPIDEMIOLOGY; YOUTH							Master, Christina/0000-0002-6717-4270				Cusimano Michael D, 2011, Open Med, V5, pe57; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Moreno MA, 2011, ARCH PEDIAT ADOL MED, V165, P376, DOI 10.1001/archpediatrics.2011.31; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Shrey DW, 2011, PHYS MED REH CLIN N, V22, pvii; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	16	11	11	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3							ITC2-2	10.7326/0003-4819-160-3-201402040-01002	http://dx.doi.org/10.7326/0003-4819-160-3-201402040-01002			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QN	24658701				2022-12-28	WOS:000364906900001
J	Lin, IW; Sosso, D; Chen, LQ; Gase, K; Kim, SG; Kessler, D; Klinkenberg, PM; Gorder, MK; Hou, BH; Qu, XQ; Carter, CJ; Baldwin, IT; Frommer, WB				Lin, I. Winnie; Sosso, Davide; Chen, Li-Qing; Gase, Klaus; Kim, Sang-Gyu; Kessler, Danny; Klinkenberg, Peter M.; Gorder, Molly K.; Hou, Bi-Huei; Qu, Xiao-Qing; Carter, Clay J.; Baldwin, Ian T.; Frommer, Wolf B.			Nectar secretion requires sucrose phosphate synthases and the sugar transporter SWEET9	NATURE			English	Article							DIFFERENTIAL GENE-EXPRESSION; TRANSFORMATION; GENERATION; SELECTION; PROTEINS; EXCHANGE; SEQUENCE; FLOWERS; LINES	Angiosperms developed floral nectaries that reward pollinating insects(1). Although nectar function and composition have been characterized, the mechanism of nectar secretion has remained unclear(2). Here we identify SWEET9 as a nectary-specific sugar transporter in three eudicot species: Arabidopsis thaliana, Brassica rapa (extrastaminal nectaries) and Nicotiana attenuata (gynoecial nectaries). We show that SWEET9 is essential for nectar production and can function as an efflux transporter. We also show that sucrose phosphate synthase genes, encoding key enzymes for sucrose biosynthesis, are highly expressed in nectaries and that their expression is also essential for nectar secretion. Together these data are consistent with a model in which sucrose is synthesized in the nectary parenchyma and subsequently secreted into the extracellular space via SWEET9, where sucrose is hydrolysed by an apoplasmic invertase to produce a mixture of sucrose, glucose and fructose. The recruitment of SWEET9 for sucrose export may have been a key innovation, and could have coincided with the evolution of core eudicots and contributed to the evolution of nectar secretion to reward pollinators.	[Lin, I. Winnie; Sosso, Davide; Frommer, Wolf B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Lin, I. Winnie; Sosso, Davide; Chen, Li-Qing; Hou, Bi-Huei; Qu, Xiao-Qing; Frommer, Wolf B.] Carnegie Inst Sci, Stanford, CA 94305 USA; [Gase, Klaus; Kim, Sang-Gyu; Kessler, Danny; Baldwin, Ian T.] Max Planck Inst Chem Oekol, D-07745 Jena, Germany; [Klinkenberg, Peter M.; Gorder, Molly K.; Carter, Clay J.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Qu, Xiao-Qing] China Agr Univ, Key Lab Plant & Soil Interact, Coll Resources & Environm Sci, Beijing 100193, Peoples R China	Stanford University; Carnegie Institution for Science; Max Planck Society; University of Minnesota System; University of Minnesota Duluth; China Agricultural University	Frommer, WB (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Kim, Sang-Gyu/T-5925-2017; Baldwin, Ian T/K-1809-2013; Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Baldwin, Ian/0000-0001-5371-2974	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy [DE-FG02-04ER15542]; Department of Biology, Stanford University; Carnegie; Carnegie Institution; Chinese Scholarship Council [2009635108]; US National Science Foundation [0820730]; European Research Council [293926]; Max Planck Gesellschaft; Division Of Integrative Organismal Systems [0820730] Funding Source: National Science Foundation	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy; Department of Biology, Stanford University; Carnegie; Carnegie Institution; Chinese Scholarship Council(China Scholarship Council); US National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Max Planck Gesellschaft(Max Planck Society); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to D. Ehrhardt, H. Cartwright, J. Lindeboom, K. Barton and T. Liu for help with confocal and scanning electron microscopy. We thank D. Ehrhardt for providing specific endomembrane markers and M. Jia for conducting nectar sugar assays. We thank J. Danielson for help with phylogenetic analyses. This work was made possible by support from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy under grant number DE-FG02-04ER15542 to W. B. F. I. W. L. was supported by the fellowship of Department of Biology, Stanford University and Carnegie. X.-Q.Q. was supported by the Carnegie Institution and Scholarship Program of the Chinese Scholarship Council (2009635108). C.J.C.'s work was supported by a grant from the US National Science Foundation (#0820730). I. T. B. was supported by European Research Council advanced grant ClockworkGreen (293926) and the Max Planck Gesellschaft, and thanks C. Diezel for technical assistance.	Bauby H, 2007, PLANT CELL PHYSIOL, V48, P97, DOI 10.1093/pcp/pcl045; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bender R, 2012, FLORA, V207, P491, DOI 10.1016/j.flora.2012.06.005; Bender RL, 2013, PLANT J, V74, P893, DOI 10.1111/tpj.12184; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Davis AR, 1998, PLANTA, V205, P305, DOI 10.1007/s004250050325; De la Barrera E, 2004, TRENDS PLANT SCI, V9, P65, DOI 10.1016/j.tplants.2003.12.003; Escalante-Perez M, 2012, PLANT PHYSIOL, V159, P1176, DOI 10.1104/pp.112.196014; Fahn A, 2000, ADV BOT RES, V31, P37, DOI 10.1016/S0065-2296(00)31006-0; Fior S, 2013, NEW PHYTOL, V198, P579, DOI 10.1111/nph.12163; Friedman WE, 2009, AM J BOT, V96, P5, DOI 10.3732/ajb.0800150; Gallagher SR, 1992, GUS PROTOCOLS USING; Gase K, 2011, MOL ECOL RESOUR, V11, P890, DOI 10.1111/j.1755-0998.2011.03017.x; Ge YX, 2000, PLANT J, V24, P725, DOI 10.1046/j.1365-313x.2000.00926.x; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Hampton M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008782; Heil M, 2005, SCIENCE, V308, P560, DOI 10.1126/science.1107536; Hoffmann MH, 2003, PLANT BIOLOGY, V5, P491, DOI 10.1055/s-2003-44784; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Huang M, 2012, NEW PHYTOL, V193, P997, DOI 10.1111/j.1469-8137.2011.04001.x; Isokawa S, 2010, GENES GENET SYST, V85, P87, DOI 10.1266/ggs.85.87; Johnson SD, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0500; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kasaras A, 2010, PLANT BIOLOGY, V12, P140, DOI 10.1111/j.1438-8677.2010.00381.x; Kay K. M., 2006, FLORAL CHARACTERS SP; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Kram BW, 2009, SEX PLANT REPROD, V22, P235, DOI 10.1007/s00497-009-0112-5; Kram BW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-92; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Langenberger MW, 2002, AM J BOT, V89, P1588, DOI 10.3732/ajb.89.10.1588; Lee JY, 2005, DEVELOPMENT, V132, P5021, DOI 10.1242/dev.02067; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Nicolson S.W., 2007, NECTARIES NECTAR; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Ren G, 2007, PLANT SCI, V173, P277, DOI 10.1016/j.plantsci.2007.05.008; Rizzardo RAG, 2012, AN ACAD BRAS CIENC, V84, P1137, DOI 10.1590/S0001-37652012005000057; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Sime Karen R, 2003, BMC Ecol, V3, P6, DOI 10.1186/1472-6785-3-6; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62	47	223	252	8	229	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					1	+		10.1038/nature13082	http://dx.doi.org/10.1038/nature13082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670640				2022-12-28	WOS:000334741600041
J	Murphy, LJ; Robertson, KN; Harroun, SG; Brosseau, CL; Werner-Zwanziger, U; Moilanen, J; Tuononen, HM; Clyburne, JAC				Murphy, Luke J.; Robertson, Katherine N.; Harroun, Scott G.; Brosseau, Christa L.; Werner-Zwanziger, Ulrike; Moilanen, Jani; Tuononen, Heikki M.; Clyburne, Jason A. C.			A Simple Complex on the Verge of Breakdown: Isolation of the Elusive Cyanoformate Ion	SCIENCE			English	Article							CRYSTAL-STRUCTURE; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; ETHYLENE BIOSYNTHESIS; CYANIDE; BICARBONATE; METABOLISM; CARBONATE; MECHANISM; HORMONE; OXIDASE	Why does cyanide not react destructively with the proximal iron center at the active site of 1-aminocyclopropane-1-carboxylic acid (ACC) oxidase, an enzyme central to the biosynthesis of ethylene in plants? It has long been postulated that the cyanoformate anion, [NCCO2](-), forms and then decomposes to carbon dioxide and cyanide during this process. We have now isolated and crystallographically characterized this elusive anion as its tetraphenylphosphonium salt. Theoretical calculations show that cyanoformate has a very weak C-C bond and that it is thermodynamically stable only in low dielectric media. Solution stability studies have substantiated the latter result. We propose that cyanoformate shuttles the potentially toxic cyanide away from the low dielectric active site of ACC oxidase before breaking down in the higher dielectric medium of the cell.	[Murphy, Luke J.; Robertson, Katherine N.; Harroun, Scott G.; Brosseau, Christa L.; Clyburne, Jason A. C.] St Marys Univ, Dept Chem, Atlantic Ctr Green Chem, Halifax, NS B3H 3C3, Canada; [Werner-Zwanziger, Ulrike] Dalhousie Univ, Dept Chem, Halifax, NS B3H 4J3, Canada; [Werner-Zwanziger, Ulrike] Dalhousie Univ, Inst Mat Res, Halifax, NS B3H 4J3, Canada; [Moilanen, Jani; Tuononen, Heikki M.] Univ Jyvaskyla, Dept Chem, FI-40014 Jyvaskyla, Finland	Saint Marys University - Canada; Dalhousie University; Dalhousie University; University of Jyvaskyla	Tuononen, HM (corresponding author), Univ Jyvaskyla, Dept Chem, POB 35, FI-40014 Jyvaskyla, Finland.	heikki.m.tuononen@jyu.fi; jason.clyburne@smu.ca	Moilanen, Jani Olavi/G-6614-2016; Harroun, Scott G./ABG-3694-2021	Moilanen, Jani Olavi/0000-0002-2096-593X; Tuononen, Heikki/0000-0002-4820-979X; Harroun, Scott/0000-0003-3370-5341	Natural Sciences and Engineering Research Council of Canada; Academy of Finland; Canada Research Chairs Program; Canadian Foundation for Innovation; Nova Scotia Research and Innovation Trust Fund; Technology Industries of Finland Centennial Foundation; University of Jyvaskyla; GreenCentre Canada; Encana Corporation; Magnus Ehrnrooth Foundation; Springboard	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Academy of Finland(Academy of Finland); Canada Research Chairs Program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Nova Scotia Research and Innovation Trust Fund; Technology Industries of Finland Centennial Foundation; University of Jyvaskyla; GreenCentre Canada; Encana Corporation; Magnus Ehrnrooth Foundation; Springboard	We thank the Natural Sciences and Engineering Research Council of Canada (through the Discovery Grants Program to J.A.C.C.) and the Academy of Finland (through its Research Fellowship to H. M. T.). J.A.C.C. acknowledges generous support from the Canada Research Chairs Program, the Canadian Foundation for Innovation, and the Nova Scotia Research and Innovation Trust Fund. H. M. T. acknowledges generous support from the Academy of Finland, the Technology Industries of Finland Centennial Foundation, and the University of Jyvaskyla. This work was also supported in part by GreenCentre Canada, Encana Corporation (Deep Panuke Education and Training and Research and Development Fund), Springboard, and the Magnus Ehrnrooth Foundation (postdoctoral scholarship to J.M.). We are grateful to NMR-3 (Dalhousie University) for NMR data acquisition, Canadian Microanalytical Services for elemental analyses, and the Finnish Grid Infrastructure consortium for central processing unit time. We also thank E. Plettner for her helpful discussions and T. S. Cameron and A. Linden for their crystallographic insights. Metrical parameters for the structure of tetraphenylphosphonium cyanoformate are available free of charge from the Cambridge Crystallographic Data Centre, under reference number CCDC 986380.	ADAMS DO, 1981, TRENDS BIOCHEM SCI, V6, P161, DOI 10.1016/0968-0004(81)90059-1; Alabugin IV, 2010, SCIENCE, V330, DOI 10.1126/science.1196188; ALCOCK NW, 1985, ACTA CRYSTALLOGR C, V41, P1549, DOI 10.1107/S0108270185008502; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Bassan A, 2006, CHEM-EUR J, V12, P8835, DOI 10.1002/chem.200501459; Bernsdorf A, 2012, Z KRIST-NEW CRYST ST, V227, P85, DOI 10.1524/ncrs.2012.0038; Braga D, 2002, CHEM-EUR J, V8, P1173, DOI 10.1002/1521-3765(20020301)8:5<1173::AID-CHEM1173>3.0.CO;2-K; Brunhuber NMW, 2000, BIOCHEMISTRY-US, V39, P10730, DOI 10.1021/bi0000162; BURG SP, 1965, SCIENCE, V148, P1190, DOI 10.1126/science.148.3674.1190; Dilley DR, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt031; DRUCK U, 1984, Z KRISTALLOGR, V167, P131, DOI 10.1524/zkri.1984.167.1-2.131; Duong HA, 2004, CHEM COMMUN, P112, DOI 10.1039/b311350g; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; GarciaMoreno B, 1997, BIOPHYS CHEM, V64, P211, DOI 10.1016/S0301-4622(96)02238-7; Himmel D, 2014, ANGEW CHEM INT EDIT, V53, P370, DOI 10.1002/anie.201300461; Holbrey JD, 2003, CHEM COMMUN, P28, DOI 10.1039/b211519k; KITAURA K, 1976, INT J QUANTUM CHEM, V10, P325, DOI 10.1002/qua.560100211; Kockerling M, 1999, Z KRIST-NEW CRYST ST, V214, P460; Kuhn N, 1999, Z NATURFORSCH B, V54, P427; Ling I, 2010, CRYSTENGCOMM, V12, P4321, DOI 10.1039/c002832k; MacIntosh IS, 2010, ORGANOMETALLICS, V29, P2063, DOI 10.1021/om901097r; Mani F, 2006, GREEN CHEM, V8, P995, DOI 10.1039/b602051h; MILLER FA, 1952, ANAL CHEM, V24, P1253, DOI 10.1021/ac60068a007; MILLER JM, 1980, PLANT PHYSIOL, V65, P1199, DOI 10.1104/pp.65.6.1199; Mirica LM, 2008, P NATL ACAD SCI USA, V105, P1814, DOI 10.1073/pnas.0711626105; MOROKUMA K, 1971, J CHEM PHYS, V55, P1236, DOI 10.1063/1.1676210; PEISER GD, 1984, P NATL ACAD SCI-BIOL, V81, P3059, DOI 10.1073/pnas.81.10.3059; Pirrung MC, 1999, ACCOUNTS CHEM RES, V32, P711, DOI 10.1021/ar960003+; PURCELL KF, 1969, J AM CHEM SOC, V91, P3487, DOI 10.1021/ja01041a013; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; SCHWEIZER EE, 1989, ACTA CRYSTALLOGR C, V45, P1236, DOI 10.1107/S0108270189000363; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Shoukry MM, 2014, CENT EUR J CHEM, V12, P318, DOI 10.2478/s11532-013-0374-5; Smith JM, 2000, PHYSIOL PLANTARUM, V109, P180, DOI 10.1034/j.1399-3054.2000.100210.x; YIP WK, 1988, PLANT PHYSIOL, V88, P473, DOI 10.1104/pp.88.2.473; ZHANG XZ, 1995, ANGEW CHEM INT EDIT, V34, P1858, DOI 10.1002/anie.199518581; Zhou H, 2008, J ORG CHEM, V73, P8039, DOI 10.1021/jo801457r; ZIEGLER T, 1977, THEOR CHIM ACTA, V46, P1, DOI 10.1007/BF02401406	39	35	36	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					75	78		10.1126/science.1250808	http://dx.doi.org/10.1126/science.1250808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700853	Green Accepted			2022-12-28	WOS:000333746100054
J	Polyak, K; Marusyk, A				Polyak, Kornelia; Marusyk, Andriy			CANCER Clonal cooperation	NATURE			English	Editorial Material							DIVERSITY		[Polyak, Kornelia; Marusyk, Andriy] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Polyak, Kornelia; Marusyk, Andriy] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Polyak, K (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	kornelia_polyak@dfci.harvard.edu						Almendro V, 2014, CANCER RES, V74, P1338, DOI 10.1158/0008-5472.CAN-13-2357-T; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; MESTER J, 1987, J VIROL, V61, P1073, DOI 10.1128/JVI.61.4.1073-1078.1987; Rosen JM, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3610	10	31	32	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					52	53		10.1038/508052a	http://dx.doi.org/10.1038/508052a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695309				2022-12-28	WOS:000333609900040
J	Catto, G; Cork, N; Williams, G				Catto, Graeme; Cork, Nick; Williams, Gareth			Should medical students be taught alternative medicine?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPLEMENTARY; CAM		[Catto, Graeme] Guys Hosp, Coll Med, London SE1 9RT, England; [Cork, Nick] Univ Cambridge, Sch Clin Med, Cambridge CB2 0SP, England; [Williams, Gareth] Univ Bristol, Bristol BS8 1TH, Avon, England	Guy's & St Thomas' NHS Foundation Trust; University of Cambridge; University of Bristol	Catto, G (corresponding author), Guys Hosp, Coll Med, London SE1 9RT, England.	president@collegeofmedicine.org.uk; nicholascork@gmail.com						[Anonymous], 1989, HOM PHARM US MON; Chalmers I, 2003, ANN AM ACAD POLIT SS, V589, P22, DOI 10.1177/0002716203254762; College of Medicine, 2013, CONST COLL MED; Epel E, 2009, ANN NY ACAD SCI, V1172, P34, DOI 10.1111/j.1749-6632.2009.04414.x; Ernst E., 2011, EVID-BASED COMPL ALT, V2011, P3; Ernst E, 2011, BRIT J GEN PRACT, V61, P404, DOI 10.3399/bjgp11X578070; Flexner A., 1910, MEDICAL ED US CANADA; General Medical Council, 2009, TOM DOCT OUTC STAND; General Medical Council, 2009, TOMORROWS DOCTORS; Ho D., 2013, FOCUS ALTERNAT COMPL, V18, P176; Leggatt J, 2008, TELEGRAPH; Moses GM, 2010, AUST PRESCR, V33, P177; National Cancer Institute, 2013, COMPL ALT MED CANC T; National Institute for Clinical Excellence, 2006, PARK DIS DIAGN MAN P; National Institute for Health and Care Excellence (NICE, 2009, LOW BACK PAIN EARL M; NICE, 2008, ANT CAR NICE CLIN GU; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Posadzki P, 2012, INT J CLIN PRACT, V66, P1178, DOI 10.1111/ijcp.12026; Posadzki P, 2013, CLIN MED, V13, P126, DOI 10.7861/clinmedicine.13-2-126; Posadzki P, 2013, BRIT J CLIN PHARMACO, V75, P603, DOI 10.1111/j.1365-2125.2012.04350.x; Roberts I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3879; *SEL COMM SCI TECH, 2000, 6 SEL COMM SCI TECHN; Smith KR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000074; The Royal London Hospital for Integrated Medicine, 2013, INT COMPL MED EV PRA	24	3	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2014	348								g2417	10.1136/bmj.g2417	http://dx.doi.org/10.1136/bmj.g2417			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9MF	24682533				2022-12-28	WOS:000333588500005
J	Gulland, A				Gulland, Anne			Berwick Patient Safety Team: making the NHS a safer place Five teams have been shortlisted for the Berwick award for improving patient safety. Anne Gulland describes their work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk						Department of Health, 2013, BERW REV PAT SAF	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2014	348								g2404	10.1136/bmj.g2404	http://dx.doi.org/10.1136/bmj.g2404			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9MF	24682400				2022-12-28	WOS:000333588500003
J	Buffett, B				Buffett, Bruce			Geomagnetic fluctuations reveal stable stratification at the top of the Earth's core	NATURE			English	Article							MAGNETIC-FIELD; MANTLE BOUNDARY; TORSIONAL OSCILLATIONS; SECULAR VARIATION; MOTIONS	Modern observations of the geomagnetic field reveal fluctuations(1-3) with a dominant period of about 60 years. These fluctuations are probably a result of waves in the liquid core(4), although the precise nature of the waves is uncertain. Common suggestions include a type of magnetic wave, known as a torsional oscillation(5), but recent studies(6) favour periods that are too short to account for a 60-year fluctuation. Another possibility involves MAC waves(7), which arise from the interplay between magnetic, Archimedes and Coriolis forces. Waves with a suitable period can emerge when the top of the core is stably stratified. Here I show that MAC waves provide a good description of time-dependent zonal flow at the top of the core(8), as inferred from geomagnetic secular variation(9). The same wave motion can also account for unexplained fluctuations in the dipole field(10). Both of these independent predictions require a 140-kilometre-thick stratified layer with a buoyancy frequency comparable to the Earth's rotation rate. Such a stratified layer could have a thermal origin(11,12), implying a core heat flow of about 13 terawatts. Alternatively, the layer could result from chemical stratification(13,14). In either case, the existence of a stratified layer at the top of the core obscures the nature of flow deeper in the core, where the magnetic field is continually regenerated.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Buffett, B (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	bbuffett@berkeley.edu			US National Science Foundation [EAR-1045277]	US National Science Foundation(National Science Foundation (NSF))	A. Jackson and I. Wardinski provided models of surface core flow and magnetic field. Comments and suggestions from R. Holme substantially improved the final text. This work was supported in part by the US National Science Foundation (EAR-1045277).	BLOXHAM J, 1992, J GEOPHYS RES-SOL EA, V97, P19537, DOI 10.1029/92JB01591; Braginskiy S. I., 1970, Geomagnetism and Aeronomy, V10, P1; BRAGINSKY SI, 1993, J GEOMAGN GEOELECTR, V45, P1517, DOI 10.5636/jgg.45.1517; Buffett BA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000056; Buffett BA, 2010, EARTH PLANET SC LETT, V296, P367, DOI 10.1016/j.epsl.2010.05.020; Buffett BA, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006751; Buffett BA, 2009, GEOPHYS J INT, V177, P878, DOI 10.1111/j.1365-246X.2009.04129.x; Christensen UR, 2011, PHYS EARTH PLANET IN, V187, P157, DOI 10.1016/j.pepi.2011.03.012; CURRIE RG, 1973, ASTROPHYS SPACE SCI, V21, P425, DOI 10.1007/BF00643106; Eymin C, 2005, PHYS EARTH PLANET IN, V152, P200, DOI 10.1016/j.pepi.2005.06.009; Finlay CC, 2010, GEOPHYS J INT, V183, P1216, DOI 10.1111/j.1365-246X.2010.04804.x; Finlay CC, 2010, SPACE SCI REV, V155, P177, DOI 10.1007/s11214-010-9691-6; Fox L., 1968, CHEBYSHEV POLYNOMIAL; Gillet N, 2010, NATURE, V465, P74, DOI 10.1038/nature09010; Gubbins D, 2013, PHYS EARTH PLANET IN, V215, P21, DOI 10.1016/j.pepi.2012.11.001; GUBBINS D, 1982, GEOPHYS J ROY ASTR S, V68, P241, DOI 10.1111/j.1365-246X.1982.tb06972.x; Holme R, 2006, GEOPHYS J INT, V166, P518, DOI 10.1111/j.1365-246X.2006.03033.x; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Jackson A, 1997, PHYS EARTH PLANET IN, V103, P293, DOI 10.1016/S0031-9201(97)00039-3; Jackson LP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043455; Jault D, 2008, PHYS EARTH PLANET IN, V166, P67, DOI 10.1016/j.pepi.2007.11.001; Koot L, 2010, GEOPHYS J INT, V182, P1279, DOI 10.1111/j.1365-246X.2010.04711.x; Kuang WJ, 1999, J COMPUT PHYS, V153, P51, DOI 10.1006/jcph.1999.6274; Labrosse S, 1997, PHYS EARTH PLANET IN, V99, P1, DOI 10.1016/S0031-9201(96)03207-4; Lister JR, 1998, PHYS EARTH PLANET IN, V105, P5, DOI 10.1016/S0031-9201(97)00082-4; Pozzo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.014110; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Roberts PH, 2007, GEOPHYS ASTRO FLUID, V101, P11, DOI 10.1080/03091920601083820; SORENSEN DC, 1992, SIAM J MATRIX ANAL A, V13, P357, DOI 10.1137/0613025; Wardinski I, 2012, GEOPHYS J INT, V189, P1409, DOI 10.1111/j.1365-246X.2012.05384.x; YOKOYAMA Y, 1991, J GEOMAGN GEOELECTR, V43, P563, DOI 10.5636/jgg.43.563; Zatman S, 1997, NATURE, V388, P760, DOI 10.1038/41987	32	112	113	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					484	+		10.1038/nature13122	http://dx.doi.org/10.1038/nature13122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670768				2022-12-28	WOS:000333402000037
J	Emilie; Elena; Robert; Karen; Lara; Rosy; Sri; Steve; Mima; Jiaying; Joao				Emilie; Elena; Robert; Karen; Lara; Rosy; Sri; Steve; Mima; Jiaying; Joao			Pulling It All Together	CELL			English	Editorial Material																			0	1	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					1	2		10.1016/j.cell.2014.03.022	http://dx.doi.org/10.1016/j.cell.2014.03.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679520	Bronze			2022-12-28	WOS:000333968900001
J	Huang, HL; Lv, C; Zhao, YC; Li, W; He, XM; Li, P; Sha, AG; Tian, X; Papasian, CJ; Deng, HW; Lu, GX; Xiao, HM				Huang, Hua-Lin; Lv, Chao; Zhao, Ying-Chun; Li, Wen; He, Xue-Mei; Li, Ping; Sha, Ai-Guo; Tian, Xiao; Papasian, Christopher J.; Deng, Hong-Wen; Lu, Guang-Xiu; Xiao, Hong-Mei			Mutant ZP1 in Familial Infertility	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ZONA-PELLUCIDA GLYCOPROTEINS; FEMALE MICE; EGG; DOMAIN; FOLLICULOGENESIS; FERTILIZATION; PROTEINS; LACKING	The human zona pellucida is composed of four glycoproteins (ZP1, ZP2, ZP3, and ZP4) and has an important role in reproduction. Here we describe a form of infertility with an autosomal recessive mode of inheritance, characterized by abnormal eggs that lack a zona pellucida. We identified a homozygous frameshift mutation in ZP1 in six family members. In vitro studies showed that defective ZP1 proteins and normal ZP3 proteins colocalized throughout the cells and were not expressed at the cell surface, suggesting that the aberrant ZP1 results in the sequestration of ZP3 in the cytoplasm, thereby preventing the formation of the zona pellucida around the oocyte. The zona pellucida is a clear, gelatinous matrix that surrounds the ovum and is essential to fertilization. Four sisters with primary infertility were found to harbor a mutation affecting one of the ZP proteins. Summary The human zona pellucida is composed of four glycoproteins (ZP1, ZP2, ZP3, and ZP4) and has an important role in reproduction. Here we describe a form of infertility with an autosomal recessive mode of inheritance, characterized by abnormal eggs that lack a zona pellucida. We identified a homozygous frameshift mutation in ZP1 in six family members. In vitro studies showed that defective ZP1 proteins and normal ZP3 proteins colocalized throughout the cells and were not expressed at the cell surface, suggesting that the aberrant ZP1 results in the sequestration of ZP3 in the cytoplasm, thereby preventing the formation of ...	[Huang, Hua-Lin; Lv, Chao; Li, Wen; Lu, Guang-Xiu; Xiao, Hong-Mei] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410008, Hunan, Peoples R China; [Li, Wen; Lu, Guang-Xiu; Xiao, Hong-Mei] Reprod & Genet Hosp CITIC Xiangya, Changsha, Hunan, Peoples R China; [Tian, Xiao] First High Sch Changsha, Changsha, Hunan, Peoples R China; [He, Xue-Mei; Li, Ping] Xiamen Maternal & Child Hlth Care Hosp, Xiamen, Peoples R China; [Sha, Ai-Guo] PLA Hosp 174, Xiamen, Peoples R China; [Huang, Hua-Lin; Zhao, Ying-Chun; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Papasian, Christopher J.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA	Central South University; Central South University; Tulane University; University of Missouri System; University of Missouri Kansas City	Xiao, HM (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, 88 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	xhongmei@yahoo.com		Deng, Hong-Wen/0000-0002-0387-8818	Central South University Graduate Innovation Fund [21777215050332]; National Basic Research Program (973) of China [2012CB944901]; National Institutes of Health [P50AR055081, R01AG026564, R01AR059781, R01AR050496, R01AR057049]; Edward G. Schlieder Endowment; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR059781, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Central South University Graduate Innovation Fund; National Basic Research Program (973) of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward G. Schlieder Endowment; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from Central South University Graduate Innovation Fund (21777215050332, to Drs. Xiao and Lv), the National Basic Research Program (973) of China (2012CB944901, to Dr. Lu), the National Institutes of Health (P50AR055081, R01AG026564, R01AR059781, R01AR050496, and R01AR057049, to Drs. Deng and Zhao), and the Edward G. Schlieder Endowment (to Drs. Deng and Zhao).	Conner SJ, 2005, HUM REPROD, V20, P1148, DOI 10.1093/humrep/deh835; Familiari G, 2006, MICROSC RES TECHNIQ, V69, P415, DOI 10.1002/jemt.20301; Ganguly A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-110; Gook DA, 2008, HUM REPROD, V23, P394, DOI 10.1093/humrep/dem373; Green D P, 1997, Rev Reprod, V2, P147, DOI 10.1530/ror.0.0020147; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Hoodbhoy T, 2006, MOL CELL BIOL, V26, P7991, DOI 10.1128/MCB.00904-06; Jimenez-Movilla M, 2011, J CELL SCI, V124, P940, DOI 10.1242/jcs.079988; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Lefievre L, 2004, HUM REPROD, V19, P1580, DOI 10.1093/humrep/deh301; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Margalit M, 2012, EUR J OBSTET GYN R B, V165, P70, DOI 10.1016/j.ejogrb.2012.07.022; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Monne M, 2011, BIOL REPROD, V85, P661, DOI 10.1095/biolreprod.111.092098; Naz Rajesh K, 2010, Front Biosci (Schol Ed), V2, P1092; Naz RK, 2009, FRONT BIOSCI-LANDMRK, V14, P3994, DOI 10.2741/3507; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Pokkyla RM, 2011, FERTIL STERIL, V95, P2669, DOI 10.1016/j.fertnstert.2011.01.168; Rankin T, 1999, DEVELOPMENT, V126, P3847; Rankin TL, 2001, DEVELOPMENT, V128, P1119; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wassarman PM, 1997, P ROY SOC B-BIOL SCI, V264, P323, DOI 10.1098/rspb.1997.0046; Zhao M, 2003, MOL CELL BIOL, V23, P8982, DOI 10.1128/MCB.23.24.8982-8991.2003	25	78	82	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1220	1226		10.1056/NEJMoa1308851	http://dx.doi.org/10.1056/NEJMoa1308851			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670168	Green Accepted			2022-12-28	WOS:000333426000009
J	Hickey, M; Ballard, K; Farquhar, C				Hickey, Martha; Ballard, Karen; Farquhar, Cindy			Endometriosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC PELVIC PAIN; DIAGNOSIS; ULTRASOUND; ACCURACY; EXCISION; WOMEN		[Hickey, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Hickey, Martha] Royal Womens Hosp, Parkville, Vic 3052, Australia; [Ballard, Karen] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Farquhar, Cindy] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand	University of Melbourne; University of Surrey; University of Auckland	Hickey, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia.	Hickeym@unimelb.edu.au		Hickey, Martha/0000-0002-3941-082X; Farquhar, Cynthia/0000-0002-3685-3553				Abbott J, 2004, FERTIL STERIL, V82, P878, DOI 10.1016/j.fertnstert.2004.03.046; Abou-Setta AM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005072.pub3; Abrao MS, 2007, HUM REPROD, V22, P3092, DOI 10.1093/humrep/dem187; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Ballard K, 2006, FERTIL STERIL, V86, P1296, DOI 10.1016/j.fertnstert.2006.04.054; Barlow DH, 2014, COCHRANE DA IN PRESS; Benschop L, 2010, COCHRANE DB SYST REV, V11; BROWN J, 2010, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD008475.PUB2; Brown J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009590.pub2; Busacca M, 1998, HUM REPROD, V13, P2271, DOI 10.1093/humrep/13.8.2271; De Bie B, 2014, HUM REPROD; De Graaff AA, 2013, HUM REPROD, V28, P2677, DOI 10.1093/humrep/det284; de Ziegler D, 2010, FERTIL STERIL, V94, P2796, DOI 10.1016/j.fertnstert.2010.05.056; Flower A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006568.pub3; Furness S, 2004, COCHRANE DB SYST REV, V3; Gupta J, 2012, JAMA-J AM MED ASSOC, V302, P955; Han D, 2013, GYNECOL OBSTET INVES, V76, P75, DOI 10.1159/000351165; Harrison RF, 2000, FERTIL STERIL, V74, P24, DOI 10.1016/S0015-0282(00)00577-X; Hart RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004992.pub3; Hudelist G, 2011, ULTRASOUND OBST GYN, V37, P257, DOI 10.1002/uog.8858; Hughes E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000155.pub2; Johnson NP, 2013, HUM REPROD, V28, P1552, DOI 10.1093/humrep/det050; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Koninckx PR, 2012, FERTIL STERIL, V98, P564, DOI 10.1016/j.fertnstert.2012.07.1061; Lu DH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008088.pub3; Lu DH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007677.pub3; Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002; May KE, 2010, HUM REPROD UPDATE, V16, P651, DOI 10.1093/humupd/dmq009; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; Nyholt DR, 2012, NAT GENET, V44, P1355, DOI 10.1038/ng.2445; Remorgida V, 2006, REPROD BIOL ENDOCRIN, V4, P10; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; Shakiba K, 2008, OBSTET GYNECOL, V111, P1285, DOI 10.1097/AOG.0b013e3181758ec6; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Somigliana E, 2012, FERTIL STERIL, V98, P1531, DOI 10.1016/j.fertnstert.2012.08.009; Song YS, 2014, BRIT J CANCER, DOI [10.1038/bjc, DOI 10.1038/BJC]; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; Taylor HS, 2011, REPROD SCI, V18, P814, DOI 10.1177/1933719111410713; Tekin YB, 2011, FERTIL STERIL, V95, P492, DOI 10.1016/j.fertnstert.2010.08.042; Tirlapur SA, 2013, INT J SURG, V11, P233, DOI 10.1016/j.ijsu.2013.02.003; Van Holsbeke C, 2010, ULTRASOUND OBST GYN, V35, P730, DOI 10.1002/uog.7668; Wu LX, 2013, GYNECOL ENDOCRINOL, V29, P883, DOI 10.3109/09513590.2013.819085; Zhu X., 2011, COCHRANE DB SYST REV, V9	43	113	118	2	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1752	10.1136/bmj.g1752	http://dx.doi.org/10.1136/bmj.g1752			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647161				2022-12-28	WOS:000333414500003
J	Song, YM; Li, L; Ou, YW; Gao, ZB; Li, EM; Li, XC; Zhang, WM; Wang, JQ; Xu, LY; Zhou, Y; Ma, XJ; Liu, LY; Zhao, ZT; Huang, XL; Fan, J; Dong, LJ; Chen, G; Ma, LY; Yang, J; Chen, LY; He, MH; Li, M; Zhuang, XH; Huang, K; Qiu, KL; Yin, GL; Guo, GW; Feng, Q; Chen, PS; Wu, ZY; Wu, JY; Ma, L; Zhao, JY; Luo, LH; Fu, M; Xu, BN; Chen, B; Li, YR; Tong, T; Wang, MR; Liu, ZH; Lin, DX; Zhang, XQ; Yang, HM; Wang, J; Zhan, QM				Song, Yongmei; Li, Lin; Ou, Yunwei; Gao, Zhibo; Li, Enmin; Li, Xiangchun; Zhang, Weimin; Wang, Jiaqian; Xu, Liyan; Zhou, Yong; Ma, Xiaojuan; Liu, Lingyan; Zhao, Zitong; Huang, Xuanlin; Fan, Jing; Dong, Lijia; Chen, Gang; Ma, Liying; Yang, Jie; Chen, Longyun; He, Minghui; Li, Miao; Zhuang, Xuehan; Huang, Kai; Qiu, Kunlong; Yin, Guangliang; Guo, Guangwu; Feng, Qiang; Chen, Peishan; Wu, Zhiyong; Wu, Jianyi; Ma, Ling; Zhao, Jinyang; Luo, Longhai; Fu, Ming; Xu, Bainan; Chen, Bo; Li, Yingrui; Tong, Tong; Wang, Mingrong; Liu, Zhihua; Lin, Dongxin; Zhang, Xiuqing; Yang, Huanming; Wang, Jun; Zhan, Qimin			Identification of genomic alterations in oesophageal squamous cell cancer	NATURE			English	Article							CIRCULAR BINARY SEGMENTATION; SOMATIC MUTATION; ADENOCARCINOMA; IMMORTALIZATION; ABERRATIONS; PATTERNS; EXOME	Oesophageal cancer is one of the most aggressive cancers and is the sixth leading cause of cancer death worldwide(1). Approximately 70% of global oesophageal cancer cases occur in China, with oesophageal squamous cell carcinoma (ESCC) being the histopathological form in the vast majority of cases (>90%)(2,3). Currently, there are limited clinical approaches for the early diagnosis and treatment of ESCC, resulting in a 10% five-year survival rate for patients. However, the full repertoire of genomic events leading to the pathogenesis of ESCC remains unclear. Here we describe a comprehensive genomic analysis of 158 ESCC cases, as part of the International Cancer Genome Consortium research project. We conducted whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases, of which 53 cases, plus an additional 70 ESCC cases not used in the whole-genome and whole-exome sequencing, were subjected to array comparative genomic hybridization analysis. We identified eight significantly mutated genes, of which six are well known tumour-associated genes (TP53, RB1, CDKN2A, PIK3CA, NOTCH1, NFE2L2), and two have not previously been described in ESCC (ADAM29 and FAM135B). Notably, FAM135B is identified as a novel cancer-implicated gene as assayed for its ability to promote malignancy of ESCC cells. Additionally, MIR548K, a microRNA encoded in the amplified 11q13.3-13.4 region, is characterized as a novel oncogene, and functional assays demonstrate that MIR548K enhances malignant phenotypes of ESCC cells. Moreover, we have found that several important histone regulator genes (MLL2 (also called KMT2D), ASH1L, MLL3 (KMT2C), SETD1B, CREBBP and EP300) are frequently altered in ESCC. Pathway assessment reveals that somatic aberrations are mainly involved in the Wnt, cell cycle and Notch pathways. Genomic analyses suggest that ESCC and head and neck squamous cell carcinoma share some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking. This study has explored novel biological markers and tumorigenic pathways that would greatly improve therapeutic strategies for ESCC.	[Song, Yongmei; Ou, Yunwei; Zhang, Weimin; Ma, Xiaojuan; Liu, Lingyan; Zhao, Zitong; Fan, Jing; Dong, Lijia; Ma, Liying; Ma, Ling; Fu, Ming; Tong, Tong; Wang, Mingrong; Liu, Zhihua; Lin, Dongxin; Zhan, Qimin] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Canc Hosp, Beijing 100021, Peoples R China; [Song, Yongmei; Ou, Yunwei; Zhang, Weimin; Ma, Xiaojuan; Liu, Lingyan; Zhao, Zitong; Fan, Jing; Dong, Lijia; Ma, Liying; Ma, Ling; Fu, Ming; Tong, Tong; Wang, Mingrong; Liu, Zhihua; Lin, Dongxin; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Lin; Gao, Zhibo; Li, Xiangchun; Wang, Jiaqian; Zhou, Yong; Huang, Xuanlin; Chen, Gang; Yang, Jie; Chen, Longyun; He, Minghui; Li, Miao; Zhuang, Xuehan; Huang, Kai; Qiu, Kunlong; Yin, Guangliang; Guo, Guangwu; Feng, Qiang; Chen, Peishan; Zhao, Jinyang; Luo, Longhai; Li, Yingrui; Zhang, Xiuqing; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Ou, Yunwei; Xu, Bainan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China; [Li, Enmin; Wu, Jianyi] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou 515041, Guangdong, Peoples R China; [Xu, Liyan; Chen, Bo] Shantou Univ, Coll Med, Inst Oncol Pathol, Shantou 515041, Guangdong, Peoples R China; [Wu, Zhiyong] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Tumor Surg, Shantou 515041, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Genomics Institute (BGI); Chinese People's Liberation Army General Hospital; Shantou University; Shantou University; Sun Yat Sen University	Zhan, QM (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Canc Hosp, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn	Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; xu, li/GNH-3667-2022; Chen, Bo/GRS-7546-2022; Wang, Jiaqian/AHA-3427-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Wang, Jun/0000-0002-8540-8931; song, yongmei/0000-0002-7789-0158; Wang, Jun/0000-0002-2113-5874; Lin, Dongxin/0000-0002-8723-8868; Li, Xiangchun/0000-0002-2230-2152	National High Technology Research and Development Program of China (863 program) [2012AA02A209, 2012AA02A503]; National Natural Science Foundation Fund [81021061]; Guangdong Innovative Research Team Program [2009010016]; National Natural Science Foundation of China [U0932001]; National Key Basic Research Program of China (973 program) [2011CB911004, 2009CB521801, 2012CB526608]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation Fund(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 program)(National Basic Research Program of China)	This work is supported by the funding from the National High Technology Research and Development Program of China (863 program no. 2012AA02A209 and 2012AA02A503), National Natural Science Foundation Fund (81021061), Guangdong Innovative Research Team Program (2009010016), the National Natural Science Foundation of China-GuangDong Joint Fund (U0932001), and the National Key Basic Research Program of China (973 program no. 2011CB911004, 2009CB521801 and 2012CB526608). The ESCC cell lines (KYSE30, KYSE70, KYSE180, KYSE410, KYSE450, KYSE140, COLO680N and KYSE510) were provided by Y. Shimada of Kyoto University. We also acknowledge International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) for sharing the EAC, HNSCC and lung SQCC data.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Forde PM, 2013, ONCOLOGIST, V18, P823, DOI 10.1634/theoncologist.2013-0130; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Komatsu Y, 2006, ANTICANCER RES, V26, P2029; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longman D, 2012, ONCOL RES, V20, P1, DOI 10.3727/096504012X13425470196010; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaughlin-Drubin ME, 2012, CURR OPIN VIROL, V2, P459, DOI 10.1016/j.coviro.2012.05.004; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ou YW, 2012, J BIOL CHEM, V287, P32394, DOI 10.1074/jbc.M112.393900; Panagiotakis GI, 2013, TUMOR BIOL, V34, P71, DOI 10.1007/s13277-012-0512-2; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Shen ZY, 2002, WORLD J GASTROENTERO, V8, P357; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wittchen ES, 2011, INVEST OPHTH VIS SCI, V52, P7455, DOI 10.1167/iovs.11-7295; WORKMAN C, 2002, GENOME BIOL, V0003; Xu YP, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-173; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Zhang H, 2006, CANCER GENET CYTOGEN, V165, P25, DOI 10.1016/j.cancergencyto.2005.07.016; Zhang S., 2012, CHINA CANC, V21, P241	37	717	763	19	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					91	+		10.1038/nature13176	http://dx.doi.org/10.1038/nature13176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670651				2022-12-28	WOS:000335199100045
J	Creasey, KM; Zhai, JX; Borges, F; Van Ex, F; Regulski, M; Meyers, BC; Martienssen, RA				Creasey, Kate M.; Zhai, Jixian; Borges, Filipe; Van Ex, Frederic; Regulski, Michael; Meyers, Blake C.; Martienssen, Robert A.			miRNAs trigger widespread epigenetically activated siRNAs from transposons in Arabidopsis	NATURE			English	Article							DNA METHYLATION; SMALL RNA; PLANTS; BIOGENESIS; MICRORNAS; TARGETS; DEMETHYLATION; METHYLOME; ENDOSPERM; ELEMENTS	In plants, post-transcriptional gene silencing (PTGS) is mediated by DICER-LIKE 1 (DCL1)-dependent microRNAs (miRNAs), which also trigger 21-nucleotide secondary short interfering RNAs (siRNAs) via RNA-DEPENDENT RNA POLYMERASE 6 (RDR6), DCL4 and ARGONAUTE 1 (AGO1)(1-3), whereas transcriptional gene silencing (TGS) of transposons is mediated by 24-nucleotide heterochromatic (het) siRNAs, RDR2, DCL3 and AGO4 (ref. 4). Transposons can also give rise to abundant 21-nucleotide 'epigenetically activated' small interfering RNAs (easiRNAs) in DECREASED DNA METHYLATION 1 (ddm1) and DNA METHYLTRANSFERASE 1 (met1) mutants, as well as in the vegetative nucleus of pollen grains(5) and in dedifferentiated plant cell cultures(6). Here we show that easiRNAs in Arabidopsis thaliana resemble secondary siRNAs, in that thousands of transposon transcripts are specifically targeted by more than 50 miRNAs for cleavage and processing by RDR6. Loss of RDR6, DCL4 or DCL1 in a ddm1 background results in loss of 21-nucleotide easiRNAs and severe infertility, but 24-nucleotide hetsi-RNAs are partially restored, supporting an antagonistic relationship between PTGS and TGS. Thus miRNA-directed easiRNA biogenesis is a latent mechanism that specifically targets transposon transcripts, but only when they are epigenetically reactivated during reprogramming of the germ line. This ancient recognition mechanism may have been retained both by transposons to evade long-term heterochromatic silencing and by their hosts for genome defence.	[Creasey, Kate M.; Borges, Filipe; Van Ex, Frederic; Regulski, Michael; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Zhai, Jixian; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DC 19711 USA; [Zhai, Jixian; Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DC 19711 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA; [Martienssen, Robert A.] IBENS, Chaire Blaise Pascal, F-75230 Paris, France	Cold Spring Harbor Laboratory; University of Delaware; University of Delaware; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Zhai, Jixian/HCH-9272-2022; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Borges, Filipe/0000-0002-7388-2118; Zhai, Jixian/0000-0002-0217-0666; Van Ex, Frederic/0000-0003-2481-0115	DuPont Pioneer; Belgian American Educational Foundation; University of Delaware Graduate fellowship; National Institutes of Health [RO1GM067014]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3033]; Cancer Center Support Grant [5PP30CA045508]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	DuPont Pioneer; Belgian American Educational Foundation; University of Delaware Graduate fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Colot, O. Voinnet and A. Sarazin for sharing unpublished data and for discussions, J. Simorowski for plant genetics and J. Kendall for computational advice. We thank R.K. Slotkin for sharing data before publication. K.M.C. and M.R. were supported, in part, by a research collaboration with DuPont Pioneer. F.V.E. was supported by a fellowship from the Belgian American Educational Foundation. J.Z. was supported by a University of Delaware Graduate fellowship. Research in the Martienssen laboratory is supported by a grant from the National Institutes of Health (RO1GM067014 to R.A.M.) and by the Howard Hughes Medical Institute and Gordon and Betty Moore Foundation (GBMF3033). The authors acknowledge that this work was performed with assistance from the Cold Spring Harbor Laboratory Shared Resources, which are funded, in part, by the Cancer Center Support Grant (5PP30CA045508).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jauvion V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029785; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Mari-Ordonez A, 2013, NAT GENET, V45, P1029, DOI 10.1038/ng.2703; McCue AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002474; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schwab R, 2013, EMBO REP, V14, P615, DOI 10.1038/embor.2013.58; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	33	192	201	2	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					411	+		10.1038/nature13069	http://dx.doi.org/10.1038/nature13069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24670663	Green Accepted			2022-12-28	WOS:000334403000055
J	Dobson, F				Dobson, Frank			Perils of launching a new vaccination campaign	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patelm@parliament.uk						Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2327	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2014	348								g2449	10.1136/bmj.g2449	http://dx.doi.org/10.1136/bmj.g2449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TX	24699385				2022-12-28	WOS:000333978000012
J	Hafidi, Z; Daoudi, R				Hafidi, Zouheir; Daoudi, Rajae			Anterior Dislocation of the Lens	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hafidi, Zouheir; Daoudi, Rajae] Univ Mohammed V Souissi, Rabat, Morocco	Mohammed V University in Rabat	Hafidi, Z (corresponding author), Univ Mohammed V Souissi, Rabat, Morocco.	zouheirhafidi@gmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1343	1343		10.1056/NEJMicm1307842	http://dx.doi.org/10.1056/NEJMicm1307842			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE2VA	24693894				2022-12-28	WOS:000333830000013
J	Lalazar, G; Doviner, V; Ben-Chetrit, E				Lalazar, Gadi; Doviner, Victoria; Ben-Chetrit, Eldad			Unfolding the Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE CYTOMEGALOVIRUS-INFECTION; MENETRIERS DISEASE; HYPERTROPHIC GASTROPATHY	A previously healthy, 25-year-old man was admitted to the hospital because of abdominal pain, nausea, vomiting, and weight loss. Two weeks before his admission, fever (temperature up to 40 degrees C), chills, and weakness developed. To control his fever, the patient ingested ibuprofen at a dose of 400 mg four times a day for more than a week. Subsequently, abdominal discomfort and nausea developed, and he presented to the emergency department owing to worsening of epigastric pain and vomiting. Since his gastrointestinal symptoms had started, he had lost about 4 kg of body weight. He reported no hematemesis, hematochezia, or melena. His medical history was remarkable only for a left inguinal hernioplasty 3 years earlier. He did not smoke, ingest alcohol, or use illicit drugs.	[Lalazar, Gadi; Ben-Chetrit, Eldad] Hadassah Hebrew Univ Med Ctr, Dept Med, Jerusalem, Israel; [Doviner, Victoria] Hadassah Hebrew Univ Med Ctr, Dept Pathol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ben-Chetrit, E (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Med, Jerusalem, Israel.	eldad@hadassah.org.il						DEMPSEY PJ, 1992, GASTROENTEROLOGY, V103, P1950, DOI 10.1016/0016-5085(92)91455-D; Eddleston M, 1997, CLIN INFECT DIS, V24, P52, DOI 10.1093/clinids/24.1.52; Fiske WH, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000320; Fretzayas A, 2011, ANN TROP PAEDIATR, V31, P141, DOI 10.1179/146532811X13006353133876; JARNUM S, 1972, GUT, V13, P128, DOI 10.1136/gut.13.2.128; KOMOROWSKI RA, 1986, GASTROINTEST ENDOSC, V32, P190, DOI 10.1016/S0016-5107(86)71802-6; Lambrecht Nils W G, 2011, Curr Gastroenterol Rep, V13, P513, DOI 10.1007/s11894-011-0222-8; McCormack JG, 1998, CLIN INFECT DIS, V26, P1007, DOI 10.1086/517634; Megged O, 2008, EUR J PEDIATR, V167, P1217, DOI 10.1007/s00431-008-0791-1; Rich A, 2010, GUT, V59, P1617, DOI 10.1136/gut.2010.220061; SHUSTER LD, 1989, DIGEST DIS SCI, V34, P103, DOI 10.1007/BF01536162; SUNDT TM, 1988, ANN SURG, V208, P694, DOI 10.1097/00000658-198812000-00004; Suter WR, 2000, DIGESTION, V62, P276, DOI 10.1159/000007827; WOLFSEN HC, 1993, GASTROENTEROLOGY, V104, P1310, DOI 10.1016/0016-5085(93)90339-E; Xiao SY, 2001, AM J GASTROENTEROL, V96, P223, DOI 10.1111/j.1572-0241.2001.03480.x	15	3	4	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1344	1348		10.1056/NEJMcps1300859	http://dx.doi.org/10.1056/NEJMcps1300859			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693895				2022-12-28	WOS:000333830000014
J	Padma, TV				Padma, T. V.			DEVELOPING COUNTRIES The outcomes paradox	NATURE			English	Editorial Material							SCHIZOPHRENIA; YOGA											Cohen A, 2008, SCHIZOPHRENIA BULL, V34, P229, DOI 10.1093/schbul/sbm105; Cramer H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-32; Duraiswamy G, 2007, ACTA PSYCHIAT SCAND, V116, P226, DOI 10.1111/j.1600-0447.2007.01032.x; Kulhara P, 2009, ASIAN J PSYCHIATR, V2, P55, DOI 10.1016/j.ajp.2009.04.003	4	12	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S14	S15		10.1038/508S14a	http://dx.doi.org/10.1038/508S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695329				2022-12-28	WOS:000333609900011
J	Kiberstis, P; Roberts, L				Kiberstis, Paula; Roberts, Leslie			A Race Still Unfinished INTRODUCTION	SCIENCE			English	Editorial Material																			0	3	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1451	1451		10.1126/science.343.6178.1451	http://dx.doi.org/10.1126/science.343.6178.1451			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675947				2022-12-28	WOS:000333471000027
J	Saloner, B; Sabik, L; Sommers, BD				Saloner, Brendan; Sabik, Lindsay; Sommers, Benjamin D.			Pinching the Poor? Medicaid Cost Sharing under the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH	Some U.S. states have begun experimenting with increased cost sharing for Medicaid enrollees, but policymakers will need to monitor such programs carefully to understand their impact on costs, quality, access, and health. On December 12, 2013, the Centers for Medicare and Medicaid Services (CMS) reached an agreement with the state of Iowa to expand Medicaid to low-income adults under the Affordable Care Act (ACA). The Iowa Medicaid expansion is notable for its far-reaching use of cost sharing, including copayments and monthly contributions for many enrollees. It exemplifies a growing trend in Medicaid one that raises important questions about balancing state budgetary concerns and appropriate incentives with adequate protections for patients. In addition to Iowa, last year Arizona, Arkansas, and Michigan pursued Medicaid expansions that involve substantial cost sharing for low-income adults ...	[Saloner, Brendan] Univ Penn, Robert Wood Johnson Fdn, Hlth & Soc Scholars Program, Philadelphia, PA 19104 USA; [Sabik, Lindsay] Virginia Commonwealth Univ, Dept Healthcare Policy & Res, Richmond, VA 23284 USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Virginia Commonwealth University; Harvard University; Harvard T.H. Chan School of Public Health	Saloner, B (corresponding author), Univ Penn, Robert Wood Johnson Fdn, Hlth & Soc Scholars Program, Philadelphia, PA 19104 USA.			Sabik, Lindsay/0000-0002-0613-4929				Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; MANNING WG, 1987, AM ECON REV, V77, P251; Remler DK, 2009, ANNU REV PUBL HEALTH, V30, P293, DOI 10.1146/annurev.publhealth.29.020907.090804; Wright BJ, 2010, HEALTH AFFAIR, V29, P2311, DOI 10.1377/hlthaff.2010.0211	4	21	21	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1177	1180		10.1056/NEJMp1316370	http://dx.doi.org/10.1056/NEJMp1316370			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD7EW	24670163	Green Published			2022-12-28	WOS:000333426000002
J	Vinther, J; Stein, M; Longrich, NR; Harper, DAT				Vinther, Jakob; Stein, Martin; Longrich, Nicholas R.; Harper, David A. T.			A suspension-feeding anomalocarid from the Early Cambrian	NATURE			English	Article							SIRIUS PASSET LAGERSTATTE; NORTH GREENLAND; BURGESS SHALE; BONY FISHES; PLANKTON; FOOD; WHALES; ORIGIN; EVOLUTION; BOUNDARY	Large, actively swimming suspension feeders evolved several times in Earth's history, arising independently from groups as diverse as sharks, rays and stem teleost fishes(1), and in mysticete whales(2). However, animals occupying this niche have not been identified from the early Palaeozoic era. Anomalocarids, a group of stem arthropods that were the largest nektonic animals of the Cambrian and Ordovician periods, are generally thought to have been apex predators(3-5). Here we describe new material from Tamisiocaris borealis(6), an anomalocarid from the Early Cambrian (Series 2) Sirius Passet Fauna of North Greenland, and propose that its frontal appendage is specialized for suspension feeding. The appendage bears long, slender and equally spaced ventral spines furnished with dense rows of long and fine auxiliary spines. This suggests that T. borealis was a microphagous suspension feeder, using its appendages for sweep-net capture of food items down to 0.5 mm, within the size range of mesozooplankton such as copepods. Our observations demonstrate that large, nektonic suspension feeders first evolved during the Cambrian explosion, as part of an adaptive radiation of anomalocarids. The presence of nektonic suspension feeders in the Early Cambrian, together with evidence for a diverse pelagic community containing phytoplankton(7,8) and mesozooplankton(7,9,10), indicate the existence of a complex pelagic ecosystem(11) supported by high primary productivity and nutrient flux(12,13). Cambrian pelagic ecosystems seem to have been more modern than previously believed. [GRAPHICS] .	[Vinther, Jakob] Univ Bristol, Sch Earth Sci, Bristol BS8, Avon, England; [Vinther, Jakob] Univ Bristol, Sch Biol Sci, Bristol BS8, Avon, England; [Stein, Martin] Univ Copenhagen, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark; [Longrich, Nicholas R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Harper, David A. T.] Univ Durham, Dept Earth Sci, Palaeoecosyst Grp, Durham DH1 3LE, England	University of Bristol; University of Bristol; University of Copenhagen; University of Bath; Durham University	Vinther, J (corresponding author), Univ Bristol, Sch Earth Sci, Woodland Rd, Bristol BS8, Avon, England.	jakob.vinther@bristol.ac.uk	Vinther, Jakob/GZG-4679-2022; Harper, David/AAX-7473-2020; Harper, David A.T./C-6888-2012	Harper, David/0000-0003-1315-9494; Harper, David A.T./0000-0003-1315-9494; Stein, Martin/0000-0002-8218-8232; Longrich, Nicholas/0000-0002-9586-8907; Vinther, Jakob/0000-0002-3584-9616	Geocenter Denmark; Agouron Institute; Carlsberg Foundation	Geocenter Denmark; Agouron Institute(Pfizer); Carlsberg Foundation(Carlsberg Foundation)	Our expeditions to North Greenland were financed by Geocenter Denmark, the Agouron Institute and the Carlsberg Foundation. We are grateful for discussions with members of the Bristol Palaeobiology group, E. Sperling, C. Hull, M. Matz and M. Friedman. M. S. was supported by the Carlsberg Foundation. We thank POLOG for logistic support. A. T. Nielsen and M. P. Smith assisted in the field in 2009. S. Powell assisted with figures. S. L. Jakobsen and A. T. Nielsen facilitated work and curation of the collected material at the Statens Naturhistoriske Museum, Copenhagen.	Barkley E., 1954, Zeitschrift fuer Fischerei, VBeiheft 1, Walforschung 1, Enhalt IV, P65; BOYD CM, 1984, J CRUSTACEAN BIOL, V4, P123, DOI 10.1163/1937240X84X00543; Brasier M.D., 1991, Historical Biology, V5, P85; Briggs D.E.G., 1979, Palaeontology (Oxford), V22, P631; Budy P, 2005, T AM FISH SOC, V134, P1228, DOI 10.1577/T04-159.1; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; Chen YY, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.214.3291; COOK PJ, 1984, NATURE, V308, P231, DOI 10.1038/308231a0; Daley AC, 2013, PALAEONTOLOGY, V56, P971, DOI 10.1111/pala.12029; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2010, PALAEONTOLOGY, V53, P721, DOI 10.1111/j.1475-4983.2010.00955.x; Daley AC, 2010, J PALEONTOL, V84, P352, DOI 10.1666/09-136R1.1; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Friedman M, 2012, P ROY SOC B-BIOL SCI, V279, P944, DOI 10.1098/rspb.2011.1381; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; GELLER W, 1981, OECOLOGIA, V49, P316, DOI 10.1007/BF00347591; Gould S. J., 1989, WONDERFUL LIFE BURGE; Harvey THP, 2008, NATURE, V452, P868, DOI 10.1038/nature06724; Harvey THP, 2012, P NATL ACAD SCI USA, V109, P1589, DOI 10.1073/pnas.1115244109; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Ineson JR, 2011, CAN J EARTH SCI, V48, P1259, DOI 10.1139/E11-018; JENKIN PM, 1957, PHILOS T ROY SOC B, V240, P401, DOI 10.1098/rstb.1957.0004; JERLING HL, 1995, J EXP MAR BIOL ECOL, V188, P243, DOI 10.1016/0022-0981(95)00007-E; Jorgensen CB., 1966, BIOL SUSPENSION FEED; Kruta I, 2011, SCIENCE, V331, P70, DOI 10.1126/science.1198793; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Nemoto T., 1970, P241; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Peel JS, 2011, B GEOSCI, V86, P535, DOI 10.3140/bull.geosci.1269; Peters SE, 2012, NATURE, V484, P363, DOI 10.1038/nature10969; PIVORUNAS A, 1979, AM SCI, V67, P432; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; Stein M, 2010, LETHAIA, V43, P258, DOI 10.1111/j.1502-3931.2009.00189.x; Tanaka H, 2006, J FISH BIOL, V68, P1041, DOI 10.1111/j.0022-1112.2006.00988.x; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; Vannier J, 2007, P ROY SOC B-BIOL SCI, V274, P627, DOI 10.1098/rspb.2006.3761; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; VIDAL G, 1982, NATURE, V297, P57, DOI 10.1038/297057a0; Vinther J, 2011, PALAEONTOLOGY, V54, P711, DOI 10.1111/j.1475-4983.2011.01034.x; Werth AJ, 2013, J EXP BIOL, V216, P1152, DOI 10.1242/jeb.078931; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096	42	102	103	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					496	+		10.1038/nature13010	http://dx.doi.org/10.1038/nature13010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670770	Green Submitted, Green Accepted			2022-12-28	WOS:000333402000040
J	Jaremko, L; Jaremko, M; Giller, K; Becker, S; Zweckstetter, M				Jaremko, Lukasz; Jaremko, Mariusz; Giller, Karin; Becker, Stefan; Zweckstetter, Markus			Structure of the Mitochondrial Translocator Protein in Complex with a Diagnostic Ligand	SCIENCE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA; CHOLESTEROL TRANSPORT; AFFINITY BINDING; TSPO; MEMBRANES; IDENTIFICATION; SEQUENCE; TARGET	The 18-kilodalton translocator protein TSPO is found in mitochondrial membranes and mediates the import of cholesterol and porphyrins into mitochondria. In line with the role of TSPO in mitochondrial function, TSPO ligands are used for a variety of diagnostic and therapeutic applications in animals and humans. We present the three-dimensional high-resolution structure of mammalian TSPO reconstituted in detergent micelles in complex with its high-affinity ligand PK11195. The TSPO-PK11195 structure is described by a tight bundle of five transmembrane alpha helices that form a hydrophobic pocket accepting PK11195. Ligand-induced stabilization of the structure of TSPO suggests a molecular mechanism for the stimulation of cholesterol transport into mitochondria.	[Jaremko, Lukasz; Jaremko, Mariusz; Giller, Karin; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Jaremko, Lukasz; Zweckstetter, Markus] Deutsch Zentrum Neurodegenerat Erkrankungen, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37073 Gottingen, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Becker, S (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	sabe@nmr.mpibpc.mpg.de; markus.zweckstetter@dzne.de	Jaremko, Lukasz/A-3101-2009; Jaremko, Lukasz/GQB-5017-2022	Jaremko, Lukasz/0000-0001-7684-9359; Zweckstetter, Markus/0000-0002-2536-6581; Jaremko, Mariusz/0000-0002-0787-702X	Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej); EU; Deutsche Forschungsgemeinschaft Collaborative Research Center [803]; European Research Council (ERC) [282008]	Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej); EU(European Commission); Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission)	The 3D structure of the mTSPO-PK11195 complex has been deposited at the Protein Data Bank (accession code 2mgy). Supported by the START and Ventures Programme of the Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej) cofinanced by the EU European Regional Development Fund (M.J. and L.J.) and by Deutsche Forschungsgemeinschaft Collaborative Research Center 803, Project A11, and the European Research Council (ERC grant agreement 282008) (M.Z.).	Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Fan J, 2012, CURR MOL MED, V12, P369; FARGES R, 1994, MOL PHARMACOL, V46, P1160; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Gatliff J, 2012, CURR MOL MED, V12, P356; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Joseph-Liauzun E, 1998, J BIOL CHEM, V273, P2146, DOI 10.1074/jbc.273.4.2146; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Lee YS, 2012, ACS CHEM NEUROSCI, V3, P325, DOI 10.1021/cn3000108; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Morrison EA, 2012, BBA-BIOMEMBRANES, V1818, P814, DOI 10.1016/j.bbamem.2011.12.020; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Scarf AM, 2009, J MED CHEM, V52, P581, DOI 10.1021/jm8011678; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Veenman L, 2012, CURR MOL MED, V12, P398; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385	27	183	186	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1363	1366		10.1126/science.1248725	http://dx.doi.org/10.1126/science.1248725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653034	Green Accepted			2022-12-28	WOS:000333108500040
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Let's stop consenting patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												daniel.sokol@talk21.com						Kennedy I, REV RESPONSE HEART E; Sokol D. K., 2012, DOING CLIN ETHICS HA	2	6	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g2192	10.1136/bmj.g2192	http://dx.doi.org/10.1136/bmj.g2192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647171				2022-12-28	WOS:000333414500019
J	Bjorck, M; Mani, K				Bjorck, Martin; Mani, Kevin			Improving outcomes for ruptured abdominal aortic aneurysm	LANCET			English	Editorial Material							MORTALITY; ENGLAND		[Bjorck, Martin; Mani, Kevin] Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden	Uppsala University	Bjorck, M (corresponding author), Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden.	martin@bjorck.pp.se						Anjum A, 2012, EUR J VASC ENDOVASC, V43, P161, DOI 10.1016/j.ejvs.2011.11.014; Basnyat PS, 1999, BRIT J SURG, V86, P765, DOI 10.1046/j.1365-2168.1999.01170.x; Bown MJ, 2002, BRIT J SURG, V89, P714, DOI 10.1046/j.1365-2168.2002.02122.x; Karthikesalingam A, 2014, LANCET, V383, P963, DOI 10.1016/S0140-6736(14)60109-4; Mani K, 2013, BRIT J SURG, V100, P638, DOI 10.1002/bjs.9046; Mani K, 2011, EUR J VASC ENDOVASC, V42, P598, DOI 10.1016/j.ejvs.2011.06.043; Mani K, 2009, CIRCULATION, V120, P201, DOI 10.1161/CIRCULATIONAHA.108.832774; Powell JT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7661; Reimerink JJ, 2013, ANN SURG, V258, P248, DOI 10.1097/SLA.0b013e31828d4b76; Stather PW, 2013, EUR J VASC ENDOVASC, V45, P231, DOI 10.1016/j.ejvs.2012.12.013; Svensjo S, 2011, CIRCULATION, V124, P1118; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Veith FJ, 2009, ANN SURG, V250, P818, DOI 10.1097/SLA.0b013e3181bdd7f5	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					933	934						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MR	24629283				2022-12-28	WOS:000333520700006
J	Ades, L; Itzykson, R; Fenaux, P				Ades, Lionel; Itzykson, Raphael; Fenaux, Pierre			Myelodysplastic syndromes	LANCET			English	Article							ACUTE MYELOID-LEUKEMIA; PROGNOSTIC SCORING SYSTEM; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; COLONY-STIMULATING FACTOR; TRANSFUSION-DEPENDENT PATIENTS; CONVENTIONAL CARE REGIMENS; IRON CHELATION-THERAPY; RANDOMIZED PHASE-II; REGULATORY T-CELLS	Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by ineffective haemopoiesis leading to blood cytopenias, and by progression to acute myeloid leukaemia in a third of patients. 15% of cases occur after chemotherapy or radiotherapy for a previous cancer; the syndromes are most common in elderly people. The pathophysiology involves cytogenetic changes with or without gene mutations and widespread gene hypermethylation at advanced stages. Clinical manifestations result from cytopenias (anaemia, infection, and bleeding). Diagnosis is based on examination of blood and bone marrow showing blood cytopenias and hypercellular marrow with dysplasia, with or without excess of blasts. Prognosis depends largely on the marrow blast percentage, number and extent of cytopenias, and cytogenetic abnormalities. Treatment of patients with lower-risk myelodysplastic syndromes, especially for anaemia, includes growth factors, lenalidomide, and transfusions. Treatment of higher-risk patients is with hypomethylating agents and, whenever possible, allogeneic stem-cell transplantation.	[Ades, Lionel; Itzykson, Raphael; Fenaux, Pierre] Hop St Louis, AP HP, Hematol Serv, F-75475 Paris, France; [Ades, Lionel; Itzykson, Raphael; Fenaux, Pierre] Univ Paris 07, F-75475 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fenaux, P (corresponding author), Hop St Louis, AP HP, Hematol Serv, F-75475 Paris, France.	pierre.fenaux@sls.aphp.fr	Itzykson, Raphael/M-8517-2018	Itzykson, Raphael/0000-0003-2139-6262				Ades L, 2012, HAEMATOL-HEMATOL J, V97, P213, DOI 10.3324/haematol.2011.045914; AKSOY M, 1987, BRIT J IND MED, V44, P785; Alessandrino EP, 2010, HAEMATOL-HEMATOL J, V95, P476, DOI 10.3324/haematol.2009.011429; Anderson JE, 1996, J CLIN ONCOL, V14, P220, DOI 10.1200/JCO.1996.14.1.220; Armand P, 2007, BLOOD, V109, P4586, DOI 10.1182/blood-2006-10-054924; Arnold R, 1998, BONE MARROW TRANSPL, V21, P1213, DOI 10.1038/sj.bmt.1701269; Aziz A, 2013, J CLIN INVEST, V123, P2169, DOI 10.1172/JCI66113; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bhagat TD, 2013, BLOOD, V121, P2875, DOI 10.1182/blood-2011-12-397067; Blau O, 2011, BLOOD, V118, P5583, DOI 10.1182/blood-2011-03-343467; Boehrer S, 2010, BLOOD, V116, P784, DOI 10.1182/blood.V116.21.1880.1880; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Braun T, 2011, LEUKEMIA RES, V35, P863, DOI 10.1016/j.leukres.2011.02.008; Broliden PA, 2006, HAEMATOLOGICA, V91, P667; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Castro-Malaspina H, 2002, BLOOD, V99, P1943, DOI 10.1182/blood.V99.6.1943; CHESON BD, 1987, SEMIN ONCOL, V14, P126; Claessens YE, 2002, BLOOD, V99, P1594, DOI 10.1182/blood.V99.5.1594; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Costantini B, 2013, HAEMATOLOGICA, V98, P1196, DOI 10.3324/haematol.2012.074823; Crawford J, 2002, CANCER-AM CANCER SOC, V95, P888, DOI 10.1002/cncr.10763; Cutler CS, 2004, BLOOD, V104, P579, DOI 10.1182/blood-2004-01-0338; Damm F, 2011, NEW ENGL J MED, V365, P1154, DOI 10.1056/NEJMc1108665; Davis BA, 2004, BLOOD, V104, P263, DOI 10.1182/blood-2003-08-2841; Della Porta MG, 2009, J CLIN ONCOL, V27, P754, DOI 10.1200/JCO.2008.18.2246; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Estey EH, 2002, BLOOD, V99, P4343, DOI 10.1182/blood.V99.12.4343; Estey EH, 2001, BLOOD, V98, P3575, DOI 10.1182/blood.V98.13.3575; FENAUX P, 1990, LEUKEMIA, V4, P312; Fenaux P, 2011, BLOOD, V118, P3765, DOI 10.1182/blood-2011-01-330126; Fenaux P, 2010, BRIT J HAEMATOL, V149, P244, DOI 10.1111/j.1365-2141.2010.08082.x; Fenaux P, 2009, BLOOD REV, V23, pS15, DOI 10.1016/S0268-960X(09)70005-0; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Garcia-Manero G, 2008, LEUKEMIA, V22, P538, DOI 10.1038/sj.leu.2405070; Garcia-Manero G, 2006, BLOOD, V108, P3271, DOI 10.1182/blood-2006-03-009142; GATTERMANN N, 2005, HEMATOL ONCOL CLI S1, V19, P18; Germing U, 2005, LEUKEMIA, V19, P2223, DOI 10.1038/sj.leu.2403963; Giagounidis AAN, 2012, LEUKEMIA, V26, P855, DOI 10.1038/leu.2011.268; Gore SD, 2013, HAEMATOLOGICA, V98, P1067, DOI 10.3324/haematol.2012.074831; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg Peter L, 2006, J Natl Compr Canc Netw, V4, P91; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Greenberg PL, 2009, BLOOD, V114, P2393, DOI 10.1182/blood-2009-03-211797; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; HEBBAR M, 1995, LEUKEMIA, V9, P731; Hebbar M, 1997, LEUKEMIA, V11, P2188, DOI 10.1038/sj.leu.2400863; Hellstrom-Lindberg E, 1998, BLOOD, V92, P68, DOI 10.1182/blood.V92.1.68.413k23_68_75; Hellstrom-Lindberg E, 2003, BRIT J HAEMATOL, V120, P1037, DOI 10.1046/j.1365-2141.2003.04153.x; HellstromLindberg E, 1997, BRIT J HAEMATOL, V99, P344, DOI 10.1046/j.1365-2141.1997.4013211.x; Itzykson R, 2011, LEUKEMIA, V25, P1147, DOI 10.1038/leu.2011.71; Itzykson R, 2011, BLOOD, V117, P403, DOI 10.1182/blood-2010-06-289280; Iwanaga M, 2011, J CLIN ONCOL, V29, P428, DOI 10.1200/JCO.2010.31.3080; Jadersten M, 2008, J CLIN ONCOL, V26, P3607, DOI 10.1200/JCO.2007.15.4906; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jensen PD, 2003, BLOOD, V101, P4632, DOI 10.1182/blood-2002-09-2754; Jerez A, 2012, J CLIN ONCOL, V30, P1343, DOI 10.1200/JCO.2011.36.1824; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1099, DOI 10.1002/cncr.21699; Kantarjian H, 2007, AM SOC HEMATOL, V110, P250; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Kantarjian HM, 2012, ASH ANN M, V120, P421; Kelaidi C, 2008, LEUKEMIA RES, V32, P1049, DOI 10.1016/j.leukres.2007.11.037; Kelaidi C, 2013, LEUKEMIA, V27, P1283, DOI 10.1038/leu.2013.16; Khan H, 2013, SEMIN HEMATOL, V50, P16, DOI 10.1053/j.seminhematol.2013.01.001; Knipp S, 2007, CANCER-AM CANCER SOC, V110, P345, DOI 10.1002/cncr.22779; Komrokji RS, 2012, BLOOD, V120, P3419, DOI 10.1182/blood-2012-03-415661; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Koreth J, 2013, J CLIN ONCOL, V31, P2662, DOI 10.1200/JCO.2012.46.8652; Kuendgen A, 2013, LEUKEMIA, V27, P1072, DOI 10.1038/leu.2012.369; Kulasekararaj AG, 2010, BLOOD, V116, P125; Kulasekararaj AG, 2013, BRIT J HAEMATOL, V160, P660, DOI 10.1111/bjh.12203; Lee YG, 2013, BRIT J HAEMATOL, V161, P339, DOI 10.1111/bjh.12256; Leitch HA, 2007, LEUKEMIA RES, V31, pS7, DOI 10.1016/S0145-2126(07)70460-5; Lim ZY, 2007, LEUKEMIA, V21, P1436, DOI 10.1038/sj.leu.2404747; List A, 2011, J CLIN ONCOL, V29, P6522; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lubbert M, 2011, J CLIN ONCOL, V29, P1987, DOI 10.1200/JCO.2010.30.9245; Maassen A, 2013, LEUKEMIA RES, V37, P64, DOI 10.1016/j.leukres.2012.09.021; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Malcovati L, 2006, HAEMATOLOGICA, V91, P1588; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Matsuda A, 2005, BLOOD, V106, P2633, DOI 10.1182/blood-2005-01-0040; McLaughlin P, 2005, BLOOD, V105, P4573, DOI 10.1182/blood-2004-08-3035; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965; Molldrem JJ, 1997, BRIT J HAEMATOL, V99, P699, DOI 10.1046/j.1365-2141.1997.4423249.x; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morel P, 1996, BRIT J HAEMATOL, V94, P116, DOI 10.1046/j.1365-2141.1996.6122056.x; Morrison VA, 2002, J CLIN ONCOL, V20, P3878, DOI 10.1200/JCO.2002.08.128; Muguruma Y, 2011, HAEMATOL-HEMATOL J, V96, P543, DOI 10.3324/haematol.2010.027557; Nand S, 2008, LEUKEMIA LYMPHOMA, V49, P2141, DOI 10.1080/10428190802451254; Naqvi K, 2011, J CLIN ONCOL, V29, P2240, DOI 10.1200/JCO.2010.31.3353; Neukirchen J, 2012, LEUKEMIA RES, V36, P1067, DOI 10.1016/j.leukres.2012.04.006; Neukirchen J, 2011, LEUKEMIA RES, V35, P1591, DOI 10.1016/j.leukres.2011.06.001; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Nisse C, 2001, BRIT J HAEMATOL, V112, P927, DOI 10.1046/j.1365-2141.2001.02645.x; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Park S, 2008, BLOOD, V111, P574, DOI 10.1182/blood-2007-06-096370; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Passweg JR, 2011, J CLIN ONCOL, V29, P303, DOI 10.1200/JCO.2010.31.2686; PEDERSENBJERGAARD J, 1991, LANCET, V338, P359, DOI 10.1016/0140-6736(91)90490-G; Perez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031605; Platzbecker U, 2012, LEUKEMIA, V26, P381, DOI 10.1038/leu.2011.234; Prebet T, 2010, ASH ANN M, V116, P601; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; RAZA A, 1995, BLOOD, V86, P268, DOI 10.1182/blood.V86.1.268.bloodjournal861268; Raza A, 2008, BLOOD, V111, P86, DOI 10.1182/blood-2007-01-068833; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Raza A, 2008, CANCER, V113, P1596, DOI 10.1002/cncr.23789; Rigolin GM, 1998, BRIT J HAEMATOL, V103, P189, DOI 10.1046/j.1365-2141.1998.00963.x; Rose C, 2010, LEUKEMIA RES, V34, P864, DOI 10.1016/j.leukres.2009.12.004; Saunthararajah Y, 2003, BLOOD, V102, P3025, DOI 10.1182/blood-2002-11-3325; Schanz J, 2011, J CLIN ONCOL, V29, P1963, DOI 10.1200/JCO.2010.28.3978; Sekeres MA, 2012, BLOOD, V120, P4945, DOI 10.1182/blood-2012-06-434639; Sekeres MA, 2011, CANCER-AM CANCER SOC, V117, P1253, DOI 10.1002/cncr.25686; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sierra J, 2002, BLOOD, V100, P1997; Silverman LR, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.7000; Silverman LR, 2006, J CLIN ONCOL, V24, P3895, DOI 10.1200/JCO.2005.05.4346; Silverman LR, 2011, CANCER-AM CANCER SOC, V117, P2697, DOI 10.1002/cncr.25774; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Sloand EM, 2008, J CLIN ONCOL, V26, P2505, DOI 10.1200/JCO.2007.11.9214; Sorror ML, 2007, J CLIN ONCOL, V25, P4246, DOI 10.1200/JCO.2006.09.7865; Sperr WR, 2010, ANN ONCOL, V21, P114, DOI 10.1093/annonc/mdp258; Sperr WR, 2001, ANN HEMATOL, V80, P272; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Steensma DP, 2009, J CLIN ONCOL, V27, P3842, DOI 10.1200/JCO.2008.19.6550; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tehranchi R, 2005, BLOOD, V106, P247, DOI 10.1182/blood-2004-12-4649; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Thol F, 2011, J CLIN ONCOL, V29, P2499, DOI 10.1200/JCO.2010.33.4938; Toma A, 2012, HAEMATOL-HEMATOL J, V97, P1459, DOI 10.3324/haematol.2012.063420; Traina F, 2011, BLOOD, V118, P461; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; van de Loosdrecht AA, 2008, BLOOD, V111, P1067, DOI 10.1182/blood-2007-07-098764; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Verburgh E, 2003, J CLIN ONCOL, V21, P273, DOI 10.1200/JCO.2003.04.182; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Wattel E, 1999, LEUKEMIA, V13, P524, DOI 10.1038/sj.leu.2401387; Wei S, 2009, P NATL ACAD SCI USA, V106, P12974, DOI 10.1073/pnas.0811267106; Westers TM, 2012, LEUKEMIA, V26, P1730, DOI 10.1038/leu.2012.30; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Wimazal F, 2007, LEUKEMIA RES, V31, P1461, DOI 10.1016/j.leukres.2007.03.015; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zang DY, 2001, BLOOD, V98, P3058, DOI 10.1182/blood.V98.10.3058; Zipperer E, 2009, HAEMATOL-HEMATOL J, V94, P729, DOI 10.3324/haematol.2008.002063	160	263	294	6	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2239	2252		10.1016/S0140-6736(13)61901-7	http://dx.doi.org/10.1016/S0140-6736(13)61901-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK8DO	24656536				2022-12-28	WOS:000338657600029
J	Jost, TS; Lazarus, S				Jost, Timothy Stoltzfus; Lazarus, Simon			Obama's ACA Delays - Breaking the Law or Making It Work?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jost, Timothy Stoltzfus] Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA; [Lazarus, Simon] Constitut Accountabil Ctr, Washington, DC USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							[Anonymous], 2013, COMMUNICATION; Corlette S, 2013, HILL C BLOG     0717; Jost TS, 1999, ADMIN LAW REV, V51, P39; Lazarus S., 2013, ATLANTIC        0717	4	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					1970	1971		10.1056/NEJMp1403294	http://dx.doi.org/10.1056/NEJMp1403294			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UZ	24693857				2022-12-28	WOS:000336125500004
J	Goldenberg, I; Kutyifa, V; Klein, HU; Cannom, DS; Brown, MW; Dan, A; Daubert, JP; Estes, NAM; Foster, E; Greenberg, H; Kautzner, J; Klempfner, R; Kuniss, M; Merkely, B; Pfeffer, MA; Quesada, A; Viskin, S; McNitt, S; Polonsky, B; Ghanem, A; Solomon, SD; Wilber, D; Zareba, W; Moss, AJ				Goldenberg, Ilan; Kutyifa, Valentina; Klein, Helmut U.; Cannom, David S.; Brown, Mary W.; Dan, Ariela; Daubert, James P.; Estes, N. A. Mark, III; Foster, Elyse; Greenberg, Henry; Kautzner, Josef; Klempfner, Robert; Kuniss, Malte; Merkely, Bela; Pfeffer, Marc A.; Quesada, Aurelio; Viskin, Sami; McNitt, Scott; Polonsky, Bronislava; Ghanem, Ali; Solomon, Scott D.; Wilber, David; Zareba, Wojciech; Moss, Arthur J.			Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFIBRILLATOR IMPLANTATION TRIAL; LEFT-VENTRICULAR ACTIVATION; BUNDLE-BRANCH BLOCK; MADIT-CRT; EVENTS; MORTALITY; RISK	BackgroundThe Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) showed that early intervention with cardiac-resynchronization therapy with a defibrillator (CRT-D) in patients with an electrocardiographic pattern showing left bundle-branch block was associated with a significant reduction in heart-failure events over a median follow-up of 2.4 years, as compared with defibrillator therapy alone. MethodsWe evaluated the effect of CRT-D on long-term survival in the MADIT-CRT population. Post-trial follow-up over a median period of 5.6 years was assessed among all 1691 surviving patients (phase 1) and subsequently among 854 patients who were enrolled in post-trial registries (phase 2). All reported analyses were performed on an intention-to-treat basis. ResultsAt 7 years of follow-up after initial enrollment, the cumulative rate of death from any cause among patients with left bundle-branch block was 18% among patients randomly assigned to CRT-D, as compared with 29% among those randomly assigned to defibrillator therapy alone (adjusted hazard ratio in the CRT-D group, 0.59; 95% confidence interval [CI], 0.43 to 0.80; P<0.001). The long-term survival benefit of CRT-D in patients with left bundle-branch block did not differ significantly according to sex, cause of cardiomyopathy, or QRS duration. In contrast, CRT-D was not associated with any clinical benefit and possibly with harm in patients without left bundle-branch block (adjusted hazard ratio for death from any cause, 1.57; 95% CI, 1.03 to 2.39; P=0.04; P<0.001 for interaction of treatment with QRS morphologic findings). ConclusionsOur findings indicate that in patients with mild heart-failure symptoms, left ventricular dysfunction, and left bundle-branch block, early intervention with CRT-D was associated with a significant long-term survival benefit. (Funded by Boston Scientific; ClinicalTrials.gov numbers, NCT00180271, NCT01294449, and NCT02060110.)	[Goldenberg, Ilan; Kutyifa, Valentina; Klein, Helmut U.; Brown, Mary W.; McNitt, Scott; Polonsky, Bronislava; Zareba, Wojciech; Moss, Arthur J.] Univ Rochester, Med Ctr, Dept Med, Heart Res Follow Up Program,Div Cardiol, Rochester, NY 14642 USA; [Goldenberg, Ilan; Dan, Ariela; Klempfner, Robert] Chaim Sheba Med Ctr, Leviev Heart Ctr, Israeli Assoc Cardiovasc Trials, IL-5265601 Tel Hashomer, Israel; [Goldenberg, Ilan; Viskin, Sami] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Viskin, Sami] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Cannom, David S.] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Cannom, David S.] Hosp Good Samaritan, Los Angeles, CA 90017 USA; [Daubert, James P.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Estes, N. A. Mark, III] Tufts Med Ctr, New England Cardiac Arrhythmia Ctr, Boston, MA USA; [Pfeffer, Marc A.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Pfeffer, Marc A.; Solomon, Scott D.] Harvard Univ, Sch Med, Boston, MA USA; [Foster, Elyse] Univ Calif San Francisco, Cardiol Unit, San Francisco, CA 94143 USA; [Greenberg, Henry] St Lukes Roosevelt Hosp, Cardiol Unit, New York, NY 10025 USA; [Kautzner, Josef] Inst Clin & Expt Med, Dept Cardiol, Prague, Czech Republic; [Kuniss, Malte] Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, Bad Nauheim, Germany; [Ghanem, Ali] Univ Bonn, Dept Med Cardiol, Bonn, Germany; [Merkely, Bela] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary; [Quesada, Aurelio] Hosp Gen Valencia, Valencia, Spain; [Wilber, David] Loyola Univ, Med Ctr, Cardiovasc Inst, Chicago, IL 60611 USA	University of Rochester; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Cedars Sinai Medical Center; Duke University; Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Mount Sinai St. Luke's; Mount Sinai West; Institute for Clinical & Experimental Medicine (IKEM); Kerckhoff Clinic; Max Planck Society; University of Bonn; Semmelweis University; Loyola University Chicago	Goldenberg, I (corresponding author), Chaim Sheba Med Ctr, Leviev Heart Ctr, IL-5265601 Tel Hashomer, Israel.	ilan.goldenberg@sheba.health.gov.il; heartajm@heart.rochester.edu	Daubert, James P./ABC-1476-2021; QUESADA, AURELIO/K-4925-2017; Klempfner, Robert/M-4989-2016	QUESADA, AURELIO/0000-0003-4709-1993; Merkely, Bela/0000-0001-6514-0723	Boston Scientific	Boston Scientific(Boston Scientific)	Supported by unrestricted research grants from Boston Scientific to the University of Rochester School of Medicine and Dentistry and to the Israeli Association for Cardiovascular Trials.	Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JGF, 2006, EUR HEART J, V27, P1928, DOI 10.1093/eurheartj/ehl099; Fantoni C, 2005, J CARDIOVASC ELECTR, V16, P112, DOI 10.1046/j.1540-8167.2005.40777.x; Goldenberg I, 2011, J AM COLL CARDIOL, V58, P729, DOI 10.1016/j.jacc.2011.04.024; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P34, DOI 10.1111/j.1542-474X.2005.00073.x; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Ouellet G, 2012, J AM COLL CARDIOL, V60, P1809, DOI 10.1016/j.jacc.2012.05.057; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Ypenburg C, 2008, J AM COLL CARDIOL, V52, P1402, DOI 10.1016/j.jacc.2008.06.046; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898	14	219	230	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1694	1701		10.1056/NEJMoa1401426	http://dx.doi.org/10.1056/NEJMoa1401426			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24678999	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000335405200007
J	White, HD; Held, C; Stewart, R; Tarka, E; Brown, R; Davies, RY; Budaj, A; Harrington, RA; Steg, PG; Ardis-Sino, D; Armstrong, PW; Avezum, A; Aylward, PE; Bryce, A; Chen, H; Chen, MF; Corbalan, R; Dalby, AJ; Danchin, N; De Winter, RJ; Denchev, S; Diaz, R; Elisaf, M; Flather, MD; Goudev, AR; Granger, CB; Grinfeld, L; Hochman, JS; Husted, S; Kim, HS; Koenig, W; Linhart, A; Lonn, E; Lopez-Sendon, J; Manolis, AJ; Mohler, ER; Nicolau, JC; Pais, P; Parkhomenko, A; Pedersen, TR; Pella, D; Ramos-Corrales, MA; Ruda, M; Sereg, M; Siddique, S; Sinnaeve, P; Smith, P; Sritara, P; Swart, HP; Sy, RG; Teramoto, T; Tse, HF; Watson, D; Weaver, WD; Weiss, R; Viigimaa, M; Vinereanu, D; Zhu, JR; Cannon, CP; Wallentin, L				White, Harvey D.; Held, Claes; Stewart, Ralph; Tarka, Elizabeth; Brown, Rebekkah; Davies, Richard Y.; Budaj, Andrzej; Harrington, Robert A.; Steg, P. Gabriel; Ardis-Sino, Diego; Armstrong, Paul W.; Avezum, Alvaro; Aylward, Philip E.; Bryce, Alfonso; Chen, Hong; Chen, Ming-Fong; Corbalan, Ramon; Dalby, Anthony J.; Danchin, Nicolas; De Winter, Robbert J.; Denchev, Stefan; Diaz, Rafael; Elisaf, Moses; Flather, Marcus D.; Goudev, Assen R.; Granger, Christopher B.; Grinfeld, Liliana; Hochman, Judith S.; Husted, Steen; Kim, Hyo-Soo; Koenig, Wolfgang; Linhart, Ales; Lonn, Eva; Lopez-Sendon, Jose; Manolis, Athanasios J.; Mohler, Emile R., III; Nicolau, Jose C.; Pais, Prem; Parkhomenko, Alexander; Pedersen, Terje R.; Pella, Daniel; Ramos-Corrales, Marco A.; Ruda, Mikhail; Sereg, Mtys; Siddique, Saulat; Sinnaeve, Peter; Smith, Peter; Sritara, Piyamitr; Swart, Henk P.; Sy, Rody G.; Teramoto, Tamio; Tse, Hung-Fat; Watson, David; Weaver, W. Douglas; Weiss, Robert; Viigimaa, Margus; Vinereanu, Dragos; Zhu, Junren; Cannon, Christopher P.; Wallentin, Lars		STABILITY Investigators	Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; PHOSPHOLIPASE A(2); ATHEROSCLEROTIC PLAQUE; CLINICAL-OUTCOMES; OXIDIZED LDL; LIPOPROTEIN; RISK; INHIBITOR; THERAPY; TRIAL	BackgroundElevated lipoprotein-associated phospholipase A(2) activity promotes the development of vulnerable atherosclerotic plaques, and elevated plasma levels of this enzyme are associated with an increased risk of coronary events. Darapladib is a selective oral inhibitor of lipoprotein-associated phospholipase A(2). MethodsIn a double-blind trial, we randomly assigned 15,828 patients with stable coronary heart disease to receive either once-daily darapladib (at a dose of 160 mg) or placebo. The primary end point was a composite of cardiovascular death, myocardial infarction, or stroke. Secondary end points included the components of the primary end point as well as major coronary events (death from coronary heart disease, myocardial infarction, or urgent coronary revascularization for myocardial ischemia) and total coronary events (death from coronary heart disease, myocardial infarction, hospitalization for unstable angina, or any coronary revascularization). ResultsDuring a median follow-up period of 3.7 years, the primary end point occurred in 769 of 7924 patients (9.7%) in the darapladib group and 819 of 7904 patients (10.4%) in the placebo group (hazard ratio in the darapladib group, 0.94; 95% confidence interval [CI], 0.85 to 1.03; P=0.20). There were also no significant between-group differences in the rates of the individual components of the primary end point or in all-cause mortality. Darapladib, as compared with placebo, reduced the rate of major coronary events (9.3% vs. 10.3%; hazard ratio, 0.90; 95% CI, 0.82 to 1.00; P=0.045) and total coronary events (14.6% vs. 16.1%; hazard ratio, 0.91; 95% CI, 0.84 to 0.98; P=0.02). ConclusionsIn patients with stable coronary heart disease, darapladib did not significantly reduce the risk of the primary composite end point of cardiovascular death, myocardial infarction, or stroke. (Funded by GlaxoSmithKline; STABILITY ClinicalTrials.gov number, NCT00799903.)	[White, Harvey D.; Stewart, Ralph] Auckland City Hosp, Green Lane Cardiovasc Serv, Private Bag 92024,Victoria St W, Auckland 1142, New Zealand; [White, Harvey D.; Stewart, Ralph] Univ Auckland, Auckland 1, New Zealand; [Held, Claes; Wallentin, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Held, Claes; Wallentin, Lars] Uppsala Clin Res Ctr, Uppsala, Sweden; [Tarka, Elizabeth; Davies, Richard Y.] GlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, King Of Prussia, PA USA; GlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, Res Triangle Pk, NC USA; [Granger, Christopher B.] Duke Univ, Med Ctr, Durham, NC USA; [Budaj, Andrzej] Grochowski Hosp, Postgrad Med Sch, Warsaw, Poland; [Harrington, Robert A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hospitalouniv FIRE, INSERM Unite 1148, F-75877 Paris, France; [Steg, P. Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Danchin, Nicolas] Hop Europeen Georges Pompidou, AP HP, INSERM Unite 970, Paris, France; [Danchin, Nicolas] Univ Paris 05, Paris, France; [Steg, P. Gabriel] Royal Brompton Hosp, ICMS, NHLI Imperial Coll, London SW3 6LY, England; [Ardis-Sino, Diego] Azienda Osped Univ Parma, Parma, Italy; [Armstrong, Paul W.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Avezum, Alvaro] Univ Sao Paulo, Sch Med, Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Nicolau, Jose C.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Aylward, Philip E.] Flinders Univ & Med Ctr, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Bryce, Alfonso] Cardiol Clin El Golf, Lima, Peru; [Chen, Hong] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China; [Chen, Ming-Fong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Corbalan, Ramon] Pontificia Univ Catolica Chile, Div Cardiovasc, Santiago, Chile; [Dalby, Anthony J.] Milpark Hosp, Johannesburg, South Africa; [De Winter, Robbert J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Denchev, Stefan] Univ Hosp Alexandrovska, Clin Cardiol, Sofia, Bulgaria; [Goudev, Assen R.] Queen Giovanna Univ Hosp, Dept Cardiol, Sofia, Bulgaria; [Diaz, Rafael] ECLA Estudios Cardiol Latinoamer, Rosario, Santa Fe, Argentina; [Elisaf, Moses] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece; [Flather, Marcus D.] Norwich Med Sch, Norwich, Norfolk, England; [Flather, Marcus D.] Norwich Univ Hosp, Norwich, Norfolk, England; [Grinfeld, Liliana] Univ Buenos Aires, Sch Med, Buenos Aires, DF, Argentina; [Hochman, Judith S.] NYU Langone Med Ctr, Dept Med, New York, NY USA; [Husted, Steen] Hosp Unit West, Dept Med, Herning Holstbro, Denmark; [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Linhart, Ales] Charles Univ Prague, Gen Univ Hosp, Dept Med 2, Dept Cardiovasc Med, Prague, Czech Republic; [Linhart, Ales] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Lopez-Sendon, Jose] Hosp Univ La Paz, IdiPaz, Dept Cardiol, Madrid, Spain; [Manolis, Athanasios J.] Asklepe Hosp, Dept Cardiol, Athens, Greece; [Mohler, Emile R., III] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pais, Prem] St Johns Med Collage, Bangalore, Karnataka, India; [Parkhomenko, Alexander] Inst Cardiol, Kiev, Ukraine; [Pedersen, Terje R.] Univ Oslo, Oslo, Norway; [Pedersen, Terje R.] Oslo Univ Hosp, Ctr Prevent Med, Oslo, Norway; [Pella, Daniel] Safarik Univ, Fac Med, Dept Med 1, Kosice, Slovakia; [Ramos-Corrales, Marco A.] San Jose Satelite Hosp, Naucalpan, Mexico; [Ruda, Mikhail] Russian Cardiol Res & Prod Complex Rosmedtechnol, Moscow, Russia; [Sereg, Mtys] St George Hosp, LIFE Hlth Ctr, Szekesfehervar, Hungary; [Siddique, Saulat] Shaikh Zayed Postgrad Med Inst, Lahore, Pakistan; [Sinnaeve, Peter] Katholieke Univ Leuven Hosp, Dept Cardiovasc Med, Leuven, Belgium; [Sritara, Piyamitr] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Swart, Henk P.] Antonius Hosp, Dept Cardiores, Sneek, Netherlands; [Sy, Rody G.] Univ Philippines, Coll Med, Dept Med, Manila, Philippines; [Teramoto, Tamio] Teikyo Acad Res Ctr, Itabashi Ku, Tokyo, Japan; [Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Weaver, W. Douglas] Henry Ford Hosp, Henry Ford Heart & Vasc Inst, Detroit, MI 48202 USA; [Weiss, Robert] Maine Res Associates, Auburn, AL USA; [Viigimaa, Margus] Tallinn Univ Technol, North Estonia Med Ctr, EE-19086 Tallinn, Estonia; [Vinereanu, Dragos] Univ Med & Pharm, Univ & Emergency Hosp, Bucharest, Romania; [Zhu, Junren] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Cannon, Christopher P.] Brigham & Womens Hosp, Thrombolysis Myocardial Infarct Study Grp, Boston, MA 02115 USA; [Cannon, Christopher P.] Harvard Univ, Sch Med, Boston, MA USA	Auckland City Hospital; University of Auckland; Uppsala University; Uppsala University; GlaxoSmithKline; GlaxoSmithKline; Duke University; Centre of Postgraduate Medical Education - Poland; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; University of Parma; University Hospital of Parma; University of Alberta; McMaster University; McMaster University; Population Health Research Institute; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade de Sao Paulo; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); Peking University; National Taiwan University; National Taiwan University Hospital; Pontificia Universidad Catolica de Chile; University of Amsterdam; Academic Medical Center Amsterdam; Medical University Sofia; Medical University Sofia; University of Ioannina; University of East Anglia; University of Buenos Aires; NYU Langone Medical Center; Seoul National University (SNU); Seoul National University Hospital; Ulm University; Charles University Prague; General University Hospital Prague; Charles University Prague; Hospital Universitario La Paz; University of Pennsylvania; Pennsylvania Medicine; St. John's National Academy of Health Sciences; St. John's Medical College; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; University of Oslo; University of Oslo; University of Pavol Jozef Safarik Kosice; National Medical Research Center of Cardiology; KU Leuven; University Hospital Leuven; Mahidol University; University of the Philippines System; University of the Philippines Manila; University of Hong Kong; Henry Ford Health System; Henry Ford Hospital; Tallinn University of Technology; Carol Davila University of Medicine & Pharmacy; Fudan University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	White, HD (corresponding author), Auckland City Hosp, Green Lane Cardiovasc Serv, Private Bag 92024,Victoria St W, Auckland 1142, New Zealand.	harveyw@adhb.govt.nz	Bilonko, Oksana/AAH-3518-2019; Benedek, Theodora/F-6353-2016; Tse, Hung-Fat/C-4426-2009; Thompson, Peter L/P-1071-2014; Ardissino, Diego/AAC-4041-2022; Avezum, Alvaro/AAP-7687-2020; Danchin, Nicolas/AAN-8291-2020; Esposito, Giovanni/F-2880-2010; Korzh, Oleksii/E-4291-2016; Linhart, Ales/O-2375-2017; Held, Claes/AAA-3973-2021; Chen, Ming/GVU-8412-2022; Bazylevych, Andriy/G-2834-2019; Nicolau, Jose C/E-1487-2012; Carmen, Team3/Y-7384-2019; Boldueva, Svetlana/AAH-3862-2019; Benedek, Imre/E-7052-2017; Arkhipov, Mikhail V/Q-2316-2015; Cannon, Christopher P/AAY-7644-2020; Viigimaa, Margus/AAX-3864-2020; Kubica, Jacek/D-6906-2014; Siddique, Saulat/AAA-2773-2021; Avezum, Alvaro AA/K-6137-2016; STEG, Philippe Gabriel/Z-1567-2019; Badenhorst, Melissa/E-8214-2010	Bilonko, Oksana/0000-0002-9452-3296; Benedek, Theodora/0000-0001-8326-1537; Tse, Hung-Fat/0000-0002-9578-7808; Esposito, Giovanni/0000-0003-0565-7127; Korzh, Oleksii/0000-0001-6838-4360; Linhart, Ales/0000-0002-3372-7850; Held, Claes/0000-0001-9402-7404; Bazylevych, Andriy/0000-0001-5053-2548; Nicolau, Jose C/0000-0002-9680-3689; Carmen, Team3/0000-0002-3614-0924; Boldueva, Svetlana/0000-0002-1898-084X; Benedek, Imre/0000-0003-0051-4047; Arkhipov, Mikhail V/0000-0002-7924-7668; Cannon, Christopher P/0000-0003-4596-2791; Kubica, Jacek/0000-0001-8250-754X; Avezum, Alvaro AA/0000-0002-3073-6890; Koenig, Wolfgang/0000-0002-2064-9603; Golitsyn, Sergey/0000-0001-9913-9974; solinas, emilia/0000-0003-3532-1317; Goessling, Wolfram/0000-0001-9972-1569; Viigimaa, Margus/0000-0001-5575-5978; Bauters, christophe/0000-0001-8268-8467; Budaj, Andrzej/0000-0002-6395-2098; ELISAF, MOSES/0000-0003-0505-078X; Macin, Stella/0000-0002-1869-5918; Pella, Daniel/0000-0001-9999-6271; Hochman, Judith/0000-0002-5889-5981; Sinnaeve, Peter/0000-0003-4716-5892; ELBAZ, Meyer/0000-0002-3520-7883; Varenhorst, Christoph/0000-0002-8378-3869; Tse, Hung Fat/0000-0003-4665-7887; Badenhorst, Melissa/0000-0002-4732-5027; Krempf, Michel/0000-0002-4353-9511; Lab, Carmen/0000-0002-5935-3236; Armstrong, Paul/0000-0002-0460-3445; Ballantyne, Christie/0000-0002-6432-1730; STEG, Philippe Gabriel/0000-0001-6896-2941; Aylward, Philip/0000-0002-5358-8552	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Supported by GlaxoSmithKline.	Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Blackie JA, 2003, BIOORG MED CHEM LETT, V13, P1067, DOI 10.1016/S0960-894X(03)00058-1; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Carpenter KLH, 2001, FEBS LETT, V505, P357, DOI 10.1016/S0014-5793(01)02840-X; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Hakkinen T, 1999, ARTERIOSCL THROM VAS, V19, P2909, DOI 10.1161/01.ATV.19.12.2909; Hsieh CC, 2000, ATHEROSCLEROSIS, V151, P481, DOI 10.1016/S0021-9150(00)00453-6; Johnson JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089034; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; O'Donoghue M, 2006, CIRCULATION, V113, P1745, DOI 10.1161/CIRCULATIONAHA.105.612630; Parish S, 2010, J INTERN MED, V268, P348, DOI 10.1111/j.1365-2796.2010.02258.x; Ridker PM, 2012, CLIN CHEM, V58, P877, DOI 10.1373/clinchem.2011.180281; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Steg PG, 2012, EUR HEART J, V33, P2831, DOI 10.1093/eurheartj/ehs289; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006; White HD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000360; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870	22	376	399	0	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1702	1711		10.1056/NEJMoa1315878	http://dx.doi.org/10.1056/NEJMoa1315878			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24678955	Green Published, Green Submitted			2022-12-28	WOS:000335405200008
J	Cleary, AS; Leonard, TL; Gestl, SA; Gunther, EJ				Cleary, Allison S.; Leonard, Travis L.; Gestl, Shelley A.; Gunther, Edward J.			Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers	NATURE			English	Article							CLONAL EVOLUTION; PROGENITOR CELLS; TRANSGENIC MICE; BREAST-TUMORS; PROGRESSION; ACTIVATION; TUMORIGENESIS; RECURRENCE; EXPRESSION; INDUCE	Cancer genome sequencing studies indicate that a single breast cancer typically harbours multiple genetically distinct subclones(1-4). As carcinogenesis involves a breakdown in the cell-cell cooperation that normally maintains epithelial tissue architecture, individual subclones within a malignant microenvironment are commonly depicted as self-interested competitors(5,6). Alternatively, breast cancer subclones might interact cooperatively to gain a selective growth advantage in some cases. Although interclonal cooperation has been shown to drive tumorigenesis in fruitfly models(7,8), definitive evidence for functional cooperation between epithelial tumour cell subclones in mammals is lacking. Here we use mouse models of breast cancer to show that interclonal cooperation can be essential for tumour maintenance. Aberrant expression of the secreted signalling molecule Wnt1 generates mixed-lineage mammary tumours composed of basal and luminal tumour cell subtypes, which purportedly derive from a bipotent malignant progenitor cell residing atop a tumour cell hierarchy(9). Using somatic Hras mutations as clonal markers, we show that some Wnt tumours indeed conform to a hierarchical configuration, but that others unexpectedly harbour genetically distinct basal Hras mutant and luminal Hras wild-type subclones. Both subclones are required for efficient tumour propagation, which strictly depends on luminally produced Wnt1. When biclonal tumours were challenged with Wnt withdrawal to simulate targeted therapy, analysis of tumour regression and relapse revealed that basal subclones recruit heterologous Wnt-producing cells to restore tumour growth. Alternatively, in the absence of a substitute Wnt source, the original subclones often evolve to rescue Wnt pathway activation and drive relapse, either by restoring cooperation or by switching to a defector strategy. Uncovering similar modes of interclonal cooperation in human cancers may inform efforts aimed at eradicating tumour cell communities.	[Cleary, Allison S.; Leonard, Travis L.; Gestl, Shelley A.; Gunther, Edward J.] Penn State Univ, Coll Med, Jake Gittlen Labs Canc Res, Hershey, PA 17033 USA; [Cleary, Allison S.; Leonard, Travis L.; Gestl, Shelley A.; Gunther, Edward J.] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Gunther, Edward J.] Penn State Univ, Coll Med, Dept Med Hematol Oncol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gunther, EJ (corresponding author), Penn State Univ, Coll Med, Jake Gittlen Labs Canc Res, Hershey, PA 17033 USA.	ejg12@psu.edu	Kessenbrock, Kai/B-6936-2011		National Institutes of Health/National Cancer Institute; Mary Kay Foundation; Donald B. and Dorothy L. Stabler Foundation; Pennsylvania Department of Health; Department of Defense Predoctoral Traineeship Award [W81XWH-11-1-0038]; NATIONAL CANCER INSTITUTE [R01CA152222] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mary Kay Foundation; Donald B. and Dorothy L. Stabler Foundation; Pennsylvania Department of Health; Department of Defense Predoctoral Traineeship Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the benefactors of the Jake Gittlen Laboratories for Cancer Research and the following Penn State College of Medicine staff: L. Budgeon of the Gittlen Histology Core, N. Sheaffer and J. Bednarczyk of the Flow Cytometry Core, D. Stanford of the Molecular Genetics Core, and J. Mohl of the Barrier Rodent Facility. This project was funded with grant support from the National Institutes of Health/National Cancer Institute, the Mary Kay Foundation, the Donald B. and Dorothy L. Stabler Foundation, and the Pennsylvania Department of Health. A. S. C. is supported by Department of Defense Predoctoral Traineeship Award W81XWH-11-1-0038.	Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; HEPPNER GH, 1993, STEM CELLS, V11, P199, DOI 10.1002/stem.5530110306; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030979; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; MESTER J, 1987, J VIROL, V61, P1073, DOI 10.1128/JVI.61.4.1073-1078.1987; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Podsypanina K, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-24; ROELINK H, 1992, ONCOGENE, V7, P487; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	30	309	318	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					113	+		10.1038/nature13187	http://dx.doi.org/10.1038/nature13187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695311	Green Accepted			2022-12-28	WOS:000333609900053
J	Li, YL; Schwab, C; Ryan, SL; Papaemmanuil, E; Robinson, HM; Jacobs, P; Moorman, AV; Dyer, S; Borrow, J; Griffiths, M; Heerema, NA; Carroll, AJ; Talley, P; Bown, N; Telford, N; Ross, FM; Gaunt, L; McNally, RJQ; Young, BD; Sinclair, P; Rand, V; Teixeira, MR; Joseph, O; Robinson, B; Maddison, M; Dastugue, N; Vandenberghe, P; Haferlach, C; Stephens, PJ; Cheng, JQ; Van Loo, P; Stratton, MR; Campbell, PJ; Harrison, CJ				Li, Yilong; Schwab, Claire; Ryan, Sarra L.; Papaemmanuil, Elli; Robinson, Hazel M.; Jacobs, Patricia; Moorman, Anthony V.; Dyer, Sara; Borrow, Julian; Griffiths, Mike; Heerema, Nyla A.; Carroll, Andrew J.; Talley, Polly; Bown, Nick; Telford, Nick; Ross, Fiona M.; Gaunt, Lorraine; McNally, Richard J. Q.; Young, Bryan D.; Sinclair, Paul; Rand, Vikki; Teixeira, Manuel R.; Joseph, Olivia; Robinson, Ben; Maddison, Mark; Dastugue, Nicole; Vandenberghe, Peter; Haferlach, Claudia; Stephens, Philip J.; Cheng, Jiqiu; Van Loo, Peter; Stratton, Michael R.; Campbell, Peter J.; Harrison, Christine J.			Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia	NATURE			English	Article							INTRACHROMOSOMAL AMPLIFICATION; CANCER GENOMES; CHILDREN; IAMP21; ABNORMALITIES; EVENT; RISK	Changes in gene dosage are a major driver of cancer, known to be caused by a finite, but increasingly well annotated, repertoire of mutational mechanisms(1). This can potentially generate correlated copy-number alterations across hundreds of linked genes, as exemplified by the 2% of childhood acute lymphoblastic leukaemia (ALL) with recurrent amplification of megabase regions of chromosome 21 (iAMP21)(2,3). We used genomic, cytogenetic and transcriptional analysis, coupled with novel bioinformatic approaches, to reconstruct the evolution of iAMP21 ALL. Here we show that individuals born with the rare constitutional Robertsonian translocation between chromosomes 15 and 21, rob(15;21)(q10;q10)c, have approximately 2,700-fold increased risk of developing iAMP21 ALL compared to the general population. In such cases, amplification is initiated by a chromothripsis event involving both sister chromatids of the Robertsonian chromosome, a novel mechanism for cancer predisposition. In sporadic iAMP21, breakage-fusion-bridge cycles are typically the initiating event, often followed by chromothripsis. In both sporadic and rob(15;21)c-associated iAMP21, the final stages frequently involve duplications of the entire abnormal chromosome. The end-product is a derivative of chromosome 21 or the rob(15;21)c chromosome with gene dosage optimized for leukaemic potential, showing constrained copy-number levels over multiple linked genes. Thus, dicentric chromosomes may be an important precipitant of chromothripsis, as we show rob(15;21) c to be constitutionally dicentric and breakage-fusion-bridge cycles generate dicentric chromosomes somatically. Furthermore, our data illustrate that several cancer-specific mutational processes, applied sequentially, can coordinate to fashion copy-number profiles over large genomic scales, incrementally refining the fitness benefits of aggregated gene dosage changes.	[Li, Yilong; Papaemmanuil, Elli; Joseph, Olivia; Robinson, Ben; Maddison, Mark; Stephens, Philip J.; Van Loo, Peter; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Schwab, Claire; Ryan, Sarra L.; Moorman, Anthony V.; Young, Bryan D.; Sinclair, Paul; Rand, Vikki; Harrison, Christine J.] Newcastle Univ, Northern Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Robinson, Hazel M.; Dyer, Sara; Borrow, Julian; Griffiths, Mike] Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham B15 2TG, W Midlands, England; [Jacobs, Patricia; Ross, Fiona M.] Salisbury NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; [Dyer, Sara; Borrow, Julian; Griffiths, Mike] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Heerema, Nyla A.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Talley, Polly] Sheffield Childrens NHS Fdn Trust, Sheffield Diagnost Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Bown, Nick] Northern Genet Serv, Cytogenet Lab, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Telford, Nick] Christie NHS Fdn Trust, Manchester M20 4BX, Lancs, England; [Gaunt, Lorraine] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Reg Cytogenet Unit, Manchester M13 9WL, Lancs, England; [McNally, Richard J. Q.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Teixeira, Manuel R.] Univ Porto, Portuguese Oncol Inst, Dept Genet, P-4200072 Oporto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, P-4200072 Oporto, Portugal; [Dastugue, Nicole] Hop Purpan, Lab Hematol, F-31059 Toulouse, France; [Vandenberghe, Peter; Cheng, Jiqiu; Van Loo, Peter] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Vandenberghe, Peter; Cheng, Jiqiu; Van Loo, Peter] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Haferlach, Claudia] MLL Munich Leukemia Lab, D-81377 Munich, Germany; [Cheng, Jiqiu] Katholieke Univ Leuven, Dept Elect Engn ESAT, B-3000 Louvain, Belgium; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Newcastle University - UK; Salisbury District Hospital; University of Birmingham; University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; Sheffield Children's NHS Foundation Trust; Newcastle University - UK; Christie NHS Foundation Trust; University of Manchester; Newcastle University - UK; Portuguese Institute of Oncology; Universidade do Porto; Universidade do Porto; CHU de Toulouse; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; MLL Munich Leukemia Laboratory; KU Leuven; University of Cambridge	Harrison, CJ (corresponding author), Newcastle Univ, Northern Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	pc8@sanger.ac.uk; christine.harrison@newcastle.ac.uk	Moorman, Anthony/F-5518-2010; Teixeira, Manuel AC/AAZ-7251-2020; Moorman, Anthony/G-1468-2014; Teixeira, Manuel António Rodrigues/E-4885-2011	Teixeira, Manuel AC/0000-0002-1959-0624; Moorman, Anthony/0000-0002-9781-6107; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; McNally, Richard/0000-0001-6685-6467; Van Loo, Peter/0000-0003-0292-1949; Rand, Vikki/0000-0002-2198-8949; Joseph, Olivia/0000-0002-5751-2002; Harrison, Christine/0000-0002-0526-6794; Vandenberghe, Peter/0000-0003-4719-1935	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Leukaemia and Lymphoma Research Specialist Programme; European Research Council [249891]; Research Foundation - Flanders (F.W.O.); NATIONAL CANCER INSTITUTE [U10CA180886, U10CA098543] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Leukaemia and Lymphoma Research Specialist Programme; European Research Council(European Research Council (ERC)European Commission); Research Foundation - Flanders (F.W.O.)(FWO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank member laboratories of the United Kingdom Cancer Cytogenetic Group (UKCCG) for providing cytogenetic data and material. Primary childhood leukaemia samples used in this study were provided by the Leukaemia and Lymphoma Research Childhood Leukaemia Cell Bank working with the laboratory teams in the Bristol Genetics Laboratory, Southmead Hospital, Bristol, UK; Molecular Biology Laboratory, Royal Hospital for Sick Children, Glasgow, UK; Molecular Haematology Laboratory, Royal London Hospital, London, UK; Molecular Genetics Service and Sheffield Children's Hospital, Sheffield, UK. We also thank all the members of the NCRI Childhood Cancer and Leukaemia Group (CCLG) Leukaemia Subgroup for access to material and data on clinical trial patients. This work was supported by the Wellcome Trust (077012/Z/05/Z); Leukaemia and Lymphoma Research Specialist Programme and European Research Council (249891). P.J.C. has a Wellcome Trust Senior Clinical Research Fellowship (WT088340MA). P. V. L. is supported by a postdoctoral research fellowship and P. V. is a Senior Clinical Investigator funded by the Research Foundation - Flanders (F.W.O.). P. S. is funded by the European Research Council (grant 249891).	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; HAMERTON JL, 1975, CLIN GENET, V8, P223; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Heerema NA, 2013, J CLIN ONCOL, V31, P3397, DOI 10.1200/JCO.2013.49.1308; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Moorman AV, 2007, BLOOD, V109, P2327, DOI 10.1182/blood-2006-08-040436; Moorman AV, 2013, J CLIN ONCOL, V31, P3389, DOI 10.1200/JCO.2013.48.9377; Rand V, 2011, BLOOD, V117, P6848, DOI 10.1182/blood-2011-01-329961; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robinson HM, 2007, GENE CHROMOSOME CANC, V46, P318, DOI 10.1002/gcc.20412; Sinclair PB, 2011, HUM MOL GENET, V20, P2591, DOI 10.1093/hmg/ddr159; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stiller CA, 2008, BRIT J CANCER, V98, P1006, DOI 10.1038/sj.bjc.6604237; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Strefford JC, 2006, P NATL ACAD SCI USA, V103, P8167, DOI 10.1073/pnas.0602360103	21	177	180	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					98	+		10.1038/nature13115	http://dx.doi.org/10.1038/nature13115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670643	Green Accepted, Green Submitted			2022-12-28	WOS:000333609900050
J	Marx, V				Marx, Vivien			SHARP SHOOTERS	NATURE			English	Editorial Material																		Deye JA, 2012, HEALTH PHYS, V103, P662, DOI 10.1097/HP.0b013e3182609bb7; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; PEGGS S, 2002, P EPAC PAR FRANC, P2754; Suit H, 2003, ACTA ONCOL, V42, P800, DOI 10.1080/02841860310017676; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104	5	22	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					133	138		10.1038/508133a	http://dx.doi.org/10.1038/508133a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695279	Bronze			2022-12-28	WOS:000333609900057
J	Cole, TB				Cole, Thomas B.			On the Desert	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1276	1277		10.1001/jama.2013.279418	http://dx.doi.org/10.1001/jama.2013.279418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691593				2022-12-28	WOS:000333645400001
J	Davies, E; Aziz, I				Davies, Edward; Aziz, Imran			A man with fever, a productive cough, and a striking chest radiograph	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LUNG ABSCESSES; DRAINAGE		[Davies, Edward] Royal Albert & Edward Infirm, Dept Med, Wrightington, Wigan, England; [Davies, Edward; Aziz, Imran] Leigh NHS Fdn Trust, Wigan WN1 2NN, England; [Aziz, Imran] Royal Albert & Edward Infirm, Dept Chest Med, Wrightington, Wigan, England		Davies, E (corresponding author), Royal Albert & Edward Infirm, Dept Med, Wrightington, Wigan, England.	daviesej7@doctors.org.uk						Bartlett JG, TOPIC 7030 VERSION 8; Branley HM, 2012, MEDICINE, V40, P305; Burns A, 1998, THORAX, V53, P220, DOI 10.1136/thx.53.3.220; CHAUDHURI MR, 1973, THORAX, V28, P354, DOI 10.1136/thx.28.3.354; Choi YR, 2013, KOREAN J INTERN MED, V28, P660, DOI 10.3904/kjim.2013.28.6.660; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Neto JPD, 2013, EUR J CLIN MICROBIOL, V32, P27, DOI 10.1007/s10096-012-1710-y; Fishman JA, 2008, PULMONARY DIS DISORD, P2141; Fishman JA, 2008, PULMONARY DIS DISORD, P1989; Herth F, 2005, CHEST, V127, P1378, DOI 10.1378/chest.127.4.1378; Kioumis IP, LUNG ABSCESS DIFFERE; Levison J, 2004, J PAEDIATR CHILD H, V40, P474, DOI 10.1111/j.1440-1754.2004.00433.x; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Loebinger M.R., 2012, INFECTION, V40, P329; Mason RJ, 2010, MURRAY NADELS TXB RE, P4080; Negi SI, 2012, HEART LUNG, V41, P387, DOI 10.1016/j.hrtlng.2011.09.003; SHIM C, 1990, LUNG, V168, P201, DOI 10.1007/BF02719693; Wali SO, 2012, ANN THORAC MED, V7, P3, DOI 10.4103/1817-1737.91552	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g2212	10.1136/bmj.g2212	http://dx.doi.org/10.1136/bmj.g2212			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696171				2022-12-28	WOS:000333977000002
J	Venkitaraman, AR				Venkitaraman, Ashok R.			Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2	SCIENCE			English	Editorial Material							HOMOLOGY-DIRECTED REPAIR; RAD51 FILAMENT FORMATION; DNA-DAMAGE RESPONSE; BREAST-CANCER; TUMOR SUPPRESSION; OPEN-LABEL; E3 LIGASE; SUSCEPTIBILITY GENE; MUTATION CARRIERS; PHASE-II	Germline mutations in BRCA1 and BRCA2 predispose to common humanmalignancies, most notably tumors of the breast and ovaries. The proteins encoded by these genes have been implicated in a plethora of biochemical interactions and biological functions, confounding attempts to coherently explain how their inactivation promotes carcinogenesis. Here, I argue that tumor suppression by BRCA1 and BRCA2 originates from their fundamental role in controlling the assembly and activity of macromolecular complexes that monitor chromosome duplication, maintenance, and segregation across the cell cycle. A tumor-suppressive role for the BRCA proteins as "chromosome custodians" helps to explain the clinical features of cancer susceptibility after their inactivation, provides foundations for the rational therapy of BRCA-deficient cancers, and offers general insights into the mechanisms opposing early steps in human carcinogenesis.	Univ Cambridge, Med Res Council Canc Unit, Cambridge CB2 0XZ, England	University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, Med Res Council Canc Unit, Hills Rd, Cambridge CB2 0XZ, England.	arv22@mrc-cu.cam.ac.uk			Medical Research Council [MC_UU_12022/8] Funding Source: researchfish; MRC [MC_UU_12022/1, MC_U105359877, MC_UU_12022/8, G1001522, G1001521] Funding Source: UKRI; Medical Research Council [MC_UU_12022/1, G1001521, G1001522, MC_U105359877] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Byrski T, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3231; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chandramouly G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3404; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Elledge SJ, 2002, CANCER CELL, V1, P129, DOI 10.1016/S1535-6108(02)00041-7; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filipponi D, 2013, CANCER CELL, V24, P528, DOI 10.1016/j.ccr.2013.08.022; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedman LS, 1998, CANCER RES, V58, P1338; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Jeyasekharan AD, 2013, NAT STRUCT MOL BIOL, V20, P1191, DOI 10.1038/nsmb.2666; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kaye SB, 2012, J CLIN ONCOL, V30, P372, DOI 10.1200/JCO.2011.36.9215; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Lee M, 2011, ONCOGENE, V30, P3360, DOI 10.1038/onc.2011.55; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Lucas AL, 2013, CLIN CANCER RES, V19, P3396, DOI 10.1158/1078-0432.CCR-12-3020; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Menzel T, 2011, EMBO REP, V12, P705, DOI 10.1038/embor.2011.99; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mondal G, 2012, DEV CELL, V23, P137, DOI 10.1016/j.devcel.2012.05.008; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rajendra E, 2010, NUCLEIC ACIDS RES, V38, P82, DOI 10.1093/nar/gkp873; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Reczek CR, 2013, J CELL BIOL, V201, P693, DOI 10.1083/jcb.201302145; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Rhei E, 1998, CANCER RES, V58, P3193; Rowley M, 2011, GASTROENTEROLOGY, V140, P1303, DOI 10.1053/j.gastro.2010.12.039; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Shive HR, 2010, P NATL ACAD SCI USA, V107, P19350, DOI 10.1073/pnas.1011630107; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Willems-Jones A, 2012, BJU INT, V110, pE1181, DOI 10.1111/j.1464-410X.2012.11519.x; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yu VPCC, 2000, GENE DEV, V14, P1400; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	115	166	175	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1470	1475		10.1126/science.1252230	http://dx.doi.org/10.1126/science.1252230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675954				2022-12-28	WOS:000333471000037
J	Casaer, MP; Van den Berghe, G				Casaer, Michael P.; Van den Berghe, Greet			Nutrition in the Acute Phase of Critical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTENSIVE-CARE-UNIT; SUPPLEMENTAL PARENTERAL-NUTRITION; RANDOMIZED CLINICAL-TRIAL; ENTERAL NUTRITION; ILL PATIENTS; ICU PATIENTS; MULTICENTER; METAANALYSIS; MORTALITY; GLUTAMINE	This review covers current knowledge related to the initiation of enteral or parenteral feeding among critically ill patients in the ICU. Critically ill patients requiring vital organ support in the intensive care unit (ICU) commonly have anorexia and may be unable to feed volitionally by mouth for periods ranging from days to months. Unless such patients are provided with macronutrients in the form of enteral or parenteral nutrition, they accumulate an energy deficit that rapidly reaches proportions that contribute to lean-tissue wasting and that are associated with adverse outcomes.(1) The catabolic response to acute critical illness is much more pronounced than that evoked by fasting in healthy persons, since the energy deficit in acutely ill patients is often superimposed on immobilization ...	[Van den Berghe, Greet] Katholieke Univ Leuven, Clin Dept, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Lab Intens Care Med, Div Cellular & Mol Med, B-3000 Louvain, Belgium	KU Leuven; KU Leuven	Van den Berghe, G (corresponding author), Katholieke Univ Leuven, Clin Dept, Herestr 49, B-3000 Louvain, Belgium.	greet.vandenberghe@med.kuleuven.be	Casaer, Michael/Y-7131-2019; Van den Berghe, Greet/J-6788-2018	Casaer, Michael/0000-0002-7087-0795; Van den Berghe, Greet/0000-0002-5320-1362				Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Alhazzani W, 2013, CRIT CARE MED, V41, P1555, DOI 10.1097/CCM.0b013e31828a24c6; Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Arabi YM, 2011, AM J CLIN NUTR, V93, P569, DOI 10.3945/ajcn.110.005074; Artinian V, 2006, CHEST, V129, P960, DOI 10.1378/chest.129.4.960; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; Casaer MP, 2013, AM J RESP CRIT CARE, V187, P247, DOI 10.1164/rccm.201206-0999OC; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Davies AR, 2012, CRIT CARE MED, V40, P2342, DOI 10.1097/CCM.0b013e318255d87e; De Jonghe B, 2007, CRIT CARE MED, V35, P2007, DOI 10.1097/01.ccm.0000281450.01881.d8; Dissanaike S, 2007, CRIT CARE, V11, DOI 10.1186/cc6167; Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124; Doig GS, 2009, INTENS CARE MED, V35, P2018, DOI 10.1007/s00134-009-1664-4; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Frankenfield DC, 2011, JPEN-PARENTER ENTER, V35, P563, DOI 10.1177/0148607111415859; Grau T, 2007, CRIT CARE, V11, DOI 10.1186/cc5670; Heidegger CP, 2013, LANCET, V381, P1716, DOI 10.1016/S0140-6736(13)61072-7; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Hermans G, 2013, LANCET RESP MED, V1, P621, DOI 10.1016/S2213-2600(13)70183-8; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Koretz RL, 2009, NUTR CLIN PRACT, V24, P316, DOI 10.1177/0884533609335378; Kutsogiannis J, 2011, CRIT CARE MED, V39, P2691, DOI 10.1097/CCM.0b013e3182282a83; MacLaren R, 2008, JPEN-PARENTER ENTER, V32, P412, DOI 10.1177/0148607108319803; Manzanares W, 2013, JPEN J PARENTER ENTE; Manzanares W, 2012, CRIT CARE, V16, DOI 10.1186/cc11316; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; Marik PE, 1996, ARCH SURG-CHICAGO, V131, P1043, DOI 10.1001/archsurg.1996.01430220037007; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; Montejo JC, 2010, INTENS CARE MED, V36, P1386, DOI 10.1007/s00134-010-1856-y; Needham DM, 2013, AM J RESP CRIT CARE; Nguyen NQ, 2007, CRIT CARE MED, V35, P483, DOI 10.1097/01.CCM.0000253410.36492.E9; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Peter JV, 2005, CRIT CARE MED, V33, P213, DOI 10.1097/01.CCM.0000150960.36228.C0; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Pontes-Arruda A, 2011, CRIT CARE, V15, DOI 10.1186/cc10267; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P563, DOI 10.1001/jama.2012.114; Scheinkestel CD, 2003, NUTRITION, V19, P909, DOI 10.1016/S0899-9007(03)00175-8; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Umpierrez GE, 2012, CRIT CARE MED, V40, P1792, DOI 10.1097/CCM.0b013e3182474bf9; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanderheyden S, 2012, CRIT CARE, V16, DOI 10.1186/cc11361; Wanten GJA, 2007, AM J CLIN NUTR, V85, P1171; Wernerman J, 2011, ACTA ANAESTH SCAND, V55, P812, DOI 10.1111/j.1399-6576.2011.02453.x	51	172	188	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1227	1236		10.1056/NEJMra1304623	http://dx.doi.org/10.1056/NEJMra1304623			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670169				2022-12-28	WOS:000333426000010
J	Huesch, MD				Huesch, Marco D.			Slippery Slopes and Landing on Your Feet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Huesch, Marco D.] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, USC Sol Price Sch Publ Policy, Los Angeles, CA 90045 USA; [Huesch, Marco D.] Duke Univ, Sch Med, Dept Community & Family Med, Durham, NC USA; [Huesch, Marco D.] Duke Univ, Duke Fuqua Sch Business, Hlth Sect Management Area, Durham, NC USA	University of Southern California; Duke University; Duke University	Huesch, MD (corresponding author), Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, USC Sol Price Sch Publ Policy, Los Angeles, CA 90045 USA.	huesch@usc.edu						Bohmer R, NOTE ON PHYSICIAN CO; HILLMAN AL, 1987, NEW ENGL J MED, V317, P1743, DOI 10.1056/NEJM198712313172725; Huesch M. D., 2014, HEALTH MANAGE POLICY, V2, P18; Huesch MD, 2013, POLICY APPROACHES TO; IMDB, SEINFELD SEASON 3 EP; Medicare Australia, 2014, PROVIDER PERCENTILE; Szczerba RJ, 2013, HEALTH AFF MILLWOOD; Transunion Healthcare, 2014, DETERMINE THE PATIEN	8	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1203	1204		10.1001/jama.2014.2067	http://dx.doi.org/10.1001/jama.2014.2067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668099				2022-12-28	WOS:000333340500021
J	Trancik, JE				Trancik, Jessika E.			Back the renewables boom	NATURE			English	Editorial Material							TECHNOLOGY		[Trancik, Jessika E.] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Trancik, Jessika E.] Santa Fe Inst, Santa Fe, NM USA	Massachusetts Institute of Technology (MIT); The Santa Fe Institute	Trancik, JE (corresponding author), MIT, Engn Syst Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	trancik@mit.edu						Bettencourt LMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067864; Fri RW, 2003, ENERGY J, V24, P51; Margolis RM, 1999, SCIENCE, V285, P690, DOI 10.1126/science.285.5428.690; McNerney J, 2011, ENERG POLICY, V39, P3042, DOI 10.1016/j.enpol.2011.01.037; McNerney J, 2011, P NATL ACAD SCI USA, V108, P9008, DOI 10.1073/pnas.1017298108; Nagy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052669; Seel J., 2013, WHY ARE RESIDENTIAL; Trancik JE, 2006, ENVIRON RES LETT, V1, DOI 10.1088/1748-9326/1/1/014009; Trancik JE, 2014, ENVIRON SCI TECHNOL, V48, P27, DOI 10.1021/es305093c; Trancik JE, 2013, ENVIRON SCI TECHNOL, V47, P6673, DOI 10.1021/es304922v	10	100	105	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					300	302		10.1038/507300a	http://dx.doi.org/10.1038/507300a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD1YG	24654279	Bronze			2022-12-28	WOS:000333029000013
J	Grumbach, K; Lucey, CR; Johnston, SC				Grumbach, Kevin; Lucey, Catherine R.; Johnston, S. Claiborne			Transforming From Centers of Learning to Learning Health Systems The Challenge for Academic Health Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Grumbach, Kevin] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Grumbach, Kevin; Johnston, S. Claiborne] Univ Calif San Francisco, Clin & Translat Sci Inst, San Francisco, CA 94143 USA; [Lucey, Catherine R.] Univ Calif San Francisco, Sch Med, Off Med Educ, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Grumbach, K (corresponding author), San Francisco Gen Hosp, Ward 83, 1001 Potrero Ave, San Francisco, CA 94110 USA.	kgrumbach@fcm.ucsf.edu	Grumbach, Kevin/L-9222-2016		NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000004] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Berwick Donald M, 2010, Acad Med, V85, pS56, DOI 10.1097/ACM.0b013e3181ead779; Blash L, U UTAH COMMUNITY CLI; Chen AH, 2010, HEALTH AFFAIR, V29, P969, DOI 10.1377/hlthaff.2010.0027; Institute of Medicine, 2007, LEARN HEALTHC SYST W; Magill MK, 2013, FAM MED, V45, P235; Shahian DM, 2012, ACAD MED, V87, P701, DOI 10.1097/ACM.0b013e318253676a; Washington AE, 2013, JAMA-J AM MED ASSOC, V310, P1929, DOI 10.1001/jama.2013.282012; Woolf S. H., 2006, WASH POST, pB3	8	75	77	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1109	1110		10.1001/jama.2014.705	http://dx.doi.org/10.1001/jama.2014.705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643597				2022-12-28	WOS:000333010100012
J	Bates, ER				Bates, Eric R.			Individual chest pain characteristics had low accuracy for detecting acute MI in both men and women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC11	10.7326/0003-4819-160-6-201403180-02011	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638177				2022-12-28	WOS:000333521300010
J	Wyse, DG				Wyse, D. George			In overweight or obese patients with atrial fibrillation, a weight reduction program reduced symptoms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Libin Cardiovasc Inst Alberta, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta	Wyse, DG (corresponding author), Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.							Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC6	10.7326/0003-4819-160-6-201403180-02006	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638184				2022-12-28	WOS:000333521300005
J	McGale, P; Taylor, C; Correa, C; Cutter, D; Duane, F; Ewertz, M; Gray, R; Mannu, G; Peto, R; Whelan, T; Wang, Y; Wang, Z; Darby, S				McGale, P.; Taylor, C.; Correa, C.; Cutter, D.; Duane, F.; Ewertz, M.; Gray, R.; Mannu, G.; Peto, R.; Whelan, T.; Wang, Y.; Wang, Z.; Darby, S.		EBCTCG	Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials	LANCET			English	Article							CLINICAL-PRACTICE GUIDELINES; POSTMASTECTOMY RADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY; IRRADIATION; DISSECTION; CONSENSUS; THERAPY; NODES	Background Postmastectomy radiotherapy was shown in previous meta- analyses to reduce the risks of both recurrence and breast cancer mortality in all women with node- positive disease considered together. However, the benefit in women with only one to three positive lymph nodes is uncertain. We aimed to assess the effect of radiotherapy in these women after mastectomy and axillary dissection. Methods We did a meta- analysis of individual data for 8135 women randomly assigned to treatment groups during 1964- 86 in 22 trials of radiotherapy to the chest wall and regional lymph nodes after mastectomy and axillary surgery versus the same surgery but no radiotherapy. Follow- up lasted 10 years for recurrence and to Jan 1, 2009, for mortality. Analyses were stratified by trial, individual follow- up year, age at entry, and pathological nodal status. Findings 3786 women had axillary dissection to at least level II and had zero, one to three, or four or more positive nodes. All were in trials in which radiotherapy included the chest wall, supraclavicular or axillary fossa (or both), and internal mammary chain. For 700 women with axillary dissection and no positive nodes, radiotherapy had no significant effect on locoregional recurrence (two- sided signifi cance level [2p]> 0.1), overall recurrence (rate ratio [RR], irradiated vs not, 1 . 06, 95% CI 0.76- 1 . 48, 2p> 0.1), or breast cancer mortality (RR 1 . 18, 95% CI 0.89- 1 . 55, 2p> 0.1). For 1314 women with axillary dissection and one to three positive nodes, radiotherapy reduced locoregional recurrence (2p< 0.00001), overall recurrence (RR 0.68, 95% CI 0.57- 0.82, 2p=0.00006), and breast cancer mortality (RR 0.80, 95% CI 0.67- 0.95, 2p=0.01). 1133 of these 1314 women were in trials in which systemic therapy (cyclophosphamide, methotrexate, and fluorouracil, or tamoxifen) was given in both trial groups and, for them, radiotherapy again reduced locoregional recurrence (2p< 0.00001), overall recurrence (RR 0.67, 95% CI 0.55- 0.82, 2p=0.00009), and breast cancer mortality (RR 0.78, 95% CI 0.64- 0.94, 2p=0.01). For 1772 women with axillary dissection and four or more positive nodes, radiotherapy reduced locoregional recurrence (2p< 0.00001), overall recurrence (RR 0.79, 95% CI 0.69-0.90, 2p=0.0003), and breast cancer mortality (RR 0.87, 95% CI 0.77-0.99, 2p=0.04). Interpretation After mastectomy and axillary dissection, radiotherapy reduced both recurrence and breast cancer mortality in the women with one to three positive lymph nodes in these trials even when systemic therapy was given. For today's women, who in many countries are at lower risk of recurrence, absolute gains might be smaller but proportional gains might be larger because of more effective radiotherapy. Copyright (C) EBCTCG.	[McGale, P.; Taylor, C.; Correa, C.; Cutter, D.; Duane, F.; Ewertz, M.; Gray, R.; Mannu, G.; Peto, R.; Whelan, T.; Wang, Y.; Wang, Z.; Darby, S.] Early Breast Canc Trialists Collaborat Grp EBCTCG, Clin Trial Serv Unit, Oxford OX3 7LF, England	University of Oxford	McGale, P (corresponding author), Early Breast Canc Trialists Collaborat Grp EBCTCG, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	bc.overview@ctsu.ox.ac.uk	Gnant, Michael/AAN-7054-2020; Michiels, Stefan/L-1516-2013; Greil, Richard F/C-7673-2017; Gkiokas, Georgios/AAE-6312-2020; Cutter, David/AAU-6599-2021; Evans, Diane/F-9258-2017; Roché, Henri/O-9211-2014; Falkson, Conrad/N-2681-2018; Rutgers, Emiel J T/C-5934-2015; Whelan, Timothy/D-3185-2017; Mannu, Gurdeep S/B-5825-2015; Pruneri, Giancarlo/AAC-7767-2022	Gnant, Michael/0000-0003-1002-2118; Michiels, Stefan/0000-0002-6963-2968; Greil, Richard F/0000-0002-4462-3694; Cutter, David/0000-0001-7307-7488; Roché, Henri/0000-0001-7463-205X; Falkson, Conrad/0000-0001-8959-3807; Whelan, Timothy/0000-0001-9844-2023; Bowden, Sarah/0000-0001-7506-1340; Buyse, Marc/0000-0002-4559-0994; Anderson, Stewart/0000-0001-8948-0650; Mannu, Gurdeep/0000-0003-0219-9474; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Delmestri, Antonella/0000-0003-0388-3403; Duane, Frances/0000-0001-7838-5957; Ewertz, Marianne/0000-0002-5965-969X; Di Leo, Angelo/0000-0002-3665-9056; Joensuu, Heikki/0000-0003-0281-2507; Adolfsson, Jan/0000-0003-2992-1869; Markopoulos, Christos/0000-0002-5072-6390; Cardoso, Fatima/0000-0002-6692-2249; GIANNI, LUCA/0000-0002-2372-9625; Warnberg, Fredrik/0000-0002-0130-7296; Bliss, Judith/0000-0001-7957-7424; de Vries, Elisabeth/0000-0002-8949-7425; van Tinteren, Harm/0000-0002-4626-8702; Pruneri, Giancarlo/0000-0002-7963-7172; Fredriksson, Irma/0000-0001-7811-9317; Sparano, Joseph/0000-0002-9031-2010; Hans, Trampisch/0000-0001-9136-1079; Bergh, Jonas/0000-0001-5526-1847; Valagussa, Pinuccia/0000-0003-3590-7916; Wang, Xiang/0000-0002-1522-9532; Swain, Sandra/0000-0002-1320-3830	Cancer Research UK; British Heart Foundation; UK Medical Research Council; NATIONAL CANCER INSTITUTE [U10CA180838] Funding Source: NIH RePORTER; MRC [G9600656, MC_U137686850] Funding Source: UKRI; Cancer Research UK [10588, 15955, 16896] Funding Source: researchfish; Medical Research Council [MC_U137686858, G9600656, MC_U137686850] Funding Source: researchfish; National Institute for Health Research [ACF-2012-13-010, NF-SI-0510-10026, NIHR-INF-0083] Funding Source: researchfish; Cancer Foundation Finland sr [130093, 110071, 120084] Funding Source: researchfish; Breast Cancer Now [EDN-DIXON] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; Breast Cancer Now	Cancer Research UK, British Heart Foundation, UK Medical Research Council.	Abe O, 2005, LANCET, V366, P2087; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Hennequin C, 2013, INT J RADIAT ONCOL, V86, P860, DOI 10.1016/j.ijrobp.2013.03.021; Katz A, 2000, J CLIN ONCOL, V18, P2817, DOI 10.1200/JCO.2000.18.15.2817; Kunkler IH, 2008, CLIN ONCOL-UK, V20, P31, DOI 10.1016/j.clon.2007.10.004; NICE, 2009, EARL LOC ADV BREAST; Nielsen HM, 2006, J CLIN ONCOL, V24, P2268, DOI 10.1200/JCO.2005.02.8738; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Overgaard M, 2007, RADIOTHER ONCOL, V82, P247, DOI 10.1016/j.radonc.2007.02.001; Poortmans PSH, 2013, EJC S3, V49; Recht A, 2001, J CLIN ONCOL, V19, P1539, DOI 10.1200/JCO.2001.19.5.1539; Sautter-Bihl ML, 2008, STRAHLENTHER ONKOL, V184, P347, DOI 10.1007/s00066-008-1901-8; Taylor ME, 2009, INT J RADIAT ONCOL, V73, P997, DOI 10.1016/j.ijrobp.2008.10.080; Truong PT, 2004, CAN MED ASSOC J, V170, P1263, DOI 10.1503/cmaj.1031000; Whelan TJ, 2011, P AM SOC CLIN ONCO S, V29	21	1303	1337	11	115	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2127	2135		10.1016/S0140-6736(14)60488-8	http://dx.doi.org/10.1016/S0140-6736(14)60488-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24656685	Green Published, hybrid			2022-12-28	WOS:000337906600027
J	Wang, LX; Zhang, H; Ruan, YZ; Chin, DP; Xia, YY; Cheng, SM; Chen, MT; Zhao, YL; Jiang, SW; Du, X; He, GX; Li, J; Wang, SF; Chen, W; Xu, CH; Huang, F; Liu, XQ; Wang, Y				Wang, Lixia; Zhang, Hui; Ruan, Yunzhou; Chin, Daniel P.; Xia, Yinyin; Cheng, Shiming; Chen, Mingting; Zhao, Yanlin; Jiang, Shiwen; Du, Xin; He, Guangxue; Li, Jun; Wang, Shengfen; Chen, Wei; Xu, Caihong; Huang, Fei; Liu, Xiaoqiu; Wang, Yu			Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data	LANCET			English	Article							PUBLIC-HEALTH SYSTEM; PROGRESS	Background China scaled up a tuberculosis control programme (based on the directly observed treatment, short-course [DOTS] strategy) to cover half the population during the 1990s, and to the entire population after 2000. We assessed the effect of the programme. Methods In this longitudinal analysis, we compared data from three national tuberculosis prevalence surveys done in 1990, 2000, and 2010. The 2010 survey screened 252 940 eligible individuals aged 15 years and older at 176 investigation points, chosen by stratified random sampling from all 31 mainland provinces. All individuals had chest radiographs taken. Those with abnormal radiographs, persistent cough, or both, were classified as having suspected tuberculosis. Tuberculosis was diagnosed by chest radiograph, sputum-smear microscopy, and culture. Trained staff interviewed each patient with tuberculosis. The 1990 and 2000 surveys were reanalysed and compared with the 2010 survey. Findings From 1990 to 2010, the prevalence of smear-positive tuberculosis decreased from 170 cases (95% CI 166-174) to 59 cases (49-72) per 100 000 population. During the 1990s, smear-positive prevalence fell only in the provinces with the DOTS programme; after 2000, prevalence decreased in all provinces. The percentage reduction in smear-positive prevalence was greater for the decade after 2000 than the decade before (57% vs 19%; p<0.0001). 70% of the total reduction in smear-positive prevalence (78 of 111 cases per 100 000 population) occurred after 2000. Of these cases, 68 (87%) were in known cases-ie, cases diagnosed with tuberculosis before the survey. Of the known cases, the proportion treated by the public health system (using the DOTS strategy) increased from 59 (15%) of 370 cases in 2000 to 79 (66%) of 123 cases in 2010, contributing to reduced proportions of treatment default (from 163 [43%] of 370 cases to 35 [22%] of 123 cases) and retreatment cases (from 312 [84%] of 374 cases to 48 [31%] of 137 cases; both p<0.0001). Interpretation In 20 years, China more than halved its tuberculosis prevalence. Marked improvement in tuberculosis treatment, driven by a major shift in treatment from hospitals to the public health centres (that implemented the DOTS strategy) was largely responsible for this epidemiological effect.	[Wang, Lixia; Zhang, Hui; Ruan, Yunzhou; Xia, Yinyin; Cheng, Shiming; Chen, Mingting; Zhao, Yanlin; Jiang, Shiwen; Du, Xin; He, Guangxue; Li, Jun; Wang, Shengfen; Chen, Wei; Xu, Caihong; Huang, Fei; Liu, Xiaoqiu; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China; [Chin, Daniel P.] Bill & Melinda Gates Fdn, China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.	wangyu@chinacdc.cn			Chinese Ministry of Health	Chinese Ministry of Health	Chinese Ministry of Health.	Chen XY, 2004, LANCET, V364, P417; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Diel R, 2013, EUR RESPIR J, V42, P785, DOI 10.1183/09031936.00205512; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Dye C, 2013, NATURE, V502, pS13, DOI 10.1038/502S13a; He GX, 2011, CLIN INFECT DIS, V52, pE153, DOI 10.1093/cid/cir075; Li Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-156; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Ministry of Public Health of the People's Republic of China, 2000, REP NAT RAND SURV EP; Ministry of Public Health of the People's Republic of China, 1990, NAT RAND SURV EP TUB; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Tupasi TE, 2009, INT J TUBERC LUNG D, V13, P1224; UNAIDS, 2012 CHIN AIDS RESP; Wan LY, 2007, B WORLD HEALTH ORGAN, V85, P401, DOI 10.2471/BLT.06.036376; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WHO, DEV POST2015 TB STRA; WHO, 13 M STRAT TECHN ADV; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2007, ASS TB PREV POP BAS; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1	22	363	391	7	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2057	2064		10.1016/S0140-6736(13)62639-2	http://dx.doi.org/10.1016/S0140-6736(13)62639-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24650955				2022-12-28	WOS:000337292400025
J	Blom, DJ; Hala, T; Bolognese, M; Lillestol, MJ; Toth, PD; Burgess, L; Ceska, R; Roth, E; Koren, MJ; Ballantyne, CM; Monsalvo, ML; Tsirtsonis, K; Kim, JB; Scott, R; Wasserman, SM; Stein, EA				Blom, Dirk J.; Hala, Tomas; Bolognese, Michael; Lillestol, Michael J.; Toth, Phillip D.; Burgess, Lesley; Ceska, Richard; Roth, Eli; Koren, Michael J.; Ballantyne, Christie M.; Monsalvo, Maria Laura; Tsirtsonis, Kate; Kim, Jae B.; Scott, Rob; Wasserman, Scott M.; Stein, Evan A.		DESCARTES Investigators	A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUBTILISIN/KEXIN TYPE 9; DENSITY-LIPOPROTEIN CHOLESTEROL; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; MONOCLONAL-ANTIBODY; AMG 145; SERINE-PROTEASE; DOUBLE-BLIND; LDL-C; PCSK9; EFFICACY	BACKGROUND Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in phase 2 studies. We conducted a phase 3 trial to evaluate the safety and efficacy of 52 weeks of treatment with evolocumab. METHODS We stratified patients with hyperlipidemia according to the risk categories outlined by the Adult Treatment Panel III of the National Cholesterol Education Program. On the basis of this classification, patients were started on background lipid-lowering therapy with diet alone or diet plus atorvastatin at a dose of 10 mg daily, atorvastatin at a dose of 80 mg daily, or atorvastatin at a dose of 80 mg daily plus ezetimibe at a dose of 10 mg daily, for a run-in period of 4 to 12 weeks. Patients with an LDL cholesterol level of 75 mg per deciliter (1.9 mmol per liter) or higher were then randomly assigned in a 2:1 ratio to receive either evolocumab (420 mg) or placebo every 4 weeks. The primary end point was the percent change from baseline in LDL cholesterol, as measured by means of ultracentrifugation, at week 52. RESULTS Among the 901 patients included in the primary analysis, the overall least-squares mean (+/- SE) reduction in LDL cholesterol from baseline in the evolocumab group, taking into account the change in the placebo group, was 57.0 +/- 2.1% (P<0.001). The mean reduction was 55.7 +/- 4.2% among patients who underwent background therapy with diet alone, 61.6 +/- 2.6% among those who received 10 mg of atorvastatin, 56.8 +/- 5.3% among those who received 80 mg of atorvastatin, and 48.5 +/- 5.2% among those who received a combination of 80 mg of atorvastatin and 10 mg of ezetimibe (P<0.001 for all comparisons). Evolocumab treatment also significantly reduced levels of apolipoprotein B, non-high-density lipoprotein cholesterol, lipoprotein(a), and triglycerides. The most common adverse events were nasopharyngitis, upper respiratory tract infection, influenza, and back pain. CONCLUSIONS At 52 weeks, evolocumab added to diet alone, to low-dose atorvastatin, or to high-dose atorvastatin with or without ezetimibe significantly reduced LDL cholesterol levels in patients with a range of cardiovascular risks. (Funded by Amgen; DESCARTES ClinicalTrials.gov number, NCT01516879.)	[Blom, Dirk J.] Univ Cape Town, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa; [Burgess, Lesley] Tygerberg Hosp, Dept Internal Med, Cardiol Unit, TREAD Res, Parow, South Africa; [Burgess, Lesley] Univ Stellenbosch, Parow, South Africa; [Hala, Tomas] Ctr Clin & Basic Res, Pardubice, Czech Republic; [Ceska, Richard] Charles Univ Prague, Ctr Prevent Cardiol, Dept Internal Med 3, Prague, Czech Republic; [Bolognese, Michael] Bethesda Hlth Res Ctr, Bethesda, MD USA; [Lillestol, Michael J.] Lillestol Res, Fargo, ND USA; [Toth, Phillip D.] Midwest Inst Clin Res, Indianapolis, IN USA; [Roth, Eli] Sterling Res Grp, Cincinnati, OH USA; [Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH 45225 USA; [Koren, Michael J.] Jacksonville Ctr Clin Res, Jacksonville, FL USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Monsalvo, Maria Laura; Kim, Jae B.; Scott, Rob; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA USA; [Tsirtsonis, Kate] Amgen Inc, Uxbridge, Middx, England	University of Cape Town; Tygerberg Hospital; Stellenbosch University; Center Clinical & Basic Research; Charles University Prague; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Amgen; Amgen; Amgen Limited	Stein, EA (corresponding author), Metab & Atherosclerosis Res Ctr, 5355 Medpace Way, Cincinnati, OH 45225 USA.	esteinmrl@aol.com	Ballantyne, Christie/A-6599-2008; Ceska, Richard/A-1840-2017	Ceska, Richard/0000-0002-2541-5179; Ballantyne, Christie/0000-0002-6432-1730; Blom, Dirk/0000-0003-3965-5912; Scott, Robert/0000-0001-8266-1061	Amgen	Amgen(Amgen)	Supported by Amgen.	Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; *LIP RES CLIN, 1982, MAN LAB OP LIP LIP A; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; Raal FJ, 2014, J AM COLL CARDIOL; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stone NJ, 2014, ANN INTERN MED; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790	16	494	539	4	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1809	1819		10.1056/NEJMoa1316222	http://dx.doi.org/10.1056/NEJMoa1316222			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24678979	Green Published			2022-12-28	WOS:000335997900038
J	Lee, HM; Brott, BK; Kirkby, LA; Adelson, JD; Cheng, S; Feller, MB; Datwani, A; Shatz, CJ				Lee, Hanmi; Brott, Barbara K.; Kirkby, Lowry A.; Adelson, Jaimie D.; Cheng, Sarah; Feller, Marla B.; Datwani, Akash; Shatz, Carla J.			Synapse elimination and learning rules co-regulated by MHC class I H2-D-b	NATURE			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTORS; RETINAL WAVES; RETINOGENICULATE; PLASTICITY; LTP; CNS; TRANSMISSION; SEGREGATION; REQUIREMENT	The formation of precise connections between retina and lateral geniculate nucleus (LGN) involves the activity-dependent elimination of some synapses, with strengthening and retention of others. Here we show that the major histocompatibility complex (MHC) class I molecule H2-D-b is necessary and sufficient for synapse elimination in the retinogeniculate system. In mice lacking both H2-K-b and H2-D-b ((KDb-/-)-D-b), despite intact retinal activity and basal synaptic transmission, the developmentally regulated decrease in functional convergence of retinal ganglion cell synaptic inputs to LGN neurons fails and eye-specific layers do not form. Neuronal expression of just H2-Db in (KDb-/-)-D-b mice rescues both synapse elimination and eye-specific segregation despite a compromised immune system. When patterns of stimulation mimicking endogenous retinal waves are used to probe synaptic learning rules at retinogeniculate synapses, long-term potentiation (LTP) is intact but long-term depression (LTD) is impaired in (KDb-/-)-D-b mice. This change is due to an increase in Ca2+-permeable AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors. Restoring H2-D-b to (KDb-/-)-D-b neurons renders AMPA receptors Ca2+ impermeable and rescues LTD. These observations reveal an MHC-class-I-mediated link between developmental synapse pruning and balanced synaptic learning rules enabling both LTD and LTP, and demonstrate a direct requirement for H2-D-b in functional and structural synapse pruning in CNS neurons.	[Lee, Hanmi; Brott, Barbara K.; Adelson, Jaimie D.; Cheng, Sarah; Datwani, Akash; Shatz, Carla J.] James H Clark Ctr, Dept Biol & Neurobiol, Stanford, CA 94305 USA; [Lee, Hanmi; Brott, Barbara K.; Adelson, Jaimie D.; Cheng, Sarah; Datwani, Akash; Shatz, Carla J.] James H Clark Ctr, Dept BioX, Stanford, CA 94305 USA; [Kirkby, Lowry A.; Feller, Marla B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kirkby, Lowry A.; Feller, Marla B.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shatz, CJ (corresponding author), James H Clark Ctr, Dept Biol & Neurobiol, 318 Campus Dr, Stanford, CA 94305 USA.	cshatz@stanford.edu		Steinmetz, Jaimie/0000-0003-2397-4070	NIH [R01 MH071666, EY02858, RO1 EY13528]; G. Harold and Leila Y. Mathers Charitable Foundation; NDSEG; NSF; NATIONAL EYE INSTITUTE [R37EY002858, R01EY002858, R01EY013528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071666, T32MH020016] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NDSEG; NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Shatz laboratory for helpful comments. For technical assistance, we thank N. Sotelo-Kury, C. Chechelski and P. Kemper. For training in retinogeniculate slice methods, we thank C. Chen, P. Kanold and D. Butts. This work was supported by NIH grants R01 MH071666 and EY02858, and the G. Harold and Leila Y. Mathers Charitable Foundation (C.J.S.); NIH grant RO1 EY13528 (M. B. F.); NDSEG and NSF Graduate Research Fellowships (J.D.A.); and an NSF Graduate Research Fellowship (L.A.K.).	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Hohnke CD, 2000, J NEUROSCI, V20, P8051; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Toyoda H, 2007, J CELL PHYSIOL, V211, P336, DOI 10.1002/jcp.20940; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Viesselmann C, 2011, JOVE-J VIS EXP, DOI 10.3791/2373; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziburkus J, 2009, J NEUROPHYSIOL, V102, P3082, DOI 10.1152/jn.90618.2008	49	148	152	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					195	+		10.1038/nature13154	http://dx.doi.org/10.1038/nature13154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24695230	Green Submitted, Green Accepted			2022-12-28	WOS:000335454300032
J	Wietek, J; Wiegert, JS; Adeishvili, N; Schneider, F; Watanabe, H; Tsunoda, SP; Vogt, A; Elstner, M; Oertner, TG; Hegemann, P				Wietek, Jonas; Wiegert, J. Simon; Adeishvili, Nona; Schneider, Franziska; Watanabe, Hiroshi; Tsunoda, Satoshi P.; Vogt, Arend; Elstner, Marcus; Oertner, Thomas G.; Hegemann, Peter			Conversion of Channelrhodopsin into a Light-Gated Chloride Channel	SCIENCE			English	Article							ION SELECTIVITY	The field of optogenetics uses channelrhodopsins (ChRs) for light-induced neuronal activation. However, optimized tools for cellular inhibition at moderate light levels are lacking. We found that replacement of E90 in the central gate of ChR with positively charged residues produces chloride-conducting ChRs (ChloCs) with only negligible cation conductance. Molecular dynamics modeling unveiled that a high-affinity Cl--binding site had been generated near the gate. Stabilizing the open state dramatically increased the operational light sensitivity of expressing cells (slow ChloC). In CA1 pyramidal cells, ChloCs completely inhibited action potentials triggered by depolarizing current injections or synaptic stimulation. Thus, by inverting the charge of the selectivity filter, we have created a class of directly light-gated anion channels that can be used to block neuronal output in a fully reversible fashion.	[Wietek, Jonas; Adeishvili, Nona; Schneider, Franziska; Tsunoda, Satoshi P.; Vogt, Arend; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Wiegert, J. Simon; Oertner, Thomas G.] Ctr Mol Neurobiol Hamburg, Inst Synapt Physiol, D-20251 Hamburg, Germany; [Watanabe, Hiroshi; Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, D-76131 Karlsruhe, Germany	Humboldt University of Berlin; Helmholtz Association; Karlsruhe Institute of Technology	Oertner, TG (corresponding author), Ctr Mol Neurobiol Hamburg, Inst Synapt Physiol, Falkenried 94, D-20251 Hamburg, Germany.	thomas.oertner@zmnh.uni-hamburg.de; hegemann@rz.hu-berlin.de	Wietek, Jonas/I-5911-2015; Vogt, Arend/M-4849-2015; Oertner, Thomas/F-2214-2010; Watanabe, Hiroshi/E-3724-2017; Tsunoda, Satoshi/AAN-7023-2021; Wietek, Jonas/AFQ-6404-2022; Wiegert, J. Simon/ABE-4199-2020; Watanabe, Hiroshi/Q-3928-2019; Elstner, Marcus/H-3463-2013	Wietek, Jonas/0000-0002-8079-7042; Vogt, Arend/0000-0003-0925-0308; Oertner, Thomas/0000-0002-2312-7528; Watanabe, Hiroshi/0000-0003-4379-8633; Wietek, Jonas/0000-0002-8079-7042; Watanabe, Hiroshi/0000-0003-4379-8633; Wiegert, J. Simon/0000-0003-0893-9349; Tsunoda, Satoshi/0000-0003-3636-1521	Leibniz Graduate school; Deutsche Forschungsgemeinschaft [SFB1078, FOR1279, SPP1665]	Leibniz Graduate school; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Reh, A. Klein and I. Ohmert for excellent technical support and R. Schwarzer and A. Herrmann for assistance with confocal microscopy. This work was supported by the Leibniz Graduate school (A. V.) and the Deutsche Forschungsgemeinschaft (SFB1078, B2 to P. H., FOR1279 to M. E. and P. H., and SPP1665 to P. H. and T.G.O.).	Beglov D, 1997, J PHYS CHEM B, V101, P7821, DOI 10.1021/jp971083h; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Grossman N, 2011, IEEE T BIO-MED ENG, V58, P1742, DOI 10.1109/TBME.2011.2114883; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kovalenko A, 1999, J CHEM PHYS, V110, P10095, DOI 10.1063/1.478883; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Plazzo AP, 2012, J BIOL CHEM, V287, P4818, DOI 10.1074/jbc.M111.326207; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Ullrich S, 2013, BIOL CHEM, V394, P271, DOI 10.1515/hsz-2012-0256; Watanabe H, 2013, J COMPUT CHEM, V34, P198, DOI 10.1002/jcc.23119; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Watanabe HC, 2012, J BIOL CHEM, V287, P7456, DOI 10.1074/jbc.M111.320309; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	29	239	250	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					409	412		10.1126/science.1249375	http://dx.doi.org/10.1126/science.1249375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24674867				2022-12-28	WOS:000334867800040
J	Morais, VA; Haddad, D; Craessaerts, K; De Bock, PJ; Swerts, J; Vilain, S; Aerts, L; Overbergh, L; Grunewald, A; Seibler, P; Klein, C; Gevaert, K; Verstreken, P; De Strooper, B				Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; De Bock, Pieter-Jan; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Overbergh, Lut; Gruenewald, Anne; Seibler, Philip; Klein, Christine; Gevaert, Kris; Verstreken, Patrik; De Strooper, Bart			PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling	SCIENCE			English	Article							PARKIN; DROSOPHILA; MITOPHAGY; PATHOLOGY; MACHINERY; MUTANTS; FISSION	Under resting conditions, Pink1 knockout cells and cells derived from patients with PINK1 mutations display a loss of mitochondrial complex I reductive activity, causing a decrease in the mitochondrial membrane potential. Analyzing the phosphoproteome of complex I in liver and brain from Pink1(-/-) mice, we found specific loss of phosphorylation of serine-250 in complex I subunit NdufA10. Phosphorylation of serine-250 was needed for ubiquinone reduction by complex I. Phosphomimetic NdufA10 reversed Pink1 deficits in mouse knockout cells and rescued mitochondrial depolarization and synaptic transmission defects in pink(B9)-null mutant Drosophila. Complex I deficits and adenosine triphosphate synthesis were also rescued in cells derived from PINK1 patients. Thus, this evolutionary conserved pathway may contribute to the pathogenic cascade that eventually leads to Parkinson's disease in patients with PINK1 mutations.	[Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] Leuven Res Inst Neurosci & Dis LIND, B-3000 Louvain, Belgium; [De Bock, Pieter-Jan; Gevaert, Kris] Dept Med Prot Res, B-9000 Ghent, Belgium; [De Bock, Pieter-Jan; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Overbergh, Lut] Katholieke Univ Leuven, Lab Clin & Expt Endocrinol, B-3000 Louvain, Belgium; [Gruenewald, Anne; Seibler, Philip; Klein, Christine] Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Klein, Christine] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [De Strooper, Bart] UCL, Inst Neurol, London, England	Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; Ghent University; KU Leuven; University of Lubeck; Newcastle University - UK; University of London; University College London	Morais, VA (corresponding author), VIB Ctr Biol Dis, B-3000 Louvain, Belgium.	vanessa.morais@cme.vib-kuleuven.be; bart.destrooper@cme.vib-kuleuven.be	Vilain, Sven/AHA-7944-2022; Klein, Christine/AGK-8003-2022; Verstreken, Patrik/AAC-7591-2022; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/D-6489-2017; Seibler, Philip/AAB-5097-2022; Seibler, Philip/K-4142-2019; Overbergh, Lut/AAC-3515-2020; Grünewald, Anne/ABD-1255-2021; de+Strooper, Bart/Z-1638-2019; Aerts, Liesbeth/J-7946-2015	Verstreken, Patrik/0000-0002-5073-5393; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Grünewald, Anne/0000-0002-4179-2994; Morais, Vanessa/0000-0002-0830-0548; Aerts, Liesbeth/0000-0002-7981-8176; Klein, Christine/0000-0003-2102-3431; Seibler, Philip/0000-0002-3496-7194	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham	All data are available from the authors' Web site at www.nottingham.ac.uk/similar to plzloose/phyloinc and are deposited at http://datadryad.org (DOI: 10.5061/dryad.rd70f). The authors thank B. Crother, G. Morgan, and M. Blythe for helpful discussion. Sequencing was carried out at the Genome Centre, Queen Mary, University of London by L. Bhaw-Rosun and M. Struegbig. This work was supported by the Biotechnology and Biological Sciences Research Council, Medical Research Council, and University of Nottingham.	Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; SLED VD, 1993, BIOCHIM BIOPHYS ACTA, V1141, P262, DOI 10.1016/0005-2728(93)90051-G; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P1883, DOI 10.1016/j.bbabio.2010.05.009; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	30	244	249	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					203	207		10.1126/science.1249161	http://dx.doi.org/10.1126/science.1249161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24652937				2022-12-28	WOS:000334096300037
J	Braga-Ribas, F; Sicardy, B; Ortiz, JL; Snodgrass, C; Roques, F; Vieira-Martins, R; Camargo, JIB; Assafin, M; Duffard, R; Jehin, E; Pollock, J; Leiva, R; Emilio, M; Machado, DI; Colazo, C; Lellouch, E; Skottfelt, J; Gillon, M; Ligier, N; Maquet, L; Benedetti-Rossi, G; Gomes, AR; Kervella, P; Monteiro, H; Sfair, R; El Moutamid, M; Tancredi, G; Spagnotto, J; Maury, A; Morales, N; Gil-Hutton, R; Roland, S; Ceretta, A; Gu, SH; Wang, XB; Harpsoe, K; Rabus, M; Manfroid, J; Opitom, C; Vanzi, L; Mehret, L; Lorenzini, L; Schneiter, EM; Melia, R; Lecacheux, J; Colas, F; Vachier, F; Widemann, T; Almenares, L; Sandness, RG; Char, F; Perez, V; Lemos, P; Martinez, N; Jorgensen, UG; Dominik, M; Roig, F; Reichart, DE; LaCluyze, AP; Haislip, JB; Ivarsen, KM; Moore, JP; Frank, NR; Lambas, DG				Braga-Ribas, F.; Sicardy, B.; Ortiz, J. L.; Snodgrass, C.; Roques, F.; Vieira-Martins, R.; Camargo, J. I. B.; Assafin, M.; Duffard, R.; Jehin, E.; Pollock, J.; Leiva, R.; Emilio, M.; Machado, D. I.; Colazo, C.; Lellouch, E.; Skottfelt, J.; Gillon, M.; Ligier, N.; Maquet, L.; Benedetti-Rossi, G.; Gomes, A. Ramos, Jr.; Kervella, P.; Monteiro, H.; Sfair, R.; El Moutamid, M.; Tancredi, G.; Spagnotto, J.; Maury, A.; Morales, N.; Gil-Hutton, R.; Roland, S.; Ceretta, A.; Gu, S. -H.; Wang, X. -B.; Harpsoe, K.; Rabus, M.; Manfroid, J.; Opitom, C.; Vanzi, L.; Mehret, L.; Lorenzini, L.; Schneiter, E. M.; Melia, R.; Lecacheux, J.; Colas, F.; Vachier, F.; Widemann, T.; Almenares, L.; Sandness, R. G.; Char, F.; Perez, V.; Lemos, P.; Martinez, N.; Jorgensen, U. G.; Dominik, M.; Roig, F.; Reichart, D. E.; LaCluyze, A. P.; Haislip, J. B.; Ivarsen, K. M.; Moore, J. P.; Frank, N. R.; Lambas, D. G.			A ring system detected around the Centaur (10199) Chariklo	NATURE			English	Article							TRANS-NEPTUNIAN OBJECTS; STELLAR OCCULTATION; ALBEDO; PHOTOMETRY; EVOLUTION; CHIRON; REGION; ORIGIN	Hitherto, rings have been found exclusively around the four giant planets in the Solar System(1). Rings are natural laboratories in which to study dynamical processes analogous to those that take place during the formation of planetary systems and galaxies. Their presence also tells us about the origin and evolution of the body they encircle. Here we report observations of a multichord stellar occultation that revealed the presence of a ring system around (10199) Chariklo, which is a Centaur-that is, one of a class of small objects orbiting primarily between Jupiter and Neptune-with an equivalent radius of 124 +/- 9 kilometres (ref. 2). There are two dense rings, with respective widths of about 7 and 3 kilometres, optical depths of 0.4 and 0.06, and orbital radii of 391 and 405 kilometres. The present orientation of the ring is consistent with an edge-on geometry in 2008, which provides a simple explanation for the dimming(3) of the Chariklo system between 1997 and 2008, and for the gradual disappearance of ice and other absorption features in its spectrum over the same period(4,5). This implies that the rings are partly composed of water ice. They may be the remnants of a debris disk, possibly confined by embedded, kilometre-sized satellites.	[Braga-Ribas, F.; Vieira-Martins, R.; Camargo, J. I. B.; Benedetti-Rossi, G.; Roig, F.] MCTI, Observatorio Nacl, BR-20921400 Rio De Janeiro, Brazil; [Sicardy, B.; Roques, F.; Lellouch, E.; Ligier, N.; Maquet, L.; Kervella, P.; El Moutamid, M.; Lecacheux, J.; Widemann, T.] Univ Paris 06, CNRS, UMR 8109, LESIA,Observatoire Paris, F-92195 Meudon, France; [Ortiz, J. L.; Duffard, R.; Morales, N.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Snodgrass, C.] Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany; [Vieira-Martins, R.; Assafin, M.; Gomes, A. Ramos, Jr.] Univ Fed Rio de Janeiro, Observatorio Valongo, BR-20080090 Rio de Janeiro, Brazil; [Vieira-Martins, R.; El Moutamid, M.; Colas, F.; Vachier, F.] CNRS, IMCCE, UPMC, Observatoire Paris, F-75014 Paris, France; [Jehin, E.; Gillon, M.; Manfroid, J.; Opitom, C.] Univ Liege, Inst Astrophys, B-4000 Liege, Belgium; [Pollock, J.] Appalachian State Univ, Dept Phys & Astron, Boone, NC 28608 USA; [Leiva, R.; Rabus, M.] Pontificia Univ Catolica Chile, Fac Fis, Inst Astrofis, Santiago 7820436, Chile; [Emilio, M.; Mehret, L.] Univ Estadual Ponta Grossa, DEGEO, BR-84030900 Ponta Grossa, Brazil; [Machado, D. I.; Lorenzini, L.] FPTI BR, Polo Astronom Casimiro Montenegro Filho, BR-85867900 Foz Do Iguacu, Brazil; [Machado, D. I.] Univ Estadual Oeste Parana, BR-8580650 Foz Do Iguacu, Brazil; [Colazo, C.] Ministerio Educ Provincia Cordoba, RA-5000 Cordoba, Argentina; [Colazo, C.; Schneiter, E. M.; Melia, R.; Lambas, D. G.] Univ Nacl Cordoba, Astron Observ, RA-5000 Cordoba, Argentina; [Skottfelt, J.; Harpsoe, K.; Jorgensen, U. G.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Skottfelt, J.; Harpsoe, K.; Jorgensen, U. G.] Geol Museum, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Monteiro, H.] Inst Fis & Quim, BR-37500903 Itajuba, MG, Brazil; [Sfair, R.] Univ Estadual Paulista, UNESP, BR-12516410 Guaratingueta, SP, Brazil; [Tancredi, G.; Roland, S.; Almenares, L.; Perez, V.; Martinez, N.] DICYT, MEC, Observatorio Astronom Molinos, Montevideo 12400, Uruguay; [Tancredi, G.; Ceretta, A.; Almenares, L.; Perez, V.; Lemos, P.; Martinez, N.] Univ Republica, Fac Ciencias, Dept Astron, Montevideo 11300, Uruguay; [Spagnotto, J.] Observatorio El Catalejo, RA-6300 La Pampa, Argentina; [Maury, A.; Sandness, R. G.] San Pedro Atacama Celestial Explorat, San Pedro De Atacama 1410000, Chile; [Gil-Hutton, R.] CASLEO, San Juan, Argentina; [Gil-Hutton, R.] San Juan Natl Univ, San Juan, Argentina; [Ceretta, A.] Consejo Formac Educ, Observatorio IPA, Montevideo 11800, Uruguay; [Gu, S. -H.; Wang, X. -B.] Chinese Acad Sci, Yunnan Observat, Kunming 650011, Peoples R China; [Gu, S. -H.; Wang, X. -B.] Chinese Acad Sci, Key Lab Struct & Evolut Celestial Objects, Kunming 650011, Peoples R China; [Rabus, M.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Vanzi, L.] Pontificia Univ Catolica Chile, Dept Elect Engn, Santiago 7820436, Chile; [Vanzi, L.] Pontificia Univ Catolica Chile, Ctr Astroengn, Santiago 7820436, Chile; [Schneiter, E. M.] Consejo Nacl Invest Cient & Tecn, RA-5000 Cordoba, Argentina; [Schneiter, E. M.; Lambas, D. G.] Consejo Nacl Invest Cient & Tecn, IATE, RA-5000 Cordoba, Argentina; [Schneiter, E. M.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Char, F.] Univ Antofagasta, Fac Ciencias Basicas, Unidad Astron, Antofagasta, Chile; [Dominik, M.] Univ St Andrews, Scottish Univ Phys Alliance, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Reichart, D. E.; LaCluyze, A. P.; Haislip, J. B.; Ivarsen, K. M.; Moore, J. P.; Frank, N. R.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Max Planck Society; Universidade Federal do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; University of Liege; University of North Carolina; Appalachian State University; Pontificia Universidad Catolica de Chile; Universidade Estadual de Ponta Grossa; Universidade Estadual do Oeste do Parana; National University of Cordoba; University of Copenhagen; Niels Bohr Institute; Universidade Estadual Paulista; Universidad de la Republica, Uruguay; Universidad Nacional de San Juan; Chinese Academy of Sciences; Chinese Academy of Sciences; Max Planck Society; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidad de Antofagasta; University of St Andrews; University of North Carolina; University of North Carolina Chapel Hill	Braga-Ribas, F (corresponding author), MCTI, Observatorio Nacl, Rua Gen Jose Cristino 77, BR-20921400 Rio De Janeiro, Brazil.	ribas@on.br	Sfair, Rafael/X-3439-2019; Ribas, Felipe Braga/H-4727-2012; Kervella, Pierre/A-6098-2012; Monteiro, Hektor/N-3662-2019; Maquet, Lucie/ABF-7742-2020; Roig, Fernando V./G-9721-2013; Dominik, Martin/AAA-9501-2020; Sfair, Rafael/I-4163-2013; Júnior, Altair Ramos Gomes/AAB-6776-2021; Ortiz, Jose L./L-3192-2014; Emilio, Marcelo/C-4118-2011; Duffard, Rene/A-2233-2009; Assafin, Marcelo/C-3188-2013; Leiva, Rodrigo/AAV-2908-2020; Monteiro, Hektor/M-7332-2014; Benedetti-Rossi, Gustavo/AAD-9880-2019; Bueno de Camargo, Julio Ignacio/C-3145-2013; Rossi, Gustavo/P-4417-2014	Sfair, Rafael/0000-0002-4939-013X; Ribas, Felipe Braga/0000-0003-2311-2438; Kervella, Pierre/0000-0003-0626-1749; Monteiro, Hektor/0000-0002-0596-9115; Roig, Fernando V./0000-0001-7059-5116; Dominik, Martin/0000-0002-3202-0343; Sfair, Rafael/0000-0002-4939-013X; Júnior, Altair Ramos Gomes/0000-0002-3362-2127; Ortiz, Jose L./0000-0002-8690-2413; Emilio, Marcelo/0000-0001-5589-9015; Duffard, Rene/0000-0001-5963-5850; Leiva, Rodrigo/0000-0002-6477-1360; Monteiro, Hektor/0000-0002-0596-9115; Benedetti-Rossi, Gustavo/0000-0002-4106-476X; Bueno de Camargo, Julio Ignacio/0000-0002-1642-4065; Assafin, Marcelo/0000-0002-8211-0777; Morales Palomino, Nicolas F./0000-0003-0419-1599; Skottfelt, Jesper/0000-0003-1310-8283; Snodgrass, Colin/0000-0001-9328-2905; Schneiter, Matias/0000-0002-0033-8816; Vachier, Frederic/0000-0002-4289-4466; /0000-0003-2935-7196; Maquet, Lucie/0000-0002-3443-5841; MONTEIRO, HENRIQUE LUIZ/0000-0001-6639-1532; Lemos, Pablo/0000-0002-1010-2735; Mehret, Leandro/0000-0002-4676-1396; Opitom, Cyrielle/0000-0002-9298-7484; Gillon, Michael/0000-0003-1462-7739; garcia lambas, diego/0000-0002-2929-4685	LIneA (Laboratorio Interinstitucional de e-Astronomia) of CNPq, Brazil [150541/2013-9]; Danish Natural Science Research Council (FNU); Centre for Star and Planet Formation (StarPlan); French grant 'Beyond Neptune II'; Spanish AYA grants; FEDER funds; National Natural Science Foundation of China [10873031, 11073051]; Belgian Fund for Scientific Research (FRS-FNRS); Swiss National Science Foundation (SNF); Belgian FNRS; CNPq [302657/2010-0, 482080/2009-4 478318/2007-3, 304124/2007-9]; European Union [268421]; FONDECYT [3120097]; National Aeronautics and Space Administration (NASA); National Science Foundation (NSF); NASA; NSF [0959447, 1009052, 1211782]; CONICYT [Anillo ACT-86]; STFC [ST/J001651/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001651/1] Funding Source: researchfish; Division Of Astronomical Sciences [1211782] Funding Source: National Science Foundation	LIneA (Laboratorio Interinstitucional de e-Astronomia) of CNPq, Brazil; Danish Natural Science Research Council (FNU)(Danish Natural Science Research Council); Centre for Star and Planet Formation (StarPlan); French grant 'Beyond Neptune II'; Spanish AYA grants; FEDER funds(European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union(European Commission); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF)(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Fornasier, I. Belskaya, B. Carry, E. Nogueira, P. Michel and A. Morbidelli for the discussions that helped to interpret our results. We also thank J.A. Burns for comments that helped to improve the paper. F.B.-R. acknowledges LIneA (Laboratorio Interinstitucional de e-Astronomia) for hosting the campaign webpage and the support (grant 150541/2013-9) of CNPq, Brazil. Operation of the Danish 1.54-m telescope is financed by a grant to U.G.J. by the Danish Natural Science Research Council (FNU) and by the Centre for Star and Planet Formation (StarPlan). F. Colas, J.L., L. Maquet, F. Roques, B. S., F. V. and T. W. acknowledge support from the French grant 'Beyond Neptune II'. J.L.O., R. D. and N. Morales acknowledge funding from Spanish AYA grants and FEDER funds. S.-h. G. and X.-b.W. are grateful for financial support from the National Natural Science Foundation of China through grants 10873031 and 11073051. M. D. is a Royal Society University Research Fellow at St Andrews University. TRAPPIST is a project funded by the Belgian Fund for Scientific Research (FRS-FNRS) with the participation of the Swiss National Science Foundation (SNF). E.J. and M. G. are FNRS Research Associates, J.M. is FNRS Research Director. C.O. thanks the Belgian FNRS for funding her PhD thesis. J.I.B.C., M. A. and R. V.-M. acknowledge CNPq grants 302657/2010-0, 482080/2009-4 478318/2007-3 and 304124/2007-9, respectively. The Universidad Catolica Observatory (UCO) Santa Martina is operated by the Pontificia Universidad Catolica de Chile (PUC). C. S. received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 268421. M. R. acknowledges support from FONDECYT postdoctoral fellowship 3120097. This work is partly based on observations made at the Pico dos Dias Observatory from the National Laboratory of Astrophysics (OPD/LNA) - Brazil; and partly based on observations obtained at the Southern Astrophysical Research (SOAR) telescope, which is a joint project of the Ministerio da Ciencia, Tecnologia, e Inovacao (MCTI) da Republica Federativa do Brasil, the US National Optical Astronomy Observatory (NOAO), the University of North Carolina at Chapel Hill (UNC-CH) and Michigan State University (MSU). This publication makes use of data products from the Two Micron All Sky Survey, a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration (NASA) and the National Science Foundation (NSF). It also makes use of data products from the Wide-field Infrared Survey Explorer, which is a joint project of the University of California, Los Angeles, and the Jet Propulsion Laboratory/California Institute of Technology, funded by NASA. UNC-CH gratefully acknowledges NSF awards 0959447, 1009052 and 1211782 for support of Skynet/PROMPT. L. V. and R. L. acknowledge support by CONICYT through the project Anillo ACT-86. A. M. acknowledges the use of C. Harlingten's 20-inch Planewave telescope, which is part of the Searchlight Observatory Network.	Belskaya IN, 2010, ICARUS, V210, P472, DOI 10.1016/j.icarus.2010.06.005; Braga-Ribas F, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/26; Brunini A, 2014, MON NOT R ASTRON SOC, V437, P2297, DOI 10.1093/mnras/stt2045; Bus SJ, 1996, ICARUS, V123, P478, DOI 10.1006/icar.1996.0173; Camargo JIB, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201322579; Colwell JE, 2009, SATURN FROM CASSINI-HUYGENS, P375, DOI 10.1007/978-1-4020-9217-6_13; Cuk M, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/4/89; Elliot JL, 2010, NATURE, V465, P897, DOI 10.1038/nature09109; ELLIOT JL, 1995, NATURE, V373, P46, DOI 10.1038/373046a0; Esposito L. W., 1991, URANUS, P410; Fornasier S, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321329; French R. G., 1991, URANUS, P327; GOLDREICH P, 1979, NATURE, V277, P97, DOI 10.1038/277097a0; Guilbert A, 2009, ASTRON ASTROPHYS, V501, P777, DOI 10.1051/0004-6361/200911660; Guilbert-Lepoutre A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/103; Harpsoe KBW, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201219059; Hedman MM, 2013, ICARUS, V223, P105, DOI 10.1016/j.icarus.2012.10.014; Horner J, 2004, MON NOT R ASTRON SOC, V354, P798, DOI 10.1111/j.1365-2966.2004.08240.x; Karkoschka E, 2001, ICARUS, V151, P51, DOI 10.1006/icar.2001.6596; Nogueira E, 2011, ICARUS, V214, P113, DOI 10.1016/j.icarus.2011.05.003; Noll K. S., 2008, SOLAR SYSTEM NEPTUNE, P345; Ortiz JL, 2012, NATURE, V491, P566, DOI 10.1038/nature11597; Ortiz JL, 2012, MON NOT R ASTRON SOC, V419, P2315, DOI 10.1111/j.1365-2966.2011.19876.x; Sicardy B, 2011, NATURE, V478, P493, DOI 10.1038/nature10550; Skottfelt J, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201321430; Tiscareno M., 2013, PLANETS STARS STELLA, V3, P309; Tiscareno MS, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/2/L28	27	161	164	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					72	+		10.1038/nature13155	http://dx.doi.org/10.1038/nature13155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670644	Green Submitted, Green Accepted			2022-12-28	WOS:000333609900044
J	Brody, H				Brody, Herb			Schizophrenia	NATURE			English	Editorial Material																			0	2	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S1	S1		10.1038/508S1a	http://dx.doi.org/10.1038/508S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695326	Bronze			2022-12-28	WOS:000333609900004
J	Jacobson, SA; Morbidelli, A; Raymond, SN; O'Brien, DP; Walsh, KJ; Rubie, DC				Jacobson, Seth A.; Morbidelli, Alessandro; Raymond, Sean N.; O'Brien, David P.; Walsh, Kevin J.; Rubie, David C.			Highly siderophile elements in Earth's mantle as a clock for the Moon-forming impact	NATURE			English	Article							TERRESTRIAL PLANET FORMATION; CORE FORMATION; SOLAR-SYSTEM; GIANT IMPACT; ISOTOPIC COMPOSITION; OXYGEN-ISOTOPE; LATE VENEER; ACCRETION; METAL; SILICATE	According to the generally accepted scenario, the last giant impact on Earth formed the Moon and initiated the final phase of core formation by melting Earth's mantle. A key goal of geochemistry is to date this event, but different ages have been proposed. Some(1-3) argue for an early Moon-forming event, approximately 30 million years (Myr) after the condensation of the first solids in the Solar System, whereas others(4-6) claim a date later than 50 Myr (and possibly as late as around 100 Myr) after condensation. Here we show that a Moon-forming event at 40 Myr after condensation, or earlier, is ruled out at a 99.9 per cent confidence level. We use a large number of N-body simulations to demonstrate a relationship between the time of the last giant impact on an Earth-like planet and the amount of mass subsequently added during the era known as Late Accretion. As the last giant impact is delayed, the late-accreted mass decreases in a predictable fashion. This relationship exists within both the classical scenario(7,8) and the Grand Tack scenario(9,10) of terrestrial planet formation, and holds across a wide range of disk conditions. The concentration of highly siderophile elements (HSEs) in Earth's mantle constrains the mass of chondritic material added to Earth during Late Accretion(11,12). Using HSE abundance measurements(13,14), we determine a Moon-formation age of 95 +/- 32 Myr after condensation. The possibility exists that some late projectiles were differentiated and left an incomplete HSE record in Earth's mantle. Even in this case, various isotopic constraints strongly suggest that the late-accreted mass did not exceed 1 per cent of Earth's mass, and so the HSE clock still robustly limits the timing of the Moon-forming event to significantly later than 40 Myr after condensation.	[Jacobson, Seth A.; Morbidelli, Alessandro] Observ Cote Azur, Lab Lagrange, F-06304 Nice 4, France; [Jacobson, Seth A.; Rubie, David C.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; [Raymond, Sean N.] Univ Bordeaux, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France; [Raymond, Sean N.] CNRS, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France; [O'Brien, David P.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Walsh, Kevin J.] Planetary Sci Directorate, SW Res Inst, Boulder, CO 80302 USA	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Bayreuth; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Jacobson, SA (corresponding author), Observ Cote Azur, Lab Lagrange, Blvd Observ,BP 4229, F-06304 Nice 4, France.	seth.jacobson@oca.eu	Jacobson, Seth/I-7029-2015	Jacobson, Seth/0000-0002-4952-9007; Raymond, Sean/0000-0001-8974-0758	European Research Council [290568]; NASA's Planetary Geology and Geophysics research programme [NNX09AE36G]; NASA Astrobiology Institute's Virtual Planetary Laboratory lead team; NASA [NNH05ZDA001C]	European Research Council(European Research Council (ERC)European Commission); NASA's Planetary Geology and Geophysics research programme; NASA Astrobiology Institute's Virtual Planetary Laboratory lead team; NASA(National Aeronautics & Space Administration (NASA))	S.A.J., A. M., D.P.O'B. and D. C. R were supported by the European Research Council Advanced Grant 'ACCRETE' (contract number 290568). D.P.O'B. was also supported by grant NNX09AE36G from NASA's Planetary Geology and Geophysics research programme. S.N.R. acknowledges support from the NASA Astrobiology Institute's Virtual Planetary Laboratory lead team, supported by NASA under cooperative agreement NNH05ZDA001C.	Albarede F, 2013, ICARUS, V222, P44, DOI 10.1016/j.icarus.2012.10.026; Allegre CJ, 2008, EARTH PLANET SC LETT, V267, P386, DOI 10.1016/j.epsl.2007.11.056; Armytage RMG, 2012, GEOCHIM COSMOCHIM AC, V77, P504, DOI 10.1016/j.gca.2011.10.032; Asphaug E, 2006, NATURE, V439, P155, DOI 10.1038/nature04311; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Brasser R, 2013, MON NOT R ASTRON SOC, V433, P3417, DOI 10.1093/mnras/stt986; Canup RM, 2008, ICARUS, V196, P518, DOI 10.1016/j.icarus.2008.03.011; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chambers JE, 2013, ICARUS, V224, P43, DOI 10.1016/j.icarus.2013.02.015; Chambers JE, 2001, ICARUS, V152, P205, DOI 10.1006/icar.2001.6639; Chambers JE, 2002, METEORIT PLANET SCI, V37, P1523, DOI 10.1111/j.1945-5100.2002.tb00808.x; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Chou CL., 1978, P 9 LUN SCI C, V1, P219; CHYBA CF, 1991, ICARUS, V92, P217, DOI 10.1016/0019-1035(91)90047-W; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; Dauphas N, 2004, EARTH PLANET SC LETT, V226, P465, DOI 10.1016/j.epsl.2004.07.026; Dauphas N, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001617; Day J. M. D., 2011, LUN PLAN SCI C, V42, P1288; Deguen R, 2011, EARTH PLANET SC LETT, V310, P303, DOI 10.1016/j.epsl.2011.08.041; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; Fischer-Godde M, 2011, CHEM GEOL, V280, P365, DOI 10.1016/j.chemgeo.2010.11.024; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Halliday AN, 2008, PHILOS T R SOC A, V366, P4163, DOI 10.1098/rsta.2008.0209; Hansen BMS, 2009, ASTROPHYS J, V703, P1131, DOI 10.1088/0004-637X/703/1/1131; Herwartz D., 2013, ROYAL SOC KAVL I M O; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Konig S, 2011, GEOCHIM COSMOCHIM AC, V75, P2119, DOI 10.1016/j.gca.2011.01.031; Laskar J, 1997, ASTRON ASTROPHYS, V317, pL75; Leya I, 2008, EARTH PLANET SC LETT, V266, P233, DOI 10.1016/j.epsl.2007.10.017; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; Mann U, 2012, GEOCHIM COSMOCHIM AC, V84, P593, DOI 10.1016/j.gca.2012.01.026; Meisel T, 1996, NATURE, V383, P517, DOI 10.1038/383517a0; Morbidelli A, 2012, EARTH PLANET SC LETT, V355, P144, DOI 10.1016/j.epsl.2012.07.037; Morishima R, 2010, ICARUS, V207, P517, DOI 10.1016/j.icarus.2009.11.038; O'Brien D. P., ICARUS UNPUB; O'Brien DP, 2006, ICARUS, V184, P39, DOI 10.1016/j.icarus.2006.04.005; Olson P, 2008, PHILOS T R SOC A, V366, P4253, DOI 10.1098/rsta.2008.0194; Petitat M., 2008, 39 LUN PLAN SCI C, V39, P2164; Raymond SN, 2006, ICARUS, V183, P265, DOI 10.1016/j.icarus.2006.03.011; Raymond SN, 2013, ICARUS, V226, P671, DOI 10.1016/j.icarus.2013.06.019; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Rubie DC, 2003, EARTH PLANET SC LETT, V205, P239, DOI 10.1016/S0012-821X(02)01044-0; Rudge JF, 2010, NAT GEOSCI, V3, P439, DOI 10.1038/NGEO872; Samuel H, 2012, EARTH PLANET SC LETT, V313, P105, DOI 10.1016/j.epsl.2011.11.001; Sharp ZD, 2013, EARTH PLANET SC LETT, V380, P88, DOI 10.1016/j.epsl.2013.08.015; Spicuzza MJ, 2007, EARTH PLANET SC LETT, V253, P254, DOI 10.1016/j.epsl.2006.10.030; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Taylor DJ, 2009, EARTH PLANET SC LETT, V279, P157, DOI 10.1016/j.epsl.2008.12.030; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Trinquier A, 2008, GEOCHIM COSMOCHIM AC, V72, P5146, DOI 10.1016/j.gca.2008.03.023; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Walker RJ, 2004, EARTH PLANET SC LETT, V224, P399, DOI 10.1016/j.epsl.2004.05.036; Wang ZC, 2013, NATURE, V499, P328, DOI 10.1038/nature12285; Wetherill G.W, 1991, LUNAR PLANETARY I TE, V22, P1495; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	80	130	132	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					84	+		10.1038/nature13172	http://dx.doi.org/10.1038/nature13172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695310	Green Submitted			2022-12-28	WOS:000333609900047
J	Lasser, KE; Hanchate, AD; McCormick, D; Manze, MG; Chu, C; Kressin, NR				Lasser, Karen E.; Hanchate, Amresh D.; McCormick, Danny; Manze, Meredith G.; Chu, Chieh; Kressin, Nancy R.			The effect of Massachusetts health reform on 30 day hospital readmissions: retrospective analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICARE BENEFICIARIES; 30-DAY READMISSION; HEART-FAILURE; CARE; INSURANCE; ADULTS; ACCESS; OUTCOMES; DISPARITIES; MORTALITY	Objectives To analyse changes in overall readmission rates and disparities in such rates, among patients aged 18-64 (those most likely to have been affected by reform), using all payer inpatient discharge databases (hospital episode statistics) from Massachusetts and two control states (New York and New Jersey). Design Difference in differences analysis to identify the post-reform change, adjusted for secular changes unrelated to reform. Setting US hospitals in Massachusetts, New York, and New Jersey. Participants Adults aged 18-64 admitted for any cause, excluding obstetrical. Main outcome measure Readmissions at 30 days after an index admission. Results After adjustment for known confounders, including age, sex, comorbidity, hospital ownership, teaching hospital status, and nurse to census ratio, the odds of all cause readmission in Massachusetts was slightly increased compared with control states post-reform (odds ratio 1.02, 95% confidence interval 1.01 to 1.04, P<0.05). Racial and ethnic disparities in all cause readmission rates did not change in Massachusetts compared with control states. In analyses limited to Massachusetts only, there were minimal overall differences in changes in readmission rates between counties with differing baseline uninsurance rates, but black people in counties with the highest uninsurance rates had decreased odds of readmission (0.91, 0.84 to 1.00) compared with black people in counties with lower uninsurance rates. Similarly, white people in counties with the highest uninsurance rates had decreased odds of readmission (0.96, 0.94 to 0.99) compared with white people in counties with lower uninsurance rates. Conclusions In the United States, and in Massachusetts in particular, extending health insurance coverage alone seems insufficient to improve readmission rates. Additional efforts are needed to reduce hospital readmissions and disparities in this outcome.	[Lasser, Karen E.; Hanchate, Amresh D.; Chu, Chieh; Kressin, Nancy R.] Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; [Hanchate, Amresh D.; Kressin, Nancy R.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [McCormick, Danny] Harvard Univ, Sch Med, Dept Med, Cambridge Hlth Alliance, Cambridge, MA 02138 USA; [Manze, Meredith G.] CUNY, Sch Publ Hlth, New York, NY 10021 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Cambridge Health Alliance; City University of New York (CUNY) System	Lasser, KE (corresponding author), Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA.	karen.lasser@bmc.org		Hanchate, Amresh/0000-0002-7038-4463; Kressin, Nancy/0000-0003-2767-4286	US National Institutes of Health [1R21NS062677, 1U01HL105342-01]; Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service [RCS 02-066-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062677] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research has been funded by US National Institutes of Health grants (1R21NS062677, ADH, principal investigator, and 1U01HL105342-01, NRK, principal investigator) and a grant from the Rx foundation. NRK is supported in part by a senior research career scientist award from the Department of Veterans Affairs, Health Services Research and Development Service (RCS 02-066-1). The views expressed in this article are those of the authors and do not necessarily represent the views of the National Institutes of Health, the Rx foundation, Boston University, or the Department of Veterans Affairs.	Abadie A, 2005, REV ECON STUD, V72, P1, DOI 10.1111/0034-6527.00321; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Baker DW, 2002, MED CARE, V40, P1126, DOI 10.1097/00005650-200211000-00013; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; Burke RE, 2013, J HOSP MED, V8, P102, DOI 10.1002/jhm.1990; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2007, BEH RISK FACT SURV S; CMS.gov, READM RED PROGR 2013; *COMM CONS UN BOAR, 2002, CAR COV TOO LITTL TO; Cook A, 2007, HLTH INSURANCE COVER; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; FRANKS P, 1993, AM J PUBLIC HEALTH, V83, P1295, DOI 10.2105/AJPH.83.9.1295; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Freeman JD, 2008, MED CARE, V46, P1023, DOI 10.1097/MLR.0b013e318185c913; Galbraith AA, 2013, HEALTH AFFAIR, V32, P974, DOI 10.1377/hlthaff.2012.0864; Hanchate AD, 2012, MED CARE, V50, P569, DOI 10.1097/MLR.0b013e31824e319f; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Healthcare Cost and Utilization Project, CLIN CLASS SOFTW CCS; HealthCare.gov, ESS HLTH BEN; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hersh AM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000116; Hyams T, MASSACHUSETTS HLTH R; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; KFF, SUMM AFF CAR ACT; kff.org, MASS HLTH CAR REF 6; kff.org, STAT MARK PROF MASS; Long SK, 2011, HEALTH SERV RES, V46, P365, DOI 10.1111/j.1475-6773.2010.01211.x; Long SK, 2009, HEALTH AFFAIR, V28, pW578, DOI 10.1377/hlthaff.28.4.w578; MA Division of Health Care Finance and Policy, 2009, FY2007 INP HOSP DISC; Mass.gov, MIN CRED COV; Mass.gov, HLTH CAR REF GEN INF; Massachusetts Medical Society. Massachusetts Medical Society's, 2013, MASS MED SOC 2013 PH; McCormick D, 2012, J GEN INTERN MED, V27, P1548, DOI 10.1007/s11606-012-2173-7; McDonough JE, 2008, HEALTH AFFAIR, V27, pW285, DOI 10.1377/hlthaff.27.4.w285; Medicare.gov, 30 DAY DEATH READM M; National Conference of State Legislatures, HLTH REF STAT EX; QualityNet, 2012, READM MEAS OV PUBL R; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Williams MV, 2013, JAMA-J AM MED ASSOC, V309, P394, DOI 10.1001/jama.2012.233964; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Zhu J, 2010, J GEN INTERN MED, V25, P1356, DOI 10.1007/s11606-010-1482-y	53	20	20	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2329	10.1136/bmj.g2329	http://dx.doi.org/10.1136/bmj.g2329			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4TK	24687184	Green Published, hybrid			2022-12-28	WOS:000333976100005
J	Abel, GJ; Sander, N				Abel, Guy J.; Sander, Nikola			Quantifying Global International Migration Flows	SCIENCE			English	Article							EUROPE; TABLES	Widely available data on the number of people living outside of their country of birth do not adequately capture contemporary intensities and patterns of global migration flows. We present data on bilateral flows between 196 countries from 1990 through 2010 that provide a comprehensive view of international migration flows. Our data suggest a stable intensity of global 5-year migration flows at similar to 0.6% of world population since 1995. In addition, the results aid the interpretation of trends and patterns of migration flows to and from individual countries by placing them in a regional or global context. We estimate the largest movements to occur between South and West Asia, from Latin to North America, and within Africa.	[Abel, Guy J.; Sander, Nikola] Austrian Acad Sci, Vienna Inst Demog, Wittgenstein Ctr Demog & Global Human Capital IIA, A-1040 Vienna, Austria	Austrian Academy of Sciences	Sander, N (corresponding author), Austrian Acad Sci, Vienna Inst Demog, Wittgenstein Ctr Demog & Global Human Capital IIA, Wohllebengasse 12-14, A-1040 Vienna, Austria.	nikola.sander@oeaw.ac.at	Abel, Guy/D-8106-2013; Sander, Nikola/K-1512-2019; Abel, Guy/AAH-1753-2021	Abel, Guy/0000-0002-4893-5687; Abel, Guy/0000-0002-4893-5687; Sander, Nikola/0000-0002-7176-6594	Austrian Science Fund [Z171-G11]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (Wittgenstein Grant Z171-G11). G.J.A. developed and implemented the methodology for estimating bilateral migration flows. N.S. carried out the data analysis and created the circular migration plots. We thank W. P. Butz and W. Lutz for constructive discussions that formed the nucleus of this paper. We also thank R. Bauer, J. Dawson, M. Holzapfel, P. Rees, and four anonymous referees for their helpful comments. The migration flow estimates described in this paper are presented in the supplementary materials. The authors report no conflicts of interest.	Abel GJ, 2013, DEMOGR RES, V28, P505, DOI 10.4054/DemRes.2013.28.18; Abel GJ, 2010, J R STAT SOC A STAT, V173, P797, DOI 10.1111/j.1467-985X.2009.00636.x; Bell M, 2002, J R STAT SOC A STAT, V165, P435, DOI 10.1111/1467-985X.t01-1-00247; Castles Stephen, 2009, AGE MIGRATION; Czaika M., 2013, IMI WORKING PAPERS; de Beer J, 2010, EUR J POPUL, V26, P459, DOI 10.1007/s10680-010-9220-z; Deming WE, 1940, ANN MATH STAT, V11, P427, DOI 10.1214/aoms/1177731829; Henning S, 2011, INT MIGR REV, V45, P980, DOI 10.1111/j.1747-7379.2011.00874_2.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Massey DS, 1999, P NATL ACAD SCI USA, V96, P5328, DOI 10.1073/pnas.96.9.5328; Nowok B., 2006, THESIM HARMONISED EU, P203; Ozden C, 2011, WORLD BANK ECON REV, V25, P12, DOI 10.1093/wber/lhr024; Passel Jeffrey S., 2005, RISE PEAK DECLINE TR; Raymer J, 2013, J AM STAT ASSOC, V108, P801, DOI 10.1080/01621459.2013.789435; Rees P., 1986, MIGRATION SETTLEMENT, P19; REES PH, 1977, ENVIRON PLANN A, V9, P247, DOI 10.1068/a090247; UNDP, 2013, TRENDS INT MIGR STOC; United Nations, 2013, TECHNICAL PAPER NO 2; ZLOTNIK H, 1987, INT MIGR REV, V21, P925, DOI 10.2307/2546498	19	290	300	10	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1520	1522		10.1126/science.1248676	http://dx.doi.org/10.1126/science.1248676			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675962				2022-12-28	WOS:000333471000050
J	Lu, T; Aron, L; Zullo, J; Pan, Y; Kim, H; Chen, YW; Yang, TH; Kim, HM; Drake, D; Liu, XS; Bennett, DA; Colaiacovo, MP; Yankner, BA				Lu, Tao; Aron, Liviu; Zullo, Joseph; Pan, Ying; Kim, Haeyoung; Chen, Yiwen; Yang, Tun-Hsiang; Kim, Hyun-Min; Drake, Derek; Liu, X. Shirley; Bennett, David A.; Colaiacovo, Monica P.; Yankner, Bruce A.			REST and stress resistance in ageing and Alzheimer's disease	NATURE			English	Article							GENOME-WIDE ANALYSIS; SEL-12 PRESENILIN; LIFE-SPAN; PROTEIN; REPRESSOR; EXPRESSION; CORTEX; TRANSCRIPTION; SUPPRESSORS; CHROMATIN	Human neurons are functional over an entire lifetime, yet the mechanisms that preserve function and protect against neurodegeneration during ageing are unknown. Here we show that induction of the repressor element 1-silencing transcription factor (REST; also known as neuron-restrictive silencer factor, NRSF) is a universal feature of normal ageing in human cortical and hippocampal neurons. REST is lost, however, in mild cognitive impairment and Alzheimer's disease. Chromatin immunoprecipitation with deep sequencing and expression analysis show that REST represses genes that promote cell death and Alzheimer's disease pathology, and induces the expression of stress response genes. Moreover, REST potently protects neurons from oxidative stress and amyloid beta-protein toxicity, and conditional deletion of REST in the mouse brain leads to age-related neurodegeneration. A functional orthologue of REST, Caenorhabditis elegans SPR-4, also protects against oxidative stress and amyloid beta-protein toxicity. During normal ageing, REST is induced in part by cell non-autonomous Wnt signalling. However, in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies, REST is lost from the nucleus and appears in autophagosomes together with pathological misfolded proteins. Finally, REST levels during ageing are closely correlated with cognitive preservation and longevity. Thus, the activation state of REST may distinguish neuroprotection from neurodegeneration in the ageing brain.	[Lu, Tao; Aron, Liviu; Zullo, Joseph; Pan, Ying; Kim, Haeyoung; Yang, Tun-Hsiang; Kim, Hyun-Min; Drake, Derek; Colaiacovo, Monica P.; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chen, Yiwen; Liu, X. Shirley] Dana Faber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Kim, Haeyoung; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Rush University	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	Bruce_Yankner@hms.harvard.edu	Kim, Hyun-Min/AAL-2435-2021; Aron, LIviu/E-5192-2013; Kim, Haeyoung/C-3069-2008	Kim, Hyun-Min/0000-0003-4610-3606; lu, tao/0000-0002-8247-8387	NIH [DP1OD006849, PO1AG27916, RO1AG26651, RO1GM072551, P30AG10161, R01AG15819, R01AG17917]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072551, R01GM105853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG044161, R01AG015819, P01AG027916, P30AG010161, T32AG000222, R01AG026651, R01AG017917] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Yankner laboratory for suggestions and discussion, Monlan Yuan, Allison Harwick, Kelly Dakin and Gregory Klein for assistance, and Cheng Li and Dana Gabuzda for helpful discussion. We also acknowledge the Rush Alzheimer's Disease Center, the Brigham and Women's Hospital Brain Bank, the Massachusetts General Hospital ADRC Brain Bank, and the Kathleen Price Bryan Brain Bank at Duke University for providing tissue samples. This work was supported by an NIH Director's Pioneer Award (DP1OD006849) and NIH grants PO1AG27916 and RO1AG26651 to B.A.Y., RO1GM072551 to M. P. C., P30AG10161, R01AG15819 and R01AG17917 to D. A. B., and a grant from the Glenn Foundation for Medical Research to B.A.Y. J.Z. is a Molecular Biology of Neurodegeneration fellow at Harvard Medical School.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRENNER S, 1974, GENETICS, V77, P71; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lakowski B, 2003, DEVELOPMENT, V130, P2117, DOI 10.1242/dev.00429; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mao CA, 2011, DEV BIOL, V349, P90, DOI 10.1016/j.ydbio.2010.10.008; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Peters A, 1998, CEREB CORTEX, V8, P671, DOI 10.1093/cercor/8.8.671; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shimojo M, 2006, J NEUROCHEM, V96, P1130, DOI 10.1111/j.1471-4159.2005.03608.x; Shimojo M, 2006, NEUROSCI LETT, V398, P161, DOI 10.1016/j.neulet.2005.12.080; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Wen CH, 2000, P NATL ACAD SCI USA, V97, P14524, DOI 10.1073/pnas.011446498; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu M, 2013, NEUROBIOL AGING, V34, P916, DOI 10.1016/j.neurobiolaging.2012.06.002; Yu M, 2009, NEUROSCI RES, V65, P236, DOI 10.1016/j.neures.2009.07.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	459	473	1	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					448	+		10.1038/nature13163	http://dx.doi.org/10.1038/nature13163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670762	Green Submitted, Green Accepted			2022-12-28	WOS:000333402000031
J	Zirnsak, M; Steinmetz, NA; Noudoost, B; Xu, KZ; Moore, T				Zirnsak, Marc; Steinmetz, Nicholas A.; Noudoost, Behrad; Xu, Kitty Z.; Moore, Tirin			Visual space is compressed in prefrontal cortex before eye movements	NATURE			English	Article							PERI-SACCADIC PERCEPTION; MACAQUE AREA V4; SPATIAL ATTENTION; RECEPTIVE-FIELDS; FRONTAL-CORTEX; BOTTOM-UP; NEURONS; SIGNALS; SEARCH; TARGET	We experience the visual world through a series of saccadic eye movements, each one shifting our gaze to bring objects of interest to the fovea for further processing. Although such movements lead to frequent and substantial displacements of the retinal image, these displacements go unnoticed. It is widely assumed that a primary mechanism underlying this apparent stability is an anticipatory shifting of visual receptive fields (RFs) from their presaccadic to their post-saccadic locations before movement onset(1). Evidence of this predictive 'remapping' of RFs has been particularly apparent within brain structures involved in gaze control(2-4). However, critically absent among that evidence are detailed measurements of visual RFs before movement onset. Here we show that during saccade preparation, rather than remap, RFs of neurons in a prefrontal gaze control area massively converge towards the saccadic target. We mapped the visual RFs of prefrontal neurons during stable fixation and immediately before the onset of eye movements, using multi-electrode recordings in monkeys. Following movements from an initial fixation point to a target, RFs remained stationary in retinocentric space. However, in the period immediately before movement onset, RFs shifted by as much as 18 degrees of visual angle, and converged towards the target location. This convergence resulted in a threefold increase in the proportion of RFs responding to stimuli near the target region. In addition, like in human observers(5,6), the population of prefrontal neurons grossly mislocalized presaccadic stimuli as being closer to the target. Our results show that RF shifts do not predict the retinal displacements due to saccades, but instead reflect the overriding perception of target space during eye movements.	[Zirnsak, Marc; Steinmetz, Nicholas A.; Noudoost, Behrad; Xu, Kitty Z.; Moore, Tirin] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Zirnsak, Marc; Moore, Tirin] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Zirnsak, M (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	mzirnsak@stanford.edu	Steinmetz, Nick/B-8555-2018	Steinmetz, Nick/0000-0001-7029-2908	National Institutes of Health [EY014924]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R56EY014924, R01EY014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant EY014924 and the Howard Hughes Medical Institute (T.M.). We thank D.S. Aldrich for technical assistance.	ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Conner CE, 1997, J NEUROSCI, V17, P3201; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dodge R, 1905, PSYCHOL BULL, V2, P193, DOI 10.1037/h0070501; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; Khavat P. S., 2004, VISION RES, V44, P2901; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Rao J. S., 2001, SERIES MULTIVARIATE, V5, P175; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Rolfs M, 2012, J NEUROSCI, V32, P13744, DOI 10.1523/JNEUROSCI.2676-12.2012; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Thompson KG, 2005, J NEUROPHYSIOL, V93, P337, DOI 10.1152/jn.00330.2004; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Zirnsak M, 2010, VISION RES, V50, P1328, DOI 10.1016/j.visres.2010.02.002	36	129	130	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					504	+		10.1038/nature13149	http://dx.doi.org/10.1038/nature13149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670771	Green Accepted			2022-12-28	WOS:000333402000042
J	Kypri, K; Vater, T; Bowe, SJ; Saunders, JB; Cunningham, JA; Horton, NJ; McCambridge, J				Kypri, Kypros; Vater, Tina; Bowe, Steven J.; Saunders, John B.; Cunningham, John A.; Horton, Nicholas J.; McCambridge, Jim			Web-Based Alcohol Screening and Brief Intervention for University Students A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLLEGE-STUDENTS; BINGE DRINKING; FEEDBACK; PEOPLE; ONLINE; AUDIT; MAORI	IMPORTANCE Unhealthy alcohol use is a leading contributor to the global burden of disease, particularly among young people. Systematic reviews suggest efficacy of web-based alcohol screening and brief intervention and call for effectiveness trials in settings where it could be sustainably delivered. OBJECTIVE To evaluate a national web-based alcohol screening and brief intervention program. DESIGN, SETTING, AND PARTICIPANTS Amultisite, double-blind, parallel-group, individually randomized trial was conducted at 7 New Zealand universities. In April and May of 2010, invitations containing hyperlinks to the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) screening test were e-mailed to 14 991 students aged 17 to 24 years. INTERVENTIONS Participants who screened positive (AUDIT-C score >= 4) were randomized to undergo screening alone or to 10 minutes of assessment and feedback (including comparisons with medical guidelines and peer norms) on alcohol expenditure, peak blood alcohol concentration, alcohol dependence, and access to help and information. MAIN OUTCOMES AND MEASURES A fully automated 5-month follow-up assessment was conducted that measured 6 primary outcomes: consumption per typical occasion, drinking frequency, volume of alcohol consumed, an academic problems score, and whether participants exceeded medical guidelines for acute harm (binge drinking) and chronic harm (heavy drinking). A Bonferroni-corrected significance threshold of .0083 was used to account for the 6 comparisons and a sensitivity analysis was used to assess possible attrition bias. RESULTS Of 5135 students screened, 3422 scored 4 or greater and were randomized, and 83% were followed up. There was a significant effect on 1 of the 6 prespecified outcomes. Relative to control participants, those who received intervention consumed less alcohol per typical drinking occasion (median 4 drinks [interquartile range {IQR}, 2-8] vs 5 drinks [IQR 2-8]; rate ratio [RR], 0.93 [99.17% CI, 0.86-1.00]; P = .005) but not less often (RR, 0.95 [99.17% CI, 0.88-1.03]; P = .08) or less overall (RR, 0.95 [99.17% CI, 0.81-1.10]; P = .33). Academic problem scores were not lower (RR, 0.91 [99.17% CI, 0.76-1.08]; P = .14) and effects on the risks of binge drinking (odds ratio [OR], 0.84 [99.17% CI, 0.67-1.05]; P = .04) and heavy drinking (OR, 0.77 [99.17% CI, 0.56-1.05]; P = .03) were not significantly significant. In a sensitivity analysis accounting for attrition, the effect on alcohol per typical drinking occasion was no longer statistically significant. CONCLUSIONS AND RELEVANCE A national web-based alcohol screening and brief intervention program produced no significant reductions in the frequency or overall volume of drinking or academic problems. There remains a possibility of a small reduction in the amount of alcohol consumed per typical drinking occasion.	[Kypri, Kypros] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia; [Kypri, Kypros; Vater, Tina] Univ Otago, Injury Prevent Res Unit, Dunedin, New Zealand; [Bowe, Steven J.] Swinburne Univ Technol, Fac Life & Social Sci, Melbourne, Vic, Australia; [Saunders, John B.] Univ Sydney, Discipline Psychiat, Sydney, NSW 2006, Australia; [Saunders, John B.] Univ Sydney, Discipline Addict Med, Sydney, NSW 2006, Australia; [Cunningham, John A.] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Cunningham, John A.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Horton, Nicholas J.] Amherst Coll, Dept Math, Amherst, MA 01002 USA; [McCambridge, Jim] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England	University of Newcastle; University of Otago; Swinburne University of Technology; University of Sydney; University of Sydney; Australian National University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Amherst College; University of London; London School of Hygiene & Tropical Medicine	Kypri, K (corresponding author), Univ Newcastle, Room 4104,HMRI Bldg, New Lambton Hts, NSW 2305, Australia.	kypros.kypri@newcastle.edu	Horton, Nicholas/A-2493-2008; Kypri, Kypros/D-2809-2009	Horton, Nicholas/0000-0003-3332-4311; Kypri, Kypros/0000-0002-9657-9904; McCambridge, Jim/0000-0002-5461-7001; Bowe, Steven/0000-0003-3813-842X; Cunningham, John/0000-0002-0668-5982	Health Promotion Agency, a statutory body of the New Zealand government; Australian National Health & Medical Research Council Senior Research Fellowship [APP1041867]	Health Promotion Agency, a statutory body of the New Zealand government; Australian National Health & Medical Research Council Senior Research Fellowship	The research was funded by the Alcohol Advisory Council (now the Health Promotion Agency), a statutory body of the New Zealand government. Dr Kypri's involvement in the research was partly funded by an Australian National Health & Medical Research Council Senior Research Fellowship (APP1041867).	Alcohol Advisory Council of New Zealand, 1995, UPP LIM RESP DRINK G; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Connor J, 2005, NEW ZEAL MED J, V118; Cousins K, 2008, DRUG ALCOHOL REV, V27, P566, DOI 10.1080/09595230802245246; Cunningham JA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-21; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Heather N, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-15; Houkamau CA, 2010, NEW ZEAL J PSYCHOL, V39, P8; Kuo MC, 2003, AM J PREV MED, V25, P204, DOI 10.1016/S0749-3797(03)00200-9; Kypri K, 2005, ADDICTION, V100, P713, DOI 10.1111/j.1360-0443.2005.01116.x; Kypri K, 2004, DRUG ALCOHOL DEPEN, V76, P45, DOI 10.1016/j.drugalcdep.2004.04.001; Kypri K, 2008, ADDICTION, V103, P1131, DOI 10.1111/j.1360-0443.2008.02239.x; Kypri K, 2013, ADDICTION, V108, P331, DOI 10.1111/j.1360-0443.2012.04067.x; Kypri K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-781; Kypri K, 2010, DRUG ALCOHOL DEPEN, V111, P38, DOI 10.1016/j.drugalcdep.2010.03.018; Kypri K, 2009, ARCH INTERN MED, V169, P1508, DOI 10.1001/archinternmed.2009.249; Little R.J.A., 2002, STAT ANAL MISSING DA; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P247, DOI 10.1016/j.jclinepi.2013.09.004; McCambridge J, 2013, BRIT J PSYCHIAT, V203, P334, DOI 10.1192/bjp.bp.113.128660; McCambridge J, 2013, AM J BIOETHICS, V13, P39, DOI 10.1080/15265161.2013.839751; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; McCambridge Jim, 2010, BMC Res Notes, V3, P172, DOI 10.1186/1756-0500-3-172; McGee R, 2004, AUST NZ J PUBL HEAL, V28, P321, DOI 10.1111/j.1467-842X.2004.tb00437.x; Moreira MT, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006748.pub2; Nelson TF, 2005, AM J PUBLIC HEALTH, V95, P441, DOI 10.2105/AJPH.2004.043810; New Zealand Ministry of Education, STAT TERT PART; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Rehm J, 1998, ALCOHOL CLIN EXP RES, V22, p4S, DOI 10.1111/j.1530-0277.1998.tb04368.x; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Rooke S, 2010, ADDICTION, V105, P1381, DOI 10.1111/j.1360-0443.2010.02975.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; Tait RJ, 2010, MED J AUSTRALIA, V192, pS15; Tajfel H, 1986, PSYCHOL INTERGROUP R; Teixeira-Pinto A, 2009, PSYCHIAT ANN, V39, P729, DOI 10.3928/00485713-20090625-08; Tertiary Student Health Project, WEB BAS ALC SCREEN B; Thomas BA, 2008, DRUG ALCOHOL DEPEN, V96, P121, DOI 10.1016/j.drugalcdep.2008.02.010; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Weitzman ER, 2003, J ADOLESCENT HEALTH, V32, P26, DOI 10.1016/S1054-139X(02)00457-3; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	42	64	67	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1218	1224		10.1001/jama.2014.2138	http://dx.doi.org/10.1001/jama.2014.2138			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD6CE	24668103	Green Accepted, Bronze			2022-12-28	WOS:000333340500025
J	Alegre-Cebollada, J; Kosuri, P; Giganti, D; Eckels, E; Rivas-Pardo, JA; Hamdani, N; Warren, CM; Solaro, RJ; Linke, WA; Fernandez, JM				Alegre-Cebollada, Jorge; Kosuri, Pallav; Giganti, David; Eckels, Edward; Rivas-Pardo, Jaime Andres; Hamdani, Nazha; Warren, Chad M.; Solaro, R. John; Linke, Wolfgang A.; Fernandez, Julio M.			S-Glutathionylation of Cryptic Cysteines Enhances Titin Elasticity by Blocking Protein Folding	CELL			English	Article							FORCE-CLAMP SPECTROSCOPY; DILATED CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; SINGLE PROTEIN; HEART-FAILURE; NITRIC-OXIDE; MUSCLE; MUTATIONS	The giant elastic protein titin is a determinant factor in how much blood fills the left ventricle during diastole and thus in the etiology of heart disease. Titin has been identified as a target of S-glutathionylation, an end product of the nitric-oxide-signaling cascade that increases cardiac muscle elasticity. However, it is unknown how S-glutathionylation may regulate the elasticity of titin and cardiac tissue. Here, we show that mechanical unfolding of titin immunoglobulin (Ig) domains exposes buried cysteine residues, which then can be S-glutathionylated. S-glutathionylation of cryptic cysteines greatly decreases the mechanical stability of the parent Ig domain as well as its ability to fold. Both effects favor a more extensible state of titin. Furthermore, we demonstrate that S-glutathionylation of cryptic cysteines in titin mediates mechanochemical modulation of the elasticity of human cardiomyocytes. We propose that post-translational modification of cryptic residues is a general mechanism to regulate tissue elasticity.	[Alegre-Cebollada, Jorge; Kosuri, Pallav; Giganti, David; Eckels, Edward; Rivas-Pardo, Jaime Andres; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kosuri, Pallav] Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10032 USA; [Eckels, Edward] Columbia Univ, Columbia Coll Phy & Surg, New York, NY 10032 USA; [Hamdani, Nazha; Linke, Wolfgang A.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, D-44780 Bochum, Germany; [Warren, Chad M.; Solaro, R. John] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA	Columbia University; Columbia University; Columbia University; Ruhr University Bochum; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alegre-Cebollada, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ja2544@columbia.edu; jfernandez@columbia.edu	Linke, Wolfgang A/E-8662-2012; Kosuri, Pallav/J-8279-2012; Alegre-Cebollada, Jorge/I-4301-2014	Kosuri, Pallav/0000-0002-7025-3543; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Giganti, David/0000-0001-5735-5679; Rivas Pardo, Andres/0000-0002-8304-3238; Linke, Wolfgang/0000-0003-0801-3773	NIH [HL66030, HL61228, P01 HL062426, AI106072]; European Union; German Research Foundation [SFB 1002/TP-B03]; Fundacion Ibercaja; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228, P01HL062426, R01HL066030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI106072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); German Research Foundation(German Research Foundation (DFG)); Fundacion Ibercaja; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Sergi Garcia-Manyes for his original observation that mixed disulfides prevent refolding of Ig domains. We thank Thomas Kahn for the SUMO-191 fusion protein. GRX from E. coli was a kind gift from Arne Holmgren. Monoclonal antibodies MF20 (D.A. Fischman) and 9D10 (M.L. Greaser) were obtained from the Developmental Studies Hybridoma Bank. This work was supported by the NIH grants HL66030, HL61228 (to J.M.F.), and P01 HL062426 (to R.J.S. and C. M. W.) and grants FP7-MEDIA from the European Union and SFB 1002/TP-B03 from the German Research Foundation (to W.A.L.). J.A.-C. was the recipient of a fellowship from Fundacion Ibercaja and a K99 career development award (AI106072) from NIH.	Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Anderson BR, 2013, J BIOL CHEM, V288, P5303, DOI 10.1074/jbc.M112.401372; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Avner BS, 2012, MOL CELL BIOCHEM, V363, P203, DOI 10.1007/s11010-011-1172-z; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Chen FC, 2006, AM J PHYSIOL-CELL PH, V290, pC719, DOI 10.1152/ajpcell.00419.2005; Chung CS, 2013, CIRCULATION, V128, P19, DOI 10.1161/CIRCULATIONAHA.112.001268; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Freiburg A, 2000, CIRC RES, V86, P1114; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Hamdani N, 2013, CIRC RES, V112, P664, DOI 10.1161/CIRCRESAHA.111.300105; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kellermayer MSZ, 2002, J MUSCLE RES CELL M, V23, P499, DOI 10.1023/A:1023414624092; Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Krieger CC, 2011, P NATL ACAD SCI USA, V108, P8269, DOI 10.1073/pnas.1018887108; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; LINKE WA, 1994, BIOPHYS J, V67, P782, DOI 10.1016/S0006-3495(94)80538-7; Linke WA, 2010, PHYSIOLOGY, V25, P186, DOI 10.1152/physiol.00005.2010; Lovelock JD, 2012, CIRC RES, V110, P841, DOI 10.1161/CIRCRESAHA.111.258251; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Matsumoto Y, 2005, J MUSCLE RES CELL M, V26, P367, DOI 10.1007/s10974-005-9018-5; Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3; McNally EM, 2012, NATURE, V483, P281, DOI 10.1038/483281a; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Mollica JP, 2012, J PHYSIOL-LONDON, V590, P1443, DOI 10.1113/jphysiol.2011.224535; Nedrud J, 2011, BIOPHYS J, V101, P1385, DOI 10.1016/j.bpj.2011.06.054; Norton N, 2013, CIRC-CARDIOVASC GENE, V6, P144, DOI 10.1161/CIRCGENETICS.111.000062; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Rastaldo R, 2007, LIFE SCI, V81, P779, DOI 10.1016/j.lfs.2007.07.019; RODRIGUEZ EK, 1992, AM J PHYSIOL, V263, pH293, DOI 10.1152/ajpheart.1992.263.1.H293; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Somkuti J, 2013, BBA-PROTEINS PROTEOM, V1834, P112, DOI 10.1016/j.bbapap.2012.10.001; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wu CL, 2011, CHEM-EUR J, V17, P10064, DOI 10.1002/chem.201101024	54	129	130	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1235	1246		10.1016/j.cell.2014.01.056	http://dx.doi.org/10.1016/j.cell.2014.01.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630725	Bronze, Green Accepted			2022-12-28	WOS:000332945100013
J	Ye, F; Lagarrigue, F; Ginsberg, MH				Ye, Feng; Lagarrigue, Frederic; Ginsberg, Mark H.			SnapShot: Talin and the Modular Nature of the Integrin Adhesome	CELL			English	Editorial Material							ACTIVATION; ADHESION; SWITCH		[Ye, Feng; Lagarrigue, Frederic; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ye, F (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.			Lagarrigue, Frederic/0000-0002-4660-8666	NHLBI NIH HHS [R01 HL117807, R01 HL106489, P01 HL031950, P01 HL078784] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, R01HL117807, P01HL078784, R01HL106489] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Lee HS, 2013, MOL BIOL CELL, V24, P1354, DOI 10.1091/mbc.E12-09-0695; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050	9	19	19	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6								10.1016/j.cell.2014.02.048	http://dx.doi.org/10.1016/j.cell.2014.02.048			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3RH	24630731	Green Accepted, Bronze			2022-12-28	WOS:000349545500001
J	Berkley, S				Berkley, Seth			Improving access to vaccines through tiered pricing	LANCET			English	Editorial Material									GAVI Alliance, CH-1202 Geneva, Switzerland		Berkley, S (corresponding author), GAVI Alliance, 2 Chemin Mines, CH-1202 Geneva, Switzerland.	sberkley@gavialliance.org						Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; Danzon P, 2003, 037 BROOK; GAVI Alliance, 2009, GAVI ALL GRAD POL; GAVI Alliance, 2013, COUNTR EL POL; GAVI Alliance, 2013, GLOB LEV IND; Glassman A, 2012, GLOBAL HLTH NEW BOTT; Lee LA, 2013, VACCINE S, V31S, pB61, DOI DOI 10.1016/J.VACCINE.2012.11.035]; Lopert R, 2002, LANCET, V359, P2105, DOI 10.1016/S0140-6736(02)08911-0; Plahte J, 2005, LANCET INFECT DIS, V5, P58, DOI 10.1016/S1473-3099(04)01255-1; World Bank, WE CLASS COUNTR; Yadav P., 2010, DIFFERENTIAL PRICING	11	21	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2265	2267		10.1016/S0140-6736(13)62424-1	http://dx.doi.org/10.1016/S0140-6736(13)62424-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24636625				2022-12-28	WOS:000338657600031
J	Corbett, AJ; Eckle, SBG; Birkinshaw, RW; Liu, LG; Patel, O; Mahony, J; Chen, ZJ; Reantragoon, R; Meehan, B; Cao, HW; Williamson, NA; Strugnell, RA; Van Sinderen, D; Mak, JYW; Fairlie, DP; Kjer-Nielsen, L; Rossjohn, J; McCluskey, J				Corbett, Alexandra J.; Eckle, Sidonia B. G.; Birkinshaw, Richard W.; Liu, Ligong; Patel, Onisha; Mahony, Jennifer; Chen, Zhenjun; Reantragoon, Rangsima; Meehan, Bronwyn; Cao, Hanwei; Williamson, Nicholas A.; Strugnell, Richard A.; Van Sinderen, Douwe; Mak, Jeffrey Y. W.; Fairlie, David P.; Kjer-Nielsen, Lars; Rossjohn, Jamie; McCluskey, James			T-cell activation by transitory neo-antigens derived from distinct microbial pathways	NATURE			English	Article							VITAMIN-B METABOLITES; SALMONELLA-TYPHIMURIUM; RECOGNITION; MR1; RIBOFLAVIN; BIOSYNTHESIS; SYNTHASE	T cells discriminate between foreign and host molecules by recognizing distinct microbial molecules, predominantly peptides and lipids(1-4). Riboflavin precursors found in many bacteria and yeast also selectively activate mucosal-associated invariant T (MAIT) cells(5,6), an abundant population of innate-like T cells in humans(7-9). However, the genesis of these small organic molecules and their mode of presentation to MAIT cells by the major histocompatibility complex (MHC)-related protein MR1 (ref. 8) are not well understood. Here we show that MAIT-cell activation requires key genes encoding enzymes that form 5-amino-6-D-ribitylaminouracil (5-A-RU), an early intermediate in bacterial riboflavin synthesis. Although 5-A-RU does not bind MR1 or activate MAIT cells directly, it does form potent MAIT-activating antigens via non-enzymatic reactions with small molecules, such as glyoxal and methylglyoxal, which are derived from other metabolic pathways. The MAIT antigens formed by the reactions between 5-A-RU and glyoxal/methylglyoxal were simple adducts, 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), respectively, which bound to MR1 as shown by crystal structures of MAIT TCR ternary complexes. Although 5-OP-RU and 5-OE-RU are unstable intermediates, they became trapped by MR1 as reversible covalent Schiff base complexes. Mass spectra supported the capture by MR1 of 5-OP-RU and 5-OE-RU from bacterial cultures that activate MAIT cells, but not from non-activating bacteria, indicating that these MAIT antigens are present in a range of microbes. Thus, MR1 is able to capture, stabilize and present chemically unstable pyrimidine intermediates, which otherwise convert to lumazines, as potent antigens to MAIT cells. These pyrimidine adducts are microbial signatures for MAIT-cell immunosurveillance.	[Corbett, Alexandra J.; Eckle, Sidonia B. G.; Chen, Zhenjun; Reantragoon, Rangsima; Meehan, Bronwyn; Cao, Hanwei; Strugnell, Richard A.; Kjer-Nielsen, Lars; McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Birkinshaw, Richard W.; Patel, Onisha; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Liu, Ligong; Mak, Jeffrey Y. W.; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Mahony, Jennifer; Van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Williamson, Nicholas A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Fairlie, David P.] Univ Queensland, Australian Res Council Ctr Excellence Adv Mol Ima, Brisbane, Qld 4072, Australia; [Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Monash University; University of Queensland; University College Cork; University of Melbourne; University College Cork; University of Queensland; Monash University; Cardiff University	Fairlie, DP (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia.	d.fairlie@imb.uq.edu.au; lkn@unimelb.edu.au; jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	Fairlie, David P/F-8865-2014; Mak, Jeffrey YW/E-8764-2011; liu, ligong/B-1690-2010; Eckle, Sidonia BG/O-8146-2014; McCluskey, James/A-1291-2007; Van Sinderen, Douwe/A-6778-2015; mahony, jennifer/AAG-8357-2020; Williamson, Nicholas A/O-9812-2016; Reantragoon, Rangsima/GON-4001-2022; Rossjohn, Jamie/F-9032-2013; Corbett, Alexandra/A-1225-2019; Birkinshaw, Richard/AAC-7809-2019	Fairlie, David P/0000-0002-7856-8566; Mak, Jeffrey YW/0000-0002-8011-4539; liu, ligong/0000-0002-2693-1896; Eckle, Sidonia BG/0000-0003-0766-171X; McCluskey, James/0000-0002-8597-815X; Van Sinderen, Douwe/0000-0003-1823-7957; mahony, jennifer/0000-0001-5846-6303; Williamson, Nicholas A/0000-0002-2173-3452; Rossjohn, Jamie/0000-0002-2020-7522; Corbett, Alexandra/0000-0003-1618-4337; Birkinshaw, Richard/0000-0003-1825-0182; Patel, Onisha/0000-0001-6701-7139; Strugnell, Richard/0000-0003-0614-5641; Meehan, Bronwyn/0000-0001-7368-2979	Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC); Science Foundation Ireland (SFI) [08/IN.1/B1909]; ARC; NHMRC [1027369]; NHMRC Australia	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland (SFI)(Science Foundation Ireland); ARC(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank the staff of the Monash crystallization facility and the Australian Synchrotron for assistance with crystallization and data collection, respectively, and M. J. McConville, P. O'Donnell and C.-S. Ang from the University of Melbourne Bio21 Institute mass spectrometry platform for assistance with mass spectrometry experiments. The Australian Research Council (ARC), a Program Grant and Project Grant of the National Health and Medical Research Council of Australia (NHMRC) supported this research; D. V. S. is a recipient of a Science Foundation Ireland (SFI) Principal Investigator award (ref. no. 08/IN.1/B1909); O.P. was supported by an ARC Future Fellowship; D. P. F. was supported by an NHMRC Senior Principal Research Fellowship (1027369); J. R. was supported by an NHMRC Australia Fellowship.	Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Burgess C, 2004, APPL ENVIRON MICROB, V70, P5769, DOI 10.1128/AEM.70.10.5769-5777.2004; Cushman M, 2002, J ORG CHEM, V67, P5807, DOI 10.1021/jo0201631; Eckle SBG, 2013, CURR OPIN IMMUNOL, V25, P653, DOI 10.1016/j.coi.2013.07.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Kis K, 2001, J ORG CHEM, V66, P2555, DOI 10.1021/jo001120s; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Plaut GWE, 1971, METHODS ENZYMOL B, V18, P515; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; STRUGNELL R, 1992, INFECT IMMUN, V60, P3994, DOI 10.1128/IAI.60.10.3994-4002.1992; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wang Y, 2012, CHEM SOC REV, V41, P4140, DOI 10.1039/c2cs35025d; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	27	501	508	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					361	+		10.1038/nature13160	http://dx.doi.org/10.1038/nature13160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24695216				2022-12-28	WOS:000336121200039
J	Kang, EJ; Wu, GM; Ma, H; Li, Y; Tippner-Hedges, R; Tachibana, M; Sparman, M; Wolf, DP; Scholer, HR; Mitalipov, S				Kang, Eunju; Wu, Guangming; Ma, Hong; Li, Ying; Tippner-Hedges, Rebecca; Tachibana, Masahito; Sparman, Michelle; Wolf, Don P.; Schoeler, Hans R.; Mitalipov, Shoukhrat			Nuclear reprogramming by interphase cytoplasm of two-cell mouse embryos	NATURE			English	Article							STEM-CELLS; ZYGOTES; TRANSPLANTATION; BLASTOMERES; ACTIVATION; COMPLEX; OOCYTES; GENE; MICE	Successful mammalian cloning using somatic cell nuclear transfer (SCNT) into unfertilized, metaphase II (MII)-arrested oocytes attests to the cytoplasmic presence of reprogramming factors capable of inducing totipotency in somatic cell nuclei(1-3). However, these poorly defined maternal factors presumably decline sharply after fertilization, as the cytoplasm of pronuclear-stage zygotes is reportedly inactive(4,5). Recent evidence suggests that zygotic cytoplasm, if maintained at metaphase, can also support derivation of embryonic stem (ES) cells after SCNT6-8, albeit at low efficiency. This led to the conclusion that critical oocyte reprogramming factors present in the metaphase but not in the interphase cytoplasm are 'trapped' inside the nucleus during interphase and effectively removed during enucleation(9). Here we investigated the presence of reprogramming activity in the cytoplasm of interphase two-cell mouse embryos (I2C). First, the presence of candidate reprogramming factors was documented in both intact and enucleated metaphase and interphase zygotes and two-cell embryos. Consequently, enucleation did not provide a likely explanation for the inability of interphase cytoplasm to induce reprogramming. Second, when we carefully synchronized the cell cycle stage between the transplanted nucleus (ES cell, fetal fibroblast or terminally differentiated cumulus cell) and the recipient I2C cytoplasm, the reconstructed SCNT embryos developed into blastocysts and ES cells capable of contributing to traditional germline and tetraploid chimaeras. Last, direct transfer of cloned embryos, reconstructed with ES cell nuclei, into recipients resulted in live offspring. Thus, the cytoplasm of I2C supports efficient reprogramming, with cell cycle synchronization between the donor nucleus and recipient cytoplasm as the most critical parameter determining success. The ability to use interphase cytoplasm in SCNT could aid efforts to generate autologous human ES cells for regenerative applications, as donated or discarded embryos are more accessible than unfertilized MII oocytes.	[Kang, Eunju; Ma, Hong; Li, Ying; Tippner-Hedges, Rebecca; Tachibana, Masahito; Sparman, Michelle; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Wu, Guangming; Schoeler, Hans R.] Max Planck Inst Mol Biomed, D-48149 Munster, Germany	Oregon Health & Science University; Oregon National Primate Research Center; Max Planck Society	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136; Wu, Guangming/0000-0003-1923-7609	National Institutes of Health [R01HD063276, R01HD057121, R01HD059946, R01EY021214, P51OD011092]; Leducq Fondation; Collins Medical Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057121, R01HD063276, R01HD059946] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Fondation; Collins Medical Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the Small Lab Animal Unit at Oregon National Primate Research Center for providing expertise and services that contributed to this project. We are indebted to E. Wolff, A. Sugawara, C. Ramsey, H.-S. Lee, J. Woodward, D. Melquizo Sanchis, C. Van Dyken and B. Manson for their technical support. The study was supported by grants from the National Institutes of Health (R01HD063276, R01HD057121, R01HD059946, R01EY021214, P51OD011092) and funds from the Leducq Fondation and the Collins Medical Trust.	CHEONG HT, 1993, BIOL REPROD, V48, P958, DOI 10.1095/biolreprod48.5.958; Eckardt S, 2005, REPRODUCTION, V129, P547, DOI 10.1530/rep.1.00673; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Egli D, 2009, CURR BIOL, V19, P1403, DOI 10.1016/j.cub.2009.06.065; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gurdon J.B., 2011, COLD SPRING HARB PER, V1, P3; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Riaz A, 2011, CELL RES, V21, P770, DOI 10.1038/cr.2010.180; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; STICE SL, 1994, MOL REPROD DEV, V38, P61, DOI 10.1002/mrd.1080380111; STICE SL, 1988, BIOL REPROD, V39, P657, DOI 10.1095/biolreprod39.3.657; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; TSUNODA Y, 1987, J EXP ZOOL, V242, P147, DOI 10.1002/jez.1402420205; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2000, NAT GENET, V24, P108, DOI 10.1038/72749; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	30	34	35	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					101	+		10.1038/nature13134	http://dx.doi.org/10.1038/nature13134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670652	Green Accepted			2022-12-28	WOS:000335199100047
J	Vogelstein, JT; Park, Y; Ohyama, T; Kerr, RA; Truman, JW; Priebe, CE; Zlatic, M				Vogelstein, Joshua T.; Park, Youngser; Ohyama, Tomoko; Kerr, Rex A.; Truman, James W.; Priebe, Carey E.; Zlatic, Marta			Discovery of Brainwide Neural-Behavioral Maps via Multiscale Unsupervised Structure Learning	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; COMMAND NEURON; DROSOPHILA; PROTEIN; TOOLS	A single nervous system can generate many distinct motor patterns. Identifying which neurons and circuits control which behaviors has been a laborious piecemeal process, usually for one observer-defined behavior at a time. We present a fundamentally different approach to neuron-behavior mapping. We optogenetically activated 1054 identified neuron lines in Drosophila larvae and tracked the behavioral responses from 37,780 animals. Application of multiscale unsupervised structure learning methods to the behavioral data enabled us to identify 29 discrete, statistically distinguishable, observer-unbiased behavioral phenotypes. Mapping the neural lines to the behavior(s) they evoke provides a behavioral reference atlas for neuron subsets covering a large fraction of larval neurons. This atlas is a starting point for connectivity- and activity-mapping studies to further investigate the mechanisms by which neurons mediate diverse behaviors.	[Vogelstein, Joshua T.; Park, Youngser; Priebe, Carey E.] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD 21218 USA; [Vogelstein, Joshua T.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA; [Ohyama, Tomoko; Kerr, Rex A.; Truman, James W.; Zlatic, Marta] Janelia Farm Res Campus, Ashburn, VA 20147 USA	Johns Hopkins University; Duke University; Howard Hughes Medical Institute	Priebe, CE (corresponding author), Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD 21218 USA.	cep@jhu.edu; zlaticm@janelia.hhmi.org	Vogelstein, Joshua/AAG-5489-2019	Vogelstein, Joshua/0000-0003-2487-6237; Park, Youngser/0000-0002-3978-5533; Zlatic, Marta/0000-0002-3149-2250; Ohyama, Tomoko/0000-0003-1697-1138	Larval Olympiad Project and Janelia HHMI; XDATA program of the Defense Advanced Research Projects Agency [FA8750-12-2-0303]; National Security Science and Engineering Faculty Fellowship	Larval Olympiad Project and Janelia HHMI; XDATA program of the Defense Advanced Research Projects Agency; National Security Science and Engineering Faculty Fellowship	We thank G. M. Rubin, B. D. Pfeiffer, A. Nern, and B. Condron for fly stocks; B. D. Mensh for exceptionally helpful comments on the manuscript; A. Cardona, J. H. Simpson, and K. Branson for helpful discussions; C. Sullivan and A. Mondal for help with editing; H. Li and Fly Light Project Team at Janelia HHMI for images of neuronal lines; Janelia Fly Core for setting up the fly crosses for the activation screen; and Janelia Scientific Computing for help with data processing and storage, especially E. Trautman, R. Svirskas, and D. Olbris. Supported by the Larval Olympiad Project and Janelia HHMI, the XDATA program of the Defense Advanced Research Projects Agency administered through Air Force Research Laboratory contract FA8750-12-2-0303, and a National Security Science and Engineering Faculty Fellowship. All raw data, data derivatives, and code are freely available from http://openconnecto.me/behaviotypes.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Allard WK, 2012, APPL COMPUT HARMON A, V32, P435, DOI 10.1016/j.acha.2011.08.001; [Anonymous], MODERN MULTIDIMENSIO; Bendich P, 2007, ANN IEEE SYMP FOUND, P536, DOI 10.1109/FOCS.2007.45; Benjamini Y, 2001, ANN STAT, V29, P1165; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Giles KE, 2008, COMPUTATION STAT, V23, P497, DOI 10.1007/s00180-007-0090-8; Good P. I., 2010, PERMUTATION PARAMETR; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Healy D. M., 2003, MOD SIGNAL PROCESS, V46, P223; Hedwig B, 2000, J NEUROPHYSIOL, V83, P712, DOI 10.1152/jn.2000.83.2.712; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Kane EA, 2013, P NATL ACAD SCI USA, V110, pE3868, DOI 10.1073/pnas.1215295110; Karakos D, 2005, INT CONF ACOUST SPEE, P1081; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Priebe CE, 2004, IEEE T PATTERN ANAL, V26, P699, DOI 10.1109/TPAMI.2004.12; Priebe CE, 2001, IEEE T PATTERN ANAL, V23, P404, DOI 10.1109/34.917575; Schrodel T, 2013, NAT METHODS, V10, P1013, DOI [10.1038/NMETH.2637, 10.1038/nmeth.2637]; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Wu CWH, 2011, NEURON, V70, P229, DOI 10.1016/j.neuron.2011.03.010	34	138	140	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					386	392		10.1126/science.1250298	http://dx.doi.org/10.1126/science.1250298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24674869				2022-12-28	WOS:000334867800034
J	Krajewski, WW; Fu, X; Wilkinson, M; Cronin, NB; Dillingham, MS; Wigley, DB				Krajewski, Wojciech W.; Fu, Xin; Wilkinson, Martin; Cronin, Nora B.; Dillingham, Mark S.; Wigley, Dale B.			Structural basis for translocation by AddAB helicase-nuclease and its arrest at chi sites	NATURE			English	Article							RECBCD ENZYME; BACTERIOPHAGE-LAMBDA; CRYSTAL-STRUCTURES; DNA TRANSLOCATION; RECA PROTEIN; RECOGNITION; RECOMBINATION; MECHANISM; MOTOR; SEQUENCE	In bacterial cells, processing of double-stranded DNA breaks for repair by homologous recombination is dependent upon the recombination hotspot sequence chi (Chi)(1,2) and is catalysed by either an AddAB-or RecBCD-type helicase-nuclease (reviewed in refs 3, 4). These enzyme complexes unwind and digest the DNA duplex from the broken end until they encounter a chi sequence(5), whereupon they produce a 3' single-stranded DNA tail onto which they initiate loading of the RecA protein(6). Consequently, regulation of the AddAB/RecBCD complex by chi is a key control point in DNA repair and other processes involving genetic recombination. Here we report crystal structures of Bacillus subtilis AddAB in complex with different chi-containing DNA substrates either with or without a non-hydrolysable ATP analogue. Comparison of these structures suggests a mechanism for DNA translocation and unwinding, suggests how the enzyme binds specifically to chi sequences, and explains how chi recognition leads to the arrest of AddAB (and RecBCD) translocation that is observed in single-molecule experiments(7-9).	[Krajewski, Wojciech W.; Fu, Xin; Wilkinson, Martin; Cronin, Nora B.; Wigley, Dale B.] Chester Beatty Labs, Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Dillingham, Mark S.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Bristol	Wigley, DB (corresponding author), Chester Beatty Labs, Inst Canc Res, Div Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	Dale.Wigley@icr.ac.uk		Cronin, Nora/0000-0002-4249-7313; Dillingham, Mark/0000-0002-4612-7141; Martin, Wilkinson/0000-0001-5490-613X	Royal Society; Wellcome Trust; European Research Council; Cancer Research UK; EMBO; Cancer Research UK [12799] Funding Source: researchfish	Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	We thank the European Synchrotron Radiation Facility and Diamond synchrotrons for access to beamlines. The work was funded by the Royal Society, the Wellcome Trust and the European Research Council (M.S.D.), Cancer Research UK (D.B.W.) and EMBO (W.W.K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carrasco C, 2013, P NATL ACAD SCI USA, V110, pE2562, DOI 10.1073/pnas.1303035110; Chedin F, 1998, MOL MICROBIOL, V29, P1369, DOI 10.1046/j.1365-2958.1998.01018.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; Handa N, 2012, P NATL ACAD SCI USA, V109, P8901, DOI 10.1073/pnas.1206076109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; LAM ST, 1974, GENETICS, V77, P425; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; Saikrishnan K, 2012, EMBO J, V31, P1568, DOI 10.1038/emboj.2012.9; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; THALER DS, 1989, GENOME, V31, P53, DOI 10.1139/g89-013; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Wong CJ, 2006, J MOL BIOL, V362, P26, DOI 10.1016/j.jmb.2006.07.016; Wu CG, 2010, NAT STRUCT MOL BIOL, V17, P1210, DOI 10.1038/nsmb.1901; Yang L, 2012, P NATL ACAD SCI USA, V109, P8907, DOI 10.1073/pnas.1206081109; Yeeles JTP, 2011, NUCLEIC ACIDS RES, V39, P2271, DOI 10.1093/nar/gkq1124; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108	33	37	38	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					416	+		10.1038/nature13037	http://dx.doi.org/10.1038/nature13037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24670664	Green Accepted, Green Submitted			2022-12-28	WOS:000334403000056
J	Wright, J				Wright, Jessica			GENETICS Unravelling complexity	NATURE			English	Editorial Material							SCHIZOPHRENIA; MUTATIONS											Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rees E, 2014, MOL PSYCHIATR, V19, P37, DOI 10.1038/mp.2013.156; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742	5	6	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S6	S7		10.1038/508S6a	http://dx.doi.org/10.1038/508S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695335	Bronze			2022-12-28	WOS:000333609900007
J	Pisansky, TM; Pugh, SL; Greenberg, RE; Pervez, N; Reed, DR; Rosenthal, SA; Mowat, RB; Raben, A; Buyyounouski, MK; Kachnic, LA; Bruner, DW				Pisansky, Thomas M.; Pugh, Stephanie L.; Greenberg, Richard E.; Pervez, Nadeem; Reed, Daniel R.; Rosenthal, Seth A.; Mowat, Rex B.; Raben, Adam; Buyyounouski, Mark K.; Kachnic, Lisa A.; Bruner, Deborah W.			Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPARING RADICAL PROSTATECTOMY; NIGHTLY SILDENAFIL CITRATE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; 5 MG; MEN; SATISFACTION; VARDENAFIL; EFFICACY; MULTICENTER	IMPORTANCE Tadalafil is used to treat erectile dysfunction after prostate cancer treatment, but its role as a preventive agent is undefined. OBJECTIVES To determine primarily whether tadalafil preserved erectile function in men treated with radiotherapy for prostate cancer, and secondarily to determine whether participant-or partner-reported overall sexual function and sexual and marital satisfaction were affected. DESIGN, SETTING, AND PARTICIPANTS Stratified, placebo-controlled, double-blind, parallel-group study with 1: 1 randomization at 76 community-based and tertiary medical sites in the United States and Canada. Two hundred forty-two participants with intact erectile function scheduled to receive radiotherapy for prostate cancer were recruited between November 2009 and February 2012 with follow-up through March 2013. INTERVENTIONS One hundred twenty-one participants were assigned 5 mg of tadalafil daily and 121 were assigned placebo for 24 weeks starting with external radiotherapy (63%) or brachytherapy (37%). Participant-reported International Index of Erectile Function response before radiotherapy and at weeks 2 and 4, between weeks 20 and 24, between weeks 28 and 30, and 1 year thereafter. Participants and partners could respond also to the Sexual Adjustment Questionnaire and to the Locke Marital Adjustment Test before radiotherapy, between weeks 20 and 24 and weeks 28 and 30, and at 1 year. MAIN OUTCOMES AND MEASURES Primary outcome was off-drug spontaneous erectile function 28 to 30 weeks after radiotherapy started. Secondary end points were spontaneous erection at 1 year; overall sexual function and satisfaction; marital adjustment; and partner-reported satisfaction and marital adjustment at 28 to 30 weeks and 1 year, predictors of tadalafil response; and adverse events. RESULTS Among221 evaluable participants, 80 (79%; 95% CI, 70%-88%) assigned to receive tadalafil retained erectile function between weeks 28 and 30 compared with 61 (74%; 95% CI, 63%-85%) assigned to receive placebo (P = .49); an absolute difference of 5% (95% CI, -9% to 19%). A significant difference was also not observed at 1 year (72%; 95% CI, 60%-84% vs 71%; 95% CI, 59%-84%; P = .93). Tadalafil was not associated with significantly improved overall sexual function or satisfaction; a significant difference was not observed in any domain subscale. Partners of men assigned tadalafil noted no significant effect on sexual satisfaction, and marital adjustment was not significantly improved in participants or partners. CONCLUSIONS AND RELEVANCE Among men undergoing radiotherapy for prostate cancer, daily use of tadalafil compared with placebo did not result in improved erectile function. These findings do not support daily use of tadalafil to prevent erectile dysfunction in these patients.	[Pisansky, Thomas M.] Mayo Clin, Rochester, MN 55905 USA; [Pugh, Stephanie L.] Radiat Therapy Oncol Grp, Philadelphia, PA USA; [Greenberg, Richard E.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Pervez, Nadeem] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Reed, Daniel R.] Arizona Ctr Canc Care, Phoenix, AZ USA; [Rosenthal, Seth A.] Sutter Med Grp, Sacramento, CA USA; [Mowat, Rex B.] Toledo Community Hosp, Community Clin Oncol Program, Toledo, OH USA; [Raben, Adam] Christiana Care Hlth Syst, Community Clin Oncol Program, Newark, DE USA; [Buyyounouski, Mark K.] Stanford Univ, Stanford, CA 94305 USA; [Kachnic, Lisa A.] Boston Med Ctr, Minor Based Community Clin Oncol Program, Boston, MA USA; [Bruner, Deborah W.] Emory Univ, Atlanta, GA 30322 USA	Mayo Clinic; Radiation Therapy Oncology Group (RTOG); Fox Chase Cancer Center; University of Alberta; Arizona Center Cancer Care; Christiana Care Health System; Stanford University; Boston Medical Center; Emory University	Pisansky, TM (corresponding author), Mayo Clin, Dept Radiat Oncol, 200 First St SW, Rochester, MN 55905 USA.	pisansky.thomas@mayo.edu	Greenberg, Richard E./AAI-7204-2021	, Nadeem/0000-0003-3821-4357; Bruner, Deborah/0000-0002-5770-9948	National Cancer Institute [U10 CA21661, U10 CA37422]; Eli Lilly Co.; NATIONAL CANCER INSTITUTE [U10CA180868, U10CA180822, U10CA037422, U10CA021661] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eli Lilly Co.(Eli Lilly); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This trial was conducted by the Radiation Therapy Oncology Group, which was supported by grant U10 CA21661 and by grant U10 CA37422 (Community Clinical Oncology Program) from the National Cancer Institute and by Eli Lilly & Co.	Alemozaffar M, 2011, JAMA-J AM MED ASSOC, V306, P1205, DOI 10.1001/jama.2011.1333; Aversa A, 2007, INT J IMPOT RES, V19, P200, DOI 10.1038/sj.ijir.3901513; Bannowsky A, 2008, BJU INT, V101, P1279, DOI 10.1111/j.1464-410X.2008.07515.x; Eardley I, 2005, BJU INT, V96, P1323, DOI 10.1111/j.1464-410X.2005.05892.x; Egerdie RB, 2012, J SEX MED, V9, P271, DOI 10.1111/j.1743-6109.2011.02504.x; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Henderson AR, 2005, CLIN CHIM ACTA, V359, P1, DOI 10.1016/j.cccn.2005.04.002; Ilic D, 2013, J MED IMAG RADIAT ON, V57, P81, DOI 10.1111/j.1754-9485.2012.02461.x; Incrocci L, 2006, INT J RADIAT ONCOL, V66, P439, DOI 10.1016/j.ijrobp.2006.04.047; KIMMEL D, 1974, J MARRIAGE FAM, V36, P57, DOI 10.2307/350994; Martin-Morales A, 2007, EUR UROL, V51, P541, DOI 10.1016/j.eururo.2006.09.027; McMahon C, 2005, J SEX MED, V2, P415, DOI 10.1111/j.1743-6109.2005.20360.x; Mirone V, 2009, BJU INT, V103, P1212, DOI 10.1111/j.1464-410X.2008.08267.x; Montorsi F, 2008, EUR UROL, V54, P924, DOI 10.1016/j.eururo.2008.06.083; Padma-Nathan H, 2008, INT J IMPOT RES, V20, P479, DOI 10.1038/ijir.2008.33; Porst H, 2006, EUR UROL, V50, P351, DOI 10.1016/j.eururo.2006.02.052; Porst H, 2010, J SEX MED, V7, P414, DOI 10.1111/j.1743-6109.2009.01623.x; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Seftel AD, 2009, INT J IMPOT RES, V21, P240, DOI 10.1038/ijir.2009.22; Verbecke G, 2000, LINEAR MIXED MODELS; Waterhouse J, 1986, Oncol Nurs Forum, V13, P53; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	25	39	40	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1300	1307		10.1001/jama.2014.2626	http://dx.doi.org/10.1001/jama.2014.2626			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24691606	Green Accepted, Bronze			2022-12-28	WOS:000333645400013
J	Chowdhury, R; Kunutsor, S; Vitezova, A; Oliver-Williams, C; Chowdhury, S; Kiefte-de-Jong, JC; Khan, H; Baena, CP; Prabhakaran, D; Hoshen, MB; Feldman, BS; Pan, A; Johnson, L; Crowe, F; Hu, FB; Franco, OH				Chowdhury, Rajiv; Kunutsor, Setor; Vitezova, Anna; Oliver-Williams, Clare; Chowdhury, Susmita; Kiefte-de-Jong, Jessica C.; Khan, Hassan; Baena, Cristina P.; Prabhakaran, Dorairaj; Hoshen, Moshe B.; Feldman, Becca S.; Pan, An; Johnson, Laura; Crowe, Francesca; Hu, Frank B.; Franco, Oscar H.			Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; TERM-FOLLOW-UP; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; REGRESSION DILUTION; PARATHYROID-HORMONE; FISH CONSUMPTION; DOSE-RESPONSE; MORTALITY; ASSOCIATIONS	Objective To evaluate the extent to which circulating biomarker and supplements of vitamin D are associated with mortality from cardiovascular, cancer, or other conditions, under various circumstances. Design Systematic review and meta-analysis of observational studies and randomised controlled trials. Data sources Medline, Embase, Cochrane Library, and reference lists of relevant studies to August 2013; correspondance with investigators. Study selection Observational cohort studies and randomised controlled trials in adults, which reported associations between vitamin D (measured as circulating 25-hydroxyvitamin D concentration or vitamin D supplement given singly) and cause specific mortality outcomes. Data extraction Data were extracted by two independent investigators, and a consensus was reached with involvement of a third. Study specific relative risks from 73 cohort studies (849 412 participants) and 22 randomised controlled trials (vitamin D given alone versus placebo or no treatment; 30 716 participants) were meta-analysed using random effects models and were grouped by study and population characteristics. Results In the primary prevention observational studies, comparing bottom versus top thirds of baseline circulating 25-hydroxyvitamin D distribution, pooled relative risks were 1.35 (95% confidence interval 1.13 to 1.61) for death from cardiovascular disease, 1.14 (1.01 to 1.29) for death from cancer, 1.30 (1.07 to 1.59) for non-vascular, non-cancer death, and 1.35 (1.22 to 1.49) for all cause mortality. Subgroup analyses in the observational studies indicated that risk of mortality was significantly higher in studies with lower baseline use of vitamin D supplements. In randomised controlled trials, relative risks for all cause mortality were 0.89 (0.80 to 0.99) for vitamin D-3 supplementation and 1.04 (0.97 to 1.11) for vitamin D-2 supplementation. The effects observed for vitamin D-3 supplementation remained unchanged when grouped by various characteristics. However, for vitamin D-2 supplementation, increased risks of mortality were observed in studies with lower intervention doses and shorter average intervention periods. Conclusions Evidence from observational studies indicates inverse associations of circulating 25-hydroxyvitamin D with risks of death due to cardiovascular disease, cancer, and other causes. Supplementation with vitamin D-3 significantly reduces overall mortality among older adults; however, before any widespread supplementation, further investigations will be required to establish the optimal dose and duration and whether vitamin D-3 and D-2 have different effects on mortality risk.	[Chowdhury, Rajiv; Kunutsor, Setor; Oliver-Williams, Clare; Khan, Hassan] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Vitezova, Anna; Kiefte-de-Jong, Jessica C.; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chowdhury, Susmita] Publ Hlth Genom Fdn, Cambridge, England; [Baena, Cristina P.] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Pan, An; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Pan, An] Natl Univ Singapore, Singapore 117548, Singapore; [Johnson, Laura] Univ Bristol, Sch Policy Res, Bristol BS8 1TH, Avon, England; [Crowe, Francesca] Univ Oxford, Canc Epidemiol Unit, Oxford, England	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Pontificia Universidade Catolica do Parana; Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore; University of Bristol; University of Oxford	Chowdhury, R (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	rajiv.chowdhury@phpc.cam.ac.uk; o.franco@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Baena, Cristina/W-6039-2019; Prabhakaran, Dorairaj/B-4147-2011; Chowdhury, Rajiv/AHB-1253-2022; Kunutsor, Setor K/H-9807-2019; Pan, An/C-5572-2011; Khan, Hassan/D-6267-2013; Kiefte-de Jong, Jessica/GLV-3216-2022	Franco, Óscar H/0000-0002-4606-4929; Baena, Cristina/0000-0002-5822-6622; Prabhakaran, Dorairaj/0000-0002-3172-834X; Kunutsor, Setor K/0000-0002-2625-0273; Pan, An/0000-0002-1089-7945; Khan, Hassan/0000-0003-1468-8654; Kiefte-de Jong, Jessica/0000-0002-8136-0918; Johnson, Laura/0000-0001-8985-3154; Crowe, Francesca/0000-0003-4026-1726; Oliver-Williams, Clare/0000-0002-3573-2426	Nestle Nutrition (Nestec Ltd); Metagenics Inc; AXA; Medical Research Council [1127880] Funding Source: researchfish	Nestle Nutrition (Nestec Ltd)(Nestle SA); Metagenics Inc; AXA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	None. AV, JCK-deJ, and OHF work in ErasmusAGE, a centre for aging research across the life course funded by Nestle Nutrition (Nestec Ltd), Metagenics Inc, and AXA. Nestle Nutrition (Nestec Ltd), Metagenics Inc, and AXA had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Autier P, 2012, J CLIN ENDOCR METAB, V97, P2606, DOI 10.1210/jc.2012-1238; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Dror Y, 2013, J CLIN ENDOCR METAB, V98, P2160, DOI 10.1210/jc.2013-1185; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Commission, 2012, EUROSTAT CAUSES OF D; Fenelon A, 2011, PSC WORKING PAPER SE, VPSC 11-02; Gallagher JC, 2012, ANN INTERN MED, V156, P425, DOI 10.7326/0003-4819-156-6-201203200-00005; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; Herr C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-31; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holick MF, 2005, ENCYCLOPEDIA OF HUMA; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Institute of Medicine, 2011, DIETARY REFERENCE IN; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Kritchevsky SB, 2012, J CLIN ENDOCR METAB, V97, P4156, DOI 10.1210/jc.2012-1551; Larsson SC, 2011, STROKE, V42, P3621, DOI 10.1161/STROKEAHA.111.630319; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Lips P, 2007, J STEROID BIOCHEM, V103, P620, DOI 10.1016/j.jsbmb.2006.12.076; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mahon BD, 2003, J NEUROIMMUNOL, V134, P128, DOI 10.1016/S0165-5728(02)00396-X; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Meyer F, 2011, INT J CANCER, V128, P1741, DOI 10.1002/ijc.25496; Mezawa H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-347; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Renne C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-215; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Shield KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051923; Skaaby T, 2013, ENDOCRINE, V43, P618, DOI 10.1007/s12020-012-9805-x; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tomson J, 2013, EUR HEART J, V34, P1365, DOI 10.1093/eurheartj/ehs426; Tripkovic L, 2012, AM J CLIN NUTR, V95, P1357, DOI 10.3945/ajcn.111.031070; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Trowbridge R, 2013, CANCER EPIDEM BIOMAR, V22, P1007, DOI 10.1158/1055-9965.EPI-13-0085; Wells GA, 2011, THE NEWCASTLE OTTAWA; WHO, GLOBAL HEALTH OBSERV; Winzenberg TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006944.pub2; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Ye Z, 2008, EUR J CARDIOV PREV R, V15, P26, DOI 10.1097/HJR.0b013e3282f11f95; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	67	386	393	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g1903	10.1136/bmj.g1903	http://dx.doi.org/10.1136/bmj.g1903			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24690623	Green Published, hybrid			2022-12-28	WOS:000333976300001
J	Nicholson, BD; McGrath, JS; Hamilton, W				Nicholson, Brian D.; McGrath, John S.; Hamilton, Willie			EASILY MISSED? Bladder cancer in women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENDER		[Nicholson, Brian D.] Univ Oxford, Dept Primary Hlth Care Serv, Oxford OX2 6GG, England; [McGrath, John S.] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [McGrath, John S.; Hamilton, Willie] Univ Exeter, Sch Med, Exeter EX2 4SG, Devon, England	University of Oxford; University of Exeter; University of Exeter	Nicholson, BD (corresponding author), Univ Oxford, Dept Primary Hlth Care Serv, Oxford OX2 6GG, England.	brian.nicholson@phc.ox.ac.uk	Hamilton, Willie/G-8612-2014	Hamilton, William/0000-0003-1611-1373				Allaby M, 2010, SCREENING BLADDER CA; [Anonymous], 2013, BLADD CANC; Cohn JA, 2013, CANCER, V120, P555; Fajkovic H, 2011, WORLD J UROL, V29, P457, DOI 10.1007/s00345-011-0709-9; Henning A, 2013, BJU INT, V112, P68, DOI 10.1111/j.1464-410X.2012.11661.x; Hippsley-Cox J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636074; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Lunt CR, 2012, J CLIN UROL, V5, P95, DOI 10.1016/j.bjmsu.2011.10.008; Lyratzopoulos G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002861; NICE, 2005, REF SUSP CANC CG27; Planz B, 2005, EJSO-EUR J SURG ONC, V31, P304, DOI 10.1016/j.ejso.2004.12.008; Shariat SF, 2010, BJU INT, V105, P300, DOI 10.1111/j.1464-410X.2009.09076.x; Shepherd EA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654560; Wallace DMA, 2002, BJU INT, V89, P868, DOI 10.1046/j.1464-410X.2002.02776.x	15	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2171	10.1136/bmj.g2171	http://dx.doi.org/10.1136/bmj.g2171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TK	24687312	Green Submitted			2022-12-28	WOS:000333976100001
J	Campbell, F; Conti, G; Heckman, JJ; Moon, SH; Pinto, R; Pungello, E; Pan, Y				Campbell, Frances; Conti, Gabriella; Heckman, James J.; Moon, Seong Hyeok; Pinto, Rodrigo; Pungello, Elizabeth; Pan, Yi			Early Childhood Investments Substantially Boost Adult Health	SCIENCE			English	Article							METABOLIC SYNDROME; LIFE EXPECTANCY; DISEASE RISK; LMS METHOD; OBESITY; CHILDREN; EMPLOYMENT; PREVENTION; MORTALITY; EDUCATION	High-quality early childhood programs have been shown to have substantial benefits in reducing crime, raising earnings, and promoting education. Much less is known about their benefits for adult health. We report on the long-term health effects of one of the oldest and most heavily cited early childhood interventions with long-term follow-up evaluated by the method of randomization: the Carolina Abecedarian Project (ABC). Using recently collected biomedical data, we find that disadvantaged children randomly assigned to treatment have significantly lower prevalence of risk factors for cardiovascular and metabolic diseases in their mid-30s. The evidence is especially strong for males. The mean systolic blood pressure among the control males is 143 millimeters of mercury (mm Hg), whereas it is only 126 mm Hg among the treated. One in four males in the control group is affected by metabolic syndrome, whereas none in the treatment group are affected. To reach these conclusions, we address several statistical challenges. We use exact permutation tests to account for small sample sizes and conduct a parallel bootstrap confidence interval analysis to confirm the permutation analysis. We adjust inference to account for the multiple hypotheses tested and for nonrandom attrition. Our evidence shows the potential of early life interventions for preventing disease and promoting health.	[Campbell, Frances; Pungello, Elizabeth; Pan, Yi] Univ N Carolina, Frank Porter Graham Child Dev Inst, Chapel Hill, NC 27599 USA; [Conti, Gabriella] UCL, Dept Appl Hlth Res, London WC1E 7HB, England; [Heckman, James J.; Moon, Seong Hyeok; Pinto, Rodrigo] Univ Chicago, Dept Econ, Chicago, IL 60637 USA; [Heckman, James J.] Univ Coll Dublin, Dublin 4, Ireland; [Heckman, James J.] Amer Bar Fdn, Chicago, IL 60611 USA	University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; University of Chicago; University College Dublin	Heckman, JJ (corresponding author), Univ Chicago, Dept Econ, Chicago, IL 60637 USA.	jjh.info@gmail.com		Conti, Gabriella/0000-0003-4699-2490	National Center on Minority Health and Health Disparities, NIH [5RC1MD004344]; American Bar Foundation; Pritzker Children's Initiative; Buffett Early Childhood Fund; NIH [NICHD 5R37HD065072, 1R01HD54702]; European Research Council [DEVHEALTH 269874]; Institute for New Economic Thinking (INET); Economic Opportunity Global Working Group (HCEO)-an initiative of the Becker Friedman Institute for Research in Economics (BFI); ESRC [ES/H021221/1] Funding Source: UKRI; Economic and Social Research Council [ES/H021221/1] Funding Source: researchfish; Northern Ireland Chest Heart and Stroke [Test-Frances] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD065072] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054702] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004344] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); American Bar Foundation; Pritzker Children's Initiative; Buffett Early Childhood Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Institute for New Economic Thinking (INET); Economic Opportunity Global Working Group (HCEO)-an initiative of the Becker Friedman Institute for Research in Economics (BFI); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Northern Ireland Chest Heart and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The order of authorship names does not reflect the degree of contribution. G. C., J.J.H., S. H. M., and R. P. contributed equally to the design, method, and economic analysis presented in the paper. F. C., E. P., and Y.P. generated the medical data for this work and engaged in repeated and productive discussions with G. C., J.J.H., S. H. M., and R. P. over the content of the intervention and the interpretation of the findings. Background data were generated over many years by researchers at the University of North Carolina at Chapel Hill. We thank others at the Frank Porter Graham Child Development Institute at the University of North Carolina (UNC) at Chapel Hill who contributed to this work: C. Bynum and E. Gunn, both of whom assisted in data collection and entry. In addition, thanks are due to T. Keyserling of the UNC School of Medicine, an investigator on the original grant; G. Steen, a consultant to the medical grant who contributed in numerous ways to the effort; and L. Powell-Tillman of Chapel Hill Internal Medicine, who conducted the physical examinations. We also thank M. Griffin for excellent research assistance. Funding given to FPG/UNC from grant 5RC1MD004344 (National Center on Minority Health and Health Disparities, NIH) was used to collect these data. The research was supported in part by the American Bar Foundation, the Pritzker Children's Initiative, the Buffett Early Childhood Fund, NIH grants NICHD 5R37HD065072 and 1R01HD54702, an anonymous funder, a European Research Council grant hosted by University College Dublin (DEVHEALTH 269874), and a grant from the Institute for New Economic Thinking (INET) to the Human Capital and Economic Opportunity Global Working Group (HCEO)-an initiative of the Becker Friedman Institute for Research in Economics (BFI). The views expressed in this paper are those of the authors and not necessarily those of the funders or persons named here. The data have been deposited by the principal investigator of the Abecedarian follow-up studies at the Inter-University Consortium for Political and Social Research (ICPSR) at the University of Michigan under identification number 34918.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Antos JR, 2012, NEW ENGL J MED, V367, P954, DOI 10.1056/NEJMsb1207996; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barnett WS, 2007, ECON EDUC REV, V26, P113, DOI 10.1016/j.econedurev.2005.10.007; Bray GA, 2013, DIABETES CARE, V36, P11, DOI 10.2337/dc12-1631; CAMPBELL FA, 1994, CHILD DEV, V65, P684, DOI 10.1111/j.1467-8624.1994.tb00777.x; Campbell FA, 1995, AM EDUC RES J, V32, P743, DOI 10.3102/00028312032004743; Campbell FA, 2008, EARLY CHILD RES Q, V23, P452, DOI 10.1016/j.ecresq.2008.03.003; Carneiro P., 2012, LONG TERM IMPACTS CO; Cawley J., 2011, EC OBESITY; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cutler DM, 2013, HEALTH AFFAIR, V32, P841, DOI 10.1377/hlthaff.2012.0289; D'Onise K, 2010, SOC SCI MED, V70, P1423, DOI 10.1016/j.socscimed.2009.12.037; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; DAVIS K, 1994, ARCH PEDIAT ADOL MED, V148, P1257, DOI 10.1001/archpedi.1994.02170120019003; Emanuel E, 2012, SCIENCE, V337, P1433, DOI 10.1126/science.1229493; Entringer Sonja, 2012, Sci Signal, V5, ppt12, DOI 10.1126/scisignal.2003580; Fletcher JM, 2012, HEALTH AFFAIR, V31, P27, DOI 10.1377/hlthaff.2011.0862; Flynn MAT, 2006, OBES REV, V7, P7, DOI 10.1111/j.1467-789X.2006.00242.x; Frisvold DE, 2011, J HUM RESOUR, V46, P373; Galobardes B, 2008, J EPIDEMIOL COMMUN H, V62, P387, DOI 10.1136/jech.2007.065508; Ginsburg PB, 2012, NEW ENGL J MED, V367, P2454, DOI 10.1056/NEJMc1212355; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heckman J, 2013, AM ECON REV, V103, P2052, DOI 10.1257/aer.103.6.2052; Heckman JJ, 2008, ECON INQ, V46, P289, DOI 10.1111/j.1465-7295.2008.00163.x; Hertzman C, 1999, ANN NY ACAD SCI, V896, P85, DOI 10.1111/j.1749-6632.1999.tb08107.x; Hines P, 2011, SCIENCE, V333, P951, DOI 10.1126/science.333.6045.951; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; Johnston J., 1997, ECONOMETRIC METHODS; Levy H., 2004, HLTH POLICY UNINSURE, P179; Minor T, 2013, ECON HUM BIOL, V11, P534, DOI 10.1016/j.ehb.2013.04.004; Nores M, 2010, ECON EDUC REV, V29, P271, DOI 10.1016/j.econedurev.2009.09.001; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; Romano JR, 2005, J AM STAT ASSOC, V100, P94, DOI 10.1198/016214504000000539; Sparling J., 1984, LEARNINGGAMES 3 4; Sparling J., 1979, LEARNINGGAMES 1 3 YE; Strong K., 2003, SURVEILLANCE RISK FA; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194; WHO Consultation, 1999, DEF DIAGN CLASS DIAB; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	48	558	559	9	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1478	1485		10.1126/science.1248429	http://dx.doi.org/10.1126/science.1248429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675955	Green Submitted, Green Accepted			2022-12-28	WOS:000333471000039
J	Weinberg, RA				Weinberg, Robert A.			Coming Full Circle-From Endless Complexity to Simplicity and Back Again	CELL			English	Article							DEPENDENT DNA-POLYMERASE; HUMAN BLADDER; TRANSFORMING GENE; CELL-LINES; MUTAGENS; CARCINOGENS; ACTIVATION; ONCOGENES; VIRIONS; HARVEY	Cell has celebrated the powers of reductionist molecular biology and its major successes for four decades. Those who have participated in cancer research during this period have witnessed wild fluctuations from times where endless inexplicable phenomenology reigned supreme to periods of reductionist triumphalism	[Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02142 USA; [Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu						AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; Cairns J., 1978, CANC SCI SOC; DEFEO D, 1981, P NATL ACAD SCI-BIOL, V78, P3328, DOI 10.1073/pnas.78.6.3328; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P979, DOI 10.1073/pnas.72.3.979; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SHIH C, 1979, P NATL ACAD SCI USA, V76, P5714, DOI 10.1073/pnas.76.11.5714; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SMOTKIN D, 1975, P NATL ACAD SCI USA, V72, P4910, DOI 10.1073/pnas.72.12.4910; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047	31	149	158	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					267	271		10.1016/j.cell.2014.03.004	http://dx.doi.org/10.1016/j.cell.2014.03.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679541	Bronze			2022-12-28	WOS:000333968900022
J	Christie, B; Burns, H				Christie, Bryan; Burns, Harry			INTERVIEW Harry Burns: the man who shifted Scotland's thinking on health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bryan.christie@virgin.net						ISD Scotland, QUAL MEAS FRAM; Reid J, 1972, RECTORIAL ADDRESS AL	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2014	348								g2262	10.1136/bmj.g2262	http://dx.doi.org/10.1136/bmj.g2262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7BF	24657770				2022-12-28	WOS:000333415200002
J	Clase, CM; Mann, JFE				Clase, Catherine M.; Mann, Johannes F. E.			Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Clase, Catherine M.; Mann, Johannes F. E.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Clase, CM (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Mann, Johannes/AAI-8803-2020	Clase, Catherine/0000-0002-4538-5958				Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Makani H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f360; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351	5	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6							JC3	10.7326/0003-4819-160-6-201403180-02003	http://dx.doi.org/10.7326/0003-4819-160-6-201403180-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24638181				2022-12-28	WOS:000333521300002
J	Desai, BS; Chadha, A; Cook, B				Desai, Bela S.; Chadha, Abhishek; Cook, Boaz			The stum Gene Is Essential for Mechanical Sensing in Proprioceptive Neurons	SCIENCE			English	Article							MECHANOSENSORY TRANSDUCTION; PROJECTIONS; PHORMIA; CNS	Animal locomotion depends on proprioceptive feedback, which is generated by mechanosensory neurons. We performed a genetic screen for impaired walking in Drosophila and isolated a gene, stumble (stum). The Stum protein has orthologs in animals ranging from nematodes to mammals and is predicted to contain two transmembrane domains. Expression of the mouse orthologs of stum in mutant flies rescued their phenotype, which demonstrates functional conservation. Dendrites of stum-expressing neurons in legs were stretched by both flexion and extension of corresponding joints. Joint angles that induced dendritic stretching also elicited elevation of cellular Ca2+ levels-not seen in stum mutants. Thus, we have identified an evolutionarily conserved gene, stum, which is required for transduction of mechanical stimuli in a specific subpopulation of Drosophila proprioceptive neurons that sense joint angles.	[Desai, Bela S.; Chadha, Abhishek; Cook, Boaz] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Cook, B (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	bcook@scripps.edu		Desai, Bela/0000-0001-7343-6233				Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; MERRITT DJ, 1992, J COMP NEUROL, V322, P16, DOI 10.1002/cne.903220103; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; MURPHEY RK, 1989, J NEUROSCI, V9, P3209; Shimono K, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-37; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685	12	16	18	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1256	1259		10.1126/science.1247761	http://dx.doi.org/10.1126/science.1247761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626929				2022-12-28	WOS:000332728500038
J	Huff, JT; Zilberman, D				Huff, Jason T.; Zilberman, Daniel			Dnmt1-Independent CG Methylation Contributes to Nucleosome Positioning in Diverse Eukaryotes	CELL			English	Article							DNA METHYLATION; IN-VITRO; GENOME; METHYLTRANSFERASES; CHROMATIN; DNMT3A; ORGANIZATION; EVOLUTION; INSIGHTS; PLANTS	Dnmt1 epigenetically propagates symmetrical CG methylation in many eukaryotes. Their genomes are typically depleted of CG dinucleotides because of imperfect repair of deaminated methylcytosines. Here, we extensively survey diverse species lacking Dnmt1 and show that, surprisingly, symmetrical CG methylation is nonetheless frequently present and catalyzed by a different DNA methyltransferase family, Dnmt5. Numerous Dnmt5-containing organisms that diverged more than a billion years ago exhibit clustered methylation, specifically in nucleosome linkers. Clustered methylation occurs at unprecedented densities and directly disfavors nucleosomes, contributing to nucleosome positioning between clusters. Dense methylation is enabled by a regime of genomic sequence evolution that enriches CG dinucleotides and drives the highest CG frequencies known. Species with linker methylation have small, transcriptionally active nuclei that approach the physical limits of chromatin compaction. These features constitute a previously unappreciated genome architecture, in which dense methylation influences nucleosome positions, likely facilitating nuclear processes under extreme spatial constraints.	[Huff, Jason T.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zilberman, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	danielz@berkeley.edu		Zilberman, Daniel/0000-0002-0123-8649; Huff, Jason/0000-0002-0088-1640	Arnold and Mabel Beckman Foundation; National Institutes of Health [T32HG000047]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000047] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Schuman at the National Center for Marine Algae and Microbiota for biological materials, the Fungal Genetics Stock Center for C. neoformans strains, the Vincent J. Coates Genomics Sequencing Laboratory for sequencing, A. Zemach, T.-F. Hsieh, and S. Branco for experimental advice, T. Nishimura for computational help, and R. Fischer, A. Plocik, and S. Roy for their critical reading of our manuscript. This work was supported by a Young Investigator award from the Arnold and Mabel Beckman Foundation (to D.Z.) and a National Institutes of Health Trainee appointment on grant number T32HG000047 (to J.T.H.).	Chang GS, 2012, GENOME RES, V22, P1098, DOI 10.1101/gr.131649.111; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Coleman-Derr D, 2012, Cold Spring Harb Symp Quant Biol, V77, P147, DOI 10.1101/sqb.2012.77.014944; Collings CK, 2013, NUCLEIC ACIDS RES, V41, P2918, DOI 10.1093/nar/gks893; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Felle M, 2011, NUCLEIC ACIDS RES, V39, P6956, DOI 10.1093/nar/gkr263; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Gan L, 2011, CURR BIOL, V21, P1578, DOI 10.1016/j.cub.2011.08.021; GLASNER W, 1995, J MOL BIOL, V245, P1; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Huff JT, 2012, CURR OPIN GENET DEV, V22, P132, DOI 10.1016/j.gde.2012.01.007; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Inagaki S, 2010, EMBO J, V29, P3496, DOI 10.1038/emboj.2010.227; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Jiang Y, 2011, ANAL BIOCHEM, V415, P84, DOI 10.1016/j.ab.2011.03.037; Jimenez-Useche I, 2013, SCI REP-UK, V3, DOI 10.1038/srep02121; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Okuwaki M, 2004, J BIOL CHEM, V279, P2904, DOI 10.1074/jbc.M310111200; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; Perez A, 2012, BIOPHYS J, V102, P2140, DOI 10.1016/j.bpj.2012.03.056; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Ponger L, 2005, MOL BIOL EVOL, V22, P1119, DOI 10.1093/molbev/msi098; Robertson AK, 2004, BIOCHEM BIOPH RES CO, V322, P110, DOI 10.1016/j.bbrc.2004.07.083; Schubeler D, 2012, SCIENCE, V338, P756, DOI 10.1126/science.1227243; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Shen L, 2010, NUCLEIC ACIDS RES, V38, P6054, DOI 10.1093/nar/gkq456; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeshima H, 2006, J BIOCHEM, V139, P503, DOI 10.1093/jb/mvj044; Takeshima H, 2008, J MOL BIOL, V383, P810, DOI 10.1016/j.jmb.2008.03.001; Teves SS, 2012, METHODS MOL BIOL, V833, P421, DOI 10.1007/978-1-61779-477-3_25; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Veluchamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3091; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Zemach A, 2010, CURR BIOL, V20, pR780, DOI 10.1016/j.cub.2010.07.007; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	55	105	111	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1286	1297		10.1016/j.cell.2014.01.029	http://dx.doi.org/10.1016/j.cell.2014.01.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630728	Bronze, Green Accepted			2022-12-28	WOS:000332945100017
J	Tan, AYY; Chen, YZ; Scholl, B; Seidemann, E; Priebe, NJ				Tan, Andrew Y. Y.; Chen, Yuzhi; Scholl, Benjamin; Seidemann, Eyal; Priebe, Nicholas J.			Sensory stimulation shifts visual cortex from synchronous to asynchronous states	NATURE			English	Article							NEURAL POPULATION RESPONSES; IN-VIVO; NEOCORTICAL NEURONS; STIMULUS CONTRAST; CORTICAL CIRCUITS; AUDITORY-CORTEX; BARREL CORTEX; COMPLEX CELLS; NETWORKS; DYNAMICS	In the mammalian cerebral cortex, neural responses are highly variable during spontaneous activity and sensory stimulation. To explain this variability, the cortex of alert animals has been proposed to be in an asynchronous high-conductance state in which irregular spiking arises from the convergence of large numbers of uncorrelated excitatory and inhibitory inputs onto individual neurons(1-4). Signatures of this state are that a neuron's membrane potential (V-m) hovers just below spike threshold, and its aggregate synaptic input is nearly Gaussian, arising from many uncorrelated inputs(1-4). Alternatively, irregular spiking could arise from infrequent correlated input events that elicit large fluctuations in V-m (refs 5, 6). To distinguish between these hypotheses, we developed a technique to perform whole-cell V-m measurements from the cortex of behaving monkeys, focusing on primary visual cortex (V1) of monkeys performing a visual fixation task. Here we show that, contrary to the predictions of an asynchronous state, mean V-m during fixation was far from threshold (14 mV) and spiking was triggered by occasional large spontaneous fluctuations. Distributions of V-m values were skewed beyond that expected for a range of Gaussian input(6,7), but were consistent with synaptic input arising from infrequent correlated events(5,6). Furthermore, spontaneous fluctuations in V-m were correlated with the surrounding network activity, as reflected in simultaneously recorded nearby local field potential. Visual stimulation, however, led to responses more consistent with an asynchronous state: mean V-m approached threshold, fluctuations became more Gaussian, and correlations between single neurons and the surrounding network were disrupted. These observations show that sensory drive can shift a common cortical circuitry from a synchronous to an asynchronous state.	[Tan, Andrew Y. Y.; Chen, Yuzhi; Scholl, Benjamin; Seidemann, Eyal; Priebe, Nicholas J.] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Tan, Andrew Y. Y.; Chen, Yuzhi; Scholl, Benjamin; Seidemann, Eyal; Priebe, Nicholas J.] Univ Texas Austin, Coll Nat Sci, Dept Neurosci, Austin, TX 78712 USA; [Chen, Yuzhi; Seidemann, Eyal] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Tan, AYY (corresponding author), Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA.	atyy@alum.mit.edu; nico@austin.utexas.edu	Tan, Andrew/E-7752-2011	Tan, Andrew/0000-0002-4696-1347; Seidemann, Eyal/0000-0003-2841-5948	National Institutes of Health (NIH) [EY-019288]; Pew Charitable Trusts; NIH [EY-016454, EY-16752]; NATIONAL EYE INSTITUTE [R01EY016752, R01EY016454, T32EY021462, R01EY019288] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank T. Cakic for assistance with this project, and J. Hanover, D. Ferster, K. D. Miller and A. C. Huk for discussions and comments. A.Y.Y.T., B. S. and N.J.P. were supported by grants from the National Institutes of Health (NIH) (EY-019288) and the Pew Charitable Trusts; Y.C. and E. S. were supported by grants from the NIH (EY-016454 and EY-16752).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Chen DF, 2005, J NEUROPHYSIOL, V94, P2713, DOI 10.1152/jn.00024.2005; Chen YZ, 2008, J NEUROPHYSIOL, V99, P1366, DOI 10.1152/jn.00698.2007; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; FERSTER D, 1992, J NEUROSCI, V12, P1262; Goodman Dan, 2008, Front Neuroinform, V2, P5, DOI 10.3389/neuro.11.005.2008; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hromadka T, 2013, J NEUROPHYSIOL, V109, P1989, DOI 10.1152/jn.00600.2012; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MATSUMURA M, 1979, BRAIN RES, V163, P33, DOI 10.1016/0006-8993(79)90149-5; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mehring C, 2003, BIOL CYBERN, V88, P395, DOI 10.1007/s00422-002-0384-4; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Mitra P., 2007, OBSERVED BRAIN DYNAM; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Peyrache A, 2012, P NATL ACAD SCI USA, V109, P1731, DOI 10.1073/pnas.1109895109; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Richardson MJE, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.178102; Richardson MJE, 2006, CHAOS, V16, DOI 10.1063/1.2203409; Richardson MJE, 2005, NEURAL COMPUT, V17, P923, DOI 10.1162/0899766053429444; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rudolph M, 2003, NEURAL COMPUT, V15, P2577, DOI 10.1162/089976603322385081; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wolff L, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041913; XING P, 1991, NEUROREPORT, V2, P485; Yang ZY, 2007, J NEUROPHYSIOL, V98, P1002, DOI 10.1152/jn.00417.2007	51	141	142	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					226	+		10.1038/nature13159	http://dx.doi.org/10.1038/nature13159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24695217	Green Accepted			2022-12-28	WOS:000335454300039
J	Cohen, PA				Cohen, Pieter A.			Hazards of Hindsight - Monitoring the Safety of Nutritional Supplements	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Americans spend more than $32 billion a year on dietary supplements, which do not require premarketing approval before they reach store shelves. Under current law, the FDA must identify and remove dangerous supplements only after they have caused harm. Epidemiologists at the Centers for Disease Control and Prevention (CDC) recently confirmed what an astute liver-transplant surgeon in Honolulu already suspected: OxyElite Pro, a popular over-the-counter supplement, was responsible for a cluster of cases of severe hepatitis and liver failure.(1) Although patients began to develop severe hepatitis in May 2013, the Food and Drug Administration (FDA), whose job it is to remove dangerous supplements from store shelves, did not learn of the cases until mid-September, 4 months later. By February 2014, the CDC had linked 97 cases, resulting in 47 hospitalizations, three liver transplantations, and one death, to OxyElite Pro. . . .	[Cohen, Pieter A.] Cambridge Hlth Alliance, Somerville, MA 02145 USA; [Cohen, Pieter A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School	Cohen, PA (corresponding author), Cambridge Hlth Alliance, Somerville, MA 02145 USA.							[Anonymous], 2013, Morbidity and Mortality Weekly Report, V62, P817; [Anonymous], TAINT SUPPL CDER; Cohen PA, 2013, DRUG TEST ANAL; Haller CA, 2008, J MED TOXICOL, V4, P84, DOI 10.1007/BF03160960; Pawar RS, 2014, J PHARMACEUT BIOMED, V88, P457, DOI 10.1016/j.jpba.2013.09.012	5	104	104	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1277	1280		10.1056/NEJMp1315559	http://dx.doi.org/10.1056/NEJMp1315559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693886	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000333830000003
J	Sinha, R; Fearfield, L				Sinha, Rishika; Fearfield, Louise			Zosteriform Metastases from Malignant Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 30-year-old man with a history of metastatic malignant melanoma presented with painful and itchy papulonodular lesions on the right side of his trunk (Panel A) that had developed over a period of 7 days. A computed tomographic scan showed extensive metastatic disease with necrosis throughout the right axilla and right lateral chest wall. The lesions were adjacent to the site of excision of the primary melanoma. The dermatomal distribution prompted a diagnosis of herpes zoster infection, and acyclovir was administered but with little response. A dermatologist made a diagnosis of zosteriform metastases caused by the metastatic malignant melanoma, although . . . A 30-year-old man with a history of metastatic malignant melanoma presented with painful and itchy papulonodular lesions on the right side of his trunk that had developed over a period of 7 days. A CT scan showed extensive metastatic disease with necrosis.	[Sinha, Rishika] Chelsea & Westminster Hosp, London, England; [Fearfield, Louise] Royal Marsden Hosp, London SW3 6JJ, England	Imperial College London; Royal Marsden NHS Foundation Trust	Sinha, R (corresponding author), Chelsea & Westminster Hosp, London, England.	rs280@doctors.org.uk							0	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14								10.1056/NEJMicm1305647	http://dx.doi.org/10.1056/NEJMicm1305647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693919				2022-12-28	WOS:000333830000001
J	Vagizov, F; Antonov, V; Radeonychev, YV; Shakhmuratov, RN; Kocharovskaya, O				Vagizov, Farit; Antonov, Vladimir; Radeonychev, Y. V.; Shakhmuratov, R. N.; Kocharovskaya, Olga			Coherent control of the waveforms of recoilless gamma-ray photons	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY	The concepts and ideas of coherent, nonlinear and quantum optics have been extended to photon energies in the range of 10-100 kilo-electronvolts, corresponding to soft gamma-ray radiation (the term used when the radiation is produced in nuclear transitions) or, equivalently, hard X-ray radiation (the term used when the radiation is produced by electron motion). The recent experimental achievements in this energy range include the demonstration of parametric down-conversion in the Langevin regime(1), electromagnetically induced transparency in a cavity(2), the collective Lamb shift(3), vacuum-assisted generation of atomic coherences(4) and single-photon revival in nuclear absorbing multilayer structures(5). Also, realization of single-photon coherent storage(6) and stimulated Raman adiabatic passage(7) were recently proposed in this regime. More related work is discussed in a recent review(8). However, the number of tools for the coherent manipulation of interactions between gamma-ray photons and nuclear ensembles remains limited. Here we suggest and implement an efficient method to control the waveforms of gamma-ray photons coherently. In particular, we demonstrate the conversion of individual recoilless gamma-ray photons into a coherent, ultrashort pulse train and into a double pulse. Our method is based on the resonant interaction of gamma-ray photons with an ensemble of nuclei with a resonant transition frequency that is periodically modulated in time. The frequency modulation, which is achieved by a uniform vibration of the resonant absorber, owing to the Doppler effect, renders resonant absorption and dispersion both time dependent, allowing us to shape the waveforms of the incident gamma-ray photons. We expect that this technique will lead to advances in the emerging fields of coherent and quantum gamma-ray photon optics, providing a basis for the realization of gamma-ray-photon/nuclear-ensemble interfaces and quantum interference effects at nuclear gamma-ray transitions.	[Vagizov, Farit; Antonov, Vladimir; Radeonychev, Y. V.; Kocharovskaya, Olga] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Vagizov, Farit; Antonov, Vladimir; Radeonychev, Y. V.; Kocharovskaya, Olga] Texas A&M Univ, Inst Quantum Sci & Engn, College Stn, TX 77843 USA; [Vagizov, Farit; Shakhmuratov, R. N.] Kazan Fed Univ, Kazan 420008, Russia; [Vagizov, Farit; Shakhmuratov, R. N.] Russian Acad Sci, Kazan Phys Tech Inst, Kazan 420029, Russia; [Antonov, Vladimir; Radeonychev, Y. V.] Russian Acad Sci, Inst Appl Phys, Nizhnii Novgorod 603950, Russia; [Antonov, Vladimir; Radeonychev, Y. V.] NI Lobachevsky State Univ, Nizhnii Novgorod 603950, Russia	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Kazan Federal University; Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Zavoisky Physical-Technical Institute; Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; Lobachevsky State University of Nizhni Novgorod	Kocharovskaya, O (corresponding author), Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA.	kochar@physics.tamu.edu	Antonov, Vladimir A/D-9717-2014; Vagizov, Farit/K-8210-2019; Shakhmuratov, Rustem/H-3422-2015; Vagizov, Farit/C-8106-2013; Radeonychev, Yevgeny/B-1728-2014	Antonov, Vladimir A/0000-0002-6078-6987; Vagizov, Farit/0000-0001-7965-1583; Shakhmuratov, Rustem/0000-0001-5757-8151; Vagizov, Farit/0000-0001-7965-1583; 	US NSF [PHY-1307346]; RFBR [13-02-00831, 12-02-00263]; Ministry of Education and Science of the Russian Federation [11.G34.31.0011]; Dynasty Foundation; Division Of Physics [1307346] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); RFBR(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Dynasty Foundation; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge the support from the US NSF (grant no. PHY-1307346), the RFBR (grants nos 13-02-00831 and 12-02-00263) and The Ministry of Education and Science of the Russian Federation (contract no. 11.G34.31.0011). V. A. acknowledges support from the Dynasty Foundation.	Adams BW, 2013, J MOD OPTIC, V60, P2, DOI 10.1080/09500340.2012.752113; Amann J, 2012, NAT PHOTONICS, V6, P693, DOI [10.1038/nphoton.2012.180, 10.1038/NPHOTON.2012.180]; Antonov VA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213903; Doring F, 2013, OPT EXPRESS, V21, P19311, DOI 10.1364/OE.21.019311; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Hannon JP, 1999, HYPERFINE INTERACT, V123, P127, DOI 10.1023/A:1017011621007; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Heeg KP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.073601; HELISTO P, 1986, PHYS REV B, V34, P3458, DOI 10.1103/PhysRevB.34.3458; Kagan Y, 1999, HYPERFINE INTERACT, V123, P83, DOI 10.1023/A:1017059504169; Kocharovskaya O.A., 1986, SOV PHYS JETP, V63, P945; Kolchin P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.103601; Kuznetsova E, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043825; Liao WT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.197403; Liao WT, 2011, PHYS LETT B, V705, P134, DOI 10.1016/j.physletb.2011.09.107; Lvovsky AI, 2009, NAT PHOTONICS, V3, P706, DOI 10.1038/nphoton.2009.231; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Pittman T., 2013, PHYSICS, V6, P110; Radeonychev YV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.093602; Rohlsberger R, 2012, NATURE, V482, P199, DOI 10.1038/nature10741; Rohlsberger R, 2010, SCIENCE, V328, P1248, DOI 10.1126/science.1187770; Rohlsberger R., 2005, SPRINGER TRACTS MOD, V208; Shakhmuratov RN, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013807; Shvyd'ko Y, 2011, NAT PHOTONICS, V5, P539, DOI [10.1038/NPHOTON.2011.197, 10.1038/nphoton.2011.197]; Shwartz S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.013602; Simon C, 2010, EUR PHYS J D, V58, P1, DOI 10.1140/epjd/e2010-00103-y; Smirnov GV, 1999, HYPERFINE INTERACT, V123, P633, DOI 10.1023/A:1017092411438; Smirnov GV, 1999, HYPERFINE INTERACT, V123, P31, DOI 10.1023/A:1017007520099; Wintersteiner P. P., 1970, MOSSBAUER EFFECT MET, V6, P109	30	85	89	1	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					80	+		10.1038/nature13018	http://dx.doi.org/10.1038/nature13018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670656	Green Submitted			2022-12-28	WOS:000333609900046
J	Hildebrand, DR; Ben-sassi, A; Ross, NP; Macvicar, R; Frizelle, FA; Watson, AJM				Hildebrand, D. R.; Ben-sassi, A.; Ross, N. P.; Macvicar, R.; Frizelle, F. A.; Watson, A. J. M.			Modern management of splenic trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLUNT ABDOMINAL-TRAUMA; EAST MEMBER PRACTICES; NONOPERATIVE MANAGEMENT; ARTERY EMBOLIZATION; ORGAN INJURY; FOCUSED ASSESSMENT; GRADING SYSTEMS; SELENIC INJURY; CURRENT TRENDS; SPLEEN		[Hildebrand, D. R.; Ross, N. P.; Watson, A. J. M.] Raigmore Hosp, Dept Surg, Inverness IV2 3UJ, Scotland; [Ben-sassi, A.; Frizelle, F. A.] Christchurch Publ Hosp, Christchurch, New Zealand; [Macvicar, R.] NHS Educ Scotland, Inverness, Scotland	Christchurch Hospital New Zealand; NHS Education for Scotland	Watson, AJM (corresponding author), Raigmore Hosp, Dept Surg, Inverness IV2 3UJ, Scotland.	angus.watson@nhs.net						Alejandro KV, 2003, AM SURGEON, V69, P1006; [Anonymous], 1971, JAMA, V215, P277; Aubrey-Bassler FK, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-11; Barquist ES, 2004, J TRAUMA, V56, P334, DOI 10.1097/01.TA.0000052364.71392.70; Bee TK, 2001, J TRAUMA, V50, P230, DOI 10.1097/00005373-200102000-00007; Bessoud B, 2007, J TRAUMA, V62, P1481, DOI 10.1097/TA.0b013e318047dfb8; Boscak AR, 2013, RADIOLOGY, V268, P79, DOI 10.1148/radiol.13121370; Boulanger BR, 2000, AM SURGEON, V66, P1049; Brasel KJ, 1998, J TRAUMA, V44, P283, DOI 10.1097/00005373-199802000-00006; Carobbi A, 2010, SURG ENDOSC, V24, P1325, DOI 10.1007/s00464-009-0768-9; Cirocchi R, 2013, CRIT CARE, V17, DOI 10.1186/cc12868; Costa G, 2010, ANN ITAL CHIR, V81, P95; Costamagna Daniela, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.01.2010.2601; Crawford RS, 2007, SURGERY, V142, P337, DOI 10.1016/j.surg.2007.05.003; Davies JM, 2011, BRIT J HAEMATOL, V155, P308, DOI 10.1111/j.1365-2141.2011.08843.x; DELANY HM, 1993, INJURY, V24, P585, DOI 10.1016/0020-1383(93)90118-P; Eberle BM, 2011, J TRAUMA, V70, P141, DOI 10.1097/TA.0b013e3182032f45; Ekeh AP, 2013, AM J SURG, V205, P250, DOI 10.1016/j.amjsurg.2013.01.003; Fata P, 2005, J TRAUMA, V59, P836, DOI 10.1097/01.ta.0000187652.55405.73; FEDERLE MP, 1987, RADIOLOGY, V162, P69, DOI 10.1148/radiology.162.1.3786787; Garber BG, 2000, CAN J SURG, V43, P283; Haan JM, 2004, J TRAUMA, V56, P542, DOI 10.1097/01.TA.0000114069.73054.45; Hamlat CA, 2012, ANN SURG, V255, P165, DOI 10.1097/SLA.0b013e31823840ca; Heuer M, 2010, EUR J MED RES, V15, P258, DOI 10.1186/2047-783X-15-6-258; Hori Y, 2008, SURG ENDOSC, V22, P1353, DOI [10.1007/s00464-008-9759-5, 10.1007/s00464-008-9757-7]; Huscher CGS, 2006, SURG ENDOSC, V20, P1423, DOI 10.1007/s00464-004-2241-0; Jeremitsky E, 2011, AM SURGEON, V77, P215; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Laselle BT, 2012, ANN EMERG MED, V60, P326, DOI 10.1016/j.annemergmed.2012.01.023; Leemans R, 1999, ANN SURG, V229, P279, DOI 10.1097/00000658-199902000-00017; LONGO WE, 1989, ANN SURG, V210, P626, DOI 10.1097/00000658-198911000-00010; Louredo Angel M, 2005, Cir Esp, V77, P145; LUDTKE FE, 1989, ACTA CHIR SCAND, V155, P533; Marmery H, 2007, AM J ROENTGENOL, V189, P1421, DOI 10.2214/AJR.07.2152; MILLIKAN JS, 1982, AM J SURG, V144, P711, DOI 10.1016/0002-9610(82)90556-6; MIRVIS SE, 1989, RADIOLOGY, V171, P33, DOI 10.1148/radiology.171.1.2928544; MOORE EE, 1989, J TRAUMA, V29, P1664, DOI 10.1097/00005373-198912000-00013; MOORE EE, 1995, J TRAUMA, V38, P323, DOI 10.1097/00005373-199503000-00001; Moore EE, 2010, J TRAUMA, V69, P1600, DOI 10.1097/TA.0b013e318201124e; MUCHA P, 1986, J TRAUMA, V26, P970, DOI 10.1097/00005373-198611000-00003; Nasr WI, 2004, J TRAUMA, V57, P887, DOI 10.1097/01.TA.0000057962.07187.56; O'Neill P, 2005, J TRAUMA, V59, P841; OCHSNER MG, 1990, J TRAUMA, V30, P884, DOI 10.1097/00005373-199007000-00020; Olthof DC, 2014, INJURY, V45, P146, DOI 10.1016/j.injury.2012.08.013; Orcalli F, 1998, SURG LAPAROSC ENDOSC, V8, P445, DOI 10.1097/00019509-199812000-00009; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; Pirasteh A, 2012, J VASC INTERV RADIOL, V23, P80, DOI 10.1016/j.jvir.2011.09.009; PISTERS PWT, 1994, ANN SURG, V219, P225, DOI 10.1097/00000658-199403000-00002; Radiologists T.R.C.o., 2011, ROYAL COLL RAD STAND; Renzulli P, 2010, BRIT J SURG, V97, P1696, DOI 10.1002/bjs.7203; ROTHLIN MA, 1993, J TRAUMA, V34, P488; SCATAMACCHIA SA, 1989, RADIOLOGY, V171, P725, DOI 10.1148/radiology.171.3.2717742; Schneir A, 2001, Cal J Emerg Med, V2, P33; Schnuriger B, 2011, J TRAUMA, V70, P252, DOI 10.1097/TA.0b013e3181f2a92e; Schurink GWH, 1997, INJURY, V28, P261, DOI 10.1016/S0020-1383(97)00007-7; SCLAFANI SJA, 1981, RADIOLOGY, V141, P645, DOI 10.1148/radiology.141.3.7029619; Shapiro MJ, 1999, J TRAUMA, V47, P651, DOI 10.1097/00005373-199910000-00008; Shen Han-bin, 2005, Chin J Traumatol, V8, P293; Shuman W P, 2000, Radiology, V215 Suppl, P143; Singer D B, 1973, Perspect Pediatr Pathol, V1, P285; Skattum J, 2012, BRIT J SURG, V99, P59, DOI 10.1002/bjs.7764; Smith J, 2010, POSTGRAD MED J, V86, P285, DOI 10.1136/pgmj.2008.076711; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stengel D, 2001, BRIT J SURG, V88, P901, DOI 10.1046/j.0007-1323.2001.01777.x; UPADHYAYA P, 1968, SURG GYNECOL OBSTETR, V126, P781; Velmahos GC, 2010, ARCH SURG-CHICAGO, V145, P456, DOI 10.1001/archsurg.2010.58; Weber T, 1998, WORLD J SURG, V22, P883, DOI 10.1007/s002689900487	69	23	25	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g1864	10.1136/bmj.g1864	http://dx.doi.org/10.1136/bmj.g1864			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696170				2022-12-28	WOS:000333977000001
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA NHS England's winter campaign: is earlier better?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Mintel, 2009, MINTEL; NHS Choices, FEELING UNDER THE WE; NHS England, 2014, THE EARLIER THE BETT; NHS England, THE EVIDENCE BASE FR; NHS England, 2013, TRANSFORMING URGENT; NHS England, 2013, KEOGH URGENT AND EME; Pillay N, 2010, SELFCARE, V1, P105; Poole R, 2011, FAM PRACT, V28, P210, DOI 10.1093/fampra/cmq090; Purdy S, 2012, INTERVENTIONS TO PRE; Self Care Forum, SELF CARE THE STORY; Self Care Forum, ABOUT US; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub4	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2014	348								g2474	10.1136/bmj.g2474	http://dx.doi.org/10.1136/bmj.g2474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9MF	24682515				2022-12-28	WOS:000333588500011
J	Tan, SF; Wu, L; Yang, JKW; Bai, P; Bosman, M; Nijhuis, CA				Tan, Shu Fen; Wu, Lin; Yang, Joel K. W.; Bai, Ping; Bosman, Michel; Nijhuis, Christian A.			Quantum Plasmon Resonances Controlled by Molecular Tunnel Junctions	SCIENCE			English	Article							NANOPARTICLES; ENHANCEMENT; SCALE	Quantum tunneling between two plasmonic resonators links nonlinear quantum optics with terahertz nanoelectronics. We describe the direct observation of and control over quantum plasmon resonances at length scales in the range 0.4 to 1.3 nanometers across molecular tunnel junctions made of two plasmonic resonators bridged by self-assembled monolayers (SAMs). The tunnel barrier width and height are controlled by the properties of the molecules. Using electron energy-loss spectroscopy, we directly observe a plasmon mode, the tunneling charge transfer plasmon, whose frequency (ranging from 140 to 245 terahertz) is dependent on the molecules bridging the gaps.	[Tan, Shu Fen; Nijhuis, Christian A.] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Wu, Lin; Bai, Ping] ASTAR, Inst High Performance Comp, Singapore 138632, Singapore; [Yang, Joel K. W.; Bosman, Michel; Nijhuis, Christian A.] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore; [Yang, Joel K. W.] Singapore Univ Technol & Design, Singapore 138682, Singapore; [Nijhuis, Christian A.] Natl Univ Singapore, Graphene Res Ctr, Singapore 117542, Singapore; [Nijhuis, Christian A.] Natl Univ Singapore, Solar Energy Res Inst Singapore SERIS, Singapore 117574, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE); Singapore University of Technology & Design; National University of Singapore; National University of Singapore	Bai, P (corresponding author), ASTAR, Inst High Performance Comp, 1 Fusionopolis Way,16-16 Connexis North, Singapore 138632, Singapore.	baiping@ihpc.a-star.edu.sg; michel.bosman@gmail.com; christian.nijhuis@nus.edu.sg	Wu, Lin/GOE-3613-2022; Wu, Lin/AAZ-6876-2020; Bosman, Michel/AAW-3584-2020; Tan, Shu Fen/G-8636-2017; Yang, Joel K.W./L-7892-2016	Wu, Lin/0000-0002-3188-0640; Bosman, Michel/0000-0002-8717-7655; Tan, Shu Fen/0000-0003-4818-8885; Yang, Joel K.W./0000-0003-3301-1040; Bai, Ping/0000-0002-7363-6478	National Research Foundation (NRF) [NRF-CRP 8-2011-07]; Agency for Science, Technology and Research (A*STAR); TSRP grant [1021520014]	National Research Foundation (NRF); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); TSRP grant	We acknowledge the National Research Foundation (NRF) for supporting this research under the Competitive Research Programme (CRP) program (award NRF-CRP 8-2011-07). J.K.W.Y, P. B., and L. W. acknowledge the Agency for Science, Technology and Research (A*STAR) for the A*STAR Investigatorship Grant, and TSRP grant 1021520014.	Bosman M, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/16/165505; Bosman M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01312; Brongersma ML, 2010, SCIENCE, V328, P440, DOI 10.1126/science.1186905; Choi SH, 2008, SCIENCE, V320, P1482, DOI 10.1126/science.1156538; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; Cui XD, 2002, J PHYS CHEM B, V106, P8609, DOI 10.1021/jp0206065; Duan HG, 2012, NANO LETT, V12, P1683, DOI 10.1021/nl3001309; Esteban R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1806; Henzie J, 2013, P NATL ACAD SCI USA, V110, P6640, DOI 10.1073/pnas.1218616110; Joachim C, 2005, P NATL ACAD SCI USA, V102, P8801, DOI 10.1073/pnas.0500075102; Kern J, 2012, NANO LETT, V12, P5504, DOI 10.1021/nl302315g; Marinica DC, 2012, NANO LETT, V12, P1333, DOI 10.1021/nl300269c; McCreery RL, 2004, CHEM MATER, V16, P4477, DOI 10.1021/cm049517q; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Nijhuis CA, 2012, J PHYS CHEM C, V116, P14139, DOI 10.1021/jp303072a; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Romero I, 2006, OPT EXPRESS, V14, P9988, DOI 10.1364/OE.14.009988; Salomon A, 2003, ADV MATER, V15, P1881, DOI 10.1002/adma.200306091; Savage KJ, 2012, NATURE, V491, P574, DOI 10.1038/nature11653; Scholl JA, 2013, NANO LETT, V13, P564, DOI 10.1021/nl304078v; Song P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554420; Tame MS, 2013, NAT PHYS, V9, P329, DOI [10.1038/NPHYS2615, 10.1038/nphys2615]; Wu L, 2013, ACS NANO, V7, P707, DOI 10.1021/nn304970v; Wu SM, 2008, NAT NANOTECHNOL, V3, P569, DOI 10.1038/nnano.2008.237; Zuloaga J, 2009, NANO LETT, V9, P887, DOI 10.1021/nl803811g	25	346	351	23	497	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1496	1499		10.1126/science.1248797	http://dx.doi.org/10.1126/science.1248797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675958				2022-12-28	WOS:000333471000043
J	Kandel, ER; Dudai, Y; Mayford, MR				Kandel, Eric R.; Dudai, Yadin; Mayford, Mark R.			The Molecular and Systems Biology of Memory	CELL			English	Review							LONG-TERM POTENTIATION; MEDIAL-TEMPORAL-LOBE; SPONTANEOUS TRANSMITTER RELEASE; DEPENDENT SYNAPTIC PLASTICITY; ACTIVATED PROTEIN-KINASE; HIPPOCAMPAL PLACE CELLS; MOTOR NEURON SYNAPSES; SENSORY-MOTOR; HETEROSYNAPTIC FACILITATION; BEHAVIORAL SENSITIZATION	Learning and memory are two of the most magical capabilities of our mind. Learning is the biological process of acquiring new knowledge about the world, and memory is the process of retaining and reconstructing that knowledge over time. Most of our knowledge of the world and most of our skills are not innate but learned. Thus, we are who we are in large part because of what we have learned and what we remember and forget. In this Review, we examine the molecular, cellular, and circuit mechanisms that underlie how memories are made, stored, retrieved, and lost.	[Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Kavli Inst Brain Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Neurosci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; [Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Mayford, Mark R.] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Weizmann Institute of Science; Scripps Research Institute	Kandel, ER (corresponding author), Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Kavli Inst Brain Sci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu		Mayford, Mark/0000-0002-9001-5024	Howard Hughes Medical Institute; Center of Research Excellence in the Cognitive Sciences (I-CORE) of the Planning and Grants Committee; Israeli Science Foundation [51/11]; EP7 Human Brain Project; NIMH; NIDA	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Center of Research Excellence in the Cognitive Sciences (I-CORE) of the Planning and Grants Committee; Israeli Science Foundation(Israel Science Foundation); EP7 Human Brain Project; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	We thank the following colleagues for critical reading of this manuscript: Cristina Alberini, Tom Abrams, Craig Bailey, Blair Burns Potter, Cliff Kentros, Kelsey Martin, Richard Morris, Morris Moscovitch, and Alcino Silva. Thanks to Pauline Henick and Christina Doyle for typing and organizing the various versions of this review. E.R.K. is supported by the Howard Hughes Medical Institute. Y.D. is supported by the Center of Research Excellence in the Cognitive Sciences (I-CORE) of the Planning and Grants Committee and Israeli Science Foundation (Grant 51/11) and by the EP7 Human Brain Project. M.R.M. is supported by grants from NIMH and NIDA.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; ABRAMS TW, 1991, J NEUROSCI, V11, P2655; Albensi BC, 2000, SYNAPSE, V35, P151; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; ALKON DL, 1974, J GEN PHYSIOL, V64, P70, DOI 10.1085/jgp.64.1.70; [Anonymous], 1983, CANADIAN PSYCHOL; Antonov I, 2001, J NEUROSCI, V21, P6413, DOI 10.1523/JNEUROSCI.21-16-06413.2001; Antonov I, 2010, J NEUROSCI, V30, P5781, DOI 10.1523/JNEUROSCI.4947-09.2010; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Bao JX, 1998, J NEUROSCI, V18, P458; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BARR DS, 1995, J NEUROSCI, V15, P5402; BARTLETT EC, 1932, REMEMBERING STUDY EX; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Broadbent NJ, 2013, NEUROBIOL LEARN MEM, V106, P300, DOI 10.1016/j.nlm.2013.08.008; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; Burianova L, 2012, NEUROIMAGE, V63, P1343, DOI 10.1016/j.neuroimage.2012.07.057; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Cai DC, 2012, CURR BIOL, V22, P1783, DOI 10.1016/j.cub.2012.07.038; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; CAREW T, 1979, SCIENCE, V205, P417, DOI 10.1126/science.451611; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P435, DOI 10.1146/annurev.ne.09.030186.002251; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI V, 1976, SCIENCE, V194, P1176, DOI 10.1126/science.11560; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CASTELLUCCI VF, 1978, SCIENCE, V202, P1306, DOI 10.1126/science.214854; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen TE, 1997, J NEUROSCI, V17, P2886; Conway MA, 2001, J MEM LANG, V45, P493, DOI 10.1006/jmla.2001.2781; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; DALE N, 1993, P NATL ACAD SCI USA, V90, P7163, DOI 10.1073/pnas.90.15.7163; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS M, 1994, BRAIN RES, V664, P207, DOI 10.1016/0006-8993(94)91972-0; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; DUDAI Y, 1983, NEUROSCI LETT, V42, P207, DOI 10.1016/0304-3940(83)90408-1; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Dudek SM, 2002, P NATL ACAD SCI USA, V99, P3962, DOI 10.1073/pnas.062510599; Duncan K, 2012, SCIENCE, V337, P485, DOI 10.1126/science.1221936; Edelson M, 2011, SCIENCE, V333, P108, DOI 10.1126/science.1203557; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; ELIOT LS, 1994, J NEUROSCI, V14, P368; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; Glanzman DL, 2010, CURR BIOL, V20, pR31, DOI 10.1016/j.cub.2009.10.023; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; Goense J, 2012, NEURON, V76, P629, DOI 10.1016/j.neuron.2012.09.019; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Griffin AL, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00054; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hawkins RD, 2006, J NEUROSCI, V26, P2443, DOI 10.1523/JNEUROSCI.3294-05.2006; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HAWKINS RD, 1984, PSYCHOL REV, V91, P375, DOI 10.1037/0033-295X.91.3.375; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Izquierdo I, 2004, SCIENCE, V304, P829, DOI 10.1126/science.1098139; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jin I, 2012, P NATL ACAD SCI USA, V109, P9137, DOI 10.1073/pnas.1206846109; Jin I, 2012, P NATL ACAD SCI USA, V109, P9131, DOI 10.1073/pnas.1206914109; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANDEL ER, 1968, PHYSIOL REV, V48, P65, DOI 10.1152/physrev.1968.48.1.65; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Konorski J., 1948, CONDITIONED REFLEXES; KRASNE FB, 1969, J EXP BIOL, V50, P29; Kunec S, 2005, J NEUROPHYSIOL, V94, P70, DOI 10.1152/jn.00731.2004; KUPFERMANN I, 1969, SCIENCE, V164, P847, DOI 10.1126/science.164.3881.847; Landry CD, 2013, TRENDS NEUROSCI, V36, P535, DOI 10.1016/j.tins.2013.05.004; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee SH, 2007, CELL, V129, P801, DOI 10.1016/j.cell.2007.03.041; Lee SH, 2012, P NATL ACAD SCI USA, V109, P14200, DOI 10.1073/pnas.1211997109; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Lomo T., 1966, ACTA PHYSL SCAND, V68, P277; Lonergan MH, 2013, J PSYCHIATR NEUROSCI, V38, P222, DOI 10.1503/jpn.120111; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MENZEL R, 1978, SCI AM, V239, P102, DOI 10.1038/scientificamerican0778-102; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Milner B., 1965, PHYSL HIPPOCAMPE, P257; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Muller G. E., 1900, Z PSYCHOL, V1, pS1; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; Muzzio IA, 2009, J PHYSIOL-LONDON, V587, P2837, DOI 10.1113/jphysiol.2009.172445; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Puthanveettil S, 2011, RES PER ALZ, P143, DOI 10.1007/978-3-642-16602-0_13; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Race E, 2011, J NEUROSCI, V31, P10262, DOI 10.1523/JNEUROSCI.1145-11.2011; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Rissman J, 2012, ANNU REV PSYCHOL, V63, P101, DOI 10.1146/annurev-psych-120710-100344; Roediger H.L., 2007, SCI MEMORY CONCEPTS, DOI [10.1093/acprof:oso/9780195310443.001.0001, DOI 10.1093/ACPROF:OSO/9780195310443.001.0001]; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenbaum RS, 2008, J COGNITIVE NEUROSCI, V20, P1490, DOI 10.1162/jocn.2008.20105; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; SAHLEY C, 1981, J COMP PHYSIOL, V144, P1, DOI 10.1007/BF00612791; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schacher S, 1997, J NEUROSCI, V17, P597; Schacter D.L., 1994, MEMORY SYSTEMS, P39; Schacter DL, 2013, NAT NEUROSCI, V16, P119, DOI 10.1038/nn.3294; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shimamura AP, 2011, COGN AFFECT BEHAV NE, V11, P277, DOI 10.3758/s13415-011-0031-4; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; SPENCER WA, 1966, J NEUROPHYSIOL, V29, P253, DOI 10.1152/jn.1966.29.2.253; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Squire LR, 2009, NEURON, V61, P6, DOI 10.1016/j.neuron.2008.12.023; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Staresina BP, 2012, NAT NEUROSCI, V15, P1167, DOI 10.1038/nn.3154; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Suthana N, 2012, TRENDS COGN SCI, V16, P427, DOI 10.1016/j.tics.2012.06.006; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; THOMPSON RF, 1983, PROG PSYCHOB PHYSIOL, V10, P167; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tolman EC, 1938, PSYCHOL REV, V45, P1, DOI 10.1037/h0062733; Tompa P, 1998, NEUROSCIENCE, V86, P1037; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; TRUDEAU LE, 1993, J NEUROPHYSIOL, V70, P1221, DOI 10.1152/jn.1993.70.3.1221; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Viard A, 2010, HIPPOCAMPUS, V20, P153, DOI 10.1002/hipo.20601; von Hertzen LSJ, 2005, J NEUROSCI, V25, P1935, DOI 10.1523/JNEUROSCI.4707-04.2005; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Walker MP, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c1; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; Watrous AJ, 2013, NAT NEUROSCI, V16, P349, DOI 10.1038/nn.3315; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Wixted JT, 2011, TRENDS COGN SCI, V15, P210, DOI 10.1016/j.tics.2011.03.005; Won J, 2008, NEUROBIOL LEARN MEM, V89, P285, DOI 10.1016/j.nlm.2007.08.017; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhang YL, 2012, NAT NEUROSCI, V15, P294, DOI 10.1038/nn.2990; ZUCKER RS, 1971, SCIENCE, V173, P645, DOI 10.1126/science.173.3997.645	279	549	560	22	329	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 27	2014	157	1					163	186		10.1016/j.cell.2014.03.001	http://dx.doi.org/10.1016/j.cell.2014.03.001			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE4QW	24679534	Bronze			2022-12-28	WOS:000333968900015
J	Phoa, KN; van Vilsteren, FGI; Weusten, BLAM; Bisschops, R; Schoon, EJ; Ragunath, K; Fullarton, G; Di Pietro, M; Ravi, N; Visser, M; Offerhaus, GJ; Seldenrijk, CA; Meijer, SL; ten Kate, FJW; Tijssen, JGP; Bergman, JJGHM				Phoa, K. Nadine; van Vilsteren, Frederike G. I.; Weusten, Bas L. A. M.; Bisschops, Raf; Schoon, Erik J.; Ragunath, Krish; Fullarton, Grant; Di Pietro, Massimiliano; Ravi, Narayanasamy; Visser, Mike; Offerhaus, G. Johan; Seldenrijk, Cees A.; Meijer, Sybren L.; ten Kate, Fiebo J. W.; Tijssen, Jan G. P.; Bergman, Jacques J. G. H. M.			Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAEPITHELIAL NEOPLASIA; GENERAL-POPULATION; FOCAL ABLATION; ADENOCARCINOMA; PREVALENCE; RISK; PROGRESSION; MANAGEMENT; RESECTION; SYSTEM	IMPORTANCE Barrett esophagus containing low-grade dysplasia is associated with an increased risk of developing esophageal adenocarcinoma, a cancer with a rapidly increasing incidence in the western world. OBJECTIVE To investigate whether endoscopic radiofrequency ablation could decrease the rate of neoplastic progression. DESIGN, SETTING, AND PARTICIPANTS Multicenter randomized clinical trial that enrolled 136 patients with a confirmed diagnosis of Barrett esophagus containing low-grade dysplasia at 9 European sites between June 2007 and June 2011. Patient follow-up ended May 2013. INTERVENTIONS Eligible patients were randomly assigned in a 1: 1 ratio to either endoscopic treatment with radiofrequency ablation (ablation) or endoscopic surveillance (control). Ablation was performed with the balloon device for circumferential ablation of the esophagus or the focal device for targeted ablation, with a maximum of 5 sessions allowed. MAIN OUTCOMES AND MEASURES The primary outcome was neoplastic progression to high-grade dysplasia or adenocarcinoma during a 3-year follow-up since randomization. Secondary outcomes were complete eradication of dysplasia and intestinal metaplasia and adverse events. RESULTS Sixty-eight patients were randomized to receive ablation and 68 to receive control. Ablation reduced the risk of progression to high-grade dysplasia or adenocarcinoma by 25.0%(1.5% for ablation vs 26.5% for control; 95% CI, 14.1%-35.9%; P < .001) and the risk of progression to adenocarcinoma by 7.4% (1.5% for ablation vs 8.8% for control; 95% CI, 0%-14.7%; P = .03). Among patients in the ablation group, complete eradication occurred in 92.6% for dysplasia and 88.2% for intestinal metaplasia compared with 27.9% for dysplasia and 0.0% for intestinal metaplasia among patients in the control group (P < .001). Treatment-related adverse events occurred in 19.1% of patients receiving ablation (P < .001). The most common adverse event was stricture, occurring in 8 patients receiving ablation (11.8%), all resolved by endoscopic dilation (median, 1 session). The data and safety monitoring board recommended early termination of the trial due to superiority of ablation for the primary outcome and the potential for patient safety issues if the trial continued. CONCLUSIONS AND RELEVANCE In this randomized trial of patients with Barrett esophagus and a confirmed diagnosis of low-grade dysplasia, radiofrequency ablation resulted in a reduced risk of neoplastic progression over 3 years of follow-up.	[Phoa, K. Nadine; van Vilsteren, Frederike G. I.; Bergman, Jacques J. G. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; [Weusten, Bas L. A. M.] St Antonius Hosp, Dept Gastroenterol, Nieuwegein, Netherlands; [Bisschops, Raf] Katholieke Univ Leuven Hosp, Dept Gastroenterol, Louvain, Belgium; [Schoon, Erik J.] Catharina Hosp, Dept Gastroenterol, Eindhoven, Netherlands; [Ragunath, Krish] Queens Med Ctr, Dept Gastroenterol, Nottingham NG7 2UH, England; [Fullarton, Grant] Glasgow Royal Infirm, Dept Surg Gastroenterol, Glasgow G4 0SF, Lanark, Scotland; [Di Pietro, Massimiliano] Addenbrookes Hosp, MRC, Canc Unit, Cambridge, England; [Ravi, Narayanasamy] St James Hosp, Dept Clin Med & Gastroenterol, Dublin 8, Ireland; [Visser, Mike; Offerhaus, G. Johan; Meijer, Sybren L.; ten Kate, Fiebo J. W.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Seldenrijk, Cees A.] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands; [Tijssen, Jan G. P.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; St. Antonius Hospital Utrecht; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Catharina Hospital; University of Nottingham; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht; University of Amsterdam; Academic Medical Center Amsterdam	Bergman, JJGHM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.bergman@amc.uva.nl	Bergman, Jacques/AAS-2500-2021	Bisschops, Raf/0000-0002-9994-8226; Ragunath, Krish/0000-0001-6571-5435; Bergman, Jacques/0000-0001-7548-6955; Meijer, Sybren/0000-0002-6953-2406	Covidien GI Solutions; Maag Lever Darm Stichting grant from the Dutch Digestive Diseases Foundation [WO 07-60]	Covidien GI Solutions; Maag Lever Darm Stichting grant from the Dutch Digestive Diseases Foundation	This investigator-initiated trial was supported, in part, by Covidien GI Solutions (formerly BARRX Medical) and by the Maag Lever Darm Stichting grant WO 07-60 from the Dutch Digestive Diseases Foundation. Covidien GI Solutions provided ablation devices and access to a central electronic data management system.	Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Curvers WL, 2010, AM J GASTROENTEROL, V105, P1523, DOI 10.1038/ajg.2010.171; Fan XQ, 2009, DIGEST DIS SCI, V54, P572, DOI 10.1007/s10620-008-0395-7; Fleischer DE, 2010, ENDOSCOPY, V42, P781, DOI 10.1055/s-0030-1255779; Gondrie JJ, 2008, ENDOSCOPY, V40, P370, DOI 10.1055/s-2007-995589; Gondrie JJ, 2008, ENDOSCOPY, V40, P359, DOI 10.1055/s-2007-995567; Hayeck TJ, 2010, DIS ESOPHAGUS, V23, P451, DOI 10.1111/j.1442-2050.2010.01054.x; Hur C, 2012, GASTROENTEROLOGY, V143, P567, DOI 10.1053/j.gastro.2012.05.010; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Musana AK, 2008, AM J GASTROENTEROL, V103, P516, DOI 10.1111/j.1572-0241.2007.01599.x; Orman ES, 2013, CLIN GASTROENTEROL H, V11, P1245, DOI 10.1016/j.cgh.2013.03.039; Pech O, 2007, SCAND J GASTROENTERO, V42, P682, DOI 10.1080/00365520601075803; Phoa KN, 2013, GASTROENTEROLOGY, V145, P96, DOI 10.1053/j.gastro.2013.03.046; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Pouw RE, 2011, GASTROINTEST ENDOSC, V74, P35, DOI 10.1016/j.gie.2011.03.1243; Pouw RE, 2010, CLIN GASTROENTEROL H, V8, P23, DOI 10.1016/j.cgh.2009.07.003; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Sharma VK, 2007, GASTROINTEST ENDOSC, V65, P185, DOI 10.1016/j.gie.2006.09.033; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Srivastava A, 2007, AM J GASTROENTEROL, V102, P483, DOI 10.1111/j.1572-0241.2007.01073.x; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; van Vilsteren FGI, 2011, GUT, V60, P765, DOI 10.1136/gut.2010.229310; Vieth M, 2007, ENDOSCOPY, V39, P647, DOI 10.1055/s-2007-966638; Wani S, 2011, GASTROENTEROLOGY, V141, P1179, DOI 10.1053/j.gastro.2011.06.055	29	395	408	4	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1209	1217		10.1001/jama.2014.2511	http://dx.doi.org/10.1001/jama.2014.2511			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668102	Green Accepted			2022-12-28	WOS:000333340500024
J	Bomfleur, B; McLoughlin, S; Vajda, V				Bomfleur, Benjamin; McLoughlin, Stephen; Vajda, Vivi			Fossilized Nuclei and Chromosomes Reveal 180 Million Years of Genomic Stasis in Royal Ferns	SCIENCE			English	Article							OSMUNDA OSMUNDACEAE; ADDITIONAL EVIDENCE; SOUTHERN SWEDEN; PLANTS; SIZE; ANTARCTICA; POLYPLOIDY; VOLCANISM	Rapidly permineralized fossils can provide exceptional insights into the evolution of life over geological time. Here, we present an exquisitely preserved, calcified stem of a royal fern (Osmundaceae) from Early Jurassic lahar deposits of Sweden in which authigenic mineral precipitation from hydrothermal brines occurred so rapidly that it preserved cytoplasm, cytosol granules, nuclei, and even chromosomes in various stages of cell division. Morphometric parameters of interphase nuclei match those of extant Osmundaceae, indicating that the genome size of these reputed "living fossils" has remained unchanged over at least 180 million years-a paramount example of evolutionary stasis.	[Bomfleur, Benjamin; McLoughlin, Stephen] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden; [Vajda, Vivi] Lund Univ, Dept Geol, SE-22362 Lund, Sweden	Swedish Museum of Natural History; Lund University	Bomfleur, B (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, POB 50007, SE-10405 Stockholm, Sweden.	benjamin.bomfleur@nrm.se; steve.mcloughlin@nrm.se	Vajda, Vivi/N-7693-2018	Vajda, Vivi/0000-0003-2987-5559; Bomfleur, Benjamin/0000-0002-2186-4970	Swedish Research Council (VR); Lund University Carbon Cycle Centre (LUCCI); Royal Swedish Academy of Sciences	Swedish Research Council (VR)(Swedish Research Council); Lund University Carbon Cycle Centre (LUCCI); Royal Swedish Academy of Sciences	We thank E. M. Friis and S. Bengtson (Stockholm) and F. Marone and M. Stampanoni (Villigen) for assistance with SRXTM analyses at the Swiss Light Source, Paul Scherrer Institute (Villigen); G. Grimm (Stockholm) for assistance with statistical analyses; B. Bremer and G. Larsson (Stockholm) for providing live material of Osmunda; M. A. Gandolfo Nixon and J. L. Svitko (Ithaca, New York) for permission to use images from the Cornell University Plant Anatomy Collection (CUPAC; http://cupac.bh.cornell.edu/); the members of Tjornarps Sockengille (Tjornarp) for access to the fossil locality; A.-L. Decombeix (Montpellier), I. Bergelin (Lund), C. H. Haufler (Lawrence, Kansas), N. Tian (Shenyang), Y.-D. Wang (Nanjing), and T. E. Wood (Flagstaff, Arizona) for discussion; and two anonymous referees for constructive comments. This research was jointly supported by the Swedish Research Council (VR), Lund University Carbon Cycle Centre (LUCCI), and the Royal Swedish Academy of Sciences. The material is curated at the Swedish Museum of Natural History (Stockholm, Sweden) under accession nos. S069649 to S069658 and S089687 to S089693.	Ahlberg A., 2003, GEOL SURV DEN GREENL, V1, P527, DOI [DOI 10.34194/GEUSB.V1.4682, 10.34194/geusb.v1.4682]; Augustsson C, 2001, GFF, V123, P23, DOI 10.1080/11035890101231023; Barker MS, 2010, BIOSCIENCE, V60, P177, DOI 10.1525/bio.2010.60.3.4; Bergelin I, 2009, GFF, V131, P165, DOI 10.1080/11035890902851278; BRACKHANES SD, 1978, SCIENCE, V200, P1383, DOI 10.1126/science.200.4348.1383; DEMAGGIO AE, 1971, BIOSCIENCE, V21, P313, DOI 10.2307/1295880; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; HEWITSON WALTER, 1962, ANN MISSOURI BOT GARD, V49, P57, DOI 10.2307/2394741; Leitch I.J., 2013, PHYS STRUCTURE BEHAV, V2, P307, DOI [DOI 10.1007/978-3-7091-1160-4_19, DOI 10.1007/978-3-7091-1160-4_]; Lomax BH, 2014, NEW PHYTOL, V201, P636, DOI 10.1111/nph.12523; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MILLER C N JR, 1971, Contributions from the Museum of Paleontology University of Michigan, V23, P105; NIKLAS KJ, 1982, AM J BOT, V69, P325, DOI 10.2307/2443136; Phipps CJ, 1998, AM J BOT, V85, P888, DOI 10.2307/2446424; Rothwell GW, 2002, AM J BOT, V89, P352, DOI 10.3732/ajb.89.2.352; Serbet R, 1999, INT J PLANT SCI, V160, P425, DOI 10.1086/314134; Simova I, 2012, P ROY SOC B-BIOL SCI, V279, P867, DOI 10.1098/rspb.2011.1284; Tian Ning, 2008, Palaeoworld, V17, P183, DOI 10.1016/j.palwor.2008.10.004; Tsutsumi C, 2011, SYST BOT, V36, P836, DOI 10.1600/036364411X604859	19	89	95	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1376	1377		10.1126/science.1249884	http://dx.doi.org/10.1126/science.1249884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653037	Green Submitted			2022-12-28	WOS:000333108500044
J	Schiffrin, A; Paasch-Colberg, T; Karpowicz, N; Apalkov, V; Gerster, D; Muhlbrandt, S; Korbman, M; Reichert, J; Schultze, M; Holzner, S; Barth, JV; Kienberger, R; Ernstorfer, R; Yakovlev, VS; Stockman, MI; Krausz, F				Schiffrin, Agustin; Paasch-Colberg, Tim; Karpowicz, Nicholas; Apalkov, Vadym; Gerster, Daniel; Muehlbrandt, Sascha; Korbman, Michael; Reichert, Joachim; Schultze, Martin; Holzner, Simon; Barth, Johannes V.; Kienberger, Reinhard; Ernstorfer, Ralph; Yakovlev, Vladislav S.; Stockman, Mark I.; Krausz, Ferenc			Optical-field-induced current in dielectrics (vol 70, pg 493, 2013)	NATURE			English	Correction												agustin.schiffrin@mpq.mpg.de; mstockman@gsu.edu; ferenc.krausz@mpq.mpg.de	BARTH, Johannes V/E-4060-2013; Ernstorfer, Ralph/D-1590-2009	BARTH, Johannes V/0000-0002-6270-2150; Ernstorfer, Ralph/0000-0001-6665-3520; Kienberger, Reinhard/0000-0001-8781-3685				CHEMLA DS, 1987, PHYS REV LETT, V59, P1018, DOI 10.1103/PhysRevLett.59.1018; HU BB, 1991, PHYS REV LETT, V67, P2709, DOI 10.1103/PhysRevLett.67.2709; Krausz F, 2014, NAT PHOTONICS, V8, P205, DOI 10.1038/nphoton.2014.28; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Wachter G., 2014, PREPRINT; Wannier GH., 1960, ELEMENTS SOLID STATE; YABLONOVITCH E, 1989, PHYS REV LETT, V63, P976, DOI 10.1103/PhysRevLett.63.976; YAMANISHI M, 1987, PHYS REV LETT, V59, P1014, DOI 10.1103/PhysRevLett.59.1014; ZENER C, 1934, P ROYAL SOC, V145, P523, DOI DOI 10.1098/RSPA.1934.0116	10	9	9	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					386	387		10.1038/nature13077	http://dx.doi.org/10.1038/nature13077			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24647001	Bronze			2022-12-28	WOS:000333029000040
J	Solomon, SD; Saldana, F				Solomon, Scott D.; Saldana, Fidencio			Point-of-Care Ultrasound in Medical Education - Stop Listening and Look	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICAL-EXAMINATION		[Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Solomon, SD (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.							Forbes John, 1829, TREATISE DIS CHEST M; Kobal SL, 2005, AM J CARDIOL, V96, P1002, DOI 10.1016/j.amjcard.2005.05.060; Liebo MJ, 2011, ANN INTERN MED, V155, P33, DOI 10.7326/0003-4819-155-1-201107050-00005; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Mouratev G, 2013, TEACH LEARN MED, V25, P84, DOI 10.1080/10401334.2012.741535	5	164	170	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1083	1085		10.1056/NEJMp1311944	http://dx.doi.org/10.1056/NEJMp1311944			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD2HA	24645940				2022-12-28	WOS:000333054000003
J	Fu, Y; Tucciarone, JM; Espinosa, JS; Sheng, NY; Darcy, DP; Nicoll, RA; Huang, ZJ; Stryker, MP				Fu, Yu; Tucciarone, Jason M.; Espinosa, J. Sebastian; Sheng, Nengyin; Darcy, Daniel P.; Nicoll, Roger A.; Huang, Z. Josh; Stryker, Michael P.			A Cortical Circuit for Gain Control by Behavioral State	CELL			English	Article							CRITICAL-PERIOD PLASTICITY; CHOLINERGIC MODULATION; DISINHIBITORY MICROCIRCUIT; GABAERGIC NEURONS; VISUAL RESPONSES; CORTEX; INTERNEURONS; OSCILLATIONS; INTEGRATION; ATTENTION	The brain's response to sensory input is strikingly modulated by behavioral state. Notably, the visual response of mouse primary visual cortex (V1) is enhanced by locomotion, a tractable and accessible example of a time-locked change in cortical state. The neural circuits that transmit behavioral state to sensory cortex to produce this modulation are unknown. In vivo calcium imaging of behaving animals revealed that locomotion activates vasoactive intestinal peptide (VIP)-positive neurons in mouse V1 independent of visual stimulation and largely through nicotinic inputs from basal forebrain. Optogenetic activation of VIP neurons increased V1 visual responses in stationary awake mice, artificially mimicking the effect of locomotion, and photolytic damage of VIP neurons abolished the enhancement of V1 responses by locomotion. These findings establish a cortical circuit for the enhancement of visual response by locomotion and provide a potential common circuit for the modulation of sensory processing by behavioral state.	[Fu, Yu; Espinosa, J. Sebastian; Darcy, Daniel P.; Stryker, Michael P.] Univ Calif San Francisco, Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94158 USA; [Tucciarone, Jason M.; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tucciarone, Jason M.] SUNY Stony Brook, MSTP Neurosci Grad Program, Stony Brook, NY 11790 USA; [Sheng, Nengyin; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Sheng, Nengyin; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fu, Y (corresponding author), Univ Calif San Francisco, Ctr Integrat Neurosci, Dept Physiol, 675 Nelson Rising Rd, San Francisco, CA 94158 USA.	yufu@phy.ucsf.edu; stryker@phy.ucsf.edu		Huang, Z. Josh/0000-0003-0592-028X; Sheng, Nengyin/0000-0003-3086-3950; Tucciarone, Jason/0000-0002-6053-2952; Stryker, Michael/0000-0003-1546-5831	National Institute of Health [EY002874]; NATIONAL EYE INSTITUTE [P30EY002162, R37EY002874, R01EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256, R01MH094705] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Drs. Megumi Kaneko and Cristopher M. Niell for their insightful discussion and comments. This work was supported by the National Institute of Health grant EY002874 to M.P.S.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fontanini A, 2008, J NEUROPHYSIOL, V100, P1160, DOI 10.1152/jn.90592.2008; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; GARCIARILL E, 1991, PROG NEUROBIOL, V36, P363, DOI 10.1016/0301-0082(91)90016-T; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; METHERATE R, 1992, J NEUROSCI, V12, P4701; MINK JW, 1983, BEHAV BRAIN RES, V8, P85, DOI 10.1016/0166-4328(83)90173-0; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601	51	517	520	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1139	1152		10.1016/j.cell.2014.01.050	http://dx.doi.org/10.1016/j.cell.2014.01.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630718	Bronze, Green Accepted			2022-12-28	WOS:000332945100006
J	Ruland, J				Ruland, Juergen			Inflammasome: Putting the Pieces Together	CELL			English	Editorial Material							NF-KAPPA-B	Microbial and danger signals result in inflammasome activation and release of inflammatory cytokines through mechanisms that remain elusive. Cai et al. and Lu et al. show that triggering of inflammasome sensors induces prion-like polymerization of the adaptor ASC into filaments. These structures function as platforms for inflammatory cytokine production and represent a unified mechanism for inflammasome assembly.	Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany	Technical University of Munich	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany.	jruland@lrz.tum.de	Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597				Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040	9	26	27	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1127	1129		10.1016/j.cell.2014.02.038	http://dx.doi.org/10.1016/j.cell.2014.02.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630715	Bronze			2022-12-28	WOS:000332945100003
J	Schmick, M; Bastiaens, PIH				Schmick, Malte; Bastiaens, Philippe I. H.			The Interdependence of Membrane Shape and Cellular Signal Processing	CELL			English	Review							SPATIAL-ORGANIZATION; GROWTH CONE; PROTEIN; KINASE; CHEMOTAXIS; INHIBITION; ACTIVATION; DIFFUSION; NETWORKS; RECEPTOR	Cellular membranes are constantly reshaped by vesicular fission and fusion as well as by interactions with the dynamic cytoskeleton. Signaling activity at membranes depends on their geometric parameters, such as surface area and curvature; these affect local concentration and thereby regulate the potency of molecular reactions. A membrane's shape is thus inextricably tied to information processing. Here, we review how a trinity of signaling, cytoskeletal dynamics, and membrane shape interact within a closed-loop causality that gives rise to an energy-consuming, self-organized system that changes shape to sense the extracellular environment.	[Schmick, Malte; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	Max Planck Society	Bastiaens, PIH (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de						Adam G., 1968, STRUCTURAL CHEM MOL, P198; AXELROD D, 1994, BIOPHYS J, V66, P588, DOI 10.1016/S0006-3495(94)80834-3; Bouzigues C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009243; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dehmelt L, 2010, NAT REV MOL CELL BIO, V11, P440, DOI 10.1038/nrm2903; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Fukura H, 1996, J NEUROCHEM, V67, P1426; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; PESACH D, 1987, LANGMUIR, V3, P519, DOI 10.1021/la00076a013; Rangamani P, 2013, CELL, V154, P1356, DOI 10.1016/j.cell.2013.08.026; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Zamir E., 2013, VESICLE TRAFFICKING, P57; Ziemba BP, 2013, CHEM PHYS LIPIDS, V172, P67, DOI 10.1016/j.chemphyslip.2013.04.005; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	33	94	95	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1132	1138		10.1016/j.cell.2014.02.007	http://dx.doi.org/10.1016/j.cell.2014.02.007			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630717	Bronze			2022-12-28	WOS:000332945100005
J	Colley, DG; Bustinduy, AL; Secor, E; King, CH				Colley, Daniel G.; Bustinduy, Amaya L.; Secor, Evan; King, Charles H.			Human schistosomiasis	LANCET			English	Article							REAL-TIME PCR; PLASMODIUM-FALCIPARUM; HAEMATOBIUM INFECTION; MANSONI INFECTION; IN-VIVO; INTESTINAL SCHISTOSOMIASIS; UROGENITAL SCHISTOSOMIASIS; POLYPARASITIC INFECTIONS; GENITAL SCHISTOSOMIASIS; COGNITIVE IMPAIRMENT	Human schistosomiasis-or bilharzia-is a parasitic disease caused by trematode flukes of the genus Schistosoma. By conservative estimates, at least 230 million people worldwide are infected with Schistosoma spp. Adult schistosome worms colonise human blood vessels for years, successfully evading the immune system while excreting hundreds to thousands of eggs daily, which must either leave the body in excreta or become trapped in nearby tissues. Trapped eggs induce a distinct immune-mediated granulomatous response that causes local and systemic pathological effects ranging from anaemia, growth stunting, impaired cognition, and decreased physical fitness, to organ-specific effects such as severe hepatosplenism, periportal fibrosis with portal hypertension, and urogenital inflammation and scarring. At present, preventive public health measures in endemic regions consist of treatment once every 1 or 2 years with the isoquinolinone drug, praziquantel, to suppress morbidity. In some locations, elimination of transmission is now the goal; however, more sensitive diagnostics are needed in both the field and clinics, and integrated environmental and health-care management will be needed to ensure elimination.	[Colley, Daniel G.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Colley, Daniel G.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Bustinduy, Amaya L.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Secor, Evan] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [King, Charles H.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA; Case Western Reserve University	Colley, DG (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 500 Brooks Dr,Room 330B, Athens, GA 30602 USA.	dcolley@uga.edu		King, Charles/0000-0001-8349-9270; Colley, Daniel/0000-0002-9381-8420; Bustinduy, Amaya/0000-0001-6131-4159	University of Georgia Research Foundation - Bill & Melinda Gates Foundation for the SCORE project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053695] Funding Source: NIH RePORTER	University of Georgia Research Foundation - Bill & Melinda Gates Foundation for the SCORE project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are extremely grateful for the administrative and editorial contributions of Tammy Andros. The writing of this Seminar received financial support from the University of Georgia Research Foundation, which was funded by the Bill & Melinda Gates Foundation for the SCORE project and the authors' individual institutions. The funders had no role in the writing of this Seminar. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Abbasi I, 2010, AM J TROP MED HYG, V83, P427, DOI 10.4269/ajtmh.2010.09-0764; Allan F, 2013, ACTA TROP, V128, P234, DOI 10.1016/j.actatropica.2013.01.003; Baker MC, 2010, LANCET, V375, P231, DOI 10.1016/S0140-6736(09)61458-6; Barrett J, 2009, PARASITOLOGY, V136, P1633, DOI 10.1017/S003118200900568X; Betson M, 2012, AM J TROP MED HYG, V87, P694, DOI 10.4269/ajtmh.2012.12-0059; Bourke CD, 2013, J INFECT DIS, V208, P159, DOI 10.1093/infdis/jis524; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; BRINDLEY PJ, 1987, J IMMUNOL, V139, P215; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Bustinduy AL, 2013, AM J TROP MED HYG, V88, P433, DOI 10.4269/ajtmh.12-0552; Bustinduy AL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001213; Cao J, 2010, WORLD J GASTROENTERO, V16, P723, DOI 10.3748/wjg.v16.i6.723; Carabin H, 2005, AM J TROP MED HYG, V72, P745, DOI 10.4269/ajtmh.2005.72.745; CHABASSE D, 1985, B SOC PATHOL EXOT, V78, P643; CHEEVER AW, 1968, AM J TROP MED HYG, V17, P38, DOI 10.4269/ajtmh.1968.17.38; Chen JJ, 2013, BIOMED MICRODEVICES, V15, P261, DOI 10.1007/s10544-012-9728-6; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; COLLEY DG, 1986, AM J TROP MED HYG, V35, P793, DOI 10.4269/ajtmh.1986.35.793; Coutinho HM, 2006, J NUTR, V136, P183, DOI 10.1093/jn/136.1.183; Dai JR, 2008, PARASITOL RES, V103, P405, DOI 10.1007/s00436-008-0988-2; Danso-Appiah A, 2002, TRENDS PARASITOL, V18, P125, DOI 10.1016/S1471-4922(01)02209-7; Dawson VK, 2002, J AGR FOOD CHEM, V50, P6780, DOI 10.1021/jf020443h; del Villar Perez L, 2012, PLOS ONE, V7; DESTIGTER KV, 1989, T ASSOC AM PHYSICIAN, V102, P209; DeVlas SJ, 1997, PARASITOLOGY, V114, P113, DOI 10.1017/S0031182096008207; DOEHRINGSCHWERDTFEGER E, 1990, AM J TROP MED HYG, V42, P581, DOI 10.4269/ajtmh.1990.42.581; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0; DOENHOFF MJ, 1991, PARASITOL TODAY, V7, P16, DOI 10.1016/0169-4758(91)90079-4; Downs JA, 2012, AM J TROP MED HYG, V87, P868, DOI 10.4269/ajtmh.2012.12-0395; ELOISANTOS SM, 1989, J CLIN INVEST, V84, P1028, DOI 10.1172/JCI114225; Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540; Ezeamama AE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001634; Fairfax K, 2012, SEMIN IMMUNOPATHOL, V34, P863, DOI 10.1007/s00281-012-0354-4; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Fitzsimmons CM, 2012, INFECT IMMUN, V80, P4264, DOI 10.1128/IAI.00641-12; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Friedman JF, 2005, AM J TROP MED HYG, V72, P527, DOI 10.4269/ajtmh.2005.72.527; Giboda M, 1999, PARASITOL TODAY, V15, P307, DOI 10.1016/S0169-4758(99)01487-8; Gower CM, 2013, ACTA TROP, V128, P261, DOI 10.1016/j.actatropica.2012.09.014; GRYSEELS B, 1992, TROP GEOGR MED, V44, P189; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Gurarie D, 2011, AM J TROP MED HYG, V84, P773, DOI 10.4269/ajtmh.2011.10-0642; Gutman J, 2008, ANN TROP MED PARASIT, V102, P335, DOI 10.1179/136485908X278810; Hamburger J, 2004, AM J TROP MED HYG, V71, P765, DOI 10.4269/ajtmh.2004.71.765; HSU HF, 1965, NATURE, V206, P1338, DOI 10.1038/2061338a0; Huang SCC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002996; Huyse T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000571; Ibironke O, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001464; Jordan P., 1985, SCHISTOSOMIASIS ST L; Jourdan PM, 2013, INT J GYNECOL PATHOL, V32, P137, DOI 10.1097/PGP.0b013e31824fe327; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Kallestrup P, 2005, J INFECT DIS, V192, P1956, DOI 10.1086/497696; Karanja DMS, 2002, LANCET, V360, P592, DOI 10.1016/S0140-6736(02)09781-7; KATZ N, 1991, AM J TROP MED HYG, V44, P509, DOI 10.4269/ajtmh.1991.44.509; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keating JH, 2006, J PARASITOL, V92, P1365, DOI 10.1645/GE-864R.1; Kenawy ER, 2004, MACROMOL BIOSCI, V4, P119, DOI 10.1002/mabi.200300003; KEYSTONE JS, 1978, AM J TROP MED HYG, V27, P360, DOI 10.4269/ajtmh.1978.27.360; Khalaf I, 2012, WORLD J UROL, V30, P31, DOI 10.1007/s00345-011-0751-7; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; KING CH, 1988, AM J TROP MED HYG, V39, P361, DOI 10.4269/ajtmh.1988.39.361; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; King CH, 2006, TRENDS PARASITOL, V22, P575, DOI 10.1016/j.pt.2006.09.006; King CH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001321; King CL, 1998, J IMMUNOL, V160, P3578; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Knopp S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-930; Lambertucci JR, 2000, ACTA TROP, V77, P101, DOI 10.1016/S0001-706X(00)00124-8; LAWSON JR, 1980, PARASITOLOGY, V81, P337, DOI 10.1017/S0031182000056079; Leenstra T, 2006, AM J CLIN NUTR, V83, P371; Leutscher P, 2000, LANCET, V355, P117, DOI 10.1016/S0140-6736(99)04856-4; Leutscher PDC, 2005, J INFECT DIS, V191, P1639, DOI 10.1086/429334; Leutscher PDC, 2009, ACTA TROP, V109, P41, DOI 10.1016/j.actatropica.2008.09.010; Li You-Zi, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P35; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Mbabazi PS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001396; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Mitchell KM, 2012, P NATL ACAD SCI USA, V109, P13347, DOI 10.1073/pnas.1121051109; Mitchell KM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002237; MOHAMED ARE, 1990, GUT, V31, P439, DOI 10.1136/gut.31.4.439; Montresor A, 2001, T ROY SOC TROP MED H, V95, P542, DOI 10.1016/S0035-9203(01)90034-3; Mupfasoni D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000517; NDAMBA J, 1993, ANN TROP MED PARASIT, V87, P553, DOI 10.1080/00034983.1993.11812810; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Oliveira EC, 2000, ECOTOX ENVIRON SAFE, V46, P342, DOI 10.1006/eesa.2000.1924; Olives C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001806; Olson CL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000533; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Pelletreau S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001380; PETERSON WP, 1965, J IMMUNOL, V95, P959; Pierrot C, 2006, INFECT IMMUN, V74, P3347, DOI 10.1128/IAI.01724-05; PROIETTI FA, 1989, INT J EPIDEMIOL, V18, P680, DOI 10.1093/ije/18.3.680; Pullan RL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000352; Reimert CA, 2006, CLIN VACCINE IMMUNOL, V13, P584, DOI 10.1128/CVI.13.5.584-593.2006; Richards FO, 2006, B WORLD HEALTH ORGAN, V84, P673, DOI 10.2471/BLT.06.029652; Richter J, 1998, TROP MED INT HEALTH, V3, P728, DOI 10.1046/j.1365-3156.1998.00285.x; Rollinson D, 2013, ACTA TROP, V128, P423, DOI 10.1016/j.actatropica.2012.04.013; Rollinson David, 2009, Parasitology, V136, P1801, DOI 10.1017/S0031182009990412; Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1; Ross AG, 2012, J NEUROL, V259, P22, DOI 10.1007/s00415-011-6133-7; Salem N, 2010, PLOS NEGLECT TROP D, P4; SAVIOLI L, 1990, AM J TROP MED HYG, V43, P289, DOI 10.4269/ajtmh.1990.43.289; SCHWARTZ DA, 1981, TROP GEOGR MED, V33, P1; Secor WE, 2003, INFECT IMMUN, V71, P6668, DOI 10.1128/IAI.71.11.6668-6671.2003; Shane HL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000951; Simoonga C, 2009, PARASITOLOGY, V136, P1683, DOI 10.1017/S0031182009006222; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Sousa-Figueiredo JC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001864; Sousa-Figueiredo JC, 2012, INT HEALTH, V4, P95, DOI 10.1016/j.inhe.2012.03.003; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stothard JR, 2013, TRENDS PARASITOL, V29, P197, DOI 10.1016/j.pt.2013.02.001; Stothard JR, 2011, PARASITOLOGY, V138, P1593, DOI 10.1017/S0031182011001235; Strauss Edna, 2002, Ann Hepatol, V1, P6; Sturrock HJW, 2010, AM J TROP MED HYG, V82, P1079, DOI 10.4269/ajtmh.2010.09-0702; Sturrock RF., 2001, SCHISTOSOMIASIS; Takougang I, 2007, ANN TROP MED PARASIT, V101, P479, DOI 10.1179/136485907X193833; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Terer CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002106; Tsang VCW, 1997, IMMUNOL INVEST, V26, P175, DOI 10.3109/08820139709048925; Utzinger J, 2000, LANCET, V355, P1320, DOI 10.1016/S0140-6736(00)02114-0; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105; VANOORDT BEP, 1985, MOL BIOCHEM PARASIT, V16, P117, DOI 10.1016/0166-6851(85)90080-5; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walson J, 2012, LANCET INFECT DIS, V12, P925, DOI 10.1016/S1473-3099(12)70207-4; Walter K, 2006, J IMMUNOL, V177, P5490, DOI 10.4049/jimmunol.177.8.5490; Wamachi AN, 2004, J INFECT DIS, V190, P2020, DOI 10.1086/425579; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; WARREN KS, 1974, AM J TROP MED HYG, V23, P902, DOI 10.4269/ajtmh.1974.23.902; WARREN KS, 1973, J INFECT DIS, V127, P595, DOI 10.1093/infdis/127.5.595; WHO, 1991, 2 WHO EXP COMM; WHO, 2012, SCHIST PROGR REP 200; WHO, 1995, ID HIGH RISK COMM SC; WHO, 2010, REP M REV RES STUD, P13; WHO, 1985, CONTR SCHIST REP WHO; WHO, 2013, PREV CHEM DAT; WHO, 2006, PREV CHEM HUM HELM C; Wichmann D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-55; Wilson RA, 2009, PARASITOLOGY, V136, P1581, DOI 10.1017/S0031182009005708; Wilson S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001149; Wilson S, 2010, T ROY SOC TROP MED H, V104, P110, DOI 10.1016/j.trstmh.2009.08.006; YASURAOKA K, 1989, JPN J EXP MED, V59, P149; Yole DS, 1996, PARASITOLOGY, V112, P37, DOI 10.1017/S0031182000065057; Zaki A A, 1971, East Afr Med J, V48, P218; Zerlotini A, 2013, NUCLEIC ACIDS RES, V41, pD728, DOI 10.1093/nar/gks1087	148	1304	1402	9	263	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2253	2264		10.1016/S0140-6736(13)61949-2	http://dx.doi.org/10.1016/S0140-6736(13)61949-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK8DO	24698483	Green Accepted			2022-12-28	WOS:000338657600030
J	Adams, DH; Popma, JJ; Reardon, MJ; Yakubov, SJ; Coselli, JS; Deeb, GM; Gleason, TG; Buchbinder, M; Hermiller, J; Kleiman, NS; Chetcuti, S; Heiser, J; Merhi, W; Zorn, G; Tadros, P; Robinson, N; Petrossian, G; Hughes, GC; Harrison, JK; Conte, J; Maini, B; Mumtaz, M; Chenoweth, S; Oh, JK				Adams, David H.; Popma, Jeffrey J.; Reardon, Michael J.; Yakubov, Steven J.; Coselli, Joseph S.; Deeb, G. Michael; Gleason, Thomas G.; Buchbinder, Maurice; Hermiller, James, Jr.; Kleiman, Neal S.; Chetcuti, Stan; Heiser, John; Merhi, William; Zorn, George; Tadros, Peter; Robinson, Newell; Petrossian, George; Hughes, G. Chad; Harrison, J. Kevin; Conte, John; Maini, Brijeshwar; Mumtaz, Mubashir; Chenoweth, Sharla; Oh, Jae K.		US CoreValve Clinical Investigator	Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACADEMIC RESEARCH CONSORTIUM; HIGH-RISK PATIENTS; THORACIC SURGEONS; IMPLANTATION; STENOSIS; OUTCOMES; REGURGITATION; METAANALYSIS; DEFINITIONS; SOCIETY	BackgroundWe compared transcatheter aortic-valve replacement (TAVR), using a self-expanding transcatheter aortic-valve bioprosthesis, with surgical aortic-valve replacement in patients with severe aortic stenosis and an increased risk of death during surgery. MethodsWe recruited patients with severe aortic stenosis who were at increased surgical risk as determined by the heart team at each study center. Risk assessment included the Society of Thoracic Surgeons Predictor Risk of Mortality estimate and consideration of other key risk factors. Eligible patients were randomly assigned in a 1:1 ratio to TAVR with the self-expanding transcatheter valve (TAVR group) or to surgical aortic-valve replacement (surgical group). The primary end point was the rate of death from any cause at 1 year, evaluated with the use of both noninferiority and superiority testing. ResultsA total of 795 patients underwent randomization at 45 centers in the United States. In the as-treated analysis, the rate of death from any cause at 1 year was significantly lower in the TAVR group than in the surgical group (14.2% vs. 19.1%), with an absolute reduction in risk of 4.9 percentage points (upper boundary of the 95% confidence interval, -0.4; P<0.001 for noninferiority; P = 0.04 for superiority). The results were similar in the intention-to-treat analysis. In a hierarchical testing procedure, TAVR was noninferior with respect to echocardiographic indexes of valve stenosis, functional status, and quality of life. Exploratory analyses suggested a reduction in the rate of major adverse cardiovascular and cerebrovascular events and no increase in the risk of stroke. ConclusionsIn patients with severe aortic stenosis who are at increased surgical risk, TAVR with a self-expanding transcatheter aortic-valve bioprosthesis was associated with a significantly higher rate of survival at 1 year than surgical aortic-valve replacement. (Funded by Medtronic; U.S. CoreValve High Risk Study ClinicalTrials.gov number, NCT01240902.) Transcatheter aortic-valve replacement with a new self-expanding prosthesis was compared with surgical aortic-valve replacement in patients with aortic stenosis who were at high surgical risk. The rate of death from any cause at 1 year was lower in the TAVR group. Aortic stenosis is a debilitating disease in elderly persons that carries a dismal prognosis after symptom onset.(1) Although surgical aortic-valve replacement remains the standard treatment for aortic stenosis,(2) many patients are not suitable candidates for surgical replacement owing to an increased risk of death during surgery.(3),(4) Transcatheter aortic-valve replacement (TAVR) with a balloon-expandable device improves survival, as compared with medical therapy, in patients with severe aortic stenosis who cannot undergo surgery.(5) Balloon-expandable TAVR and surgical aortic-valve replacement are associated with similar survival rates at 1 year among patients considered to be at high surgical risk, although the frequency of ...	[Adams, David H.] Mt Sinai Med Ctr, New York, NY USA; [Robinson, Newell; Petrossian, George] St Francis Hosp, Roslyn, NY USA; [Popma, Jeffrey J.] Beth Israel Deaconess Med Ctr, Boston, MA 02460 USA; [Reardon, Michael J.; Kleiman, Neal S.] Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Coselli, Joseph S.] Texas Heart Inst, St Lukes Med Ctr, Houston, TX 77025 USA; [Yakubov, Steven J.] Riverside Methodist Hosp, Columbus, OH 43214 USA; [Deeb, G. Michael; Chetcuti, Stan] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Hermiller, James, Jr.; Merhi, William] Spectrum Hlth Hosp, Grand Rapids, MI USA; [Gleason, Thomas G.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Buchbinder, Maurice] Palo Alto Vet Affairs Med Ctr, Palo Alto, CA USA; [Heiser, John] St Vincents Med Ctr, Indianapolis, IN USA; [Zorn, George; Tadros, Peter] Univ Kansas Hosp, Kansas City, KS 66160 USA; [Hughes, G. Chad; Harrison, J. Kevin] Duke Univ, Med Ctr, Durham, NC USA; [Conte, John] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Maini, Brijeshwar; Mumtaz, Mubashir] Pinnacle Hlth, Harrisburg, PA USA; [Chenoweth, Sharla] Medtronic, Minneapolis, MN USA; [Oh, Jae K.] Mayo Clin Fdn, Rochester, MN USA	Icahn School of Medicine at Mount Sinai; Harvard University; Beth Israel Deaconess Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Texas Heart Institute; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kansas; University of Kansas Medical Center; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Medtronic; Mayo Clinic	Popma, JJ (corresponding author), Beth Israel Deaconess Med Ctr, Intervent Cardiol Serv, 185 Pilgrim Rd, Boston, MA 02460 USA.	jpopma@bidmc.harvard.edu	Crestanello, Juan/E-2930-2011; Doğan, Ali/AAN-5331-2020; Reardon, Michael/ABF-8880-2021		Medtronic; St. Jude Medical; Boston Scientific; Abbott Vascular; Edwards Lifesciences	Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); Boston Scientific(Boston Scientific); Abbott Vascular(Abbott Laboratories); Edwards Lifesciences	Supported by Medtronic.; Dr. Adams reports receiving royalties through his institution from Medtronic for a patent related to a triscupid-valve annuloplasty ring and from Edwards Lifesciences for a patent related to degenerative valvular disease-specific annuloplasty rings. Dr. Popma reports receiving honoraria from Boston Scientific, Abbott Vascular, and St. Jude Medical for participation on medical advisory boards. Drs. Reardon and Conte report receiving honoraria from Medtronic for participation on a surgical advisory board. Dr. Yakubov reports receiving honoraria from Medtronic. Dr. Coselli reports receiving consulting fees from St. Jude Medical. Dr. Deeb reports serving on an unpaid advisory board for Medtronic. Dr. Hermiller reports receiving consulting fees from Medtronic, Boston Scientific, Abbott Vascular, and St. Jude Medical. Dr. Kleiman reports receiving fees through his institution from Medtronic for didactic training sessions. Dr. Chetcuti reports receiving consulting fees from Medtronic and Edwards Lifesciences. Dr. Tadros reports receiving consulting fees from Medtronic and St. Jude Medical. Dr. Hughes reports receiving consulting and lecture fees from Medtronic. Dr. Harrison reports receiving fees for serving on clinical-events committees from Edwards Lifesciences and Direct Flow Medical. Dr. Maini reports receiving lecture fees from Medtronic, St. Jude Medical, and Abbott Vascular. Ms. Chenoweth reports being an employee of Medtronic. No other potential conflict of interest relevant to this article was reported.	Athappan G, 2013, J AM COLL CARDIOL, V61, P1585, DOI 10.1016/j.jacc.2013.01.047; Binder RK, 2013, J AM COLL CARDIOL, V62, P431, DOI 10.1016/j.jacc.2013.04.036; Bonow RO, 2007, J AM COLL CARDIOL, V49, P1014; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Green P, 2012, JACC-CARDIOVASC INTE, V5, P974, DOI 10.1016/j.jcin.2012.06.011; Hahn RT, 2013, J AM COLL CARDIOL, V61, P2514, DOI 10.1016/j.jacc.2013.02.087; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Holmes DR, 2011, J AM COLL CARDIOL, V58, P445, DOI 10.1016/j.jacc.2011.05.007; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Popma JJ, 2014, J AM COLL CARDIOL; Schaff HV, 2011, NEW ENGL J MED, V364, P2256, DOI 10.1056/NEJMe1103978; Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533	21	1912	1950	0	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1790	1798		10.1056/NEJMoa1400590	http://dx.doi.org/10.1056/NEJMoa1400590			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24678937				2022-12-28	WOS:000335997900007
J	Jenkins, HE; Tolman, AW; Yuen, CM; Parr, JB; Keshavjee, S; Perez-Velez, CM; Pagano, M; Becerra, MC; Cohen, T				Jenkins, Helen E.; Tolman, Arielle W.; Yuen, Courtney M.; Parr, Jonathan B.; Keshavjee, Salmaan; Perez-Velez, Carlos M.; Pagano, Marcello; Becerra, Mercedes C.; Cohen, Ted			Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates	LANCET			English	Review							CHILDHOOD TUBERCULOSIS; UNIVERSAL ACCESS; XPERT MTB/RIF; SURVEILLANCE; DIAGNOSIS; BURDEN; TRENDS	Background Multidrug-resistant tuberculosis threatens to reverse recent reductions in global tuberculosis incidence. Although children younger than 15 years constitute more than 25% of the worldwide population, the global incidence of multidrug-resistant tuberculosis disease in children has never been quantified. We aimed to estimate the regional and global annual incidence of multidrug-resistant tuberculosis in children. Methods We developed two models: one to estimate the setting-specific risk of multidrug-resistant tuberculosis among child cases of tuberculosis, and a second to estimate the setting-specific incidence of tuberculosis disease in children. The model for risk of multidrug-resistant tuberculosis among children with tuberculosis needed a systematic literature review. We multiplied the setting-specific estimates of multidrug-resistant tuberculosis risk and tuberculosis incidence to estimate regional and global incidence of multidrug-resistant tuberculosis disease in children in 2010. Findings We identified 3403 papers, of which 97 studies met inclusion criteria for the systematic review of risk of multidrug-resistant tuberculosis. 31 studies reported the risk of multidrug-resistant tuberculosis in both children and treatment-naive adults with tuberculosis and were used for evaluation of the linear association between multidrug-resistant disease risk in these two patient groups. We identified that the setting-specific risk of multidrug-resistant tuberculosis was nearly identical in children and treatment-naive adults with tuberculosis, consistent with the assertion that multidrug-resistant disease in both groups reflects the local risk of transmitted multidrug-resistant tuberculosis. After application of these calculated risks, we estimated that around 999 792 (95% CI 937 877-1 055 414) children developed tuberculosis disease in 2010, of whom 31 948 (25 594-38 663) had multidrug-resistant disease. Interpretation Our estimates underscore that many cases of tuberculosis and multidrug-resistant tuberculosis disease are not being detected in children. Future estimates can be refined as more and better tuberculosis data and new diagnostic instruments become available.	[Jenkins, Helen E.; Parr, Jonathan B.; Keshavjee, Salmaan; Becerra, Mercedes C.; Cohen, Ted] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Tolman, Arielle W.; Yuen, Courtney M.; Parr, Jonathan B.; Keshavjee, Salmaan; Becerra, Mercedes C.] Harvard Univ, Dept Global Hlth & Social Med, Sch Med, Boston, MA 02115 USA; [Parr, Jonathan B.; Keshavjee, Salmaan; Perez-Velez, Carlos M.; Becerra, Mercedes C.] Partners In Hlth, Boston, MA USA; [Perez-Velez, Carlos M.] Univ Arizona, Coll Med, Banner Good Samaritan Med Ctr, Phoenix, AZ USA; [Pagano, Marcello] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Banner Research; Banner Health; University of Arizona; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Becerra, MC (corresponding author), Harvard Univ, Dept Global Hlth & Social Med, Sch Med, 641 Huntington Ave, Boston, MA 02115 USA.	mbecerra@post.harvard.edu		Jenkins, Helen/0000-0003-4749-1591; Cohen, Ted/0000-0002-8091-7198; Keshavjee, Salmaan/0000-0002-6967-3305; Yuen, Courtney/0000-0002-5219-2599; Parr, Jonathan/0000-0002-4465-9830	US National Institutes of Health; Helmut Wolfgang Schumann Fellowship in Preventive Medicine at Harvard Medical School; Norman E Zinberg Fellowship at Harvard Medical School; Doris and Howard Hiatt Residency in Global Health Equity and Internal Medicine at the Brigham and Women's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI102944, R01AI097015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmut Wolfgang Schumann Fellowship in Preventive Medicine at Harvard Medical School; Norman E Zinberg Fellowship at Harvard Medical School; Doris and Howard Hiatt Residency in Global Health Equity and Internal Medicine at the Brigham and Women's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	US National Institutes of Health, the Helmut Wolfgang Schumann Fellowship in Preventive Medicine at Harvard Medical School, the Norman E Zinberg Fellowship at Harvard Medical School, and the Doris and Howard Hiatt Residency in Global Health Equity and Internal Medicine at the Brigham and Women's Hospital.	Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Brent AJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/865436; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cohen T, 2008, AM J RESP CRIT CARE, V177, P1302, DOI 10.1164/rccm.200801-175PP; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Fathoala B, 2006, ARCH DIS CHILD, V91, P900, DOI 10.1136/adc.2005.083170; Feldacker C, 2012, TROP MED INT HEALTH, V17, P1108, DOI 10.1111/j.1365-3156.2012.03041.x; Galtung Hansen O., 1955, TUBERCULOSIS MORTALI; Kapata N, 2013, J TROP PEDIATRICS, V59, P134, DOI 10.1093/tropej/fms065; Keshavjee S, 2010, INT J TUBERC LUNG D, V14, P1222; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Khazaei HA, 2005, EUR J EPIDEMIOL, V20, P879, DOI 10.1007/s10654-005-2152-y; Lestari T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-784; Migliori GB, 2007, EUROSURVEILLANCE, V12, P5, DOI DOI 10.2807/ESW.12.20.03194-EN; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Rutherford ME, 2012, TROP MED INT HEALTH, V17, P1264, DOI 10.1111/j.1365-3156.2012.03053.x; Seddon JA, 2012, TUBERCULOSIS, V92, P9, DOI 10.1016/j.tube.2011.11.001; Skrahina A, 2012, EUR RESPIR J, V39, P1425, DOI 10.1183/09031936.00145411; TheWorld Bank, WORLD DEVELOPMENT IN; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; United Nations, 2013, WORLD POPULATION PRO; Van Rie A, 2013, LANCET GLOB HEALTH, V1, pE60, DOI 10.1016/S2214-109X(13)70049-4; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, 2010 GLOBAL REPORT O; WHO, 1989, EXPANDED PROGRAM ON; Zignol M, 2013, EUR RESPIR J, V42, P701, DOI 10.1183/09031936.00175812	33	218	227	7	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1572	1579		10.1016/S0140-6736(14)60195-1	http://dx.doi.org/10.1016/S0140-6736(14)60195-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24671080	Green Accepted			2022-12-28	WOS:000335495400028
J	Annaluru, N; Muller, H; Mitchell, LA; Ramalingam, S; Stracquadanio, G; Richardson, SM; Dymond, JS; Kuang, Z; Scheifele, LZ; Cooper, EM; Cai, YZ; Zeller, K; Agmon, N; Han, JS; Hadjithomas, M; Tullman, J; Caravelli, K; Cirelli, K; Guo, ZY; London, V; Yeluru, A; Murugan, S; Kandavelou, K; Agier, N; Fischer, G; Yang, K; Martin, JA; Bilgel, M; Bohutski, P; Boulier, KM; Capaldo, BJ; Chang, J; Charoen, K; Choi, WJ; Deng, P; DiCarlo, JE; Doong, J; Dunn, J; Feinberg, JI; Fernandez, C; Floria, CE; Gladowski, D; Hadidi, P; Ishizuka, I; Jabbari, J; Lau, CYL; Lee, PA; Li, S; Lin, D; Linder, ME; Ling, J; Liu, J; Liu, J; London, M; Ma, H; Mao, J; McDade, JE; McMillan, A; Moore, AM; Oh, WC; Ouyang, Y; Patel, R; Paul, M; Paulsen, LC; Qiu, J; Rhee, A; Rubashkin, MG; Soh, IY; Sotuyo, NE; Srinivas, V; Suarez, A; Wong, A; Wong, R; Xie, WR; Xu, YJ; Yu, AT; Koszul, R; Bader, JS; Boeke, JD; Chandrasegaran, S				Annaluru, Narayana; Muller, Heloise; Mitchell, Leslie A.; Ramalingam, Sivaprakash; Stracquadanio, Giovanni; Richardson, Sarah M.; Dymond, Jessica S.; Kuang, Zheng; Scheifele, Lisa Z.; Cooper, Eric M.; Cai, Yizhi; Zeller, Karen; Agmon, Neta; Han, Jeffrey S.; Hadjithomas, Michalis; Tullman, Jennifer; Caravelli, Katrina; Cirelli, Kimberly; Guo, Zheyuan; London, Viktoriya; Yeluru, Apurva; Murugan, Sindurathy; Kandavelou, Karthikeyan; Agier, Nicolas; Fischer, Gilles; Yang, Kun; Martin, J. Andrew; Bilgel, Murat; Bohutski, Pavlo; Boulier, Kristin M.; Capaldo, Brian J.; Chang, Joy; Charoen, Kristie; Choi, Woo Jin; Deng, Peter; DiCarlo, James E.; Doong, Judy; Dunn, Jessilyn; Feinberg, Jason I.; Fernandez, Christopher; Floria, Charlotte E.; Gladowski, David; Hadidi, Pasha; Ishizuka, Isabel; Jabbari, Javaneh; Lau, Calvin Y. L.; Lee, Pablo A.; Li, Sean; Lin, Denise; Linder, Matthias E.; Ling, Jonathan; Liu, Jaime; Liu, Jonathan; London, Mariya; Ma, Henry; Mao, Jessica; McDade, Jessica E.; McMillan, Alexandra; Moore, Aaron M.; Oh, Won Chan; Ouyang, Yu; Patel, Ruchi; Paul, Marina; Paulsen, Laura C.; Qiu, Judy; Rhee, Alex; Rubashkin, Matthew G.; Soh, Ina Y.; Sotuyo, Nathaniel E.; Srinivas, Venkatesh; Suarez, Allison; Wong, Andy; Wong, Remus; Xie, Wei Rose; Xu, Yijie; Yu, Allen T.; Koszul, Romain; Bader, Joel S.; Boeke, Jef D.; Chandrasegaran, Srinivasan			Total Synthesis of a Functional Designer Eukaryotic Chromosome	SCIENCE			English	Article							MYCOPLASMA-GENITALIUM GENOME; CHEMICAL-SYNTHESIS; YEAST; DNA; RECOMBINATION; PLASMID; CLONING; GENES; SITES	Rapid advances in DNA synthesis techniques have made it possible to engineer viruses, biochemical pathways and assemble bacterial genomes. Here, we report the synthesis of a functional 272,871-base pair designer eukaryotic chromosome, synIII, which is based on the 316,617-base pair native Saccharomyces cerevisiae chromosome III. Changes to synIII include TAG/TAA stop-codon replacements, deletion of subtelomeric regions, introns, transfer RNAs, transposons, and silent mating loci as well as insertion of loxPsym sites to enable genome scrambling. SynIII is functional in S. cerevisiae. Scrambling of the chromosome in a heterozygous diploid reveals a large increase in a-mater derivatives resulting from loss of the MAT alpha allele on synIII. The complete design and synthesis of synIII establishes S. cerevisiae as the basis for designer eukaryotic genome biology.	[Annaluru, Narayana; Muller, Heloise; Ramalingam, Sivaprakash; Cirelli, Kimberly; Guo, Zheyuan; London, Viktoriya; Yeluru, Apurva; Kandavelou, Karthikeyan; Chandrasegaran, Srinivasan] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Muller, Heloise; Mitchell, Leslie A.; Stracquadanio, Giovanni; Dymond, Jessica S.; Kuang, Zheng; Scheifele, Lisa Z.; Cooper, Eric M.; Cai, Yizhi; Zeller, Karen; Agmon, Neta; Caravelli, Katrina; Yang, Kun; Martin, J. Andrew; Bader, Joel S.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Muller, Heloise; Koszul, Romain] Inst Pasteur, Dept Genomes Genet, Grp Spatial Regulat Genomes, F-75015 Paris, France; [Muller, Heloise; Koszul, Romain] CNRS, UMR 3525, F-75015 Paris, France; [Mitchell, Leslie A.; Agmon, Neta; Boeke, Jef D.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Stracquadanio, Giovanni; Richardson, Sarah M.; Tullman, Jennifer; Murugan, Sindurathy; Yang, Kun; Martin, J. Andrew; Bader, Joel S.] Johns Hopkins Univ, Whiting Sch Engn, Dept Biomed Engn, Baltimore, MD 21218 USA; [Stracquadanio, Giovanni; Richardson, Sarah M.; Tullman, Jennifer; Murugan, Sindurathy; Yang, Kun; Martin, J. Andrew; Bader, Joel S.] Johns Hopkins Univ, Whiting Sch Engn, Inst Med Genet, Baltimore, MD 21218 USA; [Dymond, Jessica S.] Johns Hopkins Univ, Appl Phys Lab, Biol Sci Res & Exploratory Dev Dept, Laurel, MD 20723 USA; [Scheifele, Lisa Z.] Loyola Univ Maryland, Dept Biol, Baltimore, MD 21210 USA; [Cai, Yizhi] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Han, Jeffrey S.] Carnegie Inst Sci, Baltimore, MD 21218 USA; [Hadjithomas, Michalis; Deng, Peter; Boeke, Jef D.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Caravelli, Katrina; Cirelli, Kimberly; Boulier, Kristin M.; Feinberg, Jason I.; Fernandez, Christopher; Floria, Charlotte E.; Gladowski, David; Ishizuka, Isabel; Jabbari, Javaneh; Lin, Denise; Linder, Matthias E.; London, Mariya; McMillan, Alexandra; Moore, Aaron M.; Paul, Marina; Soh, Ina Y.; Sotuyo, Nathaniel E.; Xie, Wei Rose; Yu, Allen T.] Johns Hopkins Univ, Krieger Sch Arts & Sci, Baltimore, MD 21218 USA; [Guo, Zheyuan; London, Viktoriya; Yeluru, Apurva; Bilgel, Murat; Bohutski, Pavlo; Capaldo, Brian J.; Chang, Joy; Charoen, Kristie; Choi, Woo Jin; DiCarlo, James E.; Doong, Judy; Dunn, Jessilyn; Hadidi, Pasha; Lau, Calvin Y. L.; Lee, Pablo A.; Li, Sean; Ling, Jonathan; Liu, Jaime; Liu, Jonathan; Ma, Henry; Mao, Jessica; McDade, Jessica E.; Oh, Won Chan; Ouyang, Yu; Patel, Ruchi; Paulsen, Laura C.; Qiu, Judy; Rhee, Alex; Rubashkin, Matthew G.; Srinivas, Venkatesh; Suarez, Allison; Wong, Andy; Wong, Remus; Xu, Yijie] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD 21218 USA; [Kandavelou, Karthikeyan] Pondicherry Biotech Private Ltd, Pillaichavady 605014, Puducherry, India; [Agier, Nicolas; Fischer, Gilles] Univ Paris 06, Sorbonne Univ, UMR 7238, F-75005 Paris, France; [Agier, Nicolas; Fischer, Gilles] CNRS, UMR 7238, F-75005 Paris, France	Johns Hopkins University; Johns Hopkins University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); New York University; NYU Langone Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Loyola University Maryland; University of Edinburgh; Carnegie Institution for Science; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jef.boeke@nyumc.org; schandra@jhsph.edu	Stracquadanio, Giovanni/AAL-2648-2021; Bilgel, Murat/T-8645-2017; C, WJ/ABD-5987-2021; Fischer, Gilles/Q-4603-2019; Kuang, Zheng/ABG-3667-2021; Fischer, Gilles/G-6654-2016; DiCarlo, James/AAJ-1579-2021; Cai, Yizhi/A-3550-2010	Stracquadanio, Giovanni/0000-0001-9819-3645; Bilgel, Murat/0000-0001-5042-7422; Fischer, Gilles/0000-0001-5732-2682; DiCarlo, James/0000-0003-4728-3186; Pan, Deng/0000-0002-7061-9744; Yang, Kun/0000-0002-1060-8082; Mitchell, Leslie/0000-0001-7869-9817; McDade, Jessica/0000-0003-2260-7113; /0000-0003-3023-592X; Agmon, Neta/0000-0002-2590-3033; Liu, Jonathan/0000-0002-5761-8704; Ling, Jonathan/0000-0003-1927-9729; Guo, Zheyuan/0000-0003-0944-7813; Cai, Yizhi/0000-0003-1663-2865; Yu, Allen/0000-0002-1842-857X; Koszul, Romain/0000-0002-3086-1173; Richardson, Sarah/0000-0002-9820-9421; Capaldo, Brian/0000-0003-1244-8884; Scheifele, Lisa/0000-0003-1400-6895	NSF [MCB 0718846]; Microsoft; NIH [GM077291]; Fondation pour la Recherche Medicale and a Pasteur-Roux fellowship; Maryland Stem Cell Research Fund; National Sciences and Engineering Research Council of Canada; U.S. Department of Energy; JHU Applied Physics Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077291, R01GM090192] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1441866, 1443299] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Microsoft(Microsoft); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale and a Pasteur-Roux fellowship(Fondation pour la Recherche Medicale); Maryland Stem Cell Research Fund; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Department of Energy(United States Department of Energy (DOE)); JHU Applied Physics Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from NSF (MCB 0718846) to J.D.B., J.S.B., and S.C. and from Microsoft to J.S.B.S.M. and S.C. were supported by a grant from NIH (GM077291 to S.C.); H. Muller, by a fellowship from Fondation pour la Recherche Medicale and a Pasteur-Roux fellowship; S.R., by an Exploratory Research Grant from the Maryland Stem Cell Research Fund; L.A.M., by a fellowship from the National Sciences and Engineering Research Council of Canada; S.M.R., by a fellowship from the U.S. Department of Energy; and J.S.D., by a fellowship from JHU Applied Physics Laboratory. We thank D. Gibson for helpful suggestions regarding the isothermal assembly reaction, E. Louis and D. Gottschling for advice on synthetic telomere design, and L. Teytelman and J. Rine for advice on silent cassette DNA. The synIII sequences have been deposited at GenBank with accession numbers KJ463385 (the as-designed reference sequence version 3.3_41) and KC880027 (the actual physical sequence in strain HMSY011, sequence version 3.3_42). The authors declare no competing financial interests. Requests for materials should be addressed to J.D.B. (boekej01@nyumc.org). We dedicate this publication to the memory of Har Gobind Khorana, who synthesized the first yeast tRNA gene. N. Annaluru, H. Muller, J.S.B., J.D.B., and S.C. designed experiments. J.D.B. and S.M.R. designed synIII. N. Annaluru, H.M., L.A.M., S.R., G.S., S.M.R., J.S.D., Z.K., Y.C., Z.G., V.L., S.M., K.K., N. Agmon, G.F., and S.C. performed experiments. N. Annaluru, H.M., G.S., R.K., J.D.B., and S.C. analyzed data. N. Annaluru, H.M., J.D.B., and S.C. wrote the manuscript. JHU Build-A-Genome course students (K. Caravelli, K. Cirelli, Z.G., V.L., A.Y., M.B., P.B., K.M.B., B.J.C., J.C., K. Charoen, W.J.C., P.D., J.E.D., J. Doong, J. Dunn, J.I.F., C. F., C. E. F., D. G., P. H., I. I., J. J., C.Y.L.L., P.A.L., S.L., D.L., M.E.L., J. Ling, Jaime Liu, Jonathan Liu, M.L., H.Ma, J.M., J.E.M., A.M., A.M.M., W.C.O., Y.O., R.P., M.P., L.C.P., J.Q., A.R., M.G.R., I.Y.S., N.E.S., V.S., A.S., A.W., R.W., W.R.X., Y.X., A.T.Y.) synthesized most of the building blocks for synIII; H. Muller, G.S., S.M.R., J.S.D., L.Z.S., E.M.C., Y.C., K.Z., J.S.H., M.H., J.T. and J.D.B. taught the Build-A-Genome course. S.C. led the effort on the construction and assembly of synIII.	Annaluru Narayana, 2012, Methods Mol Biol, V852, P77, DOI 10.1007/978-1-61779-564-0_7; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Dymond J, 2012, BIOENGINEERED, V3, P168, DOI 10.4161/bbug.19543; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Larionov V, 1996, P NATL ACAD SCI USA, V93, P491, DOI 10.1073/pnas.93.1.491; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Muller Heloise, 2012, Methods Mol Biol, V852, P133, DOI 10.1007/978-1-61779-564-0_11; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	26	340	381	6	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					55	58		10.1126/science.1249252	http://dx.doi.org/10.1126/science.1249252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24674868	Green Accepted			2022-12-28	WOS:000333746100050
J	Iess, L; Stevenson, DJ; Parisi, M; Hemingway, D; Jacobson, RA; Lunine, JI; Nimmo, F; Armstrong, JW; Asmar, SW; Ducci, M; Tortora, P				Iess, L.; Stevenson, D. J.; Parisi, M.; Hemingway, D.; Jacobson, R. A.; Lunine, J. I.; Nimmo, F.; Armstrong, J. W.; Asmar, S. W.; Ducci, M.; Tortora, P.			The Gravity Field and Interior Structure of Enceladus	SCIENCE			English	Article							WATER RESERVOIR; SOUTH-POLE; PLUME	The small and active Saturnian moon Enceladus is one of the primary targets of the Cassini mission. We determined the quadrupole gravity field of Enceladus and its hemispherical asymmetry using Doppler data from three spacecraft flybys. Our results indicate the presence of a negative mass anomaly in the south-polar region, largely compensated by a positive subsurface anomaly compatible with the presence of a regional subsurface sea at depths of 30 to 40 kilometers and extending up to south latitudes of about 50 degrees. The estimated values for the largest quadrupole harmonic coefficients (10(6)J(2) = 5435.2 +/- 34.9, 10(6)C(22) = 1549.8 +/- 15.6, 1 sigma) and their ratio (J(2)/C-22 = 3.51 +/- 0.05) indicate that the body deviates mildly from hydrostatic equilibrium. The moment of inertia is around 0.335MR(2), where M is the mass and R is the radius, suggesting a differentiated body with a low-density core.	[Iess, L.; Parisi, M.; Ducci, M.] Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerospaziale, I-00184 Rome, Italy; [Stevenson, D. J.] CALTECH, Pasadena, CA 91125 USA; [Hemingway, D.; Nimmo, F.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Jacobson, R. A.; Armstrong, J. W.; Asmar, S. W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Lunine, J. I.] Cornell Univ, Dept Astron, Ithaca, NY 14850 USA; [Tortora, P.] Univ Bologna, Dipartimento Ingn Ind, I-47121 Forli, Italy	Sapienza University Rome; California Institute of Technology; University of California System; University of California Santa Cruz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; University of Bologna	Iess, L (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerospaziale, Via Eudossiana 18, I-00184 Rome, Italy.	luciano.iess@uniroma1.it	IESS, Luciano/F-4902-2011; Hemingway, Douglas/F-6332-2014; Tortora, Paolo/J-6191-2012	IESS, Luciano/0000-0002-6230-5825; Hemingway, Douglas/0000-0001-5617-207X; Tortora, Paolo/0000-0001-9259-7673; Lunine, Jonathan/0000-0003-2279-4131; Ducci, Marco/0000-0003-2586-1037	Italian Space Agency; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA))	L.I., M.P., M.D., and P.T. acknowledge support from the Italian Space Agency. D.H., F.N., and J.I.L. are grateful to NASA for support through the Cassini Project. The work of R.A.J., J.W.A., and S.W.A. was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. The Doppler data and ancillary information used in this analysis are archived in NASA's Planetary Data System.	Bland MT, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052736; Giese B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036149; Hedman MM, 2013, NATURE, V500, P182, DOI 10.1038/nature12371; Howett CJA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003718; Iess L, 2012, SCIENCE, V337, P457, DOI 10.1126/science.1219631; Iess L, 2010, SCIENCE, V327, P1367, DOI 10.1126/science.1182583; Lu W, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017004; McKinnon WB, 2013, J GEOPHYS RES-PLANET, V118, P1775, DOI 10.1002/jgre.20122; Meyer J, 2007, ICARUS, V188, P535, DOI 10.1016/j.icarus.2007.03.001; Nimmo F, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003835; OJAKANGAS GW, 1986, ICARUS, V66, P341, DOI 10.1016/0019-1035(86)90163-6; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Postberg F, 2011, NATURE, V474, P620, DOI 10.1038/nature10175; Rambaux N, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041465; Roberts JH, 2008, ICARUS, V194, P675, DOI 10.1016/j.icarus.2007.11.010; Schubert G, 2007, ICARUS, V188, P345, DOI 10.1016/j.icarus.2006.12.012; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217; Tobie G, 2008, ICARUS, V196, P642, DOI 10.1016/j.icarus.2008.03.008; Wisdom J, 2004, ASTRON J, V128, P484, DOI 10.1086/421360; Zhang K, 2009, ICARUS, V204, P597, DOI 10.1016/j.icarus.2009.07.007	21	221	227	0	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					78	80		10.1126/science.1250551	http://dx.doi.org/10.1126/science.1250551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700854				2022-12-28	WOS:000333746100055
J	Hall, CN; Reynell, C; Gesslein, B; Hamilton, NB; Mishra, A; Sutherland, BA; O'Farrell, FM; Buchan, AM; Lauritzen, M; Attwell, D				Hall, Catherine N.; Reynell, Clare; Gesslein, Bodil; Hamilton, Nicola B.; Mishra, Anusha; Sutherland, Brad A.; O'Farrell, Fergus M.; Buchan, Alastair M.; Lauritzen, Martin; Attwell, David			Capillary pericytes regulate cerebral blood flow in health and disease	NATURE			English	Article							IN-VIVO; NEURONAL-ACTIVITY; ISCHEMIC-STROKE; BRAIN; CELLS; STIMULATION; REPERFUSION; GLYCOLYSIS; PERFUSION; DIAMETER	Increases in brain blood flow, evoked by neuronal activity, power neural computation and form the basis of BOLD(blood-oxygen-level-dependent) functional imaging. Whether blood flow is controlled solely by arteriole smooth muscle, or also by capillary pericytes, is controversial. We demonstrate that neuronal activity and the neurotransmitter glutamate evoke the release of messengers that dilate capillaries by actively relaxing pericytes. Dilation is mediated by prostaglandin E-2, but requires nitric oxide release to suppress vasoconstricting 20-HETE synthesis. In vivo, when sensory input increases blood flow, capillaries dilate before arterioles and are estimated to produce 84% of the blood flow increase. In pathology, ischaemia evokes capillary constriction by pericytes. We show that this is followed by pericyte death in rigor, which may irreversibly constrict capillaries and damage the blood-brain barrier. Thus, pericytes are major regulators of cerebral blood flow and initiators of functional imaging signals. Prevention of pericyte constriction and death may reduce the long-lasting blood flow decrease that damages neurons after stroke.	[Hall, Catherine N.; Reynell, Clare; Hamilton, Nicola B.; Mishra, Anusha; O'Farrell, Fergus M.; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Gesslein, Bodil; Lauritzen, Martin] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Gesslein, Bodil; Lauritzen, Martin] Univ Copenhagen, Ctr Hlth Aging, DK-2200 Copenhagen N, Denmark; [Sutherland, Brad A.; Buchan, Alastair M.] Univ Oxford, Radcliffe Dept Med, Acute Stroke Programme, Oxford OX3 9DU, England; [Lauritzen, Martin] Glostrup Univ Hosp, Dept Clin Neurophysiol, DK-2600 Glostrup, Denmark	University of London; University College London; University of Copenhagen; University of Copenhagen; University of Oxford; University of Copenhagen	Attwell, D (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	mlauritz@sund.ku.dk; d.attwell@ucl.ac.uk	Mishra, Anusha/AAR-6128-2020; Hamilton-Whitaker, Nicola/H-8867-2012; Hall, Catherine/A-5802-2016; Sutherland, Brad/AAX-2725-2020; Buchan, Alastair M/B-9095-2009; Hall, Catherine/AAK-9652-2020; Sutherland, Brad/J-3920-2014; Attwell, David/ABE-6750-2020	Hamilton-Whitaker, Nicola/0000-0002-0168-8068; Hall, Catherine/0000-0002-2316-7714; Sutherland, Brad/0000-0002-0791-0950; Buchan, Alastair M/0000-0002-2918-5200; Hall, Catherine/0000-0002-2316-7714; reynell, clare/0000-0003-2733-3334; Mishra, Anusha/0000-0002-3642-5049; Gesslein, Bodil/0000-0001-6698-8603; Lauritzen, Martin/0000-0002-1517-1131; O'Farrell, Fergus/0000-0002-7378-9175	Fondation Leducq; European Research Council; Wellcome Trust; UK Medical Research Council; Rosetrees Trust; Nordea Foundation via the Center for Healthy Aging; Lundbeck Foundation; NOVO-Nordisk Foundation; Danish Medical Research Council; Medical Research Council [1075001, G0500495] Funding Source: researchfish	Fondation Leducq(Leducq Foundation); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); Nordea Foundation via the Center for Healthy Aging; Lundbeck Foundation(Lundbeckfonden); NOVO-Nordisk Foundation(Novo Nordisk Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank B. Clark, A. Gibb, A. Gourine, C. Howarth, R. Jolivet, C. Madry, P. Mobbs, B. Richardson and A. Silver for comments on the manuscript. This work was supported by the Fondation Leducq, European Research Council, Wellcome Trust, UK Medical Research Council, Rosetrees Trust, Nordea Foundation via the Center for Healthy Aging, the Lundbeck Foundation, NOVO-Nordisk Foundation and Danish Medical Research Council.	Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; BAIRD AE, 1994, STROKE, V25, P79, DOI 10.1161/01.STR.25.1.79; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; Crawford C, 2012, NEPHRON PHYSIOL, V120, P17, DOI 10.1159/000339110; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gupta R, 2013, J NEUROINTERV SURG, V5, P294, DOI 10.1136/neurintsurg-2011-010245; Hall CN, 2008, J PHYSIOL-LONDON, V586, P3597, DOI 10.1113/jphysiol.2008.154724; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Harrison TC, 2009, J NEUROSCI METH, V182, P211, DOI 10.1016/j.jneumeth.2009.06.021; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; Iadecola C, 1997, J NEUROPHYSIOL, V78, P651, DOI 10.1152/jn.1997.78.2.651; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH266, DOI 10.1152/ajpheart.1989.257.1.H266; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Lovick TA, 1999, NEUROSCIENCE, V92, P47, DOI 10.1016/S0306-4522(98)00737-4; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Mathiesen C, 2013, J CEREBR BLOOD F MET, V33, P161, DOI 10.1038/jcbfm.2012.175; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; PETERS BP, 1979, EXP CELL RES, V120, P321, DOI 10.1016/0014-4827(79)90392-6; Puro DG, 2007, MICROCIRCULATION, V14, P1, DOI 10.1080/10739680601072099; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schulte ML, 2003, BRAIN RES, V963, P81, DOI 10.1016/S0006-8993(02)03848-9; SEREBRYAKOV V, 1994, PROSTAGLANDINS, V47, P353, DOI 10.1016/0090-6980(94)90053-1; Vates GE, 2010, NAT MED, V16, P959, DOI 10.1038/nm0910-959; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	50	1040	1066	6	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					55	+		10.1038/nature13165	http://dx.doi.org/10.1038/nature13165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670647	Green Submitted, Green Accepted			2022-12-28	WOS:000333609900041
J	Pace, LE; Keating, NL				Pace, Lydia E.; Keating, Nancy L.			A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							AGE 40 YEARS; RANDOMIZED-TRIAL; FOLLOW-UP; MAMMOGRAPHY; WOMEN; MORTALITY; HEALTH; OVERDIAGNOSIS; PROSTATE; DENSITY	IMPORTANCE Breast cancer is the second leading cause of cancer deaths among US women. Mammography screening may be associated with reduced breast cancer mortality but can also cause harm. Guidelines recommend individualizing screening decisions, particularly for younger women. OBJECTIVES We reviewed the evidence on the mortality benefit and chief harms of mammography screening and what is known about how to individualize mammography screening decisions, including communicating risks and benefits to patients. EVIDENCE ACQUISITION We searched MEDLINE from 1960-2014 to describe (1) benefits of mammography, (2) harms of mammography, and (3) individualizing screening decisions and promoting informed decision making. We also manually searched reference lists of key articles retrieved, selected reviews, meta-analyses, and practice recommendations. We rated the level of evidence using the American Heart Association guidelines. RESULTS Mammography screening is associated with a 19% overall reduction of breast cancer mortality (approximately 15% for women in their 40s and 32% for women in their 60s). For a 40- or 50-year-old woman undergoing 10 years of annual mammograms, the cumulative risk of a false-positive result is about 61%. About 19% of the cancers diagnosed during that 10-year period would not have become clinically apparent without screening (overdiagnosis), although there is uncertainty about this estimate. The net benefit of screening depends greatly on baseline breast cancer risk, which should be incorporated into screening decisions. Decision aids have the potential to help patients integrate information about risks and benefits with their own values and priorities, although they are not yet widely available for use in clinical practice. CONCLUSIONS AND RELEVANCE To maximize the benefit of mammography screening, decisions should be individualized based on patients' risk profiles and preferences. Risk models and decision aids are useful tools, but more research is needed to optimize these and to further quantify overdiagnosis. Research should also explore other breast cancer screening strategies.	[Pace, Lydia E.] Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02115 USA; [Keating, Nancy L.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Keating, Nancy L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Keating, NL (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	keating@hcp.med.harvard.edu			Global Women's Health Fellowship at Brigham and Women's Hospital	Global Women's Health Fellowship at Brigham and Women's Hospital	Dr Pace's work on this review was funded by the Global Women's Health Fellowship at Brigham and Women's Hospital.	Alamo-Junquera D, 2012, EUR J PUBLIC HEALTH, V22, P404, DOI 10.1093/eurpub/ckr057; Albada A, 2009, PATIENT EDUC COUNS, V77, P155, DOI 10.1016/j.pec.2009.03.005; Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.012077; Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; Ayer T, 2012, OPER RES, V60, P1019, DOI 10.1287/opre.1110.1019; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Barrett B, 2011, FAM MED, V43, P248; Bastardis-Zakas K, 2010, CLIN EXP OBSTET GYN, V37, P278; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Brodersen J, 2013, ANN FAM MED, V11, P106, DOI 10.1370/afm.1466; Burman ML, 1999, ANN INTERN MED, V131, P1, DOI 10.7326/0003-4819-131-1-199907060-00002; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Canadian Task Force on Preventing Health Care, 2013, SCREEN BREAST CANC S; Champion V, 2003, PREV MED, V36, P150, DOI 10.1016/S0091-7435(02)00038-5; Champion V, 2007, PATIENT EDUC COUNS, V65, P416, DOI 10.1016/j.pec.2006.09.014; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Cummings SR, 2009, JNCI-J NATL CANCER I, V101, P384, DOI 10.1093/jnci/djp018; Edwards AGK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub3; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Espasa R, 2012, J CANCER EDUC, V27, P780, DOI 10.1007/s13187-012-0349-9; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Fitzpatrick-Lewis D, 2011, BREAST CANC SCREENIN; Gail M, 1998, J CLIN ONCOL, V16, P3105, DOI 10.1200/JCO.1998.16.9.3105; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2001, J NATL CANCER I, V93, P334, DOI 10.1093/jnci/93.5.334; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Gotzsche PC, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727-a; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317; Hafslund B, 2012, CANC NURS, V35, P26; Hanoch Y, 2004, J HEALTH COMMUN, V9, P327, DOI 10.1080/10810730490468496; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Howlader N., 2013, SEER CANC STAT REV C; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Jibaja-Weiss ML, 2003, PATIENT EDUC COUNS, V50, P123; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Lipkus IM, 2001, HEALTH COMMUN, V13, P205, DOI 10.1207/S15327027HC1302_5; Magnus MC, 2011, J WOMENS HEALTH, V20, P845, DOI 10.1089/jwh.2010.2098; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Marmot MG, 2013, JAMA-J AM MED ASSOC, V309, P2553, DOI 10.1001/jama.2013.6822; Mathieu E, 2007, ARCH INTERN MED, V167, P2039, DOI 10.1001/archinte.167.19.2039; Mathieu E, 2010, PATIENT EDUC COUNS, V81, P63, DOI 10.1016/j.pec.2010.01.001; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; National Cancer Institute, 2012, MAMM; National Cancer Institute (NCI), SEER STAT SOFTW VERS; National Cancer Institute (NCI), DEVCAN PROB DEV DYIN; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; National Health Service (NHS), WHAT DOES NHS BREAST; Nekhlyudov L, 2009, J WOMENS HEALTH, V18, P1403, DOI 10.1089/jwh.2008.1184; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Rimer BK, 2002, AM J PREV MED, V22, P247, DOI 10.1016/S0749-3797(02)00417-8; Schonberg MA, 2014, JAMA INTERN MED, V174, P417, DOI 10.1001/jamainternmed.2013.13639; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Schwartz MD, 1999, AM J PUBLIC HEALTH, V89, P924, DOI 10.2105/AJPH.89.6.924; Seigneurin A, 2011, BREAST CANCER RES TR, V127, P221, DOI 10.1007/s10549-010-1118-2; Setz-Pels W, 2013, BRIT J CANCER, V109, P2044, DOI 10.1038/bjc.2013.573; Stoddard AM, 2002, PREV MED, V34, P90, DOI 10.1006/pmed.2001.0960; Tabar L, 2011, RADIOLOGY, V260, P658, DOI 10.1148/radiol.11110469; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; van der Steeg AFW, 2011, BRIT J SURG, V98, P537, DOI 10.1002/bjs.7371; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Welch HG, 2013, NY TIMES; Yabroff K R, 2001, J Am Med Womens Assoc (1972), V56, P166; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	83	286	295	3	67	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1327	1335		10.1001/jama.2014.1398	http://dx.doi.org/10.1001/jama.2014.1398			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE0HU	24691608				2022-12-28	WOS:000333645400016
J	Couch, FJ; Nathanson, KL; Offit, K				Couch, Fergus J.; Nathanson, Katherine L.; Offit, Kenneth			Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention	SCIENCE			English	Editorial Material							GENOME-WIDE ASSOCIATION; EARLY-ONSET BREAST; HIGH FAMILIAL RISK; MUTATION CARRIERS; OVARIAN-CANCER; UNCERTAIN SIGNIFICANCE; GENETIC SUSCEPTIBILITY; SALPINGO-OOPHORECTOMY; CLINICAL-SIGNIFICANCE; ORAL-CONTRACEPTIVES	The cloning of the breast cancer susceptibility genes BRCA1 and BRCA2 nearly two decades ago helped set in motion an avalanche of research exploring how genomic information can be optimally applied to identify and clinically care for individuals with a high risk of developing cancer. Genetic testing for mutations in BRCA1, BRCA2, and other breast cancer susceptibility genes has since proved to be a valuable tool for determining eligibility for enhanced screening and prevention strategies, as well as for identifying patients most likely to benefit from a targeted therapy. Here, we discuss the landscape of inherited mutations and sequence variants in BRCA1 and BRCA2, the complexities of determining disease risk when the pathogenicity of sequence variants is uncertain, and current strategies for clinical management of women who carry BRCA1/2 mutations.	[Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol & Lab Med, Rochester, MN 55905 USA; [Nathanson, Katherine L.] Univ Penn, Div Translat Med & Human Genet, Dept Med, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Canc Biol & Genet Program, Dept Med,Sloan Kettering Inst, New York, NY 10065 USA; [Offit, Kenneth] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Offit, Kenneth] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA	Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Couch, FJ (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol & Lab Med, Rochester, MN 55905 USA.	couch.fergus@mayo.edu			NATIONAL CANCER INSTITUTE [U01CA164947, P50CA116201, R01CA135509, R01CA128978, U01CA116167, P30CA008748, P30CA016520] Funding Source: NIH RePORTER; NCI NIH HHS [CA128978, U01CA164947, R01 CA135509, CA016520, R01 CA128978, 3P30CA008748-47, P30 CA008748, P50 CA116201, R01 CA116167, CA116167, U01 CA116167, U01 CA164947, CA135509, P30 CA016520, CA116201] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Antoniou AC, 2010, CANCER RES, V70, P9742, DOI 10.1158/0008-5472.CAN-10-1907; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Biswas K, 2012, HUM MOL GENET, V21, P3993, DOI 10.1093/hmg/dds222; Bombard Y, 2013, JAMA-J AM MED ASSOC, V310, P795, DOI 10.1001/jama.2013.276573; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bubien V, 2013, J MED GENET, V50, P255, DOI 10.1136/jmedgenet-2012-101339; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Curtin N, 2014, BIOCHEM SOC T, V42, P82, DOI 10.1042/BST20130187; De Lorenzo SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00228; Domchek SM, 2013, J CLIN ONCOL, V31, P1267, DOI 10.1200/JCO.2012.46.9403; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Finch A, 2006, JAMA-J AM MED ASSOC, V296, P185, DOI 10.1001/jama.296.2.185; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Gaudet MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001183; Gayther SA, 1997, AM J HUM GENET, V60, P1239; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Gronwald J, 2006, INT J CANCER, V118, P2281, DOI 10.1002/ijc.21536; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081; Haile RW, 2006, CANCER EPIDEM BIOMAR, V15, P1863, DOI 10.1158/1055-9965.EPI-06-0258; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hall A. E., 2013, J PUBLIC HLTH, V2013; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Hermsen BBJ, 2007, BRIT J CANCER, V96, P1335, DOI 10.1038/sj.bjc.6603725; Iversen ES, 2011, CANCER EPIDEM BIOMAR, V20, P1078, DOI 10.1158/1055-9965.EPI-10-1214; Judkins T, 2012, CANCER-AM CANCER SOC, V118, P5210, DOI 10.1002/cncr.27556; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; King MC, 2014, SCIENCE, V343, P1462, DOI 10.1126/science.1251900; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lehman CD, 2005, CANCER, V103, P1898, DOI 10.1002/cncr.20971; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Maxwell KN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3591; McLaughlin JR, 2007, LANCET ONCOL, V8, P26, DOI 10.1016/S1470-2045(06)70983-4; Metcalfe KA, 2008, INT J CANCER, V122, P2017, DOI 10.1002/ijc.23340; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2002, JNCI-J NATL CANCER I, V94, P1773, DOI 10.1093/jnci/94.23.1773; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 2006, J NATL CANCER I, V98, P1675, DOI 10.1093/jnci/djj500; Offit K, 2011, HUM GENET, V130, P3, DOI 10.1007/s00439-011-1028-3; Offit K, 2010, J CLIN ONCOL, V28, P4665, DOI 10.1200/JCO.2010.31.2926; Olivier RI, 2006, GYNECOL ONCOL, V100, P20, DOI 10.1016/j.ygyno.2005.08.038; Pashayan N, 2013, J INTERN MED, V274, P451, DOI 10.1111/joim.12094; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Purrington KS, 2014, CARCINOGENESIS, V35, P1012, DOI 10.1093/carcin/bgt404; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rebbeck TR, 2011, CANCER RES, V71, P5792, DOI 10.1158/0008-5472.CAN-11-0773; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; Robson ME, 2011, J CLIN ONCOL, V29, P3724, DOI 10.1200/JCO.2011.37.2540; Rosen EM, 2014, CURR DRUG TARGETS, V15, P17, DOI 10.2174/1389450114666140106095432; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Sawyer S, 2012, J CLIN ONCOL, V30, P4330, DOI 10.1200/JCO.2012.41.7469; Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037; Stadler ZK, 2014, J CLIN ONCOL, V32, P687, DOI 10.1200/JCO.2013.49.7271; Stadler ZK, 2010, HEMATOL ONCOL CLIN N, V24, P973, DOI 10.1016/j.hoc.2010.06.009; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Wang XS, 2010, HUM MOL GENET, V19, P2886, DOI 10.1093/hmg/ddq174; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Weitzel JN, 2013, J CLIN ONCOL, V31, P210, DOI 10.1200/JCO.2011.41.0027; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu CC, 2006, CANCER RES, V66, P8287, DOI 10.1158/0008-5472.CAN-05-4247	94	229	236	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1466	1470		10.1126/science.1251827	http://dx.doi.org/10.1126/science.1251827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675953	Green Accepted			2022-12-28	WOS:000333471000036
J	Schwedt, TJ				Schwedt, Todd J.			Chronic migraine	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MEDICATION OVERUSE HEADACHE; QUALITY STANDARDS SUBCOMMITTEE; STATE FUNCTIONAL CONNECTIVITY; PERIPHERAL-NERVE STIMULATION; DEFINING REFRACTORY MIGRAINE; EVIDENCE-BASED GUIDELINES; PLACEBO-CONTROLLED PHASE; EPISODIC MIGRAINE; DOUBLE-BLIND; TRANSFORMED MIGRAINE	Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine. Chronic migraine places an enormous burden on patients owing to frequent headaches; hypersensitivity to visual, auditory, and olfactory stimuli; nausea; and vomiting. It also affects society through direct and indirect medical costs. Chronic migraine typically develops after a slow increase in headache frequency over months to years. Several factors are associated with an increased risk of transforming to chronic migraine. The diagnosis requires a carefully performed patient interview and neurologic examination, sometimes combined with additional diagnostic tests, to differentiate chronic migraine from secondary headache disorders and other primary chronic headaches of long duration. Treatment takes a multifaceted approach that may include risk factor modification, avoidance of migraine triggers, drug and non-drug based prophylaxis, and abortive migraine treatment, the frequency of which is limited to avoid drug overuse. This article provides an overview of current knowledge regarding chronic migraine, including epidemiology, risk factors for its development, pathophysiology, diagnosis, management, and guidelines. The future of chronic migraine treatment and research is also discussed.	Mayo Clin, Phoenix, AZ 85054 USA	Mayo Clinic; Mayo Clinic Phoenix	Schwedt, TJ (corresponding author), Mayo Clin, Phoenix, AZ 85054 USA.	Schwedt.todd@mayo.edu		Schwedt, Todd/0000-0002-7780-7086	Merck	Merck(Merck & Company)	Competing interests: In the past three years I have received personal compensation for consulting from Allergan, Levadex, Pfizer, Supernus, and Zogenix; I have received personal compensation for speaking from Allergan; and I have received research support from Merck.	Andrasik Frank, 2004, Expert Rev Neurother, V4, P403, DOI 10.1586/14737175.4.3.403; Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Aurora SK, 2009, CEPHALALGIA, V29, P597, DOI 10.1111/j.1468-2982.2008.01811.x; Aurora SK, 2007, HEADACHE, V47, P996, DOI 10.1111/j.1526-4610.2007.00853.x; Aurora SK, 2007, HEADACHE, V47, P486, DOI 10.1111/j.1526-4610.2006.00624.x; Aurora SK, 2011, HEADACHE, V51, P1358, DOI 10.1111/j.1526-4610.2011.01990.x; Aurora SK, 2011, CURR PAIN HEADACHE R, V15, P57, DOI 10.1007/s11916-010-0165-z; Aurora SK, 2009, NEUROLOGY, V72, pS8, DOI 10.1212/WNL.0b013e31819749fd; Aurora SK, 2005, HEADACHE, V45, P546, DOI 10.1111/j.1526-4610.2005.05108.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Bigal M, 2008, HEADACHE, V48, P1337, DOI 10.1111/j.1526-4610.2008.01083.x; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Bigal ME, 2008, NEUROLOGY, V71, P559, DOI 10.1212/01.wnl.0000323925.29520.e7; Bigal ME, 2006, NEUROLOGY, V67, P252, DOI 10.1212/01.wnl.0000225052.35019.f9; Bigal Marcelo E, 2007, J Headache Pain, V8, P263, DOI 10.1007/s10194-007-0418-3; Blumenfeld AM, 2011, CEPHALALGIA, V31, P301, DOI 10.1177/0333102410381145; Buse DC, 2010, J NEUROL NEUROSUR PS, V81, P428, DOI 10.1136/jnnp.2009.192492; Buse D, 2012, HEADACHE, V52, P3, DOI 10.1111/j.1526-4610.2011.02046.x; Buse DC, 2012, HEADACHE, V52, P1456, DOI 10.1111/j.1526-4610.2012.02223.x; Bussone G, 2010, NEUROL SCI, V31, P83, DOI 10.1007/s10072-010-0294-5; Calandre EP, 2010, CLIN NEUROPHARMACOL, V33, P35, DOI 10.1097/WNF.0b013e3181bf1dbe; Cecchini AP, 2009, NEUROL SCI, V30, pS101, DOI 10.1007/s10072-009-0073-3; Cernuda-Morollon E, 2013, NEUROLOGY, V81, P1191, DOI 10.1212/WNL.0b013e3182a6cb72; Chen YC, 2012, J HEADACHE PAIN, V13, P311, DOI 10.1007/s10194-012-0447-4; Chepla KJ, 2012, PLAST RECONSTR SURG, V129, p656E, DOI 10.1097/PRS.0b013e3182450b64; Cvetkovic VV, 2012, ACTA CLIN CROAT, V51, P323; D'Amico D, 2008, NEUROL SCI, V29, pS55, DOI 10.1007/s10072-008-0888-3; Davies P, 2012, PAIN, V153, P7, DOI 10.1016/j.pain.2011.10.021; de Tommaso M, 2005, HEADACHE, V45, P1208, DOI 10.1111/j.1526-4610.2005.00244.x; de Tommaso M, 2009, CEPHALALGIA, V29, P453, DOI 10.1111/j.1468-2982.2008.01754.x; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Diener HC, 2012, NAT REV NEUROL, V8, P162, DOI 10.1038/nrneurol.2012.13; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Edvardsson B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-479; Giacomozzi ARE, 2013, ARQ NEURO-PSIQUIAT, V71, P478, DOI 10.1590/0004-282X20130066; Evers S, 1999, CLIN NEUROPHARMACOL, V22, P201; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Guyuron B, 2005, PLAST RECONSTR SURG, V115, P1, DOI 10.1097/01.PRS.0000145631.20901.84; Guyuron B, 2011, PLAST RECONSTR SURG, V127, P603, DOI 10.1097/PRS.0b013e3181fed456; Guyuron B, 2009, PLAST RECONSTR SURG, V124, P461, DOI 10.1097/PRS.0b013e3181adcf6a; Hagen K, 2009, CEPHALALGIA, V29, P221, DOI 10.1111/j.1468-2982.2008.01711.x; Hann S, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.6.FOCUS13233; Hershey AD, 2009, HEADACHE, V49, P170, DOI 10.1111/j.1526-4610.2008.01232.x; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Houle TT, 2013, HEADACHE, V53, P920, DOI 10.1111/head.12125; Houle TT, 2013, HEADACHE, V53, P908, DOI 10.1111/head.12126; Irimia P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-94; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Limmroth V, 2002, NEUROLOGY, V59, P1011, DOI 10.1212/WNL.59.7.1011; Lipton RB, 2013, HEADACHE, V53, P1548, DOI 10.1111/head.12201; Lipton RB, 2013, HEADACHE, V53, P930, DOI 10.1111/head.12128; Lipton RB, 2010, NEUROTHERAPEUTICS, V7, P204, DOI 10.1016/j.nurt.2010.03.002; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Loder E, 2012, HEADACHE, V52, P930, DOI 10.1111/j.1526-4610.2012.02185.x; Louter MA, 2013, BRAIN, V136, P3489, DOI 10.1093/brain/awt251; Magalhaes E, 2010, CLIN NEUROL NEUROSUR, V112, P463, DOI 10.1016/j.clineuro.2010.02.004; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; Manack A, 2011, NEUROLOGY, V76, P711, DOI 10.1212/WNL.0b013e31820d8af2; Martelletti P, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-86; MARTIN NJ, 1990, HEADACHE, V30, P729, DOI 10.1111/j.1526-4610.1990.hed3011729.x; Mathew PG, 2014, HEADACHE, V54, P142, DOI 10.1111/head.12218; Melo-Carrillo A, 2013, CEPHALALGIA, V33, P1096, DOI 10.1177/0333102413486320; Mongini F, 2005, PSYCHIAT RES, V133, P101, DOI 10.1016/j.psychres.2003.12.028; Moulton EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003799; Munakata J, 2009, HEADACHE, V49, P498, DOI 10.1111/j.1526-4610.2009.01369.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Narin SO, 2003, CLIN REHABIL, V17, P624, DOI 10.1191/0269215503cr657oa; Natoli JL, 2010, CEPHALALGIA, V30, P599, DOI 10.1111/j.1468-2982.2009.01941.x; Nestoriuc Y, 2007, PAIN, V128, P111, DOI 10.1016/j.pain.2006.09.007; Oh MY, 2004, NEUROMODULATION, V7, P103, DOI 10.1111/j.1094-7159.2004.04014.x; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Pascual-Gomez J, 2008, REV NEUROLOGIA, V47, P449, DOI 10.33588/rn.4709.2008503; Peterlin BL, 2008, HEADACHE, V48, P805, DOI 10.1111/j.1526-4610.2008.01142.x; Pistoia F, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0304-9; Popeney CA, 2003, HEADACHE, V43, P369, DOI 10.1046/j.1526-4610.2003.03072.x; Pringsheim T, 2012, CAN J NEUROL SCI, V39, pS1; Pryse-Phillips WEM, 1998, CAN MED ASSOC J, V159, P47; Pusic AD, 2011, JOVE-J VIS EXP, DOI 10.3791/2910; Rapoport AM, 2012, NEUROL SCI, V33, pS119, DOI 10.1007/s10072-012-1056-3; Ravishankar K, 2011, ANN INDIAN ACAD NEUR, V14, pS40, DOI 10.4103/0972-2327.83100; Reed KL, 2010, CEPHALALGIA, V30, P260, DOI 10.1111/j.1468-2982.2009.01996.x; Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021; Saper JR, 2011, CEPHALALGIA, V31, P271, DOI 10.1177/0333102410381142; Saper JR, 2002, HEADACHE, V42, P470, DOI 10.1046/j.1526-4610.2002.02122.x; Sarchielli P, 2012, J HEADACHE PAIN, V13, pS31, DOI 10.1007/s10194-012-0437-6; SCHARFF L, 1995, HEADACHE, V35, P527, DOI 10.1111/j.1526-4610.1995.hed3509527.x; Scher AI, 2008, CEPHALALGIA, V28, P868, DOI 10.1111/j.1468-2982.2008.01634.x; Scher AI, 2008, HEADACHE, V48, P16, DOI 10.1111/j.1526-4610.2007.00970.x; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Schoenen J, 2013, NEUROLOGY, V80, P697, DOI 10.1212/WNL.0b013e3182825055; Schulman EA, 2008, HEADACHE, V48, P778, DOI 10.1111/j.1526-4610.2008.01132.x; Schulman EA, 2009, HEADACHE, V49, P509, DOI 10.1111/j.1526-4610.2009.01370.x; Schwedt TJ, 2007, CEPHALALGIA, V27, P153, DOI 10.1111/j.1468-2982.2007.01272.x; Schwedt TJ, 2014, PAIN MED, V15, P154, DOI 10.1111/pme.12267; Schwedt TJ, 2013, HEADACHE, V53, P737, DOI 10.1111/head.12081; Silberstein S, 2008, CEPHALALGIA, V28, P484, DOI 10.1111/j.1468-2982.2008.01555.x; Silberstein SD, 2013, CLIN PHARMACOL THER, V93, P78, DOI 10.1038/clpt.2012.198; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Silberstein SD, 2012, NEUROLOGY, V78, P976, DOI 10.1212/WNL.0b013e31824d5846; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2007, HEADACHE, V47, P170, DOI 10.1111/j.1526-4610.2006.00684.x; Silberstein SD, 2012, CEPHALALGIA, V32, P1165, DOI 10.1177/0333102412462642; Silvestrini M, 2003, CEPHALALGIA, V23, P820, DOI 10.1046/j.1468-2982.2003.00592.x; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Spira PJ, 2003, NEUROLOGY, V61, P1753, DOI 10.1212/01.WNL.0000100121.58594.11; Starling AJ, 2011, NEUROLOGIST, V17, P297, DOI 10.1097/NRL.0b013e31822d109c; Stewart WF, 2010, J OCCUP ENVIRON MED, V52, P8, DOI 10.1097/JOM.0b013e3181c1dc56; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Stokes M, 2011, HEADACHE, V51, P1058, DOI 10.1111/j.1526-4610.2011.01945.x; Stovner LJ, 2008, J HEADACHE PAIN, V9, P139, DOI 10.1007/s10194-008-0038-6; Straube A, 2012, NERVENARZT, V83, P1600, DOI 10.1007/s00115-012-3680-9; Stucky NL, 2011, HEADACHE, V51, P674, DOI 10.1111/j.1526-4610.2011.01882.x; Teepker M, 2010, CEPHALALGIA, V30, P137, DOI 10.1111/j.1468-2982.2009.01911.x; Teixeira AL, 2012, J HEADACHE PAIN, V13, P551, DOI 10.1007/s10194-012-0480-3; Tepper SJ, 2009, HEADACHE, V49, P983, DOI 10.1111/j.1526-4610.2009.01451.x; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Treatment Guideline Subcommittee of the Taiwan Headache Society, 2008, Acta Neurol Taiwan, V17, P132; Turner DP, 2013, HEADACHE, V53, P901, DOI 10.1111/head.12127; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Varkey E, 2011, CEPHALALGIA, V31, P1428, DOI 10.1177/0333102411419681; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.x; Welch KMA, 2002, CURR OPIN NEUROL, V15, P287, DOI 10.1097/00019052-200206000-00011; Yang CP, 2011, CEPHALALGIA, V31, P1510, DOI 10.1177/0333102411420585; Yurekli VA, 2008, J HEADACHE PAIN, V9, P37, DOI 10.1007/s10194-008-0002-5; Zeeberg P, 2006, CEPHALALGIA, V26, P1192, DOI 10.1111/j.1468-2982.2006.01190.x	128	144	149	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2014	348								g1416	10.1136/bmj.g1416	http://dx.doi.org/10.1136/bmj.g1416			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9KZ	24662044				2022-12-28	WOS:000333585300002
J	Greer, JR				Greer, Julia R.			Nanoframe Catalysts	SCIENCE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Greer, JR (corresponding author), CALTECH, 1200 East Calif Blvd MC 309-81, Pasadena, CA 91125 USA.	jrgreer@caltech.edu						Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Ferreira PJ, 2005, J ELECTROCHEM SOC, V152, pA2256, DOI 10.1149/1.2050347; Greer JR, 2011, PROG MATER SCI, V56, P654, DOI 10.1016/j.pmatsci.2011.01.005; Jang DC, 2013, NAT MATER, V12, P893, DOI [10.1038/NMAT3738, 10.1038/nmat3738]; Johnson SA, 1999, SCIENCE, V283, P963, DOI 10.1126/science.283.5404.963; Montemayor LC, 2014, ADV ENG MATER, V16, P184, DOI 10.1002/adem.201300254	7	19	19	4	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1319	1320		10.1126/science.1251865	http://dx.doi.org/10.1126/science.1251865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653024				2022-12-28	WOS:000333108500022
J	Juttler, E; Unterberg, A; Woitzik, J; Bosel, J; Amiri, H; Sakowitz, OW; Gondan, M; Schiller, P; Limprecht, R; Luntz, S; Schneider, H; Pinzer, T; Hobohm, C; Meixensberger, J; Hacke, W				Juettler, Eric; Unterberg, Andreas; Woitzik, Johannes; Boesel, Julian; Amiri, Hemasse; Sakowitz, Oliver W.; Gondan, Matthias; Schiller, Petra; Limprecht, Ronald; Luntz, Steffen; Schneider, Hauke; Pinzer, Thomas; Hobohm, Carsten; Meixensberger, Juergen; Hacke, Werner		DESTINY II Investigators	Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; DECOMPRESSIVE SURGERY; TERRITORY INFARCTION; MALIGNANT INFARCTION; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; HEMISPHERIC INFARCTION; ELDERLY-PATIENTS; CONTROLLED-TRIAL; ISCHEMIC STROKE	Background Early decompressive hemicraniectomy reduces mortality without increasing the risk of very severe disability among patients 60 years of age or younger with complete or subtotal space-occupying middle-cerebral-artery infarction. Its benefit in older patients is uncertain. Methods We randomly assigned 112 patients 61 years of age or older (median, 70 years; range, 61 to 82) with malignant middle-cerebral-artery infarction to either conservative treatment in the intensive care unit (the control group) or hemicraniectomy (the hemicraniectomy group); assignments were made within 48 hours after the onset of symptoms. The primary end point was survival without severe disability (defined by a score of 0 to 4 on the modified Rankin scale, which ranges from 0 [no symptoms] to 6 [death]) 6 months after randomization. Results Hemicraniectomy improved the primary outcome; the proportion of patients who survived without severe disability was 38% in the hemicraniectomy group, as compared with 18% in the control group (odds ratio, 2.91; 95% confidence interval, 1.06 to 7.49; P = 0.04). This difference resulted from lower mortality in the surgery group (33% vs. 70%). No patients had a modified Rankin scale score of 0 to 2 (survival with no disability or slight disability); 7% of patients in the surgery group and 3% of patients in the control group had a score of 3 (moderate disability); 32% and 15%, respectively, had a score of 4 (moderately severe disability [requirement for assistance with most bodily needs]); and 28% and 13%, respectively, had a score of 5 (severe disability). Infections were more frequent in the hemicraniectomy group, and herniation was more frequent in the control group. Conclusions Hemicraniectomy increased survival without severe disability among patients 61 years of age or older with a malignant middle-cerebral-artery infarction. The majority of survivors required assistance with most bodily needs.	[Juettler, Eric; Boesel, Julian; Amiri, Hemasse; Hacke, Werner] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Unterberg, Andreas; Sakowitz, Oliver W.] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Gondan, Matthias; Schiller, Petra; Limprecht, Ronald] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Luntz, Steffen] Heidelberg Univ, Coordinat Ctr Clin Trials, Heidelberg, Germany; [Juettler, Eric] Univ Ulm, Dept Neurol, Univ Hosp, D-89069 Ulm, Germany; [Juettler, Eric] Univ Ulm, Dept Neurol, Rehabil Hosp, D-89069 Ulm, Germany; [Juettler, Eric] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Woitzik, Johannes] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Schneider, Hauke] Univ Dresden, Dept Neurol, Dresden, Germany; [Pinzer, Thomas] Univ Dresden, Dept Neurosurg, Dresden, Germany; [Hobohm, Carsten] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany; [Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Technische Universitat Dresden; Leipzig University; Leipzig University	Hacke, W (corresponding author), Heidelberg Univ, Dept Neurol, Neuenheimer Feld 400, Heidelberg, Germany.	werner.hacke@med.uni-heidelberg.de	Schiller, Petra/AGZ-3992-2022; Hacke, Werner/ABE-8661-2020; Nestler, Ulf/D-6503-2014; Hill, Michael D/C-9073-2012	Nestler, Ulf/0000-0002-2963-4344; Hill, Michael D/0000-0002-6269-1543; Gondan, Matthias/0000-0001-9974-0057; Woitzik, Johannes/0000-0002-1865-4606; Schneider, Hauke/0000-0002-9641-0922; Schiller, Petra/0000-0002-9957-1465; Poppert, Holger/0000-0003-2189-7681; Sakowitz, Oliver/0000-0003-3248-6335	Deutsche Forschungsgemeinschaft [JU2764/1-1]; MRC [G0601025] Funding Source: UKRI; Medical Research Council [G0601025] Funding Source: researchfish; National Institute for Health Research [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the Deutsche Forschungsgemeinschaft; DESTINY II Current Controlled Trials number, ISRCTN21702227.); Supported by a grant (JU2764/1-1) from the Deutsche Forschungsgemeinschaft.	Arac A, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0958; Barth M, 2009, J NEUROSURG, V110, P955, DOI 10.3171/2008.2.17670; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Christensen MC, 2009, CEREBROVASC DIS, V27, P353, DOI 10.1159/000202012; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; Committee for Medicinal Products for Human Use (CHMP), 2007, REFL PAP METH ISS CO; Gunzelmann T, 2006, Z GERONTOL GERIATR, V39, P109, DOI 10.1007/s00391-006-0352-z; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Huttner HB, 2007, STROKE, V38, P3084; Intiso D, 2011, BRAIN INJURY, V25, P379, DOI 10.3109/02699052.2011.558046; Juttler E, 2011, STROKE, V42, P843, DOI 10.1161/STROKEAHA.110.603597; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; King JT, 2009, NEUROSURGERY, V65, P565, DOI 10.1227/01.NEU.0000350980.01519.D8; Leonhardt G, 2002, J NEUROL, V249, P1433, DOI 10.1007/s00415-002-0875-1; Lund A, 2012, CLIN REHABIL, V26, P502, DOI 10.1177/0269215511429473; Molina CA, 2011, STROKE, V42, P847, DOI 10.1161/STROKEAHA.110.603613; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; SILVER FL, 1984, STROKE, V15, P492, DOI 10.1161/01.STR.15.3.492; Sprigg N, 2012, J STROKE CEREBROVASC, V21, P587, DOI 10.1016/j.jstrokecerebrovasdis.2011.01.007; Tjahjadi M, 2013, WORLD NEUROSURG, V79, P296, DOI 10.1016/j.wneu.2012.10.009; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van der Worp HB, 2011, STROKE, V42, P845, DOI 10.1161/STROKEAHA.110.603605; van der Worp HB, 2010, NEUROLOGY, V75, P676, DOI 10.1212/WNL.0b013e3181eee521; Weimar C, 2002, STROKE, V33, P2053, DOI 10.1161/01.STR.0000022808.21776.BF; Whitehead J, 1997, PLANNING EVALUATION; Whitehead J, 1997, DESIGN ANAL SEQUENTI; WOODROOFE M, 1992, BIOMETRIKA, V79, P347, DOI 10.1093/biomet/79.2.347; Yao Y, 2005, SURG NEUROL, V64, P165, DOI 10.1016/j.surneu.2004.10.021	38	334	348	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1091	1100		10.1056/NEJMoa1311367	http://dx.doi.org/10.1056/NEJMoa1311367			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645942				2022-12-28	WOS:000333054000005
J	Spence, D				Spence, Des			FROM THE FRONTLINE The lives of others	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2014	348								g2209	10.1136/bmj.g2209	http://dx.doi.org/10.1136/bmj.g2209			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6YD	24638059				2022-12-28	WOS:000333406500011
J	Condon, MA; Scheffer, SJ; Lewis, ML; Wharton, R; Adams, DC; Forbes, AA				Condon, Marty A.; Scheffer, Sonja J.; Lewis, Matthew L.; Wharton, Robert; Adams, Dean C.; Forbes, Andrew A.			Lethal Interactions Between Parasites and Prey Increase Niche Diversity in a Tropical Community	SCIENCE			English	Article							HOST-SPECIFICITY; DROSOPHILA; PLANTS	Ecological specialization should minimize niche overlap, yet herbivorous neotropical flies (Blepharoneura) and their lethal parasitic wasps (parasitoids) exhibit both extreme specialization and apparent niche overlap in host plants. From just two plant species at one site in Peru, we collected 3636 flowers yielding 1478 fly pupae representing 14 Blepharoneura fly species, 18 parasitoid species (14 Bellopius species), and parasitoid-host associations, all discovered through analysis of molecular data. Multiple sympatric species specialize on the same sex flowers of the same fly host-plant species-which suggests extreme niche overlap; however, niche partitioning was exposed by interactions between wasps and flies. Most Bellopius species emerged as adults from only one fly species, yet evidence from pupae (preadult emergence samples) show that most Bellopius also attacked additional fly species but never emerged as adults from those flies.	[Condon, Marty A.] Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA; [Scheffer, Sonja J.; Lewis, Matthew L.] USDA ARS, Systemat Entomol Lab, Beltsville, MD 20705 USA; [Wharton, Robert] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Adams, Dean C.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Adams, Dean C.] Univ Iowa, Dept Stat, Ames, IA 50011 USA; [Forbes, Andrew A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Cornell University; Smithsonian Institution; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Iowa State University; University of Iowa; University of Iowa	Condon, MA (corresponding author), Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA.	mcondon@cornellcollege.edu		Dean, Adams/0000-0001-9172-7894; Forbes, Andrew/0000-0001-8332-6652	NSF [0919027]; NSF ROA [1145355]; University of Iowa;  [NSF-0330845];  [0949361]; Direct For Biological Sciences [0949361] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF ROA(National Science Foundation (NSF)); University of Iowa; ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NSF-0330845, 0949361 to M.A.C; NSF 0919027 to R.W.; NSF ROA (1145355), University of Iowa to A.A.F. Data are available in supplementary materials and archived at National Center for Biotechnology Information, NIH, GenBank (accession numbers: KF473465 to KF475237). The Institute Nacional de Recursos Naturales-Intendencia Forestal y de Fauna Silvestre del Peru authorized collections (autorizacion no. 110-2008-INRENA-IFFS-DCB) and exportation of specimens (permiso no 011832-AG-INRENA). T. Litwak assisted with illustrations. The authors declare no conflicts of interest. USDA is an equal opportunity provider and employer.	[Anonymous], 1861, ORIGIN SPECIES MEANS; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Chase J.M., 2009, ECOLOGICAL NICHES LI; Condon MA, 2008, SCIENCE, V320, P928, DOI 10.1126/science.1155832; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Forbes AA, 2009, SCIENCE, V323, P776, DOI 10.1126/science.1166981; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Mohamed SA, 2003, BIOL CONTROL, V28, P155, DOI 10.1016/S1049-9644(03)00099-9; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Singer MS, 2005, ECOL LETT, V8, P1247, DOI 10.1111/j.1461-0248.2005.00835.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Strong D., 1984, INSECTS PLANTS COMMU; Thompson J.N., 2005, INTERSPEC INTERACT; Veijalainen A, 2012, P ROY SOC B-BIOL SCI, V279, P4694, DOI 10.1098/rspb.2012.1664; Wilson EO, 1999, DIVERSITY LIFE	20	50	52	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1240	1244		10.1126/science.1245007	http://dx.doi.org/10.1126/science.1245007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626926				2022-12-28	WOS:000332728500034
J	Haldar, M; Kohyama, M; So, AYL; Wumesh, KC; Wu, XD; Briseno, CG; Satpathy, AT; Kretzer, NM; Arase, H; Rajasekaran, NS; Wang, L; Egawa, T; Igarashi, K; Baltimore, D; Murphy, TL; Murphy, KM				Haldar, Malay; Kohyama, Masako; So, Alex Yick-Lun; Wumesh, K. C.; Wu, Xiaodi; Briseno, Carlos G.; Satpathy, Ansuman T.; Kretzer, Nicole M.; Arase, Hisashi; Rajasekaran, Namakkal S.; Wang, Li; Egawa, Takeshi; Igarashi, Kazuhiko; Baltimore, David; Murphy, Theresa L.; Murphy, Kenneth M.			Heme-Mediated SPI-C Induction Promotes Monocyte Differentiation into Iron-Recycling Macrophages	CELL			English	Article							COLONY-STIMULATING FACTOR; HEMOLYTIC-ANEMIA; GENE-EXPRESSION; DENDRITIC CELLS; MYELOID CELLS; BACH1; HOMEOSTASIS; MOUSE; TRANSCRIPTION; RECEPTOR	Splenic red pulp macrophages (RPM) degrade senescent erythrocytes and recycle heme-associated iron. The transcription factor SPI-C is selectively expressed by RPM and is required for their development, but the physiologic stimulus inducing Spic is unknown. Here, we report that Spic also regulated the development of F4/80(+)VCAM1(+) bone marrow macrophages (BMM) and that Spic expression in BMM and RPM development was induced by heme, a metabolite of erythrocyte degradation. Pathologic hemolysis induced loss of RPM and BMM due to excess heme but induced Spic in monocytes to generate new RPM and BMM. Spic expression in monocytes was constitutively inhibited by the transcriptional repressor BACH1. Heme induced proteasome-dependent BACH1 degradation and rapid Spic derepression. Furthermore, cysteine-proline dipeptide motifs in BACH1 that mediate hemedependent degradation were necessary for Spic induction by heme. These findings are the first example of metabolite-driven differentiation of a tissue-resident macrophage subset and provide new insights into iron homeostasis.	[Haldar, Malay; Wumesh, K. C.; Wu, Xiaodi; Briseno, Carlos G.; Satpathy, Ansuman T.; Kretzer, Nicole M.; Egawa, Takeshi; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kohyama, Masako; Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochemi, Suita, Osaka 5650871, Japan; [So, Alex Yick-Lun; Baltimore, David] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Rajasekaran, Namakkal S.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Div Cardiol & Pulm, Salt Lake City, UT 84132 USA; [Wang, Li] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Div Gastroenterol, Salt Lake City, UT 84132 USA; [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Osaka University; California Institute of Technology; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Tohoku University; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Arase, Hisashi/C-8442-2009	Arase, Hisashi/0000-0002-1153-3166; Igarashi, Kazuhiko/0000-0002-2470-2475; Satpathy, Ansuman/0000-0002-5167-537X; Briseno, Carlos/0000-0002-4159-3864	Howard Hughes Medical Institute; Department of Defence [W81XWH-09-1-0185]; National Institutes of Health [AI076427-02, T32 CA 9547-27, 1K08AI106953, K99HL118754, 5R01AI093531]; Physician Scientist Training Program in the Department of Pathology and Immunology at the Washington University School of Medicine; American Heart Association [12PRE8610005, 12PRE12050419]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL118754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI106953, T32AI007163, R01AI076427, R01AI093531, R01AI097244] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25670143] Funding Source: KAKEN	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Defence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Physician Scientist Training Program in the Department of Pathology and Immunology at the Washington University School of Medicine; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Howard Hughes Medical Institute (K.M.M.), Department of Defence (W81XWH-09-1-0185 to K.M.M.), National Institutes of Health (AI076427-02 to K.M.M., T32 CA 9547-27 to M.H., 1K08AI106953 to M. H., K99HL118754 to A.Y.-L.S., and 5R01AI093531 to D.B.), the Physician Scientist Training Program in the Department of Pathology and Immunology at the Washington University School of Medicine (M. H.), and the American Heart Association (12PRE8610005 to A.T.S. and 12PRE12050419 to W.K.).	Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Beaumont C, 2009, SEMIN HEMATOL, V46, P328, DOI 10.1053/j.seminhematol.2009.06.004; Bemark M, 1999, J BIOL CHEM, V274, P10259, DOI 10.1074/jbc.274.15.10259; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; Carlsson R, 2002, GENE, V299, P271, DOI 10.1016/S0378-1119(02)01078-8; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Delaby C, 2008, BIOCHEM J, V411, P123, DOI 10.1042/BJ20071474; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guillaud C, 2012, EXPERT REV HEMATOL, V5, P229, DOI [10.1586/ehm.12.3, 10.1586/EHM.12.3]; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; ITANO HA, 1975, NATURE, V256, P665, DOI 10.1038/256665a0; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schulz S, 2012, PEDIATR RES, V72, P161, DOI 10.1038/pr.2012.62; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; VANPUTTEN LM, 1958, BLOOD, V13, P789, DOI 10.1182/blood.V13.8.789.789; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	44	261	266	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1223	1234		10.1016/j.cell.2014.01.069	http://dx.doi.org/10.1016/j.cell.2014.01.069			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630724	Green Accepted, Bronze			2022-12-28	WOS:000332945100012
J	Schauer, PR; Bhatt, DL; Kirwan, JP; Wolski, K; Brethauer, SA; Navaneethan, SD; Aminian, A; Pothier, CE; Kim, ESH; Nissen, SE; Kashyap, SR				Schauer, Philip R.; Bhatt, Deepak L.; Kirwan, John P.; Wolski, Kathy; Brethauer, Stacy A.; Navaneethan, Sankar D.; Aminian, Ali; Pothier, Claire E.; Kim, Esther S. H.; Nissen, Steven E.; Kashyap, Sangeeta R.		STAMPEDE Investigators	Bariatric Surgery versus Intensive Medical Therapy for Diabetes-3-Year Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC BYPASS-SURGERY; AMERICAN SOCIETY; MANAGEMENT; RISK	BACKGROUND In short-term randomized trials (duration, 1 to 2 years), bariatric surgery has been associated with improvement in type 2 diabetes mellitus. METHODS We assessed outcomes 3 years after the randomization of 150 obese patients with uncontrolled type 2 diabetes to receive either intensive medical therapy alone or intensive medical therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy. The primary end point was a glycated hemoglobin level of 6.0% or less. RESULTS The mean (+/- SD) age of the patients at baseline was 48 +/- 8 years, 68% were women, the mean baseline glycated hemoglobin level was 9.3 +/- 1.5%, and the mean baseline body-mass index (the weight in kilograms divided by the square of the height in meters) was 36.0 +/- 3.5. A total of 91% of the patients completed 36 months of follow-up. At 3 years, the criterion for the primary end point was met by 5% of the patients in the medical-therapy group, as compared with 38% of those in the gastric-bypass group (P<0.001) and 24% of those in the sleeve-gastrectomy group (P = 0.01). The use of glucose-lowering medications, including insulin, was lower in the surgical groups than in the medical-therapy group. Patients in the surgical groups had greater mean percentage reductions in weight from baseline, with reductions of 24.5 +/- 9.1% in the gastric-bypass group and 21.1 +/- 8.9% in the sleeve-gastrectomy group, as compared with a reduction of 4.2 +/- 8.3% in the medical-therapy group (P<0.001 for both comparisons). Quality-of-life measures were significantly better in the two surgical groups than in the medical-therapy group. There were no major late surgical complications. CONCLUSIONS Among obese patients with uncontrolled type 2 diabetes, 3 years of intensive medical therapy plus bariatric surgery resulted in glycemic control in significantly more patients than did medical therapy alone. Analyses of secondary end points, including body weight, use of glucose-lowering medications, and quality of life, also showed favorable results at 3 years in the surgical groups, as compared with the group receiving medical therapy alone.	[Schauer, Philip R.; Brethauer, Stacy A.; Aminian, Ali] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44195 USA; [Kirwan, John P.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Wolski, Kathy; Pothier, Claire E.; Kim, Esther S. H.; Nissen, Steven E.] Cleveland Clin, Inst Heart & Vasc, Cleveland, OH 44195 USA; [Navaneethan, Sankar D.] Cleveland Clin, Urol & Kidney Inst, Cleveland, OH 44195 USA; [Kashyap, Sangeeta R.] Cleveland Clin, Inst Endocrinol, Cleveland, OH 44195 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schauer, PR (corresponding author), Cleveland Clin, Bariatr & Metab Inst, M61,9500 Euclid Ave, Cleveland, OH 44195 USA.	schauep@ccf.org	Kirwan, John P/G-6942-2012	Schauer, Philip/0000-0002-4029-7537; Kashyap, Sangeeta/0000-0002-7489-6650	Ethicon [EES IIS 19900]; Investigator-Initiated Study Program of LifeScan; Cleveland Clinic; National Institutes of Health [R01 DK089547]; Novo Nordisk; Eli Lilly; Nestle; Global Academy for Medical Education; Surgiquest; Barosense; RemedyMD; SE Healthcare Quality Consulting; Stryker; Medscape Cardiology; Amarin; AstraZeneca; Bristol-Myers Squibb; Eisai; Ethicon; Medtronic; Sanofi-Aventis; Medicines Company; FlowCo; PLx Pharma; Roche; Takeda; International Life Sciences Institute; GE; Philips; Anthera; Amgen; Karo Bio; Pfizer; Novartis; Resverlogix; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089547] Funding Source: NIH RePORTER	Ethicon; Investigator-Initiated Study Program of LifeScan; Cleveland Clinic; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk(Novo Nordisk); Eli Lilly(Eli Lilly); Nestle(Nestle SA); Global Academy for Medical Education; Surgiquest; Barosense; RemedyMD; SE Healthcare Quality Consulting; Stryker; Medscape Cardiology; Amarin; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Ethicon; Medtronic(Medtronic); Sanofi-Aventis(Sanofi-Aventis); Medicines Company; FlowCo; PLx Pharma; Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); International Life Sciences Institute; GE; Philips; Anthera; Amgen(Amgen); Karo Bio; Pfizer(Pfizer); Novartis(Novartis); Resverlogix; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from Ethicon (EES IIS 19900), the Investigator-Initiated Study Program of LifeScan, the Cleveland Clinic, and the National Institutes of Health (R01 DK089547).; Dr. Schauer reports receiving consulting fees from Ethicon and Novo Nordisk, lecture fees from Ethicon, Eli Lilly, Nestle, and Global Academy for Medical Education, fees for board membership and stock options or equity from Surgiquest, Barosense, RemedyMD, and SE Healthcare Quality Consulting, fees for providing expert testimony from Physicians Review of Surgery regarding complications of surgery, and financial support for a fellowship program from Stryker and having a pending patent application with the Cleveland Clinic regarding medical devices for weight loss; Dr. Bhatt, receiving consulting fees from Medscape Cardiology, receiving honoraria for serving on a steering committee from WebMD, having a pending consulting relationship with Regado Biosciences, and receiving grant support from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi-Aventis, the Medicines Company, FlowCo, PLx Pharma, Roche, and Takeda; Dr. Kirwan, receiving grant support from Nestle, lecture fees from Eli Lilly, Novo Nordisk, and International Life Sciences Institute, and honoraria from Cereal Partners Worldwide; Dr. Kim, receiving grant support from GE and consulting fees from Philips; Dr. Nissen, receiving grant support through his institution from AstraZeneca, Anthera, Amgen, Karo Bio, Pfizer, the Medicines Company, Novartis, Takeda, Resverlogix, Ethicon, Orexigen, Vivus, and Eli Lilly; and Dr. Kashyap, receiving consulting fees from Ethicon. No other potential conflict of interest relevant to this article was reported.	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Brethauer SA, 2013, ANN SURG, V258, P628, DOI 10.1097/SLA.0b013e3182a5034b; Cohen RV, 2012, DIABETES CARE, V35, P1420, DOI 10.2337/dc11-2289; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Iaconelli A, 2011, DIABETES CARE, V34, P561, DOI 10.2337/dc10-1761; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Jesudason DR, 2012, INT J OBESITY, V36, P1421, DOI 10.1038/ijo.2011.242; Kashyap SR, 2010, DIABETES OBES METAB, V12, P833; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Kashyap SR, 2010, DIABETES OBES METAB, V12, P452, DOI 10.1111/j.1463-1326.2009.01172.x; Liang ZW, 2013, DIABETES RES CLIN PR, V101, P50, DOI 10.1016/j.diabres.2013.04.005; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P376; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Vest AR, 2012, HEART, V98, P1763, DOI 10.1136/heartjnl-2012-301778	26	1095	1143	5	105	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					2002	2013		10.1056/NEJMoa1401329	http://dx.doi.org/10.1056/NEJMoa1401329			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24679060	Bronze, Green Accepted			2022-12-28	WOS:000336125500008
J	Shaw, AT; Engelman, JA				Shaw, Alice T.; Engelman, Jeffrey A.			Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Shaw, Alice T.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Shaw, AT (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	ashaw1@partners.org	De Pas, tommaso/K-4879-2018; Santoro, Armando/J-9594-2018; Vansteenkiste, Johan F/B-8191-2014; Riely, Gregory/AAF-4300-2019; Kim, Dong-Wan/J-5391-2012; Camidge, David Ross/AAG-9144-2019; FELIP, ENRIQUETA/AAG-6316-2019	Santoro, Armando/0000-0003-1709-9492; Vansteenkiste, Johan F/0000-0002-6721-2775; Solomon, Benjamin/0000-0003-3059-5730; Balmana, Judith/0000-0002-0762-6415; Liu, Geoffrey/0000-0002-2603-7296; FELIP, ENRIQUETA/0000-0002-7620-0098	NCI NIH HHS [5R01CA164273, R01 CA164273] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2014, ZYK PACK INS; Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; Friboulet L, 2014, CANCER DISCOV, DOI [10.1056/NEJMc1404894, DOI 10.1056/NEJMC1404894]; Marsilje TH, 2013, J MED CHEM, V56, P5675, DOI 10.1021/jm400402q	4	1146	1219	8	161	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2537	2539		10.1056/NEJMoa1311107	http://dx.doi.org/10.1056/NEJMoa1311107			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963575	Green Accepted			2022-12-28	WOS:000337804400016
J	Shaw, AT; Kim, DW; Mehra, R; Tan, DSW; Felip, E; Chow, LQM; Camidge, DR; Vansteenkiste, J; Sharma, S; De Pas, T; Riely, GJ; Solomon, BJ; Wolf, J; Thomas, M; Schuler, M; Liu, G; Santoro, A; Lau, YY; Goldwasser, M; Boral, AL; Engelman, JA				Shaw, Alice T.; Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S. W.; Felip, Enriqueta; Chow, Laura Q. M.; Camidge, D. Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J.; Solomon, Benjamin J.; Wolf, Juergen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Lau, Yvonne Y.; Goldwasser, Meredith; Boral, Anthony L.; Engelman, Jeffrey A.			Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EML4-ALK FUSION GENE; KINASE INHIBITOR; ACQUIRED-RESISTANCE; CLINICAL RESISTANCE; MUTATION; EGFR; CRIZOTINIB; GEFITINIB; STI-571; TRIALS	BackgroundNon-small-cell lung cancer (NSCLC) harboring the anaplastic lymphoma kinase gene (ALK) rearrangement is sensitive to the ALK inhibitor crizotinib, but resistance invariably develops. Ceritinib (LDK378) is a new ALK inhibitor that has shown greater antitumor potency than crizotinib in preclinical studies. MethodsIn this phase 1 study, we administered oral ceritinib in doses of 50 to 750 mg once daily to patients with advanced cancers harboring genetic alterations in ALK. In an expansion phase of the study, patients received the maximum tolerated dose. Patients were assessed to determine the safety, pharmacokinetic properties, and antitumor activity of ceritinib. Tumor biopsies were performed before ceritinib treatment to identify resistance mutations in ALK in a group of patients with NSCLC who had had disease progression during treatment with crizotinib. ResultsA total of 59 patients were enrolled in the dose-escalation phase. The maximum tolerated dose of ceritinib was 750 mg once daily; dose-limiting toxic events included diarrhea, vomiting, dehydration, elevated aminotransferase levels, and hypophosphatemia. This phase was followed by an expansion phase, in which an additional 71 patients were treated, for a total of 130 patients overall. Among 114 patients with NSCLC who received at least 400 mg of ceritinib per day, the overall response rate was 58% (95% confidence interval [CI], 48 to 67). Among 80 patients who had received crizotinib previously, the response rate was 56% (95% CI, 45 to 67). Responses were observed in patients with various resistance mutations in ALK and in patients without detectable mutations. Among patients with NSCLC who received at least 400 mg of ceritinib per day, the median progression-free survival was 7.0 months (95% CI, 5.6 to 9.5). ConclusionsCeritinib was highly active in patients with advanced, ALK-rearranged NSCLC, including those who had had disease progression during crizotinib treatment, regardless of the presence of resistance mutations in ALK. (Funded by Novartis Pharmaceuticals and others; ClinicalTrials.gov number, NCT01283516.) Ceritinib is 20 times as potent as crizotinib at inhibiting anaplastic lymphoma kinase (ALK) in vitro. In patients, ceritinib produced antitumor responses in 56% of those who had resistance to crizotinib. Genetic alterations in the anaplastic lymphoma kinase gene (ALK) are implicated in the pathogenesis of several human cancers.(1) ALK can be aberrantly activated by mutation, gene amplification, or chromosomal rearrangement, leading to the expression of a potent oncogenic driver. In non-small-cell lung cancer (NSCLC), ALK rearrangement occurs in approximately 5% of cases.(2)-(8)ALK-rearranged tumors depend on ALK for growth and survival and show marked sensitivity to ALK inhibitors such as crizotinib. Among patients with advanced, ALK-rearranged NSCLC, crizotinib has been associated with response rates of approximately 60% across multiple studies and a median progression-free survival ...	[Shaw, Alice T.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Mehra, Ranee] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Tan, Daniel S. W.] Natl Canc Ctr, Singapore, Singapore; [Tan, Daniel S. W.] Genome Inst Singapore, Singapore, Singapore; [Felip, Enriqueta] Vall dHebron Univ, Barcelona, Spain; [Chow, Laura Q. M.] Univ Washington, Seattle, WA 98195 USA; [Camidge, D. Ross] Univ Colorado, Denver, CO 80202 USA; [Vansteenkiste, Johan] Univ Hosp KU Leuven, Louvain, Belgium; [Sharma, Sunil] Huntsman Canc Inst, Salt Lake City, UT USA; [De Pas, Tommaso] Ist Europeo Oncol, Milan, Italy; [Santoro, Armando] Ist Clin Humanitas, Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Riely, Gregory J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Solomon, Benjamin J.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Wolf, Juergen] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Thomas, Michael] Heidelberg Univ, Thoraxklin, Translat Lung Res Ctr Heidelberg, German Ctr Lung Res, Heidelberg, Germany; [Schuler, Martin] German Canc Consortium, Heidelberg, Germany; [Schuler, Martin] Univ Duisburg Essen, Essen, Germany; [Liu, Geoffrey] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lau, Yvonne Y.; Goldwasser, Meredith; Boral, Anthony L.] Novartis Inst BioMed Res, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Seoul National University (SNU); Seoul National University Hospital; Fox Chase Cancer Center; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Denver; KU Leuven; University Hospital Leuven; Huntsman Cancer Institute; IRCCS European Institute of Oncology (IEO); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Humanitas Research Hospital; Memorial Sloan Kettering Cancer Center; Peter Maccallum Cancer Center; University of Cologne; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Novartis	Shaw, AT (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Yawkey 7B,32 Fruit St, Boston, MA 02114 USA.	ashaw1@mgh.harvard.edu	De Pas, tommaso/K-4879-2018; Santoro, Armando/J-9594-2018; Vansteenkiste, Johan F/B-8191-2014; Riely, Gregory/AAF-4300-2019; Kim, Dong-Wan/J-5391-2012; Camidge, David Ross/AAG-9144-2019; FELIP, ENRIQUETA/AAG-6316-2019	Santoro, Armando/0000-0003-1709-9492; Vansteenkiste, Johan F/0000-0002-6721-2775; Solomon, Benjamin/0000-0003-3059-5730; Balmana, Judith/0000-0002-0762-6415; Liu, Geoffrey/0000-0002-2603-7296; FELIP, ENRIQUETA/0000-0002-7620-0098	Novartis Pharmaceuticals; National Cancer Institute [5R01CA164273]; V Foundation Translational Research Grant; Be a Piece of the Solution; Evan Spirito Memorial Foundation; NCI NIH HHS [5R01CA164273, R01 CA164273] Funding Source: Medline	Novartis Pharmaceuticals(Novartis); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation Translational Research Grant; Be a Piece of the Solution; Evan Spirito Memorial Foundation; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Novartis Pharmaceuticals, by a grant from the National Cancer Institute (5R01CA164273, to Drs. Shaw and Engelman), by a V Foundation Translational Research Grant (to Drs. Shaw and Engelman), by Be a Piece of the Solution, and by the Evan Spirito Memorial Foundation.	Babb J, 1998, STAT MED, V17, P1103, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9; Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Boland JM, 2009, HUM PATHOL, V40, P1152, DOI 10.1016/j.humpath.2009.01.012; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Campbell A, 2010, ANN M AM SOC CLIN ON; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kim DW, 2012, EUR SOC MED ONC ANN; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Li N, 2011, AACR NCI EORTC INT C; Marsilje TH, 2013, J MED CHEM, V56, P5675, DOI 10.1021/jm400402q; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Miller VA, 2012, LANCET ONCOL, V13, pE186; National Comprehensive Cancer Network, 2013, NCCN GUID NONSMALL C; Neuenschwander B, 2008, STAT MED, V27, P2420, DOI 10.1002/sim.3230; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Shaw AT, 2013, ANN M AM SOC CLIN ON; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181	28	1146	1219	8	161	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1189	1197		10.1056/NEJMoa1311107	http://dx.doi.org/10.1056/NEJMoa1311107			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24963575	Green Accepted			2022-12-28	WOS:000333426000006
